Citrus Sinensis ID: 011698

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------48
Protein Sequence
MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPAASFLQRNT
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHcccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEcccccEEEEEEEcccccEEEEEEccccccccccHHHHHHHHHHHHHHccccEEEcccccccccccEEEEEEEccccHHHHHHHHccccccccHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEEccccccccccccccccccccccccHHHHccccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHccccccccccccccHHHHHcccccccccHHHHHccccccccccccccccccccccHHccccccccccccccccccccccccEEEccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccEEEcccccccccccccEEEcccccccccccccccccccccccccccccccccEEccccccEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccEccHHHEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEHHHHHHcccHHHHHHHHHHHcccccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHcEEcccccEEEccccccEEccccEcEcccccccccccHHHHccccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHcccccccccccHHHHHHHHHHccccHHHcccccccccHHHHccHHHccccHHHHHHccccccccccccccccccccccHHcccccccccccccHHHHHHccccEEccccccHccccc
Coil and Loop (DISEMBL)
mvssqlsslngdcagkpflnqlllprgppdalssdyvefdfsdvfgpapvqasieVGGEISyanelvydqpavihsrshslvgpssyvsqslklSKLTLHEAEdslglvegineetqegpnnlSVVDAalgkptghidnlpsenqcvgledfEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSErniltkvdhpfIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLhangimhrdlkpenilldadghvmltdfglakqfdentrsnsmcgtleymspeivlgkghdkaaDWWSVGILLFEMltgqppftggnrQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEAskrlgsgpggsqeikshkWFKMINWKKlearetrpsflpevagkhcVANFEecwtnmplldspvaspkfnenpfkgftyvrpaasflqrnt
Flexible Loop (DISEMBL)
mvssqlsslngdcAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGafakvyqvrrigtseiyamkvmRKDKIMEKNHAEYMKSerniltkvdhpfIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEAskrlgsgpggsqeikshkwFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFtyvrpaasflqrnt
Low Complexity Region (SEG)
MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRqkiqqkiikdkikLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPAASFLQRNT
Disordered region (IsUnstruct)
****************PFLNQLLLPR****ALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSR****************************************************L****GHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSS******************************HKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRP*********
Disordered Region (DISOPRED)
*********************************SDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLV********************************************************************DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLL************PFKGFTYVRPAAS******
Disordered Region (DISEMBL)
*********NGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHS***************LKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASK*********QEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPAASFLQRNT
Disordered Region (DISPRO)
*************AGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINE*****************************NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPA********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPAASFLQRNT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	479	2.2.26 [Sep-21-2011]
Q39030	471	Serine/threonine-protein	yes	no	0.970	0.987	0.686	0.0
P42818	465	Serine/threonine-protein	no	no	0.960	0.989	0.656	1e-173
P28178	479	Protein kinase 2 OS=Dicty	yes	no	0.672	0.672	0.486	3e-91
Q6TJY3	527	Ribosomal protein S6 kina	yes	no	0.672	0.611	0.486	7e-89
Q8BSK8	525	Ribosomal protein S6 kina	yes	no	0.670	0.611	0.487	8e-89
P23443	525	Ribosomal protein S6 kina	yes	no	0.670	0.611	0.487	8e-89
P67998	525	Ribosomal protein S6 kina	yes	no	0.670	0.611	0.487	8e-89
P67999	525	Ribosomal protein S6 kina	yes	no	0.670	0.611	0.487	9e-89
Q8MYF1	456	Probable serine/threonine	no	no	0.670	0.703	0.464	4e-86
Q9UBS0	482	Ribosomal protein S6 kina	no	no	0.728	0.724	0.440	4e-85

>sp|Q39030|KPK2_ARATH Serine/threonine-protein kinase AtPK2/AtPK19 OS=Arabidopsis thaliana GN=ATPK2 PE=1 SV=2

 Score =  671 bits (1732), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/482 (68%), Positives = 382/482 (79%), Gaps = 17/482 (3%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
           MVSSQ S  N +  GKPF   L L   PP ++  D +E  FSDVFGP P   S E     
Sbjct: 1   MVSSQCSVANKNQTGKPFQKHLSLSISPPKSVLGDNLELQFSDVFGPMPEANSEE----- 55

Query: 61  SYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGP 120
             A ++ YD+PAV++SRSHSLVGPS  VS SLK++KLTL E EDS+ LVE +  E+ +  
Sbjct: 56  --ACDVAYDEPAVVYSRSHSLVGPSLVVSHSLKMNKLTLRETEDSVDLVECVEGESIKEN 113

Query: 121 NNLSVVDAALGKPTGHIDNLPSE-NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYA 179
           +  S      G      +  P E +  VG+EDFEVLKVVGQGAF KVYQVR+  TSEIYA
Sbjct: 114 DEFS------GNDDTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQVRKKDTSEIYA 167

Query: 180 MKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF 239
           MKVMRKDKI+EKNHAEYMK+ER+ILTK+DHPFIVQL+YSFQTKYRLYLVLDF+NGGHLFF
Sbjct: 168 MKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFF 227

Query: 240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ 299
           QLY QGLFREDLAR+YTAEIVSAVSHLH  GIMHRDLKPENIL+D DGHVMLTDFGLAK+
Sbjct: 228 QLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDVDGHVMLTDFGLAKE 287

Query: 300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ 359
           F+ENTRSNSMCGT EYM+PEIV GKGHDKAADWWSVGILL+EMLTG+PPF  G++ KIQQ
Sbjct: 288 FEENTRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGKPPFL-GSKGKIQQ 346

Query: 360 KIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEAR 419
           KI+KDKIKLP FLS+EAH+LLKGLLQKE  +RLGSGP G++EIK HKWFK INWKKLEAR
Sbjct: 347 KIVKDKIKLPQFLSNEAHALLKGLLQKEPERRLGSGPSGAEEIKKHKWFKAINWKKLEAR 406

Query: 420 ETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFN--ENPFKGFTYVRPAASFLQR 477
           E +PSF P V+G+ C+ANF++CWT+M +LDSP +SP  +   NPF  FTYVRP  SFL R
Sbjct: 407 EVQPSFKPAVSGRQCIANFDKCWTDMSVLDSPASSPNSDAKANPFTNFTYVRPPHSFLHR 466

Query: 478 NT 479
            T
Sbjct: 467 TT 468

Downstream effector of TOR signaling pathway. May be involved in adaptation of plant to cold or high-salt conditions.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P42818|KPK1_ARATH Serine/threonine-protein kinase AtPK1/AtPK6 OS=Arabidopsis thaliana GN=ATPK1 PE=1 SV=1

 Score =  607 bits (1565), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 316/481 (65%), Positives = 372/481 (77%), Gaps = 21/481 (4%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
           MVSSQ    N          Q  L   P +++  D VE +FSDVFGP P +A        
Sbjct: 1   MVSSQRPVPN------KIQKQQYLSISPSNSVLKDDVELEFSDVFGPLPEEA-------- 46

Query: 61  SYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGP 120
              N++ YD+PAV++SRSHSLVGP S  S SLKL+KLTL E EDS+ LVE +  E+ +  
Sbjct: 47  ---NDIAYDEPAVVYSRSHSLVGPCSLDSHSLKLTKLTLLETEDSIDLVECLEGESLKEN 103

Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           ++ S  D +  +     D L   +  VG++DFEV+KVVG+GAF KVYQVR+  TSEIYAM
Sbjct: 104 DDFSGNDDSDNEKALEGD-LVKVSGVVGIDDFEVMKVVGKGAFGKVYQVRKKETSEIYAM 162

Query: 181 KVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ 240
           KVMRKD IMEKNHAEYMK+ER+ILTK+DHPFIVQL+YSFQTKYRLYLVLDF+NGGHLFFQ
Sbjct: 163 KVMRKDHIMEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQ 222

Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           LY QGLFREDLAR+YTAEIVSAVSHLH  GIMHRDLKPENIL+D DGHVMLTDFGLAK+F
Sbjct: 223 LYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDTDGHVMLTDFGLAKEF 282

Query: 301 DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQK 360
           +ENTRSNSMCGT EYM+PEIV GKGHDKAADWWSVGILL+EMLTG+PPF  G++ KIQQK
Sbjct: 283 EENTRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGKPPFL-GSKGKIQQK 341

Query: 361 IIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARE 420
           I+KDKIKLP FLS+EAH++LKGLLQKE  +RLGSG  G++EIK HKWFK INWKKLEARE
Sbjct: 342 IVKDKIKLPQFLSNEAHAILKGLLQKEPERRLGSGLSGAEEIKQHKWFKGINWKKLEARE 401

Query: 421 TRPSFLPEVAGKHCVANFEECWTNMPLL--DSPVASPKFNENPFKGFTYVRPAASFLQRN 478
             PSF PEV+G+ C+ANF++CWT+M +L   +   S     NPF  FTYVRP  SFL ++
Sbjct: 402 VMPSFKPEVSGRQCIANFDKCWTDMSVLDSPASSPSSDPKANPFTNFTYVRPPPSFLHQS 461

Query: 479 T 479
           T
Sbjct: 462 T 462

Downstream effector of TOR signaling pathway involved in osmotic stress response. Could be involved in the control of plant growth and development. Phosphorylates the ribosomal proteins P14, P16 and S6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28178|PK2_DICDI Protein kinase 2 OS=Dictyostelium discoideum GN=pkgB PE=1 SV=2

 Score =  335 bits (860), Expect = 3e-91,   Method: Compositional matrix adjust.
 Identities = 160/329 (48%), Positives = 222/329 (67%), Gaps = 7/329 (2%)

Query: 145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           Q    +DFE+L V+G+G+F KV QV++ G  +I+AMKV+RKD I+ +    + KSE+ IL
Sbjct: 146 QSATKDDFELLNVIGKGSFGKVMQVKKKGEDKIFAMKVLRKDAIIARKQVNHTKSEKTIL 205

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
             + HPFIV L Y+FQTK +LY+VLDFVNGG LFF L R+G F E   +IY AEIVSA+ 
Sbjct: 206 QCISHPFIVNLHYAFQTKDKLYMVLDFVNGGELFFHLKREGRFSEPRVKIYAAEIVSALD 265

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK 324
           HLH   I++RDLKPENILLD++GH+ +TDFGL+K+ +    + + CGT EY++PE++ G 
Sbjct: 266 HLHKQDIVYRDLKPENILLDSEGHICITDFGLSKKIETTDGTFTFCGTPEYLAPEVLNGH 325

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLL 384
           GH  A DWWS+G LL+EMLTG PPF   N   + QKI+  ++K+P ++S EA SLL+GLL
Sbjct: 326 GHGCAVDWWSLGTLLYEMLTGLPPFYSQNVSTMYQKILNGELKIPTYISPEAKSLLEGLL 385

Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
            +E  KRLG+  GG  E+K H WFK I+W+KL+ +E    F P+V     ++  +  +T 
Sbjct: 386 TREVDKRLGTKGGG--EVKQHPWFKNIDWEKLDRKEVEVHFKPKVKSGTDISQIDPVFTQ 443

Query: 445 MPLLDSPVASPKF-----NENPFKGFTYV 468
              +DS V +         +  F+GFTYV
Sbjct: 444 ERPMDSLVETSALGDAMGKDTSFEGFTYV 472

Required for morphogenesis during multicellular development. Phosphorylates talB, gefN, gefS, PI4P 5-kinase and gacQ.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6TJY3|KS6B1_BOVIN Ribosomal protein S6 kinase beta-1 OS=Bos taurus GN=RPS6KB1 PE=2 SV=1

 Score =  328 bits (840), Expect = 7e-89,   Method: Compositional matrix adjust.
 Identities = 160/329 (48%), Positives = 231/329 (70%), Gaps = 7/329 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 89  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct: 209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLL 384
           GH++A DWWS+G L+++MLTG PPFTG NR+K   KI+K K+ LP +L+ EA  LLK LL
Sbjct: 269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
           ++ A+ RLG+GPG + E+++H +F+ INW++L AR+  P F P +  +  V+ F+  +T 
Sbjct: 329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query: 445 MPLLDSP--VASPKFNENPFKGFTYVRPA 471
              +DSP   A  +     F GFTYV P+
Sbjct: 389 QTPVDSPDDSALSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8BSK8|KS6B1_MOUSE Ribosomal protein S6 kinase beta-1 OS=Mus musculus GN=Rps6kb1 PE=1 SV=2

 Score =  328 bits (840), Expect = 8e-89,   Method: Compositional matrix adjust.
 Identities = 161/330 (48%), Positives = 233/330 (70%), Gaps = 9/330 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 89  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct: 209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLL 384
           GH++A DWWS+G L+++MLTG PPFTG NR+K   KI+K K+ LP +L+ EA  LLK LL
Sbjct: 269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
           ++ A+ RLG+GPG + E+++H +F+ INW++L AR+  P F P +  +  V+ F+  +T 
Sbjct: 329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query: 445 MPLLDSPVASPKFNENP---FKGFTYVRPA 471
              +DSP  S   +E+    F GFTYV P+
Sbjct: 389 QTPVDSPDDS-TLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P23443|KS6B1_HUMAN Ribosomal protein S6 kinase beta-1 OS=Homo sapiens GN=RPS6KB1 PE=1 SV=2

 Score =  328 bits (840), Expect = 8e-89,   Method: Compositional matrix adjust.
 Identities = 161/330 (48%), Positives = 233/330 (70%), Gaps = 9/330 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 89  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct: 209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLL 384
           GH++A DWWS+G L+++MLTG PPFTG NR+K   KI+K K+ LP +L+ EA  LLK LL
Sbjct: 269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
           ++ A+ RLG+GPG + E+++H +F+ INW++L AR+  P F P +  +  V+ F+  +T 
Sbjct: 329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query: 445 MPLLDSPVASPKFNENP---FKGFTYVRPA 471
              +DSP  S   +E+    F GFTYV P+
Sbjct: 389 QTPVDSPDDS-TLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial URI1 leading to dissociation of a URI1-PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P67998|KS6B1_RABIT Ribosomal protein S6 kinase beta-1 OS=Oryctolagus cuniculus GN=RPS6KB1 PE=2 SV=1

 Score =  328 bits (840), Expect = 8e-89,   Method: Compositional matrix adjust.
 Identities = 161/330 (48%), Positives = 233/330 (70%), Gaps = 9/330 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 89  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct: 209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLL 384
           GH++A DWWS+G L+++MLTG PPFTG NR+K   KI+K K+ LP +L+ EA  LLK LL
Sbjct: 269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
           ++ A+ RLG+GPG + E+++H +F+ INW++L AR+  P F P +  +  V+ F+  +T 
Sbjct: 329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query: 445 MPLLDSPVASPKFNENP---FKGFTYVRPA 471
              +DSP  S   +E+    F GFTYV P+
Sbjct: 389 QTPVDSPDDS-TLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P67999|KS6B1_RAT Ribosomal protein S6 kinase beta-1 OS=Rattus norvegicus GN=Rps6kb1 PE=1 SV=1

 Score =  327 bits (839), Expect = 9e-89,   Method: Compositional matrix adjust.
 Identities = 161/330 (48%), Positives = 233/330 (70%), Gaps = 9/330 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 89  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct: 209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLL 384
           GH++A DWWS+G L+++MLTG PPFTG NR+K   KI+K K+ LP +L+ EA  LLK LL
Sbjct: 269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
           ++ A+ RLG+GPG + E+++H +F+ INW++L AR+  P F P +  +  V+ F+  +T 
Sbjct: 329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query: 445 MPLLDSPVASPKFNENP---FKGFTYVRPA 471
              +DSP  S   +E+    F GFTYV P+
Sbjct: 389 QTPVDSPDDS-TLSESANQVFLGFTYVAPS 417

Serine/threonine-protein kinase that acts downstream of mTOR signaling in response to growth factors and nutrients to promote cell proliferation, cell growth and cell cycle progression. Regulates protein synthesis through phosphorylation of EIF4B, RPS6 and EEF2K, and contributes to cell survival by repressing the pro-apoptotic function of BAD. Under conditions of nutrient depletion, the inactive form associates with the EIF3 translation initiation complex. Upon mitogenic stimulation, phosphorylation by the mammalian target of rapamycin complex 1 (mTORC1) leads to dissociation from the EIF3 complex and activation. The active form then phosphorylates and activates several substrates in the preinitiation complex, including the EIF2B complex and the cap-binding complex component EIF4B. Also controls translation initiation by phosphorylating a negative regulator of EIF4A, PDCD4, targeting it for ubiquitination and subsequent proteolysis. Promotes initiation of the pioneer round of protein synthesis by phosphorylating POLDIP3/SKAR. In response to IGF1, activates translation elongation by phosphorylating EEF2 kinase (EEF2K), which leads to its inhibition and thus activation of EEF2. Also plays a role in feedback regulation of mTORC2 by mTORC1 by phosphorylating RICTOR, resulting in the inhibition of mTORC2 and AKT1 signaling. Mediates cell survival by phosphorylating the pro-apoptotic protein BAD and suppressing its pro-apoptotic function. Phosphorylates mitochondrial RMP leading to dissociation of a RMP:PPP1CC complex. The free mitochondrial PPP1CC can then dephosphorylate RPS6KB1 at 'Thr-412', which is proposed to be a negative feedback mechanism for the RPS6KB1 anti-apoptotic function. Mediates TNF-alpha-induced insulin resistance by phosphorylating IRS1 at multiple serine residues, resulting in accelerated degradation of IRS1. In cells lacking functional TSC1-2 complex, constitutively phosphorylates and inhibits GSK3B. May be involved in cytoskeletal rearrangement through binding to neurabin.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8MYF1|Y2070_DICDI Probable serine/threonine-protein kinase DDB_G0277449 OS=Dictyostelium discoideum GN=DDB_G0277449 PE=3 SV=1

 Score =  318 bits (816), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 152/327 (46%), Positives = 217/327 (66%), Gaps = 6/327 (1%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + L +F +  +VG+G F KV+QV  + T ++YA+KV++K+ I+ K       +E++IL K
Sbjct: 123 INLSNFIIKHLVGKGGFGKVFQVVHVDTQKVYALKVIKKNHIIAKKSVVNTLAEKDILKK 182

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           + HPFIV L Y+FQ + +LYLV+DFVNGG LF+ L ++ +F ED  R Y AE++ A+ HL
Sbjct: 183 ISHPFIVNLHYAFQNEKKLYLVMDFVNGGQLFYHLQKEAIFSEDQVRFYMAELILALEHL 242

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAK-QFDENTRSNSMCGTLEYMSPEIVLGKG 325
           H + I+HRDLKPENILLD+ GH +LTDFGLAK +   N  + S  GTLEYM+PE++    
Sbjct: 243 HDSNIVHRDLKPENILLDSQGHCILTDFGLAKLEVKTNNETFSFAGTLEYMAPEMIQHAT 302

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQ 385
             KA DWWS+GIL+++M+ G+PPF   NR  +Q+KII +K K P F+SS A SL+ GLL 
Sbjct: 303 CGKAVDWWSIGILMYDMMIGKPPFEHKNRALMQEKIISEKAKFPKFVSSSARSLINGLLT 362

Query: 386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNM 445
           K+ +KRLG+   G+ EIK H +FK I W+K+E +E  P F+P   G   ++NF+      
Sbjct: 363 KDPTKRLGA--NGAIEIKRHPFFKSIQWRKIENKEITPPFVPSTKGIDDISNFDHASLKA 420

Query: 446 PLLDSPVASPKFNENP---FKGFTYVR 469
              DS   SP  + +    F GF++VR
Sbjct: 421 HQRDSFSTSPTLSSSQQAYFDGFSFVR 447

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9UBS0|KS6B2_HUMAN Ribosomal protein S6 kinase beta-2 OS=Homo sapiens GN=RPS6KB2 PE=1 SV=2

 Score =  315 bits (808), Expect = 4e-85,   Method: Compositional matrix adjust.
 Identities = 160/363 (44%), Positives = 236/363 (65%), Gaps = 14/363 (3%)

Query: 123 LSVVDAALGKPTGHIDNLPSENQCV-------GLEDFEVLKVVGQGAFAKVYQVRRI-GT 174
           L+ + AA  +P GH + +      V       G   FE+L+V+G+G + KV+QVR++ GT
Sbjct: 31  LAELRAAGLEPVGHYEEVELTETSVNVGPERIGPHCFELLRVLGKGGYGKVFQVRKVQGT 90

Query: 175 S--EIYAMKVMRKDKIMEK-NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231
           +  +IYAMKV+RK KI+       + ++ERNIL  V HPFIV+L Y+FQT  +LYL+L+ 
Sbjct: 91  NLGKIYAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQTGGKLYLILEC 150

Query: 232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML 291
           ++GG LF  L R+G+F ED A  Y AEI  A+ HLH+ GI++RDLKPENI+L + GH+ L
Sbjct: 151 LSGGELFTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRDLKPENIMLSSQGHIKL 210

Query: 292 TDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFT 350
           TDFGL K+   E   +++ CGT+EYM+PEI++  GH++A DWWS+G L+++MLTG PPFT
Sbjct: 211 TDFGLCKESIHEGAVTHTFCGTIEYMAPEILVRSGHNRAVDWWSLGALMYDMLTGSPPFT 270

Query: 351 GGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
             NR+K   KII+ K+ LP +L+ +A  L+K  L++  S+R+G GPG + +++ H +F+ 
Sbjct: 271 AENRKKTMDKIIRGKLALPPYLTPDARDLVKKFLKRNPSQRIGGGPGDAADVQRHPFFRH 330

Query: 411 INWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSP--VASPKFNENPFKGFTYV 468
           +NW  L A    P F P +  +  V+ F+  +T    +DSP   A  +     F GFTYV
Sbjct: 331 MNWDDLLAWRVDPPFRPCLQSEEDVSQFDTRFTRQTPVDSPDDTALSESANQAFLGFTYV 390

Query: 469 RPA 471
            P+
Sbjct: 391 APS 393

Phosphorylates specifically ribosomal protein S6.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	479
255575604	481	ribosomal protein S6 kinase, putative [R	0.979	0.975	0.733	0.0
356532147	479	PREDICTED: serine/threonine-protein kina	0.985	0.985	0.739	0.0
225439717	489	PREDICTED: serine/threonine-protein kina	1.0	0.979	0.736	0.0
224139384	475	predicted protein [Populus trichocarpa]	0.981	0.989	0.721	0.0
224087877	475	predicted protein [Populus trichocarpa]	0.981	0.989	0.715	0.0
363806700	479	uncharacterized protein LOC100805922 [Gl	0.983	0.983	0.724	0.0
297735529	446	unnamed protein product [Vitis vinifera]	0.924	0.993	0.728	0.0
115452853	480	Os03g0334000 [Oryza sativa Japonica Grou	0.972	0.970	0.701	0.0
326524133	481	predicted protein [Hordeum vulgare subsp	0.974	0.970	0.693	0.0
356551817	472	PREDICTED: serine/threonine-protein kina	0.962	0.976	0.700	0.0

>gi|255575604|ref|XP_002528702.1| ribosomal protein S6 kinase, putative [Ricinus communis] gi|223531874|gb|EEF33691.1| ribosomal protein S6 kinase, putative [Ricinus communis]

 Score =  723 bits (1865), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/488 (73%), Positives = 406/488 (83%), Gaps = 19/488 (3%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPP--DALSSDYVEFDFSDVFGPAPVQASIEVG- 57
           MVSSQ S L+     KPF +QLL    PP  DAL SD VE DF+DVFGP PVQ S EV  
Sbjct: 1   MVSSQFSELSKAHMCKPFRSQLLFTENPPPPDALVSD-VELDFADVFGPLPVQTSTEVNS 59

Query: 58  GEISY------ANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEG 111
           G+++         EL+YD P VIH+RSHSLVGPSS+VS SLKL+KLTLHE EDS+ L+E 
Sbjct: 60  GDLANPLSGADVTELIYDDPVVIHNRSHSLVGPSSFVSHSLKLNKLTLHETEDSMELLE- 118

Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR 171
           ++E + +  N+    D   G      D L  E + VG+EDFEVLKVVGQGAF KVYQV++
Sbjct: 119 LDESSLDDDNSEKATDDVSG------DAL--EVRSVGIEDFEVLKVVGQGAFGKVYQVKK 170

Query: 172 IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231
            GTSEIYAMKVMRKDKI+EKNH EYMK+ER+ILTKVDHPFIVQL+YSFQTKYRLYL+LDF
Sbjct: 171 KGTSEIYAMKVMRKDKIVEKNHVEYMKAERDILTKVDHPFIVQLKYSFQTKYRLYLILDF 230

Query: 232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML 291
           +NGGHLFFQLY QGLFREDLARIY AEIVSAV HLHANGIMHRDLKPENILLDADGHVML
Sbjct: 231 INGGHLFFQLYHQGLFREDLARIYAAEIVSAVCHLHANGIMHRDLKPENILLDADGHVML 290

Query: 292 TDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           TDFGLAKQFDENTRSNSMCGT+EYM+PEIVLG+GHDKAADWWSVG+LL+EMLTG+PPF G
Sbjct: 291 TDFGLAKQFDENTRSNSMCGTVEYMAPEIVLGRGHDKAADWWSVGVLLYEMLTGKPPFIG 350

Query: 352 GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI 411
           GNR+KIQQKI+KDK+KLPAFLSSEAHSLLKGLLQK+ SKRLG+GP G +EIK HKW K I
Sbjct: 351 GNREKIQQKIVKDKMKLPAFLSSEAHSLLKGLLQKDVSKRLGNGPTGGEEIKRHKWLKPI 410

Query: 412 NWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPA 471
           NWKKL+ARE +PSF P+VAGKHC+ANFE+ WT+MPL DSP ASPK N NPF  F+YVRPA
Sbjct: 411 NWKKLDAREIQPSFRPQVAGKHCIANFEKRWTDMPLSDSPAASPKSNVNPFVNFSYVRPA 470

Query: 472 ASFLQRNT 479
           A FLQ+N+
Sbjct: 471 AFFLQKNS 478

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356532147|ref|XP_003534635.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Glycine max]

 Score =  721 bits (1860), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/483 (73%), Positives = 402/483 (83%), Gaps = 11/483 (2%)

Query: 1   MVSSQLSSLNGDCAG-KPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQAS---IEV 56
           MVSSQ S L    AG KP   QLL P   PD ++++++E DFSDVFGP  V  +      
Sbjct: 1   MVSSQFSGLT--MAGYKPAQTQLLFPANLPDTVNTEHIELDFSDVFGPVTVDLNNIDSTT 58

Query: 57  GGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEET 116
           G  +   NELVYD P VI++RSHSLVGPS+ VSQSLKL KLT+HE EDSL LV+ +N ET
Sbjct: 59  GEPLEEVNELVYDDPPVIYTRSHSLVGPSTCVSQSLKLGKLTIHETEDSLELVDHVNGET 118

Query: 117 QEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE 176
            +   + S VD +L    G++  +    Q V +EDFE+LKVVGQGAFAKVYQVR+ GTSE
Sbjct: 119 IKDIKDSSFVDKSLKDEDGNLKKI----QRVSIEDFEILKVVGQGAFAKVYQVRKKGTSE 174

Query: 177 IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH 236
           IYAMKVMRKDKIMEKNHAEYMK+ER+I TK++HPF+VQLRYSFQTKYRLYLVLDFVNGGH
Sbjct: 175 IYAMKVMRKDKIMEKNHAEYMKAERDIWTKIEHPFVVQLRYSFQTKYRLYLVLDFVNGGH 234

Query: 237 LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL 296
           LFFQLY QGLFREDLARIYTAEIV AVSHLH+NGIMHRDLKPENILLDADGHVMLTDFGL
Sbjct: 235 LFFQLYHQGLFREDLARIYTAEIVCAVSHLHSNGIMHRDLKPENILLDADGHVMLTDFGL 294

Query: 297 AKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK 356
           AKQF+E+TRSNSMCGTLEYM+PEI+LGKGHDKAADWWSVGILLFEMLTG+PPF GGNR K
Sbjct: 295 AKQFEESTRSNSMCGTLEYMAPEIILGKGHDKAADWWSVGILLFEMLTGKPPFCGGNRDK 354

Query: 357 IQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL 416
           IQQKI+KDKIKLPAFLSSEAHSLLKGLLQKE  +RLG GP G +EIKSHKWFK INW+KL
Sbjct: 355 IQQKIVKDKIKLPAFLSSEAHSLLKGLLQKEPGRRLGCGPRGVEEIKSHKWFKPINWRKL 414

Query: 417 EARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPAASFLQ 476
           EARE +PSF PEVAG  CVANFE+ WT+MP++DSP ASP    NPFK F+YVRPAASFLQ
Sbjct: 415 EAREIQPSFRPEVAGVQCVANFEKRWTDMPVVDSPAASPN-GGNPFKDFSYVRPAASFLQ 473

Query: 477 RNT 479
           RN+
Sbjct: 474 RNS 476

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225439717|ref|XP_002273012.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Vitis vinifera]

 Score =  717 bits (1851), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/486 (73%), Positives = 395/486 (81%), Gaps = 7/486 (1%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEV---- 56
           MV S +  L      KP  NQLL P  P D +  D+VE DF+DVFGP PVQ   E+    
Sbjct: 1   MVFSDVPGLTKTRMCKPIQNQLLFPMNPTDIVPLDHVELDFADVFGPLPVQTPSEMNPGD 60

Query: 57  -GGEISYA--NELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGIN 113
            G  +S A  N+L+Y  P VI+SRSHSLVGPS+ +SQSLKLSKL LHE EDS  LVE ++
Sbjct: 61  SGDSVSAADTNDLIYGDPVVIYSRSHSLVGPSTCLSQSLKLSKLALHEIEDSEELVECLH 120

Query: 114 EETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIG 173
           EE  +     S  D    K    ID+  +  + VGLEDFEV+K+VGQGAF KV+QVR+  
Sbjct: 121 EEAVKELQRTSSSDDISEKSFEDIDSDSTTVETVGLEDFEVMKLVGQGAFGKVFQVRKRN 180

Query: 174 TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN 233
           TSEIYAMKVMRKDKIMEK+HAEYMK+ER+ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN
Sbjct: 181 TSEIYAMKVMRKDKIMEKDHAEYMKAERDILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN 240

Query: 234 GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTD 293
           GGHLFFQLY  GLFREDLARIY AEIVSAVSHLHANGIMHRDLKPENILLDADGH MLTD
Sbjct: 241 GGHLFFQLYNHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLDADGHAMLTD 300

Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           FGLAK+FDENTRSNSMCGT+EYMSPEI LGKGHDKAADWWSVGILLFEMLTG+PPF GGN
Sbjct: 301 FGLAKEFDENTRSNSMCGTVEYMSPEIFLGKGHDKAADWWSVGILLFEMLTGKPPFIGGN 360

Query: 354 RQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW 413
           RQKIQQKIIKDKIKLPAFLSS+AHS+LKGLLQK+ SKRLGSGP G  EIK HKWFK INW
Sbjct: 361 RQKIQQKIIKDKIKLPAFLSSDAHSVLKGLLQKDPSKRLGSGPLGIDEIKHHKWFKPINW 420

Query: 414 KKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPAAS 473
           +KLEARE +PSF PEV GK C+ANFE+ WT+MPL DSP ASPK N N F GFTYVRPAAS
Sbjct: 421 RKLEAREIQPSFRPEVDGKLCIANFEKRWTDMPLADSPAASPKANGNIFTGFTYVRPAAS 480

Query: 474 FLQRNT 479
           FL+RN+
Sbjct: 481 FLRRNS 486

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139384|ref|XP_002323086.1| predicted protein [Populus trichocarpa] gi|222867716|gb|EEF04847.1| predicted protein [Populus trichocarpa]

 Score =  710 bits (1833), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 347/481 (72%), Positives = 393/481 (81%), Gaps = 11/481 (2%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
           MVSSQL  L          N+LL P  P D + SD+VE DF+DVFGP P    +  G  +
Sbjct: 1   MVSSQLPGLTK--------NRLLFPVNPSDTVVSDHVELDFTDVFGPLP-SIDVNCGDPL 51

Query: 61  SYAN--ELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQE 118
           S  +  EL+YD P V+H+RSHSLVGPSSYVSQSLKLSKL L E EDSL LVE + +ET +
Sbjct: 52  SVGDGSELIYDDPVVVHNRSHSLVGPSSYVSQSLKLSKLNLQETEDSLELVECVLDETIK 111

Query: 119 GPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY 178
                 + D A+ K    +    S+ Q VG+EDFEVLKVVGQGAF KVYQVR+ GT EIY
Sbjct: 112 ELEESFIDDDAVEKDMEDVSGDTSKVQTVGIEDFEVLKVVGQGAFGKVYQVRKKGTPEIY 171

Query: 179 AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF 238
           AMKVMRKD+I+EKNH EYM+ ER+ILTK+DHPFIVQL+YSFQTKYRLYLVLDF+NGGHLF
Sbjct: 172 AMKVMRKDRIVEKNHVEYMRGERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLF 231

Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
           FQLY  GLFREDLA IY AEI SAVSHLHANGIMHRDLKPENILLD+DGH MLTDFGLAK
Sbjct: 232 FQLYNHGLFREDLACIYAAEIASAVSHLHANGIMHRDLKPENILLDSDGHAMLTDFGLAK 291

Query: 299 QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ 358
           +FDENTRSNSMCGT+EYM+PEIV GKGHDKAADWWSVGILL+EMLTG+PPF GGNR KIQ
Sbjct: 292 EFDENTRSNSMCGTVEYMAPEIVQGKGHDKAADWWSVGILLYEMLTGKPPFIGGNRNKIQ 351

Query: 359 QKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEA 418
           QKI+KDKIKLP+FLSSEAHSLLKGLL K+A+KRLGSG  GS+EIK HKWFK INWKKL+A
Sbjct: 352 QKIVKDKIKLPSFLSSEAHSLLKGLLNKDAAKRLGSGSLGSEEIKRHKWFKPINWKKLDA 411

Query: 419 RETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPAASFLQRN 478
           RE +PSF PEVAGKHC+ANF++CWT+M L DSP ASPK N NPF  FTYVRPAASFL++N
Sbjct: 412 REIQPSFRPEVAGKHCIANFDKCWTDMKLSDSPAASPKTNTNPFVNFTYVRPAASFLKQN 471

Query: 479 T 479
           +
Sbjct: 472 S 472

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224087877|ref|XP_002308257.1| predicted protein [Populus trichocarpa] gi|222854233|gb|EEE91780.1| predicted protein [Populus trichocarpa]

 Score =  707 bits (1826), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 344/481 (71%), Positives = 393/481 (81%), Gaps = 11/481 (2%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
           MVSSQL             N+LL P    D   SD+VE DF+DVFGP P    +  G  +
Sbjct: 1   MVSSQLPGSTK--------NRLLFPVNSLDTEVSDHVELDFTDVFGPLP-SIDVNCGDPL 51

Query: 61  SYAN--ELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQE 118
           S  +  EL+YD P VIH+RSHSLVGPSSYVSQSLKLSKL L+E EDS+ LV+ + +ET +
Sbjct: 52  SVGDGSELIYDNPVVIHNRSHSLVGPSSYVSQSLKLSKLNLNETEDSMELVKCVLDETIK 111

Query: 119 GPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY 178
                S+ D A+ K    +     E Q VG+EDFEVLKVVGQGAF KVYQVR+ GT EIY
Sbjct: 112 ELEECSIDDDAIEKDVEGVSGDTLEVQTVGIEDFEVLKVVGQGAFGKVYQVRKKGTPEIY 171

Query: 179 AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF 238
           AMKVMRKD+I+EKNH +YM+ ER+ILTK+ HPFIVQL+YSFQTKYRLYLVLDF+NGGHLF
Sbjct: 172 AMKVMRKDRIVEKNHVDYMRGERDILTKIAHPFIVQLKYSFQTKYRLYLVLDFINGGHLF 231

Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
           FQLY  GLFREDLARIY AEIVSAV HLHANGIMHRDLKPENILLD+DGHVMLTDFGLAK
Sbjct: 232 FQLYNHGLFREDLARIYAAEIVSAVCHLHANGIMHRDLKPENILLDSDGHVMLTDFGLAK 291

Query: 299 QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ 358
           QFDENTRSNSMCGT+EYM+PEIV G+GHDKAADWWSVGILL+EMLTG+PPF GGNR KIQ
Sbjct: 292 QFDENTRSNSMCGTVEYMAPEIVQGRGHDKAADWWSVGILLYEMLTGKPPFVGGNRDKIQ 351

Query: 359 QKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEA 418
           QKI+KDKIKLP+FL+SEAH+LLKGLL K+ASKRLGSGP GS+EIK HKWFK INWKKL+A
Sbjct: 352 QKIVKDKIKLPSFLTSEAHTLLKGLLNKDASKRLGSGPLGSEEIKRHKWFKAINWKKLDA 411

Query: 419 RETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPAASFLQRN 478
           RE +PSF P+VAGKHC+ANF++CWT+M L DSP ASPK N NPF  FTYVRPAASFLQ++
Sbjct: 412 REIQPSFRPDVAGKHCIANFDKCWTDMTLSDSPAASPKMNTNPFVNFTYVRPAASFLQQS 471

Query: 479 T 479
           +
Sbjct: 472 S 472

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363806700|ref|NP_001242011.1| uncharacterized protein LOC100805922 [Glycine max] gi|255636025|gb|ACU18357.1| unknown [Glycine max]

 Score =  700 bits (1807), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/482 (72%), Positives = 395/482 (81%), Gaps = 11/482 (2%)

Query: 1   MVSSQLSSLNGDCAG-KPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQAS---IEV 56
           MVSSQ S+     AG KP   QLL P    D ++++++E DFSDVFGP  +  +      
Sbjct: 1   MVSSQFSAFT--LAGYKPSQTQLLFPAKLVDTVNTEHIELDFSDVFGPVTLDLNNIDSTT 58

Query: 57  GGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEET 116
              +   NELVYD P VI++RSHSLVGPS+ VSQSLK  KLT+HE EDSL LVE +N E 
Sbjct: 59  SEPMEEVNELVYDDPPVIYTRSHSLVGPSTCVSQSLKFGKLTIHETEDSLELVEHVNGEA 118

Query: 117 QEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE 176
            +     S V+ +L    G++  +      V ++DFE+LKVVGQGAFAKVYQVR+ GTSE
Sbjct: 119 IKDIKESSFVEESLKDEDGNLMKI----HRVSIDDFEILKVVGQGAFAKVYQVRKKGTSE 174

Query: 177 IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH 236
           IYAMKVMRKDKIMEKNHAEYMK+ER+I TK++HPF VQLRYSFQTKYRLYLVLDFVNGGH
Sbjct: 175 IYAMKVMRKDKIMEKNHAEYMKAERDIWTKIEHPFGVQLRYSFQTKYRLYLVLDFVNGGH 234

Query: 237 LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL 296
           LFFQLY QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL
Sbjct: 235 LFFQLYHQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL 294

Query: 297 AKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK 356
           AKQF+E+TRSNSMCGTLEYM+PEI+LGKGHDKAADWWSVG+LLFEMLTG+PPF GGN  K
Sbjct: 295 AKQFEESTRSNSMCGTLEYMAPEIILGKGHDKAADWWSVGVLLFEMLTGKPPFCGGNCDK 354

Query: 357 IQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL 416
           IQQKI+KDKIKLPAFLSSEAHSLLKGLLQKE ++RLG GP G +EIKSHKWFK INW+KL
Sbjct: 355 IQQKIVKDKIKLPAFLSSEAHSLLKGLLQKEQARRLGCGPRGVEEIKSHKWFKPINWRKL 414

Query: 417 EARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPAASFLQ 476
           EARE +PSF PEVAG HCVAN E+ WT+MP++DSP ASP    NPFK F+YVRPAASFLQ
Sbjct: 415 EAREIQPSFRPEVAGVHCVANVEKRWTDMPVVDSPAASPN-GGNPFKDFSYVRPAASFLQ 473

Query: 477 RN 478
           RN
Sbjct: 474 RN 475

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297735529|emb|CBI18023.3| unnamed protein product [Vitis vinifera]

 Score =  699 bits (1804), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/479 (72%), Positives = 381/479 (79%), Gaps = 36/479 (7%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
           MV S +  L      KP  NQLL P  P D +  D+VE DF+DVFGP PVQ   +     
Sbjct: 1   MVFSDVPGLTKTRMCKPIQNQLLFPMNPTDIVPLDHVELDFADVFGPLPVQTPTD----- 55

Query: 61  SYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGP 120
              N+L+Y  P VI+SRSHSLVGPS+ +SQSLKLSKL LHE EDS  LVE ++EE     
Sbjct: 56  --TNDLIYGDPVVIYSRSHSLVGPSTCLSQSLKLSKLALHEIEDSEELVECLHEEA---- 109

Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
                                     VGLEDFEV+K+VGQGAF KV+QVR+  TSEIYAM
Sbjct: 110 -------------------------TVGLEDFEVMKLVGQGAFGKVFQVRKRNTSEIYAM 144

Query: 181 KVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ 240
           KVMRKDKIMEK+HAEYMK+ER+ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ
Sbjct: 145 KVMRKDKIMEKDHAEYMKAERDILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ 204

Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           LY  GLFREDLARIY AEIVSAVSHLHANGIMHRDLKPENILLDADGH MLTDFGLAK+F
Sbjct: 205 LYNHGLFREDLARIYAAEIVSAVSHLHANGIMHRDLKPENILLDADGHAMLTDFGLAKEF 264

Query: 301 DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQK 360
           DENTRSNSMCGT+EYMSPEI LGKGHDKAADWWSVGILLFEMLTG+PPF GGNRQKIQQK
Sbjct: 265 DENTRSNSMCGTVEYMSPEIFLGKGHDKAADWWSVGILLFEMLTGKPPFIGGNRQKIQQK 324

Query: 361 IIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARE 420
           IIKDKIKLPAFLSS+AHS+LKGLLQK+ SKRLGSGP G  EIK HKWFK INW+KLEARE
Sbjct: 325 IIKDKIKLPAFLSSDAHSVLKGLLQKDPSKRLGSGPLGIDEIKHHKWFKPINWRKLEARE 384

Query: 421 TRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPAASFLQRNT 479
            +PSF PEV GK C+ANFE+ WT+MPL DSP ASPK N N F GFTYVRPAASFL+RN+
Sbjct: 385 IQPSFRPEVDGKLCIANFEKRWTDMPLADSPAASPKANGNIFTGFTYVRPAASFLRRNS 443

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|115452853|ref|NP_001050027.1| Os03g0334000 [Oryza sativa Japonica Group] gi|108707998|gb|ABF95793.1| Serine/threonine-protein kinase AtPK19, putative, expressed [Oryza sativa Japonica Group] gi|113548498|dbj|BAF11941.1| Os03g0334000 [Oryza sativa Japonica Group] gi|125586157|gb|EAZ26821.1| hypothetical protein OsJ_10738 [Oryza sativa Japonica Group] gi|215704239|dbj|BAG93079.1| unnamed protein product [Oryza sativa Japonica Group] gi|215769106|dbj|BAH01335.1| unnamed protein product [Oryza sativa Japonica Group]

 Score =  698 bits (1801), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/486 (70%), Positives = 400/486 (82%), Gaps = 20/486 (4%)

Query: 1   MVSSQLSSLNGDCAGKP--FLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVG- 57
           MVSS++SS+    A  P  F  ++LLP GPPD + S+ VEFDFSDVFGP  VQ   ++  
Sbjct: 1   MVSSEISSVTTTHAQGPKLFRGKILLPMGPPDVVPSENVEFDFSDVFGPTAVQTPTDLSI 60

Query: 58  ------GEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEG 111
                   ++ ++E +Y+ P VI  RSHSLVGPSS VSQSL LSKLTLHE++ +L L+E 
Sbjct: 61  LTPDSPAPLTESSEGIYNDPLVIVKRSHSLVGPSSLVSQSLPLSKLTLHESDSALDLLEC 120

Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR 171
             E+     N  ++ D  L       D+  +EN  VGL+DFEVLK+VGQGAF KV+QVR+
Sbjct: 121 TKEKKS---NQEALSDEEL-------DDTKNENGVVGLDDFEVLKLVGQGAFGKVFQVRK 170

Query: 172 IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231
            GTSEIYAMKVMRKDKI+EKNHAEYMK+ER+ILTKVDHPF+VQLRYSFQTKYRLYLVLDF
Sbjct: 171 KGTSEIYAMKVMRKDKILEKNHAEYMKAERDILTKVDHPFVVQLRYSFQTKYRLYLVLDF 230

Query: 232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML 291
           +NGGHLFFQLY+QGLFRE+LARIYTAEIVSAV+HLHANGIMHRDLKPENILLDADGH ML
Sbjct: 231 INGGHLFFQLYQQGLFREELARIYTAEIVSAVAHLHANGIMHRDLKPENILLDADGHAML 290

Query: 292 TDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           TDFGLAK+FDENTRSNSMCGT+EYM+PEIV G+GHDKAADWWSVGILLFEMLTG+PPF G
Sbjct: 291 TDFGLAKEFDENTRSNSMCGTVEYMAPEIVQGRGHDKAADWWSVGILLFEMLTGKPPFVG 350

Query: 352 GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI 411
           GNR K+QQKI+K+KIKLPA+LSSE HSLLKGLL KEA +RLG GPGGS EIK+HKWFK +
Sbjct: 351 GNRDKVQQKIVKEKIKLPAYLSSEVHSLLKGLLHKEAGRRLGCGPGGSNEIKNHKWFKSV 410

Query: 412 NWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPA 471
           NWKKL++R+ +PSF P VAGK C+ANF+ECWT+MP+LDSPVASP   ++ F GF+YVRPA
Sbjct: 411 NWKKLDSRQIQPSFRPNVAGKTCIANFDECWTSMPVLDSPVASPVAADSNFVGFSYVRPA 470

Query: 472 ASFLQR 477
             FLQR
Sbjct: 471 P-FLQR 475

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326524133|dbj|BAJ97077.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  692 bits (1785), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/486 (69%), Positives = 394/486 (81%), Gaps = 19/486 (3%)

Query: 1   MVSSQLSSLNGDCAGKP--FLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVG- 57
           MVSS++ S+      +P  F   +LLP+GPPD +  + VEFDF+DVFG   V    EV  
Sbjct: 1   MVSSEMPSVTTAHTQRPKLFTGMILLPKGPPDVVLPENVEFDFNDVFGATAVHTPTEVSI 60

Query: 58  ------GEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEG 111
                   ++ +NE VY+ P VI  RSHSLVGP+S VSQSL LSKLTLHE+E SL L+E 
Sbjct: 61  LTPGSPAPLAESNEEVYNDPVVITKRSHSLVGPTSLVSQSLPLSKLTLHESESSLDLLEC 120

Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR 171
           +++E +     L+            ++N   EN+ VGL+DFE+LK+VGQGAF KVYQVRR
Sbjct: 121 LSKEKKSEQGGLN---------DEELNNTTKENEAVGLDDFELLKLVGQGAFGKVYQVRR 171

Query: 172 IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231
             TSEIYAMKVMRKDKI+EKNHAEYMK+ER+ILTKVDHPF+VQLRYSFQTKYRLYLVLDF
Sbjct: 172 KCTSEIYAMKVMRKDKILEKNHAEYMKAERDILTKVDHPFVVQLRYSFQTKYRLYLVLDF 231

Query: 232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML 291
           VNGGHLFFQLY+QGLFRE+LAR+YTAEIVSAV+HLHANGIMHRDLKPENILLDA GH ML
Sbjct: 232 VNGGHLFFQLYQQGLFREELARLYTAEIVSAVAHLHANGIMHRDLKPENILLDAHGHAML 291

Query: 292 TDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           TDFGLAK+FDENTRSNSMCGT+EYM+PEIV G+GHDKAADWWSVGILLFEMLTG+PPF G
Sbjct: 292 TDFGLAKEFDENTRSNSMCGTVEYMAPEIVQGRGHDKAADWWSVGILLFEMLTGKPPFFG 351

Query: 352 GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI 411
           GNR KIQQKI+K+K+KLP +LSSE HSLLKGLL KEA +RLGSGPGGS EIK+HKWFK +
Sbjct: 352 GNRDKIQQKIVKEKMKLPTYLSSEVHSLLKGLLHKEAGRRLGSGPGGSDEIKNHKWFKAV 411

Query: 412 NWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPA 471
           NWKKLEAR+ +PSF P VAG+ C+ANF+ECWT+MP+LDSPVASP   ++ F GF+YVRP 
Sbjct: 412 NWKKLEARQIQPSFCPNVAGQTCIANFDECWTSMPVLDSPVASPVAADSNFVGFSYVRPE 471

Query: 472 ASFLQR 477
             FLQR
Sbjct: 472 P-FLQR 476

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356551817|ref|XP_003544270.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Glycine max]

 Score =  689 bits (1779), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/484 (70%), Positives = 396/484 (81%), Gaps = 23/484 (4%)

Query: 1   MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDAL-SSDYVEFDFSDVFGPAPVQAS--IEVG 57
           MVS+Q S LN + + KPFLNQLLLP GPPD L SS+ V+F+FSDVFGP+PV+AS  I V 
Sbjct: 1   MVSAQFSILNENGSQKPFLNQLLLPNGPPDRLPSSNCVDFEFSDVFGPSPVEASNSISVS 60

Query: 58  GE-------ISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVE 110
            E          ++E +Y  P  IH RS SL+ P++ + QSL+LSKLT HE +D+L LVE
Sbjct: 61  SEKHGNSVATRGSSENIYKDPDCIHIRSQSLLAPTTCIGQSLQLSKLTFHETDDALDLVE 120

Query: 111 GINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVR 170
            +  ET E     SV +  L             NQ +G++DFEVLKVVGQGAF KVYQVR
Sbjct: 121 EVFIETHEELKEYSVNNYCLN------------NQTIGVQDFEVLKVVGQGAFGKVYQVR 168

Query: 171 RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD 230
           R GTSEIYAMKVMRKDKIM++NHAEY+KSER+ILTK+D+PF+V++RY+FQTKYRLYLVLD
Sbjct: 169 RTGTSEIYAMKVMRKDKIMQRNHAEYVKSERDILTKLDNPFVVRIRYAFQTKYRLYLVLD 228

Query: 231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM 290
           FVNGGHLFF LY QGLFREDLAR Y AEI+ AVS+LHAN IMHRDLKPENILLDADGH +
Sbjct: 229 FVNGGHLFFHLYHQGLFREDLARFYAAEIICAVSYLHANDIMHRDLKPENILLDADGHAV 288

Query: 291 LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFT 350
           LTDFGLAK+F+EN RSNSMCGT+EYM+PEIV+GKGHDKAADWWSVGILL+EMLTG+PPF+
Sbjct: 289 LTDFGLAKKFNENERSNSMCGTVEYMAPEIVMGKGHDKAADWWSVGILLYEMLTGKPPFS 348

Query: 351 GGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
           GGNR KIQQKIIKDKIKLPAFLS+EAHSLLKGLLQK+ SKRLGSG  GS+EIKSHKWFK+
Sbjct: 349 GGNRHKIQQKIIKDKIKLPAFLSNEAHSLLKGLLQKDVSKRLGSGSRGSEEIKSHKWFKL 408

Query: 411 INWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYV-R 469
           +NWKKLE RETRPSF+P+VAGK+CVANFEE WT+MPLL+SP ASPK ++N F  F+Y   
Sbjct: 409 VNWKKLECRETRPSFVPDVAGKYCVANFEERWTSMPLLNSPAASPKKDDNTFNKFSYSGT 468

Query: 470 PAAS 473
           P AS
Sbjct: 469 PVAS 472

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	479
TAIR|locus:2077843	471	S6K2 "serine/threonine protein	0.970	0.987	0.663	6.8e-166
TAIR|locus:2077873	465	PK1 "protein-serine kinase 1"	0.931	0.959	0.657	6.1e-158
DICTYBASE|DDB_G0290157	479	pkgB "SGK family protein kinas	0.678	0.678	0.474	3.7e-80
ZFIN|ZDB-GENE-040426-2038	502	rps6kb1b "ribosomal protein S6	0.695	0.663	0.461	1.2e-79
UNIPROTKB|F1MNP4	525	RPS6KB1 "Ribosomal protein S6	0.670	0.611	0.472	1.6e-79
UNIPROTKB|Q6TJY3	527	RPS6KB1 "Ribosomal protein S6	0.670	0.609	0.472	1.6e-79
UNIPROTKB|E2RMD8	525	RPS6KB1 "Uncharacterized prote	0.670	0.611	0.472	1.6e-79
UNIPROTKB|B4DLT4	472	RPS6KB1 "cDNA FLJ53847, highly	0.670	0.680	0.472	1.6e-79
UNIPROTKB|P23443	525	RPS6KB1 "Ribosomal protein S6	0.670	0.611	0.472	1.6e-79
UNIPROTKB|Q7Z721	451	RPS6KB1 "RPS6KB1 protein" [Hom	0.670	0.711	0.472	1.6e-79

TAIR|locus:2077843 S6K2 "serine/threonine protein kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1614 (573.2 bits), Expect = 6.8e-166, P = 6.8e-166
 Identities = 320/482 (66%), Positives = 370/482 (76%)

Query:     1 MVSSQLSSLNGDCAGKPFLNQLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEI 60
             MVSSQ S  N +  GKPF   L L   PP ++  D +E  FSDVFGP P   S E     
Sbjct:     1 MVSSQCSVANKNQTGKPFQKHLSLSISPPKSVLGDNLELQFSDVFGPMPEANSEE----- 55

Query:    61 SYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGP 120
               A ++ YD+PAV++SRSHSLVGPS  VS SLK++KLTL E EDS+ LVE +  E+ +  
Sbjct:    56 --ACDVAYDEPAVVYSRSHSLVGPSLVVSHSLKMNKLTLRETEDSVDLVECVEGESIKEN 113

Query:   121 NNLSVVDAALGKPTGHIDNLPSE-NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYA 179
             +  S      G      +  P E +  VG+EDFEVLKVVGQGAF KVYQVR+  TSEIYA
Sbjct:   114 DEFS------GNDDTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQVRKKDTSEIYA 167

Query:   180 MKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF 239
             MKVMRKDKI+EKNHAEYMK+ER+ILTK+DHPFIVQL+YSFQTKYRLYLVLDF+NGGHLFF
Sbjct:   168 MKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFF 227

Query:   240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ 299
             QLY QGLFREDLAR+YTAEIVSAVSHLH  GIMHRDLKPENIL+D DGHVMLTDFGLAK+
Sbjct:   228 QLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDVDGHVMLTDFGLAKE 287

Query:   300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXX 359
             F+ENTRSNSMCGT EYM+PEIV GKGHDKAADWWSVGILL+EMLTG+PPF G ++     
Sbjct:   288 FEENTRSNSMCGTTEYMAPEIVRGKGHDKAADWWSVGILLYEMLTGKPPFLG-SKGKIQQ 346

Query:   360 XXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEAR 419
                     LP FLS+EAH+LLKGLLQKE  +RLGSGP G++EIK HKWFK INWKKLEAR
Sbjct:   347 KIVKDKIKLPQFLSNEAHALLKGLLQKEPERRLGSGPSGAEEIKKHKWFKAINWKKLEAR 406

Query:   420 ETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNE--NPFKGFTYVRPAASFLQR 477
             E +PSF P V+G+ C+ANF++CWT+M +LDSP +SP  +   NPF  FTYVRP  SFL R
Sbjct:   407 EVQPSFKPAVSGRQCIANFDKCWTDMSVLDSPASSPNSDAKANPFTNFTYVRPPHSFLHR 466

Query:   478 NT 479
              T
Sbjct:   467 TT 468

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0009408 "response to heat" evidence=IEP

TAIR|locus:2077873 PK1 "protein-serine kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1539 (546.8 bits), Expect = 6.1e-158, P = 6.1e-158
 Identities = 303/461 (65%), Positives = 359/461 (77%)

Query:    21 QLLLPRGPPDALSSDYVEFDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHS 80
             Q  L   P +++  D VE +FSDVFGP P +A           N++ YD+PAV++SRSHS
Sbjct:    15 QQYLSISPSNSVLKDDVELEFSDVFGPLPEEA-----------NDIAYDEPAVVYSRSHS 63

Query:    81 LVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNL 140
             LVGP S  S SLKL+KLTL E EDS+ LVE +  E+ +  ++ S  D +  +     D L
Sbjct:    64 LVGPCSLDSHSLKLTKLTLLETEDSIDLVECLEGESLKENDDFSGNDDSDNEKALEGD-L 122

Query:   141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
                +  VG++DFEV+KVVG+GAF KVYQVR+  TSEIYAMKVMRKD IMEKNHAEYMK+E
Sbjct:   123 VKVSGVVGIDDFEVMKVVGKGAFGKVYQVRKKETSEIYAMKVMRKDHIMEKNHAEYMKAE 182

Query:   201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
             R+ILTK+DHPFIVQL+YSFQTKYRLYLVLDF+NGGHLFFQLY QGLFREDLAR+YTAEIV
Sbjct:   183 RDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHQGLFREDLARVYTAEIV 242

Query:   261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
             SAVSHLH  GIMHRDLKPENIL+D DGHVMLTDFGLAK+F+ENTRSNSMCGT EYM+PEI
Sbjct:   243 SAVSHLHEKGIMHRDLKPENILMDTDGHVMLTDFGLAKEFEENTRSNSMCGTTEYMAPEI 302

Query:   321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
             V GKGHDKAADWWSVGILL+EMLTG+PPF G ++             LP FLS+EAH++L
Sbjct:   303 VRGKGHDKAADWWSVGILLYEMLTGKPPFLG-SKGKIQQKIVKDKIKLPQFLSNEAHAIL 361

Query:   381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
             KGLLQKE  +RLGSG  G++EIK HKWFK INWKKLEARE  PSF PEV+G+ C+ANF++
Sbjct:   362 KGLLQKEPERRLGSGLSGAEEIKQHKWFKGINWKKLEAREVMPSFKPEVSGRQCIANFDK 421

Query:   441 CWTNMPLLDSPVASPKFNE--NPFKGFTYVRPAASFLQRNT 479
             CWT+M +LDSP +SP  +   NPF  FTYVRP  SFL ++T
Sbjct:   422 CWTDMSVLDSPASSPSSDPKANPFTNFTYVRPPPSFLHQST 462

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IMP;IDA

GO:0045727 "positive regulation of translation" evidence=RCA;TAS

GO:0009409 "response to cold" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

DICTYBASE|DDB_G0290157 pkgB "SGK family protein kinase PkgB" [Dictyostelium discoideum (taxid:44689)]

 Score = 805 (288.4 bits), Expect = 3.7e-80, P = 3.7e-80
 Identities = 158/333 (47%), Positives = 217/333 (65%)

Query:   142 SEN-QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
             S+N Q    +DFE+L V+G+G+F KV QV++ G  +I+AMKV+RKD I+ +    + KSE
Sbjct:   142 SKNKQSATKDDFELLNVIGKGSFGKVMQVKKKGEDKIFAMKVLRKDAIIARKQVNHTKSE 201

Query:   201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
             + IL  + HPFIV L Y+FQTK +LY+VLDFVNGG LFF L R+G F E   +IY AEIV
Sbjct:   202 KTILQCISHPFIVNLHYAFQTKDKLYMVLDFVNGGELFFHLKREGRFSEPRVKIYAAEIV 261

Query:   261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
             SA+ HLH   I++RDLKPENILLD++GH+ +TDFGL+K+ +    + + CGT EY++PE+
Sbjct:   262 SALDHLHKQDIVYRDLKPENILLDSEGHICITDFGLSKKIETTDGTFTFCGTPEYLAPEV 321

Query:   321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
             + G GH  A DWWS+G LL+EMLTG PPF   N              +P ++S EA SLL
Sbjct:   322 LNGHGHGCAVDWWSLGTLLYEMLTGLPPFYSQNVSTMYQKILNGELKIPTYISPEAKSLL 381

Query:   381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
             +GLL +E  KRLG+  GG  E+K H WFK I+W+KL+ +E    F P+V     ++  + 
Sbjct:   382 EGLLTREVDKRLGTKGGG--EVKQHPWFKNIDWEKLDRKEVEVHFKPKVKSGTDISQIDP 439

Query:   441 CWTNMPLLDSPVASPKFNE-----NPFKGFTYV 468
              +T    +DS V +    +       F+GFTYV
Sbjct:   440 VFTQERPMDSLVETSALGDAMGKDTSFEGFTYV 472

GO:0006468 "protein phosphorylation" evidence=IEA;IGI;IDA

GO:0043327 "chemotaxis to cAMP" evidence=IGI

GO:0031288 "sorocarp morphogenesis" evidence=IMP

GO:0005886 "plasma membrane" evidence=IEA;IDA

GO:0004691 "cAMP-dependent protein kinase activity" evidence=IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0006935 "chemotaxis" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0044351 "macropinocytosis" evidence=RCA

ZFIN|ZDB-GENE-040426-2038 rps6kb1b "ribosomal protein S6 kinase b, polypeptide 1b" [Danio rerio (taxid:7955)]

 Score = 800 (286.7 bits), Expect = 1.2e-79, P = 1.2e-79
 Identities = 158/342 (46%), Positives = 227/342 (66%)

Query:   138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEK-NH 193
             DN+    + +  E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+     
Sbjct:    51 DNVNQGTENIRPECFELLRVLGKGGYGKVFQVRKVSGAATGKIFAMKVLKKAMIVRNAKD 110

Query:   194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
               + K+ERNIL +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A 
Sbjct:   111 TAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTAC 170

Query:   254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGT 312
              Y AEI  A+ HLH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT
Sbjct:   171 FYLAEISMALGHLHQKGIIYRDLKPENIMLNNQGHVKLTDFGLCKESIHDGTVTHTFCGT 230

Query:   313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFL 372
             +EYM+PEI++  GH++A DWWS+G L+++MLTG PPFTG NR             LP +L
Sbjct:   231 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL 290

Query:   373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGK 432
             + EA  LLK LL++ AS RLG+GPG + E+++H +F+ +NW  L AR+  P F P +   
Sbjct:   291 TQEARDLLKRLLKRSASSRLGAGPGDATEVQTHPFFRHVNWDDLLARKVEPPFKPFLQFA 350

Query:   433 HCVANFEECWTNMPLLDSP---VASPKFNENPFKGFTYVRPA 471
               V+ F+  +T+   +DSP     S   N+  F GFTYV P+
Sbjct:   351 EDVSQFDSKFTSQTPVDSPDDSTLSESANQ-VFLGFTYVAPS 391

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0005840 "ribosome" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

UNIPROTKB|F1MNP4 RPS6KB1 "Ribosomal protein S6 kinase beta-1" [Bos taurus (taxid:9913)]

 Score = 799 (286.3 bits), Expect = 1.6e-79, P = 1.6e-79
 Identities = 156/330 (47%), Positives = 224/330 (67%)

Query:   150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
             E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct:    89 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query:   206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct:   149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query:   266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
             LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct:   209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query:   325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLL 384
             GH++A DWWS+G L+++MLTG PPFTG NR             LP +L+ EA  LLK LL
Sbjct:   269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query:   385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
             ++ A+ RLG+GPG + E+++H +F+ INW++L AR+  P F P +  +  V+ F+  +T 
Sbjct:   329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query:   445 MPLLDSP---VASPKFNENPFKGFTYVRPA 471
                +DSP     S   N+  F GFTYV P+
Sbjct:   389 QTPVDSPDDSALSESANQ-VFLGFTYVAPS 417

GO:0071363 "cellular response to growth factor stimulus" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0045931 "positive regulation of mitotic cell cycle" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

GO:0031929 "TOR signaling cascade" evidence=IEA

GO:0007281 "germ cell development" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q6TJY3 RPS6KB1 "Ribosomal protein S6 kinase beta-1" [Bos taurus (taxid:9913)]

 Score = 799 (286.3 bits), Expect = 1.6e-79, P = 1.6e-79
 Identities = 156/330 (47%), Positives = 224/330 (67%)

Query:   150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
             E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct:    89 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query:   206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct:   149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query:   266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
             LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct:   209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query:   325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLL 384
             GH++A DWWS+G L+++MLTG PPFTG NR             LP +L+ EA  LLK LL
Sbjct:   269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query:   385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
             ++ A+ RLG+GPG + E+++H +F+ INW++L AR+  P F P +  +  V+ F+  +T 
Sbjct:   329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query:   445 MPLLDSP---VASPKFNENPFKGFTYVRPA 471
                +DSP     S   N+  F GFTYV P+
Sbjct:   389 QTPVDSPDDSALSESANQ-VFLGFTYVAPS 417

GO:0004672 "protein kinase activity" evidence=ISS

GO:0005739 "mitochondrion" evidence=ISS

GO:0071363 "cellular response to growth factor stimulus" evidence=ISS

GO:0043066 "negative regulation of apoptotic process" evidence=ISS

GO:0043005 "neuron projection" evidence=IEA

GO:0005741 "mitochondrial outer membrane" evidence=IEA

GO:0045948 "positive regulation of translational initiation" evidence=IEA

GO:0045931 "positive regulation of mitotic cell cycle" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0031929 "TOR signaling cascade" evidence=IEA

GO:0007281 "germ cell development" evidence=IEA

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IEA

GO:0045202 "synapse" evidence=IEA

GO:0030054 "cell junction" evidence=IEA

GO:0006915 "apoptotic process" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|E2RMD8 RPS6KB1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 799 (286.3 bits), Expect = 1.6e-79, P = 1.6e-79
 Identities = 156/330 (47%), Positives = 224/330 (67%)

Query:   150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
             E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct:    89 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query:   206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct:   149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query:   266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
             LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct:   209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query:   325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLL 384
             GH++A DWWS+G L+++MLTG PPFTG NR             LP +L+ EA  LLK LL
Sbjct:   269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query:   385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
             ++ A+ RLG+GPG + E+++H +F+ INW++L AR+  P F P +  +  V+ F+  +T 
Sbjct:   329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query:   445 MPLLDSP---VASPKFNENPFKGFTYVRPA 471
                +DSP     S   N+  F GFTYV P+
Sbjct:   389 QTPVDSPDDSTLSESANQ-VFLGFTYVAPS 417

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

UNIPROTKB|B4DLT4 RPS6KB1 "cDNA FLJ53847, highly similar to Ribosomal protein S6 kinase beta-1 (EC 2.7.11.1)" [Homo sapiens (taxid:9606)]

 Score = 799 (286.3 bits), Expect = 1.6e-79, P = 1.6e-79
 Identities = 156/330 (47%), Positives = 224/330 (67%)

Query:   150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
             E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct:    36 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 95

Query:   206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct:    96 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 155

Query:   266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
             LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct:   156 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 215

Query:   325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLL 384
             GH++A DWWS+G L+++MLTG PPFTG NR             LP +L+ EA  LLK LL
Sbjct:   216 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 275

Query:   385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
             ++ A+ RLG+GPG + E+++H +F+ INW++L AR+  P F P +  +  V+ F+  +T 
Sbjct:   276 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 335

Query:   445 MPLLDSP---VASPKFNENPFKGFTYVRPA 471
                +DSP     S   N+  F GFTYV P+
Sbjct:   336 QTPVDSPDDSTLSESANQ-VFLGFTYVAPS 364

GO:0005840 "ribosome" evidence=IEA

GO:0003009 "skeletal muscle contraction" evidence=IEA

GO:0004711 "ribosomal protein S6 kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005739 "mitochondrion" evidence=IEA

GO:0007281 "germ cell development" evidence=IEA

GO:0007568 "aging" evidence=IEA

GO:0007584 "response to nutrient" evidence=IEA

GO:0007616 "long-term memory" evidence=IEA

GO:0009408 "response to heat" evidence=IEA

GO:0009611 "response to wounding" evidence=IEA

GO:0009612 "response to mechanical stimulus" evidence=IEA

GO:0009636 "response to toxic substance" evidence=IEA

GO:0009749 "response to glucose stimulus" evidence=IEA

GO:0009986 "cell surface" evidence=IEA

GO:0014732 "skeletal muscle atrophy" evidence=IEA

GO:0014878 "response to electrical stimulus involved in regulation of muscle adaptation" evidence=IEA

GO:0014911 "positive regulation of smooth muscle cell migration" evidence=IEA

GO:0016477 "cell migration" evidence=IEA

GO:0032496 "response to lipopolysaccharide" evidence=IEA

GO:0032868 "response to insulin stimulus" evidence=IEA

GO:0032870 "cellular response to hormone stimulus" evidence=IEA

GO:0033574 "response to testosterone stimulus" evidence=IEA

GO:0033762 "response to glucagon stimulus" evidence=IEA

GO:0034612 "response to tumor necrosis factor" evidence=IEA

GO:0042277 "peptide binding" evidence=IEA

GO:0042493 "response to drug" evidence=IEA

GO:0043201 "response to leucine" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0045471 "response to ethanol" evidence=IEA

GO:0046324 "regulation of glucose import" evidence=IEA

GO:0046627 "negative regulation of insulin receptor signaling pathway" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0048633 "positive regulation of skeletal muscle tissue growth" evidence=IEA

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=IEA

GO:0051384 "response to glucocorticoid stimulus" evidence=IEA

UNIPROTKB|P23443 RPS6KB1 "Ribosomal protein S6 kinase beta-1" [Homo sapiens (taxid:9606)]

 Score = 799 (286.3 bits), Expect = 1.6e-79, P = 1.6e-79
 Identities = 156/330 (47%), Positives = 224/330 (67%)

Query:   150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
             E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct:    89 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query:   206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct:   149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query:   266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
             LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct:   209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query:   325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLL 384
             GH++A DWWS+G L+++MLTG PPFTG NR             LP +L+ EA  LLK LL
Sbjct:   269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query:   385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
             ++ A+ RLG+GPG + E+++H +F+ INW++L AR+  P F P +  +  V+ F+  +T 
Sbjct:   329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query:   445 MPLLDSP---VASPKFNENPFKGFTYVRPA 471
                +DSP     S   N+  F GFTYV P+
Sbjct:   389 QTPVDSPDDSTLSESANQ-VFLGFTYVAPS 417

GO:0006915 "apoptotic process" evidence=IEA

GO:0030054 "cell junction" evidence=IEA

GO:0045202 "synapse" evidence=IEA

GO:0007281 "germ cell development" evidence=IEA

GO:0007568 "aging" evidence=IEA

GO:0007584 "response to nutrient" evidence=IEA

GO:0007616 "long-term memory" evidence=IEA

GO:0009408 "response to heat" evidence=IEA

GO:0009611 "response to wounding" evidence=IEA

GO:0009612 "response to mechanical stimulus" evidence=IEA

GO:0009636 "response to toxic substance" evidence=IEA

GO:0009749 "response to glucose stimulus" evidence=IEA

GO:0009986 "cell surface" evidence=IEA

GO:0014732 "skeletal muscle atrophy" evidence=IEA

GO:0014878 "response to electrical stimulus involved in regulation of muscle adaptation" evidence=IEA

GO:0014911 "positive regulation of smooth muscle cell migration" evidence=IEA

GO:0016477 "cell migration" evidence=IEA

GO:0032496 "response to lipopolysaccharide" evidence=IEA

GO:0033574 "response to testosterone stimulus" evidence=IEA

GO:0033762 "response to glucagon stimulus" evidence=IEA

GO:0034612 "response to tumor necrosis factor" evidence=IEA

GO:0042277 "peptide binding" evidence=IEA

GO:0042493 "response to drug" evidence=IEA

GO:0043201 "response to leucine" evidence=IEA

GO:0043491 "protein kinase B signaling cascade" evidence=IEA

GO:0045471 "response to ethanol" evidence=IEA

GO:0046324 "regulation of glucose import" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0048633 "positive regulation of skeletal muscle tissue growth" evidence=IEA

GO:0048661 "positive regulation of smooth muscle cell proliferation" evidence=IEA

GO:0051384 "response to glucocorticoid stimulus" evidence=IEA

GO:0003009 "skeletal muscle contraction" evidence=IEA

GO:0004711 "ribosomal protein S6 kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA;IDA

GO:0005741 "mitochondrial outer membrane" evidence=IEA

GO:0043005 "neuron projection" evidence=IEA

GO:0031929 "TOR signaling cascade" evidence=IDA

GO:0045727 "positive regulation of translation" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0045931 "positive regulation of mitotic cell cycle" evidence=IMP

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=IMP

GO:0048015 "phosphatidylinositol-mediated signaling" evidence=TAS

GO:0005737 "cytoplasm" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0005739 "mitochondrion" evidence=IDA

GO:0043066 "negative regulation of apoptotic process" evidence=IMP

GO:0045948 "positive regulation of translational initiation" evidence=IMP

GO:0071363 "cellular response to growth factor stimulus" evidence=IDA

GO:0046627 "negative regulation of insulin receptor signaling pathway" evidence=IMP

GO:0007165 "signal transduction" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=IDA

UNIPROTKB|Q7Z721 RPS6KB1 "RPS6KB1 protein" [Homo sapiens (taxid:9606)]

 Score = 799 (286.3 bits), Expect = 1.6e-79, P = 1.6e-79
 Identities = 156/330 (47%), Positives = 224/330 (67%)

Query:   150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
             E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct:    89 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 148

Query:   206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct:   149 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 208

Query:   266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
             LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct:   209 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 268

Query:   325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLL 384
             GH++A DWWS+G L+++MLTG PPFTG NR             LP +L+ EA  LLK LL
Sbjct:   269 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 328

Query:   385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
             ++ A+ RLG+GPG + E+++H +F+ INW++L AR+  P F P +  +  V+ F+  +T 
Sbjct:   329 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 388

Query:   445 MPLLDSP---VASPKFNENPFKGFTYVRPA 471
                +DSP     S   N+  F GFTYV P+
Sbjct:   389 QTPVDSPDDSTLSESANQ-VFLGFTYVAPS 417

GO:0007165 "signal transduction" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005840 "ribosome" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q39030	KPK2_ARATH	2, ., 7, ., 1, 1, ., 1	0.6867	0.9707	0.9872	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00161333 hypothetical protein (475 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	479
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-145
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-132
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-123
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-112
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-111
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-109
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-107
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-105
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-105
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-104
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-103
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-103
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-100
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-98
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-97
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-97
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-95
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-94
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-93
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-92
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-92
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-91
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-91
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-90
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-90
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-90
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-88
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-88
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-87
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-87
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-86
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-85
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-85
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-84
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-84
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-82
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-82
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-82
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-81
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-79
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-79
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-79
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-76
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-74
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-74
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-73
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-73
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-73
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-73
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-72
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-72
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-71
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-71
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-68
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-66
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-66
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-66
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-65
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-65
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-63
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-63
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-62
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-62
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-62
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-61
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-60
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-60
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-58
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-58
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-58
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-55
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-54
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-53
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-51
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-49
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-48
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-45
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-44
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-42
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-42
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-41
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-41
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-41
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-40
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-40
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-40
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-39
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-39
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-39
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-39
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-38
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-38
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-38
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-38
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	9e-38
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-38
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-37
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-37
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-37
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-36
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-35
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-35
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-34
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-34
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-33
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-33
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-33
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-32
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-32
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-32
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-32
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-31
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-31
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-31
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-31
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-31
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-31
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-31
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-30
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-30
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-30
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-30
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-29
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-29
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-29
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-29
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-29
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-29
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-29
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-29
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-28
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-28
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-28
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-28
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-28
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-27
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-27
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-27
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-27
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-27
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-27
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-26
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-26
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-26
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-26
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-25
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-25
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-25
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-25
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-25
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-25
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-25
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-25
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-25
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-25
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-25
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-24
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-24
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-24
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-24
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-24
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-23
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-23
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-23
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-23
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-23
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-23
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-22
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-22
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-22
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-22
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-22
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-22
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-21
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-21
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-21
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-20
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-20
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-20
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-20
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-20
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-20
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-20
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-20
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-20
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-19
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-19
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-19
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-19
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-19
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-18
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-18
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-18
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-18
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-18
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-17
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-17
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-17
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-17
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-17
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-16
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-16
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-16
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-15
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-15
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-15
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-14
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-14
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-14
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-14
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-13
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-13
smart00133	64	smart00133, S_TK_X, Extension to Ser/Thr-type prot	5e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-11
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-11
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-10
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-07
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-07
pfam00433	47	pfam00433, Pkinase_C, Protein kinase C terminal do	3e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	4e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-06
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	2e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-06
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-06
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	9e-06
PRK09188	365	PRK09188, PRK09188, serine/threonine protein kinas	1e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-05
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	2e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	4e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	7e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	7e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-04
COG4248	637	COG4248, COG4248, Uncharacterized protein with pro	5e-04
TIGR01982	437	TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase	9e-04
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	0.001
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.001
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	0.003
PRK01723	239	PRK01723, PRK01723, 3-deoxy-D-manno-octulosonic-ac	0.004

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  414 bits (1067), Expect = e-145
 Identities = 140/252 (55%), Positives = 199/252 (78%), Gaps = 3/252 (1%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F KV  VR+  T ++YAMKV++K KI+++   E+  +ERNIL++++HPFIV+L Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           +FQT+ +LYLVL++  GG LF  L ++G F E+ AR Y AEIV A+ +LH+ GI++RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 278 PENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
           PENILLDADGH+ LTDFGLAK+   E +R+N+ CGT EY++PE++LGKG+ KA DWWS+G
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLG 180

Query: 337 ILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGP 396
           +LL+EMLTG+PPF   +R++I +KI+KD ++ P FLS EA  L+ GLLQK+ +KRLGSG 
Sbjct: 181 VLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240

Query: 397 GGSQEIKSHKWF 408
             ++EIK+H +F
Sbjct: 241 --AEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  383 bits (985), Expect = e-132
 Identities = 129/291 (44%), Positives = 197/291 (67%), Gaps = 2/291 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE +K +G G+F +V  VR  G+ + YA+K++ K KI++    E++ +E+ IL  + H
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF+V L  SFQ    LYLV+++V GG LF  L + G F E +AR Y A++V A+ +LH+ 
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
            I++RDLKPEN+LLD+DG++ +TDFG AK+    T   ++CGT EY++PEI+L KG+ KA
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILSKGYGKA 178

Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEAS 389
            DWW++GIL++EML G PPF   N  +I +KI++ K++ P+F S +A  L++ LLQ + +
Sbjct: 179 VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLT 238

Query: 390 KRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           KRLG+   G  +IK+H WF  I+W  L  R+    F+P+V G    +NF++
Sbjct: 239 KRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDD 289

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  363 bits (933), Expect = e-123
 Identities = 162/324 (50%), Positives = 223/324 (68%), Gaps = 9/324 (2%)

Query: 155 LKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIM--EKNHAEYMKSERNILTKVDH 209
           LKV+G+G + KV+QVR++    T +I+AMKV++K  I+  +K+ A + K+ERNIL  V H
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTA-HTKAERNILEAVKH 59

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PFIV L Y+FQT  +LYL+L++++GG LF  L R+G+F ED A  Y +EI  A+ HLH  
Sbjct: 60  PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           GI++RDLKPENILLDA GHV LTDFGL K+   E T +++ CGT+EYM+PEI++  GH K
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGK 179

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA 388
           A DWWS+G L+++MLTG PPFT  NR+K   KI+K K+ LP +L+ EA  LLK LL++  
Sbjct: 180 AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNP 239

Query: 389 SKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLL 448
           S RLG+GPG + E++SH +F+ +NW  L AR+  P F P +  +  V+ F+  +T    +
Sbjct: 240 SSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPV 299

Query: 449 DSPVASPKFN--ENPFKGFTYVRP 470
           DSP  S         F GFTYV P
Sbjct: 300 DSPDDSTLSESANQIFLGFTYVAP 323

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  332 bits (853), Expect = e-112
 Identities = 118/261 (45%), Positives = 169/261 (64%), Gaps = 11/261 (4%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+L+ +G+G+F KVY  R   T ++ A+KV++K KI  K   E +  E  IL K+ HP 
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+L   F+ + +LYLV+++  GG LF  L ++G   ED AR Y  +I+SA+ +LH+ GI
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
           +HRDLKPENILLD DGHV L DFGLA+Q D   +  +  GT EYM+PE++LGKG+ KA D
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178

Query: 332 WWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKIKLPAF---LSSEAHSLLKGLLQKE 387
            WS+G++L+E+LTG+PPF G     ++ +KI K K   P     +S EA  L++ LL K+
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKD 238

Query: 388 ASKRLGSGPGGSQEIKSHKWF 408
             KRL      ++E   H +F
Sbjct: 239 PEKRL-----TAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  332 bits (852), Expect = e-111
 Identities = 151/319 (47%), Positives = 218/319 (68%), Gaps = 6/319 (1%)

Query: 155 LKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           LKV+GQG+F KV+ VR+I      ++YAMKV++K  +  ++     K ER+IL +V+HPF
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHPF 59

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + Y AE+  A+ HLH+ GI
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           ++RDLKPENILLD +GH+ LTDFGL+K+  D   ++ S CGT+EYM+PE+V  +GH ++A
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 179

Query: 331 DWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASK 390
           DWWS G+L+FEMLTG  PF G +R++    I+K K+ +P FLS EA SLL+ L ++  + 
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPAN 239

Query: 391 RLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDS 450
           RLG+GP G +EIK H +F  I+W KL  RE +P F P V        F+  +T+    DS
Sbjct: 240 RLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDS 299

Query: 451 PVASPKFNENP-FKGFTYV 468
           P   P  N +  F+GF++V
Sbjct: 300 PGIPPSANAHQLFRGFSFV 318

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  326 bits (837), Expect = e-109
 Identities = 155/332 (46%), Positives = 229/332 (68%), Gaps = 12/332 (3%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNH-AEYMKSERNILTK 206
           +FE+LKV+G GA+ KV+ VR++    T ++YAMKV++K  +++K    E+ ++ERN+L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           V   PF+V L Y+FQT+ +L+L+LD+V+GG +F  LY++  F ED  R Y+ EI+ A+ H
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLG 323
           LH  GI++RD+K ENILLD++GHV+LTDFGL+K+F  +E  R+ S CGT+EYM+PEI+ G
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180

Query: 324 K-GHDKAADWWSVGILLFEMLTGQPPFT-GGNRQ---KIQQKIIKDKIKLPAFLSSEAHS 378
           K GH KA DWWS+GIL+FE+LTG  PFT  G R    ++ ++I+K     P+F+  EA  
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240

Query: 379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANF 438
           LL  LL+K+  KRLG+GP G+ EIK H +FK ++W+ L  R+  P F P +  +  V NF
Sbjct: 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNF 300

Query: 439 EECWTNMPLLDSPVASPKFNENPFKGFTYVRP 470
            E +TN+  + SP  +P      F+G+++V P
Sbjct: 301 AEEFTNLEPVYSPAGTPPSGARVFQGYSFVAP 332

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  320 bits (821), Expect = e-107
 Identities = 132/318 (41%), Positives = 205/318 (64%), Gaps = 5/318 (1%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
           KV+G+G+F KV      GT E+YA+KV++KD I++ +  E   +E+ +L     HPF+ Q
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQTK RL+ V+++VNGG L F + R G F E  AR Y AEIV  +  LH  GI++R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLK +N+LLD++GH+ + DFG+ K+       +++ CGT +Y++PEI+  + +  A DWW
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
           ++G+LL+EML GQ PF G +  ++ Q I++D+++ P +LS EA S+LK  L K   KRLG
Sbjct: 181 ALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLG 240

Query: 394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVA 453
             P G Q+IK H +F+ I+W KLE +E +P F P++ G+  V+NF++ +T    + +P  
Sbjct: 241 CLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPD 300

Query: 454 SP---KFNENPFKGFTYV 468
                  ++  F+GF+Y+
Sbjct: 301 EAIIRNIDQEEFRGFSYI 318

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  316 bits (812), Expect = e-105
 Identities = 137/324 (42%), Positives = 204/324 (62%), Gaps = 12/324 (3%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQ 214
           KV+G+G+F KV   +     + YA+KV++K  I++K   +++ +ERN+L K V HPF+V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L YSFQT  +LY VLD+VNGG LFF L R+  F E  AR Y AEI SA+ +LH+  I++R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLKPENILLD+ GHV+LTDFGL K+  + +  +++ CGT EY++PE++  + +D+  DWW
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
            +G +L+EML G PPF   +  ++   I+   ++L   +S  A  LL+GLLQK+ +KRLG
Sbjct: 181 CLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLG 240

Query: 394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVA 453
           +      EIK+H +F  INW  L  ++  P F P V+G   + +F+  +T  P+ +S   
Sbjct: 241 AK-DDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGK 299

Query: 454 SPKFN---------ENPFKGFTYV 468
           SP            ++ F GF+Y 
Sbjct: 300 SPDSVLVSASVKEADDAFLGFSYA 323

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  315 bits (808), Expect = e-105
 Identities = 140/290 (48%), Positives = 201/290 (69%), Gaps = 15/290 (5%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNH-AEYMKSERNILTK 206
           +FE+L+V+G GA+ KV+ VR++G     ++YAMKV++K  I++K   AE+ ++ER +L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 207 VDH-PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           V   PF+V L Y+FQT  +L+L+LD+VNGG LF  LY++  F E   R+Y AEIV A+ H
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLG 323
           LH  GI++RD+K ENILLD++GHV+LTDFGL+K+F  +E  R+ S CGT+EYM+PE++ G
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180

Query: 324 K--GHDKAADWWSVGILLFEMLTGQPPFT---GGNRQK-IQQKIIKDKIKLPAFLSSEAH 377
              GHDKA DWWS+G+L FE+LTG  PFT     N Q  I ++I+K K   P  +S+EA 
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240

Query: 378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP 427
             ++ LL+K+  KRLG+   G+ EIK+H +F+ I+W  L A+     F P
Sbjct: 241 DFIQKLLEKDPKKRLGA--NGADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  312 bits (802), Expect = e-104
 Identities = 116/267 (43%), Positives = 176/267 (65%), Gaps = 13/267 (4%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           + +GA+ +V+  ++  T +IYA+KV++K  ++ KN  + + +ER+IL++   P++V+L Y
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           SFQ K  LYLV++++ GG L   L   G   ED+ARIY AEIV A+ +LH+NGI+HRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 278 PENILLDADGHVMLTDFGLAK---------QFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           P+NIL+D++GH+ LTDFGL+K           D+      + GT +Y++PE++LG+GH K
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAF--LSSEAHSLLKGLLQK 386
             DWWS+G +L+E L G PPF G   ++I Q I+  KI+ P    +S EA  L+  LL  
Sbjct: 181 TVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP 240

Query: 387 EASKRLGSGPGGSQEIKSHKWFKMINW 413
           +  KRLG+     +EIK+H +FK I+W
Sbjct: 241 DPEKRLGA--KSIEEIKNHPFFKGIDW 265

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  313 bits (803), Expect = e-103
 Identities = 141/356 (39%), Positives = 211/356 (59%), Gaps = 45/356 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFEV+KV+G+GAF +V+ VR   T ++YAMKV+RK  ++++N   ++++ER+IL   D 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P+IV+L YSFQ +  LYLV++++ GG L   L R+ +F E+ AR Y AE+V A+  +H  
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-------------------------- 303
           G +HRD+KP+NIL+DADGH+ L DFGL K+ ++                           
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180

Query: 304 ----TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ 359
                R+NS  GT +Y++PE++ G  +    DWWS+G++L+EML G PPF     Q+   
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240

Query: 360 KII--KDKIKLPAF--LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK 415
           KII  K+ ++ P    +S EA  L+  LL  +   RLGS     +EIKSH +FK I+W+ 
Sbjct: 241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGS----FEEIKSHPFFKGIDWEN 295

Query: 416 LEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPV-ASPKFN---ENPFKGFTY 467
           L  RET+P F+PE++     +NF++   +  L D     S K N   +  F GFTY
Sbjct: 296 L--RETKPPFVPELSSPLDTSNFDDFEDDKDLSDYLSQNSKKLNKGKQLAFVGFTY 349

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  310 bits (796), Expect = e-103
 Identities = 137/314 (43%), Positives = 207/314 (65%), Gaps = 6/314 (1%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F KV QVR+  T  IYA+K +RK  I+ ++   +  +ER +L +V+ PFIV L++
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           SFQ+  +LYLVL F+NGG LF  L R+G F    AR YTAE++ A+ +LH   +++RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 278 PENILLDADGHVMLTDFGLAK-QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
           PENILLD  GH+ L DFGL K    ++ ++N+ CGT EY++PE++LG G+ KA DWW++G
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLG 180

Query: 337 ILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGP 396
           +LL+EMLTG PPF   N  ++ +KI+++ ++ P     +A  LL GLL ++ ++RLG   
Sbjct: 181 VLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGY-- 238

Query: 397 GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPK 456
            G+QEIK+H +F  ++WKKL  +  +P F P V+     +NF+E +T    +DS V    
Sbjct: 239 NGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSVVDDSH 298

Query: 457 FNEN---PFKGFTY 467
            +E     F G++Y
Sbjct: 299 LSETVQQQFGGWSY 312

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  301 bits (774), Expect = e-100
 Identities = 126/316 (39%), Positives = 185/316 (58%), Gaps = 37/316 (11%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            F+ +K++G+G   +V+ VR  GT +++A+KV+ K +++++N  + + +E+ IL  +DHP
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHA 268
           F+  L  SFQT+  L LV+D+  GG LF  L RQ      E++AR Y AE++ A+ +LH 
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-------------------------- 302
            GI++RDLKPENILL   GH+ML+DF L+KQ D                           
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181

Query: 303 ----NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ 358
               + RSNS  GT EY++PE++ G GH  A DWW++GILL+EML G  PF G NR +  
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241

Query: 359 QKIIKDKIKLP--AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL 416
             I+K ++  P    +SS A  L++ LL K+ SKRLGS   G+ EIK H +F+ +NW  +
Sbjct: 242 SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK-RGAAEIKQHPFFRGVNWALI 300

Query: 417 EARETRPSFLPEVAGK 432
             R T P  +P     
Sbjct: 301 --RHTTPPIIPRPDDG 314

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  298 bits (764), Expect = 3e-98
 Identities = 135/328 (41%), Positives = 208/328 (63%), Gaps = 15/328 (4%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF  L V+G+G+F KV    R GT E+YA+K+++KD I++ +  E    E+ +L     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 211 -FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            F+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y AEI   +  LH+ 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQ--FDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           GI++RDLK +N++LDA+GH+ + DFG+ K+  F   T + + CGT +Y++PEI+  + + 
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT-TRTFCGTPDYIAPEIIAYQPYG 179

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKE 387
           K+ DWW+ G+LL+EML GQPPF G +  ++ Q I++  +  P  LS EA S+ KGLL K 
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH 239

Query: 388 ASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPL 447
            +KRLG GP G ++I+ H +F+ I+W+KLE RE +P F P+V G+    NF++ +T  P 
Sbjct: 240 PAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFFTREP- 298

Query: 448 LDSPVASP-------KFNENPFKGFTYV 468
              PV +P         +++ F+GF++V
Sbjct: 299 ---PVLTPPDKLVIANIDQSEFQGFSFV 323

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  294 bits (754), Expect = 3e-97
 Identities = 115/290 (39%), Positives = 187/290 (64%), Gaps = 2/290 (0%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D E +K VG G F +V+ VR   +   YA+KVM   +++     +++ +E+ +L +V H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PFI++L ++   +  LY+++++V GG LF  L   G F       Y +EIV A+ +LH+ 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
            I++RDLKPENILLD +GH+ LTDFG AK+  +  R+ ++CGT EY++PE++  KGH+KA
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--RTWTLCGTPEYLAPEVIQSKGHNKA 178

Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEAS 389
            DWW++GIL++EML G PPF   N   I +KI+  K++ P  L   A  L+K LL  + +
Sbjct: 179 VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRT 238

Query: 390 KRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFE 439
           +RLG+   G+ ++K+H+WFK ++W  +  R+ +P  +P+V+     +NF+
Sbjct: 239 RRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFD 288

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  292 bits (750), Expect = 6e-97
 Identities = 108/262 (41%), Positives = 171/262 (65%), Gaps = 4/262 (1%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F +V  V+    +  +A+K ++K  I+E    E++ SE+ IL + +HPFIV+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           +F+ K  +Y+++++  GG L+  L  +GLF E  AR Y A +V A  +LH  GI++RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 278 PENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGI 337
           PEN+LLD++G+V L DFG AK+     ++ + CGT EY++PEI+L KG+D + D+WS+GI
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGI 180

Query: 338 LLFEMLTGQPPFTGGNR--QKIQQKIIK--DKIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
           LL+E+LTG+PPF   +    +I   I+K   K++ P ++   A  L+K LL++   +RLG
Sbjct: 181 LLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLG 240

Query: 394 SGPGGSQEIKSHKWFKMINWKK 415
           +  GG ++IK HKWF   +W+ 
Sbjct: 241 NLKGGIKDIKKHKWFNGFDWEG 262

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  289 bits (740), Expect = 9e-95
 Identities = 128/324 (39%), Positives = 196/324 (60%), Gaps = 15/324 (4%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT-KVDHPFIVQ 214
           KV+G+G+F KV      GT E+YA+KV++KD I++ +  +   +E+ IL     HPF+  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQTK RL+ V+++VNGG L FQ+ R   F E  +R Y AE+  A+  LH +G+++R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLK +NILLDA+GH  L DFG+ K+       + + CGT +Y++PEI+    +  + DWW
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
           ++G+L++EM+ GQPPF   N   + + I+ D +  P +LS EA S+LK  + K  +KRLG
Sbjct: 181 ALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLG 240

Query: 394 SGP--GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSP 451
                GG   IK H +FK I+W  LE R+ +P F P++  K  V NF++ +T     + P
Sbjct: 241 CVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTK----EEP 296

Query: 452 VASP-------KFNENPFKGFTYV 468
           V +P       + N+  F+GF++ 
Sbjct: 297 VLTPVDPAVIKQINQEEFRGFSFF 320

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  287 bits (736), Expect = 5e-94
 Identities = 128/317 (40%), Positives = 197/317 (62%), Gaps = 4/317 (1%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L DFE+ + +G G+F +V   +  GT E YA+K ++K +I++    +++  E++IL ++ 
Sbjct: 17  LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFIV +  SFQ + R+Y +L+FV GG LF  L + G F  D+A+ Y AE+V A  +LH+
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             I++RDLKPEN+LLD  GHV +TDFG AK+  +  R+ ++CGT EY++PE++  KGH K
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--RTFTLCGTPEYLAPEVIQSKGHGK 194

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA 388
           A DWW++G+LL+E + G PPF      +I +KI+  ++K P +    A  L+KGLLQ + 
Sbjct: 195 AVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDH 254

Query: 389 SKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLL 448
           +KRLG+  GG  ++K+H +F   NW KL AR         V      +NFE+ + + P+ 
Sbjct: 255 TKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEK-YPDSPVD 313

Query: 449 DSPVASPKFNENPFKGF 465
             P  +    +  F GF
Sbjct: 314 RLPPLTAA-QQAEFAGF 329

Length = 329

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  285 bits (730), Expect = 1e-93
 Identities = 134/290 (46%), Positives = 201/290 (69%), Gaps = 13/290 (4%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEK-NHAEYMKSERNILTK 206
           +FE+LKV+G GA+ KV+ VR++    + ++YAMKV++K  I++K    E+ ++ER +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 207 VDH-PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +   PF+V L Y+FQT  +L+L+LD++NGG LF  L ++  F+E   +IY+ EIV A+ H
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLG 323
           LH  GI++RD+K ENILLD++GHV+LTDFGL+K+F  DE  R+ S CGT+EYM+P+IV G
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180

Query: 324 --KGHDKAADWWSVGILLFEMLTGQPPFT----GGNRQKIQQKIIKDKIKLPAFLSSEAH 377
              GHDKA DWWS+G+L++E+LTG  PFT      ++ +I ++I+K +   P  +S+ A 
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240

Query: 378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP 427
            +++ LL K+  KRLG GP  + EIK H +F+ INW  L A++    F P
Sbjct: 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  283 bits (726), Expect = 2e-92
 Identities = 116/327 (35%), Positives = 195/327 (59%), Gaps = 13/327 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL---TKVD 208
           F  L V+G+G F KV       T E+YA+K ++K  I+ ++  E +  E+ I        
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPF+V L   FQT+  +  V+++  GG L   ++   +F E  A  Y A +V  + +LH 
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE 119

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQ---FDENTRSNSMCGTLEYMSPEIVLGKG 325
           N I++RDLK +N+LLD +G V + DFGL K+   F +  R+++ CGT E+++PE++    
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETS 177

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G+L++EML G+ PF G + +++   I+ D+++ P FLS EA S+++ LL+
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237

Query: 386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNM 445
           +   +RLGSG   ++++K   +F+ INW  L AR+ +P F+P + G   V+NF+E +T+ 
Sbjct: 238 RNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEEFTSE 297

Query: 446 PLLDSPVASPKF----NENPFKGFTYV 468
             + +P   P+      +  F+GF YV
Sbjct: 298 APVLTPPREPRLLTEEEQELFRGFDYV 324

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  281 bits (722), Expect = 2e-92
 Identities = 104/281 (37%), Positives = 165/281 (58%), Gaps = 23/281 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD- 208
           +DF+  K++G+G+F+ V   +   T++ YA+K++ K +++++   +Y+K E+ +LT+++ 
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I++L Y+FQ +  LY VL++   G L   + + G   E   R Y AEI+ A+ +LH+
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---------------------TRSN 307
            GI+HRDLKPENILLD D H+ +TDFG AK  D N                      R  
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK 367
           S  GT EY+SPE++  K   K++D W++G ++++MLTG+PPF G N     QKI+K +  
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240

Query: 368 LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
            P     +A  L++ LL  +   RLG    G  E+K+H +F
Sbjct: 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNE-GYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  277 bits (712), Expect = 3e-91
 Identities = 106/266 (39%), Positives = 156/266 (58%), Gaps = 15/266 (5%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+L+ +G G+F  VY+ +  GT +I A+K+++K     K        E  IL ++ HP 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPN 59

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+L  +F+ K  LYLV+++  GG LF  L R G   ED A+    +I+  + +LH+NGI
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVL-GKGHDKA 329
           +HRDLKPENILLD +G V + DFGLAK+  +++ S  +  GT  YM+PE++L G G+   
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAF-------LSSEAHSLLKG 382
            D WS+G++L+E+LTG+PPF+G N     Q I +       F        S EA  L+K 
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWF 408
            L K+ SKR       ++EI  H WF
Sbjct: 240 CLNKDPSKRP-----TAEEILQHPWF 260

Length = 260

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  279 bits (716), Expect = 6e-91
 Identities = 139/331 (41%), Positives = 199/331 (60%), Gaps = 22/331 (6%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQ 214
           +G+G F +VYQVR+  T  IYAMKV+ K +I+ K    +   ERNIL +    + PFIV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L++SFQT   LYLV D+++GG LF+ L ++G F ED A+ Y AE+V A+ HLH   I++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAK-QFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADW 332
           DLKPENILLDA GH+ L DFGL+K    +N  +N+ CGT EY++PE++L  KG+ K  D+
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180

Query: 333 WSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-AFLSSEAHSLLKGLLQKEASKR 391
           WS+G+L+FEM  G  PF   + Q++ + I   K++ P   LS E    +KGLL +    R
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240

Query: 392 LGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSP 451
           LG+    + E+K H +F  I+W  L  ++  P F P V     V+NF+  +TN  LL++ 
Sbjct: 241 LGA-HRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFTNSSLLNAG 299

Query: 452 VAS-------PKFNENP--------FKGFTY 467
           +         P  N  P        F+GFT+
Sbjct: 300 IVPWEDVPGLPGANSTPLSSSVQENFRGFTF 330

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  279 bits (715), Expect = 2e-90
 Identities = 127/367 (34%), Positives = 203/367 (55%), Gaps = 52/367 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE +KV+G+GAF +V  V++  T  IYAMK +RK +++EK    ++++ER+IL + D+
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++V+L YSFQ +  LYL+++++ GG +   L ++  F E+  R Y AE + A+  +H  
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN---------------------- 307
           G +HRD+KP+N+LLDA GH+ L+DFGL     ++ R+                       
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 308 -----------------SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFT 350
                            S  GT +Y++PE+ L  G++K  DWWS+G++++EML G PPF 
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240

Query: 351 GGNRQKIQQKII--KDKIKLP--AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHK 406
             N Q+  +KII  K+ ++ P    LS EA  L+K L   EA +RLG+   G  EIKSH 
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN--NGVNEIKSHP 297

Query: 407 WFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENP----F 462
           +FK ++W+ +  RE     +PE+      +NF++       + +    P+         F
Sbjct: 298 FFKGVDWEHI--RERPAPIIPELKSITDTSNFDDFEEIDLDVPTSPGPPRGKIKSKDLAF 355

Query: 463 KGFTYVR 469
            G+TY R
Sbjct: 356 IGYTYKR 362

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  277 bits (710), Expect = 4e-90
 Identities = 123/298 (41%), Positives = 193/298 (64%), Gaps = 3/298 (1%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K++G+G F KV  VR   T + YAMK+++K+ I+ K+   +  +E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +LH+  +++RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 276 LKPENILLDADGHVMLTDFGLAKQ--FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           LK EN++LD DGH+ +TDFGL K+   D  T   + CGT EY++PE++    + +A DWW
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
            +G++++EM+ G+ PF   + +K+ + I+ ++I+ P  LS EA SLL GLL+K+  +RLG
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239

Query: 394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSP 451
            GP  ++EI  H++F  INW+ +  ++  P F P+V  +     F+E +T   +  +P
Sbjct: 240 GGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQSITITP 297

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  274 bits (704), Expect = 4e-90
 Identities = 105/260 (40%), Positives = 165/260 (63%), Gaps = 6/260 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FE+L+V+G+GAF KV  V++  T +++AMK M K K +EK     + +ER IL +++HPF
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +V L YSFQ +  +YLV+D + GG L + L ++  F E+  + +  EIV A+ +LH+ GI
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
           +HRD+KP+NILLD  GHV +TDF +A +   +T + S  GT  YM+PE++  +G+  A D
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVD 181

Query: 332 WWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA 388
           WWS+G+  +E L G+ P+ G     R +I+ K     +  PA  S+EA   +  LL+++ 
Sbjct: 182 WWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDP 241

Query: 389 SKRLGSGPGGSQEIKSHKWF 408
            KRLG      +++K+H +F
Sbjct: 242 QKRLGDNL---KDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  273 bits (699), Expect = 1e-88
 Identities = 132/321 (41%), Positives = 195/321 (60%), Gaps = 9/321 (2%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQ 214
           KV+G+G+F KV   +R      YA+KV++K  I++K    ++ +ERN+L K + HPF+V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L YSFQT  +LY VLD+VNGG LFF L R+  F E  AR Y AE+ SA+ +LH+  I++R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLKPENILLD+ GHV+LTDFGL K+  +    +++ CGT EY++PE++  + +D+  DWW
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
            +G +L+EML G PPF   +  ++   I+   ++LP   +  A  LL GLL K+  +RLG
Sbjct: 181 CLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLG 240

Query: 394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVA 453
           +      EIK+H +F  INW  L  +   P + P VAG   + +F+  +T   +  S   
Sbjct: 241 A-KADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQ 299

Query: 454 SPKFN------ENPFKGFTYV 468
           +P          + F GF+Y 
Sbjct: 300 TPDLTASSSSASSAFLGFSYA 320

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  273 bits (698), Expect = 2e-88
 Identities = 138/326 (42%), Positives = 206/326 (63%), Gaps = 12/326 (3%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQ 214
           KV+G+G+F KV   R     + YA+KV++K  I++K   +++ SERN+L K V HPF+V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L +SFQT  +LY VLD++NGG LF+ L R+  F E  AR Y AEI SA+ +LH+  I++R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLKPENILLD+ GH++LTDFGL K+  + N  +++ CGT EY++PE++  + +D+  DWW
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
            +G +L+EML G PPF   N  ++   I+   ++L   +++ A  LL+GLLQK+ +KRLG
Sbjct: 181 CLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLG 240

Query: 394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVA 453
           +      EIK+H +F  INW  L  ++  P F P V+G + + +F+  +T  P+ +S   
Sbjct: 241 A-KDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQ 299

Query: 454 SP---------KFNENPFKGFTYVRP 470
           SP         K     F GF+Y  P
Sbjct: 300 SPDSILVTASVKEAAEAFLGFSYAPP 325

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  269 bits (690), Expect = 4e-87
 Identities = 133/323 (41%), Positives = 205/323 (63%), Gaps = 6/323 (1%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E    E+ +L   D P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 211 -FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            F+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y AEI   +  LH  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           GI++RDLK +N++LD++GH+ + DFG+ K+   +   + + CGT +Y++PEI+  + + K
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGK 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA 388
           + DWW+ G+LL+EML GQPPF G +  ++ Q I++  +  P  LS EA S+ KGL+ K  
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP 240

Query: 389 SKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWT-NMPL 447
           SKRLG GP G ++I+ H +F+ I+W KLE RE +P F P+V GK    NF++ +T   P+
Sbjct: 241 SKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKFFTRGQPV 299

Query: 448 LDSP--VASPKFNENPFKGFTYV 468
           L  P  +     ++  F+GF+YV
Sbjct: 300 LTPPDQLVIANIDQADFEGFSYV 322

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  269 bits (689), Expect = 4e-87
 Identities = 121/322 (37%), Positives = 196/322 (60%), Gaps = 13/322 (4%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT-KVDHPFIVQ 214
           KV+G+G+F KV      GT+E +A+K ++KD ++E +  E    ER +L    +HPF+  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L  +FQTK  L+ V++++NGG L F +   G F E  AR Y AEI+  +  LH  GI++R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAK-QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLK +N+LLD DGH+ + DFG+ K   +   ++++ CGT +Y++PEI+ G+ ++++ DWW
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
           S G+LL+EML GQ PF G +  ++   I+ D+   P ++S EA   L  L +++ +KRLG
Sbjct: 181 SFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLG 240

Query: 394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN-----MPLL 448
                  +I+ H +F+ I+W++LE RE  P F P+V      +NF+  +TN      P+ 
Sbjct: 241 V----DGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRLSPVD 296

Query: 449 DSPVASPKFNENPFKGFTYVRP 470
              +AS   ++  F+GF++  P
Sbjct: 297 KKLLAS--MDQEQFRGFSFTNP 316

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  267 bits (683), Expect = 4e-86
 Identities = 127/327 (38%), Positives = 205/327 (62%), Gaps = 14/327 (4%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E    E+ +L     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 211 -FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            F+ QL   FQT  RLY V+++VNGG L +Q+ + G F+E  A  Y AEI   +  LH+ 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           GI++RDLK +N++LD++GH+ + DFG+ K+   +   + + CGT +Y++PEI+  + + K
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA 388
           + DWW+ G+LL+EML GQ PF G +  ++ Q I++  +  P  +S EA ++ KGL+ K  
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 240

Query: 389 SKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLL 448
            KRLG GP G ++IK H +F+ I+W+KLE +E +P + P+  G+    NF++ +T  P  
Sbjct: 241 GKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACGRD-AENFDKFFTRHP-- 297

Query: 449 DSPVASP-------KFNENPFKGFTYV 468
             PV +P         +++ F+GF+YV
Sbjct: 298 --PVLTPPDQEVIMNLDQSEFEGFSYV 322

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  265 bits (678), Expect = 2e-85
 Identities = 126/331 (38%), Positives = 209/331 (63%), Gaps = 21/331 (6%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL-TKVDHPFIVQ 214
           +V+G+G++AKV  V    T  IYAMKV++K+ + +    +++++E+++  T  +HPF+V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQT+ RL+ V++FV+GG L F + RQ    E+ AR Y+AEI  A++ LH  GI++R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQFDENTR----SNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLK +N+LLDA+GH+ LTD+G+ K   E  R    +++ CGT  Y++PEI+ G+ +  + 
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 331 DWWSVGILLFEMLTGQPPF--TGGNRQKIQ-------QKIIKDKIKLPAFLSSEAHSLLK 381
           DWW++G+L+FEM+ G+ PF   G +    Q       Q I++ +I++P  LS +A S+LK
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237

Query: 382 GLLQKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           G L K+  +RLG  P  G ++IKSH +F+ I+W  LE ++  P + P +     + NF+ 
Sbjct: 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDP 297

Query: 441 CWTNMPLL---DSPVASPKFNENPFKGFTYV 468
            +T+ P+    D P    + +++ F+GF Y+
Sbjct: 298 QFTDEPVQLTPDDPDVIARIDQSEFEGFEYI 328

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  264 bits (677), Expect = 2e-85
 Identities = 116/297 (39%), Positives = 191/297 (64%), Gaps = 1/297 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +LH+  +++RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 276 LKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
           +K EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++    + +A DWW 
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 180

Query: 335 VGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGS 394
           +G++++EM+ G+ PF   + +++ + I+ ++I+ P  LS EA SLL GLL+K+  +RLG 
Sbjct: 181 LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 240

Query: 395 GPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSP 451
           GP  ++E+  H++F  INW+ +  ++  P F P+V  +     F++ +T   +  +P
Sbjct: 241 GPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITP 297

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  262 bits (671), Expect = 2e-84
 Identities = 120/319 (37%), Positives = 191/319 (59%), Gaps = 6/319 (1%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
           +V+G+G+F KV   R   +  +YA+KV++KD I++ +  E   +E+ IL+   +HPF+ Q
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQT  RL+ V++FVNGG L F + +   F E  AR Y AEI SA+  LH  GI++R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLK +N+LLD +GH  L DFG+ K+       +++ CGT +Y++PEI+    +  + DWW
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
           ++G+LL+EML G  PF   N   + + I+ D++  P +LS +A  +LK  + K  + RLG
Sbjct: 181 AMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLG 240

Query: 394 S-GPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPV 452
           S   GG + I  H +FK ++W+KL  R+  P F P +  +  V+NF+  +     + +P+
Sbjct: 241 SLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKEDPVLTPI 300

Query: 453 AS---PKFNENPFKGFTYV 468
                P  N++ F+ F+Y 
Sbjct: 301 EESLLPMINQDEFRNFSYT 319

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  262 bits (670), Expect = 3e-84
 Identities = 124/311 (39%), Positives = 197/311 (63%), Gaps = 3/311 (0%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K++G+G F KV  VR   + + YAMK+++K+ I+ K+   +  +E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +YSFQTK RL  V+++VNGG LFF L R+ +F ED  R Y AEIVSA+ +LH+  I++RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 276 LKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
           LK EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++    + +A DWW 
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 180

Query: 335 VGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGS 394
           +G++++EM+ G+ PF   + +K+ + I+ + IK P  LS++A SLL GLL K+ +KRLG 
Sbjct: 181 LGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGG 240

Query: 395 GPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVAS 454
           GP  ++EI  H +F  +NW+ +  ++  P F P+V  +     F+E +T   +  +P   
Sbjct: 241 GPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQTITITP--P 298

Query: 455 PKFNENPFKGF 465
            K++E+     
Sbjct: 299 EKYDEDGMDCM 309

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  258 bits (660), Expect = 1e-82
 Identities = 132/326 (40%), Positives = 200/326 (61%), Gaps = 12/326 (3%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQ 214
           KV+G+G+F KV   +R    + YA+KV++K  ++ +   +++ +ERN+L K V HPF+V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L YSFQT  +LY VLDFVNGG LFF L R+  F E  AR Y AEI SA+ +LH+  I++R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLKPENILLD+ GHV+LTDFGL K+   ++  + + CGT EY++PE++  + +D   DWW
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
            +G +L+EML G PPF   +  ++   I+   + L    S  A S+L+ LL+K+  +RLG
Sbjct: 181 CLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLG 240

Query: 394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVA 453
           +      EI+ H +F+ ++W  LE ++  P F P V G   ++NF+  +T   +  S   
Sbjct: 241 AKE-DFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCF 299

Query: 454 SPKFN---------ENPFKGFTYVRP 470
           S  ++         ++ F GF+Y  P
Sbjct: 300 SSDYSIVNASVLEADDAFVGFSYAPP 325

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  256 bits (656), Expect = 5e-82
 Identities = 125/325 (38%), Positives = 196/325 (60%), Gaps = 9/325 (2%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L    HPF+  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHR 274
           +YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +LH+   +++R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLK EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++    + +A DWW
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 180

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
            +G++++EM+ G+ PF   + +K+ + I+ ++I+ P  LS EA SLL GLL+K+  +RLG
Sbjct: 181 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLG 240

Query: 394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVA 453
            GP  ++EI  HK+F  I W+ +  ++  P F P+V  +     F+E +T   +  +P  
Sbjct: 241 GGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMITITPPD 300

Query: 454 SPKFNEN-------PFKGFTYVRPA 471
                E         F  F+Y   A
Sbjct: 301 QDDSMETVDNERRPHFPQFSYSASA 325

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  258 bits (660), Expect = 6e-82
 Identities = 135/376 (35%), Positives = 203/376 (53%), Gaps = 62/376 (16%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  +K +G GAF +V  VR++ T+ +YAMK +RK  ++ +N A ++K+ER+IL + D+ +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +V+L YSFQ K  LY V+D++ GG +   L R G+F EDLAR Y AE+  A+  +H  G 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF-----------DENTRSNSM----------- 309
           +HRD+KP+NIL+D DGH+ LTDFGL   F            ++ R +SM           
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 310 ----------------------CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQP 347
                                  GT  Y++PE++L  G+ +  DWWSVG++L+EML GQP
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 348 PFTGGNRQKIQQKII--KDKIKLP--AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIK 403
           PF      + Q K+I  +  + +P  A LS EA  L+  L    A  RLG    G+ EIK
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK--NGADEIK 299

Query: 404 SHKWFKMINWKKLEARETRPSFLPEVAGKHCVANF-----EECWTNMPLLDSPVASPKFN 458
           +H +FK I++  L  R+  P ++P++      +NF     E+  ++     SP  + K N
Sbjct: 300 AHPFFKGIDFASLIRRQKAP-YIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDRNVKPN 358

Query: 459 -----ENPFKGFTYVR 469
                E+ F  FT+ R
Sbjct: 359 NRKRTEHAFYEFTFRR 374

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  255 bits (652), Expect = 2e-81
 Identities = 120/340 (35%), Positives = 184/340 (54%), Gaps = 33/340 (9%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF++L  VGQG + +V+  ++  T EI A+K M+K  + + N   ++ +ER+ILT     
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           ++V+L Y+FQ    LYL +++V GG     L   G+  ED AR Y AE+  AV  LH  G
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
            +HRDLKPEN L+DA GH+ LTDFGL+K     T +NS+ G+ +YM+PE++ GKG+D   
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGI--VTYANSVVGSPDYMAPEVLRGKGYDFTV 179

Query: 331 DWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK--------DKIKLPAFLSSEAHSLLKG 382
           D+WS+G +L+E L G PPF+G    +  + +                  LS EA  L+  
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITK 239

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECW 442
           L+  + S+R GS     ++IK+H +FK ++W +L  RE +P F+PE+  +     F++ +
Sbjct: 240 LIN-DPSRRFGS----LEDIKNHPFFKEVDWNEL--RELKPPFVPELESEIDTGYFDD-F 291

Query: 443 TNMPLLD---------------SPVASPKFNENPFKGFTY 467
            N   +                        N   F GFT+
Sbjct: 292 ENEDDMAKYKDVHEKKKAAGKGGANGRDPGNRRKFVGFTF 331

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  248 bits (636), Expect = 1e-79
 Identities = 100/277 (36%), Positives = 164/277 (59%), Gaps = 6/277 (2%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F +V   +   T ++YA K + K ++ ++   +   +E+ IL KV   FIV L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +F+TK  L LV+  +NGG L + +Y  G   F E  A  Y A+I+  + HLH   I++RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 276 LKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSV 335
           LKPEN+LLD  G+V ++D GLA +     +     GT  YM+PE++ G+ +D + DW+++
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFAL 180

Query: 336 GILLFEMLTGQPPF----TGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKR 391
           G  L+EM+ G+ PF        +++++++ ++  ++ P   S EA  L + LLQK+  KR
Sbjct: 181 GCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240

Query: 392 LGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
           LG   G + E++ H  FK +NW++LEA    P F+P+
Sbjct: 241 LGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  249 bits (638), Expect = 2e-79
 Identities = 122/326 (37%), Positives = 205/326 (62%), Gaps = 13/326 (3%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQ 214
           +V+G+G++AKV  VR     +IYAMKV++K+ + +    +++++E+++  +   +PF+V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQT  RL+LV+++VNGG L F + RQ    E+ AR Y AEI  A++ LH  GI++R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLK +N+LLDADGH+ LTD+G+ K+       +++ CGT  Y++PEI+ G+ +  + DWW
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWW 180

Query: 334 SVGILLFEMLTGQPPF-------TGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQK 386
           ++G+L+FEM+ G+ PF              + Q I++  I++P FLS +A  +LKG L K
Sbjct: 181 ALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNK 240

Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNM 445
           +  +RLG  P  G  +IKSH +F+ I+W  LE ++  P F P++   + + NF+  +T+ 
Sbjct: 241 DPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFDTQFTSE 300

Query: 446 PLLDSPVAS---PKFNENPFKGFTYV 468
           P+  +P       + +++ F+GF Y+
Sbjct: 301 PVQLTPDDEDVIKRIDQSEFEGFEYI 326

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  247 bits (631), Expect = 3e-79
 Identities = 112/264 (42%), Positives = 163/264 (61%), Gaps = 10/264 (3%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL-TKVDHPFIV 213
           LK + +GAF  VY  ++  T + +A+KV++K  ++ KN    +K+ER I+  + + P++ 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
           +L YSFQ+K  LYLV++++NGG     +   G   ED A+ Y AE+V  V  LH  GI+H
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           RD+KPEN+L+D  GH+ LTDFGL++   EN +     GT +Y++PE +LG G DK +DWW
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKK---FVGTPDYLAPETILGVGDDKMSDWW 177

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKGLLQKEAS 389
           S+G ++FE L G PPF       +   I+  +I  P     F S EA  L+  LL  + +
Sbjct: 178 SLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA 237

Query: 390 KRLGSGPGGSQEIKSHKWFKMINW 413
           KRLG+   G QEIKSH +FK INW
Sbjct: 238 KRLGA--NGYQEIKSHPFFKSINW 259

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  239 bits (613), Expect = 2e-76
 Identities = 83/247 (33%), Positives = 146/247 (59%), Gaps = 7/247 (2%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            +E++K +G+G+F KVY VRR    ++Y +K +    + EK   + +  E  IL K++HP
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHP 59

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHL 266
            I++   SF+ K +L +V+++ +GG L  ++ +Q      F E+    +  ++  A+ +L
Sbjct: 60  NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVLGKG 325
           H+  I+HRD+KP+NI L ++G V L DFG++K          ++ GT  Y+SPE+   K 
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP 179

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAFLSSEAHSLLKGLL 384
           ++  +D WS+G +L+E+ T + PF G N  ++  KI+K +   +P+  SSE  +L+  LL
Sbjct: 180 YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL 239

Query: 385 QKEASKR 391
           QK+  +R
Sbjct: 240 QKDPEER 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  236 bits (603), Expect = 3e-74
 Identities = 121/328 (36%), Positives = 210/328 (64%), Gaps = 15/328 (4%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
           +V+G+G++AKV  VR   T  IYAMKV++K+ + +    +++++E+++  +  +HPF+V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++LH  GI++R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           DLK +N+LLD++GH+ LTD+G+ K+       +++ CGT  Y++PEI+ G+ +  + DWW
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 180

Query: 334 SVGILLFEMLTGQPPF--TGGNRQKIQ-------QKIIKDKIKLPAFLSSEAHSLLKGLL 384
           ++G+L+FEM+ G+ PF   G +    Q       Q I++ +I++P  LS +A S+LK  L
Sbjct: 181 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL 240

Query: 385 QKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWT 443
            K+  +RLG  P  G  +I+ H +F+ ++W  +E ++  P F P ++G+  + NF+  +T
Sbjct: 241 NKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFDAQFT 300

Query: 444 NMPLLDSPVASP---KFNENPFKGFTYV 468
           N P+  +P       K +++ F+GF Y+
Sbjct: 301 NEPVQLTPDDDDIVRKIDQSEFEGFEYI 328

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  235 bits (600), Expect = 7e-74
 Identities = 117/322 (36%), Positives = 195/322 (60%), Gaps = 13/322 (4%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
           K++G+G+F KV+     GT++ +A+K ++KD ++  +  E    E+ +L+   +HPF+  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR--IYTAEIVSAVSHLHANGIM 272
           L  +FQTK  L+ V++++NGG L F +  Q   + DL R   Y AEI+  +  LH+ GI+
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118

Query: 273 HRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
           +RDLK +NILLD DGH+ + DFG+ K+    + ++ + CGT +Y++PEI+LG+ ++ + D
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVD 178

Query: 332 WWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKR 391
           WWS G+LL+EML GQ PF G + +++ Q I  D    P +L+ EA  +L  L  +E  +R
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERR 238

Query: 392 LGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN-MPLLDS 450
           LG       +I+ H +F+ I+W  LE RE  P F P+V   +  +NF++ + N  P L  
Sbjct: 239 LGV----KGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLSV 294

Query: 451 P--VASPKFNENPFKGFTYVRP 470
              +     ++N F+ F+++ P
Sbjct: 295 TDRMLINSMDQNMFENFSFINP 316

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  234 bits (598), Expect = 2e-73
 Identities = 119/343 (34%), Positives = 185/343 (53%), Gaps = 37/343 (10%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DF+V  +VG+G F +V  VR   T +IYAMKVM+K  ++ +    + + ER+IL+  + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
           P+I QL+Y+FQ K  LYLV+++  GG L   L R +  F ED+A+ Y AE+V A+  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM--CGTLEYMSPEIVL---- 322
            G +HRD+KPEN+L+D  GH+ L DFG A +   N   NS    GT +Y++PE++     
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180

Query: 323 -GKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII--KDKIKLPAFL--SSEA 376
            GKG +    DWWS+G++ +EM+ G+ PF  G   K    I+  +  +K P     SS+ 
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240

Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVA 436
             L++ LL     +RL     G + +  H +F  I+W  +  R + P F+P +      +
Sbjct: 241 LDLIQSLLCG-QKERL-----GYEGLCCHPFFSKIDWNNI--RNSLPPFVPTLKSDDDTS 292

Query: 437 NFEECWTNMPLLDSPVASPKFNEN-----------PFKGFTYV 468
           NF+E     P  +S   S                 PF GF+++
Sbjct: 293 NFDE-----PEKNSTRRSQSSTTQLKPNGFSGKDLPFVGFSFI 330

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  235 bits (601), Expect = 3e-73
 Identities = 129/381 (33%), Positives = 196/381 (51%), Gaps = 67/381 (17%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF  +KV+G+GAF +V  V++  T +IYAMK + K ++ +K+   ++K+ER++L + D 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++V L YSFQ    LYL+++F+ GG L   L +   F ED+ R Y AE V A+  +H  
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLA----KQFDEN---------------------- 303
           G +HRD+KP+NIL+D  GH+ L+DFGL+    KQ D                        
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 304 ------TRSN----------------SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFE 341
                 T S+                S  GT +Y++PEI L +G+ +  DWWS+G ++FE
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240

Query: 342 MLTGQPPFTGGNRQKIQQKII--KDKIKLP--AFLSSEAHSLLKGLLQKEASKRLGSGPG 397
            L G PPF   N  +  +KII  ++ +  P    LS EA  L++ L+   A  RLG   G
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGR--G 297

Query: 398 GSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWT----NMPLLDSP-- 451
           G+ EIKSH +F+ ++W  +  R+ R  F+P++      + F           P L     
Sbjct: 298 GAHEIKSHPFFRGVDWDTI--RQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAP 355

Query: 452 ---VASPKFNENPFKGFTYVR 469
                S + +   F G+TY R
Sbjct: 356 AQQEESVELDL-AFIGYTYKR 375

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  235 bits (600), Expect = 4e-73
 Identities = 123/339 (36%), Positives = 189/339 (55%), Gaps = 24/339 (7%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  EDF+V+KV+G+GAF +V  VR   + ++YAMK++ K ++++++ + +   ER+I+  
Sbjct: 40  MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH 99

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            +  +IVQL Y+FQ    LY+V++++ GG L   L       E  AR YTAE+V A+  +
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEKWARFYTAEVVLALDAI 158

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGK 324
           H+ G +HRD+KP+N+LLD  GH+ L DFG   + D N   R ++  GT +Y+SPE++  +
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218

Query: 325 GHD----KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII--KDKIKLP--AFLSSEA 376
           G D    +  DWWSVG+ L+EML G  PF   +      KI+  K+ +  P    +S +A
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278

Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVA 436
             L+   L  +   RLG    G  EIKSH +FK   W     RET    +PE++     +
Sbjct: 279 KDLICAFLT-DREVRLGR--NGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTS 335

Query: 437 NFEECWTNMPLLDSPVAS---PK-FNEN--PFKGFTYVR 469
           NF++        D    +   PK F  N  PF GFTY +
Sbjct: 336 NFDDIED----DDKNEETFPLPKAFAGNQLPFIGFTYSK 370

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  234 bits (597), Expect = 4e-73
 Identities = 125/324 (38%), Positives = 181/324 (55%), Gaps = 9/324 (2%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVR-RIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           P     +  EDF  ++ +G G+F +V     +       A+K   K KI+++   +++ S
Sbjct: 21  PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80

Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           ER IL  ++HPF V L  SF+ +  LYLVL+FV GG  F  L R   F  D+   Y A+I
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           V    +L +  I++RDLKPEN+LLD DG + +TDFG AK  D  TR+ ++CGT EY++PE
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD--TRTYTLCGTPEYIAPE 198

Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSL 379
           I+L  GH KAADWW++GI ++E+L G PPF       I QKI++  I  P FL +    L
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258

Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFE 439
           +K LL  + +KR G+   G+Q +K H WF  I+W  L  +     + P+       +NFE
Sbjct: 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFE 318

Query: 440 ECWTNMPLLDSPVASPKFNEN-PF 462
               ++ + D        NEN PF
Sbjct: 319 RVQEDLTIADKIT-----NENDPF 337

Length = 340

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  230 bits (588), Expect = 2e-72
 Identities = 105/284 (36%), Positives = 165/284 (58%), Gaps = 8/284 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK-SERNILTKVDHP 210
           F   +V+G+G F +V   +   T ++YA K + K +I +K   E M  +E+ IL KV+  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKQILEKVNSR 60

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHA 268
           F+V L Y+++TK  L LVL  +NGG L F +Y      F E+ A  Y AEI   +  LH 
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             I++RDLKPENILLD  GH+ ++D GLA +  E        GT+ YM+PE+V  + +  
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLL 384
           + DWW +G L++EM+ G+ PF        R+++++++ +D+ +     S  A S+ + LL
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL 240

Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
            K+   RLG    G++E+K+H +F+  N+K+LEA    P F P+
Sbjct: 241 TKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  231 bits (590), Expect = 2e-72
 Identities = 116/327 (35%), Positives = 191/327 (58%), Gaps = 23/327 (7%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
           KV+G+G+F KV      G  E +A+K ++KD ++  +  E    E+ +L    ++PF+  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L  +FQTK  L+ V++F+NGG L F +  +G F    A  Y AEIV  +  LH+ GI++R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 275 DLKPENILLDADGHVMLTDFGLAKQ--FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADW 332
           DLK +N++LD DGH+ + DFG+ K+  F +N R+++ CGT +Y++PEI+ G  +  + DW
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RASTFCGTPDYIAPEILQGLKYTFSVDW 179

Query: 333 WSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRL 392
           WS G+LL+EML GQ PF G +  ++ + I  D    P +++ E+  +L+ L +++ ++RL
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRL 239

Query: 393 GSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE---------CWT 443
           G        I+ H +FK INW  LE RE  P F P+V      +NF+           ++
Sbjct: 240 GV----VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLSYS 295

Query: 444 NMPLLDSPVASPKFNENPFKGFTYVRP 470
           +  L+DS       +++ F GF+++ P
Sbjct: 296 DKNLIDS------MDQSAFAGFSFINP 316

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  230 bits (587), Expect = 1e-71
 Identities = 123/336 (36%), Positives = 190/336 (56%), Gaps = 24/336 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE+LKV+G+GAF +V  V+   T ++YAMK++ K +++++      + ER++L   D 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ +  LYLV+D+  GG L   L + +    ED+AR Y AE+V A+  +H 
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFG--LAKQFDENTRSNSMCGTLEYMSPEIVL---- 322
            G +HRD+KP+N+LLD +GH+ L DFG  L    D   +SN   GT +Y+SPEI+     
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180

Query: 323 GKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII--KDKIKLPAF---LSSEA 376
           GKG      DWWS+G+ ++EML G+ PF   +  +   KI+  K+  + P     +S EA
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240

Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVA 436
             L++ L+      RLG    G Q+ K H +F+ I+W  +  R +   ++PEV+     +
Sbjct: 241 KDLIRRLICS-PETRLGR--NGLQDFKDHPFFEGIDWDNI--RNSTAPYVPEVSSPTDTS 295

Query: 437 NF---EECWTNMPLLDSPVASPKFNEN--PFKGFTY 467
           NF   ++   N   L  P +   F+ N  PF GFTY
Sbjct: 296 NFDVDDDDLRNTESL-PPSSHGAFSGNHLPFVGFTY 330

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  227 bits (581), Expect = 4e-71
 Identities = 111/302 (36%), Positives = 182/302 (60%), Gaps = 23/302 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE +K++  GA+  VY VR   T + +AMK + K  ++ +N  + +  ER+ILT  ++
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF+V +  SF+TK  L +V+++V GG     L   G    D+AR+Y AE V A+ +LH  
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAK-------------QFDENTRS---NSMCGTL 313
           GI+HRDLKP+N+L+ + GH+ LTDFGL+K               +++TR      +CGT 
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180

Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA--- 370
           EY++PE++L +G+ K  DWW++GI+L+E L G  PF G   +++  ++I D I+ P    
Sbjct: 181 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240

Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVA 430
            L ++A  L+  LL++   +RLG+  GG+ E+K H++F  ++W  L     +  F+P++ 
Sbjct: 241 ALPADAQDLISRLLRQNPLERLGT--GGAFEVKQHRFFLGLDWNGL--LRQKAEFIPQLE 296

Query: 431 GK 432
            +
Sbjct: 297 SE 298

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  222 bits (568), Expect = 3e-68
 Identities = 121/340 (35%), Positives = 182/340 (53%), Gaps = 56/340 (16%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  +K +G GAF +V   R++ T  +YAMK +RK  ++ +N   ++K+ER+IL + D+ +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +V+L YSFQ K  LY V+D++ GG +   L R G+F EDLAR Y AE+  AV  +H  G 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF----------------------------DEN 303
           +HRD+KP+NIL+D DGH+ LTDFGL   F                              N
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 304 TR--------------------SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
            R                    ++S+ GT  Y++PE++L  G+ +  DWWSVG++L+EML
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 344 TGQPPFTGGNRQKIQQKIIKDK----IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGS 399
            GQPPF      + Q K+I  +    I   A LS EA  L+  L  +    RLG    G+
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK--NGA 299

Query: 400 QEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFE 439
            EIK+H +FK I++   + R+    ++P++      +NF+
Sbjct: 300 DEIKAHPFFKTIDFSS-DLRQQSAPYIPKITHPTDTSNFD 338

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  213 bits (546), Expect = 2e-66
 Identities = 85/249 (34%), Positives = 140/249 (56%), Gaps = 9/249 (3%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++   +++G+G+F  VY      T E+ A+K +      E+      + E  IL+ + HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALER-EIRILSSLQHP 59

Query: 211 FIVQLRYSFQTKYR--LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV+   S + + +  L + L++V+GG L   L + G   E + R YT +I+  +++LH+
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKG 325
           NGI+HRD+K  NIL+D+DG V L DFG AK+  +      + S+ GT  +M+PE++ G+ 
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKIK--LPAFLSSEAHSLLKG 382
           + +AAD WS+G  + EM TG+PP++  GN      KI        +P  LS EA   L+ 
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239

Query: 383 LLQKEASKR 391
            L+++  KR
Sbjct: 240 CLRRDPKKR 248

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  213 bits (544), Expect = 4e-66
 Identities = 108/279 (38%), Positives = 171/279 (61%), Gaps = 10/279 (3%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIV 213
           ++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ V   D PFIV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
            + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  + H+H   +++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG--HDKAAD 331
           RDLKP NILLD  GHV ++D GLA  F +  + ++  GT  YM+PE VL KG  +D +AD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPE-VLQKGVAYDSSAD 178

Query: 332 WWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA 388
           W+S+G +LF++L G  PF      ++ +I +  +   ++LP   S E  SLL+GLLQ++ 
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 238

Query: 389 SKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP 427
           ++RLG    G+QE+K H +F+ ++W+ +  ++  P  +P
Sbjct: 239 NRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIP 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  217 bits (553), Expect = 5e-66
 Identities = 129/381 (33%), Positives = 198/381 (51%), Gaps = 67/381 (17%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  +K +G GAF +V    ++ T  +YAMK +RK  ++ +N   ++K+ER+IL + D+ +
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +V+L YSFQ K  LY V+D++ GG +   L R  +F E LAR Y AE+  A+  +H  G 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF--DENTR----------------------SN 307
           +HRD+KP+NIL+D DGH+ LTDFGL   F    N++                      SN
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 308 SMCG----TLE--------------------YMSPEIVLGKGHDKAADWWSVGILLFEML 343
             CG    TLE                    Y++PE++L KG+ +  DWWSVG++LFEML
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 344 TGQPPFTGGNRQKIQQKII--KDKIKLPA--FLSSEAHSLLKGLLQKEASKRLGSGPGGS 399
            GQPPF      + Q K+I  ++ + +P    LS EA  L+   L   A +RLG    G+
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLI-TKLCCSAEERLGR--NGA 299

Query: 400 QEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDS--------- 450
            +IK+H +F  +++      +  P ++P+++     +NF+      P  D+         
Sbjct: 300 DDIKAHPFFSEVDFSSDIRTQPAP-YVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWD 358

Query: 451 PVASP--KFNENPFKGFTYVR 469
            + SP  K  E+ F  FT+ R
Sbjct: 359 TLCSPNGKHPEHAFYEFTFRR 379

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  212 bits (540), Expect = 2e-65
 Identities = 108/278 (38%), Positives = 170/278 (61%), Gaps = 8/278 (2%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIV 213
           ++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ V   D PFIV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
            + Y+F T  +L  +LD +NGG L + L + G+F E   R Y  EI+  + H+H   +++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL-GKGHDKAADW 332
           RDLKP NILLD  GHV ++D GLA  F +  + ++  GT  YM+PE++  G  +D +ADW
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGTAYDSSADW 179

Query: 333 WSVGILLFEMLTGQPPF---TGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEAS 389
           +S+G +LF++L G  PF      ++ +I +  +   ++LP   S E  SLL+GLLQ++ S
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS 239

Query: 390 KRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP 427
           KRLG    G+QE+K H +FK I+W+++  ++  P  +P
Sbjct: 240 KRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  210 bits (537), Expect = 6e-65
 Identities = 104/283 (36%), Positives = 166/283 (58%), Gaps = 6/283 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F   +V+G+G F +V   +   T ++YA K + K +I ++       +E+ IL KV+  F
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHAN 269
           +V L Y+++TK  L LVL  +NGG L F +Y  G   F E+ A  Y AEI+  +  LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
             ++RDLKPENILLD  GH+ ++D GLA +  E        GT+ YM+PE++  + +  +
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181

Query: 330 ADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQ 385
            D+W +G L++EM+ GQ PF G      R+++ +++++ +    A  S EA S+ K LL 
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241

Query: 386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
           K+  +RLG    G+ E+K H +F+ +N+K+LEA    P F+P+
Sbjct: 242 KDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  206 bits (526), Expect = 3e-63
 Identities = 111/284 (39%), Positives = 164/284 (57%), Gaps = 8/284 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F   +V+G+G F +V   +   T ++YA K + K +I ++       +E+ IL KV+  F
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHAN 269
           +V L Y+++TK  L LVL  +NGG L F +Y  G   F E  A  Y AEI   +  LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
            I++RDLKPENILLD  GH+ ++D GLA    E        GT+ YM+PE+V  + +  +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181

Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-----LPAFLSSEAHSLLKGLL 384
            DWW++G LL+EM+ GQ PF    ++KI+++ ++  +K          S +A SL K LL
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQ-QRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL 240

Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
            K+  +RLG   GG++E+K H  FK IN+K+LEA    P F P+
Sbjct: 241 CKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  206 bits (525), Expect = 3e-63
 Identities = 101/280 (36%), Positives = 166/280 (59%), Gaps = 9/280 (3%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F +V   +   T ++YA K + K ++ ++   E    E+ IL KV   FIV L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
           +FQTK  L LV+  +NGG L + +Y        F E  A  YTA+I+S + HLH   I++
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDKAADW 332
           RDLKPEN+LLD DG+V ++D GLA +  D  +++    GT  +M+PE++ G+ +D + D+
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDY 180

Query: 333 WSVGILLFEMLTGQPPF-TGGNR---QKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA 388
           +++G+ L+EM+  + PF   G +   ++++Q+I+ D +  P   S  + S  + LL K+ 
Sbjct: 181 FALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP 240

Query: 389 SKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
            KRLG   G    +++H  F+ +NW++LEA    P F+P+
Sbjct: 241 EKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  203 bits (520), Expect = 1e-62
 Identities = 91/264 (34%), Positives = 140/264 (53%), Gaps = 18/264 (6%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEYMKSERNILTKVD 208
            FE+L+ +G+G F +VY+ R   T +  A+KV+     +  EK   E       IL K  
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEI-----QILKKCK 55

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           HP IV+   S+  K  L++V++F +GG L    +   Q L    +A +   E++  + +L
Sbjct: 56  HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYV-CKELLKGLEYL 114

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           H+NGI+HRD+K  NILL +DG V L DFGL+ Q  +    N+M GT  +M+PE++ GK +
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY 174

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGL 383
           D  AD WS+GI   E+  G+PP++     K   KI  +    ++ P   S E    LK  
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKC 234

Query: 384 LQKEASKRLGSGPGGSQEIKSHKW 407
           LQK   KR       ++++  H +
Sbjct: 235 LQKNPEKR-----PTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  207 bits (527), Expect = 2e-62
 Identities = 117/331 (35%), Positives = 187/331 (56%), Gaps = 45/331 (13%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE LKV+G+GAF +V  V++  T  IYAMK++RK  ++EK    ++++ER+IL + D 
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            ++V++ YSFQ K  LYL+++F+ GG +   L ++    E+  + Y AE V A+  +H  
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGL--------------------------------- 296
           G +HRD+KP+N+LLDA GHV L+DFGL                                 
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180

Query: 297 -AKQFDENTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
            A+ + +N R  + S  GT +Y++PE+ +  G++K  DWWS+G++++EML G PPF    
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 354 RQKIQQKIIKDKIKL---PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
            Q+  +K++  K  L   P    SE    L      ++  R+GS   G +EIKSH +F+ 
Sbjct: 241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGS--NGVEEIKSHPFFEG 298

Query: 411 INWKKLEARETRPSFLP-EVAGKHCVANFEE 440
           ++W  +  RE RP+ +P E+      +NF+E
Sbjct: 299 VDWGHI--RE-RPAAIPIEIKSIDDTSNFDE 326

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  203 bits (518), Expect = 3e-62
 Identities = 103/283 (36%), Positives = 159/283 (56%), Gaps = 6/283 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F   +V+G+G F +V   +   T ++YA K + K +I ++       +E+ IL KV+  F
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHAN 269
           +V L Y+++TK  L LVL  +NGG L F +Y  G   F E  A  Y AE+   +  L   
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
            I++RDLKPENILLD  GH+ ++D GLA Q  E        GT+ YM+PE++  + +  +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181

Query: 330 ADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQ 385
            DWW +G L++EM+ GQ PF        R+++ +++ +D+ +     S +A S+ + LL 
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241

Query: 386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
           K   +RLG    G+  +K H  FK IN+K+LEA    P F P+
Sbjct: 242 KNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  204 bits (520), Expect = 2e-61
 Identities = 118/332 (35%), Positives = 190/332 (57%), Gaps = 16/332 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED++V+KV+G+GAF +V  VR   + ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL  +FQ    LY+V++++ GG L   L       E  A+ YTAE+V A+  +H+ 
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHD 327
           G++HRD+KP+N+LLD  GH+ L DFG   + DE    R ++  GT +Y+SPE++  +G D
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 328 ----KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII--KDKIKLP--AFLSSEAHSL 379
               +  DWWSVG+ LFEML G  PF   +      KI+  K+ +  P    +S  A +L
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNL 281

Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFE 439
           +   L  +   RLG    G +EIK H +FK   W     RET    +PE++     +NF+
Sbjct: 282 ICAFL-TDREVRLGR--NGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFD 338

Query: 440 ECWTNMPLLDSPVASPKF--NENPFKGFTYVR 469
           +   +   +++      F  N+ PF GFTY R
Sbjct: 339 DIEDDKGDVETFPIPKAFVGNQLPFIGFTYYR 370

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  201 bits (513), Expect = 2e-60
 Identities = 115/330 (34%), Positives = 188/330 (56%), Gaps = 16/330 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EV+KV+G+GAF +V  VR   T ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL Y+FQ    LY+V++++ GG L   L       E  AR YTAE+V A+  +H+ 
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHD 327
           G +HRD+KP+N+LLD  GH+ L DFG   + ++    R ++  GT +Y+SPE++  +G D
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 328 ----KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII--KDKIKLP--AFLSSEAHSL 379
               +  DWWSVG+ L+EML G  PF   +      KI+  K+ +  P    +S EA +L
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 281

Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFE 439
           +   L     + +  G  G +EIK H +FK   W     R+T    +P+++     +NF+
Sbjct: 282 ICAFL---TDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFD 338

Query: 440 ECWTNMPLLDSPVASPKF--NENPFKGFTY 467
           +   +    ++      F  N+ PF GFTY
Sbjct: 339 DIEEDKGEEETFPIPKAFVGNQLPFVGFTY 368

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  200 bits (509), Expect = 7e-60
 Identities = 120/359 (33%), Positives = 198/359 (55%), Gaps = 46/359 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE LKV+G+GAF +V  V++  T  +YAMK++RK  ++EK    ++++ER+IL + D 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            ++V++ YSFQ K  LYL+++F+ GG +   L ++    E+  + Y AE V A+  +H  
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGL--------------------------------- 296
           G +HRD+KP+N+LLD+ GHV L+DFGL                                 
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 297 -AKQFDENTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
            A+ +  N R  + S  GT +Y++PE+ +  G++K  DWWS+G++++EML G PPF    
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 354 RQKIQQKIIKDKIKL---PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
            Q+  +K++  K  L   P    SE    L      E   R+G+   G +EIK++ +F+ 
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGA--PGVEEIKTNPFFEG 298

Query: 411 INWKKLEARETRPSFLP-EVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYV 468
           ++W+ +  RE RP+ +P E+      +NF+E + +  +L   VA+    E  +K   +V
Sbjct: 299 VDWEHI--RE-RPAAIPIEIKSIDDTSNFDE-FPDSDILKPTVATSNHPETDYKNKDWV 353

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  196 bits (499), Expect = 1e-58
 Identities = 116/339 (34%), Positives = 192/339 (56%), Gaps = 30/339 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE++KV+G+GAF +V  V+   T  IYAMK++ K +++++      + ERN+L   D 
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ +  LYLV+D+  GG L   L + +    ED+AR Y AE+V A+  +H 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFG--LAKQFDENTRSNSMCGTLEYMSPEIV----- 321
              +HRD+KP+N+LLD +GH+ L DFG  L    D   +S+   GT +Y+SPEI+     
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 322 -LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII--KDKIKLPAFL---SSE 375
            +GK +    DWWS+G+ ++EML G+ PF   +  +   KI+  +++ + P+ +   S E
Sbjct: 181 GMGK-YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239

Query: 376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCV 435
           A  L++ L+     +RLG    G ++ K H +F+ I+W+ +  R     ++P+V+     
Sbjct: 240 AKDLIQRLICSR-ERRLGQ--NGIEDFKKHAFFEGIDWENI--RNLEAPYIPDVSSPSDT 294

Query: 436 ANFEECWTNMPLLDSPVASPKFNEN-------PFKGFTY 467
           +NF+    +  +L +P  +P  +         PF GFTY
Sbjct: 295 SNFD---VDDDVLRNPEIAPPSSHTGFSGLHLPFVGFTY 330

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  195 bits (497), Expect = 2e-58
 Identities = 116/335 (34%), Positives = 189/335 (56%), Gaps = 22/335 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE+LKV+G+GAF +V  V+     +++AMK++ K +++++      + ER++L   D+
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ +  LYLV+D+  GG L   L + +    ED+AR Y AE+V A+  +H 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFG--LAKQFDENTRSNSMCGTLEYMSPEIVL---- 322
              +HRD+KP+NIL+D +GH+ L DFG  L    D   +S+   GT +Y+SPEI+     
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 323 GKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII--KDKIKLPAF---LSSEA 376
           GKG +    DWWS+G+ ++EML G+ PF   +  +   KI+  K++ + PA    +S +A
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240

Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVA 436
             L++ L+    S+    G  G ++ K H +F  I+W  +  R     ++PEV+     +
Sbjct: 241 KDLIRRLI---CSREHRLGQNGIEDFKQHPFFTGIDWDNI--RNCEAPYIPEVSSPTDTS 295

Query: 437 NF---EECWTNMPLLDSPVASPKFNEN-PFKGFTY 467
           NF   ++C  N   +  P  +     + PF GFTY
Sbjct: 296 NFDVDDDCLKNSETMPPPSHTAFSGHHLPFVGFTY 330

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  190 bits (485), Expect = 5e-58
 Identities = 85/252 (33%), Positives = 130/252 (51%), Gaps = 42/252 (16%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F  VY  R   T +  A+K+++K+        E +  E  IL K++HP IV+L  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
            F+ +  LYLV+++  GG L   L    G   ED       +I+  + +LH+NGI+HRDL
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 277 KPENILLDAD-GHVMLTDFGLAKQFDENTR-SNSMCGTLEYMSPEIVLGKGH-DKAADWW 333
           KPENILLD+D G V L DFGL+K    +     ++ GT  YM+PE++LGKG+  + +D W
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178

Query: 334 SVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
           S+G++L+E+                                E   L++ +LQK+  KR  
Sbjct: 179 SLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRP- 206

Query: 394 SGPGGSQEIKSH 405
                ++EI  H
Sbjct: 207 ----SAKEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  189 bits (479), Expect = 2e-55
 Identities = 110/355 (30%), Positives = 166/355 (46%), Gaps = 35/355 (9%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            + +L+ +G+G+F +VY  R     ++ A+KV+ K    +    E    E  IL  ++HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 211 -FIVQLRYSFQTKYRLYLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             IV+L   FQ +  LYLV+++V+GG    L  ++ R+G   E  A    A+I+SA+ +L
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 267 HANGIMHRDLKPENILLDADGH-VMLTDFGLAKQFDE-------NTRSNSMCGTLEYMSP 318
           H+ GI+HRD+KPENILLD DG  V L DFGLAK   +           ++  GT  YM+P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 319 EIVLGKGH---DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK------------ 363
           E++LG        ++D WS+GI L+E+LTG PPF G        + +K            
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 364 -DKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL----EA 418
                 P  +S  A  LLK LL K+   RL S    S ++ +H   K  +   L    ++
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297

Query: 419 RETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPAAS 473
              R S  P +       N      +   LD    S +   N      +   +  
Sbjct: 298 APLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLL 352

Length = 384

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  183 bits (466), Expect = 1e-54
 Identities = 91/278 (32%), Positives = 163/278 (58%), Gaps = 8/278 (2%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F +V  V+   T ++YA K + K ++ +K+  +    E+ IL KV+ PFIV L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLHANGIMHRD 275
           +F++K  L LV+  +NGG L + +Y  G    ++ R+  Y+A+I   + HLH+  I++RD
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 276 LKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSV 335
           +KPEN+LLD  G+  L+D GLA +  +        GT  YM+PEI+  + +    DW+++
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAM 180

Query: 336 GILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLP-AFLSSEAHSLLKGLLQKEASK 390
           G  ++EM+ G+ PF        +++++++ ++D++K      + E+  + +  L K+   
Sbjct: 181 GCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPED 240

Query: 391 RLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
           RLGS    + + + H++FK IN+ +LEA    P F+P+
Sbjct: 241 RLGS-REKNDDPRKHEFFKTINFPRLEAGLIPPPFVPD 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  180 bits (458), Expect = 2e-53
 Identities = 80/254 (31%), Positives = 137/254 (53%), Gaps = 8/254 (3%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR 216
           ++G+GAF  VY+   + T +  A+K +  +KI E+     M  E ++L  + HP IV+  
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIM-QEIDLLKNLKHPNIVKYI 65

Query: 217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
            S +T   LY++L++   G L   + + G F E L  +Y  +++  +++LH  G++HRD+
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDI 125

Query: 277 KPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTLEYMSPEIVLGKGHDKAADWWSV 335
           K  NIL   DG V L DFG+A + ++ ++   S+ GT  +M+PE++   G   A+D WS+
Sbjct: 126 KAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSL 185

Query: 336 GILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLLKGLLQKEASKRLGS 394
           G  + E+LTG PP+   N      +I++D    LP  +S E    L    QK+ + R   
Sbjct: 186 GCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRP-- 243

Query: 395 GPGGSQEIKSHKWF 408
               ++++  H W 
Sbjct: 244 ---TAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  175 bits (445), Expect = 2e-51
 Identities = 88/255 (34%), Positives = 142/255 (55%), Gaps = 16/255 (6%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D+EVL+ +G+G+F  V +VRR    +I   K +    + EK   + + SE NIL ++ HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHP 59

Query: 211 FIVQL--RYSFQTKYRLYLVLDFVNGGHL--FFQLYRQ--GLFREDLA-RIYTAEIVSAV 263
            IV+   R   ++   LY+V+++  GG L    Q  ++      E+   RI T +++ A+
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-QLLLAL 118

Query: 264 SHLH-----ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMS 317
              H      N ++HRDLKP NI LDA+ +V L DFGLAK    ++  + +  GT  YMS
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEA 376
           PE +    +D+ +D WS+G L++E+    PPFT  N+ ++  KI + K  ++P   SSE 
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238

Query: 377 HSLLKGLLQKEASKR 391
           + ++K +L  +  KR
Sbjct: 239 NEVIKSMLNVDPDKR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  169 bits (430), Expect = 3e-49
 Identities = 87/272 (31%), Positives = 140/272 (51%), Gaps = 18/272 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            D E +KV+GQG+   VY+VR   T +IYA+K +  D   ++   + +  E   L   + 
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVD--GDEEFRKQLLRELKTLRSCES 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED-LARIYTAEIVSAVSHLHA 268
           P++V+   +F  +  + +VL++++GG L   L + G   E  LA I   +I+  + +LH 
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYI-ARQILKGLDYLHT 117

Query: 269 N-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--SNSMCGTLEYMSPEIVLGKG 325
              I+HRD+KP N+L+++ G V + DFG++K   ENT    N+  GT+ YMSPE + G+ 
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL-ENTLDQCNTFVGTVTYMSPERIQGES 176

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQK----IQQKIIKDKIKLPA-FLSSEAHSLL 380
           +  AAD WS+G+ L E   G+ PF    +      +Q         LPA   S E    +
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236

Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN 412
              LQK+  KR       + E+  H + K  +
Sbjct: 237 SACLQKDPKKRP-----SAAELLQHPFIKKAD 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  166 bits (423), Expect = 2e-48
 Identities = 81/243 (33%), Positives = 135/243 (55%), Gaps = 9/243 (3%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMR--KDKIMEKNHAEYMKSERNILTKVDHPFIV 213
           +++G G+F  VY+   +   + +A+K +    D    +   + ++ E  +L+K+ HP IV
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
           Q   + + +  LY+ L+ V GG L   L + G F E + R+YT +I+  + +LH    +H
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG-HDKAADW 332
           RD+K  NIL+D +G V L DFG+AKQ  E + + S  G+  +M+PE++  +G +  AAD 
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185

Query: 333 WSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIKDKI--KLPAFLSSEAHSLLKGLLQKEA 388
           WS+G  + EM TG+PP+     + +    KI + K    +P  LS EA   +   LQ++ 
Sbjct: 186 WSLGCTVLEMATGKPPW--SQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDP 243

Query: 389 SKR 391
           S R
Sbjct: 244 SLR 246

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  157 bits (399), Expect = 9e-45
 Identities = 82/250 (32%), Positives = 134/250 (53%), Gaps = 15/250 (6%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
              +G G F KVY    + T E+ A+K +R      K   E +  E  +L  + HP +V+
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE-IADEMKVLELLKHPNLVK 63

Query: 215 LRYSFQT-KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
             Y  +  + ++Y+ +++ +GG L   L    +  E + R+YT +++  +++LH++GI+H
Sbjct: 64  Y-YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPEIVLG---KG 325
           RD+KP NI LD +G + L DFG A +   NT +      S+ GT  YM+PE++ G   KG
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKI-IKDKIKLP--AFLSSEAHSLLK 381
           H +AAD WS+G ++ EM TG+ P++   N  +I   +    K  +P    LS E    L 
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLD 242

Query: 382 GLLQKEASKR 391
             L+ +  KR
Sbjct: 243 RCLESDPKKR 252

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  156 bits (397), Expect = 1e-44
 Identities = 73/248 (29%), Positives = 133/248 (53%), Gaps = 7/248 (2%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF+VLK +G+G++  VY+V+R+  ++ YA+K +    + +K   + + +E  IL  V+HP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHP 59

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSHL 266
            I+  + +F    +L +V+++   G L   + ++     L  E        +++  +  L
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           H   I+HRDLK  NILL A+  V + D G++K   +   + +  GT  YM+PE+  G+ +
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVL-KKNMAKTQIGTPHYMAPEVWKGRPY 178

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGLLQ 385
              +D WS+G LL+EM T  PPF   + Q ++ K+ + K   +P   S +  + ++ +LQ
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ 238

Query: 386 KEASKRLG 393
            +   R  
Sbjct: 239 VKPKLRPN 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  151 bits (382), Expect = 2e-42
 Identities = 77/245 (31%), Positives = 136/245 (55%), Gaps = 5/245 (2%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DFE+L  +G+G+F  V++V R     +YAMK +   K+  +   E +   R +L K+D  
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR-VLAKLDSS 59

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           +I++   SF  K +L +V+++   G  H   ++ R     ED    +  +I+  ++HLH+
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTLEYMSPEIVLGKGHD 327
             I+HRD+K  N+ LDA  +V + D G+AK   +NT  +N++ GT  Y+SPE+   K ++
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN 179

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAFLSSEAHSLLKGLLQK 386
           + +D W++G++L+E  TG+ PF   N+  +  KII+     +    S +   L+   L K
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239

Query: 387 EASKR 391
           +  +R
Sbjct: 240 DYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  151 bits (384), Expect = 2e-42
 Identities = 80/266 (30%), Positives = 135/266 (50%), Gaps = 18/266 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           ++ L+ +G+GA  +VY+     T +  A+K MR    + K + E + +E  I+    HP 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF--REDLARIYTAEIVSAVSHLHAN 269
           IV    S+     L++V+++++GG L   + +  +      +A +   E++  + +LH+ 
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVLQGLEYLHSQ 135

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
            ++HRD+K +NILL  DG V L DFG A Q   E ++ NS+ GT  +M+PE++  K +  
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGP 195

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQK----IQQKIIKDKIKLPAFLSSEAHSLLKGLL 384
             D WS+GI+  EM  G+PP+      +    I  K I   +K P   S E    L   L
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPEFKDFLNKCL 254

Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKM 410
            K+  KR       ++E+  H + K 
Sbjct: 255 VKDPEKR-----PSAEELLQHPFLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  148 bits (376), Expect = 1e-41
 Identities = 82/244 (33%), Positives = 127/244 (52%), Gaps = 8/244 (3%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNILTKVDHPFIV 213
           K++GQGAF +VY    + T    A+K +  D      K     ++ E  +L  + H  IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
           Q     +    L + ++++ GG +  QL   G   E + R YT +I+  V +LH+N I+H
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFD----ENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
           RD+K  NIL D+ G+V L DFG +K+        T   S+ GT  +MSPE++ G+G+ + 
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK 187

Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI--KLPAFLSSEAHSLLKGLLQKE 387
           AD WSVG  + EMLT +PP+          KI       +LP+ +S +A + L+    + 
Sbjct: 188 ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVEN 247

Query: 388 ASKR 391
           A KR
Sbjct: 248 AKKR 251

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  148 bits (376), Expect = 1e-41
 Identities = 80/244 (32%), Positives = 135/244 (55%), Gaps = 5/244 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +  ++V+G+GAF +    RR     +   K +   ++ EK   + + +E  IL+ + HP 
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-NEIVILSLLQHPN 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHAN 269
           I+     F     L + +++ NGG L+ ++ RQ   LF E++   Y  +IVSAVS++H  
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           GI+HRD+K  NI L   G + L DFG++K    E + + ++ GT  YMSPE+  G  ++ 
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII-KDKIKLPAFLSSEAHSLLKGLLQKE 387
            +D W++G +L+E+LT +  F   N   +  KI+  +   + +  SSE  SL+  LLQ++
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQD 240

Query: 388 ASKR 391
             KR
Sbjct: 241 PEKR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  147 bits (374), Expect = 3e-41
 Identities = 70/248 (28%), Positives = 132/248 (53%), Gaps = 12/248 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F++L+ +G+G++  VY+     T ++ A+KV+  +        + +  E +IL + D 
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDS 57

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P+IV+   S+     L++V+++   G +    ++  + L  E++A I   + +  + +LH
Sbjct: 58  PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAI-LYQTLKGLEYLH 116

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGH 326
           +N  +HRD+K  NILL+ +G   L DFG++ Q  D   + N++ GT  +M+PE++   G+
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGL 383
           +  AD WS+GI   EM  G+PP++  +  +    I       +  P   S E +  +K  
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236

Query: 384 LQKEASKR 391
           L K+  +R
Sbjct: 237 LVKDPEER 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  146 bits (370), Expect = 2e-40
 Identities = 92/297 (30%), Positives = 145/297 (48%), Gaps = 55/297 (18%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E L+ +G+G +  VY+ R   T EI A+K +R D   E   +  ++ E ++L ++ HP 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPN 59

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSAVSHL 266
           IV+L     T+ +LYLV ++ +       L      R G    +L +    +++  +++ 
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLG 323
           H++ I+HRDLKP+NIL++ DG + L DFGLA+ F    R+     +  TL Y +PEI+LG
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLG 172

Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK----------------- 363
            K +  A D WSVG +  EM+TG+P F G    +I Q  KI +                 
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPG--DSEIDQLFKIFQILGTPTEESWPGVTKLP 230

Query: 364 -DKIKLPAF-----------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
             K   P F           L  E   LL  +LQ   +KR+      ++E   H +F
Sbjct: 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI-----SAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  146 bits (370), Expect = 3e-40
 Identities = 80/297 (26%), Positives = 140/297 (47%), Gaps = 50/297 (16%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-HAEYMKSERNILTKVDHP 210
           +E +  +G+G + +VY+ R   T E+ A+K +R +   EK         E  +L K+ HP
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRME--NEKEGFPITAIREIKLLQKLRHP 58

Query: 211 FIVQLRYSFQTKYR--LYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHL 266
            IV+L+    +K +  +Y+V ++++  H    L      +   ++I  Y  +++  + +L
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMD--HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTR--SNSMCGTLEYMSPEIVLG 323
           H+NGI+HRD+K  NIL++ DG + L DFGLA+ +   N+   +N +  TL Y  PE++LG
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLG 175

Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK------------------- 363
              +    D WSVG +L E+  G+P F G    +  +KI +                   
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235

Query: 364 DKIKLP------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
           + +K                +   A  LL  LL  +  KR+      + +   H++F
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI-----SADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  145 bits (367), Expect = 4e-40
 Identities = 75/267 (28%), Positives = 135/267 (50%), Gaps = 19/267 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM----RKDKIMEKNHAEYMKSERNILT 205
           E F +L+ +G+G+F +VY+     T+++ A+KV+     +D+I      E ++ E   L+
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI------EDIQQEIQFLS 54

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +   P+I +   SF    +L++++++  GG     L + G   E        E++  + +
Sbjct: 55  QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLDETYIAFILREVLLGLEY 113

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIVLGK 324
           LH  G +HRD+K  NILL  +G V L DFG++ Q     ++ N+  GT  +M+PE++   
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS 173

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL--PAFLSSEAHSLLKG 382
           G+D+ AD WS+GI   E+  G+PP +  +  ++   I K+          S      +  
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL 233

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFK 409
            L K+  +R    P   + +K HK+ K
Sbjct: 234 CLNKDPKER----PSAKELLK-HKFIK 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  150 bits (381), Expect = 2e-39
 Identities = 63/150 (42%), Positives = 103/150 (68%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F ++K + +GAF KVY  R+   S++YA+KV++K  ++ KN    +++ER+ L    
Sbjct: 3   IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            PFIV L YS Q+   +YLV++++ GG +   L+  G F E++A  Y +E+  A+ +LH 
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAK 298
           +GI+HRDLKP+N+L+  +GH+ LTDFGL+K
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  142 bits (361), Expect = 2e-39
 Identities = 81/253 (32%), Positives = 132/253 (52%), Gaps = 9/253 (3%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L +F++ K +G+G F+ VY+   +    + A+K ++  ++M+    +    E ++L ++D
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG---HLFFQLYRQG-LFREDLARIYTAEIVSAVS 264
           HP +++   SF     L +VL+  + G    +     +Q  L  E     Y  ++ SA+ 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIVLG 323
           H+H+  IMHRD+KP N+ + A G V L D GL + F   T  ++S+ GT  YMSPE +  
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGG--NRQKIQQKIIK-DKIKLPA-FLSSEAHSL 379
            G++  +D WS+G LL+EM   Q PF G   N   + +KI K D   LPA   S E   L
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDL 240

Query: 380 LKGLLQKEASKRL 392
           +   +  +  KR 
Sbjct: 241 VSRCINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  142 bits (361), Expect = 3e-39
 Identities = 78/268 (29%), Positives = 143/268 (53%), Gaps = 21/268 (7%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-- 209
           ++ L+++G+GA+  VY+ + + T  + A+K++  D     +    ++ E  +L+++    
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQ 60

Query: 210 -PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            P I +   S+    RL++++++  GG +   L + G   E    +   E++ A+ ++H 
Sbjct: 61  PPNITKYYGSYLKGPRLWIIMEYAEGGSVR-TLMKAGPIAEKYISVIIREVLVALKYIHK 119

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEIVL-GKGH 326
            G++HRD+K  NIL+   G+V L DFG+A   ++N+   S   GT  +M+PE++  GK +
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHS-LLK---- 381
           D  AD WS+GI ++EM TG PP++  +  +    I K K   P  L    +S LL+    
Sbjct: 180 DTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK---PPRLEDNGYSKLLREFVA 236

Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWFK 409
             L +E  +RL      ++E+   KW K
Sbjct: 237 ACLDEEPKERL-----SAEELLKSKWIK 259

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  142 bits (361), Expect = 4e-39
 Identities = 72/212 (33%), Positives = 113/212 (53%), Gaps = 14/212 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKV 207
             +EVL VVG+GA+  V + R   T EI A+K   K K  E +      + R +  L ++
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK---KFKESEDDEDVKKTALREVKVLRQL 57

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTAEIVSAVS 264
            H  IV L+ +F+ K RLYLV ++V       +L      GL   D  R Y  +++ A++
Sbjct: 58  RHENIVNLKEAFRRKGRLYLVFEYV--ERTLLELLEASPGGL-PPDAVRSYIWQLLQAIA 114

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN--SMCGTLEYMSPEIVL 322
           + H++ I+HRD+KPENIL+   G + L DFG A+       S       T  Y +PE+++
Sbjct: 115 YCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV 174

Query: 323 GKG-HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G   + K  D W++G ++ E+L G+P F G +
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  140 bits (354), Expect = 2e-38
 Identities = 71/271 (26%), Positives = 131/271 (48%), Gaps = 19/271 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D E L  +G G    V +V    T +I A+K +R +             E +IL K + 
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR--ELDILHKCNS 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P+IV    +F     + + +++++GG L    +  +  +    L +I  A ++  +++LH
Sbjct: 59  PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA-VLKGLTYLH 117

Query: 268 AN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
               I+HRD+KP NIL+++ G + L DFG++ Q   N+ + +  GT  YM+PE + G  +
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTFVGTSSYMAPERIQGNDY 176

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNR------QKIQQKIIKDKIKLPA-FLSSEAHSL 379
              +D WS+G+ L E+ TG+ P+   N       + +Q  + +   +LP+   S +    
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236

Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
           +   L K+  +R        +E+  H + K 
Sbjct: 237 VNLCLIKDPRER--PSY---KELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  140 bits (354), Expect = 4e-38
 Identities = 81/277 (29%), Positives = 131/277 (47%), Gaps = 41/277 (14%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILTKV 207
           ++ L  +G+G +  VY+ R   T EI A+K     KI  +  +E +      E  +L ++
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIK-----KIKLRFESEGIPKTALREIKLLKEL 55

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           +HP I++L   F+ K  LYLV +F++         RQ    E L + Y  +++  ++  H
Sbjct: 56  NHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVLG-KG 325
           ++GI+HRDLKPEN+L++ +G + L DFGLA+ F    R       T  Y +PE++LG KG
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN---------------RQKIQQKIIK----DKI 366
           +    D WSVG +  E+L+ +P F G +                 ++  K        K 
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235

Query: 367 KLPAF-----------LSSEAHSLLKGLLQKEASKRL 392
             P              S +A  LL  +L  +  KR+
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI 272

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  139 bits (352), Expect = 4e-38
 Identities = 77/244 (31%), Positives = 129/244 (52%), Gaps = 5/244 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +  +K +G+G+F K   V+     + Y +K +   K+  K   E  K E  +L+ + HP 
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK-EVAVLSNMKHPN 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHAN 269
           IVQ + SF+    LY+V+D+  GG L+ ++  Q   LF ED    +  +I  A+ H+H  
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC-GTLEYMSPEIVLGKGHDK 328
            I+HRD+K +NI L  DG + L DFG+A+  +        C GT  Y+SPEI   + ++ 
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGLLQKE 387
            +D W++G +L+EM T +  F  GN + +  KII+     + +  S +  +L+  L ++ 
Sbjct: 181 KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRN 240

Query: 388 ASKR 391
              R
Sbjct: 241 PRDR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  140 bits (354), Expect = 4e-38
 Identities = 84/298 (28%), Positives = 132/298 (44%), Gaps = 53/298 (17%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            +++L  +G+GA   V++ +   T E  A+K +   ++      + ++ E   L    HP
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHP 59

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSAVSH 265
           ++V+L   F       LV++++        L       +    E   + Y   ++  V++
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS--NSMCGTLEYMSPEIVLG 323
           +HANGIMHRDLKP N+L+ ADG + + DFGLA+ F E      +    T  Y +PE++ G
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174

Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK----------------- 363
               D   D W+VG +  E+L G P F G N   I+Q   + +                 
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGEN--DIEQLAIVFRTLGTPNEETWPGLTSLP 232

Query: 364 --DKIKLPA-----------FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
             +KI  P              S EA  LLKGLL  + SKRL      + E   H +F
Sbjct: 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL-----SAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score =  137 bits (347), Expect = 9e-38
 Identities = 82/256 (32%), Positives = 124/256 (48%), Gaps = 30/256 (11%)

Query: 161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ 220
           G   KV  V    T + + +K +RK        +EY +    I+     P +V L     
Sbjct: 4   GVIDKVLLVMDTRTQQTFILKGLRKS-------SEYSRERLTIIPHC-VPNMVCLHKYIV 55

Query: 221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN 280
           ++  ++LVL    GG L+  + +     E+  + + AE+V A+  LH  GI+ RDL P N
Sbjct: 56  SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115

Query: 281 ILLDADGHVMLTDFG----LAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
           ILLD  GH+ LT F     +    D     N  C      +PE+       +A DWWS+G
Sbjct: 116 ILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------APEVGGISEETEACDWWSLG 169

Query: 337 ILLFEMLTG----QPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRL 392
            +LFE+LTG    +   +G N            + +P ++S EA SLL+ LLQ   ++RL
Sbjct: 170 AILFELLTGKTLVECHPSGINTHT--------TLNIPEWVSEEARSLLQQLLQFNPTERL 221

Query: 393 GSGPGGSQEIKSHKWF 408
           G+G  G ++IKSH +F
Sbjct: 222 GAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  138 bits (349), Expect = 9e-38
 Identities = 83/246 (33%), Positives = 131/246 (53%), Gaps = 8/246 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G+G+F K+Y  +    SE   +K +   K M     E  K E  +L K+ HP 
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHPN 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHAN 269
           IV    SFQ   RL++V+++ +GG L  ++ RQ   LF ED    +  +I   + H+H  
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120

Query: 270 GIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMC-GTLEYMSPEIVLGKGHD 327
            I+HRD+K +NI L  +G V  L DFG+A+Q +++      C GT  Y+SPEI   + ++
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYN 180

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--LPAFLSSEAHSLLKGLLQ 385
              D WS+G +L+E+ T + PF G N  ++  KI +       P F S +  SL+  L +
Sbjct: 181 NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNF-SRDLRSLISQLFK 239

Query: 386 KEASKR 391
                R
Sbjct: 240 VSPRDR 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 1e-37
 Identities = 78/254 (30%), Positives = 127/254 (50%), Gaps = 15/254 (5%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            ED+E+++ +G G +  VY+ R I T E+ A+KV+   K+   +  E ++ E ++L +  
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECR 58

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           HP IV    S+  + +L++V+++  GG L   +Q+ R  L    +A +   E +  +++L
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYV-CRETLKGLAYL 117

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIV---L 322
           H  G +HRD+K  NILL  DG V L DFG++ Q      +  S  GT  +M+PE+     
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAF-----LSSEAH 377
             G+D   D W++GI   E+   QPP    +  +    I K     P        S   H
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237

Query: 378 SLLKGLLQKEASKR 391
             +K  L K+  KR
Sbjct: 238 DFIKKCLTKDPKKR 251

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  136 bits (344), Expect = 4e-37
 Identities = 78/245 (31%), Positives = 131/245 (53%), Gaps = 6/245 (2%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            + VL+VVG+G+F +   V+ + + + YAMK +R  K    +  E  + E  +L K+ HP
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV  + SF+    LY+V+++ +GG L    +L R  LF ED    +  ++   V H+H 
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHD 327
             ++HRD+K +NI L  +G V L DFG A+        + +  GT  Y+ PEI     ++
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAFLSSEAHSLLKGLLQK 386
             +D WS+G +L+E+ T + PF   + + +  K+ +   K LP+  S E  SL+K + ++
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238

Query: 387 EASKR 391
               R
Sbjct: 239 NPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  136 bits (344), Expect = 6e-37
 Identities = 81/227 (35%), Positives = 121/227 (53%), Gaps = 18/227 (7%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIY-AMK-------VMRKDKIMEKNHAEYMKSERNI 203
           + VL+ +G GAF  VY+VR+    +   A+K          KDK         + SE  I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 204 LTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNG---GHLFFQLY-RQGLFREDLARIYT-- 256
           + + + HP IV+   +F    RLY+V+D + G   G  F  L  ++  F E+  RI+   
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE--RIWNIF 119

Query: 257 AEIVSAVSHLHANG-IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY 315
            ++V A+ +LH    I+HRDL P NI+L  D  V +TDFGLAKQ    ++  S+ GT+ Y
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII 362
             PEIV  + + + AD W+ G +L++M T QPPF   N   +  KI+
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV 226

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  134 bits (339), Expect = 4e-36
 Identities = 80/274 (29%), Positives = 138/274 (50%), Gaps = 22/274 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D+E+++V+G GA A VY    +  +E  A+K +  +K  + +  E  K E   +++ +H
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRK-EVQAMSQCNH 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P +V+   SF     L+LV+ +++GG    +    Y +G   E +      E++  + +L
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----RSNSMCGTLEYMSPEIV 321
           H+NG +HRD+K  NILL  DG V + DFG++    +          +  GT  +M+PE++
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 322 -LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK-DKIKLPAFLSSEAHS- 378
               G+D  AD WS GI   E+ TG  P++     K+    ++ D   L      + +S 
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238

Query: 379 ----LLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
               ++   LQK+ SKR    P   + +K HK+F
Sbjct: 239 SFRKMISLCLQKDPSKR----PTAEELLK-HKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  132 bits (333), Expect = 1e-35
 Identities = 71/244 (29%), Positives = 131/244 (53%), Gaps = 5/244 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E ++VVG+GAF  V+  RR    ++  +K +  ++ M K+     ++E  +L  + HP 
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ-MTKDERLAAQNECQVLKLLSHPN 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           I++   +F     L +V+++  GG L  + Q     L  ED    +  +I+ A+ H+H  
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 270 GIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
            I+HRDLK +NILLD    V+ + DFG++K     +++ ++ GT  Y+SPE+  GK +++
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAFLSSEAHSLLKGLLQKE 387
            +D W++G +L+E+ + +  F   N   +  KI+      +    S +   L+  +L  +
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLD 240

Query: 388 ASKR 391
            SKR
Sbjct: 241 PSKR 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  131 bits (331), Expect = 6e-35
 Identities = 82/278 (29%), Positives = 138/278 (49%), Gaps = 29/278 (10%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
             FE+++V+G+G + KVY+ R   T ++ A+K+M   +  E    E +K E NIL K  +
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNILRKYSN 61

Query: 209 HPFIVQLRYSFQTK------YRLYLVLDFVNGG---HLFFQLYRQG-LFREDLARIYTAE 258
           HP I     +F  K       +L+LV++   GG    L   L ++G   +E+       E
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMS 317
            +  +++LH N ++HRD+K +NILL  +  V L DFG++ Q D    R N+  GT  +M+
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181

Query: 318 PEIVLGK-----GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLP 369
           PE++         +D  +D WS+GI   E+  G+PP    +  +   KI ++    +K P
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241

Query: 370 AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKW 407
              S + +  +   L K   +R    P   +E+  H +
Sbjct: 242 ENWSKKFNDFISECLIKNYEQR----P-FMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  129 bits (326), Expect = 3e-34
 Identities = 67/215 (31%), Positives = 124/215 (57%), Gaps = 14/215 (6%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMK-------VMRKDKIMEKNHAEYMKSERNILTKVD 208
           +++G+G + +VY    + T E+ A+K       +  +    +K+  + ++SE   L  +D
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IVQ      T+  L + L++V GG +   L   G F E L R +T +++  +++LH+
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE---NTRSNSMCGTLEYMSPEIV--LG 323
            GI+HRDLK +N+L+DADG   ++DFG++K+ D+   N ++ SM G++ +M+PE++    
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186

Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ 358
           +G+    D WS+G ++ EM  G+ P+   + + I 
Sbjct: 187 QGYSAKVDIWSLGCVVLEMFAGRRPW--SDEEAIA 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  128 bits (324), Expect = 5e-34
 Identities = 81/276 (29%), Positives = 139/276 (50%), Gaps = 35/276 (12%)

Query: 149 LEDFEV---LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK--IMEKNHAEYMKSERNI 203
           L++ E+   LK++  G F KV  ++   T +++  K+++      +E    + MK     
Sbjct: 13  LKNCEIVKKLKLI-DGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMK----- 66

Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
               D+P  ++L YS  T     L++D++  G LF  L ++G   E   +    ++V A+
Sbjct: 67  ----DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEAL 122

Query: 264 SHLHANGIMHRDLKPENILLD-ADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + LH + I+H D+K EN+L D A   + L D+GL K     T S    GTL+Y SPE + 
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IGTPS-CYDGTLDYFSPEKIK 179

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI--------QQKIIKDKIKLPAFLSS 374
           G  +D + DWW+VG+L +E+LTG+ PF     +++        QQK    K+     +S 
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----KLPFIKNVSK 235

Query: 375 EAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
            A+  ++ +L+   + RL +      EI  H + K+
Sbjct: 236 NANDFVQSMLKYNINYRLTNY----NEIIKHPFLKI 267

Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  127 bits (321), Expect = 2e-33
 Identities = 70/213 (32%), Positives = 109/213 (51%), Gaps = 21/213 (9%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM-RKDKIMEKNHAEYMK-SERNILTKV-D 208
           ++V+K +G G F  VY  R   T E+ A+K M +K    E    E M   E   L K+ +
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE----ECMNLREVKSLRKLNE 56

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSH 265
           HP IV+L+  F+    LY V +++ G    +QL +      F E + R    +I+  ++H
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYMEGN--LYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN----SMCGTLEYMSPEIV 321
           +H +G  HRDLKPEN+L+     V + DFGLA++     RS         T  Y +PEI+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLARE----IRSRPPYTDYVSTRWYRAPEIL 170

Query: 322 LGKG-HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           L    +    D W++G ++ E+ T +P F G +
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  127 bits (320), Expect = 2e-33
 Identities = 90/255 (35%), Positives = 135/255 (52%), Gaps = 18/255 (7%)

Query: 150 EDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           E+F E++  +G GAF KVY+ +   T  + A KV+  D   E+   +YM  E +IL   D
Sbjct: 4   EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSH 265
           HP IV+L  +F  +  L+++++F  GG +     +L R     E   R+   + + A+++
Sbjct: 61  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNY 118

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVL-- 322
           LH N I+HRDLK  NIL   DG + L DFG+ AK      R +S  GT  +M+PE+V+  
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 323 ---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEA 376
               + +D  AD WS+GI L EM   +PP    N  ++  KI K +   +  P+  SSE 
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF 238

Query: 377 HSLLKGLLQKEASKR 391
              LK  L+K    R
Sbjct: 239 KDFLKKCLEKNVDAR 253

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  125 bits (316), Expect = 5e-33
 Identities = 59/203 (29%), Positives = 115/203 (56%), Gaps = 9/203 (4%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVM---RKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           + +G GAF+  YQ R + T  + A+K +   R     ++   E ++ E  ++ +++HP I
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           +++  +        L ++++ GG +   L + G F+E +   YT +++  +S+LH N I+
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125

Query: 273 HRDLKPENILLDADGH-VMLTDFGLAKQFDEN-TRSN----SMCGTLEYMSPEIVLGKGH 326
           HRD+K  N+L+D+ G  + + DFG A +     T +      + GT+ +M+PE++ G+ +
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY 185

Query: 327 DKAADWWSVGILLFEMLTGQPPF 349
            ++ D WSVG ++ EM T +PP+
Sbjct: 186 GRSCDVWSVGCVIIEMATAKPPW 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  124 bits (314), Expect = 1e-32
 Identities = 77/265 (29%), Positives = 136/265 (51%), Gaps = 24/265 (9%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA------EYMKSERNILTKVDHP 210
           ++G G+F  VY      + E+ A+K +    +   +        + +  E  +L ++ H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IVQ   S      L + L++V GG +   L   G F E L R +  +I+  +++LH  G
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN-------SMCGTLEYMSPEIVLG 323
           I+HRD+K  NIL+D  G + ++DFG++K+ + N+ S        S+ G++ +M+PE+V  
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186

Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ----KIQQKIIKDKIKLPAFLSSEAHSL 379
             + + AD WS+G L+ EMLTG+ PF    +     KI +    +   +P+ +SSEA   
Sbjct: 187 TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE---IPSNISSEAIDF 243

Query: 380 LKGLLQKEASKRLGSGPGGSQEIKS 404
           L+   + + +KR    P  ++ +K 
Sbjct: 244 LEKTFEIDHNKR----PTAAELLKH 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 1e-32
 Identities = 75/282 (26%), Positives = 120/282 (42%), Gaps = 43/282 (15%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E L  +G+GA+  VY+ R + T    A+K +R   +        + + R I     L  
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57

Query: 207 VDHPFIVQLRYSFQTKYR-----LYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIV 260
            +HP IV+L              L LV + V+     +     +     +  +    +++
Sbjct: 58  FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
             V  LH++ I+HRDLKP+NIL+ +DG V + DFGLA+ +       S+  TL Y +PE+
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEV 177

Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----------- 369
           +L   +    D WSVG +  E+   +P F  G  +  Q   I D I LP           
Sbjct: 178 LLQSSYATPVDMWSVGCIFAELFRRRPLF-RGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236

Query: 370 ---AF--------------LSSEAHSLLKGLLQKEASKRLGS 394
              +F              +  E   LLK +L     KR+ +
Sbjct: 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  124 bits (312), Expect = 3e-32
 Identities = 83/278 (29%), Positives = 139/278 (50%), Gaps = 22/278 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +E++  +G GAF KVY+ +   T    A K++   +I  +   E    E +IL++  H
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECKH 61

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P IV L  ++  + +L+++++F +GG L     +L R     E   R    +++ A++ L
Sbjct: 62  PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFL 119

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVL--- 322
           H++ ++HRDLK  NILL  DG V L DFG+ AK      + ++  GT  +M+PE+V    
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179

Query: 323 --GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAH 377
                +D  AD WS+GI L E+   +PP    N  ++  KI+K     +  P+  SS  +
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239

Query: 378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK 415
             LK  L K+   R  +      E+  H +    +  K
Sbjct: 240 DFLKSCLVKDPDDRPTAA-----ELLKHPFVSDQSDNK 272

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  124 bits (313), Expect = 3e-32
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 34/219 (15%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDH 209
           +E  K +G+G +A VY+ R   T  I A+K ++  +  E        + R I  L ++ H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--------------- 254
           P I+ L   F  K  + LV +F+                 DL ++               
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFMET---------------DLEKVIKDKSIVLTPADIKS 106

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTL 313
           Y    +  + +LH+N I+HRDLKP N+L+ +DG + L DFGLA+ F   N +      T 
Sbjct: 107 YMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTR 166

Query: 314 EYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
            Y +PE++ G + +    D WSVG +  E+L   P   G
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  122 bits (308), Expect = 1e-31
 Identities = 86/254 (33%), Positives = 135/254 (53%), Gaps = 17/254 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E +E++  +G GAF KVY+ +   T  + A KV+  +   E+   +YM  E  IL   +H
Sbjct: 12  EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYM-VEIEILATCNH 68

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P+IV+L  +F    +L+++++F  GG    +  +L R GL  E   ++   +++ A+ +L
Sbjct: 69  PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDR-GL-TEPQIQVICRQMLEALQYL 126

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  I+HRDLK  N+LL  DG + L DFG+ AK      R +S  GT  +M+PE+V+ + 
Sbjct: 127 HSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186

Query: 326 -----HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAH 377
                +D  AD WS+GI L EM   +PP    N  ++  KI K +   +  P+  S E  
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246

Query: 378 SLLKGLLQKEASKR 391
             LK  L K    R
Sbjct: 247 DFLKTALDKHPETR 260

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  122 bits (307), Expect = 2e-31
 Identities = 76/266 (28%), Positives = 135/266 (50%), Gaps = 17/266 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
              +    +G+G+   V       T    A+K M    + ++   E + +E  I+    H
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRDYQH 75

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV++  S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA 
Sbjct: 76  PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLA-VLKALSFLHAQ 134

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIVLGKGHDK 328
           G++HRD+K ++ILL +DG V L+DFG   Q  +   R  S+ GT  +M+PE++    +  
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQ-QKIIKD----KIKLPAFLSSEAHSLLKGL 383
             D WS+GI++ EM+ G+PP+   N   +Q  K I+D    K+K    +S    S L  +
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYF--NEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252

Query: 384 LQKEASKRLGSGPGGSQEIKSHKWFK 409
           L ++ ++R       + E+ +H +  
Sbjct: 253 LVRDPAQR-----ATAAELLNHPFLA 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  122 bits (307), Expect = 2e-31
 Identities = 66/203 (32%), Positives = 116/203 (57%), Gaps = 4/203 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++HP 
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H++ 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGHDK 328
           ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K +  
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180

Query: 329 AADWWSVGILLFEMLTGQPPFTG 351
           A D WS+G +  EM+T +  F G
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  121 bits (304), Expect = 2e-31
 Identities = 72/223 (32%), Positives = 124/223 (55%), Gaps = 13/223 (5%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L +F++ K +G+G F++VY+   +   +  A+K ++  ++M+    +    E ++L +++
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL-----FFQLYRQGLFREDLARIYTAEIVSAV 263
           HP +++   SF     L +VL+  + G L     +F+  ++ L  E     Y  ++ SAV
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKR-LIPERTVWKYFVQLCSAV 119

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVL 322
            H+H+  +MHRD+KP N+ + A G V L D GL + F  + T ++S+ GT  YMSPE + 
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNR------QKIQQ 359
             G++  +D WS+G LL+EM   Q PF G         QKI+Q
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  121 bits (305), Expect = 2e-31
 Identities = 73/202 (36%), Positives = 107/202 (52%), Gaps = 3/202 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FEVL VVG+GA+  V + R   T EI A+K   KD    +   E    E  +L  +    
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+L+ +F+ + +LYLV ++V    L            +  R Y  +++ A+   H N I
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN--SMCGTLEYMSPEIVLGKGHDKA 329
           +HRD+KPEN+L+  +  + L DFG A+   E + +N      T  Y SPE++LG  + KA
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 330 ADWWSVGILLFEMLTGQPPFTG 351
            D WSVG +L E+  GQP F G
Sbjct: 182 VDMWSVGCILGELSDGQPLFPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  120 bits (302), Expect = 4e-31
 Identities = 80/248 (32%), Positives = 129/248 (52%), Gaps = 10/248 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKV 207
            ++ + K++G+GAF +VY      T    A+K +  D   ++   E   ++ E  +L  +
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61

Query: 208 DHPFIVQLRYSFQ--TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
            H  IVQ     +   + +L + ++++ GG +  QL   G   E++ R YT +I+  VS+
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD----ENTRSNSMCGTLEYMSPEIV 321
           LH+N I+HRD+K  NIL D+ G+V L DFG +K+        T   S+ GT  +MSPE++
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--LPAFLSSEAHSL 379
            G+G+ + AD WSV   + EMLT +PP+          KI     K  LP  +S      
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241

Query: 380 LKGLLQKE 387
           LK +  +E
Sbjct: 242 LKQIFVEE 249

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  119 bits (300), Expect = 7e-31
 Identities = 81/237 (34%), Positives = 121/237 (51%), Gaps = 12/237 (5%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKVDHPFIV 213
           K++GQGAF +VY      T    A+K ++ D    +   E   ++ E  +L  + H  IV
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 214 QLRYSF---QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           Q  Y       +  L + ++ + GG +  QL   G   E++ R YT +I+  VS+LH+N 
Sbjct: 68  QY-YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFD----ENTRSNSMCGTLEYMSPEIVLGKGH 326
           I+HRD+K  NIL D+ G+V L DFG +K+        T   S+ GT  +MSPE++ G+G+
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI--KLPAFLSSEAHSLLK 381
            + AD WSVG  + EMLT +PP+          KI        LP  +S      LK
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLK 243

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  118 bits (298), Expect = 2e-30
 Identities = 78/253 (30%), Positives = 132/253 (52%), Gaps = 11/253 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L +F + K +G+G F++VY+   +      A+K ++   +M+         E ++L +++
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL-----FFQLYRQGLFREDLARIYTAEIVSAV 263
           HP +++   SF     L +VL+  + G L      F+  ++ L  E     Y  ++ SA+
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR-LIPEKTVWKYFVQLCSAL 119

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVL 322
            H+H+  +MHRD+KP N+ + A G V L D GL + F  + T ++S+ GT  YMSPE + 
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGG--NRQKIQQKIIK-DKIKLPA-FLSSEAHS 378
             G++  +D WS+G LL+EM   Q PF G   N   + +KI + D   LP+   S E   
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239

Query: 379 LLKGLLQKEASKR 391
           L+   +  +  KR
Sbjct: 240 LVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 4e-30
 Identities = 66/208 (31%), Positives = 116/208 (55%), Gaps = 14/208 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILTKV 207
           ++ ++ +G+G +  VY+ R   T EI A+K     KI  +   E + S    E ++L ++
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALK-----KIRLETEDEGVPSTAIREISLLKEL 55

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +HP IV+L     ++ +LYLV +F++             GL    L + Y  +++  +++
Sbjct: 56  NHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP-PLIKSYLYQLLQGIAY 114

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG- 323
            H++ ++HRDLKP+N+L+D +G + L DFGLA+ F    R+ +    TL Y +PEI+LG 
Sbjct: 115 CHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGS 174

Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           + +    D WS+G +  EM+  +P F G
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRRPLFPG 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  117 bits (294), Expect = 5e-30
 Identities = 71/202 (35%), Positives = 113/202 (55%), Gaps = 8/202 (3%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKVDHPFIV 213
           K++GQGAF +VY    + T    A K ++ D    +   E   ++ E  +L  + H  IV
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 214 QLRYSFQTKYR--LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           Q     + +    L + ++++ GG +  QL   G   E + R YT +I+  +S+LH+N I
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFD----ENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +HRD+K  NIL D+ G+V L DFG +K+        T   S+ GT  +MSPE++ G+G+ 
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG 187

Query: 328 KAADWWSVGILLFEMLTGQPPF 349
           + AD WS+G  + EMLT +PP+
Sbjct: 188 RKADVWSLGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  117 bits (295), Expect = 6e-30
 Identities = 69/213 (32%), Positives = 114/213 (53%), Gaps = 19/213 (8%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FE+++VVG G + +VY+ R + T ++ A+KVM     + ++  E +K E N+L K  H  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73

Query: 212 IVQLRY-SFQTKY------RLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            +   Y +F  K       +L+LV++F   G +    +  +    +ED       EI+  
Sbjct: 74  NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIV 321
           ++HLHA+ ++HRD+K +N+LL  +  V L DFG++ Q D    R N+  GT  +M+PE++
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 322 L-----GKGHDKAADWWSVGILLFEMLTGQPPF 349
                    +D  +D WS+GI   EM  G PP 
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  116 bits (292), Expect = 2e-29
 Identities = 70/224 (31%), Positives = 122/224 (54%), Gaps = 22/224 (9%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F+ L+ +G+G +A VY+ R   T EI A+K +  D   E+        E +++ ++ H  
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHEN 59

Query: 212 IVQLRYSFQTKYRLYLVLDFVNG---------GHLFFQLYRQGLFREDLARIYTAEIVSA 262
           IV+L     T+ +L LV ++++          G        +G    +  + +T +++  
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGV-------RGALDPNTVKSFTYQLLKG 112

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSMCGTLEYMSPEI 320
           ++  H N ++HRDLKP+N+L++  G + L DFGLA+ F    NT SN +  TL Y +P++
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDV 171

Query: 321 VLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
           +LG + +  + D WSVG ++ EM+TG+P F G N +    KI +
Sbjct: 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  116 bits (292), Expect = 2e-29
 Identities = 76/257 (29%), Positives = 133/257 (51%), Gaps = 13/257 (5%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    I T +  A+K M    + ++   E + +E  ++ +  +P IV    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 83

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALDFLHSNQVIHRDIK 142

Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +    D WS+G
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 337 ILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
           I+  EM+ G+PP+   N  +    I  +   +++ P  LS+     L   L+ +  +R  
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRR-- 260

Query: 394 SGPGGSQEIKSHKWFKM 410
              G ++E+  H + K+
Sbjct: 261 ---GSAKELLQHPFLKL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  116 bits (292), Expect = 2e-29
 Identities = 78/257 (30%), Positives = 132/257 (51%), Gaps = 13/257 (5%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A+K M   +  +K   E + +E  ++ +  HP IV    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 142

Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +    D WS+G
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 337 ILLFEMLTGQPPFTGGNRQKIQQKII---KDKIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
           I+  EM+ G+PP+   N  +    I      +++ P  LS+     L   L+ +  KR  
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR-- 260

Query: 394 SGPGGSQEIKSHKWFKM 410
              G ++E+  H + K+
Sbjct: 261 ---GSAKELLQHPFLKI 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  115 bits (289), Expect = 3e-29
 Identities = 65/209 (31%), Positives = 112/209 (53%), Gaps = 11/209 (5%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMR---KDKIMEKNHAEYMKSERNILTKVDHPFI 212
           +V+G+GA+  VY        ++ A+K +     + +  +   E ++ E ++L  + H  I
Sbjct: 6   EVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           VQ   +      + + ++FV GG +   L R G   E +   YT +I+  V++LH N ++
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124

Query: 273 HRDLKPENILLDADGHVMLTDFGLAKQFD----ENTRSN---SMCGTLEYMSPEIVLGKG 325
           HRD+K  N++L  +G + L DFG A++        T SN   SM GT  +M+PE++   G
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNR 354
           + + +D WS+G  +FEM TG+PP    +R
Sbjct: 185 YGRKSDIWSIGCTVFEMATGKPPLASMDR 213

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  119 bits (300), Expect = 3e-29
 Identities = 86/264 (32%), Positives = 135/264 (51%), Gaps = 33/264 (12%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNILTKVDHPFIV 213
           +V+G GA   V   +R+   E +A+KV+  + + E  KN A+   +E   L   D   IV
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ---AEVCCLLNCDFFSIV 94

Query: 214 QLRYSFQTK--------YRLYLVLDFVNGGHLFFQLYRQGL---------FREDLARIYT 256
           +    F  K          + LVLD+ N G L     RQ +         FRE  A +  
Sbjct: 95  KCHEDFAKKDPRNPENVLMIALVLDYANAGDL-----RQEIKSRAKTNRTFREHEAGLLF 149

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN----SMCGT 312
            +++ AV H+H+  ++HRD+K  NILL ++G V L DFG +K +   T S+    + CGT
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY-AATVSDDVGRTFCGT 208

Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAF 371
             Y++PEI   K + K AD +S+G+LL+E+LT + PF G N +++  K +  +   LP  
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS 268

Query: 372 LSSEAHSLLKGLLQKEASKRLGSG 395
           +S E   ++  LL  +  +R  S 
Sbjct: 269 ISPEMQEIVTALLSSDPKRRPSSS 292

Length = 496

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  115 bits (291), Expect = 4e-29
 Identities = 89/310 (28%), Positives = 140/310 (45%), Gaps = 64/310 (20%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
           C  ++++E L  + +G +  VY+ R   T EI A+K ++ +K  E      ++ E NIL 
Sbjct: 1   CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILL 59

Query: 206 KVDHPFIVQLRY----SFQTKYRLYLVLDFV---------NGGHLFFQLYRQGLFREDLA 252
           K+ HP IV ++     S   K  +Y+V+++V              F Q   + L  + L 
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDK--IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL- 116

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-NSMCG 311
                   S V+HLH N I+HRDLK  N+LL+  G + + DFGLA+++    +    +  
Sbjct: 117 --------SGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV 168

Query: 312 TLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK------D 364
           TL Y +PE++LG      A D WSVG +  E+LT +P F G +      KI K      +
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE 228

Query: 365 KI-----KLP---------------------AFLSSEAHSLLKGLLQKEASKRLGSGPGG 398
           KI     +LP                       LS     LL  LL  + +KR+      
Sbjct: 229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRI-----S 283

Query: 399 SQEIKSHKWF 408
           +++   H +F
Sbjct: 284 AEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  115 bits (288), Expect = 7e-29
 Identities = 75/257 (29%), Positives = 133/257 (51%), Gaps = 13/257 (5%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143

Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +    D WS+G
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203

Query: 337 ILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
           I+  EM+ G+PP+   N  +    I  +   +++ P  LS+     L   L  +  KR  
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR-- 261

Query: 394 SGPGGSQEIKSHKWFKM 410
              G ++E+  H++ K+
Sbjct: 262 ---GSAKELLQHQFLKI 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 8e-29
 Identities = 66/255 (25%), Positives = 124/255 (48%), Gaps = 23/255 (9%)

Query: 156 KVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           K +G+GAF +VY+     + G +   A+K +++D   E+   +++K E  ++ K+ HP +
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA-SEEERKDFLK-EARVMKKLGHPNV 58

Query: 213 VQLR-YSFQTKYRLYLVLDFVNGGHL----------FFQLYRQGLFREDLARIYTAEIVS 261
           V+L       +  LYLVL+++ GG L          F    +  L  +DL      +I  
Sbjct: 59  VRLLGVCT-EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF-AIQIAK 116

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT---LEYMSP 318
            + +L +   +HRDL   N L+  D  V ++DFGL++   ++       G    + +M+P
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA 376
           E +        +D WS G+LL+E+ T G  P+ G + +++ + + K  ++  P +   E 
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDEL 236

Query: 377 HSLLKGLLQKEASKR 391
           + L+    Q +   R
Sbjct: 237 YELMLSCWQLDPEDR 251

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  117 bits (295), Expect = 1e-28
 Identities = 73/211 (34%), Positives = 121/211 (57%), Gaps = 10/211 (4%)

Query: 190 EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--- 246
           ++  A Y +SE + L   DH  IV+    F++  +L L++++ +GG L  Q+ +Q L   
Sbjct: 105 DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-KQRLKEH 163

Query: 247 --FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT 304
             F+E    +   +IV A+  +H+  +MHRDLK  NI L   G + L DFG +KQ+ ++ 
Sbjct: 164 LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223

Query: 305 R---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKI 361
               ++S CGT  Y++PE+   K + K AD WS+G++L+E+LT   PF G ++++I Q++
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283

Query: 362 IKDKIK-LPAFLSSEAHSLLKGLLQKEASKR 391
           +  K    P  +SS   +LL  LL K  + R
Sbjct: 284 LYGKYDPFPCPVSSGMKALLDPLLSKNPALR 314

Length = 478

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  113 bits (284), Expect = 1e-28
 Identities = 76/255 (29%), Positives = 123/255 (48%), Gaps = 20/255 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE+++ +G G +  VY+ R + T E+ A+KV+   K+        ++ E  ++    H
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKH 65

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
             IV    S+  + +L++ ++F  GG L    +  G   E      + E +  + +LH+ 
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIVLGK---G 325
           G MHRD+K  NILL  +GHV L DFG++ Q      +  S  GT  +M+PE+   +   G
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG---------GNRQKIQQKIIKDKIKLPAFLSSEA 376
           +++  D W+VGI   E+   QPP              +   Q   +KDK+K     S+  
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK----WSNSF 241

Query: 377 HSLLKGLLQKEASKR 391
           H  +K  L K   KR
Sbjct: 242 HHFVKMALTKNPKKR 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  113 bits (283), Expect = 2e-28
 Identities = 62/200 (31%), Positives = 110/200 (55%), Gaps = 4/200 (2%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G+G+F +VY+     T E+ A+K++  D    ++  E ++ E  +L++ D P+
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           I +   S+    +L+++++++ GG     L + G   E        EI+  + +LH+   
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERK 122

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           +HRD+K  N+LL   G V L DFG+A Q  D   + N+  GT  +M+PE++    +D  A
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182

Query: 331 DWWSVGILLFEMLTGQPPFT 350
           D WS+GI   E+  G+PP +
Sbjct: 183 DIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  113 bits (284), Expect = 3e-28
 Identities = 75/207 (36%), Positives = 112/207 (54%), Gaps = 9/207 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEYMKSERNILTKV 207
           E +E L +VG+G++  V + +   T +I A+K     +D  M K  A  M+ E  +L ++
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA--MR-EIRMLKQL 57

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            H  +V L   F+ K RLYLV +FV+   L   + Y  GL  E   R Y  +I+  +   
Sbjct: 58  RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGL-DESRVRKYLFQILRGIEFC 116

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVLGK- 324
           H++ I+HRD+KPENIL+   G V L DFG A+              T  Y +PE+++G  
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTG 351
            + +A D W+VG L+ EMLTG+P F G
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPG 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  112 bits (280), Expect = 6e-28
 Identities = 62/200 (31%), Positives = 111/200 (55%), Gaps = 4/200 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 61

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L R G F E        EI+  + +LH+ 
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+  GT  +M+PE++    +D 
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180

Query: 329 AADWWSVGILLFEMLTGQPP 348
            AD WS+GI   E+  G+PP
Sbjct: 181 KADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  112 bits (281), Expect = 7e-28
 Identities = 77/257 (29%), Positives = 133/257 (51%), Gaps = 13/257 (5%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   V+    + T +  A+K +   K  +K   E + +E  ++ ++ +P IV    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---ELIINEILVMKELKNPNIVNFLD 83

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           SF     L++V++++ GG L   +    +    +A +   E + A+  LHAN ++HRD+K
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV-CRECLQALEFLHANQVIHRDIK 142

Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +N+LL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +    D WS+G
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 337 ILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
           I+  EM+ G+PP+   N  +    I  +   +++ P  LS      L   L+ +  KR  
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKR-- 260

Query: 394 SGPGGSQEIKSHKWFKM 410
              G ++E+  H + K+
Sbjct: 261 ---GSAKELLQHPFLKL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  110 bits (278), Expect = 1e-27
 Identities = 66/229 (28%), Positives = 116/229 (50%), Gaps = 14/229 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNILTKVD 208
            E+ K +G+GAF +VY+    G  E    KV     K+   E+   E+++ E +I+ K+ 
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLE-EASIMKKLS 59

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           HP IV+L         LY+V +++ GG L  F + + + L  +DL +    +I   + +L
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQ-MALQIAKGMEYL 118

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE---YMSPEIVLG 323
            +   +HRDL   N L+  +  V ++DFGL++   E+       G      +M+PE +  
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178

Query: 324 KGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQKIIKDKIKLPA 370
                 +D WS G+LL+E+ T G+ P+ G  N + ++   ++D  +LP 
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL--LEDGYRLPR 225

Length = 258

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  110 bits (276), Expect = 2e-27
 Identities = 75/268 (27%), Positives = 136/268 (50%), Gaps = 11/268 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  ++   ++  E ++ E  +L++ D 
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDS 61

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 62  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+  GT  +M+PE++    +D 
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLLKGLLQKE 387
            AD WS+GI   E+  G+PP +  +  K+   I K+    L    S      ++  L KE
Sbjct: 181 KADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 240

Query: 388 ASKRLGSGPGGSQEIKSHKWFKMINWKK 415
            S R       ++E+  HK F +   KK
Sbjct: 241 PSFR-----PTAKELLKHK-FIVRFAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  109 bits (274), Expect = 3e-27
 Identities = 73/244 (29%), Positives = 129/244 (52%), Gaps = 10/244 (4%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           ++VVG+G++ +V  VR     + Y +K +  R     E+  AE    E  +L+++ HP I
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE---QEAQLLSQLKHPNI 61

Query: 213 VQLRYSFQTK-YRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHAN 269
           V  R S++ +   LY+V+ F  GG L+ +L  Q   L  E+    +  +I  A+ +LH  
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDK 328
            I+HRDLK +N+ L     + + D G+A+  + +   ++++ GT  YMSPE+   K ++ 
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNY 181

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGLLQKE 387
            +D W++G  ++EM T +  F   +   +  +II+ K+  +P   S E   L+  +L K 
Sbjct: 182 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKR 241

Query: 388 ASKR 391
             KR
Sbjct: 242 PEKR 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  109 bits (275), Expect = 4e-27
 Identities = 65/200 (32%), Positives = 113/200 (56%), Gaps = 7/200 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D +  +++G G    VY+   + T  I A+KV+  D  +E    + + SE  IL K D 
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDS 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P+I+    +F  + R+ +  +F++GG L   +YR+ +    L RI  A +V  +++L + 
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSL--DVYRK-IPEHVLGRIAVA-VVKGLTYLWSL 114

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
            I+HRD+KP N+L++  G V L DFG++ Q   N+ + +  GT  YM+PE + G+ +   
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTYVGTNAYMAPERISGEQYGIH 173

Query: 330 ADWWSVGILLFEMLTGQPPF 349
           +D WS+GI   E+  G+ P+
Sbjct: 174 SDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  109 bits (273), Expect = 4e-27
 Identities = 66/213 (30%), Positives = 110/213 (51%), Gaps = 19/213 (8%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FE++++VG G + +VY+ R + T ++ A+KVM     +  +  E +K E N+L K  H  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63

Query: 212 IVQLRYSFQTKY-------RLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            +   Y    K        +L+LV++F   G +    +  +    +E+       EI+  
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIV 321
           +SHLH + ++HRD+K +N+LL  +  V L DFG++ Q D    R N+  GT  +M+PE++
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183

Query: 322 L-----GKGHDKAADWWSVGILLFEMLTGQPPF 349
                    +D  +D WS+GI   EM  G PP 
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  111 bits (278), Expect = 6e-27
 Identities = 84/262 (32%), Positives = 131/262 (50%), Gaps = 32/262 (12%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           L + E +  +G GA   VY+V    T  +YA+KV+        NH + ++     E  IL
Sbjct: 73  LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG------NHEDTVRRQICREIEIL 126

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
             V+HP +V+    F     + ++L+F++GG L         F  D+AR    +I+S ++
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIA 182

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFG----LAKQFDENTRSNSMCGTLEYMSPEI 320
           +LH   I+HRD+KP N+L+++  +V + DFG    LA+  D     NS  GT+ YMSPE 
Sbjct: 183 YLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPER 239

Query: 321 V---LGKG-HDK-AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII-----KDKIKLPA 370
           +   L  G +D  A D WS+G+ + E   G+ PF  G RQ     ++         + PA
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG-RQGDWASLMCAICMSQPPEAPA 298

Query: 371 FLSSEAHSLLKGLLQKEASKRL 392
             S E    +   LQ+E +KR 
Sbjct: 299 TASREFRHFISCCLQREPAKRW 320

Length = 353

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  108 bits (271), Expect = 2e-26
 Identities = 73/223 (32%), Positives = 112/223 (50%), Gaps = 12/223 (5%)

Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
            +  +     L D E L  +G G   +VY++R   T  + A+K MR+    E+N    M 
Sbjct: 4   TIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMD 63

Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYT 256
            +  +L   D P+IV+    F T   +++ ++ +       +L +  QG   ED+    T
Sbjct: 64  LDV-VLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMT 120

Query: 257 AEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLE 314
             IV A+ +L    G++HRD+KP NILLDA G+V L DFG++ +  D   ++ S  G   
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAA 179

Query: 315 YMSPE-IVLGKGHDK---AADWWSVGILLFEMLTGQPPFTGGN 353
           YM+PE I     + K    AD WS+GI L E+ TGQ P+    
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  107 bits (269), Expect = 2e-26
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 11/206 (5%)

Query: 155 LKVVGQGAFAKVYQ----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            K +G+GAF +VY+     +  G     A+K +++D   E+   E+++ E  I+ K+DHP
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA-SEQQIEEFLR-EARIMRKLDHP 61

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV+L      +  L +V++++ GG L  + +  R           +  +I   + +L +
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY--MSPEIVLGKGH 326
              +HRDL   N L+  +  V ++DFGL++   ++       G L    M+PE +     
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181

Query: 327 DKAADWWSVGILLFEMLT-GQPPFTG 351
              +D WS G+LL+E+ T G+ P+ G
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPG 207

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  107 bits (270), Expect = 3e-26
 Identities = 66/223 (29%), Positives = 113/223 (50%), Gaps = 16/223 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +E L+ +G+G + KVY+ R   T ++ A+K  R +   E      ++ E ++L  +  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSE 59

Query: 210 -PFIVQLRYSFQT-----KYRLYLVLDFVNGG-HLFFQLYRQGLFR---EDLARIYTAEI 259
             +IV+L           K  LYLV ++++     F     +G  R       + +  ++
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSM-CGTLEYMS 317
           +  V+H H +G+MHRDLKP+N+L+D    ++ + D GL + F    +S +    TL Y +
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179

Query: 318 PEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ 359
           PE++LG  H     D WSVG +  EM   QP F G +  ++QQ
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS--ELQQ 220

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  107 bits (270), Expect = 3e-26
 Identities = 82/321 (25%), Positives = 132/321 (41%), Gaps = 71/321 (22%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  L D+E+L  +G+G F +VY+ R+I T  + A+K     KI+  N  +        E 
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREI 58

Query: 202 NILTKVDHPFIVQL-----RYSFQTKYRL---YLVLDFVN---GGHLFFQLYRQGLFRED 250
            IL K+ HP +V L         ++K +    Y+V  +++    G L     +     E 
Sbjct: 59  KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTES 115

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------- 303
             + Y  +++  +++LH N I+HRD+K  NIL+D  G + + DFGLA+ +D         
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 304 -----TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI 357
                 +  ++  T  Y  PE++LG + +  A D W +G +  EM T +P   G +    
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235

Query: 358 QQKIIK-----------DKIKLPAF-------------------LSSEAHSLLKGLLQKE 387
              I K               LP                     L  E   LL  LL  +
Sbjct: 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLD 295

Query: 388 ASKRLGSGPGGSQEIKSHKWF 408
             KRL      + +   H +F
Sbjct: 296 PYKRL-----TASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  105 bits (264), Expect = 1e-25
 Identities = 59/204 (28%), Positives = 109/204 (53%), Gaps = 12/204 (5%)

Query: 155 LKVVGQGAFAKVYQ---VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            K +G+GAF +VY+     + G  ++  A+K +++D   E+   E+++ E  I+ K+DHP
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLR-EARIMRKLDHP 61

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            +V+L      +  LY+V++++ GG L  + +  R  L   DL   +  +I   + +L +
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLS-FALQIARGMEYLES 120

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGH 326
              +HRDL   N L+  +  V ++DFGL++    D+  R       + +M+PE +     
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180

Query: 327 DKAADWWSVGILLFEMLT-GQPPF 349
              +D WS G+LL+E+ T G+ P+
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPY 204

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  105 bits (262), Expect = 2e-25
 Identities = 73/255 (28%), Positives = 124/255 (48%), Gaps = 20/255 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            D+E+++ VG G +  VY+ R + T E+ A+K++   K+   +    ++ E  ++ +  H
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECKH 65

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
             IV    S+ ++ +L++ +++  GG L    +  G   E        E +  +++LH+ 
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIVL---GKG 325
           G MHRD+K  NILL  +G V L DFG+A +      +  S  GT  +M+PE+       G
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG---------GNRQKIQQKIIKDKIKLPAFLSSEA 376
           +++  D W+VGI   E+   QPP             ++   Q   +KDK K     SS  
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK----WSSTF 241

Query: 377 HSLLKGLLQKEASKR 391
           H+ +K  L K   KR
Sbjct: 242 HNFVKISLTKNPKKR 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  105 bits (263), Expect = 2e-25
 Identities = 78/273 (28%), Positives = 133/273 (48%), Gaps = 28/273 (10%)

Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM 197
           D+ P  +     + +E+++ +G+G + KV++V         A+K++  D I + +  E +
Sbjct: 11  DSFPDPS-----DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDID--EEI 61

Query: 198 KSERNILTKV-DHPFIVQL-----RYSFQTKYRLYLVLDFVNGGHLF----FQLYRQGLF 247
           ++E NIL  + DHP +V+      +   +   +L+LVL+  NGG +       L R    
Sbjct: 62  EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRS 306
            E +      E +  + HLH N  +HRD+K  NILL  +G V L DFG++ Q      R 
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181

Query: 307 NSMCGTLEYMSPEIV-----LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKI 361
           N+  GT  +M+PE++     L   +D   D WS+GI   E+  G PP    +  +   KI
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241

Query: 362 IKD---KIKLPAFLSSEAHSLLKGLLQKEASKR 391
            ++    +  P   S+E +  ++  L K+  KR
Sbjct: 242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKR 274

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  106 bits (267), Expect = 2e-25
 Identities = 87/292 (29%), Positives = 136/292 (46%), Gaps = 58/292 (19%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNI--L 204
           L  +E+L+ +G+GA+  V++     T E+ A+K     KI +  +N  +  ++ R I  L
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK-----KIFDAFRNATDAQRTFREIMFL 60

Query: 205 TKV-DHPFIVQLR--YSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIV 260
            ++ DHP IV+L      +    +YLV +++    H    + R  +  +   R    +++
Sbjct: 61  QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLH---AVIRANILEDVHKRYIMYQLL 117

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM------CGTLE 314
            A+ ++H+  ++HRDLKP NILL++D  V L DFGLA+   E   +           T  
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177

Query: 315 YMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KII--------- 362
           Y +PEI+LG   + K  D WSVG +L EML G+P F G     + Q  KII         
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG--TSTLNQLEKIIEVIGPPSAE 235

Query: 363 -------------------KDKIKLPAFL---SSEAHSLLKGLLQKEASKRL 392
                              + +  L   L   S +A  LLK LL    +KRL
Sbjct: 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL 287

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  104 bits (262), Expect = 5e-25
 Identities = 70/237 (29%), Positives = 111/237 (46%), Gaps = 28/237 (11%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  +  +E L  +GQG F +V++ R   T +I A+K     K++ +N  E        E 
Sbjct: 8   CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALREI 62

Query: 202 NILTKVDHPFIVQL------RYSFQTKYR--LYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            IL  + H  +V L      + +   +Y+   YLV +F    H    L      +  L+ 
Sbjct: 63  KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE--HDLAGLLSNKNVKFTLSE 120

Query: 254 IYTA--EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSM 309
           I      +++ + ++H N I+HRD+K  NIL+  DG + L DFGLA+ F   +N++ N  
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180

Query: 310 CG---TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII 362
                TL Y  PE++LG + +    D W  G ++ EM T  P   G   Q  Q  +I
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-QLTLI 236

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score =  108 bits (272), Expect = 5e-25
 Identities = 68/240 (28%), Positives = 115/240 (47%), Gaps = 20/240 (8%)

Query: 174 TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-YRLYLVLDFV 232
           T    A+K++R D   E++     + E  +  ++ HP IV L  S +     L+ V ++V
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 233 NGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---H 288
            G  L   L   G L   +  R+   +++ A++  H  GI+HRDLKP+NI++   G   H
Sbjct: 62  PGRTLREVLAADGALPAGETGRLML-QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 289 VMLTDFGL------AKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLF 340
             + DFG+       +  D    TR+  + GT  Y +PE + G+     +D ++ G++  
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180

Query: 341 EMLTGQPPFTGGNRQKI-QQKIIKDKIKLPAFLSSEAHSL---LKGLLQKEASKRLGSGP 396
           E LTGQ    G +  +I  Q++    + LP ++    H L   L+  L K+  +R  S P
Sbjct: 181 ECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI--AGHPLGQVLRKALNKDPRQRAASAP 238

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  104 bits (261), Expect = 6e-25
 Identities = 82/302 (27%), Positives = 134/302 (44%), Gaps = 48/302 (15%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-- 203
           C  + +FE L  +G+G +  VY+ R   + EI A+K +R D   E++    + S R I  
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN--ERDGIP-ISSLREITL 59

Query: 204 LTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNG--GHLFFQLYRQGLFREDLARIYTAEI 259
           L  + HP IV+L+     K+   ++LV+++       L   +     F E   +    ++
Sbjct: 60  LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQL 117

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC-GTLEYMSP 318
           +  + +LH N I+HRDLK  N+LL   G + + DFGLA+ +    +  +    TL Y +P
Sbjct: 118 LRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177

Query: 319 EIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK-------------- 363
           E++LG   +  A D W+VG +L E+L  +P   G +  +    II+              
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237

Query: 364 -----DKIKLPA-----------FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKW 407
                 K  LP            +LS     LL  LL  +  KR       ++E     +
Sbjct: 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKR-----ATAEEALESSY 292

Query: 408 FK 409
           FK
Sbjct: 293 FK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  103 bits (259), Expect = 7e-25
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 23/214 (10%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK--DKIMEKNHAEYMKSERNILTKV-D 208
           +++L  +G+G F++V + +   T + YA+K M+K    + + N+      E   L ++  
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL----REIQALRRLSP 56

Query: 209 HPFIVQLR---YSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIV 260
           HP I++L    +  +T  RL LV + ++       LY     R+    E   + Y  +++
Sbjct: 57  HPNILRLIEVLFDRKTG-RLALVFELMDM-----NLYELIKGRKRPLPEKRVKSYMYQLL 110

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
            ++ H+H NGI HRD+KPENIL+  D  + L DFG  +             T  Y +PE 
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPEC 169

Query: 321 VLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +L  G +    D W+VG + FE+L+  P F G N
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  104 bits (262), Expect = 7e-25
 Identities = 71/274 (25%), Positives = 117/274 (42%), Gaps = 61/274 (22%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK---DKIMEKNHAEYMKSERNILTKVD 208
           +E+LK +G GA+  V       T    A+K +     D I     A+ +  E  +L  + 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI----DAKRILREIKLLRHLR 57

Query: 209 HPFIVQL--------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI------ 254
           H  I+ L           F     +Y+V +               L   DL ++      
Sbjct: 58  HENIIGLLDILRPPSPEDFND---VYIVTE---------------LMETDLHKVIKSPQP 99

Query: 255 --------YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS 306
                   +  +I+  + +LH+  ++HRDLKP NIL++++  + + DFGLA+  D +   
Sbjct: 100 LTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159

Query: 307 NS-MCG---TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ-K 360
              +     T  Y +PE++L    + KA D WSVG +  E+LT +P F G  R  I Q  
Sbjct: 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG--RDYIDQLN 217

Query: 361 IIKDKIKLP------AFLSSEAHSLLKGLLQKEA 388
           +I + +  P         S +A + LK L +K  
Sbjct: 218 LIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPK 251

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  103 bits (259), Expect = 8e-25
 Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 15/210 (7%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILTK 206
           D+  ++ +G+G +  VY+ R   T +I AMK     KI  ++  E + S    E ++L +
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMK-----KIRLESEEEGVPSTAIREISLLKE 55

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVN---GGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
           + HP IV L+     + RLYL+ +F++     +L   L +      +L + Y  +I+  +
Sbjct: 56  LQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLD-SLPKGQYMDAELVKSYLYQILQGI 114

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVL 322
              H+  ++HRDLKP+N+L+D  G + L DFGLA+ F    R  +    TL Y +PE++L
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLL 174

Query: 323 GKG-HDKAADWWSVGILLFEMLTGQPPFTG 351
           G   +    D WS+G +  EM T +P F G
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  102 bits (256), Expect = 8e-25
 Identities = 67/246 (27%), Positives = 127/246 (51%), Gaps = 9/246 (3%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS--ERNILTKVDHPFIVQL 215
           +G+G+F  VY V+         +KV+++  + E N  E +++  E  +L+K+DHP IV+ 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQL--YRQG--LFREDLARIYTAEIVSAVSHLHANGI 271
             SF  +    ++ ++  G  L  +L   +       E+    +  +++  V ++H   I
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTLEYMSPEIVLGKGHDKAA 330
           +HRDLK +NI L  +  + + DFG+++    +   + +  GT  YMSPE +  +G+D  +
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKS 186

Query: 331 DWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK-DKIKLPAFLSSEAHSLLKGLLQKEAS 389
           D WS+G +L+EM      F G N   +  +I++     LP   S + +S+++ +L K+ S
Sbjct: 187 DIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPS 246

Query: 390 KRLGSG 395
            R  + 
Sbjct: 247 LRPSAA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  103 bits (259), Expect = 1e-24
 Identities = 82/290 (28%), Positives = 139/290 (47%), Gaps = 52/290 (17%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ F+++  +G+G + +VY+ R   T E+ A+K +R D   E      ++ E  IL +++
Sbjct: 6   VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLN 64

Query: 209 HPFIVQLR---------YSF-QTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYT 256
           H  IV L+           F + K   YLV ++++  H    L   GL  F ED  + + 
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD--HDLMGLLESGLVHFSEDHIKSFM 122

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTL 313
            +++  +++ H    +HRD+K  NILL+  G + L DFGLA+ ++       +N +  TL
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TL 181

Query: 314 EYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK--------- 363
            Y  PE++LG+  +  A D WS G +L E+ T +P F   N++  Q ++I          
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ-ANQELAQLELISRLCGSPCPA 240

Query: 364 ---DKIKLP-------------------AFLSSEAHSLLKGLLQKEASKR 391
              D IKLP                   +F+ + A  LL  +L  + SKR
Sbjct: 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKR 290

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  102 bits (256), Expect = 2e-24
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 8/207 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR--KDKIMEKNHAEYMKSERNILTKV 207
           ED E +  +G G    V +V+ I T  + A KV+       + K     +  E  I+ + 
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ----ILRELQIMHEC 60

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
             P+IV    +F  +  + + ++F++ G L     + G    ++       +V  +++L+
Sbjct: 61  RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120

Query: 268 -ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
             + IMHRD+KP NIL+++ G + L DFG++ +   N+ +++  GT  YMSPE + G  +
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFVGTSTYMSPERIQGGKY 179

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
              +D WS+GI + E+  G+ PF   N
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFSN 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  102 bits (255), Expect = 2e-24
 Identities = 71/232 (30%), Positives = 123/232 (53%), Gaps = 10/232 (4%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLKALSVLHAQGVIHRDIK 143

Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R  S+ GT  +M+PE++    +    D WS+G
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 203

Query: 337 ILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSS--EAHSLLKGLLQK 386
           I++ EM+ G+PP+      K   K+I+D   LP  L +  +    LKG L +
Sbjct: 204 IMVIEMVDGEPPYFNEPPLK-AMKMIRD--NLPPKLKNLHKVSPSLKGFLDR 252

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  102 bits (255), Expect = 3e-24
 Identities = 56/193 (29%), Positives = 109/193 (56%), Gaps = 5/193 (2%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V   R   +    A+K+M    + ++   E + +E  I+    H  +V++  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L+++++F+ GG L   + +  L  E +A +  + ++ A+ +LH+ G++HRD+K
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCES-VLQALCYLHSQGVIHRDIK 144

Query: 278 PENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q  ++  +  S+ GT  +M+PE++    +    D WS+G
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLG 204

Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 205 IMVIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  101 bits (252), Expect = 4e-24
 Identities = 74/247 (29%), Positives = 121/247 (48%), Gaps = 17/247 (6%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL--TKVDHPFIVQ 214
           V+G+G +  VY  R + T    A+K     +I E++          I   + + H  IVQ
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIK-----EIPERDSRYVQPLHEEIALHSYLKHRNIVQ 69

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGI 271
              S        + ++ V GG L   L  +       E     YT +I+  + +LH N I
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129

Query: 272 MHRDLKPENILLDA-DGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMSPEIVLG--KGHD 327
           +HRD+K +N+L++   G V ++DFG +K+    N  + +  GTL+YM+PE++    +G+ 
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189

Query: 328 KAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKI--IKDKIKLPAFLSSEAHSLLKGLL 384
             AD WS+G  + EM TG+PPF   G  Q    K+   K   ++P  LS+EA + +    
Sbjct: 190 APADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCF 249

Query: 385 QKEASKR 391
           + +  KR
Sbjct: 250 EPDPDKR 256

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  101 bits (253), Expect = 4e-24
 Identities = 67/234 (28%), Positives = 125/234 (53%), Gaps = 14/234 (5%)

Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
           ++K  + ++   E + +E  I+    H  +V +  S+     L++V++F+ GG L   + 
Sbjct: 52  VKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT 111

Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD- 301
              +  E +A +    ++ A+S+LH  G++HRD+K ++ILL +DG + L+DFG   Q   
Sbjct: 112 HTRMNEEQIATV-CLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170

Query: 302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ-QK 360
           E  +  S+ GT  +M+PE++    +    D WS+GI++ EM+ G+PP+   N   +Q  +
Sbjct: 171 EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF--NEPPLQAMR 228

Query: 361 IIKDKIKLPAFLSSEAHSLLKGLLQ----KEASKRLGSGPGGSQEIKSHKWFKM 410
            I+D +      S +  S+L+G L     +E S+R       +QE+  H + K+
Sbjct: 229 RIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQR-----ATAQELLQHPFLKL 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 74/284 (26%), Positives = 126/284 (44%), Gaps = 38/284 (13%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILTK 206
           E    L  +G+GA   V + R   T  I+A+K      I    + +  K    E  I   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKT-----ITTDPNPDLQKQILRELEINKS 55

Query: 207 VDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFFQLYRQGLFREDLARI------YTAE 258
              P+IV+   +F  +    + + +++  GG L   +Y++   ++   RI        AE
Sbjct: 56  CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKK--VKKRGGRIGEKVLGKIAE 112

Query: 259 -IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
            ++  +S+LH+  I+HRD+KP NILL   G V L DFG++ +   N+ + +  GT  YM+
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-VNSLAGTFTGTSFYMA 171

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK----------IQQKI--IKDK 365
           PE + GK +   +D WS+G+ L E+   + PF                 +      +KD+
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231

Query: 366 IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                  S E    +K  L+K+ ++R         ++  H W K
Sbjct: 232 PGNGIKWSEEFKDFIKQCLEKDPTRR-----PTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 99.5 bits (248), Expect = 2e-23
 Identities = 65/208 (31%), Positives = 120/208 (57%), Gaps = 7/208 (3%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E ++ +G+G +  VY+ R   T+E  A+K +R ++  E   +  ++ E ++L ++ 
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQ 59

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED--LARIYTAEIVSAVSHL 266
           H  IV+L+    ++ RLYLV ++++   L   +     F ++  L + Y  +I+  +++ 
Sbjct: 60  HGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 267 HANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLGK 324
           H++ ++HRDLKP+N+L+D   + + L DFGLA+ F    R+ +    TL Y +PEI+LG 
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS 178

Query: 325 GH-DKAADWWSVGILLFEMLTGQPPFTG 351
            H     D WSVG +  EM+  +P F G
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQKPLFPG 206

Length = 294

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  100 bits (251), Expect = 3e-23
 Identities = 76/288 (26%), Positives = 125/288 (43%), Gaps = 61/288 (21%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK---DKIMEKNHAEYMKSERNILTKVD 208
           ++ L  VG GA+ +V       T    A+K + +     I    HA+    E  +L  +D
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI----HAKRTYRELRLLKHMD 72

Query: 209 HPFIVQL---------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           H  ++ L            FQ    +YLV   +  G     + +     +D  +    +I
Sbjct: 73  HENVIGLLDVFTPASSLEDFQD---VYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQI 127

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYM 316
           +  + ++H+ GI+HRDLKP NI ++ D  + + DFGLA+  D+      M G   T  Y 
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 182

Query: 317 SPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNR-------------------QK 356
           +PEI+L   H ++  D WSVG ++ E+LTG+  F G +                    QK
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242

Query: 357 IQQKIIKDKIK-LP---------AFL--SSEAHSLLKGLLQKEASKRL 392
           I  +  ++ I+ LP          F   +  A  LL+ +L  +  KR+
Sbjct: 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI 290

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 98.7 bits (246), Expect = 4e-23
 Identities = 68/277 (24%), Positives = 127/277 (45%), Gaps = 41/277 (14%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILTKV 207
           +E L+ +G+G +  V++ +   T EI A+K +R D     +  E + S    E  +L ++
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD-----DDDEGVPSSALREICLLKEL 56

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            H  IV+L     +  +L LV ++ +     +     G    ++ + +  +++  ++  H
Sbjct: 57  KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R  S    TL Y  P+++ G K 
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 176

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK-----------------DKIK 367
           +  + D WS G +  E+   G+P F G +     ++I +                 D   
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236

Query: 368 LPAF------------LSSEAHSLLKGLLQKEASKRL 392
            P +            L+S    LL+ LL     +R+
Sbjct: 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRI 273

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 98.5 bits (245), Expect = 5e-23
 Identities = 74/219 (33%), Positives = 115/219 (52%), Gaps = 26/219 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
           + +E+++ +G+G + KVY+V       + A+K++  D I + +  E +++E NIL  + +
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVD--EEIEAEYNILQSLPN 77

Query: 209 HPFIVQLRYSF--QTKY---RLYLVLDFVNGG---HLFFQLYRQGLFREDLARI----YT 256
           HP +V+    F    K    +L+LVL+  NGG    L   L   G  R D A I    Y 
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISYILYG 136

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEY 315
           A +   + HLH N I+HRD+K  NILL  +G V L DFG++ Q      R N+  GT  +
Sbjct: 137 ALL--GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 194

Query: 316 MSPEIVLGK-----GHDKAADWWSVGILLFEMLTGQPPF 349
           M+PE++  +      +D   D WS+GI   E+  G PP 
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 97.6 bits (243), Expect = 8e-23
 Identities = 73/257 (28%), Positives = 129/257 (50%), Gaps = 19/257 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++ EVL  +G+G +  VY+V    T    AMK +R +  ++++    +  E +IL K   
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFR----EDLARIYTAEIVSAVSH 265
           P+IV    +F  +  +Y+ +++++ G L  +LY  G+      ED+ R  T  +V  +  
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 266 L-HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK 324
           L   + I+HRD+KP N+L++ +G V L DFG++      + + +  G   YM+PE +   
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNIGCQSYMAPERIKSG 176

Query: 325 GHDKA------ADWWSVGILLFEMLTGQ---PPFTGGNRQKIQQKIIK-DKIKLPAFLSS 374
           G ++       +D WS+G+ + EM  G+   PP T  N       I+  D   LP+  S 
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236

Query: 375 EAHSLLKGLLQKEASKR 391
           +A   +   L K  ++R
Sbjct: 237 DAQDFVAKCLNKIPNRR 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 41/229 (17%)

Query: 152 FEVLKVVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEY----MKSERNI-- 203
           +E+   +G+G + +VY+ +R      + YA+K  + DK       +Y      + R I  
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDK------EQYTGISQSACREIAL 55

Query: 204 LTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTA- 257
           L ++ H  +V L   F       +YL+ D+    H  +Q+   +RQ         I  + 
Sbjct: 56  LRELKHENVVSLVEVFLEHADKSVYLLFDYAE--HDLWQIIKFHRQ----AKRVSIPPSM 109

Query: 258 ------EIVSAVSHLHANGIMHRDLKPENILLDADGH----VMLTDFGLAKQFDENTRS- 306
                 +I++ V +LH+N ++HRDLKP NIL+  +G     V + D GLA+ F+   +  
Sbjct: 110 VKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169

Query: 307 ---NSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTG 351
              + +  T+ Y +PE++LG  H  KA D W++G +  E+LT +P F G
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 96.3 bits (240), Expect = 3e-22
 Identities = 80/303 (26%), Positives = 126/303 (41%), Gaps = 58/303 (19%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SERNIL 204
           LE ++ L  +G+G++A VY+ R   T ++ A+K +R        H E        E ++L
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRL------EHEEGAPFTAIREASLL 57

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVS 261
             + H  IV L     TK  L LV +++       + Y     G       R++  +++ 
Sbjct: 58  KDLKHANIVTLHDIIHTKKTLTLVFEYL---DTDLKQYMDDCGGGLSMHNVRLFLFQLLR 114

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL--AKQFDENTRSNSMCGTLEYMSPE 319
            +++ H   ++HRDLKP+N+L+   G + L DFGL  AK     T SN +  TL Y  P+
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPD 173

Query: 320 IVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ-QKIIK-----------DKI 366
           ++LG   +  + D W VG + +EM TG+P F G    + Q  KI +              
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233

Query: 367 KLPAF---------------------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH 405
             P F                            L    LQ E  KR+      + E   H
Sbjct: 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI-----SAAEAMKH 288

Query: 406 KWF 408
            +F
Sbjct: 289 PYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 95.9 bits (238), Expect = 4e-22
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 6/206 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           LE +  L  +G+G +A V++ R   T  + A+K +R +   E+        E ++L  + 
Sbjct: 4   LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLK 61

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV L     T+  L LV ++++     +      L      +I+  +++  +S+ H 
Sbjct: 62  HANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGL--AKQFDENTRSNSMCGTLEYMSPEIVLGKG- 325
             I+HRDLKP+N+L++  G + L DFGL  AK     T SN +  TL Y  P+++LG   
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTE 180

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +    D W VG +L+EM TG+P F G
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPG 206

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 96.0 bits (239), Expect = 4e-22
 Identities = 68/252 (26%), Positives = 117/252 (46%), Gaps = 16/252 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G G+F  VY  R + T+E+ A+K M           + +  E   L ++ HP 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            ++ +  +  ++  +LV+++  G      +++++ L   ++A I     +  +++LH++ 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI-CHGALQGLAYLHSHE 135

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG--KGH-D 327
            +HRD+K  NILL   G V L DFG A        +NS  GT  +M+PE++L   +G  D
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSP---ANSFVGTPYWMAPEVILAMDEGQYD 192

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSS-----EAHSLLKG 382
              D WS+GI   E+   +PP    N       I ++       LSS        + +  
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---SPTLSSNDWSDYFRNFVDS 249

Query: 383 LLQKEASKRLGS 394
            LQK    R  S
Sbjct: 250 CLQKIPQDRPSS 261

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 95.9 bits (238), Expect = 5e-22
 Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 8/206 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK-SERNILTKVD 208
           + +E L+ +G+G++A VY+ +     ++ A+KV+R   + E+    +    E ++L  + 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLK 61

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV L     TK  L LV ++V+     +     G    +  +++  +++  +S++H 
Sbjct: 62  HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGL--AKQFDENTRSNSMCGTLEYMSPEIVLGKG- 325
             I+HRDLKP+N+L+   G + L DFGL  AK    +T SN +  TL Y  P+++LG   
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTE 180

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +    D W VG +  EM+ G   F G
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPG 206

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 96.0 bits (239), Expect = 5e-22
 Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 20/208 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE L  +G G    V +V    +  I A K++         H E   + RN       
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLI---------HLEIKPAIRNQIIRELK 51

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED-LARIYTAEIVS 261
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E+ L +I  A ++ 
Sbjct: 52  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-VLR 110

Query: 262 AVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
            +++L     IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE 
Sbjct: 111 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPER 169

Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPP 348
           + G  +   +D WS+G+ L EM  G+ P
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 20/215 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILTK 206
             ++ L  +G+GA+  V       T    A+K     KI    H  + +    E  IL +
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK-----KISPFEHQTFCQRTLREIKILRR 59

Query: 207 VDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
             H  I+ +       SF++   +Y+V + +    L+  +  Q L   D  + +  +I+ 
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHL-SNDHIQYFLYQILR 117

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+ +  + + DFGLA+  D              T  Y +
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ KA D WSVG +L EML+ +P F G
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 93.9 bits (234), Expect = 4e-21
 Identities = 59/255 (23%), Positives = 109/255 (42%), Gaps = 23/255 (9%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM----EKNHAEYMKSERNILTKV 207
           ++ ++ +G GA+  V       + +  A+K     KI         A+    E  IL   
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRHF 61

Query: 208 DHPFIVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
            H  I+ +R   +         Y+V+D +    L   ++      E+  R +  +++  +
Sbjct: 62  KHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGL 120

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-----CGTLEYMSP 318
            ++H+  ++HRDLKP N+L++ D  + + DFG+A+    +   +         T  Y +P
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180

Query: 319 EIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP--AFLSSE 375
           E++L    +  A D WSVG +  EML  +  F G N    Q K+I   +  P    L+  
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSVLGSPSEEVLNRI 239

Query: 376 AHSLLKGLLQKEASK 390
               ++  +Q    K
Sbjct: 240 GSDRVRKYIQNLPRK 254

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 93.2 bits (231), Expect = 5e-21
 Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 8/206 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G G+F  VY  R + T+E+ A+K M           + +  E   L ++ HP 
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 212 IVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            ++ +  +  ++  +LV+++  G      +++++ L   ++A I T   +  +++LH++ 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI-THGALQGLAYLHSHN 145

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG---HD 327
           ++HRD+K  NILL   G V L DFG A      + +NS  GT  +M+PE++L      +D
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMDEGQYD 202

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
              D WS+GI   E+   +PP    N
Sbjct: 203 GKVDVWSLGITCIELAERKPPLFNMN 228

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 92.1 bits (229), Expect = 6e-21
 Identities = 71/261 (27%), Positives = 135/261 (51%), Gaps = 28/261 (10%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNI-LTK 206
           +D EV++ +G+GA+  V ++R + T  I A+K +R       N  E   +  + +I +  
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIR----ATVNSQEQKRLLMDLDISMRS 56

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQGLF-REDLARIYTAEIVSAV 263
           VD P+ V    +   +  +++ ++ ++      + ++Y +GL   ED+       IV A+
Sbjct: 57  VDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKAL 116

Query: 264 SHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE-----YMS 317
            +LH+   ++HRD+KP N+L++ +G V L DFG++         +S+  T++     YM+
Sbjct: 117 EYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL-----VDSVAKTIDAGCKPYMA 171

Query: 318 PEIVLG----KGHDKAADWWSVGILLFEMLTGQPPFT--GGNRQKIQQKIIKDKIKLPA- 370
           PE +      KG+D  +D WS+GI + E+ TG+ P+       Q+++Q + +   +LPA 
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAE 231

Query: 371 FLSSEAHSLLKGLLQKEASKR 391
             S E    +   L+K   +R
Sbjct: 232 KFSPEFQDFVNKCLKKNYKER 252

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 92.4 bits (229), Expect = 1e-20
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 18/218 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  I A K++         H E   + RN       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLI---------HLEIKPAIRNQIIRELQ 55

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 56  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 115

Query: 263 VSHL-HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q  + + +NS  GT  YMSPE +
Sbjct: 116 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERL 174

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ 359
            G  +   +D WS+G+ L EM  G+ P    + ++++ 
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 91.6 bits (227), Expect = 1e-20
 Identities = 73/233 (31%), Positives = 111/233 (47%), Gaps = 21/233 (9%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E +  +G GA+  VY+ R   +    A+K +R   +        + + R +     L  
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEA 58

Query: 207 VDHPFIVQL-------RYSFQTKYRLYLVLDFVNGGHLFF--QLYRQGLFREDLARIYTA 257
            DHP IV+L       R   +TK  + LV + V+     +  ++   GL  E + +    
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETK--VTLVFEHVDQDLRTYLDKVPPPGLPAETI-KDLMR 115

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
           + +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +        +  TL Y +
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA 370
           PE++L   +    D WSVG +  EM   +P F  GN +  Q   I D I LP 
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQLGKIFDLIGLPP 227

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 93.9 bits (233), Expect = 1e-20
 Identities = 65/211 (30%), Positives = 113/211 (53%), Gaps = 26/211 (12%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR 216
           ++G G+F  VY+   I TSE  A+K + +D        +Y   E  I+  ++H  I+ L+
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQD-------PQYKNRELLIMKNLNHINIIFLK 125

Query: 217 -YSFQTKYR-------LYLVLDFV-NGGHLFFQLYRQG-----LFREDLARIYTAEIVSA 262
            Y +   ++       L +V++F+    H + + Y +      LF   L ++Y+ ++  A
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF---LVKLYSYQLCRA 182

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           ++++H+  I HRDLKP+N+L+D + H + L DFG AK      RS S   +  Y +PE++
Sbjct: 183 LAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELM 242

Query: 322 LGK-GHDKAADWWSVGILLFEMLTGQPPFTG 351
           LG   +    D WS+G ++ EM+ G P F+G
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273

Length = 440

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 83/303 (27%), Positives = 138/303 (45%), Gaps = 61/303 (20%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILT 205
           E +E L  +G+G++  V++ R   T +I A+K     K +E      +K     E  +L 
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLK 55

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVS 264
           ++ HP +V L   F+ K +L+LV ++ +   L   +   +G+  E L +    + + AV+
Sbjct: 56  QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGV-PEHLIKKIIWQTLQAVN 114

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAK----QFDENTRSNSMCGTLEYMSPEI 320
             H +  +HRD+KPENIL+   G + L DFG A+      D+ T       T  Y +PE+
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT---DYVATRWYRAPEL 171

Query: 321 VLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIKD------------- 364
           ++G   +    D W++G +  E+LTGQP + G  +  + Q   I K              
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG--KSDVDQLYLIRKTLGDLIPRHQQIFS 229

Query: 365 -------------------KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH 405
                              + K P  +SS A S LKG LQ + ++RL       +E+  H
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERL-----SCEELLEH 283

Query: 406 KWF 408
            +F
Sbjct: 284 PYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 91.3 bits (226), Expect = 2e-20
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G G+F  VY  R +  SE+ A+K M           + +  E   L K+ HP 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 212 IVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            +Q R  +  ++  +LV+++  G      +++++ L   ++A + T   +  +++LH++ 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV-THGALQGLAYLHSHN 135

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG---HD 327
           ++HRD+K  NILL   G V L DFG A        +N   GT  +M+PE++L      +D
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYD 192

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
              D WS+GI   E+   +PP    N
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMN 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 94.0 bits (233), Expect = 3e-20
 Identities = 76/276 (27%), Positives = 138/276 (50%), Gaps = 34/276 (12%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L ++EV+K +G G F +V+ V+   T E +  K +    + E+  ++ +  E N++ ++ 
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQ-LVIEVNVMRELK 70

Query: 209 HPFIVQL--RYSFQTKYRLYLVLDFVNGGHL---FFQLYRQ-GLFREDLARIYTAEIVSA 262
           H  IV+   R+  +   +LY++++F + G L     + Y+  G   E      T +++ A
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130

Query: 263 VSHLH-----ANG--IMHRDLKPENILL---------------DADGHVM--LTDFGLAK 298
           +++ H      NG  ++HRDLKP+NI L               + +G  +  + DFGL+K
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 299 QFDENTRSNSMCGTLEYMSPEIVL--GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK 356
                + ++S  GT  Y SPE++L   K +D  +D W++G +++E+ +G+ PF   N   
Sbjct: 191 NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250

Query: 357 IQQKIIKDKIKLP-AFLSSEAHSLLKGLLQKEASKR 391
                +K    LP    S E + L+K LL   A +R
Sbjct: 251 QLISELKRGPDLPIKGKSKELNILIKNLLNLSAKER 286

Length = 1021

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 90.1 bits (223), Expect = 5e-20
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 6/206 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           LE +  L  +G+G +A VY+ R   T  + A+K +R +   E+        E ++L  + 
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 62

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV L     T+  L LV ++++     +             +++  +++  +++ H 
Sbjct: 63  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGL--AKQFDENTRSNSMCGTLEYMSPEIVLGK-G 325
             ++HRDLKP+N+L++  G + L DFGL  AK     T SN +  TL Y  P+I+LG   
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTD 181

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +    D W VG + +EM TG+P F G
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGRPLFPG 207

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 90.5 bits (225), Expect = 5e-20
 Identities = 73/269 (27%), Positives = 124/269 (46%), Gaps = 58/269 (21%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSE-----------IYAMKVMRKDKIMEKNHAEYMKSE 200
           +E++K +GQGA+  V   R   TSE           +++ K++ K  + E     + +  
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARI----- 254
           +NI    D                    +D V  G+ F +LY  + L   DL +I     
Sbjct: 62  KNITCLYD--------------------MDIVFPGN-FNELYLYEELMEADLHQIIRSGQ 100

Query: 255 ---------YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
                    +  +I+  + ++H+  ++HRDLKP N+L++AD  + + DFGLA+ F EN  
Sbjct: 101 PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160

Query: 306 SNS-----MCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ 359
            N+        T  Y +PEI+L  + + KA D WSVG +L E+L  +P F G +      
Sbjct: 161 ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220

Query: 360 KIIK-----DKIKLPAFLSSEAHSLLKGL 383
           +I++     D+  L    S +A + ++ L
Sbjct: 221 QILQVLGTPDEETLSRIGSPKAQNYIRSL 249

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 89.7 bits (222), Expect = 7e-20
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 6/206 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G +A V++ R   T  + A+K +R +   E+        E ++L  + 
Sbjct: 5   METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 62

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV L     T   L LV ++++     +      +      +I+  +I+  +++ H 
Sbjct: 63  HANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGL--AKQFDENTRSNSMCGTLEYMSPEIVLGKG- 325
             ++HRDLKP+N+L++  G + L DFGL  AK     T SN +  TL Y  P+++LG   
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSE 181

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +    D W VG + FEM +G+P F G
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPG 207

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 8/201 (3%)

Query: 155 LKVVGQGAFAKVYQ-VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV 213
           L+ +G+G++A VY+ + RI   ++ A+KV+      E+        E ++L  + H  IV
Sbjct: 10  LEKLGEGSYATVYKGISRI-NGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIV 66

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
            L     TK  L  V ++++     + +   G       R++  +++  ++++H   I+H
Sbjct: 67  LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126

Query: 274 RDLKPENILLDADGHVMLTDFGLA--KQFDENTRSNSMCGTLEYMSPEIVLGK-GHDKAA 330
           RDLKP+N+L+   G + L DFGLA  K     T S+ +  TL Y  P+++LG   +  A 
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSAL 185

Query: 331 DWWSVGILLFEMLTGQPPFTG 351
           D W  G +  EML GQP F G
Sbjct: 186 DIWGAGCIFIEMLQGQPAFPG 206

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 80/328 (24%), Positives = 129/328 (39%), Gaps = 99/328 (30%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS-------------ERN 202
             +G+G + KV +     T +I A+K ++  +I   N     +              E  
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEI--SNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           I+ ++ H  I+ L   +     + LV+D +                 DL ++   +I   
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMAS---------------DLKKVVDRKIRLT 117

Query: 263 VSH--------------LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-------- 300
            S               LH    MHRDL P NI +++ G   + DFGLA+++        
Sbjct: 118 ESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177

Query: 301 ---DENTRSN----SMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              DE  +      S   TL Y +PE+++G  K H  A D WSVG +  E+LTG+P F G
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHF-AVDMWSVGCIFAELLTGKPLFPG 236

Query: 352 GNRQKIQQ--KIIK-----------DKIKLPAFL-----------------SSEAHSLLK 381
            N  +I Q  +I +              KLP +                  S +A  LL+
Sbjct: 237 EN--EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQ 294

Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWFK 409
            LL+    +R+      ++E   H++FK
Sbjct: 295 SLLKLNPLERI-----SAKEALKHEYFK 317

Length = 335

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 18/208 (8%)

Query: 152 FEVLKVV---GQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
              LK +   G+G F KV   R       T E  A+K +      E+ H    + E  IL
Sbjct: 3   KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS--GEEQHRSDFEREIEIL 60

Query: 205 TKVDHPFIVQLRYSFQTKYR--LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIV 260
             +DH  IV+ +   +      L L+++++  G L  + Q +R  +  + L   ++++I 
Sbjct: 61  RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL-FSSQIC 119

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGT-LEYM 316
             + +L +   +HRDL   NIL++++  V ++DFGLAK   +  +         + + + 
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT 344
           +PE +       A+D WS G+ L+E+ T
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 88.5 bits (219), Expect = 3e-19
 Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 10/221 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  +L  V+
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 78

Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+    L  E ++ +   +++  
Sbjct: 79  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLY-QMLCG 135

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    N        T  Y +PE++L
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
           G G+ +  D WSVG ++ E++ G   F G +      K+I+
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 236

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 89.9 bits (223), Expect = 4e-19
 Identities = 44/121 (36%), Positives = 69/121 (57%), Gaps = 10/121 (8%)

Query: 311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP- 369
           GT +Y++PE++LGK H  A DWW++G+ LFE LTG PPF     Q++ Q I+   I  P 
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPE 601

Query: 370 --AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP 427
               LS  A + ++ LL  + +KR      G +E+K H  F  ++W+ L+ +     F+P
Sbjct: 602 GEEKLSVNAQNAIEILLTMDPTKR-----AGLKELKQHPLFHGVDWENLQNQT--MPFIP 654

Query: 428 E 428
           +
Sbjct: 655 Q 655

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 87.4 bits (216), Expect = 4e-19
 Identities = 69/253 (27%), Positives = 121/253 (47%), Gaps = 14/253 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L  +G G+F  VY      T+E+ A+K M           + +  E   L ++ H
Sbjct: 21  EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH 80

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P  ++ +  +  ++  +LV+++  G      +++++ L   ++A I T   +  +++LH+
Sbjct: 81  PNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI-THGALQGLAYLHS 139

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG--- 325
           + ++HRD+K  NILL   G V L DFG A +   ++ +NS  GT  +M+PE++L      
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASK---SSPANSFVGTPYWMAPEVILAMDEGQ 196

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGL-- 383
           +D   D WS+GI   E+   +PP    N       I ++    P   S+E     +G   
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTDSFRGFVD 254

Query: 384 --LQKEASKRLGS 394
             LQK   +R  S
Sbjct: 255 YCLQKIPQERPAS 267

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 88.0 bits (218), Expect = 4e-19
 Identities = 52/193 (26%), Positives = 94/193 (48%), Gaps = 11/193 (5%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           + V+K +  G+  +V+   + G  +   +K+ +K   +          E  +L  V+HP 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +++++ +  +     +VL   +     +   R      D A I   +I+  + +LHA  I
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRI 178

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN-SMCGTLEYMSPEIVLGKGHDKAA 330
           +HRD+K ENI ++    V + D G A QF     +   + GT+E  +PE++    ++  A
Sbjct: 179 IHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKA 237

Query: 331 DWWSVGILLFEML 343
           D WS GI+LFEML
Sbjct: 238 DIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 87.7 bits (217), Expect = 5e-19
 Identities = 84/309 (27%), Positives = 144/309 (46%), Gaps = 70/309 (22%)

Query: 150 EDFEVLKVVGQGAFAKV-YQV-RRIGT------------SEIYAMKVMRKDKIMEKNHAE 195
           + +  LK VG GA+  V   + RR G             SE++A +  R+ ++++     
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK----- 69

Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
           +MK E N++  +D   +     S    +  YLV+ F+  G    +L +     ED  +  
Sbjct: 70  HMKHE-NVIGLLD---VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFL 123

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---T 312
             +++  + ++HA GI+HRDLKP N+ ++ D  + + DFGLA+Q D     + M G   T
Sbjct: 124 VYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD-----SEMTGYVVT 178

Query: 313 LEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNR----------------- 354
             Y +PE++L   H  +  D WSVG ++ EMLTG+P F G +                  
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238

Query: 355 --QKIQQKIIKDKIK-LPAF-----------LSSEAHSLLKGLLQKEASKRLGSGPGGSQ 400
             QK+Q +  K+ +K LP F            +  A ++L+ +L  +A  R+ +      
Sbjct: 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAA----- 293

Query: 401 EIKSHKWFK 409
           E  +H +F+
Sbjct: 294 EALAHPYFE 302

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 58/200 (29%), Positives = 105/200 (52%), Gaps = 11/200 (5%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           +K +G G F  V+  +     ++ A+K + +  + E++  E    E  ++ K+ HP +VQ
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQ 63

Query: 215 LRYSFQTKYR-LYLVLDFV-NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           L Y   T+ + LY+V +F+ NG  L +   RQG   +D+      ++   + +L  N  +
Sbjct: 64  L-YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122

Query: 273 HRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           HRDL   N L+ + G V ++DFG+ +    DE T S+     +++  PE+     +   +
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 331 DWWSVGILLFEMLT-GQPPF 349
           D WS G+L++E+ T G+ PF
Sbjct: 183 DVWSFGVLMWEVFTEGKMPF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 63/248 (25%), Positives = 117/248 (47%), Gaps = 15/248 (6%)

Query: 156 KVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           K +G G+F  V +       G     A+K ++ DK +     +++K E  I+  +DH  +
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK-LSDIMDDFLK-EAAIMHSLDHENL 58

Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLHANG 270
           ++L Y     + L +V +    G L  +L +  L    ++ +  Y  +I + + +L +  
Sbjct: 59  IRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSPEIVLGKGH 326
            +HRDL   NILL +D  V + DFGL +   +N     M   L+    + +PE +  +  
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 327 DKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKL--PAFLSSEAHSLLKGL 383
             A+D W  G+ L+EM T G+ P+ G +  +I +KI K+  +L  P     + ++++   
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC 237

Query: 384 LQKEASKR 391
                + R
Sbjct: 238 WAHNPADR 245

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 16/223 (7%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V       T +  A+K + +       HA+    E  ++  V+
Sbjct: 15  LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV-THAKRAYRELVLMKLVN 73

Query: 209 HPFIVQLRYSF--QTKYR----LYLVLDFVNGGHLFFQLYRQGLFREDLAR-IYTAEIVS 261
           H  I+ L   F  Q        +YLV++ ++      Q+ +  L  E ++  +Y  +++ 
Sbjct: 74  HKNIIGLLNVFTPQKSLEEFQDVYLVMELMD--ANLCQVIQMDLDHERMSYLLY--QMLC 129

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
            + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 189

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KII 362
           LG G+ +  D WSVG ++ EM+ G   F G +   I Q  KII
Sbjct: 190 LGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH--IDQWNKII 230

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 18/207 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V +V+   +  I A K++         H E   + RN       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLI---------HLEIKPAIRNQIIRELQ 55

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L       E++    +  ++  
Sbjct: 56  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG 115

Query: 263 VSHL-HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q  + + +NS  GT  YMSPE +
Sbjct: 116 LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERL 174

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPP 348
            G  +   +D WS+G+ L E+  G+ P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 63/235 (26%), Positives = 115/235 (48%), Gaps = 20/235 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----L 204
           + +E +  +G+GA+ KV++ R +     +    +++ ++        + + R +     L
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAVLRHL 58

Query: 205 TKVDHPFIVQL-------RYSFQTKYRLYLVLDFVNGGHLFF--QLYRQGLFREDLARIY 255
              +HP +V+L       R   +TK  L LV + V+     +  ++   G+  E +  + 
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM- 115

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY 315
             +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +       S+  TL Y
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 175

Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA 370
            +PE++L   +    D WSVG +  EM   +P F  G+    Q   I D I LP 
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR-GSSDVDQLGKILDVIGLPG 229

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 85.1 bits (210), Expect = 5e-18
 Identities = 60/221 (27%), Positives = 110/221 (49%), Gaps = 10/221 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81

Query: 209 HPFIVQL------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L      + S +    +Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLY-QMLCG 138

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
           G G+ +  D WSVG ++ EM+ G   F G +      K+I+
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 239

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 84.0 bits (207), Expect = 1e-17
 Identities = 61/221 (27%), Positives = 109/221 (49%), Gaps = 10/221 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74

Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLY-QMLCG 131

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
           G G+ +  D WSVG ++ EM+  +  F G +      K+I+
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 85.6 bits (212), Expect = 1e-17
 Identities = 60/253 (23%), Positives = 121/253 (47%), Gaps = 37/253 (14%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-MEKNHAEYMKSERNILTKV 207
           ++ +++++++G+G   +VY       S   A+K +R+D          +++ E  I   +
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLR-EAKIAADL 59

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNG---GHLFFQLYRQGLFREDLA---------RIY 255
            HP IV +         +Y  + ++ G     L   ++++    ++LA          I+
Sbjct: 60  IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK----------------- 298
             +I + + ++H+ G++HRDLKP+NILL   G V++ D+G A                  
Sbjct: 120 H-KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 299 --QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK 356
              +   T    + GT +YM+PE +LG    ++ D +++G++L++MLT   P+    R+K
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY---RRKK 235

Query: 357 IQQKIIKDKIKLP 369
            ++   +D I  P
Sbjct: 236 GRKISYRDVILSP 248

Length = 932

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 51/187 (27%), Positives = 93/187 (49%), Gaps = 28/187 (14%)

Query: 200 ERNILTKVDHPFIVQL-------------RYSFQTKYR-LYLVLDFVNGGHLFFQLYRQG 245
           E  I+ ++DH  IV++                  T+   +Y+V +++        +  QG
Sbjct: 52  EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQG 109

Query: 246 LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENT 304
              E+ AR++  +++  + ++H+  ++HRDLKP N+ ++ +  V+ + DFGLA+  D + 
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169

Query: 305 RSNSMCGTLE-------YMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQK 356
              S  G L        Y SP ++L   +  KA D W+ G +  EMLTG+P F G +  +
Sbjct: 170 ---SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226

Query: 357 IQQKIIK 363
             Q I++
Sbjct: 227 QMQLILE 233

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 83.0 bits (205), Expect = 3e-17
 Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 24/166 (14%)

Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-------DL 251
            E +IL  + H  I+ L ++++ K  + +V+            Y+  LF          L
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVM----------PKYKCDLFTYVDRSGPLPL 184

Query: 252 ARIYTAE--IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM 309
            +  T +  ++ A+++LH  GI+HRD+K ENI LD   + +L DFG A + D +  +   
Sbjct: 185 EQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT-PQ 243

Query: 310 C----GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           C    GTLE  SPE++    +    D WS G++LFEM        G
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289

Length = 392

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 11/202 (5%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           LK +G G F  V+  +  G  ++ A+K++R+  + E +  E    E  ++ K+ HP +VQ
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIE----EAKVMMKLSHPNLVQ 63

Query: 215 LRYSFQTKYR-LYLVLDF-VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           L Y   TK R +++V ++  NG  L +   R+G    +      +++  A+ +L +NG +
Sbjct: 64  L-YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122

Query: 273 HRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           HRDL   N L+  D  V ++DFGLA+    D+ T S      +++  PE+         +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182

Query: 331 DWWSVGILLFEMLT-GQPPFTG 351
           D WS G+L++E+ + G+ P+  
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYER 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 80.6 bits (199), Expect = 5e-17
 Identities = 60/248 (24%), Positives = 109/248 (43%), Gaps = 11/248 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E+F + + +G G F +V++        + A+K+++ D        ++ K E   L ++ H
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSD--DLLKQQDFQK-EVQALKRLRH 61

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR---QGLFREDLARIYTAEIVSAVSHL 266
             ++ L         +Y++ + +  G L   L     Q L    L  +   ++   +++L
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDM-ACQVAEGMAYL 120

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT-LEYMSPEIVLGKG 325
                +HRDL   NIL+  D    + DFGLA+   E+   +S      ++ +PE      
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT 180

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGL 383
               +D WS GILL+EM T GQ P+ G N  ++  +I    ++  PA    E + ++   
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC 240

Query: 384 LQKEASKR 391
              E   R
Sbjct: 241 WAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 81.1 bits (200), Expect = 7e-17
 Identities = 76/279 (27%), Positives = 121/279 (43%), Gaps = 50/279 (17%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           LK VG GA+  V       T E  A+K + +     +  A+    E  +L  + H  ++ 
Sbjct: 20  LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHENVIG 78

Query: 215 LR------YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           L        S       YLV+ ++       Q        ED  +    +++  + ++H+
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYM---QTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS 135

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPEIVLGKG 325
            GI+HRDLKP N+ ++ D  + + DFGLA+  D       M G   T  Y +PE++L   
Sbjct: 136 AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWM 190

Query: 326 H-DKAADWWSVGILLFEMLTGQPPFTGGNR-------------------QKIQQKIIKDK 365
           H ++  D WSVG ++ EMLTG+  F G +                    QK++ K  K  
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY 250

Query: 366 IK-LPAF-----------LSSEAHSLLKGLLQKEASKRL 392
           IK LP +            S +A  LL+ +L+ +  KRL
Sbjct: 251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 59/248 (23%), Positives = 124/248 (50%), Gaps = 12/248 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++ K+ H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMKLSH 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +VQL      +  +Y+V ++++ G L   L R+   R   +++     ++   +++L 
Sbjct: 59  EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLE 117

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKG 325
           +   +HRDL   N L+D  G V ++DFGL++    DE T S      + +  PE++L   
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGL 383
               +D W+ G+L++E+ + G+ P+   N  +  +K+ +  ++  P   S + ++++   
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSC 237

Query: 384 LQKEASKR 391
             ++A +R
Sbjct: 238 WHEKAEER 245

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 76/299 (25%), Positives = 124/299 (41%), Gaps = 64/299 (21%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR--------KDKIMEKNHAEYMKSER 201
           ED + L  +G+GAF  V ++    +  I A+K +R        K  +M+      M+S  
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMD--LDVVMRSS- 60

Query: 202 NILTKVDHPFIVQ-----------------LRYSFQTKYRL-YLVLDFVNGGHLFFQLYR 243
                 D P+IV+                 +  S    Y+  Y VL              
Sbjct: 61  ------DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-------------- 100

Query: 244 QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDE 302
           + +  E++        V A+++L     I+HRD+KP NILLD +G++ L DFG++ Q  +
Sbjct: 101 KSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160

Query: 303 NTRSNSMCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNR--QKI 357
           +       G   YM+PE +      G+D  +D WS+GI L+E+ TG+ P+   N    ++
Sbjct: 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220

Query: 358 QQKIIKDKIKLP----AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN 412
            Q +  D   L        S    + +   L K+ SKR         E+  H + K   
Sbjct: 221 TQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYK-----ELLEHPFIKDYE 274

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 64/240 (26%), Positives = 115/240 (47%), Gaps = 12/240 (5%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 67

Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 68  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127

Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 334 SVGILLFEMLT-GQPPFTGG-NRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR+ + Q     ++  P       H L+    +KE  +R
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++V+G+G F KV    Y     GT E+ A+K ++++    + +    K E NIL  + H 
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHE 66

Query: 211 FIVQLR--YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV+ +   S Q    L L++++V  G L   L +  L    L  ++  +I   +++LH+
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL-LFAQQICEGMAYLHS 125

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-----TRSNSMCGTLEYMSPEIVLG 323
              +HRDL   N+LLD D  V + DFGLAK   E       R +       Y + E +  
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKE 184

Query: 324 KGHDKAADWWSVGILLFEMLT 344
                A+D WS G+ L+E+LT
Sbjct: 185 NKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 15/205 (7%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILTKVDHP 210
           L+ VG GAF  V   R   T +  A+K     KIM+       A+    E  +L  + H 
Sbjct: 15  LQPVGMGAFGLVCSARDQLTGQNVAIK-----KIMKPFSTPVLAKRTYRELKLLKHLRHE 69

Query: 211 FIVQLRYSFQTKYR-LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            I+ L   F +    +Y V + +  G    +L       +   + +  +I+  + ++H+ 
Sbjct: 70  NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDK 328
           G++HRDLKP NIL++ +  + + DFGLA+  D   +      T  Y +PEI+L  + +D 
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQD--PQMTGYVSTRYYRAPEIMLTWQKYDV 185

Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
             D WS G +  EML G+P F G +
Sbjct: 186 EVDIWSAGCIFAEMLEGKPLFPGKD 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 80.9 bits (199), Expect = 3e-16
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 35/243 (14%)

Query: 149 LEDFEVLKVVGQGAFAKVY-----------QVRRIGTSEIYAMKVMRKDKIMEK------ 191
           L  F V+  +  GAF K++           + RR   S        + ++++ K      
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNST--NQGKPKCERLIAKRVKAGS 204

Query: 192 NHAEYMKSERNILTKVDHPFIVQ----LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF 247
             A  +++E   L +++H  I++    LR    T Y +    DF     L+  +Y +   
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANT-YMITQKYDF----DLYSFMYDEAFD 259

Query: 248 RED-----LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE 302
            +D       R    +++ AV ++H   ++HRD+K ENI L+ DG ++L DFG A  F++
Sbjct: 260 WKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319

Query: 303 N--TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQK 360
                     GT+   SPEI+ G G+ +  D WS G++L +ML+      G    K  ++
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379

Query: 361 IIK 363
           ++K
Sbjct: 380 LLK 382

Length = 501

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 80.0 bits (197), Expect = 3e-16
 Identities = 51/160 (31%), Positives = 78/160 (48%), Gaps = 23/160 (14%)

Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF--REDLARIYT 256
           +E +IL  ++HP I+QL+ +F       L+L            Y+  L+        I  
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLIL----------PRYKTDLYCYLAAKRNIAI 181

Query: 257 AEIVS-------AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM 309
            +I++       A+ +LH N I+HRD+K ENI ++  G V L DFG A  F  +  +N  
Sbjct: 182 CDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKY 240

Query: 310 ---CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQ 346
               GT+   +PE++    +  A D WS GI+LFEM T  
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 77.0 bits (189), Expect = 7e-16
 Identities = 63/253 (24%), Positives = 128/253 (50%), Gaps = 22/253 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  +++K +G G F +V+     G +++ A+K ++   +  ++  E    E  I+ K+ H
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQIMKKLRH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-------DLARIYTAEIVSA 262
             +VQL Y+  ++  +Y+V ++++ G L   L + G  R        D+A    A++ + 
Sbjct: 61  DKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMA----AQVAAG 114

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEI 320
           ++++     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE 
Sbjct: 115 MAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS 378
            L       +D WS GILL E++T G+ P+ G N +++ +++ +  ++  P       H 
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE 234

Query: 379 LLKGLLQKEASKR 391
           L+    +K+  +R
Sbjct: 235 LMLQCWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 77.8 bits (191), Expect = 9e-16
 Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 32/216 (14%)

Query: 158 VGQGAFAKVYQVRRI-GTSEI-YAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDHPFIV 213
           VG+G +  VY+ +R  G  E  YA+K +    I        M + R I  L ++ HP ++
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-------MSACREIALLRELKHPNVI 61

Query: 214 QLRYSF--QTKYRLYLVLDFVNGG--HLFFQLYRQG-------LFREDLARIYTAEIVSA 262
            L+  F   +  +++L+ D+      H+  + +R              + +    +I+  
Sbjct: 62  ALQKVFLSHSDRKVWLLFDYAEHDLWHII-KFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 263 VSHLHANGIMHRDLKPENILLDAD----GHVMLTDFGLAKQFDENTRS----NSMCGTLE 314
           + +LHAN ++HRDLKP NIL+  +    G V + D G A+ F+   +     + +  T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 315 YMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPF 349
           Y +PE++LG  H  KA D W++G +  E+LT +P F
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 62/251 (24%), Positives = 120/251 (47%), Gaps = 13/251 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           ED  + + +G+G F  VYQ   +         A+K  +          E    E  I+ +
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSV--REKFLQEAYIMRQ 63

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
            DHP IV+L     T+  +++V++    G L  + Q+ +  L    L  +Y+ ++ +A++
Sbjct: 64  FDHPHIVKL-IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLI-LYSYQLSTALA 121

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPEIVL 322
           +L +   +HRD+   N+L+ +   V L DFGL++  ++ +   +  G L  ++M+PE + 
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181

Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK-DKIKLPAFLSSEAHSLL 380
            +    A+D W  G+ ++E+L  G  PF G     +  +I   +++ +P       +SL+
Sbjct: 182 FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 241

Query: 381 KGLLQKEASKR 391
                 + SKR
Sbjct: 242 TKCWAYDPSKR 252

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 56/240 (23%), Positives = 123/240 (51%), Gaps = 14/240 (5%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +++G+G F  V Q    G  +  A+K ++ D       A+    E  ++TK+ H  +V+L
Sbjct: 12  EIIGEGEFGAVLQGEYTG--QKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRL 64

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLHANGIMH 273
                    LY+V++ ++ G+L   L  +G     + ++  ++ ++   + +L +  ++H
Sbjct: 65  -LGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVH 123

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           RDL   NIL+  DG   ++DFGLA+       ++ +   +++ +PE +  K     +D W
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL--PVKWTAPEALKHKKFSSKSDVW 181

Query: 334 SVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKR 391
           S G+LL+E+ + G+ P+   + +++++ + K  +++ P    ++ + L+    + E  KR
Sbjct: 182 SYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 17/216 (7%)

Query: 153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           ++L+ +G G F +V++     T+ + A+K ++   +  K   +++  E  I+ K+ HP +
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTMDPK---DFLA-EAQIMKKLRHPKL 63

Query: 213 VQLRYSFQTKYR-LYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHA 268
           +QL Y+  T    +Y+V + +  G L   L       L    L  +  A++ S +++L A
Sbjct: 64  IQL-YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM-AAQVASGMAYLEA 121

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT---LEYMSPEIVLGKG 325
              +HRDL   N+L+  +    + DFGLA+   E+    +  G    +++ +PE  L   
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNR 180

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
               +D WS GILL E++T G+ P+ G  N + +QQ
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ 216

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 24/227 (10%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            E +KV+G GAF  VY+   I   E      A+KV+R++    K + E +  E  ++  V
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILD-EAYVMASV 66

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-------YTAEIV 260
           DHP +V+L        ++ L+   +  G L   +      R     I       +  +I 
Sbjct: 67  DHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYV------RNHKDNIGSQYLLNWCVQIA 119

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMS 317
             +S+L    ++HRDL   N+L+    HV +TDFGLAK  D + +     G    +++M+
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK 363
            E +L + +   +D WS G+ ++E++T G  P+ G    +I   + K
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 51/209 (24%), Positives = 98/209 (46%), Gaps = 17/209 (8%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT--SEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           +  ++ ++   +G+G F  V      G    +  A+K ++ D       A+   +E +++
Sbjct: 3   INSKELKLGATIGKGEFGDVML----GDYRGQKVAVKCLKDDS----TAAQAFLAEASVM 54

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY---RQGLFREDLARIYTAEIVS 261
           T + HP +VQL         LY+V +++  G L   L    R  +        +  ++  
Sbjct: 55  TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQ-LGFALDVCE 113

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
            + +L     +HRDL   N+L+  D    ++DFGLAK+  +   S  +   +++ +PE +
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL--PVKWTAPEAL 171

Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPF 349
             K     +D WS GILL+E+ + G+ P+
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 75.5 bits (185), Expect = 5e-15
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 32/216 (14%)

Query: 158 VGQGAFAKVYQVRRIGTSEI--YAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDHPFIV 213
           VG+G +  VY+ +R    +   YA+K +    I        M + R I  L ++ HP ++
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-------MSACREIALLRELKHPNVI 61

Query: 214 QLRYSF--QTKYRLYLVLDFVNGG--HLFFQLYRQGLFRED-------LARIYTAEIVSA 262
            L+  F      +++L+ D+      H+  + +R     +        + +    +I+  
Sbjct: 62  SLQKVFLSHADRKVWLLFDYAEHDLWHII-KFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 263 VSHLHANGIMHRDLKPENILLDAD----GHVMLTDFGLAKQFDENTRS----NSMCGTLE 314
           + +LHAN ++HRDLKP NIL+  +    G V + D G A+ F+   +     + +  T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 315 YMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPF 349
           Y +PE++LG  H  KA D W++G +  E+LT +P F
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 75.9 bits (186), Expect = 6e-15
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 12/211 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V         +  A+K + +       HA     E  +L  + H
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKH 73

Query: 210 PFIVQL------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L        S +    +YLV + + G  L   +  Q L  ++  +    +++  +
Sbjct: 74  ENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKL-SDEHVQFLIYQLLRGL 131

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+ GI+HRDLKP N+ ++ D  + + DFGLA+Q D+         T  Y +PEI+L 
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM--TGYVATRWYRAPEIMLN 189

Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+L G+  F G +
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGND 220

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 74.5 bits (183), Expect = 7e-15
 Identities = 67/262 (25%), Positives = 121/262 (46%), Gaps = 29/262 (11%)

Query: 156 KVVGQGAFAKVYQ-----VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
             +G GAF +VY+     +   G+  I  A+K +RK    ++   E++K E ++++  +H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLK-EAHLMSNFNH 58

Query: 210 PFIV-QLRYSFQTKYRLYLVLDFVNGGHLFFQL--------YRQGLFREDLARIYTAEIV 260
           P IV  L      +   Y++++ + GG L   L            L  ++L  I   ++ 
Sbjct: 59  PNIVKLLGVCLLNE-PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI-CLDVA 116

Query: 261 SAVSHLHANGIMHRDLKPENILL-----DADGHVMLTDFGLAKQF---DENTRSNSMCGT 312
               +L     +HRDL   N L+     DAD  V + DFGLA+     D   +       
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPA 370
           + +M+PE +L       +D WS G+L++E+LT GQ P+   N Q++ Q +    +++ P 
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPE 236

Query: 371 FLSSEAHSLLKGLLQKEASKRL 392
               + + L+     ++ S+R 
Sbjct: 237 NCPDKIYQLMTNCWAQDPSERP 258

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 75.1 bits (184), Expect = 8e-15
 Identities = 66/254 (25%), Positives = 114/254 (44%), Gaps = 19/254 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 75

Query: 210 PFIVQL------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L        S +    +YLV   + G  L   +  Q L  +D  +    +I+  +
Sbjct: 76  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKL-TDDHVQFLIYQILRGL 133

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 191

Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
             H ++  D WSVG ++ E+LTG+  F G +     + I++        + +    LLK 
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR-------LVGTPGAELLKK 244

Query: 383 LLQKEASKRLGSGP 396
           +  + A   + S  
Sbjct: 245 ISSESARNYIQSLT 258

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 73.9 bits (181), Expect = 8e-15
 Identities = 54/213 (25%), Positives = 112/213 (52%), Gaps = 9/213 (4%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +++G+G F +V++      + + A+K  ++D  + +       SE  IL + DHP IV+L
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPV-AVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKL 57

Query: 216 RYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
                 +  +Y+V++ V GG    F +  +  L  + L + +  +  + +++L +   +H
Sbjct: 58  IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVK-FALDAAAGMAYLESKNCIH 116

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  + ++DFG+++Q D+   S+S      +++ +PE +    +   +D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 332 WWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK 363
            WS GILL+E  + G  P+ G   Q+ ++++ K
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTNQQAREQVEK 209

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 65/259 (25%), Positives = 127/259 (49%), Gaps = 21/259 (8%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERN 202
           CV +E+     V+G G F +V   +++  G  EI+ A+K + K    EK   +++ SE +
Sbjct: 5   CVKIEE-----VIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFL-SEAS 57

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIV 260
           I+ + DHP I+ L         + ++ +F+  G L  F +    G F           I 
Sbjct: 58  IMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIA 116

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL------E 314
           + + +L     +HRDL   NIL++++    ++DFGL++  +++T   +   +L       
Sbjct: 117 AGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176

Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFL 372
           + +PE +  +    A+D WS GI+++E+++ G+ P+   + Q +   I +D ++  P   
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDC 236

Query: 373 SSEAHSLLKGLLQKEASKR 391
            +  H L+    QK+ + R
Sbjct: 237 PTALHQLMLDCWQKDRNAR 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 54/205 (26%), Positives = 105/205 (51%), Gaps = 13/205 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +++ ++L+ +G+G F  V      G     A+K ++ D       A+   +E +++T++ 
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAFLAEASVMTQLR 57

Query: 209 HPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSH 265
           H  +VQL     + K  LY+V +++  G L   L  +G  +   D    ++ ++  A+ +
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           L AN  +HRDL   N+L+  D    ++DFGL K+      +  +   +++ +PE +  K 
Sbjct: 118 LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKK 175

Query: 326 HDKAADWWSVGILLFEMLT-GQPPF 349
               +D WS GILL+E+ + G+ P+
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 65/240 (27%), Positives = 118/240 (49%), Gaps = 12/240 (5%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+++ A+K ++   +M     E    E  I+ K+ H  +V L Y
Sbjct: 14  LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPL-Y 67

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V +F+  G L   L         L ++    A+I   ++++     +HRD
Sbjct: 68  AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127

Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 334 SVGILLFEMLT-GQPPFTGG-NRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E++T G+ P+ G  NR+ ++Q     ++  P       H L+K   +K+  +R
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDER 247

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 35/178 (19%)

Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSN 307
           D  +++  +I+  + +LH+ GI+HRD+KP N+L++++  + + DFGLA+  + DE+    
Sbjct: 103 DHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162

Query: 308 SMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLT---------------------G 345
               T  Y +PEI++G  H   A D WSVG +  E+L                      G
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG 222

Query: 346 QPPFT--GGNRQKIQQKIIKDKIKLPAF---------LSSEAHSLLKGLLQKEASKRL 392
            P         +  +  I++   K P+           + EA  LL  +L  +  KR+
Sbjct: 223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI 280

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 64/224 (28%), Positives = 111/224 (49%), Gaps = 37/224 (16%)

Query: 152 FEV------LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNI 203
           FEV      +K +G+GA+  V   +   T+E  A+K     KI     N  +  ++ R I
Sbjct: 1   FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIK-----KIANAFDNRIDAKRTLREI 55

Query: 204 --LTKVDHPFIVQL--------RYSFQTKYRLYLVLDFVNGGHLFFQLYR--QGLFREDL 251
             L  +DH  ++ +        R +F   Y +Y ++D     H   Q+ R  Q L  +D 
Sbjct: 56  KLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD--TDLH---QIIRSSQTL-SDDH 109

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
            + +  +++  + ++H+  ++HRDLKP N+LL+A+  + + DFGLA+    + + + M  
Sbjct: 110 CQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTE 167

Query: 312 ---TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              T  Y +PE++L    +  A D WSVG +  E+L  +P F G
Sbjct: 168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 65/272 (23%), Positives = 121/272 (44%), Gaps = 39/272 (14%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E    E    E  ++ K+ HP +VQL  
Sbjct: 12  IGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYG 66

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q G F ++       ++   +++L ++ ++HRDL
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126

Query: 277 KPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
              N L+  +  V ++DFG+ +    D+ T S      +++ SPE+     +   +D WS
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 335 VGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG 393
            G+L++E+ + G+ P+   +  ++ + I            +    L K  L   AS+ + 
Sbjct: 187 FGVLMWEVFSEGKTPYENRSNSEVVETI------------NAGFRLYKPRL---ASQSV- 230

Query: 394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSF 425
                  E+  H W         E  E RPSF
Sbjct: 231 ------YELMQHCW--------KERPEDRPSF 248

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 32/220 (14%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +F+ +KV+G GAF  VY+   I   E      A+K +R +    K + E +  E  ++  
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEIL-DEAYVMAS 65

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF----REDLARI-------Y 255
           VD+P + +L           L +   +   L  QL   G      RE    I       +
Sbjct: 66  VDNPHVCRL-----------LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 114

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---T 312
             +I   +++L    ++HRDL   N+L+    HV +TDFGLAK    + +     G    
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           +++M+ E +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 55/211 (26%), Positives = 110/211 (52%), Gaps = 12/211 (5%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F  VY+    G +E+ A+K  R     +    ++++    IL + DHP IV+L  
Sbjct: 3   IGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPD-LKRKFLQEAE-ILKQYDHPNIVKLIG 59

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRD 275
               K  +Y+V++ V GG L   L ++   L  + L ++ + +  + + +L +   +HRD
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQM-SLDAAAGMEYLESKNCIHRD 118

Query: 276 LKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT----LEYMSPEIVLGKGHDKAAD 331
           L   N L+  +  + ++DFG++++ +    + S  G     +++ +PE +    +   +D
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVS-DGLKQIPIKWTAPEALNYGRYTSESD 177

Query: 332 WWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
            WS GILL+E  + G  P+ G + Q+ +++I
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERI 208

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 72.5 bits (178), Expect = 7e-14
 Identities = 65/239 (27%), Positives = 113/239 (47%), Gaps = 34/239 (14%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +++ +V+G+G++  V       T E  A+K +  D     + A  +  E  +L  + HP 
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPD 60

Query: 212 IVQLRY-----SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFR-----EDLAR----IYTA 257
           IV++++     S +    +Y+V          F+L    L +     +DL       +  
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVV----------FELMESDLHQVIKANDDLTPEHHQFFLY 110

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS----NSMCGTL 313
           +++ A+ ++H   + HRDLKP+NIL +AD  + + DFGLA+    +T +         T 
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 314 EYMSPEIV---LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP 369
            Y +PE+      K +  A D WS+G +  E+LTG+P F G N    Q  +I D +  P
Sbjct: 171 WYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLLGTP 227

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 59/263 (22%), Positives = 113/263 (42%), Gaps = 22/263 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY---AMKVMRKDKIMEKNHAEYMKSERNIL 204
           E   +++ +GQG+F  VY+   + +   E     A+K + ++  M +        E +++
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN--EASVM 63

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ--------GLFREDLARIY- 255
            + +   +V+L     T     +V++ +  G L   L  +        GL    L +   
Sbjct: 64  KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 256 -TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTL 313
             AEI   +++L A   +HRDL   N ++  D  V + DFG+ +  ++ +       G L
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 314 --EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQKIIKDKIKLP 369
              +M+PE +        +D WS G++L+EM T  + P+ G  N + ++  I    + LP
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLP 243

Query: 370 AFLSSEAHSLLKGLLQKEASKRL 392
                +   L++   Q     R 
Sbjct: 244 ENCPDKLLELMRMCWQYNPKMRP 266

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 70.8 bits (174), Expect = 9e-14
 Identities = 63/220 (28%), Positives = 114/220 (51%), Gaps = 19/220 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ + +G G F +V+     GT+++ A+K + K   M      +++ E  I+ K+ H
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKV-AVKTL-KPGTMSP--EAFLQ-EAQIMKKLRH 60

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVS 264
             +VQL Y+  ++   +Y+V ++++ G L     + G    L    L  +  A+I   ++
Sbjct: 61  DKLVQL-YAVCSEEEPIYIVTEYMSKGSLL-DFLKSGEGKKLRLPQLVDM-AAQIAEGMA 117

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPE-IV 321
           +L +   +HRDL   NIL+  +    + DFGLA+    DE T        +++ +PE   
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAAN 177

Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            G+   K +D WS GILL E++T G+ P+ G  NR+ ++Q
Sbjct: 178 YGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ 216

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 66/255 (25%), Positives = 128/255 (50%), Gaps = 30/255 (11%)

Query: 156 KVVGQGAFAKVY--QVRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           KV+G G F +V   +++  G  EI  A+K + K    EK   +++ SE +I+ + DHP I
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFL-SEASIMGQFDHPNI 67

Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------SAVSH 265
           + L         + +V +++  G L          R+   +    ++V       S + +
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSL------DAFLRKHDGQFTVIQLVGMLRGIASGMKY 121

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEYMSPE 319
           L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + + +PE
Sbjct: 122 LSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPE 179

Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEA-- 376
            +  +    A+D WS GI+++E+++ G+ P+   + Q +  K I++  +LPA +   A  
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-IKAIEEGYRLPAPMDCPAAL 238

Query: 377 HSLLKGLLQKEASKR 391
           H L+    QK+ ++R
Sbjct: 239 HQLMLDCWQKDRNER 253

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 71/254 (27%), Positives = 120/254 (47%), Gaps = 24/254 (9%)

Query: 156 KVVGQGAFAKVYQVRRIGTS-EIYAMKVMRKDKIMEKNHA-----EYMKSERNILTKV-D 208
           K +G GAF KV +    G S     MKV  K   M K  A     E + SE  I++ + +
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVK---MLKPTAHSSEREALMSELKIMSHLGN 97

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSH 265
           H  IV L  +      + ++ ++   G L   L R+    L  EDL   ++ ++   ++ 
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS-FSYQVAKGMAF 156

Query: 266 LHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF--DEN--TRSNSMCGTLEYMSPEI 320
           L +   +HRDL   N+LL   G ++ + DFGLA+    D N   + N+    +++M+PE 
Sbjct: 157 LASKNCIHRDLAARNVLL-THGKIVKICDFGLARDIMNDSNYVVKGNARL-PVKWMAPES 214

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKL--PAFLSSEAH 377
           +    +   +D WS GILL+E+ + G  P+ G        K+IK+  ++  P    +E +
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIY 274

Query: 378 SLLKGLLQKEASKR 391
            ++K     +  KR
Sbjct: 275 DIMKTCWDADPLKR 288

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 59/243 (24%), Positives = 121/243 (49%), Gaps = 16/243 (6%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +  +   E++K E  ++ ++ HP +VQL  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLK-EAAVMKEIKHPNLVQLLG 69

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---ARIYTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L   L      R+++     +Y A +I SA+ +L     +H
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKNFIH 127

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT---LEYMSPEIVLGKGHDKAA 330
           RDL   N L+  +  V + DFGL++    +T + +  G    +++ +PE +        +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKS 186

Query: 331 DWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEA 388
           D W+ G+LL+E+ T G  P+ G +  ++ + + K  +++ P     + + L++   Q   
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNP 246

Query: 389 SKR 391
           S R
Sbjct: 247 SDR 249

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 61/273 (22%), Positives = 113/273 (41%), Gaps = 32/273 (11%)

Query: 147 VGLEDFEVLKVVGQGAFAKVY-----QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           V  +   + + +G+GAF KV+      +      E+ A+K + K+        ++ + E 
Sbjct: 2   VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFER-EA 59

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---------------L 246
            +LT   H  IV+            +V +++  G L   L   G               L
Sbjct: 60  ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DEN 303
               L +I   +I S + +L +   +HRDL   N L+  D  V + DFG+++     D  
Sbjct: 120 TLSQLLQI-AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178

Query: 304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT--GQPPFTGGNRQKIQQKI 361
                    + +M PE ++ +     +D WS G++L+E+ T   QP +   N + I  + 
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI--EC 236

Query: 362 IKDKIKL--PAFLSSEAHSLLKGLLQKEASKRL 392
           I     L  P    SE + ++ G  +++  +R+
Sbjct: 237 ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRI 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 55/243 (22%), Positives = 119/243 (48%), Gaps = 14/243 (5%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F +V+  R    +   A+K  R + +     A++++  R IL +  HP IV+L  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEAR-ILKQYSHPNIVRLIG 60

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRD 275
               K  +Y+V++ V GG     L  +G  L  ++L ++      + + +L +   +HRD
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM-VENAAAGMEYLESKHCIHRD 119

Query: 276 LKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL-----EYMSPEIVLGKGHDKAA 330
           L   N L+     + ++DFG++++ ++   +++  G +     ++ +PE +    +   +
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYAST--GGMKQIPVKWTAPEALNYGRYSSES 177

Query: 331 DWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEA 388
           D WS GILL+E  + G  P+   + Q+ ++ I +  ++  P       + L++   + + 
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237

Query: 389 SKR 391
            +R
Sbjct: 238 GQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 47/213 (22%), Positives = 98/213 (46%), Gaps = 13/213 (6%)

Query: 158 VGQGAFAKVYQ--VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           +G G F  V +         E+  A+K ++++  +     E+++ E +++ ++DHP IV+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH-IAAGKKEFLR-EASVMAQLDHPCIVR 60

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L    + +  L LV++    G L   L ++        +    ++   +++L +   +HR
Sbjct: 61  LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119

Query: 275 DLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGT--LEYMSPE-IVLGKGHDKA 329
           DL   N+LL       ++DFG+++      +    +  G   L++ +PE I  GK     
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK-FSSK 178

Query: 330 ADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
           +D WS G+ L+E  + G  P+      ++   +
Sbjct: 179 SDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases

 Score = 63.5 bits (155), Expect = 5e-13
 Identities = 22/62 (35%), Positives = 35/62 (56%), Gaps = 3/62 (4%)

Query: 411 INWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFNENPFKGFTY 467
           I+W KLE +E  P F+P++      +NF+  +T    + +PV SP      + PF+GF+Y
Sbjct: 3   IDWDKLENKEIEPPFVPKIKSPTDTSNFDPEFTEETPVLTPVDSPLSGGIQQEPFRGFSY 62

Query: 468 VR 469
           V 
Sbjct: 63  VF 64

Length = 64

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 68.8 bits (168), Expect = 6e-13
 Identities = 66/276 (23%), Positives = 132/276 (47%), Gaps = 48/276 (17%)

Query: 156 KVVGQGAFAKVYQVR------RIGTSEIYAMKVMRKDKIMEKNHAEYMK--SERNILTKV 207
           K +G+G F KV +        R G + + A+K+++++     + +E     SE N+L +V
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTV-AVKMLKENA----SSSELRDLLSEFNLLKQV 60

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQ---------------GLFRED 250
           +HP +++L  +      L L++++   G L  F +  R+                L   D
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 251 LARIYTAEIVS-------AVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDE 302
              +   +++S        + +L    ++HRDL   N+L+ A+G  M ++DFGL++   E
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVYE 179

Query: 303 N----TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI 357
                 RS      +++M+ E +    +   +D WS G+LL+E++T G  P+ G   +++
Sbjct: 180 EDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238

Query: 358 QQKIIKD--KIKLPAFLSSEAHSLLKGLLQKEASKR 391
              ++K   +++ P   S E ++L+    ++E  KR
Sbjct: 239 FN-LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKR 273

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 68.0 bits (166), Expect = 9e-13
 Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 11/207 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  +++K +G G F +V+     G +++ A+K + K   M     E   +E N++ ++ H
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSL-KQGSMS---PEAFLAEANLMKQLQH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
           P +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++ + 
Sbjct: 61  PRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  + +E T        +++ +PE +    
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 179

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS GILL E++T G+ P+ G
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 60/250 (24%), Positives = 124/250 (49%), Gaps = 23/250 (9%)

Query: 152 FEVLKVVGQGAFAKVYQVR---RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           F + +++G+G F  V + +     G+ +  A+K+++ D     +  E+++ E   + + D
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLR-EAACMKEFD 59

Query: 209 HPFIVQL---RYSFQTKYRL---YLVLDFVNGG--HLFFQLYRQG-----LFREDLARIY 255
           HP +++L       + K RL    ++L F+  G  H F  + R G     L  + L R +
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR-F 118

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--- 312
             +I S + +L +   +HRDL   N +L+ +  V + DFGL+K+          C +   
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178

Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK-DKIKLPA 370
           +++++ E +    +   +D W+ G+ ++E++T GQ P+ G    +I   +IK +++K P 
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238

Query: 371 FLSSEAHSLL 380
               + + L+
Sbjct: 239 DCLEDVYELM 248

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 64/257 (24%), Positives = 120/257 (46%), Gaps = 35/257 (13%)

Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F  V    Y   +  T E+ A+K ++        H    + E  IL  + H 
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHD 65

Query: 211 FIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSH 265
            IV+ +   YS   +  L LV++++  G L  + Q +R+ L    L  +Y ++I   + +
Sbjct: 66  NIVKYKGVCYS-AGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL-LYASQICKGMEY 123

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSPEIV 321
           L +   +HRDL   NIL++++  V + DFGL K   ++     +    E    + +PE +
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 322 LGKGHDKAADWWSVGILLFEMLT-----GQPP-----FTGGNRQKIQ-----QKIIKDKI 366
                  A+D WS G++L+E+ T       PP       G ++Q         +++K+  
Sbjct: 184 TESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243

Query: 367 KLPAFLS--SEAHSLLK 381
           +LPA     +E ++++K
Sbjct: 244 RLPAPPGCPAEIYAIMK 260

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 32/216 (14%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +KV+G GAF  VY+   I   E      A+KV+R++   + N  + +  E  ++  V  P
Sbjct: 12  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 69

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF----REDLARI-------YTAEI 259
           ++ +L           L +   +   L  QL   G      RE+  RI       +  +I
Sbjct: 70  YVCRL-----------LGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI 118

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYM 316
              +S+L    ++HRDL   N+L+ +  HV +TDFGLA+  D +       G    +++M
Sbjct: 119 AKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + E +L +     +D WS G+ ++E++T G  P+ G
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 14/211 (6%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----KNHAEYMKSERNILT 205
           + + +KV+G GAF  VY  + I   E   +K+    KI+      K + E+M  E  I+ 
Sbjct: 8   ELKRVKVLGSGAFGTVY--KGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALIMA 64

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVS 264
            +DHP +V+L         + LV   +  G L   ++  +      L   +  +I   + 
Sbjct: 65  SMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM 123

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPEIV 321
           +L    ++HRDL   N+L+ +  HV +TDFGLA+  + + +  +  G    +++M+ E +
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
             +     +D WS G+ ++E++T G  P+ G
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 55/203 (27%), Positives = 104/203 (51%), Gaps = 17/203 (8%)

Query: 158 VGQGAFAKVYQ-VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +G G F  V + V ++   +I  A+KV++ +   EK+  + M  E  I+ ++D+P+IV++
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS----HLHANGI 271
               + +  L LV++  +GG L   L  +   ++++      E++  VS    +L     
Sbjct: 61  IGVCEAE-ALMLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LEYMSPEIVLGKGHD 327
           +HRDL   N+LL    +  ++DFGL+K    D++       G   L++ +PE +  +   
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 328 KAADWWSVGILLFEMLT-GQPPF 349
             +D WS GI ++E  + GQ P+
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 29/206 (14%)

Query: 158 VGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV 213
           +G+G F KV    Y      T E  A+K ++ +     NH   +K E  IL  + H  IV
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 69

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR-----------IYTAEIVSA 262
                   KY+     D  NG  L  +    G  +E L R            Y  +I   
Sbjct: 70  --------KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKG 121

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSP 318
           + +L +   +HRDL   N+L++++  V + DFGL K  + +    T  + +   + + +P
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E ++      A+D WS G+ L+E+LT
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 11/207 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ K +G G F +V+       +++ A+K M+   +      E   +E N++  + H
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 61  DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+ A     + DFGLA+  ++N  T        +++ +PE +    
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS GILL E++T G+ P+ G
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 59/231 (25%), Positives = 107/231 (46%), Gaps = 25/231 (10%)

Query: 150 EDFEVLKVVGQGAFAKVYQV----RRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNIL 204
           +   +L+ +G GAF +VY+     R     E+  A+K + +    E++ ++++  E  I+
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLM-EALIM 63

Query: 205 TKVDHPFIVQL-RYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFR------EDLARIY 255
           +K +H  IV+L   SF+   R +++L+ + GG L  F +  R    R      +DL    
Sbjct: 64  SKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC- 121

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFGLAKQF---DENTRSNSM 309
             ++     +L  N  +HRD+   N LL   G      + DFG+A+         +    
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181

Query: 310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQ 359
              +++M PE  L        D WS G+LL+E+ + G  P+ G   Q++ +
Sbjct: 182 MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 63/258 (24%), Positives = 128/258 (49%), Gaps = 22/258 (8%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
            V +E     KV+G G F +V +  ++  G  EI       K    +K   +++ +E +I
Sbjct: 5   YVTIE-----KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASI 58

Query: 204 LTKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIV 260
           + + DHP I++L     TK R + ++ +++  G L  F +          L  +    I 
Sbjct: 59  MGQFDHPNIIRL-EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRG-IA 116

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS--NSMCG--TLEYM 316
           S + +L     +HRDL   NIL++++    ++DFGL++   E++ +   +  G   + + 
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYTTKGGKIPIRWT 175

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPAFLS-- 373
           +PE +  +    A+D WS GI+++E+++ G+ P+   + Q + +  ++D  +LP  +   
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKA-VEDGYRLPPPMDCP 234

Query: 374 SEAHSLLKGLLQKEASKR 391
           S  + L+    QK+ ++R
Sbjct: 235 SALYQLMLDCWQKDRNER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 63/257 (24%), Positives = 126/257 (49%), Gaps = 34/257 (13%)

Query: 156 KVVGQGAFAKVYQ--VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           KV+G G F +V++  ++  G  E+  A+K + K    EK   +++ SE +I+ +  H  I
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQDFL-SEASIMGQFSHHNI 68

Query: 213 VQLRYSFQTKYR-LYLVLDFVNGGHL----------FFQLYRQGLFREDLARIYTAEIVS 261
           ++L     TK++   ++ +++  G L          F      G+ R          I +
Sbjct: 69  IRLE-GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG---------IAA 118

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGT-LEYMS 317
            + +L     +HRDL   NIL++++    ++DFGL++      E T + S     + + +
Sbjct: 119 GMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPAFLS--S 374
           PE +  +    A+D WS GI+++E+++ G+ P+   +  ++  K I D  +LPA +   S
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-MKAINDGFRLPAPMDCPS 237

Query: 375 EAHSLLKGLLQKEASKR 391
             + L+    Q++ ++R
Sbjct: 238 AVYQLMLQCWQQDRARR 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 30/88 (34%), Positives = 54/88 (61%), Gaps = 5/88 (5%)

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN----SMCGTL 313
           +++SA+ ++H  GI+HRD+K EN+L++    + L DFG A  F   + S      + GT+
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTPFHYGIAGTV 326

Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFE 341
           +  +PE++ G  +  + D WS G+++FE
Sbjct: 327 DTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 61/249 (24%), Positives = 112/249 (44%), Gaps = 32/249 (12%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIY-----AMKVMRKDKIMEKNHAEYMKSERNI 203
           L     L+ +G+GAF KVY+    G +E       A+K + K+    K   E+ + E  +
Sbjct: 4   LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEF-RQEAEL 61

Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-----------------L 246
           ++ + HP IV L      +    ++ +++  G L   L R                   L
Sbjct: 62  MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--- 303
              D   I   +I + + +L ++  +HRDL   N L+     V ++DFGL++        
Sbjct: 122 DCSDFLHI-AIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180

Query: 304 -TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
             +S S+   + +M PE +L       +D WS G++L+E+ + G  P+ G + Q++ + +
Sbjct: 181 RVQSKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE-M 238

Query: 362 IKDKIKLPA 370
           I+ +  LP 
Sbjct: 239 IRSRQLLPC 247

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 51/208 (24%), Positives = 107/208 (51%), Gaps = 12/208 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  +++K +G G F +V+      ++++ A+K ++   +  +   E    E N++  + H
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAFLE----EANLMKTLQH 60

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHL 266
             +V+L Y+  TK   +Y++ +++  G L   L      +  L ++  ++A+I   ++++
Sbjct: 61  DKLVRL-YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGK 324
                +HRDL+  N+L+       + DFGLA+  ++N  T        +++ +PE +   
Sbjct: 120 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 179

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG 351
                +D WS GILL+E++T G+ P+ G
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPYPG 207

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 59/240 (24%), Positives = 114/240 (47%), Gaps = 26/240 (10%)

Query: 158 VGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV 213
           +G G F  V    Y++++  + +  A+K+++ D        E ++ E N++ ++D+P+IV
Sbjct: 3   LGSGNFGTVKKGMYKMKK--SEKTVAVKILKNDNNDPALKDELLR-EANVMQQLDNPYIV 59

Query: 214 QLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQGLFREDLARIYTAEIVSAVS----HLH 267
           ++    + +    LV++    G  + F Q  +       +      E+V  VS    +L 
Sbjct: 60  RMIGICEAE-SWMLVMELAELGPLNKFLQKNKH------VTEKNITELVHQVSMGMKYLE 112

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LEYMSPEIVLG 323
               +HRDL   N+LL    +  ++DFGL+K    DEN       G   +++ +PE +  
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172

Query: 324 KGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK-DKIKLPAFLSSEAHSLLK 381
                 +D WS G+L++E  + GQ P+ G    ++ Q I   ++++ P     E + L+K
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMK 232

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 44/160 (27%), Positives = 80/160 (50%), Gaps = 13/160 (8%)

Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           LY++ L  EDL   Y+ ++   +  L +   +HRDL   NILL  +  V + DFGLA+  
Sbjct: 171 LYKKVLTLEDLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229

Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK 356
            ++    R       L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G    K
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---VK 286

Query: 357 IQQKIIK-----DKIKLPAFLSSEAHSLLKGLLQKEASKR 391
           I ++  +      +++ P + + E +  +      E S+R
Sbjct: 287 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 326

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 57/262 (21%), Positives = 123/262 (46%), Gaps = 23/262 (8%)

Query: 151 DFEVLKVVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           D +   V+G+G F +V +  +++ G     A+K M K+   + +H ++   E  +L K+ 
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDF-AGELEVLCKLG 65

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI------------- 254
            HP I+ L  + + +  LYL +++   G+L   L +  +   D A               
Sbjct: 66  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 255 ---YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
              + A++   + +L     +HRDL   NIL+  +    + DFGL++  +   +      
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 185

Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLP 369
            + +M+ E +    +   +D WS G+LL+E+++ G  P+ G    ++ +K+ +  +++ P
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 245

Query: 370 AFLSSEAHSLLKGLLQKEASKR 391
                E + L++   +++  +R
Sbjct: 246 LNCDDEVYDLMRQCWREKPYER 267

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 44/157 (28%), Positives = 80/157 (50%), Gaps = 7/157 (4%)

Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           L++  L  EDL   Y+ ++   +  L +   +HRDL   NILL  +  V + DFGLA+  
Sbjct: 166 LWKSPLTMEDLI-CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224

Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK 356
            ++    R  S    L++M+PE +  K +   +D WS G+LL+E+ + G  P+ G    +
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284

Query: 357 IQQKIIKD--KIKLPAFLSSEAHSLLKGLLQKEASKR 391
              + +KD  +++ P   + E + ++    Q +  +R
Sbjct: 285 EFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 50/224 (22%), Positives = 104/224 (46%), Gaps = 33/224 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHA-----EYMKS 199
           +   +  ++ +G F +++       +     E++   V        K+HA       +  
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV--------KDHASEIQVTLLLQ 57

Query: 200 ERNILTKVDHPFIVQ-LRYSFQTKYRLYLVLDFVNGGHL--FFQLYR-------QGLFRE 249
           E  +L  + H  I+  L    +     +++  ++N G+L  F Q  R       Q L  +
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117

Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRS 306
            L  +   +I   +S+LH  G++H+D+   N ++D +  V +TD  L++     D +   
Sbjct: 118 QLVHMAI-QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176

Query: 307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
           ++    +++M+ E ++ K +  A+D WS G+LL+E++T GQ P+
Sbjct: 177 DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 65/251 (25%), Positives = 104/251 (41%), Gaps = 61/251 (24%)

Query: 135 GHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR------KD-- 186
           GH   +  E+  V  + F++L ++G+G F KV +       E  A+K++R      +D  
Sbjct: 114 GHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAK 173

Query: 187 ---KIMEK-------NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH 236
              + MEK       +    MK +R    +  H  IV  +Y                G  
Sbjct: 174 IEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY----------------GPC 217

Query: 237 LFFQLYRQGLFREDLARIYTAEIV----SAVSHLHAN-GIMHRDLKPENILLDADG---- 287
           L   + + G F       + A+I+     A+ + H    +MH DLKPENIL++       
Sbjct: 218 LLDWIMKHGPFSHR----HLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVD 273

Query: 288 ------------HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSV 335
                        V + D G     DE     ++  T  Y SPE+VLG G   + D WS+
Sbjct: 274 PVTNRALPPDPCRVRICDLGGC--CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSM 331

Query: 336 GILLFEMLTGQ 346
           G +++E+ TG+
Sbjct: 332 GCIIYELYTGK 342

Length = 467

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 61/266 (22%), Positives = 131/266 (49%), Gaps = 33/266 (12%)

Query: 156 KVVGQGAFAKVYQVRRIGTSE-------IYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           K +G+G F +V     +G  +         A+K M KD   EK+ ++ + SE  ++  + 
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVK-MLKDDATEKDLSD-LVSEMEMMKMIG 78

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQ-GL-FREDLARI--------- 254
            H  I+ L  +      LY+++++ + G+L  + +  R  G+ +  D+AR+         
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 255 ---YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
               T ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--K 365
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G   +++  K++K+  +
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEGHR 257

Query: 366 IKLPAFLSSEAHSLLKGLLQKEASKR 391
           +  PA  ++E + +++       S R
Sbjct: 258 MDKPANCTNELYMMMRDCWHAIPSHR 283

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 61/268 (22%), Positives = 116/268 (43%), Gaps = 29/268 (10%)

Query: 151 DFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
           D  + + +G+GAF KV     Y +       + A+K ++   +  +      + E  +LT
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD---FQREAELLT 62

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLY------------RQGLFREDL 251
            + H  IV+          L +V +++  G L  F + +            RQ      L
Sbjct: 63  NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 252 ARIY--TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRS 306
           +++    ++I S + +L +   +HRDL   N L+ A+  V + DFG+++     D     
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182

Query: 307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT--GQPPFTGGNRQKIQQKIIKD 364
                 + +M PE ++ +     +D WS G++L+E+ T   QP F   N + I+      
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242

Query: 365 KIKLPAFLSSEAHSLLKGLLQKEASKRL 392
            ++ P     E + ++ G  Q+E  +RL
Sbjct: 243 VLERPRVCPKEVYDIMLGCWQREPQQRL 270

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 55/253 (21%), Positives = 120/253 (47%), Gaps = 23/253 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ED +   V+G+G F +V +  +++ G     A+K M K+   E +H ++   E  +L K+
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIK-MLKEFASENDHRDF-AGELEVLCKL 59

Query: 208 -DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI------------ 254
             HP I+ L  + + +  LY+ +++   G+L   L +  +   D A              
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119

Query: 255 ----YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC 310
               + +++ + + +L     +HRDL   N+L+  +    + DFGL++  +   +     
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGR 179

Query: 311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKL 368
             + +M+ E +    +   +D WS G+LL+E+++ G  P+ G    ++ +K+ +  +++ 
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK 239

Query: 369 PAFLSSEAHSLLK 381
           P     E + L++
Sbjct: 240 PRNCDDEVYELMR 252

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 59/266 (22%), Positives = 126/266 (47%), Gaps = 33/266 (12%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+G F +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 24  KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 82

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + +  R               + L  +DL
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 143 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--K 365
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G   +++  K++K+  +
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKLLKEGHR 260

Query: 366 IKLPAFLSSEAHSLLKGLLQKEASKR 391
           +  P+  ++E + +++       S+R
Sbjct: 261 MDKPSNCTNELYMMMRDCWHAVPSQR 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 38/116 (32%), Positives = 63/116 (54%), Gaps = 5/116 (4%)

Query: 240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ 299
           +LY++ L  EDL   Y+ ++   +  L +   +HRDL   NILL  +  V + DFGLA+ 
Sbjct: 164 ELYKEPLTLEDLIS-YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARD 222

Query: 300 FDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
             ++    R       L++M+PE +  K +   +D WS G+LL+E+ + G  P+ G
Sbjct: 223 IYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 34/232 (14%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEI-YAMKV---MRKDKIMEKNHAEYMKSERNIL 204
            +   + K +G+GAF +V +   +G         V   M KD   EK+ ++ + SE  ++
Sbjct: 11  RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLV-SEMEMM 69

Query: 205 TKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FF-------QLYRQGLFREDLARI 254
             +  H  I+ L      +  LY+V+++   G+L  F        +       R     +
Sbjct: 70  KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129

Query: 255 YTAEIVS-------AVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDEN--- 303
              ++VS        +  L +   +HRDL   N+L+  + HVM + DFGLA+        
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV-TEDHVMKIADFGLARDIHHIDYY 188

Query: 304 -TRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
              +N   G L  ++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 189 RKTTN---GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 35/240 (14%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK------NHAEYMKSERNI--LTKV 207
             +G G F KV         E +    M K +++ K         E +   + +    ++
Sbjct: 1   DEIGNGWFGKVLL------GEAHRG--MSKARVVVKELRASATPDEQLLFLQEVQPYREL 52

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFRED-----LARIYTAEIVS 261
           +HP ++Q            LVL+F   G L   L   +G+  +      L R+   E+ S
Sbjct: 53  NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVAS 111

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA-KQFDENTRSNSMCGT--LEYMSP 318
            +  LH    +H DL   N  L AD  V + D+GLA +Q+ E+      C    L +++P
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171

Query: 319 EIVLGKGHD-------KAADWWSVGILLFEMLT--GQPPFTGGNRQKIQQKIIKDKIKLP 369
           E+V  +G D       K ++ WS+G+ ++E+ T   QP     + Q ++Q + +  IKLP
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 52/241 (21%), Positives = 117/241 (48%), Gaps = 30/241 (12%)

Query: 155 LKVVGQGAFAKVYQ----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+ AF K+Y+    +  +  +++ A+K ++   I         + E +++ ++ HP
Sbjct: 10  MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAELHHP 67

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQ------------GLFREDLAR---I 254
            IV L      +  + ++ +++N G L  F + R             G  +  L     +
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 255 YTA-EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSM 309
           + A +I + + +L ++  +H+DL   NIL+    HV ++D GL+++         +  S+
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKL 368
              + +M PE ++       +D WS G++L+E+ + G  P+ G + Q++ + + K ++ L
Sbjct: 188 L-PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL-L 245

Query: 369 P 369
           P
Sbjct: 246 P 246

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 59/246 (23%), Positives = 118/246 (47%), Gaps = 23/246 (9%)

Query: 157 VVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIV 213
           V+G+G F +V +  +++ G     A+K   K+   + +H ++   E  +L K+  HP I+
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDF-AGELEVLCKLGHHPNII 59

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED--LARIY-TAEIVSAVSHLH--- 267
            L  + + +  LYL +++   G+L   L +  +   D   A    TA  +S+   LH   
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 268 --ANGI--------MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
             A G+        +HRDL   NIL+  +    + DFGL++  +   +       + +M+
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 179

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE 375
            E +    +   +D WS G+LL+E+++ G  P+ G    ++ +K+ +  +++ P     E
Sbjct: 180 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDE 239

Query: 376 AHSLLK 381
            + L++
Sbjct: 240 VYDLMR 245

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 28/223 (12%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKN------HAEYMK---SE 200
           K +G+G F +V     IG  +    K       M KD   +K+        E MK     
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF---QLYRQGLFREDLA 252
           +NI+  +     D P  V + Y+ +   R YL      G    F   +L  + L  +DL 
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSM 309
                ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ + 
Sbjct: 138 SC-AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
              +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 55/257 (21%), Positives = 113/257 (43%), Gaps = 24/257 (9%)

Query: 158 VGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +G+GAF KV+  +   +   +   +  ++  K   ++  +  + E  +LT + H  IV+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 216 RYSFQTKYR-LYLVLDFVNGG-------------HLFFQLYRQGLFREDLARIY--TAEI 259
            Y   T+ R L +V +++  G              +          +  L ++    ++I
Sbjct: 73  -YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYM 316
            S + +L +   +HRDL   N L+     V + DFG+++     D           + +M
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM 191

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT--GQPPFTGGNRQKIQQKIIKDKIKLPAFLSS 374
            PE +L +     +D WS G++L+E+ T   QP +   N + I+      +++ P     
Sbjct: 192 PPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPP 251

Query: 375 EAHSLLKGLLQKEASKR 391
           E +++++G  Q+E  +R
Sbjct: 252 EVYAIMQGCWQREPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 44/151 (29%), Positives = 80/151 (52%), Gaps = 11/151 (7%)

Query: 249 EDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF--DEN-- 303
           +DL R +++++   +  L +   +HRD+   N+LL  DG V  + DFGLA+    D N  
Sbjct: 212 DDLLR-FSSQVAQGMDFLASKNCIHRDVAARNVLL-TDGRVAKICDFGLARDIMNDSNYV 269

Query: 304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKII 362
            + N+    +++M+PE +    +   +D WS GILL+E+ + G+ P+ G        K++
Sbjct: 270 VKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV 328

Query: 363 KDKIKL--PAFLSSEAHSLLKGLLQKEASKR 391
           K   ++  P F   E +S++K     E ++R
Sbjct: 329 KRGYQMSRPDFAPPEIYSIMKMCWNLEPTER 359

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 44/187 (23%), Positives = 85/187 (45%), Gaps = 22/187 (11%)

Query: 182 VMRKDKIMEKNHAEY--MKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH--- 236
            ++K  +   +  +   ++ E     ++ HP I+    SF     LY+V   +  G    
Sbjct: 29  AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88

Query: 237 LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL 296
           L    + +G   E        ++++A+ ++H+ G +HR +K  +ILL  DG V+L+    
Sbjct: 89  LLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRY 147

Query: 297 AKQFDEN----------TRSNSMCGTLEYMSPEIVLGK---GHDKAADWWSVGILLFEML 343
           +    ++           +S+     L ++SPE VL +   G+++ +D +SVGI   E+ 
Sbjct: 148 SVSMIKHGKRQRVVHDFPKSSVK--NLPWLSPE-VLQQNLQGYNEKSDIYSVGITACELA 204

Query: 344 TGQPPFT 350
            G  PF 
Sbjct: 205 NGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 59/247 (23%), Positives = 109/247 (44%), Gaps = 25/247 (10%)

Query: 156 KVVGQGAFAKVYQVR---RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           K++G+G F  V + +     G+    A+K M+ D        E++ SE   +   DHP +
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDHPNV 63

Query: 213 VQL-RYSFQTKYRLYL-----VLDFVNGG--HLFFQLYRQGLFREDLAR----IYTAEIV 260
           ++L    F+      +     +L F+  G  H F    R G   E L       +  +I 
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-----FDENTRSNSMCGTLEY 315
             + +L     +HRDL   N +L  D  V + DFGL+K+     +    R   M   +++
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181

Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK-DKIKLPAFLS 373
           ++ E +  + +   +D W+ G+ ++E+ T GQ P+ G    +I   +   +++K P    
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCL 241

Query: 374 SEAHSLL 380
            E + L+
Sbjct: 242 DELYDLM 248

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 58/238 (24%), Positives = 110/238 (46%), Gaps = 28/238 (11%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKD---KIMEKNHAEYMKSERNILTKVDHPFI 212
           K +G+G F  V + +     +   +KV  K     I  ++  E   SE   + + DHP +
Sbjct: 5   KTLGEGEFGSVMEGQL--NQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 213 VQL-RYSFQTKYRL-----YLVLDFVNGG--HLFFQLYRQG-----LFREDLARIYTAEI 259
           ++L     QT          ++L F+  G  H F    R G     L  + L + +  +I
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDI 121

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-----FDENTRSNSMCGTLE 314
            S + +L +   +HRDL   N +L+ + +V + DFGL+K+     +    R   M   ++
Sbjct: 122 ASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVK 179

Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK-DKIKLPA 370
           +++ E +  + +   +D WS G+ ++E+ T GQ P+ G    +I   + + +++K P 
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 52/233 (22%), Positives = 107/233 (45%), Gaps = 19/233 (8%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSE-----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +  +G+G F +V+  +  G  E     +  +K ++K K  ++N     + E ++  K+ H
Sbjct: 10  ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSH 67

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV---- 263
             +V+L    +     Y++L++ + G L  F +  +    +     + T + V+      
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 264 ---SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSP 318
               HL     +HRDL   N L+ +   V ++   L+K     E  +  +    L +++P
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPA 370
           E V        +D WS G+L++E+ T G+ PF G + +++  ++   K++LP 
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 55/226 (24%), Positives = 108/226 (47%), Gaps = 34/226 (15%)

Query: 156 KVVGQGAFAKVYQVRRIGTSE-------IYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           K +G+G F +V +    G  +         A+K M KD   +K+ A+ + SE  ++  + 
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK-MLKDNATDKDLADLI-SEMELMKLIG 75

Query: 209 -HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR----------------QGLFRE 249
            H  I+ L      +  LY+++++   G+L  F +  R                Q  F++
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRS 306
            ++  Y  ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++
Sbjct: 136 LVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193

Query: 307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           ++    +++M+PE +  + +   +D WS GIL++E+ T G  P+ G
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 24/212 (11%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV------- 207
           LK++G G F  V+  + I   E  ++K+    K ++       +S R    ++       
Sbjct: 12  LKLLGSGVFGTVH--KGIWIPEGDSIKIPVAIKTIQD------RSGRQTFQEITDHMLAM 63

Query: 208 ---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL-YRQGLFREDLARIYTAEIVSAV 263
              DH +IV+L         L LV      G L   +   +          +  +I   +
Sbjct: 64  GSLDHAYIVRL-LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGM 122

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEI 320
            +L  + ++HR+L   NILL +D  V + DFG+A      D+    +     +++M+ E 
Sbjct: 123 YYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           +L   +   +D WS G+ ++EM++ G  P+ G
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 56.4 bits (136), Expect = 9e-09
 Identities = 53/232 (22%), Positives = 104/232 (44%), Gaps = 33/232 (14%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
           + E ++ +GQGAF +V+Q R  G        + A+K M K++      A++ + E  ++ 
Sbjct: 6   NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALMA 63

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYT-------- 256
           + DHP IV+L         + L+ +++  G L  F  +R    +  L+   +        
Sbjct: 64  EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123

Query: 257 -------------AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--- 300
                         ++ + +++L     +HRDL   N L+  +  V + DFGL++     
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183

Query: 301 DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           D    S +    + +M PE +    +   +D W+ G++L+E+ + G  P+ G
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 11/151 (7%)

Query: 249 EDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS 308
           EDL   ++ ++   +S L +   +HRDL   NILL       + DFGLA+  D    SN 
Sbjct: 214 EDLLS-FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR--DIRNDSNY 270

Query: 309 MCG-----TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKII 362
           +        +++M+PE +    +   +D WS GILL+E+ + G  P+ G        K+I
Sbjct: 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330

Query: 363 KDKIKL--PAFLSSEAHSLLKGLLQKEASKR 391
           K+  ++  P    SE + ++K     +  KR
Sbjct: 331 KEGYRMLSPECAPSEMYDIMKSCWDADPLKR 361

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 59/262 (22%), Positives = 112/262 (42%), Gaps = 36/262 (13%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---------EKNHAEYMKSERNILTKVD 208
           +G+GAF KV+       +E Y +    +DKI+           N  +    E  +LT + 
Sbjct: 13  LGEGAFGKVF------LAECYNL-CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--------------LFREDLARI 254
           H  IV+          L +V +++  G L   L   G              L +  +  I
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCG 311
              +I + + +L +   +HRDL   N L+  +  V + DFG+++     D          
Sbjct: 126 -AQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184

Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKI-KLP 369
            + +M PE ++ +     +D WS+G++L+E+ T G+ P+   +  ++ + I + ++ + P
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 244

Query: 370 AFLSSEAHSLLKGLLQKEASKR 391
                E + L+ G  Q+E   R
Sbjct: 245 RTCPKEVYDLMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 59/249 (23%), Positives = 113/249 (45%), Gaps = 30/249 (12%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHAEYMKSER 201
           + L     ++ +G+  F KVY+    GT     ++  A+K + KDK  E    E  K E 
Sbjct: 2   INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKA-EGPLREEFKHEA 59

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFF---------------QLYRQ 244
            + +++ HP IV L      +  L ++  + +    H F                +  + 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 245 GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT 304
            L   D   I T +I + +  L ++ ++H+DL   N+L+    +V ++D GL ++     
Sbjct: 120 TLEPADFVHIVT-QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178

Query: 305 RSNSMCGTL---EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQK 360
               M  +L    +MSPE ++       +D WS G++L+E+ + G  P+ G + Q + + 
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIE- 237

Query: 361 IIKDKIKLP 369
           +I+++  LP
Sbjct: 238 MIRNRQVLP 246

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 22/213 (10%)

Query: 166 VYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL 225
           VY  R   T  +  +++   +   E+ H + +++E  +     HP I+     F T   L
Sbjct: 16  VYLARHTPTGTLVTVRITDLENCTEE-HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74

Query: 226 YLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL 282
           +++  F+  G    L    + +G+  E L        +  +++LH NG +HR++K  +IL
Sbjct: 75  WVISPFMAYGSANSLLKTYFPEGM-SEALIGNILFGALRGLNYLHQNGYIHRNIKASHIL 133

Query: 283 LDADGHVMLTD----FGLAKQ-------FDENTRSNSMCGTLEYMSPEIVLGK--GHDKA 329
           +  DG V L+     + L +        +D    S S+   L ++SPE++     G++  
Sbjct: 134 ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELLRQDLYGYNVK 190

Query: 330 ADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKI 361
           +D +SVGI   E+ TG+ PF    R Q + QK+
Sbjct: 191 SDIYSVGITACELATGRVPFQDMLRTQMLLQKL 223

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 32/236 (13%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD------HPF 211
           +G G F KV        SEIY    + +  + E       K +   L + D      HP 
Sbjct: 3   IGNGWFGKVL------LSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPN 56

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED-----LARIYTAEIVSAVSHL 266
           I+Q            LV ++   G L   L ++   R +     L R+   EI + V+H+
Sbjct: 57  ILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM-ACEIAAGVTHM 115

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLA-KQFDEN--TRSNSMCGTLEYMSPEIVLG 323
           H +  +H DL   N  L +D  V + D+G+   ++ E+     +  C  L +++PE+V G
Sbjct: 116 HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELV-G 174

Query: 324 KGHD--------KAADWWSVGILLFEML--TGQPPFTGGNRQKIQQKIIKDKIKLP 369
           + H         K ++ W++G+ L+E+     QP     +R+ +   I   ++KL 
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF 230

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 35/112 (31%), Positives = 58/112 (51%), Gaps = 5/112 (4%)

Query: 244 QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN 303
           +GL   DL   +T ++   +  L +   +HRDL   N+LL     V + DFGLA+    +
Sbjct: 232 EGLTTLDLLS-FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 304 TRSNSMCGT---LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           +   S   T   +++M+PE +    +   +D WS GILL+E+ + G  P+ G
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 18/169 (10%)

Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLA 252
           +++ E ++    +HP IV  R +F     L++V  F+  G    L    +  G+    +A
Sbjct: 45  FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIA 104

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM--- 309
            I    ++ A+ ++H  G +HR +K  +IL+  DG V L+  GL            +   
Sbjct: 105 YILQG-VLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVV 161

Query: 310 -------CGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPF 349
                     L ++SPE++    +G+D  +D +SVGI   E+  G  PF
Sbjct: 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain

 Score = 46.5 bits (111), Expect = 3e-07
 Identities = 14/46 (30%), Positives = 22/46 (47%), Gaps = 3/46 (6%)

Query: 428 EVAGKHCVANFEECWTNMPLLDSPVASPKFNEN---PFKGFTYVRP 470
           +V      +NF+  +T+ P   SP  S   +      F+GF+YV P
Sbjct: 1   KVKSPTDTSNFDPEFTSEPPKLSPPDSEVLSSIDQLEFRGFSYVNP 46

Length = 47

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 46/200 (23%), Positives = 93/200 (46%), Gaps = 9/200 (4%)

Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYT 256
           +E   L + DH  IV+L         + +V ++++ G L  F + +   L    L  +  
Sbjct: 55  AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP 114

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG--TLE 314
             + S + +L   G +H+ L    +L+++D    ++ F   ++        +M G   + 
Sbjct: 115 G-LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL 173

Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPAFLS 373
           + +PE +       A+D WS GI+++E+++ G+ P+   + Q +  K ++D  +LPA  +
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV-IKAVEDGFRLPAPRN 232

Query: 374 SEA--HSLLKGLLQKEASKR 391
                H L+    QKE  +R
Sbjct: 233 CPNLLHQLMLDCWQKERGER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 37/143 (25%), Positives = 70/143 (48%), Gaps = 6/143 (4%)

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT-- 312
           ++ ++ + +  L +   +HRDL   N+L+     V + DFGLA+    ++   S   T  
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 313 -LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKL-- 368
            L++M+PE +    +   +D WS GILL+E+ T G  P+      +     IK   ++  
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAK 363

Query: 369 PAFLSSEAHSLLKGLLQKEASKR 391
           PA  S E + +++   +++   R
Sbjct: 364 PAHASDEIYEIMQKCWEEKFEIR 386

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 25/64 (39%), Positives = 37/64 (57%), Gaps = 2/64 (3%)

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE--Y 315
           ++++ +  LH  GI+HRD+KPEN+L+  DG V + DFG A         N + G L+  Y
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376

Query: 316 MSPE 319
             PE
Sbjct: 377 SPPE 380

Length = 507

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 29/105 (27%), Positives = 54/105 (51%), Gaps = 4/105 (3%)

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTL 313
            EI   +++L+AN  +HRDL   N ++  D  V + DFG+ +   E     +       +
Sbjct: 126 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185

Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI 357
            +MSPE +        +D WS G++L+E+ T  + P+ G + +++
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV 230

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 12/124 (9%)

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGTLE 314
           EI   + HLH N  +H DL   N LL AD  V + D+GL+    + D     + +   L 
Sbjct: 108 EIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR 167

Query: 315 YMSPEIV-------LGKGHDKAADWWSVGILLFEM--LTGQPPFTGGNRQKIQQKIIKDK 365
           +++PE+V       L     K ++ WS+G+ ++E+  L  QP     + Q +   + + +
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227

Query: 366 IKLP 369
           +KLP
Sbjct: 228 LKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 36/166 (21%), Positives = 71/166 (42%), Gaps = 28/166 (16%)

Query: 156 KVVGQGAFAKVYQVRRIG---------------TSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           K++G G F  VY+ +                   +E   M+ +  + I + +     K+ 
Sbjct: 18  KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77

Query: 201 RNILTKVDHPFIVQL----RYSFQTKYRLYLVLD--FVNGGHLFFQLYRQGLFREDLARI 254
            NI    DH  I +      +     Y  +++L+    N   +F    R     + L + 
Sbjct: 78  HNI----DHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIF---KRIKCKNKKLIKN 130

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
              ++++ + ++H +GI H D+KPENI++D +    + D+G+A  F
Sbjct: 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176

Length = 294

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 38/155 (24%), Positives = 60/155 (38%), Gaps = 27/155 (17%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIY---AMKVMRKDKIMEKNHAEYMKSERNILTK----- 206
           + ++ QGA A +Y    +G   +      K  R  ++ EK   E  + E  IL K     
Sbjct: 1   MDLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAG 60

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA---EIVSAV 263
           V  P +    Y         +V++++ G           L ++ L         E+   V
Sbjct: 61  VPVPIV----YDVDP-DNGLIVMEYIEGE----------LLKDALEEARPDLLREVGRLV 105

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
             LH  GI+H DL   NI+L     +   DFGL +
Sbjct: 106 GKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139

Length = 204

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 6/84 (7%)

Query: 272 MHRDLKPENILLDADGHVMLTDFGLA-----KQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           +HRDL   N +LD    V + DFGLA     K++            +++M+ E +  +  
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179

Query: 327 DKAADWWSVGILLFEMLT-GQPPF 349
              +D WS G+LL+E++T G PP+
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 48/218 (22%), Positives = 99/218 (45%), Gaps = 35/218 (16%)

Query: 158 VGQGAFAKVYQVRRIGTSE--------------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +G+G F +V+     G +E              + A+K++R D + +    +++K E  I
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLK-EIKI 70

Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF-------------RED 250
           ++++ +P I++L     +   L ++ +++  G L   L ++ +                +
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSN 307
           L  +   +I S + +L +   +HRDL   N L+     + + DFG+++     D      
Sbjct: 131 LLYM-AVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 308 SMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLT 344
                + +M+ E I+LGK    A+D W+ G+ L+EM T
Sbjct: 190 RAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 45.9 bits (109), Expect = 9e-06
 Identities = 27/77 (35%), Positives = 43/77 (55%), Gaps = 8/77 (10%)

Query: 273 HRDLKPENILLDADGHVMLTDFG-LAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
           HR  K  NILL  DG + L   G +A +  E +R +       +M+PE++ G+ + + AD
Sbjct: 34  HRQAKSGNILLTWDGLLKL--DGSVAFKTPEQSRPDPY-----FMAPEVIQGQSYTEKAD 86

Query: 332 WWSVGILLFEMLTGQPP 348
            +S+GI L+E L  + P
Sbjct: 87  IYSLGITLYEALDYELP 103

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 28/80 (35%), Positives = 34/80 (42%), Gaps = 8/80 (10%)

Query: 227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL-KPENILLDA 285
           LV  +  G  L   L R      D A   +A    A+  LH  GI H DL KP+N L+  
Sbjct: 95  LVRGWTEGVPL--HLARP---HGDPAWFRSAH--RALRDLHRAGITHNDLAKPQNWLMGP 147

Query: 286 DGHVMLTDFGLAKQFDENTR 305
           DG   + DF LA  F     
Sbjct: 148 DGEAAVIDFQLASVFRRRGA 167

Length = 365

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 31/145 (21%), Positives = 61/145 (42%), Gaps = 13/145 (8%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--PFI 212
           +K++  G   +VY +      E Y +K+               + E  IL  +      +
Sbjct: 3   IKLLKGGLTNRVYLLG--TKDEDYVLKINPSR-----EKGADREREVAILQLLARKGLPV 55

Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
            ++  S ++    YL+++++ G  L          +ED+A    AE+++ +  L    + 
Sbjct: 56  PKVLASGESDGWSYLLMEWIEGETLDE---VSEEEKEDIAEQL-AELLAKLHQLPLLVLC 111

Query: 273 HRDLKPENILLDADGHVMLTDFGLA 297
           H DL P NIL+D    + + D+  A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 27/106 (25%), Positives = 55/106 (51%), Gaps = 4/106 (3%)

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---RSNSMCGT 312
            AEI   +++L+A   +HRDL   N ++  D  V + DFG+ +   E     +       
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI 357
           + +M+PE +       ++D WS G++L+E+ +  + P+ G + +++
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 46.8 bits (112), Expect = 2e-05
 Identities = 37/157 (23%), Positives = 64/157 (40%), Gaps = 30/157 (19%)

Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNILTK-----VDH 209
           +G+GA A + +   +G   +   +V    R  ++ E+   E  ++E  +L++     V  
Sbjct: 341 IGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT 400

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH---- 265
           P I    Y         +V++++ G             ++ L      E+V  V      
Sbjct: 401 PVI----YDV-DPEEKTIVMEYIGGK----------DLKDVLE--GNPELVRKVGEIVAK 443

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE 302
           LH  GI+H DL   N ++  D  + L DFGL K  D 
Sbjct: 444 LHKAGIVHGDLTTSNFIVR-DDRLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 45.3 bits (107), Expect = 4e-05
 Identities = 44/195 (22%), Positives = 84/195 (43%), Gaps = 24/195 (12%)

Query: 171 RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD 230
           R G   + A+K++R D    KN       E  IL+++  P I++L      +  L ++ +
Sbjct: 42  RKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITE 99

Query: 231 FVNGGHLF-FQLYRQGLFRED------------LARIYTA------EIVSAVSHLHANGI 271
           ++  G L  F        +E+             A  Y++      +I S + +L +   
Sbjct: 100 YMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           +HRDL   N L+  +  + + DFG+++     D           + +M+ E +L      
Sbjct: 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT 219

Query: 329 AADWWSVGILLFEML 343
           A+D W+ G+ L+E+L
Sbjct: 220 ASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 44.5 bits (106), Expect = 4e-05
 Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 22/154 (14%)

Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAM---KVMRKDKIMEKNHAEYMKSERNIL------- 204
           +K++ +GA A++Y    +G   +      K  R  ++ E+   E  + E  I+       
Sbjct: 1   MKLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAG 60

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
             V   + V             +V++++ G  L   +   G+   +L+R    EI   V 
Sbjct: 61  VNVPAVYFVDP-------ENFIIVMEYIEGEPLKDLINSNGMEELELSR----EIGRLVG 109

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
            LH+ GI+H DL   N++L + G + L DFGLA+
Sbjct: 110 KLHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAE 142

Length = 211

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 43.4 bits (103), Expect = 7e-05
 Identities = 37/154 (24%), Positives = 68/154 (44%), Gaps = 21/154 (13%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNILTK-----VD 208
           ++ +GA A +Y    +G   +   +V    R  ++ E+   E  ++E  +L++     V+
Sbjct: 1   LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVN 60

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            P +    Y         +V++++ G     +  +  +   +   +   EI   V  LH 
Sbjct: 61  TPVV----YDV-DPDNKTIVMEYIEG-----KPLKDVIEEGNDELLR--EIGRLVGKLHK 108

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE 302
            GI+H DL   NI++  D  + L DFGL K  DE
Sbjct: 109 AGIVHGDLTTSNIIVRDDK-LYLIDFGLGKYSDE 141

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.8 bits (106), Expect = 7e-05
 Identities = 17/41 (41%), Positives = 26/41 (63%), Gaps = 1/41 (2%)

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLD-ADGHVMLTDFGLA 297
           +I+ A+  LH+ GI+HRD+KP+NI+     G   + D G A
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 44.1 bits (104), Expect = 9e-05
 Identities = 46/183 (25%), Positives = 86/183 (46%), Gaps = 22/183 (12%)

Query: 179 AMKVMRKDKIMEKN-HAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL 237
           A+K++R+D    KN   +++K E  I++++  P I++L     T   L ++ +++  G L
Sbjct: 50  AVKMLREDA--NKNARNDFLK-EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106

Query: 238 FFQLYRQGLFREDLA------------RIYTAEIVSAVSHLHANGIMHRDLKPENILLDA 285
             Q   +   +E                    +I S + +L +   +HRDL   N L+  
Sbjct: 107 N-QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK 165

Query: 286 DGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFE 341
           +  + + DFG+++     D           + +MS E I+LGK    A+D W+ G+ L+E
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWE 224

Query: 342 MLT 344
           +LT
Sbjct: 225 ILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 57/256 (22%), Positives = 114/256 (44%), Gaps = 33/256 (12%)

Query: 158 VGQGAFAKVYQ-VRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILTKVDHPF 211
           +GQG F K+++ +RR      E++  +V+ K  +++K+H  Y +S     ++++++ H  
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLK--VLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANG 270
           +V             +V ++V  G L   L +         ++  A ++  A+  L   G
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 271 IMHRDLKPENILLDADGH--------VMLTDFG-----LAKQFDENTRSNSMCGTLEYMS 317
           + H ++  +N+LL  +          + L+D G     L K+         +   + ++ 
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--------LLERIPWVP 172

Query: 318 PEIVLGKGH-DKAADWWSVGILLFEMLTG-QPPFTGGNRQKIQQKIIKDKIKLPAFLSSE 375
           PE +    +   AAD WS G  L+E+ +G   P +  + QK  Q   +D+ +LPA   +E
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKWTE 231

Query: 376 AHSLLKGLLQKEASKR 391
             +L+   +  E   R
Sbjct: 232 LANLINQCMDYEPDFR 247

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 25/105 (23%), Positives = 45/105 (42%), Gaps = 7/105 (6%)

Query: 254 IYTA-EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT 312
           +  A  + SA + LH +G +  D+   + L+  D  V+L D    +     T      G 
Sbjct: 120 LRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGV 179

Query: 313 LEYMSPE-----IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            E+  PE       +G       D + + +L+F +L  G+ P++G
Sbjct: 180 SEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224

Length = 637

>gnl|CDD|233667 TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase

 Score = 41.1 bits (97), Expect = 9e-04
 Identities = 16/56 (28%), Positives = 26/56 (46%)

Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
           D   +      S ++ +  +G  H DL P NI +  DG ++  DFG+  +  E  R
Sbjct: 257 DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSEEDR 312

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol -> 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]. Length = 437

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 41.1 bits (97), Expect = 0.001
 Identities = 15/37 (40%), Positives = 22/37 (59%)

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
           +G  H D  P NIL+ +DG ++L DFG+  + D   R
Sbjct: 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKFR 320

Length = 517

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 40/150 (26%), Positives = 74/150 (49%), Gaps = 14/150 (9%)

Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
           + K+ HP IV+L    +++   YL+ +++ G +L   L  + L  E   +I    I  A+
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL--RNLSWERRRKIAIG-IAKAL 793

Query: 264 SHLHAN---GIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
             LH      ++  +L PE I++D   + H+ L+  GL     +   S++      Y++P
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA------YVAP 847

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPP 348
           E    K   + +D +  G++L E+LTG+ P
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 39.3 bits (92), Expect = 0.003
 Identities = 44/181 (24%), Positives = 81/181 (44%), Gaps = 18/181 (9%)

Query: 179 AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF 238
           A+KV+R D     N  E    E  IL+++  P I +L         L ++++++  G L 
Sbjct: 50  AVKVLRPDAS--DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 239 FQLYRQGLFREDLAR----------IYTA-EIVSAVSHLHANGIMHRDLKPENILLDADG 287
             L +       LA           +Y A +I S + +L +   +HRDL   N L+  + 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY 167

Query: 288 HVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
            + + DFG+++    +     +  +    + +M+ E VL       +D W+ G+ L+E+L
Sbjct: 168 TIKIADFGMSRNLYSSDYYRVQGRAPL-PIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226

Query: 344 T 344
           T
Sbjct: 227 T 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|234975 PRK01723, PRK01723, 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

 Score = 38.3 bits (90), Expect = 0.004
 Identities = 15/29 (51%), Positives = 16/29 (55%)

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDF 294
            H  G+ H DL   NILLD DG   L DF
Sbjct: 158 FHDAGVYHADLNAHNILLDPDGKFWLIDF 186

Length = 239

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	479
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
PRK10345	210	hypothetical protein; Provisional	99.84
smart00090	237	RIO RIO-like kinase.	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.74
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.61
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.58
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.55
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.5
KOG1243	690	consensus Protein kinase [General function predict	99.45
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.42
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.35
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.29
KOG3087	229	consensus Serine/threonine protein kinase [General	99.23
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.2
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.15
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.05
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.02
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.92
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.81
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.8
COG4248	637	Uncharacterized protein with protein kinase and he	98.75
PRK09902	216	hypothetical protein; Provisional	98.63
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.59
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.53
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.52
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.47
PF01636	239	APH: Phosphotransferase enzyme family This family	98.37
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.37
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.36
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.21
smart00133	64	S_TK_X Extension to Ser/Thr-type protein kinases.	98.17
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.15
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.08
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.07
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.01
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.01
PLN02876	822	acyl-CoA dehydrogenase	97.99
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.87
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.79
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.67
PRK10593	297	hypothetical protein; Provisional	97.59
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.44
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.43
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.43
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.37
PRK05231	319	homoserine kinase; Provisional	97.36
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.29
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.01
KOG2270	520	consensus Serine/threonine protein kinase involved	96.87
PLN02236	344	choline kinase	96.82
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.8
PF00433	48	Pkinase_C: Protein kinase C terminal domain; Inter	96.79
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.52
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.47
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.47
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.44
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.29
PLN02756	418	S-methyl-5-thioribose kinase	96.23
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.08
PRK12396	409	5-methylribose kinase; Reviewed	95.99
PTZ00384	383	choline kinase; Provisional	95.76
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.61
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.51
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.11
PRK06148	1013	hypothetical protein; Provisional	94.76
PRK11768	325	serine/threonine protein kinase; Provisional	94.35
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.32
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.11

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8e-78  Score=586.96  Aligned_cols=324  Identities=55%  Similarity=0.955  Sum_probs=304.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+..++|+++++||+|+||+||+++.++|++.||||+++|..+.+....+..+.|+++|.+++||+||++++.||+..++
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            46679999999999999999999999999999999999999999888899999999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc-cCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENT  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~-~~~~~  304 (479)
                      |+|+||+.||+|+.+|++++.|+|+.+++|+++|+.||.|||++|||||||||||||+|.+||++|+|||+|+. ...+.
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999996 55667


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCccCCHHHHHHHHhh
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~lI~~~  383 (479)
                      .+.++|||+.|||||++.+.+|+.++||||||+++|||++|.+||.+.+...+.++|..++ ...|..++.++++||+++
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~L  260 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKL  260 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHH
Confidence            7888999999999999999999999999999999999999999999999999999999998 556666999999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCC-C-------
Q 011698          384 LQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVAS-P-------  455 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~-~-------  455 (479)
                      |++||++|+| ...++++|++||||+.+||+++.++++.|||+|.+.+..|.++|+.++|.+....++..+ +       
T Consensus       261 L~rdp~~RLg-~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~~~Fd~eft~~~~~~~~~~~~~~~~~~~~  339 (357)
T KOG0598|consen  261 LKRDPRQRLG-GPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDTSNFDNEFTSYTVDYSPVDSSPDMSAFTA  339 (357)
T ss_pred             hccCHHHhcC-CCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccccccccHHHHhccccCCccccCcccccccc
Confidence            9999999998 556899999999999999999999999999999999999999999999998776666542 2       


Q ss_pred             --CCCCCCccCeeeecC
Q 011698          456 --KFNENPFKGFTYVRP  470 (479)
Q Consensus       456 --~~~~~~f~~f~~~~~  470 (479)
                        ...+..|.||+|+.+
T Consensus       340 ~~~~~~~~f~gft~~~~  356 (357)
T KOG0598|consen  340 FSRTYNKIFPGFTYVAS  356 (357)
T ss_pred             cccccccccCCccccCC
Confidence              234577999999876

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-74  Score=595.71  Aligned_cols=330  Identities=38%  Similarity=0.785  Sum_probs=311.3

Q ss_pred             CCCCCcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEE
Q 011698          140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYS  218 (479)
Q Consensus       140 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~  218 (479)
                      .|.....+++++|.++++||+|+||+|+++..+.+++.||||+++|+.+...+.++..+.|.+|++... ||++++++.+
T Consensus       358 ~~~~~~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~  437 (694)
T KOG0694|consen  358 FPPRRGPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC  437 (694)
T ss_pred             CCCCCCcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc
Confidence            333335788999999999999999999999999999999999999999999999999999999999875 9999999999


Q ss_pred             EeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcc
Q 011698          219 FQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (479)
Q Consensus       219 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~  298 (479)
                      ||+.+++|+||||+.||++ .+++..+.|++..+++|+++|+.||+|||++||||||||.+|||+|.+|++||+|||+|+
T Consensus       438 fQT~~~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  438 FQTKEHLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             cccCCeEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence            9999999999999999994 455566789999999999999999999999999999999999999999999999999999


Q ss_pred             c-cCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHH
Q 011698          299 Q-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAH  377 (479)
Q Consensus       299 ~-~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  377 (479)
                      . +..+.++.++||||.|||||++.+..|+.++|||||||+|||||.|+.||.+++.++++..|+.+.+.+|..+|.++.
T Consensus       517 e~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~  596 (694)
T KOG0694|consen  517 EGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAI  596 (694)
T ss_pred             ccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHH
Confidence            8 457778999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC--
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP--  455 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~--  455 (479)
                      ++|++||.++|++|+|+.+.++++|+.||||+.|+|++|++++++|||+|.+.++.+.+|||+.||.++...+| ..+  
T Consensus       597 ~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~-~~~~~  675 (694)
T KOG0694|consen  597 AIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALTP-SDPRP  675 (694)
T ss_pred             HHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCCCccCC-CCccc
Confidence            99999999999999999989999999999999999999999999999999999999999999999999888886 333  


Q ss_pred             --CCCCCCccCeeeecCc
Q 011698          456 --KFNENPFKGFTYVRPA  471 (479)
Q Consensus       456 --~~~~~~f~~f~~~~~~  471 (479)
                        ..+|.+|.||+|+++.
T Consensus       676 l~~~~q~~F~~Fs~~~~~  693 (694)
T KOG0694|consen  676 LTEEEQEAFRDFSFVAEW  693 (694)
T ss_pred             cchhhHHHhcCccccCCC
Confidence              4679999999999863

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-71  Score=527.07  Aligned_cols=296  Identities=44%  Similarity=0.816  Sum_probs=286.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ..+++|+.++.||.|+||+|.+++.+.+|..||+|++.++.+.+..+.+...+|..+|+.+.||++++++++|.+..++|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            66899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~  306 (479)
                      +||||++||.|+.++++.++|+|..+++|++||+.||+|||+++|++|||||||||||.+|++||+|||+|+.+..  ++
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--rT  198 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--RT  198 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC--cE
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999998754  47


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~  386 (479)
                      .+.||||.|+|||++..++|+.++|||||||++|||+.|.+||.+.+...++++|+.+++.+|..+++++++||+++|++
T Consensus       199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~v  278 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQV  278 (355)
T ss_pred             EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhh
Confidence            89999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcc-ccCCcccccCccccccC
Q 011698          387 EASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP-EVAGKHCVANFEECWTN  444 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p-~~~~~~~~~~f~~~~~~  444 (479)
                      |-.+|.|+..++.++|++||||++++|.++..+.++|||.| ...+..+.+||+..-++
T Consensus       279 D~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gdtsnfd~y~e~  337 (355)
T KOG0616|consen  279 DLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGDTSNFDDYEEE  337 (355)
T ss_pred             hhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCcccccccccccc
Confidence            99999999888999999999999999999999999999998 77888899999886554

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.8e-69  Score=543.62  Aligned_cols=320  Identities=41%  Similarity=0.762  Sum_probs=284.6

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .++++||++++.||+|+||.||+|+.+.||+.||||+++|......+.++.++.|.++|...++|+||+||++||+..++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            57889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC---
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE---  302 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~---  302 (479)
                      ||||||++||++..+|.+.+.|+|+.+++|+++++.|++-||+.|+|||||||+|+|||..||+||+|||||+.+..   
T Consensus       217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999864311   


Q ss_pred             ---------------------CC------------------------CcccccCCCCCcchhHhcCCCCCccccchhhHH
Q 011698          303 ---------------------NT------------------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGI  337 (479)
Q Consensus       303 ---------------------~~------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGv  337 (479)
                                           ..                        ...+.+|||.|||||++.+++|+..+|||||||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~  376 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC  376 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence                                 00                        012468999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhcc--CCCCc--cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          338 LLFEMLTGQPPFTGGNRQKIQQKIIKDK--IKLPA--FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       338 ilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      ||||||.|.+||.+.+..+++.+|...+  +.+|.  .++.+++|||.+||. ||++|+|.  ++++||++||||++++|
T Consensus       377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~--~G~~EIK~HPfF~~v~W  453 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS--KGAEEIKKHPFFKGVDW  453 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc--ccHHHHhcCCccccCCc
Confidence            9999999999999999999999999875  66775  478999999999999 99999984  49999999999999999


Q ss_pred             hhhhcccCCCCCccccCCcccccCccccccCCCCCCCC--CCCC------------CCCCCCccCeeeecCc
Q 011698          414 KKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSP--VASP------------KFNENPFKGFTYVRPA  471 (479)
Q Consensus       414 ~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~--~~~~------------~~~~~~f~~f~~~~~~  471 (479)
                      +.+..+.  |||+|.+.+..+..+|++.- +.......  ...+            ...+..|.||+|.+..
T Consensus       454 ~~l~~~~--apfvP~v~~~~DT~yFddF~-e~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~FvgfTyk~~~  522 (550)
T KOG0605|consen  454 DHLREMP--APFVPQVNSELDTQYFDDFP-EEDSMTPTADKSGPSRKMLSMVDTNNSSKDINFVGFTYKNFD  522 (550)
T ss_pred             chhhcCC--CCCCCCCCCcccccccccCc-ccccCcccccccccchhhhhcccccCCcccccccceeeeccc
Confidence            9996555  99999999999999998643 32221111  1111            1234569999998754

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-70  Score=521.05  Aligned_cols=406  Identities=34%  Similarity=0.669  Sum_probs=343.0

Q ss_pred             cccccCCCceeccccccccCCCCccccccccCccchhhhccccCccccccccccCCCC--CCc-ccc----cc-cCCCC-
Q 011698           64 NELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPN--NLS-VVD----AA-LGKPT-  134 (479)
Q Consensus        64 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~----~~-~~~~~-  134 (479)
                      +.+-.+|+++||++||.+| +-.|..........+....++++... ....+..++..  +.+ .-+    .. ..++. 
T Consensus       158 gyrcinckl~vhkkch~~v-~~~cg~~~~~~~~~p~~p~~~s~~~~-~~~s~~t~~~~~i~~~~~he~~~~~~~~~~~a~  235 (593)
T KOG0695|consen  158 GYRCINCKLLVHKKCHGLV-PLTCGKHMDSVMPSPEPPVDDSNEDA-DLPSEETDGIAYISSSRKHESIKDDSEDLKPAI  235 (593)
T ss_pred             cceeecceeehhhhhcccc-cchhhhhccCCCCCCCCCCCCccccC-CCCchhcCcccccCccccchhhhcCccchhhhh
Confidence            3667799999999999999 44444444334444443333333211 11111111110  000 000    00 00111 


Q ss_pred             CCCCCCCCCCcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCee
Q 011698          135 GHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIV  213 (479)
Q Consensus       135 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv  213 (479)
                      ..++. -...+.+++++|.++++||+|+|++|.+++.+.|.++||||+++++-..+.+..++.+.|..+..+- +||++|
T Consensus       236 ~~m~g-~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflv  314 (593)
T KOG0695|consen  236 DGMDG-IKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLV  314 (593)
T ss_pred             hhccc-cccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEE
Confidence            11111 1234568899999999999999999999999999999999999999888888999999999999875 799999


Q ss_pred             eEeEEEeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEee
Q 011698          214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTD  293 (479)
Q Consensus       214 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~D  293 (479)
                      -++.+|+++..+++|.||++||+|..+++++..++|+.+++|.++|+.||.|||++|||+||||.+|+|+|..|++||+|
T Consensus       315 glhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltd  394 (593)
T KOG0695|consen  315 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTD  394 (593)
T ss_pred             ehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCccc-cCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCC--------CCHHHHHHHHHhc
Q 011698          294 FGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG--------GNRQKIQQKIIKD  364 (479)
Q Consensus       294 FGla~~-~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~--------~~~~~~~~~i~~~  364 (479)
                      +|+++. +..+..+.++||||.|+|||+++|..|+.++|||+|||+|+||+.|+.||.-        ++.+-+++.|++.
T Consensus       395 ygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek  474 (593)
T KOG0695|consen  395 YGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK  474 (593)
T ss_pred             cchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh
Confidence            999998 6677888999999999999999999999999999999999999999999962        3456788889999


Q ss_pred             cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCC-CHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCcccccc
Q 011698          365 KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPG-GSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWT  443 (479)
Q Consensus       365 ~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~-t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~  443 (479)
                      ++.+|..+|..+..+++..|++||.+|+||.++ ++.+++.|+||+.++|+.++++++.|||.|.+.+...+.||+..||
T Consensus       475 qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft  554 (593)
T KOG0695|consen  475 QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFT  554 (593)
T ss_pred             cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCccccccccc
Confidence            999999999999999999999999999999985 5799999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCC---CCCCCCccCeeeecCch
Q 011698          444 NMPLLDSPVASP---KFNENPFKGFTYVRPAA  472 (479)
Q Consensus       444 ~~~~~~~~~~~~---~~~~~~f~~f~~~~~~~  472 (479)
                      ++++..+|....   ..+|..|+||.|++|..
T Consensus       555 ~e~~qltpdd~d~i~ridqsefegfeyinpl~  586 (593)
T KOG0695|consen  555 SEPVQLTPDDEDAIKRIDQSEFEGFEYINPLL  586 (593)
T ss_pred             cCCcccCCCCHHHHHhcchhhcCcceecchhh
Confidence            999999988765   58899999999999875

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-69  Score=514.95  Aligned_cols=332  Identities=39%  Similarity=0.749  Sum_probs=314.0

Q ss_pred             CcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       144 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      ...+.+++|+.+++||+|.||+|.+++.+.+++.||||+++++.+..++.+..-..|-++|+..+||++..+.+.||+.+
T Consensus       162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d  241 (516)
T KOG0690|consen  162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD  241 (516)
T ss_pred             cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence            34578999999999999999999999999999999999999999888888888889999999999999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc-cCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDE  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~-~~~  302 (479)
                      ++|+||||..||.|+.+|.+...|+|+.+++|.++|+.||.|||+++||+||||.+|+|+|++||+||+|||+|+. +..
T Consensus       242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999997 667


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHh
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG  382 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~  382 (479)
                      +..+.++||||.|+|||++....|+.++|||.+||+||||++|+.||+..+...++..|+.+.+.+|..++++++.|+.+
T Consensus       322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsG  401 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSG  401 (516)
T ss_pred             cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHH
Confidence            77889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC-------
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP-------  455 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~-------  455 (479)
                      +|.+||.+|+|.++..+.||.+|+||.+++|..+-.+++.|||+|.+.+..+.+.||+.||.++...+|....       
T Consensus       402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTryFD~EFT~q~v~lTPP~r~~~~~~~~  481 (516)
T KOG0690|consen  402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTRYFDEEFTSQPVTLTPPDRYGSTVDED  481 (516)
T ss_pred             HhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchhhhhhhhhcceeEecCCCCCCcccchh
Confidence            9999999999999999999999999999999999999999999999999999999999999998877765432       


Q ss_pred             CCCCCCccCeeeecCchhhh
Q 011698          456 KFNENPFKGFTYVRPAASFL  475 (479)
Q Consensus       456 ~~~~~~f~~f~~~~~~~~~~  475 (479)
                      ...+..|.-|+|.....+.+
T Consensus       482 ~e~~~~FpQFsy~~~~~s~~  501 (516)
T KOG0690|consen  482 EERRPHFPQFSYSASMGSIN  501 (516)
T ss_pred             hhhccCCcceeeecchhhhh
Confidence            13467899999998766443

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-67  Score=512.77  Aligned_cols=327  Identities=39%  Similarity=0.787  Sum_probs=309.2

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~  224 (479)
                      .+...+|..+.+||+|+||+|.+|..+++.+.||||+++++.+...+..+.-..|.++|... +-|++++++.+|++-++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            56778999999999999999999999999999999999999888888888888899999887 57899999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc-cCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDEN  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~-~~~~  303 (479)
                      +|+||||+.||+|..+++.-+.|.|..+.+|+++|+-||-+||++|||+||||.+|||+|.+|++||+|||+++. +-..
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999997 5566


Q ss_pred             CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhh
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~  383 (479)
                      ..+.++||||.|+|||++..++|+.++||||+||+||||+.|++||.+.+.+++++.|......+|..+|.++.++++.+
T Consensus       505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~  584 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGL  584 (683)
T ss_pred             cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHH
Confidence            77889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCC
Q 011698          384 LQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFNEN  460 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---~~~~~  460 (479)
                      |.+.|.+|+||++.+-++|..||||+.|+|+++++++++|||+|.+....+..|||+.||..+...+|.+--   ..+|.
T Consensus       585 ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD~~v~~nldq~  664 (683)
T KOG0696|consen  585 LTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPTDLTPPDKLVMMNLDQS  664 (683)
T ss_pred             hhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCCCCCCchHHHHhcCchh
Confidence            999999999999999999999999999999999999999999999988888999999999888777665433   47899


Q ss_pred             CccCeeeecCch
Q 011698          461 PFKGFTYVRPAA  472 (479)
Q Consensus       461 ~f~~f~~~~~~~  472 (479)
                      .|+||+|++|.-
T Consensus       665 eF~gFsfvNpef  676 (683)
T KOG0696|consen  665 EFEGFSFVNPEF  676 (683)
T ss_pred             hcCceeeeChhh
Confidence            999999999853

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-61  Score=491.10  Aligned_cols=276  Identities=40%  Similarity=0.704  Sum_probs=259.4

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~  224 (479)
                      .....||.+.+.||.|+|++|++|+.+.+++.||||++.|..+..++..+++..|..+|.+| .||.|++|+..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            45678999999999999999999999999999999999999999999999999999999999 89999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      +|+|+||+++|+|..+|.+.|.|++..+++|++||+.||+|||++|||||||||||||+|.||++||+|||.|+.+....
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999874321


Q ss_pred             ------------C--cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc
Q 011698          305 ------------R--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA  370 (479)
Q Consensus       305 ------------~--~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~  370 (479)
                                  .  ..+++||..|.+||++.....+.++|+|+||||||+|+.|.+||.+.+.-.++++|+.-.+.||+
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~  308 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE  308 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence                        1  15689999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcc
Q 011698          371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP  427 (479)
Q Consensus       371 ~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p  427 (479)
                      .+++.+++||+++|.+||.+|+     |+++|++||||.+++|+.+... ..|+..|
T Consensus       309 ~fp~~a~dLv~KLLv~dp~~Rl-----t~~qIk~HpFF~~Vdw~nlw~~-~PP~l~p  359 (604)
T KOG0592|consen  309 GFPEDARDLIKKLLVRDPSDRL-----TSQQIKAHPFFEGVDWENLWQQ-TPPKLQP  359 (604)
T ss_pred             CCCHHHHHHHHHHHccCccccc-----cHHHHhhCcccccCChhhhhhc-CCCcccC
Confidence            9999999999999999999999     8899999999999999997543 3343333

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-61  Score=474.50  Aligned_cols=288  Identities=42%  Similarity=0.732  Sum_probs=264.0

Q ss_pred             CcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       144 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      ...+++++|++++.||+|.-|+||+|+.++++..+|||+|.++.+...+...+++.|..||+.++||+++.||..|+++.
T Consensus        71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~  150 (459)
T KOG0610|consen   71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK  150 (459)
T ss_pred             CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence            34578899999999999999999999999999999999999999888888999999999999999999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      ..|+|||||+||+|..+++++  +.|+++.+++|+++|+.||+|||..|||+||||||||||.++||+.|+||.|+....
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            999999999999999988876  469999999999999999999999999999999999999999999999999864320


Q ss_pred             ------------------------------------C---------------------CCCcccccCCCCCcchhHhcCC
Q 011698          302 ------------------------------------E---------------------NTRSNSMCGTLEYMSPEIVLGK  324 (479)
Q Consensus       302 ------------------------------------~---------------------~~~~~~~~gt~~y~APE~l~~~  324 (479)
                                                          .                     +.++++++||-.|+|||++.|.
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~  310 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE  310 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence                                                0                     0123457899999999999999


Q ss_pred             CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc--cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHH
Q 011698          325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA--FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEI  402 (479)
Q Consensus       325 ~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~ei  402 (479)
                      +++.++|||+|||++|||+.|..||.|.+..+++.+|+...+.+|.  .++..++|||+++|.+||++|+|+.. +|.||
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~r-GA~eI  389 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKR-GAAEI  389 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcccc-chHHh
Confidence            9999999999999999999999999999999999999999999886  47899999999999999999999864 89999


Q ss_pred             HhCccccCCChhhhhcccCCCCCccccCCccc
Q 011698          403 KSHKWFKMINWKKLEARETRPSFLPEVAGKHC  434 (479)
Q Consensus       403 l~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~  434 (479)
                      ++||||+++||..  .+-.+||++|.+....+
T Consensus       390 K~HpFF~gVnWaL--ir~~~PP~iP~~~d~~~  419 (459)
T KOG0610|consen  390 KRHPFFEGVNWAL--IRCARPPEIPKPVDGGL  419 (459)
T ss_pred             hcCccccCCChhh--eeccCCCcCCCccccCc
Confidence            9999999999993  46778999998765544

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-62  Score=481.83  Aligned_cols=294  Identities=40%  Similarity=0.707  Sum_probs=277.5

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      +.+..+.|+..++||+|+||.|+-++.+.||+.||+|.+.+.++..........+|..||.+++.++||.+-+.|++.+.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            55778899999999999999999999999999999999999888777777888899999999999999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      +|+||..|+||+|..+|.+.+  .|+|..+++|+++|+.||++||+.+||+|||||+|||+|+.||++|+|+|+|..+.+
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999999998877  799999999999999999999999999999999999999999999999999999998


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhccCCCCccCCHHHHH
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAHS  378 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~  378 (479)
                      .......+||.+|||||++.++.|+.++|||||||+||||+.|+.||...    ..+++.+++......+|..+|+++++
T Consensus       340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaks  419 (591)
T KOG0986|consen  340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKS  419 (591)
T ss_pred             CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHH
Confidence            88888889999999999999999999999999999999999999999763    45678888888899999999999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCc
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANF  438 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f  438 (479)
                      |.+.+|++||.+|+||+..+++++++||||+++||..+++.++.|||+|.+...+|..-+
T Consensus       420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~  479 (591)
T KOG0986|consen  420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVL  479 (591)
T ss_pred             HHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhh
Confidence            999999999999999999999999999999999999999999999999999877664433

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-61  Score=515.59  Aligned_cols=318  Identities=39%  Similarity=0.710  Sum_probs=284.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..+||+++++||+|+||.|.+++++.|+++||||+++|-..........|+.|..+|..-+.+.|++++++|+++.++|
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            55689999999999999999999999999999999999977777777888999999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC--
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~--  304 (479)
                      +|||||+||+|..++.+.+.++|+.+++|+++|+.||.-||+.|+|||||||+|||||..||+||+|||.|-.+..+.  
T Consensus       152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998876543  


Q ss_pred             CcccccCCCCCcchhHhcC-----CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCC--ccCCHH
Q 011698          305 RSNSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLP--AFLSSE  375 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~-----~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~  375 (479)
                      .....+|||.|++||++..     +.|+..+|||||||++|||+.|..||+..+..+++-+|+..  .+.||  ..+|.+
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee  311 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE  311 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence            3567899999999999963     45899999999999999999999999999999999999976  78888  569999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCC-CCCCCCC
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPL-LDSPVAS  454 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~-~~~~~~~  454 (479)
                      +++||.++|. +|..|+|-  +++++|++||||.+++|+.+  |...|||+|.+.+..+++||+.+-..... ...|...
T Consensus       312 akdLI~~ll~-~~e~RLgr--ngiedik~HpFF~g~~W~~i--R~~~pP~vPevssd~DTsnFd~~~dd~~~~e~~p~~~  386 (1317)
T KOG0612|consen  312 AKDLIEALLC-DREVRLGR--NGIEDIKNHPFFEGIDWDNI--RESVPPVVPEVSSDDDTSNFDVDEDDLRDAETFPPRI  386 (1317)
T ss_pred             HHHHHHHHhc-Chhhhccc--ccHHHHHhCccccCCChhhh--hhcCCCCCCcCCCCCccccccccccccchhhccCCCC
Confidence            9999999998 89999964  58999999999999999766  77889999999999999999544322211 1112112


Q ss_pred             C---CCCCCCccCeeeec
Q 011698          455 P---KFNENPFKGFTYVR  469 (479)
Q Consensus       455 ~---~~~~~~f~~f~~~~  469 (479)
                      +   .+++-+|.||||..
T Consensus       387 ~~~f~Gn~LPFIGfTy~~  404 (1317)
T KOG0612|consen  387 PKAFSGNHLPFIGFTYTH  404 (1317)
T ss_pred             CCCCcCCcCCeeeeeecc
Confidence            2   36788999999996

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-58  Score=476.21  Aligned_cols=255  Identities=33%  Similarity=0.610  Sum_probs=248.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      .+|+..+.||+|||++||.+++..+|+.||+|++.+..+......+.+.+|++|.+.|+|||||+++.+|++.+++|+|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            56999999999999999999999999999999999998888888999999999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~~  308 (479)
                      |+|..++|..++++.+.++|.+++.|+.||+.||.|||+++|||||||..|++++++.++||+|||||..+... .+..+
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T  177 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT  177 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998644 77889


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhch
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA  388 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP  388 (479)
                      .||||.|+|||++...+++..+||||+||+||-||+|++||...+..+++.+|....+.+|..+|.++++||.+||++||
T Consensus       178 lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P  257 (592)
T KOG0575|consen  178 LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNP  257 (592)
T ss_pred             ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCHHHHHhCcccc
Q 011698          389 SKRLGSGPGGSQEIKSHKWFK  409 (479)
Q Consensus       389 ~~R~~~~~~t~~eil~hp~f~  409 (479)
                      .+||     ++++|+.|+||+
T Consensus       258 ~~Rp-----sl~~vL~h~Ff~  273 (592)
T KOG0575|consen  258 SERP-----SLDEVLDHPFFK  273 (592)
T ss_pred             ccCC-----CHHHHhcCHhhh
Confidence            9999     999999999994

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-59  Score=460.84  Aligned_cols=260  Identities=34%  Similarity=0.584  Sum_probs=238.2

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH----HHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK----NHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      ..+.|.+.+.||+|+||.|-+|..+.||+.||||++.+......    .....+++|+++|++|+|||||+++++|....
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            34568889999999999999999999999999999998765442    23444679999999999999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC---CcEEEeecCCcccc
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD---GHVMLTDFGLAKQF  300 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~---g~vkL~DFGla~~~  300 (479)
                      ..|+|||||+||+|++.+-.++.+.|+..+.++.|++.|+.|||++||+||||||+|||+..+   -.+||+|||+|+..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999999999999999999999999999999999999999999999999999999999776   68999999999999


Q ss_pred             CCCCCcccccCCCCCcchhHhcCCCC---CccccchhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCCCC----ccC
Q 011698          301 DENTRSNSMCGTLEYMSPEIVLGKGH---DKAADWWSVGILLFEMLTGQPPFTGGNRQK-IQQKIIKDKIKLP----AFL  372 (479)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~---~~~~DiwSLGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~~p----~~~  372 (479)
                      .+...+.++||||.|.|||++.++++   ..++|+|||||+||-+++|.+||.+..... +.+.|.++++.+-    ..+
T Consensus       330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~I  409 (475)
T KOG0615|consen  330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRI  409 (475)
T ss_pred             ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhh
Confidence            99999999999999999999988764   457899999999999999999998866555 8999999987764    358


Q ss_pred             CHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       373 s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      |.++.+||+.||..||++|+     +++|+|+||||+...
T Consensus       410 seea~dlI~~mL~VdP~~R~-----s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  410 SEEALDLINWMLVVDPENRP-----SADEALNHPWFKDAP  444 (475)
T ss_pred             hHHHHHHHHHhhEeCcccCc-----CHHHHhcChhhhccc
Confidence            99999999999999999999     999999999999875

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-56  Score=453.37  Aligned_cols=314  Identities=39%  Similarity=0.754  Sum_probs=281.1

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg  235 (479)
                      +.||+|+||+||+|+++.+|+.||+|++++...........+.+|+.++++++||||++++++++....+|+||||+.||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998766555555666788999999999999999999999999999999999999


Q ss_pred             cHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCCCCcccccCCCC
Q 011698          236 HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLE  314 (479)
Q Consensus       236 sL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~~~~~~~~gt~~  314 (479)
                      +|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.. .........+||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~  160 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence            99999999889999999999999999999999999999999999999999999999999999763 23334456789999


Q ss_pred             CcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcCC
Q 011698          315 YMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGS  394 (479)
Q Consensus       315 y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~  394 (479)
                      |+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+..+...+|..++.++.+||++||++||++|++.
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  240 (323)
T cd05571         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG  240 (323)
T ss_pred             ccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCC
Confidence            99999999999999999999999999999999999999989999999989999999999999999999999999999987


Q ss_pred             CCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCCC-------CCCCCccCeee
Q 011698          395 GPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPK-------FNENPFKGFTY  467 (479)
Q Consensus       395 ~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~-------~~~~~f~~f~~  467 (479)
                      .+.+++++++||||.+++|..+..+...|++.|.+....+...|++.++......+|.....       ..+..|.+|+|
T Consensus       241 ~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  320 (323)
T cd05571         241 GPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQSITITPPDRYDSLGLLQLEERPHFPQFSY  320 (323)
T ss_pred             CCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCcccCCCCcccccccccccccccCCCCee
Confidence            77789999999999999999999999999999998888888888887777655444432221       12567999999


Q ss_pred             ec
Q 011698          468 VR  469 (479)
Q Consensus       468 ~~  469 (479)
                      ..
T Consensus       321 ~~  322 (323)
T cd05571         321 SA  322 (323)
T ss_pred             eC
Confidence            75

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.9e-56  Score=446.65  Aligned_cols=318  Identities=39%  Similarity=0.803  Sum_probs=279.2

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +|++++.||+|+||+||+|+++.+++.||+|++++.........+....|..++..+ +|++|+++++++.+.+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            689999999999999999999999999999999886544444555667788888877 5899999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC-CCCCccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~~~~~~~  308 (479)
                      ||++||+|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .......
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~  160 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT  160 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999998643 2334456


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhch
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA  388 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP  388 (479)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.+......+|..++.++.+||.+||++||
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p  240 (323)
T cd05616         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP  240 (323)
T ss_pred             CCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCH
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCCCccCe
Q 011698          389 SKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFNENPFKGF  465 (479)
Q Consensus       389 ~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---~~~~~~f~~f  465 (479)
                      .+|+++.+.+.+++++||||+.++|..+..+.++|++.|.... .+..+++..+...+....|....   ..++..|+||
T Consensus       241 ~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (323)
T cd05616         241 GKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACG-RDAENFDKFFTRHPPVLTPPDQEVIMNLDQSEFEGF  319 (323)
T ss_pred             HhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCC-chhhhcCchhccCCccCCCCCccccccccccccCCC
Confidence            9999887777899999999999999999999999999997654 45566766665444333333322   2346789999


Q ss_pred             eeec
Q 011698          466 TYVR  469 (479)
Q Consensus       466 ~~~~  469 (479)
                      +|++
T Consensus       320 ~~~~  323 (323)
T cd05616         320 SYVN  323 (323)
T ss_pred             cccC
Confidence            9974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.6e-56  Score=448.22  Aligned_cols=316  Identities=40%  Similarity=0.752  Sum_probs=277.3

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      ...+++|++.+.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.++++++||||+++++++.+.+.+
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   93 (329)
T PTZ00263         14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV   93 (329)
T ss_pred             CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence            34568999999999999999999999999999999999876655555667788999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      |+||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....  
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--  171 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--  171 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence            999999999999999999899999999999999999999999999999999999999999999999999999876443  


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhh
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...+.+.+..+.+.+|..++..+++||++||+
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~  251 (329)
T PTZ00263        172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQ  251 (329)
T ss_pred             cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhh
Confidence            34568999999999999999999999999999999999999999999988999999999999999999999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCCCCCCCCccCe
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGF  465 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~f~~f  465 (479)
                      +||.+|+++...+++++++||||++.+|..+..+...+++.+.........+|.... ..+....+ ......+..|.||
T Consensus       252 ~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~~-~~~~~~~~~~~~~  329 (329)
T PTZ00263        252 TDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEKYP-DSPVDRLP-PLTAAQQAEFAGF  329 (329)
T ss_pred             cCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcccchhccCCc-ccccccCC-CCchhhhhhcCCC
Confidence            999999987667899999999999999999998888888777776666666775432 11111111 1112346778887

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.2e-55  Score=445.43  Aligned_cols=319  Identities=41%  Similarity=0.813  Sum_probs=283.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC-CCeeeEeEEEeeCCeEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+..|+.+++.++| ++|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999988655455556677889999999976 56888999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC-CCCCccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~~~~~~~  308 (479)
                      ||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... .......
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT  160 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence            999999999999888889999999999999999999999999999999999999999999999999987532 2333456


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhch
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA  388 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP  388 (479)
                      .+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..++...+......+|..++.++.++|++||++||
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P  240 (324)
T cd05587         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHP  240 (324)
T ss_pred             ecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCCCccCe
Q 011698          389 SKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFNENPFKGF  465 (479)
Q Consensus       389 ~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---~~~~~~f~~f  465 (479)
                      .+|+++.....+++++||||+.++|..+..+...+++.|.........+|+..++..+...+|....   ..++..|++|
T Consensus       241 ~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (324)
T cd05587         241 AKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKFFTREPPVLTPPDKLVIANIDQSEFQGF  320 (324)
T ss_pred             HHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcchhhhcCcccccCccccCCCCccccccccccccCCC
Confidence            9999876667799999999999999999999999999999888788888988776655544444333   3456889999


Q ss_pred             eeec
Q 011698          466 TYVR  469 (479)
Q Consensus       466 ~~~~  469 (479)
                      +|++
T Consensus       321 ~~~~  324 (324)
T cd05587         321 SFVN  324 (324)
T ss_pred             cccC
Confidence            9874

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.8e-56  Score=446.50  Aligned_cols=316  Identities=36%  Similarity=0.731  Sum_probs=280.7

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHH---HhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL---TKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL---~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      |++++.||+|+||+||+|+++.+++.||||++++.........+.+.+|++++   +.++||||+++++++.+...+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78899999999999999999999999999999876544445556677777665   456799999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC-CCCCcc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSN  307 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~~~~~~  307 (479)
                      |||++||+|...+.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... ......
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS  159 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence            999999999887754 578999999999999999999999999999999999999999999999999987632 233345


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhc
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      ..+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..++...+......+|..++.++.++|++||++|
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d  239 (324)
T cd05589         160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRN  239 (324)
T ss_pred             ccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            67899999999999999999999999999999999999999999999999999999988899999999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC----CCCCCCcc
Q 011698          388 ASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP----KFNENPFK  463 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~----~~~~~~f~  463 (479)
                      |.+|++....+++++++||||++++|..+..+.+.|++.|.+....+..+|+..++..+...+|..++    ..+|..|.
T Consensus       240 P~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (324)
T cd05589         240 PERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAPVLTPPREPRLLTEEEQELFR  319 (324)
T ss_pred             HhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcchhhhcCccccccccccCCCccccccchhhhcccC
Confidence            99999887778999999999999999999999999999999988888889988776665544444332    36789999


Q ss_pred             Ceeee
Q 011698          464 GFTYV  468 (479)
Q Consensus       464 ~f~~~  468 (479)
                      +|+|+
T Consensus       320 ~~~~~  324 (324)
T cd05589         320 GFDYV  324 (324)
T ss_pred             CcccC
Confidence            99985

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-57  Score=439.70  Aligned_cols=259  Identities=29%  Similarity=0.510  Sum_probs=240.3

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe-
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR-  224 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~-  224 (479)
                      .+.+.+.+.++.||+|..|+||+++++.|++.+|+|++...  .+....+++.+|+++++.++||+||.+|++|..+.. 
T Consensus        75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            46678999999999999999999999999999999999443  355667889999999999999999999999999994 


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      ++++||||+||+|...+...+.++|.....++.+|++||.|||. ++||||||||+||||+..|.+||||||.++.+...
T Consensus       153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            99999999999999999999999999999999999999999995 89999999999999999999999999999987655


Q ss_pred             CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhc-cCCCCcc-CCHHH
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG-----NRQKIQQKIIKD-KIKLPAF-LSSEA  376 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~~  376 (479)
                       ..++++||..|||||.+.+..|+.++||||||++++||++|+.||...     +..+++..|..+ .+.+|.. +|+++
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef  311 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF  311 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence             678999999999999999999999999999999999999999999874     678889999985 5678886 99999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      ++||..||++||.+|+     +++|+++|||++...
T Consensus       312 ~~FV~~CL~Kdp~~R~-----s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  312 RSFVSCCLRKDPSERP-----SAKQLLQHPFIKKFE  342 (364)
T ss_pred             HHHHHHHhcCCcccCC-----CHHHHhcCHHHhhcc
Confidence            9999999999999999     999999999998753

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-58  Score=463.42  Aligned_cols=299  Identities=38%  Similarity=0.706  Sum_probs=288.8

Q ss_pred             CcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       144 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      ...+.+.+++++..||-|+||+|-+++.+.....+|+|+++|..+.+..+.+.+..|.++|..++.|+||++|..|.+..
T Consensus       414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k  493 (732)
T KOG0614|consen  414 FAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK  493 (732)
T ss_pred             hcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence            34567889999999999999999999998777679999999999999999999999999999999999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      .+|++||-|-||.|...|+.++.|++..+++|++.+++|++|||++|||+|||||||++++.+|.+||.|||+|+.+..+
T Consensus       494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCccCCHHHHHHHH
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSLLK  381 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~lI~  381 (479)
                      .++.++||||.|.|||++.+++++.++|+||||+++|||++|.+||.+.+++.+++.|+++  .+.+|..++..+.+||+
T Consensus       574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik  653 (732)
T KOG0614|consen  574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIK  653 (732)
T ss_pred             CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHH
Confidence            9999999999999999999999999999999999999999999999999999999999997  78899999999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccc
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECW  442 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~  442 (479)
                      ++...+|.+|+|+..+++.+|++|.||.++||..+..+.++||++|.+.++.+++||+...
T Consensus       654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~p  714 (732)
T KOG0614|consen  654 KLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNFP  714 (732)
T ss_pred             HHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCCC
Confidence            9999999999999889999999999999999999999999999999999999999998743

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.4e-55  Score=447.04  Aligned_cols=316  Identities=38%  Similarity=0.671  Sum_probs=279.0

Q ss_pred             CcccCCCCeEEEEEeccCCceEEEEEEEcCCC-eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       144 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      ...+..++|++++.||+|+||.||+|+++.++ ..||+|++.+.........+.+.+|+.+++.++||||+++++++.+.
T Consensus        24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~  103 (340)
T PTZ00426         24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE  103 (340)
T ss_pred             CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence            34567789999999999999999999977665 68999999876655555567788999999999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      ..+|+||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+..
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999999999999999988999999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHh
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG  382 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~  382 (479)
                        ...+.+||+.|||||++.+..++.++|||||||++|||++|..||.+.+...+.+.+..+...+|..++.++.++|++
T Consensus       184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  261 (340)
T PTZ00426        184 --RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKK  261 (340)
T ss_pred             --CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence              234678999999999999999999999999999999999999999999988899999999889999999999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCCCCCCCCc
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPF  462 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~f  462 (479)
                      ||+.||++|++....+++++++||||++++|..+..+.+.+++.|........++|...-..    ..+......++++|
T Consensus       262 ~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  337 (340)
T PTZ00426        262 LLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFERVQED----LTIADKITNENDPF  337 (340)
T ss_pred             HcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCCcchhhcCCCccc----ccccCCCccccCcc
Confidence            99999999987766799999999999999999999999999999998777666666542222    22223333445778


Q ss_pred             cCe
Q 011698          463 KGF  465 (479)
Q Consensus       463 ~~f  465 (479)
                      .||
T Consensus       338 ~~~  340 (340)
T PTZ00426        338 FDW  340 (340)
T ss_pred             cCC
Confidence            776

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.4e-55  Score=444.50  Aligned_cols=316  Identities=40%  Similarity=0.742  Sum_probs=280.3

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg  235 (479)
                      +.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.++||||++++++++..+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998866555555667788999999999999999999999999999999999999


Q ss_pred             cHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC-CCCCcccccCCCC
Q 011698          236 HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLE  314 (479)
Q Consensus       236 sL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~~~~~~~~~gt~~  314 (479)
                      +|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++... ........+||+.
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~  160 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE  160 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence            999999888889999999999999999999999999999999999999999999999999997632 2233455789999


Q ss_pred             CcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcCC
Q 011698          315 YMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGS  394 (479)
Q Consensus       315 y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~  394 (479)
                      |+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+......+|..++.++.+||++||++||++|++.
T Consensus       161 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  240 (328)
T cd05593         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGG  240 (328)
T ss_pred             ccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence            99999999999999999999999999999999999998888888888888889999999999999999999999999988


Q ss_pred             CCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---------CCCCCCccCe
Q 011698          395 GPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---------KFNENPFKGF  465 (479)
Q Consensus       395 ~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---------~~~~~~f~~f  465 (479)
                      .+.+++++++|+||.+++|..+......|++.|..........|+..++.......+...-         ...+..|.+|
T Consensus       241 ~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (328)
T cd05593         241 GPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTAQTITITPPEKYDEDGMDCMDNERRPHFPQF  320 (328)
T ss_pred             CCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCcccccCCcccCCccccccccccccccccccccCCc
Confidence            8889999999999999999999999999999999888777788887776554433322211         1235779999


Q ss_pred             eeecCc
Q 011698          466 TYVRPA  471 (479)
Q Consensus       466 ~~~~~~  471 (479)
                      +|.+..
T Consensus       321 ~~~~~~  326 (328)
T cd05593         321 SYSASG  326 (328)
T ss_pred             eeeCCC
Confidence            998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.3e-55  Score=444.76  Aligned_cols=314  Identities=38%  Similarity=0.774  Sum_probs=276.8

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +.||+|+||+||+|+++.+++.||+|++++...........+..|..+++.+ +||||++++++|.+...+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999999999999999987655555667788999999998 799999999999999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCCCCcccccCCC
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTL  313 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~~~~~~~~gt~  313 (479)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. .........+||+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence            999999988889999999999999999999999999999999999999999999999999999753 3334445678999


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhccCCCCccCCHHHHHHHHhhh
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG---------NRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLL  384 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L  384 (479)
                      .|+|||++.+..++.++|+|||||++|||++|+.||...         ....+.+.+......+|..++.++.++|++||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  240 (329)
T cd05588         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFL  240 (329)
T ss_pred             cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            999999999999999999999999999999999999631         22345667777788899999999999999999


Q ss_pred             hhchhhhcCCCC-CCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCC---CCCCCC
Q 011698          385 QKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVAS---PKFNEN  460 (479)
Q Consensus       385 ~~dP~~R~~~~~-~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~---~~~~~~  460 (479)
                      ++||.+|+++.. .+++++++||||.+++|..++.++..|++.|.+.......+|+..++..+...+|...   ...+|.
T Consensus       241 ~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  320 (329)
T cd05588         241 NKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTPDDPDVIARIDQS  320 (329)
T ss_pred             ccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCCcchhhhcCCccccCccccCCCCcccccccccc
Confidence            999999997543 3689999999999999999999999999999988887888898888777766665544   246789


Q ss_pred             CccCeeeec
Q 011698          461 PFKGFTYVR  469 (479)
Q Consensus       461 ~f~~f~~~~  469 (479)
                      .|+||.|++
T Consensus       321 ~~~~~~~~~  329 (329)
T cd05588         321 EFEGFEYIN  329 (329)
T ss_pred             ccCCCcccC
Confidence            999999874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.5e-55  Score=442.75  Aligned_cols=314  Identities=38%  Similarity=0.750  Sum_probs=276.2

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +.||+|+||+||+|+++.+++.||+|++++.........+.+..|..+++.+ +||||+++++++.+...+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999999999999999999876554445566677888888876 699999999999999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC-CCCCcccccCCC
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~~~~~~~~~gt~  313 (479)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... ........+||+
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP  160 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence            9999999988899999999999999999999999999999999999999999999999999997642 233445678999


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcC
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~  393 (479)
                      .|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+..+...+|..++.++.+||++||++||.+|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~  240 (320)
T cd05590         161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLG  240 (320)
T ss_pred             cccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999995


Q ss_pred             CCC-CCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCC---CCCCCCCCccCeeeec
Q 011698          394 SGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVA---SPKFNENPFKGFTYVR  469 (479)
Q Consensus       394 ~~~-~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~---~~~~~~~~f~~f~~~~  469 (479)
                      +.. .+.+++++||||++++|..+..+...|+|.|.+....+..+|+..........++..   .+..+++.|++|+|..
T Consensus       241 ~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (320)
T cd05590         241 SLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKEDPVLTPIEESLLPMINQDEFRNFSYTA  320 (320)
T ss_pred             CCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCccCCCCcccccccccccCcCCCcccC
Confidence            422 234999999999999999999999999999999988888999876655433333321   2345678999999863

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.6e-55  Score=441.43  Aligned_cols=313  Identities=40%  Similarity=0.778  Sum_probs=276.3

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +.||+|+||+||+|+++.+++.||+|++++.........+.+..|..+++.+ +||||+++++++++...+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            3699999999999999999999999999886655555566677889998876 799999999999999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC-CCCCcccccCCC
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~~~~~~~~~gt~  313 (479)
                      |+|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... ........+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP  160 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence            9999999988899999999999999999999999999999999999999999999999999997642 233345678999


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcC
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~  393 (479)
                      .|+|||++.+..++.++|||||||++|||++|+.||.+.+.....+.+..+...+|..++.++.+||++||++||++|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~  240 (321)
T cd05591         161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLG  240 (321)
T ss_pred             cccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence            99999999999999999999999999999999999999999999999999998899999999999999999999999998


Q ss_pred             CCCC--CHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCCCccCeeee
Q 011698          394 SGPG--GSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFNENPFKGFTYV  468 (479)
Q Consensus       394 ~~~~--t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---~~~~~~f~~f~~~  468 (479)
                      +...  +++++++||||..++|..++.+...|++.|.........+|+..++.......|....   ..+++.|+||+|.
T Consensus       241 ~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (321)
T cd05591         241 CVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTKEEPVLTPVDPAVIKQINQEEFRGFSFF  320 (321)
T ss_pred             CCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchhhhcCCccccCccccCCCCccccccccccccCCCccc
Confidence            7553  8999999999999999999999999999998877777777876655443333333222   4678889999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-55  Score=438.54  Aligned_cols=308  Identities=44%  Similarity=0.826  Sum_probs=275.3

Q ss_pred             eccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCCcH
Q 011698          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (479)
Q Consensus       158 LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL  237 (479)
                      ||+|+||+||+|+++.+++.||+|++++...........+.+|+.+|++++||||+++++++.....+|+||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999999999999999876555555566778899999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC-CCCCcccccCCCCCc
Q 011698          238 FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYM  316 (479)
Q Consensus       238 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~~~~~~~~~gt~~y~  316 (479)
                      ..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... ........+||+.|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~  160 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL  160 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence            9999988899999999999999999999999999999999999999999999999999998642 233345678999999


Q ss_pred             chhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcCCCC
Q 011698          317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGP  396 (479)
Q Consensus       317 APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~  396 (479)
                      |||++.+..++.++|||||||++|||++|+.||.+.+..++.+.+..+...+|..++.++++||.+||+.||.+|++.  
T Consensus       161 aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~--  238 (312)
T cd05585         161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGY--  238 (312)
T ss_pred             CHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCC--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999999964  


Q ss_pred             CCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCC---CCCCCCCccCeee
Q 011698          397 GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVAS---PKFNENPFKGFTY  467 (479)
Q Consensus       397 ~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~---~~~~~~~f~~f~~  467 (479)
                      .++.++++||||...+|..+..+...+++.|......+.++|+..++.....++....   +...|..|.||+|
T Consensus       239 ~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (312)
T cd05585         239 NGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSVVDDSHLSETVQQQFGGWSY  312 (312)
T ss_pred             CCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhhcCccccccccccCCCccccccchhccccCCCCC
Confidence            3789999999999999999999999999999888777888888777654443333222   2345788999987

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.2e-55  Score=440.73  Aligned_cols=314  Identities=39%  Similarity=0.789  Sum_probs=278.3

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +.||+|+||+||+|+++.+++.||+|++++.........+.+.+|+.++.++ +||+|+++++++++...+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999987655556677788999999888 699999999999999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCCCCcccccCCC
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTL  313 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~~~~~~~~gt~  313 (479)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.. .........+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP  160 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence            999999988889999999999999999999999999999999999999999999999999999763 2334445678999


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCC-------CCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhh
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG-------GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~-------~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~  386 (479)
                      .|+|||++.+..++.++|||||||++|||++|..||..       .....+.+.+......+|..++..+.++|++||++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~  240 (327)
T cd05617         161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNK  240 (327)
T ss_pred             ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcc
Confidence            99999999999999999999999999999999999953       22345666677777888999999999999999999


Q ss_pred             chhhhcCCCC-CCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCCCc
Q 011698          387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFNENPF  462 (479)
Q Consensus       387 dP~~R~~~~~-~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---~~~~~~f  462 (479)
                      ||.+|+++.+ .+++++++||||+.++|..+..+...|+|.|......+..+|+..+...+...+|....   ..++..|
T Consensus       241 dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (327)
T cd05617         241 DPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFDTQFTSEPVQLTPDDEDVIKRIDQSEF  320 (327)
T ss_pred             CHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCCcchhhcCCccccCcccCCCCCcccccccccccc
Confidence            9999997643 36799999999999999999999999999999988888999988887777766665543   4678899


Q ss_pred             cCeeeec
Q 011698          463 KGFTYVR  469 (479)
Q Consensus       463 ~~f~~~~  469 (479)
                      .||+|++
T Consensus       321 ~~~~~~~  327 (327)
T cd05617         321 EGFEYIN  327 (327)
T ss_pred             CCCcCCC
Confidence            9999874

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-55  Score=436.19  Aligned_cols=290  Identities=40%  Similarity=0.785  Sum_probs=268.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||+||+|.++.+++.||+|++...........+.+.+|+.++++++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999998765444445667889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~  309 (479)
                      ||+.+|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....  .....
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~--~~~~~  158 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD--RTWTL  158 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC--Ccccc
Confidence            9999999999999988999999999999999999999999999999999999999999999999999987643  23456


Q ss_pred             cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchh
Q 011698          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEAS  389 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~  389 (479)
                      +||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+.+.+..+...+|..++..+++||++||+.||.
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~  238 (291)
T cd05612         159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRT  238 (291)
T ss_pred             cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHH
Confidence            89999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCcccc
Q 011698          390 KRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEEC  441 (479)
Q Consensus       390 ~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~  441 (479)
                      +|+++...+++++++||||..++|..+..+...|+..|.+.......||+.|
T Consensus       239 ~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  290 (291)
T cd05612         239 RRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDDY  290 (291)
T ss_pred             HccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCccccccccCC
Confidence            9997766789999999999999999999999999999998888888888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.7e-55  Score=440.25  Aligned_cols=313  Identities=42%  Similarity=0.825  Sum_probs=278.7

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +.||+|+||+||+|+++.+++.||+|++++...........+..|..+++.+ +||||+++++++.+...+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999987655555566677899999887 799999999999999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCCCCcccccCCC
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTL  313 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~~~~~~~~gt~  313 (479)
                      |+|...+.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. .........+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~  160 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP  160 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence            999999998889999999999999999999999999999999999999999999999999999763 2233345568999


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcC
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~  393 (479)
                      .|+|||++.+..++.++|+|||||++|+|++|+.||.+.+...+...+......+|..++.++.+||++||++||.+|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s  240 (318)
T cd05570         161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLG  240 (318)
T ss_pred             cccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCC
Confidence            99999999999999999999999999999999999999998888899998888899999999999999999999999995


Q ss_pred             CCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCCCccCeeee
Q 011698          394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFNENPFKGFTYV  468 (479)
Q Consensus       394 ~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---~~~~~~f~~f~~~  468 (479)
                      .......++++||||+.++|.....+...|++.|.........+|+..+...+...+|....   ..+|+.|+||+|+
T Consensus       241 ~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (318)
T cd05570         241 CLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNIDQEEFRGFSYI  318 (318)
T ss_pred             CCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCchhccCcccCCCCcccccccccccccCCCCCC
Confidence            43334499999999999999999999999999999988888888887776555555554444   3678999999995

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.7e-55  Score=437.71  Aligned_cols=311  Identities=39%  Similarity=0.789  Sum_probs=276.6

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHh-CCCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +.||+|+||+||+|+++.+++.||+|++++.........+....|..++.. .+||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            369999999999999999999999999987654444445556667777765 4899999999999999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC-CCCCcccccCCC
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~~~~~~~~~gt~  313 (479)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~  160 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence            9999999888899999999999999999999999999999999999999999999999999998643 233445678999


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcC
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~  393 (479)
                      .|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+......+|..++.++.+||++||+.||++|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~  240 (316)
T cd05592         161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLG  240 (316)
T ss_pred             cccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            99999999999999999999999999999999999999999999999988888899999999999999999999999993


Q ss_pred             CCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCCCccCeeeecC
Q 011698          394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFNENPFKGFTYVRP  470 (479)
Q Consensus       394 ~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---~~~~~~f~~f~~~~~  470 (479)
                          ...++++||||+.++|..+..+...|++.|.........+|+..++......++....   ..++..|.||+|.+|
T Consensus       241 ----~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (316)
T cd05592         241 ----VDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRLSPVDKKLLASMDQEQFRGFSFTNP  316 (316)
T ss_pred             ----ChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccccccCCCccccccccccccccCCCcccCc
Confidence                3568999999999999999999999999999888888889998888776555554433   467899999999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.1e-54  Score=436.62  Aligned_cols=318  Identities=41%  Similarity=0.806  Sum_probs=277.0

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +|+..+.||+|+||+||+|+++.+++.||+|++.+.........+.+..|..+++.+. |++|+++++++++.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            5889999999999999999999999999999998765544555666778899998885 578889999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC-CCCccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~-~~~~~~  308 (479)
                      ||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ......
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~  160 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT  160 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence            9999999999999888999999999999999999999999999999999999999999999999999976432 233455


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhch
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA  388 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP  388 (479)
                      .+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.+......+|..++.++.+++.+||+++|
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p  240 (323)
T cd05615         161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP  240 (323)
T ss_pred             ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCH
Confidence            77999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCCCccCe
Q 011698          389 SKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFNENPFKGF  465 (479)
Q Consensus       389 ~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---~~~~~~f~~f  465 (479)
                      .+|++......+++++||||+.++|..+..+.+.+++.|..... ...+|+...+......++..+-   ..+...|+||
T Consensus       241 ~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (323)
T cd05615         241 SKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKFFTRGQPVLTPPDQLVIANIDQADFEGF  319 (323)
T ss_pred             hhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCCC-chhhcCccccccCCCCCCCcccccccccccccCCC
Confidence            99998766678999999999999999999999999999976654 3667777665443332221111   2345689999


Q ss_pred             eeec
Q 011698          466 TYVR  469 (479)
Q Consensus       466 ~~~~  469 (479)
                      +|++
T Consensus       320 ~~~~  323 (323)
T cd05615         320 SYVN  323 (323)
T ss_pred             cccC
Confidence            9864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.7e-54  Score=442.62  Aligned_cols=315  Identities=36%  Similarity=0.681  Sum_probs=264.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||+||+|+++.+++.||+|++++...........+++|+.++++++||||+++++.+++...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998866555566677889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-----
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----  304 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-----  304 (479)
                      ||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+....     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            999999999999998999999999999999999999999999999999999999999999999999997643211     


Q ss_pred             -------------------------------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 011698          305 -------------------------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN  353 (479)
Q Consensus       305 -------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~  353 (479)
                                                     .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence                                           1134689999999999999999999999999999999999999999988


Q ss_pred             HHHHHHHHHhc--cCCCCc--cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcccc
Q 011698          354 RQKIQQKIIKD--KIKLPA--FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEV  429 (479)
Q Consensus       354 ~~~~~~~i~~~--~~~~p~--~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~  429 (479)
                      ..+...++...  .+.+|.  .++.++++||.+|+. +|.+|++.  .+++||++||||++++|+.+..+...++.  .+
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r--~~~~ei~~hp~f~~~~~~~~~~~~~~~~~--~~  315 (363)
T cd05628         241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGA--PGVEEIKTNPFFEGVDWEHIRERPAAIPI--EI  315 (363)
T ss_pred             HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCC--CCHHHHhCCCCCCCCCHHHHHhCCCCCCc--cC
Confidence            88888888863  455554  478999999999886 77877642  38999999999999999999877655553  44


Q ss_pred             CCcccccCccccccCCCCC---CC---CCCCCCCCCCCccCeeeec
Q 011698          430 AGKHCVANFEECWTNMPLL---DS---PVASPKFNENPFKGFTYVR  469 (479)
Q Consensus       430 ~~~~~~~~f~~~~~~~~~~---~~---~~~~~~~~~~~f~~f~~~~  469 (479)
                      ....+..+|+...+...+.   .+   |...-......|.||+|..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (363)
T cd05628         316 KSIDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVFINYTYKR  361 (363)
T ss_pred             CCcchhhccCCCCccccccccccccCCcccccCcCCcccCCceeec
Confidence            5556667776644332111   11   1111123357799999984

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-54  Score=437.71  Aligned_cols=314  Identities=38%  Similarity=0.748  Sum_probs=278.0

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg  235 (479)
                      +.||+|+||+||+|+++.+|+.||+|++++...........+.+|+.+++.++||||++++++|.....+|+||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998865545555666788999999999999999999999999999999999999


Q ss_pred             cHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCCCCcccccCCCC
Q 011698          236 HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLE  314 (479)
Q Consensus       236 sL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~~~~~~~~gt~~  314 (479)
                      +|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.. .........+||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~  160 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence            99999998889999999999999999999999999999999999999999999999999998763 22333445789999


Q ss_pred             CcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcCC
Q 011698          315 YMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGS  394 (479)
Q Consensus       315 y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~  394 (479)
                      |+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..+...+|..+++++.+||++||++||.+|++.
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  240 (323)
T cd05595         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG  240 (323)
T ss_pred             cCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCC
Confidence            99999999999999999999999999999999999998988888999888889999999999999999999999999988


Q ss_pred             CCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCC-CC-----C-CCCCCccCeee
Q 011698          395 GPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVA-SP-----K-FNENPFKGFTY  467 (479)
Q Consensus       395 ~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~-~~-----~-~~~~~f~~f~~  467 (479)
                      .+.++.++++|+||.+++|..+..+...|++.|..........|+..++......+|.. ..     . .-...|.+|+|
T Consensus       241 ~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (323)
T cd05595         241 GPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQRTHFPQFSY  320 (323)
T ss_pred             CCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCcccccCCccCCCCcccccccccccccccccCCCcc
Confidence            88899999999999999999999999999999999888888888887776544322211 11     1 11356899998


Q ss_pred             ec
Q 011698          468 VR  469 (479)
Q Consensus       468 ~~  469 (479)
                      ..
T Consensus       321 ~~  322 (323)
T cd05595         321 SA  322 (323)
T ss_pred             cC
Confidence            74

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.1e-54  Score=436.39  Aligned_cols=316  Identities=51%  Similarity=0.914  Sum_probs=278.9

Q ss_pred             EEEeccCCceEEEEEEEc---CCCeEEEEEEeehhhhch-HHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          155 LKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      ++.||+|+||.||+|++.   .+++.||+|++++..... ......+..|+.+|+.++||||++++++|..++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999874   578899999998754322 2334557789999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC-CCCCcccc
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSM  309 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~~~~~~~~  309 (479)
                      |+.||+|...+.+.+.+.+..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... ........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            99999999999998999999999999999999999999999999999999999999999999999997642 33334557


Q ss_pred             cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchh
Q 011698          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEAS  389 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~  389 (479)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..+...+|..++.++.+||++||++||+
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  240 (323)
T cd05584         161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPS  240 (323)
T ss_pred             CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHh
Confidence            89999999999999999999999999999999999999999999888899999999999999999999999999999999


Q ss_pred             hhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC--CCCCCCccCeee
Q 011698          390 KRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP--KFNENPFKGFTY  467 (479)
Q Consensus       390 ~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~--~~~~~~f~~f~~  467 (479)
                      +|++..+.+++++++||||...+|..+......|++.+......+...|+..++.....++|....  ......|.||+|
T Consensus       241 ~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (323)
T cd05584         241 SRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSESANQIFLGFTY  320 (323)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCchhcccccccCccccccccccccCcCCCee
Confidence            999888889999999999999999999999999999998887888888887777665555554433  223588999999


Q ss_pred             ecC
Q 011698          468 VRP  470 (479)
Q Consensus       468 ~~~  470 (479)
                      +.+
T Consensus       321 ~~~  323 (323)
T cd05584         321 VAP  323 (323)
T ss_pred             cCC
Confidence            875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.7e-54  Score=437.00  Aligned_cols=314  Identities=38%  Similarity=0.779  Sum_probs=274.2

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +.||+|+||+||+|+++.+++.||+|++++...........+..|+.++.++ +||||+++++++.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999987555555566788899988876 899999999999999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCCCCcccccCCC
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTL  313 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~~~~~~~~gt~  313 (479)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.. .........+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence            999999988889999999999999999999999999999999999999999999999999999763 2233445678999


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhccCCCCccCCHHHHHHHHhhh
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---------GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLL  384 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L  384 (479)
                      .|+|||++.+..++.++|||||||++|||++|+.||..         .....+.+.+......+|..++..+.+||++||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L  240 (329)
T cd05618         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL  240 (329)
T ss_pred             cccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHh
Confidence            99999999999999999999999999999999999952         123345666777788899999999999999999


Q ss_pred             hhchhhhcCCCC-CCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCC
Q 011698          385 QKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFNEN  460 (479)
Q Consensus       385 ~~dP~~R~~~~~-~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---~~~~~  460 (479)
                      ++||++|+++.+ .+++++++||||++++|..+..++..|++.|...+.....+|++..++.+...+|....   ..++.
T Consensus       241 ~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (329)
T cd05618         241 NKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFDAQFTNEPVQLTPDDDDIVRKIDQS  320 (329)
T ss_pred             cCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCcccchhcCcccccCCccCCCCccccccccccc
Confidence            999999997643 35799999999999999999999999999999988877888887777766655555433   34568


Q ss_pred             CccCeeeec
Q 011698          461 PFKGFTYVR  469 (479)
Q Consensus       461 ~f~~f~~~~  469 (479)
                      .|.||.|++
T Consensus       321 ~~~~~~~~~  329 (329)
T cd05618         321 EFEGFEYIN  329 (329)
T ss_pred             ccCCCcccC
Confidence            899998864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-55  Score=432.24  Aligned_cols=257  Identities=35%  Similarity=0.612  Sum_probs=240.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      ..+|++.+.||+|+||+||+|+++.++..||||.+.+..+ .....+.+..|+.+|+.++|||||++++++.+++.+|+|
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            4789999999999999999999999999999999998775 455678889999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC------CcEEEeecCCccccCC
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD------GHVMLTDFGLAKQFDE  302 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~------g~vkL~DFGla~~~~~  302 (479)
                      ||||+||+|.+++++.+.++|..++.++.||+.||++||+++||||||||.||||+..      -.+||+|||+|+.+..
T Consensus        88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence            9999999999999999999999999999999999999999999999999999999775      4689999999999998


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---CCCccCCHHHHHH
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---KLPAFLSSEAHSL  379 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~l  379 (479)
                      .....+.||+|.|||||++....|+.|+|+||+|+|+|+|++|+.||...+..++...+.++.-   .+|..++....+|
T Consensus       168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~L  247 (429)
T KOG0595|consen  168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLREL  247 (429)
T ss_pred             hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhh
Confidence            8888999999999999999999999999999999999999999999999999999998887743   3556789999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +..+|++++..|.     +..+-..|++...-
T Consensus       248 l~~ll~~~~~~~~-----~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  248 LISLLQRNPKDRI-----SFEDFFDHPFLAAN  274 (429)
T ss_pred             hhHHHhcCccccC-----chHHhhhhhhcccC
Confidence            9999999999998     78888888888764

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.4e-54  Score=433.95  Aligned_cols=320  Identities=47%  Similarity=0.893  Sum_probs=276.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEc---CCCeEEEEEEeehhhhc-hHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIM-EKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~  225 (479)
                      +|++++.||+|+||+||+|++.   .+++.||+|++.+.... .....+.+..|+.+++.+ +||+|+++++++.....+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999874   47899999999875432 223455678899999999 599999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC--
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~--  303 (479)
                      |+||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+...  
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence            999999999999999998888999999999999999999999999999999999999999999999999999865332  


Q ss_pred             CCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhccCCCCccCCHHHHH
Q 011698          304 TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAHS  378 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~  378 (479)
                      ......+||+.|||||++.+. .++.++|||||||++|||++|+.||...    ....+...+......+|..++..+.+
T Consensus       161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (332)
T cd05614         161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD  240 (332)
T ss_pred             CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            233457899999999999875 4789999999999999999999999642    34455666777777888899999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCCCCC
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFN  458 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~  458 (479)
                      ||.+||+.||++|+++.+.+++++++||||++.+|..+..+...+++.|.........+|...+.......+|...+...
T Consensus       241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (332)
T cd05614         241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGTPPSG  320 (332)
T ss_pred             HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCCcccCCCCCCccc
Confidence            99999999999999887779999999999999999999999999999998887777778877666655555665555455


Q ss_pred             CCCccCeeeecC
Q 011698          459 ENPFKGFTYVRP  470 (479)
Q Consensus       459 ~~~f~~f~~~~~  470 (479)
                      ...|+||+|..+
T Consensus       321 ~~~~~~~~~~~~  332 (332)
T cd05614         321 ARVFQGYSFVAP  332 (332)
T ss_pred             ccccCCceecCC
Confidence            688999999854

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-55  Score=450.24  Aligned_cols=319  Identities=39%  Similarity=0.722  Sum_probs=276.2

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +...-|..++.||-|+||+|.+++..+|...||+|.++|..+...+.+..++.|.+||..-+.+.||+||+.|++++++|
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            44456999999999999999999999999999999999998888999999999999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC----
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE----  302 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~----  302 (479)
                      +||+|++||++..+|.+.+.|.|+.+++|++++.+|+++.|+.|+|||||||+|||||.+|||||+|||||.-+..    
T Consensus       706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999975421    


Q ss_pred             -----C----------------------------------CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHH
Q 011698          303 -----N----------------------------------TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML  343 (479)
Q Consensus       303 -----~----------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyell  343 (479)
                           +                                  ......+||+.|+|||++...+|+..+||||.|||||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                 0                                  0112467999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhc--cCCCC--ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcc
Q 011698          344 TGQPPFTGGNRQKIQQKIIKD--KIKLP--AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEAR  419 (479)
Q Consensus       344 tG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~  419 (479)
                      .|++||...+..+...+|.+.  .+.+|  ..+|.++.++|.++.. +++.|+|.  +++++|++||||++|+|..+  |
T Consensus       866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGk--ng~d~vKaHpfFkgIDfssl--R  940 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGK--NGADQVKAHPFFKGIDFSSL--R  940 (1034)
T ss_pred             hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhcc--cchhhhhcCccccccchHhh--h
Confidence            999999999988888888765  33444  5799999999999765 89999975  47889999999999999985  4


Q ss_pred             cCCCCCccccCCcccccCccccccCCCCCCCCCCCCC--CC-----CCCccCeeeecCc
Q 011698          420 ETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPK--FN-----ENPFKGFTYVRPA  471 (479)
Q Consensus       420 ~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~--~~-----~~~f~~f~~~~~~  471 (479)
                      +.+.+|+|.+....+.+|||..-. +.+.+....++.  .+     ...|-+|+|.+..
T Consensus       941 kq~ApYIP~ItHptDTSNFdpvdp-eklwnddses~~~~~~~nkhpehaFyEFTfRrFF  998 (1034)
T KOG0608|consen  941 KQRAPYIPRITHPTDTSNFDPVDP-EKLWNDDSESPNVRDTLNKHPEHAFYEFTFRRFF  998 (1034)
T ss_pred             hccCCcCccccCCCccccCCcCCc-cccccccccCCCcccccccCCccceeEeeeehhc
Confidence            556779999999999999986432 233322222331  11     2568888887743

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.8e-54  Score=433.37  Aligned_cols=311  Identities=36%  Similarity=0.715  Sum_probs=272.0

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHh-CCCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +.||+|+||+||+|+++.+|+.||+|++++.........+....|..++.. ++||||+++++++.+.+.+|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999999999999999999987654333445566778888876 4899999999999999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC-CCCCcccccCCC
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~~~~~~~~~gt~  313 (479)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++... ........+||+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence            9999999888889999999999999999999999999999999999999999999999999987532 223345678999


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcC
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~  393 (479)
                      .|+|||++.+..++.++|||||||++|||++|..||.+.+...+.+.+......+|..++.++++||++||+.||++|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~  240 (316)
T cd05620         161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLG  240 (316)
T ss_pred             CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            99999999999999999999999999999999999999998888998888888889999999999999999999999993


Q ss_pred             CCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCC---CCCCCCCccCeeeecC
Q 011698          394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVAS---PKFNENPFKGFTYVRP  470 (479)
Q Consensus       394 ~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~---~~~~~~~f~~f~~~~~  470 (479)
                          ..+++++||||+.++|..+...+..+++.|......+..+|+..........+....   ...++..|+||+|.+|
T Consensus       241 ----~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (316)
T cd05620         241 ----VVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLSYSDKNLIDSMDQSAFAGFSFINP  316 (316)
T ss_pred             ----ChHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccccccCcccCCCcccccccccccCcCCCcccCC
Confidence                246899999999999999999999999999988888888888766554433333222   1467789999999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.6e-54  Score=432.95  Aligned_cols=310  Identities=37%  Similarity=0.732  Sum_probs=273.1

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHh-CCCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +.||+|+||+||+|+++.+++.||+|++++..............|..+++. ++||||+++++++.+...+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999987654333344556677888876 5899999999999999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC-CCCCcccccCCC
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~~~~~~~~~gt~  313 (479)
                      |+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence            9999999888889999999999999999999999999999999999999999999999999997632 223345678999


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcC
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~  393 (479)
                      .|+|||++.+..++.++|||||||++|||++|..||.+.+..++.+.+......+|..++.++++||.+||++||++|+ 
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-  239 (316)
T cd05619         161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRL-  239 (316)
T ss_pred             cccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcC-
Confidence            9999999999999999999999999999999999999988888888888888888889999999999999999999999 


Q ss_pred             CCCCCH-HHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCC---CCCCCCCCccCeeeec
Q 011698          394 SGPGGS-QEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVA---SPKFNENPFKGFTYVR  469 (479)
Q Consensus       394 ~~~~t~-~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~---~~~~~~~~f~~f~~~~  469 (479)
                          ++ +++++||||+.++|..+..+...|++.|.........+|+..+.+.....+...   ..+.+++.|+||++.+
T Consensus       240 ----~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (316)
T cd05619         240 ----GVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLSVTDRMLINSMDQNMFENFSFIN  315 (316)
T ss_pred             ----CChHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcChhhhcCCcccCCCcccccccccccccCCCcccC
Confidence                56 499999999999999999999999999999888888999988876654433221   1246789999999987


Q ss_pred             C
Q 011698          470 P  470 (479)
Q Consensus       470 ~  470 (479)
                      |
T Consensus       316 ~  316 (316)
T cd05619         316 P  316 (316)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.6e-54  Score=433.17  Aligned_cols=312  Identities=44%  Similarity=0.796  Sum_probs=270.6

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHH-HHHhCCCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN-ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +.||+|+||+||+|+++.+|+.||+|++.+...........+..|.. +++.++||||+++++.+.....+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999999999999998765444444444455554 56789999999999999999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCCCCcccccCCC
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTL  313 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~~~~~~~~gt~  313 (479)
                      |+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.. .........+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP  160 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence            999999998889999999999999999999999999999999999999999999999999999763 2233345678999


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcC
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~  393 (479)
                      .|+|||++.+..++.++|||||||++|||++|..||.+.+..++.+.+......++..++.++.++|++||++||.+|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  240 (323)
T cd05575         161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLG  240 (323)
T ss_pred             hhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCC
Confidence            99999999999999999999999999999999999999998999999998888888889999999999999999999996


Q ss_pred             CCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---------CCCCCCccC
Q 011698          394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---------KFNENPFKG  464 (479)
Q Consensus       394 ~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---------~~~~~~f~~  464 (479)
                      .. ..+.++++||||..++|..+..+...+++.|.+.......+|+..++..+...+...++         ..-.+.|.|
T Consensus       241 ~~-~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (323)
T cd05575         241 AK-DDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEADDAFLG  319 (323)
T ss_pred             CC-CCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcchhhhcCccccccccccccCCCcccccccccccccccccCC
Confidence            64 36789999999999999999999999999999887777778877666554433322221         233588999


Q ss_pred             eeee
Q 011698          465 FTYV  468 (479)
Q Consensus       465 f~~~  468 (479)
                      |+|.
T Consensus       320 ~~~~  323 (323)
T cd05575         320 FSYA  323 (323)
T ss_pred             CccC
Confidence            9984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.9e-54  Score=424.16  Aligned_cols=278  Identities=36%  Similarity=0.658  Sum_probs=248.2

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      .|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++++++|++|+++++++.+.+.+++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            37899999999999999999999999999999987655444445567789999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccc
Q 011698          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (479)
Q Consensus       231 ~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~  308 (479)
                      |+.+|+|...+...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG  160 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence            99999998877653  3589999999999999999999999999999999999999999999999999987655544556


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCCCCccCCHHHHHHHHhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR----QKIQQKIIKDKIKLPAFLSSEAHSLLKGLL  384 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L  384 (479)
                      .+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+.    ..+...+......++..++.++.+||++||
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  240 (285)
T cd05631         161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL  240 (285)
T ss_pred             CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHh
Confidence            7899999999999999999999999999999999999999987543    233444445566778889999999999999


Q ss_pred             hhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccc
Q 011698          385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE  428 (479)
Q Consensus       385 ~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~  428 (479)
                      +.||.+|+++...+++++++||||.+++|+.++++..+|||+|.
T Consensus       241 ~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05631         241 TKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD  284 (285)
T ss_pred             hcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence            99999999877678999999999999999999999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.7e-54  Score=432.52  Aligned_cols=314  Identities=42%  Similarity=0.746  Sum_probs=271.9

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHH-HHHhCCCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN-ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +.||+|+||+||+|+++.+|+.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999998765444334444555554 56779999999999999999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCCCCcccccCCC
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTL  313 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~~~~~~~~gt~  313 (479)
                      |+|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.. .........+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP  160 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence            999999998889999999999999999999999999999999999999999999999999999763 2233445678999


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcC
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~  393 (479)
                      .|||||++.+..++.++|||||||++|||++|..||.+.+..++.+.+......++...+..+.++|++||++||.+|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~  240 (325)
T cd05604         161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLG  240 (325)
T ss_pred             hhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCC
Confidence            99999999999999999999999999999999999999998899999998888888889999999999999999999997


Q ss_pred             CCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---------CCCCCCccC
Q 011698          394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---------KFNENPFKG  464 (479)
Q Consensus       394 ~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---------~~~~~~f~~  464 (479)
                      .+ .++.++++||||+.++|..+..+...+++.|.........+|+..++......+...++         ..-.++|.|
T Consensus       241 ~~-~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (325)
T cd05604         241 AK-EDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDAFVG  319 (325)
T ss_pred             CC-CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCCccccCCcccCcccccccccccccccccccccCC
Confidence            64 36789999999999999999999999999998887777888887666554433332111         223578999


Q ss_pred             eeeecC
Q 011698          465 FTYVRP  470 (479)
Q Consensus       465 f~~~~~  470 (479)
                      |+|..|
T Consensus       320 ~~~~~~  325 (325)
T cd05604         320 FSYAPP  325 (325)
T ss_pred             CEecCC
Confidence            999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.3e-53  Score=438.71  Aligned_cols=313  Identities=39%  Similarity=0.701  Sum_probs=263.1

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      .|++++.||+|+||+||+|+++.+++.||+|++.+...........+++|+.++++++||||+++++++.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            68999999999999999999999999999999988766666667788999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-------
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-------  303 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-------  303 (479)
                      |++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+...       
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~  161 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ  161 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence            9999999999998889999999999999999999999999999999999999999999999999998643110       


Q ss_pred             -----------------------------------------CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHH
Q 011698          304 -----------------------------------------TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEM  342 (479)
Q Consensus       304 -----------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyel  342 (479)
                                                               ....+.+||+.|+|||++.+..++.++|||||||++|||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el  241 (381)
T cd05626         162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM  241 (381)
T ss_pred             ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence                                                     011346899999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHhc--cCCCCc--cCCHHHHHHHHhhhhh--chhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          343 LTGQPPFTGGNRQKIQQKIIKD--KIKLPA--FLSSEAHSLLKGLLQK--EASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       343 ltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~lI~~~L~~--dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                      ++|..||...+......++...  .+.+|.  .+++++.+||.+||..  ++.+|+     +++++++||||..++|...
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~-----~~~~~l~hp~f~~~~~~~~  316 (381)
T cd05626         242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN-----GADDIKAHPFFSEVDFSSD  316 (381)
T ss_pred             HhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCC-----CHHHHhcCcccCCCChhHH
Confidence            9999999988877777766642  344554  5899999999997654  444477     8999999999999999886


Q ss_pred             hcccCCCCCccccCCcccccCccccccCCCCC----CCCC-----CCC--CCCCCCccCeeeec
Q 011698          417 EARETRPSFLPEVAGKHCVANFEECWTNMPLL----DSPV-----ASP--KFNENPFKGFTYVR  469 (479)
Q Consensus       417 ~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~----~~~~-----~~~--~~~~~~f~~f~~~~  469 (479)
                      . +...+++.|.+....+..+|+......+..    ++..     .++  ....+.|.||+|.+
T Consensus       317 ~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (381)
T cd05626         317 I-RTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFRR  379 (381)
T ss_pred             h-hcCCCCccCcCCCcchhhhcCCCCcccccccCCccchhhhccccCcccccccccccccEeec
Confidence            5 355678999988888888887654433321    1111     111  12358899999985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-53  Score=435.45  Aligned_cols=316  Identities=40%  Similarity=0.738  Sum_probs=266.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||+||+|+++.+++.||||++.+...........+++|+.+|+.++||||++++++|++...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998765555556677889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-----
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----  304 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-----  304 (479)
                      ||+.||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+....     
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999987643211     


Q ss_pred             ----------------------------------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCC
Q 011698          305 ----------------------------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFT  350 (479)
Q Consensus       305 ----------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~  350 (479)
                                                        ...+.+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~  240 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence                                              1123579999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHhcc--CCCCc--cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCc
Q 011698          351 GGNRQKIQQKIIKDK--IKLPA--FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFL  426 (479)
Q Consensus       351 ~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~  426 (479)
                      +.+..+....+....  +.+|.  .+++++++||++||. +|.+|++.  .+++++++||||++++|..+.  ...+++.
T Consensus       241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~--~~~~~ll~h~~~~~~~~~~~~--~~~~~~~  315 (364)
T cd05599         241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN--NGVNEIKSHPFFKGVDWEHIR--ERPAPII  315 (364)
T ss_pred             CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC--CCHHHHhcCCCcCCCCHHHHh--hcCCCCC
Confidence            988888887777643  33443  478999999999997 99999943  269999999999999999875  3457788


Q ss_pred             cccCCcccccCccccccCCCCCCCC----CCCCCCCCCCccCeeeecC
Q 011698          427 PEVAGKHCVANFEECWTNMPLLDSP----VASPKFNENPFKGFTYVRP  470 (479)
Q Consensus       427 p~~~~~~~~~~f~~~~~~~~~~~~~----~~~~~~~~~~f~~f~~~~~  470 (479)
                      |......+..+|+..-+.......+    .......+..|.||+|.+.
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (364)
T cd05599         316 PELKSITDTSNFDDFEEIDLDVPTSPGPPRGKIKSKDLAFIGYTYKRF  363 (364)
T ss_pred             CCCCCchhhhhccccccccccccCCCccccccccccCCCCCCCeeeCC
Confidence            8877777777776533222221111    1111345688999999864

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.9e-53  Score=429.71  Aligned_cols=290  Identities=41%  Similarity=0.779  Sum_probs=264.3

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg  235 (479)
                      +.||+|+||+||+|+++.+++.||+|++.+...........+..|+.+++.++||||+++++++.....+|+||||++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998866555555666778999999999999999999999999999999999999


Q ss_pred             cHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEeCCCCcEEEeecCCccccC-CCCCcccccCCC
Q 011698          236 HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (479)
Q Consensus       236 sL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~~~~~~~~~gt~  313 (479)
                      +|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++... ........+||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            999999888899999999999999999999997 799999999999999999999999999997632 233344568999


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcC
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~  393 (479)
                      .|||||++.+..++.++|||||||++|||++|..||.+.+...+...+......+|..+++++.+||++||++||++|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  240 (325)
T cd05594         161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLG  240 (325)
T ss_pred             ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCC
Confidence            99999999999999999999999999999999999999888888999988899999999999999999999999999998


Q ss_pred             CCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCC
Q 011698          394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNM  445 (479)
Q Consensus       394 ~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~  445 (479)
                      ..+.+++++++||||.++.|.....+...|++.|..........|++.++..
T Consensus       241 ~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (325)
T cd05594         241 GGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQ  292 (325)
T ss_pred             CCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCchhhcC
Confidence            8778999999999999999999998989999999888777777787766554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.2e-53  Score=435.27  Aligned_cols=315  Identities=37%  Similarity=0.701  Sum_probs=264.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||+||+|+++.+++.||+|++++...........++.|+.++..++||+|+++++.+++...+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998766555566777889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-----
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----  304 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-----  304 (479)
                      ||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+....     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999987543211     


Q ss_pred             -------------------------------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 011698          305 -------------------------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN  353 (479)
Q Consensus       305 -------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~  353 (479)
                                                     ...+.+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence                                           1224689999999999999999999999999999999999999999988


Q ss_pred             HHHHHHHHHhc--cCCCCc--cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcccc
Q 011698          354 RQKIQQKIIKD--KIKLPA--FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEV  429 (479)
Q Consensus       354 ~~~~~~~i~~~--~~~~p~--~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~  429 (479)
                      ......++...  .+.+|.  .++.++++||.+|+. ||.+|++.  .+++++++||||++++|..+..+...+|+  .+
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~--~~~~ei~~hp~f~~~~~~~~~~~~~~~~~--~~  315 (360)
T cd05627         241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGS--NGVEEIKSHPFFEGVDWGHIRERPAAIPI--EI  315 (360)
T ss_pred             HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCC--CCHHHHhcCCCCCCCCHHHHhcCCCCCCc--cC
Confidence            88888888763  344554  378999999999874 99999964  37899999999999999999877665553  44


Q ss_pred             CCcccccCccccccCCCCCCCCCC-CC--CCCCCCccCeeeec
Q 011698          430 AGKHCVANFEECWTNMPLLDSPVA-SP--KFNENPFKGFTYVR  469 (479)
Q Consensus       430 ~~~~~~~~f~~~~~~~~~~~~~~~-~~--~~~~~~f~~f~~~~  469 (479)
                      ....+..+|+......-....... .+  +...+.|.+|+|.+
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  358 (360)
T cd05627         316 KSIDDTSNFDEFPESDILQPAENTIEPDYKSKDWVFLNYTYKR  358 (360)
T ss_pred             CCcchhhhcCCCCcccccCCCccccccccCcCCcccCCceeec
Confidence            556667777653332211111111 11  34568899999974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-54  Score=439.15  Aligned_cols=260  Identities=38%  Similarity=0.697  Sum_probs=243.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH--HHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK--NHAEYMKSERNILTKVD-HPFIVQLRYSFQTKY  223 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~  223 (479)
                      .....|++.+.||+|+||+|++|++..+++.||+|++.+......  ...+.+.+|+.+++.++ ||||++++.++.+..
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            445789999999999999999999999999999998877533211  34566779999999999 999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC-CcEEEeecCCcccc-C
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQF-D  301 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~-g~vkL~DFGla~~~-~  301 (479)
                      .+|+||||+.||+|++++.+.+.+.|..++.++.||+.|++|||++||+||||||||||++.+ +++||+|||++... .
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999 99999999999988 5


Q ss_pred             CCCCcccccCCCCCcchhHhcCCC-CC-ccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccC-CHHHHH
Q 011698          302 ENTRSNSMCGTLEYMSPEIVLGKG-HD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFL-SSEAHS  378 (479)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~-~~-~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~~~~  378 (479)
                      ......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.+...+..+|..+.+.+|..+ |.++++
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~  253 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARS  253 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHH
Confidence            677888999999999999999988 85 899999999999999999999999999999999999999999999 999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ||++||..||.+|+     ++.+|+.||||+..
T Consensus       254 Li~~mL~~~P~~R~-----t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  254 LIEKMLVPDPSTRI-----TLLEILEHPWFQKE  281 (370)
T ss_pred             HHHHHcCCCcccCC-----CHHHHhhChhhccC
Confidence            99999999999999     99999999999973

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-53  Score=433.60  Aligned_cols=311  Identities=44%  Similarity=0.796  Sum_probs=271.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||+||+|++..+++.||+|++++...........+..|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999998876555556677889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-----
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----  304 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-----  304 (479)
                      ||+.|++|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......     
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999998764433     


Q ss_pred             -------------------------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHH
Q 011698          305 -------------------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ  359 (479)
Q Consensus       305 -------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~  359 (479)
                                               ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~  240 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN  240 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence                                     2345679999999999999999999999999999999999999999988888888


Q ss_pred             HHHh--ccCCCCcc--CCHHHHHHHHhhhhhchhhhcCCCCCC-HHHHHhCccccCCChhhhhcccCCCCCccccCCccc
Q 011698          360 KIIK--DKIKLPAF--LSSEAHSLLKGLLQKEASKRLGSGPGG-SQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHC  434 (479)
Q Consensus       360 ~i~~--~~~~~p~~--~s~~~~~lI~~~L~~dP~~R~~~~~~t-~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~  434 (479)
                      ++..  ....+|..  +++++.+||.+||. ||.+|+     + ++++++||||++++|....  ...|++.|.+.....
T Consensus       241 ~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~-----~s~~~ll~hp~~~~~~~~~~~--~~~~~~~~~~~~~~~  312 (350)
T cd05573         241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRL-----GSFEEIKSHPFFKGIDWENLR--ETKPPFVPELSSPLD  312 (350)
T ss_pred             HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcC-----CCHHHHhcCCCcCCCCHHHHh--hCCCCcCCCCCCchh
Confidence            8887  45555544  59999999999997 999999     5 9999999999999999876  666889998888777


Q ss_pred             ccCccccccCCCCCCCCCC----CCCCCCCCccCeeee
Q 011698          435 VANFEECWTNMPLLDSPVA----SPKFNENPFKGFTYV  468 (479)
Q Consensus       435 ~~~f~~~~~~~~~~~~~~~----~~~~~~~~f~~f~~~  468 (479)
                      ..+|+..-.+.+..+.+..    ..+..+..|.||+|.
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (350)
T cd05573         313 TSNFDDFEDDKDLSDYLSQNSKKLNKGKQLAFVGFTYK  350 (350)
T ss_pred             hhhcCCCCcccccccccccccccccccccCccCCCccC
Confidence            7788775554444332111    223567899999983

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-53  Score=434.78  Aligned_cols=316  Identities=40%  Similarity=0.740  Sum_probs=263.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||+||+|+++.+++.||||++.+.........+.+++|+.++++++||||++++++|++...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999998765555556677889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-----
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----  304 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-----  304 (479)
                      ||++||+|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.+....     
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999996431100     


Q ss_pred             -------------------------------------------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHH
Q 011698          305 -------------------------------------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFE  341 (479)
Q Consensus       305 -------------------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilye  341 (479)
                                                                 .....+||+.|+|||++.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE  240 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence                                                       0013579999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHhc--cCCCCc--cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhh
Q 011698          342 MLTGQPPFTGGNRQKIQQKIIKD--KIKLPA--FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLE  417 (479)
Q Consensus       342 lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~  417 (479)
                      |++|..||.+.+..+....+...  .+.+|.  .++.++++||.+||+ +|.+|++.  .++.++++||||++++|..+ 
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r--~~~~~~l~hp~~~~~~~~~~-  316 (377)
T cd05629         241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGR--GGAHEIKSHPFFRGVDWDTI-  316 (377)
T ss_pred             hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCC--CCHHHHhcCCCcCCCCHHHH-
Confidence            99999999988887777777753  455554  478999999999997 89998743  38999999999999999988 


Q ss_pred             cccCCCCCccccCCcccccCccccccCC----CCC--CCCC--CCCCCCCCCccCeeeecC
Q 011698          418 ARETRPSFLPEVAGKHCVANFEECWTNM----PLL--DSPV--ASPKFNENPFKGFTYVRP  470 (479)
Q Consensus       418 ~~~~~p~~~p~~~~~~~~~~f~~~~~~~----~~~--~~~~--~~~~~~~~~f~~f~~~~~  470 (479)
                       +.+.+++.|......+...|.......    +..  ..+.  ..+...+-.|.||+|.+.
T Consensus       317 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (377)
T cd05629         317 -RQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGYTYKRF  376 (377)
T ss_pred             -ccCCCCcccCCCCccccccCCccccccCccccccccccccccccccccCcccccceecCC
Confidence             466788988877666555554332211    110  0111  111244678999999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7e-53  Score=425.51  Aligned_cols=314  Identities=43%  Similarity=0.782  Sum_probs=270.3

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHH-HHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER-NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~-~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +.||+|+||+||+|+++.+++.||+|++.+...........+..|. .+++.++||||+++++++...+.+|+||||+.|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999876543333333344444 457889999999999999999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC-CCCCcccccCCC
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTL  313 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~~~~~~~~~gt~  313 (479)
                      |+|...+...+.+.+..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... ........+||+
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  160 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP  160 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence            9999999988889999999999999999999999999999999999999999999999999997642 333445678999


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcC
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~  393 (479)
                      .|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+......++..++..+.++|.+||++||.+|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  240 (325)
T cd05602         161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLG  240 (325)
T ss_pred             cccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCC
Confidence            99999999999999999999999999999999999999998888899988888888889999999999999999999996


Q ss_pred             CCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---------CCCCCCccC
Q 011698          394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---------KFNENPFKG  464 (479)
Q Consensus       394 ~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---------~~~~~~f~~  464 (479)
                      .. ....++++|+||..++|..+..+...|++.|..........|+..++..+...+....+         ......|.|
T Consensus       241 ~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  319 (325)
T cd05602         241 AK-DDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSIGQSPDSILVTASVKEAAEAFLG  319 (325)
T ss_pred             CC-CCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcchhhhcCCccccCCcccccCCCchhhhhcccccccccccCC
Confidence            53 35779999999999999999999999999998888888888877666655544433222         123466999


Q ss_pred             eeeecC
Q 011698          465 FTYVRP  470 (479)
Q Consensus       465 f~~~~~  470 (479)
                      |+|..|
T Consensus       320 ~~~~~~  325 (325)
T cd05602         320 FSYAPP  325 (325)
T ss_pred             CccCCC
Confidence            998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-52  Score=433.24  Aligned_cols=287  Identities=41%  Similarity=0.770  Sum_probs=251.8

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++++++||||+++++.|++...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            69999999999999999999999999999999988665555667788999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC--------
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE--------  302 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~--------  302 (479)
                      |++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..+..        
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~  161 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  161 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999753210        


Q ss_pred             ----------------------------------------CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHH
Q 011698          303 ----------------------------------------NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEM  342 (479)
Q Consensus       303 ----------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyel  342 (479)
                                                              .....+.+||+.|+|||++.+..++.++|||||||++|||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el  241 (382)
T cd05625         162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  241 (382)
T ss_pred             cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence                                                    0011345799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHhc--cCCCC--ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhc
Q 011698          343 LTGQPPFTGGNRQKIQQKIIKD--KIKLP--AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEA  418 (479)
Q Consensus       343 ltG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~  418 (479)
                      ++|+.||.+.+..+....+...  ...+|  ..+++++.++|.+|+ .+|.+|++.  .+++++++||||+.++|.... 
T Consensus       242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~--~~~~ei~~hp~f~~~~~~~~~-  317 (382)
T cd05625         242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK--NGADEIKAHPFFKTIDFSSDL-  317 (382)
T ss_pred             HhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC--CCHHHHhcCCCcCCcChHHHH-
Confidence            9999999988887777777653  33344  458999999999986 599999952  369999999999999998764 


Q ss_pred             ccCCCCCccccCCcccccCcccc
Q 011698          419 RETRPSFLPEVAGKHCVANFEEC  441 (479)
Q Consensus       419 ~~~~p~~~p~~~~~~~~~~f~~~  441 (479)
                      .+..+++.|.+....+..+|+..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~  340 (382)
T cd05625         318 RQQSAPYIPKITHPTDTSNFDPV  340 (382)
T ss_pred             hcCCCCccCcCCCcchhhhcCCC
Confidence            45678899998888888887653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.3e-53  Score=425.63  Aligned_cols=313  Identities=47%  Similarity=0.867  Sum_probs=267.7

Q ss_pred             EEEeccCCceEEEEEEE---cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEe
Q 011698          155 LKVVGQGAFAKVYQVRR---IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~  231 (479)
                      ++.||+|+||+||++++   +.+|+.||+|++.+..... .....+..|+.+|++++||||+++++++.+...+|+||||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            36799999999999986   3578999999998755322 2334567899999999999999999999999999999999


Q ss_pred             ccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCccccc
Q 011698          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMC  310 (479)
Q Consensus       232 ~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~~~~  310 (479)
                      +.||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ......+
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  159 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC  159 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence            999999999988888999999999999999999999999999999999999999999999999999875433 3445678


Q ss_pred             CCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhh
Q 011698          311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASK  390 (479)
Q Consensus       311 gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~  390 (479)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+......+|..++.++.+||++||++||++
T Consensus       160 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~  239 (318)
T cd05582         160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPAN  239 (318)
T ss_pred             CChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhH
Confidence            99999999999999999999999999999999999999999998888999998888999999999999999999999999


Q ss_pred             hcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC-CCCCCCccCeeee
Q 011698          391 RLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP-KFNENPFKGFTYV  468 (479)
Q Consensus       391 R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~-~~~~~~f~~f~~~  468 (479)
                      |+++....++++++||||..++|..+..++..|++.|..........++..+........+...+ ......|.||+|+
T Consensus       240 R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~  318 (318)
T cd05582         240 RLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDSPGIPPSANAHQLFRGFSFV  318 (318)
T ss_pred             cCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCCCCcchhhhcCcccccCccccCCCCccccccccccCCCEeC
Confidence            99765555899999999999999999999999999887765555555554443322222222222 2235779999985

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.6e-52  Score=431.11  Aligned_cols=319  Identities=36%  Similarity=0.682  Sum_probs=265.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+|
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999999999999999998755444455666889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC--
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~--  304 (479)
                      +||||++||+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+....  
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            999999999999988654 58999999999999999999999999999999999999999999999999998764332  


Q ss_pred             CcccccCCCCCcchhHhcCCC----CCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCc--cCCHHH
Q 011698          305 RSNSMCGTLEYMSPEIVLGKG----HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPA--FLSSEA  376 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~----~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~  376 (479)
                      ...+.+||+.|||||++.+..    ++.++|||||||++|||++|+.||.+.+......+|...  .+.+|.  .++..+
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  278 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA  278 (370)
T ss_pred             ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHH
Confidence            234678999999999997643    788999999999999999999999998888888888764  355565  469999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCC-CCCCC
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDS-PVASP  455 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~-~~~~~  455 (479)
                      +++|..||+. +.+|++.  .+++|+++||||+...|.....+...+++.|.+....+..+|+..-.......+ +...+
T Consensus       279 ~~li~~~L~~-~~~r~~R--~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (370)
T cd05621         279 KNLICAFLTD-REVRLGR--NGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKA  355 (370)
T ss_pred             HHHHHHHccC-chhccCC--CCHHHHhcCcccCCCCcChHhcCCCCCCcCCCCCCcchhhhcCCccccccccccCCCCcc
Confidence            9999999984 4444321  289999999999998887777777888999998888778888754333222211 22111


Q ss_pred             -CCCCCCccCeeeec
Q 011698          456 -KFNENPFKGFTYVR  469 (479)
Q Consensus       456 -~~~~~~f~~f~~~~  469 (479)
                       -..+..|.||+|++
T Consensus       356 ~~~~~~~~~~~~~~~  370 (370)
T cd05621         356 FVGNQLPFIGFTYYR  370 (370)
T ss_pred             ccccccccCCCEecC
Confidence             13468899999975

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.9e-52  Score=430.48  Aligned_cols=315  Identities=36%  Similarity=0.663  Sum_probs=268.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            45679999999999999999999999999999999998765544455566788999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC--
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~--  304 (479)
                      +||||++||+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......  
T Consensus       120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence            99999999999988865 468999999999999999999999999999999999999999999999999998764332  


Q ss_pred             CcccccCCCCCcchhHhcCC----CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCc--cCCHHH
Q 011698          305 RSNSMCGTLEYMSPEIVLGK----GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPA--FLSSEA  376 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~----~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~  376 (479)
                      .....+||+.|||||++.+.    .++.++|||||||++|||++|+.||.+.+......+|...  .+.+|.  .+|.++
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA  278 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence            23457899999999999764    3789999999999999999999999998888888888764  355565  579999


Q ss_pred             HHHHHhhhhhchhh--hcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCC
Q 011698          377 HSLLKGLLQKEASK--RLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVAS  454 (479)
Q Consensus       377 ~~lI~~~L~~dP~~--R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~  454 (479)
                      ++||++||+.+|.+  |+     +++++++||||++.+|.....+...+++.|.........+|++......... ....
T Consensus       279 ~~li~~~L~~~p~r~~R~-----s~~ell~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~  352 (370)
T cd05596         279 KDLICAFLTDREVRLGRN-----GVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDIEDDDKNEE-TFPL  352 (370)
T ss_pred             HHHHHHHccChhhccCCC-----CHHHHhcCcccCCCChhhHHhcCCCcCccCcCCCcchhhhcCCccccccccc-cCCC
Confidence            99999999998877  77     8999999999999999988888888999999888877888876554331111 1112


Q ss_pred             C---CCCCCCccCeeee
Q 011698          455 P---KFNENPFKGFTYV  468 (479)
Q Consensus       455 ~---~~~~~~f~~f~~~  468 (479)
                      |   ..++..|.||+|.
T Consensus       353 ~~~~~~~~~~~~~~~~~  369 (370)
T cd05596         353 PKAFAGNQLPFIGFTYS  369 (370)
T ss_pred             ccccccccCccCCCeec
Confidence            2   2234569999996

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.5e-52  Score=422.14  Aligned_cols=312  Identities=42%  Similarity=0.760  Sum_probs=268.0

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHH-HHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER-NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~-~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +.||+|+||+||+|+++.+++.||+|++.+...........+..|. .+++.++||||+++++.+.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3699999999999999999999999999876544444444455555 467889999999999999999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCCCCcccccCCC
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTL  313 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~~~~~~~~gt~  313 (479)
                      |+|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.. .........+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP  160 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence            999999988888999999999999999999999999999999999999999999999999999763 2233345678999


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcC
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~  393 (479)
                      .|+|||++.+..++.++|||||||++|||++|..||.+.+...+...+......+|...+.++.++|.+||++||.+|++
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  240 (321)
T cd05603         161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLG  240 (321)
T ss_pred             ccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCC
Confidence            99999999999999999999999999999999999999998889999998888899999999999999999999999996


Q ss_pred             CCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC------CCCCCCccCeee
Q 011698          394 SGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP------KFNENPFKGFTY  467 (479)
Q Consensus       394 ~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~------~~~~~~f~~f~~  467 (479)
                      ... ++.++++|+||..++|..+..+...|++.|..........++..++......+...++      ......|.||+|
T Consensus       241 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (321)
T cd05603         241 AKA-DFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSASSAFLGFSY  319 (321)
T ss_pred             CCC-CHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCCcccccccccccCCCCcccccccccccccCCCcc
Confidence            542 5789999999999999999988889999988887777777776665444433333222      122356999987


Q ss_pred             e
Q 011698          468 V  468 (479)
Q Consensus       468 ~  468 (479)
                      .
T Consensus       320 ~  320 (321)
T cd05603         320 A  320 (321)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.7e-54  Score=442.68  Aligned_cols=261  Identities=32%  Similarity=0.552  Sum_probs=247.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      ..-|++.+.||.|+-|.|-+|++..||+.+|||++.+...........+.+|+-||+.+.||||+++|+.+++..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            45699999999999999999999999999999999987544555566688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~  308 (479)
                      .||++||.|++++.++|.++|..+..++.||+.|+.|+|..+|+||||||||+|+|..+++||+|||+|..-.++....+
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998777778889


Q ss_pred             ccCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhc
Q 011698          309 MCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      -||+|.|.|||++.|..| +.++||||.|||||.||||+.||++.+...++.++.++.+.+|..++.++++||++||..|
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VD  250 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVD  250 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccC
Confidence            999999999999999998 6899999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          388 ASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                      |++|+     |.+||++|||+.+..-.
T Consensus       251 p~~Ri-----T~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  251 PSTRI-----TTEEILKHPFLSGYTSL  272 (786)
T ss_pred             ccccc-----cHHHHhhCchhhcCCCC
Confidence            99999     99999999999987543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.5e-54  Score=436.51  Aligned_cols=256  Identities=36%  Similarity=0.627  Sum_probs=241.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|.+.+.||+|+||+||+|+.+.|.+.||||.+.|.... +.....+++|++|++.++|||||.++++|++..++|+|
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            36899999999999999999999999999999999886643 34567789999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC-cc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SN  307 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~-~~  307 (479)
                      .||+.| +|+.++...+.++|+.++.++.+++.||.|||+++|+|||+||.|||++..|++|+||||+|+.+..++. ..
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence            999988 9999999999999999999999999999999999999999999999999999999999999999876544 45


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhc
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      +..|||.|||||++.+..|+..+|+||||||+|||++|++||...+...+.+.|..+...+|...|..+.+||+++|++|
T Consensus       159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kd  238 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKD  238 (808)
T ss_pred             eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcC
Confidence            67899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHhCccccCC
Q 011698          388 ASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      |.+|+     +..+++.|||.++-
T Consensus       239 P~~Rl-----tW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  239 PAQRL-----TWTDLLGHPFWKGK  257 (808)
T ss_pred             hhhcc-----cHHHHhcChHHhhh
Confidence            99999     89999999999873

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-52  Score=424.63  Aligned_cols=285  Identities=45%  Similarity=0.819  Sum_probs=252.2

Q ss_pred             eccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC---CCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       158 LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      ||+|+||+||+|+++.+++.||+|++.+..............|..++..+   +||||++++..+.+...+|+||||+.|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999999876554444444555677777665   699999999999999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCCCCcccccCCC
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTL  313 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~~~~~~~~gt~  313 (479)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.. .........+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  160 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT  160 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence            999999998899999999999999999999999999999999999999999999999999999764 2333445678999


Q ss_pred             CCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc-cCCHHHHHHHHhhhhhchhhh
Q 011698          314 EYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA-FLSSEAHSLLKGLLQKEASKR  391 (479)
Q Consensus       314 ~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~~lI~~~L~~dP~~R  391 (479)
                      .|||||++.+. .++.++|||||||++|||++|+.||.+.+..++.+.+..+...+|. .++.++++||++||+.||.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R  240 (330)
T cd05586         161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR  240 (330)
T ss_pred             cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence            99999999764 5899999999999999999999999999988888899888777775 479999999999999999999


Q ss_pred             cCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCcccccc
Q 011698          392 LGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWT  443 (479)
Q Consensus       392 ~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~  443 (479)
                      +++. .+++++++||||+.++|..+..+.+.|++.|.........+|+..++
T Consensus       241 ~~~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (330)
T cd05586         241 LGAH-RDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFT  291 (330)
T ss_pred             CCCC-CCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcchhhcCcccc
Confidence            9764 38999999999999999999999999999998877777777765544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.3e-51  Score=424.51  Aligned_cols=288  Identities=42%  Similarity=0.782  Sum_probs=250.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      .+|++++.||+|+||+||+|+++.+++.||+|++.+...........+++|+.+|++++||||+++++.|++++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            37999999999999999999999999999999998765545555677889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC------
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------  303 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~------  303 (479)
                      ||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|..+...      
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            99999999999999889999999999999999999999999999999999999999999999999998532100      


Q ss_pred             --------------------------------------CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhC
Q 011698          304 --------------------------------------TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTG  345 (479)
Q Consensus       304 --------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG  345 (479)
                                                            ......+||+.|||||++.+..++.++|||||||++|||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G  240 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG  240 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence                                                  011245899999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhc--cCCCC--ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccC
Q 011698          346 QPPFTGGNRQKIQQKIIKD--KIKLP--AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARET  421 (479)
Q Consensus       346 ~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~  421 (479)
                      +.||.+.+..+....+...  ...+|  ..++.++.++|.+|+ .+|.+|++.  .++.++++||||++++|..+. +..
T Consensus       241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~--~t~~ell~h~~~~~~~~~~~~-~~~  316 (376)
T cd05598         241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK--NGADEIKAHPFFKGIDFASLI-RRQ  316 (376)
T ss_pred             CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC--CCHHHHhCCCCcCCCCHHHHh-hcC
Confidence            9999998887777766653  22333  358999999999976 599999953  379999999999999999987 555


Q ss_pred             CCCCccccCCcccccCcccc
Q 011698          422 RPSFLPEVAGKHCVANFEEC  441 (479)
Q Consensus       422 ~p~~~p~~~~~~~~~~f~~~  441 (479)
                      .+++.|.+....+.++|+..
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~  336 (376)
T cd05598         317 KAPYIPKITHPTDTSNFDPV  336 (376)
T ss_pred             CCCCCCcCCCcchhhhcCCC
Confidence            67788888777766666543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.6e-51  Score=422.15  Aligned_cols=320  Identities=36%  Similarity=0.675  Sum_probs=266.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            35568999999999999999999999999999999999875544445566678899999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-  304 (479)
                      |+||||++||+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+.... 
T Consensus       119 ~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence            9999999999999888654 58999999999999999999999999999999999999999999999999998764332 


Q ss_pred             -CcccccCCCCCcchhHhcCCC----CCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CCCCc--cCCHH
Q 011698          305 -RSNSMCGTLEYMSPEIVLGKG----HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--IKLPA--FLSSE  375 (479)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~~----~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~  375 (479)
                       .....+||+.|||||++.+..    ++.++|||||||++|||++|..||.+.+......+|....  +.+|.  .++..
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  277 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence             234678999999999997643    7899999999999999999999999998888888887643  44553  58999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCC-CCCC
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDS-PVAS  454 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~-~~~~  454 (479)
                      +++||..||. +|.+|++.  .++++|++|+||++..|.....+...+++.|.........+|++.-.+...... +...
T Consensus       278 ~~~li~~~L~-~~~~r~~r--~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (371)
T cd05622         278 AKNLICAFLT-DREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDIEEDKGEEETFPIPK  354 (371)
T ss_pred             HHHHHHHHcC-ChhhhcCC--CCHHHHhcCcccCCCChhHHhcCCCCCCCCCCCCCcchhhhcCCCcccccccccCCCCc
Confidence            9999999998 67776642  389999999999998887777788888999988777766677654333221111 1111


Q ss_pred             C-CCCCCCccCeeeec
Q 011698          455 P-KFNENPFKGFTYVR  469 (479)
Q Consensus       455 ~-~~~~~~f~~f~~~~  469 (479)
                      . ...+..|.||+|..
T Consensus       355 ~~~~~~~~~~~~~~~~  370 (371)
T cd05622         355 AFVGNQLPFVGFTYYS  370 (371)
T ss_pred             cccccccccCCCeecC
Confidence            1 12347899999974

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-53  Score=392.67  Aligned_cols=260  Identities=34%  Similarity=0.645  Sum_probs=248.6

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      ....+++|++.+.||+|-||.||+|+.+.++-+||+|++.++.+.......++++|++|-..|+||||+++|++|.+...
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r   96 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR   96 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence            34678999999999999999999999999999999999999998888888889999999999999999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHH--HcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          225 LYLVLDFVNGGHLFFQLY--RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~--~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      .|+++||..+|+|+..|.  +.+.++|..++.|+.|++.||.|+|.++||||||||+|+|++.+|.+||+|||-+..-. 
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999999999  66789999999999999999999999999999999999999999999999999997654 


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHh
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG  382 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~  382 (479)
                      ..+..+.|||..|.+||...+..++..+|+|++|++.||++.|.+||...+..+++++|.+-++.+|..++.+++|||.+
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~  255 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISR  255 (281)
T ss_pred             CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHH
Confidence            56678899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      ||.++|.+|+     ...|++.|||+..
T Consensus       256 ll~~~p~~r~-----~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  256 LLVKNPIERL-----ALTEVMDHPWIVA  278 (281)
T ss_pred             HhccCccccc-----cHHHHhhhHHHHh
Confidence            9999999999     8999999999865

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-51  Score=416.23  Aligned_cols=311  Identities=36%  Similarity=0.695  Sum_probs=264.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++++...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999999876545556677889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC--c
Q 011698          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--S  306 (479)
Q Consensus       230 E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~--~  306 (479)
                      ||++||+|..++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.....  .
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            999999999999876 6799999999999999999999999999999999999999999999999999987644332  2


Q ss_pred             ccccCCCCCcchhHhc------CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CCCCc--cCCHHH
Q 011698          307 NSMCGTLEYMSPEIVL------GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--IKLPA--FLSSEA  376 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~------~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~  376 (479)
                      ...+||+.|+|||++.      +..++.++|||||||++|||++|+.||...+......++....  ..+|.  .++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF  240 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence            3457999999999997      4567899999999999999999999999888888777777542  33443  579999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCC---
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVA---  453 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~---  453 (479)
                      .+||+.||+ +|.+|+     +++++++||||..++|..+..  ..|++.|......+..+|++..+..+.......   
T Consensus       241 ~~li~~ll~-~p~~R~-----t~~~l~~h~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (330)
T cd05601         241 LDLIQSLLC-GQKERL-----GYEGLCCHPFFSKIDWNNIRN--SLPPFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQL  312 (330)
T ss_pred             HHHHHHHcc-ChhhCC-----CHHHHhCCCCcCCCCHHHHhh--CCCCccCcCCCcchhhhcCCCccccccccccccccC
Confidence            999999998 999999     899999999999999998864  567888888887777888765554433322111   


Q ss_pred             CC---CCCCCCccCeeee
Q 011698          454 SP---KFNENPFKGFTYV  468 (479)
Q Consensus       454 ~~---~~~~~~f~~f~~~  468 (479)
                      .+   .....+|.||+|+
T Consensus       313 ~~~~~~~~~~~~~~~~~~  330 (330)
T cd05601         313 KPNGFSGKDLPFVGFSFI  330 (330)
T ss_pred             CCcCCCCCCCCccCceeC
Confidence            11   2345789999984

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-51  Score=404.74  Aligned_cols=278  Identities=36%  Similarity=0.667  Sum_probs=247.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      .|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48899999999999999999999999999999987654444445567789999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccc
Q 011698          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (479)
Q Consensus       231 ~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~  308 (479)
                      |+.||+|..++...  ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++...........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG  160 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence            99999998888654  4589999999999999999999999999999999999999999999999999987654444456


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhccCCCCccCCHHHHHHHHhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK----IQQKIIKDKIKLPAFLSSEAHSLLKGLL  384 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~lI~~~L  384 (479)
                      .+|++.|+|||++.+..++.++||||+||++|||++|+.||.+.+...    +...+......++..++..+.+||.+||
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05605         161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL  240 (285)
T ss_pred             ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHc
Confidence            689999999999999999999999999999999999999998765432    3344445566677889999999999999


Q ss_pred             hhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccc
Q 011698          385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE  428 (479)
Q Consensus       385 ~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~  428 (479)
                      +.||++|+++...+++++++||||...+|+++.+++..|||+|.
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (285)
T cd05605         241 TKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD  284 (285)
T ss_pred             cCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCC
Confidence            99999999887778999999999999999999999999999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-51  Score=412.64  Aligned_cols=280  Identities=39%  Similarity=0.713  Sum_probs=249.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||++++++++....+|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998876544455667889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~  309 (479)
                      ||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....  .....
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~  158 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSV  158 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCc
Confidence            9999999999999888999999999999999999999999999999999999999999999999999986543  34567


Q ss_pred             cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CCCCc------cCCHHHHHHHH
Q 011698          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--IKLPA------FLSSEAHSLLK  381 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~------~~s~~~~~lI~  381 (479)
                      +||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+....  +..|.      .++.++.+||.
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~  238 (333)
T cd05600         159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT  238 (333)
T ss_pred             ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHH
Confidence            89999999999999999999999999999999999999999988888777776532  22222      45899999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCc
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANF  438 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f  438 (479)
                      +||+.+|.+|+     +++++++||||+.++|..+.  ...|++.|..........|
T Consensus       239 ~~l~~~~~rr~-----s~~~ll~h~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  288 (333)
T cd05600         239 KLINDPSRRFG-----SLEDIKNHPFFKEVDWNELR--ELKPPFVPELESEIDTGYF  288 (333)
T ss_pred             HHhhChhhhcC-----CHHHHHhCcccCCCCHHHHh--hCCCCCCCCCCCcchhhhc
Confidence            99999999998     89999999999999998876  6778898887655444444

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.5e-53  Score=399.92  Aligned_cols=259  Identities=28%  Similarity=0.452  Sum_probs=224.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      ++.|+.+.++|+|+||.||+|+++.||++||||++.... .+....+...+|+++|++++|+|+|.++++|.....+++|
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            367999999999999999999999999999999986543 3445566678999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC-CCCCcc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSN  307 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~~~~~~  307 (479)
                      +|||+..-|.++-+....++++.++.|+.|++.|+.|+|++++||||||||||||+.+|.+||||||+|+.+. .+...+
T Consensus        80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT  159 (396)
T KOG0593|consen   80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT  159 (396)
T ss_pred             eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence            9999985554444444568999999999999999999999999999999999999999999999999999987 555566


Q ss_pred             cccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------------cCC
Q 011698          308 SMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------------KIK  367 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-------------------~~~  367 (479)
                      ..+.|.||.|||.+.| ..|+..+||||+||++.||++|++.|.+.+..+....|...                   .+.
T Consensus       160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~  239 (396)
T KOG0593|consen  160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR  239 (396)
T ss_pred             hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence            7789999999999998 68999999999999999999999999998776665555441                   012


Q ss_pred             CC------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          368 LP------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       368 ~p------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      +|            +.++.-+.+|+++||..||.+|+     +.+|++.|+||.++--
T Consensus       240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~-----sc~qll~H~yFd~~~e  292 (396)
T KOG0593|consen  240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRL-----SCEQLLHHPYFDGFIE  292 (396)
T ss_pred             cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccc-----cHHHHhcChHHHHHHH
Confidence            22            24678899999999999999999     8899999999966533

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.9e-50  Score=406.09  Aligned_cols=315  Identities=36%  Similarity=0.694  Sum_probs=257.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..++|++|+++++++++...+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999998755545555666888999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC--Cc
Q 011698          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RS  306 (479)
Q Consensus       230 E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~--~~  306 (479)
                      ||+.||+|..++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....  ..
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999999999987 4678999999999999999999999999999999999999999999999999997653322  22


Q ss_pred             ccccCCCCCcchhHhc-----CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CCCCc---cCCHHH
Q 011698          307 NSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--IKLPA---FLSSEA  376 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~-----~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~~  376 (479)
                      ...+||+.|||||++.     ...++.++|||||||++|||++|+.||.+.+..+...++....  ..+|.   .++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~  240 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA  240 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence            3468999999999996     3457899999999999999999999999988888888887653  33443   579999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCc---cccccCCCCCCCCCC
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANF---EECWTNMPLLDSPVA  453 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f---~~~~~~~~~~~~~~~  453 (479)
                      ++||++||..++ +|++.  .+++++++||||.+++|..+..  ..++++|.........++   +.+.++......|..
T Consensus       241 ~~li~~ll~~~~-~r~~r--~~~~~~~~h~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (332)
T cd05623         241 KDLIRRLICSRE-HRLGQ--NGIEDFKQHPFFTGIDWDNIRN--CEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPSH  315 (332)
T ss_pred             HHHHHHHccChh-hhcCC--CCHHHHhCCCCcCCCCHHHHhh--CCCCccCCCCCCcccccCCCCcccccccCCCCCCCc
Confidence            999999998654 44421  2899999999999999998854  456778877665555544   233333222111111


Q ss_pred             -CCCCCCCCccCeeeec
Q 011698          454 -SPKFNENPFKGFTYVR  469 (479)
Q Consensus       454 -~~~~~~~~f~~f~~~~  469 (479)
                       ....-..+|.+|+|.+
T Consensus       316 ~~~~~~~~~~~~~~~~~  332 (332)
T cd05623         316 TAFSGHHLPFVGFTYTS  332 (332)
T ss_pred             cccccCCCCcCCeeecC
Confidence             1123457899999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-53  Score=399.99  Aligned_cols=246  Identities=32%  Similarity=0.530  Sum_probs=224.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeE-EEeeCCe-
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY-SFQTKYR-  224 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~~~~~~~-  224 (479)
                      ..+.+|+++++||+|+||+||++++..+|..+|.|.+.-+.+ +....+....|+.+|++|+|||||++++ .|..+.. 
T Consensus        16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev   94 (375)
T KOG0591|consen   16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV   94 (375)
T ss_pred             ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence            446789999999999999999999999999999999986554 4555677788999999999999999998 6666655 


Q ss_pred             EEEEEEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHh--CC--CccCCCCCccEEeCCCCcEEEeecCC
Q 011698          225 LYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHA--NG--IMHRDLKPENILLDADGHVMLTDFGL  296 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~--~~--IiHrDLKpeNILl~~~g~vkL~DFGl  296 (479)
                      ++||||+|.+|+|...+++    +..++|..+|.|+.|+|.||+++|+  .+  |+||||||.||+|+.+|.+||+|||+
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL  174 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL  174 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence            9999999999999888754    3569999999999999999999999  45  99999999999999999999999999


Q ss_pred             ccccCCCC-CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CC-ccCC
Q 011698          297 AKQFDENT-RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LP-AFLS  373 (479)
Q Consensus       297 a~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s  373 (479)
                      ++.+...+ ...+.+|||.||+||.+.+.+|+.++|||||||++|||+.-++||.+.+-.++.++|.++..+ +| ..+|
T Consensus       175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS  254 (375)
T KOG0591|consen  175 GRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYS  254 (375)
T ss_pred             HhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhh
Confidence            99886553 457899999999999999999999999999999999999999999999999999999999765 77 7899


Q ss_pred             HHHHHHHHhhhhhchhhhcC
Q 011698          374 SEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       374 ~~~~~lI~~~L~~dP~~R~~  393 (479)
                      .++..||..|+..||..||+
T Consensus       255 ~~l~~li~~ci~vd~~~RP~  274 (375)
T KOG0591|consen  255 TDLRELINMCIAVDPEQRPD  274 (375)
T ss_pred             hHHHHHHHHHccCCcccCCC
Confidence            99999999999999999995

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.1e-50  Score=398.64  Aligned_cols=270  Identities=37%  Similarity=0.688  Sum_probs=239.6

Q ss_pred             eccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCCcH
Q 011698          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (479)
Q Consensus       158 LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL  237 (479)
                      ||+|+||+||+|.++.+++.||+|++.+.........+.+..|+.+++.++||||+++++++.....+|+||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999999999999999999876554444556678899999999999999999999999999999999999999


Q ss_pred             HHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-CcccccCC
Q 011698          238 FFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGT  312 (479)
Q Consensus       238 ~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~~~~gt  312 (479)
                      ...+..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ......||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            877743    3468999999999999999999999999999999999999999999999999998764432 23456799


Q ss_pred             CCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCCCCccCCHHHHHHHHhhhhhch
Q 011698          313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR----QKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA  388 (479)
Q Consensus       313 ~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP  388 (479)
                      +.|+|||++.+..++.++|+|||||++|||++|+.||...+.    ......+......+|..++.++.+++.+||+.||
T Consensus       161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  240 (280)
T cd05608         161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP  240 (280)
T ss_pred             cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCH
Confidence            999999999999999999999999999999999999976432    3444555556667788899999999999999999


Q ss_pred             hhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcc
Q 011698          389 SKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP  427 (479)
Q Consensus       389 ~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p  427 (479)
                      ++|++....+++++++||||+.++|..++.....+|+.|
T Consensus       241 ~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~  279 (280)
T cd05608         241 EKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP  279 (280)
T ss_pred             HHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCC
Confidence            999988777999999999999999999999999999887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.8e-50  Score=404.23  Aligned_cols=286  Identities=36%  Similarity=0.706  Sum_probs=245.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..++|++|+++++++++.+.+|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999998755444555666888999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC--c
Q 011698          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--S  306 (479)
Q Consensus       230 E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~--~  306 (479)
                      ||+.||+|..++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+.....  .
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            99999999999987 46789999999999999999999999999999999999999999999999999987643322  2


Q ss_pred             ccccCCCCCcchhHhcC-----CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CCCCc---cCCHHH
Q 011698          307 NSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--IKLPA---FLSSEA  376 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~-----~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~~  376 (479)
                      ...+||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+.+..+...++....  +.+|.   .++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~  240 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA  240 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence            34679999999999976     457899999999999999999999999888888888887643  44454   368999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccc
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE  440 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~  440 (479)
                      +++|.+||..++ +|++.  .+++++++|+||++++|..+.  ...+++.|.........+|+.
T Consensus       241 ~~li~~ll~~~~-~~~~~--~~~~~~~~h~~f~~~~~~~~~--~~~~~~~p~~~~~~~~~~~~~  299 (331)
T cd05624         241 KDLIQRLICSRE-RRLGQ--NGIEDFKKHAFFEGIDWENIR--NLEAPYIPDVSSPSDTSNFDV  299 (331)
T ss_pred             HHHHHHHccCch-hhcCC--CCHHHHhcCCCcCCCCHHHHh--hCCCCccCCCCCcchhhhcCC
Confidence            999999999655 55432  389999999999999999874  566788887766665556543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-49  Score=403.48  Aligned_cols=314  Identities=36%  Similarity=0.682  Sum_probs=254.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||+||+++++.+++.||+|++.+.........+.+.+|+.+++.++|+||+++++++.++.++|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765545555667889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC--c
Q 011698          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--S  306 (479)
Q Consensus       230 E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~--~  306 (479)
                      ||+.||+|..++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..+.....  .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99999999999976 45799999999999999999999999999999999999999999999999999977543322  2


Q ss_pred             ccccCCCCCcchhHhcC-----CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CCCCc---cCCHHH
Q 011698          307 NSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--IKLPA---FLSSEA  376 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~-----~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~~  376 (479)
                      ...+||+.|||||++.+     ..++.++|||||||++|||++|+.||.+.+..+....+....  ..+|.   .++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA  240 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence            33579999999999974     457889999999999999999999999888888777776542  33333   479999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCC---CCCCCC-
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMP---LLDSPV-  452 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~---~~~~~~-  452 (479)
                      ++||++||.. +.+|++.  .+++++++||||.+++|..+..  ..+++.|.........+|+..-+...   ....+. 
T Consensus       241 ~~li~~ll~~-~~~r~~r--~~~~~~l~hp~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (331)
T cd05597         241 KDLIRRLICS-PETRLGR--NGLQDFKDHPFFEGIDWDNIRN--STAPYVPEVSSPTDTSNFDVDDDDLRNTESLPPSSH  315 (331)
T ss_pred             HHHHHHHccC-cccccCC--CCHHHHhcCCCCCCCCHHHHhh--CCCCccCcCCCcchhhhcCCcccccccccccCCCCc
Confidence            9999999975 4455421  2899999999999999998864  35678887766666556654322211   111111 


Q ss_pred             CCCCCCCCCccCeeee
Q 011698          453 ASPKFNENPFKGFTYV  468 (479)
Q Consensus       453 ~~~~~~~~~f~~f~~~  468 (479)
                      ......--++.+|+|.
T Consensus       316 ~~~~~~~~~~~~~~~~  331 (331)
T cd05597         316 GAFSGNHLPFVGFTYT  331 (331)
T ss_pred             CcCCcCCCCCCceeeC
Confidence            1112334668899884

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-51  Score=408.79  Aligned_cols=261  Identities=31%  Similarity=0.579  Sum_probs=229.8

Q ss_pred             CcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH-----------HHHHHHHHHHHHHHhCCCCCe
Q 011698          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK-----------NHAEYMKSERNILTKVDHPFI  212 (479)
Q Consensus       144 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~-----------~~~~~~~~E~~iL~~l~hp~I  212 (479)
                      .....+++|++++.||+|.||+|-+|++..+++.||||++.+......           ...+..++|+.+|++|.||||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            445678999999999999999999999999999999999987543221           234678899999999999999


Q ss_pred             eeEeEEEeeC--CeEEEEEEeccCCcHHHHHHHcCC-CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcE
Q 011698          213 VQLRYSFQTK--YRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (479)
Q Consensus       213 v~l~~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~v  289 (479)
                      |+|+++..+.  +.+|||+|||..|.+.. .-..+. +++.++|.|+.+++.||+|||.+|||||||||.|+||+.+|++
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence            9999998764  58999999999998743 223334 9999999999999999999999999999999999999999999


Q ss_pred             EEeecCCccccCCC------CCcccccCCCCCcchhHhcCCC---C-CccccchhhHHHHHHHHhCCCCCCCCCHHHHHH
Q 011698          290 MLTDFGLAKQFDEN------TRSNSMCGTLEYMSPEIVLGKG---H-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ  359 (479)
Q Consensus       290 kL~DFGla~~~~~~------~~~~~~~gt~~y~APE~l~~~~---~-~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~  359 (479)
                      ||+|||.+..+...      ......+|||.|||||.+.++.   + +.+.|||||||+||.|+.|+.||.+....+++.
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~  329 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD  329 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence            99999999876222      2234478999999999998732   3 689999999999999999999999999999999


Q ss_pred             HHHhccCCCCcc--CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          360 KIIKDKIKLPAF--LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       360 ~i~~~~~~~p~~--~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      +|.+..+.+|..  +...+++||++||++||++|+     ++.+|+.|||...
T Consensus       330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri-----~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRI-----TLPDIKLHPWVTR  377 (576)
T ss_pred             HHhcCcccCCCcccccHHHHHHHHHHhhcChhhee-----ehhhheecceecc
Confidence            999999999976  799999999999999999999     8999999999865

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.7e-49  Score=393.67  Aligned_cols=289  Identities=44%  Similarity=0.844  Sum_probs=265.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|++++++++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998766555556677889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~  309 (479)
                      ||+++++|..++.+.+.+++..+..++.||+.||.|||++||+||||+|+|||++.+|.+||+|||++......  ....
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~  158 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTL  158 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCC
Confidence            99999999999998889999999999999999999999999999999999999999999999999999876544  4456


Q ss_pred             cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchh
Q 011698          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEAS  389 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~  389 (479)
                      +|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.....+.+..+...+|..++..++++|++||+.||.
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  238 (290)
T cd05580         159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLT  238 (290)
T ss_pred             CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHH
Confidence            79999999999998889999999999999999999999999888888888888888889999999999999999999999


Q ss_pred             hhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccc
Q 011698          390 KRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE  440 (479)
Q Consensus       390 ~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~  440 (479)
                      +|++....+++|+++||||+.++|..+....+.+++.|........++|++
T Consensus       239 ~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (290)
T cd05580         239 KRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDD  289 (290)
T ss_pred             HccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCCCccccccccC
Confidence            999877779999999999999999999999999999988776666666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.4e-49  Score=392.30  Aligned_cols=279  Identities=39%  Similarity=0.684  Sum_probs=242.1

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+..|+.++++++|++|+.+++.+.+.+.+|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            47889999999999999999999999999999987654444445567789999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccc
Q 011698          231 FVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~  308 (479)
                      |+.|++|...+...+  .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG  160 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence            999999988886543  589999999999999999999999999999999999999999999999999987654444455


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH-hccCCCCccCCHHHHHHHHhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ---KIQQKII-KDKIKLPAFLSSEAHSLLKGLL  384 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~---~~~~~i~-~~~~~~p~~~s~~~~~lI~~~L  384 (479)
                      ..||..|+|||++.+..++.++|+|||||++|+|++|+.||......   .....+. .....++..++.++.+||+.||
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05630         161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL  240 (285)
T ss_pred             CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHh
Confidence            68999999999999999999999999999999999999999864321   2222222 2233466778999999999999


Q ss_pred             hhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcccc
Q 011698          385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEV  429 (479)
Q Consensus       385 ~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~  429 (479)
                      +.||++|+++...+++|+++||||+.++|..++..+..|+|+|.+
T Consensus       241 ~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~  285 (285)
T cd05630         241 CKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP  285 (285)
T ss_pred             hcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCCC
Confidence            999999996554469999999999999999999999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-52  Score=385.65  Aligned_cols=257  Identities=32%  Similarity=0.566  Sum_probs=238.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      -+.|++-++||+|.|+.|+++.+..||+.+|+|++....+... ..+.+.+|++|-+.|+|||||+++..+++....|+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            3678999999999999999999999999999999987665444 567789999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC---CCcEEEeecCCccccCCCCC
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~---~g~vkL~DFGla~~~~~~~~  305 (479)
                      +|+|.|++|+.-+-....++|..+-.++.||++||.|+|.+||||||+||+|+|+-.   ..-+||+|||+|..+.....
T Consensus        89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~  168 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA  168 (355)
T ss_pred             EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence            999999999888877678899999999999999999999999999999999999943   34699999999999987777


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc----cCCHHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK  381 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~lI~  381 (479)
                      ...++|||.|||||+++..+|+..+|||+.|||||-|+.|.+||.+.+...+++.|..+.+.+|.    .+++++++||+
T Consensus       169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvr  248 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIR  248 (355)
T ss_pred             cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHH
Confidence            78899999999999999999999999999999999999999999999999999999999888775    68999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +||..||++|+     |+.|+|+|||+.+-
T Consensus       249 rML~~dP~kRI-----ta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  249 RMLTVNPKKRI-----TADEALKHPWICNR  273 (355)
T ss_pred             HHhccChhhhc-----cHHHHhCCchhcch
Confidence            99999999999     99999999999874

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.3e-51  Score=400.19  Aligned_cols=253  Identities=32%  Similarity=0.599  Sum_probs=242.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      .+|++.+.||+|.||+|-+|.....|+.||||.|+++.+.++...-.+++|++||..|+||||+++|.+|+..+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            57999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~  309 (479)
                      ||..+|.|++++.+.+.++|..++.+++||+.|+.|+|+++++|||||.+|||+|.++++||+|||++..+.......++
T Consensus       133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTF  212 (668)
T KOG0611|consen  133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTF  212 (668)
T ss_pred             EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999888889999


Q ss_pred             cCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhch
Q 011698          310 CGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA  388 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP  388 (479)
                      ||+|.|.+||++.|.+| +..+|-|||||+||-|+.|..||++.+...+...|..+.+.-|.. +.++.-||+.||..||
T Consensus       213 CGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwmLmVNP  291 (668)
T KOG0611|consen  213 CGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIRWMLMVNP  291 (668)
T ss_pred             cCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHHHHHhcCc
Confidence            99999999999999998 688999999999999999999999999999999999998776653 6678999999999999


Q ss_pred             hhhcCCCCCCHHHHHhCccc
Q 011698          389 SKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       389 ~~R~~~~~~t~~eil~hp~f  408 (479)
                      ++|.     |+++|-+|=|.
T Consensus       292 ~RRA-----TieDiAsHWWv  306 (668)
T KOG0611|consen  292 ERRA-----TIEDIASHWWV  306 (668)
T ss_pred             ccch-----hHHHHhhhhee
Confidence            9998     99999999775

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-50  Score=400.32  Aligned_cols=255  Identities=33%  Similarity=0.558  Sum_probs=224.0

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC--eEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLY  226 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~~~  226 (479)
                      ..+|...+.||+|+||.||++.++.+|+.+|||.+.....   ...+.+.+|+.+|++++|||||+.++......  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            3568889999999999999999999999999999977521   12677899999999999999999999855544  699


Q ss_pred             EEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC-CCcEEEeecCCccccCC--
Q 011698          227 LVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLAKQFDE--  302 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~-~g~vkL~DFGla~~~~~--  302 (479)
                      +.|||++||+|.+++.+.+ .++|..++.|++||++||.|||++|||||||||+|||++. +|.+||+|||+++....  
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999999999887 7999999999999999999999999999999999999999 79999999999988663  


Q ss_pred             --CCCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcc--CCCCccCCHHH
Q 011698          303 --NTRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDK--IKLPAFLSSEA  376 (479)
Q Consensus       303 --~~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~  376 (479)
                        ........||+.|||||++... ....++|||||||++.||+||+.||.. .......-.|..+.  +.+|..+|.++
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence              2234568899999999999963 334599999999999999999999987 45555555555443  67899999999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ++||.+|+.+||++||     ||+++|+|||.+..
T Consensus       253 ~~Fl~~C~~~~p~~Rp-----ta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRP-----TAEELLEHPFLKQN  282 (313)
T ss_pred             HHHHHHHhhcCcccCc-----CHHHHhhChhhhcc
Confidence            9999999999999999     99999999999874

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.3e-49  Score=387.90  Aligned_cols=279  Identities=37%  Similarity=0.661  Sum_probs=246.2

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      .|+..+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+|+.++|+||+.+++++..++..|+|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            37889999999999999999999999999999987655444455667889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccc
Q 011698          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (479)
Q Consensus       231 ~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~  308 (479)
                      |+.+++|..++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG  160 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence            99999998888654  3589999999999999999999999999999999999999999999999999977654444455


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHhccCCCCccCCHHHHHHHHhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ----QKIIKDKIKLPAFLSSEAHSLLKGLL  384 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~----~~i~~~~~~~p~~~s~~~~~lI~~~L  384 (479)
                      ..|+..|+|||++.+..++.++|+|||||++|||++|..||.+.......    ..+......++..++.++.+|+..||
T Consensus       161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05632         161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL  240 (285)
T ss_pred             CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHc
Confidence            68999999999999999999999999999999999999999876654333    33334455667789999999999999


Q ss_pred             hhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcccc
Q 011698          385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEV  429 (479)
Q Consensus       385 ~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~  429 (479)
                      +.||++|+++....+.++++|+||+.++|+++++++..|+|.|.+
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (285)
T cd05632         241 TKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP  285 (285)
T ss_pred             cCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCCC
Confidence            999999997766669999999999999999999999999998863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-50  Score=413.10  Aligned_cols=252  Identities=34%  Similarity=0.550  Sum_probs=231.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ..|+...+||+|+.|.||.|+...+++.||||.|.....   ...+.+.+|+.+|+..+|+|||.+++.|--.+.+|+||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            468889999999999999999999999999999987643   34567889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Cccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~~  308 (479)
                      |||+||+|.+.+.. ..++|.++..++.+++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+.... +..+
T Consensus       350 Eym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             eecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence            99999999877765 458999999999999999999999999999999999999999999999999999876554 6788


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---cCCCCccCCHHHHHHHHhhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      .+|||+|||||++..+.|+.++||||||++++||+-|++||-..+.......|...   ++..|..+|+.+++||.+||+
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~  508 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLV  508 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhh
Confidence            99999999999999999999999999999999999999999988887777777764   556788999999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccC
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      .|+.+|+     +|.|+|+||||+.
T Consensus       509 ~dv~~Ra-----sA~eLL~HpFl~~  528 (550)
T KOG0578|consen  509 VDVEQRA-----SAKELLEHPFLKM  528 (550)
T ss_pred             cchhcCC-----CHHHHhcChhhhh
Confidence            9999999     9999999999955

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-49  Score=391.44  Aligned_cols=263  Identities=31%  Similarity=0.492  Sum_probs=234.6

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      ....++|++..+||.|..++||+|+...+++.||||++..+....  ..+.+++|+..|+.++||||++++.+|..+..+
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            356789999999999999999999999999999999999876433  378899999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      |+||.||.+|++.+.+...  ..++|..+..+++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+...
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999999999764  45899999999999999999999999999999999999999999999999988765322


Q ss_pred             -CC----cccccCCCCCcchhHhcC--CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-------
Q 011698          304 -TR----SNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-------  369 (479)
Q Consensus       304 -~~----~~~~~gt~~y~APE~l~~--~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p-------  369 (479)
                       .+    ..+++||++|||||++..  .+|+.|+||||||++..||++|..||....++++...-+++.++.+       
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~  259 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK  259 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence             22    266799999999999644  6899999999999999999999999999888888777777766532       


Q ss_pred             ---ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhh
Q 011698          370 ---AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK  415 (479)
Q Consensus       370 ---~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~  415 (479)
                         ..++..++.+|..||++||++||     ||+++++|+||+...-..
T Consensus       260 d~~k~~~ksf~e~i~~CL~kDP~kRp-----tAskLlkh~FFk~~k~~~  303 (516)
T KOG0582|consen  260 DEDKKFSKSFREMIALCLVKDPSKRP-----TASKLLKHAFFKKAKSKE  303 (516)
T ss_pred             HHhhhhcHHHHHHHHHHhhcCcccCC-----CHHHHhccHHHhhccchh
Confidence               24788999999999999999999     999999999999875444

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.5e-49  Score=386.99  Aligned_cols=269  Identities=33%  Similarity=0.649  Sum_probs=231.1

Q ss_pred             eccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCCcH
Q 011698          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (479)
Q Consensus       158 LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL  237 (479)
                      ||+|+||+||+++.+.+|+.||+|++.+...........+..|++++++++||||+++++++++...+|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999999999999999999875544433445566799999999999999999999999999999999999999


Q ss_pred             HHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccccCCCCC
Q 011698          238 FFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY  315 (479)
Q Consensus       238 ~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt~~y  315 (479)
                      ..++...+  .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.............||+.|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY  160 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence            88886543  4788889999999999999999999999999999999999999999999999876654444556799999


Q ss_pred             cchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCCCC-ccCCHHHHHHHHhhhhhchhh
Q 011698          316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR----QKIQQKIIKDKIKLP-AFLSSEAHSLLKGLLQKEASK  390 (479)
Q Consensus       316 ~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~p-~~~s~~~~~lI~~~L~~dP~~  390 (479)
                      +|||++.+..++.++|+|||||++|||++|+.||.+...    ..+...+......++ ..++.++++||++||++||.+
T Consensus       161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~  240 (277)
T cd05607         161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPED  240 (277)
T ss_pred             cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhh
Confidence            999999999999999999999999999999999976432    344444444444433 468999999999999999999


Q ss_pred             hcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcc
Q 011698          391 RLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP  427 (479)
Q Consensus       391 R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p  427 (479)
                      |+++.. -.++++.|+||+.++|..++.+...|||.|
T Consensus       241 R~~~~~-~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~  276 (277)
T cd05607         241 RLGSRE-KNDDPRKHEFFKTINFPRLEAGLIPPPFVP  276 (277)
T ss_pred             CCCCcc-chhhhhcChhhcCCCHHHHhcCcCCCCCCC
Confidence            994321 137899999999999999999999899876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-50  Score=401.45  Aligned_cols=257  Identities=31%  Similarity=0.505  Sum_probs=226.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC--Ce
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YR  224 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~  224 (479)
                      ...+.|+.+++||+|.||.||+|++..||+.||+|.++.+.. +......+.+|+.||++|+||||++|.+...+.  ..
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            345679999999999999999999999999999999998764 344456678899999999999999999998877  68


Q ss_pred             EEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      +|+|+|||+. +|.-++... -.|++.+++.|+.||+.||+|||.+||+|||||..|||||.+|.+||+|||||+.+...
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999999987 776666653 46999999999999999999999999999999999999999999999999999976544


Q ss_pred             C--CcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------cCCCC-
Q 011698          304 T--RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD----------KIKLP-  369 (479)
Q Consensus       304 ~--~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~----------~~~~p-  369 (479)
                      .  ..+..+-|.+|.|||++.|. .|+.++|+||.||||.||++|++.|.+.+..+...+|.+-          ...+| 
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence            3  45677889999999999985 6999999999999999999999999999998888888762          11222 


Q ss_pred             ------------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          370 ------------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       370 ------------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                                        ..++..+.+|+..||..||.+|.     ||.++|+|+||..
T Consensus       352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~-----tA~~aL~seyF~t  405 (560)
T KOG0600|consen  352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRG-----TASSALQSEYFTT  405 (560)
T ss_pred             ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccc-----cHHHHhcCccccc
Confidence                              24689999999999999999998     9999999999943

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-50  Score=401.31  Aligned_cols=257  Identities=29%  Similarity=0.505  Sum_probs=227.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCC-e
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKY-R  224 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~-~  224 (479)
                      +..++|.++++||.|+||.||+|+.+.+|+.||||.|++....-++ . .-.+|+..|++++ ||||+++.+.+.+.+ .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~-~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-C-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-H-HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            4467899999999999999999999999999999999876543222 2 2357999999998 999999999998888 9


Q ss_pred             EEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      +|+|||||+. .|+.+++.+ ..|++..++.|+.||++||+|+|++|+.||||||||||+.....+||+|||+|+.+...
T Consensus        85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence            9999999987 888888654 56999999999999999999999999999999999999998999999999999999888


Q ss_pred             CCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--c----------------
Q 011698          304 TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK--D----------------  364 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~--~----------------  364 (479)
                      ...+..+.|.+|.|||++.. ..|+.++||||+|||++|+++-++.|.|.+..+...+|..  +                
T Consensus       164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~  243 (538)
T KOG0661|consen  164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA  243 (538)
T ss_pred             CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence            88888899999999999876 5579999999999999999999999999888777777665  1                


Q ss_pred             -cCCCC-----------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          365 -KIKLP-----------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       365 -~~~~p-----------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                       .+.+|           +..+.++.+||..||.-||.+||     ||.++++||||+.-
T Consensus       244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp-----TA~~al~~pffq~~  297 (538)
T KOG0661|consen  244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP-----TASQALQHPFFQVG  297 (538)
T ss_pred             hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc-----cHHHHhcCcccccc
Confidence             12223           23789999999999999999999     99999999999874

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-49  Score=401.92  Aligned_cols=257  Identities=35%  Similarity=0.621  Sum_probs=240.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~l  227 (479)
                      .+.|++.+.||+|.||.||+++.+.||+.+|+|++.+.........+.+.+|+.+|+++. |||||.+++.|++...+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            357999999999999999999999999999999999987665556678999999999998 9999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC----CcEEEeecCCccccCCC
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD----GHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~----g~vkL~DFGla~~~~~~  303 (479)
                      |||++.||.|++.+.+. .++|..+..++.||+.++.|||+.||+||||||||+|+...    +.+|++|||++......
T Consensus       114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~  192 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG  192 (382)
T ss_pred             EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence            99999999999999887 49999999999999999999999999999999999999543    57999999999998777


Q ss_pred             CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc----cCCHHHHHH
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSL  379 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l  379 (479)
                      ......|||+.|+|||++.+..|+..+||||+||++|.|++|.+||.+.+.......|..+.+.++.    .+|..+++|
T Consensus       193 ~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~  272 (382)
T KOG0032|consen  193 ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDF  272 (382)
T ss_pred             ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHH
Confidence            7888999999999999999999999999999999999999999999999999999999999877653    479999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      |+.||..||.+|+     ++.++|+|||+++.
T Consensus       273 i~~ll~~dp~~R~-----ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  273 IRKLLEFDPRKRL-----TAAQALQHPWIKSI  299 (382)
T ss_pred             HHHhcccCcccCC-----CHHHHhcCccccCC
Confidence            9999999999999     99999999999875

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-48  Score=394.20  Aligned_cols=252  Identities=27%  Similarity=0.464  Sum_probs=223.2

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-e
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-R  224 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-~  224 (479)
                      .+..+++.+.+.||+|+||+||+|.|+++.. ||+|++......... .+.+.+|+.+|++++|||||++++++.+.. .
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~  114 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGS  114 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEEEeCCcee-EEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            3455667777889999999999999965432 999999876654444 778999999999999999999999999888 7


Q ss_pred             EEEEEEeccCCcHHHHHHH--cCCCcHHHHHHHHHHHHHHHHHHHhCC-CccCCCCCccEEeCCCC-cEEEeecCCcccc
Q 011698          225 LYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANG-IMHRDLKPENILLDADG-HVMLTDFGLAKQF  300 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~-IiHrDLKpeNILl~~~g-~vkL~DFGla~~~  300 (479)
                      +++|||||++|+|..++.+  +..++...+..++.||++||.|||+++ ||||||||+|||++.++ ++||+|||+++..
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            9999999999999999988  678999999999999999999999999 99999999999999998 9999999999886


Q ss_pred             CCC-CCcccccCCCCCcchhHhc--CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCccCCHH
Q 011698          301 DEN-TRSNSMCGTLEYMSPEIVL--GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSE  375 (479)
Q Consensus       301 ~~~-~~~~~~~gt~~y~APE~l~--~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~  375 (479)
                      ... .......||+.|||||++.  ...|+.++||||||++||||+||+.||.+.........+..+  ++.+|..+++.
T Consensus       195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~  274 (362)
T KOG0192|consen  195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPH  274 (362)
T ss_pred             ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence            554 3444578999999999999  569999999999999999999999999998887777766643  66778889999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +..||..||+.||.+||     ++.+|..
T Consensus       275 l~~l~~~CW~~dp~~RP-----~f~ei~~  298 (362)
T KOG0192|consen  275 LSSLMERCWLVDPSRRP-----SFLEIVS  298 (362)
T ss_pred             HHHHHHHhCCCCCCcCC-----CHHHHHH
Confidence            99999999999999999     7777754

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-49  Score=395.01  Aligned_cols=259  Identities=36%  Similarity=0.608  Sum_probs=242.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      .=|.+.+.||+|.|+.|-+|++.-||+.||||++.+..+.. -....+..|++.|+.++|||||+||.+..+...+|||+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            34888899999999999999999999999999999877543 34556778999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe-CCCCcEEEeecCCccccCCCCCcc
Q 011698          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL-DADGHVMLTDFGLAKQFDENTRSN  307 (479)
Q Consensus       230 E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl-~~~g~vkL~DFGla~~~~~~~~~~  307 (479)
                      |+-++|+|++++.++ ..+.|+.++.|++||+.|+.|+|+..+||||||||||.+ .+-|-+||+|||++..+..+....
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~  176 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT  176 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence            999999999999765 569999999999999999999999999999999999876 567999999999999999999999


Q ss_pred             cccCCCCCcchhHhcCCCCC-ccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhh
Q 011698          308 SMCGTLEYMSPEIVLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~-~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~  386 (479)
                      +.||+..|-|||++.|..|+ +++||||||||||-|++|++||...+..+....|+..++..|..+|.++++||..||.+
T Consensus       177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvR  256 (864)
T KOG4717|consen  177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVR  256 (864)
T ss_pred             cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhc
Confidence            99999999999999999996 78999999999999999999999999999999999999999999999999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          387 EASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                      ||++|.     +.++|.+|+|++.++-.
T Consensus       257 dPkkRA-----slEeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  257 DPKKRA-----SLEEIVSTSWLQAGDRG  279 (864)
T ss_pred             Cchhhc-----cHHHHhccccccCCCCC
Confidence            999998     99999999999998753

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.9e-49  Score=377.59  Aligned_cols=274  Identities=32%  Similarity=0.520  Sum_probs=233.8

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe--eCC
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ--TKY  223 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~  223 (479)
                      .-.+++|+.+..|++|+||.||+|+++.|+++||+|.++.+.-.....+. -.+|+++|.+++|||||.+..+..  +-+
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPIt-sLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPIT-SLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcch-hHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            34568899999999999999999999999999999999876533333333 357999999999999999988775  345


Q ss_pred             eEEEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      .+|+|||||+. +|..++...+ +|...+++.++.|++.|++|||.+.|+|||||++|+|++..|.+||+|||+|+.+.+
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            79999999987 8988888776 899999999999999999999999999999999999999999999999999999876


Q ss_pred             CC-CcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------------
Q 011698          303 NT-RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD----------------  364 (479)
Q Consensus       303 ~~-~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~----------------  364 (479)
                      .. ..+..+-|.+|.|||++.| ..|+.++||||+|||+.||+++++.|.|.+..+...+|...                
T Consensus       230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence            53 4566788999999999998 46999999999999999999999999999888888877751                


Q ss_pred             ---cCCCC------------cc-CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccc
Q 011698          365 ---KIKLP------------AF-LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE  428 (479)
Q Consensus       365 ---~~~~p------------~~-~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~  428 (479)
                         ...++            .. ++....+|+..+|..||.+|+     ||+|.|+|.||...      .....|.+.|.
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~-----tA~~~L~h~~F~e~------P~p~~P~~~Pt  378 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRI-----TAEDGLKHEYFRET------PLPIDPSMFPT  378 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccc-----cHHHhhcccccccC------CCCCChhhcCC
Confidence               11111            11 579999999999999999999     99999999999885      34455666665


Q ss_pred             cCCc
Q 011698          429 VAGK  432 (479)
Q Consensus       429 ~~~~  432 (479)
                      ...+
T Consensus       379 ~P~k  382 (419)
T KOG0663|consen  379 WPAK  382 (419)
T ss_pred             Cccc
Confidence            5443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.6e-48  Score=365.15  Aligned_cols=255  Identities=28%  Similarity=0.476  Sum_probs=223.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|..+++||+|.||.||+|++..||+.||||.++.....+. ......+|++.|+.++|+||+.++++|.....+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG-i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG-INRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC-ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            578899999999999999999999999999999988654333 3344678999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc-c
Q 011698          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-N  307 (479)
Q Consensus       230 E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~-~  307 (479)
                      |||+. +|...++.. ..++..+++.|+.++++||+|||++.|+||||||+|+||+.+|.+||+|||+|+.+...... .
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            99986 888888765 46899999999999999999999999999999999999999999999999999997655433 3


Q ss_pred             cccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cC---------CCC------
Q 011698          308 SMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KI---------KLP------  369 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~---------~~p------  369 (479)
                      ..+-|.+|.|||.+.| +.|+..+||||.|||+.||+-|.+-|.|.+.-+....|..-  .+         .+|      
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence            3478999999999988 57999999999999999999999999998887777777652  11         111      


Q ss_pred             -----------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          370 -----------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       370 -----------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                 ...+.++.+|+.+||..||.+|+     ++.|+++|+||+..
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Ri-----ta~qaL~~~yf~~~  287 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRI-----TASQALKHPYFKSL  287 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcc-----cHHHHhcchhhhcC
Confidence                       12578899999999999999999     89999999999873

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-47  Score=379.01  Aligned_cols=253  Identities=32%  Similarity=0.491  Sum_probs=216.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            479999999999999999999999999999999976532 2234556788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC--Ccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RSN  307 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~--~~~  307 (479)
                      ||+.++.+..+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..+....  ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            999998776655555679999999999999999999999999999999999999999999999999998764332  233


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-------------------CCC
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------------------IKL  368 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-------------------~~~  368 (479)
                      ...||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+....+....                   ..+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            4679999999999999999999999999999999999999998876544433332210                   011


Q ss_pred             -------------CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          369 -------------PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       369 -------------p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                                   ...++.++.+||++||++||++|+     +++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~-----s~~~~l~hp~f  287 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY-----LTEQCLNHPAF  287 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCC-----CHHHHhcCCCC
Confidence                         123688899999999999999999     99999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-50  Score=397.83  Aligned_cols=255  Identities=27%  Similarity=0.486  Sum_probs=234.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ..|+.+++||+|+||.||+|.+..+++.||+|++..+.  .+...+.+++|+.+|.+++++||.++|++|-.+..++++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            46888899999999999999999999999999998765  3445677899999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Cccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~~  308 (479)
                      |||.||++.+.+...+.+.|..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+.... +..+
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            999999999999998888999999999999999999999999999999999999999999999999998876554 3488


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCccCCHHHHHHHHhhhhhc
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      ++|||.|||||++.+.+|+.++||||||++.|||++|.+|+....++.....|.+..+ .+...+|+.+++||..||++|
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~  250 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKN  250 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcC
Confidence            9999999999999999999999999999999999999999999888777777776643 355679999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHhCccccCC
Q 011698          388 ASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      |+.||     +|.++++|+|++..
T Consensus       251 P~~Rp-----sA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  251 PEFRP-----SAKELLKHKFIKRA  269 (467)
T ss_pred             cccCc-----CHHHHhhhHHHHhc
Confidence            99999     99999999999974

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.6e-49  Score=370.27  Aligned_cols=258  Identities=30%  Similarity=0.538  Sum_probs=236.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhh-----chHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeC
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-----MEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK  222 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~  222 (479)
                      .+.|+--+.||+|..+.|-++.++.+|..+|+|++.....     ......+.-.+|+.||+++ .||+|+++.++|+++
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            4567778899999999999999999999999999965221     1223445567899999997 699999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      ..+++|+|.|+.|.|+++|...-.++|...+.+++|++.|++|||.++||||||||+|||++++.++||+|||+++.+..
T Consensus        96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcccccCCCCCcchhHhcC------CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccC
Q 011698          303 NTRSNSMCGTLEYMSPEIVLG------KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFL  372 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~------~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~  372 (479)
                      +.+....||||+|+|||.+..      .+|+..+|+||+|||||-|+.|.+||......-+...|+.+++.|-    ..+
T Consensus       176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadi  255 (411)
T KOG0599|consen  176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADI  255 (411)
T ss_pred             chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhc
Confidence            999999999999999999964      4688999999999999999999999999999999999999988764    258


Q ss_pred             CHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       373 s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      |.+.++||.+||+.||.+|+     |++|+|+||||..+
T Consensus       256 s~~~KdLIsrlLqVdp~~Ri-----take~LaHpff~q~  289 (411)
T KOG0599|consen  256 SATVKDLISRLLQVDPTKRI-----TAKEALAHPFFIQI  289 (411)
T ss_pred             cccHHHHHHHHHeeCchhcc-----cHHHHhcChHHHHH
Confidence            99999999999999999999     99999999999765

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.2e-47  Score=373.80  Aligned_cols=271  Identities=37%  Similarity=0.705  Sum_probs=240.0

Q ss_pred             eccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCCcH
Q 011698          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (479)
Q Consensus       158 LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL  237 (479)
                      ||+|+||+||+|.+..+|+.||+|++.+...........+..|+.+|++++||||+++++.+...+.+|+||||++|++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999999999999999999875544444455667899999999999999999999999999999999999999


Q ss_pred             HHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccccCCCCC
Q 011698          238 FFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY  315 (479)
Q Consensus       238 ~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt~~y  315 (479)
                      .+++.+.+  .+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.............++..|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY  160 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence            99998766  7899999999999999999999999999999999999999999999999999876544444556788899


Q ss_pred             cchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhh
Q 011698          316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR----QKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKR  391 (479)
Q Consensus       316 ~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R  391 (479)
                      +|||.+.+..++.++|+|||||++|+|++|+.||...+.    ..+...+......++..+++++.++|++||+.||.+|
T Consensus       161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  240 (277)
T cd05577         161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR  240 (277)
T ss_pred             CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHc
Confidence            999999988899999999999999999999999977543    3444444445566777889999999999999999999


Q ss_pred             cCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccc
Q 011698          392 LGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE  428 (479)
Q Consensus       392 ~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~  428 (479)
                      ++.+..++.++++||||+.++|.++.+....|+|.|+
T Consensus       241 ~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~  277 (277)
T cd05577         241 LGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIPD  277 (277)
T ss_pred             cCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCCC
Confidence            9887779999999999999999999998888988763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.6e-47  Score=380.57  Aligned_cols=257  Identities=28%  Similarity=0.444  Sum_probs=212.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++++.||+|+||+||+|+++.+++.||+|+++....  ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            3689999999999999999999999999999999975432  12233467899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCc
Q 011698          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRS  306 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~  306 (479)
                      |||+.+ +|...+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... ...
T Consensus        82 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  160 (303)
T cd07869          82 FEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY  160 (303)
T ss_pred             EECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence            999965 67666655 456899999999999999999999999999999999999999999999999999764322 233


Q ss_pred             ccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhc--cC----------------
Q 011698          307 NSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIKD--KI----------------  366 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~-~~~~~~i~~~--~~----------------  366 (479)
                      ...+||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ......+...  ..                
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence            456789999999998764 578999999999999999999999987432 2222222110  00                


Q ss_pred             ---C--CC---------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          367 ---K--LP---------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       367 ---~--~p---------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                         .  .|         ..++.++.+||.+||+.||++|+     |++|+++||||+++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~-----s~~~~l~h~~f~~~~~  296 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRL-----SAQAALSHEYFSDLPP  296 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhcc-----CHHHHhcCcccccCCh
Confidence               0  00         02457899999999999999999     9999999999999865

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.9e-47  Score=376.84  Aligned_cols=253  Identities=30%  Similarity=0.485  Sum_probs=215.8

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      .+++|++++.||.|+||+||+|+++.+++.||+|+++....  ......+.+|+.++++++||||+++++++.+....++
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            35789999999999999999999999999999999975432  1223456789999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-C
Q 011698          228 VLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-R  305 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~  305 (479)
                      ||||+.+ +|..++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...... .
T Consensus        81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~  159 (288)
T cd07871          81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT  159 (288)
T ss_pred             EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence            9999986 8888886654 57899999999999999999999999999999999999999999999999997653322 2


Q ss_pred             cccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-------------------
Q 011698          306 SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------------------  365 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-------------------  365 (479)
                      .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+....                   
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            345678999999999876 568999999999999999999999999877666555543310                   


Q ss_pred             CCCC-----------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          366 IKLP-----------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       366 ~~~p-----------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      ..+|           ..++.++.+||++||+.||.+|+     |++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~-----t~~~~l~hp~f  288 (288)
T cd07871         240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRI-----SAEAALRHSYF  288 (288)
T ss_pred             cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCC-----CHHHHhcCCCC
Confidence            0111           24688999999999999999999     99999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.6e-46  Score=378.76  Aligned_cols=258  Identities=25%  Similarity=0.419  Sum_probs=223.5

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|++++.||+|+||.||+|+++.++..||+|++....  .....+.+.+|+++|++++||||+++++++...+.+++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4579999999999999999999999999999999997642  23345668899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~  306 (479)
                      ||||++||+|.+++.+...+++..++.++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||++..+... ..
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  159 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA  159 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-cc
Confidence            999999999999999888899999999999999999999986 6999999999999999999999999999876432 33


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------------------------
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII------------------------  362 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~------------------------  362 (479)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+.                        
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence            45679999999999999999999999999999999999999997655544332211                        


Q ss_pred             ----------------------hc-cCCCC-ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          363 ----------------------KD-KIKLP-AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       363 ----------------------~~-~~~~p-~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                                            .+ ....+ ..++.++++||++||++||++||     ++++|++||||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rp-----t~~ell~h~~~~~~~~  309 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERA-----DLKMLMNHTFIKRSEV  309 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCC-----CHHHHhcChHHhhccc
Confidence                                  11 11111 24688999999999999999999     9999999999987543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-47  Score=389.53  Aligned_cols=256  Identities=34%  Similarity=0.545  Sum_probs=240.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe-EEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR-LYL  227 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~-~~l  227 (479)
                      +++|+.+++||+|+||.+++++++..+..|++|.++......... +...+|..++++++|||||.+++.|..++. ++|
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            578999999999999999999999999999999999877655544 367889999999999999999999999888 999


Q ss_pred             EEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-
Q 011698          228 VLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-  304 (479)
                      ||+||+||+|...+.+++  .|+|+.+..|+.||+.|+.|||+++|+|||||+.||++++++.|||+|||+|+.+.... 
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            999999999999997654  69999999999999999999999999999999999999999999999999999988776 


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCccCCHHHHHHHHhh
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~lI~~~  383 (479)
                      ...+.+|||.||+||++.+.+|+.++|||||||++|||++-+++|.+.+...+..+|..+. .++|..++.+++.+|+.|
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~  241 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSM  241 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHH
Confidence            7788999999999999999999999999999999999999999999999999999999987 678899999999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          384 LQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      |.++|..||     ++.++|.+|....
T Consensus       242 l~~~P~~RP-----sa~~LL~~P~l~~  263 (426)
T KOG0589|consen  242 LRKNPEHRP-----SALELLRRPHLLR  263 (426)
T ss_pred             hhcCCccCC-----CHHHHhhChhhhh
Confidence            999999999     9999999988874

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-46  Score=372.78  Aligned_cols=278  Identities=45%  Similarity=0.813  Sum_probs=241.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+..|+.+++.++||||+++++.+......|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999998766554456677889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC---
Q 011698          230 DFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---  304 (479)
Q Consensus       230 E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~---  304 (479)
                      ||+.|++|..++.+.  ..+++..++.++.||+.||.|||+.|++|+||||+||+++.+|.++|+|||++.......   
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999988764  568999999999999999999999999999999999999999999999999987543211   


Q ss_pred             ---------------------------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHH
Q 011698          305 ---------------------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI  357 (479)
Q Consensus       305 ---------------------------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~  357 (479)
                                                 ......||..|+|||++.+..++.++||||||+++|+|++|..||.+.+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                       11234688999999999999999999999999999999999999998888888


Q ss_pred             HHHHHhccCCCCcc--CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccC
Q 011698          358 QQKIIKDKIKLPAF--LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVA  430 (479)
Q Consensus       358 ~~~i~~~~~~~p~~--~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~  430 (479)
                      ...+......++..  ++.+++++|++||.+||++|++.. .+++++++||||++++|..+..  ..||-.|.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~-~~~~~ll~~~~~~~~~~~~~~~--~~~~~~~~~~  312 (316)
T cd05574         241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK-RGAAEIKQHPFFRGVNWALIRH--TTPPIIPRPD  312 (316)
T ss_pred             HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCch-hhHHHHHcCchhhcCChhhccc--CCCCCCCCcc
Confidence            88887776666654  699999999999999999999211 1299999999999999998865  4455555543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.3e-46  Score=366.70  Aligned_cols=270  Identities=40%  Similarity=0.757  Sum_probs=226.0

Q ss_pred             EeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHH---hCCCCCeeeEeEEEeeCCeEEEEEEecc
Q 011698          157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT---KVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (479)
Q Consensus       157 ~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~---~l~hp~Iv~l~~~~~~~~~~~lV~E~~~  233 (479)
                      .||+|+||.||++.+..+++.||+|++.+.............+|..+++   ..+||+|+.+++.+...+.+++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999998755433332333344544444   3479999999999999999999999999


Q ss_pred             CCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccccCCC
Q 011698          234 GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL  313 (479)
Q Consensus       234 ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt~  313 (479)
                      ||+|..++...+.+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++....... .....||+
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~  159 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  159 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCc
Confidence            99999999888899999999999999999999999999999999999999999999999999997654322 23457999


Q ss_pred             CCcchhHhc-CCCCCccccchhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchh
Q 011698          314 EYMSPEIVL-GKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEAS  389 (479)
Q Consensus       314 ~y~APE~l~-~~~~~~~~DiwSLGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~  389 (479)
                      .|+|||.+. +..++.++|+|||||++|+|++|..||....   ...+..........+|..++.+++++|++||++||+
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  239 (279)
T cd05633         160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS  239 (279)
T ss_pred             CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHH
Confidence            999999986 4668999999999999999999999997532   233333333445567788999999999999999999


Q ss_pred             hhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcc
Q 011698          390 KRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP  427 (479)
Q Consensus       390 ~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p  427 (479)
                      +|+++...+++++++||||++++|.........+|-+|
T Consensus       240 ~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~  277 (279)
T cd05633         240 KRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIP  277 (279)
T ss_pred             HhcCCCCCCHHHHHhCccccCCCHhHHhcCCCCCCCCC
Confidence            99987777899999999999999988766555555444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.4e-45  Score=368.46  Aligned_cols=282  Identities=39%  Similarity=0.727  Sum_probs=244.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||.||++.++.+++.||+|.+.+...........+.+|+++++.++||||+++++.+..+..+|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999998765444455567788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC------
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------  303 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~------  303 (479)
                      ||++|++|..++...+.+++..++.++.|++.||.|||++|++||||||+||+++.+|.+||+|||+++.....      
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998642100      


Q ss_pred             ----------CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc---
Q 011698          304 ----------TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA---  370 (479)
Q Consensus       304 ----------~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~---  370 (479)
                                .......|+..|+|||.+.+..++.++|+|||||++|||++|..||.+.+..++...+..+....|.   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE  240 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence                      0112346788999999999988999999999999999999999999988888888888776554443   


Q ss_pred             cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccc
Q 011698          371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCV  435 (479)
Q Consensus       371 ~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~  435 (479)
                      .++.++.++|++||++||++||++.  ++.++++||||...+|.......  ..++|.+....+.
T Consensus       241 ~~~~~~~~li~~~l~~~P~~R~~~~--~~~~ll~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  301 (305)
T cd05609         241 ALPADAQDLISRLLRQNPLERLGTG--GAFEVKQHRFFLGLDWNGLLRQK--AEFIPQLESEDDT  301 (305)
T ss_pred             cCCHHHHHHHHHHhccChhhccCcc--CHHHHHhCccccCCCHHHHhhcC--CCCCCCCCCcccc
Confidence            5789999999999999999999652  68999999999999999876443  3566766544433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.5e-46  Score=378.19  Aligned_cols=256  Identities=26%  Similarity=0.394  Sum_probs=213.0

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC-----CeE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----YRL  225 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~~  225 (479)
                      +|++.+.||+|+||.||+|+++.+++.||||++..... .......+.+|+.++++++||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            58999999999999999999999999999999875321 222344578899999999999999999887543     358


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-  304 (479)
                      |+||||+. ++|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... 
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            99999995 5899999888889999999999999999999999999999999999999999999999999998643221 


Q ss_pred             ---CcccccCCCCCcchhHhcC--CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------
Q 011698          305 ---RSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK----------------  363 (479)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~--~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~----------------  363 (479)
                         .....+||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+.......+..                
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence               1234679999999999976  6789999999999999999999999987654332221111                


Q ss_pred             ----------ccCCCC-----ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          364 ----------DKIKLP-----AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       364 ----------~~~~~p-----~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                                .....+     ..+++++.++|.+||+.||++||     +++|+++||||+++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~e~l~hp~f~~~~~  298 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP-----TAEEALADPYFKGLAK  298 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCC-----CHHHHhcCchhhhcCc
Confidence                      000000     24678899999999999999999     9999999999998654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-47  Score=369.09  Aligned_cols=255  Identities=29%  Similarity=0.453  Sum_probs=220.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee-----CCe
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-----KYR  224 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~~  224 (479)
                      ..|..++.||+|+||.|+.|.++.+|+.||||.+... .......++..+|+.+|+.++|+||+.+++.+..     -..
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            4566689999999999999999999999999999743 2344556778899999999999999999999866     357


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC--
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE--  302 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~--  302 (479)
                      +|+|+|+|+ .+|...++.+..++++.++.++.||++||.|+|+.+|+||||||.|+|++.+..+||+|||+|+....  
T Consensus       101 vYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             eEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            899999994 58988888888899999999999999999999999999999999999999999999999999998764  


Q ss_pred             -CCCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------------
Q 011698          303 -NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK-----------------  363 (479)
Q Consensus       303 -~~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~-----------------  363 (479)
                       ....+..+.|.+|.|||++.. ..|+.++||||+|||+.||++|++.|.|.+..+..+.|..                 
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence             344466778999999999865 6799999999999999999999999999775554444433                 


Q ss_pred             ------ccCCCC--------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          364 ------DKIKLP--------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       364 ------~~~~~p--------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                            ..+..|        +..++.+.+|+.+||..||.+|+     |++|+|+|||+...
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRi-----ta~eAL~hPYl~~~  316 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRI-----TAEEALAHPYLAPY  316 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccC-----CHHHHhcChhhhhh
Confidence                  111111        35799999999999999999999     99999999999885

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.6e-45  Score=363.48  Aligned_cols=270  Identities=38%  Similarity=0.745  Sum_probs=229.3

Q ss_pred             EeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHH---HHHHhCCCCCeeeEeEEEeeCCeEEEEEEecc
Q 011698          157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER---NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (479)
Q Consensus       157 ~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~---~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~  233 (479)
                      .||+|+||.||+|++..+++.||+|++.+..............|.   .+++...||+|+++++.+.+...+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999999875443222222233343   34445689999999999999999999999999


Q ss_pred             CCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccccCCC
Q 011698          234 GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL  313 (479)
Q Consensus       234 ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt~  313 (479)
                      ||+|..++.+.+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++..+... .....+|+.
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~  159 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTH  159 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCCc
Confidence            9999999988888999999999999999999999999999999999999999999999999999765432 234567999


Q ss_pred             CCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchh
Q 011698          314 EYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEAS  389 (479)
Q Consensus       314 ~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~  389 (479)
                      .|+|||.+.+. .++.++|+||+||++|||++|+.||.+.   ........+......+|..++.++.++|.+||..+|.
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~  239 (278)
T cd05606         160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN  239 (278)
T ss_pred             CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHH
Confidence            99999999754 6899999999999999999999999875   4444444555556778888899999999999999999


Q ss_pred             hhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcc
Q 011698          390 KRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP  427 (479)
Q Consensus       390 ~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p  427 (479)
                      +|+.++..+++++++||||+.++|..+......|+-+|
T Consensus       240 ~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~  277 (278)
T cd05606         240 RRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIP  277 (278)
T ss_pred             hccCCCCCCHHHHHhCccccCCCchHhhhcccCCCCCC
Confidence            99988878999999999999999999876665555444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.8e-46  Score=392.10  Aligned_cols=253  Identities=28%  Similarity=0.452  Sum_probs=213.0

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC-----
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----  222 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----  222 (479)
                      ...+|++.+.||+|+||+||+|.+..+++.||||++....       ....+|+.+|+.++||||++++++|...     
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            3468999999999999999999999999999999986532       1235699999999999999998877432     


Q ss_pred             ---CeEEEEEEeccCCcHHHHHH----HcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC-cEEEeec
Q 011698          223 ---YRLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDF  294 (479)
Q Consensus       223 ---~~~~lV~E~~~ggsL~~~l~----~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g-~vkL~DF  294 (479)
                         ..+++||||+++ +|...+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence               257899999986 5655553    346789999999999999999999999999999999999998665 6999999


Q ss_pred             CCccccCCCCCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------
Q 011698          295 GLAKQFDENTRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---------  364 (479)
Q Consensus       295 Gla~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~---------  364 (479)
                      |+|+.+.........+||+.|||||++.+. .|+.++|||||||++|||++|.+||.+.+..+...++...         
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            999987655555667899999999998764 6899999999999999999999999987766555544321         


Q ss_pred             --------cC------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          365 --------KI------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       365 --------~~------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                              .+            .+|...+.++.+||.+||++||.+|+     ++.|+++||||..+..
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~-----ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL-----NPIEALADPFFDDLRD  359 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCc-----CHHHHhCChhHHhhhc
Confidence                    11            13445788999999999999999999     9999999999988754

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.9e-45  Score=358.33  Aligned_cols=257  Identities=42%  Similarity=0.801  Sum_probs=232.3

Q ss_pred             eccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCCcH
Q 011698          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (479)
Q Consensus       158 LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL  237 (479)
                      ||.|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.++..+|+||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            79999999999999999999999999876555455567789999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccccCCCCCcc
Q 011698          238 FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS  317 (479)
Q Consensus       238 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~A  317 (479)
                      .+++.+...+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++.............|++.|+|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  160 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA  160 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence            99999888899999999999999999999999999999999999999999999999999988765544455688999999


Q ss_pred             hhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC--HHHHHHHHH--hccCCCCccCCHHHHHHHHhhhhhchhhhcC
Q 011698          318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN--RQKIQQKII--KDKIKLPAFLSSEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       318 PE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~  393 (479)
                      ||.+.+..++.++|+||||+++|+|++|..||...+  .......+.  .....+|...+.++.++|.+||+.+|.+|++
T Consensus       161 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~  240 (262)
T cd05572         161 PEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLG  240 (262)
T ss_pred             hhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcC
Confidence            999998889999999999999999999999998766  666777777  4567788888999999999999999999995


Q ss_pred             CCCCCHHHHHhCccccCCChh
Q 011698          394 SGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       394 ~~~~t~~eil~hp~f~~~~~~  414 (479)
                      ....+++|+++||||++.+|+
T Consensus       241 ~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         241 NLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             CcccCHHHHhcChhhhCCCCC
Confidence            433459999999999999995

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-45  Score=365.49  Aligned_cols=252  Identities=27%  Similarity=0.428  Sum_probs=211.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcC-CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC---CCCCeeeEeEEEe-----
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQ-----  220 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~-----  220 (479)
                      ++|++++.||+|+||+||+|++.. +++.||+|+++...... .......+|+.+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999854 57889999987643222 1223345677777665   6999999999885     


Q ss_pred             eCCeEEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcc
Q 011698          221 TKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (479)
Q Consensus       221 ~~~~~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~  298 (479)
                      ....+++||||+.+ +|..++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        80 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            34578999999974 888888654  358999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-----C------
Q 011698          299 QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-----K------  367 (479)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-----~------  367 (479)
                      ............||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+.....     .      
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence            76555555667899999999999999999999999999999999999999998877776666654210     0      


Q ss_pred             ----------------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          368 ----------------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       368 ----------------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                                      +.+.++..+++||.+||+.||++||     ++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----s~~~~l~hp~f  290 (290)
T cd07862         239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-----SAYSALSHPYF  290 (290)
T ss_pred             ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC-----CHHHHhcCCCC
Confidence                            1124678899999999999999999     99999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.2e-45  Score=375.10  Aligned_cols=255  Identities=29%  Similarity=0.478  Sum_probs=215.3

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      ...+++|+.++.||+|+||+||+|++..+++.||||++....  .......+.+|+.+++.++|+||+++++++.....+
T Consensus        70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            345678999999999999999999999999999999996543  233456688999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-  304 (479)
                      |+||||+.+|+|..    .....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.... 
T Consensus       148 ~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        148 QVLLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             EEEEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            99999999999853    2345778888899999999999999999999999999999999999999999998764332 


Q ss_pred             CcccccCCCCCcchhHhcC-----CCCCccccchhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH-hccCCCCccCCHH
Q 011698          305 RSNSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGNR---QKIQQKII-KDKIKLPAFLSSE  375 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~-----~~~~~~~DiwSLGvilyelltG~~Pf~~~~~---~~~~~~i~-~~~~~~p~~~s~~  375 (479)
                      ......||..|+|||++..     ...+.++|||||||++|||++|+.||.....   ......+. ......+..++.+
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE  303 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence            2345689999999998853     2345789999999999999999999974332   22233332 2344556788999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +++||.+||+.||++||     +++|+++||||...
T Consensus       304 l~~li~~~l~~~P~~Rp-----t~~ell~hp~~~~~  334 (353)
T PLN00034        304 FRHFISCCLQREPAKRW-----SAMQLLQHPFILRA  334 (353)
T ss_pred             HHHHHHHHccCChhhCc-----CHHHHhcCcccccC
Confidence            99999999999999999     99999999999885

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-45  Score=380.99  Aligned_cols=250  Identities=26%  Similarity=0.339  Sum_probs=210.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +...+|++++.||+|+||.||+|.+..+++.||+|+...         ..+.+|+++|++++||||++++++|......+
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            455789999999999999999999999999999997542         23578999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC--C
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--T  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~--~  304 (479)
                      +|||++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....  .
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            9999996 588888888888999999999999999999999999999999999999999999999999999754222  2


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh--------------
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN-------RQKIQQKIIK--------------  363 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~-------~~~~~~~i~~--------------  363 (479)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+       .......+..              
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            3345689999999999999999999999999999999999998875421       1111111111              


Q ss_pred             ------------ccCCCC---------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          364 ------------DKIKLP---------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       364 ------------~~~~~p---------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                  .....|         ..++.++.+||.+||+.||.+||     |++|+++||||+.+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rp-----ta~elL~hp~f~~~  382 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRP-----SAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCC-----CHHHHhcChhhccC
Confidence                        000001         12466899999999999999999     99999999999874

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.1e-45  Score=376.73  Aligned_cols=253  Identities=28%  Similarity=0.445  Sum_probs=214.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC------
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------  222 (479)
                      .++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...      
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            5789999999999999999999999999999999976432 233345577899999999999999999887543      


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      ..+|+||||+.+ +|...+..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            357999999976 56666643  478889999999999999999999999999999999999999999999999987655


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------------
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------  364 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~------------------  364 (479)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+...++...                  
T Consensus       179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (364)
T cd07875         179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  258 (364)
T ss_pred             CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHH
Confidence            54555678999999999999999999999999999999999999999987766655555431                  


Q ss_pred             ----cCCC--------------------CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          365 ----KIKL--------------------PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       365 ----~~~~--------------------p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                          ...+                    ....+.++++||.+||+.||.+||     |++++++||||..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~-----t~~e~L~hp~~~~  323 (364)
T cd07875         259 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI-----SVDEALQHPYINV  323 (364)
T ss_pred             HHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCC-----CHHHHhcCccccc
Confidence                0100                    011356789999999999999999     9999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.4e-45  Score=374.43  Aligned_cols=254  Identities=27%  Similarity=0.427  Sum_probs=212.3

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC----
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----  223 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----  223 (479)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++....    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            35799999999999999999999999999999999976432 2334556778999999999999999999986543    


Q ss_pred             --eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          224 --RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       224 --~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                        .+|+||||+.+ +|...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence              57999999986 4555553  347889999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------------
Q 011698          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK------------------  363 (479)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~------------------  363 (479)
                      .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..                  
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR  254 (359)
T ss_pred             cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence            44445567899999999999999999999999999999999999999987664433222211                  


Q ss_pred             ----ccCCC--------------------CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          364 ----DKIKL--------------------PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       364 ----~~~~~--------------------p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                          ....+                    +...+.++++||.+||+.||++||     |++|+++||||..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~-----t~~e~l~hp~~~~  320 (359)
T cd07876         255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI-----SVDEALRHPYITV  320 (359)
T ss_pred             HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCC-----CHHHHhcCchhhh
Confidence                11111                    112467899999999999999999     9999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6e-46  Score=362.64  Aligned_cols=257  Identities=29%  Similarity=0.510  Sum_probs=223.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCC-eeeEeEEEeeCC----
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTKY----  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~~~~~~----  223 (479)
                      +..|+.+++||+|+||+||+|+.+.+|+.||+|+++.+.-. +..-....+|+.+|+.++|+| ||++++++.+.+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            56788889999999999999999999999999999876432 122344678999999999999 999999999888    


Q ss_pred             --eEEEEEEeccCCcHHHHHHHcC----CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          224 --RLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       224 --~~~lV~E~~~ggsL~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                        .+++|+||++. +|..++....    .++...++.++.||+.||+|||+++|+||||||+||||+++|.+||+|||+|
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              89999999976 8888887655    5777899999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCC-cccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--c---C----
Q 011698          298 KQFDENTR-SNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--K---I----  366 (479)
Q Consensus       298 ~~~~~~~~-~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~---~----  366 (479)
                      +.+.-..+ ....++|.+|.|||++.|. .|+..+||||+|||++||++++..|.+.+..+...+|.+-  .   -    
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            98764443 5667899999999999997 7899999999999999999999999999888777777651  1   1    


Q ss_pred             ---------CCC------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          367 ---------KLP------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       367 ---------~~p------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                               .++            +..+.+..+++.+||+.+|.+|.     +++.++.||||....
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~-----Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRI-----SAKGALTHPYFSELP  309 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCc-----CHHHHhcChhhcccc
Confidence                     111            12345899999999999999999     999999999999873

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1e-44  Score=359.02  Aligned_cols=277  Identities=48%  Similarity=0.909  Sum_probs=239.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEc---CCCeEEEEEEeehhhhc-hHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIM-EKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~  225 (479)
                      +|++.+.||.|+||.||+|++.   .+|+.||+|+++..... .....+.+.+|+.+++++ +|+||++++++++....+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999885   47899999999864432 223446678899999999 599999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-  304 (479)
                      |+||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            9999999999999999988889999999999999999999999999999999999999999999999999998754322 


Q ss_pred             -CcccccCCCCCcchhHhcCC--CCCccccchhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhccCCCCccCCHHHH
Q 011698          305 -RSNSMCGTLEYMSPEIVLGK--GHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAH  377 (479)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~--~~~~~~DiwSLGvilyelltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~  377 (479)
                       ......|+..|+|||.+.+.  .++.++|+||||+++|+|++|..||...    ....+...+......+|..++..+.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T cd05613         161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK  240 (290)
T ss_pred             cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence             23356789999999998753  4688999999999999999999999643    2344555555566677888999999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcc
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP  427 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p  427 (479)
                      ++|.+||+.||++|+++.+.++++++.||||..++|+.+..+..+++|.|
T Consensus       241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  290 (290)
T cd05613         241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAPFKP  290 (290)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhhccCCCCCCC
Confidence            99999999999999988888999999999999999999887777777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.2e-46  Score=364.46  Aligned_cols=249  Identities=34%  Similarity=0.551  Sum_probs=216.6

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-----eE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----RL  225 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----~~  225 (479)
                      .|+-.+++|.|+||.||+|....+++.||||.+-.+..       .-.+|..+|+.++|||||+|..+|....     .+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            58889999999999999999999999999999876532       2346999999999999999998885432     46


Q ss_pred             EEEEEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC-CcEEEeecCCcccc
Q 011698          226 YLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQF  300 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~-g~vkL~DFGla~~~  300 (479)
                      .+|||||+. +|...++.    +..++.-.++.|+.||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+.+
T Consensus        98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen   98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            789999986 88888874    5678888999999999999999999999999999999999987 89999999999998


Q ss_pred             CCCCCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------
Q 011698          301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---------------  364 (479)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~---------------  364 (479)
                      ..+....+...|..|.|||.+.| ..|+.+.||||.||++.||+-|++-|.|.+..+....|.+-               
T Consensus       177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence            87777788888999999999988 56999999999999999999999999998876666655540               


Q ss_pred             --cCCC------------CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          365 --KIKL------------PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       365 --~~~~------------p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                        ...+            ....++++.+|+.++|..+|++|.     ++.|++.||||....
T Consensus       257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~-----~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL-----SALEALAHPFFDELR  313 (364)
T ss_pred             cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC-----CHHHHhcchhhHHhh
Confidence              1112            234789999999999999999999     899999999998753

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.3e-45  Score=370.31  Aligned_cols=256  Identities=27%  Similarity=0.463  Sum_probs=220.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|++.++||+|+||.||+|+++.++..+|+|++....  .....+.+.+|++++++++||||++++++|.+.+.+|+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            4578999999999999999999999999999999987642  23345668899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~  306 (479)
                      ||||+.||+|.+++.+.+.+++..++.++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||++..+... ..
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~  159 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA  159 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-cc
Confidence            999999999999999888899999999999999999999985 7999999999999999999999999999765332 23


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHH--------------------------
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQK--------------------------  360 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~--------------------------  360 (479)
                      ...+||..|+|||++.+..++.++|+|||||++|||++|+.||...+...+...                          
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (333)
T cd06650         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS  239 (333)
T ss_pred             ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence            456799999999999999999999999999999999999999976544332211                          


Q ss_pred             ------------------HHhc-cCCCC-ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          361 ------------------IIKD-KIKLP-AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       361 ------------------i~~~-~~~~p-~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                        +... ...++ ..++.++++||.+||++||++||     +++|++.|+||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rp-----t~~ell~h~~~~~~  305 (333)
T cd06650         240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERA-----DLKQLMVHAFIKRS  305 (333)
T ss_pred             hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCc-----CHHHHhhCHHHhcC
Confidence                              1111 11122 13678999999999999999999     99999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6e-45  Score=386.94  Aligned_cols=254  Identities=31%  Similarity=0.508  Sum_probs=226.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCC-CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGT-SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      ..|.+.+.||+|+||.||+|....+ ++.||+|.+...   .......+++|+.+|+.++|||||++++++...+.+|+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            4599999999999999999998877 788999987543   233445678899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          229 LDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      |||++||+|..++..    ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+....
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999999887753    3568999999999999999999999999999999999999999999999999998764332


Q ss_pred             ---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCccCCHHHHHHH
Q 011698          305 ---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLL  380 (479)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~lI  380 (479)
                         .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+..+.. .+|..++.++.+||
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  303 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL  303 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHH
Confidence               24567899999999999999999999999999999999999999999888888888877654 46778999999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      .+||++||++||     ++++++.|+|++.+
T Consensus       304 ~~~L~~dP~~Rp-----s~~~~l~~~~~~~~  329 (478)
T PTZ00267        304 DPLLSKNPALRP-----TTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHhccChhhCc-----CHHHHHhCHHHHHH
Confidence            999999999999     89999999999754

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=352.60  Aligned_cols=254  Identities=33%  Similarity=0.510  Sum_probs=224.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc--hHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++......  .......+.+|+.++++++||||+++++++.....+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5789999999999999999999999999999998754322  22334568899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc-
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-  306 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~-  306 (479)
                      |+||++|++|.+.+...+.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++........ 
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999999865432211 


Q ss_pred             ---ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCccCCHHHHHHHH
Q 011698          307 ---NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSLLK  381 (479)
Q Consensus       307 ---~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~lI~  381 (479)
                         ....|+..|+|||++.+..++.++||||||+++|||++|+.||...+.......+...  ...+|..++..+.++|+
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  241 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR  241 (263)
T ss_pred             ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHH
Confidence               3456889999999999999999999999999999999999999877666555555443  45577889999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      +||+++|.+||     ++.++++|+||
T Consensus       242 ~~l~~~p~~Rp-----t~~~ll~~~~~  263 (263)
T cd06625         242 RTFVENAKKRP-----SAEELLRHFFV  263 (263)
T ss_pred             HHhhcCcccCC-----CHHHHhhCCCC
Confidence            99999999999     99999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.6e-45  Score=386.82  Aligned_cols=252  Identities=25%  Similarity=0.407  Sum_probs=207.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC------CCeeeEeEEEee
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH------PFIVQLRYSFQT  221 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h------p~Iv~l~~~~~~  221 (479)
                      ..++|+++++||+|+||+||+|.+..+++.||||+++...    ......+.|+.+++.++|      .+|++++++|..
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            4578999999999999999999999999999999997532    122334567777776654      458899888876


Q ss_pred             C-CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEeCCCC------------
Q 011698          222 K-YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADG------------  287 (479)
Q Consensus       222 ~-~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl~~~g------------  287 (479)
                      . .++|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++            
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence            5 5789999988 67898999888899999999999999999999998 5999999999999998776            


Q ss_pred             ----cEEEeecCCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 011698          288 ----HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK  363 (479)
Q Consensus       288 ----~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~  363 (479)
                          .+||+|||++...  .......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+..
T Consensus       282 ~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~  359 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK  359 (467)
T ss_pred             CCCceEEECCCCccccC--ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence                4999999998643  2334567899999999999999999999999999999999999999988776554444332


Q ss_pred             ccCCCCc------------------------------------------cCCHHHHHHHHhhhhhchhhhcCCCCCCHHH
Q 011698          364 DKIKLPA------------------------------------------FLSSEAHSLLKGLLQKEASKRLGSGPGGSQE  401 (479)
Q Consensus       364 ~~~~~p~------------------------------------------~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~e  401 (479)
                      ....+|.                                          ..+..+.+||.+||++||.+|+     +++|
T Consensus       360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~-----ta~e  434 (467)
T PTZ00284        360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL-----NARQ  434 (467)
T ss_pred             HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC-----CHHH
Confidence            1111110                                          1145678999999999999999     9999


Q ss_pred             HHhCccccCC
Q 011698          402 IKSHKWFKMI  411 (479)
Q Consensus       402 il~hp~f~~~  411 (479)
                      +++||||...
T Consensus       435 ~L~Hp~~~~~  444 (467)
T PTZ00284        435 MTTHPYVLKY  444 (467)
T ss_pred             HhcCcccccc
Confidence            9999999763

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.7e-45  Score=364.74  Aligned_cols=255  Identities=28%  Similarity=0.486  Sum_probs=215.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|++++.||+|+||.||+|+++.+++.||+|+++....  ......+.+|+.++++++||||+++++++..++..|+|
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            5789999999999999999999999999999999976432  12233466799999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Cc
Q 011698          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RS  306 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~  306 (479)
                      |||+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            999986 777777654 458899999999999999999999999999999999999999999999999997653322 23


Q ss_pred             ccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------------cC
Q 011698          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------------KI  366 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-------------------~~  366 (479)
                      ....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.+..+....+...                   ..
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            34578999999999876 45789999999999999999999999887765554444321                   01


Q ss_pred             CCC-----------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          367 KLP-----------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       367 ~~p-----------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      .+|           ..++.++++||++||+.||.+|+     |++|+++||||+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~~~~~  292 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI-----SAEEAMKHAYFRSL  292 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCC-----CHHHHhcChhhhhc
Confidence            111           24688999999999999999999     99999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.7e-45  Score=359.83  Aligned_cols=251  Identities=29%  Similarity=0.443  Sum_probs=209.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC---CCCCeeeEeEEEee-----C
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQT-----K  222 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~-----~  222 (479)
                      +|++++.||+|+||+||+|+++.+++.||+|+++...... .......+|+.+++.+   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            5899999999999999999999999999999987643211 1122345566666654   79999999998864     3


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~  300 (479)
                      ..+++||||+.+ +|..++.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            468999999985 788887664  34899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------CC--
Q 011698          301 DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-----------IK--  367 (479)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-----------~~--  367 (479)
                      ..........||..|+|||++.+..++.++|||||||++|||++|.+||.+.+......++....           ..  
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP  238 (288)
T ss_pred             cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence            55544556678999999999999999999999999999999999999998877666555554310           00  


Q ss_pred             --------------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          368 --------------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       368 --------------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                                    ..+.++..+.+||.+||++||++||     ++.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~~~l~hp~f  288 (288)
T cd07863         239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI-----SAFRALQHPFF  288 (288)
T ss_pred             ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCC-----CHHHHhcCCCC
Confidence                          1124678899999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.1e-45  Score=354.25  Aligned_cols=251  Identities=37%  Similarity=0.637  Sum_probs=217.5

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEe
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~  231 (479)
                      |++++.||+|+||+||+|++..+++.||+|++......... .....+|+.++++++||||+++++++.....+++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            78999999999999999999999999999999887543333 23345599999999999999999999999999999999


Q ss_pred             ccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCCCCccccc
Q 011698          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMC  310 (479)
Q Consensus       232 ~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~~~~~~~~  310 (479)
                      +.+++|..++...+.+++..+..++.||+.||.+||++||+|+||||+||+++.++.++|+|||.+... ..........
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999998889999999999999999999999999999999999999999999999999999763 3334456678


Q ss_pred             CCCCCcchhHhc-CCCCCccccchhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCC----CccCCHHHHHHHHh
Q 011698          311 GTLEYMSPEIVL-GKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKIKL----PAFLSSEAHSLLKG  382 (479)
Q Consensus       311 gt~~y~APE~l~-~~~~~~~~DiwSLGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~----p~~~s~~~~~lI~~  382 (479)
                      +|..|+|||++. +..++.++|+||||+++|+|++|..||...+   ......+........    ....+.++.++|+.
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  239 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK  239 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence            899999999998 8889999999999999999999999999873   333333333322211    11224899999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      ||+.||++||     ++.++++||||
T Consensus       240 ~l~~~p~~R~-----~~~~l~~~~~~  260 (260)
T PF00069_consen  240 MLSKDPEQRP-----SAEELLKHPWF  260 (260)
T ss_dssp             HSSSSGGGST-----THHHHHTSGGG
T ss_pred             HccCChhHCc-----CHHHHhcCCCC
Confidence            9999999999     89999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8e-45  Score=387.22  Aligned_cols=260  Identities=30%  Similarity=0.494  Sum_probs=228.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC----
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----  223 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----  223 (479)
                      ..++|++.+.||+|+||+||+|++..+++.||||++...... ......+.+|+.++..++|+||++++..+....    
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            347999999999999999999999999999999999876543 334566788999999999999999988775432    


Q ss_pred             ----eEEEEEEeccCCcHHHHHHHc----CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecC
Q 011698          224 ----RLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFG  295 (479)
Q Consensus       224 ----~~~lV~E~~~ggsL~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFG  295 (479)
                          .+++||||+++|+|.+++...    ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence                378999999999999988653    468999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCC---CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCcc
Q 011698          296 LAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAF  371 (479)
Q Consensus       296 la~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~  371 (479)
                      +++.+...   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+..+.. .+|..
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  268 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS  268 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence            99865322   233567899999999999999999999999999999999999999999888888888877644 46788


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      +++++.+||..||+.||.+||     ++.++++|||++...-
T Consensus       269 ~~~~l~~li~~~L~~dP~~RP-----s~~ell~~p~~~~~~~  305 (496)
T PTZ00283        269 ISPEMQEIVTALLSSDPKRRP-----SSSKLLNMPICKLFIS  305 (496)
T ss_pred             CCHHHHHHHHHHcccChhhCc-----CHHHHHhCHHHHHhhh
Confidence            999999999999999999999     8999999999987543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-46  Score=377.78  Aligned_cols=249  Identities=24%  Similarity=0.421  Sum_probs=219.7

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      ..+..+.+++++.||+|.||.||+|.++++. .||+|.++.....    .+.+.+|+++|++|+|++||++++++..+..
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p  275 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEP  275 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCCC-cccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence            3444556778899999999999999997654 4999999875433    2346689999999999999999999999889


Q ss_pred             EEEEEEeccCCcHHHHHHH--cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          225 LYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      +|||||||+.|+|.++|+.  ++.+...+...++.|||+||+||+++++|||||..+||||++++.+||+|||+|+.+.+
T Consensus       276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence            9999999999999999987  46689999999999999999999999999999999999999999999999999996544


Q ss_pred             CCCccc--ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHH
Q 011698          303 NTRSNS--MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (479)
Q Consensus       303 ~~~~~~--~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (479)
                      +.....  .--...|.|||.+....++.++|||||||+||||+| |+.||.+.+..++.+.+.++ +++-|..++.++.+
T Consensus       356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~  435 (468)
T KOG0197|consen  356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYE  435 (468)
T ss_pred             CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHH
Confidence            432222  222457999999999999999999999999999999 99999999999999999988 78889999999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHH
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIK  403 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil  403 (479)
                      +++.||..+|++||     |++.+.
T Consensus       436 lM~~CW~~~P~~RP-----tF~~L~  455 (468)
T KOG0197|consen  436 LMKSCWHEDPEDRP-----TFETLR  455 (468)
T ss_pred             HHHHHhhCCcccCC-----CHHHHH
Confidence            99999999999999     666543

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-46  Score=381.49  Aligned_cols=261  Identities=33%  Similarity=0.592  Sum_probs=247.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ....|.+++.||+|.|++|.+|++..++..||||++.+....... ...+.+|+++|+.++|||||+++.+..++..+|+
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            356799999999999999999999999999999999987765444 3448899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcc
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~  307 (479)
                      ||||+.+|.+++++.+.+...+..++.++.|++.|++|||+++|+|||||.+||||+.+.++||+|||++..+.......
T Consensus       133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq  212 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ  212 (596)
T ss_pred             EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999989999


Q ss_pred             cccCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhh
Q 011698          308 SMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~  386 (479)
                      +.||++.|.|||++.+..| +..+|+||||+++|-|+.|.+||++.+..++..+.+.+++.+|..++.++.++|+++|..
T Consensus       213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl  292 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVL  292 (596)
T ss_pred             ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHhhcc
Confidence            9999999999999999888 689999999999999999999999999999999999999999999999999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          387 EASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                      +|.+|+     +.++|..|.|...-.-.
T Consensus       293 ~Pskr~-----~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  293 NPSKRG-----PCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             CccccC-----CHHHhhhhcccchhhhh
Confidence            999998     89999999999875544

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.2e-45  Score=375.68  Aligned_cols=256  Identities=24%  Similarity=0.352  Sum_probs=217.5

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-----eE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----RL  225 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----~~  225 (479)
                      +|++++.||+|+||+||+|.+..+++.||+|++.... ......+.+.+|+.+|+.++||||+++++++....     .+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            5788999999999999999999999999999986532 12233456788999999999999999999998876     89


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC--
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~--  303 (479)
                      |+||||+. ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            99999997 478888888888999999999999999999999999999999999999999999999999999865322  


Q ss_pred             CCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------------
Q 011698          304 TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK-------------------  363 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~-------------------  363 (479)
                      .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......|..                   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence            223345689999999999875 479999999999999999999999988776655544432                   


Q ss_pred             ----ccC---------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          364 ----DKI---------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       364 ----~~~---------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                          ...         .+....+.++.+||.+||+.||++||     +++|+++||||++..+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~-----t~~e~l~hp~~~~~~~  296 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI-----SAADALAHPYLDEGRL  296 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc-----CHHHHhcCHhhCCCcc
Confidence                111         12234688999999999999999999     9999999999998654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-44  Score=370.03  Aligned_cols=255  Identities=26%  Similarity=0.416  Sum_probs=213.5

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC-----
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----  222 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----  222 (479)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            35799999999999999999999999999999999976432 233445677899999999999999999988654     


Q ss_pred             -CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 -YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 -~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                       ..+|+||||+++ +|...+..  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence             357999999986 56555543  47889999999999999999999999999999999999999999999999998766


Q ss_pred             CCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----------------
Q 011698          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-----------------  364 (479)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-----------------  364 (479)
                      .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...                 
T Consensus       171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (355)
T cd07874         171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_pred             CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence            555556678999999999999999999999999999999999999999887654433322211                 


Q ss_pred             -----cC-----C---------------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          365 -----KI-----K---------------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       365 -----~~-----~---------------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                           ..     .               .+...+.++++||.+||+.||++||     |++|+++||||...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp-----s~~ell~hp~~~~~  317 (355)
T cd07874         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-----SVDEALQHPYINVW  317 (355)
T ss_pred             HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcC-----CHHHHhcCcchhcc
Confidence                 00     0               1122456789999999999999999     99999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=9.9e-45  Score=352.46  Aligned_cols=253  Identities=42%  Similarity=0.765  Sum_probs=228.9

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++.+.||.|+||.||+|++..+++.||+|++.+.........+.+.+|+.++++++||||+++++++.....+|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58999999999999999999999999999999987665554566778899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccccc
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC  310 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~  310 (479)
                      |+.|++|...+.....+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.............
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~  160 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS  160 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence            99999999999888889999999999999999999999999999999999999999999999999998765554455677


Q ss_pred             CCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhc
Q 011698          311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       311 gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      |+..|+|||.+.+..++.++|+||||+++|+|++|..||...+   ...+.+.+......+|..++.++.++|.+||+.|
T Consensus       161 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  240 (258)
T cd05578         161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERD  240 (258)
T ss_pred             CChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCC
Confidence            8999999999999889999999999999999999999998776   4444444444667788889999999999999999


Q ss_pred             hhhhcCCCCCCH--HHHHhCccc
Q 011698          388 ASKRLGSGPGGS--QEIKSHKWF  408 (479)
Q Consensus       388 P~~R~~~~~~t~--~eil~hp~f  408 (479)
                      |.+|+     ++  +|+++||||
T Consensus       241 p~~R~-----~~~~~~l~~~~~~  258 (258)
T cd05578         241 PQKRL-----GDNLKDLKNHPYF  258 (258)
T ss_pred             hhHcC-----CccHHHHhcCCCC
Confidence            99999     55  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-44  Score=350.54  Aligned_cols=254  Identities=43%  Similarity=0.802  Sum_probs=221.7

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHH-HhCCCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL-TKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +.||.|+||.||+|.+..+++.||+|++.+...........+..|..++ ...+|+||+++++++...+.+|+||||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999999999999999999765443333333444555444 456899999999999999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccccCCCC
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE  314 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt~~  314 (479)
                      ++|..++...+.+++..+..++.||+.||.|||+.+|+||||+|+||+++.++.+||+|||++.....   .....|++.
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~  158 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPD  158 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcC
Confidence            99999999888899999999999999999999999999999999999999999999999999976433   334568899


Q ss_pred             CcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHHHHHhhhhhchhh
Q 011698          315 YMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLKGLLQKEASK  390 (479)
Q Consensus       315 y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~lI~~~L~~dP~~  390 (479)
                      |+|||.+.+..++.++||||||+++|+|++|..||...+...+...+......++    ..++.++.++|.+||+.+|++
T Consensus       159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~  238 (260)
T cd05611         159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK  238 (260)
T ss_pred             ccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHH
Confidence            9999999988899999999999999999999999998888888777776654433    357899999999999999999


Q ss_pred             hcCCCCCCHHHHHhCccccCCChh
Q 011698          391 RLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       391 R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                      |+++.  +++|+++||||++++|+
T Consensus       239 R~~~~--~~~~~l~~~~~~~~~~~  260 (260)
T cd05611         239 RLGAN--GYQEIKSHPFFKSINWD  260 (260)
T ss_pred             ccCCC--cHHHHHcChHhhcCCCC
Confidence            99653  77999999999999995

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-46  Score=354.15  Aligned_cols=250  Identities=32%  Similarity=0.542  Sum_probs=222.5

Q ss_pred             CCCeEEE-EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHh-CCCCCeeeEeEEEee----C
Q 011698          149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQT----K  222 (479)
Q Consensus       149 ~~~y~~~-~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~----~  222 (479)
                      .++|.+- ++||-|-.|+|..+.++.||+.+|+|++....        ..++|+++--. -.|||||++++.|+.    .
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r  131 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQGR  131 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence            4677765 57999999999999999999999999986432        24667766444 479999999988754    5


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCC--CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC---CcEEEeecCCc
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD---GHVMLTDFGLA  297 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~---g~vkL~DFGla  297 (479)
                      ..+.+|||.|+||.|+..++.++.  |+|..+..++.||+.|+.|||+.+|.||||||||+|....   ..+||+|||+|
T Consensus       132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence            578999999999999999998875  9999999999999999999999999999999999999654   47999999999


Q ss_pred             cccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccCCCCc---
Q 011698          298 KQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN----RQKIQQKIIKDKIKLPA---  370 (479)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~----~~~~~~~i~~~~~~~p~---  370 (479)
                      +.-.......+.|-||+|.|||++..+.|+.++|+||+||+||-||+|.+||+...    ...+..+|..+.+.||.   
T Consensus       212 K~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW  291 (400)
T KOG0604|consen  212 KETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW  291 (400)
T ss_pred             cccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH
Confidence            98777777889999999999999999999999999999999999999999998754    35678899999999985   


Q ss_pred             -cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          371 -FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       371 -~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                       .+|++++++|+.||..+|++|+     |++++++|||+..-
T Consensus       292 s~VSe~aKdlIR~LLkt~PteRl-----TI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  292 SCVSEAAKDLIRKLLKTEPTERL-----TIEEVMDHPWINQY  328 (400)
T ss_pred             hHHHHHHHHHHHHHhcCCchhhe-----eHHHhhcCchhccc
Confidence             4899999999999999999999     99999999999874

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.5e-45  Score=379.17  Aligned_cols=249  Identities=30%  Similarity=0.456  Sum_probs=217.2

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-C-----CCeeeEeEEEeeCCe
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-H-----PFIVQLRYSFQTKYR  224 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-h-----p~Iv~l~~~~~~~~~  224 (479)
                      +|++++.||+|+||+|.+|.+..|++.||||++++..    ....+...|+.+|..|+ |     -|||+++++|...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            7999999999999999999999999999999998753    34566778999999996 3     489999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC--cEEEeecCCcccc
Q 011698          225 LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG--HVMLTDFGLAKQF  300 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g--~vkL~DFGla~~~  300 (479)
                      +|||+|.+.. +|+++++.+.  .|+...++.++.||+.||.+||+.||||+|||||||||..-+  .+||+|||.++..
T Consensus       263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999999965 9999998764  488999999999999999999999999999999999997654  7999999999875


Q ss_pred             CCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------------
Q 011698          301 DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD----------------  364 (479)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~----------------  364 (479)
                      ..  ...+.+.+..|.|||++.|.+|+.+.||||||||++||++|.+.|.|.+..+.+..|.+-                
T Consensus       342 ~q--~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~  419 (586)
T KOG0667|consen  342 SQ--RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAH  419 (586)
T ss_pred             CC--cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccc
Confidence            44  334778899999999999999999999999999999999999999998887777666650                


Q ss_pred             ----c--------------------------------CCCCc-----------cCCHHHHHHHHhhhhhchhhhcCCCCC
Q 011698          365 ----K--------------------------------IKLPA-----------FLSSEAHSLLKGLLQKEASKRLGSGPG  397 (479)
Q Consensus       365 ----~--------------------------------~~~p~-----------~~s~~~~~lI~~~L~~dP~~R~~~~~~  397 (479)
                          .                                ...|.           .-...+.+||++||..||.+|+     
T Consensus       420 kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~-----  494 (586)
T KOG0667|consen  420 KFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI-----  494 (586)
T ss_pred             eehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC-----
Confidence                0                                00120           1235679999999999999999     


Q ss_pred             CHHHHHhCccccCC
Q 011698          398 GSQEIKSHKWFKMI  411 (479)
Q Consensus       398 t~~eil~hp~f~~~  411 (479)
                      |+.++++||||.+.
T Consensus       495 tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  495 TPAQALNHPFLTGT  508 (586)
T ss_pred             CHHHHhcCcccccc
Confidence            99999999999964

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.8e-44  Score=353.78  Aligned_cols=275  Identities=49%  Similarity=0.907  Sum_probs=237.9

Q ss_pred             CeEEEEEeccCCceEEEEEEEc---CCCeEEEEEEeehhhhch-HHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~  225 (479)
                      +|++.+.||+|+||.||+|++.   .+++.||+|++++..... ....+.+.+|+.+++++ +||||+++++.+.....+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999999864   467889999998654322 23445678899999999 599999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-  304 (479)
                      |+||||+.+|+|...+.....+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++.+.... 
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999998754332 


Q ss_pred             -CcccccCCCCCcchhHhcCCC--CCccccchhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccCCCCccCCHHHH
Q 011698          305 -RSNSMCGTLEYMSPEIVLGKG--HDKAADWWSVGILLFEMLTGQPPFTGGN----RQKIQQKIIKDKIKLPAFLSSEAH  377 (479)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~~--~~~~~DiwSLGvilyelltG~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~  377 (479)
                       .....+|+..|+|||.+.+..  .+.++|+||||+++|||++|..||....    ..++.+.+.......|..++.++.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  240 (288)
T cd05583         161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR  240 (288)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence             233457899999999997765  7889999999999999999999996432    344555566666777888999999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcc
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP  427 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p  427 (479)
                      ++|.+||+.||++||+..  ++.++++||||++++|..+.+++..|+|.|
T Consensus       241 ~li~~~l~~~p~~R~t~~--~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  288 (288)
T cd05583         241 DFIQKLLEKDPKKRLGAN--GADEIKNHPFFQGIDWDDLAAKRIPAPFKP  288 (288)
T ss_pred             HHHHHHhcCCHhhccCcc--hHHHHhcCcccccCCHHHHhhhccCCCCCC
Confidence            999999999999999643  688999999999999999999999998865

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.4e-44  Score=349.03  Aligned_cols=254  Identities=45%  Similarity=0.842  Sum_probs=229.0

Q ss_pred             eccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCCcH
Q 011698          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (479)
Q Consensus       158 LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL  237 (479)
                      ||.|+||.||+|++..+++.||+|++...........+.+.+|++++++++||||+++++.+......|++|||+.|++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999999999999999876655556677788999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC---------Cccc
Q 011698          238 FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---------RSNS  308 (479)
Q Consensus       238 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~---------~~~~  308 (479)
                      ..++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......         ....
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            9999888889999999999999999999999999999999999999999999999999987643221         2234


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccC--CHHHHHHHHhhhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFL--SSEAHSLLKGLLQK  386 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~lI~~~L~~  386 (479)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..+...+|...  +..+.++|++||+.
T Consensus       161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  240 (265)
T cd05579         161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP  240 (265)
T ss_pred             cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcC
Confidence            5688999999999988899999999999999999999999998888888888888777777665  99999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          387 EASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      +|.+||+.  .++.++++||||+.++|
T Consensus       241 ~p~~Rpt~--~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         241 DPEKRLGA--KSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             CHhhcCCC--ccHHHHhcCccccCCCC
Confidence            99999943  14499999999999998

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.3e-44  Score=364.88  Aligned_cols=251  Identities=24%  Similarity=0.406  Sum_probs=208.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc-----CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEe
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQ  220 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~  220 (479)
                      +..++|++.+.||+|+||.||+|.+.     .+++.||+|+++...  .......+.+|+.+|+++ +||||+++++++.
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            45578999999999999999999853     345789999987542  223345678899999999 8999999999887


Q ss_pred             eC-CeEEEEEEeccCCcHHHHHHHc-------------------------------------------------------
Q 011698          221 TK-YRLYLVLDFVNGGHLFFQLYRQ-------------------------------------------------------  244 (479)
Q Consensus       221 ~~-~~~~lV~E~~~ggsL~~~l~~~-------------------------------------------------------  244 (479)
                      .. ..+++||||++||+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            64 4689999999999999988753                                                       


Q ss_pred             -------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC---CcccccCCCC
Q 011698          245 -------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLE  314 (479)
Q Consensus       245 -------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~---~~~~~~gt~~  314 (479)
                             ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+....   ......+++.
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                   236778888999999999999999999999999999999999999999999998653321   1223456788


Q ss_pred             CcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhc-cCCCCccCCHHHHHHHHhhhhhchhhh
Q 011698          315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK-IQQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKR  391 (479)
Q Consensus       315 y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R  391 (479)
                      |||||++.+..++.++|||||||++|||++ |..||.+....+ +...+..+ ....|..+++++.+||.+||+.||.+|
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  321 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER  321 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence            999999999999999999999999999997 999998765443 33333333 345677889999999999999999999


Q ss_pred             cCCCCCCHHHHHh
Q 011698          392 LGSGPGGSQEIKS  404 (479)
Q Consensus       392 ~~~~~~t~~eil~  404 (479)
                      |     ++.++++
T Consensus       322 P-----s~~el~~  329 (338)
T cd05102         322 P-----TFSALVE  329 (338)
T ss_pred             c-----CHHHHHH
Confidence            9     8888875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-43  Score=367.70  Aligned_cols=256  Identities=26%  Similarity=0.361  Sum_probs=215.5

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcC--CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      ...+|++++.||+|+||.||+|...+  +++.||+|.+....        ...+|+.+|++++||||+++++++.....+
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            34689999999999999999997653  56789999886532        245799999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      |+|||++. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus       162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            99999996 58888887778899999999999999999999999999999999999999999999999999987543322


Q ss_pred             ---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhc----c----------
Q 011698          306 ---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR---QKIQQKIIKD----K----------  365 (479)
Q Consensus       306 ---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~---~~~~~~i~~~----~----------  365 (479)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+...   ......+...    .          
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence               2356799999999999999999999999999999999999999976432   1111111110    0          


Q ss_pred             ---------------CCCC-----ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhh
Q 011698          366 ---------------IKLP-----AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLE  417 (479)
Q Consensus       366 ---------------~~~p-----~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~  417 (479)
                                     ...|     ..++.++.+||++||..||++||     ++.|+++||||....|+.+.
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp-----sa~e~l~~p~f~~~~~~~~~  387 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP-----SAQDILSLPLFTKEPINLLN  387 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCC-----CHHHHhhCchhhccchhhhc
Confidence                           1111     13467899999999999999999     99999999999999988774

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-45  Score=350.40  Aligned_cols=255  Identities=33%  Similarity=0.572  Sum_probs=225.7

Q ss_pred             eEEE-EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEEEEE
Q 011698          152 FEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       152 y~~~-~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      |++. +.||+|+|+.|--+....+|..||||++.|.   ......++.+|++++.+++ |+||++|+++|+++.++||||
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf  155 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF  155 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence            4443 5799999999999999999999999999875   3345667889999999985 999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC---cEEEeecCCccccCCCC--
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDFGLAKQFDENT--  304 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g---~vkL~DFGla~~~~~~~--  304 (479)
                      |.|.||.|..+++++..|+|..+..++.+|+.||.|||.+||.||||||||||...-.   -+|||||.+...+....  
T Consensus       156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            9999999999999999999999999999999999999999999999999999997665   48999999886543221  


Q ss_pred             ------CcccccCCCCCcchhHhc-----CCCCCccccchhhHHHHHHHHhCCCCCCCC-------C--------HHHHH
Q 011698          305 ------RSNSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGG-------N--------RQKIQ  358 (479)
Q Consensus       305 ------~~~~~~gt~~y~APE~l~-----~~~~~~~~DiwSLGvilyelltG~~Pf~~~-------~--------~~~~~  358 (479)
                            ...+.||+..|||||+..     ...|+.++|.||||||+|-||+|.+||.+.       +        ...++
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF  315 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF  315 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence                  234678999999999974     246899999999999999999999999762       1        46788


Q ss_pred             HHHHhccCCCCc----cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          359 QKIIKDKIKLPA----FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       359 ~~i~~~~~~~p~----~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                      ..|..+.+.||+    .+|.+++++|..+|.+|+.+|+     ++.++++|||+..+.-+
T Consensus       316 esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rl-----sa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  316 ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRL-----SAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhh-----hhhhccCCccccccchh
Confidence            999999999996    4899999999999999999999     89999999999998654

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-44  Score=367.56  Aligned_cols=250  Identities=26%  Similarity=0.388  Sum_probs=205.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +...+|++++.||+|+||+||+|++..+++.||+|+..+..         ...|+.++++++||||+++++++......+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence            33457999999999999999999999999999999865432         245899999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          227 LVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      +|||++.+ +|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       134 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  212 (357)
T PHA03209        134 MVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA  212 (357)
T ss_pred             EEEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence            99999965 77777754 46789999999999999999999999999999999999999999999999999986544444


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCC-CCCCCH---------HHHHHHHHhc----cCCCC--
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPP-FTGGNR---------QKIQQKIIKD----KIKLP--  369 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~P-f~~~~~---------~~~~~~i~~~----~~~~p--  369 (479)
                      .....||+.|+|||++.+..++.++|||||||++|||+++..+ |.....         ......+...    ...+|  
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            4567899999999999999999999999999999999995444 443111         0111111110    00111  


Q ss_pred             ----------------------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          370 ----------------------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       370 ----------------------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                                  ..++.++.+||++||+.||++||     |++|+++||||+.+
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp-----ta~e~l~hp~f~~~  357 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRP-----SAEEILNYPMFAQL  357 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCc-----CHHHHhcCchhccC
Confidence                                        13567788899999999999999     99999999999864

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.3e-44  Score=355.18  Aligned_cols=257  Identities=29%  Similarity=0.475  Sum_probs=216.6

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      .+++|++++.||.|+||.||+|+++.+++.||+|.++....  ......+.+|+.+++.++||||+++++++.....+|+
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            46789999999999999999999999999999999875432  1223346689999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-C
Q 011698          228 VLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-R  305 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~  305 (479)
                      ||||+.+ +|...+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus        82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence            9999975 888777654 568999999999999999999999999999999999999999999999999997653322 2


Q ss_pred             cccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------------c
Q 011698          306 SNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------------K  365 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-------------------~  365 (479)
                      .....+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+...                   .
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence            2345678999999998764 5788999999999999999999999887765554443321                   0


Q ss_pred             CCCC-----------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          366 IKLP-----------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       366 ~~~p-----------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      ..+|           ..+++++++||.+||+.||.+|+     |++|+++||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~-----t~~eil~h~~f~~~~  293 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI-----SAEEAMKHPYFHCLG  293 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCc-----CHHHHhcCccccccc
Confidence            1111           24688999999999999999999     999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.1e-43  Score=342.32  Aligned_cols=252  Identities=28%  Similarity=0.497  Sum_probs=221.8

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee-CCeEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-KYRLYLVL  229 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~~~lV~  229 (479)
                      +|++++.||+|++|.||++.++.+++.||+|.+...... ....+.+.+|+.++++++|+|++++++.+.. ...+|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            589999999999999999999999999999999765432 2334567889999999999999999988864 44689999


Q ss_pred             EeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCc
Q 011698          230 DFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRS  306 (479)
Q Consensus       230 E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~  306 (479)
                      ||+++++|.+++...  ..+++..++.++.+++.||.+||++||+||||||+||+++.++.++|+|||++..+... ...
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            999999999888763  45899999999999999999999999999999999999999999999999999876432 233


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCccCCHHHHHHHHhhhh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~lI~~~L~  385 (479)
                      ....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+..+.. ..+..++.++.++|.+||+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  239 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS  239 (257)
T ss_pred             ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhc
Confidence            456789999999999999999999999999999999999999998887777777766644 4567789999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccc
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      .||.+||     ++.++++||||
T Consensus       240 ~~p~~Rp-----~~~~~l~~~~~  257 (257)
T cd08223         240 KRPEKRP-----SVKSILRQPYI  257 (257)
T ss_pred             cCcccCC-----CHHHHhcCCCC
Confidence            9999999     89999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1e-43  Score=355.89  Aligned_cols=254  Identities=28%  Similarity=0.455  Sum_probs=218.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||+|+||.||+|++..++..||+|.+....  .......+.+|++++++++||||+++++++.+++.+|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            47999999999999999999999999999999987542  2334556788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~  308 (479)
                      ||++|++|..++.+.+.+++..++.++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++...... ....
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~  157 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS  157 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cccc
Confidence            999999999999988889999999999999999999997 59999999999999999999999999999765332 2345


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------------------
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------------  364 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~------------------------  364 (479)
                      .+|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+...                        
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM  237 (308)
T ss_pred             CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence            68899999999999888999999999999999999999999765543332222111                        


Q ss_pred             -------------cCCCC-ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          365 -------------KIKLP-AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       365 -------------~~~~p-~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                   .+..| ..++.++++||.+||..||++||     +++++++||||.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~ll~~~~~~~~  293 (308)
T cd06615         238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA-----DLKELTKHPFIKRA  293 (308)
T ss_pred             hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCc-----CHHHHhcChhhhhc
Confidence                         11122 13678999999999999999999     89999999999763

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.9e-44  Score=355.35  Aligned_cols=259  Identities=31%  Similarity=0.498  Sum_probs=224.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +.|++++.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.+++.++||||+++++.+..+..+|+||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            5699999999999999999999999999999998754   2334566788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcc
Q 011698          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (479)
Q Consensus       230 E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~  307 (479)
                      ||++|++|...+.+ ...+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++...... ....
T Consensus        89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence            99999999877754 456899999999999999999999999999999999999999999999999998764322 2234


Q ss_pred             cccCCCCCcchhHhc-----CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---CCCCccCCHHHHHH
Q 011698          308 SMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSL  379 (479)
Q Consensus       308 ~~~gt~~y~APE~l~-----~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~l  379 (479)
                      ...+++.|+|||++.     ...++.++|+|||||++|||++|..||...+......++....   ...+..++.++.++
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDF  248 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHH
Confidence            557889999999985     3446889999999999999999999998877666655555432   23456788999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                      |++||+.+|++||     +++++++||||..++|.+.
T Consensus       249 i~~~l~~~p~~Rp-----~~~~il~~~~~~~~~~~~~  280 (292)
T cd06644         249 LKTALDKHPETRP-----SAAQLLEHPFVSSVTSNRP  280 (292)
T ss_pred             HHHHhcCCcccCc-----CHHHHhcCccccccccchh
Confidence            9999999999999     8999999999999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.5e-43  Score=341.29  Aligned_cols=252  Identities=31%  Similarity=0.535  Sum_probs=225.2

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++.+.||+|++|.||+|.++.+++.|++|.+...... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            588999999999999999999999999999999765433 3345567889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Ccc
Q 011698          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (479)
Q Consensus       231 ~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~  307 (479)
                      |++|++|.+++...  ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++.+.... ...
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            99999999998764  568999999999999999999999999999999999999999999999999998764432 234


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCccCCHHHHHHHHhhhhh
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~lI~~~L~~  386 (479)
                      ..+|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+..+.. .++..++.++.++|.+||+.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK  239 (256)
T ss_pred             ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccC
Confidence            56789999999999999999999999999999999999999998888777777776643 45557899999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccc
Q 011698          387 EASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      +|++||     ++.++++|||+
T Consensus       240 ~p~~Rp-----~~~~ll~~~~~  256 (256)
T cd08529         240 DYRQRP-----DTFQLLRNPSL  256 (256)
T ss_pred             CcccCc-----CHHHHhhCCCC
Confidence            999999     89999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.9e-44  Score=352.54  Aligned_cols=240  Identities=18%  Similarity=0.210  Sum_probs=212.8

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee----CCeEEEEEEe
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRLYLVLDF  231 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~~~lV~E~  231 (479)
                      ..||+|++|.||+|.+  +|+.||||++++.........+.+.+|+.+|++++||||+++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6799999999999998  688999999987654444446778899999999999999999999876    4578999999


Q ss_pred             ccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccccc
Q 011698          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC  310 (479)
Q Consensus       232 ~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~  310 (479)
                      ++||+|..++...+.+++.....++.+++.||.|||+. +++||||||+|||++.+|.+||+|||+++.+...  .....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--~~~~~  181 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNV  181 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--ccccc
Confidence            99999999999888899999999999999999999985 9999999999999999999999999999865432  23457


Q ss_pred             CCCCCcchhHhcC--CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCccCCHHHHHHHHhhhhh
Q 011698          311 GTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       311 gt~~y~APE~l~~--~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~lI~~~L~~  386 (479)
                      ||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+..++...+...  ++.+|...+.++++||.+||+.
T Consensus       182 ~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~  261 (283)
T PHA02988        182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSH  261 (283)
T ss_pred             CcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcC
Confidence            8999999999977  67899999999999999999999999998888888887654  4556667899999999999999


Q ss_pred             chhhhcCCCCCCHHHHHh
Q 011698          387 EASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~  404 (479)
                      ||++||     +++++++
T Consensus       262 dp~~Rp-----s~~ell~  274 (283)
T PHA02988        262 DSIKRP-----NIKEILY  274 (283)
T ss_pred             CcccCc-----CHHHHHH
Confidence            999999     8888874

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-43  Score=345.37  Aligned_cols=253  Identities=30%  Similarity=0.509  Sum_probs=221.9

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc------hHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM------EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+......      .....+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            367788999999999999999999999999998754322      12334668899999999999999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      .++||||+++++|..++.+.+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||+++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999998764221


Q ss_pred             -------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHH
Q 011698          305 -------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       305 -------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                             ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+... ...+|..++.++
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEA  240 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHH
Confidence                   112356889999999999988999999999999999999999999876665555554443 445677889999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      .++|++||+.||.+||     ++.++++||||
T Consensus       241 ~~li~~~l~~~p~~Rp-----~~~~il~~~~~  267 (267)
T cd06628         241 IDFLEKTFEIDHNKRP-----TAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHccCCchhCc-----CHHHHhhCCCC
Confidence            9999999999999999     89999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.3e-43  Score=388.36  Aligned_cols=150  Identities=42%  Similarity=0.765  Sum_probs=141.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|+++++||+|+||+||+|++..+++.||||++++...........+..|+.+++.++||||+++++++.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            57899999999999999999999999999999999876655555667788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~  298 (479)
                      |||+.|++|..++...+.+++..++.++.||+.||.|||.++|+||||||+||||+.+|++||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-44  Score=363.97  Aligned_cols=254  Identities=26%  Similarity=0.427  Sum_probs=212.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC------
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------  222 (479)
                      .++|++++.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+|++++||||+++++++...      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            3689999999999999999999999999999999976432 223345567899999999999999999887543      


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      ..+|+++|++ +++|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            4579999998 678876664 45799999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------------
Q 011698          303 NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK----------------  365 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~----------------  365 (479)
                        .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....                
T Consensus       171 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07878         171 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA  248 (343)
T ss_pred             --CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence              2345679999999999987 568999999999999999999999998776555444433210                


Q ss_pred             -------CCCC--------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          366 -------IKLP--------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       366 -------~~~p--------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                             ...+        ...++.+.+||.+||+.||.+|+     ++.|+++||||....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~-----s~~ell~hp~~~~~~  305 (343)
T cd07878         249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRI-----SASEALAHPYFSQYH  305 (343)
T ss_pred             HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCC-----CHHHHhcCcchhccC
Confidence                   0011        23567789999999999999999     999999999998753

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=374.40  Aligned_cols=246  Identities=26%  Similarity=0.426  Sum_probs=223.4

Q ss_pred             CCcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       143 ~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      +.+.+.++...-++-||.|+-|.||+|+.+  ++.||||+++.-          -..+++-|++|+||||+.+.++|...
T Consensus       117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqs  184 (904)
T KOG4721|consen  117 ELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQS  184 (904)
T ss_pred             hhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCC
Confidence            344566666777889999999999999984  577999987532          13577889999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      ..+|||||||..|-|...|+....+.......|..+|+.||.|||.+.|||||||.-||||..+..|||+|||.++.+..
T Consensus       185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD  264 (904)
T ss_pred             ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCccCCHHHHHHH
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSLL  380 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~lI  380 (479)
                      .....+++||..|||||++++++.+.|+|||||||+|||||||..||.+.+...++..+-.+  .+..|..++..++=||
T Consensus       265 ~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~  344 (904)
T KOG4721|consen  265 KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLL  344 (904)
T ss_pred             hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHH
Confidence            77778999999999999999999999999999999999999999999988877776666655  4556788999999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      +.||+-.|..||     ++.+|+.|
T Consensus       345 Kqcw~sKpRNRP-----SFrqil~H  364 (904)
T KOG4721|consen  345 KQCWNSKPRNRP-----SFRQILLH  364 (904)
T ss_pred             HHHHhcCCCCCc-----cHHHHHHH
Confidence            999999999999     89999987

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=349.52  Aligned_cols=257  Identities=30%  Similarity=0.489  Sum_probs=224.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||.|+||+||+|.+..+++.||+|++...   .....+.+.+|+.++++++||||+++++.+..+..+|+||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            6799999999999999999999989999999998753   2334456778999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcc
Q 011698          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (479)
Q Consensus       230 E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~  307 (479)
                      ||+++++|..++.+. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++...... ....
T Consensus        82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            999999999988764 56999999999999999999999999999999999999999999999999998764322 2334


Q ss_pred             cccCCCCCcchhHhcC-----CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---CCCCccCCHHHHHH
Q 011698          308 SMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSL  379 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~-----~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~l  379 (479)
                      ...|++.|+|||.+..     ..++.++|+|||||++|+|++|+.||...+......++....   +..|..++.++.++
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF  241 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence            5678999999999853     446789999999999999999999999887777666666553   23456789999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                      |..||+.+|.+||     +++++++|+||.+....
T Consensus       242 i~~~l~~~p~~Rp-----s~~~il~~~~~~~~~~~  271 (280)
T cd06611         242 LKSCLVKDPDDRP-----TAAELLKHPFVSDQSDN  271 (280)
T ss_pred             HHHHhccChhhCc-----CHHHHhcChhhcccchh
Confidence            9999999999999     89999999999987543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.7e-43  Score=346.89  Aligned_cols=253  Identities=30%  Similarity=0.474  Sum_probs=215.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||.||+|+++.+++.||+|++..... .....+.+.+|+.++++++||||+++++++.....+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            479999999999999999999999999999999875432 1223345678999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Cccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~~  308 (479)
                      ||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++....... ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            999999888877777789999999999999999999999999999999999999999999999999998765433 2334


Q ss_pred             ccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------------cCCC
Q 011698          309 MCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------------KIKL  368 (479)
Q Consensus       309 ~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-------------------~~~~  368 (479)
                      ..++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+...                   ....
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            567899999999876 45789999999999999999999999877654444333220                   0001


Q ss_pred             C------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          369 P------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       369 p------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      |            ..++..+.+||.+||+.+|++||     ++.|++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----~~~eil~~~~f  286 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERL-----SCEELLEHPYF  286 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC-----CHHHHhcCCCC
Confidence            1            24688899999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.1e-43  Score=358.57  Aligned_cols=253  Identities=22%  Similarity=0.365  Sum_probs=210.2

Q ss_pred             EEEEeccC--CceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEe
Q 011698          154 VLKVVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (479)
Q Consensus       154 ~~~~LG~G--~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~  231 (479)
                      ++++||+|  +||+||+++++.+|+.||+|++..... .....+.+++|+.+++.++||||+++++++..++.+|+||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            56789999  789999999999999999999976542 233456788899999999999999999999999999999999


Q ss_pred             ccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-----
Q 011698          232 VNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----  304 (479)
Q Consensus       232 ~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-----  304 (479)
                      +++|+|.+++...  ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.++++||+.+.......     
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            9999999988653  458999999999999999999999999999999999999999999999998764432111     


Q ss_pred             ---CcccccCCCCCcchhHhcC--CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------------
Q 011698          305 ---RSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK------------  367 (479)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~--~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~------------  367 (479)
                         ......++..|+|||++.+  ..++.++|||||||++|||++|+.||..............+...            
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence               1123456788999999976  46899999999999999999999999875544433333222110            


Q ss_pred             ----------------------------------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          368 ----------------------------------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       368 ----------------------------------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                                                        +...+++++.+||.+||+.||++||     |++++++||||+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----t~~ell~~p~f~~~~  314 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARP-----SASTLLNHSFFKQIK  314 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcC-----CHHHHhcChhhhhcc
Confidence                                              1123577899999999999999999     999999999998864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=377.68  Aligned_cols=258  Identities=31%  Similarity=0.505  Sum_probs=232.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +.|+++..||.|+||+||+|..+.++-..|-|+|...   ..+..+.+.-|+.||..++||+||+|++.|--++.++++.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            4588999999999999999999999999999998643   3455666778999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCCCCcc
Q 011698          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSN  307 (479)
Q Consensus       230 E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~~~~~  307 (479)
                      |||.||-....+-. ...+.+++++.+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+... ....+..
T Consensus       109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD  188 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD  188 (1187)
T ss_pred             eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence            99999988776655 456999999999999999999999999999999999999999999999999998653 3334567


Q ss_pred             cccCCCCCcchhHhc-----CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---CCccCCHHHHHH
Q 011698          308 SMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK---LPAFLSSEAHSL  379 (479)
Q Consensus       308 ~~~gt~~y~APE~l~-----~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~l  379 (479)
                      ++.|||+|||||++.     ..+|++++||||||++|.||..+.+|....+.+.+.-+|.+..++   -|..++..+.||
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~Df  268 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDF  268 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHH
Confidence            899999999999985     468999999999999999999999999999999999999987543   478899999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhh
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK  415 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~  415 (479)
                      |++||.+||..||     ++.++++||||.++.-.+
T Consensus       269 Lk~cL~Knp~~Rp-----~aaqll~Hpfv~~~~SnK  299 (1187)
T KOG0579|consen  269 LKRCLVKNPRNRP-----PAAQLLKHPFVQNAPSNK  299 (1187)
T ss_pred             HHHHHhcCCccCC-----CHHHHhhCcccccCCcch
Confidence            9999999999999     899999999999887655

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-43  Score=346.38  Aligned_cols=255  Identities=28%  Similarity=0.517  Sum_probs=225.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||.|+||.||+|++..+++.||+|++....  .......+.+|+.+++.++|+||+++++++.+...+|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            47889999999999999999999999999999997643  2233455788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~~  308 (479)
                      ||+.+++|.+++... .+++..++.++.|++.||.|||+++++||||+|+||+++.++.++|+|||+++.+... .....
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            999999999988765 7899999999999999999999999999999999999999999999999999887544 33455


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCCcc-CCHHHHHHHHhhhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPAF-LSSEAHSLLKGLLQK  386 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~-~s~~~~~lI~~~L~~  386 (479)
                      ..|++.|+|||.+.+..++.++|||||||++|+|+||..||...+.......+... ...++.. ++.++.++|.+||..
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  237 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK  237 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhC
Confidence            67899999999999988999999999999999999999999887776666666655 3334444 789999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccccCCC
Q 011698          387 EASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      +|++||     +++++++||||....
T Consensus       238 ~p~~Rp-----t~~~il~~~~~~~~~  258 (274)
T cd06609         238 DPKERP-----SAKELLKHKFIKKAK  258 (274)
T ss_pred             ChhhCc-----CHHHHhhChhhcCCC
Confidence            999999     899999999998853

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-45  Score=366.45  Aligned_cols=254  Identities=33%  Similarity=0.580  Sum_probs=230.1

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg  235 (479)
                      ++||.|.||+||-|+++.+|+.||||+|.|.+...+ ....+++|+.||+++.||.||.+-..|++.+.+++|||.+.|.
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            789999999999999999999999999998776444 3478999999999999999999999999999999999999875


Q ss_pred             cHHHHH-HHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC---cEEEeecCCccccCCCCCcccccC
Q 011698          236 HLFFQL-YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDFGLAKQFDENTRSNSMCG  311 (479)
Q Consensus       236 sL~~~l-~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g---~vkL~DFGla~~~~~~~~~~~~~g  311 (479)
                      -|.-.| .+.+.+++...++++.||+.||.|||-++|+|+||||||||+....   .+||||||+|+.+.+.....+.+|
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG  728 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG  728 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence            554444 3568899999999999999999999999999999999999997654   799999999999999999999999


Q ss_pred             CCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc----cCCHHHHHHHHhhhhhc
Q 011698          312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       312 t~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~lI~~~L~~d  387 (479)
                      ||.|+|||+++.++|..+-||||+|||+|.-++|..||.  ..+++-+.|.+..+.+|+    .++.++.+||..+|+..
T Consensus       729 TPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVk  806 (888)
T KOG4236|consen  729 TPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVK  806 (888)
T ss_pred             CccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999999999995  445677778887777775    58999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHhCccccCC-Chhhhh
Q 011698          388 ASKRLGSGPGGSQEIKSHKWFKMI-NWKKLE  417 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~hp~f~~~-~~~~l~  417 (479)
                      -.+|.     +.+..+.|||+++. .|.+|.
T Consensus       807 m~kRy-----svdk~lsh~Wlq~yq~w~DLR  832 (888)
T KOG4236|consen  807 MRKRY-----SVDKSLSHPWLQDYQTWLDLR  832 (888)
T ss_pred             HHHhc-----chHhhccchhhhcchHHHHHH
Confidence            99999     89999999999986 566654

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.7e-43  Score=345.59  Aligned_cols=252  Identities=27%  Similarity=0.453  Sum_probs=216.3

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|++.+.||+|+||.||+|+++.+++.||+|++....   ......+++|+.++++++||||+++++++.....+|+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i   83 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI   83 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence            3468999999999999999999999999999999987542   2234457889999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCc
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRS  306 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~  306 (479)
                      ||||+++++|.+++.+.+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..+... ...
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR  163 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999999876432 223


Q ss_pred             ccccCCCCCcchhHhc---CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-----CccCCHHHHH
Q 011698          307 NSMCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL-----PAFLSSEAHS  378 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~---~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~-----p~~~s~~~~~  378 (479)
                      ....|++.|+|||.+.   ...++.++|+|||||++|||++|+.||...+.......+....+..     +..++..+.+
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN  243 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence            4567899999999985   3457889999999999999999999997655444333333332222     2347899999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhCcc
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSHKW  407 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~hp~  407 (479)
                      ||++||+.+|++||     ++++|++|+|
T Consensus       244 li~~~l~~~P~~Rp-----~~~~il~~l~  267 (267)
T cd06646         244 FVKISLTKNPKKRP-----TAERLLTHLF  267 (267)
T ss_pred             HHHHHhhCChhhCc-----CHHHHhcCCC
Confidence            99999999999999     8999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.3e-43  Score=343.13  Aligned_cols=252  Identities=28%  Similarity=0.465  Sum_probs=218.9

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhh---chHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI---MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      +|++.+.||+|+||+||+|.. .+++.+|+|.+.....   ........+.+|+.++++++|+||+++++++.+...+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            578889999999999999986 4788899999875321   123345668899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC-----
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-----  302 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~-----  302 (479)
                      ||||++|++|..++.+.+.+++..++.++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++.....     
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            999999999999998888899999999999999999999999999999999999999999999999999876421     


Q ss_pred             --CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---cCCCCccCCHHHH
Q 011698          303 --NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAH  377 (479)
Q Consensus       303 --~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~  377 (479)
                        ........|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+...   ....+..++.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI  239 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence              11223456899999999999999999999999999999999999999876655544444433   2346677899999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      ++|++||+++|.+||     ++.++++||||
T Consensus       240 ~~i~~~l~~~p~~Rp-----~~~~~l~~~~~  265 (265)
T cd06631         240 DFVTSCLTRDQHERP-----SALQLLRHDFL  265 (265)
T ss_pred             HHHHHHhcCCcccCC-----CHHHHhcCCCC
Confidence            999999999999999     89999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.2e-43  Score=346.81  Aligned_cols=251  Identities=26%  Similarity=0.445  Sum_probs=214.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....  .......+.+|++++++++||||+++++.+......++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            47889999999999999999999999999999987643  2233456788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~  309 (479)
                      ||+++++|...    ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++..+... .....
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~  153 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTY  153 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCC
Confidence            99999988543    35788899999999999999999999999999999999999999999999999876433 23456


Q ss_pred             cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcc-CCC-CccCCHHHHHHH
Q 011698          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN-------RQKIQQKIIKDK-IKL-PAFLSSEAHSLL  380 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~-~~~-p~~~s~~~~~lI  380 (479)
                      +||..|+|||++.+..++.++|+|||||++|+|++|+.||....       .....+.+.... ... ...++.++.++|
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI  233 (279)
T ss_pred             CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence            89999999999999999999999999999999999999996522       122233333322 222 235788999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      .+||+++|.+||     +++++++||||...+
T Consensus       234 ~~~l~~~P~~Rp-----~~~eil~~~~~~~~~  260 (279)
T cd06619         234 TQCMRKQPKERP-----APENLMDHPFIVQYN  260 (279)
T ss_pred             HHHhhCChhhCC-----CHHHHhcCccccccc
Confidence            999999999999     899999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3e-43  Score=389.91  Aligned_cols=261  Identities=28%  Similarity=0.459  Sum_probs=221.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee--CCe
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYR  224 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~  224 (479)
                      ..+++|++++.||+|+||+||+|+++.++..||+|++...... ......+..|+.+|++++|||||+++++|..  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            4568999999999999999999999999999999999865433 3345667889999999999999999998854  457


Q ss_pred             EEEEEEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhC-------CCccCCCCCccEEeCC--------
Q 011698          225 LYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHAN-------GIMHRDLKPENILLDA--------  285 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-------~IiHrDLKpeNILl~~--------  285 (479)
                      +||||||+.+|+|..+|..    .+.+++..++.|+.||+.||.|||+.       +||||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            9999999999999998865    25799999999999999999999984       4999999999999964        


Q ss_pred             ---------CCcEEEeecCCccccCCCCCcccccCCCCCcchhHhcC--CCCCccccchhhHHHHHHHHhCCCCCCCCCH
Q 011698          286 ---------DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNR  354 (479)
Q Consensus       286 ---------~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~DiwSLGvilyelltG~~Pf~~~~~  354 (479)
                               .+.+||+|||++..+.........+||+.|+|||++.+  ..++.++||||||||||||+||..||...+.
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~  248 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN  248 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                     34599999999987765555566789999999999965  4578999999999999999999999986554


Q ss_pred             HHHHHHHHhccCCCC-ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          355 QKIQQKIIKDKIKLP-AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       355 ~~~~~~i~~~~~~~p-~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      ......+....+.+| ...+.++.+||..||+.+|.+||     ++.|++.|+|++.+..
T Consensus       249 ~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRP-----Sa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        249 FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERP-----SALQCLGYQIIKNVGP  303 (1021)
T ss_pred             HHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCc-----CHHHHhccHHHhhcCC
Confidence            443333444333333 45789999999999999999999     8999999999987754

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.2e-43  Score=342.40  Aligned_cols=254  Identities=33%  Similarity=0.503  Sum_probs=218.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhh--chHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee--CCeE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI--MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRL  225 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~~  225 (479)
                      .+|+..+.||+|+||.||+|.+..++..||+|++.....  ........+.+|+.++++++||||+++++++..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            378999999999999999999999999999999875432  122345668899999999999999999998875  3678


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC--
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~--  303 (479)
                      +++|||+++++|...+...+.+++...+.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++.+...  
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            999999999999999988888999999999999999999999999999999999999999999999999999765321  


Q ss_pred             --CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCccCCHHHHHH
Q 011698          304 --TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSL  379 (479)
Q Consensus       304 --~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l  379 (479)
                        .......|+..|+|||.+.+..++.++|+|||||++|||++|+.||...+.......+...  ...+|..++..++++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF  241 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence              1123356889999999999988999999999999999999999999876655444444332  345677789999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhCcccc
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFK  409 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~hp~f~  409 (479)
                      | .||..+|++||     +++||++||||+
T Consensus       242 i-~~~~~~p~~Rp-----~~~eil~hp~~~  265 (266)
T cd06651         242 L-GCIFVEARHRP-----SAEELLRHPFAQ  265 (266)
T ss_pred             H-HHhcCChhhCc-----CHHHHhcCcccc
Confidence            9 57778999999     899999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-43  Score=346.29  Aligned_cols=252  Identities=29%  Similarity=0.487  Sum_probs=216.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|++.+.||+|+||.||+|++..+++.||+|+++...   ......+++|+.+++.++||||+++++.+.....+|+
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l   83 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI   83 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence            3468999999999999999999999999999999987643   2233457789999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCc
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRS  306 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~  306 (479)
                      ||||+++++|.+++...+.+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++..+... ...
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR  163 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence            9999999999999988889999999999999999999999999999999999999999999999999999765432 223


Q ss_pred             ccccCCCCCcchhHhc---CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-----ccCCHHHHH
Q 011698          307 NSMCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-----AFLSSEAHS  378 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~---~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~  378 (479)
                      ....|+..|+|||++.   ...++.++|+|||||++|+|++|..||...........+.......+     ..++..+.+
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH  243 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence            4567999999999985   45688999999999999999999999976554444433333332222     246788999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhCcc
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSHKW  407 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~hp~  407 (479)
                      +|.+||+.+|++||     +++++++|||
T Consensus       244 li~~~l~~~P~~R~-----~~~~ll~~~~  267 (267)
T cd06645         244 FVKMALTKNPKKRP-----TAEKLLQHPF  267 (267)
T ss_pred             HHHHHccCCchhCc-----CHHHHhcCCC
Confidence            99999999999999     8999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.3e-43  Score=345.59  Aligned_cols=251  Identities=29%  Similarity=0.496  Sum_probs=209.8

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++++.||+|+||.||+|+++.+++.||+|+++.... .......+.+|+.++++++||||+++++++.++..+|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            58999999999999999999999999999999876432 22234567789999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHc---CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Cc
Q 011698          231 FVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RS  306 (479)
Q Consensus       231 ~~~ggsL~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~  306 (479)
                      |+. ++|..++...   ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... ..
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            998 4787777543   468999999999999999999999999999999999999999999999999997654322 22


Q ss_pred             ccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--------------------
Q 011698          307 NSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--------------------  365 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------------------  365 (479)
                      ....+++.|+|||++.+. .++.++|+|||||++|+|+||+.||.+.+.......+....                    
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            334678999999998764 47899999999999999999999998765443332221100                    


Q ss_pred             ---------CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          366 ---------IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       366 ---------~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                               ......++.++++||++||+.||.+||     +++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----t~~~ll~~~~~  285 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRI-----SAKKALNHPYF  285 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCC-----CHHHHhcCCCC
Confidence                     001234789999999999999999999     99999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8.6e-43  Score=340.44  Aligned_cols=254  Identities=33%  Similarity=0.493  Sum_probs=219.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhh--chHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC--CeE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI--MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRL  225 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~  225 (479)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....  ......+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            579999999999999999999999999999999864321  1233456788999999999999999999998763  568


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC--
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~--  303 (479)
                      +++|||++|++|.+++.+.+.+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++......  
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            899999999999999988888999999999999999999999999999999999999999999999999999865321  


Q ss_pred             --CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCccCCHHHHHH
Q 011698          304 --TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSL  379 (479)
Q Consensus       304 --~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l  379 (479)
                        .......|+..|+|||++.+..++.++|+|||||++|||++|+.||...+.......+...  ....|..++..+.++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF  241 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence              1233457899999999999988999999999999999999999999876555544444433  344567789999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhCcccc
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFK  409 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~hp~f~  409 (479)
                      |++||. +|++||     +++++++|||+.
T Consensus       242 i~~~l~-~p~~Rp-----~~~~il~~~~~~  265 (265)
T cd06652         242 LKRIFV-EAKLRP-----SADELLRHTFVH  265 (265)
T ss_pred             HHHHhc-ChhhCC-----CHHHHhcCcccC
Confidence            999995 999999     899999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.9e-43  Score=346.25  Aligned_cols=252  Identities=33%  Similarity=0.525  Sum_probs=219.5

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEe
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~  231 (479)
                      |++++.||+|+||.||+|++..++..+|+|.+....   ....+.+.+|+.+++.++||||+++++.+......|+||||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            688899999999999999999999999999986532   23355678899999999999999999999999999999999


Q ss_pred             ccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcccc
Q 011698          232 VNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSM  309 (479)
Q Consensus       232 ~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~~~  309 (479)
                      +++++|...+.+ ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... ......
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence            999999887765 467899999999999999999999999999999999999999999999999999764322 233456


Q ss_pred             cCCCCCcchhHhc-----CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---CCCCccCCHHHHHHHH
Q 011698          310 CGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSLLK  381 (479)
Q Consensus       310 ~gt~~y~APE~l~-----~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~lI~  381 (479)
                      .|++.|+|||++.     +..++.++|+|||||++|||++|+.||...+.......+....   ...|..++.++.+||.
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK  243 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence            7899999999984     3457889999999999999999999998877766666665542   2346678999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +||+.||.+||     +++++++||||+..
T Consensus       244 ~~l~~~p~~Rp-----~~~~il~~~~~~~~  268 (282)
T cd06643         244 KCLEKNVDARW-----TTTQLLQHPFVTVN  268 (282)
T ss_pred             HHccCChhhCc-----CHHHHhcCCCEecc
Confidence            99999999999     89999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-46  Score=356.01  Aligned_cols=251  Identities=25%  Similarity=0.437  Sum_probs=227.0

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      -|.++.+||+|+||.||+|.++.+|+.+|||.+..+.     ..+.+..|+.++++++.|++|++|+.|-....+|+|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            4888999999999999999999999999999987543     35567789999999999999999999999999999999


Q ss_pred             eccCCcHHHHHH-HcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCccc
Q 011698          231 FVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNS  308 (479)
Q Consensus       231 ~~~ggsL~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~~  308 (479)
                      ||..|+..+.++ +++.++|+.+..++...+.||+|||...-||||||..|||++.+|+.||+|||.|..+... .+.++
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            999999999886 4578999999999999999999999999999999999999999999999999999876433 45678


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---cCCCCccCCHHHHHHHHhhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      +.|||.|||||++..-+|+.++||||||++..||.-|++||.+..++...-.|...   .+.-|..+|.++.+||+.||.
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi  268 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI  268 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence            99999999999999999999999999999999999999999987777655555544   233467799999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCC
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ++|++|-     ||.++++|+|.++-
T Consensus       269 K~PE~R~-----TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  269 KKPEERK-----TALRLCEHTFIKNA  289 (502)
T ss_pred             CCHHHHH-----HHHHHhhhhhhcCC
Confidence            9999998     99999999999974

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.2e-43  Score=339.83  Aligned_cols=252  Identities=30%  Similarity=0.509  Sum_probs=220.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||.|+||+||+|.+..++..+|+|++.......  ....+.+|+.+++.++|+||+++++.+......|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47999999999999999999999999999999987644322  4567889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHc---CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC-
Q 011698          230 DFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-  305 (479)
Q Consensus       230 E~~~ggsL~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~-  305 (479)
                      |+++|++|...+...   ..+++..++.++.|++.||.|||+.||+||||||+||++++++.++|+|||++..+..... 
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999999764   4589999999999999999999999999999999999999999999999999987543322 


Q ss_pred             ----cccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCC-----ccCCH
Q 011698          306 ----SNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLP-----AFLSS  374 (479)
Q Consensus       306 ----~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p-----~~~s~  374 (479)
                          ....+|+..|+|||++... .++.++|+|||||++|+|++|+.||...+......++..... .++     ..++.
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK  238 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence                2445789999999999877 789999999999999999999999988777666666555422 122     25688


Q ss_pred             HHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          375 EAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       375 ~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      .+.++|.+||++||++||     +++++++||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp-----~~~~ll~~p~~  267 (267)
T cd06610         239 SFRKMISLCLQKDPSKRP-----TAEELLKHKFF  267 (267)
T ss_pred             HHHHHHHHHcCCChhhCc-----CHHHHhhCCCC
Confidence            999999999999999999     89999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-43  Score=339.61  Aligned_cols=250  Identities=30%  Similarity=0.490  Sum_probs=220.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|++.....   ...+.+.+|+.++++++||||+++++++.....+|++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            689999999999999999999999999999999976432   24567889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Ccc
Q 011698          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (479)
Q Consensus       230 E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~  307 (479)
                      ||+.+++|..++... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++..+.... ...
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            999999999988776 789999999999999999999999999999999999999999999999999998764432 334


Q ss_pred             cccCCCCCcchhHhcCC---CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-----CCccCCHHHHHH
Q 011698          308 SMCGTLEYMSPEIVLGK---GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-----LPAFLSSEAHSL  379 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~---~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~l  379 (479)
                      ...|+..|+|||.+.+.   .++.++|+|||||++|||++|+.||.+.+.......+....+.     .+..++.++.+|
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF  239 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence            56789999999999877   7899999999999999999999999887766655555544222     234567889999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhCcc
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSHKW  407 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~hp~  407 (479)
                      |++||..+|.+||     ++.+|+.|+|
T Consensus       240 i~~~l~~~p~~Rp-----t~~~il~~~~  262 (262)
T cd06613         240 IKKCLTKDPKKRP-----TATKLLQHPF  262 (262)
T ss_pred             HHHHcCCChhhCC-----CHHHHhcCCC
Confidence            9999999999999     8999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.6e-43  Score=337.16  Aligned_cols=252  Identities=27%  Similarity=0.477  Sum_probs=225.4

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+.+|+.++||||+++++.+.....+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            5899999999999999999999999999999998754333 345678899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC-cEEEeecCCccccCCCCCcc
Q 011698          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDENTRSN  307 (479)
Q Consensus       231 ~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g-~vkL~DFGla~~~~~~~~~~  307 (479)
                      |++|++|.+++...  ..+++..+..++.+++.||.|||++||+|+||||+||+++.++ .+||+|||++..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence            99999999999764  3489999999999999999999999999999999999998654 68999999998876655555


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhhhhh
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~  386 (479)
                      ...|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+... ...++..++.++.++|.+||+.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  239 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL  239 (256)
T ss_pred             ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccC
Confidence            677899999999999988999999999999999999999999988877777776655 3456777999999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccc
Q 011698          387 EASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      +|.+||     +++|+++||||
T Consensus       240 ~p~~Rp-----t~~~ll~~p~~  256 (256)
T cd08220         240 DPSKRP-----QLSQIMAQPIC  256 (256)
T ss_pred             ChhhCC-----CHHHHhhCCCC
Confidence            999999     99999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.4e-43  Score=344.53  Aligned_cols=254  Identities=41%  Similarity=0.750  Sum_probs=232.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++.+..+........+.+|..++++++ ||||+++++++.....+++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999998765555555677889999999998 99999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC----
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT----  304 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~----  304 (479)
                      |||+.+++|...+.+.+.+++..++.++.|++.||.|||+.|++|+||||+||+++.+|.++|+|||++.......    
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            9999999999999988899999999999999999999999999999999999999999999999999998654322    


Q ss_pred             -----------------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 011698          305 -----------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK  367 (479)
Q Consensus       305 -----------------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  367 (479)
                                       ......|+..|+|||++.+..++.++|+||||+++|++++|..||...+.....+.+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS  240 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC
Confidence                             223456789999999999888999999999999999999999999988877778888888888


Q ss_pred             CCccCCHHHHHHHHhhhhhchhhhcCCCCCCH----HHHHhCccc
Q 011698          368 LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGS----QEIKSHKWF  408 (479)
Q Consensus       368 ~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~----~eil~hp~f  408 (479)
                      +|..+++.+.+||..||+.+|.+||     ++    +++++||||
T Consensus       241 ~~~~~~~~~~~li~~~l~~~p~~R~-----~~~~~~~~ll~~~~~  280 (280)
T cd05581         241 FPPNFPPDAKDLIEKLLVLDPQDRL-----GVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCccCHHHHHHHHHHhcCCHhhCC-----CcccCHHHHhcCCCC
Confidence            9999999999999999999999999     77    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1e-42  Score=344.74  Aligned_cols=260  Identities=20%  Similarity=0.304  Sum_probs=220.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  221 (479)
                      +..++|++.+.||+|+||.||+|..+.     .+..||+|.+....  .......+.+|+.+++.++||||+++++++.+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            456799999999999999999997653     35589999986543  12223446789999999999999999999999


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHcC----------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEE
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQG----------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML  291 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~~----------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL  291 (479)
                      ....|+||||+.+|+|.+++.+.+          .++...+..++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999999997532          2456778889999999999999999999999999999999999999


Q ss_pred             eecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cC
Q 011698          292 TDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KI  366 (479)
Q Consensus       292 ~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~  366 (479)
                      +|||+++.......   .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..+....+..+ ..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL  240 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999986532221   122345678999999999889999999999999999999 89999988888777777654 44


Q ss_pred             CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh------CccccCCCh
Q 011698          367 KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS------HKWFKMINW  413 (479)
Q Consensus       367 ~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~------hp~f~~~~~  413 (479)
                      ..+...+..++++|.+||+.||++||     ++.++++      ||||.+++|
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         241 DQPDNCPERVTDLMRMCWQFNPKMRP-----TFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCc-----CHHHHHHHHHhhcCCCCCCCCC
Confidence            56777889999999999999999999     7888876      999999998

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.1e-43  Score=347.95  Aligned_cols=251  Identities=25%  Similarity=0.477  Sum_probs=209.0

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++++.||+|+||.||+|+++.+|+.||+|+++.... .......+.+|+.++++++||||+++++++.+...+|+|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            58999999999999999999999999999999976432 22223456789999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC-ccc
Q 011698          231 FVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNS  308 (479)
Q Consensus       231 ~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~-~~~  308 (479)
                      |+.+ +|...+.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....... ...
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            9975 67776654 56799999999999999999999999999999999999999999999999999986543322 234


Q ss_pred             ccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcc-----------------C---
Q 011698          309 MCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPF-TGGNRQKIQQKIIKDK-----------------I---  366 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf-~~~~~~~~~~~i~~~~-----------------~---  366 (479)
                      ..+++.|+|||++.+. .++.++|||||||++|||+||..|| .+.+..+..+.+....                 .   
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP  238 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence            5678999999998775 4689999999999999999988885 4444444444332210                 0   


Q ss_pred             ---------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          367 ---------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       367 ---------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                               .....++.++++||++||+.||.+||     |++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----t~~~il~h~~f  284 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRI-----SAEEALQHPYF  284 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcC-----CHHHHhcCCCC
Confidence                     01124788999999999999999999     99999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.6e-42  Score=336.27  Aligned_cols=252  Identities=30%  Similarity=0.545  Sum_probs=224.2

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++++.||+|+||+||+++...+++.||+|.+....... .....+.+|+.++++++||||+++++++...+..|+|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            5899999999999999999999999999999997654332 234567889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC-cc
Q 011698          231 FVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SN  307 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~-~~  307 (479)
                      |+.+++|...+....  .+++..+..++.|++.||.|||+++++|+||+|+|||++.++.++|+|||++........ ..
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            999999999887643  578999999999999999999999999999999999999999999999999987544322 23


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCccCCHHHHHHHHhhhhh
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~lI~~~L~~  386 (479)
                      ...|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..++...+..+.. ..+..++.++.++|.+||+.
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (256)
T cd08218         160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR  239 (256)
T ss_pred             hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhC
Confidence            45688999999999998899999999999999999999999998888877777776643 46778899999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccc
Q 011698          387 EASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      +|.+||     ++.++++||||
T Consensus       240 ~p~~Rp-----~~~~vl~~~~~  256 (256)
T cd08218         240 NPRDRP-----SVNSILEKNFI  256 (256)
T ss_pred             ChhhCc-----CHHHHhhCcCC
Confidence            999999     99999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.4e-43  Score=338.42  Aligned_cols=249  Identities=27%  Similarity=0.480  Sum_probs=219.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||.|+||.||+|.++.+++.||+|.+.....     .+.+.+|+.++++++||||+++++.+.+...+|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            589999999999999999999999899999999875431     566889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Ccc
Q 011698          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (479)
Q Consensus       230 E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~  307 (479)
                      ||+.+++|.+++.. ...+++..++.++.|++.||.|||+.+|+||||+|+||+++.++.+||+|||++....... ...
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence            99999999999875 4568999999999999999999999999999999999999999999999999998765443 334


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---cCCCCccCCHHHHHHHHhhh
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLL  384 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~lI~~~L  384 (479)
                      ...|+..|+|||++.+..++.++||||||+++|+|++|+.||...+.......+...   ....+..++.++.++|.+||
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL  237 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence            456889999999999999999999999999999999999999876655444333332   22345567899999999999


Q ss_pred             hhchhhhcCCCCCCHHHHHhCccc
Q 011698          385 QKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       385 ~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      +.||++||     ++++++.||||
T Consensus       238 ~~~P~~Rp-----s~~~il~~~~~  256 (256)
T cd06612         238 VKDPEERP-----SAIQLLQHPFI  256 (256)
T ss_pred             hcChhhCc-----CHHHHhcCCCC
Confidence            99999999     89999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.9e-43  Score=345.84  Aligned_cols=252  Identities=22%  Similarity=0.378  Sum_probs=219.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCC-----eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  221 (479)
                      +.+++|++++.||+|+||.||+|.+...+     ..||+|.++...  .......+.+|+.++++++||||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            44678999999999999999999987655     689999987543  23345568899999999999999999999999


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHc----------------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~  285 (479)
                      ....|++|||+++|+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            99999999999999999999765                45788889999999999999999999999999999999999


Q ss_pred             CCcEEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 011698          286 DGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI  361 (479)
Q Consensus       286 ~g~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i  361 (479)
                      ++.+||+|||+++......   ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++...+
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999998653322   2234466889999999998889999999999999999998 99999998888888887


Q ss_pred             Hhcc-CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          362 IKDK-IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       362 ~~~~-~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ..+. ...|..++.++.+|+.+||+.||.+||     ++.+|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp-----~~~~i~~~  279 (283)
T cd05048         240 RSRQLLPCPEDCPARVYALMIECWNEIPARRP-----RFKDIHTR  279 (283)
T ss_pred             HcCCcCCCcccCCHHHHHHHHHHccCChhhCc-----CHHHHHHH
Confidence            7654 345778999999999999999999999     89998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.6e-43  Score=341.98  Aligned_cols=250  Identities=30%  Similarity=0.492  Sum_probs=213.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeC------
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK------  222 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~------  222 (479)
                      +.|++.+.||+|+||+||+|++..+++.||+|++.....    ....+..|+.+++++ +||||+++++++...      
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            468889999999999999999999999999999875431    234567899999998 799999999998753      


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~  300 (479)
                      ..+|+||||+.+++|..++...  ..+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            4689999999999999998764  46899999999999999999999999999999999999999999999999999875


Q ss_pred             CCC-CCcccccCCCCCcchhHhc-----CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--CCCccC
Q 011698          301 DEN-TRSNSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI--KLPAFL  372 (479)
Q Consensus       301 ~~~-~~~~~~~gt~~y~APE~l~-----~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~  372 (479)
                      ... .......|++.|+|||++.     +..++.++|||||||++|||++|..||...........+.....  ..+..+
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW  241 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCc
Confidence            432 2344577999999999986     34578899999999999999999999987665555544443321  223457


Q ss_pred             CHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       373 s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      +.++.+||.+||+.||.+||     ++++++.||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp-----t~~~il~~~~~  272 (272)
T cd06637         242 SKKFQSFIESCLVKNHSQRP-----TTEQLMKHPFI  272 (272)
T ss_pred             CHHHHHHHHHHcCCChhhCC-----CHHHHhhCCCC
Confidence            89999999999999999999     89999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.7e-42  Score=334.60  Aligned_cols=252  Identities=31%  Similarity=0.520  Sum_probs=225.0

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++++.||.|+||.||.++...+++.+++|.+....... .....+.+|+.++++++|+||+++++++.+...++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            5899999999999999999999999999999987654333 334567789999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Ccc
Q 011698          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (479)
Q Consensus       231 ~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~  307 (479)
                      |+++++|...+.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            99999999999765  468999999999999999999999999999999999999999999999999998754333 334


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CCccCCHHHHHHHHhhhhh
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~lI~~~L~~  386 (479)
                      ...|++.|+|||.+.+..++.++|+||||+++|||++|..||...+..+....+..+... .+..++.++.++|.+||+.
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ  239 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccc
Confidence            567899999999999888999999999999999999999999988888888787766443 3456899999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccc
Q 011698          387 EASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      +|.+||     +++++++|+|+
T Consensus       240 ~p~~R~-----s~~~ll~~~~l  256 (256)
T cd08221         240 DPEKRP-----TADEVLDQPLL  256 (256)
T ss_pred             CcccCC-----CHHHHhhCcCC
Confidence            999999     89999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-42  Score=341.54  Aligned_cols=257  Identities=26%  Similarity=0.450  Sum_probs=211.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHH-HHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN-ILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      ++|++++.||+|+||.||+|+++.+|+.||+|+++..... ....+ +..|.. .++.++||||+++++++......|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~-~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKR-LLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHH-HHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            4799999999999999999999999999999999765322 22223 334554 46677999999999999999999999


Q ss_pred             EEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          229 LDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      |||++| +|...+..    ...+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999974 67666643    34689999999999999999999997 9999999999999999999999999999876544


Q ss_pred             CCcccccCCCCCcchhHhcC----CCCCccccchhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhc-cCCCC-ccCCHHH
Q 011698          304 TRSNSMCGTLEYMSPEIVLG----KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKD-KIKLP-AFLSSEA  376 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~----~~~~~~~DiwSLGvilyelltG~~Pf~~~~-~~~~~~~i~~~-~~~~p-~~~s~~~  376 (479)
                      .......|+..|+|||.+.+    ..++.++|+|||||++|+|++|+.||.... ..+....+..+ ...+| ..++.++
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF  237 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence            33344678999999999865    456889999999999999999999997532 22223333332 33444 3578999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                      .++|.+||..+|.+||     +++++++||||....+.
T Consensus       238 ~~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~~~~  270 (283)
T cd06617         238 QDFVNKCLKKNYKERP-----NYPELLQHPFFELHLSK  270 (283)
T ss_pred             HHHHHHHccCChhhCc-----CHHHHhcCchhhhcccc
Confidence            9999999999999999     89999999999997655

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-42  Score=335.77  Aligned_cols=253  Identities=32%  Similarity=0.515  Sum_probs=222.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhh--chHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI--MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +|+..+.||+|+||+||+|.+..+++.||+|.+.....  ......+.+.+|+.+++.++|+||+++++++.....+|++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            46778899999999999999998999999999876432  2234556788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~  308 (479)
                      +||+++++|..++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++...........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999987654444456


Q ss_pred             ccCCCCCcchhHhcCCC-CCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCCCccCCHHHHHHHHhhhh
Q 011698          309 MCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK--DKIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~-~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      ..|+..|+|||.+.... ++.++|+|||||++|+|++|+.||...........+..  ....+|..++.++.++|.+||+
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  240 (258)
T cd06632         161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ  240 (258)
T ss_pred             cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence            77899999999998776 89999999999999999999999987665554444443  2345677889999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccc
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      .+|.+||     ++++++.|||+
T Consensus       241 ~~p~~Rp-----~~~~~l~~~~~  258 (258)
T cd06632         241 RDPSLRP-----TAAELLEHPFV  258 (258)
T ss_pred             cCcccCc-----CHHHHhcCCCC
Confidence            9999999     89999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-42  Score=340.73  Aligned_cols=251  Identities=19%  Similarity=0.284  Sum_probs=216.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc---CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      +..++|++.+.||+|+||.||+|.++   ..+..||+|.++...  .......+.+|+.++++++||||+++++++....
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   79 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN   79 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence            34568999999999999999999875   456789999987643  2233456788999999999999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      ..++||||+++|+|..++... +.+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999999998774 5789999999999999999999999999999999999999999999999998865432


Q ss_pred             CCC--cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHH
Q 011698          303 NTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (479)
Q Consensus       303 ~~~--~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (479)
                      ...  .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++.+.+..+ ....|..++..+.+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ  239 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            211  122345678999999999999999999999999999875 99999988888777777655 34567788999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ++..||+.+|.+||     ++++|++
T Consensus       240 li~~c~~~~p~~RP-----~~~~i~~  260 (266)
T cd05064         240 LMLDCWQKERGERP-----RFSQIHS  260 (266)
T ss_pred             HHHHHcCCCchhCC-----CHHHHHH
Confidence            99999999999999     8888865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-42  Score=344.95  Aligned_cols=253  Identities=29%  Similarity=0.491  Sum_probs=220.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      .+|++++.||+|+||.||+|.+..+++.||+|.+......   ..+.+.+|+.+++.++||||+++++.+......|+||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            5899999999999999999999999999999998764422   2456788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Cccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~~  308 (479)
                      ||+.|++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus        97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  175 (296)
T cd06654          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (296)
T ss_pred             cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence            99999999988865 467899999999999999999999999999999999999999999999999987654322 2334


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---cCCCCccCCHHHHHHHHhhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      ..|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+...   ....+..++..+.++|.+||.
T Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  255 (296)
T cd06654         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (296)
T ss_pred             ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCc
Confidence            57899999999999988999999999999999999999999877654433333322   223456788999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCC
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +||++||     +++++++|+||...
T Consensus       256 ~~p~~Rp-----t~~eil~~~~~~~~  276 (296)
T cd06654         256 MDVEKRG-----SAKELLQHQFLKIA  276 (296)
T ss_pred             CCcccCc-----CHHHHhhChhhhcc
Confidence            9999999     89999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-43  Score=346.30  Aligned_cols=255  Identities=27%  Similarity=0.462  Sum_probs=218.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||.||+|++..+++.||+|.++...  .......+.+|+.++++++||||+++++++.....+|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            47899999999999999999999999999999987542  2333456788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHc---CCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          230 DFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       230 E~~~ggsL~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      ||++|++|..++...   ..+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++..+... .
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~  157 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-L  157 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-c
Confidence            999999998888763   378999999999999999999997 59999999999999999999999999999765432 2


Q ss_pred             cccccCCCCCcchhHhcCC------CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHH---HHhc-cCCCCccCCHH
Q 011698          306 SNSMCGTLEYMSPEIVLGK------GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQK---IIKD-KIKLPAFLSSE  375 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~------~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~---i~~~-~~~~p~~~s~~  375 (479)
                      .....|++.|+|||.+.+.      .++.++|+|||||++|+|++|+.||...+.......   +... ...+|..++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD  237 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence            3445688999999998654      357899999999999999999999976555443333   3332 34567779999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      +.+||.+||+.+|++||     +++++++||||....
T Consensus       238 ~~~li~~~l~~~p~~Rp-----~~~~l~~~~~~~~~~  269 (286)
T cd06622         238 AQDFVAKCLNKIPNRRP-----TYAQLLEHPWLVKYK  269 (286)
T ss_pred             HHHHHHHHcccCcccCC-----CHHHHhcChhhhhcc
Confidence            99999999999999999     899999999997753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.6e-43  Score=340.50  Aligned_cols=254  Identities=27%  Similarity=0.504  Sum_probs=218.5

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc---hHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      +|+..+.||+|+||.||+|.+..+++.||+|++......   .....+.+++|+.++++++|+||+++++++.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999999999999999999754321   12245678899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC-cEEEeecCCccccCCCC--
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDENT--  304 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g-~vkL~DFGla~~~~~~~--  304 (479)
                      ||||+.|++|.+++.+.+.+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++.......  
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999999888899999999999999999999999999999999999998876 59999999998764321  


Q ss_pred             ---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHH---HHHh--ccCCCCccCCHHH
Q 011698          305 ---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ---KIIK--DKIKLPAFLSSEA  376 (479)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~---~i~~--~~~~~p~~~s~~~  376 (479)
                         ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+......   .+..  ....+|..++.++
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL  240 (268)
T ss_pred             CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHH
Confidence               1234568899999999999889999999999999999999999997544322222   2221  2345667789999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhCcccc
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK  409 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~  409 (479)
                      .++|..||..+|.+||     ++.++++||||+
T Consensus       241 ~~~i~~~l~~~p~~R~-----~~~~ll~~~~~~  268 (268)
T cd06630         241 RDVTLRCLELQPEDRP-----PSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHcCCCcccCc-----CHHHHhcCcccC
Confidence            9999999999999999     999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.2e-42  Score=335.37  Aligned_cols=248  Identities=31%  Similarity=0.563  Sum_probs=219.8

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++.+.||+|+||.||+++++.+++.||+|.++...  .....+.+..|+.+++.++|+||+++++.+.+...+|+|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            5899999999999999999999999999999987543  22345667889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Ccc
Q 011698          231 FVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (479)
Q Consensus       231 ~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~  307 (479)
                      |+++++|...+...  ..++++.++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ...
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence            99999998888653  458999999999999999999999999999999999999999999999999998764322 234


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCccCCHHHHHHHHhhhhh
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~lI~~~L~~  386 (479)
                      ...|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..+.. .+|..++..+.+||++||++
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  238 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR  238 (255)
T ss_pred             cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhC
Confidence            46789999999999999999999999999999999999999998887777777766643 46778899999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhC
Q 011698          387 EASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~h  405 (479)
                      ||.+||     ++.++++-
T Consensus       239 ~P~~Rp-----~~~~il~~  252 (255)
T cd08219         239 NPRSRP-----SATTILSR  252 (255)
T ss_pred             CcccCC-----CHHHHhhc
Confidence            999999     89999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-42  Score=344.82  Aligned_cols=253  Identities=29%  Similarity=0.495  Sum_probs=222.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      .+|++++.||.|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++.....+|+|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            579999999999999999999999999999999875432   23456788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Cccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~~  308 (479)
                      ||+.+++|..++.. ..+++..+..++.+++.||.|||++|++||||||+||+++.++.+||+|||++....... ....
T Consensus        96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence            99999999988765 468999999999999999999999999999999999999999999999999988754332 2344


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---cCCCCccCCHHHHHHHHhhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      ..|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+.......+...   ....+..++..+.+||++||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE  254 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhh
Confidence            67899999999999988999999999999999999999999887765555555433   233456789999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCC
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      .||.+||     ++.+++.||||+..
T Consensus       255 ~dp~~Rp-----t~~~il~~~~~~~~  275 (296)
T cd06655         255 MDVEKRG-----SAKELLQHPFLKLA  275 (296)
T ss_pred             cChhhCC-----CHHHHhhChHhhhc
Confidence            9999999     99999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2e-42  Score=336.20  Aligned_cols=256  Identities=32%  Similarity=0.534  Sum_probs=227.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||+|++|.||+|++..+++.||+|++......  .....+.+|+.++.+++|+||+++++++.....+++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            4789999999999999999999999999999998765421  34566889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc-c
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-N  307 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~-~  307 (479)
                      ||+++++|.+++.....+++..++.++.||+.||.|||+ ++++||||+|+||+++.++.++|+|||++......... .
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            999999999999888889999999999999999999999 99999999999999999999999999999876544332 2


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhc-cCCCCcc-CCHHHHHHHHh
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKD-KIKLPAF-LSSEAHSLLKG  382 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~---~~~~~~~~i~~~-~~~~p~~-~s~~~~~lI~~  382 (479)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||...   ...+....+... ....+.. ++..+.++|..
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  238 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA  238 (264)
T ss_pred             ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHH
Confidence            567889999999999999999999999999999999999999776   445555555544 3445556 89999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      ||..+|++||     ++.++++||||+.++
T Consensus       239 ~l~~~p~~R~-----~~~~ll~~~~~~~~~  263 (264)
T cd06623         239 CLQKDPKKRP-----SAAELLQHPFIKKAD  263 (264)
T ss_pred             HccCChhhCC-----CHHHHHhCHHHHhcc
Confidence            9999999999     899999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.2e-43  Score=350.33  Aligned_cols=243  Identities=27%  Similarity=0.473  Sum_probs=193.8

Q ss_pred             EEEeccCCceEEEEEEEc--CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee--CCeEEEEEE
Q 011698          155 LKVVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRLYLVLD  230 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~~~lV~E  230 (479)
                      .++||+|+||+||+|+++  .+++.||+|.+.....     ...+.+|+.+|++++||||+++++++..  ...+|++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            368999999999999976  3678999999875432     2335789999999999999999998854  567899999


Q ss_pred             eccCCcHHHHHHHc---------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe----CCCCcEEEeecCCc
Q 011698          231 FVNGGHLFFQLYRQ---------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL----DADGHVMLTDFGLA  297 (479)
Q Consensus       231 ~~~ggsL~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl----~~~g~vkL~DFGla  297 (479)
                      |+.+ +|..++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            9965 777776532         248999999999999999999999999999999999999    46689999999999


Q ss_pred             cccCCCC----CcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHH---------HHHHHHHh
Q 011698          298 KQFDENT----RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQ---------KIQQKIIK  363 (479)
Q Consensus       298 ~~~~~~~----~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~---------~~~~~i~~  363 (479)
                      +.+....    .....+||+.|+|||++.+. .++.++|||||||++|||++|++||......         .....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            8764321    23456889999999999874 5899999999999999999999999753311         11111111


Q ss_pred             c----------------------------cCC----------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          364 D----------------------------KIK----------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       364 ~----------------------------~~~----------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      .                            ...          .....+.++.+||++||+.||.+|+     |++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~-----t~~e~l~h  314 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI-----TSEQAMQD  314 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCC-----CHHHHhcC
Confidence            0                            000          0012356789999999999999999     99999999


Q ss_pred             ccc
Q 011698          406 KWF  408 (479)
Q Consensus       406 p~f  408 (479)
                      |||
T Consensus       315 p~f  317 (317)
T cd07868         315 PYF  317 (317)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.3e-42  Score=354.67  Aligned_cols=253  Identities=28%  Similarity=0.455  Sum_probs=213.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC------
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------  222 (479)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.++++++||||++++++|...      
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4789999999999999999999999999999999865432 233445567899999999999999999988644      


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      ...|+||||+.+ +|...+...  +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            357999999975 787777654  89999999999999999999999999999999999999999999999999987665


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------------
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------  364 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~------------------  364 (479)
                      ........|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+......++...                  
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN  250 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence            54455667899999999999999999999999999999999999999877655444443321                  


Q ss_pred             ----cCC--------------C-------CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          365 ----KIK--------------L-------PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       365 ----~~~--------------~-------p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                          ...              +       +...+..+++||.+||+.||++||     ++.|++.||||+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~eiL~~~~~~~  316 (353)
T cd07850         251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI-----SVDDALQHPYINV  316 (353)
T ss_pred             HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCc-----CHHHHhcChhHhh
Confidence                000              0       112456789999999999999999     9999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=333.45  Aligned_cols=260  Identities=30%  Similarity=0.478  Sum_probs=223.0

Q ss_pred             CcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeC
Q 011698          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK  222 (479)
Q Consensus       144 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~  222 (479)
                      .....+++.+.+..||.|+.|+||+++.+.+|...|||.+++..  ..+..+++...++++... ++|+||+.+++|..+
T Consensus        86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n  163 (391)
T KOG0983|consen   86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN  163 (391)
T ss_pred             ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence            44567788999999999999999999999999999999998754  344456667777776665 599999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCCCcEEEeecCCcccc
Q 011698          223 YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g~vkL~DFGla~~~  300 (479)
                      ..+++.||.|.. .+..++.+ +++++|..+-.+..-++.||.||.++ ||||||+||+|||+|..|++||||||++..+
T Consensus       164 ~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  164 TDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             chHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence            999999999964 34444443 46799999999999999999999886 8999999999999999999999999999987


Q ss_pred             CCCCCcccccCCCCCcchhHhcC---CCCCccccchhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCC-CC--ccCC
Q 011698          301 DENTRSNSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKDKIK-LP--AFLS  373 (479)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~DiwSLGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~-~p--~~~s  373 (479)
                      -+....+...|.+.|||||.+.-   ..|+..+||||||++++||+||+.||.+.+ .-++..+|+++.++ +|  ..+|
T Consensus       243 vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFS  322 (391)
T KOG0983|consen  243 VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFS  322 (391)
T ss_pred             ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcC
Confidence            76666666789999999999964   468999999999999999999999999854 45777788876543 33  3489


Q ss_pred             HHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       374 ~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +.+++|+..||++|+.+||     ...++++|||+...
T Consensus       323 p~F~~fv~~CL~kd~r~RP-----~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  323 PDFQSFVKDCLTKDHRKRP-----KYNKLLEHPFIKRY  355 (391)
T ss_pred             HHHHHHHHHHhhcCcccCc-----chHHHhcCcceeec
Confidence            9999999999999999999     78999999999865

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-42  Score=366.37  Aligned_cols=247  Identities=21%  Similarity=0.299  Sum_probs=206.0

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....         ..+.+|+++|++++|||||++++++......++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            4579999999999999999999999999999996432         2246799999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC---
Q 011698          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---  304 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~---  304 (479)
                      ||++. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....   
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            99996 5787777654 569999999999999999999999999999999999999999999999999998754322   


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhccC---CCC----
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN--------RQKIQQKIIKDKI---KLP----  369 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~~---~~p----  369 (479)
                      .....+||+.|||||++.+..++.++|||||||++|||++|..|+....        ...+.+.|.....   .++    
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            1234679999999999999999999999999999999999876653321        2223333222111   011    


Q ss_pred             ---------------------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          370 ---------------------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       370 ---------------------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                                                 ..++.++.+||.+||+.||.+||     +++|+|+||||+.
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RP-----sa~elL~hp~f~~  460 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRP-----SAAELLRLPLFQS  460 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCc-----CHHHHhhCcccCC
Confidence                                       02456899999999999999999     9999999999975

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.4e-42  Score=335.02  Aligned_cols=252  Identities=33%  Similarity=0.565  Sum_probs=223.4

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee--CCeEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRLYLV  228 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~~~lV  228 (479)
                      +|++++.||.|+||.||+|.+..+++.||+|++..... .....+.+..|+.++++++||||+++++.+..  ...+|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            58999999999999999999999999999999976543 33345667889999999999999999987753  4578999


Q ss_pred             EEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHH-----hCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          229 LDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLH-----ANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH-----~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      |||+++++|..++.+    ...+++..++.++.||+.||.|||     +.+|+|+||||+||+++.++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999988865    357899999999999999999999     89999999999999999999999999999988


Q ss_pred             cCCCCC-cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCccCCHHHH
Q 011698          300 FDENTR-SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAH  377 (479)
Q Consensus       300 ~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~  377 (479)
                      ...... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+...+.+.+..... .++..++.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN  239 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHH
Confidence            654443 3456789999999999998899999999999999999999999998887777777776644 46778899999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      +++.+||+.+|++||     ++++|++|||+
T Consensus       240 ~l~~~~l~~~p~~Rp-----~~~~il~~~~~  265 (265)
T cd08217         240 EVIKSMLNVDPDKRP-----STEELLQLPLI  265 (265)
T ss_pred             HHHHHHccCCcccCC-----CHHHHhhCCCC
Confidence            999999999999999     99999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.8e-43  Score=340.76  Aligned_cols=253  Identities=28%  Similarity=0.469  Sum_probs=220.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.+.....  ......+.+|+.++++++||||+++++.+.....+++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            468889999999999999999999999999999976532  234566788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcc
Q 011698          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (479)
Q Consensus       230 E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~  307 (479)
                      ||+.+++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+........ .
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  157 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-K  157 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-h
Confidence            999999999999876 789999999999999999999999 9999999999999999999999999999976543222 2


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhc-cCCCCcc-CCHHHHHHH
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG-----NRQKIQQKIIKD-KIKLPAF-LSSEAHSLL  380 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p~~-~s~~~~~lI  380 (479)
                      ...|+..|+|||.+.+..++.++|+||||+++|+|++|..||...     ......+.+... ....+.. ++.++.++|
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV  237 (265)
T ss_pred             cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence            277899999999999999999999999999999999999999754     233444444443 3344444 899999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      ..||..||++||     ++.+++.||||+.
T Consensus       238 ~~~l~~~p~~Rp-----t~~~ll~~~~~~~  262 (265)
T cd06605         238 NLCLIKDPRERP-----SYKELLEHPFIKK  262 (265)
T ss_pred             HHHcCCCchhCc-----CHHHHhhCchhhc
Confidence            999999999999     8999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.6e-43  Score=359.25  Aligned_cols=252  Identities=23%  Similarity=0.369  Sum_probs=211.5

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCC-----eEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSF  219 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~  219 (479)
                      .+..++|++.+.||+|+||.||+|++..++     ..||+|+++....  ....+.+.+|+.+++.+ +|+||+++++++
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            455678999999999999999999875443     5799999976432  23356688899999999 899999999999


Q ss_pred             eeCCeEEEEEEeccCCcHHHHHHHc-------------------------------------------------------
Q 011698          220 QTKYRLYLVLDFVNGGHLFFQLYRQ-------------------------------------------------------  244 (479)
Q Consensus       220 ~~~~~~~lV~E~~~ggsL~~~l~~~-------------------------------------------------------  244 (479)
                      .....+|+||||+.+|+|.+++...                                                       
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            9999999999999999999988643                                                       


Q ss_pred             ---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC---c
Q 011698          245 ---------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR---S  306 (479)
Q Consensus       245 ---------------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~---~  306 (479)
                                     ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+.....   .
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                           1367788999999999999999999999999999999999999999999999987543322   1


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc--cCCCCccCCHHHHHHHHhh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~lI~~~  383 (479)
                      ....+++.|||||++.+..++.++|||||||++|||++ |+.||...........+...  ....|..++.++.++|.+|
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  351 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC  351 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence            12335568999999999999999999999999999997 99999876554444444443  3445667899999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHh
Q 011698          384 LQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~  404 (479)
                      |+.||.+||     +++++.+
T Consensus       352 l~~dp~~RP-----s~~~l~~  367 (374)
T cd05106         352 WNLEPTERP-----TFSQISQ  367 (374)
T ss_pred             cCCChhhCc-----CHHHHHH
Confidence            999999999     8888865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.1e-42  Score=345.54  Aligned_cols=252  Identities=22%  Similarity=0.363  Sum_probs=214.2

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeE--EEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEI--YAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY  223 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~  223 (479)
                      +.+++|++.+.||+|+||.||+|+++.++..  +|+|.+...  ........+.+|+.++.++ +||||+++++++...+
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~   81 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   81 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence            5578999999999999999999999877764  466665432  2334456678899999999 8999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHcC----------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g  287 (479)
                      .+|+||||+++|+|..++.+.+                .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence            9999999999999999997643                478889999999999999999999999999999999999999


Q ss_pred             cEEEeecCCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-c
Q 011698          288 HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-K  365 (479)
Q Consensus       288 ~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~  365 (479)
                      .+||+|||++.............++..|+|||.+.+..++.++|||||||++|||+| |..||.+.+..+..+.+... .
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  241 (303)
T cd05088         162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  241 (303)
T ss_pred             cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCc
Confidence            999999999965322222222334668999999998889999999999999999998 99999888877777766554 3


Q ss_pred             CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          366 IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       366 ~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ...+..++.++.+||.+||+.+|++||     ++++++.+
T Consensus       242 ~~~~~~~~~~~~~li~~~l~~~p~~Rp-----~~~~il~~  276 (303)
T cd05088         242 LEKPLNCDDEVYDLMRQCWREKPYERP-----SFAQILVS  276 (303)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            445667889999999999999999999     88998875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.8e-42  Score=339.38  Aligned_cols=252  Identities=29%  Similarity=0.475  Sum_probs=214.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeC-----
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK-----  222 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~-----  222 (479)
                      .++|++.+.||+|+||.||+|..+.+++.+|+|++....    .....+.+|+.+++++ +||||+++++++...     
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            478999999999999999999999999999999986532    1234567899999998 899999999998654     


Q ss_pred             CeEEEEEEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcc
Q 011698          223 YRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~  298 (479)
                      ..+|+||||++|++|.+++..    ...+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++.
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~  176 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA  176 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence            368999999999999888753    4568999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC-CcccccCCCCCcchhHhcCC-----CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---CCCC
Q 011698          299 QFDENT-RSNSMCGTLEYMSPEIVLGK-----GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLP  369 (479)
Q Consensus       299 ~~~~~~-~~~~~~gt~~y~APE~l~~~-----~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p  369 (479)
                      ...... ......|+..|+|||.+...     .++.++|||||||++|||++|+.||...+.......+....   ...+
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  256 (291)
T cd06639         177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHP  256 (291)
T ss_pred             hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcc
Confidence            754332 23445789999999998653     36889999999999999999999998877655555555442   2335


Q ss_pred             ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCcccc
Q 011698          370 AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK  409 (479)
Q Consensus       370 ~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~  409 (479)
                      ..++..+.+||.+||+.+|++||     ++.+|++||||+
T Consensus       257 ~~~~~~l~~li~~~l~~~p~~Rp-----s~~~il~~~~~~  291 (291)
T cd06639         257 EKWCRSFNHFISQCLIKDFEARP-----SVTHLLEHPFIK  291 (291)
T ss_pred             cccCHHHHHHHHHHhhcChhhCc-----CHHHHhcCcccC
Confidence            56788999999999999999999     899999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.2e-42  Score=342.64  Aligned_cols=253  Identities=32%  Similarity=0.463  Sum_probs=215.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||.||+|.++.+++.||+|++.+.... ....+.+.+|+.+++.++||||+++++++.++...|+||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            4799999999999999999999999999999998764322 234456788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Cccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~~  308 (479)
                      ||+++++|..+......+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.... ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            999999998877776679999999999999999999999999999999999999999999999999998754332 2234


Q ss_pred             ccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------------cCC-
Q 011698          309 MCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------------KIK-  367 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-------------------~~~-  367 (479)
                      ..++..|+|||++.+. .++.++||||||+++|||++|+.||...+..+....+...                   ... 
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            5688999999998764 4688999999999999999999999876654443333320                   000 


Q ss_pred             -----------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          368 -----------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       368 -----------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                                 ..+.++..+.+||.+||+.+|++||     +++++++|+||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----~~~~il~~~~~  286 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP-----SSSQLLHHEFF  286 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch-----hHHHHhcCCCC
Confidence                       1235688999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-42  Score=341.40  Aligned_cols=253  Identities=32%  Similarity=0.535  Sum_probs=217.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||+|+||.||+|.++.+++.||+|+++.... .....+.+.+|++++++++|+||+++++++...+.+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            479999999999999999999999999999999876432 2334566889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC--Ccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RSN  307 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~--~~~  307 (479)
                      ||++++.+.....+...+++..++.++.||+.||.|||+++++||||+|+||+++.++.+||+|||++.......  ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            999998777666666779999999999999999999999999999999999999999999999999998765443  334


Q ss_pred             cccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----------------------
Q 011698          308 SMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD----------------------  364 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~----------------------  364 (479)
                      ...++..|+|||++.+. .++.++|+||||+++|+|++|+.||.+.+..+....+...                      
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            56788999999999888 8899999999999999999999999876554433322210                      


Q ss_pred             ----------cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          365 ----------KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       365 ----------~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                                ...++..++.++.+||++||+.+|++||     +++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~f  288 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL-----TCDELLQHPYF  288 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcc-----cHHHHhcCCCC
Confidence                      0013345689999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.9e-42  Score=343.23  Aligned_cols=249  Identities=19%  Similarity=0.292  Sum_probs=207.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcC----------------CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCe
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIG----------------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI  212 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~I  212 (479)
                      .++|++.++||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.+|++++||||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence            4689999999999999999998643                44579999987643  23345568889999999999999


Q ss_pred             eeEeEEEeeCCeEEEEEEeccCCcHHHHHHHcC-------------------CCcHHHHHHHHHHHHHHHHHHHhCCCcc
Q 011698          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-------------------LFREDLARIYTAEIVSAVSHLHANGIMH  273 (479)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------------~l~e~~~~~~~~qi~~aL~~LH~~~IiH  273 (479)
                      +++++++.+....++||||+.+|+|.+++....                   .+++..++.++.||+.||.|||++||+|
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            999999999999999999999999999886532                   3567788899999999999999999999


Q ss_pred             CCCCCccEEeCCCCcEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh--CCCC
Q 011698          274 RDLKPENILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT--GQPP  348 (479)
Q Consensus       274 rDLKpeNILl~~~g~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt--G~~P  348 (479)
                      |||||+|||++.++.+||+|||+++.+.....   .....++..|||||++.+..++.++|||||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986543321   223456788999999999899999999999999999987  6788


Q ss_pred             CCCCCHHHHHHHHHhc--------cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          349 FTGGNRQKIQQKIIKD--------KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       349 f~~~~~~~~~~~i~~~--------~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      |.+.+..+....+...        ....|..++..+.+||.+||+.||++||     ++++|.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----s~~~i~~  300 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP-----SFSDIHA  300 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCc-----CHHHHHH
Confidence            9877666555443321        1234566889999999999999999999     8888843

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-42  Score=343.49  Aligned_cols=255  Identities=26%  Similarity=0.446  Sum_probs=220.8

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++.....+++
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            4578999999999999999999999999999999987543  23345678899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~  306 (479)
                      ||||+++++|..++.+.+.+++..++.++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++...... ..
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~  159 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IA  159 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-cc
Confidence            99999999999999888889999999999999999999997 59999999999999999999999999998765322 23


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhc-cCCCCcc-CC
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ-----------KIQQKIIKD-KIKLPAF-LS  373 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~-----------~~~~~i~~~-~~~~p~~-~s  373 (479)
                      ...+|+..|+|||++.+..++.++|+|||||++|+|++|..||...+..           +....+..+ ...++.. ++
T Consensus       160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd06620         160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP  239 (284)
T ss_pred             CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence            4568999999999998888999999999999999999999999865431           233334333 2333333 78


Q ss_pred             HHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       374 ~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      .++.+||.+||++||.+||     +++|+++|+||..
T Consensus       240 ~~~~~li~~~l~~dp~~Rp-----t~~e~~~~~~~~~  271 (284)
T cd06620         240 EDLRDFVDACLLKDPTERP-----TPQQLCAMPPFIQ  271 (284)
T ss_pred             HHHHHHHHHHhcCCcccCc-----CHHHHhcCccccc
Confidence            8999999999999999999     9999999999965

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.4e-42  Score=344.43  Aligned_cols=257  Identities=31%  Similarity=0.476  Sum_probs=215.4

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC--CeE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRL  225 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~  225 (479)
                      ..++|++.+.||+|+||.||+|.++.+|+.||+|+++...... .......+|+.++++++|+||+++++++...  +.+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            4678999999999999999999999999999999987543222 1222356799999999999999999998755  578


Q ss_pred             EEEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      ++||||+.+ +|..++.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999999975 77777765 3678999999999999999999999999999999999999999999999999998764332


Q ss_pred             -CcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------------
Q 011698          305 -RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------  364 (479)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~------------------  364 (479)
                       ......+++.|+|||.+.+ ..++.++|+|||||++|||++|+.||.+.+.......+...                  
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence             2233346788999999876 55789999999999999999999999988877776666541                  


Q ss_pred             -cCCCC-----------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          365 -KIKLP-----------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       365 -~~~~p-----------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                       ...++           ..+++++.+||.+||+.||++||     +++++++||||+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~-----t~~~il~h~~f~~~  296 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRA-----TAEEALESSYFKEK  296 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCc-----CHHHHhcChhhccC
Confidence             11111           12588999999999999999999     89999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.5e-42  Score=344.05  Aligned_cols=253  Identities=29%  Similarity=0.489  Sum_probs=219.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      .+|++++.||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            689999999999999999999999999999999975432   23455788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC-ccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~-~~~  308 (479)
                      ||++|++|..++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++........ ...
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  174 (297)
T cd06656          96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (297)
T ss_pred             cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence            99999999988865 4578999999999999999999999999999999999999999999999999987543322 234


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---cCCCCccCCHHHHHHHHhhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      ..|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.......+...   ....|..++..+++||.+||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLE  254 (297)
T ss_pred             ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHcc
Confidence            57899999999999998999999999999999999999999876554333323322   223456788999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCC
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      .+|++||     +++++++||||+..
T Consensus       255 ~~p~~Rp-----s~~~il~~~~~~~~  275 (297)
T cd06656         255 MDVDRRG-----SAKELLQHPFLKLA  275 (297)
T ss_pred             CChhhCc-----CHHHHhcCchhccc
Confidence            9999999     89999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.8e-42  Score=336.19  Aligned_cols=253  Identities=29%  Similarity=0.498  Sum_probs=215.9

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc-------hHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-------EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      +|.+.+.||.|+||.||+|....+++.||+|.++.....       .....+.+.+|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            578889999999999999999999999999998643211       1123456788999999999999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      .+++||||+.|++|..++.+.+.+++..++.++.||+.||.|||+++++||||+|+||+++.++.++|+|||+++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999765322


Q ss_pred             ---CCcccccCCCCCcchhHhcCCC--CCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCc----cC
Q 011698          304 ---TRSNSMCGTLEYMSPEIVLGKG--HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPA----FL  372 (479)
Q Consensus       304 ---~~~~~~~gt~~y~APE~l~~~~--~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~----~~  372 (479)
                         .......|+..|+|||.+.+..  ++.++|+||||+++|+|++|..||...+.......+...  ...++.    .+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence               1233456889999999998754  789999999999999999999999765554444333322  223333    46


Q ss_pred             CHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       373 s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      +.++.++|.+||+.+|.+||     +++++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRP-----TARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCC-----CHHHHhhCCCC
Confidence            89999999999999999999     89999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.5e-42  Score=339.04  Aligned_cols=252  Identities=33%  Similarity=0.523  Sum_probs=215.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++.+.||.|+||.||+|++..+|+.||+|++...... ......+.+|+.++++++||||+++++++.....+|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            589999999999999999999999999999999875432 2334567889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC--Ccc
Q 011698          231 FVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RSN  307 (479)
Q Consensus       231 ~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~--~~~  307 (479)
                      |+ +++|..++.. ...+++..++.++.||+.||+|||+.||+|+||||+||+++.++.++|+|||++.......  ...
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            99 9999998865 3568999999999999999999999999999999999999999999999999998764433  234


Q ss_pred             cccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------------cCC
Q 011698          308 SMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------------KIK  367 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-------------------~~~  367 (479)
                      ...|+..|+|||.+.+. .++.++|||||||++|||++|.+||.+.+.......+...                   ...
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT  238 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence            46789999999998764 4689999999999999999999999877665555444431                   000


Q ss_pred             C-----------CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCcccc
Q 011698          368 L-----------PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK  409 (479)
Q Consensus       368 ~-----------p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~  409 (479)
                      +           ....+.++.+||++||+.+|++||     +++++++||||.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----~~~~~l~h~~~~  286 (286)
T cd07832         239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL-----SAAEALRHPYFT  286 (286)
T ss_pred             CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCC-----CHHHHhhCcCcC
Confidence            1           124578999999999999999999     899999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.8e-42  Score=339.54  Aligned_cols=256  Identities=27%  Similarity=0.481  Sum_probs=223.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ..|+.++.||.|+||.||+|.++.++..||+|++.....  ......+.+|+.++++++||||+++++++.+....|+||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            358888999999999999999999999999999875432  234567888999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Cccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~~  308 (479)
                      ||++||+|.+++.. +.+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..+.... ....
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            99999999988865 568999999999999999999999999999999999999999999999999997754332 2334


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhhhhhc
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      ..++..|+|||.+.+..++.++|+|||||++|||++|..||...+.......+... ...++..++..+.++|.+||+.+
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  240 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKD  240 (277)
T ss_pred             ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccC
Confidence            56888999999999988999999999999999999999999887776666555443 33455568899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          388 ASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      |++||     +++++++|+||.....
T Consensus       241 p~~Rp-----~~~~il~~~~~~~~~~  261 (277)
T cd06640         241 PSFRP-----TAKELLKHKFIVKNAK  261 (277)
T ss_pred             cccCc-----CHHHHHhChHhhhcch
Confidence            99999     8999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-42  Score=331.73  Aligned_cols=246  Identities=56%  Similarity=1.016  Sum_probs=226.6

Q ss_pred             eccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCCcH
Q 011698          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (479)
Q Consensus       158 LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL  237 (479)
                      ||+|+||.||++.+..+++.||+|++++...........+..|+.++++++||||+++++.++.+...|+||||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999999999999999999887665555677789999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcccccCCCCCc
Q 011698          238 FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYM  316 (479)
Q Consensus       238 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~~~~gt~~y~  316 (479)
                      .+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......|+..|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL  160 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence            999998888999999999999999999999999999999999999999999999999999876443 2344567889999


Q ss_pred             chhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcCCCC
Q 011698          317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGP  396 (479)
Q Consensus       317 APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~  396 (479)
                      |||.+.+...+.++|+||||+++|+|++|..||...+...+.+.+......+|..++..+.++|++||..||++||    
T Consensus       161 ~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~----  236 (250)
T cd05123         161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRL----  236 (250)
T ss_pred             ChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCC----
Confidence            9999998888999999999999999999999998888888888888888889999999999999999999999999    


Q ss_pred             CCH---HHHHhCccc
Q 011698          397 GGS---QEIKSHKWF  408 (479)
Q Consensus       397 ~t~---~eil~hp~f  408 (479)
                       ++   +++++||||
T Consensus       237 -~~~~~~~l~~~~~f  250 (250)
T cd05123         237 -GSGGAEEIKAHPFF  250 (250)
T ss_pred             -CcccHHHHHhCCCC
Confidence             56   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.2e-42  Score=337.79  Aligned_cols=248  Identities=29%  Similarity=0.471  Sum_probs=207.7

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeC--CeEEEE
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTK--YRLYLV  228 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~--~~~~lV  228 (479)
                      |++++.||+|+||.||+|.+..+++.||+|++++... ..... ...+|+.+++++. |+||+++++++.+.  +.+++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            6789999999999999999999999999999876432 22222 2346888888885 99999999999987  899999


Q ss_pred             EEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcc
Q 011698          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~  307 (479)
                      |||+.+ +|...+.. .+.+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||+++.+.......
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence            999975 77777765 457899999999999999999999999999999999999999 999999999998765544444


Q ss_pred             cccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------------cCCC
Q 011698          308 SMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------KIKL  368 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~------------------~~~~  368 (479)
                      ...++..|+|||.+.+ ..++.++|||||||++|||++|..||.+.+..+....+...                  ...+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            5678999999998754 45689999999999999999999999887765554444321                  1111


Q ss_pred             C-----------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          369 P-----------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       369 p-----------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      |           ..++.++.+||.+||+++|++||     +++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI-----TAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCccccc-----CHHHHhhCCCC
Confidence            1           24689999999999999999999     89999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9e-42  Score=331.86  Aligned_cols=252  Identities=31%  Similarity=0.549  Sum_probs=219.4

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++.+.||+|+||.||+|.+..+++.||+|+++..... ....+.+.+|+.+++.++|+||+++++.+.....+++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            588999999999999999999999999999999875432 4466778999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC-----
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-----  305 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~-----  305 (479)
                      |+++++|.+++...+.+++..++.++.+++.||.|||+.||+|+||+|+||+++.++.+||+|||++........     
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            999999999998887899999999999999999999999999999999999999999999999999987643322     


Q ss_pred             cccccCCCCCcchhHhcCCC---CCccccchhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhc-cCCCCccC--CHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKG---HDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKD-KIKLPAFL--SSEAHS  378 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~---~~~~~DiwSLGvilyelltG~~Pf~~~~-~~~~~~~i~~~-~~~~p~~~--s~~~~~  378 (479)
                      .....+++.|+|||++.+..   ++.++||||||+++|+|++|+.||...+ .......+..+ ...+|...  +..+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence            12356889999999998776   8899999999999999999999997653 33333333332 34455544  899999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      +|++||+.+|.+||     ++++++.|||+
T Consensus       240 li~~~l~~~p~~R~-----~~~~i~~~~~~  264 (264)
T cd06626         240 FLDRCLESDPKKRP-----TASELLQHPFV  264 (264)
T ss_pred             HHHHHccCCcccCC-----CHHHHhcCCCC
Confidence            99999999999999     89999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.6e-42  Score=337.75  Aligned_cols=251  Identities=30%  Similarity=0.496  Sum_probs=211.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEee------
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQT------  221 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~------  221 (479)
                      .+.|++.+.||.|+||.||+|++..+++.||+|++....    .....+..|+.+++++ +||||+++++++..      
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            368999999999999999999999999999999986542    2234577899999998 79999999999853      


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      ...+|++|||+.+|+|..++...  ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            46789999999999999988753  4588889999999999999999999999999999999999999999999999986


Q ss_pred             cCCC-CCcccccCCCCCcchhHhc-----CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-C-CCcc
Q 011698          300 FDEN-TRSNSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-K-LPAF  371 (479)
Q Consensus       300 ~~~~-~~~~~~~gt~~y~APE~l~-----~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~-~p~~  371 (479)
                      .... .......|++.|+|||.+.     +..++.++|+|||||++|||++|..||...........+..... . .+..
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  250 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKK  250 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccc
Confidence            5432 2334567899999999986     34678899999999999999999999987665444443333321 1 2235


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      ++.++.+||++||+.||.+||     ++.||++||||
T Consensus       251 ~~~~~~~li~~cl~~~p~~Rp-----~~~ell~~~~~  282 (282)
T cd06636         251 WSKKFIDFIEGCLVKNYLSRP-----STEQLLKHPFI  282 (282)
T ss_pred             cCHHHHHHHHHHhCCChhhCc-----CHHHHhcCCCC
Confidence            789999999999999999999     89999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.2e-42  Score=337.25  Aligned_cols=246  Identities=29%  Similarity=0.541  Sum_probs=207.4

Q ss_pred             CCeEEEEEe--ccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEE
Q 011698          150 EDFEVLKVV--GQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       150 ~~y~~~~~L--G~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ++|++.+.+  |.|+||.||+++.+.++..+|+|++.......        .|......+ +||||+++++.|...+.+|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            456666665  99999999999999999999999987643211        122222222 7999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC-cEEEeecCCccccCCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g-~vkL~DFGla~~~~~~~~  305 (479)
                      +||||++|++|..++.....++++.++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||+++.....  
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--  163 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--  163 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence            9999999999999998888999999999999999999999999999999999999999999 9999999999765432  


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccCCCCccCCHHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI----QQKIIKDKIKLPAFLSSEAHSLLK  381 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~lI~  381 (479)
                       ....|+..|+|||++.+..++.++||||||+++|||++|..||.......+    ...........+..++..+.+||.
T Consensus       164 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  242 (267)
T PHA03390        164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQ  242 (267)
T ss_pred             -ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHH
Confidence             235689999999999999999999999999999999999999986543322    111223445566679999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      +||+.+|.+|+.    +++++++||||++
T Consensus       243 ~~l~~~p~~R~~----~~~~~l~h~~~~~  267 (267)
T PHA03390        243 SMLKYNINYRLT----NYNEIIKHPFLKI  267 (267)
T ss_pred             HHhccChhhCCc----hHHHHhcCCcccC
Confidence            999999999992    4699999999975

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.4e-42  Score=338.23  Aligned_cols=252  Identities=29%  Similarity=0.489  Sum_probs=212.0

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEe-----e
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQ-----T  221 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~-----~  221 (479)
                      ..++|++++.||+|+||+||+|.++.+++.||+|++....    .....+.+|+.+++.+ +||||+++++++.     .
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            3578999999999999999999999999999999986532    1224567899999998 7999999999873     4


Q ss_pred             CCeEEEEEEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                      ...+++||||++|++|..++..    ...+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            5679999999999999887653    356889999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC-CCcccccCCCCCcchhHhcC-----CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---cCCC
Q 011698          298 KQFDEN-TRSNSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKL  368 (479)
Q Consensus       298 ~~~~~~-~~~~~~~gt~~y~APE~l~~-----~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~  368 (479)
                      +.+... .......|++.|+|||++..     ..++.++|||||||++|||++|+.||...+.......+...   ....
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ  251 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccC
Confidence            875432 23345578999999999853     45789999999999999999999999876654444333332   2224


Q ss_pred             CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          369 PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       369 p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      |..++.++.+||.+||+.||++||     ++.|+++|+||
T Consensus       252 ~~~~~~~~~~li~~~l~~~p~~Rp-----s~~ell~~~~~  286 (286)
T cd06638         252 PELWSNEFNDFIRKCLTKDYEKRP-----TVSDLLQHVFI  286 (286)
T ss_pred             CCCcCHHHHHHHHHHccCCcccCC-----CHHHHhhcccC
Confidence            556788999999999999999999     99999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-42  Score=334.47  Aligned_cols=251  Identities=31%  Similarity=0.501  Sum_probs=214.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCC----
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY----  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~----  223 (479)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++.....    ..+.+.+|+.+++++ +|+||+++++++....    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            3689999999999999999999999999999999876432    235678999999998 7999999999997644    


Q ss_pred             --eEEEEEEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          224 --RLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       224 --~~~lV~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                        .+|+||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence              58999999999999888865    357899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC-CCcccccCCCCCcchhHhcC-----CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---CCC
Q 011698          298 KQFDEN-TRSNSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKL  368 (479)
Q Consensus       298 ~~~~~~-~~~~~~~gt~~y~APE~l~~-----~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~  368 (479)
                      ...... .......|+..|+|||++..     ..++.++|||||||++|+|++|+.||...+.......+....   ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  240 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS  240 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence            765432 22345678999999999864     346789999999999999999999998766665555555542   223


Q ss_pred             CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          369 PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       369 p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      +..++.++.+||.+||..||++||     +++++++|||+
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rp-----t~~~ll~~~~~  275 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRP-----FMEELLEHPFI  275 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCc-----CHHHHhcCCCC
Confidence            344788999999999999999999     99999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.1e-42  Score=355.15  Aligned_cols=251  Identities=23%  Similarity=0.351  Sum_probs=209.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE-----cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEe
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQ  220 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~  220 (479)
                      +..++|++.+.||+|+||+||+|++     ..++..||+|+++....  ....+.+.+|+.+|+.+ +||||+++++++.
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            4456899999999999999999975     34677899999875432  22345678899999999 8999999999999


Q ss_pred             eCCeEEEEEEeccCCcHHHHHHHcC-------------------------------------------------------
Q 011698          221 TKYRLYLVLDFVNGGHLFFQLYRQG-------------------------------------------------------  245 (479)
Q Consensus       221 ~~~~~~lV~E~~~ggsL~~~l~~~~-------------------------------------------------------  245 (479)
                      .....++||||++||+|..++.+..                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            9999999999999999998886532                                                       


Q ss_pred             --------------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          246 --------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       246 --------------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                                          .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                                367788889999999999999999999999999999999999999999999987543321


Q ss_pred             ---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhc-cCCCCccCCHHHHHH
Q 011698          306 ---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK-IQQKIIKD-KIKLPAFLSSEAHSL  379 (479)
Q Consensus       306 ---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~l  379 (479)
                         .....++..|+|||++.+..++.++|||||||++|||++ |..||....... ..+.+..+ ....|...+.++.+|
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  349 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDI  349 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHH
Confidence               122334667999999999999999999999999999998 999998765443 33333333 334456678999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      |..||+.||++||     ++.+|++
T Consensus       350 i~~cl~~dP~~RP-----s~~eil~  369 (375)
T cd05104         350 MKSCWDADPLKRP-----TFKQIVQ  369 (375)
T ss_pred             HHHHccCChhHCc-----CHHHHHH
Confidence            9999999999999     8999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4e-42  Score=341.48  Aligned_cols=255  Identities=28%  Similarity=0.425  Sum_probs=216.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc--hHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +|++.+.||+|+||.||+|.+..+++.||+|.++.....  .......+..|+.++++++|+||+++++++.+...+++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            488999999999999999999999999999999875432  122344567899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Cc
Q 011698          229 LDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RS  306 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~  306 (479)
                      |||+ +|+|..++.+.. .+++..++.++.||+.||.|||++||+|+||||+||+++.+|.+||+|||+++...... ..
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 889999998776 79999999999999999999999999999999999999999999999999998765432 22


Q ss_pred             ccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-------------------
Q 011698          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-------------------  366 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-------------------  366 (479)
                      ....+++.|+|||.+.+ ..++.++|+|||||++|||++|.+||.+.+..+...++.....                   
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            33457889999999865 4578999999999999999999999987766555555432100                   


Q ss_pred             ----C-----CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          367 ----K-----LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       367 ----~-----~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                          .     .....+.++.+||.+||+.||++||     +++|++.|+||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----s~~e~l~~~~~~~~  288 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI-----TARQALEHPYFSND  288 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCc-----CHHHHhhCccccCC
Confidence                0     1123578899999999999999999     99999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.6e-42  Score=341.18  Aligned_cols=253  Identities=32%  Similarity=0.536  Sum_probs=215.0

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC--CeEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRLY  226 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~~  226 (479)
                      .++|++.+.||.|+||.||+|.++.+++.+|+|.++..... ......+.+|+.++++++||||+++++++...  ..+|
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            46899999999999999999999999999999999765432 22334466899999999999999999998877  8999


Q ss_pred             EEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-C
Q 011698          227 LVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-T  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~  304 (479)
                      +||||+.+ +|...+.... .+++..++.++.||+.||+|||++||+|+||||+|||++.+|.+||+|||++...... .
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            99999985 8888887644 5899999999999999999999999999999999999999999999999999876543 2


Q ss_pred             CcccccCCCCCcchhHhcCCC-CCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------------------
Q 011698          305 RSNSMCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK------------------  365 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~-~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~------------------  365 (479)
                      ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+......++....                  
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence            334456789999999997654 6899999999999999999999998877665555543210                  


Q ss_pred             -------------CCCCcc-CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          366 -------------IKLPAF-LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       366 -------------~~~p~~-~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                                   ..++.. ++..+.++|++||+.||++||     +++|++.|+||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----t~~ell~~~~f  293 (293)
T cd07843         242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRI-----SAEDALKHPYF  293 (293)
T ss_pred             ccccccccchhhhccccccCCChHHHHHHHHHhccCccccC-----CHHHHhcCCCC
Confidence                         112333 688999999999999999999     99999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8.9e-42  Score=336.72  Aligned_cols=252  Identities=20%  Similarity=0.354  Sum_probs=215.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc----CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRI----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      +.+++|++.+.||+|+||+||+|.+.    .++..||+|.+....  .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            34678999999999999999999863    456789999987532  233446678899999999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcC-----------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQG-----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~-----------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~  285 (479)
                      ...|+||||+.+++|.+++....                 .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            99999999999999999886432                 3678888999999999999999999999999999999999


Q ss_pred             CCcEEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 011698          286 DGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI  361 (479)
Q Consensus       286 ~g~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i  361 (479)
                      ++.+||+|||+++......   ......++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+...+.+.+
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999998753322   2234456778999999998889999999999999999999 99999887777776666


Q ss_pred             Hhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          362 IKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       362 ~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ... .+..+..++..+.++|..||+.||.+||     ++.+|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~i~~~  279 (283)
T cd05090         240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP-----RFKDIHTR  279 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcccCcccCc-----CHHHHHHH
Confidence            654 3456677899999999999999999999     88888764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.1e-41  Score=332.31  Aligned_cols=250  Identities=29%  Similarity=0.478  Sum_probs=214.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||+|+||.||+|+++.+++.||||.+.............+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            68999999999999999999999999999999987644444555666788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-
Q 011698          230 DFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       230 E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-  304 (479)
                      ||+++|+|..++..    ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.... 
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            99999999887753    3458999999999999999999999999999999999999999999999999998764332 


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcc-CCC-CccCCHHHHHHH
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN--RQKIQQKIIKDK-IKL-PAFLSSEAHSLL  380 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~--~~~~~~~i~~~~-~~~-p~~~s~~~~~lI  380 (479)
                      ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||....  ...+...+.... ... +..++..+.++|
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELV  241 (267)
T ss_pred             HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHH
Confidence            2234578899999999999889999999999999999999999997543  334444444332 222 235788999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHh
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+||+.+|++||     +++++++
T Consensus       242 ~~cl~~~p~~Rp-----~~~~vl~  260 (267)
T cd08228         242 SMCIYPDPDQRP-----DIGYVHQ  260 (267)
T ss_pred             HHHCCCCcccCc-----CHHHHHH
Confidence            999999999999     8999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.9e-42  Score=343.70  Aligned_cols=251  Identities=23%  Similarity=0.376  Sum_probs=212.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeE----EEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEI----YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      +...+|++++.||+|+||+||+|++..+++.    ||+|+++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            3457899999999999999999998766654    8999986432  233455678899999999999999999998764


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                       ..++|+||+.+|+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence             578999999999999998874 468888999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCc---ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHH
Q 011698          302 ENTRS---NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       302 ~~~~~---~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                      .....   ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....++...+..+ .+..|..++.++
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  240 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence            43322   22334678999999999999999999999999999998 99999887766655444433 345567789999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      .++|..||..+|.+||     ++.+++.+
T Consensus       241 ~~li~~cl~~~p~~Rp-----s~~~l~~~  264 (316)
T cd05108         241 YMIMVKCWMIDADSRP-----KFRELIIE  264 (316)
T ss_pred             HHHHHHHccCChhhCc-----CHHHHHHH
Confidence            9999999999999999     89999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.5e-42  Score=337.49  Aligned_cols=250  Identities=22%  Similarity=0.379  Sum_probs=217.0

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      ..++|.+++.||+|+||.||+|++..     +++.||+|+++...  .....+.+.+|+++|+.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            35689999999999999999998753     46789999987643  223456788999999999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcC--------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQG--------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~--------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~  288 (479)
                      ...++||||++|++|..++...+              .+++..+..++.||+.||.|||++|++||||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999997643              3788889999999999999999999999999999999999999


Q ss_pred             EEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 011698          289 VMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD  364 (479)
Q Consensus       289 vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~  364 (479)
                      +||+|||+++......   ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+..+
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG  240 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            9999999997643221   1223446788999999999999999999999999999999 99999988888888888876


Q ss_pred             cCC-CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          365 KIK-LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       365 ~~~-~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ... .+..++..+.++|.+||++||++||     +++|+++
T Consensus       241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----~~~eil~  276 (280)
T cd05049         241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRI-----NIKDIHE  276 (280)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCC-----CHHHHHH
Confidence            543 4567899999999999999999999     8898875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1e-41  Score=331.13  Aligned_cols=247  Identities=22%  Similarity=0.381  Sum_probs=214.2

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      +.++|++++.||+|+||.||+|+++. +..+|+|.+......    .+.+.+|+.+|++++||||+++++++.....+++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   76 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI   76 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence            34689999999999999999999865 457999998754322    2346789999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc
Q 011698          228 VLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~  306 (479)
                      ||||++||+|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            99999999999988753 56899999999999999999999999999999999999999999999999999865332221


Q ss_pred             --ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHh
Q 011698          307 --NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKG  382 (479)
Q Consensus       307 --~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~  382 (479)
                        ....++..|+|||.+.+..++.++|+||||+++|||++ |+.||...+..+....+..+ ....|...+.++.++|.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS  236 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence              22335568999999999899999999999999999999 99999988888888888765 344567788999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHh
Q 011698          383 LLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ||+.+|++||     +++++++
T Consensus       237 c~~~~p~~Rp-----s~~~l~~  253 (256)
T cd05114         237 CWHEKPEGRP-----TFAELLR  253 (256)
T ss_pred             HccCCcccCc-----CHHHHHH
Confidence            9999999999     8899875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.9e-41  Score=327.07  Aligned_cols=252  Identities=33%  Similarity=0.581  Sum_probs=225.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++.+.||.|+||.||++.+..+++.||+|++..... .......+.+|+++++.++|||++++++.+......++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            58999999999999999999999999999999976543 23445667889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHc----CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-C
Q 011698          231 FVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-R  305 (479)
Q Consensus       231 ~~~ggsL~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~  305 (479)
                      |+++++|...+.+.    ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            99999999998764    679999999999999999999999999999999999999999999999999998764433 3


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhhh
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLL  384 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~L  384 (479)
                      .....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+...+...+... ...+|..++.++.++|..||
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  239 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL  239 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence            34567899999999999999999999999999999999999999888877777776655 33466688999999999999


Q ss_pred             hhchhhhcCCCCCCHHHHHhCccc
Q 011698          385 QKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       385 ~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      +.+|++||     ++.++++||||
T Consensus       240 ~~~p~~Rp-----~~~~ll~~~~~  258 (258)
T cd08215         240 QKDPEERP-----SIAQILQSPFI  258 (258)
T ss_pred             CCChhhCc-----CHHHHhcCCCC
Confidence            99999999     99999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-41  Score=332.38  Aligned_cols=249  Identities=23%  Similarity=0.361  Sum_probs=218.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +...+|++.+.||+|+||.||+|.++.+++.||+|++....    .....+.+|+++++.++||||+++++++.....++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            44568999999999999999999999999999999987542    22445778999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      +||||+++++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            999999999999998764  358889999999999999999999999999999999999999999999999998765432


Q ss_pred             Cc--ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHH
Q 011698          305 RS--NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (479)
Q Consensus       305 ~~--~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI  380 (479)
                      ..  ....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+... ....|..++.++.++|
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM  238 (263)
T ss_pred             eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence            21  12234568999999999999999999999999999998 99999988888877777664 5567788999999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHh
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+||+.||++||     ++.++++
T Consensus       239 ~~cl~~~p~~Rp-----~~~~l~~  257 (263)
T cd05052         239 RACWQWNPSDRP-----SFAEIHQ  257 (263)
T ss_pred             HHHccCCcccCC-----CHHHHHH
Confidence            999999999999     8888865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-41  Score=330.08  Aligned_cols=253  Identities=32%  Similarity=0.480  Sum_probs=219.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhh--hchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC--CeE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK--IMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRL  225 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~  225 (479)
                      .+|++.+.||+|+||.||+|+++.+++.||+|++....  .........+++|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47999999999999999999999999999999986431  12234456788999999999999999999998764  568


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC--
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~--  303 (479)
                      +++|||+++++|...+.+.+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++.....  
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            999999999999999988888999999999999999999999999999999999999999999999999999865321  


Q ss_pred             --CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCccCCHHHHHH
Q 011698          304 --TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSL  379 (479)
Q Consensus       304 --~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l  379 (479)
                        .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||..........++...  ...+|..++..+.++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  241 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF  241 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHH
Confidence              1223456899999999999988999999999999999999999999877665555555433  345788899999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      |.+||+ +|.+||     ++.++++|||.
T Consensus       242 i~~~l~-~~~~r~-----~~~~~~~~~~~  264 (264)
T cd06653         242 LKQIFV-EEKRRP-----TAEFLLRHPFV  264 (264)
T ss_pred             HHHHhc-CcccCc-----cHHHHhcCCCC
Confidence            999999 579999     89999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=337.06  Aligned_cols=252  Identities=29%  Similarity=0.476  Sum_probs=207.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|++.+.||+|+||.||+|.++.+++.||+|.+......  .....+.+|+.++++++||||+++++++.+....|+|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            57899999999999999999999999999999998764321  1223356799999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Cc
Q 011698          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RS  306 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~  306 (479)
                      |||+.+ +|..++.+. ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++...... ..
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence            999985 898888764 468999999999999999999999999999999999999999999999999987643221 12


Q ss_pred             ccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhc-------------------c
Q 011698          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKD-------------------K  365 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~-~~~~~~~i~~~-------------------~  365 (479)
                      ....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+ ..+....+...                   .
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            23457889999999876 458899999999999999999999997654 22222222110                   0


Q ss_pred             CCC-----------CccCC--HHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          366 IKL-----------PAFLS--SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       366 ~~~-----------p~~~s--~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      ...           ...++  .++.++|.+||+.+|++||     ++.++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rp-----s~~e~l~~~~f  291 (291)
T cd07844         241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI-----SAAEAMKHPYF  291 (291)
T ss_pred             ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccccc-----CHHHHhcCCCC
Confidence            000           01234  7889999999999999999     89999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=353.45  Aligned_cols=252  Identities=25%  Similarity=0.366  Sum_probs=218.0

Q ss_pred             CCcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       143 ~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      ..+.+..+++.+...||+|+||+||+|+|-++   ||||+++.+..... ..+.|++|+.+|++-+|-||+=+.+++..+
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            45567778888999999999999999999765   99999998776554 789999999999999999999999999888


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc--
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ--  299 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~--  299 (479)
                      .. .||+.||+|.+|+.+++-. ..|.....+.|+.||++||.|||.++|||||||..||++.++++|||+|||++..  
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            77 9999999999999999754 4688889999999999999999999999999999999999999999999999975  


Q ss_pred             -cCCCCCcccccCCCCCcchhHhcC---CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-----CCc
Q 011698          300 -FDENTRSNSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-----LPA  370 (479)
Q Consensus       300 -~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~  370 (479)
                       +..........|...|||||+++.   .+|++.+||||||+++|||+||..||...+.+.++-.+-++...     .-.
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s  619 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS  619 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence             222333445568889999999975   46899999999999999999999999987777777766666322     223


Q ss_pred             cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       371 ~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ..+.++++|+..||.+++++||     .+.+|+.
T Consensus       620 ~~pk~mk~Ll~~C~~~~~~eRP-----~F~~il~  648 (678)
T KOG0193|consen  620 NCPKAMKRLLSDCWKFDREERP-----LFPQLLS  648 (678)
T ss_pred             cCHHHHHHHHHHHHhcCcccCc-----cHHHHHH
Confidence            4677999999999999999999     7888875

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-41  Score=324.97  Aligned_cols=252  Identities=31%  Similarity=0.574  Sum_probs=225.2

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|++++++++|||++++++++.+...++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            588999999999999999999999999999999876533 2445678899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC-cccc
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSM  309 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~-~~~~  309 (479)
                      |+++++|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++........ ....
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            999999999998888899999999999999999999999999999999999999999999999999987654433 2456


Q ss_pred             cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-hccCCCCccCCHHHHHHHHhhhhhch
Q 011698          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII-KDKIKLPAFLSSEAHSLLKGLLQKEA  388 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~lI~~~L~~dP  388 (479)
                      .|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+......++. .....++..++..+.++|.+||+.+|
T Consensus       160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  239 (254)
T cd06627         160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDP  239 (254)
T ss_pred             ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCCh
Confidence            78999999999988889999999999999999999999998766555444444 34556777899999999999999999


Q ss_pred             hhhcCCCCCCHHHHHhCccc
Q 011698          389 SKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       389 ~~R~~~~~~t~~eil~hp~f  408 (479)
                      ++||     ++.++++||||
T Consensus       240 ~~R~-----~~~~~l~~~~~  254 (254)
T cd06627         240 NLRP-----TAKQLLKHPWI  254 (254)
T ss_pred             hhCc-----CHHHHhcCCCC
Confidence            9999     89999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-41  Score=337.16  Aligned_cols=252  Identities=27%  Similarity=0.411  Sum_probs=204.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.....  ......+.+|+.+++.++|+||+++++++..+...|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            3689999999999999999999999999999999875432  11223456899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCc
Q 011698          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRS  306 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~  306 (479)
                      |||+. ++|...+.. .+.+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            99996 566555544 456788889999999999999999999999999999999999999999999999764322 223


Q ss_pred             ccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhc--------------cC----
Q 011698          307 NSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKD--------------KI----  366 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~-~~~~~i~~~--------------~~----  366 (479)
                      ....+++.|+|||.+.+. .++.++|+|||||++|||++|..||.+.+.. +....+...              ..    
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            445678999999998764 5788999999999999999999999765432 222221110              00    


Q ss_pred             -----CCCc---------cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          367 -----KLPA---------FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       367 -----~~p~---------~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                           ..+.         ..+.++.++|.+||+.||++||     |++|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~-----t~~~~l~h~~~  291 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI-----SAQDALLHPYF  291 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCc-----CHHHHhcCCCC
Confidence                 0000         1256889999999999999999     99999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.6e-41  Score=328.85  Aligned_cols=252  Identities=31%  Similarity=0.556  Sum_probs=220.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++.+.||+|+||.||+|.++.+|..||+|.+....... ...+.+.+|+.+++.++|+||+++++.+.....+|+|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            5889999999999999999999999999999997754322 234567889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc-EEEeecCCccccCCCCC-c
Q 011698          231 FVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH-VMLTDFGLAKQFDENTR-S  306 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~-vkL~DFGla~~~~~~~~-~  306 (479)
                      |+.+++|..++.+..  .+++..+..++.|++.||.|||+++++|+||||+||+++.++. +||+|||.+........ .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            999999999987654  4789999999999999999999999999999999999998864 69999999987644322 2


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCccCCHHHHHHHHhhhh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~lI~~~L~  385 (479)
                      ....|++.|+|||.+.+..++.++|+||||+++|||++|..||...+..+....+..+.. ..+..++.++.++|.+||+
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  239 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK  239 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhc
Confidence            334689999999999988899999999999999999999999988777776666665533 3456688999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccc
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      .+|++||     +++++++||||
T Consensus       240 ~~p~~Rp-----t~~~ll~~~~~  257 (257)
T cd08225         240 VSPRDRP-----SITSILKRPFL  257 (257)
T ss_pred             cChhhCc-----CHHHHhhCCCC
Confidence            9999999     99999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.4e-42  Score=337.91  Aligned_cols=251  Identities=29%  Similarity=0.497  Sum_probs=210.8

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|+.++.||.|++|.||+|+++.+++.||||++..... .......+.+|++++++++||||+++++++.+....++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            58999999999999999999999999999999875432 22233567889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHH--cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Ccc
Q 011698          231 FVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (479)
Q Consensus       231 ~~~ggsL~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~  307 (479)
                      |+. ++|..++..  ...+++..++.++.||+.||+|||+.+++||||+|+||+++.++.+||+|||++....... ...
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            996 578887765  3568999999999999999999999999999999999999999999999999998654332 223


Q ss_pred             cccCCCCCcchhHhcCCC-CCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------------------CC-
Q 011698          308 SMCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK------------------IK-  367 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~-~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~------------------~~-  367 (479)
                      ...+++.|+|||.+.+.. ++.++|||||||++|||+||+.||.+.+......++....                  .. 
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF  238 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence            446788999999887644 5889999999999999999999998776544433332210                  00 


Q ss_pred             ----------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          368 ----------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       368 ----------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                                ....++.+++++|.+||+.||++||     +++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~~l~~~~f  284 (284)
T cd07860         239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI-----SAKAALAHPFF  284 (284)
T ss_pred             ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCC-----CHHHHhcCCCC
Confidence                      1234688999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1e-42  Score=342.28  Aligned_cols=256  Identities=28%  Similarity=0.484  Sum_probs=221.8

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      .|+.++.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.++++++||||+++++++......|+|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            4667788999999999999999999999999987543  22345678899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Ccccc
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSM  309 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~~~  309 (479)
                      |+++++|..++.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..+.... .....
T Consensus        83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06642          83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence            9999999888764 568999999999999999999999999999999999999999999999999998754332 22345


Q ss_pred             cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhhhhhch
Q 011698          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEA  388 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP  388 (479)
                      .|+..|+|||.+.+..++.++|+|||||++|||++|..||...........+... ...++..++.++.++|.+||+.+|
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  241 (277)
T cd06642         162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDP  241 (277)
T ss_pred             cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCc
Confidence            6889999999999999999999999999999999999999876665555555443 233455678899999999999999


Q ss_pred             hhhcCCCCCCHHHHHhCccccCCChh
Q 011698          389 SKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       389 ~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                      ++||     ++.++++|+||....+.
T Consensus       242 ~~Rp-----~~~~il~~~~~~~~~~~  262 (277)
T cd06642         242 RFRP-----TAKELLKHKFITRYTKK  262 (277)
T ss_pred             ccCc-----CHHHHHHhHHHHHHhhh
Confidence            9999     99999999999876554

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.5e-41  Score=336.84  Aligned_cols=257  Identities=29%  Similarity=0.478  Sum_probs=213.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|++.+.||+|++|+||+|.++.+++.||+|.+..... .....+.+.+|++++++++||||+++++++.+...+|+|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            3689999999999999999999999999999999876432 222345577899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCC--CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC-CCcEEEeecCCccccCCCC-
Q 011698          229 LDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~-~g~vkL~DFGla~~~~~~~-  304 (479)
                      |||+++ +|...+.....  +++..++.++.||+.||+|||+++|+||||||+||+++. ++.+||+|||++....... 
T Consensus        80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            999965 77777765443  578889999999999999999999999999999999985 5579999999997654322 


Q ss_pred             CcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------------------
Q 011698          305 RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK------------------  365 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~------------------  365 (479)
                      ......|++.|+|||.+.+. .++.++|||||||++|+|+||..||...+..+...++....                  
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence            22345678999999998764 57899999999999999999999998776655554443210                  


Q ss_pred             ---CC--------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          366 ---IK--------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       366 ---~~--------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                         ..        ....++.++.++|.+||+.+|++||     +++++++||||.+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----s~~~~l~~~~~~~~~  291 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI-----TARAALEHEYFKDLG  291 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc-----CHHHHhcCchHhHHh
Confidence               00        1134688999999999999999999     899999999998864

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.7e-41  Score=336.06  Aligned_cols=249  Identities=23%  Similarity=0.389  Sum_probs=216.0

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEE-----cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      ..++|.+.+.||+|+||+||++..     ..++..+|+|.+....   ......+.+|+.++++++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            346899999999999999999986     3356679999987532   23455688899999999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcC-------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcE
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQG-------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~-------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~v  289 (479)
                      ..+++||||+++++|..++...+             .+++..++.++.||+.||+|||++|++||||||+|||++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999999999999999987654             38999999999999999999999999999999999999999999


Q ss_pred             EEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 011698          290 MLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK  365 (479)
Q Consensus       290 kL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~~  365 (479)
                      ||+|||+++.......   .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+..+.
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~  239 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  239 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999986533221   223345778999999999999999999999999999999 999999888888888888765


Q ss_pred             -CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          366 -IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       366 -~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                       ...+..++.++.+||.+||+.||.+||     +++++++
T Consensus       240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~v~~  274 (288)
T cd05093         240 VLQRPRTCPKEVYDLMLGCWQREPHMRL-----NIKEIHS  274 (288)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCC-----CHHHHHH
Confidence             345667899999999999999999999     8888854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.2e-42  Score=339.63  Aligned_cols=261  Identities=26%  Similarity=0.411  Sum_probs=214.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~l  227 (479)
                      .++|+..+.||+|+||.||++.+..+++.||+|.+......  .....+.+|+.++.++. ||||+++++++..+...++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            45788889999999999999999999999999998764322  33456788999999986 9999999999999999999


Q ss_pred             EEEeccCCcHHH---HHH--HcCCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          228 VLDFVNGGHLFF---QLY--RQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       228 V~E~~~ggsL~~---~l~--~~~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      +|||+.+ ++..   .+.  ..+.+++..+..++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9999875 4433   222  236789999999999999999999975 99999999999999999999999999998765


Q ss_pred             CCCCcccccCCCCCcchhHhcCC---CCCccccchhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhc-cCCCC----ccC
Q 011698          302 ENTRSNSMCGTLEYMSPEIVLGK---GHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIKD-KIKLP----AFL  372 (479)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~---~~~~~~DiwSLGvilyelltG~~Pf~~~~~-~~~~~~i~~~-~~~~p----~~~  372 (479)
                      .........|+..|+|||++.+.   .++.++|||||||++|||++|+.||...+. .+....+..+ ...++    ..+
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF  239 (288)
T ss_pred             cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence            44444455789999999999876   689999999999999999999999976542 1222222222 12222    247


Q ss_pred             CHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhh
Q 011698          373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLE  417 (479)
Q Consensus       373 s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~  417 (479)
                      +.++.+||.+||++||++||     ++++|++||||+...|.+..
T Consensus       240 ~~~l~~li~~~l~~~p~~Rp-----t~~~i~~~~~~~~~~~~~~~  279 (288)
T cd06616         240 SPSFVNFINLCLIKDESKRP-----KYKELLEHPFIKDYEERNVD  279 (288)
T ss_pred             CHHHHHHHHHHccCChhhCc-----CHHHHhcChhhhchhhcchh
Confidence            89999999999999999999     99999999999998776544

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.7e-41  Score=324.58  Aligned_cols=252  Identities=34%  Similarity=0.548  Sum_probs=224.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC--CeEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRLYLV  228 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~~lV  228 (479)
                      +|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+...  ..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            588899999999999999999999999999999765432 34567788999999999999999999999988  899999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC---
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR---  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~---  305 (479)
                      +||+.+++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999999988765543   


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHh--ccCCCCccCCHHHHHHHHh
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIK--DKIKLPAFLSSEAHSLLKG  382 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~-~~~~~~~i~~--~~~~~p~~~s~~~~~lI~~  382 (479)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+ .......+..  ....+|..++..+.++|.+
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  239 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK  239 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence            455678999999999999889999999999999999999999998765 3333344442  3456778889999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      ||+.||.+||     ++.++++||||
T Consensus       240 ~l~~~p~~Rp-----~~~~ll~~~~~  260 (260)
T cd06606         240 CLRRDPKKRP-----TADELLQHPFL  260 (260)
T ss_pred             hCcCChhhCC-----CHHHHhhCCCC
Confidence            9999999999     99999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.7e-41  Score=336.19  Aligned_cols=253  Identities=29%  Similarity=0.490  Sum_probs=209.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCe----
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYR----  224 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~----  224 (479)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++.... .......+.+|+.+++.+. ||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            479999999999999999999999999999999876432 2223345678999999995 6999999999987766    


Q ss_pred             -EEEEEEeccCCcHHHHHHHc-----CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC-CCcEEEeecCCc
Q 011698          225 -LYLVLDFVNGGHLFFQLYRQ-----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLA  297 (479)
Q Consensus       225 -~~lV~E~~~ggsL~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~-~g~vkL~DFGla  297 (479)
                       .|+||||+++ +|..++...     ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999986 787777543     35799999999999999999999999999999999999998 899999999999


Q ss_pred             cccCCC-CCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------
Q 011698          298 KQFDEN-TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---------  366 (479)
Q Consensus       298 ~~~~~~-~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------  366 (479)
                      ..+... .......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.+......++....-         
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            865332 22233467889999999865 4578999999999999999999999988776655544433100         


Q ss_pred             --------CCC-----------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCcccc
Q 011698          367 --------KLP-----------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK  409 (479)
Q Consensus       367 --------~~p-----------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~  409 (479)
                              .++           +.++.++.+||.+||++||.+||     +++|++.||||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~-----~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI-----SAKAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcC-----CHHHHhcCCCcC
Confidence                    001           24788999999999999999999     899999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.3e-41  Score=338.83  Aligned_cols=254  Identities=29%  Similarity=0.435  Sum_probs=207.0

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC----
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----  223 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----  223 (479)
                      .+++|++++.||+|+||.||+|+++.+++.||||++...... ......+.+|+.++++++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            357899999999999999999999999999999998754322 122334567999999999999999999886654    


Q ss_pred             ----eEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcc
Q 011698          224 ----RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (479)
Q Consensus       224 ----~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~  298 (479)
                          ..++||||+.+ +|...+... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence                45999999975 777777654 368999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC-----cccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-------
Q 011698          299 QFDENTR-----SNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------  365 (479)
Q Consensus       299 ~~~~~~~-----~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-------  365 (479)
                      .+.....     .....++..|+|||.+.+. .++.++|+||||+++|||++|..||.+.+.......+..-.       
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV  247 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            6533221     2345678899999998765 46889999999999999999999998876554433322210       


Q ss_pred             ------------CCCC-------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          366 ------------IKLP-------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       366 ------------~~~p-------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                                  ..+|             ...+..+.+||.+||+.||.+||     +++++++||||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~-----t~~e~l~h~~f  310 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI-----DADTALNHDFF  310 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhcc-----CHHHHhcCCCC
Confidence                        0111             12357788999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.7e-42  Score=341.40  Aligned_cols=253  Identities=28%  Similarity=0.476  Sum_probs=218.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +.|.....||+|+||.||++.+..++..||||.+....   ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            44666788999999999999999999999999986532   234556788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~~  308 (479)
                      ||+++++|..++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .....
T Consensus        99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658          99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence            99999999887754 56899999999999999999999999999999999999999999999999999765322 22345


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---cCCCCccCCHHHHHHHHhhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      ..|+..|+|||.+.+..++.++|+||||+++|||++|+.||...+.......+...   .......++..+.++|..||.
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  257 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV  257 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHcc
Confidence            67899999999999988999999999999999999999999887766655555433   222233578899999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCC
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      .||++||     +++++++||||+..
T Consensus       258 ~~P~~Rp-----t~~~il~~~~~~~~  278 (292)
T cd06658         258 REPSQRA-----TAQELLQHPFLKLA  278 (292)
T ss_pred             CChhHCc-----CHHHHhhChhhhcc
Confidence            9999999     99999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2e-41  Score=333.19  Aligned_cols=252  Identities=21%  Similarity=0.301  Sum_probs=213.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  221 (479)
                      +..++|++.+.||+|+||.||+|.+++     ++..||+|++....  .......+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            345789999999999999999998753     45679999986532  12234457789999999999999999999999


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHcC----------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEE
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQG----------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML  291 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~~----------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL  291 (479)
                      ....++||||+.+|+|.+++.+..          .++...+..++.|++.||.|||+.|++||||||+|||++.++.++|
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999999987532          2466788889999999999999999999999999999999999999


Q ss_pred             eecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-C
Q 011698          292 TDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK-I  366 (479)
Q Consensus       292 ~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~~-~  366 (479)
                      +|||+++.......   .....+++.|||||++.+..++.++|+|||||++|||++ |..||.+.+.......+.... .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL  240 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            99999976533221   122345788999999999899999999999999999999 799999888877777666653 4


Q ss_pred             CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          367 KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       367 ~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ..+..++..+.++|.+||+.||++||     ++.|++++
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~e~l~~  274 (277)
T cd05062         241 DKPDNCPDMLFELMRMCWQYNPKMRP-----SFLEIISS  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            56777899999999999999999999     88998763

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.6e-41  Score=330.54  Aligned_cols=251  Identities=27%  Similarity=0.459  Sum_probs=211.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +.+.....||+|+||.||+|++..++..||+|.+....   ....+.+.+|+.++++++|+||+++++++...+..++|+
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            44445578999999999999999999999999987543   233456889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHc-CCC--cHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC-CCcEEEeecCCccccCCCC-
Q 011698          230 DFVNGGHLFFQLYRQ-GLF--REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       230 E~~~ggsL~~~l~~~-~~l--~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~-~g~vkL~DFGla~~~~~~~-  304 (479)
                      ||+.+++|..++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++....... 
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            999999999998764 455  78888999999999999999999999999999999976 6799999999997654322 


Q ss_pred             CcccccCCCCCcchhHhcCC--CCCccccchhhHHHHHHHHhCCCCCCCCCHHH--HHHH-HHhccCCCCccCCHHHHHH
Q 011698          305 RSNSMCGTLEYMSPEIVLGK--GHDKAADWWSVGILLFEMLTGQPPFTGGNRQK--IQQK-IIKDKIKLPAFLSSEAHSL  379 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~--~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~--~~~~-i~~~~~~~p~~~s~~~~~l  379 (479)
                      ......|++.|+|||.+.+.  .++.++|+||||+++|+|++|..||.......  .... .......+|..++.++.+|
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF  244 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence            23345688999999998764  37899999999999999999999997643221  1111 2233456778899999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      |++||+.+|.+||     ++++++.||||
T Consensus       245 i~~~l~~~p~~Rp-----t~~~ll~~~~~  268 (268)
T cd06624         245 ILRCFEPDPDKRA-----SAHDLLQDPFL  268 (268)
T ss_pred             HHHHcCCCchhCC-----CHHHHHhCCCC
Confidence            9999999999999     99999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.2e-42  Score=342.57  Aligned_cols=242  Identities=27%  Similarity=0.490  Sum_probs=192.1

Q ss_pred             EEeccCCceEEEEEEEcC--CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe--eCCeEEEEEEe
Q 011698          156 KVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ--TKYRLYLVLDF  231 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~~~~lV~E~  231 (479)
                      .+||+|+||+||+|+++.  ++..||+|.+.....     ...+.+|+.+|++++||||+++++++.  ....+|+||||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            589999999999999764  568899999875432     234678999999999999999999884  45688999999


Q ss_pred             ccCCcHHHHHHHc---------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe----CCCCcEEEeecCCcc
Q 011698          232 VNGGHLFFQLYRQ---------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL----DADGHVMLTDFGLAK  298 (479)
Q Consensus       232 ~~ggsL~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl----~~~g~vkL~DFGla~  298 (479)
                      +.+ +|...+...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            876 676666421         247889999999999999999999999999999999999    567899999999998


Q ss_pred             ccCCCC----CcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHH---------HHHHHHHh-
Q 011698          299 QFDENT----RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQ---------KIQQKIIK-  363 (479)
Q Consensus       299 ~~~~~~----~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~---------~~~~~i~~-  363 (479)
                      .+....    ......||+.|+|||++.+. .++.++|||||||++|||+||++||......         .....+.. 
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            764332    23456789999999999874 5799999999999999999999999753321         00111000 


Q ss_pred             ---------------------------ccC----------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCc
Q 011698          364 ---------------------------DKI----------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHK  406 (479)
Q Consensus       364 ---------------------------~~~----------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp  406 (479)
                                                 ...          ......+..+.+||.+||+.||.+||     |++|+++||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~-----t~~e~l~hp  315 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRI-----TSEQALQDP  315 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCccccc-----CHHHHhcCC
Confidence                                       000          00112456788999999999999999     999999999


Q ss_pred             cc
Q 011698          407 WF  408 (479)
Q Consensus       407 ~f  408 (479)
                      ||
T Consensus       316 ~f  317 (317)
T cd07867         316 YF  317 (317)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.4e-41  Score=333.78  Aligned_cols=253  Identities=27%  Similarity=0.463  Sum_probs=220.4

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      .|...+.||+|++|.||++.+..+++.+|+|++....   ....+.+.+|+.+++.++||||+++++++...+..|+++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            4556689999999999999999999999999986432   2334557889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Ccccc
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSM  309 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~~~  309 (479)
                      |+.|++|.+++.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....... .....
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            9999999998877 678999999999999999999999999999999999999999999999999987654322 22345


Q ss_pred             cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC---CCccCCHHHHHHHHhhhhh
Q 011698          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK---LPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~lI~~~L~~  386 (479)
                      .|++.|+|||.+.+..++.++|+|||||++|||++|+.||...+.......+......   .+..++..+.+||.+||+.
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR  255 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence            6899999999999988999999999999999999999999887777766666655322   2334789999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccccCCC
Q 011698          387 EASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      +|++||     ++.++++|+||+...
T Consensus       256 ~p~~Rp-----t~~~il~~~~~~~~~  276 (285)
T cd06648         256 DPAQRA-----TAAELLNHPFLAKAG  276 (285)
T ss_pred             ChhhCc-----CHHHHccCcccccCC
Confidence            999999     899999999998853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=358.28  Aligned_cols=251  Identities=27%  Similarity=0.398  Sum_probs=224.8

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      -|.-++.||.|+||.||.|++..+.+.||||.|.-......+....+..|+.+|++++|||++.+.+||-.+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            37778999999999999999999999999999987655555666778899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHH-HcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccc
Q 011698          231 FVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (479)
Q Consensus       231 ~~~ggsL~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~  309 (479)
                      ||-| +-.+++. .++++.|..+..++.+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|....   ..+++
T Consensus       107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---PAnsF  182 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA---PANSF  182 (948)
T ss_pred             HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC---chhcc
Confidence            9977 5555553 34678999999999999999999999999999999999999999999999999997653   46789


Q ss_pred             cCCCCCcchhHhcC---CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCC-ccCCHHHHHHHHhhh
Q 011698          310 CGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKLP-AFLSSEAHSLLKGLL  384 (479)
Q Consensus       310 ~gt~~y~APE~l~~---~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p-~~~s~~~~~lI~~~L  384 (479)
                      +|||+|||||++..   +.|+-++||||||++..||.-.++|+...+.+....-|..+. +.++ ..+|..++.|+..||
T Consensus       183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CL  262 (948)
T KOG0577|consen  183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL  262 (948)
T ss_pred             cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHH
Confidence            99999999999964   679999999999999999999999999999998888888764 4444 468999999999999


Q ss_pred             hhchhhhcCCCCCCHHHHHhCccccC
Q 011698          385 QKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       385 ~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      ++-|.+||     |.++++.|+|...
T Consensus       263 qKipqeRp-----tse~ll~H~fv~R  283 (948)
T KOG0577|consen  263 QKIPQERP-----TSEELLKHRFVLR  283 (948)
T ss_pred             hhCcccCC-----cHHHHhhcchhcc
Confidence            99999999     8999999999854

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.1e-41  Score=333.42  Aligned_cols=250  Identities=30%  Similarity=0.524  Sum_probs=212.1

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++++.||.|++|.||+|+++.+|+.||+|+++....  ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            58999999999999999999999999999999976532  2223456779999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHc---CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Cc
Q 011698          231 FVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RS  306 (479)
Q Consensus       231 ~~~ggsL~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~  306 (479)
                      |+.+ +|..++...   ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence            9986 787777654   358999999999999999999999999999999999999999999999999997654332 22


Q ss_pred             ccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------------------CC
Q 011698          307 NSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK------------------IK  367 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~------------------~~  367 (479)
                      ....++..|++||++.+. .++.++|+|||||++|+|++|+.||.+.+..+....+....                  ..
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            345678999999998764 56899999999999999999999998877666555543210                  00


Q ss_pred             -----------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          368 -----------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       368 -----------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                                 +.+.++..+.++|.+||+.||.+||     +++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~-----~~~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI-----SAHDALQHPWF  284 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCC-----CHHHHhcCCCC
Confidence                       1124678899999999999999999     89999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.2e-41  Score=333.14  Aligned_cols=253  Identities=28%  Similarity=0.491  Sum_probs=221.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      -|++++.||.|+||.||+|.+..+++.||+|++.....  ......+.+|+.++++++||||+++++++......|+|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            47788999999999999999999999999999865432  2344567889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Ccccc
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSM  309 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~~~  309 (479)
                      |+.+++|..++.. +.+++..+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++..+.... .....
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence            9999999988764 568999999999999999999999999999999999999999999999999997654332 23345


Q ss_pred             cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhhhhhch
Q 011698          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEA  388 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP  388 (479)
                      .|+..|+|||.+.+...+.++|+|||||++|+|++|..||...+.......+... ...++..++.++.++|..||+.+|
T Consensus       162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  241 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP  241 (277)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            7889999999999888899999999999999999999999887766666666544 334566789999999999999999


Q ss_pred             hhhcCCCCCCHHHHHhCccccCC
Q 011698          389 SKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       389 ~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      .+||     ++.++++||||...
T Consensus       242 ~~Rp-----~~~~~l~~~~~~~~  259 (277)
T cd06641         242 SFRP-----TAKELLKHKFIVRF  259 (277)
T ss_pred             hhCc-----CHHHHHhCHHHhhh
Confidence            9999     89999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-42  Score=347.55  Aligned_cols=256  Identities=29%  Similarity=0.476  Sum_probs=212.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~  225 (479)
                      +.-..|+++++||+||.++||++...+.+ .||+|.+.... .+.....-+++|+.+|.+|+ |.+||+||++-..++.+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            44567999999999999999999986554 56666665433 35556778899999999995 99999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCC-cHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLF-REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l-~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      |+||||-+ .+|..+|...+.. ....+++|..||+.|+.++|..||||.||||.|+|+ -.|.+||+|||+|..+..++
T Consensus       436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence            99999854 4898888877653 335889999999999999999999999999999999 68999999999999987765


Q ss_pred             Cc---ccccCCCCCcchhHhcCCC-----------CCccccchhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhc--cCC
Q 011698          305 RS---NSMCGTLEYMSPEIVLGKG-----------HDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKD--KIK  367 (479)
Q Consensus       305 ~~---~~~~gt~~y~APE~l~~~~-----------~~~~~DiwSLGvilyelltG~~Pf~~~~-~~~~~~~i~~~--~~~  367 (479)
                      ..   .+.+||+.||+||.+....           .++++||||||||||+|+.|++||..-. ...-+..|..-  .+.
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie  593 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE  593 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence            43   5679999999999996432           3589999999999999999999997532 23333444433  557


Q ss_pred             CCccCCHH-HHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          368 LPAFLSSE-AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       368 ~p~~~s~~-~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ||..-+.. +.++++.||..||.+|+     ++.++|+|||...+
T Consensus       594 fp~~~~~~~li~~mK~CL~rdPkkR~-----si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  594 FPDIPENDELIDVMKCCLARDPKKRW-----SIPELLQHPFLQIQ  633 (677)
T ss_pred             ccCCCCchHHHHHHHHHHhcCcccCC-----CcHHHhcCcccccc
Confidence            77665544 99999999999999999     89999999999874

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.9e-41  Score=333.55  Aligned_cols=251  Identities=22%  Similarity=0.357  Sum_probs=215.2

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      ..++|++.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            34689999999999999999999987     78899999886432  222345577899999999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcC-------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC---cEEEe
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQG-------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLT  292 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g---~vkL~  292 (479)
                      ...++||||+.|++|..++.+.+       .+++..+..++.||+.||+|||+++++||||||+|||++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999999987654       488899999999999999999999999999999999998765   69999


Q ss_pred             ecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCC
Q 011698          293 DFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIK  367 (479)
Q Consensus       293 DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~  367 (479)
                      |||+++.+.....   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+... ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD  241 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            9999987632211   112233567999999999999999999999999999997 99999988877777666544 556


Q ss_pred             CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          368 LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       368 ~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      +|..++..+.++|.+||+.+|++||     ++.++++|
T Consensus       242 ~~~~~~~~~~~~i~~cl~~~p~~Rp-----s~~~vl~~  274 (277)
T cd05036         242 PPKGCPGPVYRIMTDCWQHTPEDRP-----NFATILER  274 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCc-----CHHHHHHH
Confidence            6788999999999999999999999     89999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.3e-41  Score=336.71  Aligned_cols=249  Identities=20%  Similarity=0.354  Sum_probs=212.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCe--EEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ++|++.+.||+|+||+||+|.++.++.  .+|+|.++...  .....+.+.+|+.+++++ +||||+++++++.....+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            689999999999999999999887764  46888876321  223345678899999999 7999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcC----------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEE
Q 011698          227 LVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM  290 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vk  290 (479)
                      +||||+++++|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999997643                478889999999999999999999999999999999999999999


Q ss_pred             EeecCCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCC
Q 011698          291 LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKL  368 (479)
Q Consensus       291 L~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~  368 (479)
                      |+|||++..............+..|+|||.+.+..++.++|||||||++|||++ |..||.+.+.......+..+ ....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK  239 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            999999865332222222233557999999999999999999999999999998 99999988888877777665 3456


Q ss_pred             CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          369 PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       369 p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      |..++.++.+||.+||+.+|.+||     +++++++.
T Consensus       240 ~~~~~~~~~~li~~~l~~~p~~Rp-----~~~~i~~~  271 (297)
T cd05089         240 PRNCDDEVYELMRQCWRDRPYERP-----PFAQISVQ  271 (297)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            677999999999999999999999     88998653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-41  Score=330.84  Aligned_cols=251  Identities=22%  Similarity=0.328  Sum_probs=216.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCC-----eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  221 (479)
                      +..++|++.+.||+|+||.||+|.++..+     ..||+|.+....  .......+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            45679999999999999999999987544     789999986543  22234557789999999999999999999999


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHcC----------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEE
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQG----------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML  291 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~~----------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL  291 (479)
                      ....++||||+++|+|..++....          .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            999999999999999999986532          3677888999999999999999999999999999999999999999


Q ss_pred             eecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cC
Q 011698          292 TDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KI  366 (479)
Q Consensus       292 ~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~  366 (479)
                      +|||+++.+....   ......++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+.....+.+..+ ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL  240 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence            9999998754332   2234456789999999998889999999999999999998 99999988888777777754 45


Q ss_pred             CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          367 KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       367 ~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+|..++.++.++|.+||+.+|++||     ++.++++
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~l~~  273 (277)
T cd05032         241 DLPENCPDKLLELMRMCWQYNPKMRP-----TFLEIVS  273 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCC-----CHHHHHH
Confidence            67788899999999999999999999     8899875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=333.60  Aligned_cols=254  Identities=28%  Similarity=0.539  Sum_probs=217.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC---CCCeeeEeEEEeeCCeEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~~~~~~~~l  227 (479)
                      .|++++.||+|+||.||+|.+..+++.||+|+++...  .......+.+|+.++++++   ||||+++++++......|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            5788899999999999999999999999999987542  2233456788999999986   9999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Cc
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RS  306 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~  306 (479)
                      ||||++|++|.+++.. +.+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            9999999999988865 478999999999999999999999999999999999999999999999999998764433 23


Q ss_pred             ccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCc-cCCHHHHHHHHhh
Q 011698          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKLPA-FLSSEAHSLLKGL  383 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~-~~s~~~~~lI~~~  383 (479)
                      ....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+.... ..++. .++.++.++|..|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC  238 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHH
Confidence            44578999999999875 456899999999999999999999998876655544443332 22333 3788999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          384 LQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      |+.||++||     ++.++++|+||+...
T Consensus       239 l~~~p~~R~-----~~~~il~~~~~~~~~  262 (277)
T cd06917         239 LDEEPKERL-----SAEELLKSKWIKAHS  262 (277)
T ss_pred             cCCCcccCc-----CHHHHhhChHhhccc
Confidence            999999999     899999999998754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.4e-41  Score=328.17  Aligned_cols=248  Identities=21%  Similarity=0.369  Sum_probs=213.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|+++++||+|+||.||+|.+. ++..||+|.+.....    ..+.+.+|+.+++.++|+||+++++.+......+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            45689999999999999999999975 456699999865332    2456788999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      ++|||+.+++|..++.+.  ..+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||++.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999999988753  457888999999999999999999999999999999999999999999999998764332


Q ss_pred             C--cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHH
Q 011698          305 R--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (479)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI  380 (479)
                      .  .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+... ....+..++.++.++|
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM  237 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            1  122345678999999998889999999999999999998 99999988877777777654 3334456889999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHh
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+||+.+|++||     +++++.+
T Consensus       238 ~~~l~~~p~~Rp-----~~~~i~~  256 (261)
T cd05072         238 KTCWKEKAEERP-----TFDYLQS  256 (261)
T ss_pred             HHHccCCcccCc-----CHHHHHH
Confidence            999999999999     8888764

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.5e-41  Score=338.04  Aligned_cols=253  Identities=26%  Similarity=0.386  Sum_probs=216.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +.|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+....|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            56999999999999999999999999999999997654344445566889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHH-HcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccc
Q 011698          230 DFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~  308 (479)
                      ||+.| ++.+.+. ..+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++......   ..
T Consensus        95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~  170 (307)
T cd06607          95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NS  170 (307)
T ss_pred             HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CC
Confidence            99985 5655554 3467899999999999999999999999999999999999999999999999999765332   34


Q ss_pred             ccCCCCCcchhHhc---CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCC-CccCCHHHHHHHHhh
Q 011698          309 MCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKL-PAFLSSEAHSLLKGL  383 (479)
Q Consensus       309 ~~gt~~y~APE~l~---~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~-p~~~s~~~~~lI~~~  383 (479)
                      ..|++.|+|||++.   ...++.++||||||+++|||++|+.||.+.+.......+.... ..+ +..++.++.++|.+|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  250 (307)
T cd06607         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC  250 (307)
T ss_pred             ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHH
Confidence            56889999999884   3567899999999999999999999998877666555555432 222 335788999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          384 LQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      |+.+|++||     ++.+|+.|+||..-
T Consensus       251 l~~~p~~Rp-----~~~~il~~~~~~~~  273 (307)
T cd06607         251 LQKIPQDRP-----SSEELLKHRFVLRE  273 (307)
T ss_pred             hcCChhhCc-----CHHHHhcChhhccc
Confidence            999999999     89999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.5e-41  Score=327.44  Aligned_cols=242  Identities=21%  Similarity=0.373  Sum_probs=207.8

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg  235 (479)
                      +.||+|+||.||+|+++.+++.||+|.+....  .......+.+|++++++++||||+++++++.....+|+||||+.++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            36899999999999999999999999986532  2334566888999999999999999999999999999999999999


Q ss_pred             cHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcc---cccC
Q 011698          236 HLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN---SMCG  311 (479)
Q Consensus       236 sL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~---~~~g  311 (479)
                      +|.+++.+.+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........   ...+
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            9999987654 58999999999999999999999999999999999999999999999999997654322111   1122


Q ss_pred             CCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhhhhhchh
Q 011698          312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEAS  389 (479)
Q Consensus       312 t~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~  389 (479)
                      +..|+|||.+.+..++.++|+|||||++|||++ |..||...+.......+... ....+..++..+.+||.+||+.+|+
T Consensus       159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  238 (252)
T cd05084         159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPG  238 (252)
T ss_pred             ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChh
Confidence            456999999999889999999999999999998 99999877766666655543 4556777899999999999999999


Q ss_pred             hhcCCCCCCHHHHHh
Q 011698          390 KRLGSGPGGSQEIKS  404 (479)
Q Consensus       390 ~R~~~~~~t~~eil~  404 (479)
                      +||     ++.++++
T Consensus       239 ~Rp-----s~~~~~~  248 (252)
T cd05084         239 QRP-----SFSTVHQ  248 (252)
T ss_pred             hCc-----CHHHHHH
Confidence            999     8888864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.3e-41  Score=330.92  Aligned_cols=256  Identities=27%  Similarity=0.428  Sum_probs=214.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC--CeEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRLYL  227 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~~l  227 (479)
                      ++|+..+.||.|++|.||+|.+..+++.||+|.+.....  ......+.+|++++++++||||++++++|...  ..+|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            479999999999999999999999999999999976432  23456678899999999999999999988653  47899


Q ss_pred             EEEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          228 VLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      ||||++|++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999999877653    345889999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhc-cCCCC------cc
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG-----NRQKIQQKIIKD-KIKLP------AF  371 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~-----~~~~~~~~i~~~-~~~~p------~~  371 (479)
                      .. ....++..|+|||.+.+..++.++|+|||||++|+|++|..||...     ...+....+... ...++      ..
T Consensus       159 ~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd06621         159 LA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK  237 (287)
T ss_pred             cc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence            22 2456788999999999999999999999999999999999999765     223444444432 12222      13


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      +++.+.+||.+||..+|.+||     ++.|++.|+||++..-
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rp-----t~~eil~~~~~~~~~~  274 (287)
T cd06621         238 WSEEFKDFIKQCLEKDPTRRP-----TPWDMLEHPWIKAQMK  274 (287)
T ss_pred             hHHHHHHHHHHHcCCCcccCC-----CHHHHHhCcccccccc
Confidence            467899999999999999999     9999999999987643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-41  Score=328.96  Aligned_cols=250  Identities=22%  Similarity=0.343  Sum_probs=215.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCC---CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .++|++.+.||+|+||+||+|.++.+   ...||+|+++...  .......+.+|+.++++++||||+++++.+......
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            46899999999999999999998754   4579999987543  233345577899999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      ++||||+++++|.+++... +.+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||+++......
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999998764 468999999999999999999999999999999999999999999999999998764211


Q ss_pred             C---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHH
Q 011698          305 R---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSL  379 (479)
Q Consensus       305 ~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l  379 (479)
                      .   .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+... ....+..++..+.+|
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  240 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL  240 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            1   122344678999999999999999999999999999998 99999888877777777665 345566789999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      +.+||+.+|++||     ++++++++
T Consensus       241 i~~cl~~~p~~Rp-----~~~ei~~~  261 (266)
T cd05033         241 MLDCWQKDRNERP-----TFSQIVST  261 (266)
T ss_pred             HHHHcCCCcccCc-----CHHHHHHH
Confidence            9999999999999     88998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3e-41  Score=328.35  Aligned_cols=241  Identities=22%  Similarity=0.347  Sum_probs=208.0

Q ss_pred             EeccCCceEEEEEEE--cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          157 VVGQGAFAKVYQVRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       157 ~LG~G~fG~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +||+|+||.||+|.+  +.++..+|+|+++.... .....+.+.+|+.+++.++||||++++++++ ....++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            689999999999965  45778999999875432 3344567888999999999999999999875 4567899999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC----ccccc
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR----SNSMC  310 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~----~~~~~  310 (479)
                      |+|..++...+.+++..+..++.|++.||.|||++||+||||||.|||++.++.+||+|||+++.+.....    .....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            99999998888899999999999999999999999999999999999999999999999999987643322    12233


Q ss_pred             CCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhhhhhch
Q 011698          311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEA  388 (479)
Q Consensus       311 gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP  388 (479)
                      ++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..++.+.+..+ .+..|..++.++.++|..||+.||
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p  239 (257)
T cd05116         160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV  239 (257)
T ss_pred             CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCc
Confidence            4678999999988889999999999999999998 99999988888887777765 456778899999999999999999


Q ss_pred             hhhcCCCCCCHHHHHh
Q 011698          389 SKRLGSGPGGSQEIKS  404 (479)
Q Consensus       389 ~~R~~~~~~t~~eil~  404 (479)
                      ++||     ++++|..
T Consensus       240 ~~Rp-----~~~~i~~  250 (257)
T cd05116         240 DERP-----GFAVVEL  250 (257)
T ss_pred             hhCc-----CHHHHHH
Confidence            9999     7777643

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.1e-41  Score=331.27  Aligned_cols=250  Identities=23%  Similarity=0.381  Sum_probs=213.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCe----EEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      +..++|++++.||+|+||+||+|++..+++    .||+|+++...  .....+.+.+|+.+++.++||||+++++++...
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS   81 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence            445789999999999999999999887776    48999987543  233345678899999999999999999988754


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                       ..++++||+++|+|.+.+... +.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence             578999999999999999764 568999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCCc---ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHH
Q 011698          302 ENTRS---NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       302 ~~~~~---~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                      .....   ....+++.|+|||.+.+..++.++|||||||++|||++ |..||.......+...+... ....+..++.++
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence            33222   12234678999999999999999999999999999998 99999887777666666554 345567789999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .++|.+||+.||++||     ++.+++.
T Consensus       241 ~~li~~~l~~dp~~Rp-----~~~~l~~  263 (279)
T cd05109         241 YMIMVKCWMIDSECRP-----RFRELVD  263 (279)
T ss_pred             HHHHHHHcCCChhhCc-----CHHHHHH
Confidence            9999999999999999     8899874

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4e-41  Score=325.55  Aligned_cols=243  Identities=26%  Similarity=0.443  Sum_probs=217.2

Q ss_pred             EEeccCCceEEEEEEEcCC---CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEec
Q 011698          156 KVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFV  232 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~  232 (479)
                      +.||+|+||.||+|.+...   +..||+|++.......  ..+.+.+|+.+++.++|+||+++++++.....+++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4699999999999999865   8899999997654322  4667889999999999999999999999999999999999


Q ss_pred             cCCcHHHHHHHc---------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          233 NGGHLFFQLYRQ---------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       233 ~ggsL~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      ++++|..++...         ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999875         77999999999999999999999999999999999999999999999999999876543


Q ss_pred             ---CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHH
Q 011698          304 ---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (479)
Q Consensus       304 ---~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (479)
                         .......++..|+|||.+.+..++.++|+|||||++|||++ |..||...+...+.+.+..+ ....|..++.++.+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYE  238 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHH
Confidence               22345567889999999998889999999999999999999 69999998888888887754 55677888999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      +|.+||+.+|.+||     ++++++++
T Consensus       239 li~~~l~~~p~~Rp-----s~~~l~~~  260 (262)
T cd00192         239 LMLSCWQLDPEDRP-----TFSELVER  260 (262)
T ss_pred             HHHHHccCCcccCc-----CHHHHHHh
Confidence            99999999999999     89999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1e-40  Score=320.23  Aligned_cols=249  Identities=36%  Similarity=0.556  Sum_probs=218.8

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++.+.||+|++|.||++.+..+++.+++|++.....   .....+.+|+.++++++|++|+++++++......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            58899999999999999999998999999999976542   345668889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccc
Q 011698          231 FVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (479)
Q Consensus       231 ~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~  309 (479)
                      |++|++|.+++... ..+++..++.++.|++.||.+||.+|++||||+|+||+++.++.++|+|||.+............
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  157 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM  157 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence            99999999988776 67899999999999999999999999999999999999999999999999999876554434566


Q ss_pred             cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCCc--cCCHHHHHHHHhhhhh
Q 011698          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPA--FLSSEAHSLLKGLLQK  386 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~p~--~~s~~~~~lI~~~L~~  386 (479)
                      .|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+... ....+.  .++.++.++|.+||+.
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  237 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK  237 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence            7899999999999888999999999999999999999999877554444444332 223333  3489999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCcc
Q 011698          387 EASKRLGSGPGGSQEIKSHKW  407 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~  407 (479)
                      ||++||     ++.++++|||
T Consensus       238 ~p~~R~-----t~~~~l~~~~  253 (253)
T cd05122         238 NPEKRP-----TAEQLLKHPF  253 (253)
T ss_pred             ChhhCC-----CHHHHhcCCC
Confidence            999999     9999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.7e-41  Score=371.89  Aligned_cols=252  Identities=24%  Similarity=0.370  Sum_probs=207.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|+++++||+|+||.||+|++..+++.||+|+++.+........+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            36899999999999999999999999999999999865433344456688899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHc-----------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          229 LDFVNGGHLFFQLYRQ-----------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~-----------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                      |||++||+|..++...           ..++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999888642           22445667889999999999999999999999999999999999999999999


Q ss_pred             cccCCC-------------------CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHH
Q 011698          298 KQFDEN-------------------TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ  358 (479)
Q Consensus       298 ~~~~~~-------------------~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~  358 (479)
                      +.....                   ......+||+.|||||++.+..++.++|||||||++|||+||..||...+...+.
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            865211                   1112357999999999999999999999999999999999999999875544333


Q ss_pred             HHHHh-ccCCC--CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          359 QKIIK-DKIKL--PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       359 ~~i~~-~~~~~--p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ..... .....  ...+++.+.+++.+||+.||++|++    +++++++
T Consensus       241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~s----s~eeLl~  285 (932)
T PRK13184        241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYS----SVQELKQ  285 (932)
T ss_pred             hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence            22111 11111  1357889999999999999999983    4455443

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.5e-41  Score=343.92  Aligned_cols=255  Identities=24%  Similarity=0.385  Sum_probs=213.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee----CCeE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRL  225 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~~  225 (479)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+|++++||||+++++++..    ...+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            689999999999999999999999999999999876432 22334566789999999999999999988753    4578


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      |+||||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            99999996 58988888888899999999999999999999999999999999999999999999999999976533221


Q ss_pred             -----cccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------
Q 011698          306 -----SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---------------  364 (479)
Q Consensus       306 -----~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~---------------  364 (479)
                           ....+|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.......+...               
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence                 234578999999999866 45899999999999999999999999876543332222110               


Q ss_pred             -----------cCCC-----CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          365 -----------KIKL-----PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       365 -----------~~~~-----p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                 ....     ...++.++.++|++||+.+|.+||     ++++++.||||+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~~l~~~~~~~~  300 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI-----TVEQALQHPFLAQY  300 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc-----CHHHHHhChhhhhc
Confidence                       0111     134689999999999999999999     89999999999865

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.2e-41  Score=335.43  Aligned_cols=251  Identities=22%  Similarity=0.347  Sum_probs=216.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCC-----CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  221 (479)
                      +.+.+|++++.||+|+||+||+|.+..+     +..||+|+++...  .....+.+..|+.+++.++||||+++++++.+
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~   79 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK   79 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            4456789999999999999999987643     5789999997543  23345668889999999999999999999999


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHc----------------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~  285 (479)
                      ....++++||+.+++|..++...                ..+++..+..++.|++.||.|||++||+||||||+|||+++
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD  159 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence            99999999999999999888532                34788888999999999999999999999999999999999


Q ss_pred             CCcEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 011698          286 DGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI  361 (479)
Q Consensus       286 ~g~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i  361 (479)
                      ++.+||+|||+++.......   .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++...+
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999999999987543221   233456789999999998889999999999999999998 99999988888888888


Q ss_pred             HhccC-CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          362 IKDKI-KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       362 ~~~~~-~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ..... .+|..++..+.+|+..||+++|.+||     ++++|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----~~~~i~~  278 (283)
T cd05091         240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRP-----RFKDIHS  278 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCC-----CHHHHHH
Confidence            77643 46778999999999999999999999     8999876

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.4e-41  Score=327.39  Aligned_cols=248  Identities=22%  Similarity=0.380  Sum_probs=213.4

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|++++.||+|+||+||+|++.+. ..+|+|.+......    .+.+.+|+.++++++||||+++++++.....+++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~-~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   76 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI   76 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecCC-CcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence            346899999999999999999988653 45999998754322    2457889999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC-
Q 011698          228 VLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-  305 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~-  305 (479)
                      ||||+.+|+|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++....... 
T Consensus        77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            99999999999998764 4689999999999999999999999999999999999999999999999999986543321 


Q ss_pred             -cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-CCCCccCCHHHHHHHHh
Q 011698          306 -SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLLKG  382 (479)
Q Consensus       306 -~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~lI~~  382 (479)
                       .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.......+..+. ...+...+..+.+++..
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS  236 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence             112235567999999998889999999999999999999 999998888777777777653 33466688999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhC
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ||+.||.+||     ++.+|+.+
T Consensus       237 cl~~~p~~Rp-----~~~~ll~~  254 (256)
T cd05113         237 CWHEKAEERP-----TFQQLLSS  254 (256)
T ss_pred             HcCCCcccCC-----CHHHHHHh
Confidence            9999999999     89998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-41  Score=341.96  Aligned_cols=253  Identities=27%  Similarity=0.422  Sum_probs=207.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC-----Ce
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----YR  224 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~  224 (479)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++....  .......+.+|+.++++++||||+++++++...     ..
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            68999999999999999999999999999999986422  223345567899999999999999999876544     35


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      .|+|+||+.+ +|...+. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          83 VYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             EEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            8999999975 7776664 4578999999999999999999999999999999999999999999999999997653322


Q ss_pred             C----cccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------------c
Q 011698          305 R----SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK---------------D  364 (479)
Q Consensus       305 ~----~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~---------------~  364 (479)
                      .    ....+||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..               .
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence            1    133578999999998765 5689999999999999999999999987654333222211               0


Q ss_pred             -----------cCC-----CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          365 -----------KIK-----LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       365 -----------~~~-----~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                 ...     ..+.++.++.+||.+||+.||++||     ++.++++||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----t~~e~l~hp~~~~~  298 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI-----TVEEALAHPYLEQY  298 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc-----CHHHHhcCcccccc
Confidence                       000     1124678899999999999999999     89999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9.4e-41  Score=325.25  Aligned_cols=250  Identities=31%  Similarity=0.507  Sum_probs=215.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++..........+.+.+|+.++++++|++|+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999999999999997654444555677889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-
Q 011698          230 DFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       230 E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-  304 (479)
                      ||+++|+|..++..    ...+++..++.++.+|+.||.|||+.||+||||||+||+++.++.++|+|||++..+.... 
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            99999999988864    3458999999999999999999999999999999999999999999999999998754332 


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcc-CCCCc-cCCHHHHHHH
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN--RQKIQQKIIKDK-IKLPA-FLSSEAHSLL  380 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~--~~~~~~~i~~~~-~~~p~-~~s~~~~~lI  380 (479)
                      ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||....  .....+.+..+. ...|. .++.++.++|
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  241 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV  241 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence            2344578999999999999999999999999999999999999996543  334444444432 23444 6888999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHh
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+||+.+|++||     ++.+|++
T Consensus       242 ~~cl~~~p~~Rp-----~~~~il~  260 (267)
T cd08224         242 SRCINPDPEKRP-----DISYVLQ  260 (267)
T ss_pred             HHHcCCCcccCC-----CHHHHHH
Confidence            999999999999     8888764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.5e-41  Score=329.91  Aligned_cols=250  Identities=29%  Similarity=0.483  Sum_probs=214.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||+|+||.||+|+++.+++.||||.+.............+.+|+.+++.++||||+++++++...+.++++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57999999999999999999999999999999987655445555667889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          230 DFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       230 E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      ||++|++|..++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            99999999988864    34689999999999999999999999999999999999999999999999999987643322


Q ss_pred             -cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccC-CC-CccCCHHHHHHH
Q 011698          306 -SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR--QKIQQKIIKDKI-KL-PAFLSSEAHSLL  380 (479)
Q Consensus       306 -~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~--~~~~~~i~~~~~-~~-p~~~s~~~~~lI  380 (479)
                       ....+|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+...  ....+.+..... .. +..++.+++++|
T Consensus       162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  241 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV  241 (267)
T ss_pred             ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHH
Confidence             2345789999999999999999999999999999999999999976443  333444443222 22 245789999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHh
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+||+.||++||     |+++|++
T Consensus       242 ~~~l~~~p~~Rp-----t~~~i~~  260 (267)
T cd08229         242 NMCINPDPEKRP-----DITYVYD  260 (267)
T ss_pred             HHhcCCCcccCC-----CHHHHHH
Confidence            999999999999     8887754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-41  Score=337.50  Aligned_cols=252  Identities=28%  Similarity=0.491  Sum_probs=206.1

Q ss_pred             CeEEEEEeccCCceEEEEEEEcC--CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC--CeEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRLY  226 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~~  226 (479)
                      .|++.+.||+|+||.||+|.++.  +++.||+|++...........+.+.+|+.++++++||||+++++++.+.  ..+|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            48899999999999999999988  8999999999874322233345567899999999999999999999988  8899


Q ss_pred             EEEEeccCCcHHHHHHHc-----CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC----CCcEEEeecCCc
Q 011698          227 LVLDFVNGGHLFFQLYRQ-----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA----DGHVMLTDFGLA  297 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~----~g~vkL~DFGla  297 (479)
                      +||||+++ +|...+...     ..+++..++.++.||+.||.|||+++|+||||||+|||++.    +|.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999986 565555422     36899999999999999999999999999999999999999    999999999999


Q ss_pred             cccCCCC----CcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHH---------HHHHHHh
Q 011698          298 KQFDENT----RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQK---------IQQKIIK  363 (479)
Q Consensus       298 ~~~~~~~----~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~---------~~~~i~~  363 (479)
                      ..+....    .....+++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+...         ....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            8754322    23345788999999998774 57899999999999999999999997644321         0111100


Q ss_pred             --------------------------ccCCCC-----------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCc
Q 011698          364 --------------------------DKIKLP-----------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHK  406 (479)
Q Consensus       364 --------------------------~~~~~p-----------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp  406 (479)
                                                ....++           ...+.++.++|.+||+.||++||     ++.|+++||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----s~~eil~~~  314 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI-----TAEEALEHP  314 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCc-----CHHHHhcCC
Confidence                                      011111           14677899999999999999999     999999999


Q ss_pred             cc
Q 011698          407 WF  408 (479)
Q Consensus       407 ~f  408 (479)
                      ||
T Consensus       315 ~f  316 (316)
T cd07842         315 YF  316 (316)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.8e-41  Score=332.29  Aligned_cols=253  Identities=21%  Similarity=0.380  Sum_probs=217.1

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCC-----eEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSF  219 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~  219 (479)
                      .+..++|++.+.||+|+||.||++.++..+     ..+|+|.+....  .......+.+|+.+++++ +|+||+++++++
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            455678999999999999999999987543     789999987643  222345578899999999 899999999999


Q ss_pred             eeCCeEEEEEEeccCCcHHHHHHHc----------------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe
Q 011698          220 QTKYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL  283 (479)
Q Consensus       220 ~~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl  283 (479)
                      .....++++|||+.+|+|..++.+.                +.+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~  165 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV  165 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence            9999999999999999999998653                357888999999999999999999999999999999999


Q ss_pred             CCCCcEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHH
Q 011698          284 DADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQ  359 (479)
Q Consensus       284 ~~~g~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~  359 (479)
                      +.++.+||+|||+++.+.....   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+..+
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            9999999999999987543321   122334578999999999999999999999999999998 999999888877777


Q ss_pred             HHHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          360 KIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       360 ~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      .+..+ ....|...+.++.+||.+||..||++||     ++++++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~eil~~  287 (293)
T cd05053         246 LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRP-----TFKQLVED  287 (293)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCc-----CHHHHHHH
Confidence            77665 3456777899999999999999999999     89998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7.6e-41  Score=323.53  Aligned_cols=251  Identities=30%  Similarity=0.526  Sum_probs=223.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|++.+.||+|+||.||+++++.+++.+|+|.+....... .....+.+|+.+++.++|+||+++++++.+....|+|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            5899999999999999999999999999999998755433 334556789999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc
Q 011698          231 FVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       231 ~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~  306 (479)
                      |+++++|..++.+    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~  158 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MA  158 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cc
Confidence            9999999988866    356899999999999999999999999999999999999999999999999999876544 33


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCccCCHHHHHHHHhhhh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~lI~~~L~  385 (479)
                      ....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+...+...+..... ..+..++.+++++|.+||+
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  238 (256)
T cd08530         159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQ  238 (256)
T ss_pred             ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcC
Confidence            446688999999999999999999999999999999999999998888777777766543 4566789999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccc
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      .+|++||     +++++++||+.
T Consensus       239 ~~p~~Rp-----~~~~~l~~p~~  256 (256)
T cd08530         239 VKPKLRP-----NCDKILASPAV  256 (256)
T ss_pred             CCcccCC-----CHHHHhcCCCC
Confidence            9999999     99999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2e-41  Score=337.75  Aligned_cols=252  Identities=26%  Similarity=0.465  Sum_probs=217.6

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      .|+....||+|+||.||+|.+..+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++..+...|+|||
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence            34455689999999999999999999999999865432   234557789999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcccc
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSM  309 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~~~  309 (479)
                      |+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+... ......
T Consensus        99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659          99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence            9999999886654 56899999999999999999999999999999999999999999999999999765433 223456


Q ss_pred             cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---CCCCccCCHHHHHHHHhhhhh
Q 011698          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~lI~~~L~~  386 (479)
                      +|+..|+|||++.+..++.++|+|||||++|||++|+.||...+.......+....   ...+..++..+.++|++||+.
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~  257 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR  257 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcC
Confidence            78999999999999889999999999999999999999998777666555554432   223446788999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccccCC
Q 011698          387 EASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +|.+||     +++++++||||...
T Consensus       258 ~P~~Rp-----s~~~ll~~~~~~~~  277 (297)
T cd06659         258 EPQERA-----TAQELLDHPFLLQT  277 (297)
T ss_pred             CcccCc-----CHHHHhhChhhccC
Confidence            999999     89999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.2e-41  Score=342.21  Aligned_cols=255  Identities=24%  Similarity=0.407  Sum_probs=213.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC-----Ce
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----YR  224 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~  224 (479)
                      ++|++++.||+|+||+||+|++..+++.||||.+..... .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            579999999999999999999999999999999875432 222344567899999999999999999887654     35


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-  303 (479)
                      +|+|+||+. ++|..++...+.+++..++.++.||+.||.|||+++++||||||+||+++.++.+||+|||+++..... 
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            899999996 588888888888999999999999999999999999999999999999999999999999999875433 


Q ss_pred             CCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------------
Q 011698          304 TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------  364 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~------------------  364 (479)
                      .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+..-                  
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07858         163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR  242 (337)
T ss_pred             ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence            23345578899999999875 46899999999999999999999999876543332222110                  


Q ss_pred             ----------cC---CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          365 ----------KI---KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       365 ----------~~---~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                ..   ...+.++.++.+||++||+.+|++||     +++++++||||+.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----s~~ell~h~~~~~~  297 (337)
T cd07858         243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI-----TVEEALAHPYLASL  297 (337)
T ss_pred             HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhcc-----CHHHHHcCcchhhh
Confidence                      00   01235789999999999999999999     89999999999875

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.8e-41  Score=335.80  Aligned_cols=255  Identities=29%  Similarity=0.488  Sum_probs=218.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++++.||+|+||.||++.+..++..||+|.+....   ....+.+.+|+.+++.++||||+++++.+......|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            368999999999999999999999899999999986432   22345678899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Ccc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~  307 (479)
                      +||+++++|..++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence            9999999999888654 57888999999999999999999999999999999999999999999999987654332 233


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cC--CCCccCCHHHHHHHHhhh
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KI--KLPAFLSSEAHSLLKGLL  384 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~--~~p~~~s~~~~~lI~~~L  384 (479)
                      ...|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+... ..  ..+..++..++++|.+||
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  253 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHc
Confidence            457889999999999888999999999999999999999999876654433333222 22  234457889999999999


Q ss_pred             hhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          385 QKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       385 ~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      +.+|++||     ++++++.|+||+..+
T Consensus       254 ~~~p~~Rp-----~~~~il~h~~~~~~~  276 (293)
T cd06647         254 EMDVEKRG-----SAKELLQHPFLKIAK  276 (293)
T ss_pred             cCChhhCc-----CHHHHhcCHHHhcCc
Confidence            99999999     899999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-41  Score=327.56  Aligned_cols=248  Identities=21%  Similarity=0.314  Sum_probs=210.9

Q ss_pred             eEEEEEeccCCceEEEEEEEcCC---CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe----
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR----  224 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~----  224 (479)
                      |++.+.||+|+||.||+|....+   +..||+|+++.+.. .......+.+|+.+++.++||||+++++.+.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            56789999999999999987653   47899999876432 23345668899999999999999999998765544    


Q ss_pred             --EEEEEEeccCCcHHHHHHHc------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCC
Q 011698          225 --LYLVLDFVNGGHLFFQLYRQ------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL  296 (479)
Q Consensus       225 --~~lV~E~~~ggsL~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGl  296 (479)
                        .+++|||+++|+|..++...      ..+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              79999999999998887543      3588999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCcc
Q 011698          297 AKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAF  371 (479)
Q Consensus       297 a~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  371 (479)
                      ++.+.....   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++.+.+..+ ....|..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED  239 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcC
Confidence            987543321   122335678999999998899999999999999999999 99999988888887777765 4557788


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ++.++.++|.+||+.||++||     ++.+++++
T Consensus       240 ~~~~~~~li~~~l~~~p~~Rp-----~~~e~~~~  268 (273)
T cd05035         240 CLDELYDLMYSCWRADPKDRP-----TFTKLREV  268 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            999999999999999999999     88888763

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.8e-41  Score=330.93  Aligned_cols=255  Identities=31%  Similarity=0.479  Sum_probs=223.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +.|+..+.||.|+||.||+|.+..++..||+|++.....    ..+.+.+|+.+++.++|+||+++++.+......|+|+
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            568899999999999999999998899999999976432    3456788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcc
Q 011698          230 DFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~  307 (479)
                      ||++|++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...... ....
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  174 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN  174 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence            9999999999998876 8999999999999999999999999999999999999999999999999998765332 2223


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-C--CCccCCHHHHHHHHhhh
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-K--LPAFLSSEAHSLLKGLL  384 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~--~p~~~s~~~~~lI~~~L  384 (479)
                      ...+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+..... .  .+..++.++.++|..||
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCL  254 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHh
Confidence            45688999999999998899999999999999999999999988776655555544322 2  23347899999999999


Q ss_pred             hhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          385 QKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       385 ~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      +.+|.+||     ++.++++|+||+...|
T Consensus       255 ~~~p~~Rp-----t~~~il~~~~~~~~~~  278 (286)
T cd06614         255 VKDPEKRP-----SAEELLQHPFLKKACP  278 (286)
T ss_pred             ccChhhCc-----CHHHHhhChHhhccCc
Confidence            99999999     9999999999999544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-41  Score=331.59  Aligned_cols=250  Identities=29%  Similarity=0.503  Sum_probs=211.3

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEe
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~  231 (479)
                      |++++.||.|++|.||+|.++.+|..||+|++...... ....+.+.+|+.++++++||||+++++++.+....|++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            67889999999999999999999999999999765322 22334567899999999999999999999999999999999


Q ss_pred             ccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC-ccc
Q 011698          232 VNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNS  308 (479)
Q Consensus       232 ~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~-~~~  308 (479)
                      ++ ++|..++....  .+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++........ ...
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            95 58988887765  689999999999999999999999999999999999999999999999999976543222 233


Q ss_pred             ccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------------------
Q 011698          309 MCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK----------------------  365 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~----------------------  365 (479)
                      ..++..|+|||++.+. .++.++|+||||+++|+|++|+.||.+.+......++....                      
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP  238 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence            4568899999988764 56899999999999999999999998876655444433210                      


Q ss_pred             -------CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          366 -------IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       366 -------~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                             ......++.++.++|.+||+.||.+||     ++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~il~~~~~  283 (283)
T cd07835         239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI-----SAKAALQHPYF  283 (283)
T ss_pred             cccccchhhhcCCCCHHHHHHHHHHhcCChhhCc-----CHHHHhcCCCC
Confidence                   011245778999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-41  Score=326.37  Aligned_cols=247  Identities=21%  Similarity=0.399  Sum_probs=212.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      ..+|++.+.||+|+||.||+|+++. +..+|+|++.+....    ...+.+|+.+++.++||||+++++++......|+|
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            4579999999999999999999864 567999998754322    23466799999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc-
Q 011698          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-  306 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~-  306 (479)
                      |||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++........ 
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999999998764 46899999999999999999999999999999999999999999999999999865432211 


Q ss_pred             -ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhh
Q 011698          307 -NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       307 -~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~  383 (479)
                       ....++..|+|||.+.+..++.++|+||||+++|||++ |..||...+..+....+... ....|..++.++.+++.+|
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  237 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSC  237 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence             11223457999999999999999999999999999999 89999888777777777655 4566777899999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhC
Q 011698          384 LQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      |+.+|++||     ++.++++.
T Consensus       238 l~~~p~~Rp-----t~~~~l~~  254 (256)
T cd05059         238 WHEKPEDRP-----AFKKLLSQ  254 (256)
T ss_pred             hcCChhhCc-----CHHHHHHH
Confidence            999999999     89998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=356.36  Aligned_cols=248  Identities=28%  Similarity=0.482  Sum_probs=217.5

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg  235 (479)
                      -+||+|.||+||.|+++.|...+|||.+....   ....+-+..|+.+-++|+|.|||++++++..++.+-|.||-++||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            37999999999999999999999999986532   234556788999999999999999999999999999999999999


Q ss_pred             cHHHHHHHc-CCC--cHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeC-CCCcEEEeecCCccccC-CCCCccccc
Q 011698          236 HLFFQLYRQ-GLF--REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-ADGHVMLTDFGLAKQFD-ENTRSNSMC  310 (479)
Q Consensus       236 sL~~~l~~~-~~l--~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~-~~g~vkL~DFGla~~~~-~~~~~~~~~  310 (479)
                      +|..+|+.. |++  .|...-+|..||++||.|||.+.|||||||-+||||+ -.|.+||+|||.++.+. -...+.++.
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence            999999876 666  8888999999999999999999999999999999995 57899999999999863 344567889


Q ss_pred             CCCCCcchhHhcC--CCCCccccchhhHHHHHHHHhCCCCCCCC-CHH-HHHHH-HHhccCCCCccCCHHHHHHHHhhhh
Q 011698          311 GTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGG-NRQ-KIQQK-IIKDKIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       311 gt~~y~APE~l~~--~~~~~~~DiwSLGvilyelltG~~Pf~~~-~~~-~~~~~-i~~~~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      ||..|||||++..  .+|+.++|||||||++.||.||++||... +.. .+++. +.+-.+++|..+|.+++.||.+|..
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe  817 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE  817 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence            9999999999976  47999999999999999999999999753 232 33332 2234678999999999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCC
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      .||.+||     +|.++|..||++.-
T Consensus       818 pd~~~R~-----sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  818 PDPCDRP-----SAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCcccCc-----cHHHhccCcccccC
Confidence            9999999     89999999999875

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-41  Score=362.05  Aligned_cols=263  Identities=25%  Similarity=0.377  Sum_probs=201.5

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCC-eEEEEE--------------EeehhhhchHHHHHHHHHHHHHHHhCCCCCe
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMK--------------VMRKDKIMEKNHAEYMKSERNILTKVDHPFI  212 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~-~~vAiK--------------~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~I  212 (479)
                      ..++|++++.||+|+||+||+|..+... +.++.|              ++.+...........+.+|+.+|++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3578999999999999999998765432 222222              1111111122334567899999999999999


Q ss_pred             eeEeEEEeeCCeEEEEEEeccCCcHHHHHHHc-----CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC
Q 011698          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (479)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g  287 (479)
                      +++++++...+..|+|+|++.+ +|..++...     .......++.++.||+.||.|||++|||||||||+|||++.+|
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence            9999999999999999999965 666666442     2234667888999999999999999999999999999999999


Q ss_pred             cEEEeecCCccccCCCC--CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCC-CCCC--CHHHHHHHHH
Q 011698          288 HVMLTDFGLAKQFDENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPP-FTGG--NRQKIQQKII  362 (479)
Q Consensus       288 ~vkL~DFGla~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~P-f~~~--~~~~~~~~i~  362 (479)
                      .+||+|||+++.+....  .....+||+.|+|||++.+..++.++|||||||++|||++|..+ |...  +......++.
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~  384 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII  384 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence            99999999998764432  23456899999999999999999999999999999999998764 4322  2212222211


Q ss_pred             hc----cCCCC----------------------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          363 KD----KIKLP----------------------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       363 ~~----~~~~p----------------------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      ..    ...+|                            ..++.++.++|.+||+.||.+||     ++.|+++||||..
T Consensus       385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp-----sa~elL~hp~f~~  459 (501)
T PHA03210        385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP-----GAAELLALPLFSA  459 (501)
T ss_pred             HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCc-----CHHHHhhChhhhc
Confidence            10    00011                            12466788899999999999999     9999999999998


Q ss_pred             CChhhh
Q 011698          411 INWKKL  416 (479)
Q Consensus       411 ~~~~~l  416 (479)
                      ..++.+
T Consensus       460 ~~~~~~  465 (501)
T PHA03210        460 EEEEEI  465 (501)
T ss_pred             CCchHH
Confidence            776544

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-40  Score=330.64  Aligned_cols=250  Identities=21%  Similarity=0.310  Sum_probs=213.6

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCC----------------eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCC
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTS----------------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF  211 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~----------------~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~  211 (479)
                      ..++|++++.||+|+||.||+|.+..++                ..||+|.+.....  ....+.+.+|++++++++|||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence            3468999999999999999999876544                5689999876532  244567889999999999999


Q ss_pred             eeeEeEEEeeCCeEEEEEEeccCCcHHHHHHHcC-----------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCcc
Q 011698          212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-----------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (479)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeN  280 (479)
                      |+++++++..+...+++|||+.+++|..++.+..           .+++..++.++.|++.||.|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999998766           68999999999999999999999999999999999


Q ss_pred             EEeCCCCcEEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh--CCCCCCCCCHH
Q 011698          281 ILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT--GQPPFTGGNRQ  355 (479)
Q Consensus       281 ILl~~~g~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt--G~~Pf~~~~~~  355 (479)
                      |+++.++.++|+|||+++......   ......+++.|+|||.+.+..++.++|||||||++|||++  |..||...+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            999999999999999998653322   2234456788999999998889999999999999999998  78899877766


Q ss_pred             HHHHHHHhc--------cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          356 KIQQKIIKD--------KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       356 ~~~~~i~~~--------~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+...+...        ....+..++.++.++|.+||+.||++||     ++.+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~el~~  292 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRP-----TFREIHL  292 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCC-----CHHHHHH
Confidence            666655432        1233456789999999999999999999     8999854

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-40  Score=339.37  Aligned_cols=254  Identities=28%  Similarity=0.432  Sum_probs=213.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-----
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----  223 (479)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+|++++||||+++++++....     
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            467999999999999999999999999999999986532 22333456778999999999999999999997654     


Q ss_pred             -eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 -RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 -~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                       .+++||||+ |++|..++. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence             458999999 678877765 45789999999999999999999999999999999999999999999999999986543


Q ss_pred             CCCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--------------
Q 011698          303 NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--------------  367 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--------------  367 (479)
                      .  .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+......              
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07880         171 E--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA  248 (343)
T ss_pred             C--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence            2  234567899999999976 45789999999999999999999999887665554444331111              


Q ss_pred             -----------------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          368 -----------------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       368 -----------------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                                       +...++..+.++|.+||+.||++||     ++.+++.||||+.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~-----t~~~~l~~~~~~~~~  305 (343)
T cd07880         249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI-----TAAEALAHPYFEEFH  305 (343)
T ss_pred             HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCC-----CHHHHhcCccHhhhc
Confidence                             1235788899999999999999999     899999999999763

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.4e-41  Score=342.52  Aligned_cols=252  Identities=23%  Similarity=0.402  Sum_probs=208.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEe
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQ  220 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~  220 (479)
                      +..++|++.+.||+|+||.||+|.+.+     +++.||+|+++...  .....+.+..|+.+++++ +|+||+++++++.
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            344689999999999999999997544     45789999987533  222345577899999999 8999999999876


Q ss_pred             e-CCeEEEEEEeccCCcHHHHHHHc-------------------------------------------------------
Q 011698          221 T-KYRLYLVLDFVNGGHLFFQLYRQ-------------------------------------------------------  244 (479)
Q Consensus       221 ~-~~~~~lV~E~~~ggsL~~~l~~~-------------------------------------------------------  244 (479)
                      . ...++++|||+++++|...+...                                                       
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            4 45789999999999999888642                                                       


Q ss_pred             ------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC---CcccccCCCCC
Q 011698          245 ------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEY  315 (479)
Q Consensus       245 ------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~---~~~~~~gt~~y  315 (479)
                            ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....   ......++..|
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence                  257888899999999999999999999999999999999999999999999998754322   12334567789


Q ss_pred             cchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc--cCCCCccCCHHHHHHHHhhhhhchhhhc
Q 011698          316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSLLKGLLQKEASKRL  392 (479)
Q Consensus       316 ~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~lI~~~L~~dP~~R~  392 (479)
                      +|||++.+..++.++|||||||++|||++ |..||.+....+........  ....|...+.++.+++.+||+.+|++||
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP  321 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP  321 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence            99999999999999999999999999998 99999875544333333332  3445677899999999999999999999


Q ss_pred             CCCCCCHHHHHhC
Q 011698          393 GSGPGGSQEIKSH  405 (479)
Q Consensus       393 ~~~~~t~~eil~h  405 (479)
                           +++++++|
T Consensus       322 -----s~~ell~~  329 (337)
T cd05054         322 -----TFSELVEI  329 (337)
T ss_pred             -----CHHHHHHH
Confidence                 89998874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-41  Score=328.80  Aligned_cols=250  Identities=30%  Similarity=0.465  Sum_probs=212.0

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC---CCCCeeeEeEEEeeCCe----
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQTKYR----  224 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~~~~----  224 (479)
                      |++.+.||+|+||.||+|+++.+++.||+|+++.... .......+.+|+.+++++   +||||+++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            6889999999999999999998999999999975432 222234455677777665   69999999999988776    


Q ss_pred             -EEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          225 -LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       225 -~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                       ++++|||+.+ +|..++.+..  .+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++....
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             9999999985 7888887643  48999999999999999999999999999999999999999999999999998875


Q ss_pred             CCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----CC---------
Q 011698          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-----IK---------  367 (479)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-----~~---------  367 (479)
                      .........++..|+|||.+.+..++.++|+|||||++|||++|.+||.+.+..+...++....     ..         
T Consensus       159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07838         159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR  238 (287)
T ss_pred             CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence            5544455568899999999999999999999999999999999999999888777666665421     00         


Q ss_pred             --C-----------CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          368 --L-----------PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       368 --~-----------p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                        +           ...++..+.++|.+||+.||.+||     +++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----~~~~il~~~~~  287 (287)
T cd07838         239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI-----SAFEALQHPYF  287 (287)
T ss_pred             hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC-----CHHHHhcCcCC
Confidence              0           013567889999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.4e-41  Score=347.24  Aligned_cols=251  Identities=23%  Similarity=0.358  Sum_probs=209.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCC-----CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEe
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQ  220 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~  220 (479)
                      +..++|++.+.||+|+||.||+|.+...     +..||||+++...  .....+.+.+|+.+|++++ ||||+++++++.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            4467899999999999999999987543     3579999997543  2334566888999999996 999999999999


Q ss_pred             eCCeEEEEEEeccCCcHHHHHHHc--------------------------------------------------------
Q 011698          221 TKYRLYLVLDFVNGGHLFFQLYRQ--------------------------------------------------------  244 (479)
Q Consensus       221 ~~~~~~lV~E~~~ggsL~~~l~~~--------------------------------------------------------  244 (479)
                      ....+|+|||||++|+|.+++...                                                        
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            999999999999999999888643                                                        


Q ss_pred             ----------------------------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeC
Q 011698          245 ----------------------------------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD  284 (479)
Q Consensus       245 ----------------------------------------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~  284 (479)
                                                              ..+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~  271 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence                                                    1367778888999999999999999999999999999999


Q ss_pred             CCCcEEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHH-H
Q 011698          285 ADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQ-Q  359 (479)
Q Consensus       285 ~~g~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~-~  359 (479)
                      .++.+||+|||+++......   ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......... .
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            99999999999998653322   2233456788999999999999999999999999999997 99999876544333 3


Q ss_pred             HHHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          360 KIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       360 ~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+..+ .+..+..++.++.++|.+||+.||++||     ++.++.+
T Consensus       352 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~l~~  392 (400)
T cd05105         352 KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP-----SFLHLSD  392 (400)
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCc-----CHHHHHH
Confidence            33333 3455677899999999999999999999     7777654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-41  Score=340.90  Aligned_cols=255  Identities=27%  Similarity=0.395  Sum_probs=220.3

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-----eE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----RL  225 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----~~  225 (479)
                      +|++.+.||.|+||.||+|++..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++....     .+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            5899999999999999999999999999999987643 12334566888999999999999999999988775     78


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-  304 (479)
                      |+||||+.+ +|...+.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... 
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            999999985 888888887889999999999999999999999999999999999999999999999999998765442 


Q ss_pred             ---CcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------------
Q 011698          305 ---RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-------------  367 (479)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-------------  367 (479)
                         ......++..|+|||++.+. .++.++|+||||+++|+|++|..||.+.+..+....+....-.             
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence               23445688999999999888 7899999999999999999999999988776666555542110             


Q ss_pred             ------------------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          368 ------------------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       368 ------------------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                                        ....++.++.+||.+||+++|.+||     +++++++||||+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~ll~~~~~~~~~  296 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI-----TADEALAHPYLAQLH  296 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCC-----CHHHHHhCccHHhhc
Confidence                              1123688999999999999999999     899999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1e-40  Score=329.07  Aligned_cols=249  Identities=22%  Similarity=0.373  Sum_probs=213.8

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEc-----CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      ...+|++.++||+|+||.||+|+..     .++..+|+|.+....   ....+.+.+|+++++.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            4468999999999999999999753     356789999886532   33455688999999999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcC---------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQG---------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~---------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g  287 (479)
                      ...+++|||+.+++|.+++...+               .+++..++.++.||+.||.|||++||+||||||+|||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999987653               478899999999999999999999999999999999999999


Q ss_pred             cEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 011698          288 HVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK  363 (479)
Q Consensus       288 ~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~  363 (479)
                      .+||+|||+++.......   .....+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+..
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ  239 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence            999999999976533221   122345678999999999999999999999999999998 9999988777777777765


Q ss_pred             c-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          364 D-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       364 ~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      + ....|..+++.+.+||.+||+.||.+||     ++++|++
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----~~~~l~~  276 (280)
T cd05092         240 GRELERPRTCPPEVYAIMQGCWQREPQQRM-----VIKDIHS  276 (280)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCChhhCC-----CHHHHHH
Confidence            5 4456677899999999999999999999     8888864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=386.34  Aligned_cols=255  Identities=31%  Similarity=0.539  Sum_probs=226.3

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +|....+||.|.||.||-|....||+..|+|.++..... ......+.+|..+|..++|||+|+.|++-.+.+.++|.||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            466678999999999999999999999999999765433 4445668899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-----C
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----R  305 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-----~  305 (479)
                      ||+||+|.+.+...+..+|...+.|..|++.|+.|||+.|||||||||+||+++.+|.+|++|||.|..+....     .
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            99999999999998889999999999999999999999999999999999999999999999999999876553     2


Q ss_pred             cccccCCCCCcchhHhcC---CCCCccccchhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHh-ccCCCCccCCHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIK-DKIKLPAFLSSEAHSLL  380 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~---~~~~~~~DiwSLGvilyelltG~~Pf~~~~~-~~~~~~i~~-~~~~~p~~~s~~~~~lI  380 (479)
                      .....||+.|||||++.+   ++...++|||||||++.||+||+.||...+. -.++..+.. ..+.+|..+|++.++||
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence            346789999999999976   4578999999999999999999999976443 344444444 47889999999999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ..||..||++|.     ++.|++.|.|=+..
T Consensus      1475 e~Cl~~dP~~Rw-----~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRW-----TASQLLEHAFGKSC 1500 (1509)
T ss_pred             HHHHhcCchhhh-----HHHHHHHhhccccc
Confidence            999999999998     88999999887654

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.4e-41  Score=341.64  Aligned_cols=250  Identities=24%  Similarity=0.356  Sum_probs=205.7

Q ss_pred             EEeccC--CceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEecc
Q 011698          156 KVVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (479)
Q Consensus       156 ~~LG~G--~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~  233 (479)
                      ..||+|  +||+||+|++..+|+.||+|++...... ....+.+++|+.+++.++||||++++++|..+..+|+||||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            356666  9999999999999999999998765432 3445778899999999999999999999999999999999999


Q ss_pred             CCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-C-----
Q 011698          234 GGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-R-----  305 (479)
Q Consensus       234 ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~-----  305 (479)
                      +++|..++.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+....... .     
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            99999988764  348999999999999999999999999999999999999999999999998654321111 1     


Q ss_pred             --cccccCCCCCcchhHhcCC--CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------------
Q 011698          306 --SNSMCGTLEYMSPEIVLGK--GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---------------  366 (479)
Q Consensus       306 --~~~~~gt~~y~APE~l~~~--~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------------  366 (479)
                        .....++..|||||++.+.  .++.++|||||||++|||++|..||.+.........+.....               
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR  242 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence              1112346679999999774  478999999999999999999999987665444333322211               


Q ss_pred             --------------------------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          367 --------------------------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       367 --------------------------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                                      ..+..++.++.+||++||+.||++||     |++++++|+||+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp-----ta~e~l~~~~~~~~  314 (328)
T cd08226         243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP-----SASSLLSHAFFKQV  314 (328)
T ss_pred             hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCC-----CHHHHhhCHHHHHH
Confidence                                            11223577899999999999999999     99999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.4e-41  Score=327.91  Aligned_cols=245  Identities=31%  Similarity=0.517  Sum_probs=208.2

Q ss_pred             EEEEEeccCCceEEEEEEEc----CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          153 EVLKVVGQGAFAKVYQVRRI----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       153 ~~~~~LG~G~fG~V~~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      ++.+.||.|.||.||+|.+.    ..+..|+||+++..  ......+.+.+|++.+++++||||+++++++.....+++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence            57889999999999999998    45678999999553  2333467788899999999999999999999988889999


Q ss_pred             EEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC-
Q 011698          229 LDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~-  305 (479)
                      |||+++|+|.+++...  ..+++.....++.||+.||.|||+++|+|++|+++|||++.++.+||+|||++........ 
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999887  6799999999999999999999999999999999999999999999999999987632221 


Q ss_pred             --cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHH
Q 011698          306 --SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK  381 (479)
Q Consensus       306 --~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~  381 (479)
                        .....+...|+|||.+.+..++.++||||||+++|||++ |+.||...+..++...+..+ ....|..++..+.++|.
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  239 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQ  239 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHH
Confidence              233446778999999999889999999999999999999 78999998888888888665 44567789999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHh
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .||..||.+||     ++++|++
T Consensus       240 ~C~~~~p~~RP-----s~~~i~~  257 (259)
T PF07714_consen  240 QCWSHDPEKRP-----SFQEILQ  257 (259)
T ss_dssp             HHT-SSGGGS-------HHHHHH
T ss_pred             HHcCCChhhCc-----CHHHHHh
Confidence            99999999999     8998874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.5e-40  Score=322.92  Aligned_cols=244  Identities=24%  Similarity=0.429  Sum_probs=211.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEE-eeCCeE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF-QTKYRL  225 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-~~~~~~  225 (479)
                      +..++|++.+.||+|+||.||++...  +..||+|.++...     ..+.+.+|+.++++++|++|+++++++ ......
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            45679999999999999999999874  6779999986542     234578899999999999999999875 456679


Q ss_pred             EEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      ++||||+++++|.+++...+  .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999999987654  3788999999999999999999999999999999999999999999999999865432


Q ss_pred             CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHH
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK  381 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~  381 (479)
                      .  ....++..|+|||++.+..++.++|||||||++|||++ |+.||...+...+...+..+ ....+..++..+.++|.
T Consensus       156 ~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMK  233 (256)
T ss_pred             C--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            2  23445678999999999999999999999999999998 99999888877777777655 44556778999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHh
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +||+.+|++||     ++.++++
T Consensus       234 ~~l~~~p~~Rp-----t~~~l~~  251 (256)
T cd05082         234 QCWHLDAATRP-----SFLQLRE  251 (256)
T ss_pred             HHhcCChhhCc-----CHHHHHH
Confidence            99999999999     8888864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.5e-40  Score=329.73  Aligned_cols=249  Identities=23%  Similarity=0.387  Sum_probs=214.2

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      ...+|.+.+.||+|+||.||+|++..     ++..+|+|.+....   ....+.+.+|+.++++++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            34689999999999999999998643     45679999986543   22345678899999999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcC----------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~  286 (479)
                      ...++||||+++++|.+++...+                .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999997643                37889999999999999999999999999999999999999


Q ss_pred             CcEEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 011698          287 GHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKII  362 (479)
Q Consensus       287 g~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~  362 (479)
                      +.+||+|||+++......   ......|+..|+|||.+.+..++.++|||||||++|||+| |..||...+..+..+.+.
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  239 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT  239 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence            999999999997654322   1233456788999999999999999999999999999999 999998888877777776


Q ss_pred             hccC-CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          363 KDKI-KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       363 ~~~~-~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+.. ..+...+..+.++|.+||++||++||     +++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~v~~  277 (291)
T cd05094         240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRL-----NIKEIYK  277 (291)
T ss_pred             CCCCCCCCccCCHHHHHHHHHHcccChhhCc-----CHHHHHH
Confidence            6544 34566789999999999999999999     8888864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1e-40  Score=326.53  Aligned_cols=246  Identities=21%  Similarity=0.331  Sum_probs=207.8

Q ss_pred             EEEEEeccCCceEEEEEEEcCCCe--EEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC------Ce
Q 011698          153 EVLKVVGQGAFAKVYQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------YR  224 (479)
Q Consensus       153 ~~~~~LG~G~fG~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------~~  224 (479)
                      .+.+.||+|+||.||+|++..++.  .||+|.++... ......+.+.+|+.+++.++||||+++++.+...      ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            467889999999999999987775  69999987643 2334466778899999999999999999876422      35


Q ss_pred             EEEEEEeccCCcHHHHHHHc------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcc
Q 011698          225 LYLVLDFVNGGHLFFQLYRQ------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~  298 (479)
                      .+++|||+.+|+|..++...      ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            78999999999998877421      347899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCC
Q 011698          299 QFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLS  373 (479)
Q Consensus       299 ~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s  373 (479)
                      .+.....   .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+.+...+...+..+ ....+..++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCL  240 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            7643321   123346778999999999999999999999999999999 89999988877777777765 345667789


Q ss_pred             HHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       374 ~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ..+.++|.+||+.||++||     +++++++
T Consensus       241 ~~~~~li~~~l~~~p~~Rp-----s~~~l~~  266 (272)
T cd05075         241 DGLYSLMSSCWLLNPKDRP-----SFETLRC  266 (272)
T ss_pred             HHHHHHHHHHcCCCcccCc-----CHHHHHH
Confidence            9999999999999999999     8999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-40  Score=323.58  Aligned_cols=248  Identities=22%  Similarity=0.375  Sum_probs=213.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++.+.||+|+||.||+|.+.. ++.||+|.++....    ..+.+.+|+.++++++||||+++++++...+.+|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence            345789999999999999999999764 46799999876432    2344778999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      +||||+.+++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999999999999987654  68999999999999999999999999999999999999999999999999998765322


Q ss_pred             Cc--ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHH
Q 011698          305 RS--NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (479)
Q Consensus       305 ~~--~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI  380 (479)
                      ..  ....++..|+|||.+.+..++.++|+||||+++|||++ |+.||.+.+...+...+... ....+..++..+.++|
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM  237 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence            11  11222457999999999999999999999999999999 99999988887777777654 3445667899999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHh
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+||+.+|.+||     +++++.+
T Consensus       238 ~~~l~~~P~~Rp-----~~~~l~~  256 (261)
T cd05068         238 LDCWKEDPDDRP-----TFETLQW  256 (261)
T ss_pred             HHHhhcCcccCC-----CHHHHHH
Confidence            999999999999     7888764

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=362.92  Aligned_cols=247  Identities=28%  Similarity=0.423  Sum_probs=211.4

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEE-Eee--
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYS-FQT--  221 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~-~~~--  221 (479)
                      .++-.++++.+.|.+|||+.||+|++...|..||+|.+-..   ++...+.+++|+++|++|+ |+|||.+++. ...  
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~  109 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS  109 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence            45667889999999999999999999988889999998653   5667888999999999997 9999999993 221  


Q ss_pred             ----CCeEEEEEEeccCCcHHHHHHH--cCCCcHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCccEEeCCCCcEEEee
Q 011698          222 ----KYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGHVMLTD  293 (479)
Q Consensus       222 ----~~~~~lV~E~~~ggsL~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~--IiHrDLKpeNILl~~~g~vkL~D  293 (479)
                          ...++|.||||.||.|.+++..  +..|+|.++..|+.|+|+|+.+||...  |||||||-|||||+.+|+.||||
T Consensus       110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence                2357899999999999999974  456999999999999999999999997  99999999999999999999999


Q ss_pred             cCCccccCCCC-Cc---------ccccCCCCCcchhHh---cCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 011698          294 FGLAKQFDENT-RS---------NSMCGTLEYMSPEIV---LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQK  360 (479)
Q Consensus       294 FGla~~~~~~~-~~---------~~~~gt~~y~APE~l---~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~  360 (479)
                      ||.|....... ..         -....|+.|+|||++   .+.+.+.|+|||+|||+||-|+....||.+..    .-.
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----~la  265 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----KLA  265 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----cee
Confidence            99997632211 11         112458999999998   46788999999999999999999999998653    235


Q ss_pred             HHhccCCCCc--cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          361 IIKDKIKLPA--FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       361 i~~~~~~~p~--~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      |+.+.+.+|+  .++..+++||+.||+.||.+||     ++-+++.
T Consensus       266 Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP-----nI~Qv~~  306 (738)
T KOG1989|consen  266 ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERP-----NIYQVLE  306 (738)
T ss_pred             EEeccccCCCCccHHHHHHHHHHHHhccCcccCC-----CHHHHHH
Confidence            7788888886  6999999999999999999999     7877764

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.4e-40  Score=324.90  Aligned_cols=246  Identities=24%  Similarity=0.383  Sum_probs=209.7

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|++.++||+|+||.||+|++..++ .||+|++++...    ..+.+.+|+.++++++||||+++++.+.. ...|+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence            4468999999999999999999987665 599999976432    12457889999999999999999988754 56899


Q ss_pred             EEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          228 VLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      ||||+.+|+|.+++.+.  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999999999763  3578899999999999999999999999999999999999999999999999987643322


Q ss_pred             c--ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHH
Q 011698          306 S--NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK  381 (479)
Q Consensus       306 ~--~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~  381 (479)
                      .  ....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.....+...+... ....+..++..+.++|.
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  237 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC  237 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence            1  23346678999999998899999999999999999999 89999888777777776654 34455678999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHh
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +||++||++||     +++++++
T Consensus       238 ~~l~~~p~~Rp-----~~~~~~~  255 (262)
T cd05071         238 QCWRKEPEERP-----TFEYLQA  255 (262)
T ss_pred             HHccCCcccCC-----CHHHHHH
Confidence            99999999999     7887754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=321.68  Aligned_cols=245  Identities=23%  Similarity=0.391  Sum_probs=215.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++.+.||+|+||.||+|...  |+.||+|.+.....    ..+.+.+|+.+++.++|+||+++++++.+....+
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY   76 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence            45678999999999999999999874  67899999976532    3566788999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      +||||+++++|.+++....  .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999999999998765  68999999999999999999999999999999999999999999999999998764322


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHh
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKG  382 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~  382 (479)
                      .  ...++..|+|||.+.+..++.++|+||||+++|||++ |..||...+...+...+..+ ....|..+++++.++|.+
T Consensus       157 ~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (256)
T cd05039         157 D--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKD  234 (256)
T ss_pred             c--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHH
Confidence            2  3345668999999998889999999999999999998 99999988877777766654 445677789999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHh
Q 011698          383 LLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ||+.+|++||     +++++++
T Consensus       235 ~l~~~p~~Rp-----~~~~l~~  251 (256)
T cd05039         235 CWELDPAKRP-----TFKQLRE  251 (256)
T ss_pred             HhccChhhCc-----CHHHHHH
Confidence            9999999999     8888875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.4e-40  Score=332.70  Aligned_cols=251  Identities=21%  Similarity=0.361  Sum_probs=213.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcC-------CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~  218 (479)
                      +..++|.+.+.||+|+||.||+|++.+       ++..+|+|.+....  .......+..|+.+++.+ +||||++++++
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            334789999999999999999998754       23569999997642  223345577899999999 79999999999


Q ss_pred             EeeCCeEEEEEEeccCCcHHHHHHHcC----------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEE
Q 011698          219 FQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (479)
Q Consensus       219 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNIL  282 (479)
                      +.....+|+||||+.+|+|..++....                .++...+..++.||+.||+|||++|++||||||+|||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            999999999999999999999997642                3788889999999999999999999999999999999


Q ss_pred             eCCCCcEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHH
Q 011698          283 LDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQ  358 (479)
Q Consensus       283 l~~~g~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~  358 (479)
                      ++.++.+||+|||+++.......   .....+++.|+|||++.+..++.++|+|||||++|||++ |..||.+.+..++.
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~  252 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  252 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence            99999999999999976543221   122234578999999999989999999999999999998 99999888877777


Q ss_pred             HHHHhcc-CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          359 QKIIKDK-IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       359 ~~i~~~~-~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ..+.... ...|..++.++.+||.+||..+|.+||     ++.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~evl~  294 (307)
T cd05098         253 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-----TFKQLVE  294 (307)
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCc-----CHHHHHH
Confidence            7776653 466778899999999999999999999     8888875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-40  Score=338.54  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=208.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC-------
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-------  222 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-------  222 (479)
                      .+|++.+.||.|+||.||+|.++.+++.||+|++.....   ...+.+.+|+.++++++||||+++++++...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            589999999999999999999999999999999876432   3345678899999999999999998776543       


Q ss_pred             -------CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC-CCcEEEeec
Q 011698          223 -------YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDF  294 (479)
Q Consensus       223 -------~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~-~g~vkL~DF  294 (479)
                             ..+|+||||+.+ +|...+.. +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          82 VGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             cccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence                   368999999974 88777754 56899999999999999999999999999999999999974 557899999


Q ss_pred             CCccccCCCC----CcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----
Q 011698          295 GLAKQFDENT----RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK----  365 (479)
Q Consensus       295 Gla~~~~~~~----~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~----  365 (479)
                      |+++.+....    ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+....    
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9997653221    1123467889999998755 567899999999999999999999998776555444433210    


Q ss_pred             ---------------------C-----CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          366 ---------------------I-----KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       366 ---------------------~-----~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                                           .     .+...++.++.+||.+||+.||.+||     ++.++++||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~ell~h~~~~~~~  307 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL-----TAEEALMHPYMSCYS  307 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhcc-----CHHHHhCCCcccccc
Confidence                                 0     01135788999999999999999999     899999999998653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=348.97  Aligned_cols=259  Identities=23%  Similarity=0.388  Sum_probs=224.8

Q ss_pred             CCCCcccCCCCeEEEEEeccCCceEEEEEEEcCCCe---E-EEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEe
Q 011698          141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---I-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR  216 (479)
Q Consensus       141 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~---~-vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~  216 (479)
                      +...+.+.-++..+.++||+|+||.||+|+.+..+.   . ||+|..+.+..........+.+|+++|++++|||||++|
T Consensus       148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y  227 (474)
T KOG0194|consen  148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY  227 (474)
T ss_pred             cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            444455667788888999999999999999876422   3 899999864444566677788999999999999999999


Q ss_pred             EEEeeCCeEEEEEEeccCCcHHHHHHHcCC-CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecC
Q 011698          217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFG  295 (479)
Q Consensus       217 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFG  295 (479)
                      |+...+..+++|||+|+||+|.++|++.+. ++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+||+|||
T Consensus       228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             EEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccc
Confidence            999999999999999999999999998874 9999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCCccccc-CCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc--cCCCCcc
Q 011698          296 LAKQFDENTRSNSMC-GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--KIKLPAF  371 (479)
Q Consensus       296 la~~~~~~~~~~~~~-gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~  371 (479)
                      +++.-.........+ -...|+|||.+....|+.++|||||||++||+++ |..||.+.+..++..+|..+  +...|..
T Consensus       308 Ls~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~  387 (474)
T KOG0194|consen  308 LSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSK  387 (474)
T ss_pred             cccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCC
Confidence            997654222222122 3568999999999999999999999999999999 89999999999999999654  4567778


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+.++..++..|+..||++|+     +..++.+
T Consensus       388 ~p~~~~~~~~~c~~~~p~~R~-----tm~~i~~  415 (474)
T KOG0194|consen  388 TPKELAKVMKQCWKKDPEDRP-----TMSTIKK  415 (474)
T ss_pred             CHHHHHHHHHHhccCChhhcc-----CHHHHHH
Confidence            899999999999999999999     7777754

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.4e-40  Score=331.27  Aligned_cols=256  Identities=26%  Similarity=0.370  Sum_probs=217.6

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      -|...+.||+|+||+||+|++..+++.||+|++.............+.+|+.+++.++|||++++++++.+....|+|||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            37778889999999999999999999999999976544444455667889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccc
Q 011698          231 FVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM  309 (479)
Q Consensus       231 ~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~  309 (479)
                      |+.| ++...+.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++....   .....
T Consensus       102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---~~~~~  177 (313)
T cd06633         102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSF  177 (313)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---CCCCc
Confidence            9975 66666654 4568999999999999999999999999999999999999999999999999986532   23456


Q ss_pred             cCCCCCcchhHhc---CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CC-CccCCHHHHHHHHhhh
Q 011698          310 CGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KL-PAFLSSEAHSLLKGLL  384 (479)
Q Consensus       310 ~gt~~y~APE~l~---~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~lI~~~L  384 (479)
                      .|+..|+|||++.   +..++.++|+|||||++|+|++|..||...+.......+..... .. ...++..+++||.+||
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  257 (313)
T cd06633         178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCL  257 (313)
T ss_pred             cccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHc
Confidence            7899999999984   35678899999999999999999999988776666655554422 22 2357788999999999


Q ss_pred             hhchhhhcCCCCCCHHHHHhCccccCCChhh
Q 011698          385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKK  415 (479)
Q Consensus       385 ~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~  415 (479)
                      +++|.+||     ++.++++||||....-.+
T Consensus       258 ~~~P~~Rp-----~~~~~l~~~~~~~~~~~~  283 (313)
T cd06633         258 QKIPQERP-----ASAELLRHDFVRRDRPAR  283 (313)
T ss_pred             cCChhhCc-----CHHHHhcCcccCCCchhH
Confidence            99999999     899999999999865333

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.6e-40  Score=325.04  Aligned_cols=249  Identities=24%  Similarity=0.371  Sum_probs=212.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCC---eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      ..+|++.+.||+|+||.||+|+++.++   ..+|+|.++...  .....+.+.+|+.++++++||||+++++++...+..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            468999999999999999999986444   379999987543  223456788899999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      |+||||+++++|..++.+. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++..+....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999999765 468999999999999999999999999999999999999999999999999998764332


Q ss_pred             C----cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHH
Q 011698          305 R----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (479)
Q Consensus       305 ~----~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (479)
                      .    .....++..|+|||.+.+..++.++|+|||||++||+++ |..||.+.+..+....+..+ ....+..++..+.+
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ  240 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHH
Confidence            1    112233568999999999889999999999999999887 99999887777777776654 33445667899999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ++.+||+++|.+||     ++.++++
T Consensus       241 li~~~l~~~p~~Rp-----~~~~i~~  261 (267)
T cd05066         241 LMLDCWQKDRNERP-----KFEQIVS  261 (267)
T ss_pred             HHHHHcccCchhCC-----CHHHHHH
Confidence            99999999999999     7888764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.5e-40  Score=332.69  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=217.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +.|+..+.||+|+||.||+|++..++..||+|++.............+.+|+.++++++|||++++++++.+....|+||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34888999999999999999999999999999997654434445566888999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHH-HcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccc
Q 011698          230 DFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~  308 (479)
                      ||+.| +|.+.+. ....+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....   ...
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~  180 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANS  180 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---ccc
Confidence            99986 6666664 356689999999999999999999999999999999999999999999999999875432   234


Q ss_pred             ccCCCCCcchhHhc---CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CCccCCHHHHHHHHhh
Q 011698          309 MCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--LPAFLSSEAHSLLKGL  383 (479)
Q Consensus       309 ~~gt~~y~APE~l~---~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~lI~~~  383 (479)
                      ..|++.|+|||.+.   +..++.++|||||||++|||++|..||...+.......+......  .+..++..+++||.+|
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  260 (317)
T cd06635         181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC  260 (317)
T ss_pred             ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHH
Confidence            57889999999984   456789999999999999999999999887776666666655332  2345788999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          384 LQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      |+.+|.+||     ++.++++|+|+...
T Consensus       261 l~~~p~~Rp-----t~~~il~~~~~~~~  283 (317)
T cd06635         261 LQKIPQDRP-----TSEELLKHMFVLRE  283 (317)
T ss_pred             ccCCcccCc-----CHHHHHhChhhhcc
Confidence            999999999     89999999999663

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-43  Score=361.71  Aligned_cols=306  Identities=44%  Similarity=0.778  Sum_probs=279.5

Q ss_pred             EeccCCceEEEEEEE---cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEEEEEEec
Q 011698          157 VVGQGAFAKVYQVRR---IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFV  232 (479)
Q Consensus       157 ~LG~G~fG~V~~a~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lV~E~~  232 (479)
                      .+|.|+||.|++++.   ...+..||+|+.++......... .-+.|..++..++ ||++|+++..|+++..++++++|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            379999999999754   34678899999988655443333 5567889999987 999999999999999999999999


Q ss_pred             cCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccccCC
Q 011698          233 NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT  312 (479)
Q Consensus       233 ~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt  312 (479)
                      .||+|+..+.....+.+...+.+.++++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-.....   |||
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt  156 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGT  156 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999986544433   999


Q ss_pred             CCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhc
Q 011698          313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRL  392 (479)
Q Consensus       313 ~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~  392 (479)
                      ..|||||++.  ++..++||||+|++++||+||..||.+    ++...|.+.++.+|..++..+++++..++.++|.+|+
T Consensus       157 ~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrL  230 (612)
T KOG0603|consen  157 YEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRL  230 (612)
T ss_pred             hhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHh
Confidence            9999999998  678999999999999999999999987    8889999999999999999999999999999999999


Q ss_pred             CCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCCC-CCCCCccCeeeecCc
Q 011698          393 GSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPK-FNENPFKGFTYVRPA  471 (479)
Q Consensus       393 ~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~-~~~~~f~~f~~~~~~  471 (479)
                      +..+..+.+|++|+||..++|..+..++++|+|+|.+....+..+|+..+|.....++|..++. .++..|.||+|+.+.
T Consensus       231 g~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~eft~~~P~dsp~~~~~~s~~~if~g~sfva~~  310 (612)
T KOG0603|consen  231 GAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPEFTSQVPADSPLLSASGSDHTIFSGPSFVAPG  310 (612)
T ss_pred             ccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCchhccCCcccCCCCCCCccccchhcCCCccChH
Confidence            9999999999999999999999999999999999999999999999999999988888877774 456889999999986


Q ss_pred             h
Q 011698          472 A  472 (479)
Q Consensus       472 ~  472 (479)
                      .
T Consensus       311 i  311 (612)
T KOG0603|consen  311 V  311 (612)
T ss_pred             H
Confidence            5

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.1e-40  Score=324.21  Aligned_cols=249  Identities=24%  Similarity=0.383  Sum_probs=213.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCe---EEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      ..+|++.+.||+|+||.||+|+++.+++   .||+|++....  .......+..|+.++++++||||+++++++.+...+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            4679999999999999999999987664   69999987542  233456688999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      ++||||+.+++|..++... +.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999888764 568999999999999999999999999999999999999999999999999987654322


Q ss_pred             Ccc----ccc--CCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHH
Q 011698          305 RSN----SMC--GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       305 ~~~----~~~--gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                      ...    ...  ++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+... ....+..++..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTAL  240 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHH
Confidence            111    111  2357999999999999999999999999999987 99999988877777777544 345566788999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+++..||+++|.+||     ++++|+.
T Consensus       241 ~~li~~~l~~~p~~Rp-----~~~~i~~  263 (269)
T cd05065         241 HQLMLDCWQKDRNARP-----KFGQIVS  263 (269)
T ss_pred             HHHHHHHcCCChhhCc-----CHHHHHH
Confidence            9999999999999999     8888875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.8e-40  Score=331.56  Aligned_cols=252  Identities=23%  Similarity=0.368  Sum_probs=213.3

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE-----cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSF  219 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~  219 (479)
                      .+..++|++.+.||+|+||.||+|.+     ..++..||+|+++...  .....+.+.+|+.+++++ +||||+++++++
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            45667899999999999999999985     3356689999987543  223456688999999999 799999999999


Q ss_pred             eeCCeEEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          220 QTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       220 ~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                      ...+.+|+||||+.+|+|..++.+..  .+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999999987643  3899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc--cCCCCcc
Q 011698          298 KQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--KIKLPAF  371 (479)
Q Consensus       298 ~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~  371 (479)
                      +.+.....   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.............  ....+..
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  268 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH  268 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence            87543321   122345778999999999999999999999999999998 99999877665555444443  2334567


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+.++.+||.+||+++|++||     ++.++++
T Consensus       269 ~~~~~~~li~~cl~~~p~~Rp-----t~~ell~  296 (302)
T cd05055         269 APAEIYDIMKTCWDADPLKRP-----TFKQIVQ  296 (302)
T ss_pred             CCHHHHHHHHHHcCCCchhCc-----CHHHHHH
Confidence            889999999999999999999     8888875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-40  Score=321.69  Aligned_cols=241  Identities=21%  Similarity=0.326  Sum_probs=207.3

Q ss_pred             EEeccCCceEEEEEEEcCCC---eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEec
Q 011698          156 KVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFV  232 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~  232 (479)
                      ++||+|+||.||+|.+..++   ..||+|.+......  ...+.+.+|+.+++.++||||+++++++. ....++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            46999999999999876655   78999999865432  34456788999999999999999999876 45689999999


Q ss_pred             cCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc----cc
Q 011698          233 NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS----NS  308 (479)
Q Consensus       233 ~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~----~~  308 (479)
                      .+|+|.+++.+.+.+++..+..++.|++.||.|||.++++||||||+|||++.++.+||+|||+++........    ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            99999999998888999999999999999999999999999999999999999999999999999876433221    11


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhhhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~  386 (479)
                      ..++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..++...+... ....|..++..++++|.+||+.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  237 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKY  237 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcC
Confidence            223467999999999999999999999999999998 99999888877777766655 3456778899999999999999


Q ss_pred             chhhhcCCCCCCHHHHHh
Q 011698          387 EASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~  404 (479)
                      +|++||     ++.++++
T Consensus       238 ~p~~Rp-----~~~~l~~  250 (257)
T cd05060         238 RPEDRP-----TFSELES  250 (257)
T ss_pred             ChhhCc-----CHHHHHH
Confidence            999999     8888764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.8e-40  Score=327.31  Aligned_cols=250  Identities=20%  Similarity=0.331  Sum_probs=209.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeE----EEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEI----YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      +..++|++++.||+|+||+||+|.+..+++.    +++|.+....  .......+..|+.++++++||||+++++++. .
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~   80 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G   80 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence            4557899999999999999999999877764    6677764321  2233455677888899999999999999875 4


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      ...++++||+.+|+|.+++... +.+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            5678999999999999999764 568999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHH
Q 011698          302 ENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       302 ~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                      ....   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....+.+.+..+ .+..+...+.++
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV  240 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence            3221   233456778999999999889999999999999999998 99999988777666655544 344556678899


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+++..||..||++||     ++.|+++
T Consensus       241 ~~li~~c~~~~p~~Rp-----s~~el~~  263 (279)
T cd05111         241 YMVMVKCWMIDENVRP-----TFKELAN  263 (279)
T ss_pred             HHHHHHHcCCCcccCc-----CHHHHHH
Confidence            9999999999999999     8888865

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.9e-40  Score=331.59  Aligned_cols=251  Identities=20%  Similarity=0.346  Sum_probs=213.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcC-------CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~  218 (479)
                      +..++|.+.+.||+|+||.||+|++..       ....+|+|+++...  .......+..|+.+++++ +||||++++++
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGV   86 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence            345789999999999999999998643       34579999987542  223355678899999999 69999999999


Q ss_pred             EeeCCeEEEEEEeccCCcHHHHHHHc----------------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEE
Q 011698          219 FQTKYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (479)
Q Consensus       219 ~~~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNIL  282 (479)
                      +.....+|+||||+.+|+|..++...                ..++...+..++.||+.||.|||++||+||||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  166 (314)
T cd05099          87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL  166 (314)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence            99999999999999999999998763                24788888999999999999999999999999999999


Q ss_pred             eCCCCcEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHH
Q 011698          283 LDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQ  358 (479)
Q Consensus       283 l~~~g~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~  358 (479)
                      ++.++.+||+|||+++.......   .....++..|||||++.+..++.++|||||||++|||++ |..||.+.+..++.
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999987543221   122234568999999999999999999999999999999 99999988888888


Q ss_pred             HHHHhcc-CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          359 QKIIKDK-IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       359 ~~i~~~~-~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ..+..+. ...+..++.++.++|.+||+.+|++||     ++.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~~ll~  288 (314)
T cd05099         247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRP-----TFKQLVE  288 (314)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc-----CHHHHHH
Confidence            7777653 456777889999999999999999999     8888875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-40  Score=332.27  Aligned_cols=253  Identities=30%  Similarity=0.477  Sum_probs=207.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC------
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------  222 (479)
                      +++|++.+.||+|+||.||+|.++.+++.||+|++........ ......+|+.+++.++||||+++++.+...      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            6899999999999999999999999999999999876432221 223457899999999999999999877443      


Q ss_pred             --CeEEEEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          223 --YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       223 --~~~~lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                        ..+++||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence              357999999976 56665554 45799999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCCC------------cccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Q 011698          300 FDENTR------------SNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI  366 (479)
Q Consensus       300 ~~~~~~------------~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  366 (479)
                      ......            .....|++.|+|||.+.+. .++.++|||||||++|||++|++||.+.+.......+....-
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            532211            1234578899999988764 578999999999999999999999988777665555443100


Q ss_pred             -----------------------CCC-------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          367 -----------------------KLP-------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       367 -----------------------~~p-------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                                             ..+       ..++..+.++|.+||+.||.+||     ++.++++||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~-----t~~ell~~~~f  311 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL-----TASDALEHPYF  311 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCc-----CHHHHhcCCCC
Confidence                                   000       13457889999999999999999     89999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.8e-41  Score=325.73  Aligned_cols=247  Identities=23%  Similarity=0.382  Sum_probs=216.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      ..+|++++.||.|+||.||+|.++. +..+|+|++.....   .....+..|+.+++.++||||+++++++.....+++|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            3579999999999999999999988 88899999876432   2344578899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC-
Q 011698          229 LDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~-  305 (479)
                      |||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            9999999999999753  4589999999999999999999999999999999999999999999999999987643322 


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhh
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~  383 (479)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+..++...+..+ ....+..++..+.++|.+|
T Consensus       161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  240 (261)
T cd05148         161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC  240 (261)
T ss_pred             ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHH
Confidence            223345678999999999899999999999999999998 89999988887777777765 4456678899999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHh
Q 011698          384 LQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~  404 (479)
                      |+.||.+||     ++.++++
T Consensus       241 l~~~p~~Rp-----t~~~l~~  256 (261)
T cd05148         241 WAAEPEDRP-----SFKALRE  256 (261)
T ss_pred             cCCCchhCc-----CHHHHHH
Confidence            999999999     8888764

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.2e-40  Score=331.17  Aligned_cols=255  Identities=28%  Similarity=0.472  Sum_probs=210.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC---
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY---  223 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~---  223 (479)
                      ...++|++.+.||+|+||.||+|.++.+++.||+|+++.... .......+.+|+.++++++||||+++++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            346789999999999999999999999999999999976432 1222345678999999999999999999987655   


Q ss_pred             -------eEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecC
Q 011698          224 -------RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFG  295 (479)
Q Consensus       224 -------~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFG  295 (479)
                             .+|+|+||+++ ++...+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence                   89999999987 565666543 468999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCC--CcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--C----
Q 011698          296 LAKQFDENT--RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--I----  366 (479)
Q Consensus       296 la~~~~~~~--~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~----  366 (479)
                      ++..+....  ......++..|+|||.+.+. .++.++|||||||++|||++|++||...+.......+....  .    
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (302)
T cd07864         162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV  241 (302)
T ss_pred             ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            998764332  12234567889999998754 57899999999999999999999998776655544443310  0    


Q ss_pred             ------------------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          367 ------------------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       367 ------------------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                                              .....++..+.++|..||+.||.+||     ++++++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----~~~~il~~~~~  302 (302)
T cd07864         242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC-----TAEEALNSPWL  302 (302)
T ss_pred             cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCC-----CHHHHhcCCCC
Confidence                                    00124688999999999999999999     89999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-40  Score=337.75  Aligned_cols=253  Identities=26%  Similarity=0.408  Sum_probs=210.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC------
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------  222 (479)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.+... .....+.+.+|+.++++++||||+++++++...      
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            3789999999999999999999999999999999876432 222345577899999999999999999988643      


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      ...|++++++ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            3478888887 6788777654 4689999999999999999999999999999999999999999999999999976533


Q ss_pred             CCCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------------
Q 011698          303 NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---------------  366 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------------  366 (479)
                        ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+.....               
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (345)
T cd07877         173 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  250 (345)
T ss_pred             --cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence              2344578999999999877 5678999999999999999999999987665544443322110               


Q ss_pred             --------CCC--------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          367 --------KLP--------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       367 --------~~p--------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                              ..|        ...++++.+||.+||+.||.+|+     ++.++++||||...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~f~~~  306 (345)
T cd07877         251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-----TAAQALAHAYFAQY  306 (345)
T ss_pred             HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC-----CHHHHhcChhhhhc
Confidence                    111        13578899999999999999999     89999999999863

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-40  Score=339.02  Aligned_cols=253  Identities=27%  Similarity=0.417  Sum_probs=214.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe----
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR----  224 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~----  224 (479)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.... ........+.+|+.++++++||||+++++++.....    
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            468999999999999999999999999999999987542 222334556789999999999999999988876554    


Q ss_pred             --EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          225 --LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       225 --~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                        +|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence              89999999 5689887765 5689999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--------------
Q 011698          303 NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--------------  367 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--------------  367 (479)
                      .  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.......+......              
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07851         171 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA  248 (343)
T ss_pred             c--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence            3  344578899999999876 36789999999999999999999999887766655554432110              


Q ss_pred             -----------------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          368 -----------------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       368 -----------------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                       ....++.++.+||.+||+.||++||     |+.+|++||||...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rp-----t~~ell~h~~~~~~  304 (343)
T cd07851         249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI-----TAAEALAHPYLAEY  304 (343)
T ss_pred             HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCC-----CHHHHhcCCCcccc
Confidence                             0123688999999999999999999     89999999999864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=326.16  Aligned_cols=250  Identities=30%  Similarity=0.532  Sum_probs=211.9

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC--CeEEEEE
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--YRLYLVL  229 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~~~~lV~  229 (479)
                      |++++.||.|+||.||+|.+..+++.+|+|++.... ........+.+|+.++++++|||++++++++...  ..+++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            688999999999999999999999999999998754 2233345577899999999999999999999888  8999999


Q ss_pred             EeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC--Cc
Q 011698          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RS  306 (479)
Q Consensus       230 E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~--~~  306 (479)
                      ||+++ +|..++.+. ..+++..++.++.||+.||+|||+.|++|+||||+||++++++.+||+|||++.......  ..
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            99985 888877665 578999999999999999999999999999999999999999999999999998764433  23


Q ss_pred             ccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-------------------
Q 011698          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-------------------  366 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-------------------  366 (479)
                      ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+.....                   
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            34567889999998775 4578999999999999999999999988776655554443100                   


Q ss_pred             ------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          367 ------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       367 ------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                                  .+...++.++.++|++||+.+|.+||     ++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----~~~~~l~~~~~  287 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI-----SADQALQHEYF  287 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc-----CHHHHhhCcCC
Confidence                        00111388999999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.2e-40  Score=329.40  Aligned_cols=258  Identities=31%  Similarity=0.488  Sum_probs=212.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~  224 (479)
                      .+..++|++.+.||+|+||+||+|.+..+++.||+|.+++....  .....+..|+.++.+. .||||+++++++.+...
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            45678999999999999999999999999999999999764321  2233445566666665 59999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          225 LYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      +|+||||+.+ +|...+.. .+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++..+..
T Consensus        89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9999999865 66666554 4578999999999999999999997 5999999999999999999999999999987654


Q ss_pred             CCCcccccCCCCCcchhHhcCCC----CCccccchhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcc-CCCC--ccCCH
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKG----HDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIKDK-IKLP--AFLSS  374 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~----~~~~~DiwSLGvilyelltG~~Pf~~~~~-~~~~~~i~~~~-~~~p--~~~s~  374 (479)
                      ........++..|+|||.+.+..    ++.++|+||||+++|+|++|+.||..... .+....+.... ..++  ..++.
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP  247 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCH
Confidence            44444556888999999997654    78899999999999999999999976332 33444444432 2233  24789


Q ss_pred             HHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          375 EAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       375 ~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ++.+||.+||+.||.+||     +++++++|+||...
T Consensus       248 ~l~~li~~~l~~~p~~Rp-----~~~~il~~~~~~~~  279 (296)
T cd06618         248 DFCSFVDLCLTKDHRKRP-----KYRELLQHPFIRRY  279 (296)
T ss_pred             HHHHHHHHHccCChhhCC-----CHHHHhcChhhhcc
Confidence            999999999999999999     89999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-40  Score=337.47  Aligned_cols=255  Identities=29%  Similarity=0.442  Sum_probs=211.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC------C
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------Y  223 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------~  223 (479)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++...      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            589999999999999999999999999999999876432 222334567899999999999999999998754      3


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      .+|+|+||+.+ +|...+  ...+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus        94 ~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-  169 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-  169 (342)
T ss_pred             eEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence            56999999975 665544  34689999999999999999999999999999999999999999999999999976533 


Q ss_pred             CCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------------
Q 011698          304 TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-----------------  365 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-----------------  365 (479)
                       ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.......+....                 
T Consensus       170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (342)
T cd07879         170 -EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK  248 (342)
T ss_pred             -CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence             2334578899999999876 468899999999999999999999999877655544443310                 


Q ss_pred             ------CCCC--------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhh
Q 011698          366 ------IKLP--------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK  415 (479)
Q Consensus       366 ------~~~p--------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~  415 (479)
                            ...+        +..+.++.+||.+||+.||.+||     ++++++.||||+.+.+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~-----~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL-----TATEALEHPYFDSFRDAD  307 (342)
T ss_pred             HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc-----CHHHHhcCcchhhccccc
Confidence                  0011        24678899999999999999999     899999999999986533

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-42  Score=353.72  Aligned_cols=244  Identities=36%  Similarity=0.597  Sum_probs=215.0

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHh-CCCCCeeeEeEEEeeCCeEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ..++|++...+|.|+|+.|-.+.+..+++.+++|++.+...       ...+|+.++.. -+||||+++++.+.+..+.|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence            46789999999999999999999999999999999987521       12445644444 48999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe-CCCCcEEEeecCCccccCCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL-DADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl-~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      +|||.+.|+.+.+.+.....+. ..+..|+++|+.|+.|||++|||||||||+|||+ +..|+++|+|||.++.....  
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999999999998888877666 7788899999999999999999999999999999 69999999999999887554  


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCCccCCHHHHHHHHhhh
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKIKLPAFLSSEAHSLLKGLL  384 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~lI~~~L  384 (479)
                      ..+.|-|..|.|||++...+|+.++||||||++||+||+|+.||...... ++..+|..+.+.  ..+|.++++||++||
T Consensus       470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~LL  547 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQLL  547 (612)
T ss_pred             hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHHHhc
Confidence            44567788999999999999999999999999999999999999875555 666666655444  889999999999999


Q ss_pred             hhchhhhcCCCCCCHHHHHhCccc
Q 011698          385 QKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       385 ~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      +.||.+||     ++.+++.||||
T Consensus       548 ~~dP~~Rl-----~~~~i~~h~w~  566 (612)
T KOG0603|consen  548 QVDPALRL-----GADEIGAHPWF  566 (612)
T ss_pred             cCChhhCc-----ChhhhccCcch
Confidence            99999999     89999999999

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.7e-40  Score=327.53  Aligned_cols=247  Identities=22%  Similarity=0.369  Sum_probs=210.8

Q ss_pred             CeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+....  .....+.+.+|+.+++.++||||+++++.+......
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            57889999999999999998753     23579999887543  223346688899999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHc------------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccE
Q 011698          226 YLVLDFVNGGHLFFQLYRQ------------------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~------------------------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNI  281 (479)
                      +++|||+.+|+|.+++...                        ..+++..++.++.|++.||.|||+++|+||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999888642                        2467888899999999999999999999999999999


Q ss_pred             EeCCCCcEEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHH
Q 011698          282 LLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI  357 (479)
Q Consensus       282 Ll~~~g~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~  357 (479)
                      |+++++.+||+|||+++......   ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+.....+
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999998653222   1233456778999999999999999999999999999999 9999998887777


Q ss_pred             HHHHHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          358 QQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       358 ~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+.+... ....|..++.++.++|..||+.+|++||     +++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp-----~~~~i~~  281 (290)
T cd05045         239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP-----TFADISK  281 (290)
T ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCC-----CHHHHHH
Confidence            7766554 4455777899999999999999999999     8888864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.5e-40  Score=321.50  Aligned_cols=240  Identities=23%  Similarity=0.341  Sum_probs=203.9

Q ss_pred             EeccCCceEEEEEEEc--CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          157 VVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       157 ~LG~G~fG~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.++++++||||++++++++. ...++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            4899999999999775  456679999987542  23445668899999999999999999998864 578999999999


Q ss_pred             CcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC----cccc
Q 011698          235 GHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR----SNSM  309 (479)
Q Consensus       235 gsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~----~~~~  309 (479)
                      ++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++........    ....
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999998875 45789999999999999999999999999999999999999999999999999986543322    1112


Q ss_pred             cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhhhhhc
Q 011698          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      .++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+.......+..+ ....|...+.++.++|.+||..+
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~  238 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYK  238 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence            23578999999998889999999999999999996 99999988877777766654 45667788999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHh
Q 011698          388 ASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~  404 (479)
                      |++||     ++.+|.+
T Consensus       239 ~~~Rp-----~~~~i~~  250 (257)
T cd05115         239 WEDRP-----NFAKVEE  250 (257)
T ss_pred             hhhCc-----CHHHHHH
Confidence            99999     7777653

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.8e-40  Score=321.81  Aligned_cols=247  Identities=23%  Similarity=0.381  Sum_probs=210.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++++.||+|+||.||+|.+. .+..+|+|.+......    .+.+.+|+.++++++|+||+++++++. ....|
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence            44578999999999999999999876 4556999998764432    235788999999999999999998875 45689


Q ss_pred             EEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      ++|||+.+++|.+++...  ..+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||++..+....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999998764  358999999999999999999999999999999999999999999999999998754332


Q ss_pred             C--cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHH
Q 011698          305 R--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (479)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI  380 (479)
                      .  .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+... ....+...+..+.+||
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM  236 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence            1  122335568999999998889999999999999999999 99999988877777777654 4556777899999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHh
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+||+++|++||     |++++.+
T Consensus       237 ~~~l~~~p~~Rp-----t~~~l~~  255 (260)
T cd05070         237 LQCWKKDPEERP-----TFEYLQS  255 (260)
T ss_pred             HHHcccCcccCc-----CHHHHHH
Confidence            999999999999     7887753

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.4e-40  Score=336.68  Aligned_cols=256  Identities=28%  Similarity=0.386  Sum_probs=213.7

Q ss_pred             CCeEE-EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHH-----------HHHHHHHHHHHHHhCCCCCeeeEeE
Q 011698          150 EDFEV-LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-----------HAEYMKSERNILTKVDHPFIVQLRY  217 (479)
Q Consensus       150 ~~y~~-~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~~~E~~iL~~l~hp~Iv~l~~  217 (479)
                      ++|.. .+.||.|+||+||+|.++.+++.||+|+++........           ....+.+|+.+++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            46654 47799999999999999999999999999764322210           0123678999999999999999999


Q ss_pred             EEeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       218 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                      ++......|+||||+. |+|..++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence            9999999999999997 589999988888999999999999999999999999999999999999999999999999999


Q ss_pred             cccCC---------------CCCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 011698          298 KQFDE---------------NTRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKI  361 (479)
Q Consensus       298 ~~~~~---------------~~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i  361 (479)
                      .....               ........+++.|+|||.+.+. .++.++|+|||||++|||++|..||.+.+..+....+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            76541               1112234578899999999764 4689999999999999999999999988776665555


Q ss_pred             Hhcc--C--------------------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          362 IKDK--I--------------------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       362 ~~~~--~--------------------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ....  .                          ......+.++.++|.+||+.+|++|+     +++|++.|+||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----s~~~~l~~~~~~~~  319 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI-----SAKEALKHEYFKSD  319 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhcc-----CHHHHhcCcccCCC
Confidence            4310  0                          00123578899999999999999999     89999999999864

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.1e-40  Score=329.55  Aligned_cols=252  Identities=20%  Similarity=0.366  Sum_probs=215.5

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcC-------CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~  217 (479)
                      .+..++|++.+.||+|+||.||+|++..       .+..||+|.+....  .......+.+|+.+++.+ +||||+++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            3556789999999999999999998532       34579999987542  223456688899999999 8999999999


Q ss_pred             EEeeCCeEEEEEEeccCCcHHHHHHHcC----------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccE
Q 011698          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (479)
Q Consensus       218 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNI  281 (479)
                      ++......|+||||+.+|+|..++.+..                .++...+..++.||+.||.|||++||+||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            9999999999999999999999987642                366778888999999999999999999999999999


Q ss_pred             EeCCCCcEEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHH
Q 011698          282 LLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI  357 (479)
Q Consensus       282 Ll~~~g~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~  357 (479)
                      |++.++.+||+|||+++.+....   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..++
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            99999999999999998764322   1223445678999999999899999999999999999998 8999998888888


Q ss_pred             HHHHHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          358 QQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       358 ~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ...+..+ ....+..++.++.+||.+||+.+|.+||     ++.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~e~l~  291 (304)
T cd05101         249 FKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRP-----TFKQLVE  291 (304)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCC-----CHHHHHH
Confidence            8877665 3345677899999999999999999999     8888876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.4e-40  Score=321.57  Aligned_cols=250  Identities=20%  Similarity=0.327  Sum_probs=213.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCe---EEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      ..++|+..+.||+|+||.||+|..+.++.   .+|+|.+....  .....+.+..|+.++++++||||+++++++.....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            45689999999999999999999876554   79999986542  22334567889999999999999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      .|+||||+++++|..++... +.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999998764 57899999999999999999999999999999999999999999999999999865432


Q ss_pred             CCc----ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHH
Q 011698          304 TRS----NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (479)
Q Consensus       304 ~~~----~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (479)
                      ...    .....+..|+|||.+.+..++.++|||||||++|||++ |..||...+..++...+... ....+..++.++.
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  240 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY  240 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            211    11223457999999998889999999999999999998 99999888877777777654 3344456789999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +++.+||+.+|++||     ++.+|++
T Consensus       241 ~li~~c~~~~p~~Rp-----~~~~i~~  262 (268)
T cd05063         241 QLMLQCWQQDRARRP-----RFVDIVN  262 (268)
T ss_pred             HHHHHHcCCCcccCc-----CHHHHHH
Confidence            999999999999999     7888864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=323.80  Aligned_cols=241  Identities=22%  Similarity=0.368  Sum_probs=204.9

Q ss_pred             EeccCCceEEEEEEEcCCCe--EEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEEEEEEecc
Q 011698          157 VVGQGAFAKVYQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVN  233 (479)
Q Consensus       157 ~LG~G~fG~V~~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~  233 (479)
                      .||+|+||.||+|+++.++.  .+|+|.++...  .....+.+.+|+.+++++ +||||+++++++.....+|+||||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            58999999999999988775  46888876422  233445678899999999 89999999999999999999999999


Q ss_pred             CCcHHHHHHHcC----------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          234 GGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       234 ggsL~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                      +|+|.+++....                .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence            999999987643                3788899999999999999999999999999999999999999999999998


Q ss_pred             cccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHH
Q 011698          298 KQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (479)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  375 (479)
                      ..............+..|+|||++.+..++.++|+|||||++|||++ |..||.+.+..+..+.+... ....+..++.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (270)
T cd05047         160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDE  239 (270)
T ss_pred             cccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHH
Confidence            64332222222334567999999999899999999999999999997 99999888877777777654 44566678899


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +.+++.+||+.||.+||     ++++++.
T Consensus       240 ~~~li~~~l~~~p~~Rp-----s~~~il~  263 (270)
T cd05047         240 VYDLMRQCWREKPYERP-----SFAQILV  263 (270)
T ss_pred             HHHHHHHHcccChhhCC-----CHHHHHH
Confidence            99999999999999999     8888865

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.6e-41  Score=321.70  Aligned_cols=234  Identities=33%  Similarity=0.538  Sum_probs=201.0

Q ss_pred             CCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCCcHHHH
Q 011698          161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ  240 (479)
Q Consensus       161 G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~  240 (479)
                      |.||+||+|+++.+++.||+|.+++...        ..+|...+....||||+++++++.+....|+||||++||+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            8999999999999999999999976431        22344555566799999999999999999999999999999999


Q ss_pred             HHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccccCCCCCcchhH
Q 011698          241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI  320 (479)
Q Consensus       241 l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~  320 (479)
                      +.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+..+...  .....++..|+|||.
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~  153 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV  153 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence            988888999999999999999999999999999999999999999999999999988765432  234456788999999


Q ss_pred             hcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHH
Q 011698          321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQ  400 (479)
Q Consensus       321 l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~  400 (479)
                      +.+..++.++|+||+||++|||++|..||...... ..   ....+.+|..++..++++|.+||++||++|++....+.+
T Consensus       154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~  229 (237)
T cd05576         154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSG-IN---THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVE  229 (237)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-cc---cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchH
Confidence            98888999999999999999999999988643211 10   112345778899999999999999999999976666789


Q ss_pred             HHHhCccc
Q 011698          401 EIKSHKWF  408 (479)
Q Consensus       401 eil~hp~f  408 (479)
                      ++++||||
T Consensus       230 ~~~~h~~~  237 (237)
T cd05576         230 DIKSHPFF  237 (237)
T ss_pred             HHHcCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.2e-40  Score=326.47  Aligned_cols=250  Identities=22%  Similarity=0.369  Sum_probs=213.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      ..++|++++.||+|+||.||+|.+..     ++..||+|++....  .......+.+|+.++++++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            34789999999999999999999753     67889999987543  223345678899999999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcC----------------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCcc
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQG----------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~----------------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeN  280 (479)
                      ..+++||||+++|+|..++....                      .+++..+..++.||+.||.|||+++++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999987532                      36778889999999999999999999999999999


Q ss_pred             EEeCCCCcEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHH
Q 011698          281 ILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK  356 (479)
Q Consensus       281 ILl~~~g~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~  356 (479)
                      |+++.++.++|+|||++........   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876532211   222334677999999999999999999999999999998 889998888888


Q ss_pred             HHHHHHhccC-CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          357 IQQKIIKDKI-KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       357 ~~~~i~~~~~-~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +...+..+.. ..|..++.++.+||.+||+.||.+||     +++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~el~~  284 (288)
T cd05050         241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRP-----SFASINR  284 (288)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCC-----CHHHHHH
Confidence            8777776643 45677899999999999999999999     8888764

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.9e-40  Score=322.74  Aligned_cols=252  Identities=27%  Similarity=0.464  Sum_probs=216.2

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc--hHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +|.+.+.||+|+||.||++++..++..+++|+++.....  .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            588999999999999999999888777888877653221  122334466789999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-
Q 011698          229 LDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-  303 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-  303 (479)
                      |||+++++|...+..    ...+++..++.++.|++.||.|||++|++|+||||+||+++ ++.+||+|||+++..... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~-~~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee-cCCEeecccCceeecCCCc
Confidence            999999999888754    35689999999999999999999999999999999999996 467999999999875433 


Q ss_pred             CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHh
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKG  382 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~  382 (479)
                      .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..+ ....+..++.++.++|.+
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQS  239 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHH
Confidence            2334567889999999998888999999999999999999999999887777666666655 344567789999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      ||+.+|++||     +++++++||||
T Consensus       240 ~l~~~p~~Rp-----~~~~il~~~~~  260 (260)
T cd08222         240 MLNKDPSLRP-----SAAEILRNPFI  260 (260)
T ss_pred             HhcCChhhCc-----CHHHHhhCCCC
Confidence            9999999999     89999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.6e-40  Score=331.17  Aligned_cols=253  Identities=27%  Similarity=0.388  Sum_probs=216.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +.|+..+.||+|+||.||+|+++.+++.+|+|.+.............+.+|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            35888899999999999999999999999999987643333344556778999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHH-HcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccc
Q 011698          230 DFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~  308 (479)
                      ||+.| ++...+. ....+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||++......   ..
T Consensus        95 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~  170 (308)
T cd06634          95 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NX  170 (308)
T ss_pred             EccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---cc
Confidence            99975 6766664 3456899999999999999999999999999999999999999999999999999765432   34


Q ss_pred             ccCCCCCcchhHhc---CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-C-CCccCCHHHHHHHHhh
Q 011698          309 MCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-K-LPAFLSSEAHSLLKGL  383 (479)
Q Consensus       309 ~~gt~~y~APE~l~---~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s~~~~~lI~~~  383 (479)
                      ..|++.|+|||.+.   ...++.++|||||||++|+|++|..||...+.......+..... . .+..++..+.+||++|
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  250 (308)
T cd06634         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  250 (308)
T ss_pred             ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHH
Confidence            56889999999985   34578899999999999999999999987766655555555433 2 2346889999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          384 LQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      |+++|.+||     +++++++|+|+...
T Consensus       251 l~~~P~~Rp-----~~~~ll~~~~~~~~  273 (308)
T cd06634         251 LQKIPQDRP-----TSEVLLKHRFVLRE  273 (308)
T ss_pred             hhCCcccCC-----CHHHHhhCcccccc
Confidence            999999999     89999999999884

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=302.43  Aligned_cols=255  Identities=27%  Similarity=0.505  Sum_probs=220.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ..|..+++||+|.||+||+|+.+.++++||+|.++.+... +..-....+|+-+|+.++|.|||++++...++..+.+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            3577788999999999999999999999999999876532 223345678999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc-c
Q 011698          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-N  307 (479)
Q Consensus       230 E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~-~  307 (479)
                      |||.. +|..+... ++.++.+.++.++.|+++||.|+|+.++.||||||.|+||+.+|.+||+|||+++.+.-..+. .
T Consensus        81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys  159 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS  159 (292)
T ss_pred             HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence            99976 67666643 577999999999999999999999999999999999999999999999999999988765533 3


Q ss_pred             cccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc--cC---------C------C
Q 011698          308 SMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--KI---------K------L  368 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~--~~---------~------~  368 (479)
                      ..+-|.+|.+|.++.|. -|+.+.|+||-|||+.|+.. |++.|.+.+..+..++|..-  .+         .      +
T Consensus       160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence            45679999999999885 58999999999999999998 89999999998888888751  10         1      1


Q ss_pred             C------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          369 P------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       369 p------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      |            +.++...++|++++|.-+|.+|+     +++++++||||...
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qri-----saeaalqhpyf~d~  289 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRI-----SAEAALQHPYFSDF  289 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCccccc-----CHHHHhcCcccccc
Confidence            1            23567789999999999999999     89999999999864

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-40  Score=318.58  Aligned_cols=248  Identities=23%  Similarity=0.373  Sum_probs=214.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++.+.||+|+||.||+|.+++ +..||+|.+.....    ..+.+.+|+.++++++|+||+++++++......+
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            456899999999999999999999864 46799999876432    2345788999999999999999999999989999


Q ss_pred             EEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      +||||+++++|..++....  .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+....
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999999987653  68999999999999999999999999999999999999999999999999998764321


Q ss_pred             C--cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHH
Q 011698          305 R--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (479)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI  380 (479)
                      .  .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+.....+.+..+ ....|...+.++.+++
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLM  237 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            1  112234568999999999889999999999999999999 99999988887777777765 4455677899999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHh
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+||+.+|.+||     +++++++
T Consensus       238 ~~~l~~~p~~Rp-----~~~~l~~  256 (261)
T cd05034         238 LQCWDKDPEERP-----TFEYLQS  256 (261)
T ss_pred             HHHcccCcccCC-----CHHHHHH
Confidence            999999999999     8888764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.3e-40  Score=317.59  Aligned_cols=247  Identities=21%  Similarity=0.377  Sum_probs=213.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      ..+|++.+.||+|+||.||+|.+.. +..+|+|++......    ...+.+|++++++++||||+++++++......++|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            4689999999999999999998864 667999998754332    23467899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC--
Q 011698          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~--  305 (479)
                      |||+.+++|.+++... +.++++.++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||++........  
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999999988764 5689999999999999999999999999999999999999999999999999976543221  


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhh
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~  383 (479)
                      .....++..|+|||.+.+..++.++|+||||+++|||++ |..||...+...+.+.+..+ ....|...+..+.+|+.+|
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  237 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC  237 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence            122335678999999998889999999999999999998 99999988878777777665 3445667899999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhC
Q 011698          384 LQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      |+.+|++||     ++++++++
T Consensus       238 l~~~p~~Rp-----~~~~~l~~  254 (256)
T cd05112         238 WKERPEDRP-----SFSLLLHQ  254 (256)
T ss_pred             cccChhhCC-----CHHHHHHh
Confidence            999999999     89998763

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.5e-40  Score=333.19  Aligned_cols=252  Identities=21%  Similarity=0.360  Sum_probs=214.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCC-------CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT-------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~  218 (479)
                      +...+|++.+.||+|+||.||+|++...       +..||+|+++...  .....+.+.+|+.+++++ +||||++++++
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            4456899999999999999999987432       2368999887532  233456688899999999 79999999999


Q ss_pred             EeeCCeEEEEEEeccCCcHHHHHHHcC----------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEE
Q 011698          219 FQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (479)
Q Consensus       219 ~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNIL  282 (479)
                      +.....++++|||+.+|+|.+++.+..                .++...+..++.||+.||.|||++||+||||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  166 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL  166 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence            999999999999999999999987642                3667788889999999999999999999999999999


Q ss_pred             eCCCCcEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHH
Q 011698          283 LDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQ  358 (479)
Q Consensus       283 l~~~g~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~  358 (479)
                      ++.++.+||+|||+++.......   .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+..
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  246 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  246 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999999987543321   122334567999999999999999999999999999999 89999988888888


Q ss_pred             HHHHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          359 QKIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       359 ~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ..+... ....+..++.++.+||.+||+.+|.+||     ++.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----s~~ell~~  289 (334)
T cd05100         247 KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRP-----TFKQLVED  289 (334)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCc-----CHHHHHHH
Confidence            777665 3456677899999999999999999999     89999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.1e-40  Score=328.49  Aligned_cols=251  Identities=27%  Similarity=0.463  Sum_probs=215.7

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEe
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~  231 (479)
                      |+...+||+|+||.||++..+.+++.||+|++....   ......+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            333467999999999999999999999999985432   23455688899999999999999999999999999999999


Q ss_pred             ccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Cccccc
Q 011698          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMC  310 (479)
Q Consensus       232 ~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~~~~  310 (479)
                      +++++|.+++. .+.+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ......
T Consensus        99 ~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657          99 LEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence            99999988764 4568999999999999999999999999999999999999999999999999987654322 234467


Q ss_pred             CCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---CCCCccCCHHHHHHHHhhhhhc
Q 011698          311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       311 gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      |++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......+....   ......++..+.++|.+||+.|
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  257 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD  257 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence            8999999999988888999999999999999999999998877666555554332   2233457899999999999999


Q ss_pred             hhhhcCCCCCCHHHHHhCccccCC
Q 011698          388 ASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      |.+|+     ++.++++||||...
T Consensus       258 P~~R~-----~~~~ll~~~~~~~~  276 (292)
T cd06657         258 PAQRA-----TAAELLKHPFLAKA  276 (292)
T ss_pred             cccCc-----CHHHHhcChHHhcc
Confidence            99999     89999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.1e-40  Score=318.52  Aligned_cols=247  Identities=22%  Similarity=0.376  Sum_probs=211.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|+++++||+|+||.||+|..+ +++.||+|.+.....    ..+.+.+|+.++++++|+||+++++++. ...++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            44578999999999999999999875 467799999876442    2345778999999999999999998874 56789


Q ss_pred             EEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      ++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999999999988654  358889999999999999999999999999999999999999999999999998754222


Q ss_pred             C--cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHH
Q 011698          305 R--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (479)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI  380 (479)
                      .  .....++..|+|||++.+..++.++|+||||+++|||++ |+.||.+.+..+....+... ....+..++.++.++|
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELM  236 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            1  223345678999999999889999999999999999999 99999988877777766554 3455677889999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHh
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+||+.+|++||     +++++++
T Consensus       237 ~~~l~~~p~~Rp-----~~~~l~~  255 (260)
T cd05067         237 RLCWKEKPEERP-----TFEYLRS  255 (260)
T ss_pred             HHHccCChhhCC-----CHHHHHH
Confidence            999999999999     8888865

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-40  Score=322.09  Aligned_cols=250  Identities=25%  Similarity=0.396  Sum_probs=215.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCe----EEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      +...+|++++.||+|+||+||+|.++.+|+    .+|+|.+.....  ......+.+|+.++++++||||+++++++.+ 
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            345789999999999999999999877665    589998876532  3345667889999999999999999999887 


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      ...++||||+.+|+|.+++.+. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            7899999999999999998774 468999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCCcc---cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHH
Q 011698          302 ENTRSN---SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       302 ~~~~~~---~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                      ......   ...++..|+|||.+....++.++|+|||||++|||++ |..||.+.+..++.+.+..+ ....|...+..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence            332221   1223568999999988889999999999999999999 99999998888887777765 455677788999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+++.+||..||++||     ++.++++
T Consensus       241 ~~~~~~~l~~~p~~Rp-----~~~~l~~  263 (279)
T cd05057         241 YMVLVKCWMIDAESRP-----TFKELIN  263 (279)
T ss_pred             HHHHHHHcCCChhhCC-----CHHHHHH
Confidence            9999999999999999     7777754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.2e-40  Score=316.73  Aligned_cols=246  Identities=25%  Similarity=0.414  Sum_probs=215.2

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCC----eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTS----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      +++.+.||.|+||.||++++..++    ..||+|++.....  ......+..|+.+++.++|+||+++++.+.+....++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            356789999999999999998766    8999999976432  2245678899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCC--CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          228 VLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      +|||+++++|.+++.....  +++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++........
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999999976554  89999999999999999999999999999999999999999999999999987654322


Q ss_pred             cc--cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHH
Q 011698          306 SN--SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK  381 (479)
Q Consensus       306 ~~--~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~  381 (479)
                      ..  ...+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+...+.+.+... ....+..++.++.+++.
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  238 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLML  238 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence            11  1236789999999988889999999999999999999 89999988888888777765 34456678999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHh
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +||+.||++||     ++.++++
T Consensus       239 ~~l~~~p~~Rp-----t~~~ll~  256 (258)
T smart00219      239 QCWAEDPEDRP-----TFSELVE  256 (258)
T ss_pred             HHCcCChhhCc-----CHHHHHh
Confidence            99999999999     8999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=8.8e-41  Score=355.57  Aligned_cols=253  Identities=23%  Similarity=0.394  Sum_probs=221.6

Q ss_pred             CcccCCCCeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEE
Q 011698          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYS  218 (479)
Q Consensus       144 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~  218 (479)
                      ...+...+.+..+.||+|.||+||+|+..+     ....||||.++...  +......|++|+.+|..++|||||+|++.
T Consensus       480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGV  557 (774)
T KOG1026|consen  480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGV  557 (774)
T ss_pred             eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            344667788899999999999999998753     34689999998754  34456779999999999999999999999


Q ss_pred             EeeCCeEEEEEEeccCCcHHHHHHHcC--------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeC
Q 011698          219 FQTKYRLYLVLDFVNGGHLFFQLYRQG--------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD  284 (479)
Q Consensus       219 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~  284 (479)
                      +..++.+|+|+|||..|+|..+|...+              .++..+...++.||+.||+||-++.+|||||-.+|+||.
T Consensus       558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG  637 (774)
T ss_pred             EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence            999999999999999999999997542              277888899999999999999999999999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCCcc---cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 011698          285 ADGHVMLTDFGLAKQFDENTRSN---SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQK  360 (479)
Q Consensus       285 ~~g~vkL~DFGla~~~~~~~~~~---~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~  360 (479)
                      ++-.|||+|||+++.+-..+...   ...-...||+||.+....|+.++||||+||+|||+++ |+.||.+.+.++..+.
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~  717 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC  717 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence            99999999999999753322111   1122468999999999999999999999999999999 9999999999999999


Q ss_pred             HHhccC-CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHH
Q 011698          361 IIKDKI-KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIK  403 (479)
Q Consensus       361 i~~~~~-~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil  403 (479)
                      |..+++ .-|...+.++.+|+..||+.+|++||     ++.||-
T Consensus       718 i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RP-----sF~eI~  756 (774)
T KOG1026|consen  718 IRAGQLLSCPENCPTEVYSLMLECWNENPKRRP-----SFKEIH  756 (774)
T ss_pred             HHcCCcccCCCCCCHHHHHHHHHHhhcCcccCC-----CHHHHH
Confidence            999854 56889999999999999999999999     788874

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.3e-40  Score=322.18  Aligned_cols=250  Identities=21%  Similarity=0.371  Sum_probs=215.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      .++|++++.||+|+||+||+|+.+.     +.+.||+|.+....  .....+.+.+|++++++++||||+++++++....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            4689999999999999999999764     34679999886532  2234566889999999999999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHcC---------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeec
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQG---------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDF  294 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~---------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DF  294 (479)
                      ..|+||||+++|+|.+++....         .+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999998766         6899999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCC--CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCC--CC
Q 011698          295 GLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIK--LP  369 (479)
Q Consensus       295 Gla~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~--~p  369 (479)
                      |+++.....  .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+......  .+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP  241 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence            998754221  12234456778999999998888999999999999999999 89999887777777777655443  45


Q ss_pred             ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          370 AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       370 ~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ..++..+.++|.+||+.+|.+||     ++.+++++
T Consensus       242 ~~~~~~l~~~i~~~l~~~p~~Rp-----~~~~~l~~  272 (275)
T cd05046         242 EGCPSRLYKLMTRCWAVNPKDRP-----SFSELVSA  272 (275)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCC-----CHHHHHHH
Confidence            67889999999999999999999     89998763

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.4e-40  Score=318.67  Aligned_cols=246  Identities=25%  Similarity=0.386  Sum_probs=209.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|++.+.||+|+||.||+|.+..++ .+|+|.+.....    ..+.+.+|+.++++++||||+++++++. ....++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI   77 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence            3467999999999999999999987665 589998875432    2345778999999999999999998875 456899


Q ss_pred             EEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          228 VLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      ||||+.+++|.+++....  .+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||+++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            999999999999997643  478889999999999999999999999999999999999999999999999987543321


Q ss_pred             --cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHH
Q 011698          306 --SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK  381 (479)
Q Consensus       306 --~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~  381 (479)
                        .....++..|+|||.+.+..++.++|+||||+++|||++ |..||.+....+....+..+ ....+..++..+.++|+
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  237 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMK  237 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHH
Confidence              122345678999999998889999999999999999999 99999988877777776654 34456778999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHh
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +||++||.+||     +++++++
T Consensus       238 ~~l~~~p~~Rp-----~~~~i~~  255 (260)
T cd05069         238 LCWKKDPDERP-----TFEYIQS  255 (260)
T ss_pred             HHccCCcccCc-----CHHHHHH
Confidence            99999999999     7888764

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5e-40  Score=341.41  Aligned_cols=253  Identities=22%  Similarity=0.346  Sum_probs=211.6

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEE
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYS  218 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~  218 (479)
                      ..+..++|.+.+.||+|+||.||+|++.+     +++.||+|+++...  .....+.+.+|+.+|.++. ||||++++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            34556789999999999999999999643     45689999997643  2223446788999999997 9999999999


Q ss_pred             EeeCCeEEEEEEeccCCcHHHHHHHcC-----------------------------------------------------
Q 011698          219 FQTKYRLYLVLDFVNGGHLFFQLYRQG-----------------------------------------------------  245 (479)
Q Consensus       219 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------------------------------------  245 (479)
                      +.....+++||||+.+|+|.+++++.+                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999999999999999999999987542                                                     


Q ss_pred             ---------------------------------------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCcc
Q 011698          246 ---------------------------------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (479)
Q Consensus       246 ---------------------------------------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeN  280 (479)
                                                                   .++...++.++.||+.||.|||+++|+||||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                         25566778899999999999999999999999999


Q ss_pred             EEeCCCCcEEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHH
Q 011698          281 ILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK  356 (479)
Q Consensus       281 ILl~~~g~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~  356 (479)
                      ||++.++.+||+|||+++......   ......+++.|||||.+.+..++.++|||||||++|||++ |..||......+
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            999999999999999998653221   1233467889999999999889999999999999999998 899998765544


Q ss_pred             HHHH-HHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          357 IQQK-IIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       357 ~~~~-i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .... +..+ .+..|..++.++.+||.+||+.+|.+||     ++++|++
T Consensus       350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RP-----s~~ell~  394 (401)
T cd05107         350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRP-----DFSQLVH  394 (401)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            4433 3333 3456778899999999999999999999     8899876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-39  Score=322.09  Aligned_cols=247  Identities=25%  Similarity=0.364  Sum_probs=201.1

Q ss_pred             CCe-EEEEEeccCCceEEEEEEE----cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC--
Q 011698          150 EDF-EVLKVVGQGAFAKVYQVRR----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--  222 (479)
Q Consensus       150 ~~y-~~~~~LG~G~fG~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--  222 (479)
                      ++| ++++.||+|+||+||++..    ..++..||+|+++...  .......+.+|+.+|++++||||+++++++...  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            345 8999999999999988753    3567899999987542  223345677899999999999999999987653  


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      ..+++||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            4689999999999999988764 589999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC----cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHH---------------HHHHHHHh
Q 011698          303 NTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ---------------KIQQKIIK  363 (479)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~---------------~~~~~i~~  363 (479)
                      ...    .....++..|+|||.+.+..++.++||||||+++|||+||..||......               ...+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence            322    12234567799999999888999999999999999999999998643211               11111111


Q ss_pred             -ccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          364 -DKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       364 -~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                       .....|..++.++.+++..||+.+|++||     +++++++
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~~i~~  276 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRP-----TFRSLIP  276 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCC-----CHHHHHH
Confidence             12334667889999999999999999999     8888875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7e-40  Score=317.89  Aligned_cols=241  Identities=24%  Similarity=0.394  Sum_probs=208.7

Q ss_pred             EEeccCCceEEEEEEEcC-CC--eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEec
Q 011698          156 KVVGQGAFAKVYQVRRIG-TS--EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFV  232 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~-~~--~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~  232 (479)
                      +.||+|++|.||+|.+.. ++  ..||+|.+......  ...+.+.+|+.++++++||||+++++.+.. ..+++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            368999999999999865 33  36999999876543  456678899999999999999999999988 8999999999


Q ss_pred             cCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC----c
Q 011698          233 NGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR----S  306 (479)
Q Consensus       233 ~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~----~  306 (479)
                      ++++|...+....  .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.+.....    .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999999997764  689999999999999999999999999999999999999999999999999987643221    1


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc--cCCCCccCCHHHHHHHHhh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~lI~~~  383 (479)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |..||...+..++...+...  ....+..++..+.+++.+|
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  237 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC  237 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence            23456788999999999999999999999999999999 99999888877777776643  3345567889999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHh
Q 011698          384 LQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~  404 (479)
                      |+.+|++||     ++.++++
T Consensus       238 l~~~p~~Rp-----s~~~~~~  253 (257)
T cd05040         238 WAHNPADRP-----TFAALRE  253 (257)
T ss_pred             CCCCcccCC-----CHHHHHH
Confidence            999999999     8888875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-40  Score=324.74  Aligned_cols=250  Identities=31%  Similarity=0.535  Sum_probs=213.1

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEe
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~  231 (479)
                      |++.+.||.|++|.||+|.+..+++.+|+|.+...... ......+.+|+.++++++|+||+++++.+..+..+++||||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            56789999999999999999999999999998765432 23445677899999999999999999999999999999999


Q ss_pred             ccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Ccccc
Q 011698          232 VNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSM  309 (479)
Q Consensus       232 ~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~~~  309 (479)
                      +.+ +|...+.. .+.+++..+..++.||+.||.|||+.+|+|+||||+||+++.++.++|+|||.+....... .....
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            986 77777766 4678999999999999999999999999999999999999999999999999998765443 22335


Q ss_pred             cCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-------------------CC--
Q 011698          310 CGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------------------IK--  367 (479)
Q Consensus       310 ~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-------------------~~--  367 (479)
                      .++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+...++...-                   ..  
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP  238 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence            678899999999877 78999999999999999999999998877655554443210                   00  


Q ss_pred             ---------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          368 ---------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       368 ---------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                               ....++.++.++|.+||+.||.+||     +++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----~~~~ll~~~~~  283 (283)
T cd05118         239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI-----TAEQALAHPYF  283 (283)
T ss_pred             cccccCHHHhhhhhCHHHHHHHHHHhccCcccCc-----CHHHHhhCCCC
Confidence                     1124678999999999999999999     99999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-40  Score=323.88  Aligned_cols=250  Identities=35%  Similarity=0.558  Sum_probs=213.5

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEe
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~  231 (479)
                      |++.+.||+|+||.||+|+...+++.||+|++.... ......+.+..|+.++++++|+||+++++++.+...+++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            677889999999999999999999999999998754 2223345567899999999999999999999999999999999


Q ss_pred             ccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Ccccc
Q 011698          232 VNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSM  309 (479)
Q Consensus       232 ~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~~~  309 (479)
                      +.+ +|..++.+. ..+++..++.++.+++.||.|||++||+||||+|+||+++.++.+||+|||+++...... .....
T Consensus        80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            985 899999876 579999999999999999999999999999999999999999999999999998764433 23344


Q ss_pred             cCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------------cCCCC-
Q 011698          310 CGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------KIKLP-  369 (479)
Q Consensus       310 ~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~------------------~~~~p-  369 (479)
                      .++..|+|||.+.+. .++.++|+|||||++|||++|..||.+.+......++...                  ...++ 
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            567889999999876 7899999999999999999999999887766555544321                  00011 


Q ss_pred             ----------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          370 ----------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       370 ----------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                                +.++..+.++|++||+.||++||     +++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp-----~~~~~l~~p~~  282 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI-----SAKEALKHPYF  282 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCC-----CHHHHhhCcCC
Confidence                      12478899999999999999999     89999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-41  Score=347.32  Aligned_cols=251  Identities=24%  Similarity=0.390  Sum_probs=222.4

Q ss_pred             EEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc-hHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe--EEEEE
Q 011698          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR--LYLVL  229 (479)
Q Consensus       153 ~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~--~~lV~  229 (479)
                      +...+||+|+|-+||+|.+..+|..||--.++...+. .....+.+..|+.+|+.|+||||+++|.+|.+..+  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4457899999999999999999999998777665443 34456889999999999999999999999988766  88899


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC--CCccCCCCCccEEeCC-CCcEEEeecCCccccCCCCCc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--GIMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--~IiHrDLKpeNILl~~-~g~vkL~DFGla~~~~~~~~~  306 (479)
                      |.|..|+|..++.+.+.++...++.|++||++||.|||++  .|||||||-+||+|+. .|.+||+|+|||+.+.... .
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-a  201 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-A  201 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc-c
Confidence            9999999999999999999999999999999999999998  6999999999999975 4899999999999876544 3


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCC--CCccCCHHHHHHHHhh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKIK--LPAFLSSEAHSLLKGL  383 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~lI~~~  383 (479)
                      ...+|||.|||||+.. +.|+..+||||||++|+||+|+..||.. .+...+++++..+..+  +-..-.+++++||.+|
T Consensus       202 ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekC  280 (632)
T KOG0584|consen  202 KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKC  280 (632)
T ss_pred             ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHH
Confidence            4489999999999998 7799999999999999999999999965 6788999999988442  3334478999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          384 LQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      |.. .+.|+     ++.|+|.||||..-
T Consensus       281 l~~-~~~R~-----sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  281 LAT-KSERL-----SAKELLKDPFFDED  302 (632)
T ss_pred             hcC-chhcc-----CHHHHhhChhhccc
Confidence            999 89999     99999999999874

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-40  Score=326.39  Aligned_cols=249  Identities=19%  Similarity=0.307  Sum_probs=207.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCC--------------CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeee
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGT--------------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ  214 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~--------------~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~  214 (479)
                      .++|++.+.||+|+||.||+|++.++              ...||+|.++...  .....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            36899999999999999999987643              2359999987642  2334556889999999999999999


Q ss_pred             EeEEEeeCCeEEEEEEeccCCcHHHHHHHcC------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEE
Q 011698          215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (479)
Q Consensus       215 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNIL  282 (479)
                      +++++......++||||+.+++|..++....            .+++..+..++.|++.||.|||++|++||||||+|||
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999886542            3677888899999999999999999999999999999


Q ss_pred             eCCCCcEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh--CCCCCCCCCHHHH
Q 011698          283 LDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT--GQPPFTGGNRQKI  357 (479)
Q Consensus       283 l~~~g~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt--G~~Pf~~~~~~~~  357 (479)
                      ++.++.+||+|||++..+.....   .....++..|+|||++.+..++.++|+|||||++|+|++  |..||...+..+.
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999976533221   122345678999999999889999999999999999998  7789988776665


Q ss_pred             HHHHHh-----c---cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          358 QQKIIK-----D---KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       358 ~~~i~~-----~---~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ...+..     .   ....+..++..+.+||.+||+.||++||     ++++|++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP-----s~~~i~~  291 (295)
T cd05097         242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP-----TFNKIHH  291 (295)
T ss_pred             HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCc-----CHHHHHH
Confidence            554432     1   1233556789999999999999999999     8888864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.3e-40  Score=335.57  Aligned_cols=256  Identities=32%  Similarity=0.493  Sum_probs=211.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeC--CeE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK--YRL  225 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~--~~~  225 (479)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++.+... .......+.+|+.+++++ +||||+++++++...  ..+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4689999999999999999999999999999999865322 222334567899999999 999999999988653  468


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-  304 (479)
                      |+||||+.+ +|..++... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++....... 
T Consensus        85 ~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          85 YLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             EEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            999999975 888888765 78889999999999999999999999999999999999999999999999998754322 


Q ss_pred             -----CcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------------
Q 011698          305 -----RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI------------  366 (479)
Q Consensus       305 -----~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~------------  366 (479)
                           ......||..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+........++.....            
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence                 2234568999999998865 4578999999999999999999999987655444333322110            


Q ss_pred             -------------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          367 -------------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       367 -------------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                                         .....++.++.++|.+||+.||++||     ++.++++||||+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-----s~~~il~~~~~~~~~  302 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL-----TAEEALEHPYVAQFH  302 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccccc-----CHHHHhhChhhhhhc
Confidence                               01123688999999999999999999     899999999998863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.9e-40  Score=330.81  Aligned_cols=250  Identities=22%  Similarity=0.350  Sum_probs=204.2

Q ss_pred             EeccC--CceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          157 VVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       157 ~LG~G--~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +||+|  ++|.||.++.+.+++.||+|+++.... .....+.+.+|+.+++.++||||+++++++......|++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            44544  556777777778999999999987532 334567789999999999999999999999999999999999999


Q ss_pred             CcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC--------
Q 011698          235 GHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--------  304 (479)
Q Consensus       235 gsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~--------  304 (479)
                      |+|..++.+.  ..+++..++.++.||+.||.|||+++|+||||||+||+++.+|.+||+|||.+.......        
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            9999998764  458899999999999999999999999999999999999999999999999987643211        


Q ss_pred             CcccccCCCCCcchhHhcC--CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------------
Q 011698          305 RSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-----------------  365 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~--~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-----------------  365 (479)
                      ......++..|+|||++.+  ..++.++|+|||||++|||++|..||..............+.                 
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM  243 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence            1233457788999999976  458899999999999999999999998755433222111110                 


Q ss_pred             -----------------CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          366 -----------------IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       366 -----------------~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                                       ...+..++.++.+||..||+.||++||     +++++++||||+.+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp-----t~~~ll~~p~~~~~~  302 (314)
T cd08216         244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP-----SASQLLNHSFFKQCK  302 (314)
T ss_pred             CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc-----CHHHHhcCchHhhhc
Confidence                             011123467899999999999999999     999999999998763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=9.6e-40  Score=324.73  Aligned_cols=248  Identities=22%  Similarity=0.357  Sum_probs=206.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcC----------------CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCee
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIG----------------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV  213 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv  213 (479)
                      ++|++.+.||+|+||.||++++..                ++..||+|+++...  .......+.+|+.+++.++|+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            579999999999999999986543                34579999987542  233456688999999999999999


Q ss_pred             eEeEEEeeCCeEEEEEEeccCCcHHHHHHHcC-----------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEE
Q 011698          214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-----------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (479)
Q Consensus       214 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNIL  282 (479)
                      ++++++......++||||+.+|+|..++....           .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            99999999999999999999999999987643           3567789999999999999999999999999999999


Q ss_pred             eCCCCcEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh--CCCCCCCCCHHHH
Q 011698          283 LDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT--GQPPFTGGNRQKI  357 (479)
Q Consensus       283 l~~~g~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt--G~~Pf~~~~~~~~  357 (479)
                      ++.++.++|+|||+++.+.....   .....+++.|+|||...+..++.++|+|||||++|||++  |..||...+..+.
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            99999999999999986533221   122344678999999988889999999999999999998  8899987666555


Q ss_pred             HHHHHh--------ccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          358 QQKIIK--------DKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       358 ~~~i~~--------~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ......        .....+..++..+.+||..||+.||.+||     ++.+|.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~i~~  292 (296)
T cd05095         243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP-----SFQEIHA  292 (296)
T ss_pred             HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCC-----CHHHHHH
Confidence            443321        12234556789999999999999999999     7888754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-40  Score=323.05  Aligned_cols=249  Identities=31%  Similarity=0.516  Sum_probs=210.0

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEEEEEE
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      |++.+.||+|+||+||+|....+++.||||.+......  .......+|+..+++++ ||||+++++++..+...|+|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            67889999999999999999999999999998764321  11223456889999998 9999999999999999999999


Q ss_pred             eccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccc
Q 011698          231 FVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~  308 (479)
                      |+ +|+|...+....  .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence            99 778988887765  789999999999999999999999999999999999999999999999999987765544455


Q ss_pred             ccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------------cCC-
Q 011698          309 MCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------------KIK-  367 (479)
Q Consensus       309 ~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-------------------~~~-  367 (479)
                      ..|+..|+|||++.+ ..++.++|+||||+++|||++|+.||...+..+...++...                   ... 
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            678999999998854 45789999999999999999999999877655544433321                   000 


Q ss_pred             ----------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          368 ----------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       368 ----------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                                +....+.++.++|++||+.||++||     +++|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----t~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP-----TASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCC-----CHHHHhhCCCC
Confidence                      0112368899999999999999999     89999999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=315.03  Aligned_cols=241  Identities=24%  Similarity=0.385  Sum_probs=208.6

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg  235 (479)
                      ++||+|+||.||+|.+.. ++.||+|++......  .....+.+|++++++++|+||+++++++.+....++||||+.|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            369999999999999987 899999998765422  34566888999999999999999999999999999999999999


Q ss_pred             cHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc---ccccC
Q 011698          236 HLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCG  311 (479)
Q Consensus       236 sL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~---~~~~g  311 (479)
                      +|..++... ..+++..+..++.+++.||.|||+++++||||||+|||++.++.+||+|||++.........   ....+
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999998664 46889999999999999999999999999999999999999999999999999865422211   12234


Q ss_pred             CCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhhhhhchh
Q 011698          312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEAS  389 (479)
Q Consensus       312 t~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~  389 (479)
                      +..|+|||.+.+..++.++|+|||||++|||+| |..||...+.......+... .+..|..++.++.++|.+||+.+|.
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  237 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPE  237 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChh
Confidence            567999999998889999999999999999999 89999888777777766654 4556778899999999999999999


Q ss_pred             hhcCCCCCCHHHHHh
Q 011698          390 KRLGSGPGGSQEIKS  404 (479)
Q Consensus       390 ~R~~~~~~t~~eil~  404 (479)
                      +||     +++|+++
T Consensus       238 ~Rp-----~~~ell~  247 (251)
T cd05041         238 NRP-----SFSEIYN  247 (251)
T ss_pred             hCc-----CHHHHHH
Confidence            999     8999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.5e-39  Score=320.14  Aligned_cols=251  Identities=18%  Similarity=0.307  Sum_probs=213.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcC----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee-
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-  221 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-  221 (479)
                      +..++|++.+.||+|+||.||+|.+..    ++..||+|.+....  .....+.+.+|+.++++++||||+++++++.. 
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            345789999999999999999999876    35789999886432  34446678889999999999999999998655 


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHc--------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEee
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQ--------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTD  293 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~--------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~D  293 (479)
                      ....++++||+.+++|..++...        ..+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            56789999999999999988654        3588999999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCC
Q 011698          294 FGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKL  368 (479)
Q Consensus       294 FGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~  368 (479)
                      ||+++.+.....   .....++..|+|||.+.+..++.++|||||||++||+++ |+.||...+..++...+..+ .+..
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ  240 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence            999986543221   122345678999999999999999999999999999999 99999988877777666654 3345


Q ss_pred             CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          369 PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       369 p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +..++.++.+++.+||+.||++||     ++.++++
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~~~  271 (280)
T cd05043         241 PINCPDELFAVMACCWALDPEERP-----SFSQLVQ  271 (280)
T ss_pred             CCcCCHHHHHHHHHHcCCChhhCC-----CHHHHHH
Confidence            566789999999999999999999     8888874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.1e-39  Score=330.15  Aligned_cols=254  Identities=29%  Similarity=0.408  Sum_probs=208.5

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCC--CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEee----CC
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGT--SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQT----KY  223 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~----~~  223 (479)
                      +|++.+.||+|+||.||+|++..+  +..||+|++.... ........+.+|+.+++++ +||||+++++.+..    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            589999999999999999999988  8999999987532 1222345567899999998 59999999986533    24


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      .+|+++||+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.+...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            6789999986 589899888888999999999999999999999999999999999999999999999999999865432


Q ss_pred             C-----CcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Q 011698          304 T-----RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------  364 (479)
Q Consensus       304 ~-----~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-------------  364 (479)
                      .     ......||+.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+.......+...             
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            1     1234578999999998866 56899999999999999999999999876644433332221             


Q ss_pred             ---------------cCCC---CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          365 ---------------KIKL---PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       365 ---------------~~~~---p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                     ...+   ....+..+.+||.+||+.||++||     ++++++.||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----t~~~ll~~~~~~~~  298 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI-----SVEEALEHPYLAIW  298 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCC-----CHHHHhcChhhhhh
Confidence                           0011   123578999999999999999999     89999999999653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.5e-40  Score=334.19  Aligned_cols=252  Identities=23%  Similarity=0.414  Sum_probs=206.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc-----CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEe
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQ  220 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~  220 (479)
                      +..++|++.+.||+|+||+||+|++.     .+++.||||+++...  .......+.+|+.+|.++ +||||+++++++.
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            34578999999999999999999853     457889999997543  223345677899999999 6899999998876


Q ss_pred             e-CCeEEEEEEeccCCcHHHHHHHcC------------------------------------------------------
Q 011698          221 T-KYRLYLVLDFVNGGHLFFQLYRQG------------------------------------------------------  245 (479)
Q Consensus       221 ~-~~~~~lV~E~~~ggsL~~~l~~~~------------------------------------------------------  245 (479)
                      . ...+++||||+++|+|.+++....                                                      
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            5 456899999999999999886531                                                      


Q ss_pred             -------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC---Ccccc
Q 011698          246 -------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---RSNSM  309 (479)
Q Consensus       246 -------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~---~~~~~  309 (479)
                                   .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......   .....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                         35677788899999999999999999999999999999999999999999998653221   12223


Q ss_pred             cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhc-cCCCCccCCHHHHHHHHhhhhh
Q 011698          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK-IQQKIIKD-KIKLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~  386 (479)
                      .++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..... ....+..+ ....|..+++++.+++..||+.
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~  321 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  321 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence            45678999999999999999999999999999997 999998754433 33333332 4456677889999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhC
Q 011698          387 EASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~h  405 (479)
                      ||++||     ++.+|++|
T Consensus       322 ~p~~Rp-----s~~eil~~  335 (343)
T cd05103         322 EPSQRP-----TFSELVEH  335 (343)
T ss_pred             ChhhCc-----CHHHHHHH
Confidence            999999     89999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.4e-39  Score=329.32  Aligned_cols=253  Identities=28%  Similarity=0.426  Sum_probs=209.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee-CCeEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-KYRLYL  227 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~~~l  227 (479)
                      .++|++++.||.|+||.||+|.++.+++.||+|++.+... .....+.+..|+.++++++||||++++++|.. ...+|+
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            4689999999999999999999999999999999875432 22334567789999999999999999999875 567899


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcc
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~  307 (479)
                      ||||+ +++|...+.. ..+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++.....  ...
T Consensus        88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~~  163 (328)
T cd07856          88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMT  163 (328)
T ss_pred             Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--CcC
Confidence            99999 4588776654 5678899999999999999999999999999999999999999999999999976533  223


Q ss_pred             cccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------------c-------
Q 011698          308 SMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK---------------D-------  364 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~---------------~-------  364 (479)
                      ...+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+.+               +       
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd07856         164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ  243 (328)
T ss_pred             CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence            4567889999999866 5689999999999999999999999987654322221111               0       


Q ss_pred             ----cCCCC-----ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          365 ----KIKLP-----AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       365 ----~~~~p-----~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                          ....|     ..++.++.++|++||+.+|++||     ++++++.|+||...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~-----t~~ell~~~~~~~~  294 (328)
T cd07856         244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI-----SAAEALAHPYLAPY  294 (328)
T ss_pred             hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC-----CHHHHhcCCccccc
Confidence                00111     34678999999999999999999     89999999999753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.7e-39  Score=313.85  Aligned_cols=241  Identities=22%  Similarity=0.398  Sum_probs=206.4

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCC
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg  235 (479)
                      +.||+|+||.||+|... ++..||+|++....  .......+.+|+.++++++||||+++++.+......++||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            36899999999999865 57789999987543  2233445788999999999999999999999999999999999999


Q ss_pred             cHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc--ccccCC
Q 011698          236 HLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS--NSMCGT  312 (479)
Q Consensus       236 sL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~--~~~~gt  312 (479)
                      +|..++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........  ....++
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            999988754 45789999999999999999999999999999999999999999999999999764332211  122345


Q ss_pred             CCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhhhhhchhh
Q 011698          313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEASK  390 (479)
Q Consensus       313 ~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~  390 (479)
                      ..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+.......+... ....+..++.++.+++.+||+.+|++
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  237 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPEN  237 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCccc
Confidence            67999999998889999999999999999999 99999988777777766654 44566778999999999999999999


Q ss_pred             hcCCCCCCHHHHHh
Q 011698          391 RLGSGPGGSQEIKS  404 (479)
Q Consensus       391 R~~~~~~t~~eil~  404 (479)
                      ||     ++.++++
T Consensus       238 Rp-----~~~~l~~  246 (250)
T cd05085         238 RP-----KFSELQK  246 (250)
T ss_pred             CC-----CHHHHHH
Confidence            99     8888865

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.1e-39  Score=313.80  Aligned_cols=247  Identities=22%  Similarity=0.368  Sum_probs=209.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++.+.||+|+||.||+|.+.. +..+|+|++....    ...+.+.+|+.++++++|+||+++++.+.. ...+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            456789999999999999999998654 4569999887542    234567889999999999999999999887 7889


Q ss_pred             EEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      ++|||+++++|.+++.+.  ..++...+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++..+....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999999764  357888889999999999999999999999999999999999999999999997654322


Q ss_pred             C--cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHH
Q 011698          305 R--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (479)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI  380 (479)
                      .  .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+...+...+..+ ....+...+.++.+++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  236 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM  236 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence            1  122345677999999998889999999999999999999 99999988877777766655 3345567889999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHh
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+||+++|++||     ++.++++
T Consensus       237 ~~~l~~~p~~Rp-----~~~~l~~  255 (260)
T cd05073         237 MRCWKNRPEERP-----TFEYIQS  255 (260)
T ss_pred             HHHcccCcccCc-----CHHHHHH
Confidence            999999999999     7777653

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.3e-39  Score=317.04  Aligned_cols=249  Identities=24%  Similarity=0.390  Sum_probs=211.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCC---CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      ..++|.+.+.||+|+||.||+|.+...   ...||+|......  .....+.+.+|+.++++++||||+++++++.+ ..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            446799999999999999999987654   4468999886543  23345678889999999999999999998875 45


Q ss_pred             EEEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      .|+||||+++|+|.+++.+.. .+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            789999999999999997644 5899999999999999999999999999999999999999999999999999875433


Q ss_pred             CC--cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHH
Q 011698          304 TR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSL  379 (479)
Q Consensus       304 ~~--~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l  379 (479)
                      ..  .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..+....+..+ .+..|..++.++.++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL  240 (270)
T ss_pred             cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence            21  122234568999999998889999999999999999996 99999988877777666654 456778899999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      |.+||..+|.+||     ++.+++.
T Consensus       241 i~~~l~~~P~~Rp-----t~~~~~~  260 (270)
T cd05056         241 MTKCWAYDPSKRP-----RFTELKA  260 (270)
T ss_pred             HHHHcCCChhhCc-----CHHHHHH
Confidence            9999999999999     8888765

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.9e-40  Score=319.62  Aligned_cols=236  Identities=22%  Similarity=0.329  Sum_probs=199.2

Q ss_pred             EeccCCceEEEEEEEcCCCeE-------EEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          157 VVGQGAFAKVYQVRRIGTSEI-------YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       157 ~LG~G~fG~V~~a~~~~~~~~-------vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      .||+|+||.||+|.++.++..       ||+|.+....   ....+.+.+|..+++.++||||+++++++......++||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            689999999999998765443       8888875432   233456778999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc--------EEEeecCCcccc
Q 011698          230 DFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH--------VMLTDFGLAKQF  300 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~--------vkL~DFGla~~~  300 (479)
                      ||+++|+|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.        ++++|||++...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9999999999997654 5899999999999999999999999999999999999988775        699999998764


Q ss_pred             CCCCCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhC-CCCCCCCCHHHHHHHHHhccCCCCccCCHHHHH
Q 011698          301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTG-QPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHS  378 (479)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  378 (479)
                      ..   .....++..|+|||++.+ ..++.++|||||||++|||++| ..||...+..... .+......+|...+.++.+
T Consensus       159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  234 (258)
T cd05078         159 LP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWTELAN  234 (258)
T ss_pred             CC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcHHHHH
Confidence            32   234568899999999987 4579999999999999999998 5677665554433 3445566778888899999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ||.+||+.||++||     ++++|++
T Consensus       235 li~~~l~~~p~~Rp-----s~~~il~  255 (258)
T cd05078         235 LINQCMDYEPDFRP-----SFRAIIR  255 (258)
T ss_pred             HHHHHhccChhhCC-----CHHHHHH
Confidence            99999999999999     8999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.7e-39  Score=313.77  Aligned_cols=243  Identities=24%  Similarity=0.425  Sum_probs=208.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +.+++|++.+.||+|+||.||++..  +++.||+|+++...     ..+.+.+|+.+++.++||||+++++++... ..+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   74 (254)
T cd05083           3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY   74 (254)
T ss_pred             ccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence            3457899999999999999999875  67789999986532     234578899999999999999999998764 479


Q ss_pred             EEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      +||||+.+++|..++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... 
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-  153 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence            9999999999999987654  4788999999999999999999999999999999999999999999999999764322 


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHh
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKG  382 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~  382 (479)
                       ......+..|+|||.+.+..++.++|+|||||++|||++ |..||...+..+....+..+ .+..+..++..+.++|.+
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  232 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTS  232 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHH
Confidence             122334578999999998889999999999999999998 99999988887777776655 344556788999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHh
Q 011698          383 LLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ||+++|.+||     ++++++.
T Consensus       233 ~l~~~p~~Rp-----~~~~l~~  249 (254)
T cd05083         233 CWETEPKKRP-----SFHKLRE  249 (254)
T ss_pred             HcCCChhhCc-----CHHHHHH
Confidence            9999999999     8888864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.6e-39  Score=319.47  Aligned_cols=248  Identities=23%  Similarity=0.352  Sum_probs=204.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEE----cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC--C
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRR----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--Y  223 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~  223 (479)
                      .-|++++.||+|+||.||+|++    +.++..||+|.++...  .......+.+|+.+++.++||||+++++++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            3478999999999999999985    4578899999987543  233456688999999999999999999998775  5


Q ss_pred             eEEEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      ..++||||++|++|..++.+.. .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.+..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            7899999999999999987653 589999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC----cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC---------------HHHHHHHHHh
Q 011698          303 NTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN---------------RQKIQQKIIK  363 (479)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~---------------~~~~~~~i~~  363 (479)
                      ...    .....|+..|+|||.+.+..++.++|||||||++|||+++..|+....               .......+..
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            321    224556778999999999889999999999999999999877653211               1111111111


Q ss_pred             c-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          364 D-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       364 ~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      + ....+..++..+.+||.+||+.+|.+||     +++++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~  278 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRT-----TFQNLIE  278 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCc-----CHHHHHH
Confidence            1 3345667899999999999999999999     8999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3e-39  Score=322.59  Aligned_cols=250  Identities=22%  Similarity=0.386  Sum_probs=209.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCe----EEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      +..++|+.++.||+|+||.||+|.+..+++    .||+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~   81 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP   81 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence            445789999999999999999999987776    46888876532  222334578899999999999999999998754


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                       ..++++||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence             4678999999999999987654 58899999999999999999999999999999999999999999999999998754


Q ss_pred             CCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHH
Q 011698          302 ENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       302 ~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                      ....   .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+..+ .+..+...+..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV  240 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence            3322   223345678999999999999999999999999999998 99999887666655555443 344556688999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .++|..||..+|++||     +++++++
T Consensus       241 ~~li~~c~~~~p~~Rp-----~~~~l~~  263 (303)
T cd05110         241 YMVMVKCWMIDADSRP-----KFKELAA  263 (303)
T ss_pred             HHHHHHHcCCChhhCc-----CHHHHHH
Confidence            9999999999999999     8888876

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2e-39  Score=316.82  Aligned_cols=242  Identities=24%  Similarity=0.407  Sum_probs=205.8

Q ss_pred             EEeccCCceEEEEEEEcCCC------eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          156 KVVGQGAFAKVYQVRRIGTS------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +.||+|+||.||+|+++...      +.+|+|.+.+..  .......+.+|+.+++.++||||+++++++......++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            36899999999999987544      789999886542  1233456778999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHc-------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC-----cEEEeecCCc
Q 011698          230 DFVNGGHLFFQLYRQ-------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-----HVMLTDFGLA  297 (479)
Q Consensus       230 E~~~ggsL~~~l~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g-----~vkL~DFGla  297 (479)
                      ||+++++|..++.+.       ..+++..+..++.||+.||.|||+++++|+||||+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998653       3478888999999999999999999999999999999999888     8999999999


Q ss_pred             cccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccC
Q 011698          298 KQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFL  372 (479)
Q Consensus       298 ~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~  372 (479)
                      +.......   .....++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+..+ .+..+..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC  238 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence            76533221   123345688999999999999999999999999999998 99999887777777766554 45667788


Q ss_pred             CHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       373 s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +..+.++|.+||+++|.+||     +++++++
T Consensus       239 ~~~~~~li~~~l~~~p~~Rp-----~~~~i~~  265 (269)
T cd05044         239 PDKIYQLMTNCWAQDPSERP-----TFDRIQE  265 (269)
T ss_pred             hHHHHHHHHHHcCCCcccCC-----CHHHHHH
Confidence            99999999999999999999     8888864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.7e-39  Score=312.95  Aligned_cols=242  Identities=21%  Similarity=0.330  Sum_probs=200.4

Q ss_pred             EEeccCCceEEEEEEEcC---CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe-eCCeEEEEEEe
Q 011698          156 KVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ-TKYRLYLVLDF  231 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-~~~~~~lV~E~  231 (479)
                      +.||+|+||.||+|.+..   .+..||+|.+....  .....+.+.+|+.+++.++||||+++++++. .+...++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            368999999999998753   34679999875422  2334566778999999999999999999765 45568999999


Q ss_pred             ccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-----C
Q 011698          232 VNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----R  305 (479)
Q Consensus       232 ~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-----~  305 (479)
                      +.+|+|..++.+. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+....     .
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            9999999998764 346777788899999999999999999999999999999999999999999997653321     1


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhh
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~  383 (479)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..++...+..+ ....+..++..+.+++..|
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  238 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSC  238 (262)
T ss_pred             cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHH
Confidence            123346778999999998899999999999999999999 57778877777777666655 3445667889999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHh
Q 011698          384 LQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~  404 (479)
                      |+.+|++||     ++.++++
T Consensus       239 l~~~p~~Rp-----~~~~il~  254 (262)
T cd05058         239 WHPKPEMRP-----TFSELVS  254 (262)
T ss_pred             cCCChhhCC-----CHHHHHH
Confidence            999999999     8888875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=357.21  Aligned_cols=251  Identities=22%  Similarity=0.390  Sum_probs=219.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCC-----eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  221 (479)
                      +..+..++.+.||+|.||.||.|...+..     ..||||.+++.  .+......+.+|..+|++++|||||++++.+-+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            44567899999999999999999886543     24889988764  356677888999999999999999999999999


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHc-------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeec
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQ-------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDF  294 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DF  294 (479)
                      ....+|++|||.||+|..+|++.       ..++......++.||++|+.||+++++|||||..+|+||+....+||+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999876       34888999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCC--cccc-cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHh-ccCCCC
Q 011698          295 GLAKQFDENTR--SNSM-CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK-DKIKLP  369 (479)
Q Consensus       295 Gla~~~~~~~~--~~~~-~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~-~~~~~p  369 (479)
                      |+|+.+.....  .... .-...|||||.+....++.++|||||||+|||++| |..||.+.++.++..-.++ +++..|
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P  926 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP  926 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence            99995432211  1111 12357999999999999999999999999999999 9999999998888885554 588999


Q ss_pred             ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          370 AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       370 ~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+++..+.++|..||+.+|++||     ++..|++
T Consensus       927 ~~CP~~ly~lM~~CW~~~pe~RP-----~F~~i~~  956 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQCWKHDPEDRP-----SFRTIVE  956 (1025)
T ss_pred             CCCChHHHHHHHHHccCChhhCc-----cHHHHHh
Confidence            99999999999999999999999     7888876

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.6e-39  Score=314.65  Aligned_cols=238  Identities=20%  Similarity=0.272  Sum_probs=195.6

Q ss_pred             EEeccCCceEEEEEEEcCC------------CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          156 KVVGQGAFAKVYQVRRIGT------------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~------------~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      +.||+|+||.||+|+....            ...+|+|++....   ......+.+|+.+++.++||||+++++++....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            3689999999999986432            2358889876532   233445778899999999999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc-------EEEeecC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH-------VMLTDFG  295 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~-------vkL~DFG  295 (479)
                      ..++||||+++|+|..++.+. +.+++..++.++.||+.||+|||+++|+||||||+|||++.++.       +|++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998888754 56899999999999999999999999999999999999987764       8999999


Q ss_pred             CccccCCCCCcccccCCCCCcchhHhc-CCCCCccccchhhHHHHHHHH-hCCCCCCCCCHHHHHHHHHhccCCCCccCC
Q 011698          296 LAKQFDENTRSNSMCGTLEYMSPEIVL-GKGHDKAADWWSVGILLFEML-TGQPPFTGGNRQKIQQKIIKDKIKLPAFLS  373 (479)
Q Consensus       296 la~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~~DiwSLGvilyell-tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s  373 (479)
                      ++.....   .....|+..|+|||.+. +..++.++|||||||++|||+ +|..||......+.. .+...........+
T Consensus       158 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~  233 (262)
T cd05077         158 IPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVTPSC  233 (262)
T ss_pred             CCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCCCCh
Confidence            9876432   23456788999999987 467899999999999999998 589999776544432 33334444444457


Q ss_pred             HHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       374 ~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      .++.+||.+||+.||.+||     ++.+|+++
T Consensus       234 ~~~~~li~~cl~~dp~~Rp-----~~~~il~~  260 (262)
T cd05077         234 KELADLMTHCMNYDPNQRP-----FFRAIMRD  260 (262)
T ss_pred             HHHHHHHHHHcCCChhhCc-----CHHHHHHh
Confidence            8899999999999999999     89999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-38  Score=314.81  Aligned_cols=247  Identities=22%  Similarity=0.364  Sum_probs=201.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEE----cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee--CC
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRR----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KY  223 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~  223 (479)
                      ++|++++.||+|+||.||+|..    ..+++.||+|.+....   ....+.+.+|++++++++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            5799999999999999999984    4578899999986542   3345668899999999999999999987643  45


Q ss_pred             eEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      .+++||||+++++|..++.+. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            689999999999999998764 4689999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCc----ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHH---------------HHHHHHh
Q 011698          303 NTRS----NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK---------------IQQKIIK  363 (479)
Q Consensus       303 ~~~~----~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~---------------~~~~i~~  363 (479)
                      ....    ....++..|+|||++.+..++.++|||||||++|||++|..++.......               ....+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            3221    11223456999999999899999999999999999999887764322110               0111222


Q ss_pred             c--cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          364 D--KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       364 ~--~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .  .+..+..++.++.+||.+||+.+|++||     |+++|++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----t~~ei~~  278 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRP-----SFSELAL  278 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCC-----CHHHHHH
Confidence            2  2344567889999999999999999999     8999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.2e-39  Score=313.03  Aligned_cols=241  Identities=22%  Similarity=0.339  Sum_probs=194.6

Q ss_pred             EEeccCCceEEEEEEEcC--CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEecc
Q 011698          156 KVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~  233 (479)
                      +.||+|+||+||+|....  ....+|+|.+....  .......+.+|+.+++.++||||+++++.+.....+|+||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            368999999999997543  34578888876432  23334557789999999999999999999999999999999999


Q ss_pred             CCcHHHHHHHcC-----CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC---C
Q 011698          234 GGHLFFQLYRQG-----LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---R  305 (479)
Q Consensus       234 ggsL~~~l~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~---~  305 (479)
                      +|+|.+++....     .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......   .
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999999987643     24677888999999999999999999999999999999999999999999987542221   1


Q ss_pred             cccccCCCCCcchhHhcC-------CCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cC-----CCCcc
Q 011698          306 SNSMCGTLEYMSPEIVLG-------KGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KI-----KLPAF  371 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~-------~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~-----~~p~~  371 (479)
                      .....+++.|+|||++..       ..++.++|||||||++|||++ |..||......+....+... ..     .++..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            233445778999999853       356789999999999999999 88999877766655554443 22     23446


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ++..+.+++..|+ .||++||     ++++|++
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rp-----t~~~v~~  265 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRP-----TAEEVHE  265 (269)
T ss_pred             CCHHHHHHHHHHh-cCccccc-----CHHHHHH
Confidence            8899999999998 5999999     7888765

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.7e-39  Score=313.37  Aligned_cols=249  Identities=32%  Similarity=0.527  Sum_probs=212.4

Q ss_pred             CeEEEEEeccCCceEEEEEEEcC-CCeEEEEEEeehhhh-------chHHHHHHHHHHHHHHHh-CCCCCeeeEeEEEee
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKI-------MEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQT  221 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~-~~~~vAiK~i~~~~~-------~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~  221 (479)
                      +|++.+.||+|+||.||+|+++. +++.+|+|.+.....       ........+..|+.++.+ ++||||+++++.+..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47889999999999999999988 788999999864321       122334556678888875 799999999999999


Q ss_pred             CCeEEEEEEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEeCCCCcEEEeecCC
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGL  296 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl~~~g~vkL~DFGl  296 (479)
                      .+..++||||++|++|.+++..    ...+++..++.++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999887743    3468999999999999999999996 7899999999999999999999999999


Q ss_pred             ccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CC-ccCCH
Q 011698          297 AKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LP-AFLSS  374 (479)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s~  374 (479)
                      +.............|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+...... .+ ..++.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE  240 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence            98765544445667899999999999988999999999999999999999999887777777766655433 22 25789


Q ss_pred             HHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          375 EAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       375 ~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ++.++|.+||+.||++||     ++.|+..
T Consensus       241 ~l~~li~~cl~~~p~~Rp-----~~~e~~~  265 (269)
T cd08528         241 DVTDVITSCLTPDAEARP-----DIIQVSA  265 (269)
T ss_pred             HHHHHHHHHCCCCCccCC-----CHHHHHH
Confidence            999999999999999999     7888765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.7e-39  Score=312.73  Aligned_cols=241  Identities=22%  Similarity=0.309  Sum_probs=194.9

Q ss_pred             EEeccCCceEEEEEEEc--CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEecc
Q 011698          156 KVVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~  233 (479)
                      +.||+|+||.||+|.+.  .++..+|+|.++....  ......+.+|+.++++++||||+++++++.+...+++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            36899999999999865  3567799999876432  2233457789999999999999999999999999999999999


Q ss_pred             CCcHHHHHHHcC-----CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC---C
Q 011698          234 GGHLFFQLYRQG-----LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---R  305 (479)
Q Consensus       234 ggsL~~~l~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~---~  305 (479)
                      +|+|.+++....     ..++..++.++.|++.||.|||+++++||||||+||+++.++++||+|||+++......   .
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999999987532     35667788899999999999999999999999999999999999999999997543221   1


Q ss_pred             cccccCCCCCcchhHhcCC-------CCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCC-----cc
Q 011698          306 SNSMCGTLEYMSPEIVLGK-------GHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLP-----AF  371 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~-------~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p-----~~  371 (479)
                      .....|+..|+|||++.+.       .++.++|+|||||++|||++ |..||...+..+.......+ ...++     ..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            2345678899999998643       35789999999999999997 99999876665554433322 22222     24


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+..+.++|..|+ .+|++||     ++++|+.
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rp-----t~~~l~~  265 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRP-----SAEEVHL  265 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCC-----CHHHHHH
Confidence            6788999999998 6899999     8888863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.9e-39  Score=316.13  Aligned_cols=237  Identities=22%  Similarity=0.307  Sum_probs=196.1

Q ss_pred             EeccCCceEEEEEEEcCC------------------------CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCe
Q 011698          157 VVGQGAFAKVYQVRRIGT------------------------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI  212 (479)
Q Consensus       157 ~LG~G~fG~V~~a~~~~~------------------------~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~I  212 (479)
                      +||+|+||.||+|....+                        ...||+|++....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            699999999999975322                        2458999886542   2234557788999999999999


Q ss_pred             eeEeEEEeeCCeEEEEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC----
Q 011698          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG----  287 (479)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g----  287 (479)
                      +++++++.+....++||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999888865 46789999999999999999999999999999999999997654    


Q ss_pred             ---cEEEeecCCccccCCCCCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHH-hCCCCCCCCCHHHHHHHHH
Q 011698          288 ---HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEML-TGQPPFTGGNRQKIQQKII  362 (479)
Q Consensus       288 ---~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyell-tG~~Pf~~~~~~~~~~~i~  362 (479)
                         .+|++|||++......   ....++..|+|||.+.+ ..++.++|+|||||++|||+ +|+.||.+.+...... ..
T Consensus       159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~  234 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FY  234 (274)
T ss_pred             ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HH
Confidence               4899999998654221   23457888999999876 56899999999999999995 6999998766554433 33


Q ss_pred             hccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          363 KDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       363 ~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      .....+|...+.++.++|.+||+.+|++||     ++++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----s~~~il~~  272 (274)
T cd05076         235 EKKHRLPEPSCKELATLISQCLTYEPTQRP-----SFRTILRD  272 (274)
T ss_pred             HhccCCCCCCChHHHHHHHHHcccChhhCc-----CHHHHHHh
Confidence            444556666778999999999999999999     89999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=307.32  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=209.6

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-  223 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-  223 (479)
                      ..++-++|++.+.||.|||+.||+++...+++.||+|.+.-..   .+..+...+|++.-++++||||++++++...+. 
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~   92 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK   92 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence            3466789999999999999999999999999999999997654   345667889999999999999999987764433 


Q ss_pred             ----eEEEEEEeccCCcHHHHHHHc----CCCcHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCccEEeCCCCcEEEee
Q 011698          224 ----RLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGHVMLTD  293 (479)
Q Consensus       224 ----~~~lV~E~~~ggsL~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~--IiHrDLKpeNILl~~~g~vkL~D  293 (479)
                          ..|+++.|...|+|.+.+.+.    ..++|.++..|+.+|++||++||+..  ++||||||.|||+.+.+.++|.|
T Consensus        93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence                489999999999999888653    36999999999999999999999998  99999999999999999999999


Q ss_pred             cCCccccCCCCCc----------ccccCCCCCcchhHhcCC---CCCccccchhhHHHHHHHHhCCCCCCCC--CHHHHH
Q 011698          294 FGLAKQFDENTRS----------NSMCGTLEYMSPEIVLGK---GHDKAADWWSVGILLFEMLTGQPPFTGG--NRQKIQ  358 (479)
Q Consensus       294 FGla~~~~~~~~~----------~~~~gt~~y~APE~l~~~---~~~~~~DiwSLGvilyelltG~~Pf~~~--~~~~~~  358 (479)
                      ||.++...-.-..          .....|..|.|||.+.-+   ..+.++|||||||++|+|+.|..||...  .-..+.
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            9999864321111          122357899999999654   4589999999999999999999999631  111222


Q ss_pred             HHHHhccCCCCc--cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          359 QKIIKDKIKLPA--FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       359 ~~i~~~~~~~p~--~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      -.+..+++.+|.  .+|+.+.+||+.||+.||.+||     ++.+++.+
T Consensus       253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP-----~i~~ll~~  296 (302)
T KOG2345|consen  253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRP-----TIPELLSK  296 (302)
T ss_pred             EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCC-----CHHHHHHH
Confidence            234455666664  4899999999999999999999     88888763

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=325.06  Aligned_cols=252  Identities=27%  Similarity=0.473  Sum_probs=212.6

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC--C----CeeeEeEEEee
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--P----FIVQLRYSFQT  221 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h--p----~Iv~l~~~~~~  221 (479)
                      ..++|++++.+|+|.||+|-.+.+..++..||+|+++.-    ....+..+-|+++|.++.+  |    -+|++.++|.-
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            357899999999999999999999999999999999752    2345667889999999942  2    37889999999


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC--------------
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA--------------  285 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~--------------  285 (479)
                      .++.|+|+|.+ |-++++.+..++  +++..+++.++.|++.++.|||+.+++|-||||||||+.+              
T Consensus       163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999999998 558999998764  5899999999999999999999999999999999999932              


Q ss_pred             ------CCcEEEeecCCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHH---
Q 011698          286 ------DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK---  356 (479)
Q Consensus       286 ------~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~---  356 (479)
                            +-.++|+|||.|+.-.+..  ++.+.|..|.|||++.|-+++..+||||+||||+|++||...|...+..+   
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa  319 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA  319 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence                  3368999999998755443  67888999999999999999999999999999999999999998766444   


Q ss_pred             HHHHHHh------------------ccCCCCcc-------------------------CCHHHHHHHHhhhhhchhhhcC
Q 011698          357 IQQKIIK------------------DKIKLPAF-------------------------LSSEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       357 ~~~~i~~------------------~~~~~p~~-------------------------~s~~~~~lI~~~L~~dP~~R~~  393 (479)
                      ++++|+.                  +++.+|..                         -..++.+||++||..||.+|+ 
T Consensus       320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri-  398 (415)
T KOG0671|consen  320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI-  398 (415)
T ss_pred             HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc-
Confidence            4444443                  11222211                         134689999999999999999 


Q ss_pred             CCCCCHHHHHhCccccCC
Q 011698          394 SGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       394 ~~~~t~~eil~hp~f~~~  411 (479)
                          |+.|++.||||+..
T Consensus       399 ----Tl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  399 ----TLREALSHPFFARL  412 (415)
T ss_pred             ----cHHHHhcCHHhhcC
Confidence                99999999999864

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.4e-39  Score=310.48  Aligned_cols=235  Identities=21%  Similarity=0.276  Sum_probs=196.4

Q ss_pred             EEeccCCceEEEEEEEcCCC----------eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          156 KVVGQGAFAKVYQVRRIGTS----------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~----------~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      +.||+|+||.||+|.+..++          ..+++|++.....    ....+.+|+.++++++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            36899999999999998777          3578887754331    14567889999999999999999999988 778


Q ss_pred             EEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC-------cEEEeecCCc
Q 011698          226 YLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-------HVMLTDFGLA  297 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g-------~vkL~DFGla  297 (479)
                      ++||||+.+|+|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++       .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998766 789999999999999999999999999999999999999888       8999999999


Q ss_pred             cccCCCCCcccccCCCCCcchhHhcCC--CCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCCccCCH
Q 011698          298 KQFDENTRSNSMCGTLEYMSPEIVLGK--GHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPAFLSS  374 (479)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~  374 (479)
                      .....   .....++..|+|||++.+.  .++.++|+|||||++|||++ |..||...+......... .....+.....
T Consensus       156 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  231 (259)
T cd05037         156 ITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCA  231 (259)
T ss_pred             ccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCch
Confidence            87543   2334567889999999887  78999999999999999999 688887765443333332 22223333458


Q ss_pred             HHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          375 EAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       375 ~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+.++|.+||+.+|.+||     ++.++++
T Consensus       232 ~~~~li~~~l~~~p~~Rp-----t~~~il~  256 (259)
T cd05037         232 ELANLINQCWTYDPTKRP-----SFRAILR  256 (259)
T ss_pred             HHHHHHHHHhccChhhCC-----CHHHHHH
Confidence            999999999999999999     8888875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.3e-38  Score=311.66  Aligned_cols=247  Identities=22%  Similarity=0.360  Sum_probs=206.6

Q ss_pred             eEEEEEeccCCceEEEEEEEc---CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-----
Q 011698          152 FEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----  223 (479)
                      |++.+.||+|+||.||+|.++   .+++.||||++..+.. .....+.+.+|++++++++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            567889999999999999865   3578999999976432 3334566788999999999999999999885432     


Q ss_pred             -eEEEEEEeccCCcHHHHHHHc------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCC
Q 011698          224 -RLYLVLDFVNGGHLFFQLYRQ------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL  296 (479)
Q Consensus       224 -~~~lV~E~~~ggsL~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGl  296 (479)
                       ..++++||+.+|+|..++...      ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             247899999999998776432      2478889999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCcc
Q 011698          297 AKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAF  371 (479)
Q Consensus       297 a~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~  371 (479)
                      ++......   ......+++.|++||.+.+..++.++|||||||++|||++ |..||.+.+..++...+... ....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPD  239 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence            98754322   1223345678999999999999999999999999999999 99999888877777766654 3455667


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+..+.+++.+||+.+|++||     ++.+++.
T Consensus       240 ~~~~~~~l~~~~l~~~p~~Rp-----s~~~~~~  267 (273)
T cd05074         240 CLEDVYELMCQCWSPEPKCRP-----SFQHLRD  267 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            889999999999999999999     8888875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.5e-40  Score=315.66  Aligned_cols=257  Identities=28%  Similarity=0.496  Sum_probs=208.7

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCC----eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee-C
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTS----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-K  222 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~  222 (479)
                      .+..|+.++.||+|.||.||+|..+.++    +.||||.++-+.... .......+|+.+++.++||||+.|..+|-+ +
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            3578999999999999999999665543    268999987653211 223446789999999999999999998877 8


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-----CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC----CcEEEee
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD----GHVMLTD  293 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~----g~vkL~D  293 (479)
                      ..+++++||.+. +|...++-.     ..++...++.++.||+.|+.|||++-|+||||||.|||+..+    |.+||+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence            899999999987 787777532     458899999999999999999999999999999999999888    8999999


Q ss_pred             cCCccccCCCC----CcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCH---------HHHHH
Q 011698          294 FGLAKQFDENT----RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNR---------QKIQQ  359 (479)
Q Consensus       294 FGla~~~~~~~----~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~---------~~~~~  359 (479)
                      ||+++.+...-    ....++-|.+|.|||.+.|. .|+.+.|+||+|||+.||+|-++.|.+...         .+..+
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999875442    33556779999999999984 689999999999999999999999976321         12233


Q ss_pred             HHHh--cc---------CCCCc--------------------------cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHH
Q 011698          360 KIIK--DK---------IKLPA--------------------------FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEI  402 (479)
Q Consensus       360 ~i~~--~~---------~~~p~--------------------------~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~ei  402 (479)
                      +|.+  +.         ..+|.                          .-++.+.+|+.+||+.||.+|+     |++++
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRI-----ta~qA  334 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRI-----TAEQA  334 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhc-----cHHHH
Confidence            3332  00         01121                          1256699999999999999999     99999


Q ss_pred             HhCccccCC
Q 011698          403 KSHKWFKMI  411 (479)
Q Consensus       403 l~hp~f~~~  411 (479)
                      ++|+||...
T Consensus       335 leh~yF~~d  343 (438)
T KOG0666|consen  335 LEHPYFTED  343 (438)
T ss_pred             hcccccccC
Confidence            999999875

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.1e-38  Score=313.43  Aligned_cols=249  Identities=17%  Similarity=0.224  Sum_probs=192.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCC---CeEEEEEEeehhhhch--HH-H-----HHHHHHHHHHHHhCCCCCeeeEeE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIME--KN-H-----AEYMKSERNILTKVDHPFIVQLRY  217 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~---~~~vAiK~i~~~~~~~--~~-~-----~~~~~~E~~iL~~l~hp~Iv~l~~  217 (479)
                      -++|++.+.||+|+||+||+|++..+   +..+|+|+........  +. .     ......+...+..++|++|+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            46899999999999999999999887   6778888654322110  00 0     011122334455678999999998


Q ss_pred             EEeeCC----eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEee
Q 011698          218 SFQTKY----RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTD  293 (479)
Q Consensus       218 ~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~D  293 (479)
                      ++....    ..++++|++.. ++...+......++..++.++.|++.||.|||+++|+||||||+|||++.++.++|+|
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D  169 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID  169 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence            776543    34778887754 5666666656678889999999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCC--------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCH-H--------H
Q 011698          294 FGLAKQFDENT--------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR-Q--------K  356 (479)
Q Consensus       294 FGla~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~-~--------~  356 (479)
                      ||+|+.+....        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+. .        +
T Consensus       170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~  249 (294)
T PHA02882        170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD  249 (294)
T ss_pred             cCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence            99998753221        12335799999999999999999999999999999999999999987632 2        1


Q ss_pred             HHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          357 IQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       357 ~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ....+..+...+ ...+.++.++++.|++.+|++||     +.+++++
T Consensus       250 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp-----~~~~l~~  291 (294)
T PHA02882        250 FIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKP-----DYDALIK  291 (294)
T ss_pred             HHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCC-----CHHHHHH
Confidence            223344444433 34689999999999999999999     8888864

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.4e-38  Score=311.10  Aligned_cols=248  Identities=24%  Similarity=0.363  Sum_probs=206.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcC----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee--CC
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIG----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KY  223 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~  223 (479)
                      ++|++++.||+|+||.||+|++..    +++.||+|++......  ...+.+.+|+.+++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            578899999999999999998753    4889999999865432  345678899999999999999999998877  56


Q ss_pred             eEEEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      ..++||||+++++|..++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            8999999999999999997654 589999999999999999999999999999999999999999999999999987653


Q ss_pred             CCCc----ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHH---------------HHHHHHHh
Q 011698          303 NTRS----NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ---------------KIQQKIIK  363 (479)
Q Consensus       303 ~~~~----~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~---------------~~~~~i~~  363 (479)
                      ....    ....++..|+|||.+.+..++.++|+||||+++|||++|..||......               .+...+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            2221    1223456799999999888999999999999999999999998653221               11222222


Q ss_pred             c-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          364 D-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       364 ~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      . ....+..++.++.+|+.+||+.+|++||     ++.||++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----t~~ei~~  278 (284)
T cd05038         242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRP-----SFADLIL  278 (284)
T ss_pred             CCcCCCCccCCHHHHHHHHHHhccChhhCC-----CHHHHHH
Confidence            1 2334556788999999999999999999     8888875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=324.30  Aligned_cols=247  Identities=24%  Similarity=0.343  Sum_probs=199.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-eEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-RLY  226 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-~~~  226 (479)
                      ..++|.--..||+|+||.||+|...+. ..||||.+.......   ...+.+|+.+|.+++|||+|+|+++|.+.+ ..+
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~  148 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL  148 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence            346888889999999999999998654 789999876644221   333899999999999999999999999988 599


Q ss_pred             EEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhC---CCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          227 LVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHAN---GIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~---~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      ||+|||.+|+|.++|+...  .+++.....|+.++++||+|||+.   .|||||||++|||+|.+..+||+|||+|+...
T Consensus       149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~  228 (361)
T KOG1187|consen  149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP  228 (361)
T ss_pred             EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence            9999999999999998765  789999999999999999999996   39999999999999999999999999997765


Q ss_pred             C-CCCcccc-cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC------HHHHHHHHH-hcc------C
Q 011698          302 E-NTRSNSM-CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN------RQKIQQKII-KDK------I  366 (479)
Q Consensus       302 ~-~~~~~~~-~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~------~~~~~~~i~-~~~------~  366 (479)
                      . .....+. .||.+|+|||.+.....+.++|||||||+|.||+||+.+.....      ..+...... .+.      .
T Consensus       229 ~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~  308 (361)
T KOG1187|consen  229 EGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDP  308 (361)
T ss_pred             ccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCC
Confidence            5 4443334 89999999999999889999999999999999999998886432      111111111 111      1


Q ss_pred             CCC-ccCC-----HHHHHHHHhhhhhchhhhcCCCCCCHHHHH
Q 011698          367 KLP-AFLS-----SEAHSLLKGLLQKEASKRLGSGPGGSQEIK  403 (479)
Q Consensus       367 ~~p-~~~s-----~~~~~lI~~~L~~dP~~R~~~~~~t~~eil  403 (479)
                      .+. ..+.     ..+..+...|++.+|.+||     +..|+.
T Consensus       309 ~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP-----~m~~Vv  346 (361)
T KOG1187|consen  309 RLKEGEYPDEKEVKKLAELALRCLRPDPKERP-----TMSQVV  346 (361)
T ss_pred             CccCCCCChHHHHHHHHHHHHHHcCcCCCcCc-----CHHHHH
Confidence            111 1222     2256678899999999999     666653

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.7e-38  Score=306.64  Aligned_cols=240  Identities=21%  Similarity=0.332  Sum_probs=194.3

Q ss_pred             EeccCCceEEEEEEEcCC--CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          157 VVGQGAFAKVYQVRRIGT--SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       157 ~LG~G~fG~V~~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      .||+|+||+||+|+....  ...+++|.+....  .....+.+.+|+.+++.++||||+++++.+.+....|+||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            699999999999976433  2346667665432  223356688899999999999999999999999999999999999


Q ss_pred             CcHHHHHHHc----CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC---CCcc
Q 011698          235 GHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TRSN  307 (479)
Q Consensus       235 gsL~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~---~~~~  307 (479)
                      |+|..++.+.    ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......   ....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence            9999998764    23566778889999999999999999999999999999999999999999998643211   1223


Q ss_pred             cccCCCCCcchhHhcC-------CCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc------CCCCccCC
Q 011698          308 SMCGTLEYMSPEIVLG-------KGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK------IKLPAFLS  373 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~-------~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~~------~~~p~~~s  373 (479)
                      ..+|+..|+|||++..       ..++.++|||||||++|||++ |..||...+..+....+..+.      ..++..++
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS  239 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence            5678899999999853       235789999999999999997 678998777776666655442      23344678


Q ss_pred             HHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       374 ~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ..+.++|..|| .+|.+||     ++++|++
T Consensus       240 ~~~~~l~~~c~-~~P~~Rp-----~~~~i~~  264 (268)
T cd05086         240 ERWYEVLQFCW-LSPEKRA-----TAEEVHR  264 (268)
T ss_pred             HHHHHHHHHHh-hCcccCC-----CHHHHHH
Confidence            99999999999 6799999     8888864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-39  Score=334.44  Aligned_cols=241  Identities=36%  Similarity=0.507  Sum_probs=201.6

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC------e
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY------R  224 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~------~  224 (479)
                      -|..-+.||+|+||.||+++++.+|+.||||.+++..  .....+..-+|+++|++++|+|||++++.-++..      .
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            4677789999999999999999999999999998755  3334667788999999999999999988766544      4


Q ss_pred             EEEEEEeccCCcHHHHHHH---cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC--CC--cEEEeecCCc
Q 011698          225 LYLVLDFVNGGHLFFQLYR---QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA--DG--HVMLTDFGLA  297 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~---~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~--~g--~vkL~DFGla  297 (479)
                      ..+|||||.||+|+..|.+   ...++|.....++.+++.||.|||++||+||||||.||++-.  +|  .-||+|||.|
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            6899999999999999965   346999999999999999999999999999999999999832  23  4799999999


Q ss_pred             cccCCCCCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhc--------
Q 011698          298 KQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKD--------  364 (479)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~----~~~~~~~~i~~~--------  364 (479)
                      +.++++....+++||+.|++||+... +.|+..+|.|||||++|+++||..||...    +..++...+...        
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~  251 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG  251 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence            99999999999999999999999985 88999999999999999999999999542    223344333331        


Q ss_pred             -------------cCCCCccCCHH----HHHHHHhhhhhchhhhcC
Q 011698          365 -------------KIKLPAFLSSE----AHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       365 -------------~~~~p~~~s~~----~~~lI~~~L~~dP~~R~~  393 (479)
                                   .+++|..++..    +-..+..+|.-+|.+|-+
T Consensus       252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~  297 (732)
T KOG4250|consen  252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH  297 (732)
T ss_pred             eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence                         12344445544    456788899999999974

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=309.03  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=213.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHh-CCCCCeeeEeEEEeeCCeE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~~~~~  225 (479)
                      +.-++.+-+..||.|+||+|++..++.+|+..|||.++....  .....++..|.+...+ -++||||++|+..-.++..
T Consensus        61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc  138 (361)
T KOG1006|consen   61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC  138 (361)
T ss_pred             cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence            344567778899999999999999999999999999987654  2334556667765554 5799999999999999999


Q ss_pred             EEEEEeccCCcHHHHHH-----HcCCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          226 YLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~-----~~~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      |+.||.|.- +|..+..     .+..++|+.+-.+....+.||.||.+. .|||||+||+|||++..|.+||||||++..
T Consensus       139 WiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  139 WICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ  217 (361)
T ss_pred             eeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence            999999975 5533222     345789999999999999999999875 899999999999999999999999999988


Q ss_pred             cCCCCCcccccCCCCCcchhHhcC--CCCCccccchhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCC---CCc---
Q 011698          300 FDENTRSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKDKIK---LPA---  370 (479)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~DiwSLGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~---~p~---  370 (479)
                      +..+-..+.-.|...|||||.+..  .+|+.++|+||||++|||++||..||.+.+ ..+....+..+.++   .+.   
T Consensus       218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~  297 (361)
T KOG1006|consen  218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV  297 (361)
T ss_pred             HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence            766655666778899999999964  569999999999999999999999998743 33444445555443   222   


Q ss_pred             cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       371 ~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      .++..+..+|..||.+|-+.||     ...+++.+||++.-
T Consensus       298 ~~s~~~~~fintCl~Kd~~~Rp-----ky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  298 HYSFSMVRFINTCLIKDRSDRP-----KYDDLKKFPFYRMY  333 (361)
T ss_pred             ccCHHHHHHHHHHhhcccccCc-----chhhhhcCchhhhh
Confidence            3899999999999999999999     78999999999874

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.1e-38  Score=347.47  Aligned_cols=251  Identities=31%  Similarity=0.488  Sum_probs=208.0

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee-------
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-------  221 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-------  221 (479)
                      +.+|+.++.||+||||.||+++.+-+|+.||||.|....  .......+.+|+.+|.+|+|||||++|..|..       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            568999999999999999999999999999999998764  34445668899999999999999998422100       


Q ss_pred             --------------------------------------------------------------------------------
Q 011698          222 --------------------------------------------------------------------------------  221 (479)
Q Consensus       222 --------------------------------------------------------------------------------  221 (479)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CeEEEEEEeccCCcHHHHHHHcCCC-cHHHHHHHHHHHHHHHHHHHh
Q 011698          222 ------------------------K--------YRLYLVLDFVNGGHLFFQLYRQGLF-REDLARIYTAEIVSAVSHLHA  268 (479)
Q Consensus       222 ------------------------~--------~~~~lV~E~~~ggsL~~~l~~~~~l-~e~~~~~~~~qi~~aL~~LH~  268 (479)
                                              +        ..+||-||||+...|.+.+.++... ..+.+|.+++||++||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                    0        2368899999997777777766554 478899999999999999999


Q ss_pred             CCCccCCCCCccEEeCCCCcEEEeecCCccccC-------------------CCCCcccccCCCCCcchhHhcCCC---C
Q 011698          269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-------------------ENTRSNSMCGTLEYMSPEIVLGKG---H  326 (479)
Q Consensus       269 ~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-------------------~~~~~~~~~gt~~y~APE~l~~~~---~  326 (479)
                      +|||||||||.||+++.++.|||+|||+|+...                   .....++.+||.-|+|||++.+..   |
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            999999999999999999999999999998721                   111345678999999999998765   9


Q ss_pred             CccccchhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCCcc----CCHHHHHHHHhhhhhchhhhcCCCCCCHHH
Q 011698          327 DKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKIKLPAF----LSSEAHSLLKGLLQKEASKRLGSGPGGSQE  401 (479)
Q Consensus       327 ~~~~DiwSLGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~----~s~~~~~lI~~~L~~dP~~R~~~~~~t~~e  401 (479)
                      +.|+||||||||++||+.   ||.. .....+..++..+.++.|..    --+.-.++|+.||++||++||     ||.|
T Consensus       796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRP-----tA~e  867 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRP-----TATE  867 (1351)
T ss_pred             cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCC-----CHHH
Confidence            999999999999999995   5743 44556666666666666532    235678899999999999999     9999


Q ss_pred             HHhCcccc
Q 011698          402 IKSHKWFK  409 (479)
Q Consensus       402 il~hp~f~  409 (479)
                      +|++.||-
T Consensus       868 LL~s~llp  875 (1351)
T KOG1035|consen  868 LLNSELLP  875 (1351)
T ss_pred             HhhccCCC
Confidence            99999998

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5.2e-37  Score=292.13  Aligned_cols=240  Identities=48%  Similarity=0.797  Sum_probs=213.7

Q ss_pred             CceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCCcHHHHH
Q 011698          162 AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL  241 (479)
Q Consensus       162 ~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l  241 (479)
                      +||.||+|.+..+++.+|+|++........  .+.+.+|+..+++++|+||+++++++......++++||+.+++|..++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999999999999999999976543221  567889999999999999999999999999999999999999999999


Q ss_pred             HHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccccCCCCCcchhHh
Q 011698          242 YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV  321 (479)
Q Consensus       242 ~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l  321 (479)
                      .....++...++.++.+++.++.+||+.+|+|+||+|.||+++.++.++|+|||.+.............++..|++||.+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            87776899999999999999999999999999999999999999999999999999887665555667789999999999


Q ss_pred             cCCCCCccccchhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCCcc---CCHHHHHHHHhhhhhchhhhcCCCCC
Q 011698          322 LGKGHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKIKLPAF---LSSEAHSLLKGLLQKEASKRLGSGPG  397 (479)
Q Consensus       322 ~~~~~~~~~DiwSLGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~lI~~~L~~dP~~R~~~~~~  397 (479)
                      .+..++.++|+||||+++|+|++|..||.. .+...+.+.+..........   ++.++.+++.+||..+|++||     
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp-----  233 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL-----  233 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc-----
Confidence            988899999999999999999999999987 56666666666555544333   889999999999999999999     


Q ss_pred             CHHHHHhCccc
Q 011698          398 GSQEIKSHKWF  408 (479)
Q Consensus       398 t~~eil~hp~f  408 (479)
                      ++.++++||||
T Consensus       234 ~~~~~~~~~~~  244 (244)
T smart00220      234 TAEEALQHPFF  244 (244)
T ss_pred             CHHHHhhCCCC
Confidence            89999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-38  Score=331.59  Aligned_cols=253  Identities=30%  Similarity=0.529  Sum_probs=223.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEe-----eC
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQ-----TK  222 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~-----~~  222 (479)
                      .+-|++..+||.|.+|+||+++.+.+++..|+|++....    ...+.++.|.++|+.. .|||++.+|++|.     .+
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            357999999999999999999999999999999987643    2344577899999987 6999999999985     35


Q ss_pred             CeEEEEEEeccCCcHHHHHHH--cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc
Q 011698          223 YRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~  300 (479)
                      +.+|||||||.||+.-++++.  ...+.|+.+..++++++.||.+||.+.+||||||-.|||++.+|.+||+|||.+..+
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            689999999999999888865  356899999999999999999999999999999999999999999999999999887


Q ss_pred             CCC-CCcccccCCCCCcchhHhcC-----CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---CCCCcc
Q 011698          301 DEN-TRSNSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAF  371 (479)
Q Consensus       301 ~~~-~~~~~~~gt~~y~APE~l~~-----~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~  371 (479)
                      +.. .+.++.+|||.|||||++..     ..|+..+|+||||++..||.-|.+|+.+..++...-.|..+.   +.-|..
T Consensus       174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k  253 (953)
T KOG0587|consen  174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK  253 (953)
T ss_pred             ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence            544 45678899999999999964     357889999999999999999999999988888887777763   334678


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      ++.++.+||..||.+|-.+||     +..+++.|||++.
T Consensus       254 Ws~~FndFIs~cL~Kd~e~RP-----~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  254 WSKKFNDFISTCLVKDYEQRP-----STEELLKHPFITE  287 (953)
T ss_pred             HHHHHHHHHHHHHhhccccCc-----chhhhccCCcccc
Confidence            999999999999999999999     8999999999984

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-39  Score=303.75  Aligned_cols=255  Identities=30%  Similarity=0.458  Sum_probs=210.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee-------
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-------  221 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-------  221 (479)
                      ...|+.+.+||+|.||+||+|+.+.+|+.||+|++-.+..... .-....+|+++|..++|+|++.+++.+.+       
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG-fpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC-CcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            3568888999999999999999999999999998754332222 22335679999999999999998877643       


Q ss_pred             -CCeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          222 -KYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       222 -~~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                       ...+|+||.+|+. +|+-+|... ..++...++.++.++..||.|+|+..|+|||+|++|+||+.+|.+||+|||+++.
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence             2358999999987 788788765 5799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCC-----CCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cc------
Q 011698          300 FDEN-----TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK--DK------  365 (479)
Q Consensus       300 ~~~~-----~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~--~~------  365 (479)
                      +...     .+.+..+-|.+|.+||.+.| +.|+.+.|||+-||||.||+||.+-|.+++.......|..  +.      
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            6432     22344566999999999988 5789999999999999999999999998877666655543  10      


Q ss_pred             -----------C---CCC-------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          366 -----------I---KLP-------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       366 -----------~---~~p-------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                                 +   ++|             -.-++++.+|+..||..||.+|+     ++.++++|.||..
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~-----~ad~alnh~~F~k  320 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI-----DADQALNHDFFWK  320 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc-----chHhhhchhhhhc
Confidence                       0   011             11256899999999999999999     8999999999976

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3e-37  Score=332.79  Aligned_cols=258  Identities=19%  Similarity=0.309  Sum_probs=184.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCC----CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEE---
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGT----SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYS---  218 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~----~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~---  218 (479)
                      ....++|++.+.||+|+||.||+|++..+    +..||+|.+......     +....|  .++...+.+++.+...   
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            35678999999999999999999999988    899999987643211     111111  1122222222222211   


Q ss_pred             ---EeeCCeEEEEEEeccCCcHHHHHHHcCC--------------------CcHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 011698          219 ---FQTKYRLYLVLDFVNGGHLFFQLYRQGL--------------------FREDLARIYTAEIVSAVSHLHANGIMHRD  275 (479)
Q Consensus       219 ---~~~~~~~~lV~E~~~ggsL~~~l~~~~~--------------------l~e~~~~~~~~qi~~aL~~LH~~~IiHrD  275 (479)
                         ......+++||||+.+++|.+++.....                    ..+..++.++.||+.||.|||+++|+|||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence               2456789999999999999988875431                    12345667999999999999999999999


Q ss_pred             CCCccEEeCC-CCcEEEeecCCccccCCC--CCcccccCCCCCcchhHhcCCC----------------------CCccc
Q 011698          276 LKPENILLDA-DGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG----------------------HDKAA  330 (479)
Q Consensus       276 LKpeNILl~~-~g~vkL~DFGla~~~~~~--~~~~~~~gt~~y~APE~l~~~~----------------------~~~~~  330 (479)
                      |||+|||++. ++.+||+|||+|+.+...  ......+||+.|||||.+....                      ++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999985 589999999999865432  2335678999999999775332                      34467


Q ss_pred             cchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------------------CCCccCCHHHHHHHHhhhhhchh
Q 011698          331 DWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---------------------KLPAFLSSEAHSLLKGLLQKEAS  389 (479)
Q Consensus       331 DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------------------~~p~~~s~~~~~lI~~~L~~dP~  389 (479)
                      |||||||++|||+++..++... .......+.....                     .........+.+||++||++||+
T Consensus       361 DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            9999999999999987765421 1111111111110                     00111233456899999999999


Q ss_pred             hhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          390 KRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       390 ~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                      +||     |++++++||||.+..+..+
T Consensus       440 kR~-----ta~e~L~Hpff~~~~~~~~  461 (566)
T PLN03225        440 QRI-----SAKAALAHPYFDREGLLGL  461 (566)
T ss_pred             cCC-----CHHHHhCCcCcCCCCcccc
Confidence            999     9999999999999887643

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=326.97  Aligned_cols=250  Identities=22%  Similarity=0.393  Sum_probs=221.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCC---CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      |..++.++.++||+|+||.|++|.|+..   ...||||+++.+....  ....|.+|+.+|.+|+|||+++||+...+ .
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-q  183 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q  183 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence            4456788889999999999999999753   3469999998765432  56678999999999999999999999987 7


Q ss_pred             eEEEEEEeccCCcHHHHHHH--cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          224 RLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      .+.+|||++++|+|.+.|++  +..|.......|+.||+.||.||.++++|||||-.+|||+-....+||+||||.+.+.
T Consensus       184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence            78899999999999999987  3568888888999999999999999999999999999999999999999999999987


Q ss_pred             CCCCcccccC----CCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHH
Q 011698          302 ENTRSNSMCG----TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (479)
Q Consensus       302 ~~~~~~~~~g----t~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  375 (479)
                      .....+.+.+    ...|+|||.++...++.++|+|++||+||||+| |+.||.+.....+.++|-.+ ++.-|+.++.+
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csed  343 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSED  343 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHH
Confidence            7665554433    346999999999999999999999999999999 99999999999999999865 77889999999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +.++++.||..+|++||     ++..|..
T Consensus       344 IY~imk~cWah~paDRp-----tFsair~  367 (1039)
T KOG0199|consen  344 IYQIMKNCWAHNPADRP-----TFSAIRE  367 (1039)
T ss_pred             HHHHHHHhccCCccccc-----cHHHHHH
Confidence            99999999999999999     7777654

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-38  Score=328.38  Aligned_cols=252  Identities=23%  Similarity=0.366  Sum_probs=225.2

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCC---eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      .+......+.++||.|.||+|++|+.+..|   ..||||.++...  .+.....|..|+.||-+++||||++|.+.....
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            356667889999999999999999998766   479999998754  344556688999999999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      ..+.||.|||++|+|..+|+.+ +.|+.-++..+++.|+.||.||-.+|+|||||..+|||++.+-.+|++|||+++.+.
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence            9999999999999999999765 678888999999999999999999999999999999999999999999999999875


Q ss_pred             CCC-Cccc-ccC--CCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHH
Q 011698          302 ENT-RSNS-MCG--TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (479)
Q Consensus       302 ~~~-~~~~-~~g--t~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  375 (479)
                      ++. ..++ .-|  ...|.|||.+..+.++.++||||+|++|||.++ |+.||.+.++++.++.|..+ +++.|..++..
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~a  862 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAA  862 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHH
Confidence            443 2222 223  468999999999999999999999999999988 99999999999999999988 77888899999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +..|+..||++|-.+||     .+.+|.+
T Consensus       863 L~qLMldCWqkdR~~RP-----~F~qiV~  886 (996)
T KOG0196|consen  863 LYQLMLDCWQKDRNRRP-----KFAQIVS  886 (996)
T ss_pred             HHHHHHHHHHHHhhcCC-----CHHHHHH
Confidence            99999999999999999     8888876

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.5e-38  Score=318.61  Aligned_cols=251  Identities=28%  Similarity=0.422  Sum_probs=215.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC------CCCeeeEeEEEeeC
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD------HPFIVQLRYSFQTK  222 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~------hp~Iv~l~~~~~~~  222 (479)
                      -.+|.+....|+|-|++|..|++...|..||||+|++..++...    -..|+.+|++|+      --++++++..|...
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~Kt----Gl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKT----GLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhh----hhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            36899999999999999999999999999999999987665433    467999999995      34899999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcC---CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC-cEEEeecCCcc
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAK  298 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g-~vkL~DFGla~  298 (479)
                      +++|||+|-+.- +|.++|.+-|   .|....++.|+.|++.||..|..+||+|.||||.|||++... .+||||||.|.
T Consensus       507 nHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  507 NHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             ceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence            999999998864 8899998765   478899999999999999999999999999999999998765 68999999998


Q ss_pred             ccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc--------
Q 011698          299 QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA--------  370 (479)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~--------  370 (479)
                      ...+...+.. .-+..|.|||++.|..|+...|+||+||+||||+||+..|.|.++..+....+.-+-+||.        
T Consensus       586 ~~~eneitPY-LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF  664 (752)
T KOG0670|consen  586 FASENEITPY-LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF  664 (752)
T ss_pred             ccccccccHH-HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch
Confidence            8776655443 3457899999999999999999999999999999999999998877776655543222221        


Q ss_pred             ----------------------------------------------------cCCHHHHHHHHhhhhhchhhhcCCCCCC
Q 011698          371 ----------------------------------------------------FLSSEAHSLLKGLLQKEASKRLGSGPGG  398 (479)
Q Consensus       371 ----------------------------------------------------~~s~~~~~lI~~~L~~dP~~R~~~~~~t  398 (479)
                                                                          ..-.++++||.+||..||++|+     +
T Consensus       665 ~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi-----t  739 (752)
T KOG0670|consen  665 KDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI-----T  739 (752)
T ss_pred             hhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC-----C
Confidence                                                                0135789999999999999999     8


Q ss_pred             HHHHHhCccccC
Q 011698          399 SQEIKSHKWFKM  410 (479)
Q Consensus       399 ~~eil~hp~f~~  410 (479)
                      ..++|.||||..
T Consensus       740 ~nqAL~HpFi~~  751 (752)
T KOG0670|consen  740 VNQALKHPFITE  751 (752)
T ss_pred             HHHHhcCCcccC
Confidence            999999999964

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-38  Score=311.43  Aligned_cols=256  Identities=31%  Similarity=0.514  Sum_probs=215.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc----hHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe-eCCe
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM----EKNHAEYMKSERNILTKVDHPFIVQLRYSFQ-TKYR  224 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-~~~~  224 (479)
                      ++|-++.+||+|+|+.||+|-+...++.||+|+-....-.    ..+..+...+|.+|-+.|+||.||++|++|. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            5688889999999999999999999999999986443222    3345667789999999999999999999995 5567


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC--CCccCCCCCccEEeC---CCCcEEEeecCCccc
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--GIMHRDLKPENILLD---ADGHVMLTDFGLAKQ  299 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--~IiHrDLKpeNILl~---~~g~vkL~DFGla~~  299 (479)
                      +|-|+|||+|.+|..+|.....++|..++.|+.||+.||.||.+.  .|||-||||.|||+-   .-|.+||+|||+++.
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            899999999999999999999999999999999999999999987  699999999999994   346899999999998


Q ss_pred             cCCCC--------CcccccCCCCCcchhHhcCC----CCCccccchhhHHHHHHHHhCCCCCCCCC-HHHHHH--HHHh-
Q 011698          300 FDENT--------RSNSMCGTLEYMSPEIVLGK----GHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQ--KIIK-  363 (479)
Q Consensus       300 ~~~~~--------~~~~~~gt~~y~APE~l~~~----~~~~~~DiwSLGvilyelltG~~Pf~~~~-~~~~~~--~i~~-  363 (479)
                      ++...        .+....||.||++||.+.-.    ..+.++||||+|||+|.++.|+-||..+- ..++.+  .|++ 
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA  702 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA  702 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence            85442        23557899999999988543    35889999999999999999999997642 233322  2222 


Q ss_pred             ccCCCC--ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          364 DKIKLP--AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       364 ~~~~~p--~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      ..+.||  +.+++++++||++||++.-++|.     ...++-.||||..
T Consensus       703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~-----DV~qLA~dpyllP  746 (775)
T KOG1151|consen  703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRI-----DVQQLACDPYLLP  746 (775)
T ss_pred             eeccCCCCCccCHHHHHHHHHHHHhhhhhhh-----hHHHHccCccccc
Confidence            245566  46999999999999999999998     8899999999865

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=318.68  Aligned_cols=244  Identities=24%  Similarity=0.406  Sum_probs=212.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcC----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      +..+..++.+.||.|-||.||+|.+..    ..--||||..+.+..  .+..+.+..|..+|+.++||||+++++.+.+ 
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e-  462 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-  462 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence            334455666889999999999998753    344699999987653  3346778899999999999999999999865 


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      ...|+|||.++-|.|..+|+.++ .++......|+.||+.||.|||++++|||||..+|||+....-+||+|||+++.+.
T Consensus       463 ~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  463 QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            46899999999999999998764 58888888999999999999999999999999999999999999999999999886


Q ss_pred             CCCCcccccC--CCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHH
Q 011698          302 ENTRSNSMCG--TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (479)
Q Consensus       302 ~~~~~~~~~g--t~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (479)
                      .........|  ...|||||-+.-+.++.++|||.|||+|||++. |.-||.+..+.+..-.|-++ +++.|+.+++.+.
T Consensus       543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LY  622 (974)
T KOG4257|consen  543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALY  622 (974)
T ss_pred             ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHH
Confidence            6544333233  457999999999999999999999999999998 99999998888777777776 7899999999999


Q ss_pred             HHHHhhhhhchhhhcC
Q 011698          378 SLLKGLLQKEASKRLG  393 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~  393 (479)
                      .|+.+||..||.+||.
T Consensus       623 slmskcWayeP~kRPr  638 (974)
T KOG4257|consen  623 SLMSKCWAYEPSKRPR  638 (974)
T ss_pred             HHHHHHhccCcccCCc
Confidence            9999999999999994

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-37  Score=314.55  Aligned_cols=247  Identities=23%  Similarity=0.372  Sum_probs=219.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+...+..+..+||-|.||.||.|.|+.-.-.||||.++.+..    .++.+..|+.+|+.++|||+|+|+++|..+..+
T Consensus       263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            3444567778999999999999999999999999999976543    356688899999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCC--CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      |||+|||..|+|.++|++...  ++.-....++.||..||+||..+++|||||-.+|+|+.++..+|++|||+++.+..+
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD  418 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence            999999999999999987643  566667778999999999999999999999999999999999999999999998765


Q ss_pred             CCcccccC---CCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHH
Q 011698          304 TRSNSMCG---TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (479)
Q Consensus       304 ~~~~~~~g---t~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (479)
                      +.+ ...|   ...|.|||-+....++.++|||+|||+|||+.| |..||.+.+...++..+.++ ++.-|.++++.+..
T Consensus       419 TYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYe  497 (1157)
T KOG4278|consen  419 TYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYE  497 (1157)
T ss_pred             cee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHH
Confidence            433 2223   457999999999999999999999999999999 99999999999888877776 67789999999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHH
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEI  402 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~ei  402 (479)
                      |++.||+-.|.+||     ++.||
T Consensus       498 LMraCW~WsPsDRP-----sFaei  516 (1157)
T KOG4278|consen  498 LMRACWNWSPSDRP-----SFAEI  516 (1157)
T ss_pred             HHHHHhcCCcccCc-----cHHHH
Confidence            99999999999999     67776

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.2e-36  Score=316.16  Aligned_cols=260  Identities=22%  Similarity=0.266  Sum_probs=192.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc----------------CCCeEEEEEEeehhhhchH-----------HHHHHHH
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRI----------------GTSEIYAMKVMRKDKIMEK-----------NHAEYMK  198 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~----------------~~~~~vAiK~i~~~~~~~~-----------~~~~~~~  198 (479)
                      .+..++|++.++||+|+||+||+|.+.                ..++.||||.+........           ...+...
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            356789999999999999999999752                2456799999865321100           0112233


Q ss_pred             HHHHHHHhCCCCCe-----eeEeEEEee--------CCeEEEEEEeccCCcHHHHHHHcC--------------------
Q 011698          199 SERNILTKVDHPFI-----VQLRYSFQT--------KYRLYLVLDFVNGGHLFFQLYRQG--------------------  245 (479)
Q Consensus       199 ~E~~iL~~l~hp~I-----v~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~--------------------  245 (479)
                      .|+.++.+++|.++     ++++++|..        ....++||||+.+++|.+++....                    
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            47777777776554     566666542        356899999999999999886421                    


Q ss_pred             ----CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccc--ccCCCCCcchh
Q 011698          246 ----LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS--MCGTLEYMSPE  319 (479)
Q Consensus       246 ----~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~--~~gt~~y~APE  319 (479)
                          .+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++..+........  ..+|+.|+|||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence                234567888999999999999999999999999999999999999999999976544333232  33488999999


Q ss_pred             HhcCCC--------------------CC--ccccchhhHHHHHHHHhCCC-CCCCCCHH-----------HHHHHHHhcc
Q 011698          320 IVLGKG--------------------HD--KAADWWSVGILLFEMLTGQP-PFTGGNRQ-----------KIQQKIIKDK  365 (479)
Q Consensus       320 ~l~~~~--------------------~~--~~~DiwSLGvilyelltG~~-Pf~~~~~~-----------~~~~~i~~~~  365 (479)
                      .+....                    |+  .+.|+||+||++|+|++|.. ||.+....           .....+....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            986432                    11  34799999999999999886 77542111           1111222233


Q ss_pred             CCCC--ccCCHHHHHHHHhhhhhch---hhhcCCCCCCHHHHHhCccccC
Q 011698          366 IKLP--AFLSSEAHSLLKGLLQKEA---SKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       366 ~~~p--~~~s~~~~~lI~~~L~~dP---~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      +.++  ...+..+++||.+||.++|   .+|+     |++|+|+||||..
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~Rl-----Sa~eaL~Hp~f~~  505 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRL-----SVGQALSHRFFLP  505 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCC-----CHHHHhCCCCcCC
Confidence            3333  4578999999999999876   6899     9999999999964

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-37  Score=293.63  Aligned_cols=251  Identities=28%  Similarity=0.454  Sum_probs=211.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-----
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----  223 (479)
                      ..+|.-++.+|.|.- .|..|-+.-+++.||+|.+... .....+.+...+|..++..++|+||++++.+|....     
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            457888999999998 7888888889999999998776 334556777889999999999999999999996543     


Q ss_pred             -eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 -RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 -~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                       ..|+|||+|.. +|...+.  -.++-+.++.+..|++.|+.|||+.||+||||||+||++..++.+||.|||+|+.-+.
T Consensus        94 ~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   94 QEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             HhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence             57999999976 7766666  3467788999999999999999999999999999999999999999999999987655


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------------------
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD------------------  364 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~------------------  364 (479)
                      .-..+..+.|..|.|||++.+.+|...+||||+||++.||++|...|.|.+.-+.+.+|...                  
T Consensus       171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~  250 (369)
T KOG0665|consen  171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN  250 (369)
T ss_pred             ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence            54566778899999999999999999999999999999999999999987654444333320                  


Q ss_pred             ----c-----C----CCCc-----------cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCcccc
Q 011698          365 ----K-----I----KLPA-----------FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK  409 (479)
Q Consensus       365 ----~-----~----~~p~-----------~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~  409 (479)
                          .     .    .+|+           .-+..+++++.+||..||++|.     +++++|+||||+
T Consensus       251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ri-----sv~daL~HPY~~  314 (369)
T KOG0665|consen  251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRI-----SVDDALRHPYIK  314 (369)
T ss_pred             HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcc-----cHHHHhcCCeee
Confidence                0     0    1111           1245689999999999999999     999999999999

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=302.20  Aligned_cols=250  Identities=20%  Similarity=0.320  Sum_probs=211.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +.-+...+.++||+|-||.|.+++-.. +..||+|.++.+.  ..+....+.+|+++|.+|+||||++++++|..++.++
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence            444678889999999999999999854 6889999998764  3344677899999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      +|+|||++|+|..++.++.  .+.......++.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+-...
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence            9999999999999998873  23444555699999999999999999999999999999999999999999999754332


Q ss_pred             Cc---ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh--CCCCCCCCCHHHHHHHHHh---c-----cCCCCcc
Q 011698          305 RS---NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT--GQPPFTGGNRQKIQQKIIK---D-----KIKLPAF  371 (479)
Q Consensus       305 ~~---~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt--G~~Pf~~~~~~~~~~~i~~---~-----~~~~p~~  371 (479)
                      ..   ...+-...|||+|.+....++.++|+|+||+++||+++  .+.||...+.+++.++...   +     -+..|.-
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~  771 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPA  771 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCc
Confidence            21   22334578999999999999999999999999999876  8999988777766655432   1     2345778


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ++..+.++|..||.+|-.+||     +++++..
T Consensus       772 cp~~lyelml~Cw~~es~~RP-----sFe~lh~  799 (807)
T KOG1094|consen  772 CPQGLYELMLRCWRRESEQRP-----SFEQLHL  799 (807)
T ss_pred             CcHHHHHHHHHHhchhhhcCC-----CHHHHHH
Confidence            999999999999999999999     8888743

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=6.7e-37  Score=281.47  Aligned_cols=251  Identities=28%  Similarity=0.471  Sum_probs=210.4

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCC--e
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKY--R  224 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~--~  224 (479)
                      ..++|++++++|+|.|++||.|....+++.++||+++.-.      .+.+++|+.+|+.|. ||||+.+++...+..  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            3578999999999999999999999999999999987532      345899999999997 999999999987654  4


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC-cEEEeecCCccccCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDEN  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g-~vkL~DFGla~~~~~~  303 (479)
                      ..+|+||+++.+...+.   ..++.-.++.|+.|++.||.|+|++||+|||+||.|++||... .++|+|+|+|......
T Consensus       110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            67999999987654333   3478889999999999999999999999999999999998654 6999999999998877


Q ss_pred             CCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHh-------------ccCCC
Q 011698          304 TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFT-GGNRQKIQQKIIK-------------DKIKL  368 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~-~~~~~~~~~~i~~-------------~~~~~  368 (479)
                      ...+..+.+..|-.||.+.. ..|+.+-|+|||||++..|+..+-||- |.++.+..-+|.+             -.+.+
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            77778888999999999976 668999999999999999999998874 4444333333332             11111


Q ss_pred             C------------------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          369 P------------------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       369 p------------------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      +                        ..+++++.+||.++|..|-.+|+     ||+|++.||||..+.
T Consensus       267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRl-----TakEam~HpyF~~~~  329 (338)
T KOG0668|consen  267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERL-----TAKEAMAHPYFAPVR  329 (338)
T ss_pred             ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcccccc-----chHHHhcCchHHHHH
Confidence            1                        12579999999999999999999     999999999998763

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=295.88  Aligned_cols=250  Identities=24%  Similarity=0.383  Sum_probs=200.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-----C---CCeeeEeEEEee
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----H---PFIVQLRYSFQT  221 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-----h---p~Iv~l~~~~~~  221 (479)
                      .+|.+.++||.|.|++||+|.+..+.+.||||+++...    ...+....|+.+|++++     |   .+||+|++.|..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            68999999999999999999999999999999998643    45667788999999873     3   379999999964


Q ss_pred             ----CCeEEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCC--------
Q 011698          222 ----KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDAD--------  286 (479)
Q Consensus       222 ----~~~~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~--------  286 (479)
                          +.++|+|+|++ |.+|..++.+.  ..++...++.|+.||+.||.|||++ ||||-||||||||+..+        
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~  232 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA  232 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence                56899999999 56888888765  4689999999999999999999986 99999999999999300        


Q ss_pred             --------------------------------------------------------------------------------
Q 011698          287 --------------------------------------------------------------------------------  286 (479)
Q Consensus       287 --------------------------------------------------------------------------------  286 (479)
                                                                                                      
T Consensus       233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~  312 (590)
T KOG1290|consen  233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN  312 (590)
T ss_pred             hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence                                                                                            


Q ss_pred             ------------------------------------------------------------------------------Cc
Q 011698          287 ------------------------------------------------------------------------------GH  288 (479)
Q Consensus       287 ------------------------------------------------------------------------------g~  288 (479)
                                                                                                    -.
T Consensus       313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~  392 (590)
T KOG1290|consen  313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR  392 (590)
T ss_pred             ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence                                                                                          02


Q ss_pred             EEEeecCCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC------HHHHHHHHH
Q 011698          289 VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN------RQKIQQKII  362 (479)
Q Consensus       289 vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~------~~~~~~~i~  362 (479)
                      |||+|||-|+....  ..+.-..|..|.|||++.|.+|+..+||||++|++|||+||...|...+      .++-...|+
T Consensus       393 vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~  470 (590)
T KOG1290|consen  393 VKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIM  470 (590)
T ss_pred             EEEeeccchhhhhh--hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHH
Confidence            45666666554321  1223356888999999999999999999999999999999999996321      111111221


Q ss_pred             ------------------------------------------hccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHH
Q 011698          363 ------------------------------------------KDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQ  400 (479)
Q Consensus       363 ------------------------------------------~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~  400 (479)
                                                                .+++.++..-..++.+||.-||+.+|++|+     ||.
T Consensus       471 ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~-----tA~  545 (590)
T KOG1290|consen  471 ELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP-----TAA  545 (590)
T ss_pred             HHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc-----cHH
Confidence                                                      223334444467889999999999999999     999


Q ss_pred             HHHhCccccCC
Q 011698          401 EIKSHKWFKMI  411 (479)
Q Consensus       401 eil~hp~f~~~  411 (479)
                      ++++|||+..+
T Consensus       546 ~cl~hPwLn~~  556 (590)
T KOG1290|consen  546 QCLKHPWLNPV  556 (590)
T ss_pred             HHhcCccccCC
Confidence            99999999986

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=319.48  Aligned_cols=239  Identities=26%  Similarity=0.435  Sum_probs=198.8

Q ss_pred             EEeccCCceE-EEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEEEEEEecc
Q 011698          156 KVVGQGAFAK-VYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVN  233 (479)
Q Consensus       156 ~~LG~G~fG~-V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~  233 (479)
                      +.+|.|+-|+ ||+|..  .|+.||||.+-.+      ....+++|+..|+.. +|||||++|+.-+++..+||+.|.|.
T Consensus       515 eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             HHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            5689999885 799988  5678999987543      355678999999998 59999999999999999999999997


Q ss_pred             CCcHHHHHHHcCC----CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC---CC--cEEEeecCCccccCCCC
Q 011698          234 GGHLFFQLYRQGL----FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DG--HVMLTDFGLAKQFDENT  304 (479)
Q Consensus       234 ggsL~~~l~~~~~----l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~---~g--~vkL~DFGla~~~~~~~  304 (479)
                      . +|.+++...+.    ......+..+.|++.||++||+.+||||||||.||||+.   ++  .++|+|||+++.+..+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            6 89998876411    111344678899999999999999999999999999976   34  78999999999976443


Q ss_pred             ----CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCC---ccCCHHH
Q 011698          305 ----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLP---AFLSSEA  376 (479)
Q Consensus       305 ----~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s~~~  376 (479)
                          +..+..||-+|+|||++.....+.++|||||||++|+.++ |.+||..  ..+-..+|+.+...+-   +....++
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd--~~~R~~NIl~~~~~L~~L~~~~d~eA  743 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD--SLERQANILTGNYTLVHLEPLPDCEA  743 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc--hHHhhhhhhcCccceeeeccCchHHH
Confidence                3456789999999999999888899999999999999999 5999954  4455667777755432   2222289


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      .+||.+||+.||..||     +|.+++.||+|..
T Consensus       744 ~dLI~~ml~~dP~~RP-----sa~~VL~HPlFW~  772 (903)
T KOG1027|consen  744 KDLISRMLNPDPQLRP-----SATDVLNHPLFWD  772 (903)
T ss_pred             HHHHHHhcCCCcccCC-----CHHHHhCCCccCC
Confidence            9999999999999999     9999999999986

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=291.99  Aligned_cols=257  Identities=26%  Similarity=0.390  Sum_probs=206.1

Q ss_pred             CCCCCCCCCCCCcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHh--CCCC
Q 011698          133 PTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK--VDHP  210 (479)
Q Consensus       133 ~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~--l~hp  210 (479)
                      -+|+..++|.-.++....+..+++.||+|.||+||+|+|+  |+.||||++....      .....+|.+|.+.  |+|+
T Consensus       194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHE  265 (513)
T KOG2052|consen  194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHE  265 (513)
T ss_pred             cCCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccc
Confidence            3455567777777777889999999999999999999995  5679999996532      2345678888775  5999


Q ss_pred             CeeeEeEEEeeC----CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCC
Q 011698          211 FIVQLRYSFQTK----YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--------GIMHRDLKP  278 (479)
Q Consensus       211 ~Iv~l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------~IiHrDLKp  278 (479)
                      ||+.+++.-...    ..+|||++|.+.|||+++|.+ ..++.+....++.-++.||+|||..        .|.|||||+
T Consensus       266 NILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS  344 (513)
T KOG2052|consen  266 NILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS  344 (513)
T ss_pred             hhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence            999998876543    368999999999999999998 5678888888999999999999964        599999999


Q ss_pred             ccEEeCCCCcEEEeecCCccccCCCC-----CcccccCCCCCcchhHhcCCCC------CccccchhhHHHHHHHHhC--
Q 011698          279 ENILLDADGHVMLTDFGLAKQFDENT-----RSNSMCGTLEYMSPEIVLGKGH------DKAADWWSVGILLFEMLTG--  345 (479)
Q Consensus       279 eNILl~~~g~vkL~DFGla~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~------~~~~DiwSLGvilyelltG--  345 (479)
                      .|||+.++|.+.|+|+|||-...+.+     ..+..+||..|||||++...--      -..+||||||+++||++.+  
T Consensus       345 KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~  424 (513)
T KOG2052|consen  345 KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE  424 (513)
T ss_pred             ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence            99999999999999999998765543     3467899999999999976421      1569999999999999863  


Q ss_pred             --------CCCCCC-----CCHHHHHHHHHhc--cCCCCccCC-----HHHHHHHHhhhhhchhhhcCCCCCCHHHHH
Q 011698          346 --------QPPFTG-----GNRQKIQQKIIKD--KIKLPAFLS-----SEAHSLLKGLLQKEASKRLGSGPGGSQEIK  403 (479)
Q Consensus       346 --------~~Pf~~-----~~~~~~~~~i~~~--~~~~p~~~s-----~~~~~lI~~~L~~dP~~R~~~~~~t~~eil  403 (479)
                              ++||.+     .+.+++.+-+...  ++.+|..+.     ..+..+++.||..+|.-|+     ||-.|+
T Consensus       425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRl-----tALriK  497 (513)
T KOG2052|consen  425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARL-----TALRIK  497 (513)
T ss_pred             cCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhh-----HHHHHH
Confidence                    578865     3445555554443  455665543     3567799999999999999     665554

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=314.44  Aligned_cols=255  Identities=28%  Similarity=0.463  Sum_probs=228.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|+++..+|.|+||.||+|+++.+++..|+|+++.+.   .....-++.|+-+++.++|||||.+++.|.....++++
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            378999999999999999999999999999999998754   33455678899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~  307 (479)
                      ||||.||+|.+..+-.++++|.++....++.++||+|||++|-+|||||-.|||+++.|.+|++|||.+..+... .+..
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence            999999999999998999999999999999999999999999999999999999999999999999999776433 3456


Q ss_pred             cccCCCCCcchhHh---cCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-----ccCCHHHHHH
Q 011698          308 SMCGTLEYMSPEIV---LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-----AFLSSEAHSL  379 (479)
Q Consensus       308 ~~~gt~~y~APE~l---~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~l  379 (479)
                      ++.||++|||||+.   +..+|...+|+|++|++..|+---++|-.+..++.......+..+..|     ..+++.+.+|
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f  250 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF  250 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence            78999999999987   456799999999999999999999999877777766666666544433     4689999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ++.+|.++|++||     +++.++.|||...-
T Consensus       251 vK~altknpKkRp-----taeklL~h~fvs~~  277 (829)
T KOG0576|consen  251 VKGALTKNPKKRP-----TAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHhcCCCccCC-----Chhhheeceeeccc
Confidence            9999999999999     89999999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=266.92  Aligned_cols=215  Identities=26%  Similarity=0.483  Sum_probs=181.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~  225 (479)
                      +..++..-+..||+|+||.|-+.++..+|...|+|.++..-  ..+....+.+|+++..+. .+|++|.+|+.+..+..+
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            44567777889999999999999999999999999997643  233345566788877665 799999999999999999


Q ss_pred             EEEEEeccCCcHHH----HHHHcCCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCCCcEEEeecCCcccc
Q 011698          226 YLVLDFVNGGHLFF----QLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       226 ~lV~E~~~ggsL~~----~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g~vkL~DFGla~~~  300 (479)
                      ++.||.|.- +|..    .+.+.+.++|..+-.++..++.||.|||++ .+||||+||.||||+.+|++||||||++..+
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            999999975 5532    344567899999999999999999999997 8999999999999999999999999999887


Q ss_pred             CCCCCcccccCCCCCcchhHhcC----CCCCccccchhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhc
Q 011698          301 DENTRSNSMCGTLEYMSPEIVLG----KGHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKD  364 (479)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~DiwSLGvilyelltG~~Pf~~-~~~~~~~~~i~~~  364 (479)
                      ..+-..+...|...|||||.+..    .+|+.++||||||+++.||.+++.||.. .++-+....+.++
T Consensus       200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            65554444668889999999864    4799999999999999999999999975 4556666666665

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-34  Score=309.51  Aligned_cols=253  Identities=24%  Similarity=0.415  Sum_probs=214.8

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcC-------CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEe
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLR  216 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~  216 (479)
                      ..+..++.++.+.||.|.||+|++|....       ....||||.++.....  ...+.+..|+++|+.+ +|+||+.++
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            33445566777899999999999997542       1457999998765432  5567789999999998 699999999


Q ss_pred             EEEeeCCeEEEEEEeccCCcHHHHHHHcC----------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCcc
Q 011698          217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (479)
Q Consensus       217 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeN  280 (479)
                      +++.....+++|+||+..|+|..+++..+                .++......++.||+.|++||+++++|||||-.+|
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN  448 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence            99999999999999999999999998766                37888899999999999999999999999999999


Q ss_pred             EEeCCCCcEEEeecCCccccCCCCCc--ccccC--CCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCC-H
Q 011698          281 ILLDADGHVMLTDFGLAKQFDENTRS--NSMCG--TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN-R  354 (479)
Q Consensus       281 ILl~~~g~vkL~DFGla~~~~~~~~~--~~~~g--t~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~-~  354 (479)
                      ||+..+..+||+|||+|+........  ..-.|  ...|||||.+....|+.++||||+||+||||+| |..||.+.. .
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99999999999999999864433222  11222  235999999999999999999999999999999 999999855 6


Q ss_pred             HHHHHHHHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          355 QKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       355 ~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .++.+.+..+ +...|.+++.++.++++.||+.+|++||     ++.++..
T Consensus       529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP-----~F~~~~~  574 (609)
T KOG0200|consen  529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRP-----TFSECVE  574 (609)
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCC-----CHHHHHH
Confidence            6677767766 6688999999999999999999999999     7777754

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=331.73  Aligned_cols=235  Identities=20%  Similarity=0.270  Sum_probs=188.0

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      .|...+.||+|+||.||+|+++.++..||+|.+.....       ....|+.++++++|||||++++++.+....|+|||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            45667889999999999999999999999999864321       11346788999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHH---hCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcc
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH---ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH---~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~  307 (479)
                      |+++|+|.+++++   +++.....++.||+.||+|||   +.+|+||||||+||+++.++..++. ||.......   ..
T Consensus       764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~  836 (968)
T PLN00113        764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DT  836 (968)
T ss_pred             CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CC
Confidence            9999999999863   788889999999999999999   6699999999999999999888876 666544321   22


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHh---------ccC----CCC
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN-----RQKIQQKIIK---------DKI----KLP  369 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~-----~~~~~~~i~~---------~~~----~~p  369 (479)
                      ...||+.|||||++.+..++.++|||||||++|||+||+.||....     ..+.......         ...    ..+
T Consensus       837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (968)
T PLN00113        837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN  916 (968)
T ss_pred             CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence            3468899999999999999999999999999999999999995321     1111111110         000    111


Q ss_pred             ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          370 AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       370 ~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .....++.+++.+||+.||++||     +++|+++
T Consensus       917 ~~~~~~~~~l~~~Cl~~~P~~RP-----t~~evl~  946 (968)
T PLN00113        917 QNEIVEVMNLALHCTATDPTARP-----CANDVLK  946 (968)
T ss_pred             HHHHHHHHHHHHhhCcCCchhCc-----CHHHHHH
Confidence            11223577899999999999999     8899875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=294.91  Aligned_cols=204  Identities=29%  Similarity=0.498  Sum_probs=185.2

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHH-----HHHHHHHHHHhCC---CCCeeeEeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAE-----YMKSERNILTKVD---HPFIVQLRYS  218 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~-----~~~~E~~iL~~l~---hp~Iv~l~~~  218 (479)
                      -.+.+|+.++.+|.|+||+|++|.++.+...|+||.+.|+++..+...+     .+-.|+.||..++   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            3456899999999999999999999999999999999998876554433     3457999999997   9999999999


Q ss_pred             EeeCCeEEEEEEecc-CCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          219 FQTKYRLYLVLDFVN-GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       219 ~~~~~~~~lV~E~~~-ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                      |++++++||+||-.. |.+|++++..+..++|..++.++.||+.|+++||++||||||||-||+.++.+|-+||+|||.|
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence            999999999999754 5599999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCcccccCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCC
Q 011698          298 KQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTG  351 (479)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~  351 (479)
                      ..... .....++||..|.|||++.|..| +..-|||+||++||-++..+.||+.
T Consensus       718 a~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  718 AYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            76543 45668899999999999999988 6789999999999999999999974

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-35  Score=279.01  Aligned_cols=253  Identities=25%  Similarity=0.405  Sum_probs=208.0

Q ss_pred             EEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-----eEEE
Q 011698          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----RLYL  227 (479)
Q Consensus       153 ~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----~~~l  227 (479)
                      +--+-||-|+||.||.+.+-.+|+.||+|++..-. ..-...+.+.+|+.+|..++|.|++..++..+...     .+|+
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            33468999999999999999999999999986522 22233456778999999999999999888776553     4688


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC--CC
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TR  305 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~--~~  305 (479)
                      ++|.|.. +|...+-.-..++.+.++.++.||++||.|||+.+|.||||||.|+|++.+..+||||||+++....+  ..
T Consensus       135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h  213 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN  213 (449)
T ss_pred             HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence            8999864 78777777778999999999999999999999999999999999999999999999999999976433  33


Q ss_pred             cccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------------------
Q 011698          306 SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK---------------------  363 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~---------------------  363 (479)
                      .+..+-|.+|.|||++.| +.|+.++||||+|||+.||+..+..|...++.+..+.|..                     
T Consensus       214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~  293 (449)
T KOG0664|consen  214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV  293 (449)
T ss_pred             hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence            445567899999999998 4689999999999999999999999988766555444432                     


Q ss_pred             --ccCCCC-----------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          364 --DKIKLP-----------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       364 --~~~~~p-----------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                        +..+-|           ..-..+..+++..+|..||.+|.     +.++++.|++.....
T Consensus       294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkri-----s~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRI-----SVEEALQHRYLEEGR  350 (449)
T ss_pred             hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccc-----cHhhhcccccccccc
Confidence              212222           12345788899999999999999     889999999987654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-34  Score=283.87  Aligned_cols=238  Identities=24%  Similarity=0.421  Sum_probs=196.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHh--CCCCCeeeEeEEEeeCC-
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK--VDHPFIVQLRYSFQTKY-  223 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~~~~~~-  223 (479)
                      ..+...+++++||+|.||.||+|+..  ++.||||++...      ..+.+++|.+|.+.  ++|+||+++++.-.... 
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~  278 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA  278 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence            44677888999999999999999984  589999998643      35668888888875  58999999998876655 


Q ss_pred             ---eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC---------CCccCCCCCccEEeCCCCcEEE
Q 011698          224 ---RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN---------GIMHRDLKPENILLDADGHVML  291 (479)
Q Consensus       224 ---~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---------~IiHrDLKpeNILl~~~g~vkL  291 (479)
                         .++||+||.+.|+|.++|..+ .++......++.-+++||+|||+-         .|+|||||..||||..|+++.|
T Consensus       279 ~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  279 DRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             cccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence               899999999999999999875 568889999999999999999973         5999999999999999999999


Q ss_pred             eecCCccccCCC---CCcccccCCCCCcchhHhcCCCC------CccccchhhHHHHHHHHhCCC------------CCC
Q 011698          292 TDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGH------DKAADWWSVGILLFEMLTGQP------------PFT  350 (479)
Q Consensus       292 ~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~------~~~~DiwSLGvilyelltG~~------------Pf~  350 (479)
                      +|||+|..+...   ..+...+||..|||||++.|.--      -.+.||||+|.+||||+++..            ||.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            999999887533   23445789999999999977421      257999999999999998643            332


Q ss_pred             -----CCCHHHHHHHHHhc--cCCCCccC-----CHHHHHHHHhhhhhchhhhcC
Q 011698          351 -----GGNRQKIQQKIIKD--KIKLPAFL-----SSEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       351 -----~~~~~~~~~~i~~~--~~~~p~~~-----s~~~~~lI~~~L~~dP~~R~~  393 (479)
                           ..+.++++..+...  ++.+|..+     -.-+++.|..||..|++-|++
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLT  492 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLT  492 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhh
Confidence                 13456677666654  66777654     346789999999999999994

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-34  Score=300.00  Aligned_cols=244  Identities=24%  Similarity=0.350  Sum_probs=212.3

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCe----EEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ..+..++||+|+||+||+|.|-..|+    +||||++....  .......+.+|+.+|.+++|||+++|++++.... +.
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            35567899999999999999976554    68888887644  2333456788999999999999999999998776 88


Q ss_pred             EEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      ||++||++|.|.++++.+ +.+-.+....|..||++||.|||.++++||||-.+|||+..-.++||+|||+++.+.....
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999999765 5688888999999999999999999999999999999999999999999999998765544


Q ss_pred             ccccc---CCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHH
Q 011698          306 SNSMC---GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (479)
Q Consensus       306 ~~~~~---gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI  380 (479)
                      .....   -.+.|||-|.+....|+.++||||+||++||++| |..|+.+....++-..+..+ ++.-|+..+.++.-++
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m  933 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM  933 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence            33322   2457999999999999999999999999999999 99999999999888877765 7888999999999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHH
Q 011698          381 KGLLQKEASKRLGSGPGGSQEI  402 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~ei  402 (479)
                      .+||..|+..||     +++++
T Consensus       934 vkCwmid~~~rp-----~fkel  950 (1177)
T KOG1025|consen  934 VKCWMIDADSRP-----TFKEL  950 (1177)
T ss_pred             HHHhccCcccCc-----cHHHH
Confidence            999999999999     55554

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=272.74  Aligned_cols=307  Identities=21%  Similarity=0.321  Sum_probs=265.7

Q ss_pred             ccccccCCCCccccccccCccchhhhccccC-ccccccccccCCCCCCcccc-cccCCCCCCCCCCCCCCcccCCCCeEE
Q 011698           77 RSHSLVGPSSYVSQSLKLSKLTLHEAEDSLG-LVEGINEETQEGPNNLSVVD-AALGKPTGHIDNLPSENQCVGLEDFEV  154 (479)
Q Consensus        77 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~y~~  154 (479)
                      -+.-|+..++.+..+||.+.++++++++.+. .+.++++..++.++.+++.| +|.|..+++++...++..++...+..+
T Consensus       115 iaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdatlsr~~gid~~~lnl  194 (448)
T KOG0195|consen  115 IAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDATLSRYTGIDVSSLNL  194 (448)
T ss_pred             HHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCcccccccccccccccccccccccccCcchhhhhh
Confidence            3456788999999999999999999999988 78889999999999999988 788899999999999999999999999


Q ss_pred             EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      +.+|.....|+.|+|+|.++.  ++.|++........ ..+.+..|.-.|+.+.||||+.+++.+++..++.++..||+.
T Consensus       195 ~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGND--IVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhccCCCcccccccccCcc--hhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            999999999999999997765  66777765443332 234467788889999999999999999999999999999999


Q ss_pred             CcHHHHHHHcCC--CcHHHHHHHHHHHHHHHHHHHhC-CCccC-CCCCccEEeCCCCcEEEe--ecCCccccCCCCCccc
Q 011698          235 GHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHAN-GIMHR-DLKPENILLDADGHVMLT--DFGLAKQFDENTRSNS  308 (479)
Q Consensus       235 gsL~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~-~IiHr-DLKpeNILl~~~g~vkL~--DFGla~~~~~~~~~~~  308 (479)
                      |+|+..++.+..  .+..++..++.+|++|++|||+. .++-| -|....++||++-+.+|+  |--++  +++..+.+ 
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs--fqe~gr~y-  348 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS--FQEVGRAY-  348 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee--eecccccc-
Confidence            999999998764  56678888999999999999997 45555 799999999999888776  32222  33333332 


Q ss_pred             ccCCCCCcchhHhcCCCCC---ccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCccCCHHHHHHHHhh
Q 011698          309 MCGTLEYMSPEIVLGKGHD---KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~---~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~lI~~~  383 (479)
                         .|.||+||.++.++.+   .++|+|||++++|||.|.+.||.+.++++...+|.-+  ++.+|++++.++..|++.|
T Consensus       349 ---~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~ic  425 (448)
T KOG0195|consen  349 ---SPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNIC  425 (448)
T ss_pred             ---CcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHH
Confidence               5899999999887654   6899999999999999999999999999999999876  6789999999999999999


Q ss_pred             hhhchhhhc
Q 011698          384 LQKEASKRL  392 (479)
Q Consensus       384 L~~dP~~R~  392 (479)
                      ++.||.+||
T Consensus       426 mnedpgkrp  434 (448)
T KOG0195|consen  426 MNEDPGKRP  434 (448)
T ss_pred             hcCCCCcCC
Confidence            999999999

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=2.4e-31  Score=251.25  Aligned_cols=213  Identities=42%  Similarity=0.671  Sum_probs=188.0

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEe
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~  231 (479)
                      |++.+.||.|++|.||+|....+++.+|+|.+......  ...+.+.+|+..+++++|+|++++++++......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            56789999999999999999988999999999865422  2456788899999999999999999999999999999999


Q ss_pred             ccCCcHHHHHHHcCC-CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC--Cccc
Q 011698          232 VNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RSNS  308 (479)
Q Consensus       232 ~~ggsL~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~--~~~~  308 (479)
                      +.+++|..++..... +++..++.++.+++.++.+||+++++|+||+|.||+++.++.++|+|||++.......  ....
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence            999999999988766 8999999999999999999999999999999999999999999999999998865543  3455


Q ss_pred             ccCCCCCcchhHh-cCCCCCccccchhhHHHHHHHHhCCCCCCC--CCHHHHHHHHHhccC
Q 011698          309 MCGTLEYMSPEIV-LGKGHDKAADWWSVGILLFEMLTGQPPFTG--GNRQKIQQKIIKDKI  366 (479)
Q Consensus       309 ~~gt~~y~APE~l-~~~~~~~~~DiwSLGvilyelltG~~Pf~~--~~~~~~~~~i~~~~~  366 (479)
                      ..++..|++||.+ ....++.++|+|+||+++|+|++|+.||..  .+...+.+.|..+.+
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  219 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP  219 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence            6788899999999 667778899999999999999999999987  444577777777653

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=9.2e-31  Score=242.35  Aligned_cols=211  Identities=39%  Similarity=0.666  Sum_probs=188.4

Q ss_pred             eccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCCcH
Q 011698          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL  237 (479)
Q Consensus       158 LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL  237 (479)
                      ||+|++|.||+++...+++.+++|++.......  ....+.+|+..++.++|++|+++++++......++++||+.|++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999998654221  346688999999999999999999999999999999999999999


Q ss_pred             HHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC-CCcEEEeecCCccccCCCC-CcccccCCCC
Q 011698          238 FFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENT-RSNSMCGTLE  314 (479)
Q Consensus       238 ~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~-~g~vkL~DFGla~~~~~~~-~~~~~~gt~~  314 (479)
                      ..++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+...
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence            9998876 57899999999999999999999999999999999999999 8999999999998765432 2334567889


Q ss_pred             CcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcC
Q 011698          315 YMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLG  393 (479)
Q Consensus       315 y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~  393 (479)
                      |++||.+... .++.+.|+|+||+++|+|                               ..+.+++..||+.+|++|| 
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R~-  206 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRP-  206 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccCc-
Confidence            9999999887 788999999999999999                               6789999999999999999 


Q ss_pred             CCCCCHHHHHhCc
Q 011698          394 SGPGGSQEIKSHK  406 (479)
Q Consensus       394 ~~~~t~~eil~hp  406 (479)
                          +++++++|+
T Consensus       207 ----~~~~l~~~~  215 (215)
T cd00180         207 ----SAKEILEHL  215 (215)
T ss_pred             ----CHHHHhhCC
Confidence                899998874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.97  E-value=7.5e-32  Score=291.36  Aligned_cols=249  Identities=38%  Similarity=0.733  Sum_probs=211.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      .+|+.++.|..|+||.||+++++.+.+.+|+ .++++.+.-.+          +|.....|++|                
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilRn----------ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILRN----------ILTFAGNPFVV----------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhh-cccccchhhhc----------cccccCCccee----------------
Confidence            6899999999999999999999999999999 45554432111          45555666666                


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-----
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----  304 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-----  304 (479)
                           |+-...+...+.++.+.        +.+++|||+.||+|||+||+|.||+.-|++|++|||+.+......     
T Consensus       136 -----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~  202 (1205)
T KOG0606|consen  136 -----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK  202 (1205)
T ss_pred             -----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence                 45556666666666544        778999999999999999999999999999999999987632111     


Q ss_pred             -----------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCcc--
Q 011698          305 -----------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAF--  371 (479)
Q Consensus       305 -----------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--  371 (479)
                                 .....||||.|+|||++..++|+..+|||++|+|+||.+-|..||.+++.++++..++.+.+.+|..  
T Consensus       203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~de  282 (1205)
T KOG0606|consen  203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDE  282 (1205)
T ss_pred             hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCc
Confidence                       1235799999999999999999999999999999999999999999999999999999999988864  


Q ss_pred             -CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccc
Q 011698          372 -LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECW  442 (479)
Q Consensus       372 -~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~  442 (479)
                       +.++++++|..||+.+|..|++..  ++-++++|.||+.++|.-|..++  ..|+|......+...|+..-
T Consensus       283 a~p~Ea~dli~~LL~qnp~~Rlgt~--ga~evk~h~ff~~LDw~~llRqk--aefvpql~~eddtsyfdTRs  350 (1205)
T KOG0606|consen  283 ALPPEAQDLIEQLLRQNPLCRLGTG--GALEVKQHGFFQLLDWKSLLRQK--AEFVPQLESEDDTSYFDTRS  350 (1205)
T ss_pred             CCCHHHHHHHHHHHHhChHhhcccc--hhhhhhhccceeecccchhhhhh--ccccccccccccchhhcccc
Confidence             789999999999999999999864  88999999999999999887665  46999998888888887543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=1.1e-30  Score=259.25  Aligned_cols=251  Identities=24%  Similarity=0.455  Sum_probs=199.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcC---CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCe
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~  224 (479)
                      .+.|.++.+||.|+|+.||++.+..   ..+.||+|.+....     ....+.+|+++|..+ .+.||+++.+++..+++
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            3579999999999999999998877   78899999987543     344588999999998 48999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC-CCcEEEeecCCccccC--
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLAKQFD--  301 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~-~g~vkL~DFGla~~~~--  301 (479)
                      ..+||||++.....+++..   ++...++.|+..++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|...+  
T Consensus       110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~  186 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY  186 (418)
T ss_pred             eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence            9999999998877666654   567889999999999999999999999999999999975 4678999999997210  


Q ss_pred             ---------------C--CC--------------------------CcccccCCCCCcchhHhcCC-CCCccccchhhHH
Q 011698          302 ---------------E--NT--------------------------RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGI  337 (479)
Q Consensus       302 ---------------~--~~--------------------------~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGv  337 (479)
                                     .  +.                          ......||++|.|||++..- ..+.++||||.||
T Consensus       187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV  266 (418)
T KOG1167|consen  187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV  266 (418)
T ss_pred             hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence                           0  00                          00124699999999999774 4589999999999


Q ss_pred             HHHHHHhCCCCCCCCCH--------------HHHHHH-HHhcc---------------------C---------------
Q 011698          338 LLFEMLTGQPPFTGGNR--------------QKIQQK-IIKDK---------------------I---------------  366 (479)
Q Consensus       338 ilyelltG~~Pf~~~~~--------------~~~~~~-i~~~~---------------------~---------------  366 (479)
                      |+.-++++..||.....              .++.+. ...++                     +               
T Consensus       267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~  346 (418)
T KOG1167|consen  267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER  346 (418)
T ss_pred             eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence            99999999999953210              000000 00001                     0               


Q ss_pred             -CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          367 -KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       367 -~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                       ..-+.++..+.+|+.+||..||.+|.     ||+++|.||||...+
T Consensus       347 ~~~~d~~~~~~~dlLdk~le~np~kRi-----tAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  347 EIGSDVFPALLLDLLDKCLELNPQKRI-----TAEDALKHPFFDEAD  388 (418)
T ss_pred             ccccccccHHHHHHHHHHccCChhhcc-----cHHHHhcCcCCcchh
Confidence             00123456899999999999999999     999999999999653

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-29  Score=247.66  Aligned_cols=247  Identities=17%  Similarity=0.269  Sum_probs=207.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCC-----eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee-CC
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTS-----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-KY  223 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~  223 (479)
                      .++++..++-+|.||+||.|.|++..     +.|-+|.++...  .+-+...+..|.-+|..+.|||+.++.+.... ..
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            56788888999999999999887532     345666665432  44567778889999999999999999887754 45


Q ss_pred             eEEEEEEeccCCcHHHHHHHc--------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQ--------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFG  295 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~--------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFG  295 (479)
                      ..++++.++.-|+|..+|...        ..++..+...++.|++.|++|||+.||||.||..+|.+||+.-.+||+|=.
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsa  441 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSA  441 (563)
T ss_pred             cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccch
Confidence            678889999999998888732        235667778899999999999999999999999999999999999999999


Q ss_pred             CccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCc
Q 011698          296 LAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPA  370 (479)
Q Consensus       296 la~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~  370 (479)
                      +++.+...+.   ....-....||+||.+.+..|+.++|+|||||+||||+| |+.||...++.++..-+..+ ++.-|-
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~  521 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPF  521 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCC
Confidence            9987533221   112223568999999999999999999999999999999 99999999999999988887 677888


Q ss_pred             cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHH
Q 011698          371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIK  403 (479)
Q Consensus       371 ~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil  403 (479)
                      .++.++..++.-||..+|++||     +.+|+.
T Consensus       522 NCPDeLf~vMacCWallpeeRP-----sf~Qlv  549 (563)
T KOG1024|consen  522 NCPDELFTVMACCWALLPEERP-----SFSQLV  549 (563)
T ss_pred             CCcHHHHHHHHHHHhcCcccCC-----CHHHHH
Confidence            9999999999999999999999     777764

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.7e-30  Score=290.53  Aligned_cols=197  Identities=17%  Similarity=0.154  Sum_probs=147.0

Q ss_pred             CCC-CCeeeEeEEE-------eeCCeEEEEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 011698          207 VDH-PFIVQLRYSF-------QTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK  277 (479)
Q Consensus       207 l~h-p~Iv~l~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLK  277 (479)
                      ++| +||++++++|       .....++++|||+ +++|..++.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            344 4666677766       2334678889987 5599999975 3468999999999999999999999999999999


Q ss_pred             CccEEeCCC-------------------CcEEEeecCCccccCCC-----------------CCcccccCCCCCcchhHh
Q 011698          278 PENILLDAD-------------------GHVMLTDFGLAKQFDEN-----------------TRSNSMCGTLEYMSPEIV  321 (479)
Q Consensus       278 peNILl~~~-------------------g~vkL~DFGla~~~~~~-----------------~~~~~~~gt~~y~APE~l  321 (479)
                      |+||||+..                   +.+||+|||+++.....                 ......+||+.|||||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            999999654                   44556666666532110                 001124689999999999


Q ss_pred             cCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHH
Q 011698          322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQ  400 (479)
Q Consensus       322 ~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~  400 (479)
                      .+..|+.++|||||||+||||++|..|+....  .....+...... ..........+++..||+++|.+||     ++.
T Consensus       188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rp-----s~~  260 (793)
T PLN00181        188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRP-----SMS  260 (793)
T ss_pred             ccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCc-----ChH
Confidence            99999999999999999999999999875422  222222221111 1111245678999999999999999     899


Q ss_pred             HHHhCccccCC
Q 011698          401 EIKSHKWFKMI  411 (479)
Q Consensus       401 eil~hp~f~~~  411 (479)
                      |+++||||...
T Consensus       261 eil~h~~~~~~  271 (793)
T PLN00181        261 ELLQSEFINEP  271 (793)
T ss_pred             HHhhchhhhhh
Confidence            99999999763

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.7e-30  Score=240.96  Aligned_cols=250  Identities=23%  Similarity=0.323  Sum_probs=190.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeE-EEeeCCeEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY-SFQTKYRLYL  227 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~-~~~~~~~~~l  227 (479)
                      +.|.+.+.||+|.||++.+|++++++..+++|.+.+....    ...+.+|...--.| .|.||+.-|+ .|++.+.+++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            5799999999999999999999999999999999876543    33456666554444 5899998764 5788899999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC--CCcEEEeecCCccccCCCCC
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~--~g~vkL~DFGla~~~~~~~~  305 (479)
                      +|||++.|+|..-+... .+.|...+.++.|++.|+.|||++++||||||.+||||-.  ..++||||||+.+..+.  .
T Consensus       100 ~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--t  176 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--T  176 (378)
T ss_pred             eeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc--e
Confidence            99999999998777653 4688889999999999999999999999999999999943  34899999999976432  2


Q ss_pred             cccccCCCCCcchhHhcCC---C--CCccccchhhHHHHHHHHhCCCCCCCCCHH----HHHHHHH-hccCCCCc---cC
Q 011698          306 SNSMCGTLEYMSPEIVLGK---G--HDKAADWWSVGILLFEMLTGQPPFTGGNRQ----KIQQKII-KDKIKLPA---FL  372 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~---~--~~~~~DiwSLGvilyelltG~~Pf~~~~~~----~~~~~i~-~~~~~~p~---~~  372 (479)
                      ....--+-.|.+||.+...   .  ..+.+|+|.||+++|.++||.+||.....+    .-+.+-. ......|.   .+
T Consensus       177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f  256 (378)
T KOG1345|consen  177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF  256 (378)
T ss_pred             ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence            2222335579999988543   2  368899999999999999999999743211    1111222 22334554   47


Q ss_pred             CHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       373 s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      |+.+..+.++-|..++++|--  .-+++.....-|.
T Consensus       257 s~~a~r~Fkk~lt~~~~drck--i~~~kk~rk~~w~  290 (378)
T KOG1345|consen  257 SEKALRLFKKSLTPRFKDRCK--IWTAKKMRKCLWK  290 (378)
T ss_pred             CHHHHHHHHHhcCCcccccch--hHHHHHHHHHHHH
Confidence            899999999999999999931  1244555444444

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=8.9e-27  Score=227.84  Aligned_cols=251  Identities=40%  Similarity=0.629  Sum_probs=209.8

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCC-CeeeEeEEEeeCCeEEEEEE
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP-FIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      |++.+.||.|+||.||++.+.   ..+|+|.+.............+.+|..+++.+.|+ +|++++..+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999997   67999999876544434567788999999999988 79999999988888999999


Q ss_pred             eccCCcHHHHHHHcC---CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC-cEEEeecCCccccCCCC--
Q 011698          231 FVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDENT--  304 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g-~vkL~DFGla~~~~~~~--  304 (479)
                      ++.++++...+....   .+.+..+..++.|++.++.|+|+.+++||||||+||+++..+ .++++|||+++.+....  
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999997776664   789999999999999999999999999999999999999998 79999999998654432  


Q ss_pred             -----CcccccCCCCCcchhHhcC---CCCCccccchhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCC-CCcc
Q 011698          305 -----RSNSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNR----QKIQQKIIKDKIK-LPAF  371 (479)
Q Consensus       305 -----~~~~~~gt~~y~APE~l~~---~~~~~~~DiwSLGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~-~p~~  371 (479)
                           .....+||..|+|||.+.+   ..+....|+||+|++++++++|..||.....    ......+...... ....
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 3467789999999999998   5788999999999999999999999887663    4555555554433 2222


Q ss_pred             CC--------HHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          372 LS--------SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       372 ~s--------~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      ..        ..+.+++..++..+|..|.     +..+...+.|...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~-----~~~~~~~~~~~~~  280 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRL-----SSSSDLSHDLLAH  280 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcC-----CHHHHhhchHhhC
Confidence            22        5789999999999999998     5666666655544

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.7e-28  Score=223.71  Aligned_cols=159  Identities=20%  Similarity=0.211  Sum_probs=131.5

Q ss_pred             CcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccccCCC
Q 011698          235 GHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL  313 (479)
Q Consensus       235 gsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt~  313 (479)
                      |+|.+++.. ...+++..++.++.||+.||.|||+++      ||+|||++.++.+|+  ||+++......    ..||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            689999986 456999999999999999999999999      999999999999999  99998754322    36899


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCC-------CCccCCH--HHHHHHHhh
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIKDKIK-------LPAFLSS--EAHSLLKGL  383 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~-~~~~~~i~~~~~~-------~p~~~s~--~~~~lI~~~  383 (479)
                      .|||||++.+..++.++|||||||++|||+||+.||..... ......+......       .+..++.  ++.++|..|
T Consensus        69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c  148 (176)
T smart00750       69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC  148 (176)
T ss_pred             cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence            99999999999999999999999999999999999976443 2333333332111       1223444  699999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          384 LQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      |+.||.+||     ++.+++.|+|+..
T Consensus       149 l~~~p~~Rp-----~~~~ll~~~~~~~  170 (176)
T smart00750      149 ASRLPQRRE-----AANHYLAHCRALF  170 (176)
T ss_pred             Hhccccccc-----CHHHHHHHHHHHH
Confidence            999999999     8999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=2.1e-28  Score=264.08  Aligned_cols=255  Identities=26%  Similarity=0.433  Sum_probs=205.3

Q ss_pred             EEEEEeccCCceEEEEEEEcCCCeEEEEEEeehh---hhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKD---KIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       153 ~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      .....+|.|++|.|+.+......+.++.|..+..   ..........+..|.-+-..+.|||++..+..+++....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4567899999998888888777776777765421   1112222222666777778889999988777776666666669


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-----C
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-----T  304 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-----~  304 (479)
                      |||++ +|+..+.+.+.+....+..++.|++.|+.|||..||.|||||++|+|++.+|.+||+|||.+..+...     .
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            99999 99999999888999999999999999999999999999999999999999999999999999875432     3


Q ss_pred             CcccccCCCCCcchhHhcCCCCC-ccccchhhHHHHHHHHhCCCCCCCCCHHHHH---------HHHHhccCCCCccCCH
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQ---------QKIIKDKIKLPAFLSS  374 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~-~~~DiwSLGvilyelltG~~Pf~~~~~~~~~---------~~i~~~~~~~p~~~s~  374 (479)
                      .....+|+..|+|||++.+..|+ ..+||||.|+++..|.+|+.||.-....+..         .++..+...+-..++.
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~  559 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR  559 (601)
T ss_pred             hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence            34678999999999999999996 5699999999999999999999754433221         1111122223345788


Q ss_pred             HHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          375 EAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       375 ~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      +.+.+|.+||+.||.+|.     ++++|++.+||+.+.-
T Consensus       560 ~~~~~~~~~l~~~P~~R~-----ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  560 ETRIIIYRMLQLDPTKRI-----TIEQILNDEWIRSIEC  593 (601)
T ss_pred             hHHHHHHHHccCChhhee-----cHHHHhhChHhhhcce
Confidence            999999999999999999     9999999999998853

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.3e-26  Score=235.86  Aligned_cols=171  Identities=20%  Similarity=0.191  Sum_probs=134.0

Q ss_pred             CcccCCCCeEEEEEeccCCceEEEEEEEcC-CCeEEEEEEeehhhh--chHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe
Q 011698          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKI--MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (479)
Q Consensus       144 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~-~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  220 (479)
                      ......++|++.+.||+|+||+||+|+++. +++.||||++.....  ........+++|+.+|++++|+||++.+..+ 
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-   90 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-   90 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence            344556789999999999999999999876 678889998753311  1233456789999999999999998533322 


Q ss_pred             eCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCC-CCccEEeCCCCcEEEeecCCccc
Q 011698          221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL-KPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       221 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDL-KpeNILl~~~g~vkL~DFGla~~  299 (479)
                        ...|+||||++|++|.. +...   .   ...++.+++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus        91 --~~~~LVmE~~~G~~L~~-~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHL-ARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             --CCcEEEEEccCCCCHHH-hCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence              45899999999999962 2111   1   1457889999999999999999999 99999999999999999999997


Q ss_pred             cCCCCC---------cccccCCCCCcchhHhcCC
Q 011698          300 FDENTR---------SNSMCGTLEYMSPEIVLGK  324 (479)
Q Consensus       300 ~~~~~~---------~~~~~gt~~y~APE~l~~~  324 (479)
                      +.....         ..+.++++.|+|||.+..+
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            643221         1356788899999998653

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=6.9e-25  Score=221.64  Aligned_cols=238  Identities=25%  Similarity=0.380  Sum_probs=187.8

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCC-eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC----CCeeeEeEEE-eeCCe
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH----PFIVQLRYSF-QTKYR  224 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h----p~Iv~l~~~~-~~~~~  224 (479)
                      +|++.+.||+|+||.||+|.+..++ +.+|+|+.........   ..++.|..++..+..    +++..+++.+ .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999998774 6799999876432111   147788999988862    6899999999 57888


Q ss_pred             EEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC-----CcEEEeecCCc
Q 011698          225 LYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-----GHVMLTDFGLA  297 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~-----g~vkL~DFGla  297 (479)
                      -|+||+.+ |.+|.++....  +.++...+..++.|++.+|++||+.|++||||||.|+++...     ..+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            89999988 66998877554  579999999999999999999999999999999999999865     36999999999


Q ss_pred             c--ccC-CCC-------C-cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--
Q 011698          298 K--QFD-ENT-------R-SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--  364 (479)
Q Consensus       298 ~--~~~-~~~-------~-~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--  364 (479)
                      +  ... ...       . ...+.||..|+++.+..+...+.+.|+||++.++.|++.|..||.+........++...  
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8  321 111       1 22355999999999999999999999999999999999999999775533222222221  


Q ss_pred             -cC-C-CCccCCHHHHHHHHhhhhhchhhhc
Q 011698          365 -KI-K-LPAFLSSEAHSLLKGLLQKEASKRL  392 (479)
Q Consensus       365 -~~-~-~p~~~s~~~~~lI~~~L~~dP~~R~  392 (479)
                       .. . +....+.++.++...+-..+...+|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P  285 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKP  285 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCC
Confidence             11 1 2234556777777777777777777

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=5.5e-25  Score=204.39  Aligned_cols=266  Identities=21%  Similarity=0.315  Sum_probs=209.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC-CCeeeEeEEEeeCCeE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQLRYSFQTKYRL  225 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~~  225 (479)
                      +....|.++++||.|+||.+|+|....+|+.||||+-.....     ..++..|..+.+.|++ ..|..+..++.+..+-
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            556789999999999999999999999999999999765431     2236678899999874 7888888888888889


Q ss_pred             EEEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC---cEEEeecCCccccC
Q 011698          226 YLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDFGLAKQFD  301 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g---~vkL~DFGla~~~~  301 (479)
                      .+||+.+ |-+|.+++.- ...|+...+..++-|++.-++|+|.+++|||||||+|+|+.-+-   .+-|+|||+|+.+.
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999998 6688877753 35689999999999999999999999999999999999996544   57899999999753


Q ss_pred             CCC--------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhccCCCC-
Q 011698          302 ENT--------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKDKIKLP-  369 (479)
Q Consensus       302 ~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~~p-  369 (479)
                      ...        ......||..|.+--...+...+...|+-|+|.+|..+.-|..||.+.   +....+++|.+.+...| 
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            221        234568999999988888888899999999999999999999999885   44566777887776655 


Q ss_pred             ----ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHH-------HhCccccCCChhhhhccc
Q 011698          370 ----AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEI-------KSHKWFKMINWKKLEARE  420 (479)
Q Consensus       370 ----~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~ei-------l~hp~f~~~~~~~l~~~~  420 (479)
                          .+++.++.-.|.-|-..--++-|...  -..++       ++|.+=--.+|..++++.
T Consensus       246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~--ylrqlFriLfr~ln~~~d~iyDW~~lkqk~  305 (341)
T KOG1163|consen  246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDYM--YLRQLFRILFRTLNHQYDYIYDWTMLKQKS  305 (341)
T ss_pred             HHHhCCCcHHHHHHHHHHhhcCCCCCCcHH--HHHHHHHHHHhhccccCCeEeeHHHHHHHh
Confidence                46788888888888665444444221  12333       233333346898887543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=2.3e-24  Score=208.36  Aligned_cols=210  Identities=24%  Similarity=0.398  Sum_probs=179.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      -.|++.++||+|+||..++|...-+++.||||.-....     ..-+++.|.+..+.|. .++|..+|++.+.+-+-.||
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            47999999999999999999999999999999854332     3455788888888885 79999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC-----cEEEeecCCccccCC
Q 011698          229 LDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-----HVMLTDFGLAKQFDE  302 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g-----~vkL~DFGla~~~~~  302 (479)
                      +|++ |-+|.+++.-++ .|+...+..++.|++.-++|+|++.+|+|||||+|+||..-|     .+-|+|||+|+....
T Consensus       103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9998 668888887654 599999999999999999999999999999999999996543     689999999998643


Q ss_pred             CC--------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcc
Q 011698          303 NT--------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKDK  365 (479)
Q Consensus       303 ~~--------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~---~~~~~~~~i~~~~  365 (479)
                      ..        ...+..||..||+=-...|+..+...|+-|||-++...|-|.+||.+.   +..+-+++|-..+
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K  255 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK  255 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence            32        124678999999999999999999999999999999999999999874   4556666666543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1e-23  Score=197.05  Aligned_cols=143  Identities=20%  Similarity=0.261  Sum_probs=113.0

Q ss_pred             EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHH-----------------------HHHHHHHHHHHHHhCCCCC
Q 011698          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-----------------------HAEYMKSERNILTKVDHPF  211 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~-----------------------~~~~~~~E~~iL~~l~hp~  211 (479)
                      ...||+|+||+||+|.+. +|+.||+|+++........                       .......|+.+|.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999997 8999999999875321111                       0123456999999998777


Q ss_pred             eeeEeEEEeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCccEEeCCCCcEE
Q 011698          212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL-HANGIMHRDLKPENILLDADGHVM  290 (479)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~L-H~~~IiHrDLKpeNILl~~~g~vk  290 (479)
                      +....... .. ..++||||++|+++.......+.+++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus        81 v~~p~~~~-~~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPIL-LK-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEE-ec-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            64332222 22 2389999999987765555567889999999999999999999 799999999999999998 58899


Q ss_pred             EeecCCccccC
Q 011698          291 LTDFGLAKQFD  301 (479)
Q Consensus       291 L~DFGla~~~~  301 (479)
                      |+|||+|....
T Consensus       158 LiDFG~a~~~~  168 (190)
T cd05147         158 IIDVSQSVEHD  168 (190)
T ss_pred             EEEccccccCC
Confidence            99999997643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=1.4e-23  Score=199.92  Aligned_cols=173  Identities=15%  Similarity=0.171  Sum_probs=136.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHH------HHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY------MKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~------~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      -++|++++.||.|+||.||++..  ++..+|+|+++.+....+.....      +.+|++.+.++.|++|..+..++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            46899999999999999999766  35579999998654433333333      67899999999999999998886643


Q ss_pred             --------CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeec
Q 011698          223 --------YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDF  294 (479)
Q Consensus       223 --------~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DF  294 (479)
                              ...++||||++|.+|.+..    .+++.    ...+|+.+|..||+.|++|||+||.||+++.+| ++|+||
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf  178 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL  178 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence                    3578999999999997663    23332    456999999999999999999999999999999 999999


Q ss_pred             CCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHH
Q 011698          295 GLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML  343 (479)
Q Consensus       295 Gla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyell  343 (479)
                      |..+...+....           -.++....|+.++|+||||+++..+.
T Consensus       179 g~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        179 SGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence            998765332221           11455566788999999999987554

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=7e-23  Score=200.76  Aligned_cols=234  Identities=26%  Similarity=0.394  Sum_probs=153.2

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC-----------CCeeeEeE--
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-----------PFIVQLRY--  217 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h-----------p~Iv~l~~--  217 (479)
                      .+...+.||.|+++.||.+++..||+.+|+|+............+.+++|.-....+.+           ..++.+--  
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            46678899999999999999999999999999876554445556667766655444322           22222211  


Q ss_pred             ------EEeeC---C-----eEEEEEEeccCCcHHHHHH---HcCCC---cHHHHHH-HHHHHHHHHHHHHhCCCccCCC
Q 011698          218 ------SFQTK---Y-----RLYLVLDFVNGGHLFFQLY---RQGLF---REDLARI-YTAEIVSAVSHLHANGIMHRDL  276 (479)
Q Consensus       218 ------~~~~~---~-----~~~lV~E~~~ggsL~~~l~---~~~~l---~e~~~~~-~~~qi~~aL~~LH~~~IiHrDL  276 (479)
                            +++..   .     +.+++|+-+.+ +|...+.   .....   ....++. +..|+++.+++||..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                  11111   1     34778888754 7766543   33222   1223333 4589999999999999999999


Q ss_pred             CCccEEeCCCCcEEEeecCCccccCCCCCcccccCCCCCcchhHhcCC--------CCCccccchhhHHHHHHHHhCCCC
Q 011698          277 KPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK--------GHDKAADWWSVGILLFEMLTGQPP  348 (479)
Q Consensus       277 KpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~--------~~~~~~DiwSLGvilyelltG~~P  348 (479)
                      ||+|++++.+|.++|+||+.....+.....  ...+..|.+||.....        .++.+.|.|+||+++|.|+||..|
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            999999999999999999888665432221  3445789999987542        468899999999999999999999


Q ss_pred             CCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhh
Q 011698          349 FTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKR  391 (479)
Q Consensus       349 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R  391 (479)
                      |...........    .+..-..+++.++.||+.||+++|.+|
T Consensus       250 f~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            986443221111    122222678999999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=8.4e-23  Score=190.88  Aligned_cols=144  Identities=21%  Similarity=0.247  Sum_probs=114.8

Q ss_pred             EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhch-----------------------HHHHHHHHHHHHHHHhCCCCC
Q 011698          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----------------------KNHAEYMKSERNILTKVDHPF  211 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~-----------------------~~~~~~~~~E~~iL~~l~hp~  211 (479)
                      .+.||+|+||+||+|.+. +|+.||||+++......                       .......+.|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 89999999998753110                       011234568999999999998


Q ss_pred             eeeEeEEEeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEeCCCCcEE
Q 011698          212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVM  290 (479)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl~~~g~vk  290 (479)
                      |.........  ..|+||||++|+++.........+++..+..++.|++.+|.++|+ +||+||||||+|||++ ++.++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            7544333322  248999999998654443345678888999999999999999999 9999999999999998 89999


Q ss_pred             EeecCCccccCC
Q 011698          291 LTDFGLAKQFDE  302 (479)
Q Consensus       291 L~DFGla~~~~~  302 (479)
                      |+|||++..+..
T Consensus       158 liDFG~a~~~~~  169 (190)
T cd05145         158 IIDVSQAVELDH  169 (190)
T ss_pred             EEEcccceecCC
Confidence            999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.89  E-value=6.5e-24  Score=230.27  Aligned_cols=295  Identities=34%  Similarity=0.560  Sum_probs=254.0

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      .....+++.+++-+-+|+++.++.++-..+|...++|+..+......+..+.+..+.+++-...+|.+++....+.....
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            45778999999999999999999999999998888888776554444455556666666666678999988777778889


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC--
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE--  302 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~--  302 (479)
                      ++|+++|..|++|...|+.-+..+++.++.++..+..++++||...++|||++|.|+|+..+|+.+++|||.......  
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999984432110  


Q ss_pred             ------------------------------CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 011698          303 ------------------------------NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG  352 (479)
Q Consensus       303 ------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~  352 (479)
                                                    ........||+.|.+||.+.+......+|||++|++++|.++|.+||...
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                                          01123457899999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHHhccCCCCc---cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcccc
Q 011698          353 NRQKIQQKIIKDKIKLPA---FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEV  429 (479)
Q Consensus       353 ~~~~~~~~i~~~~~~~p~---~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~  429 (479)
                      ..+.++++|....+.+|.   ..+.++++++..+|..+|.+|.+..  .+.++..|+||+.++|+.+....  ..|+|.+
T Consensus      1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~--~~~e~k~~~~~~~~~~~~l~~q~--~~~~p~~ 1114 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK--GAAEVKGHPFFQDVDWENLALQK--AEFVPQP 1114 (1205)
T ss_pred             chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc--cccccccCCccCCCCcccccccc--CccCCCC
Confidence            999999999999888875   4799999999999999999999653  56799999999999999986544  4578888


Q ss_pred             CCcccccCcccccc
Q 011698          430 AGKHCVANFEECWT  443 (479)
Q Consensus       430 ~~~~~~~~f~~~~~  443 (479)
                      ....+...|...|.
T Consensus      1115 ~s~~dtS~~~~r~~ 1128 (1205)
T KOG0606|consen 1115 ESTQDTSYFESRFS 1128 (1205)
T ss_pred             CCCCccchhhcccc
Confidence            77778888887776

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=2.5e-22  Score=187.87  Aligned_cols=188  Identities=18%  Similarity=0.195  Sum_probs=143.2

Q ss_pred             EEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH-HHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEEEEEE
Q 011698          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       153 ~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      .+...|++|+||+|+++..  .+..++.+.+........ -....+++|+++|+++. |++|++++++    ...|++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3567899999999998766  566677776654332211 11235789999999995 5889999875    45699999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCC-CCccEEeCCCCcEEEeecCCccccCCCCCc---
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL-KPENILLDADGHVMLTDFGLAKQFDENTRS---  306 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDL-KpeNILl~~~g~vkL~DFGla~~~~~~~~~---  306 (479)
                      |+.|.+|...+..      . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.........   
T Consensus        79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~  151 (218)
T PRK12274         79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL  151 (218)
T ss_pred             eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence            9999998654321      1 1346789999999999999999999 799999999999999999999865543321   


Q ss_pred             -----------ccccCCCCCcchhHhcCC-CCC-ccccchhhHHHHHHHHhCCCCCCCCC
Q 011698          307 -----------NSMCGTLEYMSPEIVLGK-GHD-KAADWWSVGILLFEMLTGQPPFTGGN  353 (479)
Q Consensus       307 -----------~~~~gt~~y~APE~l~~~-~~~-~~~DiwSLGvilyelltG~~Pf~~~~  353 (479)
                                 .-...++.|+.|+...-. ..+ ...+|++.|+-+|.++||..++.+++
T Consensus       152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                       112357889999976543 233 67899999999999999999986543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-23  Score=228.04  Aligned_cols=235  Identities=23%  Similarity=0.347  Sum_probs=183.8

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhh--hchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK--IMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +|...+.||++.|=+|.+|++.. |. |+||++-+..  +.-....+.+ .|++ ...+++||++++..+-.++...|+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            68889999999999999999853 54 8999987643  2222333333 3444 6667999999998887788888999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc--cCCCCCc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ--FDENTRS  306 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~--~~~~~~~  306 (479)
                      -+|... +|++.+..+..+.+-+.+.|+.|++.||.-+|+.||+|+|||.|||||+.-+.+.|+||..-+.  +.++...
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            999876 8999999998899999999999999999999999999999999999999999999999987764  2332211


Q ss_pred             --ccc----cCCCCCcchhHhcCCC-----------CCccccchhhHHHHHHHHh-CCCCCCC-----------CCHHHH
Q 011698          307 --NSM----CGTLEYMSPEIVLGKG-----------HDKAADWWSVGILLFEMLT-GQPPFTG-----------GNRQKI  357 (479)
Q Consensus       307 --~~~----~gt~~y~APE~l~~~~-----------~~~~~DiwSLGvilyellt-G~~Pf~~-----------~~~~~~  357 (479)
                        ..+    ..-..|+|||.+....           .+++.||||+||++.||++ |++||.-           .+.+..
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~  258 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL  258 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence              111    1224799999986522           4578999999999999999 8999952           111122


Q ss_pred             HHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          358 QQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       358 ~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      .++|          -+..++++|..|++.||.+|+     +|++.|+.
T Consensus       259 Le~I----------ed~~~Rnlil~Mi~rdPs~Rl-----SAedyL~~  291 (1431)
T KOG1240|consen  259 LEKI----------EDVSLRNLILSMIQRDPSKRL-----SAEDYLQK  291 (1431)
T ss_pred             HHhC----------cCccHHHHHHHHHccCchhcc-----CHHHHHHh
Confidence            2211          244789999999999999999     89999875

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.3e-22  Score=198.42  Aligned_cols=268  Identities=27%  Similarity=0.400  Sum_probs=191.0

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCC-----------------------------------eEEEEEEeehhhhc
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-----------------------------------EIYAMKVMRKDKIM  189 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~-----------------------------------~~vAiK~i~~~~~~  189 (479)
                      .++.+++|++...||+|.-..||.|+....|                                   =+.|||.|-.-...
T Consensus       152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~  231 (598)
T KOG4158|consen  152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD  231 (598)
T ss_pred             cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence            4578899999999999999999998765421                                   02466665432211


Q ss_pred             --hHHHHHHHHHHH------HHH--------Hh--------CCCCCeeeEeEEEee------------------------
Q 011698          190 --EKNHAEYMKSER------NIL--------TK--------VDHPFIVQLRYSFQT------------------------  221 (479)
Q Consensus       190 --~~~~~~~~~~E~------~iL--------~~--------l~hp~Iv~l~~~~~~------------------------  221 (479)
                        +....+.+.+|.      .++        +.        -+|||||++..+|.+                        
T Consensus       232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g  311 (598)
T KOG4158|consen  232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG  311 (598)
T ss_pred             CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence              111122222222      011        11        259999999877743                        


Q ss_pred             ---CCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe--CCCC--cEEEeec
Q 011698          222 ---KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL--DADG--HVMLTDF  294 (479)
Q Consensus       222 ---~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl--~~~g--~vkL~DF  294 (479)
                         ...+|+||..... +|..++-.+. .+....+.+++|+++|+.|||++||.|||||.+|||+  |+|+  .+.|+||
T Consensus       312 ~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF  389 (598)
T KOG4158|consen  312 AGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF  389 (598)
T ss_pred             cCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence               2357999988865 8888886654 4666777889999999999999999999999999999  4444  5889999


Q ss_pred             CCccccCC-------CCCcccccCCCCCcchhHhcCCCC------CccccchhhHHHHHHHHhCCCCCCCCCHHHHHHH-
Q 011698          295 GLAKQFDE-------NTRSNSMCGTLEYMSPEIVLGKGH------DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQK-  360 (479)
Q Consensus       295 Gla~~~~~-------~~~~~~~~gt~~y~APE~l~~~~~------~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~-  360 (479)
                      |+|-.-..       ....-...|...-||||+....+-      -.++|.|+.|.+.||+++...||++...+.+..+ 
T Consensus       390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~  469 (598)
T KOG4158|consen  390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT  469 (598)
T ss_pred             ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh
Confidence            98843211       111233457788999999975321      2689999999999999999999987443322211 


Q ss_pred             HHh-ccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          361 IIK-DKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       361 i~~-~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                      ..+ .-+.+|..+++.+++++..+|++||++|++.  +-+..+++---|..-+|-+-
T Consensus       470 Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp--~iAANvl~LsLw~~~~~vka  524 (598)
T KOG4158|consen  470 YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP--NIAANVLNLSLWRMGEDVKA  524 (598)
T ss_pred             hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc--cHHHhHHHHHHhcCchHHHH
Confidence            122 2456788999999999999999999999953  35678888777777777543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=5e-21  Score=211.47  Aligned_cols=222  Identities=23%  Similarity=0.369  Sum_probs=176.4

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC---CCCeeeEeEEEeeC
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQLRYSFQTK  222 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~~~~  222 (479)
                      .+..+.|.+-+.||+|+||+||.|...+ |+.||+|+-+.....+--.      =.+++.+|+   -+.|..+..++.-.
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI------~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI------CLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee------hHHHHHhhchhhhcchHHHHHHHccC
Confidence            3566789999999999999999999977 9999999987655433211      122334444   24566666666777


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC-------CCcEEEeecC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-------DGHVMLTDFG  295 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~-------~g~vkL~DFG  295 (479)
                      +..+||+||.+.|+|.+++...+..++..+.+++.|++..+++||..+|||+||||+|+||..       .--++|+|||
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            788999999999999999998889999999999999999999999999999999999999942       3369999999


Q ss_pred             Ccccc---CCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----cCC
Q 011698          296 LAKQF---DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-----KIK  367 (479)
Q Consensus       296 la~~~---~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-----~~~  367 (479)
                      .+..+   ...++....++|-.+-.+|+..|+.+++.+|.|.|+.+++-||.|+.-=           ...+     ...
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~~~~~~~  915 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------VKNGSSWMVKTN  915 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcCCcceecccc
Confidence            98653   4556777889999999999999999999999999999999999985421           2222     112


Q ss_pred             CCccCCHHH-HHHHHhhhh
Q 011698          368 LPAFLSSEA-HSLLKGLLQ  385 (479)
Q Consensus       368 ~p~~~s~~~-~~lI~~~L~  385 (479)
                      ++.++..++ .+|+..||+
T Consensus       916 ~~Ry~~~~~W~~~F~~lLN  934 (974)
T KOG1166|consen  916 FPRYWKRDMWNKFFDLLLN  934 (974)
T ss_pred             chhhhhHHHHHHHHHHHhC
Confidence            444444444 557788887

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=2.2e-20  Score=176.84  Aligned_cols=135  Identities=19%  Similarity=0.181  Sum_probs=107.7

Q ss_pred             EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-----CCCCeeeEeEEEeeCC---eEE
Q 011698          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-----DHPFIVQLRYSFQTKY---RLY  226 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~~~~~~---~~~  226 (479)
                      .+.||+|+||.||.  +..++.. +||++.....   ...+.+.+|+.+++.+     +||||++++++++++.   .++
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            47899999999995  6666655 7999876432   2345688999999999     6799999999999874   434


Q ss_pred             -EEEEe--ccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHH-HHHHhCCCccCCCCCccEEeCCC----CcEEEeecCCcc
Q 011698          227 -LVLDF--VNGGHLFFQLYRQGLFREDLARIYTAEIVSAV-SHLHANGIMHRDLKPENILLDAD----GHVMLTDFGLAK  298 (479)
Q Consensus       227 -lV~E~--~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL-~~LH~~~IiHrDLKpeNILl~~~----g~vkL~DFGla~  298 (479)
                       +||||  +.+|+|.+++.+. .+++.  ..++.+++.++ +|||+++|+||||||+|||++..    +.++|+||+.+.
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence             78999  5579999999764 56666  35678888888 99999999999999999999743    389999955553

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=3e-20  Score=179.57  Aligned_cols=147  Identities=22%  Similarity=0.236  Sum_probs=116.3

Q ss_pred             CeEEEEEeccCCceEEEEEE-EcCCCeEEEEEEeehhhhch---------------------HHHHHHHHHHHHHHHhCC
Q 011698          151 DFEVLKVVGQGAFAKVYQVR-RIGTSEIYAMKVMRKDKIME---------------------KNHAEYMKSERNILTKVD  208 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~-~~~~~~~vAiK~i~~~~~~~---------------------~~~~~~~~~E~~iL~~l~  208 (479)
                      .|++.+.||+|+||.||+|. +..+|+.||+|+++......                     ......++.|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47888999999999999998 66789999999998643110                     011234678999999997


Q ss_pred             CCC--eeeEeEEEeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCC-CccCCCCCccEEeCC
Q 011698          209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG-IMHRDLKPENILLDA  285 (479)
Q Consensus       209 hp~--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~-IiHrDLKpeNILl~~  285 (479)
                      +..  +.++++.    ...++||||+.|++|.........+.+..+..++.||+.+|.+||+.| |+||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            533  3444432    235899999999888665544556677778889999999999999999 99999999999998 


Q ss_pred             CCcEEEeecCCccccCC
Q 011698          286 DGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       286 ~g~vkL~DFGla~~~~~  302 (479)
                      ++.++|+|||.+.....
T Consensus       184 ~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      184 DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             CCCEEEEEChhhhccCC
Confidence            88999999999976443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=5.5e-19  Score=167.01  Aligned_cols=137  Identities=25%  Similarity=0.353  Sum_probs=114.0

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhh-----chHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-----MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +.||+|++|.||+|.+  +|..+++|+......     ........+.+|+.++..+.|++|.....++......++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999988  566799998654321     112223457789999999999998777667777788899999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      |++|++|.+.+.....    ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988865432    6777899999999999999999999999999998 88999999999865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=1.2e-18  Score=163.38  Aligned_cols=133  Identities=23%  Similarity=0.259  Sum_probs=107.0

Q ss_pred             EeccCCceEEEEEEEcCCCeEEEEEEeehhhh-----chHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEe
Q 011698          157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-----MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (479)
Q Consensus       157 ~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~  231 (479)
                      .||+|+||.||+|.+  ++..+++|+......     ........+.+|+++++.+.|+++.....++......++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            389999999999996  556799998654221     1122345677899999999888765544455566678999999


Q ss_pred             ccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       232 ~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      ++|++|.+.+.....       .++.+++.+|.+||+.|++|+|++|+||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999887765321       6788999999999999999999999999998 89999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=5.1e-21  Score=206.86  Aligned_cols=256  Identities=28%  Similarity=0.461  Sum_probs=209.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcC-CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~  226 (479)
                      ...|.+.+.||+|+|+.|-++.... +...+|+|.+.... ......+.+..|..+-+.+. |.|++.+++........+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            3568888899999999999887743 45567777765543 23444556677888888887 999999999999999999


Q ss_pred             EEEEeccCCcHHHHH-HHcC-CCcHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCccEEeCCCC-cEEEeecCCccccCC
Q 011698          227 LVLDFVNGGHLFFQL-YRQG-LFREDLARIYTAEIVSAVSHLH-ANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDE  302 (479)
Q Consensus       227 lV~E~~~ggsL~~~l-~~~~-~l~e~~~~~~~~qi~~aL~~LH-~~~IiHrDLKpeNILl~~~g-~vkL~DFGla~~~~~  302 (479)
                      ++++|..|++++..+ .... ..+...+..+..|+..++.|+| ..++.||||||+|.+++..+ .++++|||+|..+..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999999888 5544 6778888899999999999999 99999999999999999999 999999999988654


Q ss_pred             -C---CCcccccC-CCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHHHHH-HHHHhc----cCCCCcc
Q 011698          303 -N---TRSNSMCG-TLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ-QKIIKD----KIKLPAF  371 (479)
Q Consensus       303 -~---~~~~~~~g-t~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~-~~i~~~----~~~~p~~  371 (479)
                       .   ......+| ++.|+|||...+..| ....|+||.|+++.-+++|..|+......... ......    .......
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS  257 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence             2   22355788 999999999998544 78899999999999999999999764433211 111111    2334467


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      ++....+++.++|..+|..|.     +.+++..++|+..
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~-----s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRL-----SIEELKLDNWLSS  291 (601)
T ss_pred             CChhhhhcccccccCCchhcc-----ccccccccccccc
Confidence            899999999999999999999     8899999999998

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1.3e-18  Score=163.52  Aligned_cols=140  Identities=19%  Similarity=0.184  Sum_probs=109.1

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhch-------------------HHHHHHHHHHHHHHHhCCCC--
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-------------------KNHAEYMKSERNILTKVDHP--  210 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~-------------------~~~~~~~~~E~~iL~~l~hp--  210 (479)
                      |.+.+.||+|+||.||++.+. +|+.||||+++......                   .........|..++..+.|+  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            677889999999999999875 78999999987532100                   01112356788899998777  


Q ss_pred             CeeeEeEEEeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEE
Q 011698          211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM  290 (479)
Q Consensus       211 ~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vk  290 (479)
                      .++..++    ....++||||++|++|......      .....++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence            3444443    2345899999999988654321      34567889999999999999999999999999999999999


Q ss_pred             EeecCCccccCC
Q 011698          291 LTDFGLAKQFDE  302 (479)
Q Consensus       291 L~DFGla~~~~~  302 (479)
                      |+|||++.....
T Consensus       166 liDfg~~~~~~~  177 (198)
T cd05144         166 IIDWPQMVSTDH  177 (198)
T ss_pred             EEECCccccCCC
Confidence            999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.78  E-value=2.5e-19  Score=183.43  Aligned_cols=244  Identities=24%  Similarity=0.296  Sum_probs=164.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCC---CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEe------EEE-
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLR------YSF-  219 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~------~~~-  219 (479)
                      ...+.+..+++++|.++..+...+   .+-++-+....+   .-.......+++-.+.-.. |+..+..-      ..+ 
T Consensus       245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d---~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~  321 (516)
T KOG1033|consen  245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD---SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK  321 (516)
T ss_pred             cccccccccccccCCchhhhhcccchhhhhccchhhhcc---chhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence            345556677777777766554433   222333322211   1122333334444444443 33332211      011 


Q ss_pred             ----eeCCeEEEEEEeccCCcHHHHHHHcCC---CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEe
Q 011698          220 ----QTKYRLYLVLDFVNGGHLFFQLYRQGL---FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLT  292 (479)
Q Consensus       220 ----~~~~~~~lV~E~~~ggsL~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~  292 (479)
                          ....++|+.|++|.-.+|.+++.+...   .+......++.|++.|+.|   ++.+|||+||.||....+..+||.
T Consensus       322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg  398 (516)
T KOG1033|consen  322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG  398 (516)
T ss_pred             ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence                112368999999999999999975432   4556777889999999999   999999999999999999999999


Q ss_pred             ecCCccccCCCC-------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 011698          293 DFGLAKQFDENT-------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD  364 (479)
Q Consensus       293 DFGla~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~  364 (479)
                      |||+........       ..+...||.+||+||.+.+..|+.++||||||+||+|+++ =...|.   .......+..+
T Consensus       399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g  475 (516)
T KOG1033|consen  399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDG  475 (516)
T ss_pred             hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcC
Confidence            999998765444       4456789999999999999999999999999999999998 333332   22233333333


Q ss_pred             cCCCCc-cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          365 KIKLPA-FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       365 ~~~~p~-~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      .++... .--+.-..|+..||...|.+||     ++.+.--|.|.
T Consensus       476 ~ip~~~~~d~p~e~~ll~~lls~~p~~RP-----~~~~~~~~~~~  515 (516)
T KOG1033|consen  476 IIPPEFLQDYPEEYTLLQQLLSPSPEERP-----SAIEVALHEFL  515 (516)
T ss_pred             CCChHHhhcCcHHHHHHHHhcCCCcccCc-----hHHHHhhhhhc
Confidence            332001 1124456899999999999999     66666666654

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=4.6e-18  Score=183.35  Aligned_cols=139  Identities=22%  Similarity=0.266  Sum_probs=112.2

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehh-----hhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKD-----KIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .|...+.||+|+||+||+|.+....  +++|+....     ........+.+.+|+++++.++|++|+....++.+....
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            4556789999999999999886554  444432221     111222345678999999999999998877777777788


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~  300 (479)
                      ++||||++|++|.+.+.        ....++.+++.+|.+||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999999999988775        345688999999999999999999999999999 6889999999999763

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=8.2e-18  Score=155.94  Aligned_cols=140  Identities=25%  Similarity=0.299  Sum_probs=101.0

Q ss_pred             EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHH---------------------HHHHHHHHHhCCCCC--
Q 011698          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY---------------------MKSERNILTKVDHPF--  211 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~---------------------~~~E~~iL~~l~hp~--  211 (479)
                      .+.||+|+||+||+|.+. +++.||||+++............                     ...|...+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999986 78899999987643221111111                     135666666664432  


Q ss_pred             eeeEeEEEeeCCeEEEEEEeccCCcHHH-HHHHcCCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEeCCCCcE
Q 011698          212 IVQLRYSFQTKYRLYLVLDFVNGGHLFF-QLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHV  289 (479)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl~~~g~v  289 (479)
                      +.+.+++    ...++||||++|+.+.. .+.... .. ..++.++.+++.++.++|. .||+||||||+||+++ ++.+
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            4444443    24589999999954321 121111 11 6678899999999999999 9999999999999999 9999


Q ss_pred             EEeecCCccccCC
Q 011698          290 MLTDFGLAKQFDE  302 (479)
Q Consensus       290 kL~DFGla~~~~~  302 (479)
                      +|+|||.+.....
T Consensus       154 ~liDfg~a~~~~~  166 (187)
T cd05119         154 YIIDVPQAVEIDH  166 (187)
T ss_pred             EEEECcccccccC
Confidence            9999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.74  E-value=1.3e-17  Score=173.62  Aligned_cols=195  Identities=23%  Similarity=0.324  Sum_probs=154.7

Q ss_pred             HHhCCCCCeeeEeEEEeeCCeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCC-ccCCCCCccE
Q 011698          204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGI-MHRDLKPENI  281 (479)
Q Consensus       204 L~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~I-iHrDLKpeNI  281 (479)
                      |+.+.|.|+.++++.+.++...++|.+||..|+|.+.+... -.++......++++|+.||.|||.-.| .|+.|+..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            45789999999999999999999999999999999999873 346666677789999999999999876 9999999999


Q ss_pred             EeCCCCcEEEeecCCccccCCC---CCcccccCCCCCcchhHhcCCC-------CCccccchhhHHHHHHHHhCCCCCCC
Q 011698          282 LLDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKG-------HDKAADWWSVGILLFEMLTGQPPFTG  351 (479)
Q Consensus       282 Ll~~~g~vkL~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~-------~~~~~DiwSLGvilyelltG~~Pf~~  351 (479)
                      ++|....+||+|||+.......   .......-..-|.|||.+.+..       .+.+.|+||+|+++||+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998765320   1111112235699999998742       35779999999999999999999976


Q ss_pred             C----CHHHHHHHHHh-ccC-CCCc-----cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHH
Q 011698          352 G----NRQKIQQKIIK-DKI-KLPA-----FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIK  403 (479)
Q Consensus       352 ~----~~~~~~~~i~~-~~~-~~p~-----~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil  403 (479)
                      .    +..++...+.. +.. ..|.     ...+++..+++.||..+|.+||     ++++|.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rP-----s~~~i~  218 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRP-----SIEQIR  218 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCc-----cHHHHH
Confidence            2    33456666666 322 1222     3445799999999999999999     666553

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=3.3e-16  Score=151.67  Aligned_cols=137  Identities=20%  Similarity=0.289  Sum_probs=104.5

Q ss_pred             EEec-cCCceEEEEEEEcCCCeEEEEEEeehhhh----c------hHHHHHHHHHHHHHHHhCCCCCe--eeEeEEEeeC
Q 011698          156 KVVG-QGAFAKVYQVRRIGTSEIYAMKVMRKDKI----M------EKNHAEYMKSERNILTKVDHPFI--VQLRYSFQTK  222 (479)
Q Consensus       156 ~~LG-~G~fG~V~~a~~~~~~~~vAiK~i~~~~~----~------~~~~~~~~~~E~~iL~~l~hp~I--v~l~~~~~~~  222 (479)
                      ..|| .|+.|+||.+...  +..+++|.+....+    .      .......+.+|+.++.++.|++|  ++.++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 7888888888774  66799998864321    1      11233557889999999998775  6666654332


Q ss_pred             C----eEEEEEEeccC-CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          223 Y----RLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       223 ~----~~~lV~E~~~g-gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                      .    ..++|||+++| .+|..++.. ..+++..    +.+|+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence            2    23599999998 588877754 4556543    568999999999999999999999999999999999999999


Q ss_pred             cc
Q 011698          298 KQ  299 (479)
Q Consensus       298 ~~  299 (479)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            65

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=3.4e-16  Score=137.86  Aligned_cols=132  Identities=21%  Similarity=0.274  Sum_probs=111.4

Q ss_pred             EEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC--CCeeeEeEEEeeCCeEEEEEEe
Q 011698          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--PFIVQLRYSFQTKYRLYLVLDF  231 (479)
Q Consensus       154 ~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~~~~~~~~~lV~E~  231 (479)
                      +++.||+|.++.||++...+  ..+++|.......     ...+..|..+++.+.|  .++++++.++...+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            45789999999999999854  6799999866432     3457789999999976  5899999988888899999999


Q ss_pred             ccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC---CCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          232 VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN---GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       232 ~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      +.|+.+...       +......++.+++.+|.+||..   +++|+||+|+||+++..+.++++|||.+..
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            999877533       4455667889999999999985   799999999999999999999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=1.8e-15  Score=157.82  Aligned_cols=252  Identities=22%  Similarity=0.266  Sum_probs=196.2

Q ss_pred             CCeEEEEEecc--CCceEEEEEEE--cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCe
Q 011698          150 EDFEVLKVVGQ--GAFAKVYQVRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       150 ~~y~~~~~LG~--G~fG~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~  224 (479)
                      ..|.+.+.+|.  |.+|.||.++.  ..++..+|+|.-+... ........-.+|....+++ .|++.++.+..+...+.
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCCc
Confidence            45667788999  99999999998  8889999999843321 1111122224566666666 49999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHH----HHHHHHhCCCccCCCCCccEEeCCC-CcEEEeecCCcc
Q 011698          225 LYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVS----AVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAK  298 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~----aL~~LH~~~IiHrDLKpeNILl~~~-g~vkL~DFGla~  298 (479)
                      +|+-+|++. .+|..+..... .+++..++.+..+...    ||.++|+.+|+|-|+||+||++..+ ..++++|||+..
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~  271 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS  271 (524)
T ss_pred             ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence            999999996 56766665544 4889999999999999    9999999999999999999999999 899999999998


Q ss_pred             ccCCCCCc------ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhccCCCC
Q 011698          299 QFDENTRS------NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKDKIKLP  369 (479)
Q Consensus       299 ~~~~~~~~------~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~~p  369 (479)
                      .+......      ....|...|++||...+. ++.+.|+++||.++.+..+|..++...   ....+.+..  -...+-
T Consensus       272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--ip~e~~  348 (524)
T KOG0601|consen  272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--IPLEFC  348 (524)
T ss_pred             EccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--Cchhhh
Confidence            87655422      222577889999998765 789999999999999999987776443   222222111  112223


Q ss_pred             ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          370 AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       370 ~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ...+.++...+..|++.++..|+     +++.+++|++....
T Consensus       349 ~~~s~~l~~~~~~~~d~~~~~~~-----~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  349 EGGSSSLRSVTSQMLDEDPRLRL-----TAQILTALNVIHSK  385 (524)
T ss_pred             cCcchhhhhHHHHhcCcchhhhh-----HHHHHhccccccch
Confidence            44677888899999999999999     89999999999854

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.58  E-value=4.1e-15  Score=158.32  Aligned_cols=147  Identities=18%  Similarity=0.349  Sum_probs=98.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhch-------------------------------HHHHHHH
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-------------------------------KNHAEYM  197 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~-------------------------------~~~~~~~  197 (479)
                      +.+|+. +.||+|++|+||+|+.+.+|+.||||++++.-...                               .+..+.+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            456776 78999999999999999889999999998642100                               0122333


Q ss_pred             HHHHHHHH------hC----CCCCeeeEeEEEee-CCeEEEEEEeccCCcHHHH--HHHcC----CCcHHHHHHHHHHHH
Q 011698          198 KSERNILT------KV----DHPFIVQLRYSFQT-KYRLYLVLDFVNGGHLFFQ--LYRQG----LFREDLARIYTAEIV  260 (479)
Q Consensus       198 ~~E~~iL~------~l----~hp~Iv~l~~~~~~-~~~~~lV~E~~~ggsL~~~--l~~~~----~l~e~~~~~~~~qi~  260 (479)
                      .+|+++.+      ++    .+...+.+-..+.+ ....++||||+.|+.+.+.  +...+    .+.+..+..++.|++
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence            34444333      32    12222222222221 3345799999999998663  33333    244444444555543


Q ss_pred             HHHHHHHhCCCccCCCCCccEEeCCCC----cEEEeecCCccccCCC
Q 011698          261 SAVSHLHANGIMHRDLKPENILLDADG----HVMLTDFGLAKQFDEN  303 (479)
Q Consensus       261 ~aL~~LH~~~IiHrDLKpeNILl~~~g----~vkL~DFGla~~~~~~  303 (479)
                             ..|++|+|+||.||+++.+|    .++++|||++..++..
T Consensus       278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                   58999999999999999988    9999999999887544

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.55  E-value=7.3e-14  Score=146.67  Aligned_cols=144  Identities=19%  Similarity=0.312  Sum_probs=96.8

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhch-------------------------------HHHHH------HHH
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-------------------------------KNHAE------YMK  198 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~-------------------------------~~~~~------~~~  198 (479)
                      +.||.|++|+||+|+.+ +|+.||||+.+......                               ++...      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999986 68899999986531000                               00001      133


Q ss_pred             HHHHHHHhC----C-CCCeeeEeEEEeeCCeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHH-HHHHHHhCCC
Q 011698          199 SERNILTKV----D-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVS-AVSHLHANGI  271 (479)
Q Consensus       199 ~E~~iL~~l----~-hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~-aL~~LH~~~I  271 (479)
                      +|+..+.++    + +++|.-..-+..-....++||||++|++|.+..... ....   ...++..++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            455555544    2 343322111122234468999999999997765432 1122   2334555554 4678999999


Q ss_pred             ccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          272 MHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       272 iHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      +|+|+||.||+++.+|.++|+|||++..+...
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~~  310 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSEE  310 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECCHH
Confidence            99999999999999999999999999887543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=1.4e-14  Score=151.19  Aligned_cols=251  Identities=23%  Similarity=0.284  Sum_probs=191.2

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc-CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCe
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRI-GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~  224 (479)
                      ..+.+|..+..||.|.|+.|+.+..+ .++..|++|.+.+........+ .-..|..+...+ .|.++++.+..|....+
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            34568999999999999999998766 6788999999877544333333 334577777766 58999998888888888


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC-CcEEEeecCCccccCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~-g~vkL~DFGla~~~~~~  303 (479)
                      .|+-.|||+++++...+.-...+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||....+.-.
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence            89999999999887666555668888999999999999999999999999999999999876 78899999999753211


Q ss_pred             CCcccccCCCCCc--chhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHH
Q 011698          304 TRSNSMCGTLEYM--SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK  381 (479)
Q Consensus       304 ~~~~~~~gt~~y~--APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~  381 (479)
                        .....+.-+++  +++......+..++|++|||..+++.++|..--..   ......|..+..........++..+.+
T Consensus       421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~~~~~~i~~~~~p~~~~~~~~~q~~~k  495 (524)
T KOG0601|consen  421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES---GVQSLTIRSGDTPNLPGLKLQLQVLLK  495 (524)
T ss_pred             --cccccccccccccchhhccccccccccccccccccccccccCcccCcc---cccceeeecccccCCCchHHhhhhhhh
Confidence              11122233344  55555556788999999999999999998654322   122334555555555555588999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      .++..++..|+     .+.++..|.-|
T Consensus       496 v~~~~~~~~~~-----l~~~l~~~~~~  517 (524)
T KOG0601|consen  496 VMINPDRKRRP-----SAVELSLHSEF  517 (524)
T ss_pred             hhcCCccccch-----hhhhhcccchh
Confidence            99999999998     66776666544

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.45  E-value=9.5e-13  Score=138.93  Aligned_cols=178  Identities=19%  Similarity=0.249  Sum_probs=133.5

Q ss_pred             EeccCCceEEE-EEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCC
Q 011698          157 VVGQGAFAKVY-QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG  235 (479)
Q Consensus       157 ~LG~G~fG~V~-~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg  235 (479)
                      ..+-++.+ +| .|..+.++.+|.|.+.+...-   ...+.+++-+.-|+.++||||++++.+++.+..+|+|+|-+.  
T Consensus        19 ~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--   92 (690)
T KOG1243|consen   19 ETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--   92 (690)
T ss_pred             cccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--
Confidence            33334443 34 466677888899988876432   445667788889999999999999999999999999999986  


Q ss_pred             cHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC-cccccCCC
Q 011698          236 HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTL  313 (479)
Q Consensus       236 sL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH-~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~-~~~~~gt~  313 (479)
                      -|..++.+.+   ...+..-+.||+.||.||| ..+++|++|.-..|+++..|..||++|-++........ .....---
T Consensus        93 Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~  169 (690)
T KOG1243|consen   93 PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIE  169 (690)
T ss_pred             cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhh
Confidence            4555666654   4555567899999999997 56899999999999999999999999998865432221 11111112


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhC
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTG  345 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG  345 (479)
                      .|..|+.+....  -..|.|.|||+++|++.|
T Consensus       170 s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  170 SFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            356666554332  457999999999999999

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=3.9e-13  Score=122.24  Aligned_cols=128  Identities=23%  Similarity=0.291  Sum_probs=96.0

Q ss_pred             EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCe-eeEeEEEeeCCeEEEEEEecc
Q 011698          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRLYLVLDFVN  233 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~~~~~~~~~lV~E~~~  233 (479)
                      ++.|+.|.++.||+++..  +..|++|+......    ....+..|..+++.+.+.++ .+++....  ...++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            467899999999999874  67899999765421    11235678888888865444 44554433  33579999999


Q ss_pred             CCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCC-----ccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          234 GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI-----MHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       234 ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~I-----iHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      |.++...        ......++.+++.+|..||+.++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            9887532        11123456789999999999985     9999999999998 77899999999854

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.42  E-value=1.8e-12  Score=121.18  Aligned_cols=142  Identities=15%  Similarity=0.201  Sum_probs=103.3

Q ss_pred             EEeccCCceEEEEEEEcC------CCeEEEEEEeehhhh-------------------chHHHHHHH----HHHHHHHHh
Q 011698          156 KVVGQGAFAKVYQVRRIG------TSEIYAMKVMRKDKI-------------------MEKNHAEYM----KSERNILTK  206 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~------~~~~vAiK~i~~~~~-------------------~~~~~~~~~----~~E~~iL~~  206 (479)
                      ..||.|--+.||.|....      .+..+|||+.+....                   ...+....+    ++|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999998653      357899999864210                   011222333    389999998


Q ss_pred             CCC--CCeeeEeEEEeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCccEEe
Q 011698          207 VDH--PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL-HANGIMHRDLKPENILL  283 (479)
Q Consensus       207 l~h--p~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~L-H~~~IiHrDLKpeNILl  283 (479)
                      +..  -.+.+++++    ..-++||||+.+..+.....+...++++.+..+..+++.+|..| |+.||||+||++.|||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~  158 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW  158 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            853  455666654    45689999998764433222333456666777889999999998 89999999999999999


Q ss_pred             CCCCcEEEeecCCccccCC
Q 011698          284 DADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       284 ~~~g~vkL~DFGla~~~~~  302 (479)
                      + +|.+.|+|||.+.....
T Consensus       159 ~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         159 H-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             E-CCcEEEEECCCceeCCC
Confidence            6 57899999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=8.8e-13  Score=128.38  Aligned_cols=209  Identities=17%  Similarity=0.228  Sum_probs=153.0

Q ss_pred             HHHHHhCCCCCeeeEeEEEeeC-----CeEEEEEEeccCCcHHHHHHHc----CCCcHHHHHHHHHHHHHHHHHHHhC--
Q 011698          201 RNILTKVDHPFIVQLRYSFQTK-----YRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHAN--  269 (479)
Q Consensus       201 ~~iL~~l~hp~Iv~l~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~--  269 (479)
                      ..-|-++.|.|||+++.++.+.     ....++.|||..|+|...|++.    ..+.....++|+-||+.||.|||+.  
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            3445667899999999888554     4578999999999999888764    3577888888999999999999998  


Q ss_pred             CCccCCCCCccEEeCCCCcEEEeecCCcccc--CCC---CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh
Q 011698          270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF--DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT  344 (479)
Q Consensus       270 ~IiHrDLKpeNILl~~~g~vkL~DFGla~~~--~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt  344 (479)
                      -|+|+++.-+.|++..+|-+||.--.....-  -..   .......|-++|.|||.=.....+.++|||++|++..||..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            5999999999999999999998632111100  000   01112345678999997666666789999999999999999


Q ss_pred             CCCCC-CCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhh
Q 011698          345 GQPPF-TGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLE  417 (479)
Q Consensus       345 G~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~  417 (479)
                      |..-- .+.+.......|.+--+...   ..--+++|+.||+-.|..||     ++.+++.||-.-++.-.+++
T Consensus       278 lEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp-----~ar~llfHpllfeVhslkll  343 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRP-----DARLLLFHPLLFEVHSLKLL  343 (458)
T ss_pred             heeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCc-----chhhhhcCceeeecchHHHH
Confidence            87653 23333333333333222221   12236799999999999999     89999999998887665554

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.29  E-value=3.3e-11  Score=109.68  Aligned_cols=134  Identities=27%  Similarity=0.315  Sum_probs=100.7

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEe-----ehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVM-----RKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i-----~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      ..|++|+-+.++.+.+.+  ..+++|.=     +...+...-..+...+|+.++.++.--.|..-+-++.+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~g--~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG--LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeeccC--cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            357899999999998744  33555542     22334444455667789999998875555554455567778889999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      |++|-.|.+.+...   .    -.++..+-.-+.-||..||+|+||.++||++..++ +.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99998888888765   1    33566677777889999999999999999996554 99999999964

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.23  E-value=1.2e-10  Score=105.61  Aligned_cols=144  Identities=27%  Similarity=0.331  Sum_probs=106.8

Q ss_pred             EEEEeccCCceEEEEEEEcCCCeEEEEEE-----eehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKV-----MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       154 ~~~~LG~G~fG~V~~a~~~~~~~~vAiK~-----i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .+..|-+|+-++|+++.+  .|+.+.||.     .+...+..+-...+.++|+++|.++.--.|.--.-+|.+...-+|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            567889999999999988  566667764     3334444444566788999999998655554444456667777899


Q ss_pred             EEeccCC-cHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC---cEEEeecCCccc
Q 011698          229 LDFVNGG-HLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDFGLAKQ  299 (479)
Q Consensus       229 ~E~~~gg-sL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g---~vkL~DFGla~~  299 (479)
                      |||++|. ++.+++....  .........++..|-..+.-||..+|||+||..+||++..+|   .+.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9999883 5666665432  223333367888999999999999999999999999997766   358999999854

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.20  E-value=7.5e-11  Score=111.58  Aligned_cols=140  Identities=17%  Similarity=0.240  Sum_probs=103.4

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC--CCeeeEeEEEeeC---CeEEEEEE
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--PFIVQLRYSFQTK---YRLYLVLD  230 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~~~~~---~~~~lV~E  230 (479)
                      +.||.|..+.||++...+ |+.+++|+.......  .....+..|..+++.+.+  ..+.+++.+....   +..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            678999999999998754 578999998654321  123457889999999875  3456677766553   26789999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA------------------------------------------  268 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~------------------------------------------  268 (479)
                      |++|.++...+.. ..+++.....++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999877554321 345666666666777777777763                                          


Q ss_pred             --------------CCCccCCCCCccEEeCC--CCcEEEeecCCccc
Q 011698          269 --------------NGIMHRDLKPENILLDA--DGHVMLTDFGLAKQ  299 (479)
Q Consensus       269 --------------~~IiHrDLKpeNILl~~--~g~vkL~DFGla~~  299 (479)
                                    ..++|+|+++.|||++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          23699999999999998  67789999999864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.15  E-value=9.8e-10  Score=113.24  Aligned_cols=212  Identities=18%  Similarity=0.272  Sum_probs=154.8

Q ss_pred             CceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee----CCeEEEEEEeccCC-c
Q 011698          162 AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRLYLVLDFVNGG-H  236 (479)
Q Consensus       162 ~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~~~lV~E~~~gg-s  236 (479)
                      --.+.|++...-+|..|++|.+.-.+....+.   .-.-.++++++.|+|||++..+|.+    +..+++|++|.++. +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            34678999999999999999995443332221   1234567999999999999998874    45789999999874 6


Q ss_pred             HHHHHHH---------------cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          237 LFFQLYR---------------QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       237 L~~~l~~---------------~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      |.+....               ....+|..+|.|+.|+..||.++|+.|+.-+-|.+.+||++.+.+++|+..|+...+.
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            6655432               1246789999999999999999999999999999999999998899999888887765


Q ss_pred             CCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCC-CCCCCHHHH-HHHHHhccCCCCccCCHHHHHH
Q 011698          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPP-FTGGNRQKI-QQKIIKDKIKLPAFLSSEAHSL  379 (479)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~P-f~~~~~~~~-~~~i~~~~~~~p~~~s~~~~~l  379 (479)
                      ++...             -+.+   -.+-|.=.||.+++.|.||..- +.....++. ...|.       ..+|.+++++
T Consensus       445 ~d~~~-------------~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-------~~yS~D~rn~  501 (655)
T KOG3741|consen  445 EDPTE-------------PLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-------TTYSTDLRNV  501 (655)
T ss_pred             CCCCc-------------chhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-------hhhhHHHHHH
Confidence            54311             1111   1457889999999999998543 222222222 22222       3478888999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      |.-+...+++++      ++.+++.+
T Consensus       502 v~yl~s~~~~~k------sI~~llp~  521 (655)
T KOG3741|consen  502 VEYLESLNFREK------SIQDLLPM  521 (655)
T ss_pred             HHHHHhcCcccc------cHHHHHHH
Confidence            988888888753      45666543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.05  E-value=1.7e-10  Score=122.52  Aligned_cols=157  Identities=22%  Similarity=0.347  Sum_probs=122.2

Q ss_pred             HHHHHHHHHHHHhC-CCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc----------ccccCCCCCcchhHhcCC
Q 011698          256 TAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS----------NSMCGTLEYMSPEIVLGK  324 (479)
Q Consensus       256 ~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~----------~~~~gt~~y~APE~l~~~  324 (479)
                      +.+++.||.|+|.. ++||+.|.|++|.++.+|..||+.|+++.........          ....-...|.|||++.+.
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            34555999999987 8999999999999999999999999998664432211          112235689999999998


Q ss_pred             CCCccccchhhHHHHHHHH-hCCCCCCCCCHHHHHHHHH----hccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCH
Q 011698          325 GHDKAADWWSVGILLFEML-TGQPPFTGGNRQKIQQKII----KDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGS  399 (479)
Q Consensus       325 ~~~~~~DiwSLGvilyell-tG~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~  399 (479)
                      ..+.++|+|||||++|.+. .|+.-+...+....+..-.    .....++..+++++++=|.++|..++..||     ++
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp-----~~  259 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP-----TL  259 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCc-----ch
Confidence            8899999999999999999 5777776543322222111    124456678999999999999999999999     89


Q ss_pred             HHHHhCccccCCChhhhh
Q 011698          400 QEIKSHKWFKMINWKKLE  417 (479)
Q Consensus       400 ~eil~hp~f~~~~~~~l~  417 (479)
                      .+++..+||.+.--..|.
T Consensus       260 ~~l~~~~ff~D~~~~aLr  277 (700)
T KOG2137|consen  260 DLLLSIPFFSDPGLKALR  277 (700)
T ss_pred             hhhhcccccCCchhhhhh
Confidence            999999999987655553

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.02  E-value=7e-09  Score=101.98  Aligned_cols=134  Identities=15%  Similarity=0.093  Sum_probs=94.1

Q ss_pred             eEEEEEEEcCCCeEEEEEEeehhhhc---hH-----HHHHHHHHHHHHHHhCCCCCe--eeEeEEEee-----CCeEEEE
Q 011698          164 AKVYQVRRIGTSEIYAMKVMRKDKIM---EK-----NHAEYMKSERNILTKVDHPFI--VQLRYSFQT-----KYRLYLV  228 (479)
Q Consensus       164 G~V~~a~~~~~~~~vAiK~i~~~~~~---~~-----~~~~~~~~E~~iL~~l~hp~I--v~l~~~~~~-----~~~~~lV  228 (479)
                      ..|.++..  .|+.|.||........   ..     .....+.+|...+.+|..-+|  +++.+++..     ....++|
T Consensus        36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            34666655  4567888876432211   00     111136788888887743333  333444433     2357899


Q ss_pred             EEeccCC-cHHHHHHH--cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC-------CCcEEEeecCCcc
Q 011698          229 LDFVNGG-HLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-------DGHVMLTDFGLAK  298 (479)
Q Consensus       229 ~E~~~gg-sL~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~-------~g~vkL~DFGla~  298 (479)
                      ||++++. +|.+++..  ....++.....++.+++..+.-||..||+|+||++.|||++.       ++.+.|+||+.+.
T Consensus       114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9999986 78887753  344566777889999999999999999999999999999975       4689999999985


Q ss_pred             c
Q 011698          299 Q  299 (479)
Q Consensus       299 ~  299 (479)
                      .
T Consensus       194 ~  194 (268)
T PRK15123        194 I  194 (268)
T ss_pred             c
Confidence            4

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.92  E-value=8.7e-09  Score=95.90  Aligned_cols=129  Identities=26%  Similarity=0.317  Sum_probs=82.6

Q ss_pred             EEEEEEEcCCCeEEEEEEeehhh-----------------------hchHHHHHHHHHHHHHHHhCCCC--CeeeEeEEE
Q 011698          165 KVYQVRRIGTSEIYAMKVMRKDK-----------------------IMEKNHAEYMKSERNILTKVDHP--FIVQLRYSF  219 (479)
Q Consensus       165 ~V~~a~~~~~~~~vAiK~i~~~~-----------------------~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~~  219 (479)
                      .||.|.. ..|..+|+|+.+...                       ..........++|.+.|.++..-  ++.+++.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4888887 457789999986421                       01122345677899999999765  456665442


Q ss_pred             eeCCeEEEEEEecc--CCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHH-HHhCCCccCCCCCccEEeCCCCcEEEeecCC
Q 011698          220 QTKYRLYLVLDFVN--GGHLFFQLYRQGLFREDLARIYTAEIVSAVSH-LHANGIMHRDLKPENILLDADGHVMLTDFGL  296 (479)
Q Consensus       220 ~~~~~~~lV~E~~~--ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~-LH~~~IiHrDLKpeNILl~~~g~vkL~DFGl  296 (479)
                          .-++||||++  |..+.. +.... ++.+....++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||.
T Consensus        80 ----~~~ivME~I~~~G~~~~~-l~~~~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPR-LKDVD-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGC-HHHCG-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ----CCEEEEEecCCCccchhh-HHhcc-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence                3469999999  655533 33221 1134455667777775555 589999999999999999876 999999999


Q ss_pred             ccccC
Q 011698          297 AKQFD  301 (479)
Q Consensus       297 a~~~~  301 (479)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            97654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.81  E-value=5.9e-08  Score=91.83  Aligned_cols=106  Identities=25%  Similarity=0.304  Sum_probs=83.3

Q ss_pred             HHHHHHHHHHHhCCCCC--eeeEeEEEeeC----CeEEEEEEeccCC-cHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHH
Q 011698          195 EYMKSERNILTKVDHPF--IVQLRYSFQTK----YRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH  267 (479)
Q Consensus       195 ~~~~~E~~iL~~l~hp~--Iv~l~~~~~~~----~~~~lV~E~~~gg-sL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH  267 (479)
                      ....+|...+..|..-.  +++.+++....    ...++|+|+++|. +|.+++......+......++.+++..+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            34667887777764322  34445555442    2468999999985 78888877555677778889999999999999


Q ss_pred             hCCCccCCCCCccEEeCCCC---cEEEeecCCcccc
Q 011698          268 ANGIMHRDLKPENILLDADG---HVMLTDFGLAKQF  300 (479)
Q Consensus       268 ~~~IiHrDLKpeNILl~~~g---~vkL~DFGla~~~  300 (479)
                      ..||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999999999999999888   8999999998753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.80  E-value=1e-09  Score=115.45  Aligned_cols=241  Identities=18%  Similarity=0.173  Sum_probs=170.2

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCC-eeeEeEEEeeCCeEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~~~~~~~~~lV~  229 (479)
                      .+.....+++|+++++++.+...+...+ .+.+...        ....-++++|.+++||| .+..++.++.+...+++|
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence            3555677899999999999887665554 6665432        23456889999999999 777778888889999999


Q ss_pred             EeccCC-cHHH-HHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcc
Q 011698          230 DFVNGG-HLFF-QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (479)
Q Consensus       230 E~~~gg-sL~~-~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~  307 (479)
                      +++.++ +-.. .....-.+.+-+.....+.-+++++++|+.--+|||    |||.. ++..|..||+....+......+
T Consensus       314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~~  388 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKPR  388 (829)
T ss_pred             hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCcccccc
Confidence            999988 2111 000111122333344556667889999999889999    88874 5889999999998887766678


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CCCC--ccCCHHH-HHHHHh
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--IKLP--AFLSSEA-HSLLKG  382 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~-~~lI~~  382 (479)
                      +..+|+.|+|||+..+..+....|.|++|+--.+|.-|.+|-..  +......+-.+.  +.+-  ...+... .++...
T Consensus       389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~  466 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAP  466 (829)
T ss_pred             cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCccc
Confidence            88999999999999999999999999999877788878777543  110000000000  0000  0011111 247778


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      |+...|..|+     ..-.++-|++|.++.
T Consensus       467 ~~~g~P~~pk-----v~mgacfsKvfngCp  491 (829)
T KOG0576|consen  467 CLNGLPPTPK-----VHMGACFSKVFNGCP  491 (829)
T ss_pred             ccCCCCCCCc-----chhhHHHHHHhccCc
Confidence            8888888887     778888899998874

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.75  E-value=1e-07  Score=96.43  Aligned_cols=230  Identities=19%  Similarity=0.292  Sum_probs=152.0

Q ss_pred             EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHh-CCCCCeeeEeEE-------EeeCCeEE
Q 011698          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYS-------FQTKYRLY  226 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~-------~~~~~~~~  226 (479)
                      .+.||+|+-+.+|-.-...+   .+-|++.+......      ...+..|.. -.||-+-.-+.+       -......-
T Consensus        16 gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG   86 (637)
T COG4248          16 GRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG   86 (637)
T ss_pred             CccccCCccceeeecchhhc---hhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence            36799999999996543322   35577765432111      112223333 356654331111       11222377


Q ss_pred             EEEEeccCCcHHHHHH----Hc---CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          227 LVLDFVNGGHLFFQLY----RQ---GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~----~~---~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      ++|..+.|..--..+.    +.   .....+.+...++.++.+.+.||..|.+-+|++++|+|+.+++.+.|.|-..-..
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence            8888888763322221    11   2366778888999999999999999999999999999999999999997554433


Q ss_pred             cCCCCCcccccCCCCCcchhHhc-----CCCCCccccchhhHHHHHHHHhC-CCCCCCCC-----HHHHHHHHHhccCC-
Q 011698          300 FDENTRSNSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTG-QPPFTGGN-----RQKIQQKIIKDKIK-  367 (479)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~DiwSLGvilyelltG-~~Pf~~~~-----~~~~~~~i~~~~~~-  367 (479)
                      -.++......+|.+.|.+||...     +..-+...|.|.||+++++++.| ++||.+.-     .......|..+.+. 
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence            34455556678999999999876     33446789999999999999995 99998621     11222234443221 


Q ss_pred             ----------CC-----ccCCHHHHHHHHhhhhhc--hhhhcC
Q 011698          368 ----------LP-----AFLSSEAHSLLKGLLQKE--ASKRLG  393 (479)
Q Consensus       368 ----------~p-----~~~s~~~~~lI~~~L~~d--P~~R~~  393 (479)
                                -|     .-+++++..|..+|...-  +.-||+
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~  289 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPT  289 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCC
Confidence                      11     236788999999998753  456773

>PRK09902 hypothetical protein; Provisional

Probab=98.63  E-value=5.2e-07  Score=84.94  Aligned_cols=139  Identities=12%  Similarity=0.168  Sum_probs=100.2

Q ss_pred             ccCCceEEEEEEEcCCCeEEEEEEeehhh---hchHHHHHHHHHHHHHHHhCCCCC--eeeEeEEEee----CCeEEEEE
Q 011698          159 GQGAFAKVYQVRRIGTSEIYAMKVMRKDK---IMEKNHAEYMKSERNILTKVDHPF--IVQLRYSFQT----KYRLYLVL  229 (479)
Q Consensus       159 G~G~fG~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~~~~----~~~~~lV~  229 (479)
                      |+||-+-|+.....+.  .|-+|.-....   .........+.+|...|++|..-+  +.++..+...    ...-+||+
T Consensus        27 ~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            6788888988776443  57777764211   111234566888999998885322  4555432222    23478999


Q ss_pred             EeccCC-cHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc--EEEeecCCccc
Q 011698          230 DFVNGG-HLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH--VMLTDFGLAKQ  299 (479)
Q Consensus       230 E~~~gg-sL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~--vkL~DFGla~~  299 (479)
                      |-+.|- +|.+++...  ...++.....++.+|+.++.-||..|+.|+|+.+.|||++.+|.  ++++||--++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            988754 787777653  34567777789999999999999999999999999999987777  99999988765

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.59  E-value=5.2e-07  Score=87.17  Aligned_cols=139  Identities=19%  Similarity=0.227  Sum_probs=100.2

Q ss_pred             EEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc------------h-------HHHHHHHHHHHHHHHhCCCC--C
Q 011698          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM------------E-------KNHAEYMKSERNILTKVDHP--F  211 (479)
Q Consensus       153 ~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~------------~-------~~~~~~~~~E~~iL~~l~hp--~  211 (479)
                      .+...||-|--+.||.|.+. .|..+|||.=+.....            .       .-.....++|..+|.+|...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45578999999999999985 6788999974431110            0       11234467899999988644  5


Q ss_pred             eeeEeEEEeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEE
Q 011698          212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML  291 (479)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL  291 (479)
                      |.+.++    .+.-.+|||+++|-.|...-     ++.+.+..++..|+.-+.-+-..||||+|+++=|||++++|.+.+
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v  243 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV  243 (304)
T ss_pred             CCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence            555543    35668999999997664321     134445556666666666666899999999999999999999999


Q ss_pred             eecCCccccC
Q 011698          292 TDFGLAKQFD  301 (479)
Q Consensus       292 ~DFGla~~~~  301 (479)
                      +||--+....
T Consensus       244 IDwPQ~v~~~  253 (304)
T COG0478         244 IDWPQAVPIS  253 (304)
T ss_pred             EeCcccccCC
Confidence            9998886543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.53  E-value=6.2e-07  Score=100.54  Aligned_cols=239  Identities=18%  Similarity=0.223  Sum_probs=169.5

Q ss_pred             eccCCceEEEEEEEcCCC----eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe----EEEEE
Q 011698          158 VGQGAFAKVYQVRRIGTS----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR----LYLVL  229 (479)
Q Consensus       158 LG~G~fG~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~----~~lV~  229 (479)
                      |.--.+|++++.++...-    +++-++.-.......+........|...+.+..|+|++.++.+.-....    +.+..
T Consensus       186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~  265 (1351)
T KOG1035|consen  186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ  265 (1351)
T ss_pred             eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence            666677888887764211    1111111000000112334445567788888999999998877644332    34456


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCc---cEEeCCCCcEEEe--ecCCccccCCCC
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE---NILLDADGHVMLT--DFGLAKQFDENT  304 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpe---NILl~~~g~vkL~--DFGla~~~~~~~  304 (479)
                      +++.+-++...++.-+.++.+.++.+..++.+||.|+|+....|.-|...   +-.++.++...++  ||+..+......
T Consensus       266 ~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~  345 (1351)
T KOG1035|consen  266 EICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE  345 (1351)
T ss_pred             hhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcc
Confidence            88999999999999999999999999999999999999997777666555   5556677788888  999998877666


Q ss_pred             CcccccCCCCCcchhHhcCCCCCcc--ccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHh
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKA--ADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG  382 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~--~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~  382 (479)
                      ......-+..|.|+|......+..+  .|+|.+|.+...+..|..+-.-   ......++      +........+++.+
T Consensus       346 ~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~---~~~~~~~l------~~~~~~~~~d~~~~  416 (1351)
T KOG1035|consen  346 KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEK---SAVPVSLL------DVLSTSELLDALPK  416 (1351)
T ss_pred             cchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccc---ccchhhhh------ccccchhhhhhhhh
Confidence            6666666778889998887766544  7999999999999987655321   11111111      11112268899999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      |+..+.++|+     ++.+++.|+|.+.
T Consensus       417 ~~~~~~~~Rl-----~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  417 CLDEDSEERL-----SALELLTHPFLRF  439 (1351)
T ss_pred             hcchhhhhcc-----chhhhhhchhccc
Confidence            9999999999     8899999999875

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.52  E-value=2.8e-06  Score=80.39  Aligned_cols=141  Identities=18%  Similarity=0.234  Sum_probs=91.4

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHH------HHHHHHHHHhC---CCCCeeeEeEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY------MKSERNILTKV---DHPFIVQLRYS  218 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~------~~~E~~iL~~l---~hp~Iv~l~~~  218 (479)
                      .-.+|+.++++-......|.+..-  +|..+++|..+......+.....      ..+++..+.++   ..-....++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            346799999998888888877766  55779999987643222211111      12233323333   22233332222


Q ss_pred             Ee-----eCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEee
Q 011698          219 FQ-----TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTD  293 (479)
Q Consensus       219 ~~-----~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~D  293 (479)
                      .+     -....+++|||++|..|.+...    +++.    +...|..++.-||+.|++|+|..|.|++++.++ ++++|
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID  177 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID  177 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence            22     2234578999999987754321    2332    345677789999999999999999999998555 99999


Q ss_pred             cCCccc
Q 011698          294 FGLAKQ  299 (479)
Q Consensus       294 FGla~~  299 (479)
                      |+..+.
T Consensus       178 ~~~k~~  183 (229)
T PF06176_consen  178 TQGKRM  183 (229)
T ss_pred             Cccccc
Confidence            987754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.47  E-value=1.2e-06  Score=93.24  Aligned_cols=144  Identities=20%  Similarity=0.281  Sum_probs=91.9

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc---------------------------h----HHHHHH------HH
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---------------------------E----KNHAEY------MK  198 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~---------------------------~----~~~~~~------~~  198 (479)
                      .-|+.++-|+||+|+.+. |+.||||+.+..-..                           -    .+..+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            578999999999999975 899999998752100                           0    011112      22


Q ss_pred             HHHHHHHhC-----CCCCeeeEeEEEeeCCeEEEEEEeccCCcHHHH--HHHcCCCcHHHHHHHHHHHHHHHHHHHhCCC
Q 011698          199 SERNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ--LYRQGLFREDLARIYTAEIVSAVSHLHANGI  271 (479)
Q Consensus       199 ~E~~iL~~l-----~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~--l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~I  271 (479)
                      +|...+.++     +.++|.--.-+++-...-.++|||++|-.+.+.  +.. ..++...+.....++  -+..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence            344444444     234433222233334456799999999888666  344 334433322222111  1223334799


Q ss_pred             ccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          272 MHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       272 iHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      +|.|..|.||+++.+|++.+.|||+...+++.
T Consensus       287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            99999999999999999999999999887654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.37  E-value=7.7e-06  Score=77.49  Aligned_cols=138  Identities=25%  Similarity=0.349  Sum_probs=82.1

Q ss_pred             EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCC--CeeeEeEEE---eeCCeEEEEE
Q 011698          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP--FIVQLRYSF---QTKYRLYLVL  229 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~~---~~~~~~~lV~  229 (479)
                      ++.|+.|..+.||++...+ + .+++|+....     .....+..|..+++.+...  -+.+++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-S-EEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            5789999999999999865 4 7999997654     2345567888888877432  245666533   2334579999


Q ss_pred             EeccCCcHHH----------------HH---HHc----CCCcHH------HHHHH---------------HHHHHH-HHH
Q 011698          230 DFVNGGHLFF----------------QL---YRQ----GLFRED------LARIY---------------TAEIVS-AVS  264 (479)
Q Consensus       230 E~~~ggsL~~----------------~l---~~~----~~l~e~------~~~~~---------------~~qi~~-aL~  264 (479)
                      ++++|..+..                .+   +..    ..+...      .....               ...+.. .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999987766                11   111    000000      00000               011222 233


Q ss_pred             HHHh-------CCCccCCCCCccEEeC-CCCcEEEeecCCccc
Q 011698          265 HLHA-------NGIMHRDLKPENILLD-ADGHVMLTDFGLAKQ  299 (479)
Q Consensus       265 ~LH~-------~~IiHrDLKpeNILl~-~~g~vkL~DFGla~~  299 (479)
                      .+++       ..++|+|+.+.|||++ .++.+-|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            3332       3699999999999999 667778999998854

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.37  E-value=3.9e-06  Score=80.61  Aligned_cols=134  Identities=16%  Similarity=0.131  Sum_probs=83.1

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCC--eeeEeEEEeeCCeEEEEEEecc
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVN  233 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~~~~~~~~~lV~E~~~  233 (479)
                      ..||+|..+.||+.    .+..+++|......     ....+.+|.++++.+..-.  +.+.+++........+|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            57899999999973    24457889876432     1233678999998885433  4667777777788899999999


Q ss_pred             CCc-HH--------------HH-------HHHc--CCCcHHH-HHHHHH----------HHHH-HHHHHHh----CCCcc
Q 011698          234 GGH-LF--------------FQ-------LYRQ--GLFREDL-ARIYTA----------EIVS-AVSHLHA----NGIMH  273 (479)
Q Consensus       234 ggs-L~--------------~~-------l~~~--~~l~e~~-~~~~~~----------qi~~-aL~~LH~----~~IiH  273 (479)
                      |.. +.              ..       ++.-  ....... ...+..          ++.. ...+|..    ..++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            963 11              11       1110  0001000 000100          0111 1222221    24789


Q ss_pred             CCCCCccEEeCCCCcEEEeecCCccc
Q 011698          274 RDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       274 rDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      +|+.|.||++++++ +.|+||+.+..
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcCc
Confidence            99999999999888 99999998853

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.36  E-value=6.3e-06  Score=78.97  Aligned_cols=141  Identities=22%  Similarity=0.235  Sum_probs=95.8

Q ss_pred             EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH---------------------HHHHHHHHHHHHHHhCC--CCC
Q 011698          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---------------------NHAEYMKSERNILTKVD--HPF  211 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~---------------------~~~~~~~~E~~iL~~l~--hp~  211 (479)
                      ...|+.|--+.||+|.. .++..+|+|+.+.....-.                     ....+...|..-|+++.  +=.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            45778888889999886 4678899999875332111                     11233456777777763  233


Q ss_pred             eeeEeEEEeeCCeEEEEEEeccCCcH-HHHHHHcCCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEeCCCCcE
Q 011698          212 IVQLRYSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHV  289 (479)
Q Consensus       212 Iv~l~~~~~~~~~~~lV~E~~~ggsL-~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl~~~g~v  289 (479)
                      +.+-+.+.    +-.|||||+..... .-.|.. -.+..+.+..+..++++.+.-|-. .++||+||+.=|||+. +|.+
T Consensus       132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence            34444433    33689999976421 111111 123333677788888888888776 8999999999999998 9999


Q ss_pred             EEeecCCccccCC
Q 011698          290 MLTDFGLAKQFDE  302 (479)
Q Consensus       290 kL~DFGla~~~~~  302 (479)
                      .|+|||-|....+
T Consensus       206 ~iID~~QaV~~~h  218 (268)
T COG1718         206 YIIDVSQAVTIDH  218 (268)
T ss_pred             EEEECccccccCC
Confidence            9999999976543

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.21  E-value=5.9e-06  Score=75.18  Aligned_cols=130  Identities=22%  Similarity=0.274  Sum_probs=93.5

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCee-eEeEEEeeCCeEEEEEE
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV-QLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv-~l~~~~~~~~~~~lV~E  230 (479)
                      .+..+.||+|.+|.||++.+.  |..+|+|+-+.+.     ....+..|+++|..++--++- ++|.+..+    ++.||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me   92 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME   92 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence            345678999999999999995  4579999876543     356688999999999866654 44444332    35599


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCC-CCccEEeCCCCcEEEeecCCccc
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL-KPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDL-KpeNILl~~~g~vkL~DFGla~~  299 (479)
                      |+.|-.|...-...   +    +.-+..++++-.-|-..||-|..| .|..++|..++.+-|+||..|+.
T Consensus        93 ~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          93 YIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            99998876544321   1    223445666656677889999988 46666666777999999999974

>smart00133 S_TK_X Extension to Ser/Thr-type protein kinases

Probab=98.17  E-value=1.8e-06  Score=65.49  Aligned_cols=61  Identities=36%  Similarity=0.758  Sum_probs=49.7

Q ss_pred             cCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCCCC---CCCCccCeeeec
Q 011698          409 KMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKF---NENPFKGFTYVR  469 (479)
Q Consensus       409 ~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~---~~~~f~~f~~~~  469 (479)
                      ++++|++|..+++.|||+|.+.+..+..+|+..++......++......   .+..|.||+|..
T Consensus         1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~~~~~s~~~~~~~~~~~~~~F~gfsy~~   64 (64)
T smart00133        1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEETPVLTPVDSPASGGSQQEPFRGFSYVF   64 (64)
T ss_pred             CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCCCCCCCCCCccccccccccccCCCcccC
Confidence            4799999999999999999999999999999988887776666543321   147899999963

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.15  E-value=2.1e-05  Score=75.99  Aligned_cols=135  Identities=16%  Similarity=0.059  Sum_probs=82.1

Q ss_pred             EeccCCc-eEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          157 VVGQGAF-AKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       157 ~LG~G~f-G~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      .|-.|.. ..||++...  +..+.+|+.....      ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            3445555 789998753  3568888875432      223567888888773 34456777777776778999999999


Q ss_pred             CcHHHHH-------------------HHcC----CCcHH---HHHHH---HH----------------HHHHHHHHHH--
Q 011698          235 GHLFFQL-------------------YRQG----LFRED---LARIY---TA----------------EIVSAVSHLH--  267 (479)
Q Consensus       235 gsL~~~l-------------------~~~~----~l~e~---~~~~~---~~----------------qi~~aL~~LH--  267 (479)
                      .++....                   +...    .+...   .....   +.                .+...+..|-  
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            7764321                   1100    11100   00000   00                0111112221  


Q ss_pred             -----hCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          268 -----ANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       268 -----~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                           ...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence                 12489999999999999888889999998853

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.08  E-value=2e-05  Score=83.98  Aligned_cols=142  Identities=20%  Similarity=0.282  Sum_probs=88.4

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc----------------------------hHHHHHHHHH------HH
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM----------------------------EKNHAEYMKS------ER  201 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~----------------------------~~~~~~~~~~------E~  201 (479)
                      +.||.-+.|+|++|+.++ |+.||||+-+..-..                            -++..+.+..      |+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            579999999999999987 999999997642100                            0111122222      22


Q ss_pred             HH----HHhCCCCC------eeeEeEEEeeCCeEEEEEEeccCCcHH--HHHHHcCCCcHHHHHHHHHHHHHHH-HHHHh
Q 011698          202 NI----LTKVDHPF------IVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGLFREDLARIYTAEIVSAV-SHLHA  268 (479)
Q Consensus       202 ~i----L~~l~hp~------Iv~l~~~~~~~~~~~lV~E~~~ggsL~--~~l~~~~~l~e~~~~~~~~qi~~aL-~~LH~  268 (479)
                      +-    .+.+.|-+      |.++|..+.  ..-.|+||||+|..+.  +.+.+.+. +...+..   .+.++. +-+=.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi-~~~~i~~---~l~~~~~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGI-SPHDILN---KLVEAYLEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCC-CHHHHHH---HHHHHHHHHHHh
Confidence            22    22233444      455544333  3457999999998653  44555543 3332222   222221 12234


Q ss_pred             CCCccCCCCCccEEeCC----CCcEEEeecCCccccCCCC
Q 011698          269 NGIMHRDLKPENILLDA----DGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       269 ~~IiHrDLKpeNILl~~----~g~vkL~DFGla~~~~~~~  304 (479)
                      .|++|+|=.|.||+++.    ++.+.+.|||+...+....
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~  359 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT  359 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence            68999999999999984    6689999999998775543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.07  E-value=5.5e-05  Score=70.84  Aligned_cols=128  Identities=24%  Similarity=0.329  Sum_probs=89.8

Q ss_pred             CCeEEEEEeccCCc-eEEEEEEEcCCCeEEEEEEeehhhh----------ch--------HHHHHHHHHHHHHHHhC---
Q 011698          150 EDFEVLKVVGQGAF-AKVYQVRRIGTSEIYAMKVMRKDKI----------ME--------KNHAEYMKSERNILTKV---  207 (479)
Q Consensus       150 ~~y~~~~~LG~G~f-G~V~~a~~~~~~~~vAiK~i~~~~~----------~~--------~~~~~~~~~E~~iL~~l---  207 (479)
                      .+++.++.||.|.- |.||+++.  .|+.||+|+.+.-..          ..        .....-+..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68999999999999 99999998  567999999432100          00        02233456677666665   


Q ss_pred             CCCCe--eeEeEEEeeC------------------CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHH
Q 011698          208 DHPFI--VQLRYSFQTK------------------YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH  267 (479)
Q Consensus       208 ~hp~I--v~l~~~~~~~------------------~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH  267 (479)
                      .+.++  |+.+++..-.                  ...-||.||+....         .+....    +.+|.+-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence            45566  8888887211                  12467888887653         222233    557777888899


Q ss_pred             hCCCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          268 ANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       268 ~~~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                      +.||+-+|+++.|..   +  -||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc---C--CEEEecccC
Confidence            999999999999987   2  488999865

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.01  E-value=9.2e-07  Score=101.06  Aligned_cols=251  Identities=15%  Similarity=0.062  Sum_probs=164.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCe-EEEEEEeehhhh--chHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee--CC
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSE-IYAMKVMRKDKI--MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KY  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~-~vAiK~i~~~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~  223 (479)
                      ++++++.--||-|.+++   +++..... -+.+|+.+.-..  ..+-..+....|++.++...|+++...+.-...  ..
T Consensus      1228 ~e~~EV~l~i~~~~~~R---~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFR---NKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred             hhhhheeeecccceeec---cchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence            46677766666665553   33322211 135555443211  112234455567777888899998876544432  23


Q ss_pred             eEEEEEEeccCCcHHHHHHHcC----CCcHHHHHHHHHHHHHHHHHHHhC-C----CccCCCCCccEEeCCCCcEEEeec
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSHLHAN-G----IMHRDLKPENILLDADGHVMLTDF  294 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~-~----IiHrDLKpeNILl~~~g~vkL~DF  294 (479)
                      ..|.+++|+.+|.++..+.++-    .+.+..+.....+.+.+..-+|+. +    .+|++||+-|.+|..+..+|+.++
T Consensus      1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred             HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence            4688999999999999987642    234444443334436666666664 2    689999999999999999999999


Q ss_pred             CCccc-cCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCcc
Q 011698          295 GLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAF  371 (479)
Q Consensus       295 Gla~~-~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~  371 (479)
                      |+.+. -..........+++.|+++++...-.++.++|+|..|+.+|+...|..+|..-... ..+.+..+  ...++..
T Consensus      1385 gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~-~Lkgiidn~tf~sIe~l 1463 (2724)
T KOG1826|consen 1385 GLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQP-ALKGIIDNHTFFSIEKL 1463 (2724)
T ss_pred             ccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHH-HHcCccccccccccccc
Confidence            99993 22233345677889999999999988998999999999999999998888532222 22222222  2334444


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      .+.++......+|...-..||     +-..++.-+.|
T Consensus      1464 ~pgdaNve~~~~Ll~K~~~rp-----~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1464 KPGDANVEALHRLLWKYMERP-----GQYISLSRDHF 1495 (2724)
T ss_pred             CCCcccHHHHHHHHHHhhhcc-----hhhhhcccccc
Confidence            566666666666666677788     44555554444

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.01  E-value=0.00011  Score=69.14  Aligned_cols=130  Identities=24%  Similarity=0.279  Sum_probs=90.6

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhh-------------chHHHHHHHHHHHHHHHhCC------CCCeeeEe
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-------------MEKNHAEYMKSERNILTKVD------HPFIVQLR  216 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~-------------~~~~~~~~~~~E~~iL~~l~------hp~Iv~l~  216 (479)
                      ..||+|+.-.||.--.   .....||++.....             ..........+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            5789999999996433   23368999887650             00112334455665555544      88999999


Q ss_pred             EEEeeCCeEEEEEEeccCC------cHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC---
Q 011698          217 YSFQTKYRLYLVLDFVNGG------HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---  287 (479)
Q Consensus       217 ~~~~~~~~~~lV~E~~~gg------sL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g---  287 (479)
                      ++.++..-+-+|+|.+...      +|.+++.+ +.+++ ...   ..+-.-..||-..+|+.+||+|.||++...+   
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            9999999999999987642      67777754 44555 333   3334455688899999999999999995433   


Q ss_pred             -cEEEee
Q 011698          288 -HVMLTD  293 (479)
Q Consensus       288 -~vkL~D  293 (479)
                       .+.|+|
T Consensus       159 ~~lvlID  165 (199)
T PF10707_consen  159 FRLVLID  165 (199)
T ss_pred             eEEEEEe
Confidence             577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=97.99  E-value=6.7e-05  Score=85.38  Aligned_cols=81  Identities=11%  Similarity=0.250  Sum_probs=57.5

Q ss_pred             EEEEeccCCceEEEEEEEcCCC--eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCe--eeEeEEEeeC---CeE
Q 011698          154 VLKVVGQGAFAKVYQVRRIGTS--EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFI--VQLRYSFQTK---YRL  225 (479)
Q Consensus       154 ~~~~LG~G~fG~V~~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~I--v~l~~~~~~~---~~~  225 (479)
                      .++.|+.|.++.+|+......+  ..+++|+........  ....+.+|..+|+.+. |.+|  .+++.++.+.   +..
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            3678899999999998875433  457777764432111  1235778999999985 6665  7777777654   467


Q ss_pred             EEEEEeccCCc
Q 011698          226 YLVLDFVNGGH  236 (479)
Q Consensus       226 ~lV~E~~~ggs  236 (479)
                      |+||||++|..
T Consensus       120 flVME~v~G~~  130 (822)
T PLN02876        120 FYIMEYLEGRI  130 (822)
T ss_pred             eEEEEecCCcc
Confidence            89999999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.87  E-value=9.5e-05  Score=71.21  Aligned_cols=72  Identities=10%  Similarity=0.109  Sum_probs=44.4

Q ss_pred             EEeccCCce-EEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCC---CeeeEeEEEeeC---CeEEEE
Q 011698          156 KVVGQGAFA-KVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP---FIVQLRYSFQTK---YRLYLV  228 (479)
Q Consensus       156 ~~LG~G~fG-~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp---~Iv~l~~~~~~~---~~~~lV  228 (479)
                      +.|+.|+.. .||+..     ..+++|+.+...     ....+.+|..+|+.+...   -+.++++.....   ...+++
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            467766666 588762     237778754321     234578899999887531   234444443332   245889


Q ss_pred             EEeccCCcH
Q 011698          229 LDFVNGGHL  237 (479)
Q Consensus       229 ~E~~~ggsL  237 (479)
                      |++++|.++
T Consensus        73 ~~~i~G~~l   81 (235)
T cd05155          73 YRWLEGETA   81 (235)
T ss_pred             EEeecCCCC
Confidence            999999765

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.79  E-value=0.00031  Score=67.31  Aligned_cols=75  Identities=19%  Similarity=0.232  Sum_probs=48.6

Q ss_pred             EEEeccCCceEEEEEEEcC-CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC-CCeeeEeEEEeeCCeEEEEEEec
Q 011698          155 LKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQLRYSFQTKYRLYLVLDFV  232 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~~~lV~E~~  232 (479)
                      ++.|..|-...+|++.... .++.|++|+.......    .....+|..+++.+.. ...+++++.+..    .+||||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence            4678888899999997643 3567899987543211    1123468888888743 334555544332    3799999


Q ss_pred             cCCcH
Q 011698          233 NGGHL  237 (479)
Q Consensus       233 ~ggsL  237 (479)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            98764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.67  E-value=0.001  Score=69.17  Aligned_cols=80  Identities=11%  Similarity=0.085  Sum_probs=54.7

Q ss_pred             EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc--h--HHHHHHHHHHHHHHHhCC---CCCeeeEeEEEeeCCeEEE
Q 011698          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--E--KNHAEYMKSERNILTKVD---HPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~--~--~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~~~~~~~~l  227 (479)
                      .+.||.|.+..||++...+.++.++||.-......  .  .-..++...|...|+.+.   -.++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            57899999999999998654467999985421110  0  113455677888888763   2456777665  4456789


Q ss_pred             EEEeccCCc
Q 011698          228 VLDFVNGGH  236 (479)
Q Consensus       228 V~E~~~ggs  236 (479)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998743

>PRK10593 hypothetical protein; Provisional

Probab=97.59  E-value=0.00087  Score=67.11  Aligned_cols=78  Identities=9%  Similarity=0.029  Sum_probs=54.9

Q ss_pred             EEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC---CCeeeEeEEEee---CCeEE
Q 011698          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH---PFIVQLRYSFQT---KYRLY  226 (479)
Q Consensus       153 ~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h---p~Iv~l~~~~~~---~~~~~  226 (479)
                      .-.+.||.|..+.||.....+ + .+.+|..+...     ....+..|...|+.+.-   -.+.++++.+..   .+..+
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~   89 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV   89 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence            446789999999999986532 3 36777743211     12467889999988843   357778877654   36689


Q ss_pred             EEEEeccCCcH
Q 011698          227 LVLDFVNGGHL  237 (479)
Q Consensus       227 lV~E~~~ggsL  237 (479)
                      +|||+++|+++
T Consensus        90 LVmE~i~G~~~  100 (297)
T PRK10593         90 LLLERLRGVSV  100 (297)
T ss_pred             EEEeccCCEec
Confidence            99999998754

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.44  E-value=0.0007  Score=66.01  Aligned_cols=132  Identities=13%  Similarity=0.173  Sum_probs=75.5

Q ss_pred             eccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCe-eeEeEEEeeCCeEEEEEEeccCCc
Q 011698          158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRLYLVLDFVNGGH  236 (479)
Q Consensus       158 LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~~~~~~~~~lV~E~~~ggs  236 (479)
                      +..|-.+.+|+...  +++.+++|+.......  ... ...+|..+++.+....+ .++++...    -++||||++|..
T Consensus         4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~--~~~-~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~   74 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKA--LGV-DRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV   74 (256)
T ss_pred             CCCcCcCCeEEEEe--CCccEEEeeCCccccc--ccC-cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence            45677888998873  4567888876542111  001 14668888888754333 34444432    268999999865


Q ss_pred             HHH--------------H---HHHcC----CCcH-HHHHHHHHHH---------HHHHHHHHh--------CCCccCCCC
Q 011698          237 LFF--------------Q---LYRQG----LFRE-DLARIYTAEI---------VSAVSHLHA--------NGIMHRDLK  277 (479)
Q Consensus       237 L~~--------------~---l~~~~----~l~e-~~~~~~~~qi---------~~aL~~LH~--------~~IiHrDLK  277 (479)
                      +..              .   ++...    .++. ..+..+..++         ...+..+-.        ..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            421              1   11111    1111 1122222111         111222221        248999999


Q ss_pred             CccEEeCCCCcEEEeecCCccc
Q 011698          278 PENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       278 peNILl~~~g~vkL~DFGla~~  299 (479)
                      |.|||++.++ +.|+||..|..
T Consensus       155 ~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       155 AYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cCcEEEeCCC-CEEEeccccCc
Confidence            9999999877 78999998854

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.43  E-value=0.0018  Score=64.34  Aligned_cols=140  Identities=21%  Similarity=0.218  Sum_probs=83.7

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCC--eeeEeEE------EeeCC
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF--IVQLRYS------FQTKY  223 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~------~~~~~  223 (479)
                      ..-++.|..|....+|++...  +..+++|+....      ....+..|..+++.+.+..  +.+++..      ....+
T Consensus        16 ~~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          16 LLSFEGISAGIENTNYFVTTD--SGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             hhheecccCccccceEEEEeC--CCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            334677888888899998653  346899987641      1234566777777774322  4444332      23345


Q ss_pred             eEEEEEEeccCCcHHH--------------HHHHcC-CCcH--------HHHH------------HHHHHHHHHHHHHHh
Q 011698          224 RLYLVLDFVNGGHLFF--------------QLYRQG-LFRE--------DLAR------------IYTAEIVSAVSHLHA  268 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~--------------~l~~~~-~l~e--------~~~~------------~~~~qi~~aL~~LH~  268 (479)
                      ..++|++|++|..+..              .++... .+..        ....            .....+..++.++.+
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6789999999875411              011100 0000        0000            011112334444443


Q ss_pred             -------CCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          269 -------NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       269 -------~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                             .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence                   3799999999999999887789999999853

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.43  E-value=0.00042  Score=64.59  Aligned_cols=99  Identities=17%  Similarity=0.171  Sum_probs=76.7

Q ss_pred             HHHHHHHHhCCC-CCeeeEeEEEeeCCeEEEEEEeccCCcHHHH---HHHcCCCcHHHHHHHHHHHHHHHHHHHhC---C
Q 011698          198 KSERNILTKVDH-PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQ---LYRQGLFREDLARIYTAEIVSAVSHLHAN---G  270 (479)
Q Consensus       198 ~~E~~iL~~l~h-p~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~---l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---~  270 (479)
                      ..|.-+|+.+++ +++++++|+|-.    ++|.||...+++...   +..--..++.....++.+++..+++|+..   .
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357778888876 699999999833    568899987765321   11112347778888999999999999883   4


Q ss_pred             CccCCCCCccEEeCCCCcEEEeecCCcccc
Q 011698          271 IMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       271 IiHrDLKpeNILl~~~g~vkL~DFGla~~~  300 (479)
                      +.-.|++++|+-++++|++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            555799999999999999999999887543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.37  E-value=0.0036  Score=62.75  Aligned_cols=141  Identities=21%  Similarity=0.221  Sum_probs=81.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCC--eeeEeEEE------eeC
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF--IVQLRYSF------QTK  222 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~~------~~~  222 (479)
                      ....++.++.|....+|++... ++ .+++|+.....  .   .+.+..|.+++..|....  +.+++...      ...
T Consensus        23 ~~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~   95 (307)
T TIGR00938        23 ELLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA   95 (307)
T ss_pred             CceeccccCCccccceEEEEeC-CC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence            3455777888888899998753 33 58889875421  1   122445666666663211  33433321      224


Q ss_pred             CeEEEEEEeccCCcHH-----------H---HHHHc-CCC--------cHHH-----HH----------HHHHHHHHHHH
Q 011698          223 YRLYLVLDFVNGGHLF-----------F---QLYRQ-GLF--------REDL-----AR----------IYTAEIVSAVS  264 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~-----------~---~l~~~-~~l--------~e~~-----~~----------~~~~qi~~aL~  264 (479)
                      +..+++++|++|..+.           .   .++.. ..+        ....     ..          .....+...++
T Consensus        96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~  175 (307)
T TIGR00938        96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD  175 (307)
T ss_pred             CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence            5678999999985421           1   11110 001        0000     00          00112233455


Q ss_pred             HHHh-------CCCccCCCCCccEEeCCCCcEEEeecCCcc
Q 011698          265 HLHA-------NGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (479)
Q Consensus       265 ~LH~-------~~IiHrDLKpeNILl~~~g~vkL~DFGla~  298 (479)
                      ++..       .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            5532       589999999999999988877899999984

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.36  E-value=0.006  Score=61.39  Aligned_cols=31  Identities=32%  Similarity=0.537  Sum_probs=26.6

Q ss_pred             CCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       269 ~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      .++||+|+.+.|||++.+...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            3899999999999998666568999999853

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.29  E-value=0.0013  Score=65.57  Aligned_cols=75  Identities=13%  Similarity=0.104  Sum_probs=47.9

Q ss_pred             EEEeccCCceEEEEEEEcC------CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCC-eeeEeEEEeeCCeEEE
Q 011698          155 LKVVGQGAFAKVYQVRRIG------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTKYRLYL  227 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~~~~~~~~~l  227 (479)
                      ++.|..|-...||++....      +++.|++|+......    ......+|..+++.+.... ..++++++..    .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence            4566777777899887643      257899999765321    1223567888888774322 3455555542    35


Q ss_pred             EEEeccCCcH
Q 011698          228 VLDFVNGGHL  237 (479)
Q Consensus       228 V~E~~~ggsL  237 (479)
                      |+||++|..+
T Consensus        75 v~e~i~G~~l   84 (302)
T cd05156          75 IEEFIPSRTL   84 (302)
T ss_pred             hhheeCCCcC
Confidence            8999998765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.01  E-value=0.0058  Score=62.42  Aligned_cols=77  Identities=14%  Similarity=0.118  Sum_probs=49.3

Q ss_pred             EeccCCceEEEEEEEcCCCeEEEEEEeehhhhc----hHHHHHHHHHHHHHHHhCC--CC-CeeeEeEEEeeCCeEEEEE
Q 011698          157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM----EKNHAEYMKSERNILTKVD--HP-FIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       157 ~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~~~E~~iL~~l~--hp-~Iv~l~~~~~~~~~~~lV~  229 (479)
                      .||.|....||++.....++-|+||.-......    -.-..++...|...|+...  .| .++++| .| ++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~-D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HF-DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EE-ccccceehH
Confidence            589999999999998644467999976432111    0223445567888887763  35 344443 33 445566899


Q ss_pred             EeccCC
Q 011698          230 DFVNGG  235 (479)
Q Consensus       230 E~~~gg  235 (479)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.87  E-value=0.0092  Score=60.58  Aligned_cols=146  Identities=18%  Similarity=0.268  Sum_probs=96.4

Q ss_pred             EEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc-------------------hHH----HHHHHHHHHHHHHhCCC
Q 011698          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-------------------EKN----HAEYMKSERNILTKVDH  209 (479)
Q Consensus       153 ~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~-------------------~~~----~~~~~~~E~~iL~~l~h  209 (479)
                      ++-..|..|--+.||.|... +|..+|||+++-.-+.                   ..+    ..-+...|++-|++++.
T Consensus       147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            34467888999999998864 5677999998632110                   111    12345567788888765


Q ss_pred             CCeeeEeEEEeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCccEEeCCCCc
Q 011698          210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL-HANGIMHRDLKPENILLDADGH  288 (479)
Q Consensus       210 p~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~L-H~~~IiHrDLKpeNILl~~~g~  288 (479)
                      ..|..---..  -..-.|||+|+.+..-..-..+.-.++...++.+-.+++.-|.-| |.+++||.||.-=|+|+ .+|.
T Consensus       226 aGIP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~  302 (520)
T KOG2270|consen  226 AGIPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK  302 (520)
T ss_pred             cCCCCCCcee--eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence            4443211000  023468999997543222222334567777888777777777765 56799999999999999 6899


Q ss_pred             EEEeecCCccccCC
Q 011698          289 VMLTDFGLAKQFDE  302 (479)
Q Consensus       289 vkL~DFGla~~~~~  302 (479)
                      +.|+|.+-+...+.
T Consensus       303 lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  303 LYIIDVSQSVEHDH  316 (520)
T ss_pred             EEEEEccccccCCC
Confidence            99999988865443

>PLN02236 choline kinase

Probab=96.82  E-value=0.011  Score=60.59  Aligned_cols=136  Identities=15%  Similarity=0.179  Sum_probs=79.4

Q ss_pred             EEEeccCCceEEEEEEEcC----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCe-eeEeEEEeeCCeEEEEE
Q 011698          155 LKVVGQGAFAKVYQVRRIG----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~~~~~~~~~lV~  229 (479)
                      ++.|-.|-...+|++....    +++.|++|+.....   ....+ ..+|..+++.+..-++ .++++.+...    .|.
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~  112 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE  112 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence            4455568888999987543    34679999876532   11122 2568888888754333 4556666432    579


Q ss_pred             EeccCCcHHHH-----------------HHHcC------CCcHHHHHHHHHHH-----------------HHHHHHH---
Q 011698          230 DFVNGGHLFFQ-----------------LYRQG------LFREDLARIYTAEI-----------------VSAVSHL---  266 (479)
Q Consensus       230 E~~~ggsL~~~-----------------l~~~~------~l~e~~~~~~~~qi-----------------~~aL~~L---  266 (479)
                      +|++|.++...                 ++...      ....+.+..+..++                 ...+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            99987665211                 11111      00112222232111                 1111112   


Q ss_pred             -H----hCCCccCCCCCccEEeCC-CCcEEEeecCCcc
Q 011698          267 -H----ANGIMHRDLKPENILLDA-DGHVMLTDFGLAK  298 (479)
Q Consensus       267 -H----~~~IiHrDLKpeNILl~~-~g~vkL~DFGla~  298 (479)
                       .    ...++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence             1    225899999999999976 4789999999885

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.80  E-value=0.0013  Score=65.65  Aligned_cols=139  Identities=17%  Similarity=0.200  Sum_probs=92.3

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH-------------------HHHHHHHHHHHHHHhCC-CCC
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK-------------------NHAEYMKSERNILTKVD-HPF  211 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~-------------------~~~~~~~~E~~iL~~l~-hp~  211 (479)
                      +.+.+.||-|--+.||.+-+. .|.+.++|.=+..++.-.                   -..-...+|...|+.|. |-+
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            566789999999999999874 567788886443221100                   01112346777777773 322


Q ss_pred             e-eeEeEEEeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEE
Q 011698          212 I-VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM  290 (479)
Q Consensus       212 I-v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vk  290 (479)
                      = .+.+    +-+..++|||++.|-.|...-+-      ..+..+...+..-+--|-..|+||+|.+-=||+++++++++
T Consensus       173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCCcc----cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence            2 2222    34567899999999776432211      12223344445555668889999999999999999999999


Q ss_pred             EeecCCccccC
Q 011698          291 LTDFGLAKQFD  301 (479)
Q Consensus       291 L~DFGla~~~~  301 (479)
                      ++||--+....
T Consensus       243 vIDFPQmvS~s  253 (465)
T KOG2268|consen  243 VIDFPQMVSTS  253 (465)
T ss_pred             EeechHhhccC
Confidence            99998765443

>PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=96.79  E-value=0.00056  Score=48.86  Aligned_cols=43  Identities=33%  Similarity=0.608  Sum_probs=29.2

Q ss_pred             cCCcccccCccccccCCCCCCCCC-CCC---CCCCCCccCeeeecCc
Q 011698          429 VAGKHCVANFEECWTNMPLLDSPV-ASP---KFNENPFKGFTYVRPA  471 (479)
Q Consensus       429 ~~~~~~~~~f~~~~~~~~~~~~~~-~~~---~~~~~~f~~f~~~~~~  471 (479)
                      +.+..+++|||.+||.++...++. ...   ...+..|.||+|+++.
T Consensus         2 v~~~~DtsnFD~eFt~~~~~~t~~~~~~~~~~~~~~~F~GFTy~~~s   48 (48)
T PF00433_consen    2 VKSETDTSNFDPEFTEEPPVDTPPSDPSPLSSSMQENFQGFTYVNPS   48 (48)
T ss_dssp             -SSTT-GTTSCHHHHTSSSSS--S--HHHHCTSSGGGGTT-CEETCT
T ss_pred             CCchhhhhhcCcccccCCCCCCCcccCCcccccccCcCCCCeecCCC
Confidence            567789999999999999888885 211   3445669999999874

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A ....

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.52  E-value=0.029  Score=56.55  Aligned_cols=147  Identities=17%  Similarity=0.222  Sum_probs=84.0

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCC--CeeeEeEEEeeCC--eEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP--FIVQLRYSFQTKY--RLY  226 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~~~~~~--~~~  226 (479)
                      ...+++.+..|..-.+|.....  ++.+++. ... ............+|..+++.+.--  -+...++.+.++.  ..|
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf  101 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF  101 (321)
T ss_pred             CCceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence            3445566655555556655543  6778887 321 112223345567788888877432  2334455665555  679


Q ss_pred             EEEEeccCCcH---------H---------HHHHH---c--------C---CCcHHHHHHHHHHH--------------H
Q 011698          227 LVLDFVNGGHL---------F---------FQLYR---Q--------G---LFREDLARIYTAEI--------------V  260 (479)
Q Consensus       227 lV~E~~~ggsL---------~---------~~l~~---~--------~---~l~e~~~~~~~~qi--------------~  260 (479)
                      .||+|++|..+         .         +.|..   -        +   .+...++..+..+.              .
T Consensus       102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~  181 (321)
T COG3173         102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD  181 (321)
T ss_pred             EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence            99999998422         1         11110   0        0   00111111122111              2


Q ss_pred             HHHHHHHhC--------CCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          261 SAVSHLHAN--------GIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       261 ~aL~~LH~~--------~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      .-..+++.+        .++|+|+.+.||+++.++-+-+.||+++..-+
T Consensus       182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            224455443        48999999999999999999999999997643

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.47  E-value=0.044  Score=54.61  Aligned_cols=76  Identities=16%  Similarity=0.234  Sum_probs=48.1

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC---CCCeeeEeEEEeeCCeEEEE
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .+-.+.|+.|....+|+..  .+++.+-+|+-...      ....+..|..-|+.|.   --.+++++.+....+.-|||
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl   90 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL   90 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence            3456789999999999887  57778999987632      1345677888787773   34577888888887788999


Q ss_pred             EEeccCC
Q 011698          229 LDFVNGG  235 (479)
Q Consensus       229 ~E~~~gg  235 (479)
                      |||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.47  E-value=0.085  Score=52.59  Aligned_cols=29  Identities=34%  Similarity=0.572  Sum_probs=25.8

Q ss_pred             CCCccCCCCCccEEeCCCCcEEEeecCCcc
Q 011698          269 NGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (479)
Q Consensus       269 ~~IiHrDLKpeNILl~~~g~vkL~DFGla~  298 (479)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999999874

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.44  E-value=0.025  Score=55.95  Aligned_cols=30  Identities=40%  Similarity=0.591  Sum_probs=25.5

Q ss_pred             CCccCCCCCccEEeCCCCc-EEEeecCCccc
Q 011698          270 GIMHRDLKPENILLDADGH-VMLTDFGLAKQ  299 (479)
Q Consensus       270 ~IiHrDLKpeNILl~~~g~-vkL~DFGla~~  299 (479)
                      .++|+|+++.|||++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987565 56999999864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.29  E-value=0.028  Score=57.13  Aligned_cols=140  Identities=14%  Similarity=0.167  Sum_probs=78.6

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCC---CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCe-eeEeEEEeeCCeEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRLY  226 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~~~~~~~~~  226 (479)
                      +.++ +.|..|=...+|++...+.   +..|.+|+.....-   ...+ ..+|..+++.+..-++ .++++++..+    
T Consensus        16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~Id-R~~E~~il~~l~~~gl~P~~l~~~~~G----   86 (330)
T PLN02421         16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVID-RERELQAIKYLSAAGFGAKLLGVFGNG----   86 (330)
T ss_pred             ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEec-hHHHHHHHHHHHhcCCCCceeEEeCCc----
Confidence            4444 4454577788998875432   23788998765321   1111 3568888888754444 4566666322    


Q ss_pred             EEEEeccCCcHHH--------------H---HHHcC-C----C-cHHHHHHHHHHH----------------------HH
Q 011698          227 LVLDFVNGGHLFF--------------Q---LYRQG-L----F-REDLARIYTAEI----------------------VS  261 (479)
Q Consensus       227 lV~E~~~ggsL~~--------------~---l~~~~-~----l-~e~~~~~~~~qi----------------------~~  261 (479)
                      +|.+|++|..|..              .   ++... .    . ....+..|..++                      ..
T Consensus        87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~  166 (330)
T PLN02421         87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD  166 (330)
T ss_pred             EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence            5889998765411              1   11111 0    1 112222222221                      11


Q ss_pred             HHHH----HHhC----CCccCCCCCccEEeCC-CCcEEEeecCCccc
Q 011698          262 AVSH----LHAN----GIMHRDLKPENILLDA-DGHVMLTDFGLAKQ  299 (479)
Q Consensus       262 aL~~----LH~~----~IiHrDLKpeNILl~~-~g~vkL~DFGla~~  299 (479)
                      -+..    +...    -++|.||.+.|||+++ ++.++++||..|..
T Consensus       167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1111    1112    2699999999999974 57899999999843

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.23  E-value=0.047  Score=56.83  Aligned_cols=77  Identities=16%  Similarity=0.089  Sum_probs=50.7

Q ss_pred             EEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc-hH---HHHHHHHHHHHHHHhCC---CCCeeeEeEEEeeCCeEE
Q 011698          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-EK---NHAEYMKSERNILTKVD---HPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       154 ~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~-~~---~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~~~~~~~~  226 (479)
                      ..+.||.|....||++...  +..|+||.-...... ..   ....+...|...|+.+.   -..+.+++.+..  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            3678999999999999873  345889976522110 00   12334455667776653   246777877776  4467


Q ss_pred             EEEEeccC
Q 011698          227 LVLDFVNG  234 (479)
Q Consensus       227 lV~E~~~g  234 (479)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999987

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.08  E-value=0.025  Score=59.73  Aligned_cols=159  Identities=19%  Similarity=0.234  Sum_probs=100.7

Q ss_pred             HHHHHHHHHhCCCCCeeeEeEEEeeC-CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 011698          197 MKSERNILTKVDHPFIVQLRYSFQTK-YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD  275 (479)
Q Consensus       197 ~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrD  275 (479)
                      +.--..+++.+.|+|..+.+++-... ....+|||++.. +|.+.+..+. +...       ++.       ..++.|- 
T Consensus        29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~-l~~~-------s~~-------~~~~~~~-   91 (725)
T KOG1093|consen   29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN-LKDE-------SLL-------AHGVLHL-   91 (725)
T ss_pred             HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc-cchh-------hhc-------cccccee-
Confidence            45567789999999999988776543 357889999854 8888777654 2211       111       1222221 


Q ss_pred             CCCccEEeCCCCcEEEeecCCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHH
Q 011698          276 LKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ  355 (479)
Q Consensus       276 LKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~  355 (479)
                                 +.++++| -++   ..   ..+..|                +++||||+|.++.|+.-|...+......
T Consensus        92 -----------~~~~~td-~~~---t~---~~~~~~----------------pKsdVwsl~~i~~el~L~~~l~~~~~~s  137 (725)
T KOG1093|consen   92 -----------NIIYITD-HFL---TK---YPSPIG----------------PKSDVWSLGFIILELYLGISLEAELTES  137 (725)
T ss_pred             -----------hhhhccc-ccc---cc---CCCCCC----------------cchhhhhHHHHHHHHHHhhHHHHHHHHH
Confidence                       2233333 111   10   011111                4999999999999999998888765554


Q ss_pred             HHHHHHHhccC------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          356 KIQQKIIKDKI------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       356 ~~~~~i~~~~~------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +....|.+-..            .+--.++....+++..|+-..|..||     ...++.+++-|..+
T Consensus       138 ~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~-----l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  138 EYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP-----LPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc-----chhHHhcCccHHHH
Confidence            44444333100            01113567788899999999999998     67888888888765

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.99  E-value=0.052  Score=56.24  Aligned_cols=78  Identities=14%  Similarity=0.189  Sum_probs=51.1

Q ss_pred             EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhch---HHHHHHHHHHHHHHHhCC--CC-CeeeEeEEEeeCCeEEEE
Q 011698          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME---KNHAEYMKSERNILTKVD--HP-FIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~~~~E~~iL~~l~--hp-~Iv~l~~~~~~~~~~~lV  228 (479)
                      ++.||.|.-.-||++.+...++-|+||.-...-...   .-..++...|...|+...  .| .++++|.  .++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            678999999999999985334568998754321111   223455677888888763  35 4455543  345556788


Q ss_pred             EEeccC
Q 011698          229 LDFVNG  234 (479)
Q Consensus       229 ~E~~~g  234 (479)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

>PTZ00384 choline kinase; Provisional

Probab=95.76  E-value=0.06  Score=55.85  Aligned_cols=79  Identities=18%  Similarity=0.228  Sum_probs=46.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCC-eE-----EEEEEeehhhhchHHHHHHHHHHHHHHHhCCCC-CeeeEeEEEeeC
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTS-EI-----YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP-FIVQLRYSFQTK  222 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~-~~-----vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~~~~~  222 (479)
                      +++++ +.|..|-...+|++...... ..     |.+++....   ..... ...+|..+++.+... .-.++++.+.. 
T Consensus        51 ~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~-  124 (383)
T PTZ00384         51 EFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD-  124 (383)
T ss_pred             ccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC-
Confidence            34444 45656888999999764331 22     444432111   11111 135688889988644 44567777653 


Q ss_pred             CeEEEEEEeccCCcH
Q 011698          223 YRLYLVLDFVNGGHL  237 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL  237 (479)
                         ++|.||++|..|
T Consensus       125 ---g~l~efIeGr~l  136 (383)
T PTZ00384        125 ---FTIQEWVEGNTM  136 (383)
T ss_pred             ---EEEEEEeccccC
Confidence               589999998765

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.61  E-value=0.23  Score=49.83  Aligned_cols=30  Identities=20%  Similarity=0.237  Sum_probs=27.9

Q ss_pred             CCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          270 GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       270 ~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      +++|+|+.+.|||++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999998864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.51  E-value=0.049  Score=51.83  Aligned_cols=101  Identities=16%  Similarity=0.269  Sum_probs=66.4

Q ss_pred             EEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHH
Q 011698          178 YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA  257 (479)
Q Consensus       178 vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~  257 (479)
                      ..+|+++.-...  -....++.+.++++++.  .|+++..-  ....+-++.|+|.....            ...- ++.
T Consensus        88 L~lKKi~slp~~--~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~~N-~i~  148 (308)
T PF07387_consen   88 LFLKKIRSLPCC--INDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NFSN-FIT  148 (308)
T ss_pred             hhhhhccCCCcc--cchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------chhH-HHH
Confidence            455555432211  12334577888888875  68888632  44567899999865322            0111 122


Q ss_pred             HHHHHHHHHHhC--CCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          258 EIVSAVSHLHAN--GIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       258 qi~~aL~~LH~~--~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                      .=+.+|.-.|+.  +.+|+|-.|+||+-|+.|.+||.|=+..
T Consensus       149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            224667888954  7999999999999999999999996654

The function of this family is unknown.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.11  E-value=0.04  Score=51.97  Aligned_cols=30  Identities=47%  Similarity=0.705  Sum_probs=21.7

Q ss_pred             CCccCCCCCccEEe-CCCCcEEEeecCCccc
Q 011698          270 GIMHRDLKPENILL-DADGHVMLTDFGLAKQ  299 (479)
Q Consensus       270 ~IiHrDLKpeNILl-~~~g~vkL~DFGla~~  299 (479)
                      -++|.||.+.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8899999999999864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK06148 hypothetical protein; Provisional

Probab=94.76  E-value=0.77  Score=53.76  Aligned_cols=31  Identities=42%  Similarity=0.634  Sum_probs=26.5

Q ss_pred             CCCccCCCCCccEEeCCCC--cEE-EeecCCccc
Q 011698          269 NGIMHRDLKPENILLDADG--HVM-LTDFGLAKQ  299 (479)
Q Consensus       269 ~~IiHrDLKpeNILl~~~g--~vk-L~DFGla~~  299 (479)
                      .++||.|+++.|||++.++  .+. |+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999999876  555 999999854

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.35  E-value=0.95  Score=45.83  Aligned_cols=29  Identities=31%  Similarity=0.329  Sum_probs=24.5

Q ss_pred             CCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       269 ~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      .++||+|+.+.|||++ + .+.|+||+-+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            3689999999999995 4 578999999853

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.32  E-value=0.13  Score=52.46  Aligned_cols=101  Identities=24%  Similarity=0.299  Sum_probs=62.9

Q ss_pred             CCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCCCcEEEeecCCcccc
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g~vkL~DFGla~~~  300 (479)
                      ....|++|++- |+.+. .+   ..-..+++..++.+.+..++-+..+ ..-||||...||||+ +|++.|+||-+++.-
T Consensus       298 ~~y~yl~~kdh-gt~is-~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         298 TLYLYLHFKDH-GTPIS-II---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ceEEEEEEecC-Cceee-ee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            34567777774 33442 11   1224455666677766666666655 789999999999999 999999999999842


Q ss_pred             CCC-CCcccccCCCCCcchhHhcCCCCCccccchh
Q 011698          301 DEN-TRSNSMCGTLEYMSPEIVLGKGHDKAADWWS  334 (479)
Q Consensus       301 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DiwS  334 (479)
                      ... ...+     -..--|-.+.|.. +..-+||-
T Consensus       372 ~~q~~isy-----~rldhp~lF~G~d-d~QFeIYr  400 (488)
T COG5072         372 YSQGIISY-----NRLDHPDLFNGVD-DYQFEIYR  400 (488)
T ss_pred             cCCceeec-----cccCchhhhcCcc-ceeeeHHH
Confidence            111 1111     1223455555443 55666654

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.11  E-value=0.35  Score=46.41  Aligned_cols=75  Identities=16%  Similarity=0.290  Sum_probs=51.0

Q ss_pred             EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC---CCCCeeeEeEEEeeCCeEEEEEEe
Q 011698          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQTKYRLYLVLDF  231 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~~~~~~lV~E~  231 (479)
                      .+.+.-|.--..|...+  ....|-+|+=..      .....+..|+.=|+.|   +--.+.+++.+..+..+.|+||||
T Consensus        21 r~~v~gG~inea~~v~d--g~~~~FvK~n~~------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~   92 (286)
T COG3001          21 REEVSGGDINEAWRLRD--GTDPFFVKCNQR------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY   92 (286)
T ss_pred             ccccCCccccceeEeec--CCcceEEEecch------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence            34555555556666554  334578887432      3345667777666655   445678888999999999999999


Q ss_pred             ccCCcH
Q 011698          232 VNGGHL  237 (479)
Q Consensus       232 ~~ggsL  237 (479)
                      ++-|.+
T Consensus        93 L~~~~~   98 (286)
T COG3001          93 LPTGPL   98 (286)
T ss_pred             ccCCCC
Confidence            987544

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	479
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-84
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-83
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-78
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-78
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-78
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-78
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-74
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-73
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-71
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-67
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-67
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-67
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-67
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-67
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-67
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-67
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-65
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-65
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-65
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-65
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-65
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-64
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-64
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-64
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-64
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-64
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-64
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-64
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		7e-64
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-64
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-64
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-64
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-64
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-64
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-64
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-63
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-63
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-63
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-63
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-63
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-63
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-63
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-63
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-63
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-63
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-63
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-63
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-63
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-63
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-63
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-63
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-63
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-63
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-63
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-63
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-63
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-63
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-63
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-63
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-63
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-63
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-63
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-63
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-63
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-63
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-63
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-62
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-62
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-62
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-62
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-62
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-62
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-62
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-62
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-62
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-62
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-62
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-62
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-61
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-61
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-60
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-59
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-58
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-56
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-56
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-56
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-55
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-55
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-55
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-55
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-55
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-55
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-55
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-55
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-55
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-55
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-55
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-55
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-55
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-55
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-55
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-55
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-55
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-54
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-51
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-51
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-51
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-51
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-50
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-50
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-49
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-49
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-49
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-47
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-47
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-46
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-46
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-46
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-45
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-44
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-44
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-44
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-44
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-40
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-40
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-40
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-40
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-39
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-39
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-39
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-39
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-39
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-39
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-39
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-39
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-39
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-39
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-39
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-39
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-39
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-39
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-39
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-39
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-39
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-39
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-39
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-39
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-39
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-39
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-38
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-38
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-38
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-38
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-38
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-38
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-38
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-38
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-38
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-38
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-38
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-38
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-38
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-38
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-38
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-37
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-37
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-37
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-36
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		9e-36
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-35
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-35
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-35
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-35
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-34
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-34
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-34
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-34
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-34
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-33
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-33
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-33
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-33
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-33
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-33
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-33
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-33
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-33
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-32
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-32
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-32
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-32
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-32
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-32
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-32
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-32
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-32
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-32
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-32
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-31
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-31
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-31
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-31
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-31
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-30
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-30
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-30
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-30
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-30
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-30
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-30
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-30
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-30
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-30
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-30
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-30
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-30
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-30
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-29
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-29
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-29
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-29
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-29
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-29
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-29
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-29
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-29
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-28
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-28
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-28
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-28
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-28
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-28
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-28
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-28
3soa_A	444	Full-Length Human Camkii Length = 444		3e-28
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-28
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-28
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-28
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-28
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-28
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-28
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-28
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-28
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-27
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-27
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-27
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		9e-27
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-26
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-26
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-26
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-26
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-26
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-26
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-26
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-26
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-26
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-26
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-26
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-26
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-26
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-26
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-26
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-26
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-26
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-26
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-26
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-26
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-25
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-25
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-25
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-25
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-25
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-25
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-25
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-25
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-25
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-25
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-25
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-25
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-25
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-25
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-25
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-25
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-25
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-25
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-25
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-25
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-25
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-25
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-25
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-25
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-25
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-25
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-25
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-25
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-25
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-25
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-25
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-25
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-25
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-25
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-25
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-25
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-25
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-25
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-25
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-25
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-25
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-25
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-25
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-25
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-25
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-25
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-25
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-25
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-25
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-25
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-25
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-25
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-25
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-25
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-25
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		8e-25
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-25
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-25
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-25
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-25
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-25
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-25
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-25
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-25
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-25
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-25
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-24
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-24
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-24
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-24
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-24
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-24
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-24
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-24
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-24
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-24
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-24
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-24
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-24
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-24
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-24
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-24
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-24
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-24
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-24
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-24
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-24
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-24
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-24
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-24
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-24
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-24
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-24
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-24
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-24
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-24
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-24
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-24
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-24
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-24
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-24
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-24
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-24
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-24
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-24
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-24
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-24
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-24
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-24
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-24
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-24
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-24
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-24
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		9e-24
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-24
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-23
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-23
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-23
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-23
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-22
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-22
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-22
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-22
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-22
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-22
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-22
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-22
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-22
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-21
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-21
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-21
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-21
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-21
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-21
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-21
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-21
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-21
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-21
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-21
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-21
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-21
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-21
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-21
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-21
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-21
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-21
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-21
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-21
2oza_A	356	Structure Of P38alpha Complex Length = 356		6e-21
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-21
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		7e-21
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-21
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-21
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-20
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-20
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-20
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-20
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-20
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-20
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-20
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-20
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-20
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-20
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-20
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-20
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-20
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-20
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-20
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-20
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		9e-20
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		9e-20
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-20
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-20
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-19
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-19
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-19
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-19
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-19
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-19
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-19
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-19
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-19
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-19
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-19
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-19
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-19
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-19
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-19
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-19
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-19
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-19
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-19
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-19
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-19
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-19
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-19
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-19
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-19
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-19
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-19
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-19
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-18
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-18
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-18
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-18
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-18
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-18
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-18
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-18
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-18
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-18
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-18
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		9e-18
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-17
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-17
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-17
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-17
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-17
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-17
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-17
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-17
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-17
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-17
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-17
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-17
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-17
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-17
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-17
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-17
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-17
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-17
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-17
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-17
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-17
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-17
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-17
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-17
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-17
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-17
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-17
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-17
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-17
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-17
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-17
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-17
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-17
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-17
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-17
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-17
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-17
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-17
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-17
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-17
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-17
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-17
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-17
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-17
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		7e-17
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-17
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-17
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-17
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-17
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-17
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-16
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-16
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-16
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-16
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-16
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-16
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-16
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-16
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-16
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-16
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-16
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-16
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-16
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-16
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-16
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-16
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-16
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-16
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-16
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-16
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-16
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-16
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-16
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-16
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-16
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-16
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-16
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-16
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-16
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-16
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-16
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		9e-16
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-15
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-15
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-15
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-15
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-15
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-15
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-15
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-15
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-15
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-15
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-15
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		9e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-14
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-14
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-14
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-14
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-14
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-14
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-14
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-14
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-14
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-14
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-14
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-14
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-14
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-14
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-14
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-14
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-14
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-14
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-14
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-14
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-14
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-14
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-14
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-14
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-14
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-14
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-14
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		9e-14
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		9e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-13
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-13
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-13
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-13
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-13
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-13
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-13
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-13
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-13
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-13
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-13
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-13
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-13
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-13
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-13
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-13
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-13
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-13
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-12
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-12
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-12
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-12
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-12
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		6e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-12
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		6e-12
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		7e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-12
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		7e-12
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		7e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-12
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-12
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		8e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-12
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		9e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-11
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-11
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-11
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-11
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-11
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-11
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		3e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-11
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-11
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		8e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-11
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-10
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-10
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-09
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-09
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-09
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-09
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-09
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		7e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-09
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		8e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-08
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-08
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-08

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  307 bits (787), Expect = 7e-84,   Method: Compositional matrix adjust.
 Identities = 147/307 (47%), Positives = 213/307 (69%), Gaps = 5/307 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T +++ CGT+EYM+PEI++  
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS 196
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLL 384
           GH++A DWWS+G L+++MLTG PPFTG NR             LP +L+ EA  LLK LL
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 256
Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
           ++ A+ RLG+GPG + E+++H +F+ INW++L AR+  P F P +  +  V+ F+  +T 
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 316
Query: 445 MPLLDSP 451
              +DSP
Sbjct: 317 QTPVDSP 323

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  306 bits (785), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 147/307 (47%), Positives = 212/307 (69%), Gaps = 5/307 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILT 205
           E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  I+       + K+ERNIL 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+F ED A  Y AEI  A+ H
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T ++  CGT+EYM+PEI++  
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRS 196
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLL 384
           GH++A DWWS+G L+++MLTG PPFTG NR             LP +L+ EA  LLK LL
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 256
Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
           ++ A+ RLG+GPG + E+++H +F+ INW++L AR+  P F P +  +  V+ F+  +T 
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTR 316
Query: 445 MPLLDSP 451
              +DSP
Sbjct: 317 QTPVDSP 323

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  289 bits (739), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 137/283 (48%), Positives = 196/283 (69%), Gaps = 5/283 (1%)
Query: 152 FEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           FE+LKV+GQG+F KV+ VR++    +  +YAMKV++K  +  ++     K ER+IL  V+
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVR-TKMERDILADVN 88
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPF+V+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + Y AE+   + HLH+
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHS 148
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            GI++RDLKPENILLD +GH+ LTDFGL+K+  D   ++ S CGT+EYM+PE+V  +GH 
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHS 208
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
            +ADWWS G+L+FEMLTG  PF G +R             +P FLS+EA SLL+ L ++ 
Sbjct: 209 HSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRALFKRN 268
Query: 388 ASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVA 430
            + RLGSGP G++EIK H ++  I+W KL  RE +P F P VA
Sbjct: 269 PANRLGSGPDGAEEIKRHVFYSTIDWNKLYRREIKPPFKPAVA 311

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  287 bits (735), Expect = 8e-78,   Method: Compositional matrix adjust.
 Identities = 138/280 (49%), Positives = 195/280 (69%), Gaps = 5/280 (1%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           FE+LKV+GQG+F KV+ V++I  S   ++YAMKV++K  +  ++     K ER+IL +V+
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN 84
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFIV+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + Y AE+  A+ HLH+
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            GI++RDLKPENILLD +GH+ LTDFGL+K+  D   ++ S CGT+EYM+PE+V  +GH 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           ++ADWWS G+L+FEMLTG  PF G +R             +P FLS EA SLL+ L ++ 
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRN 264
Query: 388 ASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP 427
            + RLG+GP G +EIK H +F  I+W KL  RE  P F P
Sbjct: 265 PANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  287 bits (734), Expect = 9e-78,   Method: Compositional matrix adjust.
 Identities = 138/280 (49%), Positives = 195/280 (69%), Gaps = 5/280 (1%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           FE+LKV+GQG+F KV+ V++I  S   ++YAMKV++K  +  ++     K ER+IL +V+
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN 85
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFIV+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + Y AE+  A+ HLH+
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 145
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            GI++RDLKPENILLD +GH+ LTDFGL+K+  D   ++ S CGT+EYM+PE+V  +GH 
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 205
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           ++ADWWS G+L+FEMLTG  PF G +R             +P FLS EA SLL+ L ++ 
Sbjct: 206 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRN 265
Query: 388 ASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP 427
            + RLG+GP G +EIK H +F  I+W KL  RE  P F P
Sbjct: 266 PANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 305

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  287 bits (734), Expect = 9e-78,   Method: Compositional matrix adjust.
 Identities = 138/280 (49%), Positives = 195/280 (69%), Gaps = 5/280 (1%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           FE+LKV+GQG+F KV+ V++I  S   ++YAMKV++K  +  ++     K ER+IL +V+
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVN 84
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFIV+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + Y AE+  A+ HLH+
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            GI++RDLKPENILLD +GH+ LTDFGL+K+  D   ++ S CGT+EYM+PE+V  +GH 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           ++ADWWS G+L+FEMLTG  PF G +R             +P FLS EA SLL+ L ++ 
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRN 264
Query: 388 ASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP 427
            + RLG+GP G +EIK H +F  I+W KL  RE  P F P
Sbjct: 265 PANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  276 bits (705), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 146/346 (42%), Positives = 210/346 (60%), Gaps = 12/346 (3%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS N      DF  LKV+G+G+F KV   R       YA+KV++K  I++K   +++ SE
Sbjct: 29  PSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE 88
Query: 201 RNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           RN+L K V HPF+V L +SFQT  +LY VLD++NGG LF+ L R+  F E  AR Y AEI
Sbjct: 89  RNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI 148
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSP 318
            SA+ +LH+  I++RDLKPENILLD+ GH++LTDFGL K+  + N+ +++ CGT EY++P
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAP 208
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHS 378
           E++  + +D+  DWW +G +L+EML G PPF   N              L   +++ A  
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARH 268
Query: 379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANF 438
           LL+GLLQK+ +KRLG+      EIKSH +F +INW  L  ++  P F P V+G + + +F
Sbjct: 269 LLEGLLQKDRTKRLGAK-DDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHF 327
Query: 439 EECWTNMPLLDS---------PVASPKFNENPFKGFTYVRPAASFL 475
           +  +T  P+ ++           AS K     F GF+Y  P  SFL
Sbjct: 328 DPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPPTDSFL 373

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  272 bits (695), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 142/313 (45%), Positives = 205/313 (65%), Gaps = 13/313 (4%)
Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEK-NHA 194
           NL    + VG+E+FE+LKV+G GA+ KV+ VR+I    T ++YAMKV++K  I++K    
Sbjct: 43  NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 102
Query: 195 EYMKSERNILTKVDH-PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
           E+ ++ER +L  +   PF+V L Y+FQT+ +L+L+LD++NGG LF  L ++  F E   +
Sbjct: 103 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ 162
Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCG 311
           IY  EIV A+ HLH  GI++RD+K ENILLD++GHV+LTDFGL+K+F  DE  R+   CG
Sbjct: 163 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 312 TLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFT-GGNRXXXXXXXXXXXXXL 368
           T+EYM+P+IV G   GHDKA DWWS+G+L++E+LTG  PFT  G +              
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
Query: 369 PAF---LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSF 425
           P +   +S+ A  L++ LL K+  KRLG GP  + EIK H +F+ INW  L A++    F
Sbjct: 283 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPF 342
Query: 426 LPEVAGKHCVANF 438
            P +  +  V+NF
Sbjct: 343 KPVIRDELDVSNF 355

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  265 bits (678), Expect = 3e-71,   Method: Compositional matrix adjust.
 Identities = 135/336 (40%), Positives = 205/336 (61%), Gaps = 7/336 (2%)
Query: 141 PSEN-QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           PS N   V L DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E    
Sbjct: 9   PSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMV 68
Query: 200 ERNILTKVDHP-FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           E+ +L  +D P F+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y AE
Sbjct: 69  EKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE 128
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMS 317
           I   +  LH  GI++RDLK +N++LD++GH+ + DFG+ K+   +   +   CGT +Y++
Sbjct: 129 ISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIA 188
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAH 377
           PEI+  + + K+ DWW+ G+LL+EML GQPPF G +               P  LS EA 
Sbjct: 189 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAV 248
Query: 378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVAN 437
           S+ KGL+ K  +KRLG GP G ++++ H +F+ I+W+KLE RE +P F P+V GK    N
Sbjct: 249 SICKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGKG-AEN 307
Query: 438 FEECWTN-MPLLDSP--VASPKFNENPFKGFTYVRP 470
           F++ +T   P+L  P  +     +++ F+GF YV P
Sbjct: 308 FDKFFTRGQPVLXPPDQLVIANIDQSDFEGFXYVNP 343

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  254 bits (648), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 118/306 (38%), Positives = 187/306 (61%), Gaps = 1/306 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G++++EM+ G+ PF   +               P  LS EA SLL GLL+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNM 445
           K+  +RLG GP  ++E+  H++F  INW+ +  ++  P F P+V  +     F++ +T  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 301
Query: 446 PLLDSP 451
            +  +P
Sbjct: 302 SITITP 307

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  253 bits (647), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 118/306 (38%), Positives = 187/306 (61%), Gaps = 1/306 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 5   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 65  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 124
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++    
Sbjct: 125 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 184
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G++++EM+ G+ PF   +               P  LS EA SLL GLL+
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 244
Query: 386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNM 445
           K+  +RLG GP  ++E+  H++F  INW+ +  ++  P F P+V  +     F++ +T  
Sbjct: 245 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 304
Query: 446 PLLDSP 451
            +  +P
Sbjct: 305 SITITP 310

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  253 bits (646), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 118/306 (38%), Positives = 187/306 (61%), Gaps = 1/306 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G++++EM+ G+ PF   +               P  LS EA SLL GLL+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNM 445
           K+  +RLG GP  ++E+  H++F  INW+ +  ++  P F P+V  +     F++ +T  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 301
Query: 446 PLLDSP 451
            +  +P
Sbjct: 302 SITITP 307

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  253 bits (645), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 118/306 (38%), Positives = 186/306 (60%), Gaps = 1/306 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +       CGT EY++PE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G++++EM+ G+ PF   +               P  LS EA SLL GLL+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNM 445
           K+  +RLG GP  ++E+  H++F  INW+ +  ++  P F P+V  +     F++ +T  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 301
Query: 446 PLLDSP 451
            +  +P
Sbjct: 302 SITITP 307

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  252 bits (644), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 118/306 (38%), Positives = 186/306 (60%), Gaps = 1/306 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 7   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 67  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 126
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +       CGT EY++PE++    
Sbjct: 127 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 186
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G++++EM+ G+ PF   +               P  LS EA SLL GLL+
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 246
Query: 386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNM 445
           K+  +RLG GP  ++E+  H++F  INW+ +  ++  P F P+V  +     F++ +T  
Sbjct: 247 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 306
Query: 446 PLLDSP 451
            +  +P
Sbjct: 307 SITITP 312

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  252 bits (643), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 118/306 (38%), Positives = 186/306 (60%), Gaps = 1/306 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +       CGT EY++PE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G++++EM+ G+ PF   +               P  LS EA SLL GLL+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNM 445
           K+  +RLG GP  ++E+  H++F  INW+ +  ++  P F P+V  +     F++ +T  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 301
Query: 446 PLLDSP 451
            +  +P
Sbjct: 302 SITITP 307

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  251 bits (642), Expect = 4e-67,   Method: Compositional matrix adjust.
 Identities = 118/306 (38%), Positives = 185/306 (60%), Gaps = 1/306 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +       CGT EY++PE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G++++EM+ G+ PF   +               P  LS EA SLL GLL+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNM 445
           K+  +RLG GP  ++E+  H++F  INW+ +  ++  P F P+V  +     F++ +T  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 301
Query: 446 PLLDSP 451
            +   P
Sbjct: 302 SITIXP 307

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  246 bits (628), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 121/339 (35%), Positives = 209/339 (61%), Gaps = 15/339 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +GL+DF++L+V+G+G++AKV  VR   T  IYAM+V++K+ + +    +++++E+++  +
Sbjct: 49  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLK +N+LLD++GH+ LTD+G+ K+       +++ CGT  Y++PEI+ G+
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 325 GHDKAADWWSVGILLFEMLTGQPPF---------TGGNRXXXXXXXXXXXXXLPAFLSSE 375
            +  + DWW++G+L+FEM+ G+ PF                           +P  LS +
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 288
Query: 376 AHSLLKGLLQKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHC 434
           A S+LK  L K+  +RLG  P  G  +I+ H +F+ ++W  +E ++  P F P ++G+  
Sbjct: 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFG 348
Query: 435 VANFEECWTNMPLL---DSPVASPKFNENPFKGFTYVRP 470
           + NF+  +TN P+    D      K +++ F+GF Y+ P
Sbjct: 349 LDNFDSQFTNEPVQLXPDDDDIVRKIDQSEFEGFEYINP 387

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  246 bits (627), Expect = 2e-65,   Method: Compositional matrix adjust.
 Identities = 122/339 (35%), Positives = 208/339 (61%), Gaps = 15/339 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +GL+DF++L+V+G+G++AKV  VR   T  IYAMKV++K+ + +    +++++E+++  +
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 61
Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++
Sbjct: 62  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLK +N+LLD++GH+ LTD+G+ K+       ++  CGT  Y++PEI+ G+
Sbjct: 122 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 325 GHDKAADWWSVGILLFEMLTGQPPF---------TGGNRXXXXXXXXXXXXXLPAFLSSE 375
            +  + DWW++G+L+FEM+ G+ PF                           +P  LS +
Sbjct: 182 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 241
Query: 376 AHSLLKGLLQKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHC 434
           A S+LK  L K+  +RLG  P  G  +I+ H +F+ ++W  +E ++  P F P ++G+  
Sbjct: 242 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFG 301
Query: 435 VANFEECWTNMPLL---DSPVASPKFNENPFKGFTYVRP 470
           + NF+  +TN P+    D      K +++ F+GF Y+ P
Sbjct: 302 LDNFDSQFTNEPVQLXPDDDDIVRKIDQSEFEGFEYINP 340

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  245 bits (626), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 122/339 (35%), Positives = 208/339 (61%), Gaps = 15/339 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +GL+DF++L+V+G+G++AKV  VR   T  IYAMKV++K+ + +    +++++E+++  +
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLK +N+LLD++GH+ LTD+G+ K+       ++  CGT  Y++PEI+ G+
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 185
Query: 325 GHDKAADWWSVGILLFEMLTGQPPF---------TGGNRXXXXXXXXXXXXXLPAFLSSE 375
            +  + DWW++G+L+FEM+ G+ PF                           +P  LS +
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 245
Query: 376 AHSLLKGLLQKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHC 434
           A S+LK  L K+  +RLG  P  G  +I+ H +F+ ++W  +E ++  P F P ++G+  
Sbjct: 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFG 305
Query: 435 VANFEECWTNMPLL---DSPVASPKFNENPFKGFTYVRP 470
           + NF+  +TN P+    D      K +++ F+GF Y+ P
Sbjct: 306 LDNFDSQFTNEPVQLXPDDDDIVRKIDQSEFEGFEYINP 344

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  244 bits (624), Expect = 5e-65,   Method: Compositional matrix adjust.
 Identities = 123/329 (37%), Positives = 195/329 (59%), Gaps = 14/329 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E    E+ +L    
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399
Query: 209 HP-FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            P F+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y AEI   +  L 
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGH 326
           + GI++RDLK +N++LD++GH+ + DFG+ K+   +   +   CGT +Y++PEI+  + +
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY 519
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K+ DWW+ G+LL+EML GQ PF G +               P  +S EA ++ KGL+ K
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTK 579
Query: 387 EASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMP 446
              KRLG GP G ++IK H +F+ I+W+KLE +E +P + P+ +G++   NF+  +T  P
Sbjct: 580 HPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASGRN-AENFDRFFTRHP 638
Query: 447 LLDSPVASP-------KFNENPFKGFTYV 468
               PV  P         +++ F+GF +V
Sbjct: 639 ----PVLXPPDQEVIRNIDQSEFEGFXFV 663

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  244 bits (624), Expect = 5e-65,   Method: Compositional matrix adjust.
 Identities = 123/329 (37%), Positives = 194/329 (58%), Gaps = 14/329 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E    E+ +L    
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 209 HP-FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            P F+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y AEI   +  L 
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGH 326
           + GI++RDLK +N++LD++GH+ + DFG+ K+   +   +   CGT +Y++PEI+  + +
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY 198
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K+ DWW+ G+LL+EML GQ PF G +               P  +S EA ++ KGL+ K
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTK 258
Query: 387 EASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMP 446
              KRLG GP G ++IK H +F+ I+W+KLE +E +P + P+  G++   NF+  +T  P
Sbjct: 259 HPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGRN-AENFDRFFTRHP 317
Query: 447 LLDSPVASP-------KFNENPFKGFTYV 468
               PV  P         +++ F+GF +V
Sbjct: 318 ----PVLXPPDQEVIRNIDQSEFEGFXFV 342

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  242 bits (617), Expect = 4e-64,   Method: Compositional matrix adjust.
 Identities = 125/330 (37%), Positives = 191/330 (57%), Gaps = 6/330 (1%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +G+++FE ++V+G+G+F KV   R   T ++YA+KV++KD I++ +  E   +E+ IL+ 
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+ QL   FQT  RL+ V++FVNGG L F + +   F E  AR Y AEI+SA+  
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLK +N+LLD +GH  L DFG+ K+   N   + + CGT +Y++PEI+   
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLL 384
            +  A DWW++G+LL+EML G  PF   N               P +L  +A  +LK  +
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFM 259
Query: 385 QKEASKRLGS-GPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWT 443
            K  + RLGS   GG   I  H +FK I+W +L  R+  P F P +  +  V+NF+  + 
Sbjct: 260 TKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFI 319
Query: 444 NMPLLDSPVAS---PKFNENPFKGFTYVRP 470
               +  P+     P  N++ F+ F YV P
Sbjct: 320 KEEPVLXPIDEGHLPMINQDEFRNFEYVSP 349

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  241 bits (616), Expect = 5e-64,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 183/300 (61%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+ ++CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 330

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  241 bits (616), Expect = 5e-64,   Method: Compositional matrix adjust.
 Identities = 118/307 (38%), Positives = 183/307 (59%), Gaps = 2/307 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + +FE LK++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L  
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +L
Sbjct: 65  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 124
Query: 267 HA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           H+   +++RDLK EN++LD DGH+ +TDFGL K+   +       CGT EY++PE++   
Sbjct: 125 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 184
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLL 384
            + +A DWW +G++++EM+ G+ PF   +               P  L  EA SLL GLL
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 244
Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
           +K+  +RLG G   ++EI  H++F  I W+ +  ++  P F P+V  +     F+E +T 
Sbjct: 245 KKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTA 304
Query: 445 MPLLDSP 451
             +  +P
Sbjct: 305 QMITITP 311

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  241 bits (615), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 118/307 (38%), Positives = 183/307 (59%), Gaps = 2/307 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + +FE LK++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L  
Sbjct: 7   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +L
Sbjct: 67  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 126
Query: 267 HA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           H+   +++RDLK EN++LD DGH+ +TDFGL K+   +       CGT EY++PE++   
Sbjct: 127 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 186
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLL 384
            + +A DWW +G++++EM+ G+ PF   +               P  L  EA SLL GLL
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 246
Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
           +K+  +RLG G   ++EI  H++F  I W+ +  ++  P F P+V  +     F+E +T 
Sbjct: 247 KKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTA 306
Query: 445 MPLLDSP 451
             +  +P
Sbjct: 307 QMITITP 313

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  241 bits (615), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 118/307 (38%), Positives = 183/307 (59%), Gaps = 2/307 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + +FE LK++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L  
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +L
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 125
Query: 267 HA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           H+   +++RDLK EN++LD DGH+ +TDFGL K+   +       CGT EY++PE++   
Sbjct: 126 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 185
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLL 384
            + +A DWW +G++++EM+ G+ PF   +               P  L  EA SLL GLL
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 245
Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
           +K+  +RLG G   ++EI  H++F  I W+ +  ++  P F P+V  +     F+E +T 
Sbjct: 246 KKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTA 305
Query: 445 MPLLDSP 451
             +  +P
Sbjct: 306 QMITITP 312

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  241 bits (615), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 120/339 (35%), Positives = 207/339 (61%), Gaps = 15/339 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +GL+DF++L+V+G+G++AKV  VR   T  IYAMKV++K+ + +    +++++E+++  +
Sbjct: 17  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 76
Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++
Sbjct: 77  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLK +N+LLD++GH+ LTD+G+ K+       ++  CGT  Y++PEI+ G+
Sbjct: 137 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGE 196
Query: 325 GHDKAADWWSVGILLFEMLTGQPPF---------TGGNRXXXXXXXXXXXXXLPAFLSSE 375
            +  + DWW++G+L+FEM+ G+ PF                           +P  +S +
Sbjct: 197 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMSVK 256
Query: 376 AHSLLKGLLQKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHC 434
           A S+LK  L K+  +RLG  P  G  +I+ H +F+ ++W  +E ++  P F P ++G+  
Sbjct: 257 AASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFG 316
Query: 435 VANFEECWTNMPLL---DSPVASPKFNENPFKGFTYVRP 470
           + NF+  +TN  +    D      K +++ F+GF Y+ P
Sbjct: 317 LDNFDSQFTNERVQLXPDDDDIVRKIDQSEFEGFEYINP 355

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  241 bits (615), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 183/300 (61%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 19  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 77
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 78  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 137
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+ ++CGT EY++PEI
Sbjct: 138 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEYLAPEI 195
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 255
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 256 RNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 315

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  241 bits (614), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 182/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  241 bits (614), Expect = 8e-64,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 182/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  241 bits (614), Expect = 8e-64,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 182/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  241 bits (614), Expect = 8e-64,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 182/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 330

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  241 bits (614), Expect = 9e-64,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 182/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  241 bits (614), Expect = 9e-64,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 182/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 330

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  241 bits (614), Expect = 9e-64,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 182/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  240 bits (613), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 182/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  240 bits (613), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 117/299 (39%), Positives = 181/299 (60%), Gaps = 2/299 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + +FE LK++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L  
Sbjct: 148 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 207
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +L
Sbjct: 208 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 267
Query: 267 HA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           H+   +++RDLK EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++   
Sbjct: 268 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 327
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLL 384
            + +A DWW +G++++EM+ G+ PF   +               P  L  EA SLL GLL
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 387
Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWT 443
           +K+  +RLG G   ++EI  H++F  I W+ +  ++  P F P+V  +     F+E +T
Sbjct: 388 KKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFT 446

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  240 bits (613), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 117/299 (39%), Positives = 181/299 (60%), Gaps = 2/299 (0%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + +FE LK++G+G F KV  V+   T   YAMK+++K+ I+ K+   +  +E  +L  
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+YSFQT  RL  V+++ NGG LFF L R+ +F ED AR Y AEIVSA+ +L
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 267 HA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGK 324
           H+   +++RDLK EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++   
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLL 384
            + +A DWW +G++++EM+ G+ PF   +               P  L  EA SLL GLL
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 384
Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWT 443
           +K+  +RLG G   ++EI  H++F  I W+ +  ++  P F P+V  +     F+E +T
Sbjct: 385 KKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFT 443

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  239 bits (611), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 182/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFGLAK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 26  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 84
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 144
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 145 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 202
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 262
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 263 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 322

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 26  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 84
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 144
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 145 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 202
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 262
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 263 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 322

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   +AMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L YSF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  239 bits (610), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ + DFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  239 bits (610), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 330

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  239 bits (610), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 182/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFGLAK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   +AMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L YSF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 330

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 54  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 172
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 230
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 290
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 291 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 350

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  239 bits (609), Expect = 3e-63,   Method: Compositional matrix adjust.
 Identities = 115/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   +AMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L YSF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKDGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  238 bits (608), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  238 bits (607), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 114/297 (38%), Positives = 179/297 (60%), Gaps = 3/297 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVAN 437
           + LLQ + +KR G+ P G  +IK+HKWF   +W  +  R+    F+P+  G    +N
Sbjct: 270 RNLLQVDLTKRFGNLPNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSN 326

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  238 bits (607), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  238 bits (607), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 54  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 172
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 230
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 290
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 291 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 350

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  238 bits (607), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  238 bits (607), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  238 bits (607), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 20  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 78
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 79  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 138
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 139 LTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 196
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 197 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 256
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 257 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 316

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  238 bits (607), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  238 bits (607), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  238 bits (607), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 34  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 330

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  238 bits (607), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  238 bits (607), Expect = 6e-63,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  238 bits (606), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  238 bits (606), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  238 bits (606), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 28  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 86
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 87  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 146
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 147 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 204
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 205 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 264
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 265 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 324

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  238 bits (606), Expect = 8e-63,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V++++ GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ + DFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  238 bits (606), Expect = 8e-63,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 33  PAQN-TAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V++++ GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ + DFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  237 bits (605), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 180/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +I +HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIXNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 330

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  237 bits (604), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 114/300 (38%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 54  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 112
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 172
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+    T   ++CGT EY++PEI
Sbjct: 173 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATW--TLCGTPEYLAPEI 230
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 290
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 291 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 350

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  237 bits (604), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L+++M  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  236 bits (603), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 112/300 (37%), Positives = 181/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           ++ KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 IISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  236 bits (603), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 180/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 330

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  236 bits (602), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 112/300 (37%), Positives = 180/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+ +L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 330

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  236 bits (602), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 112/300 (37%), Positives = 180/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+ +L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 330

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  236 bits (602), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 112/300 (37%), Positives = 180/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE +K +G G+F +V  V+ + T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+ +L +SF+    LY+V+++  GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+++D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 330

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  236 bits (601), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 180/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++P I
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPAI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  235 bits (600), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 180/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +K  G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKAFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  234 bits (598), Expect = 6e-62,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 180/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  +CGT E ++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLCGTPEALAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  234 bits (597), Expect = 8e-62,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 180/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  + GT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLAGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  233 bits (595), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 113/300 (37%), Positives = 180/300 (60%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQN-TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+  + GT EY++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWXLXGTPEYLAPEI 209
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  232 bits (592), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 112/300 (37%), Positives = 178/300 (59%), Gaps = 3/300 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P++N    L+ FE ++ +G G+F +V  V+   T   YAMK++ K K+++    E+  +E
Sbjct: 34  PAQN-TAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE 92
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + I   V+ PF+V+L +SF+    LY+VL++  GG +F  L R G F E  AR Y A+IV
Sbjct: 93  KRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ + DFG AK+     R+  +CGT EY++PEI
Sbjct: 153 LTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV--KGRTWXLCGTPEYLAPEI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF                   P+  SS+   LL
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 270
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 330

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  229 bits (585), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 104/281 (37%), Positives = 173/281 (61%), Gaps = 2/281 (0%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+DF++L+ +G G+F +V+ +R       YAMKV++K+ ++     E+   ER +L+ V 
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFI+++  +FQ   ++++++D++ GG LF  L +   F   +A+ Y AE+  A+ +LH+
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             I++RDLKPENILLD +GH+ +TDFG AK   + T    +CGT +Y++PE+V  K ++K
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--XLCGTPDYIAPEVVSTKPYNK 182
Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEA 388
           + DWWS GIL++EML G  PF   N               P F + +   LL  L+ ++ 
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL 242
Query: 389 SKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEV 429
           S+RLG+   G++++K+H WFK + W+KL +R     + P +
Sbjct: 243 SQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPI 283

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  224 bits (571), Expect = 8e-59,   Method: Compositional matrix adjust.
 Identities = 120/343 (34%), Positives = 198/343 (57%), Gaps = 15/343 (4%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS    + +EDFE+ K++G+G+F KV+      T++ +A+K ++KD ++  +  E    E
Sbjct: 9   PSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 68
Query: 201 RNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR--IYTA 257
           + +L+   +HPF+  +  +FQTK  L+ V++++NGG L + +  Q   + DL+R   Y A
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAA 126
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYM 316
           EI+  +  LH+ GI++RDLK +NILLD DGH+ + DFG+ K+    + ++N  CGT +Y+
Sbjct: 127 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYI 186
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEA 376
           +PEI+LG+ ++ + DWWS G+LL+EML GQ PF G +               P +L  EA
Sbjct: 187 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 246
Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVA 436
             LL  L  +E  KRLG       +I+ H  F+ INW++LE +E  P F P+V      +
Sbjct: 247 KDLLVKLFVREPEKRLGV----RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCS 302
Query: 437 NFEECWTN----MPLLDSPVASPKFNENPFKGFTYVRPAASFL 475
           NF++ + N    +   D  + +   ++N F+ F ++ P    L
Sbjct: 303 NFDKEFLNEKPRLXFADRALIN-SMDQNMFRNFXFMNPGMERL 344

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  221 bits (563), Expect = 8e-58,   Method: Compositional matrix adjust.
 Identities = 119/343 (34%), Positives = 197/343 (57%), Gaps = 15/343 (4%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS    + +EDF + K++G+G+F KV+      T++ +A+K ++KD ++  +  E    E
Sbjct: 8   PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 201 RNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR--IYTA 257
           + +L+   +HPF+  +  +FQTK  L+ V++++NGG L + +  Q   + DL+R   Y A
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAA 125
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYM 316
           EI+  +  LH+ GI++RDLK +NILLD DGH+ + DFG+ K+    + ++N  CGT +Y+
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYI 185
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEA 376
           +PEI+LG+ ++ + DWWS G+LL+EML GQ PF G +               P +L  EA
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 245
Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVA 436
             LL  L  +E  KRLG       +I+ H  F+ INW++LE +E  P F P+V      +
Sbjct: 246 KDLLVKLFVREPEKRLGV----RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCS 301
Query: 437 NFEECWTN----MPLLDSPVASPKFNENPFKGFTYVRPAASFL 475
           NF++ + N    +   D  + +   ++N F+ F ++ P    L
Sbjct: 302 NFDKEFLNEKPRLSFADRALIN-SMDQNMFRNFXFMNPGMERL 343

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  214 bits (546), Expect = 7e-56,   Method: Compositional matrix adjust.
 Identities = 104/271 (38%), Positives = 164/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 214
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               PA    +A  L++ LL  
Sbjct: 215 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEKLLVL 274
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 275 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 305

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  214 bits (545), Expect = 9e-56,   Method: Compositional matrix adjust.
 Identities = 104/271 (38%), Positives = 164/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+NS  GT +Y+SPE++  K  
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 212
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 272
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 273 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 303

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  214 bits (545), Expect = 9e-56,   Method: Compositional matrix adjust.
 Identities = 104/271 (38%), Positives = 164/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+NS  GT +Y+SPE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 211
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 212 SKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  213 bits (542), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 104/271 (38%), Positives = 164/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+NS  GT +Y+SPE++  K  
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 208
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 268
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 269 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 299

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  213 bits (542), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 164/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N+  GT +Y+SPE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSA 209
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 269
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  213 bits (541), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 163/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 212 XKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  212 bits (540), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 163/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 269
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  212 bits (540), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 163/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 212
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 272
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 273 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 303

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  212 bits (539), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 163/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 189
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 190 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 249
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 250 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 280

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  212 bits (539), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 163/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  212 bits (539), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 163/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 269
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  212 bits (539), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 163/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  212 bits (539), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 163/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  212 bits (539), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 163/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 272 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 302

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  212 bits (539), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 163/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 186
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 187 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 246
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 247 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 277

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  212 bits (539), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 163/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 187
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 248 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 278

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  212 bits (539), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 163/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 188
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 189 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 248
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 249 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 279

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  211 bits (538), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 163/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 193
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 194 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 253
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 254 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 284

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  211 bits (538), Expect = 6e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 162/271 (59%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L + FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 216
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 217 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 276
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 277 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 307

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  211 bits (538), Expect = 6e-55,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 163/271 (60%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 208
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 268
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 269 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 299

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  210 bits (535), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 102/271 (37%), Positives = 162/271 (59%), Gaps = 4/271 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+     R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N   GT +Y+SPE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN               P     +A  L++ LL  
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 269
Query: 387 EASKRLGSGP-GGSQEIKSHKWFKMINWKKL 416
           +A+KRLG     G   +K+H +F+ + W+ L
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFESVTWENL 300

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 114/317 (35%), Positives = 181/317 (57%), Gaps = 14/317 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + + DF V +++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ 
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 207 V---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
           V   D PFIV + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL- 322
            H+H   +++RDLKP NILLD  GHV ++D GLA  F +  + ++  GT  YM+PE++  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQK 364
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPF---TGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           G  +D +ADW+S+G +LF++L G  PF      ++             LP   S E  SL
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP-----EVAGKHC 434
           L+GLLQ++ ++RLG    G+QE+K   +F+ ++W+ +  ++  P  +P       A    
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFD 484
Query: 435 VANFEECWTN-MPLLDS 450
           + +F+E  T  + LLDS
Sbjct: 485 IGSFDEEDTKGIKLLDS 501

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 114/317 (35%), Positives = 181/317 (57%), Gaps = 14/317 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + + DF V +++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ 
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 207 V---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
           V   D PFIV + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL- 322
            H+H   +++RDLKP NILLD  GHV ++D GLA  F +  + ++  GT  YM+PE++  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQK 364
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPF---TGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           G  +D +ADW+S+G +LF++L G  PF      ++             LP   S E  SL
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP-----EVAGKHC 434
           L+GLLQ++ ++RLG    G+QE+K   +F+ ++W+ +  ++  P  +P       A    
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFD 484
Query: 435 VANFEECWTN-MPLLDS 450
           + +F+E  T  + LLDS
Sbjct: 485 IGSFDEEDTKGIKLLDS 501

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 114/317 (35%), Positives = 181/317 (57%), Gaps = 14/317 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + + DF V +++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ 
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 207 V---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
           V   D PFIV + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  +
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL- 322
            H+H   +++RDLKP NILLD  GHV ++D GLA  F +  + ++  GT  YM+PE++  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQK 364
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPF---TGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           G  +D +ADW+S+G +LF++L G  PF      ++             LP   S E  SL
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP-----EVAGKHC 434
           L+GLLQ++ ++RLG    G+QE+K   +F+ ++W+ +  ++  P  +P       A    
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFD 484
Query: 435 VANFEECWTN-MPLLDS 450
           + +F+E  T  + LLDS
Sbjct: 485 IGSFDEEDTKGIKLLDS 501

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 114/317 (35%), Positives = 181/317 (57%), Gaps = 14/317 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + + DF V +++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ 
Sbjct: 185 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 244
Query: 207 V---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
           V   D PFIV + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  +
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL- 322
            H+H   +++RDLKP NILLD  GHV ++D GLA  F +  + ++  GT  YM+PE++  
Sbjct: 305 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQK 363
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPF---TGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           G  +D +ADW+S+G +LF++L G  PF      ++             LP   S E  SL
Sbjct: 364 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 423
Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP-----EVAGKHC 434
           L+GLLQ++ ++RLG    G+QE+K   +F+ ++W+ +  ++  P  +P       A    
Sbjct: 424 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFD 483
Query: 435 VANFEECWTN-MPLLDS 450
           + +F+E  T  + LLDS
Sbjct: 484 IGSFDEEDTKGIKLLDS 500

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  196 bits (499), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 113/332 (34%), Positives = 183/332 (55%), Gaps = 16/332 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED++V+KV+G+GAF +V  VR   + ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL  +FQ    LY+V++++ GG L   L       E  A+ YTAE+V A+  +H+ 
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 193
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHD 327
           G++HRD+KP+N+LLD  GH+ L DFG   + DE      ++  GT +Y+SPE++  +G D
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGD 253
Query: 328 ----KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXL----PAFLSSEAHSL 379
               +  DWWSVG+ LFEML G  PF   +              L     A +S  A +L
Sbjct: 254 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNL 313
Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFE 439
           +   L     + +  G  G +EIK H +FK   W     RET    +PE++     +NF+
Sbjct: 314 ICAFL---TDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFD 370
Query: 440 ECWTNMPLLDSPVASPKF--NENPFKGFTYVR 469
           +   +   +++      F  N+ PF GFTY R
Sbjct: 371 DIEDDKGDVETFPIPKAFVGNQLPFIGFTYYR 402

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  195 bits (495), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 102/304 (33%), Positives = 166/304 (54%), Gaps = 10/304 (3%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
            EN+ V  + FE+L+ +G+G+F KV  V++  T ++YAMK M K K +E+N    +  E 
Sbjct: 7   DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL 66
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I+  ++HPF+V L YSFQ +  +++V+D + GG L + L +   F+E+  +++  E+V 
Sbjct: 67  QIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           A+ +L    I+HRD+KP+NILLD  GHV +TDF +A      T+  +M GT  YM+PE+ 
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF 186
Query: 322 ---LGKGHDKAADWWSVGILLFEMLTGQPPF---TGGNRXXXXXXXXXXXXXLPAFLSSE 375
               G G+  A DWWS+G+  +E+L G+ P+   +  +               P+  S E
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE 246
Query: 376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCV 435
             SLLK LL+    +R         ++++  +   INW  +  +   P F+P     +C 
Sbjct: 247 MVSLLKKLLEPNPDQRFSQ----LSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCD 302
Query: 436 ANFE 439
             FE
Sbjct: 303 PTFE 306

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  194 bits (493), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 112/330 (33%), Positives = 182/330 (55%), Gaps = 16/330 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EV+KV+G+GAF +V  VR   T ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL Y+FQ    LY+V++++ GG L   L       E  AR YTAE+V A+  +H+ 
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHD 327
           G +HRD+KP+N+LLD  GH+ L DFG   + ++    R ++  GT +Y+SPE++  +G D
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 328 ----KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSL 379
               +  DWWSVG+ L+EML G  PF   +              L       +S EA +L
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 312
Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFE 439
           +   L     + +  G  G +EIK H +FK   W     R+T    +P+++     +NF+
Sbjct: 313 ICAFL---TDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFD 369
Query: 440 ECWTNMPLLDSPVASPKF--NENPFKGFTY 467
           +   +    ++      F  N+ PF GFTY
Sbjct: 370 DLEEDKGEEETFPIPKAFVGNQLPFVGFTY 399

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  194 bits (492), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 112/330 (33%), Positives = 182/330 (55%), Gaps = 16/330 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EV+KV+G+GAF +V  VR   T ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL Y+FQ    LY+V++++ GG L   L       E  AR YTAE+V A+  +H+ 
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 187
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHD 327
           G +HRD+KP+N+LLD  GH+ L DFG   + ++    R ++  GT +Y+SPE++  +G D
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 328 ----KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSL 379
               +  DWWSVG+ L+EML G  PF   +              L       +S EA +L
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFE 439
           +   L     + +  G  G +EIK H +FK   W     R+T    +P+++     +NF+
Sbjct: 308 ICAFL---TDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFD 364
Query: 440 ECWTNMPLLDSPVASPKF--NENPFKGFTY 467
           +   +    ++      F  N+ PF GFTY
Sbjct: 365 DLEEDKGEEETFPIPKAFVGNQLPFVGFTY 394

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  194 bits (492), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 112/330 (33%), Positives = 182/330 (55%), Gaps = 16/330 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EV+KV+G+GAF +V  VR   T ++YAMK++ K ++++++ + +   ER+I+   + 
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++VQL Y+FQ    LY+V++++ GG L   L       E  AR YTAE+V A+  +H+ 
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHD 327
           G +HRD+KP+N+LLD  GH+ L DFG   + ++    R ++  GT +Y+SPE++  +G D
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 328 ----KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSL 379
               +  DWWSVG+ L+EML G  PF   +              L       +S EA +L
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 312
Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFE 439
           +   L     + +  G  G +EIK H +FK   W     R+T    +P+++     +NF+
Sbjct: 313 ICAFL---TDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFD 369
Query: 440 ECWTNMPLLDSPVASPKF--NENPFKGFTY 467
           +   +    ++      F  N+ PF GFTY
Sbjct: 370 DLEEDKGEEETFPIPKAFVGNQLPFVGFTY 399

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  185 bits (469), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 159/298 (53%), Gaps = 6/298 (2%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q V    F   +V+G+G F +V   +   T ++YA K + K +I ++       +E+ 
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIV 260
           IL KV+  F+V L Y+++TK  L LVL  +NGG L F +Y  G   F E  A  Y AEI 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
             +  LH   I++RDLKPENILLD  GH+ ++D GLA    E        GT+ YM+PE+
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEA 376
           V  + +  + DWW++G LL+EM+ GQ PF    +             +P       S +A
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416
Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHC 434
            SL   LL K+ ++RLG   G ++E+K H  FK +N+K+L A    P F P+    +C
Sbjct: 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYC 474

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  185 bits (469), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 109/298 (36%), Positives = 159/298 (53%), Gaps = 6/298 (2%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q V    F   +V+G+G F +V   +   T ++YA K + K +I ++       +E+ 
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIV 260
           IL KV+  F+V L Y+++TK  L LVL  +NGG L F +Y  G   F E  A  Y AEI 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
             +  LH   I++RDLKPENILLD  GH+ ++D GLA    E        GT+ YM+PE+
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEA 376
           V  + +  + DWW++G LL+EM+ GQ PF    +             +P       S +A
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416
Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHC 434
            SL   LL K+ ++RLG   G ++E+K H  FK +N+K+L A    P F P+    +C
Sbjct: 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYC 474

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  181 bits (460), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 176/336 (52%), Gaps = 22/336 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE+LKV+G+GAF +V  V+     +++AMK++ K +++++      + ER++L   D 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ    LYLV+D+  GG L   L + +    E++AR Y AE+V A+  +H 
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVL---- 322
              +HRD+KP+NIL+D +GH+ L DFG   +   D   +S+   GT +Y+SPEI+     
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 323 GKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP-----AFLSSEA 376
           GKG +    DWWS+G+ ++EML G+ PF   +                       +S  A
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313
Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVA 436
             L++ L+    S+    G  G ++ K H +F  I+W  +  R     ++PEV+     +
Sbjct: 314 KDLIRRLI---CSREHRLGQNGIEDFKKHPFFSGIDWDNI--RNCEAPYIPEVSSPTDTS 368
Query: 437 NF---EECWTNMPLLDSPVASPKFNEN-PFKGFTYV 468
           NF   ++C  N   +  P  +     + PF GFTY 
Sbjct: 369 NFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYT 404

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  181 bits (459), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 112/342 (32%), Positives = 183/342 (53%), Gaps = 26/342 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE++KV+G+GAF +V  V+   T  IYAMK++ K +++++      + ER++L   D 
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ +  LYLV+D+  GG L   L + +    ED+AR Y  E+V A+  +H 
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFG--LAKQFDENTRSNSMCGTLEYMSPEIV----- 321
              +HRD+KP+N+LLD +GH+ L DFG  L    D   +S+   GT +Y+SPEI+     
Sbjct: 210 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 322 -LGKGHDKAADWWSVGILLFEMLTGQPPFTGGN--RXXXXXXXXXXXXXLPAF---LSSE 375
            +GK +    DWWS+G+ ++EML G+ PF   +                 P+    +S E
Sbjct: 270 GMGK-YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEE 328
Query: 376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCV 435
           A  L++ L+    S+    G  G ++ K H +F+ +NW+ +  R     ++P+V+     
Sbjct: 329 AKDLIQRLI---CSRERRLGQNGIEDFKKHAFFEGLNWENI--RNLEAPYIPDVSSPSDT 383
Query: 436 ANF---EECWTNMPLLDSPVASPKFN--ENPFKGFTYVRPAA 472
           +NF   ++   N  +L  P +   F+    PF GFT+   + 
Sbjct: 384 SNFDVDDDVLRNTEIL-PPGSHTGFSGLHLPFIGFTFTTESC 424

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  181 bits (459), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 112/342 (32%), Positives = 183/342 (53%), Gaps = 26/342 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDFE++KV+G+GAF +V  V+   T  IYAMK++ K +++++      + ER++L   D 
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
            +I  L Y+FQ +  LYLV+D+  GG L   L + +    ED+AR Y  E+V A+  +H 
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFG--LAKQFDENTRSNSMCGTLEYMSPEIV----- 321
              +HRD+KP+N+LLD +GH+ L DFG  L    D   +S+   GT +Y+SPEI+     
Sbjct: 194 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 322 -LGKGHDKAADWWSVGILLFEMLTGQPPFTGGN--RXXXXXXXXXXXXXLPAF---LSSE 375
            +GK +    DWWS+G+ ++EML G+ PF   +                 P+    +S E
Sbjct: 254 GMGK-YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEE 312
Query: 376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCV 435
           A  L++ L+    S+    G  G ++ K H +F+ +NW+ +  R     ++P+V+     
Sbjct: 313 AKDLIQRLI---CSRERRLGQNGIEDFKKHAFFEGLNWENI--RNLEAPYIPDVSSPSDT 367
Query: 436 ANF---EECWTNMPLLDSPVASPKFN--ENPFKGFTYVRPAA 472
           +NF   ++   N  +L  P +   F+    PF GFT+   + 
Sbjct: 368 SNFDVDDDVLRNTEIL-PPGSHTGFSGLHLPFIGFTFTTESC 408

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  178 bits (451), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 116/342 (33%), Positives = 176/342 (51%), Gaps = 29/342 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE+LKV+G+GAF++V  V+   T ++YAMK+M K  ++++      + ER++L   D 
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHA 268
            +I QL ++FQ +  LYLV+++  GG L   L + G     ++AR Y AEIV A+  +H 
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFG--LAKQFDENTRSNSMCGTLEYMSPEIVLG--- 323
            G +HRD+KP+NILLD  GH+ L DFG  L  + D   RS    GT +Y+SPEI+     
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 324 ----KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFL-----SS 374
                 +    DWW++G+  +EM  GQ PF   +              L   L       
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPE 300
Query: 375 EAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHC 434
           EA   ++ LL    + RLG   GG+ + ++H +F  ++W  L  R++ P F P+  G   
Sbjct: 301 EARDFIQRLLCPPET-RLGR--GGAGDFRTHPFFFGLDWDGL--RDSVPPFTPDFEGATD 355
Query: 435 VANF---EECWTNM------PLLDSPVASPKFNENPFKGFTY 467
             NF   E+  T M       L D    +P     PF G++Y
Sbjct: 356 TCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSY 397

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  174 bits (442), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 101/295 (34%), Positives = 164/295 (55%), Gaps = 9/295 (3%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q +G + F   +V+G+G F +V+  +   T ++YA K + K ++ ++   +    E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL----FREDLARIYTAE 258
           IL KV   FIV L Y+F+TK  L LV+  +NGG + + +Y        F+E  A  YTA+
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMS 317
           IVS + HLH   I++RDLKPEN+LLD DG+V ++D GLA +     T++    GT  +M+
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXX----XXXXXXXXXXLPAFLS 373
           PE++LG+ +D + D++++G+ L+EM+  + PF                       P   S
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417
Query: 374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
             +    + LLQK+  KRLG   G    +++H  F+ I+W++LEA    P F+P+
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  174 bits (442), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 101/295 (34%), Positives = 164/295 (55%), Gaps = 9/295 (3%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q +G + F   +V+G+G F +V+  +   T ++YA K + K ++ ++   +    E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL----FREDLARIYTAE 258
           IL KV   FIV L Y+F+TK  L LV+  +NGG + + +Y        F+E  A  YTA+
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMS 317
           IVS + HLH   I++RDLKPEN+LLD DG+V ++D GLA +     T++    GT  +M+
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXX----XXXXXXXXXXLPAFLS 373
           PE++LG+ +D + D++++G+ L+EM+  + PF                       P   S
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417
Query: 374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
             +    + LLQK+  KRLG   G    +++H  F+ I+W++LEA    P F+P+
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  174 bits (442), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 101/295 (34%), Positives = 164/295 (55%), Gaps = 9/295 (3%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q +G + F   +V+G+G F +V+  +   T ++YA K + K ++ ++   +    E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL----FREDLARIYTAE 258
           IL KV   FIV L Y+F+TK  L LV+  +NGG + + +Y        F+E  A  YTA+
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMS 317
           IVS + HLH   I++RDLKPEN+LLD DG+V ++D GLA +     T++    GT  +M+
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXX----XXXXXXXXXXLPAFLS 373
           PE++LG+ +D + D++++G+ L+EM+  + PF                       P   S
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417
Query: 374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
             +    + LLQK+  KRLG   G    +++H  F+ I+W++LEA    P F+P+
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  174 bits (441), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 101/295 (34%), Positives = 164/295 (55%), Gaps = 9/295 (3%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           E Q +G + F   +V+G+G F +V+  +   T ++YA K + K ++ ++   +    E+ 
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL----FREDLARIYTAE 258
           IL KV   FIV L Y+F+TK  L LV+  +NGG + + +Y        F+E  A  YTA+
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMS 317
           IVS + HLH   I++RDLKPEN+LLD DG+V ++D GLA +     T++    GT  +M+
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXX----XXXXXXXXXXLPAFLS 373
           PE++LG+ +D + D++++G+ L+EM+  + PF                       P   S
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417
Query: 374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
             +    + LLQK+  KRLG   G    +++H  F+ I+W++LEA    P F+P+
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPD 472

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 143/261 (54%), Gaps = 6/261 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           LEDF++ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + + 
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H+
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             ++HRD+KPEN+LL ++G + + DFG +     ++R +++CGTL+Y+ PE++ G+ HD+
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVH-APSSRRDTLCGTLDYLPPEMIEGRMHDE 189
Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEA 388
             D WS+G+L +E L G PPF                   P F++  A  L+  LL+  A
Sbjct: 190 KVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLLKHNA 249
Query: 389 SKRLGSGPGGSQEIKSHKWFK 409
           S+RL        E+  H W K
Sbjct: 250 SQRLTLA-----EVLEHPWIK 265

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 142/261 (54%), Gaps = 6/261 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           LEDF++ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + + 
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H+
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             ++HRD+KPEN+LL ++G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD+
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHDE 189
Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEA 388
             D WS+G+L +E L G PPF                   P F++  A  L+  LL+  A
Sbjct: 190 KVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLLKHNA 249
Query: 389 SKRLGSGPGGSQEIKSHKWFK 409
           S+RL        E+  H W K
Sbjct: 250 SQRLTLA-----EVLEHPWIK 265

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  161 bits (407), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 144/270 (53%), Gaps = 6/270 (2%)
Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
           N  S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++
Sbjct: 23  NEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 82
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
            E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 142
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           + +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ P
Sbjct: 143 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPP 201
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHS 378
           E++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 261
Query: 379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
           L+  LL+   S+R        +E+  H W 
Sbjct: 262 LISRLLKHNPSQR-----PMLREVLEHPWI 286

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  161 bits (407), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 144/270 (53%), Gaps = 6/270 (2%)
Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
           N  S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++
Sbjct: 23  NEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 82
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
            E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 142
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           + +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R + +CGTL+Y+ P
Sbjct: 143 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRDDLCGTLDYLPP 201
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHS 378
           E++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 261
Query: 379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
           L+  LL+   S+R        +E+  H W 
Sbjct: 262 LISRLLKHNPSQR-----PMLREVLEHPWI 286

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 139/252 (55%), Gaps = 1/252 (0%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
            +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPE 181
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           ++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 241
Query: 380 LKGLLQKEASKR 391
           +  LL+   S+R
Sbjct: 242 ISRLLKHNPSQR 253

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 81/253 (32%), Positives = 139/253 (54%), Gaps = 1/253 (0%)
Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
           N  S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++
Sbjct: 14  NEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 73
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
            E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E
Sbjct: 74  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 133
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           + +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ P
Sbjct: 134 LANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPP 192
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHS 378
           E++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 252
Query: 379 LLKGLLQKEASKR 391
           L+  LL+   S+R
Sbjct: 253 LISRLLKHNPSQR 265

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 144/267 (53%), Gaps = 6/267 (2%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R +++CGTL+Y+ PE++
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRDTLCGTLDYLPPEMI 179
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L+ 
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239
Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWF 408
            LL+   S+R        +E+  H W 
Sbjct: 240 RLLKHNPSQR-----PMLREVLEHPWI 261

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 144/269 (53%), Gaps = 6/269 (2%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
            +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPE 179
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           ++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
           +  LL+   S+R        +E+  H W 
Sbjct: 240 ISRLLKHNPSQR-----PMLREVLEHPWI 263

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 139/252 (55%), Gaps = 1/252 (0%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
            +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPE 181
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           ++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 241
Query: 380 LKGLLQKEASKR 391
           +  LL+   S+R
Sbjct: 242 ISRLLKHNPSQR 253

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  159 bits (403), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 140/261 (53%), Gaps = 6/261 (2%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L +E L G+PPF                   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 ASKRLGSGPGGSQEIKSHKWF 408
            S+R        +E+  H W 
Sbjct: 245 PSQR-----PMLREVLEHPWI 260

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 145/274 (52%), Gaps = 9/274 (3%)
Query: 135 GHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA 194
           GH +   S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +    
Sbjct: 1   GHXE---SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE 57
Query: 195 EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI 254
             ++ E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 117
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE 314
           Y  E+ +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+
Sbjct: 118 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLD 176
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSS 374
           Y+ PE + G+ HD+  D WS+G+L +E L G+PPF                   P F++ 
Sbjct: 177 YLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 236
Query: 375 EAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
            A  L+  LL+   S+R        +E+  H W 
Sbjct: 237 GARDLISRLLKHNPSQR-----PXLREVLEHPWI 265

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  159 bits (402), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 144/269 (53%), Gaps = 6/269 (2%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
            +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPE 179
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           ++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
           +  LL+   S+R        +E+  H W 
Sbjct: 240 ISRLLKHNPSQR-----PMLREVLEHPWI 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 140/261 (53%), Gaps = 6/261 (2%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R + +CGTL+Y+ PE++ G+ HD
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRDDLCGTLDYLPPEMIEGRMHD 187
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L +E L G+PPF                   P F++  A  L+  LL+  
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 388 ASKRLGSGPGGSQEIKSHKWF 408
            S+R        +E+  H W 
Sbjct: 248 PSQR-----PMLREVLEHPWI 263

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  159 bits (401), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 143/267 (53%), Gaps = 6/267 (2%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     + R++ +CGTL+Y+ PE++
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMI 179
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L+ 
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239
Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWF 408
            LL+   S+R        +E+  H W 
Sbjct: 240 RLLKHNPSQR-----PMLREVLEHPWI 261

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  159 bits (401), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 140/261 (53%), Gaps = 6/261 (2%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 124
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD
Sbjct: 125 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 183
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L +E L G+PPF                   P F++  A  L+  LL+  
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 243
Query: 388 ASKRLGSGPGGSQEIKSHKWF 408
            S+R        +E+  H W 
Sbjct: 244 PSQR-----PMLREVLEHPWI 259

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  158 bits (400), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 140/261 (53%), Gaps = 6/261 (2%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKKVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L +E L G+PPF                   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 ASKRLGSGPGGSQEIKSHKWF 408
            S+R        +E+  H W 
Sbjct: 245 PSQR-----PMLREVLEHPWI 260

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  158 bits (400), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 139/261 (53%), Gaps = 6/261 (2%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R   +CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTELCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L +E L G+PPF                   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 ASKRLGSGPGGSQEIKSHKWF 408
            S+R        +E+  H W 
Sbjct: 245 PSQR-----PMLREVLEHPWI 260

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  158 bits (400), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 80/250 (32%), Positives = 138/250 (55%), Gaps = 1/250 (0%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     + R++ +CGTL+Y+ PE++
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMI 183
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L+ 
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 243
Query: 382 GLLQKEASKR 391
            LL+   S+R
Sbjct: 244 RLLKHNPSQR 253

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  158 bits (400), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 140/261 (53%), Gaps = 6/261 (2%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 129
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD
Sbjct: 130 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 188
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L +E L G+PPF                   P F++  A  L+  LL+  
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 248
Query: 388 ASKRLGSGPGGSQEIKSHKWF 408
            S+R        +E+  H W 
Sbjct: 249 PSQR-----PMLREVLEHPWI 264

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  158 bits (400), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 140/261 (53%), Gaps = 6/261 (2%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     + R++ +CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L +E L G+PPF                   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 ASKRLGSGPGGSQEIKSHKWF 408
            S+R        +E+  H W 
Sbjct: 245 PSQR-----PMLREVLEHPWI 260

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  158 bits (400), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 79/244 (32%), Positives = 135/244 (55%), Gaps = 1/244 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 128
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD
Sbjct: 129 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIEGRMHD 187
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L +E L G+PPF                   P F++  A  L+  LL+  
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 388 ASKR 391
            S+R
Sbjct: 248 PSQR 251

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  158 bits (400), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 140/261 (53%), Gaps = 6/261 (2%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     + R++ +CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L +E L G+PPF                   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 ASKRLGSGPGGSQEIKSHKWF 408
            S+R        +E+  H W 
Sbjct: 245 PSQR-----PMLREVLEHPWI 260

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  158 bits (399), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 140/261 (53%), Gaps = 6/261 (2%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L +E L G+PPF                   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 ASKRLGSGPGGSQEIKSHKWF 408
            S+R        +E+  H W 
Sbjct: 245 PSQR-----PMLREVLEHPWI 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 80/250 (32%), Positives = 137/250 (54%), Gaps = 1/250 (0%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 121
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R   +CGTL+Y+ PE++
Sbjct: 122 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMI 180
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L+ 
Sbjct: 181 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 240
Query: 382 GLLQKEASKR 391
            LL+   S+R
Sbjct: 241 RLLKHNPSQR 250

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  157 bits (398), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 143/267 (53%), Gaps = 6/267 (2%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 2   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 61
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 121
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           A+S+ H+  ++HRD+KPEN+LL + G + + +FG +     ++R  ++CGTL+Y+ PE++
Sbjct: 122 ALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVH-APSSRRTTLCGTLDYLPPEMI 180
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
            G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L+ 
Sbjct: 181 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 240
Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWF 408
            LL+   S+R        +E+  H W 
Sbjct: 241 RLLKHNPSQR-----PMLREVLEHPWI 262

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  157 bits (398), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 139/261 (53%), Gaps = 6/261 (2%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R   +CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTXLCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L +E L G+PPF                   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 ASKRLGSGPGGSQEIKSHKWF 408
            S+R        +E+  H W 
Sbjct: 245 PSQR-----PMLREVLEHPWI 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  157 bits (398), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 6/269 (2%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
            +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R   +CGTL+Y+ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPE 179
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           ++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
           +  LL+   S+R        +E+  H W 
Sbjct: 240 ISRLLKHNPSQR-----PMLREVLEHPWI 263

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  157 bits (398), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 144/269 (53%), Gaps = 6/269 (2%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
            +A+S+ H+  ++HRD+KPEN+LL + G + + +FG +     ++R  ++CGTL+Y+ PE
Sbjct: 121 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVH-APSSRRTTLCGTLDYLPPE 179
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           ++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
           +  LL+   S+R        +E+  H W 
Sbjct: 240 ISRLLKHNPSQR-----PMLREVLEHPWI 263

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 139/261 (53%), Gaps = 6/261 (2%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R      I A+KV+ K ++ +      ++ E  I + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 122
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD
Sbjct: 123 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 181
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L +E L G+PPF                   P F++  A  L+  LL+  
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 241
Query: 388 ASKRLGSGPGGSQEIKSHKWF 408
            S+R        +E+  H W 
Sbjct: 242 PSQR-----PMLREVLEHPWI 257

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 139/261 (53%), Gaps = 6/261 (2%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R   +CGTL+Y+ PE++ G+ HD
Sbjct: 126 SKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLCGTLDYLPPEMIEGRMHD 184
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L +E L G+PPF                   P F++  A  L+  LL+  
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 388 ASKRLGSGPGGSQEIKSHKWF 408
            S+R        +E+  H W 
Sbjct: 245 PSQR-----PMLREVLEHPWI 260

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 136/261 (52%), Gaps = 6/261 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++DF++++ +G+G F  VY  R      I A+KV+ K ++ ++     ++ E  I + + 
Sbjct: 13  IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+++   F  + R+YL+L+F   G L+ +L + G F E  +  +  E+  A+ + H 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             ++HRD+KPEN+L+   G + + DFG +     + R   MCGTL+Y+ PE++ GK HD+
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRXMCGTLDYLPPEMIEGKTHDE 191
Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEA 388
             D W  G+L +E L G PPF   +               P FLS  +  L+  LL+   
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHP 251
Query: 389 SKRLGSGPGGSQEIKSHKWFK 409
            +RL       + +  H W K
Sbjct: 252 PQRL-----PLKGVMEHPWVK 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 146/261 (55%), Gaps = 7/261 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG+  Y +PE+  GK +D   
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEAS 389
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK  L    S
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPS 253
Query: 390 KRLGSGPGGSQEIKSHKWFKM 410
           KR     G  ++I   +W  +
Sbjct: 254 KR-----GTLEQIMKDRWMNV 269

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 146/261 (55%), Gaps = 7/261 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG+  Y +PE+  GK +D   
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEAS 389
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK  L    S
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPS 253
Query: 390 KRLGSGPGGSQEIKSHKWFKM 410
           KR     G  ++I   +W  +
Sbjct: 254 KR-----GTLEQIMKDRWMNV 269

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 146/261 (55%), Gaps = 7/261 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLNHP 66
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG+  Y +PE+  GK +D   
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEAS 389
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK  L    S
Sbjct: 187 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPS 246
Query: 390 KRLGSGPGGSQEIKSHKWFKM 410
           KR     G  ++I   +W  +
Sbjct: 247 KR-----GTLEQIMKDRWMNV 262

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 87/261 (33%), Positives = 145/261 (55%), Gaps = 7/261 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IMKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG   Y +PE+  GK +D   
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEAS 389
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK  L    S
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPS 253
Query: 390 KRLGSGPGGSQEIKSHKWFKM 410
           KR     G  ++I   +W  +
Sbjct: 254 KR-----GTLEQIMKDRWMNV 269

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 146/261 (55%), Gaps = 7/261 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A++++ K ++   +  +  +  R I+  ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVR-IMKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG+  Y +PE+  GK +D   
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEAS 389
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK  L    S
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPS 253
Query: 390 KRLGSGPGGSQEIKSHKWFKM 410
           KR     G  ++I   +W  +
Sbjct: 254 KR-----GTLEQIMKDRWMNV 269

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  155 bits (392), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 86/261 (32%), Positives = 145/261 (55%), Gaps = 7/261 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A++++ K ++   +  +  +  R I+  ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVR-IMKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + +  CG+  Y +PE+  GK +D   
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEAS 389
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK  L    S
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNPS 253
Query: 390 KRLGSGPGGSQEIKSHKWFKM 410
           KR     G  ++I   +W  +
Sbjct: 254 KR-----GTLEQIMKDRWMNV 269

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  155 bits (391), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 135/261 (51%), Gaps = 6/261 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++DF++ + +G+G F  VY  R      I A+KV+ K ++ ++     ++ E  I + + 
Sbjct: 14  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+++   F  + R+YL+L+F   G L+ +L + G F E  +  +  E+  A+ + H 
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 133
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             ++HRD+KPEN+L+   G + + DFG +     + R   MCGTL+Y+ PE++ GK HD+
Sbjct: 134 RKVIHRDIKPENLLMGYKGELKIADFGWSVH-APSLRRRXMCGTLDYLPPEMIEGKTHDE 192
Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEA 388
             D W  G+L +E L G PPF   +               P FLS  +  L+  LL+   
Sbjct: 193 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHP 252
Query: 389 SKRLGSGPGGSQEIKSHKWFK 409
            +RL       + +  H W K
Sbjct: 253 PQRL-----PLKGVMEHPWVK 268

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 79/252 (31%), Positives = 137/252 (54%), Gaps = 1/252 (0%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           + S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ 
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
            +A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     ++R   + GTL+Y+ PE
Sbjct: 123 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRXXLXGTLDYLPPE 181
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSL 379
           ++ G+ HD+  D WS+G+L +E L G+PPF                   P F++  A  L
Sbjct: 182 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 241
Query: 380 LKGLLQKEASKR 391
           +  LL+   S+R
Sbjct: 242 ISRLLKHNPSQR 253

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 134/244 (54%), Gaps = 1/244 (0%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +  ++HRD+KPEN+LL + G + + DFG +     ++R  ++ GTL+Y+ PE++ G+ HD
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSCH-APSSRRTTLSGTLDYLPPEMIEGRMHD 185
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKE 387
           +  D WS+G+L +E L G+PPF                   P F++  A  L+  LL+  
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 245
Query: 388 ASKR 391
            S+R
Sbjct: 246 PSQR 249

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 90/280 (32%), Positives = 151/280 (53%), Gaps = 11/280 (3%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T    A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVR-IMKILNHP 71
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYL++++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG+  Y +PE+  GK +D   
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEAS 389
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK  L     
Sbjct: 192 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPI 251
Query: 390 KRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEV 429
           KR     G  ++I   +W    +    E  E +P   PE+
Sbjct: 252 KR-----GTLEQIMKDRWINAGH----EEDELKPFVEPEL 282

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 87/258 (33%), Positives = 141/258 (54%), Gaps = 7/258 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T +  A+K++ K ++   +  +  +  R I   ++HP
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVR-IXKVLNHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV ++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG   Y +PE+  GK +D   
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEAS 389
            D WS+G++L+ +++G  PF G N              +P + S++  +LLK  L    S
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLKKFLILNPS 253
Query: 390 KRLGSGPGGSQEIKSHKW 407
           KR     G  ++I   +W
Sbjct: 254 KR-----GTLEQIXKDRW 266

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 90/280 (32%), Positives = 150/280 (53%), Gaps = 11/280 (3%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +LK +G+G FAKV   R I T    A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVR-IMKILNHP 74
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYL++++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG   Y +PE+  GK +D   
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEAS 389
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK  L     
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPI 254
Query: 390 KRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEV 429
           KR     G  ++I   +W    +    E  E +P   PE+
Sbjct: 255 KR-----GTLEQIMKDRWINAGH----EEDELKPFVEPEL 285

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 74/201 (36%), Positives = 128/201 (63%), Gaps = 7/201 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  ++V+G GAF++V+ V++  T +++A+K ++K      +  E   +E  +L K+ H  
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHEN 67
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV L   +++    YLV+  V+GG LF ++  +G++ E  A +   +++SAV +LH NGI
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 272 MHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           +HRDLKPEN+L    + +  +M+TDFGL+K  ++N   ++ CGT  Y++PE++  K + K
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPEVLAQKPYSK 186
Query: 329 AADWWSVGILLFEMLTGQPPF 349
           A D WS+G++ + +L G PPF
Sbjct: 187 AVDCWSIGVITYILLCGYPPF 207

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  147 bits (372), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 137/261 (52%), Gaps = 6/261 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++DFE+ + +G+G F  VY  R   +  I A+KV+ K +I ++     ++ E  I   + 
Sbjct: 22  IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I++L   F  + R+YL+L++   G L+ +L +   F E        E+  A+ + H 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             ++HRD+KPEN+LL   G + + DFG +     + R  +MCGTL+Y+ PE++ G+ H++
Sbjct: 142 KKVIHRDIKPENLLLGLKGELKIADFGWSVH-APSLRRKTMCGTLDYLPPEMIEGRMHNE 200
Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEA 388
             D W +G+L +E+L G PPF   +               PA + + A  L+  LL+   
Sbjct: 201 KVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRHNP 260
Query: 389 SKRLGSGPGGSQEIKSHKWFK 409
           S+RL        ++ +H W +
Sbjct: 261 SERLPLA-----QVSAHPWVR 276

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 82/251 (32%), Positives = 140/251 (55%), Gaps = 4/251 (1%)
Query: 146 CVG--LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           C+G  +EDF+V  ++G+G+FA VY+   I T    A+K++ K  + +    + +++E  I
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSA 262
             ++ HP I++L   F+    +YLVL+  + G +   L  R   F E+ AR +  +I++ 
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIV 321
           + +LH++GI+HRDL   N+LL  + ++ + DFGLA Q    + +  ++CGT  Y+SPEI 
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
               H   +D WS+G + + +L G+PPF                  +P+FLS EA  L+ 
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH 244
Query: 382 GLLQKEASKRL 392
            LL++  + RL
Sbjct: 245 QLLRRNPADRL 255

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 84/260 (32%), Positives = 141/260 (54%), Gaps = 10/260 (3%)
Query: 141 PSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           P   Q   + D ++   V+G GAF++V       T ++ A+K + K+ +  K  +  M++
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS--MEN 65
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  +L K+ HP IV L   +++   LYL++  V+GG LF ++  +G + E  A     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 260 VSAVSHLHANGIMHRDLKPENIL---LDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
           + AV +LH  GI+HRDLKPEN+L   LD D  +M++DFGL+K  D  +  ++ CGT  Y+
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FL 372
           +PE++  K + KA D WS+G++ + +L G PPF   N                +     +
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 245
Query: 373 SSEAHSLLKGLLQKEASKRL 392
           S  A   ++ L++K+  KR 
Sbjct: 246 SDSAKDFIRHLMEKDPEKRF 265

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  145 bits (365), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 84/260 (32%), Positives = 141/260 (54%), Gaps = 10/260 (3%)
Query: 141 PSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           P   Q   + D ++   V+G GAF++V       T ++ A+K + K+ +  K  +  M++
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS--MEN 65
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  +L K+ HP IV L   +++   LYL++  V+GG LF ++  +G + E  A     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 260 VSAVSHLHANGIMHRDLKPENIL---LDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
           + AV +LH  GI+HRDLKPEN+L   LD D  +M++DFGL+K  D  +  ++ CGT  Y+
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FL 372
           +PE++  K + KA D WS+G++ + +L G PPF   N                +     +
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 245
Query: 373 SSEAHSLLKGLLQKEASKRL 392
           S  A   ++ L++K+  KR 
Sbjct: 246 SDSAKDFIRHLMEKDPEKRF 265

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  144 bits (364), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 84/260 (32%), Positives = 141/260 (54%), Gaps = 10/260 (3%)
Query: 141 PSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           P   Q   + D ++   V+G GAF++V       T ++ A+K + K+ +  K  +  M++
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS--MEN 65
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  +L K+ HP IV L   +++   LYL++  V+GG LF ++  +G + E  A     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 260 VSAVSHLHANGIMHRDLKPENIL---LDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
           + AV +LH  GI+HRDLKPEN+L   LD D  +M++DFGL+K  D  +  ++ CGT  Y+
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FL 372
           +PE++  K + KA D WS+G++ + +L G PPF   N                +     +
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 245
Query: 373 SSEAHSLLKGLLQKEASKRL 392
           S  A   ++ L++K+  KR 
Sbjct: 246 SDSAKDFIRHLMEKDPEKRF 265

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/260 (32%), Positives = 140/260 (53%), Gaps = 10/260 (3%)
Query: 141 PSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           P   Q   + D ++   V+G GAF++V       T ++ A+K + K  +  K  +  M++
Sbjct: 8   PRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS--MEN 65
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E  +L K+ HP IV L   +++   LYL++  V+GG LF ++  +G + E  A     ++
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQV 125
Query: 260 VSAVSHLHANGIMHRDLKPENIL---LDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
           + AV +LH  GI+HRDLKPEN+L   LD D  +M++DFGL+K  D  +  ++ CGT  Y+
Sbjct: 126 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FL 372
           +PE++  K + KA D WS+G++ + +L G PPF   N                +     +
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 245
Query: 373 SSEAHSLLKGLLQKEASKRL 392
           S  A   ++ L++K+  KR 
Sbjct: 246 SDSAKDFIRHLMEKDPEKRF 265

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 77/203 (37%), Positives = 122/203 (60%), Gaps = 12/203 (5%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK--DKIMEKNHAEYMKSERNILTKVDH 209
           FEV   +G+GA + VY+ ++ GT + YA+KV++K  DK       + +++E  +L ++ H
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-------KIVRTEIGVLLRLSH 107
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L+  F+T   + LVL+ V GG LF ++  +G + E  A     +I+ AV++LH N
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 270 GIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPEN+L      D  + + DFGL+K  +      ++CGT  Y +PEI+ G  +
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY 227
Query: 327 DKAADWWSVGILLFEMLTGQPPF 349
               D WSVGI+ + +L G  PF
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPF 250

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 143/261 (54%), Gaps = 7/261 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ + K +G+G FAKV   R + T    A+K++ K ++   +  +  +  R I+  ++HP
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVR-IMKILNHP 74
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            IV+L    +T+  LYLV+++ +GG +F  L   G  +E  AR    +IVSAV + H   
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY 134
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-KA 329
           I+HRDLK EN+LLD D ++ + DFG + +F    + ++ CG+  Y +PE+  GK +D   
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPE 194
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEAS 389
            D WS+G++L+ +++G  PF G N              +P ++S++  +LLK LL     
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKLLVLNPI 254
Query: 390 KRLGSGPGGSQEIKSHKWFKM 410
           KR     G  ++I   +W  +
Sbjct: 255 KR-----GSLEQIMKDRWMNV 270

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  141 bits (355), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 78/247 (31%), Positives = 135/247 (54%), Gaps = 9/247 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FE  + +G GAF++V       T +++A+K + K  +  K  +  +++E  +L K+ H  
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESS--IENEIAVLRKIKHEN 81
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV L   +++   LYLV+  V+GG LF ++  +G + E  A     +++ AV +LH  GI
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 272 MHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           +HRDLKPEN+L    D +  +M++DFGL+K   +    ++ CGT  Y++PE++  K + K
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSK 201
Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FLSSEAHSLLKGLL 384
           A D WS+G++ + +L G PPF   N                +     +S  A   ++ L+
Sbjct: 202 AVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLM 261
Query: 385 QKEASKR 391
           +K+ +KR
Sbjct: 262 EKDPNKR 268

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 135/231 (58%), Gaps = 10/231 (4%)
Query: 131 GKPTGHIDNLP----SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKD 186
           G P  H+   P      +  +  + ++  +V+G+G+F +V   +   T +  A+KV+ K 
Sbjct: 26  GGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 85
Query: 187 KIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL 246
           ++ +K   E +  E  +L ++DHP I++L   F+ K   YLV +   GG LF ++  +  
Sbjct: 86  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 145
Query: 247 FRE-DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDE 302
           F E D ARI   +++S ++++H N I+HRDLKPEN+LL++   D ++ + DFGL+  F+ 
Sbjct: 146 FSEVDAARI-IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 204
Query: 303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +     GT  Y++PE++ G  +D+  D WS G++L+ +L+G PPF G N
Sbjct: 205 SKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGAN 254

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 135/231 (58%), Gaps = 10/231 (4%)
Query: 131 GKPTGHIDNLP----SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKD 186
           G P  H+   P      +  +  + ++  +V+G+G+F +V   +   T +  A+KV+ K 
Sbjct: 27  GGPGDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 86
Query: 187 KIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL 246
           ++ +K   E +  E  +L ++DHP I++L   F+ K   YLV +   GG LF ++  +  
Sbjct: 87  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 146
Query: 247 FRE-DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDE 302
           F E D ARI   +++S ++++H N I+HRDLKPEN+LL++   D ++ + DFGL+  F+ 
Sbjct: 147 FSEVDAARI-IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 205
Query: 303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +     GT  Y++PE++ G  +D+  D WS G++L+ +L+G PPF G N
Sbjct: 206 SKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGAN 255

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 146/262 (55%), Gaps = 15/262 (5%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +V+G+G+F +V   +   T +  A+KV+ K ++ +K   E +  E  +L ++DHP I++L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHANGIMHR 274
              F+ K   YLV +   GG LF ++  +  F E D ARI   +++S ++++H N I+HR
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSGITYMHKNKIVHR 150
Query: 275 DLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
           DLKPEN+LL++   D ++ + DFGL+  F+ + +     GT  Y++PE++ G  +D+  D
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCD 209
Query: 332 WWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXX--LPAF--LSSEAHSLLKGLLQKE 387
            WS G++L+ +L+G PPF G N                LP +  +S  A  L++ +L   
Sbjct: 210 VWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV 269
Query: 388 ASKRLGSGPGGSQEIKSHKWFK 409
            S R+      +++   H+W +
Sbjct: 270 PSMRI-----SARDALDHEWIQ 286

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 125/202 (61%), Gaps = 6/202 (2%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +V+G+G+F +V   +   T +  A+KV+ K ++ +K   E +  E  +L ++DHP I++L
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHANGIMHR 274
              F+ K   YLV +   GG LF ++  +  F E D ARI   +++S ++++H N I+HR
Sbjct: 98  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSGITYMHKNKIVHR 156
Query: 275 DLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
           DLKPEN+LL++   D ++ + DFGL+  F+ + +     GT  Y++PE++ G  +D+  D
Sbjct: 157 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCD 215
Query: 332 WWSVGILLFEMLTGQPPFTGGN 353
            WS G++L+ +L+G PPF G N
Sbjct: 216 VWSTGVILYILLSGCPPFNGAN 237

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 86/273 (31%), Positives = 147/273 (53%), Gaps = 14/273 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ +K +G GA+ +V   R   T    A+K++RK  +   ++++ ++ E  +L  +DH
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-EVAVLKLLDH 95
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L   F+ K   YLV++   GG LF ++  +  F E  A +   +++S V++LH +
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 270 GIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
            I+HRDLKPEN+LL++   D  + + DFGL+  F+   +     GT  Y++PE VL K +
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE-VLRKKY 214
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FLSSEAHSLLKG 382
           D+  D WS+G++LF +L G PPF G                  +     +S  A  L+K 
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274
Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK 415
           +LQ ++ +R+      +Q+   H W K +  KK
Sbjct: 275 MLQFDSQRRI-----SAQQALEHPWIKEMCSKK 302

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 123/202 (60%), Gaps = 6/202 (2%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +V+G+G+F +V   +   T +  A+KV+ K ++ +K   E +  E  +L ++DHP I +L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHANGIMHR 274
              F+ K   YLV +   GG LF ++  +  F E D ARI   +++S +++ H N I+HR
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLSGITYXHKNKIVHR 150
Query: 275 DLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
           DLKPEN+LL++   D ++ + DFGL+  F+ + +     GT  Y++PE++ G  +D+  D
Sbjct: 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT-YDEKCD 209
Query: 332 WWSVGILLFEMLTGQPPFTGGN 353
            WS G++L+ +L+G PPF G N
Sbjct: 210 VWSTGVILYILLSGCPPFNGAN 231

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 127/208 (61%), Gaps = 7/208 (3%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + ++ ++G+G+F +V + +   T + YA+KV+ K     K+ +  ++ E  +L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHA 268
           P I++L    +     Y+V +   GG LF ++ ++  F E D ARI   ++ S ++++H 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSGITYMHK 139
Query: 269 NGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           + I+HRDLKPENILL++   D  + + DFGL+  F +NT+     GT  Y++PE++ G  
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-T 198
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +D+  D WS G++L+ +L+G PPF G N
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKN 226

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 81/253 (32%), Positives = 143/253 (56%), Gaps = 11/253 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + ++ ++G+G+F +V + +   T + YA+KV+ K     K+ +  ++ E  +L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHA 268
           P I++L    +     Y+V +   GG LF ++ ++  F E D ARI   ++ S ++++H 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSGITYMHK 139
Query: 269 NGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           + I+HRDLKPENILL++   D  + + DFGL+  F +NT+     GT  Y++PE++ G  
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-T 198
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXX--LPAF--LSSEAHSLLK 381
           +D+  D WS G++L+ +L+G PPF G N                LP +  +S +A  L++
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 382 GLLQKEASKRLGS 394
            +L    S R+ +
Sbjct: 259 KMLTFHPSLRITA 271

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  137 bits (346), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 81/253 (32%), Positives = 143/253 (56%), Gaps = 11/253 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + ++ ++G+G+F +V + +   T + YA+KV+ K     K+ +  ++ E  +L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEIVSAVSHLHA 268
           P I++L    +     Y+V +   GG LF ++ ++  F E D ARI   ++ S ++++H 
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSGITYMHK 139
Query: 269 NGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           + I+HRDLKPENILL++   D  + + DFGL+  F +NT+     GT  Y++PE++ G  
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-T 198
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXX--LPAF--LSSEAHSLLK 381
           +D+  D WS G++L+ +L+G PPF G N                LP +  +S +A  L++
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 382 GLLQKEASKRLGS 394
            +L    S R+ +
Sbjct: 259 KMLTFHPSLRITA 271

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 137/270 (50%), Gaps = 9/270 (3%)
Query: 131 GKPTGHID--NLPSENQCVGLEDFEVLK------VVGQGAFAKVYQVRRIGTSEIYAMKV 182
            KP+ H+D  + P +     L D   +K       +G+G FAK Y++  + T E++A KV
Sbjct: 15  AKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 74
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
           + K  +++ +  E M +E  I   +D+P +V     F+    +Y+VL+      L     
Sbjct: 75  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK 134
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD- 301
           R+    E  AR +  + +  V +LH N ++HRDLK  N+ L+ D  V + DFGLA + + 
Sbjct: 135 RRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF 194
Query: 302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXX 361
           +  R  ++CGT  Y++PE++  KGH    D WS+G +L+ +L G+PPF            
Sbjct: 195 DGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 254
Query: 362 XXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
                 +P  ++  A +L++ +L  + + R
Sbjct: 255 KKNEYSVPRHINPVASALIRRMLHADPTLR 284

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 144/269 (53%), Gaps = 14/269 (5%)
Query: 148 GLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           GL D ++ +K +G GA+ +V   +   T    A+K+++K  +   +++  +  E  +L +
Sbjct: 18  GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 77
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           +DHP I++L   F+ K   YLV++   GG LF ++  +  F E  A +   +++S  ++L
Sbjct: 78  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 137
Query: 267 HANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           H + I+HRDLKPEN+LL++   D  + + DFGL+  F+   +     GT  Y++PE VL 
Sbjct: 138 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE-VLR 196
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXL--PAF--LSSEAHSL 379
           K +D+  D WS G++L+ +L G PPF G                   P +  +S EA  L
Sbjct: 197 KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQL 256
Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
           +K +L  E SKR+      ++E  +H W 
Sbjct: 257 VKLMLTYEPSKRI-----SAEEALNHPWI 280

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 136/270 (50%), Gaps = 9/270 (3%)
Query: 131 GKPTGHID--NLPSENQCVGLEDFEVLK------VVGQGAFAKVYQVRRIGTSEIYAMKV 182
            KP+ H+D  + P +     L D   +K       +G+G FAK Y++  + T E++A KV
Sbjct: 15  AKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 74
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
           + K  +++ +  E M +E  I   +D+P +V     F+    +Y+VL+      L     
Sbjct: 75  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK 134
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD- 301
           R+    E  AR +  + +  V +LH N ++HRDLK  N+ L+ D  V + DFGLA + + 
Sbjct: 135 RRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF 194
Query: 302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXX 361
           +  R   +CGT  Y++PE++  KGH    D WS+G +L+ +L G+PPF            
Sbjct: 195 DGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 254
Query: 362 XXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
                 +P  ++  A +L++ +L  + + R
Sbjct: 255 KKNEYSVPRHINPVASALIRRMLHADPTLR 284

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 136/270 (50%), Gaps = 9/270 (3%)
Query: 131 GKPTGHID--NLPSENQCVGLEDFEVLK------VVGQGAFAKVYQVRRIGTSEIYAMKV 182
            KP+ H+D  + P +     L D   +K       +G+G FAK Y++  + T E++A KV
Sbjct: 15  AKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 74
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
           + K  +++ +  E M +E  I   +D+P +V     F+    +Y+VL+      L     
Sbjct: 75  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK 134
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD- 301
           R+    E  AR +  + +  V +LH N ++HRDLK  N+ L+ D  V + DFGLA + + 
Sbjct: 135 RRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF 194
Query: 302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXX 361
           +  R   +CGT  Y++PE++  KGH    D WS+G +L+ +L G+PPF            
Sbjct: 195 DGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI 254
Query: 362 XXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
                 +P  ++  A +L++ +L  + + R
Sbjct: 255 KKNEYSVPRHINPVASALIRRMLHADPTLR 284

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 159/303 (52%), Gaps = 26/303 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNIL 204
           +++ + K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            K++HP I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV 
Sbjct: 76  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 265 HLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +LH NGI+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE++
Sbjct: 135 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 194
Query: 322 LG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXX--LP---AFLS 373
           +     G+++A D WS+G++LF  L+G PPF+                   +P   A +S
Sbjct: 195 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 254
Query: 374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK----LEARETRPSFLPEV 429
            +A  L+K LL  +   R       ++E   H W +  + K+    L + E   + LP+V
Sbjct: 255 EKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQV 309
Query: 430 AGK 432
             +
Sbjct: 310 LAQ 312

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 159/303 (52%), Gaps = 26/303 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNIL 204
           +++ + K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            K++HP I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV 
Sbjct: 70  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 265 HLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +LH NGI+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE++
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 322 LG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXX--LP---AFLS 373
           +     G+++A D WS+G++LF  L+G PPF+                   +P   A +S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK----LEARETRPSFLPEV 429
            +A  L+K LL  +   R       ++E   H W +  + K+    L + E   + LP+V
Sbjct: 249 EKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQV 303
Query: 430 AGK 432
             +
Sbjct: 304 LAQ 306

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 159/303 (52%), Gaps = 26/303 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNIL 204
           +++ + K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            K++HP I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV 
Sbjct: 70  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 265 HLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +LH NGI+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE++
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 322 LG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXX--LP---AFLS 373
           +     G+++A D WS+G++LF  L+G PPF+                   +P   A +S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK----LEARETRPSFLPEV 429
            +A  L+K LL  +   R       ++E   H W +  + K+    L + E   + LP+V
Sbjct: 249 EKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQV 303
Query: 430 AGK 432
             +
Sbjct: 304 LAQ 306

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 144/269 (53%), Gaps = 14/269 (5%)
Query: 148 GLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           GL D ++ +K +G GA+ +V   +   T    A+K+++K  +   +++  +  E  +L +
Sbjct: 1   GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 60
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           +DHP I++L   F+ K   YLV++   GG LF ++  +  F E  A +   +++S  ++L
Sbjct: 61  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 120
Query: 267 HANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           H + I+HRDLKPEN+LL++   D  + + DFGL+  F+   +     GT  Y++PE VL 
Sbjct: 121 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPE-VLR 179
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXL--PAF--LSSEAHSL 379
           K +D+  D WS G++L+ +L G PPF G                   P +  +S EA  L
Sbjct: 180 KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQL 239
Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
           +K +L  E SKR+      ++E  +H W 
Sbjct: 240 VKLMLTYEPSKRI-----SAEEALNHPWI 263

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 159/303 (52%), Gaps = 26/303 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNIL 204
           +++ + K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            K++HP I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV 
Sbjct: 69  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 265 HLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +LH NGI+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE++
Sbjct: 128 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 187
Query: 322 LG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXX--LP---AFLS 373
           +     G+++A D WS+G++LF  L+G PPF+                   +P   A +S
Sbjct: 188 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 247
Query: 374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK----LEARETRPSFLPEV 429
            +A  L+K LL  +   R       ++E   H W +  + K+    L + E   + LP+V
Sbjct: 248 EKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQV 302
Query: 430 AGK 432
             +
Sbjct: 303 LAQ 305

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 124/237 (52%), Gaps = 1/237 (0%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           + +G+G FAK Y++  + T E++A KV+ K  +++ +  E M +E  I   +D+P +V  
Sbjct: 32  RFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGF 91
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
              F+    +Y+VL+      L     R+    E  AR +  + +  V +LH N ++HRD
Sbjct: 92  HGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRD 151
Query: 276 LKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
           LK  N+ L+ D  V + DFGLA + + +  R   +CGT  Y++PE++  KGH    D WS
Sbjct: 152 LKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWS 211
Query: 335 VGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           +G +L+ +L G+PPF                  +P  ++  A +L++ +L  + + R
Sbjct: 212 LGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLR 268

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 127/212 (59%), Gaps = 12/212 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNIL 204
           +++ + K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            K++HP I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV 
Sbjct: 70  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 265 HLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +LH NGI+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE++
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 322 LG---KGHDKAADWWSVGILLFEMLTGQPPFT 350
           +     G+++A D WS+G++LF  L+G PPF+
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/300 (29%), Positives = 158/300 (52%), Gaps = 26/300 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNIL 204
           +++ + K +G GA  +V       T +  A++++ K K       E + A  +++E  IL
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            K++HP I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV 
Sbjct: 209 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 265 HLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +LH NGI+HRDLKPEN+LL +   D  + +TDFG +K   E +   ++CGT  Y++PE++
Sbjct: 268 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 327
Query: 322 LG---KGHDKAADWWSVGILLFEMLTGQPPFTGGN-----RXXXXXXXXXXXXXLPAFLS 373
           +     G+++A D WS+G++LF  L+G PPF+        +             + A +S
Sbjct: 328 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 387
Query: 374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK----LEARETRPSFLPEV 429
            +A  L+K LL  +   R       ++E   H W +  + K+    L + E   + LP+V
Sbjct: 388 EKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQV 442

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  133 bits (334), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 127/212 (59%), Gaps = 12/212 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNIL 204
           +++ + K +G GA  +V       T +  A++++ K K       E + A  +++E  IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            K++HP I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV 
Sbjct: 195 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 265 HLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +LH NGI+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE++
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313
Query: 322 LG---KGHDKAADWWSVGILLFEMLTGQPPFT 350
           +     G+++A D WS+G++LF  L+G PPF+
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 122/235 (51%), Gaps = 1/235 (0%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
             N+ L+ D  V + DFGLA + + +  R  ++CGT  Y++PE++  KGH    D WS+G
Sbjct: 149 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 208
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
            +++ +L G+PPF                  +P  ++  A SL++ +LQ + + R
Sbjct: 209 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 263

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  132 bits (331), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 122/235 (51%), Gaps = 1/235 (0%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
             N+ L+ D  V + DFGLA + + +  R  ++CGT  Y++PE++  KGH    D WS+G
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
            +++ +L G+PPF                  +P  ++  A SL++ +LQ + + R
Sbjct: 205 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 259

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  132 bits (331), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 122/235 (51%), Gaps = 1/235 (0%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
             N+ L+ D  V + DFGLA + + +  R  ++CGT  Y++PE++  KGH    D WS+G
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
            +++ +L G+PPF                  +P  ++  A SL++ +LQ + + R
Sbjct: 205 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 259

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 121/235 (51%), Gaps = 1/235 (0%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
             N+ L+ D  V + DFGLA + + +  R   +CGT  Y++PE++  KGH    D WS+G
Sbjct: 167 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 226
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
            +++ +L G+PPF                  +P  ++  A SL++ +LQ + + R
Sbjct: 227 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 281

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 121/235 (51%), Gaps = 1/235 (0%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
             N+ L+ D  V + DFGLA + + +  R   +CGT  Y++PE++  KGH    D WS+G
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 228
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
            +++ +L G+PPF                  +P  ++  A SL++ +LQ + + R
Sbjct: 229 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 283

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 137/267 (51%), Gaps = 14/267 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +++++ + +G+GAF+ V +  +I T + YA K++   K+  ++H + ++ E  I   + H
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDH-QKLEREARICRLLKH 62
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S   +   YLV D V GG LF  +  +  + E  A     +I+ +V+H H N
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 270 GIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVLGKG 325
           GI+HRDLKPEN+LL +      V L DFGLA +   + ++     GT  Y+SPE++    
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FLSSEAHSLLK 381
           + K  D W+ G++L+ +L G PPF   ++              P+     ++ EA  L+ 
Sbjct: 183 YGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWF 408
            +L    +KR+ +      E   H W 
Sbjct: 243 KMLTINPAKRITAS-----EALKHPWI 264

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 6/254 (2%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR 216
            +G G F KV   +   T    A+K++ + KI   +    ++ E   L    HP I++L 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               T   +++V+++V+GG LF  + + G   E  +R    +I+S V + H + ++HRDL
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142
Query: 277 KPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSV 335
           KPEN+LLDA  +  + DFGL+    +       CG+  Y +PE++ G+ +     D WS 
Sbjct: 143 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSS 202
Query: 336 GILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSG 395
           G++L+ +L G  PF   +               P +L+    SLLK +LQ +  KR    
Sbjct: 203 GVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKR---- 258
Query: 396 PGGSQEIKSHKWFK 409
               ++I+ H+WFK
Sbjct: 259 -ATIKDIREHEWFK 271

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 127/253 (50%), Gaps = 6/253 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F KV       T    A+K++ + KI   +    +K E   L    HP I++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
              T    ++V+++V+GG LF  + + G   E  AR    +I+SAV + H + ++HRDLK
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 278 PENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVG 336
           PEN+LLDA  +  + DFGL+    +     + CG+  Y +PE++ G+ +     D WS G
Sbjct: 139 PENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCG 198
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGP 396
           ++L+ +L G  PF   +              +P +L+    +LL  +LQ +  KR     
Sbjct: 199 VILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKR----- 253
Query: 397 GGSQEIKSHKWFK 409
              ++I+ H+WFK
Sbjct: 254 ATIKDIREHEWFK 266

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 137/267 (51%), Gaps = 14/267 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +++++ + +G+GAF+ V +  +I T + YA K++   K+  ++H + ++ E  I   + H
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDH-QKLEREARICRLLKH 62
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S   +   YLV D V GG LF  +  +  + E  A     +I+ +V+H H N
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 270 GIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVLGKG 325
           GI+HRDLKPEN+LL +      V L DFGLA +   + ++     GT  Y+SPE++    
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FLSSEAHSLLK 381
           + K  D W+ G++L+ +L G PPF   ++              P+     ++ EA  L+ 
Sbjct: 183 YGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWF 408
            +L    +KR+ +      E   H W 
Sbjct: 243 KMLTINPAKRITAS-----EALKHPWI 264

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 121/235 (51%), Gaps = 1/235 (0%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + H  +V    
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            F+    +++VL+      L     R+    E  AR Y  +IV    +LH N ++HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
             N+ L+ D  V + DFGLA + + +  R   +CGT  Y++PE++  KGH    D WS+G
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 202
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
            +++ +L G+PPF                  +P  ++  A SL++ +LQ + + R
Sbjct: 203 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 257

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 113/208 (54%), Gaps = 4/208 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G+F K   V+       Y +K +   ++  K   E  + E  +L  + 
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE-SRREVAVLANMK 81
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHL 266
           HP IVQ R SF+    LY+V+D+  GG LF ++  Q   LF+ED    +  +I  A+ H+
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC-GTLEYMSPEIVLGKG 325
           H   I+HRD+K +NI L  DG V L DFG+A+  +        C GT  Y+SPEI   K 
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           ++  +D W++G +L+E+ T +  F  G+
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGS 229

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 134/252 (53%), Gaps = 8/252 (3%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQH 64
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 270 GIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HR+LKPEN+LL +      V L DFGLA + +++   +   GT  Y+SPE++    +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FLSSEAHSLLKG 382
            K  D W+ G++L+ +L G PPF   ++              P+     ++ EA SL+  
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244
Query: 383 LLQKEASKRLGS 394
           +L     KR+ +
Sbjct: 245 MLTVNPKKRITA 256

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 126/253 (49%), Gaps = 6/253 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F KV       T    A+K++ + KI   +    +K E   L    HP I++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
              T    ++V+++V+GG LF  + + G   E  AR    +I+SAV + H + ++HRDLK
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 278 PENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVG 336
           PEN+LLDA  +  + DFGL+    +       CG+  Y +PE++ G+ +     D WS G
Sbjct: 139 PENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCG 198
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGP 396
           ++L+ +L G  PF   +              +P +L+    +LL  +LQ +  KR     
Sbjct: 199 VILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKR----- 253
Query: 397 GGSQEIKSHKWFK 409
              ++I+ H+WFK
Sbjct: 254 ATIKDIREHEWFK 266

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 134/252 (53%), Gaps = 8/252 (3%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQH 63
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 123
Query: 270 GIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HR+LKPEN+LL +      V L DFGLA + +++   +   GT  Y+SPE++    +
Sbjct: 124 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 183
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FLSSEAHSLLKG 382
            K  D W+ G++L+ +L G PPF   ++              P+     ++ EA SL+  
Sbjct: 184 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 243
Query: 383 LLQKEASKRLGS 394
           +L     KR+ +
Sbjct: 244 MLTVNPKKRITA 255

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 134/252 (53%), Gaps = 8/252 (3%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQH 64
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 270 GIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HR+LKPEN+LL +      V L DFGLA + +++   +   GT  Y+SPE++    +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FLSSEAHSLLKG 382
            K  D W+ G++L+ +L G PPF   ++              P+     ++ EA SL+  
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244
Query: 383 LLQKEASKRLGS 394
           +L     KR+ +
Sbjct: 245 MLTVNPKKRITA 256

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 76/250 (30%), Positives = 133/250 (53%), Gaps = 8/250 (3%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQH 87
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 270 GIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HR+LKPEN+LL +      V L DFGLA + +++   +   GT  Y+SPE++    +
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FLSSEAHSLLKG 382
            K  D W+ G++L+ +L G PPF   ++              P+     ++ EA SL+  
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267
Query: 383 LLQKEASKRL 392
           +L     KR+
Sbjct: 268 MLTVNPKKRI 277

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 81/253 (32%), Positives = 137/253 (54%), Gaps = 22/253 (8%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQ 214
           K +G+G+F+   +     +++ +A+K++ K   ME N     + E   L   + HP IV+
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEAN----TQKEITALKLCEGHPNIVK 70
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   F  +   +LV++ +NGG LF ++ ++  F E  A     ++VSAVSH+H  G++HR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 275 DLKPENILLDADG---HVMLTDFGLAK-QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPEN+L   +     + + DFG A+ +  +N    + C TL Y +PE++   G+D++ 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESC 190
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AF-------LSSEAHSL 379
           D WS+G++L+ ML+GQ PF   +R             +     +F       +S EA  L
Sbjct: 191 DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250
Query: 380 LKGLLQKEASKRL 392
           ++GLL  + +KRL
Sbjct: 251 IQGLLTVDPNKRL 263

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 82/266 (30%), Positives = 140/266 (52%), Gaps = 18/266 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G G F     +R   ++E+ A+K + + + +++N    + + R++     HP 
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL----RHPN 75
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +V+++ +GG LF ++   G F ED AR +  +++S VS+ HA  +
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 135
Query: 272 MHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-K 328
            HRDLK EN LLD      + + DFG +K    +++  S  GT  Y++PE++L K +D K
Sbjct: 136 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 195
Query: 329 AADWWSVGILLFEMLTGQPPFTG----GNRXXXXXXXXXXXXXLPAF--LSSEAHSLLKG 382
            AD WS G+ L+ ML G  PF       N              +P +  +S E   L+  
Sbjct: 196 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 255
Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWF 408
           +   + +KR+ S P    EI++H+WF
Sbjct: 256 IFVADPAKRI-SIP----EIRNHEWF 276

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 134/261 (51%), Gaps = 7/261 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +++++K +G+G+F KV       T +  A+K++ K  + + +    ++ E + L  + HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++L    ++K  + +V+++  G  LF  + ++    E  AR +  +I+SAV + H + 
Sbjct: 75  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 133
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKA 329
           I+HRDLKPEN+LLD   +V + DFGL+    +     + CG+  Y +PE++ GK +    
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 193
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEAS 389
            D WS G++L+ ML  + PF   +              LP FLS  A  L+K +L     
Sbjct: 194 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPL 253
Query: 390 KRLGSGPGGSQEIKSHKWFKM 410
            R+        EI    WFK+
Sbjct: 254 NRI-----SIHEIMQDDWFKV 269

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 134/261 (51%), Gaps = 7/261 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +++++K +G+G+F KV       T +  A+K++ K  + + +    ++ E + L  + HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++L    ++K  + +V+++  G  LF  + ++    E  AR +  +I+SAV + H + 
Sbjct: 74  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 132
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKA 329
           I+HRDLKPEN+LLD   +V + DFGL+    +     + CG+  Y +PE++ GK +    
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 192
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEAS 389
            D WS G++L+ ML  + PF   +              LP FLS  A  L+K +L     
Sbjct: 193 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPL 252
Query: 390 KRLGSGPGGSQEIKSHKWFKM 410
            R+        EI    WFK+
Sbjct: 253 NRI-----SIHEIMQDDWFKV 268

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 134/261 (51%), Gaps = 7/261 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +++++K +G+G+F KV       T +  A+K++ K  + + +    ++ E + L  + HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++L    ++K  + +V+++  G  LF  + ++    E  AR +  +I+SAV + H + 
Sbjct: 65  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 123
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKA 329
           I+HRDLKPEN+LLD   +V + DFGL+    +     + CG+  Y +PE++ GK +    
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 183
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEAS 389
            D WS G++L+ ML  + PF   +              LP FLS  A  L+K +L     
Sbjct: 184 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPL 243
Query: 390 KRLGSGPGGSQEIKSHKWFKM 410
            R+        EI    WFK+
Sbjct: 244 NRI-----SIHEIMQDDWFKV 259

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 134/261 (51%), Gaps = 7/261 (2%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +++++K +G+G+F KV       T +  A+K++ K  + + +    ++ E + L  + HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I++L    ++K  + +V+++  G  LF  + ++    E  AR +  +I+SAV + H + 
Sbjct: 69  HIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 127
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKA 329
           I+HRDLKPEN+LLD   +V + DFGL+    +     + CG+  Y +PE++ GK +    
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 187
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEAS 389
            D WS G++L+ ML  + PF   +              LP FLS  A  L+K +L     
Sbjct: 188 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPL 247
Query: 390 KRLGSGPGGSQEIKSHKWFKM 410
            R+        EI    WFK+
Sbjct: 248 NRI-----SIHEIMQDDWFKV 263

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 144/281 (51%), Gaps = 26/281 (9%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK-----------DKIMEKNHAE 195
           +G   F+V K+ G GA+ +V   +        A+KV++K           +K +EK H E
Sbjct: 34  IGESYFKVRKL-GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
            + +E ++L  +DHP I++L   F+ K   YLV +F  GG LF Q+  +  F E  A   
Sbjct: 93  -IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDFGLAKQFDENTRSNSMCGT 312
             +I+S + +LH + I+HRD+KPENILL+      ++ + DFGL+  F ++ +     GT
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGT 211
Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP--- 369
             Y++PE VL K +++  D WS G++++ +L G PPF G N                   
Sbjct: 212 AYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270
Query: 370 -AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
              +S EA  L+K +L  + +KR       ++E  + +W K
Sbjct: 271 WKNISDEAKELIKLMLTYDYNKRC-----TAEEALNSRWIK 306

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  126 bits (316), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 76/226 (33%), Positives = 119/226 (52%), Gaps = 18/226 (7%)
Query: 140 LPSENQCVGL-EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--------RKDKIME 190
           LP  +   G  E++E  +++G+G  + V +     T + YA+K++          +++ E
Sbjct: 6   LPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQE 65
Query: 191 KNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE 249
              A     E +IL KV  HP I+QL+ +++T    +LV D +  G LF  L  +    E
Sbjct: 66  LREATL--KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM 309
              R     ++  +  LH   I+HRDLKPENILLD D ++ LTDFG + Q D   +  S+
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSV 183
Query: 310 CGTLEYMSPEIVLGK------GHDKAADWWSVGILLFEMLTGQPPF 349
           CGT  Y++PEI+         G+ K  D WS G++++ +L G PPF
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 82/266 (30%), Positives = 138/266 (51%), Gaps = 18/266 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G G F     +R   ++E+ A+K + + + +  N    + + R++     HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSL----RHPN 76
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +V+++ +GG LF ++   G F ED AR +  +++S VS+ HA  +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 272 MHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-K 328
            HRDLK EN LLD      + + DFG +K    +++  S  GT  Y++PE++L K +D K
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 329 AADWWSVGILLFEMLTGQPPFTG----GNRXXXXXXXXXXXXXLPAF--LSSEAHSLLKG 382
            AD WS G+ L+ ML G  PF       N              +P +  +S E   L+  
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWF 408
           +   + +KR+ S P    EI++H+WF
Sbjct: 257 IFVADPAKRI-SIP----EIRNHEWF 277

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 82/266 (30%), Positives = 139/266 (52%), Gaps = 18/266 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G G F     +R    +E+ A+K + + + +++N    + + R++     HP 
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSL----RHPN 76
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +V+++ +GG LF ++   G F ED AR +  +++S VS+ HA  +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQV 136
Query: 272 MHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-K 328
            HRDLK EN LLD      + + DFG +K    +++  S  GT  Y++PE++L K +D K
Sbjct: 137 AHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGK 196
Query: 329 AADWWSVGILLFEMLTGQPPFTG----GNRXXXXXXXXXXXXXLPAF--LSSEAHSLLKG 382
            AD WS G+ L+ ML G  PF       N              +P +  +S E   L+  
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWF 408
           +   + +KR+ S P    EI++H+WF
Sbjct: 257 IFVADPAKRI-SIP----EIRNHEWF 277

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  124 bits (312), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 133/262 (50%), Gaps = 11/262 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDH 209
           + + + +G+G+F KV       T +  A+K + +   + K    +M+ ER I  L  + H
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQ--LLKKSDMHMRVEREISYLKLLRH 68
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L     T   + +V+++  GG LF  +  +    ED  R +  +I+ A+ + H +
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DK 328
            I+HRDLKPEN+LLD + +V + DFGL+    +     + CG+  Y +PE++ GK +   
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEA 388
             D WS GI+L+ ML G+ PF                  +P FLS  A SL++ ++  + 
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADP 247
Query: 389 SKRLGSGPGGSQEIKSHKWFKM 410
            +R+       QEI+   WF +
Sbjct: 248 MQRI-----TIQEIRRDPWFNV 264

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 131/263 (49%), Gaps = 9/263 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +++ + +G+GAF+ V +  ++   + YA K++   K+  ++H + ++ E  I   + HP 
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQK-LEREARICRLLKHPN 82
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+L  S   +   YL+ D V GG LF  +  +  + E  A     +I+ AV H H  G+
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 272 MHRDLKPENILLDAD---GHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHD 327
           +HRDLKPEN+LL +      V L DFGLA + + E        GT  Y+SPE++    + 
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYG 202
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FLSSEAHSLLKGL 383
           K  D W+ G++L+ +L G PPF   ++              P+     ++ EA  L+  +
Sbjct: 203 KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKM 262
Query: 384 LQKEASKRLGSGPGGSQEIKSHK 406
           L    SKR+ +         SH+
Sbjct: 263 LTINPSKRITAAEALKHPWISHR 285

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 75/226 (33%), Positives = 118/226 (52%), Gaps = 18/226 (7%)
Query: 140 LPSENQCVGL-EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--------RKDKIME 190
           LP  +   G  E++E  +++G+G  + V +     T + YA+K++          +++ E
Sbjct: 6   LPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQE 65
Query: 191 KNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE 249
              A     E +IL KV  HP I+QL+ +++T    +LV D +  G LF  L  +    E
Sbjct: 66  LREATL--KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM 309
              R     ++  +  LH   I+HRDLKPENILLD D ++ LTDFG + Q D   +   +
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 183
Query: 310 CGTLEYMSPEIVLGK------GHDKAADWWSVGILLFEMLTGQPPF 349
           CGT  Y++PEI+         G+ K  D WS G++++ +L G PPF
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 139/266 (52%), Gaps = 18/266 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G G F     +R   ++E+ A+K + + + +++N    + + R++     HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL----RHPN 76
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +V+++ +GG LF ++   G F ED AR +  +++S VS+ HA  +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 272 MHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-K 328
            HRDLK EN LLD      + +  FG +K    +++  S  GT  Y++PE++L K +D K
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 329 AADWWSVGILLFEMLTGQPPFTG----GNRXXXXXXXXXXXXXLPAF--LSSEAHSLLKG 382
            AD WS G+ L+ ML G  PF       N              +P +  +S E   L+  
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWF 408
           +   + +KR+ S P    EI++H+WF
Sbjct: 257 IFVADPAKRI-SIP----EIRNHEWF 277

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 114/215 (53%), Gaps = 17/215 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM--------RKDKIMEKNHAEYMKSER 201
           E++E  +++G+G  + V +     T + YA+K++          +++ E   A     E 
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATL--KEV 61
Query: 202 NILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           +IL KV  HP I+QL+ +++T    +LV D +  G LF  L  +    E   R     ++
Sbjct: 62  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 121
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
             +  LH   I+HRDLKPENILLD D ++ LTDFG + Q D   +   +CGT  Y++PEI
Sbjct: 122 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 181
Query: 321 VLGK------GHDKAADWWSVGILLFEMLTGQPPF 349
           +         G+ K  D WS G++++ +L G PPF
Sbjct: 182 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 150/297 (50%), Gaps = 19/297 (6%)
Query: 139 NLPSEN---QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA- 194
           +L +EN   Q +  + +E+ + +G G FA V + R+ GT + YA K ++K ++       
Sbjct: 12  DLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGV 71
Query: 195 --EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLA 252
             E ++ E NIL ++ HP I+ L   F+ K  + L+L+ V+GG LF  L  +    ED A
Sbjct: 72  SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA 131
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENI-LLDA---DGHVMLTDFGLAKQFDENTRSNS 308
             +  +I+  V +LH+  I H DLKPENI LLD    +  + L DFG+A + +      +
Sbjct: 132 TQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 191
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXL 368
           + GT E+++PEIV  +     AD WS+G++ + +L+G  PF G  +              
Sbjct: 192 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF 251
Query: 369 P----AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARET 421
                +  S  A   ++ LL K+  +R+      +Q ++ H W K I  + +   ++
Sbjct: 252 DEEYFSNTSELAKDFIRRLLVKDPKRRMXI----AQSLE-HSWIKAIRRRNVRGEDS 303

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 142/281 (50%), Gaps = 16/281 (5%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVD 208
           +E+ + +G G FA V + R+ GT + YA K ++K ++         E ++ E NIL ++ 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+ L   F+ K  + L+L+ V+GG LF  L  +    ED A  +  +I+  V +LH+
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 269 NGIMHRDLKPENI-LLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK 324
             I H DLKPENI LLD    +  + L DFG+A + +      ++ GT E+++PEIV  +
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLL 380
                AD WS+G++ + +L+G  PF G  +                   +  S  A   +
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 246
Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARET 421
           + LL K+  +R+      +Q ++ H W K I  + +   ++
Sbjct: 247 RRLLVKDPKRRMTI----AQSLE-HSWIKAIRRRNVRGEDS 282

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/266 (30%), Positives = 138/266 (51%), Gaps = 18/266 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E++K +G G F     +R   ++E+ A+K + + + +++N    + + R++     HP 
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL----RHPN 76
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +V+++ +GG LF ++   G F ED AR +  +++S VS+ HA  +
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 272 MHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-K 328
            HRDLK EN LLD      + +  FG +K    +++     GT  Y++PE++L K +D K
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGK 196
Query: 329 AADWWSVGILLFEMLTGQPPFTG----GNRXXXXXXXXXXXXXLPAF--LSSEAHSLLKG 382
            AD WS G+ L+ ML G  PF       N              +P +  +S E   L+  
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWF 408
           +   + +KR+ S P    EI++H+WF
Sbjct: 257 IFVADPAKRI-SIP----EIRNHEWF 277

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 132/265 (49%), Gaps = 9/265 (3%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E++++ + +G+GAF+ V +  ++   + YA  ++   K+  ++H + ++ E  I   + H
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKH 69
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S   +   YL+ D V GG LF  +  +  + E  A     +I+ AV H H  
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 270 GIMHRDLKPENILLDAD---GHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKG 325
           G++HR+LKPEN+LL +      V L DFGLA + + E        GT  Y+SPE++    
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FLSSEAHSLLK 381
           + K  D W+ G++L+ +L G PPF   ++              P+     ++ EA  L+ 
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249
Query: 382 GLLQKEASKRLGSGPGGSQEIKSHK 406
            +L    SKR+ +         SH+
Sbjct: 250 KMLTINPSKRITAAEALKHPWISHR 274

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 80/266 (30%), Positives = 137/266 (51%), Gaps = 14/266 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D+++ + +G+GAF+ V +  +   ++ YA K++   K+  ++H + ++ E  I   + H
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQK-LEREARICRLLKH 89
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S   +   YLV D V GG LF  +  +  + E  A     +I+ +V+H+H +
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH 149
Query: 270 GIMHRDLKPENILLDAD---GHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKG 325
            I+HRDLKPEN+LL +      V L DFGLA +   E        GT  Y+SPE++    
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDP 209
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FLSSEAHSLLK 381
           + K  D W+ G++L+ +L G PPF   ++              P+     ++ EA +L+ 
Sbjct: 210 YGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 269
Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKW 407
            +L    +KR+ +     Q +K H W
Sbjct: 270 QMLTINPAKRITA----DQALK-HPW 290

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 135/266 (50%), Gaps = 14/266 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +++++ + +G+GAF+ V +  ++ T   YA K++   K+  ++H + ++ E  I   + H
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQK-LEREARICRLLKH 62
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
             IV+L  S   +   YLV D V GG LF  +  +  + E  A     +I+ AV H H  
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 122
Query: 270 GIMHRDLKPENILLDAD---GHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVLGKG 325
           G++HRDLKPEN+LL +      V L DFGLA +   + ++     GT  Y+SPE++  + 
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEA 182
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA----FLSSEAHSLLK 381
           + K  D W+ G++L+ +L G PPF   ++              P+     ++ EA +L+ 
Sbjct: 183 YGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 242
Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKW 407
            +L    +KR+      + E   H W
Sbjct: 243 QMLTINPAKRI-----TAHEALKHPW 263

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 71/205 (34%), Positives = 108/205 (52%), Gaps = 12/205 (5%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVM-----RKDKIMEKNHAEYMKSERNILTKV-DHP 210
           V+G+G  + V +     T   +A+K+M     R      +   E  + E +IL +V  HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I+ L  S+++   ++LV D +  G LF  L  +    E   R     ++ AVS LHAN 
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN 220
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV------LGK 324
           I+HRDLKPENILLD +  + L+DFG +   +   +   +CGT  Y++PEI+         
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHP 280
Query: 325 GHDKAADWWSVGILLFEMLTGQPPF 349
           G+ K  D W+ G++LF +L G PPF
Sbjct: 281 GYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 141/283 (49%), Gaps = 17/283 (6%)
Query: 149 LEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNIL 204
           +EDF ++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            +V HP I+ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V+
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           +LH   I H DLKPENI LLD +    H+ L DFGLA + ++     ++ GT E+++PEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSE----A 376
           V  +     AD WS+G++ + +L+G  PF G  +                   S+    A
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEAR 419
              ++ LL KE  KRL       QE   H W   ++ ++   R
Sbjct: 250 KDFIRKLLVKETRKRL-----TIQEALRHPWITPVDTQQAMVR 287

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 138/277 (49%), Gaps = 29/277 (10%)
Query: 144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAE---YMKSE 200
           NQ   LE+      +G+G++ +V    + GT      ++ R  K + K   E     K E
Sbjct: 8   NQYYTLEN-----TIGRGSWGEVKIAVQKGT------RIRRAAKKIPKYFVEDVDRFKQE 56
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEI 259
             I+  +DHP I++L  +F+    +YLV++   GG LF ++  + +FRE D ARI   ++
Sbjct: 57  IEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDV 115
Query: 260 VSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
           +SAV++ H   + HRDLKPEN L      D  + L DFGLA +F       +  GT  Y+
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYV 175
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAF----L 372
           SP+++ G  +    D WS G++++ +L G PPF+                  P      +
Sbjct: 176 SPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNV 234
Query: 373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           S +A SL++ LL K   +R+      S +   H+WF+
Sbjct: 235 SPQAESLIRRLLTKSPKQRI-----TSLQALEHEWFE 266

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 86/277 (31%), Positives = 138/277 (49%), Gaps = 29/277 (10%)
Query: 144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAE---YMKSE 200
           NQ   LE+      +G+G++ +V    + GT      ++ R  K + K   E     K E
Sbjct: 25  NQYYTLEN-----TIGRGSWGEVKIAVQKGT------RIRRAAKKIPKYFVEDVDRFKQE 73
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYTAEI 259
             I+  +DHP I++L  +F+    +YLV++   GG LF ++  + +FRE D ARI   ++
Sbjct: 74  IEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDV 132
Query: 260 VSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
           +SAV++ H   + HRDLKPEN L      D  + L DFGLA +F       +  GT  Y+
Sbjct: 133 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYV 192
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAF----L 372
           SP+++ G  +    D WS G++++ +L G PPF+                  P      +
Sbjct: 193 SPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNV 251
Query: 373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           S +A SL++ LL K   +R+      S +   H+WF+
Sbjct: 252 SPQAESLIRRLLTKSPKQRI-----TSLQALEHEWFE 283

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 73/210 (34%), Positives = 118/210 (56%), Gaps = 7/210 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVD 208
           +E+ + +G G FA V + R+ GT + YA K ++K ++         E ++ E NIL ++ 
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+ L   F+ K  + L+L+ V+GG LF  L  +    ED A  +  +I+  V +LH+
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 269 NGIMHRDLKPENI-LLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK 324
             I H DLKPENI LLD    +  + L DFG+A + +      ++ GT E+++PEIV  +
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 193
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNR 354
                AD WS+G++ + +L+G  PF G  +
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGETK 223

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 139/271 (51%), Gaps = 18/271 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTKVDH 209
           +E+ +V+G+GAF+ V +     T + +A+K++   K         E +K E +I   + H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSH 265
           P IV+L  ++ +   LY+V +F++G  L F++ ++     ++ E +A  Y  +I+ A+ +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 266 LHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIV 321
            H N I+HRD+KPEN+LL   +    V L DFG+A Q  E+   +    GT  +M+PE+V
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP---AFLSSEAHS 378
             + + K  D W  G++LF +L+G  PF G                 P   + +S  A  
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKD 265
Query: 379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           L++ +L  + ++R+        E  +H W K
Sbjct: 266 LVRRMLMLDPAERI-----TVYEALNHPWLK 291

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/209 (37%), Positives = 117/209 (55%), Gaps = 15/209 (7%)
Query: 150 EDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           EDF E++  +G GAF KVY+ +   TS + A KV+  D   E+   +YM  E +IL   D
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSH 265
           HP IV+L  +F  +  L+++++F  GG +     +L R     E   ++   + + A+++
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNY 150
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVL-- 322
           LH N I+HRDLK  NIL   DG + L DFG+ AK      R +S  GT  +M+PE+V+  
Sbjct: 151 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCE 210
Query: 323 ---GKGHDKAADWWSVGILLFEMLTGQPP 348
               + +D  AD WS+GI L EM   +PP
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/209 (37%), Positives = 117/209 (55%), Gaps = 15/209 (7%)
Query: 150 EDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           EDF E++  +G GAF KVY+ +   TS + A KV+  D   E+   +YM  E +IL   D
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSH 265
           HP IV+L  +F  +  L+++++F  GG +     +L R     E   ++   + + A+++
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNY 150
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVL-- 322
           LH N I+HRDLK  NIL   DG + L DFG+ AK      R +S  GT  +M+PE+V+  
Sbjct: 151 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 210
Query: 323 ---GKGHDKAADWWSVGILLFEMLTGQPP 348
               + +D  AD WS+GI L EM   +PP
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 111/208 (53%), Gaps = 11/208 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +EV + +G G+++   +     T+  +A+K++ K K       E +      L    H
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEIL------LRYGQH 75
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I+ L+  +     +Y+V + + GG L  ++ RQ  F E  A      I   V +LHA 
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 270 GIMHRDLKPENIL-LDADGH---VMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGK 324
           G++HRDLKP NIL +D  G+   + + DFG AKQ   EN    + C T  +++PE++  +
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGG 352
           G+D A D WS+G+LL+ MLTG  PF  G
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTPFANG 223

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  118 bits (295), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 110/208 (52%), Gaps = 11/208 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + + V + +G G++++  +     T+  YA+KV+ K K       E +      L    H
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEIL------LRYGQH 80
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I+ L+  +     +YLV + + GG L  ++ RQ  F E  A      I   V +LH+ 
Sbjct: 81  PNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQ 140
Query: 270 GIMHRDLKPENIL-LDADGH---VMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGK 324
           G++HRDLKP NIL +D  G+   + + DFG AKQ   EN    + C T  +++PE++  +
Sbjct: 141 GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQ 200
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGG 352
           G+D+  D WS+GILL+ ML G  PF  G
Sbjct: 201 GYDEGCDIWSLGILLYTMLAGYTPFANG 228

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 114/207 (55%), Gaps = 13/207 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHP 210
           + V + +G G++++  +     T+  YA+KV+ K K   ++ +E    E  IL +   HP
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK---RDPSE----EIEILLRYGQHP 81
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I+ L+  +     +YLV + + GG L  ++ RQ  F E  A      I   V +LH+ G
Sbjct: 82  NIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG 141
Query: 271 IMHRDLKPENIL-LDADGH---VMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKG 325
           ++HRDLKP NIL +D  G+   + + DFG AKQ   EN    + C T  +++PE++  +G
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQG 201
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGG 352
           +D+  D WS+GILL+ ML G  PF  G
Sbjct: 202 YDEGCDIWSLGILLYTMLAGYTPFANG 228

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/209 (36%), Positives = 116/209 (55%), Gaps = 15/209 (7%)
Query: 150 EDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           EDF E++  +G GAF KVY+ +   TS + A KV+  D   E+   +YM  E +IL   D
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYM-VEIDILASCD 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSAVSH 265
           HP IV+L  +F  +  L+++++F  GG +     +L R     E   ++   + + A+++
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNY 150
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVL-- 322
           LH N I+HRDLK  NIL   DG + L DFG+ AK      R +   GT  +M+PE+V+  
Sbjct: 151 LHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCE 210
Query: 323 ---GKGHDKAADWWSVGILLFEMLTGQPP 348
               + +D  AD WS+GI L EM   +PP
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 142/286 (49%), Gaps = 18/286 (6%)
Query: 149 LEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNIL 204
           +EDF ++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            +V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           +LH   I H DLKPENI LLD +    H+ L DFGLA + ++     ++ GT E+++PEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSE----A 376
           V  +     AD WS+G++ + +L+G  PF G  +                   S+    A
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI-NWKKLEARET 421
              ++ LL KE  KRL       QE   H W   + N + +  RE+
Sbjct: 250 KDFIRKLLVKETRKRL-----TIQEALRHPWITPVDNQQAMVRRES 290

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 140/283 (49%), Gaps = 17/283 (6%)
Query: 149 LEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNIL 204
           +EDF ++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            +V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           +LH   I H DLKPENI LLD +    H+ L DFGLA + ++     ++ GT E+++PEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEA 376
           V  +     AD WS+G++ + +L+G  PF G  +                   +  S  A
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEAR 419
              ++ LL KE  KRL       QE   H W   ++ ++   R
Sbjct: 250 KDFIRKLLVKETRKRL-----TIQEALRHPWITPVDNQQAMVR 287

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 142/286 (49%), Gaps = 18/286 (6%)
Query: 149 LEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNIL 204
           +EDF ++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            +V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           +LH   I H DLKPENI LLD +    H+ L DFGLA + ++     ++ GT E+++PEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEA 376
           V  +     AD WS+G++ + +L+G  PF G  +                   +  S  A
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI-NWKKLEARET 421
              ++ LL KE  KRL       QE   H W   + N + +  RE+
Sbjct: 250 KDFIRKLLVKETRKRL-----TIQEALRHPWITPVDNQQAMVRRES 290

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 142/286 (49%), Gaps = 18/286 (6%)
Query: 149 LEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNIL 204
           +EDF ++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            +V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           +LH   I H DLKPENI LLD +    H+ L DFGLA + ++     ++ GT E+++PEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSE----A 376
           V  +     AD WS+G++ + +L+G  PF G  +                   S+    A
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI-NWKKLEARET 421
              ++ LL KE  KRL       QE   H W   + N + +  RE+
Sbjct: 250 KDFIRKLLVKETRKRL-----TIQEALRHPWITPVDNQQAMVRRES 290

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +EV + +G G+++   +     T+  +A+K++ K K       E +      L    HP 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEIL------LRYGQHPN 77
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           I+ L+  +     +Y+V +   GG L  ++ RQ  F E  A      I   V +LHA G+
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 272 MHRDLKPENIL-LDADGH---VMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGH 326
           +HRDLKP NIL +D  G+   + + DFG AKQ   EN    + C T  +++PE++  +G+
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGY 197
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGG 352
           D A D WS+G+LL+  LTG  PF  G
Sbjct: 198 DAACDIWSLGVLLYTXLTGYTPFANG 223

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 142/286 (49%), Gaps = 18/286 (6%)
Query: 149 LEDF-EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNIL 204
           +EDF ++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            +V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 265 HLHANGIMHRDLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           +LH   I H DLKPENI LLD +    H+ L DFGLA + ++     ++ GT E+++PEI
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEA 376
           V  +     AD WS+G++ + +L+G  PF G  +                   +  S  A
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI-NWKKLEARET 421
              ++ LL KE  KRL       QE   H W   + N + +  RE+
Sbjct: 250 KDFIRKLLVKETRKRL-----TIQEALRHPWITPVDNQQAMVRRES 290

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  116 bits (291), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 134/266 (50%), Gaps = 18/266 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           ++ +K +G G F     +R   T E+ A+K + +   +++N    + + R++     HP 
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL----RHPN 77
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV+ +    T   L +++++ +GG L+ ++   G F ED AR +  +++S VS+ H+  I
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 272 MHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD-K 328
            HRDLK EN LLD      + + DFG +K    +++  S  GT  Y++PE++L + +D K
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197
Query: 329 AADWWSVGILLFEMLTGQPPFTG----GNRXXXXXXXXXXXXXLP--AFLSSEAHSLLKG 382
            AD WS G+ L+ ML G  PF       +              +P    +S E   L+  
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISR 257
Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWF 408
           +   + + R+ S P    EIK+H WF
Sbjct: 258 IFVADPATRI-SIP----EIKTHSWF 278

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 133/260 (51%), Gaps = 15/260 (5%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +++G G F +V++     T    A K+++   + +K   E +K+E +++ ++DH  ++QL
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHANLIQL 151
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-YTAEIVSAVSHLHANGIMHR 274
             +F++K  + LV+++V+GG LF ++  +     +L  I +  +I   + H+H   I+H 
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 275 DLKPENIL-LDADG-HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADW 332
           DLKPENIL ++ D   + + DFGLA+++    +     GT E+++PE+V         D 
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271
Query: 333 WSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQKEA 388
           WSVG++ + +L+G  PF G N              L       +S EA   +  LL KE 
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 389 SKRLGSGPGGSQEIKSHKWF 408
           S R+ +      E   H W 
Sbjct: 332 SWRISAS-----EALKHPWL 346

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  116 bits (290), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 136/265 (51%), Gaps = 24/265 (9%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G GAF  V+ V    +     +K + KD+   +   E +++E  +L  +DHP I+++  
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI----VSAVSHLHANGIMH 273
            F+  + +Y+V++   GG L  ++       + L+  Y AE+    ++A+++ H+  ++H
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 274 RDLKPENILL-DADGH--VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           +DLKPENIL  D   H  + + DFGLA+ F  +  S +  GT  YM+PE V  +      
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE-VFKRDVTFKC 206
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAF------LSSEAHSLLKGLL 384
           D WS G++++ +LTG  PFTG +               P +      L+ +A  LLK +L
Sbjct: 207 DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE---PNYAVECRPLTPQAVDLLKQML 263
Query: 385 QKEASKRLGSGPGGSQEIKSHKWFK 409
            K+  +R    P  +Q +  H+WFK
Sbjct: 264 TKDPERR----PSAAQ-VLHHEWFK 283

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 127/257 (49%), Gaps = 13/257 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ + M GT  +M+PE+V  K +    D WS+G
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXX---XXXLPAFLSSEAHSLLKGLLQKEASKRLG 393
           I+  EM+ G+PP+   N                  P  LS+     L   L+ +  KR  
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR-- 261
Query: 394 SGPGGSQEIKSHKWFKM 410
              G ++E+  H++ K+
Sbjct: 262 ---GSAKELLQHQFLKI 275

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 127/257 (49%), Gaps = 13/257 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +    D WS+G
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXX---XXXLPAFLSSEAHSLLKGLLQKEASKRLG 393
           I+  EM+ G+PP+   N                  P  LS+     L   L  +  KR  
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR-- 261
Query: 394 SGPGGSQEIKSHKWFKM 410
              G ++E+  H++ K+
Sbjct: 262 ---GSAKELLQHQFLKI 275

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 131/265 (49%), Gaps = 15/265 (5%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +++L+ +G GAF  V++     T  ++  K +     ++K     +K+E +I+ ++ HP 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPK 109
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-YTAEIVSAVSHLHANG 270
           ++ L  +F+ KY + L+L+F++GG LF ++  +     +   I Y  +    + H+H + 
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 271 IMHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           I+H D+KPENI+ +      V + DFGLA + + +        T E+ +PEIV  +    
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 229
Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXL--PAF--LSSEAHSLLKGLL 384
             D W++G+L + +L+G  PF G +                  AF  +S EA   +K LL
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 289
Query: 385 QKEASKRLGSGPGGSQEIKSHKWFK 409
           QKE  KRL        +   H W K
Sbjct: 290 QKEPRKRL-----TVHDALEHPWLK 309

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 127/257 (49%), Gaps = 13/257 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 144
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ + M GT  +M+PE+V  K +    D WS+G
Sbjct: 145 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLG 204
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXX---XXXLPAFLSSEAHSLLKGLLQKEASKRLG 393
           I+  EM+ G+PP+   N                  P  LS+     L   L+ +  KR  
Sbjct: 205 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR-- 262
Query: 394 SGPGGSQEIKSHKWFKM 410
              G ++E+  H++ K+
Sbjct: 263 ---GSAKELIQHQFLKI 276

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + ++    E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + ++    E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 126/257 (49%), Gaps = 13/257 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HRD+K
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRDIK 143
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ + M GT  +M+PE+V  K +    D WS+G
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXX---XXXLPAFLSSEAHSLLKGLLQKEASKRLG 393
           I+  EM+ G+PP+   N                  P  LS+     L   L  +  KR  
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR-- 261
Query: 394 SGPGGSQEIKSHKWFKM 410
              G ++E+  H++ K+
Sbjct: 262 ---GSAKELLQHQFLKI 275

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 118/209 (56%), Gaps = 7/209 (3%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKV 207
           L +F + K +G+G F++VY+   +      A+K ++   +M+ K  A+ +K E ++L ++
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQL 89
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAV 263
           +HP +++   SF     L +VL+  + G L   +     ++ L  E     Y  ++ SA+
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVL 322
            H+H+  +MHRD+KP N+ + A G V L D GL + F  + T ++S+ GT  YMSPE + 
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTG 351
             G++  +D WS+G LL+EM   Q PF G
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYG 238

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  114 bits (286), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 128/257 (49%), Gaps = 13/257 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +P IV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++++ GG L   +    +    +A +   E + A+  LH+N ++HR++K
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSNQVIHRNIK 144
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +NILL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +    D WS+G
Sbjct: 145 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 204
Query: 337 ILLFEMLTGQPPFTGGNRXXXXXXXXXX---XXXLPAFLSSEAHSLLKGLLQKEASKRLG 393
           I+  EM+ G+PP+   N                  P  LS+     L   L+ +  KR  
Sbjct: 205 IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR-- 262
Query: 394 SGPGGSQEIKSHKWFKM 410
              G ++E+  H++ K+
Sbjct: 263 ---GSAKELIQHQFLKI 276

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  114 bits (286), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 120/207 (57%), Gaps = 4/207 (1%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           G+E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L ++
Sbjct: 1   GMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           +HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-K 324
           H++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTG 351
            +  A D WS+G +  EM+T +  F G
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINAMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 116/208 (55%), Gaps = 8/208 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG 323
            NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++ GT +Y+SPE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              D  +D +S+G +L+E+LTG+PPFTG
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 116/208 (55%), Gaps = 8/208 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG 323
            NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++ GT +Y+SPE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              D  +D +S+G +L+E+LTG+PPFTG
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 116/208 (55%), Gaps = 8/208 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG 323
            NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++ GT +Y+SPE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              D  +D +S+G +L+E+LTG+PPFTG
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQK 386
           D WS+G++ + +L+G  PF G  +                   +  S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
           +  KR+       Q+   H W K
Sbjct: 259 DPKKRM-----TIQDSLQHPWIK 276

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 116/208 (55%), Gaps = 8/208 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG 323
            NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++ GT +Y+SPE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              D  +D +S+G +L+E+LTG+PPFTG
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 121/210 (57%), Gaps = 4/210 (1%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKE 62
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           ++HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++ 
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG- 323
            H++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG 
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 182
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           K +  A D WS+G +  EM+T +  F G +
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRRALFPGDS 212

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 120/208 (57%), Gaps = 4/208 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  +S  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +  A D WS+G +  EM+T +  F G +
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQK 386
           D WS+G++ + +L+G  PF G  +                   +  S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
           +  KR+       Q+   H W K
Sbjct: 259 DPKKRM-----TIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 197
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQK 386
           D WS+G++ + +L+G  PF G  +                   +  S+ A   ++ LL K
Sbjct: 198 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 257
Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
           +  KR+       Q+   H W K
Sbjct: 258 DPKKRM-----TIQDSLQHPWIK 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQK 386
           D WS+G++ + +L+G  PF G  +                   +  S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
           +  KR+       Q+   H W K
Sbjct: 259 DPKKRM-----TIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQK 386
           D WS+G++ + +L+G  PF G  +                   +  S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
           +  KR+       Q+   H W K
Sbjct: 259 DPKKRM-----TIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQK 386
           D WS+G++ + +L+G  PF G  +                   +  S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
           +  KR+       Q+   H W K
Sbjct: 259 DPKKRM-----TIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 137
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 197
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQK 386
           D WS+G++ + +L+G  PF G  +                   +  S+ A   ++ LL K
Sbjct: 198 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 257
Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
           +  KR+       Q+   H W K
Sbjct: 258 DPKKRM-----TIQDSLQHPWIK 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQK 386
           D WS+G++ + +L+G  PF G  +                   +  S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
           +  KR+       Q+   H W K
Sbjct: 259 DPKKRM-----TIQDSLQHPWIK 276

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKPEN+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 123 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKPEN+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 124 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQK 386
           D WS+G++ + +L+G  PF G  +                   +  S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
           +  KR+       Q+   H W K
Sbjct: 259 DPKKRM-----TIQDSLQHPWIK 276

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 115/208 (55%), Gaps = 8/208 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG 323
            NGI+HRD+KP NIL+ A   V + DFG+A+   ++     ++ ++ GT +Y+SPE   G
Sbjct: 134 QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              D  +D +S+G +L+E+LTG+PPFTG
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQK 386
           D WS+G++ + +L+G  PF G  +                   +  S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
           +  KR+       Q+   H W K
Sbjct: 259 DPKKRM-----TIQDSLQHPWIK 276

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKPEN+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKPEN+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 119/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 67
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 187
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQK 386
           D WS+G++ + +L+G  PF G  +                   +  S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
           +  KR+       Q+   H W K
Sbjct: 259 DPKKRM-----TIQDSLQHPWIK 276

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 135/271 (49%), Gaps = 18/271 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTKVDH 209
           +E+ +V+G+G F+ V +     T + +A+K++   K         E +K E +I   + H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSH 265
           P IV+L  ++ +   LY+V +F++G  L F++ ++     ++ E +A  Y  +I+ A+ +
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 266 LHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIV 321
            H N I+HRD+KP  +LL   +    V L  FG+A Q  E+   +    GT  +M+PE+V
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 207
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP---AFLSSEAHS 378
             + + K  D W  G++LF +L+G  PF G                 P   + +S  A  
Sbjct: 208 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKD 267
Query: 379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           L++ +L  + ++R+        E  +H W K
Sbjct: 268 LVRRMLMLDPAERI-----TVYEALNHPWLK 293

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQK 386
           D WS+G++ + +L+G  PF G  +                   +  S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
           +  KR+       Q+   H W K
Sbjct: 259 DPKKRM-----TIQDSLQHPWIK 276

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 116/205 (56%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA  +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 119/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 119/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 67
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKY 187
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPG 213

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 135/271 (49%), Gaps = 18/271 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTKVDH 209
           +E+ +V+G+G F+ V +     T + +A+K++   K         E +K E +I   + H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSH 265
           P IV+L  ++ +   LY+V +F++G  L F++ ++     ++ E +A  Y  +I+ A+ +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 266 LHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMSPEIV 321
            H N I+HRD+KP  +LL   +    V L  FG+A Q  E+   +    GT  +M+PE+V
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP---AFLSSEAHS 378
             + + K  D W  G++LF +L+G  PF G                 P   + +S  A  
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKD 265
Query: 379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           L++ +L  + ++R+        E  +H W K
Sbjct: 266 LVRRMLMLDPAERI-----TVYEALNHPWLK 291

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 116/208 (55%), Gaps = 8/208 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 90
Query: 212 IVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 91  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 150
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG 323
            NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++ GT +Y+SPE   G
Sbjct: 151 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 210
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              D  +D +S+G +L+E+LTG+PPFTG
Sbjct: 211 DSVDARSDVYSLGCVLYEVLTGEPPFTG 238

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 112
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 230
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 259

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 115/216 (53%), Gaps = 5/216 (2%)
Query: 135 GHIDNLPSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH 193
            H+    +++  V  E+ F  L  +G+G+F +VY+     T E+ A+K++  D    ++ 
Sbjct: 3   AHLRGFANQHSRVDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKII--DLEEAEDE 60
Query: 194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            E ++ E  +L++ D P+I +   S+    +L+++++++ GG     L + G   E    
Sbjct: 61  IEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSAL-DLLKPGPLEETYIA 119
Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGT 312
               EI+  + +LH+   +HRD+K  N+LL   G V L DFG+A Q  D   + N   GT
Sbjct: 120 TILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGT 179
Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPP 348
             +M+PE++    +D  AD WS+GI   E+  G+PP
Sbjct: 180 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 120/208 (57%), Gaps = 4/208 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +  A D WS+G +  EM+T +  F G +
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 120/208 (57%), Gaps = 4/208 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +  A D WS+G +  EM+T +  F G +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDS 207

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 86/312 (27%), Positives = 138/312 (44%), Gaps = 49/312 (15%)
Query: 135 GHIDNLPSENQCVGLEDFEVL--KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN 192
           G  D+LP +      ED   L  +++G+GA+AKV     +   + YA+K++ K     ++
Sbjct: 1   GSTDSLPGK-----FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRS 55
Query: 193 HAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLA 252
                +    +     +  I++L   F+   R YLV + + GG +   + +Q  F E  A
Sbjct: 56  RV--FREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREA 113
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRSNSM 309
                ++ +A+  LH  GI HRDLKPENIL ++      V + DF L      N     +
Sbjct: 114 SRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPI 173
Query: 310 --------CGTLEYMSPEIV-----LGKGHDKAADWWSVGILLFEMLTGQPPFTGG---- 352
                   CG+ EYM+PE+V         +DK  D WS+G++L+ ML+G PPF G     
Sbjct: 174 TTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGAD 233
Query: 353 -----------NRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQKEASKRLGSGPG 397
                       +              P    A +SSEA  L+  LL ++A +RL +   
Sbjct: 234 CGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAA-- 291
Query: 398 GSQEIKSHKWFK 409
              ++  H W +
Sbjct: 292 ---QVLQHPWVQ 300

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 116
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 174
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 175 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 234
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 235 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 263

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 110/213 (51%), Gaps = 19/213 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           FE++++VG G + +VY+ R + T ++ A+KVM     +  +  E +K E N+L K  H  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 81
Query: 212 IVQLRYSFQTKY-------RLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            +   Y    K        +L+LV++F   G +    +  +    +E+       EI+  
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIV 321
           +SHLH + ++HRD+K +N+LL  +  V L DFG++ Q D    R N+  GT  +M+PE++
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 322 L-----GKGHDKAADWWSVGILLFEMLTGQPPF 349
                    +D  +D WS+GI   EM  G PP 
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 119/209 (56%), Gaps = 4/209 (1%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           +HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-K 324
           H++ ++HRDLKPEN+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K
Sbjct: 120 HSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGN 353
            +  A D WS+G +  EM+T +  F G +
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 116/215 (53%), Gaps = 15/215 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EVL  +G G++ +  ++RR    +I   K +    + E    + + SE N+L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 210 PFIVQL--RYSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSA 262
           P IV+   R   +T   LY+V+++  GG L   +      RQ L  E + R+ T ++  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT-QLTLA 123
Query: 263 VSHLH-----ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTLEYM 316
           +   H      + ++HRDLKP N+ LD   +V L DFGLA+  + +T  + +  GT  YM
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           SPE +    +++ +D WS+G LL+E+    PPFT 
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 112
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 230
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 259

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 86/342 (25%), Positives = 151/342 (44%), Gaps = 35/342 (10%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ +++ + +G GAF  V++V    T   +A K +      +K   E ++ E   ++ + 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLR 212
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLH 267
           HP +V L  +F+    + ++ +F++GG LF ++  +     ED A  Y  ++   + H+H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 268 ANGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
            N  +H DLKPENI+        + L DFGL    D         GT E+ +PE+  GK 
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXL--PAF--LSSEAHSLLK 381
                D WSVG+L + +L+G  PF G N              +   AF  +S +    ++
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392
Query: 382 GLLQKEASKRL-------------GSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
            LL  + + R+             G+ PG   +I S ++ K+ +  K +  +  P  LP 
Sbjct: 393 KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKY-DAWPEPLPP 451
Query: 429 VAGKHCVANFEECWTNMP--------LLDSPVASPKFNENPF 462
           +     ++N+     + P          D   A P+F   P+
Sbjct: 452 LGR---ISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPY 490

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 81/246 (32%), Positives = 127/246 (51%), Gaps = 29/246 (11%)
Query: 119 GPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY 178
           G  +LS V   +  P G   + P E   V   D    KV+G G+F  VYQ +   + E+ 
Sbjct: 1   GAMSLSKVTTVVATP-GQGPDRPQE---VSYTD---TKVIGNGSFGVVYQAKLCDSGELV 53
Query: 179 AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF------QTKYRLYLVLDFV 232
           A+K + +DK        +   E  I+ K+DH  IV+LRY F      + +  L LVLD+V
Sbjct: 54  AIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 106
Query: 233 NGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG 287
                 +++ R     ++ L     ++Y  ++  +++++H+ GI HRD+KP+N+LLD D 
Sbjct: 107 --PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT 164
Query: 288 HVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTG 345
            V+ L DFG AKQ      + S   +  Y +PE++ G   +  + D WS G +L E+L G
Sbjct: 165 AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 224
Query: 346 QPPFTG 351
           QP F G
Sbjct: 225 QPIFPG 230

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 114
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 172
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 173 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 232
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 233 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 261

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 120/208 (57%), Gaps = 4/208 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKY 180
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +  A D WS+G +  EM+T +  F G +
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 106
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 165 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 224
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 225 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 253

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 157
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 215
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 216 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 275
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 276 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 304

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 116/215 (53%), Gaps = 15/215 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EVL  +G G++ +  ++RR    +I   K +    + E    + + SE N+L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 210 PFIVQL--RYSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSA 262
           P IV+   R   +T   LY+V+++  GG L   +      RQ L  E + R+ T ++  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT-QLTLA 123
Query: 263 VSHLH-----ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTLEYM 316
           +   H      + ++HRDLKP N+ LD   +V L DFGLA+  + +T  + +  GT  YM
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 183
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           SPE +    +++ +D WS+G LL+E+    PPFT 
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 64
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 125 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 184
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPG 210

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 90
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 149 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 208
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 237

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 90
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 149 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 208
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 237

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 45  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 97
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 156 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 215
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 216 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 244

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 119/209 (56%), Gaps = 4/209 (1%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           +HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-K 324
           H++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGN 353
            +  A D WS+G +  EM+T +  F G +
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/342 (25%), Positives = 151/342 (44%), Gaps = 35/342 (10%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ +++ + +G GAF  V++V    T   +A K +      +K   E ++ E   ++ + 
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLR 106
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLH 267
           HP +V L  +F+    + ++ +F++GG LF ++  +     ED A  Y  ++   + H+H
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 268 ANGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
            N  +H DLKPENI+        + L DFGL    D         GT E+ +PE+  GK 
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 226
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXL--PAF--LSSEAHSLLK 381
                D WSVG+L + +L+G  PF G N              +   AF  +S +    ++
Sbjct: 227 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 286
Query: 382 GLLQKEASKRL-------------GSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
            LL  + + R+             G+ PG   +I S ++ K+ +  K +  +  P  LP 
Sbjct: 287 KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKY-DAWPEPLPP 345
Query: 429 VAGKHCVANFEECWTNMP--------LLDSPVASPKFNENPF 462
           +     ++N+     + P          D   A P+F   P+
Sbjct: 346 LGR---ISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPY 384

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 86
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 145 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 204
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 205 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 233

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 119/208 (57%), Gaps = 4/208 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +  A D WS+G +  EM+T +  F G +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDS 207

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 119/209 (56%), Gaps = 4/209 (1%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           +HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-K 324
           H++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGN 353
            +  A D WS+G +  EM+T +  F G +
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 39  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 91
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 150 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 209
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 210 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 238

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 119/207 (57%), Gaps = 4/207 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNH 60
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H+
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGH 326
           + ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
             A D WS+G +  EM+T +  F G +
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDS 207

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 61
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 119/209 (56%), Gaps = 4/209 (1%)
Query: 148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 59
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           +HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-K 324
           H++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGN 353
            +  A D WS+G +  EM+T +  F G +
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 79
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 138 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 197
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 198 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 226

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 114/208 (54%), Gaps = 10/208 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK-IMEKNHAEYMKS-ERNI--LT 205
           E ++++  +G G  + VY    +    I  +KV  K   I  +   E +K  ER +   +
Sbjct: 11  ERYKIVDKLGGGGMSTVY----LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           ++ H  IV +    +     YLV++++ G  L   +   G    D A  +T +I+  + H
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLG 323
            H   I+HRD+KP+NIL+D++  + + DFG+AK   E   T++N + GT++Y SPE   G
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           +  D+  D +S+GI+L+EML G+PPF G
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNG 214

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 82
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 141 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 200
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 201 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 229

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 110/200 (55%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 23  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 80
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
            ++ +   S+    +L+++++++ GG     L R G F E        EI+  + +LH+ 
Sbjct: 81  SYVTKYYGSYLKGSKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSE 139
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+  GT  +M+PE++    +D 
Sbjct: 140 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 199
Query: 329 AADWWSVGILLFEMLTGQPP 348
            AD WS+GI   E+  G+PP
Sbjct: 200 KADIWSLGITAIELAKGEPP 219

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 119/208 (57%), Gaps = 4/208 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +  A D WS+G +  EM+T +  F G +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDS 207

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 114/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 119/208 (57%), Gaps = 4/208 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV + V+     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +  A D WS+G +  EM+T +  F G +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDS 207

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 119/208 (57%), Gaps = 4/208 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +  A D WS+G +  EM+T +  F G +
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDS 211

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 113/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + +DK        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSFQTK------YRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F +         L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 118/206 (57%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 115/203 (56%), Gaps = 9/203 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F+VL+ +G+G++  VY+     T +I A+K +     +E +  E +K E +I+ + D 
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIK-EISIMQQCDS 83
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P +V+   S+     L++V+++   G +    +L  + L  +++A I  + +   + +LH
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL-KGLEYLH 142
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGH 326
               +HRD+K  NILL+ +GH  L DFG+A Q  D   + N + GT  +M+PE++   G+
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 327 DKAADWWSVGILLFEMLTGQPPF 349
           +  AD WS+GI   EM  G+PP+
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPY 225

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 127/263 (48%), Gaps = 16/263 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT  +++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQK 386
           D WS+G++ + +L+G  PF G  +                   +  S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
           +  KR+       Q+   H W K
Sbjct: 259 DPKKRM-----TIQDSLQHPWIK 276

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 117/208 (56%), Gaps = 14/208 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E +E++  +G GAF KVY+ +   T  + A KV+      E+   +Y+  E  IL   DH
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYI-VEIEILATCDH 67
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P+IV+L  ++    +L+++++F  GG    +  +L R GL  E   ++   +++ A++ L
Sbjct: 68  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-GL-TEPQIQVVCRQMLEALNFL 125
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  I+HRDLK  N+L+  +G + L DFG+ AK      + +S  GT  +M+PE+V+ + 
Sbjct: 126 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 185
Query: 326 -----HDKAADWWSVGILLFEMLTGQPP 348
                +D  AD WS+GI L EM   +PP
Sbjct: 186 MKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 117/206 (56%), Gaps = 4/206 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV + V+     F            L + Y  +++  ++  H
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+      TL Y +PEI+LG K 
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +  A D WS+G +  EM+T +  F G
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 119/208 (57%), Gaps = 4/208 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+  +R D   E   +  ++ E ++L +++
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN 60
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +  A D WS+G +  EM+T +  F G +
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDS 208

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 119/208 (57%), Gaps = 4/208 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+  +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELN 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KG 325
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R+ +    TL Y +PEI+LG K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +  A D WS+G +  EM+T +  F G +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDS 207

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 109/200 (54%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 84
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 85  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 143
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+  GT  +M+PE++    +D 
Sbjct: 144 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 203
Query: 329 AADWWSVGILLFEMLTGQPP 348
            AD WS+GI   E+  G+PP
Sbjct: 204 KADIWSLGITAIELARGEPP 223

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/208 (33%), Positives = 117/208 (56%), Gaps = 14/208 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E +E++  +G GAF KVY+ +   T  + A KV+      E+   +Y+  E  IL   DH
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYI-VEIEILATCDH 75
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P+IV+L  ++    +L+++++F  GG    +  +L R GL  E   ++   +++ A++ L
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-GL-TEPQIQVVCRQMLEALNFL 133
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGL-AKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  I+HRDLK  N+L+  +G + L DFG+ AK      + +S  GT  +M+PE+V+ + 
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 326 -----HDKAADWWSVGILLFEMLTGQPP 348
                +D  AD WS+GI L EM   +PP
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 109/200 (54%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 64
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+  GT  +M+PE++    +D 
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 183
Query: 329 AADWWSVGILLFEMLTGQPP 348
            AD WS+GI   E+  G+PP
Sbjct: 184 KADIWSLGITAIELARGEPP 203

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 127/263 (48%), Gaps = 16/263 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKVDHPFIVQ 214
           +G G FA V + R   T   YA K ++K +          E ++ E +IL ++ HP ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   ++ K  + L+ + V GG LF  L  +    E+ A  +  +I++ V +LH+  I H 
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 275 DLKPENI-LLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPENI LLD +     + + DFGLA + D      ++ GT E+++PEIV  +     A
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA 198
Query: 331 DWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQK 386
           D WS+G++ + +L+G  PF G  +                   +  S+ A   ++ LL K
Sbjct: 199 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK 258
Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
           +  KR+       Q+   H W K
Sbjct: 259 DPKKRM-----TIQDSLQHPWIK 276

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N M GTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLN 63
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N M GTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 109/202 (53%), Gaps = 4/202 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 79
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N   GT  +M+PE++    +D 
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS 198
Query: 329 AADWWSVGILLFEMLTGQPPFT 350
            AD WS+GI   E+  G+PP +
Sbjct: 199 KADIWSLGITAIELARGEPPHS 220

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N M GTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N M GTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 116/205 (56%), Gaps = 4/205 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E ++ L+ VG+G +  VY+ +      I A+K +R D   E   +  ++ E ++L ++ 
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELH 77
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP IV L     ++  L LV +F+           +   ++   +IY  +++  V+H H 
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGH 326
           + I+HRDLKP+N+L+++DG + L DFGLA+ F    RS +    TL Y +P++++G K +
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 327 DKAADWWSVGILLFEMLTGQPPFTG 351
             + D WS+G +  EM+TG+P F G
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPG 222

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 6/205 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 62
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N M GTL Y++PE++  + 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 326 -HDKAADWWSVGILLFEMLTGQPPF 349
            H +  D WS GI+L  ML G+ P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  D    ++  E ++ E  +L++ D 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDS 64
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N   GT  +M+PE++    +D 
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS 183
Query: 329 AADWWSVGILLFEMLTGQPP 348
            AD WS+GI   E+  G+PP
Sbjct: 184 KADIWSLGITAIELARGEPP 203

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 116/205 (56%), Gaps = 4/205 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E ++ L+ VG+G +  VY+ +      I A+K +R D   E   +  ++ E ++L ++ 
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELH 77
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP IV L     ++  L LV +F+           +   ++   +IY  +++  V+H H 
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ 137
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGH 326
           + I+HRDLKP+N+L+++DG + L DFGLA+ F    RS +    TL Y +P++++G K +
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 327 DKAADWWSVGILLFEMLTGQPPFTG 351
             + D WS+G +  EM+TG+P F G
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPG 222

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 114/215 (53%), Gaps = 15/215 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EVL  +G G++ +  ++RR    +I   K +    + E    + + SE N+L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 210 PFIVQL--RYSFQTKYRLYLVLDFVNGGHLFFQLY-----RQGLFREDLARIYTAEIVSA 262
           P IV+   R   +T   LY+V+++  GG L   +      RQ L  E + R+ T ++  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT-QLTLA 123
Query: 263 VSHLH-----ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTLEYM 316
           +   H      + ++HRDLKP N+ LD   +V L DFGLA+  + +   +    GT  YM
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYM 183
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           SPE +    +++ +D WS+G LL+E+    PPFT 
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 113/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + + K        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK-------AFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPAT--VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 113/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + + K        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK-------AFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 113/209 (54%), Gaps = 22/209 (10%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           KV+G G+F  VYQ +   + E+ A+K + + K        +   E  I+ K+DH  IV+L
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK-------AFKNRELQIMRKLDHCNIVRL 78
Query: 216 RYSF------QTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDL----ARIYTAEIVSAVS 264
           RY F      + +  L LVLD+V      +++ R     ++ L     ++Y  ++  +++
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 265 HLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           ++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              +  + D WS G +L E+L GQP F G
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 8/225 (3%)
Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME 190
           GK TG++  +  +     + D E L  +G G   +V+++R   T  + A+K MR+    E
Sbjct: 7   GKQTGYL-TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE 65
Query: 191 KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
           +N    M  +  +L   D P+IVQ   +F T   +++ ++ +       +   QG   E 
Sbjct: 66  ENKRILMDLD-VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPER 124
Query: 251 LARIYTAEIVSAVSHL-HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM 309
           +    T  IV A+ +L   +G++HRD+KP NILLD  G + L DFG++ +  ++   +  
Sbjct: 125 ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS 184
Query: 310 CGTLEYMSPEIV-----LGKGHDKAADWWSVGILLFEMLTGQPPF 349
            G   YM+PE +         +D  AD WS+GI L E+ TGQ P+
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 110/213 (51%), Gaps = 22/213 (10%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH--AEYMKSERNILTKVDHPFIVQ 214
           V+G+GA A+V     + TS+ YA+K++ K    +  H  +   +    +     H  +++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEK----QPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   F+ + R YLV + + GG +   ++++  F E  A +   ++ SA+  LH  GI HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 275 DLKPENILLDADGH---VMLTDFGLAKQFDENTRSNSM--------CGTLEYMSPEIVLG 323
           DLKPENIL +       V + DFGL      N   + +        CG+ EYM+PE+V  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195
Query: 324 KG-----HDKAADWWSVGILLFEMLTGQPPFTG 351
                  +DK  D WS+G++L+ +L+G PPF G
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 109/193 (56%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V   R   +    A+K+M    + ++   E + +E  I+    H  +V++  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L+++++F+ GG L   + +  L  E +A +  A ++ A+++LHA G++HRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEA-VLQALAYLHAQGVIHRDIK 168
Query: 278 PENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q  ++  +   + GT  +M+PE++    +    D WS+G
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLG 228
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 229 IMVIEMVDGEPPY 241

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 106/193 (54%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 215
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 274
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   + GT  +M+PE++    +    D WS+G
Sbjct: 275 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 334
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 335 IMVIEMVDGEPPY 347

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 22/213 (10%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH--AEYMKSERNILTKVDHPFIVQ 214
           V+G+GA A+V     + TS+ YA+K++ K    +  H  +   +    +     H  +++
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEK----QPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   F+ + R YLV + + GG +   ++++  F E  A +   ++ SA+  LH  GI HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 275 DLKPENILLDADGH---VMLTDFGLAKQFDENTRSNSM--------CGTLEYMSPEIVLG 323
           DLKPENIL +       V + DF L      N   + +        CG+ EYM+PE+V  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195
Query: 324 KG-----HDKAADWWSVGILLFEMLTGQPPFTG 351
                  +DK  D WS+G++L+ +L+G PPF G
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 131/298 (43%), Gaps = 39/298 (13%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----------- 190
           S   CV L  + +   +G+G++  V        +  YAMKV+ K K++            
Sbjct: 5   SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64
Query: 191 ------------KNHAEYMKSERNILTKVDHPFIVQLRYSFQ--TKYRLYLVLDFVNGGH 236
                       +   E +  E  IL K+DHP +V+L        +  LY+V + VN G 
Sbjct: 65  GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124
Query: 237 LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL 296
           +  ++       ED AR Y  +++  + +LH   I+HRD+KP N+L+  DGH+ + DFG+
Sbjct: 125 VM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 297 AKQF--DENTRSNSMCGTLEYMSPEIVLGKGH---DKAADWWSVGILLFEMLTGQPPFTG 351
           + +F   +   SN++ GT  +M+PE +         KA D W++G+ L+  + GQ PF  
Sbjct: 184 SNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
Query: 352 GNRXXXXXXXXXXXXXLP--AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKW 407
                            P    ++ +   L+  +L K    R+        EIK H W
Sbjct: 243 ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRI-----VVPEIKLHPW 295

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 106/193 (54%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 95
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 154
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   + GT  +M+PE++    +    D WS+G
Sbjct: 155 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 214
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 215 IMVIEMVDGEPPY 227

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 106/193 (54%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 138
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 197
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   + GT  +M+PE++    +    D WS+G
Sbjct: 198 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 257
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 258 IMVIEMVDGEPPY 270

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 13/210 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E +E L +VG+G++  V + R   T  I A+K     K +E +  + +K     E  +L
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLL 78
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAV 263
            ++ H  +V L    + K R YLV +FV+   L   +L+  GL  + + + Y  +I++ +
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQ-VVQKYLFQIINGI 137
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMSPEIVL 322
              H++ I+HRD+KPENIL+   G V L DFG A+         +    T  Y +PE+++
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLV 197
Query: 323 GK-GHDKAADWWSVGILLFEMLTGQPPFTG 351
           G   + KA D W++G L+ EM  G+P F G
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEPLFPG 227

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 106/193 (54%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 152
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   + GT  +M+PE++    +    D WS+G
Sbjct: 153 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 212
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 213 IMVIEMVDGEPPY 225

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 106/193 (54%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 143
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   + GT  +M+PE++    +    D WS+G
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 203
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 204 IMVIEMVDGEPPY 216

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 106/193 (54%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       + ++ A+K M    + ++   E + +E  I+    H  +V++  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  A ++ A+S LHA G++HRD+K
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-VLQALSVLHAQGVIHRDIK 147
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL  DG V L+DFG   Q   E  R   + GT  +M+PE++    +    D WS+G
Sbjct: 148 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 207
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 208 IMVIEMVDGEPPY 220

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 108/208 (51%), Gaps = 16/208 (7%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA-EYMKSERNILTKVDHPFIVQ 214
           +++G G F KVY+   IG     A+K  R D   + +   E ++ E  +   + HP I+ 
Sbjct: 13  EIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI--- 271
           LR     +  L LV++F  GG L   L  + +   D+   +  +I   +++LH   I   
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-PPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 272 MHRDLKPENILL-------DADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           +HRDLK  NIL+       D    ++ +TDFGLA+++   T+  S  G   +M+PE++  
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGAYAWMAPEVIRA 188
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
               K +D WS G+LL+E+LTG+ PF G
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  +D+E+ +V+G GA A V         E  A+K +  +K  + +  E +K E   +++
Sbjct: 7   INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLK-EIQAMSQ 64
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL--------YRQGLFREDLARIYTAE 258
             HP IV    SF  K  L+LV+  ++GG +   +        ++ G+  E        E
Sbjct: 65  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 124
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK------QFDENTRSNSMCGT 312
           ++  + +LH NG +HRD+K  NILL  DG V + DFG++           N    +  GT
Sbjct: 125 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 313 LEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPF 349
             +M+PE++   +G+D  AD WS GI   E+ TG  P+
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 222

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  +D+E+ +V+G GA A V         E  A+K +  +K  + +  E +K E   +++
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLK-EIQAMSQ 69
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL--------YRQGLFREDLARIYTAE 258
             HP IV    SF  K  L+LV+  ++GG +   +        ++ G+  E        E
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK------QFDENTRSNSMCGT 312
           ++  + +LH NG +HRD+K  NILL  DG V + DFG++           N    +  GT
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 313 LEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPF 349
             +M+PE++   +G+D  AD WS GI   E+ TG  P+
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY 227

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ + +G G F  V +     T E  A+K  R++ +  KN   +   E  I+ K++HP 
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWC-LEIQIMKKLNHPN 73
Query: 212 IVQLRYSFQTKYRL------YLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSA 262
           +V  R       +L       L +++  GG L     Q       +E   R   ++I SA
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVML---TDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           + +LH N I+HRDLKPENI+L      ++    D G AK+ D+        GTL+Y++PE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           ++  K +    D+WS G L FE +TG  PF
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ + +G G F  V +     T E  A+K  R++ +  KN   +   E  I+ K++HP 
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWC-LEIQIMKKLNHPN 74
Query: 212 IVQLRYSFQTKYRL------YLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIVSA 262
           +V  R       +L       L +++  GG L     Q       +E   R   ++I SA
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVML---TDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           + +LH N I+HRDLKPENI+L      ++    D G AK+ D+        GTL+Y++PE
Sbjct: 135 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 194
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           ++  K +    D+WS G L FE +TG  PF
Sbjct: 195 LLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 121/233 (51%), Gaps = 39/233 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DFE + V+GQGAF +V + R    S  YA+K +R      +     + SE  +L  ++H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQ 62
Query: 211 FIVQL------RYSF-------QTKYRLYLVLDFVNGGHLFFQLYRQGLF--REDLARIY 255
           ++V+       R +F       + K  L++ +++   G L+  ++ + L   R++  R++
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE------------- 302
             +I+ A+S++H+ GI+HRDLKP NI +D   +V + DFGLAK                 
Sbjct: 123 R-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 303 --NTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGG 352
             +    S  GT  Y++ E++ G GH ++  D +S+GI+ FEM+    PF+ G
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 137/278 (49%), Gaps = 30/278 (10%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 20  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 74
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 75  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 132
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 133 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 192
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF--------TGGNRXXXXXXXXXXXXXLPA 370
           E++  + +DK+ D WS+G++++ +L G PPF        + G +               +
Sbjct: 193 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 252
Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
            +S E   L++ LL+ E ++R+        E  +H W 
Sbjct: 253 EVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 285

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 137/278 (49%), Gaps = 30/278 (10%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 15  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 69
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 70  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 127
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 128 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 187
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF--------TGGNRXXXXXXXXXXXXXLPA 370
           E++  + +DK+ D WS+G++++ +L G PPF        + G +               +
Sbjct: 188 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 247
Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
            +S E   L++ LL+ E ++R+        E  +H W 
Sbjct: 248 EVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWI 280

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 124/271 (45%), Gaps = 16/271 (5%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K +G+G FA V Q     T + YA K ++K +  +   AE +     +      P ++ L
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 216 RYSFQTKYRLYLVLDFVNGGHLF---FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
              ++    + L+L++  GG +F        + +   D+ R+   +I+  V +LH N I+
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-IKQILEGVYYLHQNNIV 153
Query: 273 HRDLKPENILLDAD---GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
           H DLKP+NILL +    G + + DFG++++         + GT EY++PEI+       A
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTA 213
Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLP----AFLSSEAHSLLKGLLQ 385
            D W++GI+ + +LT   PF G +                    + +S  A   ++ LL 
Sbjct: 214 TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLV 273
Query: 386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKL 416
           K   KR       ++   SH W +  +++ L
Sbjct: 274 KNPEKR-----PTAEICLSHSWLQQWDFENL 299

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 137/278 (49%), Gaps = 30/278 (10%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 22  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 76
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 77  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 134
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 135 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 194
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF--------TGGNRXXXXXXXXXXXXXLPA 370
           E++  + +DK+ D WS+G++++ +L G PPF        + G +               +
Sbjct: 195 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 254
Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
            +S E   L++ LL+ E ++R+        E  +H W 
Sbjct: 255 EVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 287

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 137/278 (49%), Gaps = 30/278 (10%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 21  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 75
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 76  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 133
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 134 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 193
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF--------TGGNRXXXXXXXXXXXXXLPA 370
           E++  + +DK+ D WS+G++++ +L G PPF        + G +               +
Sbjct: 194 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 253
Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
            +S E   L++ LL+ E ++R+        E  +H W 
Sbjct: 254 EVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 286

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 120/249 (48%), Gaps = 13/249 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS-----ERNIL 204
           + +  +  +G GAF  V+       ++   +K ++K+K++E    E  K      E  IL
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAV 263
           ++V+H  I+++   F+ +    LV++    G  LF  + R     E LA     ++VSAV
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            +L    I+HRD+K ENI++  D  + L DFG A   +      + CGT+EY +PE+++G
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG 203
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKG 382
             +     + WS+G+ L+ ++  + PF                   P  +S E  SL+ G
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHP------PYLVSKELMSLVSG 257
Query: 383 LLQKEASKR 391
           LLQ    +R
Sbjct: 258 LLQPVPERR 266

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 137/278 (49%), Gaps = 30/278 (10%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 84
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 85  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 142
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 143 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 202
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF--------TGGNRXXXXXXXXXXXXXLPA 370
           E++  + +DK+ D WS+G++++ +L G PPF        + G +               +
Sbjct: 203 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 262
Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
            +S E   L++ LL+ E ++R+        E  +H W 
Sbjct: 263 EVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWI 295

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 137/278 (49%), Gaps = 30/278 (10%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 68
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 69  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 186
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF--------TGGNRXXXXXXXXXXXXXLPA 370
           E++  + +DK+ D WS+G++++ +L G PPF        + G +               +
Sbjct: 187 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 246
Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
            +S E   L++ LL+ E ++R+        E  +H W 
Sbjct: 247 EVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWI 279

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 116/211 (54%), Gaps = 13/211 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F+ L+ +G G +A VY+     T    A+K ++ D   E+        E +++ ++ H  
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHEN 64
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR------QGLFREDLARIYTAEIVSAVSH 265
           IV+L     T+ +L LV +F++     +   R      +GL   +L + +  +++  ++ 
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL-ELNLVKYFQWQLLQGLAF 123
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSMCGTLEYMSPEIVLG 323
            H N I+HRDLKP+N+L++  G + L DFGLA+ F    NT S+ +  TL Y +P++++G
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMG 182
Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
            + +  + D WS G +L EM+TG+P F G N
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 137/278 (49%), Gaps = 30/278 (10%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 188
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF--------TGGNRXXXXXXXXXXXXXLPA 370
           E++  + +DK+ D WS+G++++ +L G PPF        + G +               +
Sbjct: 189 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 248
Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
            +S E   L++ LL+ E ++R+        E  +H W 
Sbjct: 249 EVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 281

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 137/278 (49%), Gaps = 30/278 (10%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 114
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 115 --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF--------TGGNRXXXXXXXXXXXXXLPA 370
           E++  + +DK+ D WS+G++++ +L G PPF        + G +               +
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 292
Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
            +S E   L++ LL+ E ++R+        E  +H W 
Sbjct: 293 EVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 325

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 112/205 (54%), Gaps = 4/205 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G +  VY+ +     E +A+K +R +K  E   +  ++ E +IL ++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     TK RL LV + ++          +G      A+ +  ++++ +++ H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGH 326
             ++HRDLKP+N+L++ +G + + DFGLA+ F    R  +    TL Y +P++++G K +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 327 DKAADWWSVGILLFEMLTGQPPFTG 351
               D WSVG +  EM+ G P F G
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPG 203

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 137/278 (49%), Gaps = 30/278 (10%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 66  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 120
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 121 --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 178
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 179 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 238
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF--------TGGNRXXXXXXXXXXXXXLPA 370
           E++  + +DK+ D WS+G++++ +L G PPF        + G +               +
Sbjct: 239 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 298
Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
            +S E   L++ LL+ E ++R+        E  +H W 
Sbjct: 299 EVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 331

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 112/205 (54%), Gaps = 4/205 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G +  VY+ +     E +A+K +R +K  E   +  ++ E +IL ++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     TK RL LV + ++          +G      A+ +  ++++ +++ H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGH 326
             ++HRDLKP+N+L++ +G + + DFGLA+ F    R  +    TL Y +P++++G K +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 327 DKAADWWSVGILLFEMLTGQPPFTG 351
               D WSVG +  EM+ G P F G
Sbjct: 179 STTIDIWSVGCIFAEMVNGAPLFPG 203

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 137/278 (49%), Gaps = 30/278 (10%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 188
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF--------TGGNRXXXXXXXXXXXXXLPA 370
           E++  + +DK+ D WS+G++++ +L G PPF        + G +               +
Sbjct: 189 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 248
Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
            +S E   L++ LL+ E ++R+        E  +H W 
Sbjct: 249 EVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 281

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 112/205 (54%), Gaps = 4/205 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G +  VY+ +     E +A+K +R +K  E   +  ++ E +IL ++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     TK RL LV + ++          +G      A+ +  ++++ +++ H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGH 326
             ++HRDLKP+N+L++ +G + + DFGLA+ F    R  +    TL Y +P++++G K +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 327 DKAADWWSVGILLFEMLTGQPPFTG 351
               D WSVG +  EM+ G P F G
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPG 203

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 136/278 (48%), Gaps = 30/278 (10%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 14  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 68
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 69  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +      C T  Y++P
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAP 186
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF--------TGGNRXXXXXXXXXXXXXLPA 370
           E++  + +DK+ D WS+G++++ +L G PPF        + G +               +
Sbjct: 187 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 246
Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
            +S E   L++ LL+ E ++R+        E  +H W 
Sbjct: 247 EVSEEVKMLIRNLLKTEPTQRMTIT-----EFMNHPWI 279

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 116/230 (50%), Gaps = 12/230 (5%)
Query: 134 TGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH 193
           +G +   P ++     ED + L  +G+GA+  V ++    + +I A+K +R   + EK  
Sbjct: 6   SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS-TVDEKEQ 64
Query: 194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF-----R 248
            + +     ++   D P+IVQ   +   +   ++ ++ ++     F  Y   +       
Sbjct: 65  KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPE 124
Query: 249 EDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN 307
           E L +I T   V A++HL  N  I+HRD+KP NILLD  G++ L DFG++ Q  ++    
Sbjct: 125 EILGKI-TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT 183
Query: 308 SMCGTLEYMSPEIV----LGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
              G   YM+PE +      +G+D  +D WS+GI L+E+ TG+ P+   N
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 126/292 (43%), Gaps = 55/292 (18%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTKVDHPFIVQL 215
           +GQG++  V       T  I A+K+M K+KI + N    E +K+E  ++ K+ HP I +L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQL---------------------------------- 241
              ++ +  + LV++  +GGHL  +L                                  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 242 ---YRQGL---FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG--HVMLTD 293
              +R+ L    RE L      +I SA+ +LH  GI HRD+KPEN L   +    + L D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 294 FGLAKQF-----DENTRSNSMCGTLEYMSPEIV--LGKGHDKAADWWSVGILLFEMLTGQ 346
           FGL+K+F      E     +  GT  +++PE++    + +    D WS G+LL  +L G 
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 347 PPFTGGNRXXXXXXXXXXXXXL--PAF--LSSEAHSLLKGLLQKEASKRLGS 394
            PF G N                 P +  LS  A  LL  LL +   +R  +
Sbjct: 274 VPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 105/193 (54%), Gaps = 5/193 (2%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+   V       T +  A+K M    + ++   E + +E  I+    H  +V +  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKM---DLRKQQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           S+     L++V++F+ GG L   +    +  E +A +  + ++ A+S+LH  G++HRD+K
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSYLHNQGVIHRDIK 168
Query: 278 PENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            ++ILL +DG + L+DFG   Q   E  +   + GT  +M+PE++    +    D WS+G
Sbjct: 169 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLG 228
Query: 337 ILLFEMLTGQPPF 349
           I++ EM+ G+PP+
Sbjct: 229 IMVIEMIDGEPPY 241

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 111/200 (55%), Gaps = 10/200 (5%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR 216
           V+G+G +  VY  R +      A+K + +    +  +++ +  E  +   + H  IVQ  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPE---RDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARI--YTAEIVSAVSHLHANGIMH 273
            SF     + + ++ V GG L   L  + G  +++   I  YT +I+  + +LH N I+H
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 274 RDLKPENILLDA-DGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMSPEIVLG--KGHDKA 329
           RD+K +N+L++   G + ++DFG +K+    N  + +  GTL+YM+PEI+    +G+ KA
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 330 ADWWSVGILLFEMLTGQPPF 349
           AD WS+G  + EM TG+PPF
Sbjct: 206 ADIWSLGCTIIEMATGKPPF 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 111/200 (55%), Gaps = 10/200 (5%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR 216
           V+G+G +  VY  R +      A+K + +    +  +++ +  E  +   + H  IVQ  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPE---RDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARI--YTAEIVSAVSHLHANGIMH 273
            SF     + + ++ V GG L   L  + G  +++   I  YT +I+  + +LH N I+H
Sbjct: 72  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 131
Query: 274 RDLKPENILLDA-DGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMSPEIVLG--KGHDKA 329
           RD+K +N+L++   G + ++DFG +K+    N  + +  GTL+YM+PEI+    +G+ KA
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 191
Query: 330 ADWWSVGILLFEMLTGQPPF 349
           AD WS+G  + EM TG+PPF
Sbjct: 192 ADIWSLGCTIIEMATGKPPF 211

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 5/206 (2%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKVDH 209
           +E L  +G+G FA VY+ R   T++I A+K ++     E        + R I  L ++ H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I+ L  +F  K  + LV DF+             +      + Y    +  + +LH +
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVLG-KGHD 327
            I+HRDLKP N+LLD +G + L DFGLAK F    R+      T  Y +PE++ G + + 
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
              D W+VG +L E+L  + PF  G+
Sbjct: 192 VGVDMWAVGCILAELLL-RVPFLPGD 216

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 134/278 (48%), Gaps = 30/278 (10%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K ++      +    + ++ +      
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVELHWRASQC----- 114
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V + ++GG LF ++  +G   F E  A      I  
Sbjct: 115 --PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGE 172
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++P
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF--------TGGNRXXXXXXXXXXXXXLPA 370
           E++  + +DK+ D WS+G++ + +L G PPF        + G +               +
Sbjct: 233 EVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWS 292
Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
            +S E   L++ LL+ E ++R         E  +H W 
Sbjct: 293 EVSEEVKXLIRNLLKTEPTQRXTIT-----EFXNHPWI 325

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 120/233 (51%), Gaps = 39/233 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DFE + V+GQGAF +V + R    S  YA+K +R      +     + SE  +L  ++H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQ 62
Query: 211 FIVQL------RYSF-------QTKYRLYLVLDFVNGGHLFFQLYRQGLF--REDLARIY 255
           ++V+       R +F       + K  L++ +++     L+  ++ + L   R++  R++
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE------------- 302
             +I+ A+S++H+ GI+HRDLKP NI +D   +V + DFGLAK                 
Sbjct: 123 R-QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 303 --NTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGG 352
             +    S  GT  Y++ E++ G GH ++  D +S+GI+ FEM+    PF+ G
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 118
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 119 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 178
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE +
Sbjct: 179 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERL 237
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPF 349
            G  +   +D WS+G+ L EM  G+ P 
Sbjct: 238 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 139/299 (46%), Gaps = 31/299 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 5   NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 53
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 54  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 113
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 114 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 173
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 174 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 232
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI 411
                              +SSE   L++  L    S R        +EI++H W + +
Sbjct: 233 EEIIRGQVFFRQR------VSSECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 280

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 106/207 (51%), Gaps = 3/207 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E L+ +G+G +  V++ +   T EI A+K +R D   E   +  ++ E  +L ++ 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELK 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     +  +L LV +F +     +     G    ++ + +  +++  +   H+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGH 326
             ++HRDLKP+N+L++ +G + L DFGLA+ F    R  S    TL Y  P+++ G K +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGN 353
             + D WS G +  E+     P   GN
Sbjct: 180 STSIDMWSAGCIFAELANAARPLFPGN 206

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 139/299 (46%), Gaps = 31/299 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 6   NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 54
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 55  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 114
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 115 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 174
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 175 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI 411
                              +SSE   L++  L    S R        +EI++H W + +
Sbjct: 234 EEIIRGQVFFRQR------VSSECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 281

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 138/297 (46%), Gaps = 31/297 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 25  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 73
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 74  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 133
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 134 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 194 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                              +SSE   L++  L    S R        +EI++H W +
Sbjct: 253 EEIIRGQVFFRQR------VSSECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQ 298

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 109/212 (51%), Gaps = 18/212 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 75
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 76  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 135
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q  ++  +NS  GT  YMSPE +
Sbjct: 136 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERL 194
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
            G  +   +D WS+G+ L EM  G+ P   G+
Sbjct: 195 QGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGS 226

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 138/297 (46%), Gaps = 31/297 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 18  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 126
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 127 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 186
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 187 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                              +SSE   L++  L    S R        +EI++H W +
Sbjct: 246 EEIIRGQVFFRQR------VSSECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQ 291

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 138/297 (46%), Gaps = 31/297 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 33  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 81
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 82  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 141
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 142 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 201
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 202 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                              +SSE   L++  L    S R        +EI++H W +
Sbjct: 261 EEIIRGQVFFRQR------VSSECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQ 306

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 20/266 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+ +     LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 188
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILL++M+ G  PF                      +SSE   L++  
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHLIRWC 242
Query: 384 LQKEASKRLGSGPGGSQEIKSHKWFK 409
           L    S R        +EI++H W +
Sbjct: 243 LALRPSDR-----PTFEEIQNHPWMQ 263

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 138/297 (46%), Gaps = 31/297 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 18  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 126
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 127 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 186
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 187 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                              +SSE   L++  L    S R        +EI++H W +
Sbjct: 246 EEIIGGQVFFRQR------VSSECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQ 291

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 138/297 (46%), Gaps = 31/297 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 19  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 127
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 128 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 187
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 188 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                              +SSE   L++  L    S R        +EI++H W +
Sbjct: 247 EEIIGGQVFFRQR------VSSECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQ 292

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 138/297 (46%), Gaps = 31/297 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 18  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 126
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 127 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 186
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 187 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                              +SSE   L++  L    S R        +EI++H W +
Sbjct: 246 EEIIGGQVFFRQR------VSSECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQ 291

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 112/230 (48%), Gaps = 29/230 (12%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L  +E++K +G+GA+  V++     T E+ A+K +  D       A+    E  ILT++ 
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNSTDAQRTFREIMILTELS 66
Query: 209 -HPFIVQLRYSFQ--TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
            H  IV L    +      +YLV D++        + R  +      +    +++  + +
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--------------DENTRS----- 306
           LH+ G++HRD+KP NILL+A+ HV + DFGL++ F              +ENT +     
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 307 ---NSMCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGG 352
                   T  Y +PEI+LG   + K  D WS+G +L E+L G+P F G 
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 138/297 (46%), Gaps = 31/297 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 19  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 127
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 128 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 187
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 188 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                              +SSE   L++  L    S R        +EI++H W +
Sbjct: 247 EEIIGGQVFFRQR------VSSECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQ 292

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 107/201 (53%), Gaps = 4/201 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE +  +G G    V++V    +  + A K++  +  ++      +  E  +L + + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH-A 268
           P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  +++L   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE + G  +  
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 329 AADWWSVGILLFEMLTGQPPF 349
            +D WS+G+ L EM  G+ P 
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPI 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 107/201 (53%), Gaps = 4/201 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE +  +G G    V++V    +  + A K++  +  ++      +  E  +L + + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH-A 268
           P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  +++L   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE + G  +  
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 329 AADWWSVGILLFEMLTGQPPF 349
            +D WS+G+ L EM  G+ P 
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 107/201 (53%), Gaps = 4/201 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE +  +G G    V++V    +  + A K++  +  ++      +  E  +L + + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH-A 268
           P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  +++L   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE + G  +  
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 329 AADWWSVGILLFEMLTGQPPF 349
            +D WS+G+ L EM  G+ P 
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPI 203

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G G+F  VY  R +  SE+ A+K M           + +  E   L K+ HP 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 212 IVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            +Q R  +  ++  +LV+++  G      +++++ L   ++A + T   +  +++LH++ 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV-THGALQGLAYLHSHN 174
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG---HD 327
           ++HRD+K  NILL   G V L DFG A        +N   GT  +M+PE++L      +D
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYD 231
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
              D WS+GI   E+   +PP    N
Sbjct: 232 GKVDVWSLGITCIELAERKPPLFNMN 257

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V++V    +  + A K++         H E   + RN       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI---------HLEIKPAIRNQIIRELQ 83
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  
Sbjct: 84  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 143
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE +
Sbjct: 144 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERL 202
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPF 349
            G  +   +D WS+G+ L EM  G+ P 
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 128/268 (47%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 189
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILL++M+ G  PF                      +SSE   L++  
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHLIRWC 243
Query: 384 LQKEASKRLGSGPGGSQEIKSHKWFKMI 411
           L    S R        +EI++H W + +
Sbjct: 244 LALRPSDR-----PTFEEIQNHPWMQDV 266

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 128/268 (47%), Gaps = 20/268 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 188
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILL++M+ G  PF                      +SSE   L++  
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHLIRWC 242
Query: 384 LQKEASKRLGSGPGGSQEIKSHKWFKMI 411
           L    S R        +EI++H W + +
Sbjct: 243 LALRPSDR-----PTFEEIQNHPWMQDV 265

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 107/201 (53%), Gaps = 4/201 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE +  +G G    V++V    +  + A K++  +  ++      +  E  +L + + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH-A 268
           P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  +++L   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE + G  +  
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 329 AADWWSVGILLFEMLTGQPPF 349
            +D WS+G+ L EM  G+ P 
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 107/201 (53%), Gaps = 4/201 (1%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE +  +G G    V++V    +  + A K++  +  ++      +  E  +L + + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH-A 268
           P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  +++L   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE + G  +  
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 329 AADWWSVGILLFEMLTGQPPF 349
            +D WS+G+ L EM  G+ P 
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPI 203

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 127/266 (47%), Gaps = 20/266 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 189
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILL++M+ G  PF                      +SSE   L++  
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHLIRWC 243
Query: 384 LQKEASKRLGSGPGGSQEIKSHKWFK 409
           L    S R        +EI++H W +
Sbjct: 244 LALRPSDR-----PTFEEIQNHPWMQ 264

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 127/266 (47%), Gaps = 20/266 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 189
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILL++M+ G  PF                      +SSE   L++  
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHLIRWC 243
Query: 384 LQKEASKRLGSGPGGSQEIKSHKWFK 409
           L    S R        +EI++H W +
Sbjct: 244 LALRPSDR-----PTFEEIQNHPWMQ 264

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F  L+ +G G+F  VY  R +  SE+ A+K M           + +  E   L K+ HP 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 212 IVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            +Q R  +  ++  +LV+++  G      +++++ L   ++A + T   +  +++LH++ 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV-THGALQGLAYLHSHN 135
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG---HD 327
           ++HRD+K  NILL   G V L DFG A        +N   GT  +M+PE++L      +D
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
              D WS+GI   E+   +PP    N
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMN 218

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 138/299 (46%), Gaps = 31/299 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 6   NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 54
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 55  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 114
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 115 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 174
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 175 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI 411
                              +S E   L++  L    S R        +EI++H W + +
Sbjct: 234 EEIIRGQVFFRQR------VSXECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 281

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 13/210 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E +E +  +G+G++  V++ R   T +I A+K     K +E      +K     E  +L
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRML 56
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAV 263
            ++ HP +V L   F+ K RL+LV ++ +   L     Y++G+  E L +  T + + AV
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGV-PEHLVKSITWQTLQAV 115
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVL 322
           +  H +  +HRD+KPENIL+     + L DFG A+     +   +    T  Y SPE+++
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175
Query: 323 GKG-HDKAADWWSVGILLFEMLTGQPPFTG 351
           G   +    D W++G +  E+L+G P + G
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGVPLWPG 205

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 127/266 (47%), Gaps = 20/266 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILL++M+ G  PF                      +SSE   L++  
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHLIRWC 238
Query: 384 LQKEASKRLGSGPGGSQEIKSHKWFK 409
           L    S R        +EI++H W +
Sbjct: 239 LALRPSDR-----PTFEEIQNHPWMQ 259

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 127/266 (47%), Gaps = 20/266 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 187
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILL++M+ G  PF                      +SSE   L++  
Sbjct: 188 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSSECQHLIRWC 241
Query: 384 LQKEASKRLGSGPGGSQEIKSHKWFK 409
           L    S R        +EI++H W +
Sbjct: 242 LALRPSDR-----PTFEEIQNHPWMQ 262

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 138/299 (46%), Gaps = 31/299 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 5   NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 53
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 54  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 113
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 114 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 173
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 174 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 232
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI 411
                              +S E   L++  L    S R        +EI++H W + +
Sbjct: 233 EEIIRGQVFFRQR------VSXECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQDV 280

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 137/297 (46%), Gaps = 31/297 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 33  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 81
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 82  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 141
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 142 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 201
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 202 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                              +S E   L++  L    S R        +EI++H W +
Sbjct: 261 EEIIRGQVFFRQR------VSXECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQ 306

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 127/266 (47%), Gaps = 20/266 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILL++M+ G  PF                      +SSE   L++  
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR------VSSECQHLIRWC 238
Query: 384 LQKEASKRLGSGPGGSQEIKSHKWFK 409
           L    S R        +EI++H W +
Sbjct: 239 LALRPSDR-----PTFEEIQNHPWMQ 259

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 137/297 (46%), Gaps = 31/297 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 38  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 86
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 87  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 146
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 147 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 206
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 207 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 265
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                              +S E   L++  L    S R        +EI++H W +
Sbjct: 266 EEIIRGQVFFRQR------VSXECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQ 311

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 137/297 (46%), Gaps = 31/297 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 19  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 127
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 128 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 187
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 188 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                              +S E   L++  L    S R        +EI++H W +
Sbjct: 247 EEIIGGQVFFRQR------VSXECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQ 292

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 137/297 (46%), Gaps = 31/297 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 19  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 67
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 68  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 127
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 128 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 187
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 188 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                              +S E   L++  L    S R        +EI++H W +
Sbjct: 247 EEIIGGQVFFRQR------VSXECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQ 292

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 109/208 (52%), Gaps = 4/208 (1%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E L+ +G+G +  V++ +   T EI A+K +R D   E   +  ++ E  +L ++ 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELK 59
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     +  +L LV +F +     +     G    ++ + +  +++  +   H+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGH 326
             ++HRDLKP+N+L++ +G + L +FGLA+ F    R  S    TL Y  P+++ G K +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 327 DKAADWWSVGILLFEML-TGQPPFTGGN 353
             + D WS G +  E+   G+P F G +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGND 207

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/237 (31%), Positives = 120/237 (50%), Gaps = 20/237 (8%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 6   NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 54
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 55  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 114
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 115 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 174
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF
Sbjct: 175 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 137/297 (46%), Gaps = 31/297 (10%)
Query: 121 NNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM 180
           N+L     A GK     +  P E+Q      ++V  ++G G F  VY   R+  +   A+
Sbjct: 18  NDLHATKLAPGK-----EKEPLESQ------YQVGPLLGSGGFGSVYSGIRVSDNLPVAI 66
Query: 181 KVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLYLVLDFVNGG 235
           K + KD+I    E  +   +  E  +L KV   F  +++L   F+      L+L+     
Sbjct: 67  KHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 126
Query: 236 H-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTD 293
             LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L D
Sbjct: 127 QDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 186
Query: 294 FGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG 352
           FG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M+ G  PF   
Sbjct: 187 FG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 353 NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                              +S E   L++  L    S R        +EI++H W +
Sbjct: 246 EEIIGGQVFFRQR------VSXECQHLIRWCLALRPSDR-----PTFEEIQNHPWMQ 291

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 112/212 (52%), Gaps = 23/212 (10%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL- 215
           ++GQGA A V++ R   T +++A+KV      +     +    E  +L K++H  IV+L 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLF 73
Query: 216 --RYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHAN 269
                  T++++ L+++F   G L+  L       GL   +   I   ++V  ++HL  N
Sbjct: 74  AIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLREN 131
Query: 270 GIMHRDLKPENIL--LDADGHVM--LTDFGLAKQFDENTRSNSMCGTLEYMSPEI----V 321
           GI+HR++KP NI+  +  DG  +  LTDFG A++ +++ +  S+ GT EY+ P++    V
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191
Query: 322 LGKGHDK----AADWWSVGILLFEMLTGQPPF 349
           L K H K      D WS+G+  +   TG  PF
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 120/233 (51%), Gaps = 39/233 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DFE + V+GQGAF +V + R    S  YA+K +R  +  EK     + SE  +L  ++H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EK--LSTILSEVXLLASLNHQ 62
Query: 211 FIVQL------RYSF-------QTKYRLYLVLDFVNGGHLFFQLYRQGLF--REDLARIY 255
           ++V+       R +F       + K  L++  ++     L+  ++ + L   R++  R++
Sbjct: 63  YVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE------------- 302
             +I+ A+S++H+ GI+HR+LKP NI +D   +V + DFGLAK                 
Sbjct: 123 R-QILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 303 --NTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGG 352
             +    S  GT  Y++ E++ G GH ++  D +S+GI+ FE +    PF+ G
Sbjct: 182 GSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTG 231

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 20/266 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 211
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILL++M+ G  PF                      +S E   L++  
Sbjct: 212 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSXECQHLIRWC 265
Query: 384 LQKEASKRLGSGPGGSQEIKSHKWFK 409
           L    S R        +EI++H W +
Sbjct: 266 LALRPSDR-----PTFEEIQNHPWMQ 286

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 105/200 (52%), Gaps = 4/200 (2%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE +  +G G    V++V    +  + A K++  +  ++      +  E  +L + + 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 66
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH-A 268
           P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  +++L   
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 126
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           + IMHRD+KP NIL+++ G + L DFG++ Q  +   +N   GT  YMSPE + G  +  
Sbjct: 127 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEM-ANEFVGTRSYMSPERLQGTHYSV 185
Query: 329 AADWWSVGILLFEMLTGQPP 348
            +D WS+G+ L EM  G+ P
Sbjct: 186 QSDIWSMGLSLVEMAVGRYP 205

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 20/266 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVD 208
           ++V  ++G G F  VY   R+  +   A+K + KD+I    E  +   +  E  +L KV 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 209 HPF--IVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             F  +++L   F+      L+L+       LF  +  +G  +E+LAR +  +++ AV H
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 266 LHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLG 323
            H  G++HRD+K ENIL+D + G + L DFG +    ++T      GT  Y  PE I   
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGL 383
           + H ++A  WS+GILL++M+ G  PF                      +S E   L++  
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR------VSXECQHLIRWC 238
Query: 384 LQKEASKRLGSGPGGSQEIKSHKWFK 409
           L    S R        +EI++H W +
Sbjct: 239 LALRPSDR-----PTFEEIQNHPWMQ 259

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 112/219 (51%), Gaps = 18/219 (8%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ F+V ++ GQG F  V   +   T    A+K + +D        + M+     L  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD----LAVLH 77
Query: 209 HPFIVQLRYSFQT-----KYRLYL--VLDFV-NGGHLFFQLY--RQGLFREDLARIYTAE 258
           HP IVQL+  F T     +  +YL  V+++V +  H   + Y  RQ      L +++  +
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 259 IVSAVSHLH--ANGIMHRDLKPENILL-DADGHVMLTDFGLAKQFDENTRSNSMCGTLEY 315
           ++ ++  LH  +  + HRD+KP N+L+ +ADG + L DFG AK+   +  + +   +  Y
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 316 MSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
            +PE++ G  H   A D WSVG +  EM+ G+P F G N
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 122/259 (47%), Gaps = 40/259 (15%)
Query: 109 VEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQ 168
           + G+     + PN +  V A+ GK TG    +   N C         KV+G G+F  V+Q
Sbjct: 10  LNGVKLNPLDDPNKVIKVLASDGK-TGEQREIAYTN-C---------KVIGNGSFGVVFQ 58
Query: 169 VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF------QTK 222
            + + + E+   KV++  +        +   E  I+  V HP +V L+  F      + +
Sbjct: 59  AKLVESDEVAIKKVLQDKR--------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110
Query: 223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLA--------RIYTAEIVSAVSHLHANGIMHR 274
             L LVL++V        +YR       L         ++Y  +++ +++++H+ GI HR
Sbjct: 111 VFLNLVLEYVPE-----TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHR 165
Query: 275 DLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADW 332
           D+KP+N+LLD    V+ L DFG AK       + S   +  Y +PE++ G   +    D 
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNYTTNIDI 225
Query: 333 WSVGILLFEMLTGQPPFTG 351
           WS G ++ E++ GQP F G
Sbjct: 226 WSTGCVMAELMQGQPLFPG 244

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 111/212 (52%), Gaps = 23/212 (10%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL- 215
           ++GQGA A V++ R   T +++A+KV      +     +    E  +L K++H  IV+L 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLF 73
Query: 216 --RYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHAN 269
                  T++++ L+++F   G L+  L       GL   +   I   ++V  ++HL  N
Sbjct: 74  AIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHLREN 131
Query: 270 GIMHRDLKPENIL--LDADGHVM--LTDFGLAKQFDENTRSNSMCGTLEYMSPEI----V 321
           GI+HR++KP NI+  +  DG  +  LTDFG A++ +++ +   + GT EY+ P++    V
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAV 191
Query: 322 LGKGHDK----AADWWSVGILLFEMLTGQPPF 349
           L K H K      D WS+G+  +   TG  PF
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 121/251 (48%), Gaps = 17/251 (6%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKV 207
           ++ +  ++G+G F  V+   R+      A+KV+ +++++     + +     E  +L KV
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 208 D----HPFIVQLRYSFQTKYRLYLVLDF-VNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
                HP +++L   F+T+    LVL+  +    LF  +  +G   E  +R +  ++V+A
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 263 VSHLHANGIMHRDLKPENILLD-ADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-I 320
           + H H+ G++HRD+K ENIL+D   G   L DFG      +   ++   GT  Y  PE I
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWI 210
Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLL 380
              + H   A  WS+GILL++M+ G  PF                   PA +S +  +L+
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPAHVSPDCCALI 264
Query: 381 KGLLQKEASKR 391
           +  L  + S R
Sbjct: 265 RRCLAPKPSSR 275

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 48/133 (36%), Positives = 80/133 (60%), Gaps = 6/133 (4%)
Query: 222 KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE 279
           K  L ++++ + GG LF ++  +G   F E  A     +I +A+  LH++ I HRD+KPE
Sbjct: 98  KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE 157
Query: 280 NILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
           N+L    + D  + LTDFG AK+  +N      C T  Y++PE++  + +DK+ D WS+G
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEKYDKSCDMWSLG 216
Query: 337 ILLFEMLTGQPPF 349
           ++++ +L G PPF
Sbjct: 217 VIMYILLCGFPPF 229

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 48/133 (36%), Positives = 80/133 (60%), Gaps = 6/133 (4%)
Query: 222 KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPE 279
           K  L ++++ + GG LF ++  +G   F E  A     +I +A+  LH++ I HRD+KPE
Sbjct: 79  KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE 138
Query: 280 NILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
           N+L    + D  + LTDFG AK+  +N      C T  Y++PE++  + +DK+ D WS+G
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEKYDKSCDMWSLG 197
Query: 337 ILLFEMLTGQPPF 349
           ++++ +L G PPF
Sbjct: 198 VIMYILLCGFPPF 210

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  +L  V+
Sbjct: 21  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 79
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+    L  E ++ +   +++  
Sbjct: 80  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYL-LYQMLCG 136
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    N        T  Y +PE++L
Sbjct: 137 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVIL 196
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ E++ G   F G +
Sbjct: 197 GMGYKENVDIWSVGCIMGELVKGSVIFQGTD 227

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E +  +G GA+  VY+ R   +    A+K +R            + + R +     L  
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 207 VDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHLFF--QLYRQGLFREDLARIYTAEI 259
            +HP +V+L     T     + ++ LV + V+     +  +    GL  E +  +   + 
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR-QF 129
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +        +  TL Y +PE
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPE 189
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           ++L   +    D WSVG +  EM   +P F G +
Sbjct: 190 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 127/264 (48%), Gaps = 18/264 (6%)
Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY-MKSERNILTKVDHPFIVQL 215
           ++G+G++ KV +V    T    A+K+++K K+    + E  +K E  +L ++ H  ++QL
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 216 RYSF--QTKYRLYLVLDF-VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
                 + K ++Y+V+++ V G         +  F    A  Y  +++  + +LH+ GI+
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 273 HRDLKPENILLDADGHVMLTDFGLAKQF-----DENTRSNSMCGTLEYMSPEIVLGKGHD 327
           H+D+KP N+LL   G + ++  G+A+       D+  R++   G+  +  PEI  G    
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAFQPPEIANGLDTF 189
Query: 328 KA--ADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQ 385
                D WS G+ L+ + TG  PF G N              +P         LLKG+L+
Sbjct: 190 SGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLE 249
Query: 386 KEASKRLGSGPGGSQEIKSHKWFK 409
            E +KR        ++I+ H WF+
Sbjct: 250 YEPAKRF-----SIRQIRQHSWFR 268

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F +V+++    T    A+K +R    +E   AE + +   + +    P IV L  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVR----LEVFRAEELMACAGLTS----PRIVPLYG 152
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   +  QG   ED A  Y  + +  + +LH+  I+H D+K
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 278 PENILLDADG-HVMLTDFGLAKQFDENTRSNSMC------GTLEYMSPEIVLGKGHDKAA 330
            +N+LL +DG H  L DFG A     +    S+       GT  +M+PE+VLG+  D   
Sbjct: 213 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKV 272
Query: 331 DWWSVGILLFEMLTGQPPFT 350
           D WS   ++  ML G  P+T
Sbjct: 273 DVWSSCCMMLHMLNGCHPWT 292

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +EVLKV+G+G+F +V +       +  A+K++R +K   +  AE ++   + L K D   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH-LRKQDKDN 157
Query: 212 IVQLRYSFQT-KYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSAVSHLH 267
            + + +  +   +R ++ + F       ++L ++  F+     L R +   I+  +  LH
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 268 ANGIMHRDLKPENILLDADGH--VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
            N I+H DLKPENILL   G   + + DFG      E+ R  +   +  Y +PE++LG  
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILGAR 275
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +    D WS+G +L E+LTG P   G
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPG 301

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 6/208 (2%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L  +G+G +A VY+ +   T  + A+K +R +   E+        E ++L  + 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 58
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV L     T+  L LV ++++     +      +      +++  +++  +++ H 
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGL--AKQFDENTRSNSMCGTLEYMSPEIVLGK-G 325
             ++HRDLKP+N+L++  G + L DFGL  AK     T  N +  TL Y  P+I+LG   
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTD 177
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +    D W VG + +EM TG+P F G  
Sbjct: 178 YSTQIDMWGVGCIFYEMATGRPLFPGST 205

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +EVLKV+G+G+F +V +       +  A+K++R +K   +  AE ++   + L K D   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH-LRKQDKDN 157
Query: 212 IVQLRYSFQT-KYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSAVSHLH 267
            + + +  +   +R ++ + F       ++L ++  F+     L R +   I+  +  LH
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 268 ANGIMHRDLKPENILLDADGH--VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
            N I+H DLKPENILL   G   + + DFG      E+ R  +   +  Y +PE++LG  
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILGAR 275
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +    D WS+G +L E+LTG P   G
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPG 301

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +    +V  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLV-G 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG+++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 110/222 (49%), Gaps = 19/222 (8%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-- 203
           C   + +E +  +G+GA+ KV++ R +     +    +++ ++        + + R +  
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAV 64
Query: 204 ---LTKVDHPFIVQL-------RYSFQTKYRLYLVLDFVNGGHLFF--QLYRQGLFREDL 251
              L   +HP +V+L       R   +TK  L LV + V+     +  ++   G+  E +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
             +   +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +       S+  
Sbjct: 123 KDMM-FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           TL Y +PE++L   +    D WSVG +  EM   +P F G +
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +    +V  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLV-G 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG+++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 10/209 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 119
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 176
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           G G+ +  D WSVG ++ EM+  +  F G
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKILFPG 265

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 139
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN------- 202
           +DFE +  +G G    V +V+   +  I A K++         H E   + RN       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLI---------HLEIKPAIRNQIIRELQ 66
Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           +L + + P+IV    +F +   + + ++ ++GG L   L       E++    +  ++  
Sbjct: 67  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG 126
Query: 263 VSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +++L   + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YM+PE +
Sbjct: 127 LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMAPERL 185
Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPF 349
            G  +   +D WS+G+ L E+  G+ P 
Sbjct: 186 QGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 110/222 (49%), Gaps = 19/222 (8%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-- 203
           C   + +E +  +G+GA+ KV++ R +     +    +++ ++        + + R +  
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAV 64
Query: 204 ---LTKVDHPFIVQL-------RYSFQTKYRLYLVLDFVNGGHLFF--QLYRQGLFREDL 251
              L   +HP +V+L       R   +TK  L LV + V+     +  ++   G+  E +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
             +   +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +       S+  
Sbjct: 123 KDM-MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           TL Y +PE++L   +    D WSVG +  EM   +P F G +
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  +L  V+
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+    L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    N        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+    D WSVG ++ E++ G   F G +
Sbjct: 199 GMGYAANVDIWSVGCIMGELVKGCVIFQGTD 229

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 110/222 (49%), Gaps = 19/222 (8%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-- 203
           C   + +E +  +G+GA+ KV++ R +     +    +++ ++        + + R +  
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFV--ALKRVRVQTGEEGMPLSTIREVAV 64
Query: 204 ---LTKVDHPFIVQL-------RYSFQTKYRLYLVLDFVNGGHLFF--QLYRQGLFREDL 251
              L   +HP +V+L       R   +TK  L LV + V+     +  ++   G+  E +
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETK--LTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
             +   +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +       S+  
Sbjct: 123 KDM-MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           TL Y +PE++L   +    D WSVG +  EM   +P F G +
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 223

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E +  +G GA+  VY+ R   +    A+K +R   +        + + R +     L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGEEGLPISTVREVALLRRLEA 62
Query: 207 VDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHLFF--QLYRQGLFREDLARIYTAEI 259
            +HP +V+L     T     + ++ LV + V+     +  +    GL  E +  +   + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR-QF 121
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +      + +  TL Y +PE
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPE 181
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           ++L   +    D WSVG +  EM   +P F G +
Sbjct: 182 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 215

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F +V+++    T    A+K +R    +E   AE + +   + +    P IV L  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVR----LEVFRAEELMACAGLTS----PRIVPLYG 133
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   +  QG   ED A  Y  + +  + +LH+  I+H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 278 PENILLDADG-HVMLTDFGLAKQFDENTRSNSMC------GTLEYMSPEIVLGKGHDKAA 330
            +N+LL +DG H  L DFG A     +     +       GT  +M+PE+VLG+  D   
Sbjct: 194 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKV 253
Query: 331 DWWSVGILLFEMLTGQPPFT 350
           D WS   ++  ML G  P+T
Sbjct: 254 DVWSSCCMMLHMLNGCHPWT 273

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 9/206 (4%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +EVLKV+G+G F +V +       +  A+K++R +K   +  AE ++   + L K D   
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEH-LRKQDKDN 157
Query: 212 IVQLRYSFQT-KYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSAVSHLH 267
            + + +  +   +R ++ + F       ++L ++  F+     L R +   I+  +  LH
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 268 ANGIMHRDLKPENILLDADGH--VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
            N I+H DLKPENILL   G   + + DFG      E+ R      +  Y +PE++LG  
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYXXIQSRFYRAPEVILGAR 275
Query: 326 HDKAADWWSVGILLFEMLTGQPPFTG 351
           +    D WS+G +L E+LTG P   G
Sbjct: 276 YGMPIDMWSLGCILAELLTGYPLLPG 301

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 10/209 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 119
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 176
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           G G+ +  D WSVG ++ EM+  +  F G
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKILFPG 265

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 83
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 84  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 140
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 141 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVIL 200
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 201 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 231

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +    +V  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYLLYQMLV-G 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+ G   F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 139
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 230

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 82
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 139
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 230

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 75
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 80
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 81  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 137
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 138 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 197
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 198 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 228

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 229

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 75
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 193 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 229

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 229

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 229

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYL-LYQMLXG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 229

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 111/216 (51%), Gaps = 9/216 (4%)
Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           ++N  V  +D E +  +G+GA+  V ++R + + +I A+K +R     ++     M  + 
Sbjct: 43  NQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 102
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQG-LFREDLARIYTAE 258
           ++ T VD PF V    +   +  +++ ++ ++      + Q+  +G    ED+       
Sbjct: 103 SMRT-VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVS 161
Query: 259 IVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
           IV A+ HLH+   ++HRD+KP N+L++A G V + DFG++    ++       G   YM+
Sbjct: 162 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMA 221
Query: 318 PEIV----LGKGHDKAADWWSVGILLFEMLTGQPPF 349
           PE +      KG+   +D WS+GI + E+   + P+
Sbjct: 222 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 257

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 15/215 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E+  ++G+G+F +V +       E  A+K+++  K    N A+       ++ K D
Sbjct: 34  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-LNQAQIEVRLLELMNKHD 92
Query: 209 HP---FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSA 262
                +IV L+  F  +  L LV + ++  +  + L R   FR    +L R +  ++ +A
Sbjct: 93  TEMKYYIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 150
Query: 263 VSHLHAN--GIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           +  L      I+H DLKPENILL       + + DFG + Q  +  R      +  Y SP
Sbjct: 151 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSP 208
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           E++LG  +D A D WS+G +L EM TG+P F+G N
Sbjct: 209 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 243

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 16/214 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E +  +G GA+  VY+ R   +    A+K +R   +        + + R +     L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGEEGLPISTVREVALLRRLEA 62
Query: 207 VDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHLFF--QLYRQGLFREDLARIYTAEI 259
            +HP +V+L     T     + ++ LV + V+     +  +    GL  E +  +   + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR-QF 121
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +        +  TL Y +PE
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPE 181
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           ++L   +    D WSVG +  EM   +P F G +
Sbjct: 182 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 215

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  +  +E L  +GQG F +V++ R   T +  A+K     K++ +N  E        E 
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 68
Query: 202 NILTKVDHPFIVQLRYSFQTKYR--------LYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            IL  + H  +V L    +TK          +YLV DF    H    L    L +  L+ 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--HDLAGLLSNVLVKFTLSE 126
Query: 254 I--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSM 309
           I      +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F   +N++ N  
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 310 CG---TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                TL Y  PE++LG + +    D W  G ++ EM T  P   G  
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 234

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 15/215 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E+  ++G+G+F +V +       E  A+K+++  K    N A+       ++ K D
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-LNQAQIEVRLLELMNKHD 111
Query: 209 HP---FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSA 262
                +IV L+  F  +  L LV + ++  +  + L R   FR    +L R +  ++ +A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 263 VSHLHAN--GIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           +  L      I+H DLKPENILL       + + DFG + Q  +  R      +  Y SP
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSP 227
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           E++LG  +D A D WS+G +L EM TG+P F+G N
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 86
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 87  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 143
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 144 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 203
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 204 GMGYKENVDLWSVGCIMGEMVCHKILFPGRD 234

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAE----YMKSER 201
           C  +  +E L  +GQG F +V++ R   T +  A+K     K++ +N  E        E 
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 68
Query: 202 NILTKVDHPFIVQLRYSFQTKYR--------LYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            IL  + H  +V L    +TK          +YLV DF    H    L    L +  L+ 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCE--HDLAGLLSNVLVKFTLSE 126
Query: 254 I--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSM 309
           I      +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F   +N++ N  
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 310 CG---TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                TL Y  PE++LG + +    D W  G ++ EM T  P   G  
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 234

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYL-LYQMLXG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 229

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      YLV++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMELDHERMSYL-LYQMLXG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK----SER 201
           C  +  +E L  +GQG F +V++ R   T +  A+K     K++ +N  E        E 
Sbjct: 14  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 68
Query: 202 NILTKVDHPFIVQLRYSFQTKYR--------LYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            IL  + H  +V L    +TK          +YLV DF    H    L    L +  L+ 
Sbjct: 69  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--HDLAGLLSNVLVKFTLSE 126
Query: 254 I--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSM 309
           I      +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F   +N++ N  
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 310 CG---TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                TL Y  PE++LG + +    D W  G ++ EM T  P   G  
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 234

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAE----YMKSER 201
           C  +  +E L  +GQG F +V++ R   T +  A+K     K++ +N  E        E 
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREI 67
Query: 202 NILTKVDHPFIVQLRYSFQTKYR--------LYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
            IL  + H  +V L    +TK          +YLV DF    H    L    L +  L+ 
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--HDLAGLLSNVLVKFTLSE 125
Query: 254 I--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSM 309
           I      +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F   +N++ N  
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 310 CG---TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                TL Y  PE++LG + +    D W  G ++ EM T  P   G  
Sbjct: 186 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 111/228 (48%), Gaps = 37/228 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEI-------------YAMKVMRKDKIMEKNHAEYM 197
           DF++  ++G+GA+  V       T EI             +A++ +R+ KI++     + 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK-----HF 66
Query: 198 KSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
           K E NI+T     F +Q   SF+    +Y++ + +       ++    +  +D  + +  
Sbjct: 67  KHE-NIITI----FNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIY 119
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS--------- 308
           + + AV  LH + ++HRDLKP N+L++++  + + DFGLA+  DE+   NS         
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 309 --MCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGN 353
                T  Y +PE++L    + +A D WS G +L E+   +P F G +
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 75
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 76  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 133 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 192
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 193 GMGYKENVDLWSVGCIMGEMVCHKILFPGRD 223

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 15/215 (6%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E+  ++G+G+F +V +       E  A+K+++  K    N A+       ++ K D
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF-LNQAQIEVRLLELMNKHD 111
Query: 209 HP---FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAEIVSA 262
                +IV L+  F  +  L LV + ++  +  + L R   FR    +L R +  ++ +A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLS--YNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 263 VSHLHAN--GIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           +  L      I+H DLKPENILL       + + DFG + Q  +  R      +  Y SP
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQ--RIYQXIQSRFYRSP 227
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           E++LG  +D A D WS+G +L EM TG+P F+G N
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 109/211 (51%), Gaps = 9/211 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  +D E +  +G+GA+  V ++R + + +I A+K +R     ++     M  + ++ T 
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT- 62
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQG-LFREDLARIYTAEIVSAV 263
           VD PF V    +   +  +++ ++ ++      + Q+  +G    ED+       IV A+
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 264 SHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV- 321
            HLH+   ++HRD+KP N+L++A G V + DFG++    ++   +   G   YM+PE + 
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERIN 182
Query: 322 ---LGKGHDKAADWWSVGILLFEMLTGQPPF 349
                KG+   +D WS+GI + E+   + P+
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPY 213

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 111/228 (48%), Gaps = 37/228 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEI-------------YAMKVMRKDKIMEKNHAEYM 197
           DF++  ++G+GA+  V       T EI             +A++ +R+ KI++     + 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK-----HF 66
Query: 198 KSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
           K E NI+T     F +Q   SF+    +Y++ + +       ++    +  +D  + +  
Sbjct: 67  KHE-NIITI----FNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIY 119
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS--------- 308
           + + AV  LH + ++HRDLKP N+L++++  + + DFGLA+  DE+   NS         
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 309 --MCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGN 353
                T  Y +PE++L    + +A D WS G +L E+   +P F G +
Sbjct: 180 TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 16/214 (7%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-----LTK 206
           +E +  +G GA+  VY+ R   +    A+K +R   +        + + R +     L  
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGEEGLPISTVREVALLRRLEA 62
Query: 207 VDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHLFF--QLYRQGLFREDLARIYTAEI 259
            +HP +V+L     T     + ++ LV + V+     +  +    GL  E +  +   + 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR-QF 121
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +        +  TL Y +PE
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPE 181
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           ++L   +    D WSVG +  EM   +P F G +
Sbjct: 182 VLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 215

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 111/228 (48%), Gaps = 37/228 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEI-------------YAMKVMRKDKIMEKNHAEYM 197
           DF++  ++G+GA+  V       T EI             +A++ +R+ KI++     + 
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK-----HF 66
Query: 198 KSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
           K E NI+T     F +Q   SF+    +Y++ + +       ++    +  +D  + +  
Sbjct: 67  KHE-NIITI----FNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIY 119
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS--------- 308
           + + AV  LH + ++HRDLKP N+L++++  + + DFGLA+  DE+   NS         
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 309 --MCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGN 353
                T  Y +PE++L    + +A D WS G +L E+   +P F G +
Sbjct: 180 TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDLWSVGCIMGEMVCHKILFPGRD 229

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 81
Query: 209 HPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +  L      Y+V++ ++      Q+ +  L  E ++ +   +++  
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYL-LYQMLCG 138
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVIL 198
Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           G G+ +  D WSVG ++ EM+  +  F G +
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVCHKILFPGRD 229

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 109/210 (51%), Gaps = 18/210 (8%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  ++ EV +VVG+GAF  V + +       +  K +   +I  ++  +    E   L++
Sbjct: 6   IDYKEIEVEEVVGRGAFGVVCKAK-------WRAKDVAIKQIESESERKAFIVELRQLSR 58
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAV 263
           V+HP IV+L  +      + LV+++  GG L+  L+       +    A  +  +    V
Sbjct: 59  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 116
Query: 264 SHLHA---NGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           ++LH+     ++HRDLKP N+LL A G V+ + DFG A     +  +N   G+  +M+PE
Sbjct: 117 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE 174
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           +  G  + +  D +S GI+L+E++T + PF
Sbjct: 175 VFEGSNYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 26/231 (11%)
Query: 140 LPSENQCVGLEDFEV------LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH 193
           +P E + V  + F+V      L+ +G+GA+  V          +   +V  K KI    H
Sbjct: 27  VPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSS----AYDHVRKTRVAIK-KISPFEH 81
Query: 194 AEYMKS---ERNILTKVDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGHLFFQLYRQG 245
             Y +    E  IL +  H  ++ +R      + +    +Y+V D +      ++L +  
Sbjct: 82  QTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETD--LYKLLKSQ 139
Query: 246 LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK----QFD 301
               D    +  +I+  + ++H+  ++HRDLKP N+L++    + + DFGLA+    + D
Sbjct: 140 QLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHD 199
Query: 302 ENTRSNSMCGTLEYMSPEIVL-GKGHDKAADWWSVGILLFEMLTGQPPFTG 351
                     T  Y +PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 HTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 28/229 (12%)
Query: 142 SENQCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           S N+C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S
Sbjct: 46  SANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDS 100
Query: 200 ERNILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI 254
            RN +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + 
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKS 159
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCG 311
           Y   ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  G
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 312 TLEYMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
           T+ YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 219 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 127/250 (50%), Gaps = 13/250 (5%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D  + + +G G+F  V++    G+    A+K++ +     +   E+++ E  I+ ++ HP
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLR-EVAIMKRLRHP 94
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---ARIYTA-EIVSAVSHL 266
            IV    +      L +V ++++ G L+  L++ G  RE L    R+  A ++   +++L
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYL 153
Query: 267 HANG--IMHRDLKPENILLDADGHVMLTDFGLAK-QFDENTRSNSMCGTLEYMSPEIVLG 323
           H     I+HR+LK  N+L+D    V + DFGL++ +      S S  GT E+M+PE++  
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN--RXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
           +  ++ +D +S G++L+E+ T Q P+   N  +             +P  L+ +  ++++
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 382 GLLQKEASKR 391
           G    E  KR
Sbjct: 274 GCWTNEPWKR 283

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 126/250 (50%), Gaps = 13/250 (5%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D  + + +G G+F  V++    G+    A+K++ +     +   E+++ E  I+ ++ HP
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLR-EVAIMKRLRHP 94
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---ARIYTA-EIVSAVSHL 266
            IV    +      L +V ++++ G L+  L++ G  RE L    R+  A ++   +++L
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYL 153
Query: 267 HANG--IMHRDLKPENILLDADGHVMLTDFGLAK-QFDENTRSNSMCGTLEYMSPEIVLG 323
           H     I+HRDLK  N+L+D    V + DFGL++ +      S    GT E+M+PE++  
Sbjct: 154 HNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRD 213
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN--RXXXXXXXXXXXXXLPAFLSSEAHSLLK 381
           +  ++ +D +S G++L+E+ T Q P+   N  +             +P  L+ +  ++++
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 382 GLLQKEASKR 391
           G    E  KR
Sbjct: 274 GCWTNEPWKR 283

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 109/210 (51%), Gaps = 18/210 (8%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  ++ EV +VVG+GAF  V + +       +  K +   +I  ++  +    E   L++
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAK-------WRAKDVAIKQIESESERKAFIVELRQLSR 57
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ---GLFREDLARIYTAEIVSAV 263
           V+HP IV+L  +      + LV+++  GG L+  L+       +    A  +  +    V
Sbjct: 58  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 264 SHLHA---NGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           ++LH+     ++HRDLKP N+LL A G V+ + DFG A     +  +N   G+  +M+PE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE 173
Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           +  G  + +  D +S GI+L+E++T + PF
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 121/233 (51%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR-- 184
           D    +P  + D      +    +D+++++ +G+G +++V++   I  +E   +K+++  
Sbjct: 14  DVNTHRPREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV 73
Query: 185 -KDKI-MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            K+KI  E    E ++   NI+T  D   IV+   S        LV + VN    F QLY
Sbjct: 74  KKNKIKREIKILENLRGGPNIITLAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLY 125
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFD 301
            Q L   D+ R Y  EI+ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 126 -QTLTDYDI-RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +L  M+  + PF  G+
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 28/229 (12%)
Query: 142 SENQCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           S N+C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S
Sbjct: 46  SANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDS 100
Query: 200 ERNILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI 254
            RN +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + 
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKS 159
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCG 311
           Y   ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  G
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 312 TLEYMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
           T+ YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 219 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 117/247 (47%), Gaps = 20/247 (8%)
Query: 171 RIGTSEIYAMKVMRKDKIM---EKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRL 225
           R+  +   A+K + KD+I    E  +   +  E  +L KV   F  +++L   F+     
Sbjct: 72  RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 131
Query: 226 YLVLDFVNGGH-LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
            L+L+       LF  +  +G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D
Sbjct: 132 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 191
Query: 285 AD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEM 342
            + G + L DFG +    ++T      GT  Y  PE I   + H ++A  WS+GILL++M
Sbjct: 192 LNRGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 250
Query: 343 LTGQPPFTGGNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEI 402
           + G  PF                      +SSE   L++  L    S R        +EI
Sbjct: 251 VCGDIPFEHDEEIIRGQVFFRQR------VSSECQHLIRWCLALRPSDR-----PTFEEI 299
Query: 403 KSHKWFK 409
           ++H W +
Sbjct: 300 QNHPWMQ 306

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           VG+G+F +V++++   T    A+K +R +         +   E      +  P IV L  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYG 117
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   + + G   ED A  Y  + +  + +LH   I+H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 278 PENILLDADG-HVMLTDFGLAKQFDENTRSNSMC------GTLEYMSPEIVLGKGHDKAA 330
            +N+LL +DG    L DFG A     +    S+       GT  +M+PE+V+GK  D   
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 237
Query: 331 DWWSVGILLFEMLTGQPPFT 350
           D WS   ++  ML G  P+T
Sbjct: 238 DIWSSCCMMLHMLNGCHPWT 257

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +R+I   E   Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 92  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 104/236 (44%), Gaps = 56/236 (23%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR-------KDKIMEKNHAEYMKSER 201
           L DFE ++ +G+G F  V++ +       YA+K +R       ++K+M +  A       
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKA------- 56
Query: 202 NILTKVDHPFIVQLRYSFQTKY----------RLYLVL-----------DFVNGGHLFFQ 240
             L K++HP IV+   ++  K           ++YL +           D++NG     +
Sbjct: 57  --LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE 114
Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
             R       L      +I  AV  LH+ G+MHRDLKP NI    D  V + DFGL    
Sbjct: 115 RERSVCLHIFL------QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 168
Query: 301 DEN-------------TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
           D++              R     GT  YMSPE + G  +    D +S+G++LFE+L
Sbjct: 169 DQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           VG+G+F +V++++   T    A+K +R +         +   E      +  P IV L  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYG 133
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   + + G   ED A  Y  + +  + +LH   I+H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 278 PENILLDADG-HVMLTDFGLAKQFDENTRSNSMC------GTLEYMSPEIVLGKGHDKAA 330
            +N+LL +DG    L DFG A     +    S+       GT  +M+PE+V+GK  D   
Sbjct: 194 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 253
Query: 331 DWWSVGILLFEMLTGQPPFT 350
           D WS   ++  ML G  P+T
Sbjct: 254 DIWSSCCMMLHMLNGCHPWT 273

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 112/227 (49%), Gaps = 28/227 (12%)
Query: 144 NQCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           N+C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S R
Sbjct: 1   NECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDSYR 55
Query: 202 NILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYT 256
           N +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + Y 
Sbjct: 56  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYW 114
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTL 313
             ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  GT+
Sbjct: 115 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 314 EYMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
            YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 112/229 (48%), Gaps = 28/229 (12%)
Query: 142 SENQCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           S N+C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S
Sbjct: 46  SANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDS 100
Query: 200 ERNILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI 254
            RN +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + 
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKS 159
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCG 311
           Y   ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  G
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVG 218
Query: 312 TLEYMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
            + YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 92  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 33  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 93  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 140
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 235

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 112/227 (49%), Gaps = 28/227 (12%)
Query: 144 NQCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           N+C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S R
Sbjct: 4   NECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDSYR 58
Query: 202 NILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYT 256
           N +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + Y 
Sbjct: 59  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYW 117
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTL 313
             ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  GT+
Sbjct: 118 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 176
Query: 314 EYMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
            YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 177 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 223

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 113/233 (48%), Gaps = 19/233 (8%)
Query: 161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ 220
           GA   + ++ R   SE++A +  R+ ++++     +M+ E N++  +D   +     +  
Sbjct: 50  GAKVAIKKLYRPFQSELFAKRAYRELRLLK-----HMRHE-NVIGLLD---VFTPDETLD 100
Query: 221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN 280
                YLV+ F+  G    +L +     ED  +    +++  + ++HA GI+HRDLKP N
Sbjct: 101 DFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGN 158
Query: 281 ILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILL 339
           + ++ D  + + DFGLA+Q D       +  T  Y +PE++L    + +  D WSVG ++
Sbjct: 159 LAVNEDCELKILDFGLARQADSEMXGXVV--TRWYRAPEVILNWMRYTQTVDIWSVGCIM 216
Query: 340 FEMLTGQPPFTGGNRXXXXXXXXXXXXXLPA-----FLSSEAHSLLKGLLQKE 387
            EM+TG+  F G +               PA       S EA + +KGL + E
Sbjct: 217 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 269

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 88  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 36  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 95
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 96  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 143
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 144 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 204 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 238

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 88  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 33  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 93  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 140
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 141 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 235

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 34  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 93
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 94  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 141
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 142 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 202 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 236

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 25  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 84
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 85  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 132
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 133 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 193 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 227

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 92  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 30  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 89
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 90  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 137
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F +V++++   T    A+K +R +         +   E      +  P IV L  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYG 131
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
           + +    + + ++ + GG L   + + G   ED A  Y  + +  + +LH   I+H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 278 PENILLDADG-HVMLTDFGLAKQFDENTRSNSMC------GTLEYMSPEIVLGKGHDKAA 330
            +N+LL +DG    L DFG A     +    S+       GT  +M+PE+V+GK  D   
Sbjct: 192 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 251
Query: 331 DWWSVGILLFEMLTGQPPFT 350
           D WS   ++  ML G  P+T
Sbjct: 252 DIWSSCCMMLHMLNGCHPWT 271

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 26  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 86  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 133
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 228

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 48  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 108 DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 155
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 92  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 88  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 26  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 86  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 133
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 134 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 228

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 127/278 (45%), Gaps = 51/278 (18%)
Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +    + ++ +      
Sbjct: 16  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC----- 70
Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I  
Sbjct: 71  --PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 262 AVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+                   
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------------- 169
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPF--------TGGNRXXXXXXXXXXXXXLPA 370
               G+ +DK+ D WS+G++++ +L G PPF        + G +               +
Sbjct: 170 --TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227
Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
            +S E   L++ LL+ E ++R+        E  +H W 
Sbjct: 228 EVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWI 260

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 88  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKVYQ-----------VRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 92  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKCQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 48  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +YLV   + G  L+  L  Q L  + +   +  +I+ 
Sbjct: 108 DIIRA---PTIEQMK-------DVYLVTHLM-GADLYKLLKTQHLSNDHIC-YFLYQILR 155
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 156 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 250

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 28  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 88  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 135
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 136 GLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 230

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+     E +    
Sbjct: 30  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 90  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 137
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+ +   E +    
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGIN 91
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 92  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 139
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 117/248 (47%), Gaps = 24/248 (9%)
Query: 111 GINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVR 170
           G  E   +GP ++SV  A            PS      ++ +  +  +G+G + +VY+  
Sbjct: 10  GTLEAQTQGPGSMSVSAA------------PS---ATSIDRYRRITKLGEGTYGEVYKAI 54
Query: 171 RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD 230
              T+E  A+K +R +   E      ++ E ++L ++ H  I++L+      +RL+L+ +
Sbjct: 55  DTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113
Query: 231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADG 287
           +     L   + +       + + +  ++++ V+  H+   +HRDLKP+N+LL   DA  
Sbjct: 114 YAEND-LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASE 172
Query: 288 HVMLT--DFGLAKQFDENTRS-NSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEML 343
             +L   DFGLA+ F    R       TL Y  PEI+LG  H   + D WS+  +  EML
Sbjct: 173 TPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232
Query: 344 TGQPPFTG 351
              P F G
Sbjct: 233 MKTPLFPG 240

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 108/230 (46%), Gaps = 39/230 (16%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           F V++ +G G F +V   + I   + YA+KV+R  K     +    K E +IL K+ +  
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDD 92
Query: 212 IVQ---LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVS 264
           I     ++Y  +  Y  ++ L F   G   +++  +    G   ED+ ++Y  EI+ A++
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDI-KLYCIEILKALN 151
Query: 265 HLHANGIMHRDLKPENILLD--------------ADGH-----------VMLTDFGLAKQ 299
           +L    + H DLKPENILLD               DG            + L DFG A  
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
             ++    S+  T +Y +PE++L  G D ++D WS G +L E+ TG   F
Sbjct: 212 --KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 86
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-----DLARIYTAEIVSAVSHLHANGIM 272
            + TK +L +V  +  G  L+  L+      E     D+AR    +    + +LHA  I+
Sbjct: 87  GYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLHAKSII 142
Query: 273 HRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN---SMCGTLEYMSPEIVLGKGHDK- 328
           HRDLK  NI L  D  V + DFGLA +    + S+    + G++ +M+PE++  +  +  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 329 --AADWWSVGILLFEMLTGQPPFTGGN 353
              +D ++ GI+L+E++TGQ P++  N
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 155 LKVVGQGAFAKV-----------YQVRRIGTSE--IYAMKVMRKDKIMEKNHAEYMKSER 201
           L  +G+GA+  V             +++I   E   Y  + +R+ KI+     E +    
Sbjct: 30  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           +I+     P I Q++        +Y+V D +      ++L +      D    +  +I+ 
Sbjct: 90  DIIRA---PTIEQMK-------DVYIVQDLMETD--LYKLLKTQHLSNDHICYFLYQILR 137
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----CGTLEYMS 317
            + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +
Sbjct: 138 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 318 PEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTG 351
           PEI+L  KG+ K+ D WSVG +L EML+ +P F G
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 232

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 74
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-----DLARIYTAEIVSAVSHLHANGIM 272
            + TK +L +V  +  G  L+  L+      E     D+AR    +    + +LHA  I+
Sbjct: 75  GYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLHAKSII 130
Query: 273 HRDLKPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK- 328
           HRDLK  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  +  
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 329 --AADWWSVGILLFEMLTGQPPFTGGN 353
              +D ++ GI+L+E++TGQ P++  N
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLPYSNIN 217

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF+ ++++G G F +V++ +     + Y +K +       K + E  + E   L K+DH 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNNEKAEREVKALAKLDHV 64
Query: 211 FIVQL---------------RYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
            IV                 + S ++K + L++ ++F + G L  + +  R     + LA
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT 312
                +I   V ++H+  +++RDLKP NI L     V + DFGL      + +     GT
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGT 184
Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
           L YMSPE +  + + K  D +++G++L E+L
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           L+ VG GA+  V         +  A+K + +       HA     E  +L  + H  ++ 
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 215 L------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           L        S +    +YLV   + G  L   +  Q L  E + +    +++  + ++H+
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKSQALSDEHV-QFLVYQLLRGLKYIHS 149
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-D 327
            GI+HRDLKP N+ ++ D  + + DFGLA+Q DE         T  Y +PEI+L   H +
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM--TGYVATRWYRAPEIMLNWMHYN 207
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
           +  D WSVG ++ E+L G+  F G +
Sbjct: 208 QTVDIWSVGCIMAELLQGKALFPGSD 233

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 70
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 71  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 277 KPENILLDADGHVMLTDFGLAKQFDENTRSN---SMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA +    + S+    + G++ +M+PE++  +  DK     
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 188
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 112/231 (48%), Gaps = 26/231 (11%)
Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM 197
           +NL  ++  V    + +LK +G G  +KV+QV      +IYA+K +     +E+   + +
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTL 70
Query: 198 KSERNILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLA 252
            S RN +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWER 129
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSM 309
           + Y   ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S 
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 310 CGTLEYMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
            GT+ YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 75
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 76  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 277 KPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  DK     
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 193
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 28/226 (12%)
Query: 145 QCVGLED--FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           +C+ ++   + +LK +G G  +KV+QV      +IYA+K +     +E+   + + S RN
Sbjct: 1   ECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTLDSYRN 55
Query: 203 ILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
            +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        + Y  
Sbjct: 56  EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYWK 114
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLE 314
            ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  GT+ 
Sbjct: 115 NMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 173
Query: 315 YMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
           YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 174 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 219

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 98
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 99  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 277 KPENILLDADGHVMLTDFGLAKQFDENTRSN---SMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA +    + S+    + G++ +M+PE++  +  DK     
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 216
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 75
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 76  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 277 KPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  DK     
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 193
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 70
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 71  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 277 KPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  DK     
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 188
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 72
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 73  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 132
Query: 277 KPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  DK     
Sbjct: 133 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 190
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 191 QSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 90
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 91  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 150
Query: 277 KPENILLDADGHVMLTDFGLAKQFDENTRSN---SMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA +    + S+    + G++ +M+PE++  +  DK     
Sbjct: 151 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 208
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 209 QSDVYAFGIVLYELMTGQLPYSNIN 233

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           L+ VG GA+  V         +  A+K + +       HA     E  +L  + H  ++ 
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 215 L------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           L        S +    +YLV   + G  L   +  Q L  E + +    +++  + ++H+
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHV-QFLVYQLLRGLKYIHS 149
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-D 327
            GI+HRDLKP N+ ++ D  + + DFGLA+Q DE         T  Y +PEI+L   H +
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM--TGYVATRWYRAPEIMLNWMHYN 207
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
           +  D WSVG ++ E+L G+  F G +
Sbjct: 208 QTVDIWSVGCIMAELLQGKALFPGSD 233

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT----- 64
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +   F  DLA +  Y  ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMA 180
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 108/211 (51%), Gaps = 33/211 (15%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMK-VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           +V+G+G F +  +V    T E+  MK ++R D   E+    ++K E  ++  ++HP +++
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLK-EVKVMRCLEHPNVLK 71
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-------YTAEIVSAVSHLH 267
                    RL  + +++ GG L      +G+ +   ++        +  +I S +++LH
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTL------RGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAK-QFDENT--------------RSNSMCGT 312
           +  I+HRDL   N L+  + +V++ DFGLA+   DE T              +  ++ G 
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
             +M+PE++ G+ +D+  D +S GI+L E++
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 98
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 99  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 277 KPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  DK     
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 216
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           L+ VG GA+  V         +  A+K + +       HA     E  +L  + H  ++ 
Sbjct: 25  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIG 83
Query: 215 L------RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           L        S +    +YLV   + G  L   +  Q L  E + +    +++  + ++H+
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHV-QFLVYQLLRGLKYIHS 141
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-D 327
            GI+HRDLKP N+ ++ D  + + DFGLA+Q DE         T  Y +PEI+L   H +
Sbjct: 142 AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEM--TGYVATRWYRAPEIMLNWMHYN 199
Query: 328 KAADWWSVGILLFEMLTGQPPFTGGN 353
           +  D WSVG ++ E+L G+  F G +
Sbjct: 200 QTVDIWSVGCIMAELLQGKALFPGSD 225

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 97
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + TK +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 98  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 157
Query: 277 KPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  DK     
Sbjct: 158 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 215
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 216 QSDVYAFGIVLYELMTGQLPYSNIN 240

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 105/216 (48%), Gaps = 11/216 (5%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN 202
           EN  V  +D E +  +G+GA+  V + R + + +I A+K +R    +     + +  + +
Sbjct: 27  ENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRA--TVNSQEQKRLLXDLD 84
Query: 203 ILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGG--HLFFQLYRQG-LFREDLARIYTAE 258
           I  + VD PF V    +   +  +++  +  +      + Q+  +G    ED+       
Sbjct: 85  ISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVS 144
Query: 259 IVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
           IV A+ HLH+   ++HRD+KP N+L++A G V   DFG++    ++   +   G   Y +
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXA 204
Query: 318 PEIV----LGKGHDKAADWWSVGILLFEMLTGQPPF 349
           PE +      KG+   +D WS+GI   E+   + P+
Sbjct: 205 PERINPELNQKGYSVKSDIWSLGITXIELAILRFPY 240

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 86
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-----DLARIYTAEIVSAVSHLHANGIM 272
            + T  +L +V  +  G  L+  L+      E     D+AR    +    + +LHA  I+
Sbjct: 87  GYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR----QTARGMDYLHAKSII 142
Query: 273 HRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN---SMCGTLEYMSPEIVLGKGHDK- 328
           HRDLK  NI L  D  V + DFGLA +    + S+    + G++ +M+PE++  +  +  
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 329 --AADWWSVGILLFEMLTGQPPFTGGN 353
              +D ++ GI+L+E++TGQ P++  N
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 116/270 (42%), Gaps = 22/270 (8%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR---KDKIMEKNHAEYMKSERNILTK 206
           E + + + +G+G F  V++     + + Y  K ++    D+++       +K E +IL  
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-------VKKEISILNI 57
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSH 265
             H  I+ L  SF++   L ++ +F++G  +F ++        E     Y  ++  A+  
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 266 LHANGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           LH++ I H D++PENI+        + + +FG A+Q         +    EY +PE+   
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGNRXXXXXXXXXXXXXL--PAF--LSSEAHSL 379
                A D WS+G L++ +L+G  PF                      AF  +S EA   
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           +  LL KE   R+ +      E   H W K
Sbjct: 238 VDRLLVKERKSRMTAS-----EALQHPWLK 262

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 67
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 68  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 123
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 124 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 183
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 184 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 218

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT----- 92
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 93  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 148
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 149 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 208
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 209 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 243

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT----- 69
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 70  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 125
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 185
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-----T 66
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 67  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 122
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 123 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 182
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 183 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 217

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT----- 64
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +   F  DLA +  Y  ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ A   V L DFGL++  +++T   +  G L  ++M+
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT----- 61
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 62  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 117
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT----- 64
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQILRGL 134
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 192
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT----- 64
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +  L   DLA +  Y  ++
Sbjct: 65  MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSL---DLASLILYAYQL 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 121 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 180
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 181 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 99
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 158 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 215
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 100
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 159 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 216
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 93/194 (47%), Gaps = 15/194 (7%)
Query: 161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ 220
           G    + ++ R   SEI+A +  R+  +++    E +    ++ T            S +
Sbjct: 49  GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS---------SLR 99
Query: 221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN 280
             Y  YLV+ F+       Q      F E+  +    +++  + ++H+ G++HRDLKP N
Sbjct: 100 NFYDFYLVMPFMQTD---LQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGN 156
Query: 281 ILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILL 339
           + ++ D  + + DFGLA+  D          T  Y +PE++L   H ++  D WSVG ++
Sbjct: 157 LAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 214
Query: 340 FEMLTGQPPFTGGN 353
            EMLTG+  F G +
Sbjct: 215 AEMLTGKTLFKGKD 228

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL-----T 444
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +   F  DLA +  Y  ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ A   V L DFGL++  +++T   +  G L  ++M+
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 93/194 (47%), Gaps = 15/194 (7%)
Query: 161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ 220
           G    + ++ R   SEI+A +  R+  +++    E +    ++ T            S +
Sbjct: 67  GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS---------SLR 117
Query: 221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN 280
             Y  YLV+ F+       Q      F E+  +    +++  + ++H+ G++HRDLKP N
Sbjct: 118 NFYDFYLVMPFMQTD---LQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGN 174
Query: 281 ILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILL 339
           + ++ D  + + DFGLA+  D          T  Y +PE++L   H ++  D WSVG ++
Sbjct: 175 LAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 232
Query: 340 FEMLTGQPPFTGGN 353
            EMLTG+  F G +
Sbjct: 233 AEMLTGKTLFKGKD 246

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           DF+ ++++G G F +V++ +     + Y ++ +       K + E  + E   L K+DH 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV-------KYNNEKAEREVKALAKLDHV 65
Query: 211 FIVQL----------------------------RYSFQTKYR-LYLVLDFVNGGHL--FF 239
            IV                              + S ++K + L++ ++F + G L  + 
Sbjct: 66  NIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI 125
Query: 240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ 299
           +  R     + LA     +I   V ++H+  ++HRDLKP NI L     V + DFGL   
Sbjct: 126 EKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
              + +     GTL YMSPE +  + + K  D +++G++L E+L
Sbjct: 186 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y     GT E+ A+K ++ D      H    K E +IL  + H 
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHE 93
Query: 211 FIVQLRYSFQTK--YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            I++ +   +      L LV+++V  G L   L R  +    L  ++  +I   +++LHA
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLL-LFAQQICEGMAYLHA 152
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-----NTRSNSMCGTLEYMSPEIVLG 323
              +HRDL   N+LLD D  V + DFGLAK   E       R +       Y +PE +  
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APECLKE 211
Query: 324 KGHDKAADWWSVGILLFEMLT 344
                A+D WS G+ L+E+LT
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           E  E+ + +G+G F  V+Q   +          I   K    D + EK   E +      
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL-----T 444
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEI 259
           + + DHP IV+L     T+  ++++++    G L  F Q+ +   F  DLA +  Y  ++
Sbjct: 445 MRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQL 500
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMS 317
            +A+++L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           PE +  +    A+D W  G+ ++E+L  G  PF G
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + K       HA+    E  +L  + H
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSK-PFQSIIHAKRTYRELRLLKHMKH 92
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 151 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 208
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 192
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V     + +    A+K + +       HA+    E  +L  + H
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 109
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 167
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 168 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 225
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H +   D WSVG ++ E+LTG+  F G +
Sbjct: 226 WMHYNMTVDIWSVGCIMAELLTGRTLFPGTD 256

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 100
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 159 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--XGXVATRWYRAPEIMLN 216
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 90
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 91  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 148
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 149 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 206
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 207 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 237

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--AGFVATRWYRAPEIMLN 192
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  + V            +  K+E  +L K  H  I+ L  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAP----TPQQLQAFKNEVGVLRKTRHVNIL-LFM 70
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA-EIVSAVSHLHANGIMHRDL 276
            + T  +L +V  +  G  L+  L+      E +  I  A +    + +LHA  I+HRDL
Sbjct: 71  GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 277 KPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK----- 328
           K  NI L  D  V + DFGLA    ++  + +   + G++ +M+PE++  +  DK     
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI--RMQDKNPYSF 188
Query: 329 AADWWSVGILLFEMLTGQPPFTGGN 353
            +D ++ GI+L+E++TGQ P++  N
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--AGFVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--AGFVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 108/224 (48%), Gaps = 13/224 (5%)
Query: 130 LGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM 189
           +G      D        + +++ ++L+ +G+G F  V      G     A+K ++ D   
Sbjct: 1   MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT- 57
Query: 190 EKNHAEYMKSERNILTKVDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--L 246
               A+   +E +++T++ H  +VQL     + K  LY+V +++  G L   L  +G  +
Sbjct: 58  ----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 113
Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS 306
              D    ++ ++  A+ +L  N  +HRDL   N+L+  D    ++DFGL K+      +
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173
Query: 307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
             +   +++ +PE +  K     +D WS GILL+E+ + G+ P+
Sbjct: 174 GKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y     GT E+ A+K ++ D      H    K E +IL  + H 
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLYHE 76
Query: 211 FIVQLRYSF--QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            I++ +     Q +  L LV+++V  G L   L R  +    L  ++  +I   +++LHA
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL-LFAQQICEGMAYLHA 135
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-----NTRSNSMCGTLEYMSPEIVLG 323
              +HR+L   N+LLD D  V + DFGLAK   E       R +       Y +PE +  
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKE 194
Query: 324 KGHDKAADWWSVGILLFEMLT 344
                A+D WS G+ L+E+LT
Sbjct: 195 YKFYYASDVWSFGVTLYELLT 215

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 86
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 202
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 AMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 111/240 (46%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 76
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V +++N G L  F +       R       +A+I S ++++     +HRD
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +KE  +R
Sbjct: 197 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 256

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 82
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 198
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 111/240 (46%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 76
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V +++N G L  F +       R       +A+I S ++++     +HRD
Sbjct: 77  AVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +KE  +R
Sbjct: 197 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 256

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 99
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 158 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 215
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 86
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 202
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 100
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 159 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 216
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 87/188 (46%), Gaps = 2/188 (1%)
Query: 166 VYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL 225
           VY+        I A+K+  +    +       + E     ++  P +V +    +   +L
Sbjct: 50  VYEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQL 109
Query: 226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA 285
           Y+    +NG  L   L RQG      A     +I SA+   HA G  HRD+KPENIL+ A
Sbjct: 110 YVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA 169
Query: 286 DGHVMLTDFGLAK-QFDEN-TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
           D    L DFG+A    DE  T+  +  GTL Y +PE          AD +++  +L+E L
Sbjct: 170 DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECL 229
Query: 344 TGQPPFTG 351
           TG PP+ G
Sbjct: 230 TGSPPYQG 237

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 82
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 198
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGXVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 78
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 79  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 136
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 137 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 194
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 195 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 225

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 106/216 (49%), Gaps = 13/216 (6%)
Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM 197
           D        + +++ ++L+ +G+G F  V      G     A+K ++ D       A+  
Sbjct: 181 DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAF 233
Query: 198 KSERNILTKVDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARI 254
            +E +++T++ H  +VQL     + K  LY+V +++  G L   L  +G  +   D    
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 293
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE 314
           ++ ++  A+ +L  N  +HRDL   N+L+  D    ++DFGL K+      +  +   ++
Sbjct: 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVK 351
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
           + +PE +  K     +D WS GILL+E+ + G+ P+
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 387

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 82
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 198
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 92
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 151 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 208
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 92
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 151 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 208
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 82
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 141 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 198
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 103
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 161
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 162 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 219
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 85
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 201
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 79
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 80  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 137
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 138 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 195
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 196 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 226

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 192
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 87
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 203
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGL +  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 86
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 202
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 77
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 136 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 193
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 77
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 136 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 193
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 91
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 150 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 207
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 85
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 201
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 105/207 (50%), Gaps = 13/207 (6%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + +++ ++L+ +G+G F  V      G     A+K ++ D       A+   +E +++T+
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAFLAEASVMTQ 55
Query: 207 VDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAV 263
           + H  +VQL     + K  LY+V +++  G L   L  +G  +   D    ++ ++  A+
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            +L  N  +HRDL   N+L+  D    ++DFGL K+      +  +   +++ +PE +  
Sbjct: 116 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALRE 173
Query: 324 KGHDKAADWWSVGILLFEMLT-GQPPF 349
           K     +D WS GILL+E+ + G+ P+
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 91
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 150 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 207
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 3/203 (1%)
Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS  +    + F+ L  +G G++ +V++VR      +YA+K         K+ A  +   
Sbjct: 48  PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV 107
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEI 259
            +      HP  V+L  +++    LYL  +   G  L       G    E     Y  + 
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDT 166
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           + A++HLH+ G++H D+KP NI L   G   L DFGL  +           G   YM+PE
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226
Query: 320 IVLGKGHDKAADWWSVGILLFEM 342
           ++ G  +  AAD +S+G+ + E+
Sbjct: 227 LLQGS-YGTAADVFSLGLTILEV 248

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 85
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 201
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 108/207 (52%), Gaps = 20/207 (9%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G+F  VY+ +  G   +  +KV+  D   E+  A   ++E  +L K  H  I+ L  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVV--DPTPEQFQA--FRNEVAVLRKTRHVNIL-LFM 98
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ----GLFRE-DLARIYTAEIVSAVSHLHANGIM 272
            + TK  L +V  +  G  L+  L+ Q     +F+  D+AR    +    + +LHA  I+
Sbjct: 99  GYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIAR----QTAQGMDYLHAKNII 154
Query: 273 HRDLKPENILLDADGHVMLTDFGLA---KQFDENTRSNSMCGTLEYMSPEIVLGKGHDK- 328
           HRD+K  NI L     V + DFGLA    ++  + +     G++ +M+PE++  + ++  
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 329 --AADWWSVGILLFEMLTGQPPFTGGN 353
              +D +S GI+L+E++TG+ P++  N
Sbjct: 215 SFQSDVYSYGIVLYELMTGELPYSHIN 241

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 103
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 161
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 162 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--XGYVATRWYRAPEIMLN 219
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 86
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 145 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 202
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 113/210 (53%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA----EYMKSERNILT 205
           +D+++++ +G+G +++V++   I  +E  A+K+++  K  +        E ++   NI+T
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLRGGPNIIT 96
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D   IV+   S        LV + VN    F QLY Q L   D+ R Y  EI+ A+ +
Sbjct: 97  LAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLY-QTLTDYDI-RFYMYEILKALDY 146
Query: 266 LHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG- 323
            H+ GIMHRD+KP N+L+D +   + L D+GLA+ +      N    +  +  PE+++  
Sbjct: 147 CHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +D + D WS+G +L  M+  + PF  G+
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y     GT E+ A+K ++ D      H    K E +IL  + H 
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLYHE 76
Query: 211 FIVQLRYSF--QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            I++ +     Q +  L LV+++V  G L   L R  +    L  ++  +I   +++LH+
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL-LFAQQICEGMAYLHS 135
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-----NTRSNSMCGTLEYMSPEIVLG 323
              +HR+L   N+LLD D  V + DFGLAK   E       R +       Y +PE +  
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKE 194
Query: 324 KGHDKAADWWSVGILLFEMLT 344
                A+D WS G+ L+E+LT
Sbjct: 195 YKFYYASDVWSFGVTLYELLT 215

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 28/227 (12%)
Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK--------------DKIMEKNHA 194
           + D+ +++ + QG F K+    +   ++ YA+K   K              DKI  K+  
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 195 EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFV-NGGHLFFQLYRQGLFRE---- 249
           +  K+E  I+T + + + +           +Y++ +++ N   L F  Y   L +     
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 250 ---DLARIYTAEIVSAVSHLH-ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
               + +     ++++ S++H    I HRD+KP NIL+D +G V L+DFG ++   +   
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 306 SNSMCGTLEYMSPEIVLGKGHDKAA--DWWSVGILLFEMLTGQPPFT 350
             S  GT E+M PE    +     A  D WS+GI L+ M     PF+
Sbjct: 208 KGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  +G GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 85
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L 
Sbjct: 144 KYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLN 201
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 26/231 (11%)
Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM 197
           +NL  ++  V    + +LK +G G  +KV+QV      +IYA+K +     +E+   + +
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN----LEEADNQTL 70
Query: 198 KSERNILTKVD----HPFIVQLRYSFQ-TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLA 252
            S RN +  ++    H   +   Y ++ T   +Y+V++  N   L   L ++        
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWER 129
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR---SNSM 309
           + Y   ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +      +S 
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQ 188
Query: 310 CGTLEYMSPEIVLGKGHDK-----------AADWWSVGILLFEMLTGQPPF 349
            GT+ YM PE +      +            +D WS+G +L+ M  G+ PF
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + +++ ++L+ +G+G F  V      G     A+K ++ D       A+   +E +++T+
Sbjct: 9   LNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-----AQAFLAEASVMTQ 61
Query: 207 VDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAV 263
           + H  +VQL     + K  LY+V +++  G L   L  +G  +   D    ++ ++  A+
Sbjct: 62  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 121
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            +L  N  +HRDL   N+L+  D    ++DFGL K+      +  +   +++ +PE +  
Sbjct: 122 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALRE 179
Query: 324 KGHDKAADWWSVGILLFEMLT-GQPPF 349
                 +D WS GILL+E+ + G+ P+
Sbjct: 180 AAFSTKSDVWSFGILLWEIYSFGRVPY 206

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 112/240 (46%), Gaps = 52/240 (21%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           K +G G+F  V +V  I + + +A+K + +D         Y   E +I+  +DH  I++L
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKVLQD-------PRYKNRELDIMKVLDHVNIIKL 65
Query: 216 RYSF---------------------------------------QTKYRLYLVLDFV-NGG 235
              F                                       Q KY L +++++V +  
Sbjct: 66  VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY-LNVIMEYVPDTL 124
Query: 236 HLFFQLY-RQGL-FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLT 292
           H   + + R G     +L  IY  ++  AV  +H+ GI HRD+KP+N+L+++ D  + L 
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 293 DFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTG 351
           DFG AK+   +  S +   +  Y +PE++LG   +  + D WS+G +  E++ G+P F+G
Sbjct: 185 DFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA----EYMKSERNILT 205
           +D+++++ +G+G +++V++   I  +E   +K+++  K  +        E ++   NI+T
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 96
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D   IV+   S        LV + VN    F QLY Q L   D+ R Y  EI+ A+ +
Sbjct: 97  LAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLY-QTLTDYDI-RFYMYEILKALDY 146
Query: 266 LHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG- 323
            H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +D + D WS+G +L  M+  + PF  G+
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 111/210 (52%), Gaps = 10/210 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +  ED  + +++G+G F +VY+       G     A+K  +KD  ++ N  ++M SE  I
Sbjct: 21  IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-NKEKFM-SEAVI 78
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-YTAEIVSA 262
           +  +DHP IV+L    + +   +++++    G L   L R     + L  + Y+ +I  A
Sbjct: 79  MKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 137
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGT-LEYMSPEI 320
           +++L +   +HRD+   NIL+ +   V L DFGL++   DE+    S+    +++MSPE 
Sbjct: 138 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 197
Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
           +  +    A+D W   + ++E+L+ G+ PF
Sbjct: 198 INFRRFTTASDVWMFAVCMWEILSFGKQPF 227

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + D+GLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 111/210 (52%), Gaps = 10/210 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +  ED  + +++G+G F +VY+       G     A+K  +KD  ++ N  ++M SE  I
Sbjct: 5   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-NKEKFM-SEAVI 62
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-YTAEIVSA 262
           +  +DHP IV+L    + +   +++++    G L   L R     + L  + Y+ +I  A
Sbjct: 63  MKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 121
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGT-LEYMSPEI 320
           +++L +   +HRD+   NIL+ +   V L DFGL++   DE+    S+    +++MSPE 
Sbjct: 122 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 181
Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
           +  +    A+D W   + ++E+L+ G+ PF
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 111/210 (52%), Gaps = 10/210 (4%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +  ED  + +++G+G F +VY+       G     A+K  +KD  ++ N  ++M SE  I
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-NKEKFM-SEAVI 66
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI-YTAEIVSA 262
           +  +DHP IV+L    + +   +++++    G L   L R     + L  + Y+ +I  A
Sbjct: 67  MKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGT-LEYMSPEI 320
           +++L +   +HRD+   NIL+ +   V L DFGL++   DE+    S+    +++MSPE 
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 185
Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
           +  +    A+D W   + ++E+L+ G+ PF
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPF 215

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 275 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 328
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 329 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +KE  +R
Sbjct: 449 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 508

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 109/214 (50%), Gaps = 21/214 (9%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  +++K +G G F +V+     G +++ A+K ++   +  ++  E    E  I+ K+ H
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTKV-AIKTLKPGTMSPESFLE----EAQIMKKLKH 63
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-------DLARIYTAEIVSA 262
             +VQL Y+  ++  +Y+V +++N G L     + G  R        D+A    A++ + 
Sbjct: 64  DKLVQL-YAVVSEEPIYIVTEYMNKGSLL-DFLKDGEGRALKLPNLVDMA----AQVAAG 117
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEI 320
           ++++     +HRDL+  NIL+       + DFGLA+  ++N  +        +++ +PE 
Sbjct: 118 MAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEA 177
Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
            L       +D WS GILL E++T G+ P+ G N
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 211

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 111/210 (52%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA----EYMKSERNILT 205
           +D+++++ +G+G +++V++   I  +E   +K+++  K  +        E ++   NI+T
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 96
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D   IV+   S        LV + VN     F+  RQ L   D+ R Y  EI+ A+ +
Sbjct: 97  LAD---IVKDPVSRTPA----LVFEHVNNTD--FKQLRQTLTDYDI-RFYMYEILKALDY 146
Query: 266 LHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG- 323
            H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +D + D WS+G +L  M+  + PF  G+
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 19  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 72
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 73  AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 132
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +KE  +R
Sbjct: 193 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 252

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 14/216 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +++E+++ +G GA+  V   RR  T +  A+K +     +  N    ++ E  IL    H
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKH 113
Query: 210 PFIVQLRYSFQTKY------RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             I+ ++   +          +Y+VLD +           Q L  E + R +  +++  +
Sbjct: 114 DNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHV-RYFLYQLLRGL 172
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-----DENTRSNSMCGTLEYMSP 318
            ++H+  ++HRDLKP N+L++ +  + + DFG+A+       +          T  Y +P
Sbjct: 173 KYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 232
Query: 319 EIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           E++L    + +A D WSVG +  EML  +  F G N
Sbjct: 233 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 268

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA----EYMKSERNILT 205
           +D+++++ +G+G +++V++   I  +E   +K+++  K  +        E ++   NI+T
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 96
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D   IV+   S        LV + VN    F QLY Q L   D+ R Y  EI+ A+ +
Sbjct: 97  LAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLY-QTLTDYDI-RFYMYEILKALDY 146
Query: 266 LHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG- 323
            H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +D + D WS+G +L  M+  + PF  G+
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA----EYMKSERNILT 205
           +D+++++ +G+G +++V++   I  +E   +K+++  K  +        E ++   NI+T
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 96
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D   IV+   S        LV + VN    F QLY Q L   D+ R Y  EI+ A+ +
Sbjct: 97  LAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLY-QTLTDYDI-RFYMYEILKALDY 146
Query: 266 LHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG- 323
            H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +D + D WS+G +L  M+  + PF  G+
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA----EYMKSERNILT 205
           +D+++++ +G+G +++V++   I  +E   +K+++  K  +        E ++   NI+T
Sbjct: 42  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 101
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D   IV+   S        LV + VN    F QLY Q L   D+ R Y  EI+ A+ +
Sbjct: 102 LAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLY-QTLTDYDI-RFYMYEILKALDY 151
Query: 266 LHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG- 323
            H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  
Sbjct: 152 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 211
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +D + D WS+G +L  M+  + PF  G+
Sbjct: 212 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 241

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 87
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVL 322
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+   DE T       T  Y +PEI+L
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT---GYVATRWYRAPEIML 202
Query: 323 GKGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
              H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA----EYMKSERNILT 205
           +D+++++ +G+G +++V++   I  +E   +K+++  K  +        E ++   NI+T
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 95
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D   IV+   S        LV + VN    F QLY Q L   D+ R Y  EI+ A+ +
Sbjct: 96  LAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLY-QTLTDYDI-RFYMYEILKALDY 145
Query: 266 LHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG- 323
            H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +D + D WS+G +L  M+  + PF  G+
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA----EYMKSERNILT 205
           +D+++++ +G+G +++V++   I  +E   +K+++  K  +        E ++   NI+T
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 96
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D   IV+   S        LV + VN    F QLY Q L   D+ R Y  EI+ A+ +
Sbjct: 97  LAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLY-QTLTDYDI-RFYMYEILKALDY 146
Query: 266 LHANGIMHRDLKPENILLDADGH-VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG- 323
            H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +D + D WS+G +L  M+  + PF  G+
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA----EYMKSERNILT 205
           +D+++++ +G+G +++V++   I  +E   +K+++  K  +        E ++   NI+T
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 96
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D   IV+   S        LV + VN    F QLY Q L   D+ R Y  EI+ A+ +
Sbjct: 97  LAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLY-QTLTDYDI-RFYMYEILKALDY 146
Query: 266 LHANGIMHRDLKPENILLDADGH-VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG- 323
            H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +D + D WS+G +L  M+  + PF  G+
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA----EYMKSERNILT 205
           +D+++++ +G+G +++V++   I  +E   +K+++  K  +        E ++   NI+T
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 96
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D   IV+   S        LV + VN    F QLY Q L   D+ R Y  EI+ A+ +
Sbjct: 97  LAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLY-QTLTDYDI-RFYMYEILKALDY 146
Query: 266 LHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG- 323
            H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +D + D WS+G +L  M+  + PF  G+
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA----EYMKSERNILT 205
           +D+++++ +G+G +++V++   I  +E   +K+++  K  +        E ++   NI+T
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 95
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D   IV+   S        LV + VN    F QLY Q L   D+ R Y  EI+ A+ +
Sbjct: 96  LAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLY-QTLTDYDI-RFYMYEILKALDY 145
Query: 266 LHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG- 323
            H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +D + D WS+G +L  M+  + PF  G+
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 87
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVL 322
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+   DE T       T  Y +PEI+L
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT---GYVATRWYRAPEIML 202
Query: 323 GKGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
              H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA----EYMKSERNILT 205
           +D+++++ +G+G +++V++   I  +E   +K+++  K  +        E ++   NI+T
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 96
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D   IV+   S        LV + VN    F QLY Q L   D+ R Y  EI+ A+ +
Sbjct: 97  LAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLY-QTLTDYDI-RFYMYEILKALDY 146
Query: 266 LHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG- 323
            H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +D + D WS+G +L  M+  + PF  G+
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA----EYMKSERNILT 205
           +D+++++ +G+G +++V++   I  +E   +K+++  K  +        E ++   NI+T
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 94
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D   IV+   S        LV + VN    F QLY Q L   D+ R Y  EI+ A+ +
Sbjct: 95  LAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLY-QTLTDYDI-RFYMYEILKALDY 144
Query: 266 LHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG- 323
            H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +D + D WS+G +L  M+  + PF  G+
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA----EYMKSERNILT 205
           +D+++++ +G+G +++V++   I  +E   +K+++  K  +        E ++   NI+T
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIIT 96
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D   IV+   S        LV + VN    F QLY Q L   D+ R Y  EI+ A+ +
Sbjct: 97  LAD---IVKDPVSRTPA----LVFEHVNNTD-FKQLY-QTLTDYDI-RFYMYEILKALDY 146
Query: 266 LHANGIMHRDLKPENILLDADGH-VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG- 323
            H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           + +D + D WS+G +L  M+  + PF  G+
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 236

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 14/212 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 87
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVL 322
            ++H+  I+HRDLKP N+ ++ D  + + DFGLA+   DE T       T  Y +PEI+L
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT---GYVATRWYRAPEIML 202
Query: 323 GKGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
              H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 158 VGQGAFAKVYQ-VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +G G F  V Q V R+   +I  A+KV+++    EK   E M  E  I+ ++D+P+IV+L
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS----HLHANGI 271
               Q +  L LV++   GG L   L  +   RE++     AE++  VS    +L     
Sbjct: 76  IGVCQAE-ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LEYMSPEIVLGKGHD 327
           +HRDL   N+LL    +  ++DFGL+K    D++  +    G   L++ +PE +  +   
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 328 KAADWWSVGILLFEMLT-GQPPF 349
             +D WS G+ ++E L+ GQ P+
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPY 214

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + DF LA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V+++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +K+  +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ K +G G F +V+       +++ A+K M+   +      E   +E N++  + H
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 69
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 70  DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 128
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+ A     + DFGLA+  ++N  T        +++ +PE +    
Sbjct: 129 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 188
Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS GILL E++T G+ P+ G
Sbjct: 189 FTIKSDVWSFGILLMEIVTYGRIPYPG 215

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V+++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +K+  +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ 214
           ++ +G+G F+ V  V  +     YA+K   +    E+   E  + E ++    +HP I++
Sbjct: 34  IQKLGEGGFSYVDLVEGLHDGHFYALK---RILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 215 L-RYSFQ---TKYRLYLVLDFVNGGHLFFQLYR---QGLF-REDLARIYTAEIVSAVSHL 266
           L  Y  +    K+  +L+L F   G L+ ++ R   +G F  ED        I   +  +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----------YM 316
           HA G  HRDLKP NILL  +G  +L D G   Q   +   +    TL+          Y 
Sbjct: 151 HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 317 SPEIVLGKGH---DKAADWWSVGILLFEMLTGQPPF 349
           +PE+   + H   D+  D WS+G +L+ M+ G+ P+
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 245
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +KE  +R
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 425

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 14/216 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +++E+++ +G GA+  V   RR  T +  A+K +     +  N    ++ E  IL    H
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKH 112
Query: 210 PFIVQLRYSFQTKY------RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             I+ ++   +          +Y+VLD +           Q L  E + R +  +++  +
Sbjct: 113 DNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHV-RYFLYQLLRGL 171
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-----DENTRSNSMCGTLEYMSP 318
            ++H+  ++HRDLKP N+L++ +  + + DFG+A+       +          T  Y +P
Sbjct: 172 KYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 231
Query: 319 EIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           E++L    + +A D WSVG +  EML  +  F G N
Sbjct: 232 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 245
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +KE  +R
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 425

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ K +G G F +V+       +++ A+K M+   +      E   +E N++  + H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 242
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 243 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+ A     + DFGLA+  ++N  T        +++ +PE +    
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS GILL E++T G+ P+ G
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPG 388

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V+++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +K+  +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + +  FGLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 158 VGQGAFAKVYQ-VRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
           +G G F  V Q V R+   +I  A+KV+++    EK   E M  E  I+ ++D+P+IV+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS----HLHANGI 271
               Q +  L LV++   GG L   L  +   RE++     AE++  VS    +L     
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LEYMSPEIVLGKGHD 327
           +HR+L   N+LL    +  ++DFGL+K    D++  +    G   L++ +PE +  +   
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 328 KAADWWSVGILLFEMLT-GQPPF 349
             +D WS G+ ++E L+ GQ P+
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPY 540

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKIRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +K+  +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +K+  +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + D GLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + D GLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 17  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 70
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 71  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 130
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +K+  +R
Sbjct: 191 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 250

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 15  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 68
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 69  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 128
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +K+  +R
Sbjct: 189 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 248

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 115/236 (48%), Gaps = 34/236 (14%)
Query: 139 NLPSENQCV-GLEDFEVLKVVGQGAFAKVYQVRRIGTSEI--YAMKVMRKDKIMEKNHAE 195
            L SE + V  L ++E  KV G+G +  VY+ +R    +   YA+K +    I       
Sbjct: 10  KLSSERERVEDLFEYEGCKV-GRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS------ 62
Query: 196 YMKSERNI--LTKVDHPFIVQLRYSF--QTKYRLYLVLDFVNGG--HLFFQLYRQGLFRE 249
            M + R I  L ++ HP ++ L+  F      +++L+ D+      H+  + +R     +
Sbjct: 63  -MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHII-KFHRASKANK 120
Query: 250 D-------LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD----GHVMLTDFGLAK 298
                   + +    +I+  + +LHAN ++HRDLKP NIL+  +    G V + D G A+
Sbjct: 121 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 299 QFDENTRS----NSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPF 349
            F+   +     + +  T  Y +PE++LG  H  KA D W++G +  E+LT +P F
Sbjct: 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 12/211 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 80
Query: 210 PFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F     L      YLV   +  G     + +     +D  +    +I+  +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++H+  I+HRDLKP N+ ++ D  + + D GLA+  D+         T  Y +PEI+L 
Sbjct: 139 KYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEM--TGYVATRWYRAPEIMLN 196
Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGN 353
             H ++  D WSVG ++ E+LTG+  F G +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +K+  +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 110/240 (45%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 245
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 246 AVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +KE  +R
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 425

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 115/238 (48%), Gaps = 16/238 (6%)
Query: 126 VDAALGKPTGHIDNLPSENQCVGLEDFEV--LKVVGQGAFAKVYQVRRIGTSEIYAMKVM 183
           ++  L +P       P++ Q   L++ E+  +KV+G GAF  VY  + I   E   +K+ 
Sbjct: 12  LETELVEPLTPSGTAPNQAQLRILKETELKRVKVLGSGAFGTVY--KGIWVPEGETVKIP 69
Query: 184 RKDKIME-----KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF 238
              KI+      K + E+M  E  I+  +DHP +V+L         + LV   +  G L 
Sbjct: 70  VAIKILNETTGPKANVEFM-DEALIMASMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLL 127
Query: 239 FQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA 297
             ++  +      L   +  +I   + +L    ++HRDL   N+L+ +  HV +TDFGLA
Sbjct: 128 EYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLA 187
Query: 298 KQFDENTRSNSMCG---TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           +  + + +  +  G    +++M+ E +  +     +D WS G+ ++E++T G  P+ G
Sbjct: 188 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 245

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +K+  +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 72/128 (56%), Gaps = 5/128 (3%)
Query: 227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-A 285
           LV +++N    F QLY Q L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D  
Sbjct: 112 LVFEYINNTD-FKQLY-QILTDFDI-RFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 168
Query: 286 DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLT 344
              + L D+GLA+ +      N    +  +  PE+++  + +D + D WS+G +L  M+ 
Sbjct: 169 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 228
Query: 345 GQPPFTGG 352
            + PF  G
Sbjct: 229 RREPFFHG 236

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     IME   A   K+ + IL +    
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIMELREATSPKANKEILDEAYVM 105
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 106 ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 163
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 164 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 223
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 224 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 256

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 72/128 (56%), Gaps = 5/128 (3%)
Query: 227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-A 285
           LV +++N    F QLY Q L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D  
Sbjct: 117 LVFEYINNTD-FKQLY-QILTDFDI-RFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 173
Query: 286 DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLT 344
              + L D+GLA+ +      N    +  +  PE+++  + +D + D WS+G +L  M+ 
Sbjct: 174 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 233
Query: 345 GQPPFTGG 352
            + PF  G
Sbjct: 234 RREPFFHG 241

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 16/223 (7%)
Query: 141 PSENQCVGLEDFEV--LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----KNH 193
           P++ Q   L++ E+  +KV+G GAF  VY  + I   E   +K+    KI+      K +
Sbjct: 4   PNQAQLRILKETELKRVKVLGSGAFGTVY--KGIWVPEGETVKIPVAIKILNETTGPKAN 61
Query: 194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLA 252
            E+M  E  I+  +DHP +V+L         + LV   +  G L   ++  +      L 
Sbjct: 62  VEFM-DEALIMASMDHPHLVRL-LGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLL 119
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG- 311
             +  +I   + +L    ++HRDL   N+L+ +  HV +TDFGLA+  + + +  +  G 
Sbjct: 120 LNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 179
Query: 312 --TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
              +++M+ E +  +     +D WS G+ ++E++T G  P+ G
Sbjct: 180 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 222

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 114/257 (44%), Gaps = 17/257 (6%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           CV +E     +V+G G F +V    ++  G  EI+      K    EK   +++ SE +I
Sbjct: 34  CVKIE-----QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASI 87
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSA 262
           + + DHP ++ L         + ++ +F+  G L  F     G F           I + 
Sbjct: 88  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 147
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL------EYM 316
           + +L     +HRDL   NIL++++    ++DFGL++  +++T   +    L       + 
Sbjct: 148 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRXXXXXXXXXXXXXLPAFLSS 374
           +PE +  +    A+D WS GI+++E+++ G+ P+    N+              P    S
Sbjct: 208 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS 267
Query: 375 EAHSLLKGLLQKEASKR 391
             H L+    QK+ + R
Sbjct: 268 ALHQLMLDCWQKDRNHR 284

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E++  E    E  ++ K+ HP +VQL  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 69
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDL 129
Query: 277 KPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
              N L+  +  + ++DFG+ +    D+ T S      +++ SPE+     +   +D WS
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 335 VGILLFEMLT-GQPPF 349
            G+L++E+ + G+ P+
Sbjct: 190 FGVLMWEVFSEGKIPY 205

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 109/240 (45%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 16  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 69
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  + +V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 70  AVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 129
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGLA+  ++N  +        +++ +PE  L       +D W
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +KE  +R
Sbjct: 190 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 249

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 109/240 (45%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 79
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 80  AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L   NIL+  +    + DFGLA+  ++N  T        +++ +PE  L       +D W
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +K+  +R
Sbjct: 200 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E++  E    E  ++ K+ HP +VQL  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 69
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 129
Query: 277 KPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
              N L+  +  + ++DFG+ +    D+ T S      +++ SPE+     +   +D WS
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 335 VGILLFEMLT-GQPPF 349
            G+L++E+ + G+ P+
Sbjct: 190 FGVLMWEVFSEGKIPY 205

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 153 EVLKVVGQGAFAKVYQ--VRRIGTSE-IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++ +V+G G F +V +  ++  G  E   A+K + K    E+   E++ SE +I+ + +H
Sbjct: 19  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFL-SEASIMGQFEH 76
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P I++L         + ++ +F+  G L  F +L   G F           I S + +L 
Sbjct: 77  PNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLA 135
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGT--LEYMSPEIV 321
               +HRDL   NIL++++    ++DFGL++  +EN    T ++S+ G   + + +PE +
Sbjct: 136 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPF 349
             +    A+D WS GI+++E+++ G+ P+
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMSFGERPY 224

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 52/99 (52%), Gaps = 13/99 (13%)
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-------- 309
           +I  AV  LH+ G+MHRDLKP NI    D  V + DFGL    D++    ++        
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 310 -----CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
                 GT  YMSPE + G  +    D +S+G++LFE+L
Sbjct: 232 THXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E++  E    E  ++ K+ HP +VQL  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 72
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132
Query: 277 KPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
              N L+  +  + ++DFG+ +    D+ T S      +++ SPE+     +   +D WS
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 335 VGILLFEMLT-GQPPF 349
            G+L++E+ + G+ P+
Sbjct: 193 FGVLMWEVFSEGKIPY 208

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 11/217 (5%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           +P +   +  ED  + + +G+G F +V+  R    + + A+K  R + +     A++++ 
Sbjct: 104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQE 162
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAE 258
            R IL +  HP IV+L      K  +Y+V++ V GG     L  +G   R         +
Sbjct: 163 AR-ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL----- 313
             + + +L +   +HRDL   N L+     + ++DFG++++  +   + S  G L     
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAAS--GGLRQVPV 279
Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
           ++ +PE +    +   +D WS GILL+E  + G  P+
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E++  E    E  ++ K+ HP +VQL  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 67
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 277 KPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
              N L+  +  + ++DFG+ +    D+ T S      +++ SPE+     +   +D WS
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 335 VGILLFEMLT-GQPPF 349
            G+L++E+ + G+ P+
Sbjct: 188 FGVLMWEVFSEGKIPY 203

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 14/207 (6%)
Query: 155 LKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +KV+G GAF  VY+   I   E      A+KV+R++   + N    +  E  ++  V  P
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE--ILDEAYVMAGVGSP 79
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY--RQGLFREDLARIYTAEIVSAVSHLHA 268
           ++ +L         + LV   +  G L   +   R  L  +DL   +  +I   +S+L  
Sbjct: 80  YVSRL-LGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLN-WCMQIAKGMSYLED 137
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGT--LEYMSPEIVLGKG 325
             ++HRDL   N+L+ +  HV +TDFGLA+  D + T  ++  G   +++M+ E +L + 
Sbjct: 138 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR 197
Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS G+ ++E++T G  P+ G
Sbjct: 198 FTHQSDVWSYGVTVWELMTFGAKPYDG 224

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 11/217 (5%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           +P +   +  ED  + + +G+G F +V+  R    + + A+K  R + +     A++++ 
Sbjct: 104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQE 162
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAE 258
            R IL +  HP IV+L      K  +Y+V++ V GG     L  +G   R         +
Sbjct: 163 AR-ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL----- 313
             + + +L +   +HRDL   N L+     + ++DFG++++  +   + S  G L     
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS--GGLRQVPV 279
Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
           ++ +PE +    +   +D WS GILL+E  + G  P+
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 109/240 (45%), Gaps = 12/240 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H  +VQL Y
Sbjct: 193 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGNM----SPEAFLQEAQVMKKLRHEKLVQL-Y 246
Query: 218 SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRD 275
           +  ++  +Y+V ++++ G L  F +       R        A+I S ++++     +HRD
Sbjct: 247 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 306
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWW 333
           L+  NIL+  +    + DFGL +  ++N  T        +++ +PE  L       +D W
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 366
Query: 334 SVGILLFEMLT-GQPPFTGG-NRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
           S GILL E+ T G+ P+ G  NR              P       H L+    +K+  +R
Sbjct: 367 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEER 426

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 73  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGXLLDYVREHKDNIGSQYLLN-WCVQIAKG 130
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 131 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 157 VVGQGAFAKVYQ-VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-LTKVDHPFIVQ 214
           ++G G F KVY+ V R G       KV  K +  E +            L+   HP +V 
Sbjct: 46  LIGHGVFGKVYKGVLRDGA------KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV----SAVSHLHANG 270
           L      +  + L+  ++  G+L   LY   L    ++     EI       + +LH   
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
           I+HRD+K  NILLD +    +TDFG++K   + D+      + GTL Y+ PE  +     
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLT 219
Query: 328 KAADWWSVGILLFEMLTGQ 346
           + +D +S G++LFE+L  +
Sbjct: 220 EKSDVYSFGVVLFEVLCAR 238

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 76  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 133
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 134 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 226

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 27/222 (12%)
Query: 152 FEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +E++  +G+GAF KV +    + G   +    V   D+  E   +E    E    T  + 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 210 PF-IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHL 266
            F  VQ+   F+    + +V + + G   +  +   G   FR D  R    +I  +V+ L
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 267 HANGIMHRDLKPENILLDADGH-------------------VMLTDFGLAKQFDENTRSN 307
           H+N + H DLKPENIL     +                   + + DFG A   DE+   +
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HS 192
Query: 308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           ++  T  Y +PE++L  G  +  D WS+G +L E   G   F
Sbjct: 193 TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 74  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 73  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 130
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 131 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGLA+  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++  + H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 78
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 79  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 136
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++  
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYS 196
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
                +D W+ G+L++E+ + G+ P+
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 75  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +R+  + E++  E    E  ++ K+ HP +VQL  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 70
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 277 KPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
              N L+  +  + ++DFG+ +    D+ T S      +++ SPE+     +   +D WS
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 335 VGILLFEMLT-GQPPF 349
            G+L++E+ + G+ P+
Sbjct: 191 FGVLMWEVFSEGKIPY 206

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 16/226 (7%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR------IGTSEIYAMKVMRKDKIMEKNH 193
           L S    +G +D  +L+ +G G+F  V   RR       G +   A+K ++ D + +   
Sbjct: 8   LQSLTCLIGEKDLRLLEKLGDGSFGVV---RRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 64
Query: 194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLA 252
            +    E N +  +DH  +++L Y       + +V +    G L  +L + QG F     
Sbjct: 65  MDDFIREVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL 123
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG- 311
             Y  ++   + +L +   +HRDL   N+LL     V + DFGL +   +N     M   
Sbjct: 124 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEH 183
Query: 312 ---TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
                 + +PE +  +    A+D W  G+ L+EM T GQ P+ G N
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 153 EVLKVVGQGAFAKVYQ--VRRIGTSE-IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++ +V+G G F +V +  ++  G  E   A+K + K    E+   E++ SE +I+ + +H
Sbjct: 17  KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTL-KGGYTERQRREFL-SEASIMGQFEH 74
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P I++L         + ++ +F+  G L  F +L   G F           I S + +L 
Sbjct: 75  PNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLA 133
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGT--LEYMSPEIV 321
               +HRDL   NIL++++    ++DFGL++  +EN    T ++S+ G   + + +PE +
Sbjct: 134 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPF 349
             +    A+D WS GI+++E+++ G+ P+
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMSFGERPY 222

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++  + H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 78
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 79  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 136
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++  
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 196
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
                +D W+ G+L++E+ + G+ P+
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPY 222

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 38/249 (15%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +   + K +G+GAF +V     + + +  T    A+K
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVK 63
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHL-- 237
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 64  MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 238 -----------FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
                      +  LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL   
Sbjct: 122 YLRSKRNEFVPYKDLYKDFLTLEHLI-CYSFQVAKGMEFLASRKXIHRDLAARNILLSEK 180
Query: 287 GHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
             V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL+E+ 
Sbjct: 181 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240
Query: 344 T-GQPPFTG 351
           + G  P+ G
Sbjct: 241 SLGASPYPG 249

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 16/219 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRR------IGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           +G +D  +L+ +G G+F     VRR       G +   A+K ++ D + +    +    E
Sbjct: 5   IGEKDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEI 259
            N +  +DH  +++L Y       + +V +    G L  +L + QG F       Y  ++
Sbjct: 62  VNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG----TLEY 315
              + +L +   +HRDL   N+LL     V + DFGL +   +N     M         +
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
            +PE +  +    A+D W  G+ L+EM T GQ P+ G N
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++  + H
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 63
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 64  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++  
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYS 181
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
                +D W+ G+L++E+ + G+ P+
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 16/226 (7%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR------IGTSEIYAMKVMRKDKIMEKNH 193
           L S    +G +D  +L+ +G G+F  V   RR       G +   A+K ++ D + +   
Sbjct: 8   LQSLTCLIGEKDLRLLEKLGDGSFGVV---RRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 64
Query: 194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLA 252
            +    E N +  +DH  +++L Y       + +V +    G L  +L + QG F     
Sbjct: 65  MDDFIREVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL 123
Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG- 311
             Y  ++   + +L +   +HRDL   N+LL     V + DFGL +   +N     M   
Sbjct: 124 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183
Query: 312 ---TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
                 + +PE +  +    A+D W  G+ L+EM T GQ P+ G N
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 16/219 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRR------IGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           +G +D  +L+ +G G+F  V   RR       G +   A+K ++ D + +    +    E
Sbjct: 9   IGEKDLRLLEKLGDGSFGVV---RRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 65
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEI 259
            N +  +DH  +++L Y       + +V +    G L  +L + QG F       Y  ++
Sbjct: 66  VNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 124
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG----TLEY 315
              + +L +   +HRDL   N+LL     V + DFGL +   +N     M         +
Sbjct: 125 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
            +PE +  +    A+D W  G+ L+EM T GQ P+ G N
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 223

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGXLLDYVREHKDNIGSQYLLN-WCVQIAKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 77
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 78  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 135
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 136 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 195
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 196 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 228

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 74  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 146
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 147 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 204
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 205 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 239

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 109/206 (52%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E+  +LK +G G F  V   +  G  ++ A+K++++  + E    +    E   + K+ H
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEFFQ----EAQTMMKLSH 62
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           P +V+       +Y +Y+V ++++ G L  + + + +GL    L  +   ++   ++ L 
Sbjct: 63  PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM-CYDVCEGMAFLE 121
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT---LEYMSPEIVLGK 324
           ++  +HRDL   N L+D D  V ++DFG+ +   ++   +S+ GT   +++ +PE+    
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV-GTKFPVKWSAPEVFHYF 180
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
            +   +D W+ GIL++E+ + G+ P+
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPY 206

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 64/116 (55%), Gaps = 6/116 (5%)
Query: 244 QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDE 302
           QG   E+ AR++  +++  + ++H+  ++HRDLKP N+ ++ +  V+ + DFGLA+  D 
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173
Query: 303 NTRSNSMCG----TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           +            T  Y SP ++L    + KA D W+ G +  EMLTG+  F G +
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 16/219 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRR------IGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           +G +D  +L+ +G G+F  V   RR       G +   A+K ++ D + +    +    E
Sbjct: 5   IGEKDLRLLEKLGDGSFGVV---RRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEI 259
            N +  +DH  +++L Y       + +V +    G L  +L + QG F       Y  ++
Sbjct: 62  VNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG----TLEY 315
              + +L +   +HRDL   N+LL     V + DFGL +   +N     M         +
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
            +PE +  +    A+D W  G+ L+EM T GQ P+ G N
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 75
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 129
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 130 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 187
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 188 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 75  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 177
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 178 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 16/219 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRR------IGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           +G +D  +L+ +G G+F  V   RR       G +   A+K ++ D + +    +    E
Sbjct: 9   IGEKDLRLLEKLGDGSFGVV---RRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 65
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEI 259
            N +  +DH  +++L Y       + +V +    G L  +L + QG F       Y  ++
Sbjct: 66  VNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 124
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG----TLEY 315
              + +L +   +HRDL   N+LL     V + DFGL +   +N     M         +
Sbjct: 125 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
            +PE +  +    A+D W  G+ L+EM T GQ P+ G N
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 223

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F  V+    +   ++ A+K +++  + E +  E    E  ++ K+ HP +VQL  
Sbjct: 35  IGSGQFGLVHLGYWLNKDKV-AIKTIKEGSMSEDDFIE----EAEVMMKLSHPKLVQLYG 89
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDL 276
               +  + LV +F+  G L   L  Q GLF  +       ++   +++L    ++HRDL
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 149
Query: 277 KPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWS 334
              N L+  +  + ++DFG+ +    D+ T S      +++ SPE+     +   +D WS
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 335 VGILLFEMLT-GQPPF 349
            G+L++E+ + G+ P+
Sbjct: 210 FGVLMWEVFSEGKIPY 225

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 96
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 97  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 154
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 155 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 214
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 215 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 247

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 79  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 136
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 137 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 9   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 68
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 69  KKKKIKREIKILQNLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 119
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 120 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 178
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 179 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 231

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 177
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 178 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 75  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 75  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 133 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 177
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 178 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 29  DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 88
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 89  KKKKIKREIKILQNLXGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 139
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 140 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 198
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 199 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 251

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++  + H
Sbjct: 15  KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 69
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 70  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 127
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++  
Sbjct: 128 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 187
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
                +D W+ G+L++E+ + G+ P+
Sbjct: 188 KFSSKSDIWAFGVLMWEIYSLGKMPY 213

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 102
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 103 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 156
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 157 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 214
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 215 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 249

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++  + H
Sbjct: 8   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 62
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 63  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 120
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++  
Sbjct: 121 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 180
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
                +D W+ G+L++E+ + G+ P+
Sbjct: 181 KFSSKSDIWAFGVLMWEIYSLGKMPY 206

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL------ 204
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL      
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 157 VVGQGAFAKVYQ-VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-LTKVDHPFIVQ 214
           ++G G F KVY+ V R G       KV  K +  E +            L+   HP +V 
Sbjct: 46  LIGHGVFGKVYKGVLRDGA------KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV----SAVSHLHANG 270
           L      +  + L+  ++  G+L   LY   L    ++     EI       + +LH   
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN---SMCGTLEYMSPEIVLGKGHD 327
           I+HRD+K  NILLD +    +TDFG++K+  E  +++    + GTL Y+ PE  +     
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLT 219
Query: 328 KAADWWSVGILLFEMLTGQ 346
           + +D +S G++LFE+L  +
Sbjct: 220 EKSDVYSFGVVLFEVLCAR 238

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 38/249 (15%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +   + K +G+GAF +V     + + +  T    A+K
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVK 63
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHL-- 237
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 64  MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 238 -----------FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD 286
                      +  LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL   
Sbjct: 122 YLRSKRNEFVPYKDLYKDFLTLEHLI-XYSFQVAKGMEFLASRKXIHRDLAARNILLSEK 180
Query: 287 GHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEML 343
             V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL+E+ 
Sbjct: 181 NVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240
Query: 344 T-GQPPFTG 351
           + G  P+ G
Sbjct: 241 SLGASPYPG 249

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V +++  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL +  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 16/219 (7%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRR------IGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           +G +D  +L+ +G G+F  V   RR       G +   A+K ++ D + +    +    E
Sbjct: 5   IGEKDLRLLEKLGDGSFGVV---RRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEI 259
            N +  +DH  +++L Y       + +V +    G L  +L + QG F       Y  ++
Sbjct: 62  VNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG----TLEY 315
              + +L +   +HRDL   N+LL     V + DFGL +   +N     M         +
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
            +PE +  +    A+D W  G+ L+EM T GQ P+ G N
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 81
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 82  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 139
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 140 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 199
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 200 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 232

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 68
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 69  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAEG 126
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 127 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 186
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 187 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 219

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLMGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 177
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 178 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++  + H
Sbjct: 9   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 63
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 64  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 121
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++  
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 181
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
                +D W+ G+L++E+ + G+ P+
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPY 207

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 66  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 123
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G F +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 74
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 75  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 193 VWAFGVLLWEIATYGMSPYPG 213

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 9   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 68
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 69  KKKKIKREIKILQNLCGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 119
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 120 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 178
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 179 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 231

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 42/253 (16%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +  ++ K +G+GAF +V     + + +  T    A+K
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 63
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFF 239
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 64  MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 240 -----------------QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL 282
                             LY+  L  E L   Y+ ++   +  L +   +HRDL   NIL
Sbjct: 122 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNIL 180
Query: 283 LDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILL 339
           L     V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL
Sbjct: 181 LSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 340 FEMLT-GQPPFTG 351
           +E+ + G  P+ G
Sbjct: 241 WEIFSLGASPYPG 253

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLCGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 177
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 178 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 8   DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 67
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 68  KKKKIKREIKILQNLCGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 118
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 119 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 177
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 178 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 230

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 117/263 (44%), Gaps = 31/263 (11%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           C+ +E     KV+G G F +V   +++  G  EI       K    +K   +++ SE +I
Sbjct: 30  CIKIE-----KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASI 83
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV--- 260
           + + DHP I+ L         + ++ +++  G L          R++  R    ++V   
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGML 137
Query: 261 ----SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMC 310
               S + +L     +HRDL   NIL++++    ++DFG+++  +++      TR   + 
Sbjct: 138 RGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI- 196
Query: 311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRXXXXXXXXXXXXXL 368
             + + +PE +  +    A+D WS GI+++E+++ G+ P+    N+              
Sbjct: 197 -PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPP 255
Query: 369 PAFLSSEAHSLLKGLLQKEASKR 391
           P       H L+    QKE S R
Sbjct: 256 PMDCPIALHQLMLDCWQKERSDR 278

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 127 DAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKV 182
           D  + +P  + D      Q    +D+EV++ VG+G +++V++   +  +E         V
Sbjct: 10  DVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPV 69
Query: 183 MRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY 242
            +K    E    + +    NI+  +D   IV+ ++S        L+ ++VN     F++ 
Sbjct: 70  KKKKIKREIKILQNLCGGPNIVKLLD---IVRDQHSKTPS----LIFEYVNNTD--FKVL 120
Query: 243 RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFD 301
              L   D+ R Y  E++ A+ + H+ GIMHRD+KP N+++D +   + L D+GLA+ + 
Sbjct: 121 YPTLTDYDI-RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 179
Query: 302 ENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                N    +  +  PE+++  + +D + D WS+G +   M+  + PF  G+
Sbjct: 180 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 232

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 74
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 193 VWAFGVLLWEIATYGMSPYPG 213

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 109/252 (43%), Gaps = 41/252 (16%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +   + K +G+GAF +V     + + +  T    A+K
Sbjct: 5   DELPLDEHCERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 64
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFF 239
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 65  MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 122
Query: 240 ----------------QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL 283
                            LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL
Sbjct: 123 YLRSKRNEFVPYKTPEDLYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNILL 181
Query: 284 DADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLF 340
                V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL+
Sbjct: 182 SEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241
Query: 341 EMLT-GQPPFTG 351
           E+ + G  P+ G
Sbjct: 242 EIFSLGASPYPG 253

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 104/206 (50%), Gaps = 13/206 (6%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++  + E    E    E  ++  + H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMNLSH 58
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 59  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 116
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++  
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPF 349
                +D W+ G+L++E+ + G+ P+
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPY 202

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 74  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++M+ E
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 195 VWAFGVLLWEIATYGMSPYPG 215

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 110/251 (43%), Gaps = 40/251 (15%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +  ++ K +G+GAF +V     + + +  T    A+K
Sbjct: 6   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVK 65
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFF 239
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 66  MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 123
Query: 240 ---------------QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD 284
                           LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL 
Sbjct: 124 YLRSKRNEFVPYKPEDLYKDFLTLEHLI-XYSFQVAKGMEFLASRKXIHRDLAARNILLS 182
Query: 285 ADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFE 341
               V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL+E
Sbjct: 183 EKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 242
Query: 342 MLT-GQPPFTG 351
           + + G  P+ G
Sbjct: 243 IFSLGASPYPG 253

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/257 (23%), Positives = 113/257 (43%), Gaps = 17/257 (6%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           CV +E     +V+G G F +V    ++  G  EI+      K    EK   +++ SE +I
Sbjct: 8   CVKIE-----QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASI 61
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSA 262
           + + DHP ++ L         + ++ +F+  G L  F     G F           I + 
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 121
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL------EYM 316
           + +L     +HR L   NIL++++    ++DFGL++  +++T   +    L       + 
Sbjct: 122 MKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRXXXXXXXXXXXXXLPAFLSS 374
           +PE +  +    A+D WS GI+++E+++ G+ P+    N+              P    S
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS 241
Query: 375 EAHSLLKGLLQKEASKR 391
             H L+    QK+ + R
Sbjct: 242 ALHQLMLDCWQKDRNHR 258

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 74  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++M+ E
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 195 VWAFGVLLWEIATYGMSPYPG 215

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 117/263 (44%), Gaps = 31/263 (11%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           C+ +E     KV+G G F +V   +++  G  EI       K    +K   +++ SE +I
Sbjct: 9   CIKIE-----KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASI 62
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV--- 260
           + + DHP I+ L         + ++ +++  G L          R++  R    ++V   
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGML 116
Query: 261 ----SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMC 310
               S + +L     +HRDL   NIL++++    ++DFG+++  +++      TR   + 
Sbjct: 117 RGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI- 175
Query: 311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRXXXXXXXXXXXXXL 368
             + + +PE +  +    A+D WS GI+++E+++ G+ P+    N+              
Sbjct: 176 -PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPP 234
Query: 369 PAFLSSEAHSLLKGLLQKEASKR 391
           P       H L+    QKE S R
Sbjct: 235 PMDCPIALHQLMLDCWQKERSDR 257

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL------ 204
           +F+ +KV+  GAF  VY+   I   E    KV     I E   A   K+ + IL      
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 79  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 136
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 137 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 10/200 (5%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G+F  VY+     T+   A   + +D+ + K+  +  K E   L  + HP IV+   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 218 SFQTKYR----LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG--I 271
           S+++  +    + LV +    G L   L R  + +  + R +  +I+  +  LH     I
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 272 MHRDLKPENILLDA-DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAA 330
           +HRDLK +NI +    G V + D GLA      + + ++ GT E+ +PE    K +D++ 
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYEEK-YDESV 210
Query: 331 DWWSVGILLFEMLTGQPPFT 350
           D ++ G    E  T + P++
Sbjct: 211 DVYAFGXCXLEXATSEYPYS 230

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 117/263 (44%), Gaps = 31/263 (11%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           C+ +E     KV+G G F +V   +++  G  EI       K    +K   +++ SE +I
Sbjct: 15  CIKIE-----KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFL-SEASI 68
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV--- 260
           + + DHP I+ L         + ++ +++  G L          R++  R    ++V   
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGML 122
Query: 261 ----SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMC 310
               S + +L     +HRDL   NIL++++    ++DFG+++  +++      TR   + 
Sbjct: 123 RGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI- 181
Query: 311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRXXXXXXXXXXXXXL 368
             + + +PE +  +    A+D WS GI+++E+++ G+ P+    N+              
Sbjct: 182 -PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPP 240
Query: 369 PAFLSSEAHSLLKGLLQKEASKR 391
           P       H L+    QKE S R
Sbjct: 241 PMDCPIALHQLMLDCWQKERSDR 263

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 77
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 196 VWAFGVLLWEIATYGMSPYPG 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L++  +  G L  + + ++  +  + L   +  +I   
Sbjct: 76  ASVDNPHVCRLLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 133
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++M+ E
Sbjct: 134 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 226

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 27/222 (12%)
Query: 152 FEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +E++  +G+GAF KV +    + G   +    V   D+  E   +E    E    T  + 
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 210 PF-IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHL 266
            F  VQ+   F+    + +V + + G   +  +   G   FR D  R    +I  +V+ L
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 267 HANGIMHRDLKPENILLDADGH-------------------VMLTDFGLAKQFDENTRSN 307
           H+N + H DLKPENIL     +                   + + DFG A   DE+   +
Sbjct: 135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HS 192
Query: 308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           ++     Y +PE++L  G  +  D WS+G +L E   G   F
Sbjct: 193 TLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V + +  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 42/253 (16%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +  ++ K +G+GAF +V     + + +  T    A+K
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 63
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFF 239
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 64  MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 240 -----------------QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL 282
                             LY+  L  E L   Y+ ++   +  L +   +HRDL   NIL
Sbjct: 122 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNIL 180
Query: 283 LDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILL 339
           L     V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL
Sbjct: 181 LSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 340 FEMLT-GQPPFTG 351
           +E+ + G  P+ G
Sbjct: 241 WEIFSLGASPYPG 253

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 42/253 (16%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +  ++ K +G+GAF +V     + + +  T    A+K
Sbjct: 6   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 65
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFF 239
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 66  MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 123
Query: 240 -----------------QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL 282
                             LY+  L  E L   Y+ ++   +  L +   +HRDL   NIL
Sbjct: 124 YLRSKRNEFVPYKEAPEDLYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNIL 182
Query: 283 LDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILL 339
           L     V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL
Sbjct: 183 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 242
Query: 340 FEMLT-GQPPFTG 351
           +E+ + G  P+ G
Sbjct: 243 WEIFSLGASPYPG 255

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 42/253 (16%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +  ++ K +G+GAF +V     + + +  T    A+K
Sbjct: 41  DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 100
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFF 239
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 101 MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 158
Query: 240 -----------------QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL 282
                             LY+  L  E L   Y+ ++   +  L +   +HRDL   NIL
Sbjct: 159 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNIL 217
Query: 283 LDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILL 339
           L     V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL
Sbjct: 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277
Query: 340 FEMLT-GQPPFTG 351
           +E+ + G  P+ G
Sbjct: 278 WEIFSLGASPYPG 290

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 42/253 (16%)
Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMK 181
           D LP +  C  L           +  ++ K +G+GAF +V     + + +  T    A+K
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 63
Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RLYLVLDFVNGGHLFF 239
           ++++     ++ A  + SE  IL  + H   V       TK    L ++++F   G+L  
Sbjct: 64  MLKEGATHSEHRA--LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 240 -----------------QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL 282
                             LY+  L  E L   Y+ ++   +  L +   +HRDL   NIL
Sbjct: 122 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNIL 180
Query: 283 LDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILL 339
           L     V + DFGLA+   ++    R       L++M+PE +  + +   +D WS G+LL
Sbjct: 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
Query: 340 FEMLT-GQPPFTG 351
           +E+ + G  P+ G
Sbjct: 241 WEIFSLGASPYPG 253

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 117/278 (42%), Gaps = 50/278 (17%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HP 210
             V +V+ +G FA VY+ + +G+   YA+K +  ++  EKN A  +  E   + K+  HP
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRA--IIQEVCFMKKLSGHP 86
Query: 211 FIVQL-------RYSFQTKYRLYLVLDFVNGGHL---FFQLYRQGLFREDLARIYTAEIV 260
            IVQ        +    T    +L+L  +  G L     ++  +G    D       +  
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 261 SAVSHLHANG--IMHRDLKPENILLDADGHVMLTDFGLAKQF-----------------D 301
            AV H+H     I+HRDLK EN+LL   G + L DFG A                    +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 302 ENTRSNSMCGTLEYMSPEIV-------LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR 354
           E TR+     T  Y +PEI+       +G+      D W++G +L+ +   Q PF  G +
Sbjct: 207 EITRNT----TPMYRTPEIIDLYSNFPIGEKQ----DIWALGCILYLLCFRQHPFEDGAK 258
Query: 355 XXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRL 392
                           +  +  HSL++ +LQ    +RL
Sbjct: 259 LRIVNGKYSIPPHDTQY--TVFHSLIRAMLQVNPEERL 294

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 75
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V + +  G L          R+  A+    ++V       S
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 129
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 130 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 187
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 188 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 222

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 31/224 (13%)
Query: 156 KVVGQGAFAKV-----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           K +G+GAF +V     + + +  T    A+K++++     ++ A  + SE  IL  + H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 81
Query: 211 FIVQLRYSFQTKY--RLYLVLDFVNGGHLFF-----------------QLYRQGLFREDL 251
             V       TK    L ++++F   G+L                    LY+  L  E L
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TRSNS 308
              Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R   
Sbjct: 142 I-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D  +   +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHP 74
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHL 266
            +VQL      +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL 132
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGK 324
                +HRDL   N L+  +  V + DFGL++    +T +        +++ +PE +   
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 192
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG 351
                +D W+ G+LL+E+ T G  P+ G
Sbjct: 193 KFSIKSDVWAFGVLLWEIATYGMSPYPG 220

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 151 DFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +  + KVVG G F +V   +++     EI       K    EK   +++  E +I+ + D
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFD 104
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV-------S 261
           HP I++L         + +V + +  G L          R+  A+    ++V       S
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEXMENGSL------DSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEY 315
            + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   + +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRW 216
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            SPE +  +    A+D WS GI+L+E+++ G+ P+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 31/219 (14%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP- 210
           + +++ +G G F+ V+  + +  +   AMK++R DK+    + E  + E  +L +V+   
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDAD 76
Query: 211 ----------FIVQLRYSFQTK--YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
                      I++L   F  K    +++V+ F   G     L ++   R  +  IY  +
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR-GIPLIYVKQ 135
Query: 259 I----VSAVSHLHAN-GIMHRDLKPENILLDADG------HVMLTDFGLAKQFDENTRSN 307
           I    +  + ++H   GI+H D+KPEN+L++          + + D G A  +DE+  +N
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TN 194
Query: 308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQ 346
           S+  T EY SPE++LG      AD WS   L+FE++TG 
Sbjct: 195 SI-QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/289 (23%), Positives = 129/289 (44%), Gaps = 26/289 (8%)
Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVY--QV 169
           I+ ET E PN       A+ +    +D       C+ +E     +V+G G F +V   ++
Sbjct: 21  IDPETYEDPNR------AVHQFAKELDA-----SCIKIE-----RVIGAGEFGEVCSGRL 64
Query: 170 RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL 229
           +  G  ++       K    EK   +++  E +I+ + DHP +V L         + +V+
Sbjct: 65  KLPGKRDVAVAIKTLKVGYTEKQRRDFL-CEASIMGQFDHPNVVHLEGVVTRGKPVMIVI 123
Query: 230 DFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
           +F+  G L  F     G F           I + + +L   G +HRDL   NIL++++  
Sbjct: 124 EFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLV 183
Query: 289 VMLTDFGLAKQFDENTRS--NSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT 344
             ++DFGL++  +++  +   +  G +   + +PE +  +    A+D WS GI+++E+++
Sbjct: 184 CKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243
Query: 345 -GQPPFTG-GNRXXXXXXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
            G+ P+    N+              P    +  H L+    QKE ++R
Sbjct: 244 YGERPYWDMSNQDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAER 292

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 31/219 (14%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP- 210
           + +++ +G G F+ V+  + +  +   AMK++R DK+    + E  + E  +L +V+   
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDAD 76
Query: 211 ----------FIVQLRYSFQTK--YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
                      I++L   F  K    +++V+ F   G     L ++   R  +  IY  +
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR-GIPLIYVKQ 135
Query: 259 I----VSAVSHLHAN-GIMHRDLKPENILLDADG------HVMLTDFGLAKQFDENTRSN 307
           I    +  + ++H   GI+H D+KPEN+L++          + + D G A  +DE+  +N
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-TN 194
Query: 308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQ 346
           S+  T EY SPE++LG      AD WS   L+FE++TG 
Sbjct: 195 SI-QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 195 VWAFGVLLWEIATYGMSPYPG 215

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 107/222 (48%), Gaps = 22/222 (9%)
Query: 150 EDFEVLKVVGQGAFAKVYQVR---RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + F + +++G+G F  V + +     G+    A+K+++ D I   +  E+++ E   + +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR-EAACMKE 81
Query: 207 VDHPFIVQL---RYSFQTKYRL---YLVLDFVNGG--HLFFQLYRQG-----LFREDLAR 253
            DHP + +L       + K RL    ++L F+  G  H F    R G     L  + L R
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT- 312
            +  +I   + +L +   +HRDL   N +L  D  V + DFGL+++          C + 
Sbjct: 142 -FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 313 --LEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
             +++++ E +    +   +D W+ G+ ++E++T GQ P+ G
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG 242

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 195 VWAFGVLLWEIATYGMSPYPG 215

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 105/208 (50%), Gaps = 13/208 (6%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D  +   +G G + +VY+      S   A+K +++D +  +   E++K E  ++ ++ HP
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLK-EAAVMKEIKHP 276
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHL 266
            +VQL      +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGK 324
                +HR+L   N L+  +  V + DFGL++    +T +        +++ +PE +   
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 394
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG 351
                +D W+ G+LL+E+ T G  P+ G
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPG 422

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 74  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++M+ E
Sbjct: 132 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+  GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E    E  ++ ++ HP +VQL  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++++F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 82  VCTREPPFYIIIEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 200 VWAFGVLLWEIATYGMSPYPG 220

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 31/224 (13%)
Query: 156 KVVGQGAFAKV-----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           K +G+GAF +V     + + +  T    A+K++++     ++ A  + SE  IL  + H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 81
Query: 211 FIVQLRYSFQTKY--RLYLVLDFVNGGHLFF-----------------QLYRQGLFREDL 251
             V       TK    L ++ +F   G+L                    LY+  L  E L
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TRSNS 308
              Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R   
Sbjct: 142 I-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 107/231 (46%), Gaps = 44/231 (19%)
Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMK-VMR--KDKIMEKNHAEYMKSERNILTKVD 208
           +E+  ++G G++  V +        + A+K ++R  +D I      + +  E  IL +++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI----DCKRILREIAILNRLN 110
Query: 209 HPFIVQ-----LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL-ARIYTAEIVSA 262
           H  +V+     +    +    LY+VL+  +    F +L+R  ++  +L  +     ++  
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-------------- 308
           V ++H+ GI+HRDLKP N L++ D  V + DFGLA+  D     NS              
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 309 -----------MCG---TLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLT 344
                      + G   T  Y +PE I+L + + +A D WS+G +  E+L 
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  E  E+ +++G+G F +VY  R  G   I  + + R ++    +  +  K E     +
Sbjct: 30  IPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNE----DQLKAFKREVMAYRQ 85
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL--ARIYTAEIVSAVS 264
             H  +V    +  +   L ++     G  L+  + R      D+   R    EIV  + 
Sbjct: 86  TRHENVVLFMGACMSPPHLAIITSLCKGRTLY-SVVRDAKIVLDVNKTRQIAQEIVKGMG 144
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGL--------AKQFDENTRSNSMCGTLEYM 316
           +LHA GI+H+DLK +N+  D +G V++TDFGL        A + ++  R  +  G L ++
Sbjct: 145 YLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN--GWLCHL 201
Query: 317 SPEIVLGKGHD---------KAADWWSVGILLFEMLTGQPPF 349
           +PEI+     D         K +D +++G + +E+   + PF
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 79  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 136
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++M+ E
Sbjct: 137 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+  GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 79  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 136
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E
Sbjct: 137 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 229

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK---- 206
           +F+ +KV+G GAF  VY+   I   E    KV     I E   A   K+ + IL +    
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGE----KVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 207 --VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
             VD+P + +L     T   + L+   +  G L  + + ++  +  + L   +  +I   
Sbjct: 72  ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSPE 319
           +++L    ++HRDL   N+L+    HV +TDFG AK      +     G    +++M+ E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +L + +   +D WS G+ ++E++T G  P+ G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ K +G G F +V+       +++ A+K M+   +      E   +E N++  + H
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 236
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L ++  TK  +Y++ +F+  G L   L      ++ L ++  ++A+I   ++ + 
Sbjct: 237 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 295
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGTLEYMSPEIVLGK 324
               +HRDL+  NIL+ A     + DFGLA+   +F            +++ +PE +   
Sbjct: 296 QRNYIHRDLRAANILVSASLVCKIADFGLARVGAKF-----------PIKWTAPEAINFG 344
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG 351
                +D WS GILL E++T G+ P+ G
Sbjct: 345 SFTIKSDVWSFGILLMEIVTYGRIPYPG 372

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 102/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 74
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R++++ +   Y A +I SA+ +L     +H
Sbjct: 75  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 193 VWAFGVLLWEIATYGMSPYPG 213

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D  +   +G G + +VY+      S   A+K +++D +      E    E  ++ ++ HP
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 74
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHL 266
            +VQL      +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL 132
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGK 324
                +HRDL   N L+  +  V + DFGL++    +T +        +++ +PE +   
Sbjct: 133 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYN 192
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG 351
                +D W+ G+LL+E+ T G  P+ G
Sbjct: 193 KFSIKSDVWAFGVLLWEIATYGMSPYPG 220

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 90/192 (46%), Gaps = 26/192 (13%)
Query: 161 GAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ 220
           GA   V Q++  G  +       R+ +I++  H++++   R +      P          
Sbjct: 36  GALVAVKQLQHSGPDQ--QRDFQREIQILKALHSDFIVKYRGVSYGPGRP---------- 83
Query: 221 TKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARI--YTAEIVSAVSHLHANGIMHRDL 276
               L LV++++  G L  F Q +R    R D +R+  Y+++I   + +L +   +HRDL
Sbjct: 84  ---ELRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSRRCVHRDL 137
Query: 277 KPENILLDADGHVMLTDFGLAKQF----DENTRSNSMCGTLEYMSPEIVLGKGHDKAADW 332
              NIL++++ HV + DFGLAK      D           + + +PE +      + +D 
Sbjct: 138 AARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDV 197
Query: 333 WSVGILLFEMLT 344
           WS G++L+E+ T
Sbjct: 198 WSFGVVLYELFT 209

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+GAF +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMC 310
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+  +  +   N+  
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 311 GTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           G L  ++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 153 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 81
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 82  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 200 VWAFGVLLWEIATYGMSPYPG 220

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y     GT E+ A+K +++    +       + E  IL  + H 
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG--WQREIEILRTLYHE 71
Query: 211 FIVQLRYSF--QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV+ +     Q +  + LV+++V  G L   L R  +    L  ++  +I   +++LHA
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL-LFAQQICEGMAYLHA 130
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-----NTRSNSMCGTLEYMSPEIVLG 323
              +HR L   N+LLD D  V + DFGLAK   E       R +       Y +PE +  
Sbjct: 131 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKE 189
Query: 324 KGHDKAADWWSVGILLFEMLT 344
                A+D WS G+ L+E+LT
Sbjct: 190 CKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y     GT E+ A+K +++    +       + E  IL  + H 
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG--WQREIEILRTLYHE 70
Query: 211 FIVQLRYSF--QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            IV+ +     Q +  + LV+++V  G L   L R  +    L  ++  +I   +++LHA
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL-LFAQQICEGMAYLHA 129
Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-----NTRSNSMCGTLEYMSPEIVLG 323
              +HR L   N+LLD D  V + DFGLAK   E       R +       Y +PE +  
Sbjct: 130 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKE 188
Query: 324 KGHDKAADWWSVGILLFEMLT 344
                A+D WS G+ L+E+LT
Sbjct: 189 CKFYYASDVWSFGVTLYELLT 209

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+GAF +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+T +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 44/226 (19%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           C G+ D E + V  +  F  V   R +   +      +V+R+ +++   H   +   R+I
Sbjct: 39  CAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR-IYTAEIVSA 262
               + P            ++LYLV +               L R DLA+ I+   IV +
Sbjct: 98  FVHFEEP----------AMHKLYLVTE---------------LMRTDLAQVIHDQRIVIS 132
Query: 263 VSH--------------LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS 308
             H              LH  G++HRDL P NILL  +  + + DF LA++   +     
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192
Query: 309 MCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 Y +PE+V+  KG  K  D WS G ++ EM   +  F G  
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E    E  ++ ++ HP +VQL  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 79  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 197 VWAFGVLLWEIATYGMSPYPG 217

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 44/226 (19%)
Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           C G+ D E + V  +  F  V   R +   +      +V+R+ +++   H   +   R+I
Sbjct: 39  CAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97
Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR-IYTAEIVSA 262
               + P            ++LYLV +               L R DLA+ I+   IV +
Sbjct: 98  FVHFEEP----------AMHKLYLVTE---------------LMRTDLAQVIHDQRIVIS 132
Query: 263 VSH--------------LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS 308
             H              LH  G++HRDL P NILL  +  + + DF LA++   +     
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH 192
Query: 309 MCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                 Y +PE+V+  KG  K  D WS G ++ EM   +  F G  
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E++K E  ++ ++ HP +VQL  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLK-EAAVMKEIKHPNLVQLLG 77
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 78  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 196 VWAFGVLLWEIATYGMSPYPG 216

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           D  +   +G G + +VY+      S   A+K +++D +  +   E++K E  ++ ++ HP
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLK-EAAVMKEIKHP 315
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHL 266
            +VQL      +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L
Sbjct: 316 NLVQLLGVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYL 373
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGK 324
                +HR+L   N L+  +  V + DFGL++    +T +        +++ +PE +   
Sbjct: 374 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 433
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG 351
                +D W+ G+LL+E+ T G  P+ G
Sbjct: 434 KFSIKSDVWAFGVLLWEIATYGMSPYPG 461

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY    +G  + Y++ V  K    +    E    E  ++ ++ HP +VQL  
Sbjct: 40  LGGGQYGEVY----VGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 95
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y+V +++  G+L    Y +   RE++  +   Y A +I SA+ +L     +H
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLD--YLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIH 153
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSD 213
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 214 VWAFGVLLWEIATYGMSPYPG 234

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 31/224 (13%)
Query: 156 KVVGQGAFAKV-----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           K +G+GAF +V     + + +  T    A+K++++     ++ A  + SE  IL  + H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 81
Query: 211 FIVQLRYSFQTKY--RLYLVLDFVNGGHLFF-----------------QLYRQGLFREDL 251
             V       TK    L ++ +F   G+L                    LY+  L  E L
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TRSNS 308
              Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R   
Sbjct: 142 I-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F  VY+   +  + +   K+     I  +   +    E  ++ K  H  +V+L  
Sbjct: 39  MGEGGFGVVYK-GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQL-YRQGL------FREDLARIYTAEIVSAVSHLHANG 270
                  L LV  ++  G L  +L    G        R  +A+       + ++ LH N 
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ----GAANGINFLHENH 153
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            +HRD+K  NILLD      ++DFGLA+   +F +    + + GT  YM+PE + G+   
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGEITP 213
Query: 328 KAADWWSVGILLFEMLTGQP 347
           K +D +S G++L E++TG P
Sbjct: 214 K-SDIYSFGVVLLEIITGLP 232

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E    E  ++ ++ HP +VQL  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 81  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 138
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 199 VWAFGVLLWEIATYGMSPYPG 219

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 31/224 (13%)
Query: 156 KVVGQGAFAKV-----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           K +G+GAF +V     + + +  T    A+K++++     ++ A  + SE  IL  + H 
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGHH 81
Query: 211 FIVQLRYSFQTKY--RLYLVLDFVNGGHLFF-----------------QLYRQGLFREDL 251
             V       TK    L ++ +F   G+L                    LY+  L  E L
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TRSNS 308
              Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    R   
Sbjct: 142 I-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 244

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 104/217 (47%), Gaps = 18/217 (8%)
Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVY--QVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           E  C+ +E     +V+G G F +V   +++  G  E+       K    EK   +++  E
Sbjct: 20  EASCITIE-----RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFL-GE 73
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEI 259
            +I+ + DHP I+ L         + +V +++  G L  F     G F           I
Sbjct: 74  ASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGI 133
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTL 313
            + + +L   G +HRDL   NIL++++    ++DFGL++  +++      TR   +   +
Sbjct: 134 SAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PI 191
Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPF 349
            + +PE +  +    A+D WS GI+++E+++ G+ P+
Sbjct: 192 RWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPY 228

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/115 (32%), Positives = 61/115 (53%), Gaps = 5/115 (4%)
Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
            Y++ +  EDL   Y+ ++   +  L +   +HRDL   NILL  +  V + DFGLA+  
Sbjct: 191 FYKEPITMEDLIS-YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDI 249
Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            +N    R       L++M+PE +  K +   +D WS G+LL+E+ + G  P+ G
Sbjct: 250 YKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPG 304

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E    E  ++ ++ HP +VQL  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 82  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 200 VWAFGVLLWEIATYGMSPYPG 220

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E    E  ++ ++ HP +VQL  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 79  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 197 VWAFGVLLWEIATYGMSPYPG 217

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E    E  ++ ++ HP +VQL  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 89
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 90  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 147
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 207
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 208 VWAFGVLLWEIATYGMSPYPG 228

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E    E  ++ ++ HP +VQL  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 79  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 197 VWAFGVLLWEIATYGMSPYPG 217

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 18  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 72
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 73  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 131
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 132 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 191
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 192 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 221

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+GAF +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+GAF +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 197 MKSERNILTKVDHPFIVQLR-YSF-QTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
            + E  IL  +   FIV+ R  S+   +  L LV++++  G L  F Q +R    R D +
Sbjct: 59  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDAS 115
Query: 253 RI--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF----DENTRS 306
           R+  Y+++I   + +L +   +HRDL   NIL++++ HV + DFGLAK      D     
Sbjct: 116 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 175
Query: 307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT 344
                 + + +PE +      + +D WS G++L+E+ T
Sbjct: 176 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 40/236 (16%)
Query: 150 EDFEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           E +E++  +G+G F +V Q    R G + + A+K++   K +EK + E  + E N+L K+
Sbjct: 33  ERYEIVSTLGEGTFGRVVQCVDHRRGGARV-ALKII---KNVEK-YKEAARLEINVLEKI 87
Query: 208 DHP------FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE---DLARIYTAE 258
           +          VQ+   F   Y  ++ + F   G   F   +   +        R    +
Sbjct: 88  NEKDPDNKNLCVQMFDWFD--YHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQ 145
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGH-------------------VMLTDFGLAKQ 299
           +  AV  LH N + H DLKPENIL     +                   V + DFG A  
Sbjct: 146 LCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT- 204
Query: 300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF-TGGNR 354
           FD    S ++  T  Y +PE++L  G  +  D WS+G ++FE   G   F T  NR
Sbjct: 205 FDHEHHS-TIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNR 259

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 197 MKSERNILTKVDHPFIVQLR-YSFQT-KYRLYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
            + E  IL  +   FIV+ R  S+   +  L LV++++  G L  F Q +R    R D +
Sbjct: 71  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDAS 127
Query: 253 RI--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF----DENTRS 306
           R+  Y+++I   + +L +   +HRDL   NIL++++ HV + DFGLAK      D     
Sbjct: 128 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187
Query: 307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT 344
                 + + +PE +      + +D WS G++L+E+ T
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E    E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 195 VWAFGVLLWEIATYGMSPYPG 215

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 16  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 70
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 71  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 129
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 130 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 189
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 19  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 73
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 74  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 132
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 133 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 192
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 193 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 222

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 197 MKSERNILTKVDHPFIVQLR-YSFQT-KYRLYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
            + E  IL  +   FIV+ R  S+   +  L LV++++  G L  F Q +R    R D +
Sbjct: 58  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDAS 114
Query: 253 RI--YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF----DENTRS 306
           R+  Y+++I   + +L +   +HRDL   NIL++++ HV + DFGLAK      D     
Sbjct: 115 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 174
Query: 307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT 344
                 + + +PE +      + +D WS G++L+E+ T
Sbjct: 175 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G G + +VY+      S   A+K +++D +      E    E  ++ ++ HP +VQL  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI---YTA-EIVSAVSHLHANGIMH 273
               +   Y++ +F+  G+L    Y +   R+++  +   Y A +I SA+ +L     +H
Sbjct: 77  VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT--LEYMSPEIVLGKGHDKAAD 331
           RDL   N L+  +  V + DFGL++    +T +        +++ +PE +        +D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 332 WWSVGILLFEMLT-GQPPFTG 351
            W+ G+LL+E+ T G  P+ G
Sbjct: 195 VWAFGVLLWEIATYGMSPYPG 215

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 15  LKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 71
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++F+  G L  + Q +++ +    L + YT++I   
Sbjct: 72  QHDNIVKYKGVCYS-AGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQ-YTSQICKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F  VY+   +  + +   K+     I  +   +    E  ++ K  H  +V+L  
Sbjct: 39  MGEGGFGVVYK-GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQL-YRQGL------FREDLARIYTAEIVSAVSHLHANG 270
                  L LV  ++  G L  +L    G        R  +A+       + ++ LH N 
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ----GAANGINFLHENH 153
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            +HRD+K  NILLD      ++DFGLA+   +F +      + GT  YM+PE + G+   
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEITP 213
Query: 328 KAADWWSVGILLFEMLTGQP 347
           K +D +S G++L E++TG P
Sbjct: 214 K-SDIYSFGVVLLEIITGLP 232

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 84
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 145 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 203
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 204 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 247

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  +++K +G G F +V+      ++++ A+K ++   +  +   E    E N++  + H
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAFLE----EANLMKTLQH 66
Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHL 266
             +V+L Y+  TK   +Y++ +F+  G L   L      +  L ++  ++A+I   ++++
Sbjct: 67  DKLVRL-YAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 125
Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGK 324
                +HRDL+  N+L+       + DFGLA+  ++N  T        +++ +PE +   
Sbjct: 126 ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 185
Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG 351
                ++ WS GILL+E++T G+ P+ G
Sbjct: 186 CFTIKSNVWSFGILLYEIVTYGKIPYPG 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 20  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 74
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 75  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 133
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 134 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 193
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 194 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 223

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 81
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 142 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 200
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 201 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 244

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 64
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 65  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 183
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 104/207 (50%), Gaps = 10/207 (4%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  +++K +G G F +V+      ++++ A+K ++   +  +   E    E N++  + H
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSVQAFLE----EANLMKTLQH 67
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L      +  +Y++ +++  G L   L      +  L ++  ++A+I   ++++ 
Sbjct: 68  DKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 127
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  N+L+       + DFGLA+  ++N  T        +++ +PE +    
Sbjct: 128 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGC 187
Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS GILL+E++T G+ P+ G
Sbjct: 188 FTIKSDVWSFGILLYEIVTYGKIPYPG 214

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 77
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 138 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 153 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 85
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 146 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 204
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 205 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 248

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 133
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 194 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 253 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 12  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 66
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 67  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 125
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 126 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN 185
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 186 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 215

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q  R               + L  +DL
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 153 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY 217
           +G+G F  VY+   +  + +   K+     I  +   +    E  ++ K  H  +V+L  
Sbjct: 33  MGEGGFGVVYK-GYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 218 SFQTKYRLYLVLDFVNGGHLFFQL-YRQGL------FREDLARIYTAEIVSAVSHLHANG 270
                  L LV  ++  G L  +L    G        R  +A+       + ++ LH N 
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ----GAANGINFLHENH 147
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            +HRD+K  NILLD      ++DFGLA+   +F +      + GT  YM+PE + G+   
Sbjct: 148 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEITP 207
Query: 328 KAADWWSVGILLFEMLTGQP 347
           K +D +S G++L E++TG P
Sbjct: 208 K-SDIYSFGVVLLEIITGLP 226

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 71/138 (51%), Gaps = 20/138 (14%)
Query: 224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--------GIMHRD 275
           +LYL+ D+   G L+  L    L  + + ++  +  VS + HLH           I HRD
Sbjct: 109 QLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS-VSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 276 LKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPEIV---LGKGHD 327
           LK +NIL+  +G   + D GLA +F  +T       N+  GT  YM PE++   L + H 
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 328 KA---ADWWSVGILLFEM 342
           ++   AD +S G++L+E+
Sbjct: 228 QSYIMADMYSFGLILWEV 245

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 15  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 69
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 70  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 128
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 129 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 188
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 189 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 218

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ +
Sbjct: 16  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQ 70
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVS 264
           + H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++
Sbjct: 71  LQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 129
Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVL 322
            +     +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE + 
Sbjct: 130 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 189
Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                  +D WS GILL E++T G+ P+ G
Sbjct: 190 YGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ ++ H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++ + 
Sbjct: 68  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE +    
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS GILL E++T G+ P+ G
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ ++ H
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 68
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++ + 
Sbjct: 69  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 127
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE +    
Sbjct: 128 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 187
Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS GILL E++T G+ P+ G
Sbjct: 188 FTIKSDVWSFGILLTEIVTHGRIPYPG 214

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 104/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE-------IYAMKVMRKDKIMEK-----NHAEYMK---SE 200
           K +G+GAF +V     +G  +         A+K+++ D   E      +  E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ ++ H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++ + 
Sbjct: 68  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE +    
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS GILL E++T G+ P+ G
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ ++ H
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 62
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++ + 
Sbjct: 63  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 121
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N  T        +++ +PE +    
Sbjct: 122 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 181
Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS GILL E++T G+ P+ G
Sbjct: 182 FTIKSDVWSFGILLTEIVTHGRIPYPG 208

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y      T E  A+K ++ +     NH   +K E  IL  + H 
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE 83
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR-----------IYTAEI 259
            IV        KY+     D  NG  L  +    G  +E L +            Y  +I
Sbjct: 84  NIV--------KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----Y 315
              + +L +   +HRDL   N+L++++  V + DFGL K  + +    ++    +    +
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 195
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT 344
            +PE ++      A+D WS G+ L E+LT
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+GAF +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 105/234 (44%), Gaps = 51/234 (21%)
Query: 150 EDFEVLKVVGQGAFAKVY--------------QVRRIGTSEIYAMKVMRKDKIMEKNHAE 195
           +++ +  ++G+G++  VY              +V R+    I   +++R+  I+ +  ++
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF-REDLARI 254
           Y+    +++   D      L++       LY+VL+  +      +L++  +F  E+  + 
Sbjct: 86  YIIRLYDLIIPDD-----LLKFD-----ELYIVLEIADSD--LKKLFKTPIFLTEEHIKT 133
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN------- 307
               ++   + +H +GI+HRDLKP N LL+ D  V + DFGLA+  +    +N       
Sbjct: 134 ILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 308 ----------------SMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLT 344
                           S   T  Y +PE I+L + + K+ D WS G +  E+L 
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 155 LKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           ++ +G+G F KV    Y      T E  A+K ++ +     NH   +K E  IL  + H 
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE 71
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR-----------IYTAEI 259
            IV        KY+     D  NG  L  +    G  +E L +            Y  +I
Sbjct: 72  NIV--------KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 123
Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----Y 315
              + +L +   +HRDL   N+L++++  V + DFGL K  + +    ++    +    +
Sbjct: 124 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 183
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLT 344
            +PE ++      A+D WS G+ L E+LT
Sbjct: 184 YAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 19  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 75
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 76  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 133
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 134 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 193
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 194 ESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 108/223 (48%), Gaps = 28/223 (12%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     +G  +      +     M KD   EK+ ++ + SE  ++  +  
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIGK 99
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQ-GL-FREDLARI---------- 254
           H  I+ L  +      LY+++++ + G+L  + +  R  G+ +  D+ R+          
Sbjct: 100 HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 255 --YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSM 309
              T ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ + 
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
              +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 43  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 99
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 100 QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 157
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 158 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 217
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 37/236 (15%)
Query: 150 EDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           E+ E  KV+G GAF KV     Y + + G S   A+K++++    + +  E + SE  ++
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMM 102
Query: 205 TKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLAR--------- 253
           T++  H  IV L  +      +YL+ ++   G L   L  ++  F ED            
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 254 -------------IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
                         +  ++   +  L     +HRDL   N+L+     V + DFGLA+  
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 301 --DEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
             D N   R N+    +++M+PE +    +   +D WS GILL+E+ + G  P+ G
Sbjct: 223 MSDSNYVVRGNARL-PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 71
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 72  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 68
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 69  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 126
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 17  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 73
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 74  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 131
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 132 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 191
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 192 ESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+GAF +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 86
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 87  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 144
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 18  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 74
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 75  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 132
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 133 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 192
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 193 ESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 10  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 66
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 67  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 124
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 125 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 184
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 185 ESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 11  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 67
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 68  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 125
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 126 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 185
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 186 ESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 16  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 72
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 73  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 130
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 131 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 190
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 191 ESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM-----RKDKIMEKNHAEYMKSERNILT 205
           + E  K +G+G F  V++ R +    + A+K +       +  M +   E+ + E  I++
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR-EVFIMS 78
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVS 264
            ++HP IV+L        R+  V++FV  G L+ +L  +    +  +      +I   + 
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 265 HLHANG--IMHRDLKPENILL-----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
           ++      I+HRDL+  NI L     +A     + DFGL++Q   +   + + G  ++M+
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV--SGLLGNFQWMA 194
Query: 318 PEIVLGK--GHDKAADWWSVGILLFEMLTGQPPF 349
           PE +  +   + + AD +S  ++L+ +LTG+ PF
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 86
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 87  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 144
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 204
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 205 ESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 112/243 (46%), Gaps = 28/243 (11%)
Query: 132 KPTGHIDNLPSENQ----------------CVGLEDFEVLKVVGQGAFAKVYQVRRIGTS 175
           KP  H  ++P+E                   V  ++F    ++G+G F KVY+  R+   
Sbjct: 4   KPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYK-GRLADG 62
Query: 176 EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGG 235
            + A+K +++++   +      ++E  +++   H  +++LR    T     LV  ++  G
Sbjct: 63  TLVAVKRLKEERX--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 236 HLFFQLYRQGLFREDLARIYTAEIV----SAVSHLHAN---GIMHRDLKPENILLDADGH 288
            +   L  +   +  L       I       +++LH +    I+HRD+K  NILLD +  
Sbjct: 121 SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 180
Query: 289 VMLTDFGLAKQFD--ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQ 346
            ++ DFGLAK  D  +     ++ GT+ +++PE +      +  D +  G++L E++TGQ
Sbjct: 181 AVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 240
Query: 347 PPF 349
             F
Sbjct: 241 RAF 243

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 68
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 69  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 126
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 186
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+GAF +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 161 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 105/207 (50%), Gaps = 11/207 (5%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++++ +G G F +V+     G +++ A+K +++  +      +   +E N++ ++ H
Sbjct: 9   ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 63
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++ + 
Sbjct: 64  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 122
Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
               +HR+L+  NIL+       + DFGLA+  ++N  T        +++ +PE +    
Sbjct: 123 ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 182
Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTG 351
               +D WS GILL E++T G+ P+ G
Sbjct: 183 FTIKSDVWSFGILLTEIVTHGRIPYPG 209

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+G F +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 207 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+G F +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 148 SCTY--QLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 249

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+G F +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 150 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 251

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 28/215 (13%)
Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY---MKSERNILTK 206
            D  +L+ VG+G + +V++    G +    +   R +K   +    Y   M    NIL  
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENIL-- 65
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
               FI     S  +  +L+L+  +   G L+  L    L      RI  + I S ++HL
Sbjct: 66  ---GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHL 121
Query: 267 HAN--------GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-----SNSMCGTL 313
           H           I HRDLK +NIL+  +G   + D GLA    ++T      +N   GT 
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 314 EYMSPEI------VLGKGHDKAADWWSVGILLFEM 342
            YM+PE+      V      K  D W+ G++L+E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSE------IYAMKVMRKDKIMEKN------HAEYMK---SE 200
           K +G+G F +V     +G  +      +     M KD   EK+        E MK     
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 201 RNILTKV-----DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDL 251
           +NI+  +     D P  V + Y+ +   R YL      G    + + R    Q  F++ +
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
           +  Y  ++   + +L +   +HRDL   N+L+  +  + + DFGLA+     D   ++ +
Sbjct: 153 SCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 254

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 104/224 (46%), Gaps = 30/224 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKV------MRKDKIMEKNHAEYMKSERNILTKV-D 208
           K +G+GAF +V     IG  +    +V      M K    EK+ ++ + SE  ++  +  
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGK 92
Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR---------------QGLFREDL 251
           H  I+ L  +      LY+++++ + G+L  + Q                  + L  +DL
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNS 308
                 ++   + +L +   +HRDL   N+L+  D  + + DFGLA+     D   ++ +
Sbjct: 153 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 255

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 54/90 (60%), Gaps = 4/90 (4%)
Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSMCGTLEYMS 317
           + ++ LH N  +HRD+K  NILLD      ++DFGLA+   +F +    + + GT  Y +
Sbjct: 135 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXA 194
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQP 347
           PE + G+   K +D +S G++L E++TG P
Sbjct: 195 PEALRGEITPK-SDIYSFGVVLLEIITGLP 223

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 71
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q + + +    L + YT++I   
Sbjct: 72  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQ-YTSQICKG 129
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 130 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAP 189
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 190 ESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 68
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 69  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 126
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HRDL   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/274 (22%), Positives = 113/274 (41%), Gaps = 29/274 (10%)
Query: 145 QCVGLEDFEVLKVVGQGAFAKV-----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           Q +   D  + + +G+GAF KV     Y +       + A+K ++   +  +      + 
Sbjct: 10  QHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD---FQR 66
Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLY------------RQG 245
           E  +LT + H  IV+          L +V +++  G L  F + +            RQ 
Sbjct: 67  EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 246 LFREDLARIY--TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--- 300
                L+++    ++I S + +L +   +HRDL   N L+ A+  V + DFG+++     
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 301 DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT--GQPPFTGGNRXXXX 358
           D           + +M PE ++ +     +D WS G++L+E+ T   QP F   N     
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 246
Query: 359 XXXXXXXXXLPAFLSSEAHSLLKGLLQKEASKRL 392
                     P     E + ++ G  Q+E  +RL
Sbjct: 247 CITQGRVLERPRVCPKEVYDVMLGCWQREPQQRL 280

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 28/231 (12%)
Query: 134 TGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH 193
           +G    LP   Q        +L+ VG+G + +V++    G +    +   R +K   +  
Sbjct: 21  SGSGSGLPFLVQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRET 80
Query: 194 AEY---MKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
             Y   M    NIL      FI     S  +  +L+L+  +   G L+  L    L    
Sbjct: 81  ELYNTVMLRHENIL-----GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS 135
Query: 251 LARIYTAEIVSAVSHLHAN--------GIMHRDLKPENILLDADGHVMLTDFGLAKQFDE 302
             RI  + I S ++HLH           I HRDLK +NIL+  +G   + D GLA    +
Sbjct: 136 CLRIVLS-IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 194
Query: 303 NTR-----SNSMCGTLEYMSPEI------VLGKGHDKAADWWSVGILLFEM 342
           +T      +N   GT  YM+PE+      V      K  D W+ G++L+E+
Sbjct: 195 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 103/237 (43%), Gaps = 54/237 (22%)
Query: 150 EDFEVLKVVGQGAFAKVY--------------QVRRIGTSEIYAMKVMRKDKIMEKNHAE 195
           +++E+  ++G+G++  VY              +V R+    I   +++R+  I+ +  ++
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF-REDLARI 254
           Y+    +++   D      L++       LY+VL+  +      +L++  +F  E   + 
Sbjct: 88  YIIRLHDLIIPED-----LLKFD-----ELYIVLEIADSD--LKKLFKTPIFLTEQHVKT 135
Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----------- 303
               ++     +H +GI+HRDLKP N LL+ D  V + DFGLA+  + +           
Sbjct: 136 ILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEE 195
Query: 304 ---------------TRSNSMCGTLEYMSPE-IVLGKGHDKAADWWSVGILLFEMLT 344
                           +  S   T  Y +PE I+L + +  + D WS G +  E+L 
Sbjct: 196 KEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN 252

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 104/214 (48%), Gaps = 20/214 (9%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM-----RKDKIMEKNHAEYMKSERNILT 205
           + E  K +G+G F  V++ R +    + A+K +       +  M +   E+ + E  I++
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR-EVFIMS 78
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVS 264
            ++HP IV+L        R+  V++FV  G L+ +L  +    +  +      +I   + 
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 265 HLHANG--IMHRDLKPENILL-----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
           ++      I+HRDL+  NI L     +A     + DFG ++Q   +   + + G  ++M+
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSV--SGLLGNFQWMA 194
Query: 318 PEIVLGK--GHDKAADWWSVGILLFEMLTGQPPF 349
           PE +  +   + + AD +S  ++L+ +LTG+ PF
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEY---MKSERNILTKVDHPFI 212
           +G+G F +V++ +  G  E  A+K+   R+++   +    Y   M    NIL      FI
Sbjct: 50  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENIL-----GFI 102
Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--- 269
                   T  +L+LV D+   G LF  L R  +  E + ++  +   S ++HLH     
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVG 161
Query: 270 -----GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPE 319
                 I HRDLK +NIL+  +G   + D GLA + D  T +     N   GT  YM+PE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 320 IV---LGKGH---DKAADWWSVGILLFEM 342
           ++   +   H    K AD +++G++ +E+
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 103/212 (48%), Gaps = 12/212 (5%)
Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V  ++F    ++G+G F KVY+  R+    + A+K +++++   +      ++E  +++ 
Sbjct: 27  VASDNFXNKNILGRGGFGKVYK-GRLADGXLVAVKRLKEERT--QGGELQFQTEVEMISM 83
Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV----SA 262
             H  +++LR    T     LV  ++  G +   L  +   +  L       I       
Sbjct: 84  AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 143
Query: 263 VSHLHAN---GIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSMCGTLEYMS 317
           +++LH +    I+HRD+K  NILLD +   ++ DFGLAK  D  +     ++ G + +++
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIA 203
Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           PE +      +  D +  G++L E++TGQ  F
Sbjct: 204 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEY---MKSERNILTKVDHPFI 212
           +G+G F +V++ +  G  E  A+K+   R+++   +    Y   M    NIL      FI
Sbjct: 37  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENIL-----GFI 89
Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--- 269
                   T  +L+LV D+   G LF  L R  +  E + ++      S ++HLH     
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEIVG 148
Query: 270 -----GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPE 319
                 I HRDLK +NIL+  +G   + D GLA + D  T +     N   GT  YM+PE
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 208
Query: 320 IV---LGKGH---DKAADWWSVGILLFEM 342
           ++   +   H    K AD +++G++ +E+
Sbjct: 209 VLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 104/214 (48%), Gaps = 20/214 (9%)
Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM-----RKDKIMEKNHAEYMKSERNILT 205
           + E  K +G+G F  V++ R +    + A+K +       +  M +   E+ + E  I++
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR-EVFIMS 78
Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVS 264
            ++HP IV+L        R+  V++FV  G L+ +L  +    +  +      +I   + 
Sbjct: 79  NLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 265 HLHANG--IMHRDLKPENILL-----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
           ++      I+HRDL+  NI L     +A     + DF L++Q   +   + + G  ++M+
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSV--SGLLGNFQWMA 194
Query: 318 PEIVLGK--GHDKAADWWSVGILLFEMLTGQPPF 349
           PE +  +   + + AD +S  ++L+ +LTG+ PF
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 152 FEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            + L+ +G+G F  V   R    +  T E+ A+K ++      + H    + E  IL  +
Sbjct: 13  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSL 69
Query: 208 DHPFIVQLR---YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
            H  IV+ +   YS   +  L L+++++  G L  + Q +++ +    L + YT++I   
Sbjct: 70  QHDNIVKYKGVCYS-AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICKG 127
Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE----YMSP 318
           + +L     +HR+L   NIL++ +  V + DFGL K   ++     +    E    + +P
Sbjct: 128 MEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 187
Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT 344
           E +       A+D WS G++L+E+ T
Sbjct: 188 ESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 156 KVVGQGAFAKVY--QVRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           K++G G   +V   ++R  G  ++  A+K + K    E+   +++ SE +I+ + DHP I
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFL-SEASIMGQFDHPNI 112
Query: 213 VQLRYSFQTKYRLYLVL-DFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           ++L     T+ RL +++ +++  G L  F     G F           + + + +L   G
Sbjct: 113 IRLE-GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LEYMSPEIVLGKGH 326
            +HRDL   N+L+D++    ++DFGL++    D +    +  G   + + +PE +  +  
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTF 231
Query: 327 DKAADWWSVGILLFEMLT-GQPPF 349
             A+D WS G++++E+L  G+ P+
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERPY 255

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 116/258 (44%), Gaps = 24/258 (9%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKV-DHPF 211
           K +G GAF KV +    G  +  A+  +    +    HA   E + SE  I++ +  H  
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARI-------YTAEIVS 261
           IV L  +      + ++ ++   G L   L R+    L +ED   +       +++++  
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 163
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF--DEN--TRSNSMCGTLEYM 316
            ++ L +   +HRD+   N+LL  +GHV  + DFGLA+    D N   + N+    +++M
Sbjct: 164 GMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARL-PVKWM 221
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG--GNRXXXXXXXXXXXXXLPAFLS 373
           +PE +    +   +D WS GILL+E+ + G  P+ G   N               PAF  
Sbjct: 222 APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAP 281
Query: 374 SEAHSLLKGLLQKEASKR 391
              +S+++     E + R
Sbjct: 282 KNIYSIMQACWALEPTHR 299

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEY---MKSERNILTKVDHPFI 212
           +G+G F +V++ +  G  E  A+K+   R+++   +    Y   M    NIL      FI
Sbjct: 12  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENIL-----GFI 64
Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--- 269
                   T  +L+LV D+   G LF  L R  +  E + ++  +   S ++HLH     
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVG 123
Query: 270 -----GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPE 319
                 I HRDLK +NIL+  +G   + D GLA + D  T +     N   GT  YM+PE
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 183
Query: 320 IV---LGKGH---DKAADWWSVGILLFEM 342
           ++   +   H    K AD +++G++ +E+
Sbjct: 184 VLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 152 FEVLKVVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +E+L V+G+G      V   R   T E   ++ +  +         +++ E ++    +H
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNH 69
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLARIYTAE-IVSAVSH 265
           P IV  R +F     L++V  F+  G    L    +  G+   +LA  Y  + ++ A+ +
Sbjct: 70  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM--NELAIAYILQGVLKALDY 127
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----------CGTLEY 315
           +H  G +HR +K  +IL+  DG V L+  GL       +                  L +
Sbjct: 128 IHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 185
Query: 316 MSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPF 349
           +SPE++    +G+D  +D +SVGI   E+  G  PF
Sbjct: 186 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 221

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 152 FEVLKVVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +E+L V+G+G      V   R   T E   ++ +  +         +++ E ++    +H
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNH 85
Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLARIYTAE-IVSAVSH 265
           P IV  R +F     L++V  F+  G    L    +  G+   +LA  Y  + ++ A+ +
Sbjct: 86  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM--NELAIAYILQGVLKALDY 143
Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM----------CGTLEY 315
           +H  G +HR +K  +IL+  DG V L+  GL       +                  L +
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 316 MSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPF 349
           +SPE++    +G+D  +D +SVGI   E+  G  PF
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+  
Sbjct: 185 LYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            ++    R       L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 151 DFEVLKVVGQGAFAKVYQVR--RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           D +   V+G+G F +V + R  + G     A+K M K+   + +H ++   E  +L K+ 
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDF-AGELEVLCKLG 83
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI------------- 254
            HP I+ L  + + +  LYL +++   G+L   L +  +   D A               
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 255 ---YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
              + A++   + +L     +HRDL   NIL+  +    + DFGL++  +   +      
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 203
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            + +M+ E +    +   +D WS G+LL+E+++ G  P+ G
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 56/244 (22%)
Query: 150 EDFEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER---NIL 204
           E +E++  +G+G F KV +      G S++ A+K++R       N  +Y ++ R   N+L
Sbjct: 28  ERYEIVGNLGEGTFGKVVECLDHARGKSQV-ALKIIR-------NVGKYREAARLEINVL 79
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVN-GGHLF--FQLYRQGLF---RED-------- 250
            K+            + K+   L+ D+ N  GH+   F+L  +  F   +E+        
Sbjct: 80  KKIKEK-------DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLP 132
Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-------------------ADGHVML 291
             R    ++  A+  LH N + H DLKPENIL                      +  + +
Sbjct: 133 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 192
Query: 292 TDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF-T 350
            DFG A  FD    + ++  T  Y  PE++L  G  +  D WS+G +LFE   G   F T
Sbjct: 193 ADFGSA-TFDHEHHT-TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 250
Query: 351 GGNR 354
             NR
Sbjct: 251 HENR 254

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 80/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YT 256
           +E N++ ++ H  +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    
Sbjct: 57  AEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSMCGTLE 314
           A+I   ++ +     +HRDL+  NIL+       + DFGLA+  +  E T        ++
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK 175
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS GILL E++T G+ P+ G
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEY---MKSERNILTKVDHPFI 212
           +G+G F +V++ +  G  E  A+K+   R+++   +    Y   M    NIL      FI
Sbjct: 14  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENIL-----GFI 66
Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--- 269
                   T  +L+LV D+   G LF  L R  +  E + ++  +   S ++HLH     
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVG 125
Query: 270 -----GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPE 319
                 I HRDLK +NIL+  +G   + D GLA + D  T +     N   GT  YM+PE
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 185
Query: 320 IV---LGKGH---DKAADWWSVGILLFEM 342
           ++   +   H    K AD +++G++ +E+
Sbjct: 186 VLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY---MKSERNILTKVDHP 210
           +L+ VG+G + +V++    G +    +   R +K   +    Y   M    NIL      
Sbjct: 12  LLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENIL-----G 66
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN- 269
           FI     S  +  +L+L+  +   G L+  L    L      RI  + I S ++HLH   
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEI 125
Query: 270 -------GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-----SNSMCGTLEYMS 317
                   I HRDLK +NIL+  +G   + D GLA    ++T      +N   GT  YM+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 318 PEI------VLGKGHDKAADWWSVGILLFEM 342
           PE+      V      K  D W+ G++L+E+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 151 DFEVLKVVGQGAFAKVYQVR--RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           D +   V+G+G F +V + R  + G     A+K M K+   + +H ++   E  +L K+ 
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDF-AGELEVLCKLG 73
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI------------- 254
            HP I+ L  + + +  LYL +++   G+L   L +  +   D A               
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 255 ---YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
              + A++   + +L     +HRDL   NIL+  +    + DFGL++  +   +      
Sbjct: 134 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 193
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            + +M+ E +    +   +D WS G+LL+E+++ G  P+ G
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 234

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+  
Sbjct: 183 LYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 241
Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            ++    R       L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 242 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 296

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 56/244 (22%)
Query: 150 EDFEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER---NIL 204
           E +E++  +G+G F KV +      G S++ A+K++R       N  +Y ++ R   N+L
Sbjct: 51  ERYEIVGNLGEGTFGKVVECLDHARGKSQV-ALKIIR-------NVGKYREAARLEINVL 102
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVN-GGHLF--FQLYRQGLF---RED-------- 250
            K+            + K+   L+ D+ N  GH+   F+L  +  F   +E+        
Sbjct: 103 KKIKEK-------DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLP 155
Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-------------------ADGHVML 291
             R    ++  A+  LH N + H DLKPENIL                      +  + +
Sbjct: 156 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 215
Query: 292 TDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF-T 350
            DFG A  FD    + ++  T  Y  PE++L  G  +  D WS+G +LFE   G   F T
Sbjct: 216 ADFGSAT-FDHEHHT-TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 273
Query: 351 GGNR 354
             NR
Sbjct: 274 HENR 277

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEY---MKSERNILTKVDHPFI 212
           +G+G F +V++ +  G  E  A+K+   R+++   +    Y   M    NIL      FI
Sbjct: 17  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENIL-----GFI 69
Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--- 269
                   T  +L+LV D+   G LF  L R  +  E + ++  +   S ++HLH     
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVG 128
Query: 270 -----GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPE 319
                 I HRDLK +NIL+  +G   + D GLA + D  T +     N   GT  YM+PE
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 188
Query: 320 IV---LGKGH---DKAADWWSVGILLFEM 342
           ++   +   H    K AD +++G++ +E+
Sbjct: 189 VLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 32/209 (15%)
Query: 158 VGQGAFAKVYQVRRIGTSEIYAMKVM--RKDKIMEKNHAEY---MKSERNILTKVDHPFI 212
           +G+G F +V++ +  G  E  A+K+   R+++   +    Y   M    NIL      FI
Sbjct: 11  IGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENIL-----GFI 63
Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--- 269
                   T  +L+LV D+   G LF  L R  +  E + ++  +   S ++HLH     
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALS-TASGLAHLHMEIVG 122
Query: 270 -----GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGTLEYMSPE 319
                 I HRDLK +NIL+  +G   + D GLA + D  T +     N   GT  YM+PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 320 IV---LGKGH---DKAADWWSVGILLFEM 342
           ++   +   H    K AD +++G++ +E+
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+  
Sbjct: 190 LYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 248
Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            ++    R       L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 249 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 303

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 59/115 (51%), Gaps = 5/115 (4%)
Query: 241 LYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
           LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+  
Sbjct: 192 LYKDFLTLEHLI-CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 250
Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            ++    R       L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 251 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 305

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 116/258 (44%), Gaps = 24/258 (9%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKV-DHPF 211
           K +G GAF KV +    G  +  A+  +    +    HA   E + SE  I++ +  H  
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARI-------YTAEIVS 261
           IV L  +      + ++ ++   G L   L R+    L +ED   +       +++++  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 171
Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF--DEN--TRSNSMCGTLEYM 316
            ++ L +   +HRD+   N+LL  +GHV  + DFGLA+    D N   + N+    +++M
Sbjct: 172 GMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARL-PVKWM 229
Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG--GNRXXXXXXXXXXXXXLPAFLS 373
           +PE +    +   +D WS GILL+E+ + G  P+ G   N               PAF  
Sbjct: 230 APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAP 289
Query: 374 SEAHSLLKGLLQKEASKR 391
              +S+++     E + R
Sbjct: 290 KNIYSIMQACWALEPTHR 307

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 56/244 (22%)
Query: 150 EDFEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER---NIL 204
           E +E++  +G+G F KV +      G S++ A+K++R       N  +Y ++ R   N+L
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQV-ALKIIR-------NVGKYREAARLEINVL 70
Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVN-GGHLF--FQLYRQGLF---RED-------- 250
            K+            + K+   L+ D+ N  GH+   F+L  +  F   +E+        
Sbjct: 71  KKIKEK-------DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLP 123
Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-------------------ADGHVML 291
             R    ++  A+  LH N + H DLKPENIL                      +  + +
Sbjct: 124 HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 292 TDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF-T 350
            DFG A  FD    + ++  T  Y  PE++L  G  +  D WS+G +LFE   G   F T
Sbjct: 184 ADFGSA-TFDHEHHT-TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241
Query: 351 GGNR 354
             NR
Sbjct: 242 HENR 245

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 156 KVVGQGAFAKVY--QVRRIGTSEI-YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           K++G G   +V   ++R  G  ++  A+K + K    E+   +++ SE +I+ + DHP I
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFL-SEASIMGQFDHPNI 112
Query: 213 VQLRYSFQTKYRLYLVL-DFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           ++L     T+ RL +++ +++  G L  F     G F           + + + +L   G
Sbjct: 113 IRLE-GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCG---TLEYMSPEIVLGKGH 326
            +HRDL   N+L+D++    ++DFGL++   D+   + +  G    + + +PE +  +  
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231
Query: 327 DKAADWWSVGILLFEMLT-GQPPF 349
             A+D WS G++++E+L  G+ P+
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERPY 255

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 419 AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 477
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 478 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 537
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 538 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 575

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 420 AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 478
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 479 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 538
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 539 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 576

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 119
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 120 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVK 179
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 217

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 75  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 133
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 134 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 193
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 194 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 231

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 135
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 136 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 233

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 135
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 136 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 233

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 114/247 (46%), Gaps = 46/247 (18%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVR------RIGTSEIYAMKVMRKDKIMEKNH 193
            P +N  +G       K +G+G F KV +        R G + + A+K+++++     + 
Sbjct: 20  FPRKNLVLG-------KTLGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENA--SPSE 69
Query: 194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQ------- 244
              + SE N+L +V+HP +++L  +      L L++++   G L  F +  R+       
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 245 ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
                            L   DL   +  +I   + +L    ++HRDL   NIL+     
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLIS-FAWQISQGMQYLAEMSLVHRDLAARNILVAEGRK 188
Query: 289 VMLTDFGLAKQ-FDENTRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT- 344
           + ++DFGL++  ++E++      G +  ++M+ E +    +   +D WS G+LL+E++T 
Sbjct: 189 MKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 345 GQPPFTG 351
           G  P+ G
Sbjct: 249 GGNPYPG 255

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 67  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 125
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 119
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 120 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 179
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 217

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 156 KVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           KV+G G F +VY+       G  E+       K    EK   +++  E  I+ +  H  I
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQFSHHNI 108
Query: 213 VQLRYSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           ++L         + ++ +++  G L  F   + G F           I + + +L     
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY 168
Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG----TLEYMSPEIVLGKGHD 327
           +HRDL   NIL++++    ++DFGL++  +++  +          + + +PE +  +   
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228
Query: 328 KAADWWSVGILLFEMLT-GQPPF 349
            A+D WS GI+++E++T G+ P+
Sbjct: 229 SASDVWSFGIVMWEVMTYGERPY 251

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 55  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 113
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 114 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 173
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 174 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 211

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 6/158 (3%)
Query: 199 SERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           +E N++ ++D+P+IV++    + +  + LV++    G L   L +    ++        +
Sbjct: 57  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 115
Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGT--LE 314
           +   + +L  +  +HRDL   N+LL    +  ++DFGL+K    DEN       G   ++
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           + +PE +        +D WS G+L++E  + GQ P+ G
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 114/247 (46%), Gaps = 46/247 (18%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVR------RIGTSEIYAMKVMRKDKIMEKNH 193
            P +N  +G       K +G+G F KV +        R G + + A+K+++++     + 
Sbjct: 20  FPRKNLVLG-------KTLGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENA--SPSE 69
Query: 194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQ------- 244
              + SE N+L +V+HP +++L  +      L L++++   G L  F +  R+       
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 245 ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
                            L   DL   +  +I   + +L    ++HRDL   NIL+     
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLIS-FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 289 VMLTDFGLAKQ-FDENTRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT- 344
           + ++DFGL++  ++E++      G +  ++M+ E +    +   +D WS G+LL+E++T 
Sbjct: 189 MKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 345 GQPPFTG 351
           G  P+ G
Sbjct: 249 GGNPYPG 255

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 117/271 (43%), Gaps = 37/271 (13%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKV-DHPF 211
           K +G GAF KV +    G  +  A+  +    +    HA   E + SE  I++ +  H  
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 96
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR----------------QGLFREDLARI- 254
           IV L  +      + ++ ++   G L   L R                +GL +ED   + 
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLE 156
Query: 255 ------YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF--DEN-- 303
                 +++++   ++ L +   +HRD+   N+LL  +GHV  + DFGLA+    D N  
Sbjct: 157 LRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYI 215
Query: 304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG--GNRXXXXXX 360
            + N+    +++M+PE +    +   +D WS GILL+E+ + G  P+ G   N       
Sbjct: 216 VKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 274
Query: 361 XXXXXXXLPAFLSSEAHSLLKGLLQKEASKR 391
                   PAF     +S+++     E + R
Sbjct: 275 KDGYQMAQPAFAPKNIYSIMQACWALEPTHR 305

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 13/107 (12%)
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADG----HVM-LTDFGLAKQF-DENTRSN---- 307
           +++S + ++H+  +++RD+KPEN L+   G    HV+ + DFGLAK++ D  T+ +    
Sbjct: 105 QLLSRMEYVHSKNLIYRDVKPENFLIGRQGNKKEHVIHIIDFGLAKEYIDPETKKHIPYR 164
Query: 308 ---SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
              S+ GT  YMS    LGK   +  D  ++G +    L G  P+ G
Sbjct: 165 EHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 211

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 151 DFEVLKVVGQGAFAKVYQVR--RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           D +   V+G+G F +V + R  + G     A+K M K+   + +H ++   E  +L K+ 
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDF-AGELEVLCKLG 80
Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI------------- 254
            HP I+ L  + + +  LYL +++   G+L   L +  +   D A               
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 255 ---YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG 311
              + A++   + +L     +HR+L   NIL+  +    + DFGL++  +   +      
Sbjct: 141 LLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 200
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            + +M+ E +    +   +D WS G+LL+E+++ G  P+ G
Sbjct: 201 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 241

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 114/247 (46%), Gaps = 46/247 (18%)
Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVR------RIGTSEIYAMKVMRKDKIMEKNH 193
            P +N  +G       K +G+G F KV +        R G + + A+K+++++     + 
Sbjct: 20  FPRKNLVLG-------KTLGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENA--SPSE 69
Query: 194 AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQ------- 244
              + SE N+L +V+HP +++L  +      L L++++   G L  F +  R+       
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129
Query: 245 ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH 288
                            L   DL   +  +I   + +L    ++HRDL   NIL+     
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLIS-FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 289 VMLTDFGLAKQ-FDENTRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT- 344
           + ++DFGL++  ++E++      G +  ++M+ E +    +   +D WS G+LL+E++T 
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248
Query: 345 GQPPFTG 351
           G  P+ G
Sbjct: 249 GGNPYPG 255

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 30/263 (11%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKV-DHPF 211
           K +G GAF KV +    G  +  A+  +    +    HA   E + SE  I++ +  H  
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLF---------------FQLYRQGLFREDLARIYT 256
           IV L  +      + ++ ++   G L                F +    L   DL   ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH-FS 170
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF--DEN--TRSNSMCG 311
           +++   ++ L +   +HRD+   N+LL  +GHV  + DFGLA+    D N   + N+   
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 228
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG--GNRXXXXXXXXXXXXXL 368
            +++M+PE +    +   +D WS GILL+E+ + G  P+ G   N               
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ 288
Query: 369 PAFLSSEAHSLLKGLLQKEASKR 391
           PAF     +S+++     E + R
Sbjct: 289 PAFAPKNIYSIMQACWALEPTHR 311

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 13/107 (12%)
Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGH-----VMLTDFGLAKQF-DENTRSN---- 307
           +++S + ++H+  +++RD+KPEN L+   G+     + + DFGLAK++ D  T+ +    
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYR 172
Query: 308 ---SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
              S+ GT  YMS    LGK   +  D  ++G +    L G  P+ G
Sbjct: 173 EHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 114/263 (43%), Gaps = 30/263 (11%)
Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTKV-DHPF 211
           K +G GAF KV +    G  +  A+  +    +    HA   E + SE  I++ +  H  
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE---------------DLARIYT 256
           IV L  +      + ++ ++   G L   L R+    E               DL   ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH-FS 170
Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQF--DEN--TRSNSMCG 311
           +++   ++ L +   +HRD+   N+LL  +GHV  + DFGLA+    D N   + N+   
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARL- 228
Query: 312 TLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG--GNRXXXXXXXXXXXXXL 368
            +++M+PE +    +   +D WS GILL+E+ + G  P+ G   N               
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ 288
Query: 369 PAFLSSEAHSLLKGLLQKEASKR 391
           PAF     +S+++     E + R
Sbjct: 289 PAFAPKNIYSIMQACWALEPTHR 311

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/233 (22%), Positives = 97/233 (41%), Gaps = 43/233 (18%)
Query: 152 FEVLKVVGQGAFAKVYQVR---RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           F++   +G+G F+ VY      ++G  E  A+K      ++  +H   + +E   LT   
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALK-----HLIPTSHPIRIAAELQCLTVAG 77
Query: 209 -HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
               ++ ++Y F+    + + + ++     F  +     F+E   R Y   +  A+  +H
Sbjct: 78  GQDNVMGVKYCFRKNDHVVIAMPYLEHES-FLDILNSLSFQE--VREYMLNLFKALKRIH 134
Query: 268 ANGIMHRDLKPENILLDAD-GHVMLTDFGLAK----------QFDENTRSNSMC------ 310
             GI+HRD+KP N L +       L DFGLA+          +F ++      C      
Sbjct: 135 QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCS 194
Query: 311 -------------GTLEYMSPEIVL-GKGHDKAADWWSVGILLFEMLTGQPPF 349
                        GT  + +PE++        A D WS G++   +L+G+ PF
Sbjct: 195 ICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 201 RNILTKVDHPFIVQLRYSFQTKYRL-----YLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
           R  L +V HP IVQ+    +   R      Y+V+++V G  L     ++    E +A  Y
Sbjct: 130 RQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--Y 187
Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY 315
             EI+ A+S+LH+ G+++ DLKPENI+L  +  + L D G   + +       + GT  +
Sbjct: 188 LLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS---FGYLYGTPGF 243
Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
            +PEIV   G   A D ++VG  L  +    P   G
Sbjct: 244 QAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNG 278

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILTKVDHP 210
           LKV+G G F  V++   I   E  ++K+    K++E    +   + +      +  +DH 
Sbjct: 36  LKVLGSGVFGTVHKGVWIPEGE--SIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 93
Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHAN 269
            IV+L         L LV  ++  G L   + + +G     L   +  +I   + +L  +
Sbjct: 94  HIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 152
Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           G++HR+L   N+LL +   V + DFG+A      D+    +     +++M+ E +    +
Sbjct: 153 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 212
Query: 327 DKAADWWSVGILLFEMLT-GQPPFTG 351
              +D WS G+ ++E++T G  P+ G
Sbjct: 213 THQSDVWSYGVTVWELMTFGAEPYAG 238
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	479
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	0.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	0.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	0.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	0.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	0.0
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-180
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-178
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-176
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-176
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-173
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-172
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-172
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-170
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-166
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-165
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-165
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-165
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-164
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-164
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-163
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-161
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-158
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-120
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-118
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-101
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-96
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-92
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-91
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-90
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-90
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-89
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-84
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-84
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-83
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-82
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-82
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-81
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-81
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-81
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-80
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-80
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-80
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-80
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-80
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-79
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-79
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-79
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-79
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-78
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-78
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-78
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-78
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-78
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-78
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-78
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-78
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-77
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-77
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-77
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-76
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-76
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-76
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-76
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-75
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-75
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-75
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-75
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-75
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-74
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-74
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-74
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-74
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-74
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-73
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-73
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-73
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-73
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-73
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-73
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-72
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-72
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-72
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-72
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-72
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-71
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-70
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-70
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-69
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-68
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-68
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-66
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-65
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-62
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-60
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-60
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-60
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-59
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-59
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-56
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-55
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-53
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-53
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-53
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-52
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-50
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-50
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-50
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-49
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-49
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-48
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-47
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-47
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-47
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-46
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-46
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-46
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-45
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-44
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-44
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-44
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-44
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-43
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-43
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-43
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-43
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-42
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-41
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-41
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-41
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-41
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-41
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-40
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-40
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-40
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-40
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-39
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-39
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-39
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-38
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-38
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-38
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-38
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-36
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-34
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-34
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-34
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-34
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-33
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-33
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-33
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-32
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-31
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-31
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-31
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-30
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-30
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-30
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-28
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-28
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-28
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-27
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-26
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-26
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-26
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-25
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-25
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-24
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-23
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-23
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-23
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-23
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-23
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-22
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-22
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-22
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-22
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-21
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-21
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-21
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-21
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-21
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-21
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-21
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-21
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-21
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-20
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-20
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-20
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-20
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-19
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-19
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-18
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-18
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-16
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-14
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-14
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-13
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-04
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-05

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  528 bits (1362), Expect = 0.0
 Identities = 151/376 (40%), Positives = 228/376 (60%), Gaps = 14/376 (3%)

Query: 111 GINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVR 170
           GI++  +  P  ++   A    P+  I+  PS N      DF  LKV+G+G+F KV   R
Sbjct: 1   GISQPQE--PELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLAR 58

Query: 171 RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVL 229
                  YA+KV++K  I++K   +++ SERN+L K V HPF+V L +SFQT  +LY VL
Sbjct: 59  HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118

Query: 230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
           D++NGG LF+ L R+  F E  AR Y AEI SA+ +LH+  I++RDLKPENILLD+ GH+
Sbjct: 119 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHI 178

Query: 290 MLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPP 348
           +LTDFGL K+  + N+ +++ CGT EY++PE++  + +D+  DWW +G +L+EML G PP
Sbjct: 179 VLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

Query: 349 FTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
           F   N  ++   I+   ++L   +++ A  LL+GLLQK+ +KRLG+      EIKSH +F
Sbjct: 239 FYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGA-KDDFMEIKSHVFF 297

Query: 409 KMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNE--------- 459
            +INW  L  ++  P F P V+G + + +F+  +T  P+ ++   +P             
Sbjct: 298 SLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAA 357

Query: 460 NPFKGFTYVRPAASFL 475
             F GF+Y  P  SFL
Sbjct: 358 EAFLGFSYAPPTDSFL 373

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  518 bits (1337), Expect = 0.0
 Identities = 155/329 (47%), Positives = 228/329 (69%), Gaps = 8/329 (2%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDK 187
           G     ++  P +   +  E FE+L+V+G+G + KV+QVR++    T +I+AMKV++K  
Sbjct: 1   GSSETSVNRGPEK---IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM 57

Query: 188 IMEK-NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL 246
           I+       + K+ERNIL +V HPFIV L Y+FQT  +LYL+L++++GG LF QL R+G+
Sbjct: 58  IVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI 117

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTR 305
           F ED A  Y AEI  A+ HLH  GI++RDLKPENI+L+  GHV LTDFGL K+   + T 
Sbjct: 118 FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV 177

Query: 306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK 365
           +++ CGT+EYM+PEI++  GH++A DWWS+G L+++MLTG PPFTG NR+K   KI+K K
Sbjct: 178 THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK 237

Query: 366 IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSF 425
           + LP +L+ EA  LLK LL++ A+ RLG+GPG + E+++H +F+ INW++L AR+  P F
Sbjct: 238 LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPF 297

Query: 426 LPEVAGKHCVANFEECWTNMPLLDSPVAS 454
            P +  +  V+ F+  +T    +DSP  S
Sbjct: 298 KPLLQSEEDVSQFDSKFTRQTPVDSPDDS 326

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  509 bits (1314), Expect = 0.0
 Identities = 123/333 (36%), Positives = 203/333 (60%), Gaps = 11/333 (3%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G++++EM+ G+ PF   + +++ + I+ ++I+ P  LS EA SLL GLL+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241

Query: 386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNM 445
           K+  +RLG GP  ++E+  H++F  INW+ +  ++  P F P+V  +     F++ +T  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 301

Query: 446 PLLDSPVASPKF----------NENPFKGFTYV 468
            +  +P                 +  F+ F Y+
Sbjct: 302 SITITPPDRYDSLGLLELDQREEQEMFEDFDYI 334

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  509 bits (1312), Expect = 0.0
 Identities = 125/343 (36%), Positives = 207/343 (60%), Gaps = 8/343 (2%)

Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
           +       + L DF  L V+G+G+F KV    R GT E+YA+K+++KD +++ +  E   
Sbjct: 9   DNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM 68

Query: 199 SERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
            E+ +L      PF+ QL   FQT  RLY V+++VNGG L + + + G F+E  A  Y A
Sbjct: 69  VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA 128

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYM 316
           EI   +  L + GI++RDLK +N++LD++GH+ + DFG+ K+   +   + + CGT +Y+
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYI 188

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEA 376
           +PEI+  + + K+ DWW+ G+LL+EML GQ PF G +  ++ Q I++  +  P  +S EA
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 248

Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVA 436
            ++ KGL+ K   KRLG GP G ++IK H +F+ I+W+KLE +E +P + P+  G+    
Sbjct: 249 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAE 307

Query: 437 NFEECWTNMPLLDSPVASP---KFNENPFKGFTYVRPAASFLQ 476
           NF+  +T  P + +P         +++ F+GF++V     FL+
Sbjct: 308 NFDRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNS--EFLK 348

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  508 bits (1311), Expect = 0.0
 Identities = 126/345 (36%), Positives = 200/345 (57%), Gaps = 6/345 (1%)

Query: 132 KPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK 191
                     + +  +G+++FE ++V+G+G+F KV   R   T ++YA+KV++KD I++ 
Sbjct: 5   SSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD 64

Query: 192 NHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
           +  E   +E+ IL+   +HPF+ QL   FQT  RL+ V++FVNGG L F + +   F E 
Sbjct: 65  DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA 124

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSM 309
            AR Y AEI+SA+  LH  GI++RDLK +N+LLD +GH  L DFG+ K+       + + 
Sbjct: 125 RARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF 184

Query: 310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP 369
           CGT +Y++PEI+    +  A DWW++G+LL+EML G  PF   N   + + I+ D++  P
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 244

Query: 370 AFLSSEAHSLLKGLLQKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
            +L  +A  +LK  + K  + RLGS   GG   I  H +FK I+W +L  R+  P F P 
Sbjct: 245 TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPR 304

Query: 429 VAGKHCVANFEECWTNMPLLDSPVAS---PKFNENPFKGFTYVRP 470
           +  +  V+NF+  +     + +P+     P  N++ F+ F YV P
Sbjct: 305 IKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRNFEYVSP 349

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  507 bits (1307), Expect = e-180
 Identities = 142/313 (45%), Positives = 209/313 (66%), Gaps = 5/313 (1%)

Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHA 194
            ++   ++      FE+LKV+GQG+F KV+ V++I      ++YAMKV++K  +  ++  
Sbjct: 12  HHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV 71

Query: 195 EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI 254
              K ER+IL +V+HPFIV+L Y+FQT+ +LYL+LDF+ GG LF +L ++ +F E+  + 
Sbjct: 72  R-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF 130

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTL 313
           Y AE+  A+ HLH+ GI++RDLKPENILLD +GH+ LTDFGL+K+  D   ++ S CGT+
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190

Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLS 373
           EYM+PE+V  +GH ++ADWWS G+L+FEMLTG  PF G +R++    I+K K+ +P FLS
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLS 250

Query: 374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKH 433
            EA SLL+ L ++  + RLG+GP G +EIK H +F  I+W KL  RE  P F P      
Sbjct: 251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPE 310

Query: 434 CVANFEECWTNMP 446
               F+  +T   
Sbjct: 311 DTFYFDPEFTAKT 323

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  501 bits (1292), Expect = e-178
 Identities = 111/320 (34%), Positives = 195/320 (60%), Gaps = 5/320 (1%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
             L+DF++L+ +G G+F +V+ +R       YAMKV++K+ ++     E+   ER +L+ 
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           V HPFI+++  +FQ   ++++++D++ GG LF  L +   F   +A+ Y AE+  A+ +L
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           H+  I++RDLKPENILLD +GH+ +TDFG AK   + T   ++CGT +Y++PE+V  K +
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVVSTKPY 180

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQK 386
           +K+ DWWS GIL++EML G  PF   N  K  +KI+  +++ P F + +   LL  L+ +
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITR 240

Query: 387 EASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEV-AGKHCVANFEECWTNM 445
           + S+RLG+   G++++K+H WFK + W+KL +R     + P +  G+   + F++ +   
Sbjct: 241 DLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDK-YPEE 299

Query: 446 PLLDSPVASPKFNENPFKGF 465
            +         + +  F+ F
Sbjct: 300 DINYGVQGEDPYAD-LFRDF 318

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  500 bits (1289), Expect = e-176
 Identities = 125/360 (34%), Positives = 222/360 (61%), Gaps = 15/360 (4%)

Query: 132 KPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK 191
           K   +       +  +GL+DF++L+V+G+G++AKV  VR   T  IYAM+V++K+ + + 
Sbjct: 34  KEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD 93

Query: 192 NHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
              +++++E+++  +  +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+
Sbjct: 94  EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE 153

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSM 309
            AR Y+AEI  A+++LH  GI++RDLK +N+LLD++GH+ LTD+G+ K+       +++ 
Sbjct: 154 HARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF 213

Query: 310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFT---------GGNRQKIQQK 360
           CGT  Y++PEI+ G+ +  + DWW++G+L+FEM+ G+ PF                + Q 
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273

Query: 361 IIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEAR 419
           I++ +I++P  LS +A S+LK  L K+  +RLG  P  G  +I+ H +F+ ++W  +E +
Sbjct: 274 ILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQK 333

Query: 420 ETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFNENPFKGFTYVRPAASFLQ 476
           +  P F P ++G+  + NF+  +TN P+  +P       K +++ F+GF Y+ P     +
Sbjct: 334 QVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPLLMSAE 393

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  498 bits (1284), Expect = e-176
 Identities = 125/339 (36%), Positives = 218/339 (64%), Gaps = 15/339 (4%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +GL+DF++L+V+G+G++AKV  VR   T  IYAMKV++K+ + +    +++++E+++  +
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65

Query: 207 V-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             +HPF+V L   FQT+ RL+ V+++VNGG L F + RQ    E+ AR Y+AEI  A+++
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGK 324
           LH  GI++RDLK +N+LLD++GH+ LTD+G+ K+       +++ CGT  Y++PEI+ G+
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 185

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFT---------GGNRQKIQQKIIKDKIKLPAFLSSE 375
            +  + DWW++G+L+FEM+ G+ PF                + Q I++ +I++P  LS +
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 245

Query: 376 AHSLLKGLLQKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHC 434
           A S+LK  L K+  +RLG  P  G  +I+ H +F+ ++W  +E ++  P F P ++G+  
Sbjct: 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFG 305

Query: 435 VANFEECWTNMPLLDSPVASP---KFNENPFKGFTYVRP 470
           + NF+  +TN P+  +P       K +++ F+GF Y+ P
Sbjct: 306 LDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINP 344

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  488 bits (1259), Expect = e-173
 Identities = 146/355 (41%), Positives = 215/355 (60%), Gaps = 13/355 (3%)

Query: 97  LTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLK 156
           +  H                               K      NL    + VG+E+FE+LK
Sbjct: 1   MAHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK 60

Query: 157 VVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEK-NHAEYMKSERNILTKVDH-PF 211
           V+G GA+ KV+ VR+I    T ++YAMKV++K  I++K    E+ ++ER +L  +   PF
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +V L Y+FQT+ +L+L+LD++NGG LF  L ++  F E   +IY  EIV A+ HLH  GI
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLG--KGHD 327
           ++RD+K ENILLD++GHV+LTDFGL+K+F  DE  R+   CGT+EYM+P+IV G   GHD
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 240

Query: 328 KAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAHSLLKGL 383
           KA DWWS+G+L++E+LTG  PFT      ++ +I ++I+K +   P  +S+ A  L++ L
Sbjct: 241 KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRL 300

Query: 384 LQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANF 438
           L K+  KRLG GP  + EIK H +F+ INW  L A++    F P +  +  V+NF
Sbjct: 301 LMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  499 bits (1285), Expect = e-172
 Identities = 136/443 (30%), Positives = 230/443 (51%), Gaps = 8/443 (1%)

Query: 39  FDFSDVFGPAPVQASIEVGGEISYANELVYDQPAVIHSRSHSLVGPSSYVSQSLKLSKLT 98
           F   +      +   I      S  + +      +   +   + G    +SQ        
Sbjct: 230 FQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNV 289

Query: 99  LHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVV 158
               E S G  E   +  +      +         T    +       + L DF  L V+
Sbjct: 290 PVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVL 349

Query: 159 GQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY 217
           G+G+F KV    R GT E+YA+K+++KD +++ +  E    E+ +L      PF+ QL  
Sbjct: 350 GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409

Query: 218 SFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLK 277
            FQT  RLY V+++VNGG L + + + G F+E  A  Y AEI   +  L + GI++RDLK
Sbjct: 410 CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 469

Query: 278 PENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVG 336
            +N++LD++GH+ + DFG+ K+   +   + + CGT +Y++PEI+  + + K+ DWW+ G
Sbjct: 470 LDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFG 529

Query: 337 ILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGP 396
           +LL+EML GQ PF G +  ++ Q I++  +  P  +S EA ++ KGL+ K   KRLG GP
Sbjct: 530 VLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGP 589

Query: 397 GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP- 455
            G ++IK H +F+ I+W+KLE +E +P + P+ +G+    NF+  +T  P + +P     
Sbjct: 590 EGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASGR-NAENFDRFFTRHPPVLTPPDQEV 648

Query: 456 --KFNENPFKGFTYVRPAASFLQ 476
               +++ F+GF++V     FL+
Sbjct: 649 IRNIDQSEFEGFSFVNS--EFLK 669

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  486 bits (1252), Expect = e-172
 Identities = 121/355 (34%), Positives = 196/355 (55%), Gaps = 8/355 (2%)

Query: 113 NEETQEGPNNLSVVDAALGKPTGHIDNL--PSENQCVGLEDFEVLKVVGQGAFAKVYQVR 170
           N    +  +    V   L K                  L+ F+ +K +G G+F +V  V+
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61

Query: 171 RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD 230
              +   YAMK++ K K+++    E+  +E+ IL  V+ PF+V+L +SF+    LY+V++
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121

Query: 231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM 290
           +V GG +F  L R G F E  AR Y A+IV    +LH+  +++RDLKPEN+L+D  G++ 
Sbjct: 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

Query: 291 LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFT 350
           +TDFG AK+    T   ++CGT E ++PEI+L KG++KA DWW++G+L++EM  G PPF 
Sbjct: 182 VTDFGFAKRVKGRT--WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

Query: 351 GGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
                +I +KI+  K++ P+  SS+   LL+ LLQ + +KR G+   G  +IK+HKWF  
Sbjct: 240 ADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

Query: 411 INWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGF 465
            +W  +  R+    F+P+  G    +NF++ +    +  S           F  F
Sbjct: 300 TDWIAIYQRKVEAPFIPKFKGPGDTSNFDD-YEEEEIRVSINEK---CGKEFTEF 350

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  491 bits (1265), Expect = e-170
 Identities = 125/419 (29%), Positives = 201/419 (47%), Gaps = 20/419 (4%)

Query: 70  QPAVIHSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAA 129
           +    +  SH+       V + L  +     E      L + +   T E    LSV   A
Sbjct: 103 RNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHE---YLSVAPFA 159

Query: 130 LGKPTGHIDNL----PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
               + + +        E Q V    F   +V+G+G F +V   +   T ++YA K + K
Sbjct: 160 DYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEK 219

Query: 186 DKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG 245
            +I ++       +E+ IL KV+  F+V L Y+++TK  L LVL  +NGG L F +Y  G
Sbjct: 220 KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG 279

Query: 246 --LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN 303
              F E  A  Y AEI   +  LH   I++RDLKPENILLD  GH+ ++D GLA    E 
Sbjct: 280 QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339

Query: 304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ----KIQQ 359
                  GT+ YM+PE+V  + +  + DWW++G LL+EM+ GQ PF    ++    ++++
Sbjct: 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399

Query: 360 KIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEAR 419
            + +   +     S +A SL   LL K+ ++RLG   G ++E+K H  FK +N+K+L A 
Sbjct: 400 LVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAG 459

Query: 420 ETRPSFLPEVAGKHC--VANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRPAASFLQ 476
              P F P+    +C  V + E+  T   +   P      +++ ++ F        +  
Sbjct: 460 MLEPPFKPDPQAIYCKDVLDIEQFSTVKGVELEPT-----DQDFYQKFATGSVPIPWQN 513

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  471 bits (1214), Expect = e-166
 Identities = 112/294 (38%), Positives = 177/294 (60%), Gaps = 4/294 (1%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME 190
           G  +      P + +    EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I++
Sbjct: 11  GAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK 70

Query: 191 KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
           +N   Y+  ER++++++DHPF V+L ++FQ   +LY  L +   G L   + + G F E 
Sbjct: 71  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET 130

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSN 307
             R YTAEIVSA+ +LH  GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+N
Sbjct: 131 CTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190

Query: 308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK 367
           S  GT +Y+SPE++  K   K++D W++G ++++++ G PPF  GN   I QKIIK +  
Sbjct: 191 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD 250

Query: 368 LPAFLSSEAHSLLKGLLQKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARE 420
            P     +A  L++ LL  +A+KRLG     G   +K+H +F+ + W+ L  + 
Sbjct: 251 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT 304

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  473 bits (1218), Expect = e-165
 Identities = 115/336 (34%), Positives = 188/336 (55%), Gaps = 16/336 (4%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  ED+EV+KV+G+GAF +V  VR   T ++YAMK++ K ++++++ + +   ER+I+  
Sbjct: 66  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            + P++VQL Y+FQ    LY+V++++ GG L   +       E  AR YTAE+V A+  +
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAI 184

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGK 324
           H+ G +HRD+KP+N+LLD  GH+ L DFG   + ++    R ++  GT +Y+SPE++  +
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244

Query: 325 G----HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEA 376
           G    + +  DWWSVG+ L+EML G  PF   +      KI+  K  L       +S EA
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304

Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVA 436
            +L+   L  +   RLG    G +EIK H +FK   W     R+T    +P+++     +
Sbjct: 305 KNLICAFL-TDREVRLGR--NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTS 361

Query: 437 NFEECWTNMPLLDSPVASPKF--NENPFKGFTYVRP 470
           NF++   +    ++      F  N+ PF GFTY   
Sbjct: 362 NFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSN 397

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  474 bits (1221), Expect = e-165
 Identities = 123/337 (36%), Positives = 201/337 (59%), Gaps = 2/337 (0%)

Query: 110 EGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQV 169
           +G+ ++     +  S   +          +L      V + +FE LK++G+G F KV  V
Sbjct: 108 DGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILV 167

Query: 170 RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL 229
           +   T   YAMK+++K+ I+ K+   +  +E  +L    HPF+  L+YSFQT  RL  V+
Sbjct: 168 KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227

Query: 230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGH 288
           ++ NGG LFF L R+ +F ED AR Y AEIVSA+ +LH+   +++RDLK EN++LD DGH
Sbjct: 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH 287

Query: 289 VMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQP 347
           + +TDFGL K+   +     + CGT EY++PE++    + +A DWW +G++++EM+ G+ 
Sbjct: 288 IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347

Query: 348 PFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKW 407
           PF   + +K+ + I+ ++I+ P  L  EA SLL GLL+K+  +RLG G   ++EI  H++
Sbjct: 348 PFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

Query: 408 FKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTN 444
           F  I W+ +  ++  P F P+V  +     F+E +T 
Sbjct: 408 FAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTA 444

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  469 bits (1208), Expect = e-165
 Identities = 118/335 (35%), Positives = 196/335 (58%), Gaps = 9/335 (2%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS    + +EDF + K++G+G+F KV+      T++ +A+K ++KD ++  +  E    E
Sbjct: 8   PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67

Query: 201 RNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           + +L+   +HPF+  +  +FQTK  L+ V++++NGG L + +     F    A  Y AEI
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSP 318
           +  +  LH+ GI++RDLK +NILLD DGH+ + DFG+ K+    + ++N+ CGT +Y++P
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 187

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHS 378
           EI+LG+ ++ + DWWS G+LL+EML GQ PF G + +++   I  D    P +L  EA  
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247

Query: 379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANF 438
           LL  L  +E  KRLG       +I+ H  F+ INW++LE +E  P F P+V      +NF
Sbjct: 248 LLVKLFVREPEKRLGVRG----DIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNF 303

Query: 439 EECWTNMPLLDSPV---ASPKFNENPFKGFTYVRP 470
           ++ + N     S          ++N F+ F+++ P
Sbjct: 304 DKEFLNEKPRLSFADRALINSMDQNMFRNFSFMNP 338

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  469 bits (1209), Expect = e-164
 Identities = 115/349 (32%), Positives = 180/349 (51%), Gaps = 29/349 (8%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  +DFE+LKV+G+GAF++V  V+   T ++YAMK+M K  ++++      + ER++L  
Sbjct: 58  LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSH 265
            D  +I QL ++FQ +  LYLV+++  GG L   L + G     ++AR Y AEIV A+  
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLG 323
           +H  G +HRD+KP+NILLD  GH+ L DFG   +   D   RS    GT +Y+SPEI+  
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237

Query: 324 KG-------HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-----AF 371
            G       +    DWW++G+  +EM  GQ PF   +  +   KI+  K  L        
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297

Query: 372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAG 431
           +  EA   ++ LL      RLG   GG+ + ++H +F  ++W  L  R++ P F P+  G
Sbjct: 298 VPEEARDFIQRLLCP-PETRLGR--GGAGDFRTHPFFFGLDWDGL--RDSVPPFTPDFEG 352

Query: 432 KHCVANFEECWTNMPLLDSPV---------ASPKFNENPFKGFTYVRPA 471
                NF+     +  + S            +P     PF G++Y   A
Sbjct: 353 ATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMA 401

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  467 bits (1204), Expect = e-164
 Identities = 107/321 (33%), Positives = 174/321 (54%), Gaps = 12/321 (3%)

Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
            EN+ V  + FE+L+ +G+G+F KV  V++  T ++YAMK M K K +E+N    +  E 
Sbjct: 7   DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL 66

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I+  ++HPF+V L YSFQ +  +++V+D + GG L + L +   F+E+  +++  E+V 
Sbjct: 67  QIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           A+ +L    I+HRD+KP+NILLD  GHV +TDF +A      T+  +M GT  YM+PE+ 
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF 186

Query: 322 L---GKGHDKAADWWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLPAFLSSE 375
               G G+  A DWWS+G+  +E+L G+ P+      + ++I        +  P+  S E
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE 246

Query: 376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCV 435
             SLLK LL+    +R         ++++  +   INW  +  +   P F+P     +C 
Sbjct: 247 MVSLLKKLLEPNPDQRF----SQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCD 302

Query: 436 ANFEECWTNMPLLDSPVASPK 456
             FE     M L   P+   K
Sbjct: 303 PTFE--LEEMILESKPLHKKK 321

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  477 bits (1228), Expect = e-163
 Identities = 119/413 (28%), Positives = 205/413 (49%), Gaps = 27/413 (6%)

Query: 75  HSRSHSLVGPSSYVSQSLKLSKLTLHEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPT 134
           +     L     +   +++  +  L + +    L +      +E   NL          +
Sbjct: 112 YIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQ---PYIEEICQNLRGDVFQKFIES 168

Query: 135 GHIDNL-----PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM 189
                         N  + + DF V +++G+G F +VY  R+  T ++YAMK + K +I 
Sbjct: 169 DKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK 228

Query: 190 EKNHAEYMKSERNILTKV---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL 246
            K       +ER +L+ V   D PFIV + Y+F T  +L  +LD +NGG L + L + G+
Sbjct: 229 MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV 288

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS 306
           F E   R Y AEI+  + H+H   +++RDLKP NILLD  GHV ++D GLA  F +  + 
Sbjct: 289 FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KP 347

Query: 307 NSMCGTLEYMSPEIVL-GKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKII 362
           ++  GT  YM+PE++  G  +D +ADW+S+G +LF++L G  PF       + +I +  +
Sbjct: 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

Query: 363 KDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETR 422
              ++LP   S E  SLL+GLLQ++ ++RLG    G+QE+K   +F+ ++W+ +  ++  
Sbjct: 408 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYP 467

Query: 423 PSFLPEVAGKHC-----VANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRP 470
           P  +P     +      + +F+E  T    L         ++  ++ F     
Sbjct: 468 PPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDS------DQELYRNFPLTIS 514

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  466 bits (1200), Expect = e-161
 Identities = 109/344 (31%), Positives = 184/344 (53%), Gaps = 22/344 (6%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
             E Q +G + F   +V+G+G F +V+  +   T ++YA K + K ++ ++   +    E
Sbjct: 176 WLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYT 256
           + IL KV   FIV L Y+F+TK  L LV+  +NGG + + +Y        F+E  A  YT
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEY 315
           A+IVS + HLH   I++RDLKPEN+LLD DG+V ++D GLA +     T++    GT  +
Sbjct: 296 AQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355

Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN----RQKIQQKIIKDKIKLPAF 371
           M+PE++LG+ +D + D++++G+ L+EM+  + PF         ++++Q++++  +  P  
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415

Query: 372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAG 431
            S  +    + LLQK+  KRLG   G    +++H  F+ I+W++LEA    P F+P+   
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRT 475

Query: 432 KHC-----VANFEECWTNMPLLDSPVASPKFNENPFKGFTYVRP 470
            +      V  F             VA  K +   F+ F     
Sbjct: 476 VYAKNIQDVGAFST--------VKGVAFEKADTEFFQEFASGTC 511

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  455 bits (1172), Expect = e-158
 Identities = 107/341 (31%), Positives = 177/341 (51%), Gaps = 22/341 (6%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  EDFE+LKV+G+GAF +V  V+     +++AMK++ K +++++      + ER++L  
Sbjct: 71  LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN 130

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSH 265
            D  +I  L Y+FQ    LYLV+D+  GG L   L + +    E++AR Y AE+V A+  
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLG 323
           +H    +HRD+KP+NIL+D +GH+ L DFG   +   D   +S+   GT +Y+SPEI+  
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250

Query: 324 K-----GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-----AFLS 373
                  +    DWWS+G+ ++EML G+ PF   +  +   KI+  K +         +S
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS 310

Query: 374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKH 433
             A  L++ L+      RLG    G ++ K H +F  I+W  +  R     ++PEV+   
Sbjct: 311 ENAKDLIRRLICS-REHRLGQ--NGIEDFKKHPFFSGIDWDNI--RNCEAPYIPEVSSPT 365

Query: 434 CVANFEECWTNMPLLDSPVASPKF----NENPFKGFTYVRP 470
             +NF+     +   ++           +  PF GFTY   
Sbjct: 366 DTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTSS 406

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  352 bits (906), Expect = e-120
 Identities = 85/284 (29%), Positives = 146/284 (51%), Gaps = 12/284 (4%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++DF++ + +G+G F  VY  R      I A+KV+ K ++ ++     ++ E  I + + 
Sbjct: 13  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+++   F  + R+YL+L+F   G L+ +L + G F E  +  +  E+  A+ + H 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             ++HRD+KPEN+L+   G + + DFG +       R  +MCGTL+Y+ PE++ GK HD+
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR-RTMCGTLDYLPPEMIEGKTHDE 191

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA 388
             D W  G+L +E L G PPF   +  +  ++I+   +K P FLS  +  L+  LL+   
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHP 251

Query: 389 SKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGK 432
            +RL       + +  H W       K  +R   P        K
Sbjct: 252 PQRL-----PLKGVMEHPWV------KANSRRVLPPVYQSTQSK 284

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  347 bits (893), Expect = e-118
 Identities = 86/279 (30%), Positives = 151/279 (54%), Gaps = 6/279 (2%)

Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S+ +   LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E 
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            I + + HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           A+S+ H+  ++HRD+KPEN+LL + G + + DFG +     + R   +CGTL+Y+ PE++
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TDLCGTLDYLPPEMI 179

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
            G+ HD+  D WS+G+L +E L G+PPF     Q+  ++I + +   P F++  A  L+ 
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239

Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARE 420
            LL+   S+R        +E+  H W    + K    + 
Sbjct: 240 RLLKHNPSQRP-----MLREVLEHPWITANSSKPSNCQN 273

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  305 bits (782), Expect = e-101
 Identities = 75/301 (24%), Positives = 126/301 (41%), Gaps = 14/301 (4%)

Query: 112 INEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRR 171
                Q  P  +S       +        PS  +    + F+ L  +G G++ +V++VR 
Sbjct: 20  FQSMHQLQPRRVSF-RGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRS 78

Query: 172 IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLVLD 230
                +YA+K         K+ A  +  E     KV  HP  V+L  +++    LYL  +
Sbjct: 79  KEDGRLYAVKRSMSPFRGPKDRARKLA-EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE 137

Query: 231 FVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV 289
              G  L       G    E     Y  + + A++HLH+ G++H D+KP NI L   G  
Sbjct: 138 LC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRC 196

Query: 290 MLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQP-P 348
            L DFGL  +           G   YM+PE +L   +  AAD +S+G+ + E+      P
Sbjct: 197 KLGDFGLLVELGTAGAGEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELP 255

Query: 349 FTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
             G   Q+++Q  +  +    A LSSE  S+L  +L+ +   R       ++ + +    
Sbjct: 256 HGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMMLEPDPKLRA-----TAEALLALPVL 308

Query: 409 K 409
           +
Sbjct: 309 R 309

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  292 bits (749), Expect = 8e-96
 Identities = 68/314 (21%), Positives = 128/314 (40%), Gaps = 53/314 (16%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK--------------DKIMEKNHA 194
           + D+ +++ + QG F K+    +   ++ YA+K   K              DKI  K+  
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 195 EYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--------L 246
           +  K+E  I+T + + + +           +Y++ +++    +                 
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 247 FREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
               + +     ++++ S++H    I HRD+KP NIL+D +G V L+DFG ++   +   
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207

Query: 306 SNSMCGTLEYMSPEIVLGKG--HDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKII 362
                GT E+M PE    +   +    D WS+GI L+ M     PF+   +  ++   I 
Sbjct: 208 -KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266

Query: 363 KDKIKLPA-------------------FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIK 403
              I+ P                    FLS+E    LK  L+K  ++R+      S++  
Sbjct: 267 TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI-----TSEDAL 321

Query: 404 SHKWFKMINWKKLE 417
            H+W    N + L 
Sbjct: 322 KHEWLADTNIEDLR 335

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  280 bits (720), Expect = 2e-92
 Identities = 82/263 (31%), Positives = 145/263 (55%), Gaps = 7/263 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +EDF+V  ++G+G+FA VY+   I T    A+K++ K  + +    + +++E  I  ++ 
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL-YRQGLFREDLARIYTAEIVSAVSHLH 267
           HP I++L   F+    +YLVL+  + G +   L  R   F E+ AR +  +I++ + +LH
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGH 326
           ++GI+HRDL   N+LL  + ++ + DFGLA Q    + +  ++CGT  Y+SPEI     H
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQK 386
              +D WS+G + + +L G+PPF     +    K++    ++P+FLS EA  L+  LL++
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRR 249

Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
             + RL         +  H +  
Sbjct: 250 NPADRL-----SLSSVLDHPFMS 267

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  277 bits (712), Expect = 5e-91
 Identities = 74/262 (28%), Positives = 136/262 (51%), Gaps = 6/262 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
              +   + +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + 
Sbjct: 14  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V     F+    +++VL+      L     R+    E  AR Y  +IV    +LH 
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHD 327
           N ++HRDLK  N+ L+ D  V + DFGLA + + +  R   +CGT  Y++PE++  KGH 
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 193

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKE 387
              D WS+G +++ +L G+PPF     ++   +I K++  +P  ++  A SL++ +LQ +
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 253

Query: 388 ASKRLGSGPGGSQEIKSHKWFK 409
            + R         E+ + ++F 
Sbjct: 254 PTARP-----TINELLNDEFFT 270

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  278 bits (712), Expect = 2e-90
 Identities = 74/262 (28%), Positives = 136/262 (51%), Gaps = 6/262 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
              +   + +G+G FAK +++    T E++A K++ K  +++ +  E M  E +I   + 
Sbjct: 40  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V     F+    +++VL+      L     R+    E  AR Y  +IV    +LH 
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHD 327
           N ++HRDLK  N+ L+ D  V + DFGLA + + +  R   +CGT  Y++PE++  KGH 
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 219

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKE 387
              D WS+G +++ +L G+PPF     ++   +I K++  +P  ++  A SL++ +LQ +
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 279

Query: 388 ASKRLGSGPGGSQEIKSHKWFK 409
            + R         E+ + ++F 
Sbjct: 280 PTARP-----TINELLNDEFFT 296

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  275 bits (705), Expect = 6e-90
 Identities = 77/302 (25%), Positives = 141/302 (46%), Gaps = 45/302 (14%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
             DFE + V+GQGAF +V + R    S  YA+K +R  +         + SE  +L  ++
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST----ILSEVMLLASLN 60

Query: 209 HPFIVQLRYSFQ-------------TKYRLYLVLDFVNGGHLFFQLYRQGLF-REDLARI 254
           H ++V+   ++               K  L++ +++   G L+  ++ + L  + D    
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-------- 306
              +I+ A+S++H+ GI+HRDLKP NI +D   +V + DFGLAK    +           
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 307 -------NSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ 358
                   S  GT  Y++ E++ G GH ++  D +S+GI+ FEM+   P  TG  R  I 
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238

Query: 359 QKIIKDKIKLPAFL----SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK 414
           +K+    I+ P             +++ L+  + +KR      G++ + +  W  + +  
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP-----GARTLLNSGWLPVKHQD 293

Query: 415 KL 416
           ++
Sbjct: 294 EV 295

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  275 bits (706), Expect = 2e-89
 Identities = 83/289 (28%), Positives = 136/289 (47%), Gaps = 10/289 (3%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G+F K   V+       Y +K +   + M     E  + E  +L  + 
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMK 81

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHL 266
           HP IVQ R SF+    LY+V+D+  GG LF ++  Q   LF+ED    +  +I  A+ H+
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIVLGKG 325
           H   I+HRD+K +NI L  DG V L DFG+A+  +     + +  GT  Y+SPEI   K 
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAFLSSEAHSLLKGLL 384
           ++  +D W++G +L+E+ T +  F  G+ + +  KII      +    S +  SL+  L 
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261

Query: 385 QKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKH 433
           ++    R          I    +      K L  +     F  +   K 
Sbjct: 262 KRNPRDRP-----SVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKF 305

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  262 bits (670), Expect = 2e-84
 Identities = 71/311 (22%), Positives = 123/311 (39%), Gaps = 53/311 (17%)

Query: 144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +Q      + +  ++GQGA A V++ R   T +++A+KV      +     +    E  +
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEV 60

Query: 204 LTKVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAE 258
           L K++H  IV+L       T     L+++F   G L+  L          E    I   +
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 259 IVSAVSHLHANGIMHRDLKPENILL----DADGHVMLTDFGLAKQFDENTRSNSMCGTLE 314
           +V  ++HL  NGI+HR++KP NI+     D      LTDFG A++ +++ +  S+ GT E
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180

Query: 315 YMSPEIV--------LGKGHDKAADWWSVGILLFEMLTGQPPF----TGGNRQKIQQKII 362
           Y+ P++           K +    D WS+G+  +   TG  PF         +++  KII
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 363 KDK-------------------------IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPG 397
             K                           L   L      +L  +L+ +  K       
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW----- 295

Query: 398 GSQEIKSHKWF 408
           G  +  +    
Sbjct: 296 GFDQFFAETSD 306

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  264 bits (676), Expect = 3e-84
 Identities = 71/296 (23%), Positives = 121/296 (40%), Gaps = 48/296 (16%)

Query: 144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +Q      + +  ++GQGA A V++ R   T +++A+KV      +     +    E  +
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEV 60

Query: 204 LTKVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAE 258
           L K++H  IV+L       T     L+++F   G L+  L          E    I   +
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 259 IVSAVSHLHANGIMHRDLKPENILL----DADGHVMLTDFGLAKQFDENTRSNSMCGTLE 314
           +V  ++HL  NGI+HR++KP NI+     D      LTDFG A++ +++ +  S+ GT E
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180

Query: 315 YMSPEIV--------LGKGHDKAADWWSVGILLFEMLTGQPPF----TGGNRQKIQQKII 362
           Y+ P++           K +    D WS+G+  +   TG  PF         +++  KII
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 363 KDK-------------------------IKLPAFLSSEAHSLLKGLLQKEASKRLG 393
             K                           L   L      +L  +L+ +  K  G
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  259 bits (664), Expect = 2e-83
 Identities = 74/292 (25%), Positives = 134/292 (45%), Gaps = 28/292 (9%)

Query: 138 DNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM 197
           +NL  ++  V    + +LK +G G  +KV+QV      +IYA+K +  ++  +    +  
Sbjct: 16  ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSY 73

Query: 198 KSERNILTKVDHP--FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
           ++E   L K+      I++L     T   +Y+V++      L   L ++        + Y
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSY 132

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGT 312
              ++ AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  GT
Sbjct: 133 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 313 LEYMSPEIVLGKG-----------HDKAADWWSVGILLFEMLTGQPPFTG--GNRQKIQQ 359
           + YM PE +                   +D WS+G +L+ M  G+ PF        K+  
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251

Query: 360 KIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
            I  + +I+ P     +   +LK  L+++  +R+        E+ +H + ++
Sbjct: 252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQI 298

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  256 bits (656), Expect = 6e-82
 Identities = 73/287 (25%), Positives = 130/287 (45%), Gaps = 28/287 (9%)

Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           +E   V    + +LK +G G  +KV+QV      +IYA+K +  ++  +    +  ++E 
Sbjct: 1   NECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEI 58

Query: 202 NILTKVDHP--FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
             L K+      I++L     T   +Y+V++      L   L ++        + Y   +
Sbjct: 59  AYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNM 117

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYM 316
           + AV  +H +GI+H DLKP N L+  DG + L DFG+A Q   +T S   +S  GT+ YM
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176

Query: 317 SPEIVLGKG-----------HDKAADWWSVGILLFEMLTGQPPFTG--GNRQKIQQKIIK 363
            PE +                   +D WS+G +L+ M  G+ PF        K+   I  
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236

Query: 364 D-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           + +I+ P     +   +LK  L+++  +R+        E+ +H + +
Sbjct: 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQ 278

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  254 bits (652), Expect = 9e-82
 Identities = 76/252 (30%), Positives = 127/252 (50%), Gaps = 9/252 (3%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L +F + K +G+G F++VY+   +      A+K ++   +M+         E ++L +++
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVS 264
           HP +++   SF     L +VL+  + G L   +        L  E     Y  ++ SA+ 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIVLG 323
           H+H+  +MHRD+KP N+ + A G V L D GL + F   T  ++S+ GT  YMSPE +  
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210

Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG--GNRQKIQQKIIKDKIK-LPA-FLSSEAHSL 379
            G++  +D WS+G LL+EM   Q PF G   N   + +KI +     LP+   S E   L
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 270

Query: 380 LKGLLQKEASKR 391
           +   +  +  KR
Sbjct: 271 VNMCINPDPEKR 282

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  252 bits (647), Expect = 2e-81
 Identities = 78/267 (29%), Positives = 139/267 (52%), Gaps = 13/267 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K+  ++  + ++ E  I  K+ H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQH 64

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HR+LKPEN+LL        V L DFGLA + +++   +   GT  Y+SPE++    +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKG 382
            K  D W+ G++L+ +L G PPF   ++ ++  +I       P+     ++ EA SL+  
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFK 409
           +L     KR+      + +     W  
Sbjct: 245 MLTVNPKKRI-----TADQALKVPWIC 266

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  258 bits (661), Expect = 5e-81
 Identities = 81/279 (29%), Positives = 145/279 (51%), Gaps = 14/279 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + ++ ++G+G+F +V + +   T + YA+KV+ K     K+    +  E  +L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDH 80

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L    +     Y+V +   GG LF ++ ++  F E  A     ++ S ++++H +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
            I+HRDLKPENILL   + D  + + DFGL+  F +NT+     GT  Y++PE VL   +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTY 199

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKG 382
           D+  D WS G++L+ +L+G PPF G N   I +++   K          +S +A  L++ 
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARET 421
           +L    S R+      + +   H W +  + +     + 
Sbjct: 260 MLTFHPSLRI-----TATQCLEHPWIQKYSSETPTISDL 293

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  251 bits (644), Expect = 5e-81
 Identities = 75/274 (27%), Positives = 134/274 (48%), Gaps = 19/274 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            ED+EVL  +G G++ +  ++RR    +I   K +     M +   + + SE N+L ++ 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELK 63

Query: 209 HPFIVQLRYSFQ--TKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSA 262
           HP IV+        T   LY+V+++  GG L   + +         E+       ++  A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 263 VSHLH-----ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYM 316
           +   H      + ++HRDLKP N+ LD   +V L DFGLA+  + +T  + +  GT  YM
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSE 375
           SPE +    +++ +D WS+G LL+E+    PPFT  +++++  KI + K  ++P   S E
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243

Query: 376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
            + ++  +L  +   R        +EI  +    
Sbjct: 244 LNEIITRMLNLKDYHRP-----SVEEILENPLIL 272

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  250 bits (640), Expect = 3e-80
 Identities = 76/270 (28%), Positives = 135/270 (50%), Gaps = 18/270 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + F   + +G GAF  V+ V    +     +K + KD+       E +++E  +L  +DH
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDH 79

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF----FQLYRQGLFREDLARIYTAEIVSAVSH 265
           P I+++   F+  + +Y+V++   GG L         R     E        ++++A+++
Sbjct: 80  PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139

Query: 266 LHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
            H+  ++H+DLKPENIL         + + DFGLA+ F  +  S +  GT  YM+PE V 
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE-VF 198

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL---PAFLSSEAHSL 379
            +      D WS G++++ +LTG  PFTG + +++QQK    +         L+ +A  L
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258

Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           LK +L K+  +R       + ++  H+WFK
Sbjct: 259 LKQMLTKDPERRP-----SAAQVLHHEWFK 283

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  256 bits (655), Expect = 4e-80
 Identities = 83/276 (30%), Positives = 149/276 (53%), Gaps = 13/276 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + ++  +V+G+G+F +V   +   T +  A+KV+ K ++ +K   E +  E  +L ++DH
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L   F+ K   YLV +   GG LF ++  +  F E  A     +++S ++++H N
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
            I+HRDLKPEN+LL     D ++ + DFGL+  F+ + +     GT  Y++PE VL   +
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE-VLHGTY 204

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKG 382
           D+  D WS G++L+ +L+G PPF G N   I +K+ K K          +S  A  L++ 
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEA 418
           +L    S R+      +++   H+W +    +++  
Sbjct: 265 MLTYVPSMRI-----SARDALDHEWIQTYTKEQISV 295

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  249 bits (638), Expect = 4e-80
 Identities = 83/286 (29%), Positives = 140/286 (48%), Gaps = 27/286 (9%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME 190
           G   G I+           + + +   +G+G++ +V    + GT    A K + K  + +
Sbjct: 1   GSTKGDIN-----------QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED 49

Query: 191 KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED 250
               +  K E  I+  +DHP I++L  +F+    +YLV++   GG LF ++  + +FRE 
Sbjct: 50  V---DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES 106

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSN 307
            A     +++SAV++ H   + HRDLKPEN L      D  + L DFGLA +F       
Sbjct: 107 DAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166

Query: 308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK 367
           +  GT  Y+SP+ VL   +    D WS G++++ +L G PPF+     ++  KI +    
Sbjct: 167 TKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT 225

Query: 368 LPA----FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
            P      +S +A SL++ LL K   +R+      S +   H+WF+
Sbjct: 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRI-----TSLQALEHEWFE 266

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  252 bits (645), Expect = 5e-80
 Identities = 78/267 (29%), Positives = 137/267 (51%), Gaps = 13/267 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++++V + +G+GAF+ V +     T   +A K++   K +     + ++ E  I  K+ H
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQH 87

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S Q +   YLV D V GG LF  +  +  + E  A     +I+ ++++ H+N
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HR+LKPEN+LL        V L DFGLA + +++   +   GT  Y+SPE++    +
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKG 382
            K  D W+ G++L+ +L G PPF   ++ ++  +I       P+     ++ EA SL+  
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFK 409
           +L     KR+      + +     W  
Sbjct: 268 MLTVNPKKRI-----TADQALKVPWIC 289

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  249 bits (638), Expect = 5e-80
 Identities = 80/267 (29%), Positives = 141/267 (52%), Gaps = 14/267 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + ++ ++G+G+F +V + +   T + YA+KV+ K    +      +  E  +L K+DH
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDH 80

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L    +     Y+V +   GG LF ++ ++  F E  A     ++ S ++++H +
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
            I+HRDLKPENILL   + D  + + DFGL+  F +NT+     GT  Y++PE VL   +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTY 199

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKG 382
           D+  D WS G++L+ +L+G PPF G N   I +++   K          +S +A  L++ 
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFK 409
           +L    S R+      + +   H W +
Sbjct: 260 MLTFHPSLRI-----TATQCLEHPWIQ 281

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  251 bits (642), Expect = 3e-79
 Identities = 79/334 (23%), Positives = 139/334 (41%), Gaps = 32/334 (9%)

Query: 100 HEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPS----ENQCVGLEDFEVL 155
           H    S GLV   +   +                    D+  S    E   V    + +L
Sbjct: 2   HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP--FIV 213
           K +G G  +KV+QV      +IYA+K +  ++  +    +  ++E   L K+      I+
Sbjct: 62  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKII 119

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMH 273
           +L     T   +Y+V++      L   L ++        + Y   ++ AV  +H +GI+H
Sbjct: 120 RLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVH 178

Query: 274 RDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG----- 325
            DLKP N L+  DG + L DFG+A Q   +T S   +S  G + YM PE +         
Sbjct: 179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237

Query: 326 ------HDKAADWWSVGILLFEMLTGQPPFTG--GNRQKIQQKIIKD-KIKLPAFLSSEA 376
                     +D WS+G +L+ M  G+ PF        K+   I  + +I+ P     + 
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 297

Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
             +LK  L+++  +R+        E+ +H + ++
Sbjct: 298 QDVLKCCLKRDPKQRI-----SIPELLAHPYVQI 326

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  253 bits (649), Expect = 4e-79
 Identities = 92/279 (32%), Positives = 152/279 (54%), Gaps = 14/279 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ +K +G GA+ +V   R   T    A+K++RK  +   ++   +  E  +L  +DH
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN-SKLLEEVAVLKLLDH 95

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P I++L   F+ K   YLV++   GG LF ++  +  F E  A +   +++S V++LH +
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
            I+HRDLKPEN+LL   + D  + + DFGL+  F+   +     GT  Y++PE VL K +
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE-VLRKKY 214

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKG 382
           D+  D WS+G++LF +L G PPF G   Q+I +K+ K K    +     +S  A  L+K 
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARET 421
           +LQ ++ +R+      +Q+   H W K +  KK    E 
Sbjct: 275 MLQFDSQRRI-----SAQQALEHPWIKEMCSKKESGIEL 308

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  247 bits (633), Expect = 5e-79
 Identities = 85/267 (31%), Positives = 151/267 (56%), Gaps = 16/267 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + F  ++V+G GAF++V+ V++  T +++A+K ++K           +++E  +L K+ H
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKH 65

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
             IV L   +++    YLV+  V+GG LF ++  +G++ E  A +   +++SAV +LH N
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPEN+L    + +  +M+TDFGL+K       S + CGT  Y++PE++  K +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-TACGTPGYVAPEVLAQKPY 184

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKG 382
            KA D WS+G++ + +L G PPF      K+ +KI +   +  +     +S  A   +  
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH 244

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFK 409
           LL+K+ ++R        ++  SH W  
Sbjct: 245 LLEKDPNERY-----TCEKALSHPWID 266

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  246 bits (631), Expect = 5e-79
 Identities = 65/294 (22%), Positives = 116/294 (39%), Gaps = 37/294 (12%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
             DF+ ++++G G F +V++ +     + Y +K ++ +        E  + E   L K+D
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD 62

Query: 209 HPFIVQLRYSFQ----------------TKYRLYLVLDFVNGGHLFFQL--YRQGLFRED 250
           H  IV     +                     L++ ++F + G L   +   R     + 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC 310
           LA     +I   V ++H+  +++RDLKP NI L     V + DFGL      + +     
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK 182

Query: 311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA 370
           GTL YMSPE +  + + K  D +++G++L E+L            K    +      +  
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF--ETSKFFTDLR--DGIISD 238

Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPS 424
               +  +LL+ LL K+   R       + EI           K  E  E   +
Sbjct: 239 IFDKKEKTLLQKLLSKKPEDRP-----NTSEILRTLTVWK---KSPEKNERHTA 284

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  246 bits (630), Expect = 1e-78
 Identities = 82/298 (27%), Positives = 139/298 (46%), Gaps = 23/298 (7%)

Query: 138 DNLPSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA-- 194
             LP  +   G  + +E  +++G+G  + V +     T + YA+K++        +    
Sbjct: 4   AALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63

Query: 195 ----EYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE 249
               E    E +IL KV  HP I+QL+ +++T    +LV D +  G LF  L  +    E
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123

Query: 250 DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM 309
              R     ++  +  LH   I+HRDLKPENILLD D ++ LTDFG + Q D   +   +
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 183

Query: 310 CGTLEYMSPEIVLG------KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
           CGT  Y++PEI+         G+ K  D WS G++++ +L G PPF    +  + + I+ 
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243

Query: 364 DKIKLPA----FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLE 417
              +  +      S     L+   L  +  KR       ++E  +H +F+    +++ 
Sbjct: 244 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY-----TAEEALAHPFFQQYVVEEVR 296

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  246 bits (630), Expect = 2e-78
 Identities = 81/271 (29%), Positives = 133/271 (49%), Gaps = 16/271 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTK 206
           + +++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           V H  ++ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V++L
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 267 HANGIMHRDLKPENILL----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           H   I H DLKPENI+L        H+ L DFGLA + ++     ++ GT E+++PEIV 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHS 378
            +     AD WS+G++ + +L+G  PF G  +Q+    I               S  A  
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKD 251

Query: 379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
            ++ LL KE  KRL       QE   H W  
Sbjct: 252 FIRKLLVKETRKRL-----TIQEALRHPWIT 277

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  246 bits (630), Expect = 2e-78
 Identities = 79/286 (27%), Positives = 139/286 (48%), Gaps = 16/286 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTK 206
           + ++  + +G G FA V + R   T   YA K ++K +          E ++ E +IL +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           + HP ++ L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +L
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130

Query: 267 HANGIMHRDLKPENILL----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           H+  I H DLKPENI+L         + + DFGLA + D      ++ GT E+++PEIV 
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHS 378
            +     AD WS+G++ + +L+G  PF G  +Q+    +     +         S+ A  
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 250

Query: 379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPS 424
            ++ LL K+  KR+       Q+   H W K  + ++  +R+    
Sbjct: 251 FIRRLLVKDPKKRM-----TIQDSLQHPWIKPKDTQQALSRKASAV 291

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  244 bits (626), Expect = 3e-78
 Identities = 83/271 (30%), Positives = 137/271 (50%), Gaps = 16/271 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTK 206
           + +E+ + +G G FA V + R+ GT + YA K ++K ++         E ++ E NIL +
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           + HP I+ L   F+ K  + L+L+ V+GG LF  L  +    ED A  +  +I+  V +L
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124

Query: 267 HANGIMHRDLKPENILL----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           H+  I H DLKPENI+L      +  + L DFG+A + +      ++ GT E+++PEIV 
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL--PAF--LSSEAHS 378
            +     AD WS+G++ + +L+G  PF G  +Q+    I           F   S  A  
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD 244

Query: 379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
            ++ LL K+  +R+        +   H W K
Sbjct: 245 FIRRLLVKDPKRRM-----TIAQSLEHSWIK 270

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  246 bits (629), Expect = 4e-78
 Identities = 87/271 (32%), Positives = 155/271 (57%), Gaps = 9/271 (3%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
             E   +G  ++ +LK +G+G FAKV   R I T    A+K++ K ++   +  + +  E
Sbjct: 8   ADEQPHIG--NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS-LQKLFRE 64

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
             I+  ++HP IV+L    +T+  LYL++++ +GG +F  L   G  +E  AR    +IV
Sbjct: 65  VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           SAV + H   I+HRDLK EN+LLDAD ++ + DFG + +F    + ++ CG   Y +PE+
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPEL 184

Query: 321 VLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSL 379
             GK +D    D WS+G++L+ +++G  PF G N +++++++++ K ++P ++S++  +L
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 244

Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
           LK  L     KR        ++I   +W   
Sbjct: 245 LKRFLVLNPIKRG-----TLEQIMKDRWINA 270

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  251 bits (643), Expect = 5e-78
 Identities = 89/297 (29%), Positives = 150/297 (50%), Gaps = 34/297 (11%)

Query: 130 LGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI- 188
           + K  G I            E +  ++ +G GA+ +V   +        A+KV++K +  
Sbjct: 27  VRKKEGKIG-----------ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFD 75

Query: 189 ---------MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF 239
                      +   E + +E ++L  +DHP I++L   F+ K   YLV +F  GG LF 
Sbjct: 76  KGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE 135

Query: 240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGL 296
           Q+  +  F E  A     +I+S + +LH + I+HRD+KPENILL   ++  ++ + DFGL
Sbjct: 136 QIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL 195

Query: 297 AKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK 356
           +  F ++ +     GT  Y++PE VL K +++  D WS G++++ +L G PPF G N Q 
Sbjct: 196 SSFFSKDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254

Query: 357 IQQKIIKDKIKLPA----FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           I +K+ K K          +S EA  L+K +L  + +KR       ++E  + +W K
Sbjct: 255 IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC-----TAEEALNSRWIK 306

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  246 bits (630), Expect = 6e-78
 Identities = 83/271 (30%), Positives = 134/271 (49%), Gaps = 16/271 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTK 206
           + +++ + +G G FA V + R   T   YA K ++K +          E ++ E +IL +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           V HP I+ L   ++ +  + L+L+ V+GG LF  L ++    E+ A  +  +I+  V++L
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 267 HANGIMHRDLKPENILL----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           H   I H DLKPENI+L        H+ L DFGLA + ++     ++ GT E+++PEIV 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHS 378
            +     AD WS+G++ + +L+G  PF G  +Q+    I               S  A  
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKD 251

Query: 379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
            ++ LL KE  KRL       QE   H W  
Sbjct: 252 FIRKLLVKETRKRL-----TIQEALRHPWIT 277

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  248 bits (636), Expect = 9e-78
 Identities = 79/268 (29%), Positives = 137/268 (51%), Gaps = 14/268 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E++++ + +G+GAF+ V +  ++   + YA  ++   K+  ++H + ++ E  I   + H
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLEREARICRLLKH 69

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV+L  S   +   YL+ D V GG LF  +  +  + E  A     +I+ AV H H  
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVLGKG 325
           G++HR+LKPEN+LL        V L DFGLA + +   ++     GT  Y+SPE++    
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK 381
           + K  D W+ G++L+ +L G PPF   ++ ++ Q+I       P+     ++ EA  L+ 
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249

Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWFK 409
            +L    SKR+      + E   H W  
Sbjct: 250 KMLTINPSKRI-----TAAEALKHPWIS 272

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  244 bits (626), Expect = 1e-77
 Identities = 92/311 (29%), Positives = 164/311 (52%), Gaps = 26/311 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNIL 204
           +++ + K +G GA  +V       T +  A+K++ K K       E + A  +++E  IL
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            K++HP I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV 
Sbjct: 70  KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128

Query: 265 HLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +LH NGI+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE++
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

Query: 322 LG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKIKLP----AFLS 373
           +     G+++A D WS+G++LF  L+G PPF+    Q  ++ +I   K        A +S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248

Query: 374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK----LEARETRPSFLPEV 429
            +A  L+K LL  +   R       ++E   H W +  + K+    L + E   + LP+V
Sbjct: 249 EKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQV 303

Query: 430 AGKHCVANFEE 440
             +   +    
Sbjct: 304 LAQPSTSRKRP 314

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  246 bits (631), Expect = 3e-77
 Identities = 85/276 (30%), Positives = 151/276 (54%), Gaps = 22/276 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNIL 204
           +++ + K +G GA  +V       T +  A++++ K K       E + A  +++E  IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            K++HP I++++  F  +   Y+VL+ + GG LF ++      +E   ++Y  +++ AV 
Sbjct: 195 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 265 HLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           +LH NGI+HRDLKPEN+LL   + D  + +TDFG +K   E +   ++CGT  Y++PE++
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313

Query: 322 LG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKIKLP----AFLS 373
           +     G+++A D WS+G++LF  L+G PPF+    Q  ++ +I   K        A +S
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373

Query: 374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
            +A  L+K LL  +   R       ++E   H W +
Sbjct: 374 EKALDLVKKLLVVDPKARF-----TTEEALRHPWLQ 404

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  243 bits (622), Expect = 7e-77
 Identities = 83/285 (29%), Positives = 148/285 (51%), Gaps = 21/285 (7%)

Query: 140 LPSENQCVGLED-FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA--EY 196
           L   +  V  ED +E+ +V+G+G F+ V +     T + +A+K++   K         E 
Sbjct: 13  LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72

Query: 197 MKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----LFREDLA 252
           +K E +I   + HP IV+L  ++ +   LY+V +F++G  L F++ ++     ++ E +A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDEN-TRSNS 308
             Y  +I+ A+ + H N I+HRD+KP  +LL   +    V L  FG+A Q  E+   +  
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192

Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL 368
             GT  +M+PE+V  + + K  D W  G++LF +L+G  PF G   +++ + IIK K K+
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM 251

Query: 369 PA----FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                  +S  A  L++ +L  + ++R+        E  +H W K
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERI-----TVYEALNHPWLK 291

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  243 bits (621), Expect = 1e-76
 Identities = 49/317 (15%), Positives = 108/317 (34%), Gaps = 45/317 (14%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAE 195
           P     +G +   V  ++G+GAFA+VY+  +         + + +KV +     E     
Sbjct: 56  PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF---Y 112

Query: 196 YMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-----FQLYRQGLFRED 250
                   L        ++   +   +    LV +  + G L      ++   + +  + 
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILL-----------DADGHVMLTDFGLA-- 297
           L   +   ++  +  +H   I+H D+KP+N +L           D    + L D G +  
Sbjct: 173 LVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232

Query: 298 -KQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK 356
            K F + T   + C T  +   E++  K  +   D++ V   ++ ML G          +
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292

Query: 357 IQ--------------QKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEI 402
            +               +     + +P      +  LL+  L+K   +   +        
Sbjct: 293 CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNK----IRA 348

Query: 403 KSHKWFKMINWKKLEAR 419
             ++   ++   K   +
Sbjct: 349 LRNRLIVLLLECKRSRK 365

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  242 bits (619), Expect = 1e-76
 Identities = 81/270 (30%), Positives = 143/270 (52%), Gaps = 27/270 (10%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQ 214
           K +G+G+F+   +     +++ +A+K++ K            + E   L   + HP IV+
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLCEGHPNIVK 70

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   F  +   +LV++ +NGG LF ++ ++  F E  A     ++VSAVSH+H  G++HR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130

Query: 275 DLKPENILL---DADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEIVLGKGHDKAA 330
           DLKPEN+L    + +  + + DFG A+    + +   + C TL Y +PE++   G+D++ 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESC 190

Query: 331 DWWSVGILLFEMLTGQPPFTGGNRQ-------KIQQKIIKDKIKLP----AFLSSEAHSL 379
           D WS+G++L+ ML+GQ PF   +R        +I +KI K            +S EA  L
Sbjct: 191 DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250

Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           ++GLL  + +KRL         ++ ++W +
Sbjct: 251 IQGLLTVDPNKRL-----KMSGLRYNEWLQ 275

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  239 bits (611), Expect = 4e-76
 Identities = 80/271 (29%), Positives = 136/271 (50%), Gaps = 6/271 (2%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
              +  V +  + +   +G G F KV       T    A+K++ + KI   +    +K E
Sbjct: 2   SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
              L    HP I++L     T    ++V+++V+GG LF  + + G   E  AR    +I+
Sbjct: 62  IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           SAV + H + ++HRDLKPEN+LLDA  +  + DFGL+    +     + CG+  Y +PE+
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181

Query: 321 VLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSL 379
           + G+ +     D WS G++L+ +L G  PF   +   + +KI      +P +L+    +L
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL 241

Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
           L  +LQ +  KR        ++I+ H+WFK 
Sbjct: 242 LMHMLQVDPLKRA-----TIKDIREHEWFKQ 267

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  241 bits (617), Expect = 8e-76
 Identities = 48/321 (14%), Positives = 100/321 (31%), Gaps = 63/321 (19%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER--------- 201
                 V+GQ       +     T E + + V    +    N  + MK E          
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 202 ----------------NILTKVDHPFIVQLRYSFQTKYRLYLVL-------DFVNGGHLF 238
                           +++       ++++R   +  + L           +    G + 
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 239 FQLYRQGLFREDLARIY-TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA 297
                        AR+  T +++  ++ LH  G++H  L+P +I+LD  G V LT F   
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 298 KQFDENTRSNSMCGTLEYMSPEIVLGKG-----------HDKAADWWSVGILLFEMLTGQ 346
            +            +  +  PE+   +               + D W++G++++ +    
Sbjct: 254 VRDGARV---VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 347 PPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHK 406
            P T        + I +    +P        +LL+G L+     RL        +     
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRL-----LPLQAMETP 361

Query: 407 WFKMINWKKLEARETRPSFLP 427
            ++       + R    + LP
Sbjct: 362 EYE-------QLRTELSAALP 375

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  241 bits (616), Expect = 1e-75
 Identities = 86/314 (27%), Positives = 142/314 (45%), Gaps = 22/314 (7%)

Query: 113 NEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLED-FEVLKVVGQGAFAKVYQVRR 171
            E  +         +    +  G  D LP           ++   V+G+G  + V +   
Sbjct: 56  AEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVH 115

Query: 172 IGTSEIYAMKVMRKDKIMEKNHA-----EYMKSERNILTKV-DHPFIVQLRYSFQTKYRL 225
             T   +A+K+M                E  + E +IL +V  HP I+ L  S+++   +
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175

Query: 226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA 285
           +LV D +  G LF  L  +    E   R     ++ AVS LHAN I+HRDLKPENILLD 
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD 235

Query: 286 DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG------KGHDKAADWWSVGILL 339
           +  + L+DFG +   +   +   +CGT  Y++PEI+         G+ K  D W+ G++L
Sbjct: 236 NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

Query: 340 FEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKGLLQKEASKRLGSG 395
           F +L G PPF    +  + + I++ + +  +      SS    L+  LLQ +   RL   
Sbjct: 296 FTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL--- 352

Query: 396 PGGSQEIKSHKWFK 409
              +++   H +F+
Sbjct: 353 --TAEQALQHPFFE 364

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  249 bits (637), Expect = 1e-75
 Identities = 74/308 (24%), Positives = 124/308 (40%), Gaps = 43/308 (13%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
                      +E+ + +G G F  V +     T E  A+K  R++   +  + E    E
Sbjct: 5   SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLE 62

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRL------YLVLDFVNGGHLFFQLY---RQGLFREDL 251
             I+ K++HP +V  R       +L       L +++  GG L   L         +E  
Sbjct: 63  IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 122

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTRSNS 308
            R   ++I SA+ +LH N I+HRDLKPENI+L          + D G AK+ D+      
Sbjct: 123 IRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182

Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-- 366
             GTL+Y++PE++  K +    D+WS G L FE +TG  PF    +       +++K   
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242

Query: 367 ----------------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS 404
                                  L   L+ +    L+ +L     +R     G   +  +
Sbjct: 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR-----GTDPQNPN 297

Query: 405 HKWFKMIN 412
              F+ ++
Sbjct: 298 VGCFQALD 305

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  239 bits (613), Expect = 2e-75
 Identities = 94/319 (29%), Positives = 158/319 (49%), Gaps = 23/319 (7%)

Query: 100 HEAEDSLGLVEGINEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDF-EVLKVV 158
           H +       E +  ++       +    A   P   ID    +     L DF EV   +
Sbjct: 6   HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDA----LSDFFEVESEL 61

Query: 159 GQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYS 218
           G+GA + VY+ ++ GT + YA+KV++K    +      +++E  +L ++ HP I++L+  
Sbjct: 62  GRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-----VRTEIGVLLRLSHPNIIKLKEI 116

Query: 219 FQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKP 278
           F+T   + LVL+ V GG LF ++  +G + E  A     +I+ AV++LH NGI+HRDLKP
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKP 176

Query: 279 ENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSV 335
           EN+L      D  + + DFGL+K  +      ++CGT  Y +PEI+ G  +    D WSV
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSV 236

Query: 336 GILLFEMLTGQPPFTG-GNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKGLLQKEASK 390
           GI+ + +L G  PF      Q + ++I+  +    +     +S  A  L++ L+  +  K
Sbjct: 237 GIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKK 296

Query: 391 RLGSGPGGSQEIKSHKWFK 409
           RL      + +   H W  
Sbjct: 297 RL-----TTFQALQHPWVT 310

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  238 bits (609), Expect = 5e-75
 Identities = 80/315 (25%), Positives = 129/315 (40%), Gaps = 60/315 (19%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKV 207
           + + +   +GQG++  V       T  I A+K+M K+KI + N  +   +K+E  ++ K+
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF----------------------------- 238
            HP I +L   ++ +  + LV++  +GGHL                              
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 239 -----------FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL--DA 285
                      F+     + RE L      +I SA+ +LH  GI HRD+KPEN L   + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 286 DGHVMLTDFGLAKQFD-----ENTRSNSMCGTLEYMSPEIVLGKGH--DKAADWWSVGIL 338
              + L DFGL+K+F      E     +  GT  +++PE++           D WS G+L
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 339 LFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLKGLLQKEASKRLGS 394
           L  +L G  PF G N      +++  K+         LS  A  LL  LL +   +R   
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF-- 323

Query: 395 GPGGSQEIKSHKWFK 409
               +     H W  
Sbjct: 324 ---DAMRALQHPWIS 335

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  239 bits (611), Expect = 8e-75
 Identities = 76/268 (28%), Positives = 135/268 (50%), Gaps = 15/268 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +++L+ +G GAF  V++     T  ++  K +     ++K     +K+E +I+ ++ H
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH 107

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHA 268
           P ++ L  +F+ KY + L+L+F++GG LF ++  +     E     Y  +    + H+H 
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167

Query: 269 NGIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           + I+H D+KPENI+        V + DFGLA + + +        T E+ +PEIV  +  
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 227

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL--PAF--LSSEAHSLLKG 382
               D W++G+L + +L+G  PF G +  +  Q + +   +    AF  +S EA   +K 
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFKM 410
           LLQKE  KRL        +   H W K 
Sbjct: 288 LLQKEPRKRL-----TVHDALEHPWLKG 310

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  234 bits (599), Expect = 3e-74
 Identities = 82/282 (29%), Positives = 143/282 (50%), Gaps = 18/282 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + +  +  E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 326 HD-KAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKIKLP--AFLSSEAHSLLK 381
              +  D WS GI+L  ML G+ P+    +  +      + K  L     + S   +LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRP 423
            +L +  S R+        +IK  +W+     K L+    RP
Sbjct: 244 KILVENPSARI-----TIPDIKKDRWYN----KPLKKGAKRP 276

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  237 bits (606), Expect = 3e-74
 Identities = 75/266 (28%), Positives = 134/266 (50%), Gaps = 15/266 (5%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
                +++G G F +V++     T    A K+++   + +K   E +K+E +++ ++DH 
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHAN 269
            ++QL  +F++K  + LV+++V+GG LF ++  +     E    ++  +I   + H+H  
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 270 GIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHD 327
            I+H DLKPENIL        + + DFGLA+++    +     GT E+++PE+V      
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS 266

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL--PAF--LSSEAHSLLKGL 383
              D WSVG++ + +L+G  PF G N  +    I+  +  L    F  +S EA   +  L
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326

Query: 384 LQKEASKRLGSGPGGSQEIKSHKWFK 409
           L KE S R+      + E   H W  
Sbjct: 327 LIKEKSWRI-----SASEALKHPWLS 347

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  236 bits (603), Expect = 5e-74
 Identities = 81/273 (29%), Positives = 130/273 (47%), Gaps = 25/273 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VD 208
           + +EV + +G G+++   +     T+  +A+K++ K K            E  IL +   
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQ 74

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I+ L+  +     +Y+V + + GG L  ++ RQ  F E  A      I   V +LHA
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134

Query: 269 NGIMHRDLKPENILL----DADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLG 323
            G++HRDLKP NIL          + + DFG AKQ   EN    + C T  +++PE++  
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194

Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKDKIKLPA----FLSSEA 376
           +G+D A D WS+G+LL+ MLTG  PF  G     ++I  +I   K  L       +S  A
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254

Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
             L+  +L  +  +RL      +  +  H W  
Sbjct: 255 KDLVSKMLHVDPHQRL-----TAALVLRHPWIV 282

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  235 bits (601), Expect = 6e-74
 Identities = 76/296 (25%), Positives = 137/296 (46%), Gaps = 21/296 (7%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
             E +      +  +  +G GAF  V+       ++   +K ++K+K++E    E  K  
Sbjct: 17  ACEGEYSQ--KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74

Query: 201 R-----NILTKVDHPFIVQLRYSFQTKYRLYLVLDF-VNGGHLFFQLYRQGLFREDLARI 254
           +      IL++V+H  I+++   F+ +    LV++   +G  LF  + R     E LA  
Sbjct: 75  KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLE 314
              ++VSAV +L    I+HRD+K ENI++  D  + L DFG A   +      + CGT+E
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIE 194

Query: 315 YMSPEIVLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLS 373
           Y +PE+++G  +     + WS+G+ L+ ++  + PF         ++ ++  I  P  +S
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVS 248

Query: 374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM-INWKKLEARETRPSFLPE 428
            E  SL+ GLLQ    +R        +++ +  W    +N       E      PE
Sbjct: 249 KELMSLVSGLLQPVPERRT-----TLEKLVTDPWVTQPVNLADYTWEEVFRVNKPE 299

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  234 bits (599), Expect = 1e-73
 Identities = 67/267 (25%), Positives = 118/267 (44%), Gaps = 16/267 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + + + +G+G F  V++     + + Y  K ++     +      +K E +IL    H
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
             I+ L  SF++   L ++ +F++G  +F           E     Y  ++  A+  LH+
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 269 NGIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           + I H D++PENI+        + + +FG A+Q         +    EY +PE+      
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL--PAF--LSSEAHSLLKG 382
             A D WS+G L++ +L+G  PF     Q+I + I+  +      AF  +S EA   +  
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFK 409
           LL KE   R+      + E   H W K
Sbjct: 241 LLVKERKSRM-----TASEALQHPWLK 262

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  234 bits (599), Expect = 1e-73
 Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 16/275 (5%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQ 214
           K +G+G FA V Q     T + YA K ++K +  +   AE +  E  +L      P ++ 
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAVLELAKSCPRVIN 93

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLY--RQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           L   ++    + L+L++  GG +F         +  E+       +I+  V +LH N I+
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153

Query: 273 HRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKA 329
           H DLKP+NILL      G + + DFG++++         + GT EY++PEI+       A
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTA 213

Query: 330 ADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLKGLLQ 385
            D W++GI+ + +LT   PF G + Q+    I +  +       + +S  A   ++ LL 
Sbjct: 214 TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLV 273

Query: 386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARE 420
           K   KR       ++   SH W +  +++ L   E
Sbjct: 274 KNPEKRP-----TAEICLSHSWLQQWDFENLFHPE 303

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  234 bits (599), Expect = 2e-73
 Identities = 76/272 (27%), Positives = 140/272 (51%), Gaps = 9/272 (3%)

Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           +    + +G   + + + +G+G+F KV       T +  A+K + +  + + +    ++ 
Sbjct: 1   MAISKRHIG--PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER 58

Query: 200 ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
           E + L  + HP I++L     T   + +V+++  GG LF  +  +    ED  R +  +I
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI 117

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPE 319
           + A+ + H + I+HRDLKPEN+LLD + +V + DFGL+    +     + CG+  Y +PE
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177

Query: 320 IVLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHS 378
           ++ GK +     D WS GI+L+ ML G+ PF       + +K+      +P FLS  A S
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS 237

Query: 379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
           L++ ++  +  +R+       QEI+   WF +
Sbjct: 238 LIRRMIVADPMQRI-----TIQEIRRDPWFNV 264

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  233 bits (596), Expect = 3e-73
 Identities = 85/315 (26%), Positives = 150/315 (47%), Gaps = 18/315 (5%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + ++    E +K E  I   ++
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 326 HD-KAADWWSVGILLFEMLTGQPPF-TGGNRQKIQQKIIKDKIKLP--AFLSSEAHSLLK 381
              +  D WS GI+L  ML G+ P+    +  +      + K  L     + S   +LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEEC 441
            +L +  S R+        +IK  +W+     K L+    RP        +      +  
Sbjct: 244 KILVENPSARI-----TIPDIKKDRWYN----KPLKKGAKRPRVTSGGVSESPSGFSKHI 294

Query: 442 WTNMPLLDSPVASPK 456
            +N+       AS  
Sbjct: 295 QSNLDFSPVNSASRT 309

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  239 bits (612), Expect = 7e-73
 Identities = 71/270 (26%), Positives = 122/270 (45%), Gaps = 15/270 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +++ + +G GAF  V++V    T   +A K +      +K   E ++ E   ++ + H
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLRH 213

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P +V L  +F+    + ++ +F++GG LF           ED A  Y  ++   + H+H 
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273

Query: 269 NGIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           N  +H DLKPENI+        + L DFGL    D         GT E+ +PE+  GK  
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 333

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL--PAF--LSSEAHSLLKG 382
               D WSVG+L + +L+G  PF G N  +  + +      +   AF  +S +    ++ 
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 393

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFKMIN 412
           LL  + + R+        +   H W    N
Sbjct: 394 LLLADPNTRM-----TIHQALEHPWLTPGN 418

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  233 bits (595), Expect = 9e-73
 Identities = 80/271 (29%), Positives = 137/271 (50%), Gaps = 18/271 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            + ++ +K +G G F     +R   T E+ A+K + +   ++    E ++ E      + 
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLR 74

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP IV+ +    T   L +++++ +GG L+ ++   G F ED AR +  +++S VS+ H+
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS 134

Query: 269 NGIMHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
             I HRDLK EN LLD      + + DFG +K    +++  S  GT  Y++PE++L + +
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEY 194

Query: 327 D-KAADWWSVGILLFEMLTGQPPFTGGNR----QKIQQKIIKDKIKLP--AFLSSEAHSL 379
           D K AD WS G+ L+ ML G  PF         +K  Q+I+  K  +P    +S E   L
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254

Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
           +  +   + + R+        EIK+H WF  
Sbjct: 255 ISRIFVADPATRI-----SIPEIKTHSWFLK 280

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  231 bits (591), Expect = 1e-72
 Identities = 63/270 (23%), Positives = 116/270 (42%), Gaps = 27/270 (10%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +  + +  ++ +G+G F+ V  V  +     YA+K +      E+   E  + E ++   
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL---CHEQQDREEAQREADMHRL 82

Query: 207 VDHPFIVQLRYSF----QTKYRLYLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAE 258
            +HP I++L          K+  +L+L F   G L+ ++ R         ED        
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM--------- 309
           I   +  +HA G  HRDLKP NILL  +G  +L D G   Q   +   +           
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 310 -CGTLEYMSPEIVLGKGH---DKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKD 364
              T+ Y +PE+   + H   D+  D WS+G +L+ M+ G+ P+    ++       +++
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262

Query: 365 KIKLPAF--LSSEAHSLLKGLLQKEASKRL 392
           ++ +P     SS    LL  ++  +  +R 
Sbjct: 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRP 292

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  229 bits (587), Expect = 2e-72
 Identities = 72/290 (24%), Positives = 118/290 (40%), Gaps = 38/290 (13%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L DFE ++ +G+G F  V++ +       YA+K +R     E    + +  E   L K++
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREK-VMREVKALAKLE 61

Query: 209 HPFIVQLRYSF------------QTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLAR 253
           HP IV+   ++              K  LY+ +      +L   +  +         +  
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--------- 304
               +I  AV  LH+ G+MHRDLKP NI    D  V + DFGL    D++          
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 305 ----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQK 360
               R     GT  YMSPE + G  +    D +S+G++LFE+L   P  T   R +    
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTD 239

Query: 361 IIKDKI-KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           +   K   L        + +++ +L     +R    P  +  I  +  F+
Sbjct: 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMER----P-EAINIIENAVFE 284

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  229 bits (586), Expect = 5e-72
 Identities = 74/286 (25%), Positives = 134/286 (46%), Gaps = 18/286 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY-MKSERNILTKVDHP 210
           + +  ++G+G++ KV +V    T    A+K+++K K+    + E  +K E  +L ++ H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 211 FIVQLR--YSFQTKYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            ++QL      + K ++Y+V+++   G         +  F    A  Y  +++  + +LH
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH 126

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM---CGTLEYMSPEIVLG- 323
           + GI+H+D+KP N+LL   G + ++  G+A+        ++     G+  +  PEI  G 
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186

Query: 324 KGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
                   D WS G+ L+ + TG  PF G N  K+ + I K    +P         LLKG
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKG 246

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
           +L+ E +KR        ++I+ H WF+    KK    E      P 
Sbjct: 247 MLEYEPAKRF-----SIRQIRQHSWFR----KKHPPAEAPVPIPPS 283

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  234 bits (599), Expect = 6e-72
 Identities = 79/271 (29%), Positives = 137/271 (50%), Gaps = 6/271 (2%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
              +  V +  + +   +G G F KV   +   T    A+K++ + KI   +    ++ E
Sbjct: 7   QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
              L    HP I++L     T   +++V+++V+GG LF  + + G   E  +R    +I+
Sbjct: 67  IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL 126

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           S V + H + ++HRDLKPEN+LLDA  +  + DFGL+    +     + CG+  Y +PE+
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186

Query: 321 VLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSL 379
           + G+ +     D WS G++L+ +L G  PF   +   + +KI       P +L+    SL
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISL 246

Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
           LK +LQ +  KR        ++I+ H+WFK 
Sbjct: 247 LKHMLQVDPMKRA-----TIKDIREHEWFKQ 272

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  228 bits (584), Expect = 9e-72
 Identities = 78/299 (26%), Positives = 132/299 (44%), Gaps = 37/299 (12%)

Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           S   CV L  + +   +G+G++  V        +  YAMKV+ K K++ +         R
Sbjct: 5   SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64

Query: 202 N-----------------------ILTKVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGH 236
                                   IL K+DHP +V+L        +  LY+V + VN G 
Sbjct: 65  GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124

Query: 237 LFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL 296
           +  ++       ED AR Y  +++  + +LH   I+HRD+KP N+L+  DGH+ + DFG+
Sbjct: 125 VM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 297 AKQF-DENTRSNSMCGTLEYMSPEIVLGKGHD---KAADWWSVGILLFEMLTGQPPFTGG 352
           + +F   +   ++  GT  +M+PE +         KA D W++G+ L+  + GQ PF   
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243

Query: 353 NRQKIQQKIIKDKIKLPAF--LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
               +  KI    ++ P    ++ +   L+  +L K    R+        EIK H W  
Sbjct: 244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRI-----VVPEIKLHPWVT 297

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  226 bits (579), Expect = 6e-71
 Identities = 82/290 (28%), Positives = 137/290 (47%), Gaps = 44/290 (15%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQ 214
            V+G+GA A+V     + TS+ YA+K++ K     +     +  E  +L +   H  +++
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQCQGHRNVLE 75

Query: 215 LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
           L   F+ + R YLV + + GG +   ++++  F E  A +   ++ SA+  LH  GI HR
Sbjct: 76  LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135

Query: 275 DLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSM--------CGTLEYMSPEIVLG 323
           DLKPENIL    +    V + DF L      N   + +        CG+ EYM+PE+V  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195

Query: 324 -----KGHDKAADWWSVGILLFEMLTGQPPFTGGNR---------------QKIQQKIIK 363
                  +DK  D WS+G++L+ +L+G PPF G                    + + I +
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE 255

Query: 364 DKIKLP----AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
            K + P    A +S  A  L+  LL ++A +RL      + ++  H W +
Sbjct: 256 GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL-----SAAQVLQHPWVQ 300

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  226 bits (577), Expect = 1e-70
 Identities = 79/306 (25%), Positives = 137/306 (44%), Gaps = 20/306 (6%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME 190
                     P + +      ++V  ++G G F  VY   R+  +   A+K + KD+I +
Sbjct: 24  CNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 83

Query: 191 KNHAEYM---KSERNILTKVDH--PFIVQLRYSFQTKYRLYLVLDFVNG-GHLFFQLYRQ 244
                       E  +L KV      +++L   F+      L+L+       LF  +  +
Sbjct: 84  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 143

Query: 245 GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDEN 303
           G  +E+LAR +  +++ AV H H  G++HRD+K ENIL+D + G + L DFG      + 
Sbjct: 144 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 203

Query: 304 TRSNSMCGTLEYMSPEIVLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII 362
             ++   GT  Y  PE +    +  ++A  WS+GILL++M+ G  PF         ++II
Sbjct: 204 VYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------DEEII 256

Query: 363 KDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETR 422
           + ++     +SSE   L++  L    S R        +EI++H W + +   +  A    
Sbjct: 257 RGQVFFRQRVSSECQHLIRWCLALRPSDRP-----TFEEIQNHPWMQDVLLPQETAEIHL 311

Query: 423 PSFLPE 428
            S  P 
Sbjct: 312 HSLSPG 317

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  224 bits (574), Expect = 4e-70
 Identities = 72/270 (26%), Positives = 129/270 (47%), Gaps = 22/270 (8%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM---KSERNILTKV 207
           ++ +  ++G+G F  V+   R+      A+KV+ +++++  +          E  +L KV
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 208 D----HPFIVQLRYSFQTKYRLYLVLDF-VNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
                HP +++L   F+T+    LVL+  +    LF  +  +G   E  +R +  ++V+A
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151

Query: 263 VSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           + H H+ G++HRD+K ENIL+D   G   L DFG       +       GT  Y  PE +
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFDGTRVYSPPEWI 210

Query: 322 LGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLL 380
               +    A  WS+GILL++M+ G  PF         Q+I++ ++  PA +S +  +L+
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFPAHVSPDCCALI 264

Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
           +  L  + S R        +EI    W + 
Sbjct: 265 RRCLAPKPSSRP-----SLEEILLDPWMQT 289

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  222 bits (568), Expect = 5e-69
 Identities = 74/279 (26%), Positives = 138/279 (49%), Gaps = 33/279 (11%)

Query: 150 EDFEVLK-VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           +D+++ K V+G G   KV +     T +  A+K++       +        E +   +  
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQAS 79

Query: 208 DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVS 261
             P IV +   ++  +     L ++++ + GG LF ++  +G   F E  A     +I +
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 262 AVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           A+  LH++ I HRD+KPEN+L    + D  + LTDFG AK+  +N    + C T  Y++P
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ-TPCYTPYYVAP 198

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ----QKIIKDKIKLP----A 370
           E++  + +DK+ D WS+G++++ +L G PPF     Q I     ++I   +   P    +
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS 258

Query: 371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
            +S +A  L++ LL+ + ++RL        +  +H W  
Sbjct: 259 EVSEDAKQLIRLLLKTDPTERL-----TITQFMNHPWIN 292

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  223 bits (570), Expect = 2e-68
 Identities = 51/320 (15%), Positives = 102/320 (31%), Gaps = 56/320 (17%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSER---------- 201
                V+GQ       +     T E + + V    +    N  + MK E           
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 202 ---------------NILTKVDHPFIVQLRYSFQTKYRLYLVLDF----VNGGHLFFQLY 242
                          +++       ++++R   +  + L     +     N       L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 243 RQGLFREDL---ARIY-TAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
                 + L   AR+  T +++  ++ LH  G++H  L+P +I+LD  G V LT F    
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 299 QFDEN--TRSNSMCGTLEYMSPEIVLGKGHDK-----AADWWSVGILLFEMLTGQPPFTG 351
           +   +  +         E  +  ++    H       A D W++G+ ++ +     P T 
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319

Query: 352 GNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI 411
                  + I +    +P        +LL+G L+     RL        +      ++  
Sbjct: 320 DAALGGSEWIFRSCKNIPQ----PVRALLEGFLRYPKEDRL-----LPLQAMETPEYE-- 368

Query: 412 NWKKLEARETRPSFLPEVAG 431
                + R    + LP    
Sbjct: 369 -----QLRTELSAALPLYQT 383

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  223 bits (569), Expect = 2e-68
 Identities = 78/299 (26%), Positives = 145/299 (48%), Gaps = 34/299 (11%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM 189
             P  H+ +     +   ++D++V  +V+G G   KV Q+    T E +A+K+++     
Sbjct: 42  QFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA 101

Query: 190 EKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY----RLYLVLDFVNGGHLFFQLYRQ 244
            +        E  +  +    P IV++   ++  Y     L +V++ ++GG LF ++  +
Sbjct: 102 RR--------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 153

Query: 245 G--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQ 299
           G   F E  A      I  A+ +LH+  I HRD+KPEN+L      +  + LTDFG AK+
Sbjct: 154 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213

Query: 300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ 359
              +    + C T  Y++PE++  + +DK+ D WS+G++++ +L G PPF   +   I  
Sbjct: 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 273

Query: 360 KIIKDKIKLPAF---------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
             +K +I++  +         +S E   L++ LL+ E ++R+        E  +H W  
Sbjct: 274 G-MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWIM 326

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  216 bits (551), Expect = 4e-66
 Identities = 51/358 (14%), Positives = 107/358 (29%), Gaps = 59/358 (16%)

Query: 113 NEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRI 172
            E  +E    +  V A +             +Q  G    ++++ +  G  + V+ VR +
Sbjct: 27  EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQ--GERKLKLVEPLRVGDRSVVFLVRDV 84

Query: 173 GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR---------------- 216
              E +A+KV        ++  E +        ++      + R                
Sbjct: 85  ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144

Query: 217 ----------YSFQTKYRLYLVLDFVNG------GHLFFQLYRQGLFREDLARIYTAEIV 260
                               L++   +         L F    +G        I TA+++
Sbjct: 145 QPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLI 204

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
              ++L + G++H    P+N+ +  DG +ML D     +    TR  +    + Y   E 
Sbjct: 205 RLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK--VGTRGPASSVPVTYAPREF 262

Query: 321 VLGKG--HDKAADWWSVGILLFEMLTGQPPFTGGN--RQKIQQKIIKDKIKLPAF----- 371
           +         A + W +G+ ++ +     PF       +   ++         +      
Sbjct: 263 LNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSC 322

Query: 372 --LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP 427
             L     +L+   L  +  +RL        E      F        + +    S L 
Sbjct: 323 TPLPDFVKTLIGRFLNFDRRRRL-----LPLEAMETPEFL-------QLQNEISSSLS 368

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  211 bits (540), Expect = 2e-65
 Identities = 46/291 (15%), Positives = 106/291 (36%), Gaps = 36/291 (12%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
             +F  L+ +G G F  V++  +     IYA+K  +K      +    ++          
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGG----HLFFQLYRQGLFREDLARIYTAEIVSAVS 264
           H  +V+   ++     + +  ++ NGG     +         F+E   +    ++   + 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 265 HLHANGIMHRDLKPENILLDADGHVM-------------------LTDFGLAKQFDENTR 305
           ++H+  ++H D+KP NI +                          + D G   +    + 
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SS 186

Query: 306 SNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD 364
                G   +++ E++     H   AD +++ + +      +P    G+      +I + 
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQG 243

Query: 365 KI-KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK 414
           ++ ++P  LS E   LLK ++  +  +R    P  +  +  H      + K
Sbjct: 244 RLPRIPQVLSQEFTELLKVMIHPDPERR----P-SAMALVKHSVLLSASRK 289

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  205 bits (524), Expect = 2e-62
 Identities = 63/253 (24%), Positives = 112/253 (44%), Gaps = 18/253 (7%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +        VG+G+F +V++++   T    A+K +R +    +        E      + 
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------ELVACAGLS 108

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            P IV L  + +    + + ++ + GG L   + + G   ED A  Y  + +  + +LH 
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168

Query: 269 NGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDEN------TRSNSMCGTLEYMSPEIV 321
             I+H D+K +N+LL +DG    L DFG A     +         + + GT  +M+PE+V
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHS 378
           +GK  D   D WS   ++  ML G  P+T   R  +  KI  +     ++P   +     
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ 288

Query: 379 LLKGLLQKEASKR 391
            ++  L+KE   R
Sbjct: 289 AIQEGLRKEPVHR 301

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  203 bits (518), Expect = 1e-60
 Identities = 79/334 (23%), Positives = 139/334 (41%), Gaps = 65/334 (19%)

Query: 137 IDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY 196
           I N+P+  Q +        K++G G+   V   +        A+K M  D        + 
Sbjct: 3   IANIPNFEQSLK-NLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFC------DI 54

Query: 197 MKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIY 255
              E  +LT+ D HP +++   S  T   LY+ L+  N   L   +  + +  E+L    
Sbjct: 55  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQK 113

Query: 256 TAE-------IVSAVSHLHANGIMHRDLKPENILLD-------------ADGHVMLTDFG 295
                     I S V+HLH+  I+HRDLKP+NIL+               +  ++++DFG
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173

Query: 296 LAKQFDEN-----TRSNSMCGTLEYMSPEIVLG-------KGHDKAADWWSVGILLFEML 343
           L K+ D       T  N+  GT  + +PE++         +   ++ D +S+G + + +L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

Query: 344 T-GQPPFTGGNRQKIQQKIIKDKIKLPAF-------LSSEAHSLLKGLLQKEASKRLGSG 395
           + G+ PF  G++   +  II+    L          L +EA  L+  ++  +  KR    
Sbjct: 234 SKGKHPF--GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP--- 288

Query: 396 PGGSQEIKSHKWFKMINWKKLEARETRPSFLPEV 429
              + ++  H  F    W K      +  FL +V
Sbjct: 289 --TAMKVLRHPLF----WPK----SKKLEFLLKV 312

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  199 bits (508), Expect = 3e-60
 Identities = 74/316 (23%), Positives = 124/316 (39%), Gaps = 44/316 (13%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +G     V +V+ +G FA VY+ + +G+   YA+K +      E+     +  E   + K
Sbjct: 25  LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS---NEEEKNRAIIQEVCFMKK 81

Query: 207 V-DHPFIVQLRYSF-------QTKYRLYLVLDFVNGGHLFFQLYR---QGLFREDLARIY 255
           +  HP IVQ   +         T    +L+L  +  G L   L +   +G    D     
Sbjct: 82  LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141

Query: 256 TAEIVSAVSHLHANG--IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS----- 308
             +   AV H+H     I+HRDLK EN+LL   G + L DFG A         +      
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201

Query: 309 --------MCGTLEYMSPEIV---LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI 357
                      T  Y +PEI+         +  D W++G +L+ +   Q PF  G     
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA---- 257

Query: 358 QQKIIKDKIKLPAFL--SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK 415
           + +I+  K  +P      +  HSL++ +LQ    +RL        E+      ++   + 
Sbjct: 258 KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL-----SIAEVVHQ-LQEIAAARN 311

Query: 416 LEARETRPSFLPEVAG 431
           +  +      L +  G
Sbjct: 312 VNPKSPITELLEQNGG 327

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  201 bits (514), Expect = 6e-60
 Identities = 60/319 (18%), Positives = 123/319 (38%), Gaps = 43/319 (13%)

Query: 132 KPTGHIDNLPSENQC--VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM 189
            P+   D+   E     VG   F    V+G GA   +   R +  +   A+K +  +   
Sbjct: 4   SPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF- 61

Query: 190 EKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY--RQGL 246
                 +   E  +L + D HP +++   + + +   Y+ ++         +    +   
Sbjct: 62  -----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA--TLQEYVEQKDFA 114

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH-----VMLTDFGLAKQFD 301
                      +  S ++HLH+  I+HRDLKP NIL+           M++DFGL K+  
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174

Query: 302 ENTRS----NSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLT-GQPPFTGGN 353
               S    + + GT  +++PE++     +      D +S G + + +++ G  PF    
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234

Query: 354 RQKIQQKIIK---DKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
           +++    +     D +         A  L++ ++  +  KR       ++ +  H +F  
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP-----SAKHVLKHPFFW- 288

Query: 411 INWKKLEARETRPSFLPEV 429
                  + E +  F  +V
Sbjct: 289 -------SLEKQLQFFQDV 300

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  195 bits (499), Expect = 3e-59
 Identities = 72/246 (29%), Positives = 125/246 (50%), Gaps = 13/246 (5%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
            V+G+G +  VY  R +      A+K + +       +++ +  E  +   + H  IVQ 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQY 84

Query: 216 RYSFQTKYRLYLVLDFVNGG---HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
             SF     + + ++ V GG    L    +      E     YT +I+  + +LH N I+
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144

Query: 273 HRDLKPENILLDA-DGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLG--KGHDK 328
           HRD+K +N+L++   G + ++DFG +K+    N  + +  GTL+YM+PEI+    +G+ K
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204

Query: 329 AADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKI--KLPAFLSSEAHSLLKGLLQ 385
           AAD WS+G  + EM TG+PPF   G  Q    K+   K+  ++P  +S+EA + +    +
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFE 264

Query: 386 KEASKR 391
            +  KR
Sbjct: 265 PDPDKR 270

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  195 bits (497), Expect = 6e-59
 Identities = 72/293 (24%), Positives = 133/293 (45%), Gaps = 53/293 (18%)

Query: 136 HIDNLPSENQCVGLEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA 194
           H+ +     +   ++D++V  +V+G G   KV Q+    T E +A+K+++      +   
Sbjct: 3   HVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--- 59

Query: 195 EYMKSERNILTKV-DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LF 247
                E  +  +    P IV++   ++  Y     L +V++ ++GG LF ++  +G   F
Sbjct: 60  -----EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENT 304
            E  A      I  A+ +LH+  I HRD+KPEN+L      +  + LTDFG AK+     
Sbjct: 115 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE----- 169

Query: 305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR----QKIQQK 360
                             G+ +DK+ D WS+G++++ +L G PPF   +       ++ +
Sbjct: 170 ----------------TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 213

Query: 361 IIKDKIKLPA----FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           I   + + P      +S E   L++ LL+ E ++R+        E  +H W  
Sbjct: 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWIM 261

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  190 bits (483), Expect = 2e-56
 Identities = 71/333 (21%), Positives = 115/333 (34%), Gaps = 79/333 (23%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAM-------------KVMRKDKIMEK-NHA 194
           L DFE ++ +G+G F  V++ +       YA+             KVMR+ K + K  H 
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64

Query: 195 EYMKS-----------------------------------------ERNILTKVDHPFIV 213
             ++                                          +   +        V
Sbjct: 65  GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF---REDLARIYTAEIVSAVSHLHANG 270
                   K  LY+ +      +L   + R+         +      +I  AV  LH+ G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFD-------------ENTRSNSMCGTLEYMS 317
           +MHRDLKP NI    D  V + DFGL    D                      GT  YMS
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEA 376
           PE + G  +    D +S+G++LFE+L      T   R +I   +   K   L      + 
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDVRNLKFPLLFTQKYPQE 302

Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           H +++ +L    ++R    P  + +I  +  F+
Sbjct: 303 HMMVQDMLSPSPTER----P-EATDIIENAIFE 330

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  186 bits (474), Expect = 2e-55
 Identities = 69/244 (28%), Positives = 126/244 (51%), Gaps = 5/244 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F  L+ +G+G+F +V++     T ++ A+K++  ++  ++   E ++ E  +L++ D 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDS 79

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P++ +   S+    +L+++++++ GG     L   G   E        EI+  + +LH+ 
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSE 138

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             +HRD+K  N+LL   G V L DFG+A Q  D   + N+  GT  +M+PE++    +D 
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGLLQKE 387
            AD WS+GI   E+  G+PP +  +  K+   I K+    L    S      ++  L KE
Sbjct: 199 KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE 258

Query: 388 ASKR 391
            S R
Sbjct: 259 PSFR 262

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  181 bits (461), Expect = 2e-53
 Identities = 62/246 (25%), Positives = 124/246 (50%), Gaps = 8/246 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
              +    +G+G+   V   R   +    A+K+M    + ++   E + +E  I+    H
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQH 101

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
             +V++  S+     L+++++F+ GG L   +  Q    E+        ++ A+++LHA 
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQVRLNEEQIATVCEAVLQALAYLHAQ 160

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           G++HRD+K ++ILL  DG V L+DFG   Q   +  +  S+ GT  +M+PE++    +  
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYAT 220

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLLQ 385
             D WS+GI++ EM+ G+PP+   +  +  +++      K+K    +S      L+ +L 
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV 280

Query: 386 KEASKR 391
           ++  +R
Sbjct: 281 RDPQER 286

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  180 bits (458), Expect = 2e-53
 Identities = 61/264 (23%), Positives = 123/264 (46%), Gaps = 18/264 (6%)

Query: 156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQL 215
             +G+G+F  VY+     T+   A   ++  K+  K+  +  K E  +L  + HP IV+ 
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 216 RYSF----QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG- 270
             S+    + K  + LV + +  G L   L R  + +  + R +  +I+  +  LH    
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150

Query: 271 -IMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
            I+HRDLK +NI +    G V + D GLA     +    ++ GT E+M+PE +  + +D+
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPE-MYEEKYDE 208

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK---LPAFLSSEAHSLLKGLLQ 385
           + D ++ G+ + EM T + P++         + +   +K          E   +++G ++
Sbjct: 209 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268

Query: 386 KEASKRLGSGPGGSQEIKSHKWFK 409
           +   +R        +++ +H +F+
Sbjct: 269 QNKDERY-----SIKDLLNHAFFQ 287

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  179 bits (457), Expect = 5e-53
 Identities = 71/246 (28%), Positives = 125/246 (50%), Gaps = 8/246 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +   + +GQGA   VY    + T +  A++ M    + ++   E + +E  ++ +  +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKN 76

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV    S+     L++V++++ GG L   +  +    E        E + A+  LH+N
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHDK 328
            ++HRD+K +NILL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLLQ 385
             D WS+GI+  EM+ G+PP+   N  +    I  +   +++ P  LS+     L   L+
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255

Query: 386 KEASKR 391
            +  KR
Sbjct: 256 MDVEKR 261

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  177 bits (450), Expect = 8e-52
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 23/293 (7%)

Query: 131 GKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME 190
           GK TG++  +  +     + D E L  +G G   +V+++R   T  + A+K MR      
Sbjct: 7   GKQTGYLT-IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR----RS 61

Query: 191 KNHAEY--MKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLF 247
            N  E   +  + +++ K  D P+IVQ   +F T   +++ ++ +       +   QG  
Sbjct: 62  GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPI 121

Query: 248 REDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS 306
            E +    T  IV A+ +L   +G++HRD+KP NILLD  G + L DFG++ +  ++   
Sbjct: 122 PERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181

Query: 307 NSMCGTLEYMSPEIV-----LGKGHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQK 360
           +   G   YM+PE +         +D  AD WS+GI L E+ TGQ P+       ++  K
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK 241

Query: 361 IIKD---KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
           ++++    +      S +  S +K  L K+  KR         ++  H + K 
Sbjct: 242 VLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP-----KYNKLLEHSFIKR 289

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  173 bits (440), Expect = 2e-50
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 10/247 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E F+VL+ +G+G++  VY+     T +I A+K +     +E +  E +K E +I+ + D 
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIK-EISIMQQCDS 83

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P +V+   S+     L++V+++   G +      R     ED         +  + +LH 
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGHD 327
              +HRD+K  NILL+ +GH  L DFG+A Q  D   + N++ GT  +M+PE++   G++
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 203

Query: 328 KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLL 384
             AD WS+GI   EM  G+PP+   +  +    I  +     + P   S      +K  L
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCL 263

Query: 385 QKEASKR 391
            K   +R
Sbjct: 264 VKSPEQR 270

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  171 bits (436), Expect = 6e-50
 Identities = 77/252 (30%), Positives = 125/252 (49%), Gaps = 13/252 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E +E++  +G GAF KVY+ +   T  + A KV+      E    E    E  IL   DH
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDH 75

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P+IV+L  ++    +L+++++F  GG +    L       E   ++   +++ A++ LH+
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVL----- 322
             I+HRDLK  N+L+  +G + L DFG++ +      + +S  GT  +M+PE+V+     
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSL 379
              +D  AD WS+GI L EM   +PP    N  ++  KI K     +  P+  S E    
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255

Query: 380 LKGLLQKEASKR 391
           LK  L K    R
Sbjct: 256 LKIALDKNPETR 267

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  173 bits (439), Expect = 7e-50
 Identities = 63/252 (25%), Positives = 119/252 (47%), Gaps = 10/252 (3%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTK 206
            +DFE +  +G G    V++V    +  + A K++     +E   A    +  E  +L +
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH----LEIKPAIRNQIIRELQVLHE 87

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRED-LARIYTAEIVSAVSH 265
            + P+IV    +F +   + + ++ ++GG L   L + G   E  L ++ +  ++  +++
Sbjct: 88  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV-SIAVIKGLTY 146

Query: 266 LHANG-IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK 324
           L     IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE + G 
Sbjct: 147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGT 205

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLL 384
            +   +D WS+G+ L EM  G+ P    + ++++           A       +  + L 
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265

Query: 385 QKEASKRLGSGP 396
           +     R     
Sbjct: 266 KFGMDSRPPMAI 277

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  171 bits (435), Expect = 3e-49
 Identities = 66/248 (26%), Positives = 111/248 (44%), Gaps = 10/248 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + F  L+ +G G+F  VY  R +  SE+ A+K M           + +  E   L K+ H
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P  +Q R  +  ++  +LV+++  G         +   +E      T   +  +++LH++
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG---KGH 326
            ++HRD+K  NILL   G V L DFG A        +NS  GT  +M+PE++L      +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVILAMDEGQY 230

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGL 383
           D   D WS+GI   E+   +PP    N       I ++    ++   + S    + +   
Sbjct: 231 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-SEYFRNFVDSC 289

Query: 384 LQKEASKR 391
           LQK    R
Sbjct: 290 LQKIPQDR 297

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  168 bits (428), Expect = 8e-49
 Identities = 74/285 (25%), Positives = 127/285 (44%), Gaps = 32/285 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D+E+ +V+G GA A V         E  A+K +  +K       + +  E   +++  H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAMSQCHH 72

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGG--------HLFFQLYRQGLFREDLARIYTAEIVS 261
           P IV    SF  K  L+LV+  ++GG         +    ++ G+  E        E++ 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ------FDENTRSNSMCGTLEY 315
            + +LH NG +HRD+K  NILL  DG V + DFG++           N    +  GT  +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 316 MSPEIVL-GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK----------D 364
           M+PE++   +G+D  AD WS GI   E+ TG  P+      K+    ++           
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252

Query: 365 KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
             ++          ++   LQK+  KR    P  ++ ++ HK+F+
Sbjct: 253 DKEMLKKYGKSFRKMISLCLQKDPEKR----PTAAELLR-HKFFQ 292

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  168 bits (428), Expect = 1e-48
 Identities = 74/296 (25%), Positives = 138/296 (46%), Gaps = 29/296 (9%)

Query: 134 TGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH 193
           +G +   P ++     ED + L  +G+GA+  V ++    + +I A+K +R       + 
Sbjct: 6   SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR----STVDE 61

Query: 194 AEY--MKSERNILTK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF----QLYRQGL 246
            E   +  + +++ +  D P+IVQ   +   +   ++ ++ ++     F          +
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV 121

Query: 247 FRED-LARIYTAEIVSAVSHLHANG-IMHRDLKPENILLDADGHVMLTDFGLAKQFDENT 304
             E+ L +I T   V A++HL  N  I+HRD+KP NILLD  G++ L DFG++ Q  ++ 
Sbjct: 122 IPEEILGKI-TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180

Query: 305 RSNSMCGTLEYMSPEIV----LGKGHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQ 359
                 G   YM+PE +      +G+D  +D WS+GI L+E+ TG+ P+    +      
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT 240

Query: 360 KIIKDKI-KLPAFL----SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
           +++K    +L        S    + +   L K+ SKR        +E+  H +  M
Sbjct: 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP-----KYKELLKHPFILM 291

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  165 bits (420), Expect = 1e-47
 Identities = 71/279 (25%), Positives = 137/279 (49%), Gaps = 25/279 (8%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNIL 204
           V  +D E +  +G+GA+  V ++R + + +I A+K +R       N  E   +  + +I 
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR----ATVNSQEQKRLLMDLDIS 59

Query: 205 TK-VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFF---QLYRQGLFRED-LARIYTAEI 259
            + VD PF V    +   +  +++ ++ ++     F    + +     ED L +I    I
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI-AVSI 118

Query: 260 VSAVSHLHANG-IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           V A+ HLH+   ++HRD+KP N+L++A G V + DFG++    ++   +   G   YM+P
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178

Query: 319 EIVLG----KGHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKI-KLPA-F 371
           E +      KG+   +D WS+GI + E+   + P+   G   +  ++++++   +LPA  
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238

Query: 372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
            S+E        L+K + +R    P    E+  H +F +
Sbjct: 239 FSAEFVDFTSQCLKKNSKER----P-TYPELMQHPFFTL 272

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  165 bits (421), Expect = 1e-47
 Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 4/203 (1%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           + + ++VG+G    VY+        I A+K+M +    +      M+ E     ++  P 
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 212 IVQLRYSF-QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           +V + + F +   +LY+ +  +NG  L   L RQG      A     +I SA+   HA G
Sbjct: 96  VVPI-HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDK 328
             HRD+KPENIL+ AD    L DFG+A    +   T+  +  GTL YM+PE         
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATY 214

Query: 329 AADWWSVGILLFEMLTGQPPFTG 351
            AD +++  +L+E LTG PP+ G
Sbjct: 215 RADIYALTCVLYECLTGSPPYQG 237

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  164 bits (417), Expect = 6e-47
 Identities = 76/277 (27%), Positives = 135/277 (48%), Gaps = 26/277 (9%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
             FE++++VG G + +VY+ R + T ++ A+KVM     +  +  E +K E N+L K   
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79

Query: 209 HPFIVQLRYSF------QTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIV 260
           H  I     +F          +L+LV++F   G +    +  +    +E+       EI+
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMSPE 319
             +SHLH + ++HRD+K +N+LL  +  V L DFG++ Q D    R N+  GT  +M+PE
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199

Query: 320 IVLGK-----GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KL-PAFL 372
           ++         +D  +D WS+GI   EM  G PP    +  +    I ++   +L     
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 259

Query: 373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           S +  S ++  L K  S+R    P  ++++  H + +
Sbjct: 260 SKKFQSFIESCLVKNHSQR----P-ATEQLMKHPFIR 291

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  160 bits (408), Expect = 6e-46
 Identities = 61/202 (30%), Positives = 110/202 (54%), Gaps = 2/202 (0%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           ++++  +G G  + VY       +   A+K +      ++   +  + E +  +++ H  
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           IV +    +     YLV++++ G  L   +   G    D A  +T +I+  + H H   I
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKA 329
           +HRD+KP+NIL+D++  + + DFG+AK   E   T++N + GT++Y SPE   G+  D+ 
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192

Query: 330 ADWWSVGILLFEMLTGQPPFTG 351
            D +S+GI+L+EML G+PPF G
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNG 214

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  162 bits (411), Expect = 6e-46
 Identities = 83/322 (25%), Positives = 134/322 (41%), Gaps = 51/322 (15%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ER 201
              +E +E L +VG+G++  V + R   T  I A+K     K +E +  + +K     E 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREI 75

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            +L ++ H  +V L    + K R YLV +FV+   L             + + Y  +I++
Sbjct: 76  KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN 135

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEI 320
            +   H++ I+HRD+KPENIL+   G V L DFG A+              T  Y +PE+
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195

Query: 321 VLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK-----------DKI 366
           ++G     KA D W++G L+ EM  G+P F G +   I Q   I+               
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS--DIDQLYHIMMCLGNLIPRHQELFN 253

Query: 367 KLPAF--------------------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHK 406
           K P F                    LS     L K  L  +  KR         E+  H 
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP-----FCAELLHHD 308

Query: 407 WFKMINWKKLEARETRPSFLPE 428
           +F+M  + +  ++E +     +
Sbjct: 309 FFQMDGFAERFSQELQLKVQKD 330

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  161 bits (410), Expect = 2e-45
 Identities = 57/290 (19%), Positives = 106/290 (36%), Gaps = 18/290 (6%)

Query: 150 EDFEVLKVVGQGA--FAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
             +E+L V+G+G      V   R   T E   ++ +  +         +++ E ++    
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLF 83

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGLFREDLARIYTAEIVSAVSH 265
           +HP IV  R +F     L++V  F+  G        +      E         ++ A+ +
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENTRSNSMC-------GTLEYMS 317
           +H  G +HR +K  +IL+  DG V L+             R   +          L ++S
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203

Query: 318 PEIV--LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSE 375
           PE++    +G+D  +D +SVGI   E+  G  PF      ++  + +         L   
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT---VPCLLDT 260

Query: 376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSF 425
           +    + L    +     SG   S    + +     +      R   P F
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  157 bits (399), Expect = 2e-44
 Identities = 79/315 (25%), Positives = 134/315 (42%), Gaps = 51/315 (16%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E +E +  +G+G++  V++ R   T +I A+K     K +E      +K     E  +L
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRML 56

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVS 264
            ++ HP +V L   F+ K RL+LV ++ +   L      Q    E L +  T + + AV+
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVN 116

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEIVLG 323
             H +  +HRD+KPENIL+     + L DFG A+     +        T  Y SPE+++G
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG 176

Query: 324 KGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK-----------DKIKLP 369
                   D W++G +  E+L+G P + G  +  + Q   I K                 
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPG--KSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234

Query: 370 AF--------------------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
            F                    +S  A  LLKG L  + ++RL       +++  H +F+
Sbjct: 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL-----TCEQLLHHPYFE 289

Query: 410 MINWKKLEARETRPS 424
            I   +  A+E    
Sbjct: 290 NIREIEDLAKEHDKP 304

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  156 bits (396), Expect = 5e-44
 Identities = 63/208 (30%), Positives = 113/208 (54%), Gaps = 8/208 (3%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 212 IVQL----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV +              Y+V+++V+G  L   ++ +G      A    A+   A++  H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG 323
            NGI+HRD+KP NI++ A   V + DFG+A+   ++    T++ ++ GT +Y+SPE   G
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 324 KGHDKAADWWSVGILLFEMLTGQPPFTG 351
              D  +D +S+G +L+E+LTG+PPFTG
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  155 bits (395), Expect = 5e-44
 Identities = 69/306 (22%), Positives = 115/306 (37%), Gaps = 51/306 (16%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-- 203
            +    +E +  +G GA+  VY+ R   +    A+K +R            + + R +  
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 204 ---LTKVDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGH---LFFQLYRQGLFREDLA 252
              L   +HP +V+L           + ++ LV + V+       +           +  
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--QDLRTYLDKAPPPGLPAETI 122

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT 312
           +    + +  +  LHAN I+HRDLKPENIL+ + G V L DFGLA+ +        +  T
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 182

Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK------- 363
           L Y +PE++L   +    D WSVG +  EM   +P F G +  +  Q  KI         
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--EADQLGKIFDLIGLPPE 240

Query: 364 ----DKIKLPAF----------------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIK 403
                 + LP                  +      LL  +L     KR+      +    
Sbjct: 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI-----SAFRAL 295

Query: 404 SHKWFK 409
            H +  
Sbjct: 296 QHSYLH 301

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  154 bits (390), Expect = 3e-43
 Identities = 55/246 (22%), Positives = 119/246 (48%), Gaps = 15/246 (6%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGT--SEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
             D  + + +G G+F  V++            A+K++ +     +   E+++ E  I+ +
Sbjct: 36  WCDLNIKEKIGAGSFGTVHR----AEWHGSDVAVKILMEQDFHAERVNEFLR-EVAIMKR 90

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFRE-DLARIYT--AEIVSAV 263
           + HP IV    +      L +V ++++ G L+  L++ G   + D  R  +   ++   +
Sbjct: 91  LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150

Query: 264 SHLHANG--IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-NSMCGTLEYMSPEI 320
           ++LH     I+HR+LK  N+L+D    V + DFGL++       S  S  GT E+M+PE+
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEV 210

Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLL 380
           +  +  ++ +D +S G++L+E+ T Q P+   N  ++   +     +L   +    +  +
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--IPRNLNPQV 268

Query: 381 KGLLQK 386
             +++ 
Sbjct: 269 AAIIEG 274

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  153 bits (388), Expect = 5e-43
 Identities = 71/253 (28%), Positives = 122/253 (48%), Gaps = 21/253 (8%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            ++ EV +VVG+GAF  V + +        A+K +  +   +     ++  E   L++V+
Sbjct: 7   YKEIEVEEVVGRGAFGVVCKAKWRAK--DVAIKQIESESERK----AFIV-ELRQLSRVN 59

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSH 265
           HP IV+L Y       + LV+++  GG L+  L+       +    A  +  +    V++
Sbjct: 60  HPNIVKL-YGACLN-PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 266 LHA---NGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
           LH+     ++HRDLKP N+LL A G V+ + DFG A   D  T   +  G+  +M+PE+ 
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVF 175

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTG--GNRQKIQQKIIKDK-IKLPAFLSSEAHS 378
            G  + +  D +S GI+L+E++T + PF    G   +I   +       L   L     S
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235

Query: 379 LLKGLLQKEASKR 391
           L+     K+ S+R
Sbjct: 236 LMTRCWSKDPSQR 248

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  160 bits (406), Expect = 7e-43
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 25/219 (11%)

Query: 152 FEVLKVVGQGAFAKVYQVR--RIGTSEIYAMKVMRKDKIMEKNHAEYMK---SERNILTK 206
           +EV   +  G    +Y      +    +  +K +          AE      +ER  L +
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPV-VLKGLVHS-----GDAEAQAMAMAERQFLAE 135

Query: 207 VDHPFIVQLRYSF------QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           V HP IVQ+ ++F            Y+V+++V G  L  +  +        A  Y  EI+
Sbjct: 136 VVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQKLPVAEAIAYLLEIL 192

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
            A+S+LH+ G+++ DLKPENI+L  +  + L D G   +         + GT  + +PEI
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI---NSFGYLYGTPGFQAPEI 248

Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ 359
           V   G   A D ++VG  L  +    P   G     + +
Sbjct: 249 VRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE 286

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  153 bits (390), Expect = 7e-43
 Identities = 76/324 (23%), Positives = 129/324 (39%), Gaps = 57/324 (17%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
            + +E L  +G+G FA VY+ R   T++I A+K ++          + +      E  +L
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLG--HRSEAKDGINRTALREIKLL 66

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNG---GHLFFQLYRQGLFREDLARIYTAEIVS 261
            ++ HP I+ L  +F  K  + LV DF+       +        +      + Y    + 
Sbjct: 67  QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQ 123

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEI 320
            + +LH + I+HRDLKP N+LLD +G + L DFGLAK F    R+ +    T  Y +PE+
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query: 321 VLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK------DKI----- 366
           + G + +    D W+VG +L E+L   P   G     + Q  +I +      ++      
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPG--DSDLDQLTRIFETLGTPTEEQWPDMC 241

Query: 367 KLPAF-----------------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
            LP +                    +   L++GL       R+      + +    K+F 
Sbjct: 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI-----TATQALKMKYFS 296

Query: 410 MINWKKLEARETRPSFLPEVAGKH 433
                      T    LP      
Sbjct: 297 N------RPGPTPGCQLPRPNCPV 314

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  151 bits (383), Expect = 5e-42
 Identities = 77/307 (25%), Positives = 132/307 (42%), Gaps = 60/307 (19%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNILT 205
             F+ L+ +G G +A VY+     T    A+K ++    ++    E   S    E +++ 
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK----LDSE--EGTPSTAIREISLMK 58

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVN---GGHL--FFQLYRQGLFREDLARIYTAEIV 260
           ++ H  IV+L     T+ +L LV +F++     ++              +L + +  +++
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPE 319
             ++  H N I+HRDLKP+N+L++  G + L DFGLA+ F     + S    TL Y +P+
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178

Query: 320 IVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK-----------DK 365
           +++G + +  + D WS G +L EM+TG+P F G N    +Q   I               
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN--DEEQLKLIFDIMGTPNESLWPSV 236

Query: 366 IKLPAF-----------------------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEI 402
            KLP +                       L       L GLLQ     RL      +++ 
Sbjct: 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL-----SAKQA 291

Query: 403 KSHKWFK 409
             H WF 
Sbjct: 292 LHHPWFA 298

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  150 bits (381), Expect = 1e-41
 Identities = 74/302 (24%), Positives = 129/302 (42%), Gaps = 57/302 (18%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E +  L  +G+G +A VY+ +   T  + A+K +R    +E  H E        E ++L
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR----LE--HEEGAPCTAIREVSLL 54

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVN---GGHLFFQLYRQGLFREDLARIYTAEIVS 261
             + H  IV L     T+  L LV ++++     +L        +      +++  +++ 
Sbjct: 55  KDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYL---DDCGNIINMHNVKLFLFQLLR 111

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEI 320
            +++ H   ++HRDLKP+N+L++  G + L DFGLA+     T++      TL Y  P+I
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171

Query: 321 VLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK-----------DKI 366
           +LG   +    D W VG + +EM TG+P F G      +Q   I +             +
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST--VEEQLHFIFRILGTPTEETWPGIL 229

Query: 367 KLPAF-------------------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKW 407
               F                   L S+   LL  LLQ E   R+      +++   H +
Sbjct: 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI-----SAEDAMKHPF 284

Query: 408 FK 409
           F 
Sbjct: 285 FL 286

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  150 bits (380), Expect = 2e-41
 Identities = 71/336 (21%), Positives = 130/336 (38%), Gaps = 73/336 (21%)

Query: 142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRI-GTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
            +  C   + +E +  +G+GA+ KV++ R +       A+K +R            +++ 
Sbjct: 3   KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------------VQTG 50

Query: 201 ---------RNI-----LTKVDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGH---LF 238
                    R +     L   +HP +V+L           + +L LV + V+       +
Sbjct: 51  EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--QDLTTY 108

Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
                +     +  +    +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+
Sbjct: 109 LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

Query: 299 QFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ 358
            +       S+  TL Y +PE++L   +    D WSVG +  EM   +P F G +   + 
Sbjct: 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVD 226

Query: 359 Q--KIIK-----------DKIKLPAF----------------LSSEAHSLLKGLLQKEAS 389
           Q  KI+              + LP                  +      LL   L    +
Sbjct: 227 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 286

Query: 390 KRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSF 425
           KR+      +    SH +F+ +   K       P  
Sbjct: 287 KRI-----SAYSALSHPYFQDLERCKENLDSHLPPS 317

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  148 bits (377), Expect = 4e-41
 Identities = 70/315 (22%), Positives = 135/315 (42%), Gaps = 58/315 (18%)

Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK 198
           ++ +      ++ +  +  +G+G + +VY+     T+E  A+K +R +   E+   E + 
Sbjct: 23  SVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH--EE---EGVP 77

Query: 199 S----ERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH-LFFQLYRQGLFREDLAR 253
                E ++L ++ H  I++L+      +RL+L+ ++    + L   + +       + +
Sbjct: 78  GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE--NDLKKYMDKNPDVSMRVIK 135

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDA-----DGHVMLTDFGLAKQFDENTRSNS 308
            +  ++++ V+  H+   +HRDLKP+N+LL          + + DFGLA+ F    R  +
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195

Query: 309 M-CGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK- 363
               TL Y  PEI+LG + +  + D WS+  +  EML   P F G    +I Q  KI + 
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG--DSEIDQLFKIFEV 253

Query: 364 ----------DKIKLPAF-------------------LSSEAHSLLKGLLQKEASKRLGS 394
                         LP +                   L  E   LL  +L+ +  KR+  
Sbjct: 254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI-- 311

Query: 395 GPGGSQEIKSHKWFK 409
               ++    H +F 
Sbjct: 312 ---SAKNALEHPYFS 323

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  147 bits (373), Expect = 6e-41
 Identities = 77/304 (25%), Positives = 143/304 (47%), Gaps = 56/304 (18%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E +  L+ +G+G +  VY+ +     E +A+K +R +K  E    E + S    E +IL
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK--ED---EGIPSTTIREISIL 54

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVN---GGHLFFQLYRQGLFREDLARIYTAEIVS 261
            ++ H  IV+L     TK RL LV + ++      L      +G      A+ +  ++++
Sbjct: 55  KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLN 111

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEI 320
            +++ H   ++HRDLKP+N+L++ +G + + DFGLA+ F    R  +    TL Y +P++
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

Query: 321 VLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK-----------DKI 366
           ++G K +    D WSVG +  EM+ G P F G +  +  Q  +I +           +  
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNWPNVT 229

Query: 367 KLPAF------------------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
           +LP +                  L      LL  +L+ + ++R+      +++   H +F
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI-----TAKQALEHAYF 284

Query: 409 KMIN 412
           K  N
Sbjct: 285 KENN 288

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  147 bits (373), Expect = 9e-41
 Identities = 83/302 (27%), Positives = 142/302 (47%), Gaps = 57/302 (18%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           +E ++ L+ VG+G +  VY+ +      I A+K +R D   E    E + S    E ++L
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA--ED---EGIPSTAIREISLL 73

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVN---GGHLFFQLYRQGLFREDLARIYTAEIVS 261
            ++ HP IV L     ++  L LV +F+       L      +   ++   +IY  +++ 
Sbjct: 74  KELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVL---DENKTGLQDSQIKIYLYQLLR 130

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEI 320
            V+H H + I+HRDLKP+N+L+++DG + L DFGLA+ F    RS +    TL Y +P++
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190

Query: 321 VLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK-----------DKI 366
           ++G K +  + D WS+G +  EM+TG+P F G       Q  KI                
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG--VTDDDQLPKIFSILGTPNPREWPQVQ 248

Query: 367 KLPAF-------------------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKW 407
           +LP +                      E   LL  +L  + +KR+      +++  +H +
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI-----SARDAMNHPY 303

Query: 408 FK 409
           FK
Sbjct: 304 FK 305

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  146 bits (371), Expect = 1e-40
 Identities = 55/263 (20%), Positives = 117/263 (44%), Gaps = 26/263 (9%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYM----KSERNIL 204
             + E  K +G+G F  V++ R +    + A+K +       +          + E  I+
Sbjct: 18  DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAV 263
           + ++HP IV+L Y         +V++FV  G L+ +L  +    +  +      +I   +
Sbjct: 78  SNLNHPNIVKL-YGLMHN-PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135

Query: 264 SHLHANG--IMHRDLKPENILLDADG-----HVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
            ++      I+HRDL+  NI L +          + DFGL++        + + G  ++M
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWM 193

Query: 317 SPEIVLGKG--HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ--QKIIKDKIKLPAFL 372
           +PE +  +   + + AD +S  ++L+ +LTG+ PF   +  KI+    I ++ ++    +
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT--I 251

Query: 373 SSEAHSLLKGLLQK----EASKR 391
             +    L+ +++     +  KR
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKR 274

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  146 bits (371), Expect = 1e-40
 Identities = 73/301 (24%), Positives = 135/301 (44%), Gaps = 54/301 (17%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ERNIL 204
           ++ +E L+ +G+G +  V++ +   T EI A+K +R D   +    E + S    E  +L
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DD---EGVPSSALREICLL 55

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNG--GHLFFQLYRQGLFREDLARIYTAEIVSA 262
            ++ H  IV+L     +  +L LV +F +      F      G    ++ + +  +++  
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKG 113

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS-MCGTLEYMSPEIV 321
           +   H+  ++HRDLKP+N+L++ +G + L +FGLA+ F    R  S    TL Y  P+++
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 322 LG-KGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQ--KIIK-----------DKI 366
            G K +  + D WS G +  E+   G+P F G +     Q  +I +              
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMT 231

Query: 367 KLPAF------------------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF 408
           KLP +                  L++    LL+ LL+    +R+      ++E   H +F
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI-----SAEEALQHPYF 286

Query: 409 K 409
            
Sbjct: 287 S 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  145 bits (367), Expect = 3e-40
 Identities = 64/255 (25%), Positives = 117/255 (45%), Gaps = 18/255 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
               V + +G G+F  VY+ +  G     A+K++       +    + K+E  +L K  H
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAF-KNEVGVLRKTRH 79

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHA 268
             I+     + T  +L +V  +  G  L+  L+     F          +    + +LHA
Sbjct: 80  VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM---CGTLEYMSPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA +    + S+      G++ +M+PE++  + 
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 326 H---DKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIK-----DKIKLPAFLSSEA 376
                  +D ++ GI+L+E++TGQ P++   NR +I + + +     D  K+ +      
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258

Query: 377 HSLLKGLLQKEASKR 391
             L+   L+K+  +R
Sbjct: 259 KRLMAECLKKKRDER 273

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  146 bits (371), Expect = 5e-40
 Identities = 74/344 (21%), Positives = 122/344 (35%), Gaps = 76/344 (22%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS----ER 201
           C  +  +E L  +GQG F +V++ R   T +  A+K +  +   EK   E        E 
Sbjct: 13  CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EK---EGFPITALREI 67

Query: 202 NILTKVDHPFIVQLR--------YSFQTKYRLYLVLDFVN---GGHLFFQLYRQGLFRED 250
            IL  + H  +V L            + K  +YLV DF      G L         F   
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL---SNVLVKFTLS 124

Query: 251 LARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC 310
             +     +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F     S    
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 311 G-----TLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KII 362
                 TL Y  PE++LG + +    D W  G ++ EM T  P   G    +  Q   I 
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG--NTEQHQLALIS 242

Query: 363 K-----------DKIKLPAF---------------------LSSEAHSLLKGLLQKEASK 390
           +           +      +                         A  L+  LL  + ++
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302

Query: 391 RLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHC 434
           R+      S +  +H +F        +   +    +        
Sbjct: 303 RI-----DSDDALNHDFFWS------DPMPSDLKGMLSTHLTSM 335

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  141 bits (359), Expect = 3e-39
 Identities = 46/254 (18%), Positives = 105/254 (41%), Gaps = 18/254 (7%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            +    L  + +    ++++ R  G  +I  +KV++      +   ++ + E   L    
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRWQGN-DI-VVKVLKVRDWSTRKSRDFNE-ECPRLRIFS 65

Query: 209 HPFIVQLR--YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYT--AEIVSAVS 264
           HP ++ +             L+  ++  G L+  L+    F  D ++      ++   ++
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125

Query: 265 HLHA--NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
            LH     I    L   ++++D D    ++   +   F    R         +++PE + 
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR----MYAPAWVAPEALQ 181

Query: 323 GKGHD---KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI--KLPAFLSSEAH 377
            K  D   ++AD WS  +LL+E++T + PF   +  +I  K+  + +   +P  +S    
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVS 241

Query: 378 SLLKGLLQKEASKR 391
            L+K  + ++ +KR
Sbjct: 242 KLMKICMNEDPAKR 255

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  145 bits (367), Expect = 6e-39
 Identities = 76/273 (27%), Positives = 126/273 (46%), Gaps = 36/273 (13%)

Query: 113 NEETQEGPNNLSVVDAALGKPTGHIDNLPSENQCVGLED----FEVLKVVGQGAFAKVYQ 168
           + +  + P+    +  +  K    +  + +             +   KV+G G+F  VYQ
Sbjct: 13  SCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQ 72

Query: 169 VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR---- 224
            +   + E+ A+K     K+       +   E  I+ K+DH  IV+LRY F +       
Sbjct: 73  AKLCDSGELVAIK-----KV--LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125

Query: 225 --LYLVLDFVNGGHLFFQLYR--------QGLFREDLARIYTAEIVSAVSHLHANGIMHR 274
             L LVLD+V        +YR        +        ++Y  ++  +++++H+ GI HR
Sbjct: 126 VYLNLVLDYVPE-----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 180

Query: 275 DLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADW 332
           D+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE++ G   +  + D 
Sbjct: 181 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 240

Query: 333 WSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
           WS G +L E+L GQP F G     + Q  +IIK
Sbjct: 241 WSAGCVLAELLLGQPIFPG--DSGVDQLVEIIK 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  142 bits (359), Expect = 1e-38
 Identities = 55/254 (21%), Positives = 106/254 (41%), Gaps = 23/254 (9%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            E  E+ +++G+G F +VY  R  G     A++++  ++  E     + K E     +  
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAF-KREVMAYRQTR 87

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLH 267
           H  +V    +  +   L ++     G  L+  +    +    +  R    EIV  + +LH
Sbjct: 88  HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAK---QFDENTRSNSM---CGTLEYMSPEIV 321
           A GI+H+DLK +N+  D +G V++TDFGL           R + +    G L +++PEI+
Sbjct: 148 AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 322 ---------LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFL 372
                          K +D +++G + +E+   + PF     + I  ++       P   
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG--MKPNLS 264

Query: 373 SSEAHSLLKGLLQK 386
                  +  +L  
Sbjct: 265 QIGMGKEISDILLF 278

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  139 bits (353), Expect = 3e-38
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 22/259 (8%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKV 207
             +  + +++G G F KVY+   IG     A+K  R D   +     E ++ E  +   +
Sbjct: 6   FAELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
            HP I+ LR     +  L LV++F  GG L   L  + +  + L      +I   +++LH
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW-AVQIARGMNYLH 122

Query: 268 ANG---IMHRDLKPENILLDADGH--------VMLTDFGLAKQFDENTRSNSMCGTLEYM 316
                 I+HRDLK  NIL+             + +TDFGLA+++   T+  S  G   +M
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-SAAGAYAWM 181

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEA 376
           +PE++      K +D WS G+LL+E+LTG+ PF G +   +   +  +K+ LP  + S  
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP--IPSTC 239

Query: 377 HSLLKGLLQK----EASKR 391
                 L++     +   R
Sbjct: 240 PEPFAKLMEDCWNPDPHSR 258

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  139 bits (353), Expect = 6e-38
 Identities = 50/238 (21%), Positives = 102/238 (42%), Gaps = 20/238 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            D    +V+G+G F +  +V    T E+  MK + +     +        E  ++  ++H
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCLEH 66

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE-IVSAVSHLHA 268
           P +++         RL  + +++ GG L   +           R+  A+ I S +++LH+
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---------------RSNSMCGTL 313
             I+HRDL   N L+  + +V++ DFGLA+   +                 +  ++ G  
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKDKIKLPA 370
            +M+PE++ G+ +D+  D +S GI+L E++           R       ++  +    
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  141 bits (357), Expect = 9e-38
 Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 33/230 (14%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +   KV+G G+F  V+Q + + + E+ A+K + +DK        +   E  I+  V HP 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDK-------RFKNRELQIMRIVKHPN 93

Query: 212 IVQLRYSFQT------KYRLYLVLDFVNGGHLFFQLYR--------QGLFREDLARIYTA 257
           +V L+  F +      +  L LVL++V        +YR        +      L ++Y  
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-----TVYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYM 316
           +++ +++++H+ GI HRD+KP+N+LLD    V+ L DFG AK       + S   +  Y 
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208

Query: 317 SPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
           +PE++ G   +    D WS G ++ E++ GQP F G     I Q  +IIK
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG--ESGIDQLVEIIK 256

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  134 bits (339), Expect = 6e-36
 Identities = 50/226 (22%), Positives = 93/226 (41%), Gaps = 33/226 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKV 207
              ++L+V  +G F  V++ + +   E  A+K      I      +  ++E  +  L  +
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQLLN--EYVAVK------IFPIQDKQSWQNEYEVYSLPGM 75

Query: 208 DHPFIVQL----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
            H  I+Q     +        L+L+  F   G L   L    +   +L  I    +   +
Sbjct: 76  KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAE-TMARGL 134

Query: 264 SHLHAN----------GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM---C 310
           ++LH +           I HRD+K +N+LL  +    + DFGLA +F+    +       
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194

Query: 311 GTLEYMSPE-----IVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           GT  YM+PE     I   +      D +++G++L+E+ +      G
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  131 bits (332), Expect = 1e-34
 Identities = 58/243 (23%), Positives = 98/243 (40%), Gaps = 34/243 (13%)

Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           LP   Q    +  +++K +G+G + +V+  +  G  E  A+KV                 
Sbjct: 27  LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRG--EKVAVKVFFTT------EEASWFR 78

Query: 200 ERNI--LTKVDHPFIVQL----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
           E  I     + H  I+           +  +LYL+ D+   G L+  L    L  + + +
Sbjct: 79  ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLK 138

Query: 254 IYTAEIVSAVSHLHA--------NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
           +     VS + HLH           I HRDLK +NIL+  +G   + D GLA +F  +T 
Sbjct: 139 L-AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197

Query: 306 -----SNSMCGTLEYMSPEIVLGKGH------DKAADWWSVGILLFEMLTGQPPFTGGNR 354
                 N+  GT  YM PE++    +         AD +S G++L+E+            
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257

Query: 355 QKI 357
            ++
Sbjct: 258 YQL 260

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  130 bits (329), Expect = 1e-34
 Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 34/233 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI--LTKV 207
            D  +L+ VG+G + +V++    G  E  A+K+            +    E  +     +
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQG--ENVAVKIFSSR------DEKSWFRETELYNTVML 59

Query: 208 DHPFIVQL----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
            H  I+        S  +  +L+L+  +   G L+  L    L      RI    I S +
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLSIASGL 118

Query: 264 SHLHA--------NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-----RSNSMC 310
           +HLH           I HRDLK +NIL+  +G   + D GLA    ++T      +N   
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 311 GTLEYMSPEIVLGK------GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI 357
           GT  YM+PE++            K  D W+ G++L+E+             K 
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  131 bits (331), Expect = 3e-34
 Identities = 63/237 (26%), Positives = 111/237 (46%), Gaps = 34/237 (14%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ F+V ++ GQG F  V   +   T    A+K + +D        + M+     L  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAVLH 77

Query: 209 HPFIVQLRYSFQTKYR-------LYLVLDFVNGGHLFFQLYR---------QGLFREDLA 252
           HP IVQL+  F T          L +V+++V        L+R                L 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-----TLHRCCRNYYRRQVAP-PPILI 131

Query: 253 RIYTAEIVSAVSHLHAN--GIMHRDLKPENILLD-ADGHVMLTDFGLAKQFDENTRSNSM 309
           +++  +++ ++  LH     + HRD+KP N+L++ ADG + L DFG AK+   +  + + 
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191

Query: 310 CGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KIIK 363
             +  Y +PE++ G + +  A D WSVG +  EM+ G+P F G       Q  +I++
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG--DNSAGQLHEIVR 246

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  132 bits (333), Expect = 3e-34
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 31/219 (14%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---- 207
           +EVLKV+G+G+F +V +       +  A+K++R +K            E  IL  +    
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF----HRQAAEEIRILEHLRKQD 154

Query: 208 --DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFR---EDLARIYTAEIVSA 262
             +   ++ +  +F   +R ++ + F       ++L ++  F+     L R +   I+  
Sbjct: 155 KDNTMNVIHMLENFT--FRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212

Query: 263 VSHLHANGIMHRDLKPENILLDADGH--VMLTDFGLAKQFDEN------TRSNSMCGTLE 314
           +  LH N I+H DLKPENILL   G   + + DFG +    +       +R         
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-------- 264

Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           Y +PE++LG  +    D WS+G +L E+LTG P   G +
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  129 bits (325), Expect = 8e-34
 Identities = 58/243 (23%), Positives = 96/243 (39%), Gaps = 34/243 (13%)

Query: 140 LPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS 199
           LP   Q        + + +G+G F +V++ +  G  E  A+K+                 
Sbjct: 32  LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSR------EERSWFR 83

Query: 200 ERNI--LTKVDHPFIVQL----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
           E  I     + H  I+           T  +L+LV D+   G LF  L R  +  E + +
Sbjct: 84  EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK 143

Query: 254 IYTAEIVSAVSHLHAN--------GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
           +      S ++HLH           I HRDLK +NIL+  +G   + D GLA + D  T 
Sbjct: 144 L-ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202

Query: 306 -----SNSMCGTLEYMSPEIVLGKG------HDKAADWWSVGILLFEMLTGQPPFTGGNR 354
                 N   GT  YM+PE++            K AD +++G++ +E+            
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262

Query: 355 QKI 357
            ++
Sbjct: 263 YQL 265

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  129 bits (326), Expect = 1e-33
 Identities = 62/265 (23%), Positives = 117/265 (44%), Gaps = 66/265 (24%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + + + K +G G+F  V +V  I + + +A+K     K++      Y   E +I+  +DH
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVL--QDPRYKNRELDIMKVLDH 59

Query: 210 PFIVQLRYSFQTKYR--------------------------------------LYLVLDF 231
             I++L   F T                                         L +++++
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 232 VNGGHLFFQLYR---------QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL 282
           V        L++         + +   +L  IY  ++  AV  +H+ GI HRD+KP+N+L
Sbjct: 120 VPD-----TLHKVLKSFIRSGRSI-PMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173

Query: 283 LDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLF 340
           +++  + + L DFG AK+   +  S +   +  Y +PE++LG      + D WS+G +  
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233

Query: 341 EMLTGQPPFTGGNRQKIQQ--KIIK 363
           E++ G+P F+G     I Q  +II+
Sbjct: 234 ELILGKPLFSG--ETSIDQLVRIIQ 256

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  129 bits (325), Expect = 3e-33
 Identities = 73/332 (21%), Positives = 127/332 (38%), Gaps = 79/332 (23%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
              L ++E  KV G+G +  VY+ +R      + YA+K +    I      E       +
Sbjct: 18  VEDLFEYEGCKV-GRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA-----L 71

Query: 204 LTKVDHPFIVQLR--YSFQTKYRLYLVLDFV--------NGGHLFFQLYRQGLFREDLAR 253
           L ++ HP ++ L+  +      +++L+ D+                   +       + +
Sbjct: 72  LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDAD----GHVMLTDFGLAKQFDENTRSNSM 309
               +I+  + +LHAN ++HRDLKP NIL+  +    G V + D G A+ F+   +  + 
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 310 CG----TLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTG-------GNRQKI 357
                 T  Y +PE++LG  H  KA D W++G +  E+LT +P F          N    
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251

Query: 358 QQ--KIIK-----------DKIKLPAF---------------------------LSSEAH 377
            Q  +I             D  K+P                               S+A 
Sbjct: 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 311

Query: 378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
            LL+ LL  +  KR+      S++     +F 
Sbjct: 312 HLLQKLLTMDPIKRI-----TSEQAMQDPYFL 338

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  126 bits (317), Expect = 1e-32
 Identities = 50/231 (21%), Positives = 100/231 (43%), Gaps = 45/231 (19%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGT--SEIYAMKVMRKDKIMEKNHAEYMKSERNI--L 204
           L++ ++L+++G+G +  VY+    G+      A+KV          + +   +E+NI  +
Sbjct: 12  LDNLKLLELIGRGRYGAVYK----GSLDERPVAVKVFSF------ANRQNFINEKNIYRV 61

Query: 205 TKVDHPFIVQL-----RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEI 259
             ++H  I +      R +   +    LV+++   G L   L           R+    +
Sbjct: 62  PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-AHSV 120

Query: 260 VSAVSHLHA---------NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR----- 305
              +++LH            I HRDL   N+L+  DG  +++DFGL+ +   N       
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180

Query: 306 ----SNSMCGTLEYMSPEIVLG-------KGHDKAADWWSVGILLFEMLTG 345
               + S  GT+ YM+PE++ G       +   K  D +++G++ +E+   
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  121 bits (304), Expect = 3e-31
 Identities = 28/202 (13%), Positives = 62/202 (30%), Gaps = 28/202 (13%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           + +L   G     + +Q          A+  +    ++  +  +   S    L+++D P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 212 IVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           + ++     T+    +V +++ GG L  ++           R     + +A    H  G+
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQ-EVADTSPSPVGAIRA-MQSLAAAADAAHRAGV 150

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAAD 331
                 P  + +  DG V+L                        M          +   D
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPDA-------NPQDD 184

Query: 332 WWSVGILLFEMLTGQPPFTGGN 353
              +G  L+ +L  + P     
Sbjct: 185 IRGIGASLYALLVNRWPLPEAG 206

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  122 bits (309), Expect = 3e-31
 Identities = 56/223 (25%), Positives = 105/223 (47%), Gaps = 29/223 (13%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---- 207
           + +++ +G G F+ V+  + +  +   AMK++R DK+  +      + E  +L +V    
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVNDAD 76

Query: 208 -------DHPFIVQLRYSFQTK--YRLYLVLDF-VNGGHLFFQL--YRQGLFREDLARIY 255
                      I++L   F  K    +++V+ F V G +L   +  Y          +  
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136

Query: 256 TAEIVSAVSHLHAN-GIMHRDLKPENILLD------ADGHVMLTDFGLAKQFDENTRSNS 308
           + +++  + ++H   GI+H D+KPEN+L++          + + D G A  + +   +NS
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHYTNS 195

Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           +  T EY SPE++LG      AD WS   L+FE++TG   F  
Sbjct: 196 IQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  121 bits (305), Expect = 6e-31
 Identities = 56/205 (27%), Positives = 106/205 (51%), Gaps = 14/205 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
           +D+++++ +G+G +++V++   I  +E   +K+++  K       + +K E  IL  +  
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRG 89

Query: 209 HPFIVQLRYSFQ--TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            P I+ L    +        LV + VN    F QLY+     +   R Y  EI+ A+ + 
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNT-DFKQLYQT--LTDYDIRFYMYEILKALDYC 146

Query: 267 HANGIMHRDLKPENILLD-ADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-K 324
           H+ GIMHRD+KP N+++D     + L D+GLA+ +      N    +  +  PE+++  +
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 325 GHDKAADWWSVGILLFEMLTGQPPF 349
            +D + D WS+G +L  M+  + PF
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  122 bits (308), Expect = 1e-30
 Identities = 61/254 (24%), Positives = 112/254 (44%), Gaps = 24/254 (9%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNIL 204
           L+ ++ LK +G GA   V            A+K     K+      + HA+    E  ++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK-----KLSRPFQNQTHAKRAYRELVLM 115

Query: 205 TKVDHPFIVQLRYSFQTKYR------LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
             V+H  I+ L   F  +        +YLV++ +       Q+ +  L   +       +
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL-DHERMSYLLYQ 172

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSP 318
           ++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +P
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-----AFLS 373
           E++LG G+ +  D WSVG ++ EM+  +  F G +    Q   + +++  P       L 
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKKLQ 291

Query: 374 SEAHSLLKGLLQKE 387
               + ++   +  
Sbjct: 292 PTVRNYVENRPKYA 305

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  120 bits (303), Expect = 2e-30
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 33/221 (14%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---- 207
           +E+  ++G+G+F +V +       E  A+K+++  K          + E  +L  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF----LNQAQIEVRLLELMNKHD 111

Query: 208 --DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFR---EDLARIYTAEIVSA 262
                +IV L+  F   +R +L L F    +  + L R   FR    +L R +  ++ +A
Sbjct: 112 TEMKYYIVHLKRHFM--FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169

Query: 263 VSHLHAN--GIMHRDLKPENILLDADGH--VMLTDFGLAKQFDEN------TRSNSMCGT 312
           +  L      I+H DLKPENILL       + + DFG + Q  +       +R       
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------ 223

Query: 313 LEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
             Y SPE++LG  +D A D WS+G +L EM TG+P F+G N
Sbjct: 224 --YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  118 bits (298), Expect = 9e-30
 Identities = 61/255 (23%), Positives = 113/255 (44%), Gaps = 26/255 (10%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNIL 204
           L+ ++ LK +G GA   V            A+K     K+      + HA+    E  ++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRAYRELVLM 78

Query: 205 TKVDHPFIVQLRYSFQTKYR------LYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTA 257
             V+H  I+ L   F  +        +Y+V++ ++       Q+ +  L   +       
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC---QVIQMEL-DHERMSYLLY 134

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
           +++  + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-----AFL 372
           PE++LG G+ +  D WSVG ++ EM+ G   F G +    Q   + +++  P       L
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKKL 253

Query: 373 SSEAHSLLKGLLQKE 387
                + ++   +  
Sbjct: 254 QPTVRTYVENRPKYA 268

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  115 bits (289), Expect = 1e-28
 Identities = 63/251 (25%), Positives = 94/251 (37%), Gaps = 73/251 (29%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---- 207
           F V++ +G G F +V   + I   + YA+KV+R  K          K E +IL K+    
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY----TRSAKIEADILKKIQNDD 92

Query: 208 -DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGL-----------FREDLAR 253
            ++  IV+    F   Y            H+   F+     L           F  +  +
Sbjct: 93  INNNNIVKYHGKFM--YY----------DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK 140

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLT--------------------- 292
           +Y  EI+ A+++L    + H DLKPENILLD                             
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200

Query: 293 ----DFGLAKQFDEN------TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEM 342
               DFG A    +       TR         Y +PE++L  G D ++D WS G +L E+
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTRQ--------YRAPEVILNLGWDVSSDMWSFGCVLAEL 252

Query: 343 LTGQPPFTGGN 353
            TG   F    
Sbjct: 253 YTGSLLFRTHE 263

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  114 bits (288), Expect = 1e-28
 Identities = 50/239 (20%), Positives = 84/239 (35%), Gaps = 53/239 (22%)

Query: 152 FEVLKVVGQGAFAKVYQVR-RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV--- 207
           +E++  +G+G F KV +           A+K++R          E  + E N+L K+   
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY----REAARLEINVLKKIKEK 76

Query: 208 ---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGL-----------FREDL 251
              +    V +   F   +           GH+   F+L  +             +    
Sbjct: 77  DKENKFLCVLMSDWFN--FH----------GHMCIAFELLGKNTFEFLKENNFQPYPLPH 124

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN---- 307
            R    ++  A+  LH N + H DLKPENIL        L +   + +      ++    
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184

Query: 308 ---SMCGTLEYM----------SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
              S     E+            PE++L  G  +  D WS+G +LFE   G   F    
Sbjct: 185 DFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  113 bits (285), Expect = 3e-28
 Identities = 53/239 (22%), Positives = 88/239 (36%), Gaps = 53/239 (22%)

Query: 152 FEVLKVVGQGAFAKVYQVR-RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV--- 207
           +E++  +G+GAF KV +           A+K+++          E  +SE  +L  +   
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY----CEAARSEIQVLEHLNTT 71

Query: 208 ---DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF--FQLYRQGL-----------FREDL 251
                   VQ+   F+  +           GH+   F+L                FR D 
Sbjct: 72  DPNSTFRCVQMLEWFE--HH----------GHICIVFELLGLSTYDFIKENGFLPFRLDH 119

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN---- 307
            R    +I  +V+ LH+N + H DLKPENIL     +    +  + +        +    
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179

Query: 308 ---SMCGTLEYMS----------PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
              S     E+ S          PE++L  G  +  D WS+G +L E   G   F   +
Sbjct: 180 DFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  110 bits (277), Expect = 5e-27
 Identities = 63/259 (24%), Positives = 111/259 (42%), Gaps = 36/259 (13%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILT 205
           + +     VG GA+  V       + E  A+K     K+      +  A+    E  +L 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-----KLSRPFQSEIFAKRAYRELLLLK 78

Query: 206 KVDHPFIVQLRYSFQTKYR------LYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAE 258
            + H  ++ L   F            YLV+ F+        ++       E+  +    +
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQ---KIMGLKF-SEEKIQYLVYQ 134

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEY 315
           ++  + ++H+ G++HRDLKP N+ ++ D  + + DFGLA+  D       M G   T  Y
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWY 189

Query: 316 MSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----- 369
            +PE++L    +++  D WSVG ++ EMLTG+  F G +    Q   I     +P     
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFV 248

Query: 370 AFLSSE-AHSLLKGLLQKE 387
             L+ + A S ++ L Q  
Sbjct: 249 QKLNDKAAKSYIQSLPQTP 267

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  108 bits (273), Expect = 2e-26
 Identities = 59/238 (24%), Positives = 103/238 (43%), Gaps = 53/238 (22%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILT 205
             DF++  ++G+GA+  V       T EI A+K     KI   +   +      E  IL 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----KIEPFDKPLFALRTLREIKILK 64

Query: 206 KVDHPFIVQLRYSFQTKYR-----LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
              H  I+ +    +         +Y++ +               L + DL R+ + +++
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQE---------------LMQTDLHRVISTQML 109

Query: 261 S-------------AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN 307
           S             AV  LH + ++HRDLKP N+L++++  + + DFGLA+  DE+   N
Sbjct: 110 SDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169

Query: 308 SMCGTLE-----------YMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
           S     +           Y +PE++L    + +A D WS G +L E+   +P F G +
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  108 bits (271), Expect = 4e-26
 Identities = 62/242 (25%), Positives = 100/242 (41%), Gaps = 50/242 (20%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---ERNILTK 206
             +  L  +G+GA+  V            A+K     KI    H  Y +    E  IL +
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLR 81

Query: 207 VDHPFIVQLRYSFQTKYR-----LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
             H  I+ +    +         +Y+V D               L   DL ++   + +S
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQD---------------LMETDLYKLLKTQHLS 126

Query: 262 -------------AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS 308
                         + ++H+  ++HRDLKP N+LL+    + + DFGLA+  D +     
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186

Query: 309 M----CGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--KI 361
                  T  Y +PEI+L  KG+ K+ D WSVG +L EML+ +P F G +   + Q   I
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNHI 244

Query: 362 IK 363
           + 
Sbjct: 245 LG 246

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  106 bits (267), Expect = 7e-26
 Identities = 60/267 (22%), Positives = 115/267 (43%), Gaps = 37/267 (13%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTK 206
              +  LK +G G    V+        +  A+K     KI+  +    ++   E  I+ +
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRR 64

Query: 207 VDHPFIVQLR--------------YSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDL 251
           +DH  IV++                S      +Y+V +++         +  QG   E+ 
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA---NVLEQGPLLEEH 121

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENTRSNSM- 309
           AR++  +++  + ++H+  ++HRDLKP N+ ++  D  + + DFGLA+  D +       
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181

Query: 310 ---CGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK 365
                T  Y SP ++L    + KA D W+ G +  EMLTG+  F G +  + Q ++I + 
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILES 240

Query: 366 IKLP-----AFLSSEAHSLLKGLLQKE 387
           I +        L S     ++  + + 
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEP 267

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  107 bits (268), Expect = 1e-25
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 28/229 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILT 205
             +  L+ VG GA+  V       T    A+K     K+      +  A+    E  +L 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLK 79

Query: 206 KVDHPFIVQLRYSFQTKYR------LYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAE 258
            + H  ++ L   F            YLV+ F+        +L +     ED  +    +
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG---KLMKHEKLGEDRIQFLVYQ 136

Query: 259 IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEY 315
           ++  + ++HA GI+HRDLKP N+ ++ D  + + DFGLA+Q D     + M G   T  Y
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEMTGYVVTRWY 191

Query: 316 MSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
            +PE++L    + +  D WSVG ++ EM+TG+  F G +     ++I+K
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  105 bits (264), Expect = 4e-25
 Identities = 50/228 (21%), Positives = 84/228 (36%), Gaps = 35/228 (15%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKS---------- 199
             + V + +  G++  V            A+K     ++          +          
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVD-SEGIPVAIK-----RVFNTVSDGRTVNILSDSFLCKR 75

Query: 200 ---ERNILTKVDHPFIVQLRYSFQTKYR-----LYLVLDFVNGGHLFFQLYR-----QGL 246
              E  +L    HP I+ LR  F          LYLV + +        L +     + +
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQRIV 130

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS 306
                 + +   I+  +  LH  G++HRDL P NILL  +  + + DF LA++   +   
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190

Query: 307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGN 353
                   Y +PE+V+  KG  K  D WS G ++ EM   +  F G  
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  103 bits (259), Expect = 1e-24
 Identities = 70/256 (27%), Positives = 115/256 (44%), Gaps = 33/256 (12%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILTKV 207
           ++ L  VG GA+  V       T    A+K     K+        HA+    E  +L  +
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVK-----KLSRPFQSIIHAKRTYRELRLLKHM 85

Query: 208 DHPFIVQLRYSFQTKYR------LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
            H  ++ L   F           +YLV   + G  L   +  Q L  +D  +    +I+ 
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKL-TDDHVQFLIYQILR 143

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG---TLEYMSP 318
            + ++H+  I+HRDLKP N+ ++ D  + + DFGLA+   +      M G   T  Y +P
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAP 198

Query: 319 EIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-----AFL 372
           EI+L    +++  D WSVG ++ E+LTG+  F G +    Q K+I   +  P       +
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKI 257

Query: 373 SSE-AHSLLKGLLQKE 387
           SSE A + ++ L Q  
Sbjct: 258 SSESARNYIQSLTQMP 273

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  102 bits (257), Expect = 2e-24
 Identities = 54/222 (24%), Positives = 108/222 (48%), Gaps = 14/222 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILT 205
            +F+ +KV+G GAF  VY+   +      +I  A+K + ++    K + E +  E  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DEAYVMA 72

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
            VD+P + +L         + L+   +  G L  + + ++  +  + L   +  +I   +
Sbjct: 73  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKGM 130

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT---LEYMSPEI 320
           ++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E 
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
           +L + +   +D WS G+ ++E++T G  P+ G    +I   +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 97.7 bits (244), Expect = 4e-23
 Identities = 56/220 (25%), Positives = 109/220 (49%), Gaps = 15/220 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
           E  E+ + +G+G F  V+Q          +  A+K  +     +    +++  E   + +
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFL-QEALTMRQ 72

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
            DHP IV+L     T+  ++++++    G L  F Q+ +  L    L   Y  ++ +A++
Sbjct: 73  FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-YAYQLSTALA 130

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPE-IV 321
           +L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+PE I 
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190

Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
             +    A+D W  G+ ++E+L  G  PF G  N   I +
Sbjct: 191 FRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 229

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 98.4 bits (246), Expect = 4e-23
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 30/210 (14%)

Query: 157 VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--HAEYMKSERNILTKVDHPFIVQ 214
            +G+G F  VY+     T    A+K +     +       ++   E  ++ K  H  +V+
Sbjct: 38  KMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQF-DQEIKVMAKCQHENLVE 94

Query: 215 LR-YSFQTKYRLYLVLDFV-NG---GHLFFQLYRQGL-----FR--EDLARIYTAEIVSA 262
           L  +S        LV  ++ NG     L        L      +  +  A          
Sbjct: 95  LLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN--------G 145

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPE 319
           ++ LH N  +HRD+K  NILLD      ++DFGLA+  ++  +   ++ + GT  YM+PE
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205

Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
            + G+   K +D +S G++L E++TG P  
Sbjct: 206 ALRGEITPK-SDIYSFGVVLLEIITGLPAV 234

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 54/222 (24%), Positives = 108/222 (48%), Gaps = 14/222 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILT 205
            +F+ +KV+G GAF  VY+   +      +I  A+K + ++    K + E +  E  ++ 
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEIL-DEAYVMA 72

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
            VD+P + +L         + L+   +  G L  + + ++  +  + L   +  +I   +
Sbjct: 73  SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKGM 130

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT---LEYMSPEI 320
           ++L    ++HRDL   N+L+    HV +TDFGLAK      +     G    +++M+ E 
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
           +L + +   +D WS G+ ++E++T G  P+ G    +I   +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  100 bits (250), Expect = 5e-23
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 13/220 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E   +   +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 238

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR-QGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y+  ++  +Y+V ++++ G L  F +    + L    L  +  A+I S ++++
Sbjct: 239 EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYV 296

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY--MSPEIVLGK 324
                +HRDL+  NIL+  +    + DFGLA+  ++N  +            +PE  L  
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK 363
                +D WS GILL E+ T G+ P+ G   +++  ++ +
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 99.6 bits (248), Expect = 6e-23
 Identities = 54/271 (19%), Positives = 94/271 (34%), Gaps = 85/271 (31%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---- 207
           + V++ +G G F+ V+    I   +  AMKV++  +    ++ E    E  +L  V    
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSD 94

Query: 208 -DHP---FIVQLRYSFQTKYRLYLVLDFVNGGHL-------------FFQLYRQGLFRED 250
            + P    +VQL   F+        +  VNG H+             +            
Sbjct: 95  PNDPNREMVVQLLDDFK--------ISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLP 146

Query: 251 LARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDAD----------------------- 286
             +    +++  + +LH    I+H D+KPENILL  +                       
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206

Query: 287 --------------------------GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
                                       V + D G A    ++   +    T +Y S E+
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ--TRQYRSLEV 264

Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTG 351
           ++G G++  AD WS   + FE+ TG   F  
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEP 295

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 97.7 bits (244), Expect = 6e-23
 Identities = 56/231 (24%), Positives = 105/231 (45%), Gaps = 12/231 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +D  +L+ +G G+F  V +       G +   A+K ++ D + +    +    E N +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
           +DH  +++L Y       + +V +    G L    + ++       L+R Y  ++   + 
Sbjct: 78  LDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR-YAVQVAEGMG 135

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGTLEY--MSPEI 320
           +L +   +HRDL   N+LL     V + DFGL +    +++         + +   +PE 
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKLPA 370
           +  +    A+D W  G+ L+EM T GQ P+ G N  +I  KI K+  +LP 
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  101 bits (252), Expect = 7e-23
 Identities = 56/219 (25%), Positives = 110/219 (50%), Gaps = 13/219 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
           E  E+ + +G+G F  V+Q          +  A+K   K+   +    +++  E   + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFL-QEALTMRQ 447

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
            DHP IV+L     T+  ++++++    G L  F Q+ +  L    L   Y  ++ +A++
Sbjct: 448 FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLIL-YAYQLSTALA 505

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPEIVL 322
           +L +   +HRD+   N+L+ ++  V L DFGL++  +++T   +  G L  ++M+PE + 
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565

Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            +    A+D W  G+ ++E+L  G  PF G  N   I +
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 96.9 bits (242), Expect = 9e-23
 Identities = 58/220 (26%), Positives = 108/220 (49%), Gaps = 15/220 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
           ED  + +++G+G F +VY+         +I  A+K  +KD     N  ++M  E  I+  
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMS-EAVIMKN 69

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
           +DHP IV+L      +   +++++    G L  + +  +  L    L   Y+ +I  A++
Sbjct: 70  LDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL-YSLQICKAMA 127

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPE-IV 321
           +L +   +HRD+   NIL+ +   V L DFGL++  ++     +    L  ++MSPE I 
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 187

Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
             +    A+D W   + ++E+L+ G+ PF    N+  I  
Sbjct: 188 FRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV 226

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 97.1 bits (242), Expect = 1e-22
 Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 32/251 (12%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-P 210
           F V K +G G F ++   + + T+E  A+K+        K+ A  +  E     ++    
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP-----MKSRAPQLHLEYRFYKQLGSGD 65

Query: 211 FIVQLRYSFQTKYRLYLVLDFV--NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
            I Q+ Y         +VL+ +  +   LF    R   F      +   +++S + ++H+
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT--FSLKTVLMIAIQLISRMEYVHS 123

Query: 269 NGIMHRDLKPENILLDADGH-----VMLTDFGLAKQF-DENTRS-------NSMCGTLEY 315
             +++RD+KPEN L+   G+     + + DF LAK++ D  T+         S+ GT  Y
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183

Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLPAFL 372
           MS    LGK   +  D  ++G +    L G  P+ G      ++  QKI   K   P   
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP--- 240

Query: 373 SSEAHSLLKGL 383
                 L +  
Sbjct: 241 ---IEVLCENF 248

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 69/251 (27%), Positives = 109/251 (43%), Gaps = 69/251 (27%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNIL 204
           L  +E++K +G+GA+  V++     T E+ A+K     KI +       A+    E  IL
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-----KIFDAFQNSTDAQRTFREIMIL 62

Query: 205 TK-VDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE 258
           T+   H  IV L       + +    +YLV D++                 DL  +  A 
Sbjct: 63  TELSGHENIVNLLNVLRADNDRD---VYLVFDYME---------------TDLHAVIRAN 104

Query: 259 IVS-------------AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
           I+               + +LH+ G++HRD+KP NILL+A+ HV + DFGL++ F    R
Sbjct: 105 ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164

Query: 306 SNSMCGTLE----------------------YMSPEIVLG-KGHDKAADWWSVGILLFEM 342
             +                            Y +PEI+LG   + K  D WS+G +L E+
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224

Query: 343 LTGQPPFTGGN 353
           L G+P F G +
Sbjct: 225 LCGKPIFPGSS 235

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 97.3 bits (243), Expect = 3e-22
 Identities = 57/251 (22%), Positives = 117/251 (46%), Gaps = 14/251 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED  + + +G+G F +V+  R    + + A+K  R+        A++++ E  IL +  H
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQ-EARILKQYSH 171

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P IV+L     T+ + +Y+V++ V GG    F +     L  + L ++   +  + + +L
Sbjct: 172 PNIVRL-IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQM-VGDAAAGMEYL 229

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY----MSPEIVL 322
            +   +HRDL   N L+     + ++DFG++++  +     +  G  +      +PE + 
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV-YAASGGLRQVPVKWTAPEALN 288

Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL 380
              +   +D WS GILL+E  + G  P+   + Q+ ++ + K  ++  P         L+
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM 348

Query: 381 KGLLQKEASKR 391
           +     E  +R
Sbjct: 349 EQCWAYEPGQR 359

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 98.4 bits (245), Expect = 3e-22
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 13/220 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E   +   +GQG F +V+     GT+ + A+K ++   +      E    E  ++ K+ H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 321

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYR-QGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y+  ++  +Y+V ++++ G L  F +    + L    L  +  A+I S ++++
Sbjct: 322 EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYV 379

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY--MSPEIVLGK 324
                +HRDL+  NIL+  +    + DFGLA+  ++N  +            +PE  L  
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK 363
                +D WS GILL E+ T G+ P+ G   +++  ++ +
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 98.3 bits (245), Expect = 3e-22
 Identities = 66/306 (21%), Positives = 129/306 (42%), Gaps = 25/306 (8%)

Query: 67  VYDQPAVIHSRSHSLVGPSSYVSQSLK---LSKLTLHEAEDSLGLVEGINEETQEGPNNL 123
           +  +  V H R ++      YVS   +   L++L  H +  + GL+             L
Sbjct: 145 LRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLI-----------TTL 193

Query: 124 SVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVM 183
                   KPT +  +   +   +   D  +   +G G + +VY+      S   A+K +
Sbjct: 194 HYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL 253

Query: 184 RKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQL-- 241
           ++D +  +        E  ++ ++ HP +VQL      +   Y++ +F+  G+L   L  
Sbjct: 254 KEDTMEVEE----FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 309

Query: 242 -YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
             RQ +    L  +   +I SA+ +L     +HR+L   N L+  +  V + DFGL++  
Sbjct: 310 CNRQEVSAVVLLYM-ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368

Query: 301 DENTRSNSMCGTLEY--MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI 357
             +T +            +PE +        +D W+ G+LL+E+ T G  P+ G +  ++
Sbjct: 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 428

Query: 358 QQKIIK 363
            + + K
Sbjct: 429 YELLEK 434

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 97.6 bits (243), Expect = 5e-22
 Identities = 55/266 (20%), Positives = 103/266 (38%), Gaps = 60/266 (22%)

Query: 132 KPTGHIDNLPSENQCVGLEDFEV------LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK 185
           +   H  + P+ +      D+++        ++G G++  V +        + A+K    
Sbjct: 29  QRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK---- 84

Query: 186 DKIME----KNHAEYMKSERNILTKVDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGH 236
            KI+         + +  E  IL +++H  +V++         +    LY+VL+  +   
Sbjct: 85  -KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-- 141

Query: 237 LFFQLYR-----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML 291
                 +       L  E   +     ++  V ++H+ GI+HRDLKP N L++ D  V +
Sbjct: 142 ---DFKKLFRTPVYL-TELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKV 197

Query: 292 TDFGLAKQFDENTRSNSMCG----------------------------TLEYMSPEIVLG 323
            DFGLA+  D     NS                               T  Y +PE++L 
Sbjct: 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL 257

Query: 324 -KGHDKAADWWSVGILLFEMLTGQPP 348
            + + +A D WS+G +  E+L     
Sbjct: 258 QENYTEAIDVWSIGCIFAELLNMIKE 283

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 93.8 bits (234), Expect = 8e-22
 Identities = 47/217 (21%), Positives = 107/217 (49%), Gaps = 14/217 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            +   ++ +G G F  V+    +   ++ A+K +R+   M +   ++++ E  ++ K+ H
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGA-MSE--EDFIE-EAEVMMKLSH 62

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P +VQL Y    +   + LV +F+  G L  + +  R     E L  +   ++   +++L
Sbjct: 63  PKLVQL-YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM-CLDVCEGMAYL 120

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPEIVLGK 324
               ++HRDL   N L+  +  + ++DFG+ +   ++  ++S       ++ SPE+    
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 180

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            +   +D WS G+L++E+ + G+ P+    N + ++ 
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 217

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 49/253 (19%), Positives = 102/253 (40%), Gaps = 36/253 (14%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKVDH 209
           ++V + +G+G+F  +++   +  ++  A+K        E   ++   ++ E      +  
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-------FEPRRSDAPQLRDEYRTYKLLAG 64

Query: 210 -PFIVQLRYSFQTKYRLYLVLDFV--NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
              I  + Y  Q      LV+D +  +   L     R+  F      +   ++++ V  +
Sbjct: 65  CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSI 122

Query: 267 HANGIMHRDLKPENILLDADGH-----VMLTDFGLAKQF-DENTRS-------NSMCGTL 313
           H   +++RD+KP+N L+          + + DFG+ K + D  T+         ++ GT 
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182

Query: 314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLPA 370
            YMS    LG+   +  D  ++G +    L G  P+ G      ++  ++I + K   P 
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP- 241

Query: 371 FLSSEAHSLLKGL 383
                   L  G 
Sbjct: 242 -----LRELCAGF 249

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 96.0 bits (239), Expect = 1e-21
 Identities = 51/255 (20%), Positives = 98/255 (38%), Gaps = 67/255 (26%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM----EKNHAEYMKSERNIL 204
            +++ +  ++G+G++  VY      T +  A+K     K+     +    + +  E  IL
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK-----KVNRMFEDLIDCKRILREITIL 79

Query: 205 TKVDHPFIVQLR-----YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAE- 258
            ++   +I++L              LY+VL+  +                DL +++    
Sbjct: 80  NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD---------------SDLKKLFKTPI 124

Query: 259 -------------IVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR 305
                        ++   + +H +GI+HRDLKP N LL+ D  V + DFGLA+  +    
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184

Query: 306 SNSMCGTLE-----------------------YMSPEIVLG-KGHDKAADWWSVGILLFE 341
           +N +    E                       Y +PE++L  + + K+ D WS G +  E
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244

Query: 342 MLTGQPPFTGGNRQK 356
           +L            +
Sbjct: 245 LLNMLQSHINDPTNR 259

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 92.6 bits (231), Expect = 2e-21
 Identities = 51/217 (23%), Positives = 114/217 (52%), Gaps = 14/217 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E+  +LK +G G F  V   +  G  ++ A+K++++   M ++  E+ + E   + K+ H
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGS-MSED--EFFQ-EAQTMMKLSH 62

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P +V+  Y   +K   +Y+V ++++ G L  + + + +GL    L  +   ++   ++ L
Sbjct: 63  PKLVKF-YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM-CYDVCEGMAFL 120

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPEIVLGK 324
            ++  +HRDL   N L+D D  V ++DFG+ +   ++   +S+      ++ +PE+    
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF 180

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            +   +D W+ GIL++E+ + G+ P+    N + + +
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK 217

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 93.4 bits (233), Expect = 3e-21
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 21/210 (10%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
           +F+   ++G G F KVY+      +++ A+K    +    +   E+ ++E   L+   HP
Sbjct: 40  NFDHKFLIGHGVFGKVYKGVLRDGAKV-ALKRRTPES--SQGIEEF-ETEIETLSFCRHP 95

Query: 211 FIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---ARIYTAEIVSA--VS 264
            +V L  +  +    + L+  ++  G+L   LY   L    +    R+    I +A  + 
Sbjct: 96  HLVSLIGFCDERNEMI-LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC-IGAARGLH 153

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS----NSMCGTLEYMSPEI 320
           +LH   I+HRD+K  NILLD +    +TDFG++K+  E  ++        GTL Y+ PE 
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK-GTLGYIDPEY 212

Query: 321 VLGKGH--DKAADWWSVGILLFEMLTGQPP 348
            + KG   +K +D +S G++LFE+L  +  
Sbjct: 213 FI-KGRLTEK-SDVYSFGVVLFEVLCARSA 240

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 92.3 bits (230), Expect = 4e-21
 Identities = 46/214 (21%), Positives = 100/214 (46%), Gaps = 11/214 (5%)

Query: 156 KVVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV 213
           K +G G F  V +   +     +  A+K+++ +   +    + + +E N++ ++D+P+IV
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNPYIV 81

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIM 272
           ++           LV++    G L  +    + +  +++      ++   + +L  +  +
Sbjct: 82  RM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-LVHQVSMGMKYLEESNFV 139

Query: 273 HRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGTL--EYMSPEIVLGKGHDK 328
           HRDL   N+LL    +  ++DFGL+K  + DEN       G    ++ +PE +       
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199

Query: 329 AADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
            +D WS G+L++E  + GQ P+ G    ++   +
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 92.4 bits (230), Expect = 4e-21
 Identities = 55/251 (21%), Positives = 103/251 (41%), Gaps = 34/251 (13%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKVDH 209
           + + + +G G+F  +Y    I   E  A+K       +E    ++  +  E  I   +  
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-------LECVKTKHPQLHIESKIYKMMQG 63

Query: 210 -PFIVQLRYSFQTKYRLYLVLDFV--NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
              I  +R+         +V++ +  +   LF    R+  F      +   +++S + ++
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYI 121

Query: 267 HANGIMHRDLKPENILLDADGH---VMLTDFGLAKQF-DENTRS-------NSMCGTLEY 315
           H+   +HRD+KP+N L+        V + DFGLAK++ D  T          ++ GT  Y
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLPAFL 372
            S    LG    +  D  S+G +L     G  P+ G     +++  ++I + K+  P   
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238

Query: 373 SSEAHSLLKGL 383
                 L KG 
Sbjct: 239 ---IEVLCKGY 246

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 92.4 bits (230), Expect = 4e-21
 Identities = 57/270 (21%), Positives = 112/270 (41%), Gaps = 45/270 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIY-------AMKVMRKDKIMEKNHAEYMKSERN 202
           ED    + +GQG F K+++  R    +          +KV+ K      N++E      +
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAAS 64

Query: 203 ILTKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEI 259
           +++K+ H  +V   Y          LV +FV  G L  + +  +  +       +   ++
Sbjct: 65  MMSKLSHKHLVLN-YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV-AKQL 122

Query: 260 VSAVSHLHANGIMHRDLKPENILLDADGH--------VMLTDFGLAKQFDENTRSNSMCG 311
            +A+  L  N ++H ++  +NILL  +          + L+D G++              
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-------- 174

Query: 312 TLEY-------MSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQKI 361
             +        + PE I   K  + A D WS G  L+E+ + G  P +   +++K+Q   
Sbjct: 175 --DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-- 230

Query: 362 IKDKIKLPAFLSSEAHSLLKGLLQKEASKR 391
            +D+ +LPA  ++E  +L+   +  E   R
Sbjct: 231 YEDRHQLPAPKAAELANLINNCMDYEPDHR 260

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 91.9 bits (229), Expect = 4e-21
 Identities = 50/217 (23%), Positives = 112/217 (51%), Gaps = 14/217 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  ++ A+K++++   M ++  E+++ E  ++  + H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGS-MSED--EFIE-EAKVMMNLSH 78

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             +VQL Y   TK R ++++ +++  G L  + +  R     + L  +   ++  A+ +L
Sbjct: 79  EKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAMEYL 136

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPEIVLGK 324
            +   +HRDL   N L++  G V ++DFGL++   ++  ++S+       +  PE+++  
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 196

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
                +D W+ G+L++E+ + G+ P+    N +  + 
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 94.4 bits (235), Expect = 6e-21
 Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 14/217 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++ K +G G F +V+       +++ A+K M+   +  +       +E N++  + H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEA----FLAEANVMKTLQH 242

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY---RQGLFREDLARIYTAEIVSAVSHL 266
             +V+L ++  TK  +Y++ +F+  G L   L            L    +A+I   ++ +
Sbjct: 243 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF-SAQIAEGMAFI 300

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGK 324
                +HRDL+  NIL+ A     + DFGLA+  ++N  T        +++ +PE +   
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 360

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
                +D WS GILL E++T G+ P+ G  N + I+ 
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 397

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 92.4 bits (230), Expect = 6e-21
 Identities = 50/222 (22%), Positives = 100/222 (45%), Gaps = 14/222 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILT 205
            +   LKV+G G F  V++   +    + +I   +KV+ +DK   ++           + 
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVT-DHMLAIG 70

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
            +DH  IV+L         L LV  ++  G L    + +R  L  + L   +  +I   +
Sbjct: 71  SLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN-WGVQIAKGM 128

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT---LEYMSPEI 320
            +L  +G++HR+L   N+LL +   V + DFG+A     + +          +++M+ E 
Sbjct: 129 YYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
           +    +   +D WS G+ ++E++T G  P+ G    ++   +
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 91.9 bits (229), Expect = 6e-21
 Identities = 55/253 (21%), Positives = 110/253 (43%), Gaps = 18/253 (7%)

Query: 153 EVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
              +V+G+G F  VY   +      +I+ A+K +          ++++ +E  I+    H
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSH 85

Query: 210 PFIVQLR-YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P ++ L     +++    +VL ++  G L  F +        +DL      ++   + +L
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMKYL 144

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RSNSMCGTL---EYMSPE-I 320
            +   +HRDL   N +LD    V + DFGLA+   +      ++  G     ++M+ E +
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHS 378
              K     +D WS G+LL+E++T G PP+   N   I   +++ +    P +     + 
Sbjct: 205 QTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 263

Query: 379 LLKGLLQKEASKR 391
           ++      +A  R
Sbjct: 264 VMLKCWHPKAEMR 276

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 92.4 bits (230), Expect = 7e-21
 Identities = 50/222 (22%), Positives = 105/222 (47%), Gaps = 15/222 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNILTK 206
                 KV+G G F +VY+     +S    + V     K    EK   +++  E  I+ +
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG-EAGIMGQ 102

Query: 207 VDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
             H  I++L     +KY+ + ++ +++  G L  F +          L  +    I + +
Sbjct: 103 FSHHNIIRL-EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM-LRGIAAGM 160

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS--NSMCGTL--EYMSPE 319
            +L     +HRDL   NIL++++    ++DFGL++  +++  +   +  G +   + +PE
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220

Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            +  +    A+D WS GI+++E++T G+ P+    N + ++ 
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 262

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 52/222 (23%), Positives = 108/222 (48%), Gaps = 16/222 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
               + K++G G   +V    +R  G  ++  A+K ++     E+   +++  E +I+ +
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLS-EASIMGQ 106

Query: 207 VDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
            DHP I++L     T+ R   +V +++  G L  F + +        L  +    + + +
Sbjct: 107 FDHPNIIRL-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM-LRGVGAGM 164

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGTL--EYMSPE 319
            +L   G +HRDL   N+L+D++    ++DFGL++  + D +    +  G +   + +PE
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224

Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            +  +    A+D WS G++++E+L  G+ P+    NR  I  
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS 266

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 53/217 (24%), Positives = 105/217 (48%), Gaps = 14/217 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++++ +G G F +V+     G +++ A+K +++   M     +   +E N++ ++ H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGS-MSP---DAFLAEANLMKQLQH 67

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFR-EDLARIYTAEIVSAVSHL 266
             +V+L Y+  T+  +Y++ +++  G L  F +           L  +  A+I   ++ +
Sbjct: 68  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM-AAQIAEGMAFI 125

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY--MSPEIVLGK 324
                +HRDL+  NIL+       + DFGLA+  ++N  +            +PE +   
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
                +D WS GILL E++T G+ P+ G  N + IQ 
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 58/222 (26%), Positives = 112/222 (50%), Gaps = 16/222 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
            +  + KVVG G F +V    ++     EI  A+K ++     EK   +++  E +I+ +
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLG-EASIMGQ 102

Query: 207 VDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAV 263
            DHP I++L     TK + + +V +++  G L  F + +        L  +    I S +
Sbjct: 103 FDHPNIIRL-EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM-LRGIASGM 160

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS--NSMCGTL--EYMSPE 319
            +L   G +HRDL   NIL++++    ++DFGL +  +++  +   +  G +   + SPE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220

Query: 320 IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            +  +    A+D WS GI+L+E+++ G+ P+    N+  I+ 
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 50/233 (21%), Positives = 100/233 (42%), Gaps = 44/233 (18%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + F + +++G+G F  V +  +++   S +  A+K+++ D I   +  E++  E   + +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL-REAACMKE 81

Query: 207 VDHPFIVQL------RYSFQTKYRLYLVLDFVNGGHL--FFQLYR-----QGLFREDLAR 253
            DHP + +L        +        ++L F+  G L  F    R       L  + L R
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL 313
               +I   + +L +   +HRDL   N +L  D  V + DFGL+++              
Sbjct: 142 F-MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG---------- 190

Query: 314 EY-------------MSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           +Y             ++ E +     +   +D W+ G+ ++E++T GQ P+ G
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAG 242

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 92.7 bits (230), Expect = 4e-20
 Identities = 54/214 (25%), Positives = 103/214 (48%), Gaps = 14/214 (6%)

Query: 156 KVVGQGAFAKVYQ-VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIV 213
             +G G F  V Q V R+   +I  A+KV+++    + +  E M+ E  I+ ++D+P+IV
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMR-EAQIMHQLDNPYIV 399

Query: 214 QLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGI 271
           +L         L LV++   GG L  F    R+ +   ++A     ++   + +L     
Sbjct: 400 RL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-LLHQVSMGMKYLEEKNF 457

Query: 272 MHRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGTL--EYMSPEIVLGKGHD 327
           +HR+L   N+LL    +  ++DFGL+K    D++  +    G    ++ +PE +  +   
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517

Query: 328 KAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
             +D WS G+ ++E L+ GQ P+      + +  
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 551

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 36/217 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
              + L+ +G+G F  V   R       T E+ A+K ++     E++  ++ + E  IL 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER-EIEILK 97

Query: 206 KVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVS 261
            + H  IV+ +       +  L L+++++  G L  + Q +++ +    L + YT++I  
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICK 156

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY------ 315
            + +L     +HRDL   NIL++ +  V + DFGL K   ++          EY      
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK---------EYYKVKEP 207

Query: 316 -------MSPE-IVLGKGHDKAADWWSVGILLFEMLT 344
                   +PE +   K    A+D WS G++L+E+ T
Sbjct: 208 GESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFT 243

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 90.2 bits (224), Expect = 5e-20
 Identities = 46/245 (18%), Positives = 88/245 (35%), Gaps = 33/245 (13%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTS--------EIYAMKVMRKD-------KIMEKNHAEY 196
           +++     +     +Y+     T         + +++K+  KD          ++     
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 197 MKSERNILTKVDHPFIVQLRYS--FQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLA 252
             ++   L       I         Q KYR +LVL  + G  L     +  + +  E   
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSL-GRSLQSALDVSPKHVLSERSV 161

Query: 253 RIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD--GHVMLTDFGLAKQF-DENT----- 304
                 ++ A+  LH N  +H ++  ENI +D +    V L  +G A ++          
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221

Query: 305 --RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII 362
               +   G LE++S ++  G G  + +D  S+G  + + L G  P+T            
Sbjct: 222 EGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIM-- 279

Query: 363 KDKIK 367
           K K K
Sbjct: 280 KQKQK 284

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 88.8 bits (221), Expect = 5e-20
 Identities = 55/221 (24%), Positives = 106/221 (47%), Gaps = 15/221 (6%)

Query: 150 EDFEVLKVV-GQGAFAKVYQ-VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
           ++  +  +  G G F  V Q V R+   +I  A+KV+++    + +  E M+ E  I+ +
Sbjct: 9   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMR-EAQIMHQ 66

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVS 264
           +D+P+IV+L         L LV++   GG L  F    R+ +   ++A     ++   + 
Sbjct: 67  LDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-LLHQVSMGMK 124

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAK--QFDENTRSNSMCGTL--EYMSPEI 320
           +L     +HRDL   N+LL    +  ++DFGL+K    D++  +    G    ++ +PE 
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 184

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
           +  +     +D WS G+ ++E L+ GQ P+      + +  
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 225

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 89.6 bits (223), Expect = 5e-20
 Identities = 61/215 (28%), Positives = 112/215 (52%), Gaps = 24/215 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++F    ++G+G F KVY+ R    + + A+K + K++  +    ++ ++E  +++   H
Sbjct: 30  DNFSNKNILGRGGFGKVYKGRLADGTLV-AVKRL-KEERTQGGELQF-QTEVEMISMAVH 86

Query: 210 PFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---ARIYTAEIVSA--V 263
             +++LR +      RL LV  ++  G +   L  +   +  L    R   A + SA  +
Sbjct: 87  RNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIA-LGSARGL 144

Query: 264 SHLH--AN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-----TRSNSMCGTLEY 315
           ++LH   +  I+HRD+K  NILLD +   ++ DFGLAK  D       T    + GT+ +
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA---VRGTIGH 201

Query: 316 MSPE-IVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
           ++PE +  GK  +K  D +  G++L E++TGQ  F
Sbjct: 202 IAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAF 235

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 89.7 bits (223), Expect = 6e-20
 Identities = 55/242 (22%), Positives = 100/242 (41%), Gaps = 35/242 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQ----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
              + +  +G+G F  V           T  + A+K ++     ++   ++ + E  IL 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ--RDFQR-EIQILK 79

Query: 206 KVDHPFIVQLR-YSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVS 261
            +   FIV+ R  S+    + L LV++++  G L  F Q +R  L    L   Y+++I  
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL-YSSQICK 138

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY------ 315
            + +L +   +HRDL   NIL++++ HV + DFGLAK    +           Y      
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD--------YYVVREPG 190

Query: 316 ------MSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIK 367
                  +PE +       + +D WS G++L+E+ T      +            +D   
Sbjct: 191 QSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 249

Query: 368 LP 369
           L 
Sbjct: 250 LS 251

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 52/217 (23%), Positives = 100/217 (46%), Gaps = 36/217 (16%)

Query: 150 EDFEVLKVVGQGAFAKV----YQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
              + L+ +G+G F  V    Y   +  T E+ A+K ++     E++  ++ + E  IL 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFER-EIEILK 66

Query: 206 KVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVS 261
            + H  IV+ +       +  L L+++++  G L  + Q +++ +    L + YT++I  
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ-YTSQICK 125

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY------ 315
            + +L     +HRDL   NIL++ +  V + DFGL K   ++          E+      
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK---------EFFKVKEP 176

Query: 316 -------MSPE-IVLGKGHDKAADWWSVGILLFEMLT 344
                   +PE +   K    A+D WS G++L+E+ T
Sbjct: 177 GESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFT 212

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 35/217 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQ----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
              + ++ +G+G F KV           T E  A+K + K +    + A+  K E  IL 
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKK-EIEILR 78

Query: 206 KVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVS 261
            + H  IV+ +   +      + L+++F+  G L  +    +  +  +   + Y  +I  
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK-YAVQICK 137

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY------ 315
            + +L +   +HRDL   N+L++++  V + DFGL K  + +          EY      
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK---------EYYTVKDD 188

Query: 316 -------MSPE-IVLGKGHDKAADWWSVGILLFEMLT 344
                   +PE ++  K    A+D WS G+ L E+LT
Sbjct: 189 RDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLT 224

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 52/217 (23%), Positives = 100/217 (46%), Gaps = 12/217 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            D  +   +G G + +VY+      S   A+K +++D  ME    E++  E  ++ ++ H
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVE--EFL-KEAAVMKEIKH 68

Query: 210 PFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P +VQL     T+    Y++ +F+  G+L  + +   +      +      +I SA+ +L
Sbjct: 69  PNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPEIVLGK 324
                +HRDL   N L+  +  V + DFGL++    +T +         ++ +PE +   
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 187

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
                +D W+ G+LL+E+ T G  P+ G    Q  + 
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 224

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 90.5 bits (224), Expect = 1e-19
 Identities = 59/251 (23%), Positives = 107/251 (42%), Gaps = 34/251 (13%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEY--MKSERNILTKV-D 208
           F + + +G G+F ++Y    I T+E  A+K       +E    ++  +  E  I   +  
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLLYESKIYRILQG 61

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFV--NGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
              I  +R+         LV+D +  +   LF    R+         +   ++++ V  +
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFV 119

Query: 267 HANGIMHRDLKPENILLDADGH---VMLTDFGLAKQF-DENTRS-------NSMCGTLEY 315
           H+   +HRD+KP+N L+        V + DFGLAK++ D +T          ++ GT  Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

Query: 316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLPAFL 372
            S    LG    +  D  S+G +L   L G  P+ G   G +++  +KI + K+      
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS--- 236

Query: 373 SSEAHSLLKGL 383
                +L +G 
Sbjct: 237 ---IEALCRGY 244

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 48/223 (21%), Positives = 99/223 (44%), Gaps = 25/223 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
               + K++G+G F  V +  +++   + +  A+K M+ D   ++   E++ SE   +  
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL-SEAACMKD 92

Query: 207 VDHPFIVQL-----RYSFQTKYRLYLVLDFVNGGHL--FFQLYR-----QGLFREDLARI 254
             HP +++L       S Q   +  ++L F+  G L  +    R     + +  + L + 
Sbjct: 93  FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152

Query: 255 YTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RSNSMCGT 312
              +I   + +L     +HRDL   N +L  D  V + DFGL+K+       R       
Sbjct: 153 -MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR-IAK 210

Query: 313 L--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
           +  ++++ E +     +   +D W+ G+ ++E+ T G  P+ G
Sbjct: 211 MPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPG 252

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 55/253 (21%), Positives = 109/253 (43%), Gaps = 18/253 (7%)

Query: 153 EVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
              +V+G+G F  VY   +      +I+ A+K +          ++++ +E  I+    H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFL-TEGIIMKDFSH 149

Query: 210 PFIVQLR-YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           P ++ L     +++    +VL ++  G L  F +        +DL      ++   +  L
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAKGMKFL 208

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGT-----LEYMSPE-I 320
            +   +HRDL   N +LD    V + DFGLA+   +    +    T     +++M+ E +
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 321 VLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHS 378
              K     +D WS G+LL+E++T G PP+   N   I   +++ +    P +     + 
Sbjct: 269 QTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 327

Query: 379 LLKGLLQKEASKR 391
           ++      +A  R
Sbjct: 328 VMLKCWHPKAEMR 340

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 34/222 (15%)

Query: 150 EDFEVLKVVGQGAFAKVYQ----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
              + ++ +G+G F KV          GT E+ A+K ++ D    ++ + + + E +IL 
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQ-EIDILR 88

Query: 206 KVDHPFIVQLR--YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
            + H  I++ +          L LV+++V  G L   L R  +    L  ++  +I   +
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-LLFAQQICEGM 147

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEY-------- 315
           ++LHA   +HRDL   N+LLD D  V + DFGLAK   E           EY        
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---------EYYRVREDGD 198

Query: 316 -----MSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFT 350
                 +PE +   K    A+D WS G+ L+E+LT      +
Sbjct: 199 SPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQS 239

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 46/225 (20%), Positives = 90/225 (40%), Gaps = 20/225 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY-AMKVMRKDKIMEKNHAEYMKSERNILTK 206
                 +V+G+G F  VY         + I  A+K +       +    ++  E  ++  
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFL-REGLLMRG 78

Query: 207 VDHPFIVQLRY--SFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYTAEIVSA 262
           ++HP ++ L        +   +++L ++  G L  F +  ++    +DL      ++   
Sbjct: 79  LNHPNVLAL-IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF-GLQVARG 136

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTL---EYMS 317
           + +L     +HRDL   N +LD    V + DFGLA+   +                ++ +
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196

Query: 318 PE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            E +   +     +D WS G+LL+E+LT G PP+           
Sbjct: 197 LESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 44/254 (17%), Positives = 93/254 (36%), Gaps = 34/254 (13%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKD--------KIMEKNHAEYMKSE 200
           + + K +G G F  +Y        E    + +KV  ++        K  ++   +    +
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 201 RNILTKVDHPFIVQLRYS-----FQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLAR 253
                ++D+  I     S         YR ++V++ + G  L           F++    
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYR-FMVMERL-GIDLQKISGQNGT--FKKSTVL 154

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDAD--GHVMLTDFGLAKQF-DENTR----- 305
                ++  + ++H N  +H D+K  N+LL       V L D+GL+ ++           
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214

Query: 306 --SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK 363
                  GT+E+ S +   G    + +D   +G  +   L G+ P+    +  +  +  K
Sbjct: 215 NPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274

Query: 364 -DKIK-LPAFLSSE 375
            + +  LP  +   
Sbjct: 275 TNLLDELPQSVLKW 288

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 47/258 (18%), Positives = 90/258 (34%), Gaps = 59/258 (22%)

Query: 152 FEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKD--------KIMEKNHAEYMK 198
           ++V   +GQG F  +Y         +G+     +KV   D        K  ++       
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96

Query: 199 SERNILTKVDHPFIVQLRYS-----FQTKYRLYLVLD---------FVNGGHLF-----F 239
            +     K+ +  + +   S         YR ++++D         +      F      
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYR-FMIMDRFGSDLQKIYEANAKRFSRKTVL 155

Query: 240 QLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD--GHVMLTDFGLA 297
           QL  +              I+  + ++H +  +H D+K  N+LL+      V L D+GLA
Sbjct: 156 QLSLR--------------ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201

Query: 298 KQF-DENTRS-------NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPF 349
            ++  E               GT+E+ S +   G    +  D   +G  + + LTG  P+
Sbjct: 202 YRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261

Query: 350 TGGNRQKIQQKIIKDKIK 367
               +     +    KI+
Sbjct: 262 EDNLKDPKYVR--DSKIR 277

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 83.4 bits (207), Expect = 4e-18
 Identities = 55/219 (25%), Positives = 108/219 (49%), Gaps = 22/219 (10%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++ ++L+ +G+G F  V      G     A+K ++ D   +        +E +++T++ H
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA-----FLAEASVMTQLRH 73

Query: 210 PFIVQLRYS--FQTKYRLYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTAEIVSAVS 264
             +VQL      + K  LY+V +++  G L   L    R  L  + L +  + ++  A+ 
Sbjct: 74  SNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAME 131

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL--EYMSPEIVL 322
           +L  N  +HRDL   N+L+  D    ++DFGL K  + ++  ++  G L  ++ +PE + 
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDT--GKLPVKWTAPEALR 187

Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
            K     +D WS GILL+E+ + G+ P+     +  + +
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 226

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 84.7 bits (210), Expect = 7e-18
 Identities = 54/217 (24%), Positives = 108/217 (49%), Gaps = 18/217 (8%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ++ ++L+ +G+G F  V      G     A+K ++ D       A+   +E +++T++ H
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKND-----ATAQAFLAEASVMTQLRH 245

Query: 210 PFIVQLRY--SFQTKYRLYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTAEIVSAVS 264
             +VQL      + K  LY+V +++  G L   L    R  L  + L +  + ++  A+ 
Sbjct: 246 SNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAME 303

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK 324
           +L  N  +HRDL   N+L+  D    ++DFGL K  + ++  ++    +++ +PE +  K
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWTAPEALREK 361

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
                +D WS GILL+E+ + G+ P+     +  + +
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 398

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 50/224 (22%), Positives = 101/224 (45%), Gaps = 27/224 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           E   + + +GQG+F  VY+     V +       A+K    +    +   E++ +E +++
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK-TVNEAASMRERIEFL-NEASVM 82

Query: 205 TKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYRQGLFREDLARIYT----- 256
            + +   +V+L     ++ +   ++++ +  G L  + +  R  +    +    +     
Sbjct: 83  KEFNCHHVVRL-LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141

Query: 257 ---AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCG 311
               EI   +++L+AN  +HRDL   N ++  D  V + DFG+ +   E    R     G
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK-G 200

Query: 312 TL--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            L   +MSPE +  G      +D WS G++L+E+ T  + P+ G
Sbjct: 201 LLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQG 243

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 54/234 (23%), Positives = 104/234 (44%), Gaps = 30/234 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           ++  +++ +G GAF +VY+     +    +    A+K +  +   E++  +++  E  I+
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALII 87

Query: 205 TKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR------QGLFREDLARIY 255
           +K +H  IV+       +    +++++ + GG L  F +  R        L   DL  + 
Sbjct: 88  SKFNHQNIVRC-IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV- 145

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLD--ADGHVM-LTDFGLAKQFDEN--TRSNSMC 310
             +I     +L  N  +HRD+   N LL     G V  + DFG+A+        R     
Sbjct: 146 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC- 204

Query: 311 GTL--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
             L  ++M PE  + G       D WS G+LL+E+ + G  P+    N++ ++ 
Sbjct: 205 AMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 257

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 63/264 (23%), Positives = 110/264 (41%), Gaps = 46/264 (17%)

Query: 138 DNLPSENQCVGL-----------EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMK 181
           D LP +  C  L           +  ++ K +G+GAF +V +     + +  T    A+K
Sbjct: 4   DELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK 63

Query: 182 VMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRY--SFQTKYRLYLVLDFVNGGHL- 237
            M K+      H   M SE  IL  +  H  +V L      +    L ++++F   G+L 
Sbjct: 64  -MLKEGATHSEHRALM-SELKILIHIGHHLNVVNL-LGACTKPGGPLMVIVEFCKFGNLS 120

Query: 238 ----------------FFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI 281
                              LY+  L  E L    + ++   +  L +   +HRDL   NI
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY-SFQVAKGMEFLASRKCIHRDLAARNI 179

Query: 282 LLDADGHVMLTDFGLAKQ-FDENTRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGIL 338
           LL     V + DFGLA+  + +          L  ++M+PE +  + +   +D WS G+L
Sbjct: 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239

Query: 339 LFEMLT-GQPPFTG--GNRQKIQQ 359
           L+E+ + G  P+ G   + +  ++
Sbjct: 240 LWEIFSLGASPYPGVKIDEEFCRR 263

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 77.7 bits (192), Expect = 6e-16
 Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 28/225 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
            D +   V+G+G F +V +  +++ G     A+K   K+   + +H ++   E  +L K+
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKDDHRDFA-GELEVLCKL 82

Query: 208 -DHPFIVQLR-YSFQTKYRLYLVLDFVNGGHL--FFQLYRQGLFREDLARIYT------- 256
             HP I+ L        Y LYL +++   G+L  F +  R        A   +       
Sbjct: 83  GHHPNIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141

Query: 257 -------AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM 309
                  A++   + +L     +HRDL   NIL+  +    + DFGL++  +   +    
Sbjct: 142 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM- 200

Query: 310 CGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            G L   +M+ E +    +   +D WS G+LL+E+++ G  P+ G
Sbjct: 201 -GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 78.2 bits (193), Expect = 7e-16
 Identities = 56/234 (23%), Positives = 104/234 (44%), Gaps = 30/234 (12%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY---AMKVMRKDKIMEKNHAEYMKSERNIL 204
           ++  +++ +G GAF +VY+  V  +         A+K +  +   E++  +++  E  I+
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFL-MEALII 128

Query: 205 TKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR------QGLFREDLARIY 255
           +K +H  IV+       +    +++L+ + GG L  F +  R        L   DL  + 
Sbjct: 129 SKFNHQNIVRC-IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV- 186

Query: 256 TAEIVSAVSHLHANGIMHRDLKPENILLD--ADGHVM-LTDFGLAKQFDEN--TRSNSMC 310
             +I     +L  N  +HRD+   N LL     G V  + DFG+A+        R     
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC- 245

Query: 311 GTL--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
             L  ++M PE  + G       D WS G+LL+E+ + G  P+    N++ ++ 
Sbjct: 246 AMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 298

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 56/246 (22%), Positives = 103/246 (41%), Gaps = 40/246 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKV---MRKDKIMEKNHAEYMKSERNILT 205
           ++  + K +G+G F KV +              V   M K+        + + SE N+L 
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL-SEFNVLK 81

Query: 206 KVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR------------------- 243
           +V+HP +++L Y   ++   L L++++   G L  F +  R                   
Sbjct: 82  QVNHPHVIKL-YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 244 ----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ 299
               + L   DL      +I   + +L    ++HRDL   NIL+     + ++DFGL++ 
Sbjct: 141 HPDERALTMGDLISF-AWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199

Query: 300 FDENT--RSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GN 353
             E       S  G +  ++M+ E +    +   +D WS G+LL+E++T G  P+ G   
Sbjct: 200 VYEEDSYVKRS-QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258

Query: 354 RQKIQQ 359
            +    
Sbjct: 259 ERLFNL 264

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 55/234 (23%), Positives = 108/234 (46%), Gaps = 38/234 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNI 203
           +   + K +G+GAF +V     V         A+ V   M KD   EK+ ++ + SE  +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEM 93

Query: 204 LTKV-DHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR---------------Q 244
           +  +  H  I+ L     T+   LY+++++ + G+L  + +  R               +
Sbjct: 94  MKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 245 GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN- 303
            +  +DL    T ++   + +L +   +HRDL   N+L+  +  + + DFGLA+  +   
Sbjct: 153 QMTFKDLVSC-TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 304 ---TRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                +N     L  ++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 212 YYKKTTNGR---LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 74.6 bits (184), Expect = 6e-15
 Identities = 53/229 (23%), Positives = 95/229 (41%), Gaps = 32/229 (13%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNIL 204
            + +  K +G GAF KV +     +G  +   +KV   M K           M SE  I+
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKED-AVLKVAVKMLKSTAHADEKEALM-SELKIM 103

Query: 205 TKVD-HPFIVQLRYSFQTKYR-LYLVLDFVNGGHL---------------FFQLYRQGLF 247
           + +  H  IV L     T    + ++ ++   G L                F +      
Sbjct: 104 SHLGQHENIVNL-LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---- 303
             DL    ++++   ++ L +   +HRD+   N+LL       + DFGLA+    +    
Sbjct: 163 TRDLLHF-SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221

Query: 304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
            + N+    +++M+PE +    +   +D WS GILL+E+ + G  P+ G
Sbjct: 222 VKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 55/230 (23%), Positives = 86/230 (37%), Gaps = 30/230 (13%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKV---MRKDKIMEKNHAEYMKSERNILT 205
                 K +G GAF KV +    G      AM V   M K           M SE  +L+
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLS 81

Query: 206 KV-DHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL----------FFQLYRQGLFREDLAR 253
            + +H  IV L     T      ++ ++   G L          F          ED   
Sbjct: 82  YLGNHMNIVNL-LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 254 IYT--------AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDENT 304
                       ++   ++ L +   +HRDL   NILL       + DFGLA+   +++ 
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 305 RSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                   L  ++M+PE +    +   +D WS GI L+E+ + G  P+ G
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 38/241 (15%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKV---MRKDKIMEKNHAEYMKSERNILT 205
                ++ +G+  F KVY+    G +       V     KDK       E+   E  +  
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HEAMLRA 67

Query: 206 KVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL-----------------FFQLYRQGLF 247
           ++ HP +V L     TK + L ++  + + G L                   +  +  L 
Sbjct: 68  RLQHPNVVCL-LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---- 303
             D   +  A+I + + +L ++ ++H+DL   N+L+    +V ++D GL ++        
Sbjct: 127 PPDFVHL-VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185

Query: 304 TRSNSMCGTL--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQ 358
              NS+   L   +M+PE I+ GK     +D WS G++L+E+ + G  P+ G  N+  ++
Sbjct: 186 LLGNSL---LPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241

Query: 359 Q 359
            
Sbjct: 242 M 242

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 54/234 (23%), Positives = 107/234 (45%), Gaps = 38/234 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNI 203
           +   + K +G+G F +V     V         A+ V   M KD   EK+ ++ + SE  +
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEM 139

Query: 204 LTKV-DHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR---------------Q 244
           +  +  H  I+ L     T+   LY+++++ + G+L  + +  R               +
Sbjct: 140 MKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198

Query: 245 GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN- 303
            +  +DL    T ++   + +L +   +HRDL   N+L+  +  + + DFGLA+  +   
Sbjct: 199 QMTFKDLVSC-TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257

Query: 304 ---TRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                +N     L  ++M+PE +  + +   +D WS G+L++E+ T G  P+ G
Sbjct: 258 YYKKTTNGR---LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 53/241 (21%), Positives = 98/241 (40%), Gaps = 52/241 (21%)

Query: 150 EDFEVLKVVGQGAFAKVYQ---VRRIGTSEIYAMKV---MRKDKIMEKNHAEYMKSERNI 203
           +   + K +G+GAF +V     +           KV   M K    EK+ ++ + SE  +
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEM 127

Query: 204 LTKV-DHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL-----------------FFQLYRQ 244
           +  +  H  I+ L     T+   LY+++++ + G+L                       +
Sbjct: 128 MKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186

Query: 245 GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT 304
            L  +DL      ++   + +L +   +HRDL   N+L+  D  + + DFGLA+      
Sbjct: 187 QLSSKDLVSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI- 244

Query: 305 RSNSMCGTLEY-------------MSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFT 350
                    +Y             M+PE +  + +   +D WS G+LL+E+ T G  P+ 
Sbjct: 245 ---------DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295

Query: 351 G 351
           G
Sbjct: 296 G 296

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 52/239 (21%), Positives = 98/239 (41%), Gaps = 36/239 (15%)

Query: 150 EDFEVLKVVGQGAFAKVYQ--VRRIGTSEIY---AMKVMRKDKIMEKNHAEYMKSERNIL 204
            D  +   +G+GAF KV+      +   +     A+K +++     +   ++   E  +L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ--DFQ-REAELL 97

Query: 205 TKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL----------------FFQLYRQGLF 247
           T + H  IV+  +   T+ R L +V +++  G L                   +    L 
Sbjct: 98  TMLQHQHIVRF-FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TR 305
              L  +  +++ + + +L     +HRDL   N L+     V + DFG+++        R
Sbjct: 157 LGQLLAV-ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 215

Query: 306 SNSMCGTL--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
                  L   +M PE I+  K     +D WS G++L+E+ T G+ P+    N + I  
Sbjct: 216 VGG-RTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 71.8 bits (175), Expect = 6e-14
 Identities = 51/321 (15%), Positives = 95/321 (29%), Gaps = 73/321 (22%)

Query: 144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-----HAEYMK 198
           + C+  E  +  + +G+G F +V+Q     T    A+K++  +     N       E + 
Sbjct: 14  SHCLPTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEIL 71

Query: 199 SERNILTKV---------DHP--------FIVQLRY----------------------SF 219
            E  I  ++                      VQ  Y                       F
Sbjct: 72  PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131

Query: 220 QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKP 278
               +L++VL+F  GG    Q  R  L     A+    ++ ++++   A+    HRDL  
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQ-MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190

Query: 279 ENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGIL 338
            N+LL       L      K     +                V    +  +       ++
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGL------------QVSIIDYTLSRLERDGIVV 238

Query: 339 LFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHS----------LLKGLLQKEA 388
             ++   +  FTG       Q  I   +K         +           L   +L++  
Sbjct: 239 FCDVSMDEDLFTG---DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT 295

Query: 389 SKRLGSGPGGSQEIKSHKWFK 409
            K   + P   Q  +  + F 
Sbjct: 296 FKTKCNTPAMKQIKRKIQEFH 316

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 48/241 (19%), Positives = 98/241 (40%), Gaps = 47/241 (19%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
            + E ++ +G+GAF +V+Q     +       + A+K M K++      A++   E  ++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQ-REAALM 104

Query: 205 TKVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL-------------------------F 238
            + D+P IV+L        + + L+ +++  G L                          
Sbjct: 105 AEFDNPNIVKL-LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163

Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
                  L   +   I   ++ + +++L     +HRDL   N L+  +  V + DFGL++
Sbjct: 164 SSPGPPPLSCAEQLCI-ARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

Query: 299 QFDEN----TRSNSMCGTL--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFT 350
                       N     +   +M PE I   + +   +D W+ G++L+E+ + G  P+ 
Sbjct: 223 NIYSADYYKADGNDA---IPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYY 278

Query: 351 G 351
           G
Sbjct: 279 G 279

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 57/239 (23%), Positives = 99/239 (41%), Gaps = 35/239 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGT-SEIYAMKV---MRKDKIMEKNHAEYMKSERNILT 205
            D  + + +G+GAF KV+             M V     KD  +     ++ + E  +LT
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQR-EAELLT 72

Query: 206 KVDHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR---------------QGLF 247
            + H  IV+  Y        L +V +++  G L  F + +                  L 
Sbjct: 73  NLQHEHIVKF-YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TR 305
              +  I  ++I S + +L +   +HRDL   N L+ A+  V + DFG+++        R
Sbjct: 132 LSQMLHI-ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 190

Query: 306 SNSMCGTL--EYMSPE-IVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG-GNRQKIQQ 359
                  L   +M PE I+  K     +D WS G++L+E+ T G+ P+    N + I+ 
Sbjct: 191 VGG-HTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 247

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 63/237 (26%), Positives = 99/237 (41%), Gaps = 39/237 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           E+ E  KV+G GAF KV       + + G S   A+K M K+K         M SE  ++
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK-MLKEKADSSEREALM-SELKMM 102

Query: 205 TKV-DHPFIVQLRYSFQTKYR-LYLVLDFVNGGHL--FFQLYR----------------- 243
           T++  H  IV L     T    +YL+ ++   G L  + +  R                 
Sbjct: 103 TQLGSHENIVNL-LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161

Query: 244 -----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
                  L  EDL      ++   +  L     +HRDL   N+L+     V + DFGLA+
Sbjct: 162 EEEDLNVLTFEDLLCF-AYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

Query: 299 Q-FDENTRSNSMCGTL--EYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
               ++         L  ++M+PE +    +   +D WS GILL+E+ + G  P+ G
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 36/117 (30%), Positives = 58/117 (49%), Gaps = 5/117 (4%)

Query: 239 FQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK 298
             LY+  L  E L   Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+
Sbjct: 183 EDLYKDFLTLEHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

Query: 299 QF---DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTG 351
                 +  R       L++M+PE +  + +   +D WS G+LL+E+ + G  P+ G
Sbjct: 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 31/168 (18%), Positives = 59/168 (35%), Gaps = 13/168 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQ-----VRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           +  ++ K +G+GAF +V +     + +  T    A+K M K+      H   M  E  IL
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMS-ELKIL 79

Query: 205 TKVD-HPFIVQ-LRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
             +  H  +V  L    +    L ++++F   G+L   L      + +    Y  +    
Sbjct: 80  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----KRNEFVPYKTKGARF 135

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC 310
                  G +  DLK     + +      + F   K   +     +  
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 31/153 (20%), Positives = 58/153 (37%), Gaps = 23/153 (15%)

Query: 158 VGQGAFAKVYQVRRIGTSEIY---AMKVMRKDKIMEKNHAEYMKSERNILTK-----VDH 209
           +G+GA A + +   +    I      K  R +++ E         E   L       +  
Sbjct: 344 IGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPA 403

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P+I  +           +++ ++NG         + +  ++L   Y  +I   V  LH N
Sbjct: 404 PYIFDV-----DLDNKRIMMSYINGKLA------KDVIEDNLDIAY--KIGEIVGKLHKN 450

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDE 302
            ++H DL   N +   D  + + DFGL K  + 
Sbjct: 451 DVIHNDLTTSNFIF--DKDLYIIDFGLGKISNL 481

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 4e-05
 Identities = 45/304 (14%), Positives = 90/304 (29%), Gaps = 91/304 (29%)

Query: 122 NLSVVDAALGKPTGHIDNLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMK 181
              V D      T HI     ++  + L   EV  +       K      +         
Sbjct: 274 FKQVTDFLSAATTTHI---SLDHHSMTLTPDEVKSL-----LLKY-----LD-------- 312

Query: 182 VMRKDKI---MEKNH-------AEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF 231
             R   +   +   +       AE ++          H    +L    ++      VL+ 
Sbjct: 313 -CRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN---VLEP 368

Query: 232 VNGGHLFFQLYRQGLFRED-------LARIYTA----EIVSAVSHLHANGIMHRDLKPE- 279
                +F +L    +F          L+ I+      +++  V+ LH   ++ +  K   
Sbjct: 369 AEYRKMFDRL---SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST 425

Query: 280 ----NILLDADGHV---------MLTDFGLAKQFDENTRS-----NSMCGTLEYMSPEIV 321
               +I L+    +         ++  + + K FD +              + +      
Sbjct: 426 ISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH------ 479

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
               H K  +     + LF M+     F   + + ++QKI  D     A     + S+L 
Sbjct: 480 ----HLKNIEH-PERMTLFRMV-----FL--DFRFLEQKIRHDSTAWNA-----SGSILN 522

Query: 382 GLLQ 385
            L Q
Sbjct: 523 TLQQ 526

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	479
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.4
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.14
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.8
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.57
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.55
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.43
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.35
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.25
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.16
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.14
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.78
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.77
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.54
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.46
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.26
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.24
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.21
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.15
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.1
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.01
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.0
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.0
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.74
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.67
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.87
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.6
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.16

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2e-70  Score=547.21  Aligned_cols=273  Identities=40%  Similarity=0.741  Sum_probs=253.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ...++|++++.||+|+||+||+|+++.+|+.||||++.+......+..+.+.+|+++|++++|||||+++++|++++++|
T Consensus        29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            44578999999999999999999999999999999999877666666788999999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC---
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---  303 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~---  303 (479)
                      +|||||+||+|++++.+.+.++|..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+...   
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999987432   


Q ss_pred             CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhh
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~  383 (479)
                      ....+.|||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++.++|.++.+.+|..+|+++++||++|
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~l  268 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKL  268 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHH
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHH
Confidence            34567899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhchhhhcCCCC-CCHHHHHhCccccCCChhhhhcc
Q 011698          384 LQKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEAR  419 (479)
Q Consensus       384 L~~dP~~R~~~~~-~t~~eil~hp~f~~~~~~~l~~~  419 (479)
                      |++||++|+++.. .+..+|++||||+++||+.+.++
T Consensus       269 L~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~  305 (311)
T 4aw0_A          269 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ  305 (311)
T ss_dssp             SCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred             ccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCC
Confidence            9999999995432 23345899999999999999755

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-70  Score=547.56  Aligned_cols=280  Identities=50%  Similarity=0.923  Sum_probs=253.2

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc---CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      +..++|++++.||+|+||+||+|++.   .+++.||||++++....... ...+.+|+.+|++++|||||+++++|++++
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            44578999999999999999999984   46889999999876543322 235778999999999999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC-C
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-E  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~  302 (479)
                      .+|+|||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+... .
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999998753 3


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHh
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG  382 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~  382 (479)
                      .....+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++..+|.++.+.+|..+|+++++||++
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  259 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM  259 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence            44567789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcc
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP  427 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p  427 (479)
                      ||++||++|+++...+++|+++||||+++||+++..++++|||+|
T Consensus       260 ~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P  304 (304)
T 3ubd_A          260 LFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP  304 (304)
T ss_dssp             HTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred             HcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence            999999999987666789999999999999999999999999988

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=7.3e-69  Score=581.04  Aligned_cols=325  Identities=33%  Similarity=0.632  Sum_probs=279.5

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHH---HHHHHhCCCCCeeeEeEEEeeC
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE---RNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E---~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      .+++++|+++++||+|+||+||+|+++.+|+.||||++.+..+........+.+|   +.+++.++|||||+++++|++.
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            5778999999999999999999999999999999999998766544444444555   4556677999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      +++|+|||||+||+|+.++.+.+.+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999988754


Q ss_pred             CCCcccccCCCCCcchhHhc-CCCCCccccchhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhccCCCCccCCHHHHH
Q 011698          303 NTRSNSMCGTLEYMSPEIVL-GKGHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKDKIKLPAFLSSEAHS  378 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~-~~~~~~~~DiwSLGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~  378 (479)
                      . ...+.|||+.|||||++. +..|+.++|||||||++|||++|++||.+.   +...+...+....+.+|..+|+++++
T Consensus       345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~d  423 (689)
T 3v5w_A          345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS  423 (689)
T ss_dssp             C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHH
Confidence            3 456789999999999996 468999999999999999999999999763   45577888888999999999999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCCCCC
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFN  458 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~  458 (479)
                      ||.+||++||++|+|+...+++||++||||+++||+.+..+++.|||+|.+.+..+..+||....+.... ........+
T Consensus       424 LI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~~~~fD~~~fd~e~~-~~~~~~~~d  502 (689)
T 3v5w_A          424 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDT-KGIKLLDSD  502 (689)
T ss_dssp             HHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSSTTBCCC----------CCCCCCHHH
T ss_pred             HHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCCcCCCCCCccCCcccc-CCCCCCchH
Confidence            9999999999999998777899999999999999999999999999999888777666665321111000 001111235


Q ss_pred             CCCccCeeeecCch
Q 011698          459 ENPFKGFTYVRPAA  472 (479)
Q Consensus       459 ~~~f~~f~~~~~~~  472 (479)
                      ++.|.+|+|..+..
T Consensus       503 ~~~f~~Fs~~~~~~  516 (689)
T 3v5w_A          503 QELYRNFPLTISER  516 (689)
T ss_dssp             HTTTTTCCEECHHH
T ss_pred             HHHHhCCCccCccc
Confidence            78899999977654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.4e-66  Score=533.45  Aligned_cols=327  Identities=38%  Similarity=0.796  Sum_probs=295.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~  224 (479)
                      .+.+++|+++++||+|+||+||+|+++.+++.||+|++++.........+.+.+|+.+|+++ +||||++++++|++...
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            46778999999999999999999999999999999999987766666667788999999887 89999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc-cCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ-FDEN  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~-~~~~  303 (479)
                      +|+||||++||+|..++.+.+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+. ....
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999987 3445


Q ss_pred             CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhccCCCCccCCH
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---------GNRQKIQQKIIKDKIKLPAFLSS  374 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~  374 (479)
                      ....+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||..         .....+.+.+....+.+|..++.
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~  287 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV  287 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCH
Confidence            566788999999999999999999999999999999999999999963         23456788888999999999999


Q ss_pred             HHHHHHHhhhhhchhhhcCCCC-CCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCC
Q 011698          375 EAHSLLKGLLQKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVA  453 (479)
Q Consensus       375 ~~~~lI~~~L~~dP~~R~~~~~-~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~  453 (479)
                      ++++||++||++||++|+++.+ .+++||++||||++++|+.++.+++.|||+|.+.+..++.+|+..+|..+...+|..
T Consensus       288 ~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~~~~~~~~~~~~~  367 (396)
T 4dc2_A          288 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDD  367 (396)
T ss_dssp             HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSCHHHHTSCCCCCCCC
T ss_pred             HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhcChhhccCCCccCCCc
Confidence            9999999999999999998743 357999999999999999999999999999999999999999999999988877765


Q ss_pred             CC---CCCCCCccCeeeecCch
Q 011698          454 SP---KFNENPFKGFTYVRPAA  472 (479)
Q Consensus       454 ~~---~~~~~~f~~f~~~~~~~  472 (479)
                      ..   ..++..|.||+|++|..
T Consensus       368 ~~~~~~~~~~~f~~f~~~~~~~  389 (396)
T 4dc2_A          368 DDIVRKIDQSEFEGFEYINPLL  389 (396)
T ss_dssp             HHHHTTSCGGGGTTCCEECC--
T ss_pred             chhhccccccccCCcEeECccc
Confidence            43   35678899999999865

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-65  Score=518.55  Aligned_cols=324  Identities=38%  Similarity=0.755  Sum_probs=294.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++||||+++++++++...+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            45789999999999999999999999999999999999876555555677889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTR  305 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~~~  305 (479)
                      +||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.. .....
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            99999999999999999899999999999999999999999999999999999999999999999999999874 33445


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhh
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      ..+.+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+.+.|..+.+.+|..+++++.+||++||+
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~  241 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK  241 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence            66789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC----------
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP----------  455 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~----------  455 (479)
                      +||++|||+++.+++||++||||++++|..+..+++.|||+|.+.+..+..+|+..++..+...+|....          
T Consensus       242 ~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (337)
T 1o6l_A          242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQ  321 (337)
T ss_dssp             SSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC-----------------
T ss_pred             cCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhcccchhccCccCcCCCccccccccccccc
Confidence            9999999988889999999999999999999999999999999999999999999998877655543321          


Q ss_pred             CCCCCCccCeeeecC
Q 011698          456 KFNENPFKGFTYVRP  470 (479)
Q Consensus       456 ~~~~~~f~~f~~~~~  470 (479)
                      ..++..|.||+|+++
T Consensus       322 ~~~~~~f~~f~~~~~  336 (337)
T 1o6l_A          322 REEQEMFEDFDYIAD  336 (337)
T ss_dssp             ---CCTTTTCCEECC
T ss_pred             ccccccCCCceecCC
Confidence            125688999999875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.6e-65  Score=522.75  Aligned_cols=326  Identities=38%  Similarity=0.758  Sum_probs=291.3

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~  224 (479)
                      .+.+++|++++.||+|+||+||+|+++.+++.||||++++.........+.+.+|+.+|+.+ +||||++++++|++...
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            46788999999999999999999999999999999999987666666677788999999988 79999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DEN  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~  303 (479)
                      +|+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.. ...
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999864 333


Q ss_pred             CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhh
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~  383 (479)
                      ....+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..++.++|..+.+.+|..++.++.+||++|
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l  258 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSF  258 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            45567899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhchhhhcCC-CCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCC
Q 011698          384 LQKEASKRLGS-GPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFNE  459 (479)
Q Consensus       384 L~~dP~~R~~~-~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---~~~~  459 (479)
                      |++||++|+++ ...++++|++||||++++|..+..+++.|||+|.+.+..+..+|+..++..+...+|....   ..++
T Consensus       259 L~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~  338 (353)
T 3txo_A          259 MTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGHLPMINQ  338 (353)
T ss_dssp             TCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCHHHHTSCCCCCCCCTTSGGGSCG
T ss_pred             hhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCCcccccccCcccccCCCcCCCccccccCcccc
Confidence            99999999965 2235599999999999999999999999999999999999999999999887777765543   3457


Q ss_pred             CCccCeeeecCc
Q 011698          460 NPFKGFTYVRPA  471 (479)
Q Consensus       460 ~~f~~f~~~~~~  471 (479)
                      ..|.||+|+++.
T Consensus       339 ~~f~~f~~~~~~  350 (353)
T 3txo_A          339 DEFRNFEYVSPE  350 (353)
T ss_dssp             GGGTTCCEECC-
T ss_pred             cccCCceeeCcc
Confidence            889999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.9e-65  Score=519.26  Aligned_cols=326  Identities=38%  Similarity=0.771  Sum_probs=295.2

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~  224 (479)
                      .+.+++|++++.||+|+||+||+|+++.+++.||||++++.........+.+..|+.+|+.+ +||||+++++++++...
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            46678999999999999999999999999999999999987655555567788999999987 79999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DEN  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~  303 (479)
                      +|+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.. ...
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            9999999999999999998889999999999999999999999999999999999999999999999999999874 334


Q ss_pred             CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhh
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~  383 (479)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.++|....+.+|..++.++.+||++|
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l  255 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL  255 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            45667899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCC
Q 011698          384 LQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFNEN  460 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---~~~~~  460 (479)
                      |++||.+||++...++++|++||||++++|+.+..+++.|||+|.+.+. +..+|+..++..+...++....   ..++.
T Consensus       256 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~~~-~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  334 (353)
T 2i0e_A          256 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDRFFTRHPPVLTPPDQEVIRNIDQS  334 (353)
T ss_dssp             TCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCCC---CHHHHHHHHSCCCCCCCCHHHHHHSCTT
T ss_pred             hhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCCCc-chhhccchhccCCcccCCcccccccccccc
Confidence            9999999999877789999999999999999999999999999999888 8999999888777665554322   13578


Q ss_pred             CccCeeeecCch
Q 011698          461 PFKGFTYVRPAA  472 (479)
Q Consensus       461 ~f~~f~~~~~~~  472 (479)
                      .|.||+|+++..
T Consensus       335 ~f~~f~~~~~~~  346 (353)
T 2i0e_A          335 EFEGFSFVNSEF  346 (353)
T ss_dssp             TTCSCCEECTTC
T ss_pred             ccCCCeeeCccc
Confidence            899999998753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.9e-65  Score=503.81  Aligned_cols=256  Identities=30%  Similarity=0.555  Sum_probs=222.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++|||||+++++|++++.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            57999999999999999999999999999999999887665555667789999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~  308 (479)
                      |||| +|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.........+
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~  170 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT  170 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence            9999 679999999999999999999999999999999999999999999999999999999999999998777667778


Q ss_pred             ccCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhc
Q 011698          309 MCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      .+||+.|||||++.+..| +.++|||||||++|||+||+.||.+.+...+.+.|..+.+.+|..+|+++++||++||++|
T Consensus       171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d  250 (275)
T 3hyh_A          171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN  250 (275)
T ss_dssp             ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSS
T ss_pred             eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCC
Confidence            899999999999999886 5899999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHhCccccC
Q 011698          388 ASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      |++||     |++|+++||||+.
T Consensus       251 P~~R~-----s~~eil~hpw~k~  268 (275)
T 3hyh_A          251 PLNRI-----SIHEIMQDDWFKV  268 (275)
T ss_dssp             GGGSC-----CHHHHHHCHHHHT
T ss_pred             hhHCc-----CHHHHHcCccccc
Confidence            99999     9999999999964

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.4e-64  Score=517.89  Aligned_cols=330  Identities=43%  Similarity=0.787  Sum_probs=258.1

Q ss_pred             CcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHH-HHhCCCCCeeeEeEEEeeC
Q 011698          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-LTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       144 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~~~~~  222 (479)
                      ...+..++|++++.||+|+||+||+|+++.+++.||||++++...........+..|..+ ++.++||||++++++|++.
T Consensus        32 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~  111 (373)
T 2r5t_A           32 NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA  111 (373)
T ss_dssp             CTTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred             CCCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence            345677899999999999999999999999999999999998776555556667778776 5678999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-C
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-D  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~  301 (479)
                      ..+|+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.. .
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            999999999999999999999899999999999999999999999999999999999999999999999999999873 3


Q ss_pred             CCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHH
Q 011698          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK  381 (479)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~  381 (479)
                      ......+.+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..++.++|......+|..++.++++||+
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~  271 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE  271 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHH
T ss_pred             CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Confidence            44556778999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC------
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP------  455 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~------  455 (479)
                      +||++||.+|+++. .++++|++||||++++|+.+..+++.|||+|.+.+..+..+|+..++..+...+....+      
T Consensus       272 ~lL~~dp~~R~~~~-~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~  350 (373)
T 2r5t_A          272 GLLQKDRTKRLGAK-DDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVT  350 (373)
T ss_dssp             HHTCSSGGGSTTTT-TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCCC------------------------------
T ss_pred             HHcccCHHhCCCCC-CCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCCCcchhhhcCcccccccccccccCCccccccc
Confidence            99999999999875 46899999999999999999999999999999999999999999888876544322111      


Q ss_pred             ---CCCCCCccCeeeecCchhh
Q 011698          456 ---KFNENPFKGFTYVRPAASF  474 (479)
Q Consensus       456 ---~~~~~~f~~f~~~~~~~~~  474 (479)
                         ...+..|.||+|+++...+
T Consensus       351 ~~~~~~~~~f~~f~~~~~~~~~  372 (373)
T 2r5t_A          351 ASVKEAAEAFLGFSYAPPTDSF  372 (373)
T ss_dssp             ----------------------
T ss_pred             cccccccccCCCCcccCchhhc
Confidence               1235679999999987643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.4e-63  Score=505.03  Aligned_cols=325  Identities=38%  Similarity=0.795  Sum_probs=293.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~  225 (479)
                      +.+++|++++.||+|+||+||+|+++.+++.||||++++.........+.+.+|+.+++++ +||||+++++++++...+
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            5678999999999999999999999999999999999987766666778889999999987 899999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENT  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~~  304 (479)
                      |+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.. ....
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            999999999999999998889999999999999999999999999999999999999999999999999999864 3344


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhccCCCCccCCHH
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---------GNRQKIQQKIIKDKIKLPAFLSSE  375 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~  375 (479)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..         .+...+.+.+....+.+|..++.+
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~  245 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK  245 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHH
Confidence            56678999999999999999999999999999999999999999975         345667788888899999999999


Q ss_pred             HHHHHHhhhhhchhhhcCCCC-CCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCC
Q 011698          376 AHSLLKGLLQKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVAS  454 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~-~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~  454 (479)
                      +++||++||++||.+||++.+ .+++||++||||++++|+.+..+++.|||+|.+.+..+..+|+..++..+...++...
T Consensus       246 ~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (345)
T 3a8x_A          246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDDD  325 (345)
T ss_dssp             HHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCTTTCGGGSCHHHHTSCSSCCCCCH
T ss_pred             HHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCcccCCCccc
Confidence            999999999999999997642 3579999999999999999999999999999999999999999988887766555443


Q ss_pred             C---CCCCCCccCeeeecCc
Q 011698          455 P---KFNENPFKGFTYVRPA  471 (479)
Q Consensus       455 ~---~~~~~~f~~f~~~~~~  471 (479)
                      .   ..++..|.||+|++|.
T Consensus       326 ~~~~~~~~~~f~~f~~~~~~  345 (345)
T 3a8x_A          326 DIVRKIDQSEFEGFEYINPL  345 (345)
T ss_dssp             HHHTTSCGGGGTTCCEECCC
T ss_pred             cccccccccccCCCEeeCCC
Confidence            1   2456789999999873

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7e-64  Score=509.22  Aligned_cols=323  Identities=36%  Similarity=0.705  Sum_probs=261.9

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCC
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY  223 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~  223 (479)
                      ..+.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+..|..+|+.+ +||||+++++++++..
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            346778999999999999999999999999999999999987654445566778899999876 9999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC-C
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-E  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~  302 (479)
                      .+|+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++... .
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            999999999999999999998899999999999999999999999999999999999999999999999999998643 3


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHh
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG  382 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~  382 (479)
                      .....+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...|..+...+|..++.++++||++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  251 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK  251 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHH
Confidence            34567789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhchhhhcCCCCCCHH-HHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCC
Q 011698          383 LLQKEASKRLGSGPGGSQ-EIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFN  458 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~-eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---~~~  458 (479)
                      ||++||++||     ++. +|++||||++++|+.+..+++.|||+|.+.+..+..+|+..++......++....   ..+
T Consensus       252 lL~~dp~~R~-----~~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~  326 (345)
T 1xjd_A          252 LFVREPEKRL-----GVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMD  326 (345)
T ss_dssp             HSCSSGGGSB-----TTBSCGGGSGGGTTCCHHHHHTTCSCC--------------------------------------
T ss_pred             HhcCCHhHcC-----CChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcchhhhcchhhcccCccCCccccccccccc
Confidence            9999999999     555 9999999999999999999999999999999999999999888766554443322   245


Q ss_pred             CCCccCeeeecCch
Q 011698          459 ENPFKGFTYVRPAA  472 (479)
Q Consensus       459 ~~~f~~f~~~~~~~  472 (479)
                      +..|.||+|+++..
T Consensus       327 ~~~f~~f~~~~~~~  340 (345)
T 1xjd_A          327 QNMFRNFSFMNPGM  340 (345)
T ss_dssp             CCTTTTCCC-----
T ss_pred             ccccCCCeeeChhh
Confidence            78999999998764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.7e-64  Score=512.18  Aligned_cols=257  Identities=30%  Similarity=0.534  Sum_probs=231.4

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|+.+|++++|||||+++++|++++.+||
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            4689999999999999999999999999999999998766433 446778999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-
Q 011698          228 VLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-  304 (479)
                      |||||+||+|.+++...  ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.... 
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            99999999999999754  357999999999999999999999999999999999999999999999999998865432 


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCccCCHHHHHHHHhh
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~lI~~~  383 (479)
                      ...+.|||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++..+|..+.+ .++..+|.++++||.+|
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~  260 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL  260 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHH
Confidence            34567899999999999999999999999999999999999999999999999999998865 56778999999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          384 LQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      |++||++||     |++|+++||||+.
T Consensus       261 L~~dP~~R~-----s~~e~l~hp~~~~  282 (350)
T 4b9d_A          261 FKRNPRDRP-----SVNSILEKGFIAK  282 (350)
T ss_dssp             TCSSGGGSC-----CHHHHHTSHHHHT
T ss_pred             ccCChhHCc-----CHHHHhcCHHhhc
Confidence            999999999     9999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.7e-63  Score=504.19  Aligned_cols=253  Identities=27%  Similarity=0.448  Sum_probs=232.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +.|+++++||+|+||+||+|+++.+|+.||||++.+....   ..+.+.+|+.+|++++|||||+++++|++++.+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5799999999999999999999999999999999865432   2345788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~~  308 (479)
                      |||+||+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+... ....+
T Consensus       151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence            99999999998876 57999999999999999999999999999999999999999999999999999987543 45678


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---CCCCccCCHHHHHHHHhhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~lI~~~L~  385 (479)
                      .|||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++...|..+.   +..+..+|+++++||.+||+
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  309 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  309 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcC
Confidence            899999999999999999999999999999999999999999999999999888763   33446799999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCC
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +||++|+     |++|+++||||+..
T Consensus       310 ~dP~~R~-----ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          310 RDPAQRA-----TAAELLKHPFLAKA  330 (346)
T ss_dssp             SSTTTSC-----CHHHHTTCGGGGGC
T ss_pred             CChhHCc-----CHHHHhcCHhhcCC
Confidence            9999999     99999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.9e-63  Score=546.29  Aligned_cols=326  Identities=38%  Similarity=0.769  Sum_probs=299.8

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~  224 (479)
                      .+.+++|++++.||+|+||+||+|+++.+++.||||++++.........+.+..|+.+|..+ +||+|++++++|++...
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            46688999999999999999999999999999999999987655555667788899999987 79999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc-CCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DEN  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~-~~~  303 (479)
                      +|+||||++||+|..++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+++.. ...
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            9999999999999999999899999999999999999999999999999999999999999999999999999864 344


Q ss_pred             CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhh
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~  383 (479)
                      ....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++.+.|....+.+|..++.++.+||++|
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l  576 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL  576 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            55677899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCC
Q 011698          384 LQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFNEN  460 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---~~~~~  460 (479)
                      |++||++|+++.+.+++||++||||++++|+.++.+++.|||+|.+.+ .+..||+..+|..+...+|....   ..++.
T Consensus       577 L~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~~-~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  655 (674)
T 3pfq_A          577 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKASG-RNAENFDRFFTRHPPVLTPPDQEVIRNIDQS  655 (674)
T ss_dssp             SCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCCG-GGHHHHTTTTTSSCSSCCCCCHHHHTTCCGG
T ss_pred             ccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCCC-CchhhcCchhccCCCccCCCchhhhhccccc
Confidence            999999999887777899999999999999999999999999999988 88999999999888777766543   35678


Q ss_pred             CccCeeeecCch
Q 011698          461 PFKGFTYVRPAA  472 (479)
Q Consensus       461 ~f~~f~~~~~~~  472 (479)
                      .|.||+|+++..
T Consensus       656 ~f~~f~~~~~~~  667 (674)
T 3pfq_A          656 EFEGFSFVNSEF  667 (674)
T ss_dssp             GGTTCCEECSSC
T ss_pred             ccCCCcccChhh
Confidence            899999998864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1e-62  Score=511.82  Aligned_cols=325  Identities=35%  Similarity=0.656  Sum_probs=280.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++++.||+|+||+||+|+++.+++.||+|++++.........+.+.+|+.+++.++||||++++++|++...+|
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            45689999999999999999999999999999999998765444444556788999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC--
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~--  304 (479)
                      +||||++||+|..++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+....  
T Consensus       146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~  224 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  224 (410)
T ss_dssp             EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence            99999999999998876 468999999999999999999999999999999999999999999999999998765443  


Q ss_pred             CcccccCCCCCcchhHhcCCC----CCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCc--cCCHHH
Q 011698          305 RSNSMCGTLEYMSPEIVLGKG----HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPA--FLSSEA  376 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~----~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~  376 (479)
                      ...+.+||+.|+|||++.+..    |+.++|||||||++|||++|+.||.+.+...+..+|...  .+.+|.  .++.++
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  304 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  304 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence            345789999999999998766    789999999999999999999999999999999999875  355554  699999


Q ss_pred             HHHHHhhhhhchhh--hcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCC-CCC
Q 011698          377 HSLLKGLLQKEASK--RLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDS-PVA  453 (479)
Q Consensus       377 ~~lI~~~L~~dP~~--R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~-~~~  453 (479)
                      ++||++||+.+|.+  |+     +++||++||||++++|..+..+++.|||+|.+.+..+..+|+...+......+ |..
T Consensus       305 ~~li~~lL~~~~~rlgR~-----~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd~~~~~~~~~~~~~~~  379 (410)
T 3v8s_A          305 KNLICAFLTDREVRLGRN-----GVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIP  379 (410)
T ss_dssp             HHHHHHHSSCGGGCTTSS-----CHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSCCCCSCCSCCCCCCCC
T ss_pred             HHHHHHHccChhhhCCCC-----CHHHHhcCccccCCCHHHHhhcccCCCCCCcCCCccchhhcCCccccccccccCCCc
Confidence            99999999977766  66     89999999999999999999999999999999999999999987765443222 211


Q ss_pred             CC-CCCCCCccCeeeecCchhhhccC
Q 011698          454 SP-KFNENPFKGFTYVRPAASFLQRN  478 (479)
Q Consensus       454 ~~-~~~~~~f~~f~~~~~~~~~~~~~  478 (479)
                      .. ..++..|.||+|+++.. +|.+.
T Consensus       380 ~~~~~~~~~f~~f~~~~~~~-~~~~~  404 (410)
T 3v8s_A          380 KAFVGNQLPFVGFTYYSNRR-YLSSA  404 (410)
T ss_dssp             SSCCCTTGGGTTCCEECC--------
T ss_pred             hhhcccccccccceEeCccc-ccccC
Confidence            11 24678899999999988 77653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-61  Score=485.83  Aligned_cols=315  Identities=35%  Similarity=0.711  Sum_probs=272.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +.+++|++++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+++.++||||+++++++++...+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            45789999999999999999999999999999999998876555455677889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~  306 (479)
                      +||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....  ..
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~  160 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VT  160 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CB
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--cc
Confidence            9999999999999999989999999999999999999999999999999999999999999999999999987643  34


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~  386 (479)
                      .+.+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+..+|....+.+|..++.++.+||++||++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~  240 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITR  240 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcc
Confidence            56799999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccC-CcccccCccccccCCCCCCCCCCCCCCCCCCccCe
Q 011698          387 EASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVA-GKHCVANFEECWTNMPLLDSPVASPKFNENPFKGF  465 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~-~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~f~~f  465 (479)
                      ||++|+++...++++|++||||++++|.++..+.+.|||.|.+. +..+..+|+..... .....+. .+...+..|.||
T Consensus       241 dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~d~~~f~~~~~~-~~~~~~~-~~~~~~~~f~~f  318 (318)
T 1fot_A          241 DLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEE-DINYGVQ-GEDPYADLFRDF  318 (318)
T ss_dssp             CTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-----------------CCCTTCC-SCCTTGGGSCCC
T ss_pred             CHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCCCccchhhcCCCCcc-ccccCcc-CCchhhhhccCC
Confidence            99999988777999999999999999999999999999999987 47888899874332 2211111 112234678887

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.4e-62  Score=505.63  Aligned_cols=253  Identities=27%  Similarity=0.448  Sum_probs=232.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +.|+++++||+|+||+||+|+++.+|+.||||++......   ..+.+.+|+.+|++++|||||+++++|++.+.+||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            5799999999999999999999999999999999865432   2345789999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~~  308 (479)
                      |||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+... ....+
T Consensus       228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred             eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence            99999999998865 56999999999999999999999999999999999999999999999999999987543 45678


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---CCCCccCCHHHHHHHHhhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~lI~~~L~  385 (479)
                      .|||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...|..+.   +..+..+|+++++||.+||+
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  386 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  386 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcC
Confidence            899999999999999999999999999999999999999999999999999888763   34456799999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCC
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +||++|+     |++|+++||||+..
T Consensus       387 ~dP~~R~-----ta~ell~Hp~~~~~  407 (423)
T 4fie_A          387 RDPAQRA-----TAAELLKHPFLAKA  407 (423)
T ss_dssp             SSTTTSC-----CHHHHTTCGGGGGC
T ss_pred             CChhHCc-----CHHHHhcCHHhcCC
Confidence            9999999     99999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.7e-61  Score=488.61  Aligned_cols=313  Identities=37%  Similarity=0.727  Sum_probs=285.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++++...+|
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            45689999999999999999999999999999999998876555555677889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~  306 (479)
                      +||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....  ..
T Consensus       118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--~~  195 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RT  195 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--CB
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC--Cc
Confidence            9999999999999999989999999999999999999999999999999999999999999999999999987654  34


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~  386 (479)
                      .+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++..+|..+.+.+|..++.++.+||++||++
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~  275 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV  275 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCS
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCCCCCCCCccCe
Q 011698          387 EASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASPKFNENPFKGF  465 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~f~~f  465 (479)
                      ||.+|+++...++++|++||||++++|..+..+.+.|||+|.+.+..+..+|+ .++..+...++.   ...+..|.||
T Consensus       276 dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~-~~~~~~~~~~~~---~~~~~~f~~f  350 (350)
T 1rdq_E          276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD-DYEEEEIRVSIN---EKCGKEFTEF  350 (350)
T ss_dssp             CTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC-CCCCCCCCCCSS---CCSTTTTTTC
T ss_pred             CHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccccccc-cccccccccCCC---cchhhhcCCC
Confidence            99999976666799999999999999999999999999999999999999998 455554433322   2234678887

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.9e-61  Score=477.78  Aligned_cols=251  Identities=25%  Similarity=0.436  Sum_probs=222.5

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee----CCeEEE
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRLYL  227 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~~~l  227 (479)
                      |++.++||+|+||+||+|+++.+++.||+|++.+.... ....+.+.+|+.+|++++|||||+++++|++    +..+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            47788999999999999999999999999999876543 3446778999999999999999999999975    456899


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCccEEeCC-CCcEEEeecCCccccCCCC
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~--IiHrDLKpeNILl~~-~g~vkL~DFGla~~~~~~~  304 (479)
                      |||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|  ||||||||+||||+. +|++||+|||+|+.. ...
T Consensus       107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~-~~~  185 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RAS  185 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC-CTT
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC-CCC
Confidence            9999999999999999999999999999999999999999998  999999999999984 799999999999864 344


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccC--CCCccCCHHHHHHHH
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG-NRQKIQQKIIKDKI--KLPAFLSSEAHSLLK  381 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~~~~~lI~  381 (479)
                      ...+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+. +...+...+..+..  .++..+++++++||.
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  264 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE  264 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred             ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHH
Confidence            5667899999999999876 5999999999999999999999999765 44556666665532  356678999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      +||++||++||     |++|+++||||+.
T Consensus       265 ~~L~~dP~~R~-----s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          265 GCIRQNKDERY-----SIKDLLNHAFFQE  288 (290)
T ss_dssp             HHSCSSGGGSC-----CHHHHHTSGGGC-
T ss_pred             HHccCChhHCc-----CHHHHhcCccccC
Confidence            99999999999     9999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-61  Score=489.32  Aligned_cols=244  Identities=26%  Similarity=0.383  Sum_probs=222.0

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|++.++||+|+||+||+|+++.+|+.||||+++++..        ..+|+.+|++++|||||+++++|++++.+||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45789999999999999999999999999999999987543        2469999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC-cEEEeecCCccccCCCC--
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDENT--  304 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g-~vkL~DFGla~~~~~~~--  304 (479)
                      |||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+....  
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999999999999999999999999999999999999999999999999998 69999999999865432  


Q ss_pred             ----CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---CCCccCCHHHH
Q 011698          305 ----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---KLPAFLSSEAH  377 (479)
Q Consensus       305 ----~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~  377 (479)
                          ...+.|||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+...+..+|..+..   .+|+.++++++
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence                23457899999999999999999999999999999999999999999888888888888754   46788999999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +||.+||++||++||     |++|+++
T Consensus       288 ~li~~~L~~dP~~R~-----sa~el~~  309 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRA-----SAMELRR  309 (336)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHccCCHhHCc-----CHHHHHH
Confidence            999999999999999     8999853

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.7e-61  Score=503.17  Aligned_cols=319  Identities=33%  Similarity=0.630  Sum_probs=273.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|+++++||+|+||+||+|+++.+++.||+|++++...........+.+|+.+++.++||||++++++|++...+|
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            45679999999999999999999999999999999998765444444455788999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          227 LVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      +|||||.||+|..++.+ .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            99999999999999987 57899999999999999999999999999999999999999999999999999987654332


Q ss_pred             --cccccCCCCCcchhHhc-----CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCcc---CC
Q 011698          306 --SNSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAF---LS  373 (479)
Q Consensus       306 --~~~~~gt~~y~APE~l~-----~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~---~s  373 (479)
                        ....+||+.|||||++.     +..|+.++|||||||++|||++|+.||.+.+..++..+|...  .+.+|..   ++
T Consensus       231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s  310 (437)
T 4aw2_A          231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS  310 (437)
T ss_dssp             EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSC
T ss_pred             cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCC
Confidence              34578999999999997     566899999999999999999999999999999999999764  4566654   89


Q ss_pred             HHHHHHHHhhhhhchhh--hcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCC
Q 011698          374 SEAHSLLKGLLQKEASK--RLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSP  451 (479)
Q Consensus       374 ~~~~~lI~~~L~~dP~~--R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~  451 (479)
                      +++++||++||+.+|++  |+     +++|+++||||++++|+.+  ++..|||+|.+.+..+..+|+..++..+...++
T Consensus       311 ~~~~dLi~~lL~~~~~r~~r~-----~~~eil~Hpff~~i~w~~l--~~~~~p~~P~~~~~~d~~~fd~~~~~~~~~~~~  383 (437)
T 4aw2_A          311 ENAKDLIRRLICSREHRLGQN-----GIEDFKKHPFFSGIDWDNI--RNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETM  383 (437)
T ss_dssp             HHHHHHHHTTSSCGGGCTTTT-----TTHHHHTSGGGTTCCTTTG--GGSCCSCCCCCSSTTCCTTSCCC----------
T ss_pred             HHHHHHHHHHhcccccccCCC-----CHHHHhCCCccCCCCHHHH--hhCCCCCCCcCCCccchhhcCCcccccccccCC
Confidence            99999999999988776  65     8999999999999999999  468899999999999999999877655433322


Q ss_pred             CCC---C-CCCCCCccCeeeecCch
Q 011698          452 VAS---P-KFNENPFKGFTYVRPAA  472 (479)
Q Consensus       452 ~~~---~-~~~~~~f~~f~~~~~~~  472 (479)
                      ...   . ...+..|.||+|+++..
T Consensus       384 ~~~~~~~~~~~~~~f~~~~~~~~~~  408 (437)
T 4aw2_A          384 PPPTHTAFSGHHLPFVGFTYTSSCV  408 (437)
T ss_dssp             --------CCTTGGGTTCCEESSCT
T ss_pred             CCCccccccccCccccCCCcCCchh
Confidence            211   1 23457899999999876

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.1e-61  Score=497.44  Aligned_cols=321  Identities=35%  Similarity=0.650  Sum_probs=269.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.++..++||||++++++|++...+|
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            45689999999999999999999999999999999998865544555566889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      +||||++||+|..++.+.+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+.....
T Consensus       138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~  217 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT  217 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence            9999999999999998764 799999999999999999999999999999999999999999999999999988654432


Q ss_pred             --cccccCCCCCcchhHhc-------CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCC---cc
Q 011698          306 --SNSMCGTLEYMSPEIVL-------GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLP---AF  371 (479)
Q Consensus       306 --~~~~~gt~~y~APE~l~-------~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p---~~  371 (479)
                        ....+||+.|+|||++.       +..|+.++|||||||++|||++|+.||.+.+..++..+|...  .+.+|   ..
T Consensus       218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  297 (412)
T 2vd5_A          218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG  297 (412)
T ss_dssp             EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----C
T ss_pred             cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccC
Confidence              34579999999999997       356899999999999999999999999999999999988864  34455   57


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCC---
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLL---  448 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~---  448 (479)
                      ++.++++||++||+ +|.+|+|.  .+++||++||||++++|+.+.  ...|||+|.+.+..+..||+...+.....   
T Consensus       298 ~s~~~~dli~~lL~-~p~~Rlgr--~~~~ei~~Hpff~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~  372 (412)
T 2vd5_A          298 VPEEARDFIQRLLC-PPETRLGR--GGAGDFRTHPFFFGLDWDGLR--DSVPPFTPDFEGATDTCNFDLVEDGLTAMVSG  372 (412)
T ss_dssp             CCHHHHHHHHTTSS-CGGGCTTT--TTHHHHHTSGGGTTCCSTTST--TSCCSCCCC-----CCSSCC--CCCCCTTSSS
T ss_pred             CCHHHHHHHHHHcC-ChhhcCCC--CCHHHHhcCCCcCCCCHHHHh--hcCCCCCCcCCCcccccccCcccccccccccc
Confidence            99999999999999 99999864  389999999999999999995  46799999999999999998754322111   


Q ss_pred             ------CCCCCCCCCCCCCccCeeeecCch
Q 011698          449 ------DSPVASPKFNENPFKGFTYVRPAA  472 (479)
Q Consensus       449 ------~~~~~~~~~~~~~f~~f~~~~~~~  472 (479)
                            +.....+...+..|.||+|+++..
T Consensus       373 ~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~  402 (412)
T 2vd5_A          373 GGETLSDIREGAPLGVHLPFVGYSYSCMAL  402 (412)
T ss_dssp             SSCCTTTC-----CCTTGGGTTCCBSCCCC
T ss_pred             cCCCcccccCCCccccCCCCCCCcccCccc
Confidence                  111111123457799999998764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.1e-59  Score=488.59  Aligned_cols=300  Identities=40%  Similarity=0.766  Sum_probs=263.6

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+..++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            45678999999999999999999999999999999999987655555666778899999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEeCCCCcEEEeecCCccccC-CC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGHVMLTDFGLAKQFD-EN  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~-~~  303 (479)
                      |+||||++||+|..++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+++... ..
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            9999999999999999998999999999999999999999998 999999999999999999999999999998643 33


Q ss_pred             CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhh
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGL  383 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~  383 (479)
                      ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+......+|..+++++.+||.+|
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  383 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL  383 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            44567899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCC
Q 011698          384 LQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNM  445 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~  445 (479)
                      |++||.+||++...+++|+++||||++++|..+..+.+.|||+|.+....+..+|++.+|.+
T Consensus       384 L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~~~~~~~~~~~~~~~~  445 (446)
T 4ejn_A          384 LKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQ  445 (446)
T ss_dssp             TCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCSSTTCCTTC-------
T ss_pred             cccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCCCccchhhcchhhhcC
Confidence            99999999988778999999999999999999999999999999999999999999998854

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.2e-58  Score=466.28  Aligned_cols=307  Identities=50%  Similarity=0.909  Sum_probs=250.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc---CCCeEEEEEEeehhhhch-HHHHHHHHHHHHHHHhCCCCCeeeEeEEEee
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  221 (479)
                      .+..++|++++.||+|+||+||+|++.   .+++.||+|++++..... ......+.+|+.+|++++||||+++++++.+
T Consensus        13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            355689999999999999999999985   689999999998754322 2344567889999999999999999999999


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      ...+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            99999999999999999999998999999999999999999999999999999999999999999999999999998643


Q ss_pred             -CCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHH
Q 011698          302 -ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLL  380 (479)
Q Consensus       302 -~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI  380 (479)
                       ........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+......+|..++.++.+||
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  252 (327)
T 3a62_A          173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLL  252 (327)
T ss_dssp             ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred             cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence             3334556789999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCC
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPV  452 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~  452 (479)
                      .+||++||++||++.+.+++++++||||++++|..+..+...|||.|.+....+..+|+..++.....++|.
T Consensus       253 ~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~  324 (327)
T 3a62_A          253 KKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPD  324 (327)
T ss_dssp             HHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC------------------------
T ss_pred             HHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcCChhhhhhcchhhhccccCCCCC
Confidence            999999999999988889999999999999999999999999999999998888999998887665555554

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-59  Score=480.26  Aligned_cols=258  Identities=24%  Similarity=0.359  Sum_probs=227.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee------CC
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------KY  223 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------~~  223 (479)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++..      ..
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            579999999999999999999999999999999976543 33445667899999999999999999998764      36


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC-
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~-  302 (479)
                      .+|||||||+ |+|+.++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+.. 
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            7999999996 57999999989999999999999999999999999999999999999999999999999999987632 


Q ss_pred             ----CCCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC--------
Q 011698          303 ----NTRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP--------  369 (479)
Q Consensus       303 ----~~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p--------  369 (479)
                          .....+.+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+....|.......+        
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence                2345678999999999999885 569999999999999999999999999999888888875322111        


Q ss_pred             -----------------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          370 -----------------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       370 -----------------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                                             +.+++++.+||.+||++||++|+     |++|+|+||||+.....
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~-----ta~e~L~Hp~f~~~~~p  354 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI-----SAAAALRHPFLAKYHDP  354 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC-----CHHHHTTSGGGTTTCCG
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc-----CHHHHhcCHhhCcCCCC
Confidence                                   24689999999999999999999     99999999999987543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.3e-59  Score=468.41  Aligned_cols=254  Identities=28%  Similarity=0.454  Sum_probs=205.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-----
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----  223 (479)
                      +++|++++.||+|+||+||+|+++.+|+.||||+++...  .....+.+.+|+.+|++++|||||+++++|.+.+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            357999999999999999999999999999999997643  3344567889999999999999999999997654     


Q ss_pred             -------eEEEEEEeccCCcHHHHHHHcCCC---cHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEee
Q 011698          224 -------RLYLVLDFVNGGHLFFQLYRQGLF---REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTD  293 (479)
Q Consensus       224 -------~~~lV~E~~~ggsL~~~l~~~~~l---~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~D  293 (479)
                             .+|+|||||+||+|.+++...+.+   .+..++.++.||+.||+|||++|||||||||+|||++.+|++||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   479999999999999999877654   4566888999999999999999999999999999999999999999


Q ss_pred             cCCccccCCCC-------------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCH-HHHHH
Q 011698          294 FGLAKQFDENT-------------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQ  359 (479)
Q Consensus       294 FGla~~~~~~~-------------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~-~~~~~  359 (479)
                      ||+|+.+....             ...+.|||+.|||||++.+..|+.++|||||||++|||++   ||.+... .....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            99998765432             2245689999999999999999999999999999999996   8864321 22233


Q ss_pred             HHHhccCCCC---ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          360 KIIKDKIKLP---AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       360 ~i~~~~~~~p---~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                      .+..  ..+|   ...++.+.+||++||++||++||     |++|+++||||++++|.
T Consensus       239 ~~~~--~~~p~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          239 DVRN--LKFPPLFTQKYPCEYVMVQDMLSPSPMERP-----EAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHT--TCCCHHHHHHCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGCCC---
T ss_pred             HHhc--CCCCCCCcccCHHHHHHHHHHcCCChhHCc-----CHHHHhcCHhhCCCCCC
Confidence            3333  3334   34567889999999999999999     99999999999999984

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.1e-58  Score=472.55  Aligned_cols=291  Identities=34%  Similarity=0.668  Sum_probs=267.0

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      ..+.+++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+|+.++||||++++++|++...
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            45678999999999999999999999999999999999988765555566778899999999999999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      +|+||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+....
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            99999999999999999998899999999999999999999999999999999999999999999999999999887777


Q ss_pred             CcccccCCCCCcchhHhcC---CCCCccccchhhHHHHHHHHhCCCCCCC---CCHHHHHHHHHhccCCCCccCCHHHHH
Q 011698          305 RSNSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLPAFLSSEAHS  378 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~---~~~~~~~DiwSLGvilyelltG~~Pf~~---~~~~~~~~~i~~~~~~~p~~~s~~~~~  378 (479)
                      ...+.+||+.|+|||++.+   ..|+.++|||||||++|||++|+.||..   .....+...+......+|..++.++.+
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~  249 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVS  249 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHH
Confidence            7788999999999999974   4689999999999999999999999974   445677777888888999999999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCcc
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFE  439 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~  439 (479)
                      ||++||++||.+||+    +++++++||||++++|..+..+++.|+|+|......|...|+
T Consensus       250 li~~lL~~dP~~R~s----~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~~~~~~~~~~~  306 (384)
T 4fr4_A          250 LLKKLLEPNPDQRFS----QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRLNCDPTFE  306 (384)
T ss_dssp             HHHHHSCSSGGGSCC----SHHHHHTSGGGTTCCHHHHHTTCSCCCCCCSCCSSCCCCCCC
T ss_pred             HHHHHhcCCHhHhcc----cHHHHHcChhhhcCCHHHHHhCCCCCCCCCCCCCCCCCCccC
Confidence            999999999999994    489999999999999999999999999999886655555553

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.1e-58  Score=493.13  Aligned_cols=323  Identities=33%  Similarity=0.600  Sum_probs=279.8

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+..++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++||||++++++|++...+
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            35678999999999999999999999999999999999887655555567788999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHc----CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          226 YLVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      |+||||++||+|..++...    ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+.
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999999999764    369999999999999999999999999999999999999999999999999998875


Q ss_pred             CCCC-cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhccCCCCccCCHHH
Q 011698          302 ENTR-SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEA  376 (479)
Q Consensus       302 ~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~  376 (479)
                      .... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.    +...+.+.+......+|..++.++
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~  420 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS  420 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHH
Confidence            5433 45569999999999999999999999999999999999999999875    457788889989999999999999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcc-----cccCccccccCCCCCCCC
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKH-----CVANFEECWTNMPLLDSP  451 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~-----~~~~f~~~~~~~~~~~~~  451 (479)
                      ++||++||++||.+||++...++++|++||||++++|..++++++.|||+|......     +..+|+..   .     +
T Consensus       421 ~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~d~~~f~~~---~-----~  492 (543)
T 3c4z_A          421 KDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTV---K-----G  492 (543)
T ss_dssp             HHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCSSSCCSCC----CCCC-----------C
T ss_pred             HHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCccccccCCchhhhhcccc---C-----C
Confidence            999999999999999988766889999999999999999999999999999875432     23334321   0     1


Q ss_pred             CCCCCCCCCCccCeeeecCchhhhc
Q 011698          452 VASPKFNENPFKGFTYVRPAASFLQ  476 (479)
Q Consensus       452 ~~~~~~~~~~f~~f~~~~~~~~~~~  476 (479)
                      ......++..|.+|++.....+|-+
T Consensus       493 ~~~~~~~~~~f~~f~~~~~~~~~~~  517 (543)
T 3c4z_A          493 VAFEKADTEFFQEFASGTCPIPWQE  517 (543)
T ss_dssp             CCCCHHHHHHHHHHCCEECHHHHHH
T ss_pred             CCCCcchhhHhhcCCCCCCChhHHH
Confidence            1111123567999999876555643

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.1e-58  Score=494.17  Aligned_cols=260  Identities=27%  Similarity=0.501  Sum_probs=241.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|++++.||+|+||+||+|+++.+|+.||+|++.+...   ...+.+.+|+.+|+.++|||||+++++|++...+|+|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            5799999999999999999999999999999999987542   3356688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC--CcEEEeecCCccccCCCCC
Q 011698          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~--g~vkL~DFGla~~~~~~~~  305 (479)
                      ||||+||+|++++.+ .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+  |++||+|||+|+.+.....
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            999999999999864 4679999999999999999999999999999999999999854  8999999999999887777


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK  381 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~lI~  381 (479)
                      ..+.|||+.|||||++.+..|+.++|||||||++|||++|..||.+.+..++..+|....+.++    ..+|.++++||+
T Consensus       313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~  392 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR  392 (573)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHH
T ss_pred             eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            7888999999999999999999999999999999999999999999999999999998877665    468999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                      +||++||.+||     |++|+++||||+..+|...
T Consensus       393 ~~L~~dp~~R~-----t~~e~l~Hpw~~~~~~~~~  422 (573)
T 3uto_A          393 KLLLADPNTRM-----TIHQALEHPWLTPGNAPGR  422 (573)
T ss_dssp             TTSCSSGGGSC-----CHHHHHHSTTTSCCCCTTT
T ss_pred             HHccCChhHCc-----CHHHHhcCcCcCCCCCCCc
Confidence            99999999999     8999999999999988653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-57  Score=454.03  Aligned_cols=254  Identities=22%  Similarity=0.379  Sum_probs=225.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEc-----CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  221 (479)
                      +..++|.+.+.||+|+||+||+|++.     .++..||||+++..   .....+.+.+|+.+|++++|||||++++++.+
T Consensus        10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~   86 (299)
T 4asz_A           10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE   86 (299)
T ss_dssp             CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            55678999999999999999999975     36789999999754   23445678999999999999999999999999


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHcC-------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQG-------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~~-------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~  288 (479)
                      ++.+|+|||||+||+|.++|.+.+             .+++..+..++.||+.||+|||+++||||||||+||||+.+++
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence            999999999999999999997643             6899999999999999999999999999999999999999999


Q ss_pred             EEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 011698          289 VMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD  364 (479)
Q Consensus       289 vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~  364 (479)
                      +||+|||+|+......   .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+..+
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~  246 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG  246 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999998754332   2234579999999999999999999999999999999999 99999999999999999887


Q ss_pred             c-CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          365 K-IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       365 ~-~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      . +..|..+++++.+||.+||++||++||     ++++|  |+|++.
T Consensus       247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RP-----s~~~i--~~~L~~  286 (299)
T 4asz_A          247 RVLQRPRTCPQEVYELMLGCWQREPHMRK-----NIKGI--HTLLQN  286 (299)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHH--HHHHHH
T ss_pred             CCCCCCccchHHHHHHHHHHcCCChhHCc-----CHHHH--HHHHHH
Confidence            4 578889999999999999999999999     89999  446654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.1e-57  Score=485.55  Aligned_cols=285  Identities=37%  Similarity=0.656  Sum_probs=263.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++++.||+|+||+||+|+++.+|+.||||++.+..+........+.+|+.+|++++||||+++++++++...+|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            56789999999999999999999999999999999998876555555667889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCC--CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      +||||++||+|..++...+.  +++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+....
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            99999999999999987654  9999999999999999999999999999999999999999999999999999877666


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhccCCCCccCCHHHHHHH
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAFLSSEAHSLL  380 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~lI  380 (479)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.    ....+...+......+|..++.++++||
T Consensus       341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI  420 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLC  420 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence            666789999999999999999999999999999999999999999875    3567778888888889999999999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCC
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAG  431 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~  431 (479)
                      ++||++||.+|||+...+++||++||||++++|..+..+.+.|||+|.+..
T Consensus       421 ~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~~~  471 (576)
T 2acx_A          421 SQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQA  471 (576)
T ss_dssp             HHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC
T ss_pred             HHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCccc
Confidence            999999999999887778999999999999999999999999999998764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.7e-57  Score=455.68  Aligned_cols=251  Identities=21%  Similarity=0.361  Sum_probs=219.4

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  220 (479)
                      .+..++|.+.++||+|+||+||+|+++.     +++.||||+++..   .....+.+.+|+.+|++++|||||++++++.
T Consensus        37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            3556789999999999999999999763     6889999999754   2344567899999999999999999999999


Q ss_pred             eCCeEEEEEEeccCCcHHHHHHHc---------------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC
Q 011698          221 TKYRLYLVLDFVNGGHLFFQLYRQ---------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA  285 (479)
Q Consensus       221 ~~~~~~lV~E~~~ggsL~~~l~~~---------------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~  285 (479)
                      +...+|||||||+||+|.+++++.               +.+++..+..|+.||+.||+|||+++||||||||+||||+.
T Consensus       114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence            999999999999999999999754               35899999999999999999999999999999999999999


Q ss_pred             CCcEEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 011698          286 DGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI  361 (479)
Q Consensus       286 ~g~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i  361 (479)
                      ++++||+|||+|+.+....   .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..++...|
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999998764332   2345789999999999999999999999999999999999 99999999999999998


Q ss_pred             Hhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          362 IKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       362 ~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ..+ ++..|..+++++.+||.+||++||++||     |++||++
T Consensus       274 ~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RP-----s~~ei~~  312 (329)
T 4aoj_A          274 TQGRELERPRACPPEVYAIMRGCWQREPQQRH-----SIKDVHA  312 (329)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSC-----CHHHHHH
T ss_pred             HcCCCCCCcccccHHHHHHHHHHcCcChhHCc-----CHHHHHH
Confidence            886 5778899999999999999999999999     8999976

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5e-57  Score=461.30  Aligned_cols=250  Identities=24%  Similarity=0.424  Sum_probs=210.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEEc---CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~  225 (479)
                      ++|+++++||+|+||+||+|+++   .+++.||+|++.+..     ....+.+|+++|+.+ +|||||+++++|++.+++
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            57999999999999999999875   468899999987643     233467899999998 699999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC-CcEEEeecCCccccCCC-
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDEN-  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~-g~vkL~DFGla~~~~~~-  303 (479)
                      |+|||||+||+|.+++.   .+++..++.|+.||+.||+|||++||+||||||+|||++.+ |++||+|||+|+..... 
T Consensus        96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            99999999999998883   58999999999999999999999999999999999999877 89999999999864322 


Q ss_pred             ----------------------------CCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCC-CC
Q 011698          304 ----------------------------TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTG-GN  353 (479)
Q Consensus       304 ----------------------------~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~-~~  353 (479)
                                                  ....+.+||+.|||||++.+. .|+.++||||+||++|||+||+.||.. .+
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence                                        123456899999999999876 589999999999999999999999964 34


Q ss_pred             HHHHHHHHHhc--------------------------------------cC----------------CCCccCCHHHHHH
Q 011698          354 RQKIQQKIIKD--------------------------------------KI----------------KLPAFLSSEAHSL  379 (479)
Q Consensus       354 ~~~~~~~i~~~--------------------------------------~~----------------~~p~~~s~~~~~l  379 (479)
                      ..+....|..-                                      ..                .....+|+++.+|
T Consensus       253 ~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DL  332 (361)
T 4f9c_A          253 DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDL  332 (361)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHH
T ss_pred             HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHH
Confidence            44444333220                                      00                1113578999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      |++||+.||++|+     |++|+++||||++++
T Consensus       333 l~~lL~~dP~~R~-----ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          333 LDKLLDLNPASRI-----TAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHTCSCTTTSC-----CHHHHHTSGGGTTC-
T ss_pred             HHHHCcCChhHCc-----CHHHHhcCcccCCCC
Confidence            9999999999999     999999999999985

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.1e-57  Score=451.41  Aligned_cols=253  Identities=20%  Similarity=0.327  Sum_probs=224.8

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc-----CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  220 (479)
                      .+...+++++++||+|+||+||+|++.     .+++.||||+++...  .....+.+.+|+.+|++++|||||++++++.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            356678999999999999999999974     367899999997543  2233566899999999999999999999999


Q ss_pred             eCCeEEEEEEeccCCcHHHHHHHc----------------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeC
Q 011698          221 TKYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD  284 (479)
Q Consensus       221 ~~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~  284 (479)
                      +...+|+|||||++|+|.++|...                ..+++..+..++.||+.||+|||+++||||||||+||||+
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            999999999999999999999753                3589999999999999999999999999999999999999


Q ss_pred             CCCcEEEeecCCccccCCC---CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 011698          285 ADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQK  360 (479)
Q Consensus       285 ~~g~vkL~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~  360 (479)
                      +++++||+|||+|+.+...   ......+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..++...
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~  259 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM  259 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999999876432   23456789999999999999999999999999999999999 8999999999999998


Q ss_pred             HHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          361 IIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       361 i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      |..+ .++.|..++.++.+||..||+.||++||     ++.||+++
T Consensus       260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RP-----s~~ei~~~  300 (308)
T 4gt4_A          260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRP-----RFKDIHSR  300 (308)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHcCCCCCCcccchHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence            8876 4567889999999999999999999999     89998764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-56  Score=445.45  Aligned_cols=251  Identities=24%  Similarity=0.316  Sum_probs=210.8

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      +.+..+++++.++||+|+||+||+|++++   .||||+++.... .....+.+.+|+.+|++++|||||++++++. ++.
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~  105 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDN  105 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCe
Confidence            45677899999999999999999998754   489999975442 3445677899999999999999999999875 467


Q ss_pred             EEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      +|||||||+||+|.+++... +.+++..+..++.||+.||+|||+++||||||||+||||+.++++||+|||+|+.....
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            89999999999999999764 57999999999999999999999999999999999999999999999999999875432


Q ss_pred             ---CCcccccCCCCCcchhHhcCC---CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------CCCcc
Q 011698          304 ---TRSNSMCGTLEYMSPEIVLGK---GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI------KLPAF  371 (479)
Q Consensus       304 ---~~~~~~~gt~~y~APE~l~~~---~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~------~~p~~  371 (479)
                         ....+.+||+.|||||++.+.   .|+.++|||||||+||||+||+.||.+.+.......+.....      .++..
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  265 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN  265 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence               234567999999999999753   589999999999999999999999988766554444444322      24567


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ++.++.+||.+||++||++||     |+.||+++
T Consensus       266 ~~~~l~~li~~cl~~dP~~RP-----s~~ei~~~  294 (307)
T 3omv_A          266 CPKAMKRLVADCVKKVKEERP-----LFPQILSS  294 (307)
T ss_dssp             SCHHHHHHHHHHTCSSSTTSC-----CHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCc-----CHHHHHHH
Confidence            899999999999999999999     88887653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.3e-54  Score=436.00  Aligned_cols=261  Identities=33%  Similarity=0.608  Sum_probs=244.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ..+++|++++.||+|+||+||+|++..+|+.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+...+|
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            346799999999999999999999999999999999987654 3344566889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~  306 (479)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++........
T Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  170 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL  170 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred             EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence            99999999999999999899999999999999999999999999999999999999999999999999999987766677


Q ss_pred             ccccCCCCCcchhHhcCCCCC-ccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHD-KAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~-~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      ...+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+...+...+..+...+|..++.++.+||++||+
T Consensus       171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  250 (328)
T 3fe3_A          171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLV  250 (328)
T ss_dssp             GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCC
T ss_pred             ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCC
Confidence            788999999999999998875 8999999999999999999999999999999999999999999999999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      .||.+||     |++|+++||||+...+
T Consensus       251 ~dP~~R~-----t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          251 LNPIKRG-----TLEQIMKDRWINAGHE  273 (328)
T ss_dssp             SSTTTSC-----CHHHHTTCTTTTTTCT
T ss_pred             CChhHCc-----CHHHHhcCHhhcCCCc
Confidence            9999999     9999999999987653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.1e-55  Score=447.49  Aligned_cols=253  Identities=23%  Similarity=0.415  Sum_probs=220.6

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCC-----CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC-CCeeeEeEEE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQLRYSF  219 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~  219 (479)
                      .+..++|++.+.||+|+||+||+|++..+     ++.||||++....  .....+.+.+|+.+|++++| ||||+++++|
T Consensus        60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~  137 (353)
T 4ase_A           60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC  137 (353)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence            45668999999999999999999998764     3689999997653  23345678899999999975 8999999998


Q ss_pred             ee-CCeEEEEEEeccCCcHHHHHHHc----------------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEE
Q 011698          220 QT-KYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (479)
Q Consensus       220 ~~-~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNIL  282 (479)
                      .+ ...+|+|||||++|+|.++|+..                ..+++..+..|+.||+.||+|||+++||||||||+|||
T Consensus       138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL  217 (353)
T 4ase_A          138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  217 (353)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence            65 46799999999999999999763                34889999999999999999999999999999999999


Q ss_pred             eCCCCcEEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHH-HH
Q 011698          283 LDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQ-KI  357 (479)
Q Consensus       283 l~~~g~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~-~~  357 (479)
                      ++.++++||+|||+|+.+....   ...+.+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.. .+
T Consensus       218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~  297 (353)
T 4ase_A          218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  297 (353)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999999764432   2346789999999999999999999999999999999998 99999986644 44


Q ss_pred             HHHHHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          358 QQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       358 ~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ...+..+ ++..|..+++++.+||..||++||++||     |+.||++|
T Consensus       298 ~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RP-----t~~eil~~  341 (353)
T 4ase_A          298 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-----TFSELVEH  341 (353)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCc-----CHHHHHHH
Confidence            4555554 5778899999999999999999999999     99999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-54  Score=437.78  Aligned_cols=294  Identities=47%  Similarity=0.875  Sum_probs=255.5

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc---CCCeEEEEEEeehhhhc-hHHHHHHHHHHHHHHHhC-CCCCeeeEeEEE
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIM-EKNHAEYMKSERNILTKV-DHPFIVQLRYSF  219 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~  219 (479)
                      ..+.+++|++++.||+|+||+||+|++.   .+++.||||++++.... .....+.+.+|+.+|+++ +||||+++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            3466789999999999999999999984   58999999999764321 112234466799999999 699999999999


Q ss_pred             eeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          220 QTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       220 ~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      .....+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999999999888999999999999999999999999999999999999999999999999999987


Q ss_pred             cCCC--CCcccccCCCCCcchhHhcC--CCCCccccchhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhccCCCCcc
Q 011698          300 FDEN--TRSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDKIKLPAF  371 (479)
Q Consensus       300 ~~~~--~~~~~~~gt~~y~APE~l~~--~~~~~~~DiwSLGvilyelltG~~Pf~~~----~~~~~~~~i~~~~~~~p~~  371 (479)
                      +...  ......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||...    ....+...+......+|..
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  288 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcc
Confidence            5332  23445789999999999986  34789999999999999999999999743    4556777777788888999


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCc
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANF  438 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f  438 (479)
                      ++..+.+||.+||+.||.+||++.+.+++|+++||||+.++|..+..+...+||.|.+....+..+|
T Consensus       289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~~~~~d~~~~  355 (355)
T 1vzo_A          289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELDVSNF  355 (355)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CCC---
T ss_pred             cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCccccccccccC
Confidence            9999999999999999999999888899999999999999999999999999999998877776665

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.9e-53  Score=434.96  Aligned_cols=266  Identities=32%  Similarity=0.508  Sum_probs=244.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH---HHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++.+......   ...+.+.+|+.+|++++||||++++++|.+...+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            3679999999999999999999999999999999987543221   1245688999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC----cEEEeecCCccccC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG----HVMLTDFGLAKQFD  301 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g----~vkL~DFGla~~~~  301 (479)
                      |+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    ++||+|||+++.+.
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999999999888999999999999999999999999999999999999998887    79999999999887


Q ss_pred             CCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHH
Q 011698          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAH  377 (479)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  377 (479)
                      ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...|......++    ..++.+++
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  250 (361)
T 2yab_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAK  250 (361)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHH
Confidence            76666778999999999999999999999999999999999999999999999999999998877776    46899999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcc
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEAR  419 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~  419 (479)
                      +||++||++||.+||     |++|+++||||+.++|.....+
T Consensus       251 ~li~~~L~~dP~~R~-----t~~e~l~hp~~~~~~~~~~~~~  287 (361)
T 2yab_A          251 DFIRKLLVKETRKRL-----TIQEALRHPWITPVDTQQAMVR  287 (361)
T ss_dssp             HHHHHHSCSSTTTSC-----CHHHHHTSTTTSCSSHHHHHHH
T ss_pred             HHHHHHCCCChhHCc-----CHHHHhcCcCcCCCchhhhhhc
Confidence            999999999999999     9999999999999999776543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4e-53  Score=428.54  Aligned_cols=258  Identities=29%  Similarity=0.530  Sum_probs=237.0

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      .+++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            45789999999999999999999999999999999987654444445668899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcc
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~  307 (479)
                      ||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~  165 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK  165 (336)
T ss_dssp             EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred             EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence            99999 67999999888999999999999999999999999999999999999999999999999999999877666677


Q ss_pred             cccCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhh
Q 011698          308 SMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~  386 (479)
                      ..+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.....+...+......+|..+++++.+||++||+.
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~  245 (336)
T 3h4j_B          166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVA  245 (336)
T ss_dssp             CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCS
T ss_pred             cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCC
Confidence            8899999999999998876 789999999999999999999999877776666676777788999999999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccccCC
Q 011698          387 EASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ||.+||     |++|+++||||+.-
T Consensus       246 dP~~Rp-----t~~eil~hp~~~~~  265 (336)
T 3h4j_B          246 DPMQRI-----TIQEIRRDPWFNVN  265 (336)
T ss_dssp             SGGGSC-----CHHHHTTCHHHHTT
T ss_pred             ChhHCc-----CHHHHHhChhhccC
Confidence            999999     99999999999763

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-51  Score=415.10  Aligned_cols=264  Identities=30%  Similarity=0.487  Sum_probs=241.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH---HHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++.+......   ...+.+.+|+.+|++++||||+++++++.+...+|
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            579999999999999999999999999999999987543211   13466889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC----cEEEeecCCccccCC
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG----HVMLTDFGLAKQFDE  302 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g----~vkL~DFGla~~~~~  302 (479)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++.+..
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            9999999999999998888999999999999999999999999999999999999999888    899999999998766


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHH
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHS  378 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  378 (479)
                      .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++    ..++..+.+
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (326)
T 2y0a_A          171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD  250 (326)
T ss_dssp             TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHH
Confidence            6666678899999999999999999999999999999999999999999998888888888776665    468999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhc
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEA  418 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~  418 (479)
                      ||++||+.||.+||     +++|+++||||+..+|.....
T Consensus       251 li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~~~~~  285 (326)
T 2y0a_A          251 FIRRLLVKDPKKRM-----TIQDSLQHPWIKPKDTQQALS  285 (326)
T ss_dssp             HHHHHSCSSGGGSC-----CHHHHHHSTTTSCCSHHHHHH
T ss_pred             HHHHHccCChhhCC-----CHHHHhcCCCccCCcchhhhh
Confidence            99999999999999     999999999999999876543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9.9e-53  Score=426.46  Aligned_cols=283  Identities=29%  Similarity=0.506  Sum_probs=246.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.+....       ..+|+.++.++ +||||+++++++++...+|+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            46799999999999999999999999999999999875421       34577788877 79999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC----CcEEEeecCCccccCCC
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD----GHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~----g~vkL~DFGla~~~~~~  303 (479)
                      ||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+..+    +.+||+|||+++.....
T Consensus        94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            99999999999999999999999999999999999999999999999999999998443    35999999999876433


Q ss_pred             -CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCC---CCHHHHHHHHHhccCCCC----ccCCHH
Q 011698          304 -TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG---GNRQKIQQKIIKDKIKLP----AFLSSE  375 (479)
Q Consensus       304 -~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~---~~~~~~~~~i~~~~~~~p----~~~s~~  375 (479)
                       ....+.+||+.|+|||++.+..|+.++|||||||++|||++|..||.+   .+..++...+..+.+.++    ..++.+
T Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  253 (342)
T 2qr7_A          174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT  253 (342)
T ss_dssp             TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHH
T ss_pred             CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHH
Confidence             345677999999999999988899999999999999999999999986   466788888888877655    468999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCC
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNM  445 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~  445 (479)
                      +++||++||+.||++||     +++++++||||.  +|..+...++.+++.|.........+|....+..
T Consensus       254 ~~~li~~~L~~dP~~R~-----t~~~il~hp~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  316 (342)
T 2qr7_A          254 AKDLVSKMLHVDPHQRL-----TAALVLRHPWIV--HWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQ  316 (342)
T ss_dssp             HHHHHHHHTCSSTTTSC-----CHHHHTTSHHHH--TGGGSCCSCCCCCCCHHHHHHHHHHHHHHHTTTC
T ss_pred             HHHHHHHHCCCChhHCc-----CHHHHhcCCeec--CccccccccCCCccchhhhhhHHHHHHhhhcccC
Confidence            99999999999999999     899999999994  5988888888888887654433444555554443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.6e-52  Score=438.76  Aligned_cols=261  Identities=30%  Similarity=0.534  Sum_probs=244.1

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+.+++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+...+
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            35578999999999999999999999999999999999876554444566789999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            99999999999999999888999999999999999999999999999999999999999999999999999998776666


Q ss_pred             cccccCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhh
Q 011698          306 SNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLL  384 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L  384 (479)
                      ..+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...+..++..+....|..+++++.+||++||
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L  251 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHML  251 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHT
T ss_pred             ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHc
Confidence            677899999999999998876 7899999999999999999999999999999999999998999999999999999999


Q ss_pred             hhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          385 QKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       385 ~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +.||.+||     |++||++||||+..
T Consensus       252 ~~dP~~Rp-----t~~eil~hp~~~~~  273 (476)
T 2y94_A          252 QVDPMKRA-----TIKDIREHEWFKQD  273 (476)
T ss_dssp             CSSTTTSC-----CHHHHHTCHHHHTT
T ss_pred             CCCchhCc-----CHHHHHhCHHhhhc
Confidence            99999999     99999999999763

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.8e-51  Score=420.33  Aligned_cols=256  Identities=30%  Similarity=0.549  Sum_probs=236.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+...+|+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35799999999999999999999999999999999876543 33456788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC---cEEEeecCCccccCCCCC
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g---~vkL~DFGla~~~~~~~~  305 (479)
                      |||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++........
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence            99999999999998888999999999999999999999999999999999999998654   599999999998776666


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc----cCCHHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK  381 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~lI~  381 (479)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+..+...+|.    .++.++.+||.
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  266 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  266 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHH
T ss_pred             cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            66789999999999999999999999999999999999999999999999999999988777663    57999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      +||+.||.+||     +++++++||||..
T Consensus       267 ~~L~~dP~~R~-----t~~e~l~hp~~~~  290 (362)
T 2bdw_A          267 SMLTVNPKKRI-----TADQALKVPWICN  290 (362)
T ss_dssp             HHSCSSGGGSC-----CHHHHTTSHHHHT
T ss_pred             HHcCCChhhCc-----CHHHHhcCcccCC
Confidence            99999999999     9999999999975

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-51  Score=413.13  Aligned_cols=254  Identities=26%  Similarity=0.460  Sum_probs=235.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++.+.||+|+||+||+|.++.+++.||+|++....    .....+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            478999999999999999999999999999999987542    2345678999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC--CCcEEEeecCCccccCCCCC
Q 011698          229 LDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~--~g~vkL~DFGla~~~~~~~~  305 (479)
                      |||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.+.....
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            99999999999997654 6999999999999999999999999999999999999987  78999999999998876666


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc----cCCHHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK  381 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~lI~  381 (479)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+......++.    .++.++.+||.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  239 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD  239 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHH
Confidence            66788999999999999998999999999999999999999999999999999999998877763    68999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +||+.||.+||     |++|+++||||+..
T Consensus       240 ~~L~~dp~~Rp-----t~~e~l~hp~~~~~  264 (321)
T 1tki_A          240 RLLVKERKSRM-----TASEALQHPWLKQK  264 (321)
T ss_dssp             TTSCSSGGGSC-----CHHHHHHSHHHHSC
T ss_pred             HHcCCChhHCc-----CHHHHhcChhhccC
Confidence            99999999999     99999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3e-51  Score=401.41  Aligned_cols=260  Identities=32%  Similarity=0.628  Sum_probs=238.3

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+.+++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++++++||||+++++++.+....
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            46778999999999999999999999999999999999876655555566788999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      ++||||+++|+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~  163 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-R  163 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-c
Confidence            999999999999999998889999999999999999999999999999999999999999999999999998665433 3


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhh
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      ....+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......+|..++.++.+||.+||+
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  243 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK  243 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCC
T ss_pred             ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhc
Confidence            34568999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCC
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      .||.+||     +++|+++||||+..
T Consensus       244 ~~p~~Rp-----s~~e~l~h~~~~~~  264 (279)
T 3fdn_A          244 HNPSQRP-----MLREVLEHPWITAN  264 (279)
T ss_dssp             SSGGGSC-----CHHHHHHCHHHHHH
T ss_pred             cChhhCC-----CHHHHhhCccccCC
Confidence            9999999     99999999999874

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.9e-51  Score=400.39  Aligned_cols=270  Identities=31%  Similarity=0.639  Sum_probs=244.8

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+.+++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++++++||||+++++++.+...+
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            35678999999999999999999999999999999999876544444456788999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      |+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~  168 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-R  168 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-C
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-c
Confidence            999999999999999998889999999999999999999999999999999999999999999999999999765432 3


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhh
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      ....+||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+......+|..++.++.+||.+||+
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  248 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLR  248 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSC
T ss_pred             cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhh
Confidence            45678999999999999999999999999999999999999999999988888999988889999999999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcc
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP  427 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p  427 (479)
                      .||.+||     +++++++||||+..      .+...|+..+
T Consensus       249 ~~p~~Rp-----s~~~ll~h~~~~~~------~~~~~p~~~~  279 (284)
T 2vgo_A          249 YHPPQRL-----PLKGVMEHPWVKAN------SRRVLPPVYQ  279 (284)
T ss_dssp             SSGGGSC-----CHHHHHTCHHHHHH------CCCCCCCCC-
T ss_pred             cCHhhCC-----CHHHHhhCHHHHhh------ccccCCCccc
Confidence            9999999     99999999999863      3444555544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1e-51  Score=412.41  Aligned_cols=243  Identities=23%  Similarity=0.346  Sum_probs=196.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC----eE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----RL  225 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----~~  225 (479)
                      ++|.+.++||+|+||+||+|++  +|+.||||+++....    .....+.|+..+.+++|||||++++++.+++    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4789999999999999999998  578999999976431    1222345677777899999999999997654    68


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--------GIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                      |||||||+||+|.+++++. .++++.+..++.|++.||+|||++        +||||||||+||||+.+|++||+|||+|
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            9999999999999999764 578899999999999999999987        9999999999999999999999999999


Q ss_pred             cccCCCC-----CcccccCCCCCcchhHhcCC------CCCccccchhhHHHHHHHHhCCCCCCC---------------
Q 011698          298 KQFDENT-----RSNSMCGTLEYMSPEIVLGK------GHDKAADWWSVGILLFEMLTGQPPFTG---------------  351 (479)
Q Consensus       298 ~~~~~~~-----~~~~~~gt~~y~APE~l~~~------~~~~~~DiwSLGvilyelltG~~Pf~~---------------  351 (479)
                      +......     .....+||+.|||||++.+.      .|+.++|||||||++|||+||..||..               
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            8764432     22356899999999999875      357899999999999999999776532               


Q ss_pred             CCHHHHHHHHHhcc--CCCCccC-----CHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          352 GNRQKIQQKIIKDK--IKLPAFL-----SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       352 ~~~~~~~~~i~~~~--~~~p~~~-----s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .....+...+....  +.+|...     +..+.+||.+||+.||++||     |+.||++
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ei~~  290 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL-----TALRIKK  290 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSC-----CHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCc-----CHHHHHH
Confidence            12344455554443  3455432     34688999999999999999     8999876

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.4e-51  Score=427.36  Aligned_cols=256  Identities=30%  Similarity=0.558  Sum_probs=233.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++++.||+|+||+||+|.++.+|+.||+|++.+.... ....+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            36899999999999999999999999999999999876543 33456688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeC---CCCcEEEeecCCccccCCCC-
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD---ADGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~---~~g~vkL~DFGla~~~~~~~-  304 (479)
                      |||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++...... 
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            99999999999999999999999999999999999999999999999999999998   56889999999998765433 


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc----cCCHHHHHHH
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLL  380 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~lI  380 (479)
                      .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+...+...+..+...+|.    .+++++.+||
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  248 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI  248 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence            345678999999999999999999999999999999999999999999999999999998777663    6899999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      .+||+.||++||     +++|+++||||+.
T Consensus       249 ~~~L~~dP~~Rp-----ta~e~L~hp~~~~  273 (444)
T 3soa_A          249 NKMLTINPSKRI-----TAAEALKHPWISH  273 (444)
T ss_dssp             HHHSCSSTTTSC-----CHHHHHHSCTTHH
T ss_pred             HHHcCCChhHCC-----CHHHHhcCccccC
Confidence            999999999999     9999999999975

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.1e-51  Score=403.96  Aligned_cols=254  Identities=29%  Similarity=0.491  Sum_probs=229.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++++.||+|+||+||+|++..+++.||+|++......   ..+.+.+|+.++++++||||+++++++...+.+|+|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            36899999999999999999999999999999999765432   245578899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~  307 (479)
                      |||+.||+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ....
T Consensus        96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence            9999999999988765 6899999999999999999999999999999999999999999999999999876543 3345


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---cCCCCccCCHHHHHHHHhhh
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLL  384 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~lI~~~L  384 (479)
                      ..+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+...   ....|..++..+.+||.+||
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  254 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHS
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHc
Confidence            678999999999999999999999999999999999999999988877776666554   34456789999999999999


Q ss_pred             hhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          385 QKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       385 ~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +.||++||     +++|+++||||+..
T Consensus       255 ~~dp~~Rp-----s~~ell~h~~~~~~  276 (297)
T 3fxz_A          255 EMDVEKRG-----SAKELLQHQFLKIA  276 (297)
T ss_dssp             CSSTTTSC-----CHHHHTTCGGGGGC
T ss_pred             cCChhHCc-----CHHHHhhChhhccc
Confidence            99999999     99999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-50  Score=400.44  Aligned_cols=257  Identities=24%  Similarity=0.460  Sum_probs=221.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|++++.||+|+||+||+|+++.+++.||+|++..... .......+.+|+.++++++||||+++++++.+...+|+|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            4689999999999999999999999999999999987543 333456678899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~  307 (479)
                      |||+.++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ....
T Consensus        80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence            999987555444455678999999999999999999999999999999999999999999999999999876533 3345


Q ss_pred             cccCCCCCcchhHhcCCC-CCccccchhhHHHHHHHHhCCCC-CCCCCHHHHHHHHHhccC-------------------
Q 011698          308 SMCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPP-FTGGNRQKIQQKIIKDKI-------------------  366 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~-~~~~~DiwSLGvilyelltG~~P-f~~~~~~~~~~~i~~~~~-------------------  366 (479)
                      ..+||+.|+|||++.+.. ++.++|||||||++|||++|..| |.+.+..+....+.....                   
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence            568999999999998766 79999999999999999987777 566666666666654210                   


Q ss_pred             ----------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          367 ----------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       367 ----------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                .....++.++++||++||+.||++||     |++|+++||||+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI-----SAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTC
T ss_pred             ccccCCcchhhcccccChHHHHHHHHHhccChhhCC-----CHHHHhcCcccccC
Confidence                      11235789999999999999999999     99999999999874

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.2e-50  Score=405.99  Aligned_cols=266  Identities=31%  Similarity=0.501  Sum_probs=242.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH---HHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++........   ...+.+.+|+.++++++||||+++++++.+...+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            3679999999999999999999999999999999987543221   1245688999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC----cEEEeecCCccccC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG----HVMLTDFGLAKQFD  301 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g----~vkL~DFGla~~~~  301 (479)
                      |+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||+++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            99999999999999999888899999999999999999999999999999999999999988    89999999999877


Q ss_pred             CCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHH
Q 011698          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAH  377 (479)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  377 (479)
                      ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......++    ..++..+.
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (321)
T 2a2a_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK  250 (321)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred             ccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHH
Confidence            66666677899999999999999999999999999999999999999999999888888888776665    46899999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcc
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEAR  419 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~  419 (479)
                      +||.+||+.||++||     +++|+++||||..++|.....+
T Consensus       251 ~li~~~l~~dp~~Rp-----s~~e~l~hp~~~~~~~~~~~~~  287 (321)
T 2a2a_A          251 DFIRKLLVKETRKRL-----TIQEALRHPWITPVDNQQAMVR  287 (321)
T ss_dssp             HHHHTTSCSSTTTSC-----CHHHHHHSTTTSCSSHHHHHHH
T ss_pred             HHHHHHcCCChhhCc-----CHHHHhcCccccCCCccccccc
Confidence            999999999999999     9999999999999999776543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.2e-50  Score=393.62  Aligned_cols=262  Identities=30%  Similarity=0.529  Sum_probs=240.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++..... .....+.+.+|+.++++++||||+++++++......++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            4789999999999999999999999999999999987654 334456788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc---EEEeecCCccccCCCCC
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFGLAKQFDENTR  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~---vkL~DFGla~~~~~~~~  305 (479)
                      |||+.|++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++........
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            999999999999998899999999999999999999999999999999999999987665   99999999988776666


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK  381 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~lI~  381 (479)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+..+...+|    ..+++++.+||.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  243 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHH
Confidence            6678899999999999999999999999999999999999999999999999999988876665    368999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                      +||+.||++||     +++|+++||||++..+...
T Consensus       244 ~~l~~dp~~Rp-----s~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          244 SMLTVNPKKRI-----TADQALKVPWICNRERVAS  273 (284)
T ss_dssp             HHSCSSTTTSC-----CHHHHTTSHHHHSCCCGGG
T ss_pred             HHcccChhhCC-----CHHHHhcCccccCChhHHh
Confidence            99999999999     9999999999999766443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.3e-51  Score=413.64  Aligned_cols=258  Identities=31%  Similarity=0.562  Sum_probs=228.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH--HHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK--NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ++|++.+.||+|+||+||+|+++.+++.||||++........  ...+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            579999999999999999999999999999999986543221  134668899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHc----CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc---EEEeecCCcccc
Q 011698          228 VLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFGLAKQF  300 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~---vkL~DFGla~~~  300 (479)
                      ||||++||+|.+.+.+.    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++..
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            99999999998877543    35899999999999999999999999999999999999987665   999999999887


Q ss_pred             CCCCC-cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHH
Q 011698          301 DENTR-SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSE  375 (479)
Q Consensus       301 ~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~  375 (479)
                      ..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ...+...+..+...++    ..++.+
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~  262 (351)
T 3c0i_A          184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISES  262 (351)
T ss_dssp             CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred             cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHH
Confidence            55432 45678999999999999999999999999999999999999999874 5667777877776655    468999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      +++||++||+.||++||     ++.++++||||+..++
T Consensus       263 ~~~li~~~L~~dP~~R~-----s~~e~l~hp~~~~~~~  295 (351)
T 3c0i_A          263 AKDLVRRMLMLDPAERI-----TVYEALNHPWLKERDR  295 (351)
T ss_dssp             HHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHTHHH
T ss_pred             HHHHHHHHCCCChhHCc-----CHHHHhcChhhcCCcc
Confidence            99999999999999999     9999999999987654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.5e-50  Score=404.24  Aligned_cols=260  Identities=29%  Similarity=0.489  Sum_probs=219.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ...++|++++.||+|+||+||+|++. +++.||+|++..... .......+.+|+.++++++||||+++++++.+...+|
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   95 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT   95 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence            44589999999999999999999996 588999999976542 2334566789999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-C
Q 011698          227 LVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-T  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~  304 (479)
                      +||||+++ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus        96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            99999986 777777654 45999999999999999999999999999999999999999999999999999876533 3


Q ss_pred             CcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC----------------
Q 011698          305 RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK----------------  367 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----------------  367 (479)
                      .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......                
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  254 (311)
T 3niz_A          175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK  254 (311)
T ss_dssp             ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred             cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence            3445689999999999987 56899999999999999999999999987766666665441000                


Q ss_pred             --------------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          368 --------------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       368 --------------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                                    +...+++++.+||++||+.||++||     |++|+++||||++++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~  310 (311)
T 3niz_A          255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI-----SARDAMNHPYFKDLDPQ  310 (311)
T ss_dssp             SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSC-----CHHHHHTSGGGTTSCTT
T ss_pred             hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCC-----CHHHHhcCcccccCCcc
Confidence                          1134688999999999999999999     99999999999998764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.2e-50  Score=411.96  Aligned_cols=255  Identities=31%  Similarity=0.529  Sum_probs=215.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ...++|++++.||+|+||+||+|+++.+++.||+|++.+.....    +.+.+|+.+++.++||||+++++++.+...+|
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            34578999999999999999999999999999999998654322    34678999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc--EEEeecCCccccCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH--VMLTDFGLAKQFDENT  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~--vkL~DFGla~~~~~~~  304 (479)
                      +||||+.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            99999999999999998889999999999999999999999999999999999999987775  9999999998655555


Q ss_pred             CcccccCCCCCcchhHhcCCCCCcc-ccchhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccCCCCc--cCCHHHH
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKA-ADWWSVGILLFEMLTGQPPFTGGN----RQKIQQKIIKDKIKLPA--FLSSEAH  377 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~-~DiwSLGvilyelltG~~Pf~~~~----~~~~~~~i~~~~~~~p~--~~s~~~~  377 (479)
                      .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+    ...+.+.+......+|.  .+++++.
T Consensus       173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  252 (361)
T 3uc3_A          173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC  252 (361)
T ss_dssp             --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHH
T ss_pred             CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHH
Confidence            5566789999999999998888655 899999999999999999998743    35566667766666665  5899999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      +||++||+.||++||     |++|+++||||..
T Consensus       253 ~li~~~L~~dP~~Rp-----s~~ell~hp~f~~  280 (361)
T 3uc3_A          253 HLISRIFVADPATRI-----SIPEIKTHSWFLK  280 (361)
T ss_dssp             HHHHHHSCSCTTTSC-----CHHHHHTSHHHHT
T ss_pred             HHHHHHccCChhHCc-----CHHHHHhCcchhc
Confidence            999999999999999     9999999999954

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.8e-50  Score=400.39  Aligned_cols=268  Identities=28%  Similarity=0.425  Sum_probs=221.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|++++.||+|+||+||+|++..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++.+...+++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            478999999999999999999999999999999987654 2334456678899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~  307 (479)
                      |||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            999999999998888888999999999999999999999999999999999999999999999999999876533 3345


Q ss_pred             cccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-------------------C
Q 011698          308 SMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-------------------K  367 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-------------------~  367 (479)
                      ..+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.....                   .
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            6689999999999987 5689999999999999999999999998887766655543210                   1


Q ss_pred             CC------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCC
Q 011698          368 LP------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETR  422 (479)
Q Consensus       368 ~p------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~  422 (479)
                      .|            ..++.++.+||++||+.||.+||     |++|+++||||+++.|.....++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~~~~~~  302 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL-----TCEQLLHHPYFENIREIEDLAKEHD  302 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSC-----CHHHHHTSGGGTTCC----------
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcC-----CHHHHhcChHHHhccCHHHHHHhhc
Confidence            11            35788999999999999999999     9999999999999988665544433

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.3e-50  Score=393.82  Aligned_cols=260  Identities=31%  Similarity=0.533  Sum_probs=230.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+..++|++.+.||+|+||.||+|+++.+++.||+|++...........+.+.+|+.+++.++||||+++++++.+...+
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            35568999999999999999999999999999999999876544444566788999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      |+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            99999999999999999888999999999999999999999999999999999999999999999999999988766555


Q ss_pred             cccccCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhh
Q 011698          306 SNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLL  384 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L  384 (479)
                      ....+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+...+.+.+..+...+|..++.++.++|.+||
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  246 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHML  246 (276)
T ss_dssp             ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHc
Confidence            566789999999999998776 6899999999999999999999999998899999998888899999999999999999


Q ss_pred             hhchhhhcCCCCCCHHHHHhCccccC
Q 011698          385 QKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       385 ~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      +.||.+||     +++++++||||+.
T Consensus       247 ~~~p~~Rp-----s~~~~l~h~~~~~  267 (276)
T 2h6d_A          247 QVDPLKRA-----TIKDIREHEWFKQ  267 (276)
T ss_dssp             CSSGGGSC-----CHHHHHHSHHHHT
T ss_pred             cCChhhCC-----CHHHHHhChhhcc
Confidence            99999999     9999999999976

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.3e-50  Score=416.51  Aligned_cols=262  Identities=22%  Similarity=0.354  Sum_probs=223.1

Q ss_pred             CCCCeEEEEEeccC--CceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          148 GLEDFEVLKVVGQG--AFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       148 ~~~~y~~~~~LG~G--~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      ..++|++++.||+|  +||+||+|+++.+++.||||++..... .....+.+.+|+.++++++||||+++++++.+...+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            35789999999999  999999999999999999999987653 344567788999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      |+|||||+||+|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence            9999999999999999876  67999999999999999999999999999999999999999999999999998654211


Q ss_pred             --------CCcccccCCCCCcchhHhcC--CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-------
Q 011698          304 --------TRSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-------  366 (479)
Q Consensus       304 --------~~~~~~~gt~~y~APE~l~~--~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-------  366 (479)
                              ......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.+.......+..+..       
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (389)
T 3gni_B          182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS  261 (389)
T ss_dssp             TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred             cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence                    12234589999999999988  6789999999999999999999999987665544443332211       


Q ss_pred             ---------------------------------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCcc
Q 011698          367 ---------------------------------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKW  407 (479)
Q Consensus       367 ---------------------------------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~  407 (479)
                                                             .++..+++++.+||++||+.||++||     |++|+++|||
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----ta~ell~hp~  336 (389)
T 3gni_B          262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP-----SASTLLNHSF  336 (389)
T ss_dssp             --------------------------------------------CCHHHHHHHHHHTCSCTTTSC-----CHHHHTTSGG
T ss_pred             ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCC-----CHHHHhcCHH
Confidence                                                   24456899999999999999999999     9999999999


Q ss_pred             ccCCChhh
Q 011698          408 FKMINWKK  415 (479)
Q Consensus       408 f~~~~~~~  415 (479)
                      |+.+.|..
T Consensus       337 f~~~~~~~  344 (389)
T 3gni_B          337 FKQIKRRA  344 (389)
T ss_dssp             GGGC---C
T ss_pred             HHHHhhcc
Confidence            99988754

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-50  Score=425.28  Aligned_cols=272  Identities=25%  Similarity=0.372  Sum_probs=213.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee-----CC
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-----KY  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~~  223 (479)
                      .++|++++.||+|+||+||+|+++.+++.||||++.+.. ......+.+.+|+.+|++++||||+++++++..     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            378999999999999999999999999999999997643 234456678899999999999999999999943     35


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      .+|+||||+. |+|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||+++.+...
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            7999999985 689999988888999999999999999999999999999999999999999999999999999876422


Q ss_pred             C----------------------------CcccccCCCCCcchhHh-cCCCCCccccchhhHHHHHHHHh----------
Q 011698          304 T----------------------------RSNSMCGTLEYMSPEIV-LGKGHDKAADWWSVGILLFEMLT----------  344 (479)
Q Consensus       304 ~----------------------------~~~~~~gt~~y~APE~l-~~~~~~~~~DiwSLGvilyellt----------  344 (479)
                      .                            .....+||+.|+|||++ .+..|+.++|||||||++|||++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            1                            23456889999999987 45679999999999999999999          


Q ss_pred             -CCCCCCCCCH--------------------HHHHHHHHhc--c-----------------------------CCCCccC
Q 011698          345 -GQPPFTGGNR--------------------QKIQQKIIKD--K-----------------------------IKLPAFL  372 (479)
Q Consensus       345 -G~~Pf~~~~~--------------------~~~~~~i~~~--~-----------------------------~~~p~~~  372 (479)
                       |+++|.+.+.                    .+....|..-  .                             ....+.+
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             7778866441                    1122222110  0                             0011346


Q ss_pred             CHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCcc
Q 011698          373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP  427 (479)
Q Consensus       373 s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p  427 (479)
                      +.++.+||++||+.||++|+     |++|+++||||+++.|...+.....+...|
T Consensus       370 s~~~~dLl~~mL~~dP~~R~-----t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~  419 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRI-----TINECLAHPFFKEVRIAEVETNATEKVRLP  419 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGTTTCCGGGCCCCSSCCCCS
T ss_pred             CHHHHHHHHHHhccCccccC-----CHHHHhcCHhhhhcCCCccCCCCCCCCCCC
Confidence            89999999999999999999     999999999999999999887666555554

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-50  Score=415.27  Aligned_cols=272  Identities=28%  Similarity=0.422  Sum_probs=217.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCC--e
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKY--R  224 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~--~  224 (479)
                      .+++|++++.||+|+||+||+|.++.+|+.||||++.+.. ........+.+|+.+|+.+. ||||+++++++...+  .
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3578999999999999999999999999999999997543 23344566778999999997 999999999997554  7


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-  303 (479)
                      +|+|||||. ++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+... 
T Consensus        86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            999999998 488888866 57899999999999999999999999999999999999999999999999999875321 


Q ss_pred             ---------------------CCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 011698          304 ---------------------TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKI  361 (479)
Q Consensus       304 ---------------------~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i  361 (479)
                                           ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+.......|
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                 12344689999999999987 67899999999999999999999999998888777777


Q ss_pred             HhccC-----------------------------------------------CCCccCCHHHHHHHHhhhhhchhhhcCC
Q 011698          362 IKDKI-----------------------------------------------KLPAFLSSEAHSLLKGLLQKEASKRLGS  394 (479)
Q Consensus       362 ~~~~~-----------------------------------------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~  394 (479)
                      ....-                                               ..+..+++++.+||++||+.||++||  
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~--  321 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI--  321 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC--
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC--
Confidence            53100                                               01125789999999999999999999  


Q ss_pred             CCCCHHHHHhCccccCCC---hhhhhcccCCCCCcc
Q 011698          395 GPGGSQEIKSHKWFKMIN---WKKLEARETRPSFLP  427 (479)
Q Consensus       395 ~~~t~~eil~hp~f~~~~---~~~l~~~~~~p~~~p  427 (479)
                         |++|+++||||+.+.   |.........+++.+
T Consensus       322 ---t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~  354 (388)
T 3oz6_A          322 ---SANDALKHPFVSIFHNPNEEPNCDHIITIPIND  354 (388)
T ss_dssp             ---CHHHHTTSTTTTTTCCGGGCCCCSSCCCCC---
T ss_pred             ---CHHHHhCCHHHHHhcCCccCCCCCCCCCCCccc
Confidence               999999999987753   433333444444544

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-50  Score=406.68  Aligned_cols=262  Identities=25%  Similarity=0.420  Sum_probs=218.6

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      ...+++|++++.||+|+||+||+|++..+++.||||+++.... .....+.+.+|+.+|++++||||+++++++.+...+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            3557899999999999999999999999999999999976542 233345577899999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe-----CCCCcEEEeecCCcccc
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL-----DADGHVMLTDFGLAKQF  300 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl-----~~~g~vkL~DFGla~~~  300 (479)
                      |+||||+.| +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+     +.++.+||+|||+++.+
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            999999985 999999998899999999999999999999999999999999999999     45556999999999876


Q ss_pred             CCC-CCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-----------
Q 011698          301 DEN-TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-----------  367 (479)
Q Consensus       301 ~~~-~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----------  367 (479)
                      ... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+......           
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence            433 334556789999999999875 4899999999999999999999999998887777776643110           


Q ss_pred             -------C------------CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          368 -------L------------PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       368 -------~------------p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                             +            +..++.++.+||.+||+.||++||     |++|+++||||++++|+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI-----SAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGSSSCSC
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCC-----CHHHHhCCcccCCCCCC
Confidence                   0            112789999999999999999999     99999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-50  Score=413.74  Aligned_cols=257  Identities=28%  Similarity=0.517  Sum_probs=233.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++++.||+|+||+||+|.++.+++.||+|++.....   .....+.+|+.+|++++||||+++++++.+...+|+|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            4789999999999999999999999999999999976432   2345678999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC--CCcEEEeecCCccccCCCCC
Q 011698          229 LDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~--~g~vkL~DFGla~~~~~~~~  305 (479)
                      |||+.||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++.......
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            99999999999887654 6999999999999999999999999999999999999974  57899999999998766655


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK  381 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~lI~  381 (479)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+......++    ..++.++.+||.
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  286 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK  286 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred             eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence            6667899999999999999999999999999999999999999999998888888888765544    468999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      +||+.||.+||     +++|+++||||++..+
T Consensus       287 ~~L~~dP~~Rp-----t~~ell~hp~~~~~~~  313 (387)
T 1kob_A          287 NLLQKEPRKRL-----TVHDALEHPWLKGDHS  313 (387)
T ss_dssp             TTSCSSGGGSC-----CHHHHHTSTTTSSCCT
T ss_pred             HHcCCChhHCc-----CHHHHhhCccccCCcc
Confidence            99999999999     9999999999998654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-49  Score=393.56  Aligned_cols=258  Identities=29%  Similarity=0.521  Sum_probs=240.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            46899999999999999999999999999999999877655566677889999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~  307 (479)
                      |||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  173 (294)
T 2rku_A           94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK  173 (294)
T ss_dssp             EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccc
Confidence            999999999999998889999999999999999999999999999999999999999999999999999876432 3345


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhc
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      ..+||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+....+......+|..++..+.+||.+||+.|
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  253 (294)
T 2rku_A          174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD  253 (294)
T ss_dssp             CCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             cccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHcccC
Confidence            57899999999999999999999999999999999999999999998888888888888899999999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHhCccccCC
Q 011698          388 ASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      |++||     +++++++||||...
T Consensus       254 p~~Rp-----s~~~ll~~~~~~~~  272 (294)
T 2rku_A          254 PTARP-----TINELLNDEFFTSG  272 (294)
T ss_dssp             GGGSC-----CGGGGGGSHHHHTS
T ss_pred             hhhCc-----CHHHHhhChheecC
Confidence            99999     89999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.2e-50  Score=429.13  Aligned_cols=261  Identities=31%  Similarity=0.559  Sum_probs=239.6

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|++.+.||+|+||+||+|+++.+++.||||++.+.........+.+.+|+.+|++++||||+++++++.+...+|+
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            34689999999999999999999999999999999987655444456778899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe---CCCCcEEEeecCCccccCCCC
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl---~~~g~vkL~DFGla~~~~~~~  304 (479)
                      ||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+....
T Consensus       104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  183 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK  183 (484)
T ss_dssp             EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence            99999999999999999999999999999999999999999999999999999999   567899999999999877666


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHHHH
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLL  380 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~lI  380 (479)
                      .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..++...+..+...++    ..+++++++||
T Consensus       184 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  262 (484)
T 3nyv_A          184 KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLI  262 (484)
T ss_dssp             SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHH
T ss_pred             ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHH
Confidence            6677889999999999987 599999999999999999999999999999999999998876554    46899999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                      ++||++||.+||     |++|+++||||+...+.
T Consensus       263 ~~~L~~dp~~R~-----s~~e~l~h~~~~~~~~~  291 (484)
T 3nyv_A          263 RKMLTYVPSMRI-----SARDALDHEWIQTYTKE  291 (484)
T ss_dssp             HHHTCSSGGGSC-----CHHHHHTSHHHHHHTC-
T ss_pred             HHHCCCChhHCc-----CHHHHhhChhhcccccc
Confidence            999999999999     99999999999876553

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.8e-50  Score=403.17  Aligned_cols=260  Identities=28%  Similarity=0.465  Sum_probs=210.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++++.||+|+||+||+|+++.+|+.||+|+++...  .....+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            468999999999999999999999999999999997653  222234577899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHc------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          229 LDFVNGGHLFFQLYRQ------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      |||++| +|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus        82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            999985 898888654      3589999999999999999999999999999999999999999999999999987653


Q ss_pred             C-CCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--------------
Q 011698          303 N-TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI--------------  366 (479)
Q Consensus       303 ~-~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--------------  366 (479)
                      . ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+.....              
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence            3 334566899999999999874 689999999999999999999999999888877777654200              


Q ss_pred             --------------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          367 --------------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       367 --------------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                                          ..+..++.++.+||.+||+.||++||     |++|+++||||+...|...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~~~~  305 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL-----SAKQALHHPWFAEYYHHAS  305 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSC-----CHHHHTTSGGGGGGCC---
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCC-----CHHHHhCChhhhcccchhh
Confidence                                11235788999999999999999999     9999999999999877544

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.8e-50  Score=407.45  Aligned_cols=255  Identities=33%  Similarity=0.565  Sum_probs=212.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++....     ..+.+.+|+.+|++++||||+++++++.+...+++|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            467999999999999999999999999999999997643     234577899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC---CCcEEEeecCCccccCCCCC
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~---~g~vkL~DFGla~~~~~~~~  305 (479)
                      |||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.......
T Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  206 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL  206 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence            999999999999998888999999999999999999999999999999999999975   89999999999988766555


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCC----ccCCHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKIKLP----AFLSSEAHSLL  380 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~s~~~~~lI  380 (479)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.... .+...+......++    ..++.++.+||
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  286 (349)
T 2w4o_A          207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV  286 (349)
T ss_dssp             ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred             cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHH
Confidence            56788999999999999999999999999999999999999999876544 46677777655443    46899999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      ++||+.||++||     +++|+++||||.+..+
T Consensus       287 ~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          287 RKLIVLDPKKRL-----TTFQALQHPWVTGKAA  314 (349)
T ss_dssp             HTTSCSSGGGSC-----CHHHHHHSTTTTSTTC
T ss_pred             HHHccCChhhCc-----CHHHHhcCcccCCCcc
Confidence            999999999999     9999999999998654

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.4e-50  Score=402.33  Aligned_cols=258  Identities=29%  Similarity=0.521  Sum_probs=240.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            46899999999999999999999999999999999887655666677889999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~  307 (479)
                      |||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus       120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  199 (335)
T 2owb_A          120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK  199 (335)
T ss_dssp             ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccccc
Confidence            999999999999998889999999999999999999999999999999999999999999999999999876432 3345


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhc
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      ..+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+|..++.++.+||++||+.|
T Consensus       200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  279 (335)
T 2owb_A          200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD  279 (335)
T ss_dssp             CCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred             ccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHccCC
Confidence            67899999999999999999999999999999999999999999988888888988888999999999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHhCccccCC
Q 011698          388 ASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      |++||     +++|+++|+||...
T Consensus       280 p~~Rp-----s~~ell~~~~~~~~  298 (335)
T 2owb_A          280 PTARP-----TINELLNDEFFTSG  298 (335)
T ss_dssp             GGGSC-----CGGGGGGSHHHHTS
T ss_pred             hhHCc-----CHHHHhcCccccCC
Confidence            99999     89999999999874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9e-50  Score=390.22  Aligned_cols=252  Identities=31%  Similarity=0.562  Sum_probs=234.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||+|+||+||+|+++.++..||+|++.+....   ..+.+.+|+.++++++||||+++++++.+...+|+||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            5799999999999999999999999999999999875432   2456789999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe---CCCCcEEEeecCCccccCCCCCc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl---~~~g~vkL~DFGla~~~~~~~~~  306 (479)
                      ||++|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..+......
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~  165 (277)
T 3f3z_A           86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM  165 (277)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence            999999999999988999999999999999999999999999999999999999   88899999999999887766666


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc----cCCHHHHHHHHh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKG  382 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~lI~~  382 (479)
                      ...+||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.+..+....+..+...+|.    .+++++.+||.+
T Consensus       166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  244 (277)
T 3f3z_A          166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR  244 (277)
T ss_dssp             CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHH
T ss_pred             hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHH
Confidence            778899999999999765 899999999999999999999999999999999999998888775    689999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      ||+.||.+||     ++.++++||||+.
T Consensus       245 ~l~~dp~~R~-----s~~~~l~h~~~~~  267 (277)
T 3f3z_A          245 LLTKSPKQRI-----TSLQALEHEWFEK  267 (277)
T ss_dssp             HTCSSTTTSC-----CHHHHTTSHHHHH
T ss_pred             HccCChhhCc-----CHHHHhcCHHHhc
Confidence            9999999999     9999999999976

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.1e-49  Score=390.08  Aligned_cols=265  Identities=30%  Similarity=0.505  Sum_probs=236.3

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhh------chHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEe
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI------MEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQ  220 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~  220 (479)
                      ..++|++.+.||+|+||.||+|+++.+++.||+|++.....      ......+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            35799999999999999999999999999999999976431      11234566788999999995 999999999999


Q ss_pred             eCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc
Q 011698          221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       221 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~  300 (479)
                      ....+++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCCcccccCCCCCcchhHhc------CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----c
Q 011698          301 DENTRSNSMCGTLEYMSPEIVL------GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----A  370 (479)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~------~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~  370 (479)
                      .........+||+.|+|||++.      ...++.++||||||+++|+|++|..||.+.+.......+..+...++    .
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  254 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccccc
Confidence            7666667788999999999985      45678999999999999999999999999888888888888766554    3


Q ss_pred             cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhh
Q 011698          371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLE  417 (479)
Q Consensus       371 ~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~  417 (479)
                      .++.++.+||.+||+.||.+||     +++++++||||+...|+.+.
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~  296 (298)
T 1phk_A          255 DYSDTVKDLVSRFLVVQPQKRY-----TAEEALAHPFFQQYVVEEVR  296 (298)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSC-----CHHHHTTSGGGCTTC-----
T ss_pred             ccCHHHHHHHHHHccCCcccCC-----CHHHHHhChHhhhccchhhc
Confidence            6899999999999999999999     99999999999999887653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.3e-50  Score=395.00  Aligned_cols=256  Identities=27%  Similarity=0.474  Sum_probs=216.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|++++.||+|+||+||+|++ .+++.||+|++..... .....+.+.+|+.++++++||||+++++++.+...+|+|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            46899999999999999999998 6788999999976542 222235577899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCc
Q 011698          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRS  306 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~  306 (479)
                      |||+.+ +|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ...
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            999986 888888764 67999999999999999999999999999999999999999999999999999876433 233


Q ss_pred             ccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--C-----------------
Q 011698          307 NSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--I-----------------  366 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~-----------------  366 (479)
                      ...+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+....  .                 
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            456899999999999774 58999999999999999999999999988777776665420  0                 


Q ss_pred             ----------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          367 ----------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       367 ----------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                                .+...++.++.+||++||+.||++||     +++|+++||||++.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~n  288 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI-----TAKQALEHAYFKENN  288 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSGGGGC--
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCC-----CHHHHhcCcchhhcC
Confidence                      11235789999999999999999999     999999999998754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.6e-50  Score=393.20  Aligned_cols=260  Identities=31%  Similarity=0.585  Sum_probs=208.5

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      .+++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.++++++||||+++++++.+...+|+
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            35789999999999999999999999999999999987654444445678899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CC
Q 011698          228 VLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TR  305 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~  305 (479)
                      ||||+++++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  168 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK  168 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence            99999999999999875 67999999999999999999999999999999999999999999999999999876432 23


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhh
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      ....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+.......+......+|..++.++.+||.+||+
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  248 (278)
T 3cok_A          169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLR  248 (278)
T ss_dssp             -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSC
T ss_pred             ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHcc
Confidence            34568999999999999999999999999999999999999999987777767777666777888999999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      .||++||     +++++++||||....
T Consensus       249 ~dp~~Rp-----s~~~~l~h~~~~~~~  270 (278)
T 3cok_A          249 RNPADRL-----SLSSVLDHPFMSRNS  270 (278)
T ss_dssp             SSGGGSC-----CHHHHTTSTTTC---
T ss_pred             cCHhhCC-----CHHHHhcCccccCCC
Confidence            9999999     999999999998743

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.5e-50  Score=397.92  Aligned_cols=257  Identities=30%  Similarity=0.552  Sum_probs=222.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhch-----------------------HHHHHHHHHHHHH
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----------------------KNHAEYMKSERNI  203 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~-----------------------~~~~~~~~~E~~i  203 (479)
                      +.+++|++.+.||+|+||+||+|++..+++.||||++.+.....                       ....+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            45689999999999999999999999999999999997654321                       1123567899999


Q ss_pred             HHhCCCCCeeeEeEEEee--CCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccE
Q 011698          204 LTKVDHPFIVQLRYSFQT--KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (479)
Q Consensus       204 L~~l~hp~Iv~l~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNI  281 (479)
                      |++++||||+++++++.+  ...+|+||||+++++|.+++ ..+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            999999999999999986  67899999999999997654 345799999999999999999999999999999999999


Q ss_pred             EeCCCCcEEEeecCCccccCCCC-CcccccCCCCCcchhHhcCCC---CCccccchhhHHHHHHHHhCCCCCCCCCHHHH
Q 011698          282 LLDADGHVMLTDFGLAKQFDENT-RSNSMCGTLEYMSPEIVLGKG---HDKAADWWSVGILLFEMLTGQPPFTGGNRQKI  357 (479)
Q Consensus       282 Ll~~~g~vkL~DFGla~~~~~~~-~~~~~~gt~~y~APE~l~~~~---~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~  357 (479)
                      |++.+|.+||+|||+++.+.... .....+||+.|+|||++.+..   ++.++|||||||++|+|++|+.||.+.+...+
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            99999999999999998765432 345678999999999998765   37889999999999999999999999888888


Q ss_pred             HHHHHhccCCCC--ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCcccc
Q 011698          358 QQKIIKDKIKLP--AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK  409 (479)
Q Consensus       358 ~~~i~~~~~~~p--~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~  409 (479)
                      ...+......+|  ..++.++.+||.+||+.||++||     +++|+++||||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~-----s~~e~l~hp~~~  297 (298)
T 2zv2_A          249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRI-----VVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC-----CHHHHTTCHHHH
T ss_pred             HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCC-----CHHHHhcCcccc
Confidence            888888766655  46899999999999999999999     999999999995

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.8e-49  Score=414.77  Aligned_cols=265  Identities=25%  Similarity=0.405  Sum_probs=217.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC-----C
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----Y  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~  223 (479)
                      .++|++++.||+|+||+||+|+++.+++.||||++.+.. ......+.+.+|+.+|++++||||+++++++...     .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            468999999999999999999999999999999997643 2344566788999999999999999999999776     5


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      .+|+||||+.+ +|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       104 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          104 ELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             CEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             eEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            79999999974 99999998888999999999999999999999999999999999999999999999999999876433


Q ss_pred             C-----------------------CcccccCCCCCcchhHh-cCCCCCccccchhhHHHHHHHHhC-----------CCC
Q 011698          304 T-----------------------RSNSMCGTLEYMSPEIV-LGKGHDKAADWWSVGILLFEMLTG-----------QPP  348 (479)
Q Consensus       304 ~-----------------------~~~~~~gt~~y~APE~l-~~~~~~~~~DiwSLGvilyelltG-----------~~P  348 (479)
                      .                       .....+||+.|+|||++ .+..|+.++|||||||++|||++|           .++
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            2                       23567899999999997 456799999999999999999984           444


Q ss_pred             CCCCCH-----------------HHHHHHHHh------------------------ccCCCC-------ccCCHHHHHHH
Q 011698          349 FTGGNR-----------------QKIQQKIIK------------------------DKIKLP-------AFLSSEAHSLL  380 (479)
Q Consensus       349 f~~~~~-----------------~~~~~~i~~------------------------~~~~~p-------~~~s~~~~~lI  380 (479)
                      |.+.+.                 ......|..                        .....+       +.+++++.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence            544321                 111111111                        111111       35899999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhccc
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARE  420 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~  420 (479)
                      ++||+.||++||     |++|+++||||+.+.|...+...
T Consensus       343 ~~mL~~dP~~R~-----ta~e~L~Hp~f~~~~~~~~e~~~  377 (432)
T 3n9x_A          343 ESMLKFNPNKRI-----TIDQALDHPYLKDVRKKKLENFS  377 (432)
T ss_dssp             HHHSCSSTTTSC-----CHHHHHTCGGGTTTCCTTTC---
T ss_pred             HHHhcCCcccCC-----CHHHHhcChhhhhccCcccCcCC
Confidence            999999999999     99999999999999998876543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.6e-50  Score=424.43  Aligned_cols=260  Identities=31%  Similarity=0.566  Sum_probs=233.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      +...++|++++.||+|+||+||+|+++.+++.||||++.+...... ....+.+|+.+|++++||||+++++++.+...+
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   96 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence            3445789999999999999999999999999999999987543322 345678999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeC---CCCcEEEeecCCccccCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD---ADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~---~~g~vkL~DFGla~~~~~  302 (479)
                      |+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||+++.+..
T Consensus        97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            99999999999999999889999999999999999999999999999999999999995   556899999999988776


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHH
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHS  378 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  378 (479)
                      .......+||+.|+|||++.+. |+.++|||||||++|+|++|..||.+.+..++...+..+...++    ..++.++++
T Consensus       177 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  255 (486)
T 3mwu_A          177 NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD  255 (486)
T ss_dssp             C----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred             CCccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHH
Confidence            6666778899999999999874 99999999999999999999999999999999999998866544    468999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      ||++||+.||.+||     |+.++++||||+...
T Consensus       256 li~~~L~~dp~~R~-----t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          256 LIRKMLTFHPSLRI-----TATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHTCSSTTTSC-----CHHHHHHCHHHHHTC
T ss_pred             HHHHHcCCChhhCc-----CHHHHhcCHhhccCc
Confidence            99999999999999     999999999998764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.3e-49  Score=423.54  Aligned_cols=257  Identities=32%  Similarity=0.546  Sum_probs=232.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH----------HHHHHHHHHHHHHHhCCCCCeeeEeEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK----------NHAEYMKSERNILTKVDHPFIVQLRYS  218 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~----------~~~~~~~~E~~iL~~l~hp~Iv~l~~~  218 (479)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.+......          ...+.+.+|+.+|++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4789999999999999999999999999999999987543221          234668899999999999999999999


Q ss_pred             EeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC---cEEEeecC
Q 011698          219 FQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDFG  295 (479)
Q Consensus       219 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g---~vkL~DFG  295 (479)
                      +.+...+|+|||||+||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  194 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG  194 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence            999999999999999999999999889999999999999999999999999999999999999998876   69999999


Q ss_pred             CccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----cc
Q 011698          296 LAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AF  371 (479)
Q Consensus       296 la~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~  371 (479)
                      +++.+.........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++...+..+...++    ..
T Consensus       195 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  273 (504)
T 3q5i_A          195 LSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKN  273 (504)
T ss_dssp             TCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTT
T ss_pred             CCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCC
Confidence            9998877666777899999999999875 589999999999999999999999999999999999999887766    56


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ++.++++||++||+.||.+||     |++|+++||||+..
T Consensus       274 ~s~~~~~li~~~L~~dp~~R~-----t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          274 ISDEAKELIKLMLTYDYNKRC-----TAEEALNSRWIKKY  308 (504)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHHT
T ss_pred             CCHHHHHHHHHHcCCChhHCC-----CHHHHhcCHhhhhc
Confidence            899999999999999999999     99999999999865

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.5e-50  Score=422.01  Aligned_cols=253  Identities=26%  Similarity=0.424  Sum_probs=214.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC------
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------  222 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------  222 (479)
                      .++|++++.||+|+||+||+|++..+++.||||++.+.. ......+.+.+|+.+|+.++||||+++++++...      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            578999999999999999999999999999999998653 2344566788999999999999999999999654      


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      ..+|+||||++++ |...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++....
T Consensus       140 ~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          140 QDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             CEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             CeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            4679999999875 555554  3489999999999999999999999999999999999999999999999999998776


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC----------------
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI----------------  366 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~----------------  366 (479)
                      .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+...+|.....                
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~  296 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  296 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred             CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence            6666778999999999999999999999999999999999999999999888777777654211                


Q ss_pred             -----------C----CCcc-----------CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          367 -----------K----LPAF-----------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       367 -----------~----~p~~-----------~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                                 .    +|..           .++++.+||++||+.||++||     |++|+++||||+.
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~-----ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-----SVDDALQHPYINV  361 (464)
T ss_dssp             HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC-----CHHHHHTSTTTGG
T ss_pred             HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCC-----CHHHHhcChhhhh
Confidence                       0    0111           156799999999999999999     9999999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=407.73  Aligned_cols=258  Identities=29%  Similarity=0.502  Sum_probs=228.5

Q ss_pred             CeEE--EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          151 DFEV--LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       151 ~y~~--~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .|++  .+.||+|+||+||+|++..+|+.||+|+++....   ...+.+.+|+.+|++++||||+++++++.+...+|+|
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  164 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV  164 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            3444  6789999999999999999999999999987542   3345688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe--CCCCcEEEeecCCccccCCCCC
Q 011698          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL--DADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl--~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      |||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+  +.++.+||+|||+++.+.....
T Consensus       165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~  244 (373)
T 2x4f_A          165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK  244 (373)
T ss_dssp             EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred             EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence            9999999999888654 468999999999999999999999999999999999999  6778999999999998876666


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK  381 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~lI~  381 (479)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+......++    ..++.++.+||.
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  324 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS  324 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence            6777899999999999999999999999999999999999999999999999999988766655    468999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                      +||+.||.+||     +++|+++||||+...|...
T Consensus       325 ~~L~~dp~~Rp-----s~~e~l~hp~~~~~~~~~~  354 (373)
T 2x4f_A          325 KLLIKEKSWRI-----SASEALKHPWLSDHKLHSR  354 (373)
T ss_dssp             TTSCSSGGGSC-----CHHHHHHSHHHHCHHHHHH
T ss_pred             HHcCCChhhCC-----CHHHHhcCcCcCCCchhhh
Confidence            99999999999     9999999999999876543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4e-50  Score=403.59  Aligned_cols=257  Identities=30%  Similarity=0.488  Sum_probs=221.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            5799999999999999999999999999999999976432  22335678999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC---CC
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TR  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~---~~  305 (479)
                      |||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...   ..
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence            999999999999988888999999999999999999999999999999999999999999999999999865322   23


Q ss_pred             cccccCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCC--CccCCHHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKIKL--PAFLSSEAHSLLK  381 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~--p~~~s~~~~~lI~  381 (479)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.. .............  ...++.++.+||.
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHH
Confidence            356789999999999988776 78999999999999999999999875543 2233333332222  2568999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      +||+.||++||     +++|+++||||+...
T Consensus       244 ~~L~~dP~~R~-----t~~eil~h~~~~~~~  269 (323)
T 3tki_A          244 KILVENPSARI-----TIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHSCSSTTTSC-----CHHHHTTCTTTTCCC
T ss_pred             HHccCChhhCc-----CHHHHhhChhhcccc
Confidence            99999999999     999999999998753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-49  Score=390.73  Aligned_cols=255  Identities=29%  Similarity=0.517  Sum_probs=222.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|++.+.||+|+||+||+|+++.++..||+|++.....  ....+.+.+|+.+|++++||||+++++++.+...+|+
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   97 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI   97 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence            34789999999999999999999999999999999987542  2235668899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe---CCCCcEEEeecCCcccc
Q 011698          228 VLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQF  300 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl---~~~g~vkL~DFGla~~~  300 (479)
                      ||||++||+|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.+
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            9999999999988854    3679999999999999999999999999999999999999   55688999999999887


Q ss_pred             CCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC---ccCCHHHH
Q 011698          301 DENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP---AFLSSEAH  377 (479)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s~~~~  377 (479)
                      .........+||+.|+|||++. ..++.++|||||||++|||++|+.||.+.+.......+......++   ..+++++.
T Consensus       178 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (285)
T 3is5_A          178 KSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV  256 (285)
T ss_dssp             ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred             CCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence            6666667788999999999986 4689999999999999999999999999998888888877655544   34789999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      +||++||+.||++||     +++|+++||||+.
T Consensus       257 ~li~~~L~~dP~~Rp-----s~~e~l~hp~f~~  284 (285)
T 3is5_A          257 DLLKQMLTKDPERRP-----SAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHTCSCTTTSC-----CHHHHHTSGGGGC
T ss_pred             HHHHHHccCChhhCc-----CHHHHhcCHHhhc
Confidence            999999999999999     9999999999985

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.9e-50  Score=391.09  Aligned_cols=262  Identities=32%  Similarity=0.544  Sum_probs=232.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH---HHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ++|++++.||+|+||+||+|+++.+++.||+|++........   ...+.+.+|+.++++++||||+++++++.+...++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            579999999999999999999999999999999987543221   12566889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC----cEEEeecCCccccCC
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG----HVMLTDFGLAKQFDE  302 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g----~vkL~DFGla~~~~~  302 (479)
                      +||||+++++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++    .+||+|||++.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999999888999999999999999999999999999999999999999887    899999999988766


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHH
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHS  378 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  378 (479)
                      ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+......++    ..++..+.+
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD  244 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred             CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHH
Confidence            5555667899999999999999999999999999999999999999999988888888887766554    467899999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                      ||.+||+.||++||     +++++++||||+.+.|...
T Consensus       245 li~~~l~~dp~~Rp-----s~~~~l~h~~~~~~~~~~~  277 (283)
T 3bhy_A          245 FIRRLLVKDPKRRM-----TIAQSLEHSWIKAIRRRNV  277 (283)
T ss_dssp             HHHTTSCSSGGGSC-----CHHHHHHCHHHHHHHHCCC
T ss_pred             HHHHHccCCHhHCc-----CHHHHHhCHHHHHHHHHhh
Confidence            99999999999999     9999999999998766443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=395.25  Aligned_cols=259  Identities=27%  Similarity=0.392  Sum_probs=219.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhch--HHHHHHHHHHHHHHHhC---CCCCeeeEeEEEee
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNILTKV---DHPFIVQLRYSFQT  221 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~  221 (479)
                      +..++|++++.||+|+||+||+|++..+++.||+|++.......  ......+.+|+.+++++   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            34579999999999999999999999999999999997543211  11122345677776665   59999999999987


Q ss_pred             CC-----eEEEEEEeccCCcHHHHHHHcCC--CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeec
Q 011698          222 KY-----RLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDF  294 (479)
Q Consensus       222 ~~-----~~~lV~E~~~ggsL~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DF  294 (479)
                      ..     .+++||||+.+ +|..++.....  +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            65     58999999975 99999987654  999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-------
Q 011698          295 GLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-------  367 (479)
Q Consensus       295 Gla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-------  367 (479)
                      |+++...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+......++......       
T Consensus       165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            9999877666667789999999999999999999999999999999999999999999888888777653110       


Q ss_pred             --------------------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          368 --------------------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       368 --------------------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                          ....++.++.+||.+||+.||++||     |++|+++||||+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~h~~~~~~  303 (308)
T 3g33_A          245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI-----SAFRALQHSYLHKD  303 (308)
T ss_dssp             SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSTTC---
T ss_pred             chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCC-----CHHHHhcCccccCC
Confidence                                1135789999999999999999999     99999999999874

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=8.6e-50  Score=401.30  Aligned_cols=265  Identities=27%  Similarity=0.466  Sum_probs=229.2

Q ss_pred             CCeEEE-EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEEE
Q 011698          150 EDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       150 ~~y~~~-~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ++|.+. +.||+|+||+||+|+++.+++.||+|++.+..... .....+.+|+.+++.+. ||||+++++++.+...+|+
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            468887 89999999999999999999999999998754322 23456788999999984 6999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC---CCcEEEeecCCccccCC
Q 011698          228 VLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~---~g~vkL~DFGla~~~~~  302 (479)
                      ||||+.||+|..++...  +.+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            99999999999888543  67999999999999999999999999999999999999988   78999999999998776


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHH
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHS  378 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  378 (479)
                      .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......++    ..++..+.+
T Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  266 (327)
T 3lm5_A          187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATD  266 (327)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHH
Confidence            6666678899999999999999999999999999999999999999999998888888887655443    458999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhccc
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARE  420 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~  420 (479)
                      ||.+||+.||.+||     +++++++||||+.++|..+....
T Consensus       267 li~~~L~~dP~~Rp-----t~~~ll~h~~~~~~~~~~~~~~~  303 (327)
T 3lm5_A          267 FIQSLLVKNPEKRP-----TAEICLSHSWLQQWDFENLFHPE  303 (327)
T ss_dssp             HHHHHSCSSGGGSC-----CHHHHTTCGGGCCCCTTCC----
T ss_pred             HHHHHcCCChhhCc-----CHHHHhCCHhhcccccccccCcc
Confidence            99999999999999     99999999999999998765443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.2e-49  Score=412.14  Aligned_cols=250  Identities=30%  Similarity=0.532  Sum_probs=212.6

Q ss_pred             CCCCeEEE-EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHH-hCCCCCeeeEeEEEee----
Q 011698          148 GLEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT-KVDHPFIVQLRYSFQT----  221 (479)
Q Consensus       148 ~~~~y~~~-~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~~~~----  221 (479)
                      .+++|.++ +.||+|+||+||+|+++.+++.||||+++..        ..+.+|+.++. ..+||||++++++|..    
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~  130 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG  130 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence            45789888 7899999999999999999999999999643        23567787764 4689999999999876    


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC---CCcEEEeecCC
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGL  296 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~---~g~vkL~DFGl  296 (479)
                      ...+|+|||||.||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus       131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            678999999999999999998754  5999999999999999999999999999999999999998   78999999999


Q ss_pred             ccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCCCC---
Q 011698          297 AKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ----KIQQKIIKDKIKLP---  369 (479)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~----~~~~~i~~~~~~~p---  369 (479)
                      ++...........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..    .+...+..+...+|   
T Consensus       211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~  290 (400)
T 1nxk_A          211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  290 (400)
T ss_dssp             CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred             ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence            99876666667789999999999999999999999999999999999999999875432    25666777766665   


Q ss_pred             -ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          370 -AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       370 -~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                       ..++.++.+||++||+.||++||     |++|+++||||..
T Consensus       291 ~~~~s~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~  327 (400)
T 1nxk_A          291 WSEVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWIMQ  327 (400)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSC-----CHHHHHHSHHHHT
T ss_pred             cccCCHHHHHHHHHHCCCChhHCc-----CHHHHhcCccccC
Confidence             46899999999999999999999     9999999999976

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.5e-50  Score=405.44  Aligned_cols=259  Identities=27%  Similarity=0.491  Sum_probs=229.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH-----HHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK-----NHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      .++|++++.||+|+||+||+|+++.+++.||||++.+......     ...+.+.+|+.+|++++||||+++++++.+..
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            3689999999999999999999999999999999987543221     12334677999999999999999999999999


Q ss_pred             eEEEEEEeccCC-cHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 RLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 ~~~lV~E~~~gg-sL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      .+++||||+.+| +|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  182 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER  182 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence            999999999777 9999999988999999999999999999999999999999999999999999999999999998877


Q ss_pred             CCCcccccCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHH
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK  381 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~  381 (479)
                      .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....      .........|..++.++.+||.
T Consensus       183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l~~li~  256 (335)
T 3dls_A          183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKELMSLVS  256 (335)
T ss_dssp             TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHHHHHHH
T ss_pred             CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHHHHHHH
Confidence            666677899999999999998877 889999999999999999999997622      2334455667789999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccC------CChhhhhc
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKM------INWKKLEA  418 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~------~~~~~l~~  418 (479)
                      +||+.||.+||     +++++++||||+.      .+|+.+..
T Consensus       257 ~~L~~dP~~Rp-----s~~ell~hp~~~~~~~~~~~~~~~~~~  294 (335)
T 3dls_A          257 GLLQPVPERRT-----TLEKLVTDPWVTQPVNLADYTWEEVFR  294 (335)
T ss_dssp             HHTCSSGGGSC-----CHHHHHHCTTTTCCCCGGGCCHHHHC-
T ss_pred             HHccCChhhCc-----CHHHHhcCccccCCccccccCHHHHhh
Confidence            99999999999     9999999999965      55665543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2e-49  Score=421.18  Aligned_cols=257  Identities=33%  Similarity=0.572  Sum_probs=229.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||+||+|+++.++..||+|++.+...... ....+.+|+.+|+.++||||++++++|.+...+|+||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            579999999999999999999999999999999987543222 2456788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC---CcEEEeecCCccccCCCCCc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD---GHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~---g~vkL~DFGla~~~~~~~~~  306 (479)
                      ||+.||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..   +.+||+|||+++.+......
T Consensus       116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~  195 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM  195 (494)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence            999999999999988999999999999999999999999999999999999999764   45999999999987766666


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHHHHHh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLKG  382 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~lI~~  382 (479)
                      ...+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..++...+..+...++    ..++.++++||++
T Consensus       196 ~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  274 (494)
T 3lij_A          196 KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ  274 (494)
T ss_dssp             CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHH
T ss_pred             cccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHH
Confidence            77899999999999874 599999999999999999999999999999999999998877665    3589999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      ||+.||.+||     |++|+++||||+...+
T Consensus       275 ~L~~dp~~R~-----s~~e~l~hp~~~~~~~  300 (494)
T 3lij_A          275 MLQFDSQRRI-----SAQQALEHPWIKEMCS  300 (494)
T ss_dssp             HTCSSTTTSC-----CHHHHHTCHHHHHHHH
T ss_pred             HCCCChhhCc-----cHHHHhcCcccccCcc
Confidence            9999999999     9999999999987544

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.9e-49  Score=395.18  Aligned_cols=258  Identities=31%  Similarity=0.553  Sum_probs=218.8

Q ss_pred             CCCeEEE-EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEE
Q 011698          149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       149 ~~~y~~~-~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~  226 (479)
                      .+.|++. +.||+|+||+||+|++..+++.||||++.+..   ....+.+.+|+.+|+++ +||||+++++++.+.+.+|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            3679986 78999999999999999999999999997653   22345678899999985 7999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc---EEEeecCCccccCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFGLAKQFDEN  303 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~---vkL~DFGla~~~~~~  303 (479)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999999999999998889999999999999999999999999999999999999998876   999999999865321


Q ss_pred             --------CCcccccCCCCCcchhHhcC-----CCCCccccchhhHHHHHHHHhCCCCCCCCC---------------HH
Q 011698          304 --------TRSNSMCGTLEYMSPEIVLG-----KGHDKAADWWSVGILLFEMLTGQPPFTGGN---------------RQ  355 (479)
Q Consensus       304 --------~~~~~~~gt~~y~APE~l~~-----~~~~~~~DiwSLGvilyelltG~~Pf~~~~---------------~~  355 (479)
                              ......+||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+.+               ..
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence                    12234679999999999975     457899999999999999999999998754               34


Q ss_pred             HHHHHHHhccCCCCc----cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          356 KIQQKIIKDKIKLPA----FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       356 ~~~~~i~~~~~~~p~----~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                      .+...+..+...+|.    .++.++++||++||+.||.+||     +++|+++||||++..|.
T Consensus       248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~~~~  305 (316)
T 2ac3_A          248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL-----SAAQVLQHPWVQGCAPE  305 (316)
T ss_dssp             HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSTTCC-----
T ss_pred             HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCC-----CHHHHhcChhhcCCCCc
Confidence            567777777777773    5899999999999999999999     99999999999987664

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-49  Score=401.43  Aligned_cols=260  Identities=31%  Similarity=0.521  Sum_probs=226.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc--hHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM--EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++.+....  .....+.+.+|+.++++++||||+++++++.+...+|+
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            5799999999999999999999999999999999876432  23456778899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHH----------------------------------------cCCCcHHHHHHHHHHHHHHHHHHH
Q 011698          228 VLDFVNGGHLFFQLYR----------------------------------------QGLFREDLARIYTAEIVSAVSHLH  267 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~----------------------------------------~~~l~e~~~~~~~~qi~~aL~~LH  267 (479)
                      ||||++||+|.+++..                                        ...+++..++.++.||+.||.|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            9999999999988742                                        112467888899999999999999


Q ss_pred             hCCCccCCCCCccEEeCCCC--cEEEeecCCccccCCCC-----CcccccCCCCCcchhHhcC--CCCCccccchhhHHH
Q 011698          268 ANGIMHRDLKPENILLDADG--HVMLTDFGLAKQFDENT-----RSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGIL  338 (479)
Q Consensus       268 ~~~IiHrDLKpeNILl~~~g--~vkL~DFGla~~~~~~~-----~~~~~~gt~~y~APE~l~~--~~~~~~~DiwSLGvi  338 (479)
                      ++||+||||||+|||++.++  .+||+|||+++.+....     .....+||+.|+|||++.+  ..++.++|||||||+
T Consensus       186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i  265 (345)
T 3hko_A          186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL  265 (345)
T ss_dssp             HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred             HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence            99999999999999998777  89999999998753321     2356789999999999976  678999999999999


Q ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc----cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          339 LFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       339 lyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                      +|||++|+.||.+.+..+....+......++.    .+++++.+||.+||+.||.+||     ++.++++||||+.+.|.
T Consensus       266 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF-----DAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC-----CHHHHHHSHHHHTTSSC
T ss_pred             HHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCC-----CHHHHhcChhhccChHh
Confidence            99999999999999998888888887665543    4799999999999999999999     99999999999998653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.1e-48  Score=399.89  Aligned_cols=255  Identities=32%  Similarity=0.554  Sum_probs=232.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhh-----chHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCC
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-----MEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY  223 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~  223 (479)
                      ++|++.+.||+|+||.||+|+++.+|+.||||+++....     ......+.+.+|+.+++++ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            579999999999999999999999999999999976431     1123356678999999999 8999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      ..|+||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+...
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~  253 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG  253 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999988776


Q ss_pred             CCcccccCCCCCcchhHhcC------CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCC
Q 011698          304 TRSNSMCGTLEYMSPEIVLG------KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLS  373 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~------~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s  373 (479)
                      ......+||+.|+|||++.+      ..++.++|||||||++|+|++|..||.+.+.......+..+...++    ..++
T Consensus       254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  333 (365)
T 2y7j_A          254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS  333 (365)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSC
T ss_pred             cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence            66777899999999999964      3578999999999999999999999999888888888888776654    4688


Q ss_pred             HHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCcccc
Q 011698          374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK  409 (479)
Q Consensus       374 ~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~  409 (479)
                      .++.+||++||+.||++||     +++++++||||+
T Consensus       334 ~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~f~  364 (365)
T 2y7j_A          334 STVKDLISRLLQVDPEARL-----TAEQALQHPFFE  364 (365)
T ss_dssp             HHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGC
T ss_pred             HHHHHHHHHHcCCChhHCc-----CHHHHhcCcccC
Confidence            9999999999999999999     999999999996

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.5e-49  Score=402.63  Aligned_cols=270  Identities=28%  Similarity=0.437  Sum_probs=217.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-----
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----  223 (479)
                      .++|++++.||+|+||+||+|++..+++.||||++.... ......+.+.+|+.+++.++||||+++++++....     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            478999999999999999999999999999999998643 23445566889999999999999999999997665     


Q ss_pred             -eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 -RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 -~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                       .+|+||||+.+ +|...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence             78999999986 6777775  4589999999999999999999999999999999999999999999999999987765


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC----------------
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI----------------  366 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~----------------  366 (479)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.....                
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  259 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT  259 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred             ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence            5555667899999999999999999999999999999999999999999888777766654211                


Q ss_pred             ------CC--------------Cc------cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhccc
Q 011698          367 ------KL--------------PA------FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARE  420 (479)
Q Consensus       367 ------~~--------------p~------~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~  420 (479)
                            .+              |.      ..+.++++||++||+.||++||     |++|+++||||+..  .......
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~-----t~~e~l~hp~~~~~--~~~~~~~  332 (371)
T 2xrw_A          260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI-----SVDEALQHPYINVW--YDPSEAE  332 (371)
T ss_dssp             HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSC-----CHHHHHHSHHHHTT--CCHHHHT
T ss_pred             HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCC-----CHHHHhCCcchhhh--cCccccC
Confidence                  10              00      1256899999999999999999     99999999999863  3333344


Q ss_pred             CCCCCcccc
Q 011698          421 TRPSFLPEV  429 (479)
Q Consensus       421 ~~p~~~p~~  429 (479)
                      ..|+..|..
T Consensus       333 ~~~~~~~~~  341 (371)
T 2xrw_A          333 APPPKIPDK  341 (371)
T ss_dssp             CCCCCCCTT
T ss_pred             CCCCCCCCh
Confidence            455565543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.2e-49  Score=396.87  Aligned_cols=259  Identities=26%  Similarity=0.435  Sum_probs=224.6

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe---
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR---  224 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~---  224 (479)
                      ..++|++.+.||+|+||+||+|++..+++.||+|+++............+.+|+.++++++||||+++++++.....   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            35789999999999999999999999999999999988665556667778999999999999999999999876553   


Q ss_pred             -EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          225 -LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       225 -~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                       .|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence             4999999999999999998899999999999999999999999999999999999999999999999999999876433


Q ss_pred             C----CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHH
Q 011698          304 T----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSE  375 (479)
Q Consensus       304 ~----~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~  375 (479)
                      .    .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......+    ..++.+
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD  249 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHH
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHH
Confidence            2    23456799999999999999999999999999999999999999999888888777777654433    458999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +.+||.+||++||.+||     ++.+++.|+|++..
T Consensus       250 l~~li~~~l~~dP~~R~-----~~~~~l~~~l~~~~  280 (311)
T 3ork_A          250 LDAVVLKALAKNPENRY-----QTAAEMRADLVRVH  280 (311)
T ss_dssp             HHHHHHHHTCSSGGGSC-----SSHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCHhhCh-----hhHHHHHHHHHHHh
Confidence            99999999999999999     78999999998753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.7e-48  Score=396.07  Aligned_cols=252  Identities=29%  Similarity=0.432  Sum_probs=220.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-----CCCeeeEeEEEe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----HPFIVQLRYSFQ  220 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-----hp~Iv~l~~~~~  220 (479)
                      .+..++|+++++||+|+||+||+|++..+++.||||+++...    ........|+.+++.+.     ||||+++++++.
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            345679999999999999999999999999999999997532    23455678999999986     999999999999


Q ss_pred             eCCeEEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC-------------
Q 011698          221 TKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-------------  285 (479)
Q Consensus       221 ~~~~~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~-------------  285 (479)
                      ..+.+|+||||+ +++|.+++.+..  .+++..++.++.||+.||.|||++||+||||||+|||++.             
T Consensus       107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence            999999999999 889999998764  5899999999999999999999999999999999999975             


Q ss_pred             ------------CCcEEEeecCCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 011698          286 ------------DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN  353 (479)
Q Consensus       286 ------------~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~  353 (479)
                                  ++.+||+|||+++....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence                        88999999999987543  3346789999999999999999999999999999999999999999888


Q ss_pred             HHHHHHHHHhccCCCCc----------------------------------------------cCCHHHHHHHHhhhhhc
Q 011698          354 RQKIQQKIIKDKIKLPA----------------------------------------------FLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       354 ~~~~~~~i~~~~~~~p~----------------------------------------------~~s~~~~~lI~~~L~~d  387 (479)
                      ..+....+......+|.                                              ..++.+.+||.+||+.|
T Consensus       264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  343 (360)
T 3llt_A          264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID  343 (360)
T ss_dssp             HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence            77777666554333321                                              12377889999999999


Q ss_pred             hhhhcCCCCCCHHHHHhCcccc
Q 011698          388 ASKRLGSGPGGSQEIKSHKWFK  409 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~hp~f~  409 (479)
                      |++||     |++|+++||||+
T Consensus       344 P~~Rp-----ta~elL~hp~f~  360 (360)
T 3llt_A          344 PTLRP-----SPAELLKHKFLE  360 (360)
T ss_dssp             GGGSC-----CHHHHTTSGGGC
T ss_pred             hhhCC-----CHHHHhcCcccC
Confidence            99999     999999999996

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-49  Score=399.41  Aligned_cols=251  Identities=32%  Similarity=0.600  Sum_probs=205.3

Q ss_pred             CCeEEE---EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeE
Q 011698          150 EDFEVL---KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       150 ~~y~~~---~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~  225 (479)
                      ++|++.   +.||+|+||+||+|+++.+++.||+|++.+..      ...+.+|+.+++.+. ||||+++++++.+....
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~   81 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT   81 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence            457765   78999999999999999999999999997642      344678999999997 99999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC---cEEEeecCCccccCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDFGLAKQFDE  302 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g---~vkL~DFGla~~~~~  302 (479)
                      |+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            99999999999999999999999999999999999999999999999999999999998766   899999999987543


Q ss_pred             C-CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhccCCCCc----
Q 011698          303 N-TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN-------RQKIQQKIIKDKIKLPA----  370 (479)
Q Consensus       303 ~-~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~~~~p~----  370 (479)
                      . ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+       ..++...+..+...++.    
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (325)
T 3kn6_A          162 DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK  241 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHH
T ss_pred             CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccccc
Confidence            3 33456789999999999999999999999999999999999999998643       35677788887776663    


Q ss_pred             cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       371 ~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      .++.++++||++||+.||.+||     +++|+++||||++.
T Consensus       242 ~~s~~~~~li~~~L~~dP~~Rp-----t~~ell~h~w~~~~  277 (325)
T 3kn6_A          242 NVSQEAKDLIQGLLTVDPNKRL-----KMSGLRYNEWLQDG  277 (325)
T ss_dssp             TSCHHHHHHHHHHHCCCTTTCC-----CTTTSTTCGGGCTT
T ss_pred             CCCHHHHHHHHHHCCCChhHCC-----CHHHHhcChhhccC
Confidence            5899999999999999999999     89999999999874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=399.21  Aligned_cols=258  Identities=27%  Similarity=0.447  Sum_probs=215.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|++++.||+|+||+||+|+++.+++.||+|+++....  ......+.+|+.+|++++||||+++++++.+...+++|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            4689999999999999999999999999999999975431  11112345799999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCc
Q 011698          229 LDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRS  306 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~  306 (479)
                      |||+.| +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ...
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence            999985 888888765 45899999999999999999999999999999999999999999999999999865433 233


Q ss_pred             ccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-------------------
Q 011698          307 NSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-------------------  366 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-------------------  366 (479)
                      ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....                   
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            45688999999999987 5689999999999999999999999999888877777665211                   


Q ss_pred             C-----------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          367 K-----------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       367 ~-----------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                      .           .+..++.++.+||++||+.||++||     |++|+++||||.++.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI-----SAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC-----CHHHHTTSGGGGGGCST
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC-----CHHHHhcChhhhhcccc
Confidence            0           1124788999999999999999999     99999999999987653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.3e-49  Score=394.74  Aligned_cols=254  Identities=28%  Similarity=0.430  Sum_probs=212.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-----
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----  223 (479)
                      +++|++++.||+|+||+||+|+++.+++.||||+++...  .....+.+.+|+.+|++++||||++++++|.+..     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            468999999999999999999999999999999998643  2334567889999999999999999999986543     


Q ss_pred             ----------------------------------------------------eEEEEEEeccCCcHHHHHHHcCC---Cc
Q 011698          224 ----------------------------------------------------RLYLVLDFVNGGHLFFQLYRQGL---FR  248 (479)
Q Consensus       224 ----------------------------------------------------~~~lV~E~~~ggsL~~~l~~~~~---l~  248 (479)
                                                                          .+++||||++||+|.+++.+...   ..
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                38999999999999999987654   45


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-------------CcccccCCCCC
Q 011698          249 EDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-------------RSNSMCGTLEY  315 (479)
Q Consensus       249 e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-------------~~~~~~gt~~y  315 (479)
                      +..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......             .....+||+.|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            56788999999999999999999999999999999999999999999998865432             23456799999


Q ss_pred             cchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CCccCCHHHHHHHHhhhhhchhhhcCC
Q 011698          316 MSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-LPAFLSSEAHSLLKGLLQKEASKRLGS  394 (479)
Q Consensus       316 ~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~lI~~~L~~dP~~R~~~  394 (479)
                      +|||++.+..++.++|||||||++|||++|..|+..  .......+...... .+...++++.+||.+||+.||++||  
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--  318 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP--  318 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC--
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCC--
Confidence            999999999999999999999999999998777531  22233333333221 1234678899999999999999999  


Q ss_pred             CCCCHHHHHhCccccCC
Q 011698          395 GPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       395 ~~~t~~eil~hp~f~~~  411 (479)
                         +++|+++||||+++
T Consensus       319 ---s~~~~l~~~~f~~~  332 (332)
T 3qd2_B          319 ---EATDIIENAIFENL  332 (332)
T ss_dssp             ---CHHHHHHSTTCCCC
T ss_pred             ---CHHHHhhchhhhcC
Confidence               99999999999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.1e-49  Score=395.29  Aligned_cols=265  Identities=29%  Similarity=0.439  Sum_probs=226.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ..+++|++++.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.+...+|
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence            346899999999999999999999999999999999976542 3344566788999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CC
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TR  305 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~  305 (479)
                      +||||+.+++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+... ..
T Consensus       101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            99999999999888887888999999999999999999999999999999999999999999999999999875433 33


Q ss_pred             cccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-------------------
Q 011698          306 SNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-------------------  365 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-------------------  365 (479)
                      ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....                   
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG  260 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence            4556899999999999876 68999999999999999999999999888776665554321                   


Q ss_pred             CCCC------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhh
Q 011698          366 IKLP------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLE  417 (479)
Q Consensus       366 ~~~p------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~  417 (479)
                      ..+|            ..++.++.+||.+||+.||.+||     +++|+++||||+..+|....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~~  319 (331)
T 4aaa_A          261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP-----FCAELLHHDFFQMDGFAERF  319 (331)
T ss_dssp             CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC-----CGGGGGGSHHHHGGGHHHHH
T ss_pred             ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCC-----CHHHHhcCchhccCChhhhh
Confidence            1111            25789999999999999999999     89999999999998776544

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-49  Score=400.92  Aligned_cols=257  Identities=27%  Similarity=0.403  Sum_probs=217.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-----
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----  223 (479)
                      .++|++++.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++....     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            468999999999999999999999999999999996643 23445667889999999999999999999997763     


Q ss_pred             -eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 -RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 -~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                       .+|+||||+ +++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence             469999999 7899888876 5789999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------------
Q 011698          303 NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---------------  366 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------------  366 (479)
                        .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....|.....               
T Consensus       181 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~  258 (367)
T 1cm8_A          181 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  258 (367)
T ss_dssp             --SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             --ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence              3455789999999999988 6799999999999999999999999999887777666654211               


Q ss_pred             ----------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhh
Q 011698          367 ----------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK  415 (479)
Q Consensus       367 ----------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~  415 (479)
                                      .+...+++++.+||.+||+.||.+|+     |++|+++||||+.+.+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~-----t~~e~l~hp~f~~~~~~~  318 (367)
T 1cm8_A          259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV-----TAGEALAHPYFESLHDTE  318 (367)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGTTTC---
T ss_pred             HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCC-----CHHHHhcChHHHhhcCCc
Confidence                            12245689999999999999999999     999999999999987644

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.5e-48  Score=390.04  Aligned_cols=253  Identities=25%  Similarity=0.444  Sum_probs=226.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      .|+..+.||+|+||+||+|+++.+|+.||||++.....   ...+.+.+|+.++++++||||+++++++.....+|+|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            48888999999999999999999999999999976432   234567889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcccc
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSM  309 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~~~  309 (479)
                      |++|++|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+... ......
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            9999999988764 56899999999999999999999999999999999999999999999999999876543 234567


Q ss_pred             cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---CCCccCCHHHHHHHHhhhhh
Q 011698          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---KLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~lI~~~L~~  386 (479)
                      +||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.....   ..+..++.++.+||.+||+.
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  281 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR  281 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCS
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccC
Confidence            899999999999999999999999999999999999999999888888777776532   23456899999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccccCCC
Q 011698          387 EASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      ||++||     +++++++||||....
T Consensus       282 dp~~Rp-----s~~ell~hp~~~~~~  302 (321)
T 2c30_A          282 DPQERA-----TAQELLDHPFLLQTG  302 (321)
T ss_dssp             STTTSC-----CHHHHHTSGGGGGCC
T ss_pred             ChhhCc-----CHHHHhcChhhccCC
Confidence            999999     999999999998754

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.8e-49  Score=397.41  Aligned_cols=258  Identities=28%  Similarity=0.385  Sum_probs=220.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee-------
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-------  221 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-------  221 (479)
                      +++|++++.||+|+||+||+|+++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++..       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            57899999999999999999999999999999999765432 2223446789999999999999999999987       


Q ss_pred             -CCeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          222 -KYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       222 -~~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                       .+.+|+||||+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  173 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA  173 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence             4578999999986 666666543 6799999999999999999999999999999999999999999999999999987


Q ss_pred             cCC-----CCCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCcc--
Q 011698          300 FDE-----NTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAF--  371 (479)
Q Consensus       300 ~~~-----~~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--  371 (479)
                      +..     .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+......++..  
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  253 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  253 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            642     223355689999999999987 458999999999999999999999999988888777776532222211  


Q ss_pred             ------------------------------CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          372 ------------------------------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       372 ------------------------------~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                                                    .++++.+||.+||+.||++||     +++|+++||||+...+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI-----DSDDALNHDFFWSDPM  320 (351)
T ss_dssp             TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGGSSSC
T ss_pred             cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCC-----CHHHHhCCCCcCCCCC
Confidence                                          267899999999999999999     9999999999987654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.4e-48  Score=389.68  Aligned_cols=252  Identities=27%  Similarity=0.456  Sum_probs=216.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEee--CCeE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQT--KYRL  225 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~--~~~~  225 (479)
                      .++|++++.||+|+||+||+|++..+++.||+|++....      .+.+.+|+.++++++ ||||+++++++.+  ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            478999999999999999999999999999999997533      345788999999997 9999999999988  6789


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC-cEEEeecCCccccCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDENT  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g-~vkL~DFGla~~~~~~~  304 (479)
                      ++||||+.+++|..++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus       109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            99999999999988774   389999999999999999999999999999999999999777 89999999999877666


Q ss_pred             CcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCC-CHHHHHHHHH-------------hccCCC-
Q 011698          305 RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGG-NRQKIQQKII-------------KDKIKL-  368 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~-~~~~~~~~i~-------------~~~~~~-  368 (479)
                      .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||... +..+....+.             .....+ 
T Consensus       186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  265 (330)
T 3nsz_A          186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  265 (330)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence            6677889999999999987 67899999999999999999999999543 3322222221             111111 


Q ss_pred             -----------------------CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          369 -----------------------PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       369 -----------------------p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                                             +..++.++.+||++||+.||.+||     |++|+++||||+++.|+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL-----TAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSC-----CHHHHHTSGGGTTCC--
T ss_pred             cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCC-----CHHHHhcCccHhhhccC
Confidence                                   123799999999999999999999     99999999999999875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.6e-49  Score=411.95  Aligned_cols=262  Identities=32%  Similarity=0.587  Sum_probs=218.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhch-----HHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-----KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      .++|++.+.||+|+||+||+|.++.+++.||+|++.+.....     ......+.+|+.+|++++||||+++++++.. .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            478999999999999999999999999999999998754321     1223347889999999999999999999854 5


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC---cEEEeecCCcccc
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVMLTDFGLAKQF  300 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g---~vkL~DFGla~~~  300 (479)
                      .+|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            6899999999999999998888999999999999999999999999999999999999997654   5999999999988


Q ss_pred             CCCCCcccccCCCCCcchhHhcC---CCCCccccchhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCC----ccC
Q 011698          301 DENTRSNSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIKDKIKLP----AFL  372 (479)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~DiwSLGvilyelltG~~Pf~~~~~-~~~~~~i~~~~~~~p----~~~  372 (479)
                      .........+||+.|+|||++.+   ..++.++|||||||++|+|++|..||.+... ..+...+..+...++    ..+
T Consensus       293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  372 (419)
T 3i6u_A          293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV  372 (419)
T ss_dssp             C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTS
T ss_pred             CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhccc
Confidence            76666677899999999999864   5678999999999999999999999986543 345556666655544    358


Q ss_pred             CHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       373 s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                      +.++.+||++||+.||.+||     +++|+++||||++.+|...
T Consensus       373 ~~~~~~li~~~L~~dP~~Rp-----s~~e~l~hp~~~~~~~~~~  411 (419)
T 3i6u_A          373 SEKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKRK  411 (419)
T ss_dssp             CHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCc-----CHHHHhCCcccCChhHHHH
Confidence            99999999999999999999     9999999999999887654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.5e-48  Score=384.82  Aligned_cols=256  Identities=27%  Similarity=0.453  Sum_probs=221.2

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|++++.||+|+||.||+|++..+++.||+|++...........+.+.+|+.++++++||||+++++++.+.+.+|+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            34789999999999999999999999999999999977655556667788999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC--C
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--R  305 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~--~  305 (479)
                      ||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++......  .
T Consensus        89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            99999999999999998999999999999999999999999999999999999999999999999999998765432  2


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-----CCccCCHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-----LPAFLSSEAHSLL  380 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~lI  380 (479)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......+.......     .+..++..+.++|
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  248 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVI  248 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHH
T ss_pred             cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHH
Confidence            34568999999999999999999999999999999999999999998887776666655332     3466899999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      .+||++||.+||.    +++++ .+.|.
T Consensus       249 ~~~l~~dp~~R~~----~~~~l-~~~l~  271 (294)
T 4eqm_A          249 LRATEKDKANRYK----TIQEM-KDDLS  271 (294)
T ss_dssp             HHHSCSSGGGSCS----SHHHH-HHHHH
T ss_pred             HHHhcCCHhHccc----cHHHH-HHHHH
Confidence            9999999999993    45544 34443

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-48  Score=387.44  Aligned_cols=253  Identities=33%  Similarity=0.618  Sum_probs=228.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|+++....   ...+.+.+|+.++++++||||+++++++.+...+|+||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            579999999999999999999999999999999986432   22355788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe---CCCCcEEEeecCCccccCCCCCc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl---~~~g~vkL~DFGla~~~~~~~~~  306 (479)
                      ||++|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++..... ..
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~  164 (304)
T 2jam_A           86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IM  164 (304)
T ss_dssp             CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TT
T ss_pred             EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-cc
Confidence            999999999999988899999999999999999999999999999999999999   78899999999999764432 33


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHHHHHh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLKG  382 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~lI~~  382 (479)
                      ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...+...+..+...++    ..++.++.+||.+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  244 (304)
T 2jam_A          165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH  244 (304)
T ss_dssp             HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHH
Confidence            456799999999999999999999999999999999999999999998888888888765443    5689999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ||+.||.+||     +++++++||||++.
T Consensus       245 ~l~~dp~~Rp-----s~~~~l~h~~~~~~  268 (304)
T 2jam_A          245 LLEKDPNERY-----TCEKALSHPWIDGN  268 (304)
T ss_dssp             HHCSSTTTSC-----CHHHHHTSHHHHSS
T ss_pred             HcCCChhHCc-----CHHHHhcCccccCC
Confidence            9999999999     99999999999874

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-48  Score=389.69  Aligned_cols=256  Identities=25%  Similarity=0.368  Sum_probs=210.8

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      ..+..++|+++++||+|+||+||+|+++.+++.||||++.............+..+..+.+..+||||+++++++.+...
T Consensus        52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~  131 (311)
T 3p1a_A           52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI  131 (311)
T ss_dssp             SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence            33445789999999999999999999999999999999876543333333434433344444599999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      +|+||||+ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             EEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            99999999 56888777654 46999999999999999999999999999999999999999999999999999887766


Q ss_pred             CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--CCCccCCHHHHHHHH
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI--KLPAFLSSEAHSLLK  381 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~lI~  381 (479)
                      ......+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+   ....+..+..  .++..++.++.+||.
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~  286 (311)
T 3p1a_A          211 GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLV  286 (311)
T ss_dssp             ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred             CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHHH
Confidence            66667789999999999987 68999999999999999999977765432   2333333322  234578999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      +||+.||++||     +++|+++||||+.
T Consensus       287 ~~L~~dP~~Rp-----t~~ell~hp~~~~  310 (311)
T 3p1a_A          287 MMLEPDPKLRA-----TAEALLALPVLRQ  310 (311)
T ss_dssp             HHSCSSTTTSC-----CHHHHHTSGGGSC
T ss_pred             HHcCCChhhCc-----CHHHHHhCccccC
Confidence            99999999999     9999999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.9e-49  Score=399.17  Aligned_cols=262  Identities=26%  Similarity=0.455  Sum_probs=227.2

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++++.||+|+||+||+|++..+++.||+|++....  .....+.+.+|+.++++++||||+++++++.+...+|
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            44578999999999999999999999999999999998653  3445567889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      +||||++|++|.+++.+.+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...... .
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~  186 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  186 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-c
Confidence            9999999999999999988999999999999999999999996 9999999999999999999999999999765322 2


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHH--------------------------
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ--------------------------  359 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~--------------------------  359 (479)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...+..                          
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (360)
T 3eqc_A          187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK  266 (360)
T ss_dssp             ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred             ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence            345689999999999999999999999999999999999999998766544322                          


Q ss_pred             ----------------HHHhcc-CCCC-ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          360 ----------------KIIKDK-IKLP-AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       360 ----------------~i~~~~-~~~p-~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                                      .+.... ...+ ..++.++.+||++||+.||++||     |++|+++||||+..+|..+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~~~  336 (360)
T 3eqc_A          267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA-----DLKQLMVHAFIKRSDAEEV  336 (360)
T ss_dssp             -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSC-----CHHHHHTSHHHHHHHHSCC
T ss_pred             cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCC-----CHHHHhhChHhhcchHhhh
Confidence                            222221 1222 34789999999999999999999     9999999999998776554

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.9e-48  Score=392.16  Aligned_cols=254  Identities=27%  Similarity=0.391  Sum_probs=225.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +.|++++.||+|+||+||+|++..+++.||||++...........+.+.+|+.+|++++||||+++++++.+....|+||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45999999999999999999999999999999998755445555677889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHH-HcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccc
Q 011698          230 DFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~  308 (479)
                      ||+.| +|.+.+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....   ...
T Consensus       134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~  209 (348)
T 1u5q_A          134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANS  209 (348)
T ss_dssp             ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCC
T ss_pred             ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---CCc
Confidence            99985 6777664 456799999999999999999999999999999999999999999999999999987543   345


Q ss_pred             ccCCCCCcchhHhc---CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CCccCCHHHHHHHHhh
Q 011698          309 MCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--LPAFLSSEAHSLLKGL  383 (479)
Q Consensus       309 ~~gt~~y~APE~l~---~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~lI~~~  383 (479)
                      .+||+.|+|||++.   +..++.++|||||||++|||++|+.||.+.+.......+..+...  .+..++..+.+||..|
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  289 (348)
T 1u5q_A          210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC  289 (348)
T ss_dssp             CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            68999999999995   467899999999999999999999999988887777777765432  3457899999999999


Q ss_pred             hhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          384 LQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       384 L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      |+.||++||     +++++++||||....
T Consensus       290 l~~dP~~Rp-----s~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          290 LQKIPQDRP-----TSEVLLKHRFVLRER  313 (348)
T ss_dssp             TCSSGGGSC-----CHHHHTTCHHHHSCC
T ss_pred             cccChhhCc-----CHHHHhhChhhhccC
Confidence            999999999     999999999997643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-48  Score=400.91  Aligned_cols=253  Identities=29%  Similarity=0.464  Sum_probs=218.2

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee------
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------  221 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------  221 (479)
                      ..++|++++.||+|+||+||+|++..+|+.||||++..+..       ...+|+.+|+.++||||++++++|..      
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            34689999999999999999999999999999999976432       12469999999999999999999843      


Q ss_pred             --------------------------------CCeEEEEEEeccCCcHHHHHH----HcCCCcHHHHHHHHHHHHHHHHH
Q 011698          222 --------------------------------KYRLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAVSH  265 (479)
Q Consensus       222 --------------------------------~~~~~lV~E~~~ggsL~~~l~----~~~~l~e~~~~~~~~qi~~aL~~  265 (479)
                                                      ...+++||||++| +|...+.    ..+.+++..++.++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3458999999985 6665554    45779999999999999999999


Q ss_pred             HHhCCCccCCCCCccEEeC-CCCcEEEeecCCccccCCCCCcccccCCCCCcchhHhcCCC-CCccccchhhHHHHHHHH
Q 011698          266 LHANGIMHRDLKPENILLD-ADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEML  343 (479)
Q Consensus       266 LH~~~IiHrDLKpeNILl~-~~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~DiwSLGvilyell  343 (479)
                      ||++||+||||||+|||++ .++.+||+|||+++.+.........+||+.|+|||++.+.. ++.++|||||||++|||+
T Consensus       157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  236 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI  236 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence            9999999999999999997 68999999999999876666667788999999999998754 899999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhc-----------------cC------------CCCccCCHHHHHHHHhhhhhchhhhcCC
Q 011698          344 TGQPPFTGGNRQKIQQKIIKD-----------------KI------------KLPAFLSSEAHSLLKGLLQKEASKRLGS  394 (479)
Q Consensus       344 tG~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~  394 (479)
                      +|+.||.+.+..+....+...                 ..            .+|..++.++.+||.+||+.||.+||  
T Consensus       237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~--  314 (383)
T 3eb0_A          237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI--  314 (383)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC--
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC--
Confidence            999999998887777766541                 01            14556889999999999999999999  


Q ss_pred             CCCCHHHHHhCccccCCCh
Q 011698          395 GPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       395 ~~~t~~eil~hp~f~~~~~  413 (479)
                         |+.|+++||||+.+.+
T Consensus       315 ---t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          315 ---NPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             ---CHHHHHTSGGGHHHHH
T ss_pred             ---CHHHHhcCHHHHHHHh
Confidence               9999999999988643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=385.74  Aligned_cols=259  Identities=27%  Similarity=0.495  Sum_probs=228.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhch-HHHHHHHHHHHHHHHhCCCCCeeeEeEEE--eeCCeE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKVDHPFIVQLRYSF--QTKYRL  225 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~--~~~~~~  225 (479)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+..... ....+.+.+|+.++++++||||+++++++  .+...+
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999999999999999998754322 23456788999999999999999999998  455689


Q ss_pred             EEEEEeccCCcHHHHHHH--cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC-
Q 011698          226 YLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-  302 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~-  302 (479)
                      |+||||+.++ |.+.+..  .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... 
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            9999999987 6666665  45699999999999999999999999999999999999999999999999999987643 


Q ss_pred             --CCCcccccCCCCCcchhHhcCCCC--CccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHH
Q 011698          303 --NTRSNSMCGTLEYMSPEIVLGKGH--DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHS  378 (479)
Q Consensus       303 --~~~~~~~~gt~~y~APE~l~~~~~--~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  378 (479)
                        ........||+.|+|||++.+...  +.++|||||||++|||++|+.||.+.+...+...+..+...+|..++.++.+
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~  242 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD  242 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHH
T ss_pred             ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHH
Confidence              223345679999999999987543  7899999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      ||++||+.||.+||     +++|+++||||+....
T Consensus       243 li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          243 LLKGMLEYEPAKRF-----SIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             HHHHHTCSSTTTSC-----CHHHHHHSHHHHSCCC
T ss_pred             HHHHHccCChhhCC-----CHHHHhcCcccccCCC
Confidence            99999999999999     9999999999988654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.1e-49  Score=398.07  Aligned_cols=263  Identities=25%  Similarity=0.483  Sum_probs=235.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHH--------------HHHHHHHHHHHHHhCCCCCe
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN--------------HAEYMKSERNILTKVDHPFI  212 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~--------------~~~~~~~E~~iL~~l~hp~I  212 (479)
                      ...++|++++.||+|+||.||+|++  +++.||+|++.........              ..+.+.+|+.++++++||||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            4568999999999999999999999  8999999999875433221              12668899999999999999


Q ss_pred             eeEeEEEeeCCeEEEEEEeccCCcHHHH------HHH--cCCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEe
Q 011698          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQ------LYR--QGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILL  283 (479)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~ggsL~~~------l~~--~~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl  283 (479)
                      +++++++.+.+.+|+||||++||+|.++      +..  ...+++..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence            9999999999999999999999999887      655  5679999999999999999999999 999999999999999


Q ss_pred             CCCCcEEEeecCCccccCCCCCcccccCCCCCcchhHhcCC-CCCc-cccchhhHHHHHHHHhCCCCCCCCCH-HHHHHH
Q 011698          284 DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK-GHDK-AADWWSVGILLFEMLTGQPPFTGGNR-QKIQQK  360 (479)
Q Consensus       284 ~~~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~-~~DiwSLGvilyelltG~~Pf~~~~~-~~~~~~  360 (479)
                      +.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|||++|..||...+. .++...
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  264 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN  264 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred             cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            99999999999999876443 44567899999999999987 6666 99999999999999999999998776 788888


Q ss_pred             HHhccCCCC-------------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhh
Q 011698          361 IIKDKIKLP-------------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLE  417 (479)
Q Consensus       361 i~~~~~~~p-------------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~  417 (479)
                      +..+...+|                   ..++.++.+||.+||+.||.+||     +++|+++||||++.+|..+.
T Consensus       265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~e~l~hp~f~~~~~~~~~  335 (348)
T 2pml_X          265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI-----TSEDALKHEWLADTNIEDLR  335 (348)
T ss_dssp             HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSC-----CHHHHHTSGGGTTCCHHHHH
T ss_pred             HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCC-----CHHHHhcCccccCCCHHHHH
Confidence            888877777                   67899999999999999999999     99999999999999998865

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.3e-48  Score=382.82  Aligned_cols=261  Identities=30%  Similarity=0.557  Sum_probs=234.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ...++|++++.||+|+||+||+|+++.+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+...+|
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            3346899999999999999999999999999999999875432 233556889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC---CcEEEeecCCccccCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD---GHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~---g~vkL~DFGla~~~~~~  303 (479)
                      +||||+.+++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++......
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            999999999999999888899999999999999999999999999999999999999764   47999999999887666


Q ss_pred             CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHHH
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSL  379 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l  379 (479)
                      .......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+...+...+..+...++    ..++.++.+|
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  256 (287)
T 2wei_A          178 TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL  256 (287)
T ss_dssp             SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred             CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence            555667799999999999875 89999999999999999999999999998888888888765543    4689999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                      |++||+.||.+||     +++++++||||+...|+
T Consensus       257 i~~~l~~dp~~Rp-----s~~ell~hp~~~~~~~~  286 (287)
T 2wei_A          257 IRKMLTFHPSLRI-----TATQCLEHPWIQKYSSE  286 (287)
T ss_dssp             HHHHTCSSGGGSC-----CHHHHHHSHHHHHHCCC
T ss_pred             HHHHcccChhhCc-----CHHHHhcCHHHhccccC
Confidence            9999999999999     99999999999886653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3e-48  Score=381.25  Aligned_cols=258  Identities=25%  Similarity=0.436  Sum_probs=206.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++++.||+|+||+||+|++..+++.||+|+++.... .....+.+.++...++.++||||+++++++.+....|
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            456899999999999999999999999999999999976532 3334455566666788899999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          227 LVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      +||||++| +|..++..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++...
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999985 77666543    56799999999999999999999998 99999999999999999999999999998876


Q ss_pred             CCCCcccccCCCCCcchhHh----cCCCCCccccchhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHh-ccCCCC-ccCCH
Q 011698          302 ENTRSNSMCGTLEYMSPEIV----LGKGHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIK-DKIKLP-AFLSS  374 (479)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l----~~~~~~~~~DiwSLGvilyelltG~~Pf~~-~~~~~~~~~i~~-~~~~~p-~~~s~  374 (479)
                      ........+||+.|+|||++    .+..++.++|||||||++|+|++|+.||.. .........+.. .....+ ..++.
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (290)
T 3fme_A          162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA  241 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCH
T ss_pred             ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCH
Confidence            66666667899999999997    456789999999999999999999999986 333333333333 333333 46899


Q ss_pred             HHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          375 EAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       375 ~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ++.+||.+||+.||++||     +++|+++||||+..
T Consensus       242 ~~~~li~~~l~~~p~~Rp-----t~~e~l~hp~f~~~  273 (290)
T 3fme_A          242 EFVDFTSQCLKKNSKERP-----TYPELMQHPFFTLH  273 (290)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHhhcChhhCc-----CHHHHHhCcccccC
Confidence            999999999999999999     99999999999763

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.8e-47  Score=376.62  Aligned_cols=253  Identities=24%  Similarity=0.424  Sum_probs=221.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee----CCeE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRL  225 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~~  225 (479)
                      ..|++.+.||+|+||+||+|.+..++..||+|++...... ....+.+.+|+.++++++||||+++++++..    ...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            4589999999999999999999999999999999876543 3456778899999999999999999999875    4568


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCccEEeC-CCCcEEEeecCCccccCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLD-ADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~--IiHrDLKpeNILl~-~~g~vkL~DFGla~~~~~  302 (479)
                      |+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.....
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            999999999999999998889999999999999999999999999  99999999999997 789999999999976443


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcc--CCCCccCCHHHHHH
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKDK--IKLPAFLSSEAHSL  379 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~-~~~~~~~i~~~~--~~~p~~~s~~~~~l  379 (479)
                       ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.. ...+...+..+.  ..++...++++.+|
T Consensus       185 -~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  262 (290)
T 1t4h_A          185 -SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI  262 (290)
T ss_dssp             -TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred             -cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHH
Confidence             33455689999999998875 48999999999999999999999998744 444555554442  23456678999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      |.+||+.||.+||     +++++++||||++
T Consensus       263 i~~~l~~dp~~Rp-----s~~ell~h~~f~~  288 (290)
T 1t4h_A          263 IEGCIRQNKDERY-----SIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHSCSSGGGSC-----CHHHHHTSGGGC-
T ss_pred             HHHHccCChhhCC-----CHHHHhhCccccc
Confidence            9999999999999     9999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.1e-47  Score=391.72  Aligned_cols=253  Identities=26%  Similarity=0.388  Sum_probs=219.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC-----Ce
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----YR  224 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~  224 (479)
                      ++|++++.||+|+||+||+|++..+++.||||++....  .....+.+.+|+.+|++++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            58999999999999999999999999999999997532  334456688999999999999999999999765     47


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      +|+||||+.| +|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            8999999985 89888865 468999999999999999999999999999999999999999999999999998764332


Q ss_pred             ----CcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------------
Q 011698          305 ----RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK------------  367 (479)
Q Consensus       305 ----~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~------------  367 (479)
                          .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......            
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence                2345689999999998765 55899999999999999999999999988877766666531000            


Q ss_pred             -------------------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          368 -------------------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       368 -------------------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                         +...++.++.+||.+||+.||++||     |++|+++||||+..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-----EVEQALAHPYLEQY  320 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSGGGTTT
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCC-----CHHHHhcCcchhhc
Confidence                               1145789999999999999999999     99999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5e-48  Score=402.40  Aligned_cols=253  Identities=32%  Similarity=0.500  Sum_probs=215.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee------CC
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------KY  223 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------~~  223 (479)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.....       ...+|+.+|++++||||++++++|..      ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            479999999999999999999999999999999976431       13469999999999999999998843      22


Q ss_pred             eEEEEEEeccCCcHHHHHH----HcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC-CcEEEeecCCcc
Q 011698          224 RLYLVLDFVNGGHLFFQLY----RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAK  298 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~----~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~-g~vkL~DFGla~  298 (479)
                      .+++||||+.+ +|...+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            47899999987 5555443    34679999999999999999999999999999999999999965 578999999999


Q ss_pred             ccCCCCCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Q 011698          299 QFDENTRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------------  364 (479)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-------------  364 (479)
                      .+.........+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+....|...             
T Consensus       206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~  285 (420)
T 1j1b_A          206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  285 (420)
T ss_dssp             ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHC
T ss_pred             hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            87666666678899999999999875 7899999999999999999999999998877666665541             


Q ss_pred             ----cCC------------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhh
Q 011698          365 ----KIK------------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK  415 (479)
Q Consensus       365 ----~~~------------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~  415 (479)
                          .+.            ++..++.++.+||.+||++||.+|+     ++.|+++||||+.+.+..
T Consensus       286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~  347 (420)
T 1j1b_A          286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL-----TPLEACAHSFFDELRDPN  347 (420)
T ss_dssp             SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGGGGGCTT
T ss_pred             hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCC-----CHHHHhCCHhhccccccc
Confidence                112            2345789999999999999999999     999999999999876644

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.7e-48  Score=400.06  Aligned_cols=255  Identities=29%  Similarity=0.430  Sum_probs=216.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-----
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----  223 (479)
                      ..+|++++.||+|+||+||+|++..+++ ||+|++......       ..+|+.+|+.++||||++++++|....     
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            3579999999999999999999988777 888887654321       236999999999999999999995543     


Q ss_pred             -eEEEEEEeccCCcHHHHH---HHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeC-CCCcEEEeecCCcc
Q 011698          224 -RLYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-ADGHVMLTDFGLAK  298 (479)
Q Consensus       224 -~~~lV~E~~~ggsL~~~l---~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~-~~g~vkL~DFGla~  298 (479)
                       .+|+||||+.++.+....   .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus       111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence             389999999886443322   2356799999999999999999999999999999999999999 79999999999999


Q ss_pred             ccCCCCCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------------
Q 011698          299 QFDENTRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK------------  365 (479)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~------------  365 (479)
                      .+.........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....|....            
T Consensus       191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  270 (394)
T 4e7w_A          191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN  270 (394)
T ss_dssp             ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            87666666778899999999999775 58999999999999999999999999988777666665420            


Q ss_pred             -----C------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          366 -----I------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       366 -----~------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                           .            .++..+++++.+||.+||+.||.+||     ++.|+++||||+.+.|...
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~-----t~~e~l~hp~f~~~~~~~~  333 (394)
T 4e7w_A          271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL-----TAIEALCHPFFDELRTGEA  333 (394)
T ss_dssp             GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC-----CHHHHHTSGGGSTTTSSCC
T ss_pred             hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCC-----CHHHHhcChhhhhhccccc
Confidence                 1            12345889999999999999999999     9999999999999987544

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.4e-48  Score=390.79  Aligned_cols=260  Identities=33%  Similarity=0.608  Sum_probs=222.4

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc-----hHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      ++|++.+.||+|+||.||+|+++.+++.||||++.+....     .......+.+|+.+|++++||||+++++++.... 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            6899999999999999999999999999999999765321     1223345788999999999999999999997665 


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc---EEEeecCCccccC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDFGLAKQFD  301 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~---vkL~DFGla~~~~  301 (479)
                      +|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+++...
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence            8999999999999999988889999999999999999999999999999999999999987665   9999999998876


Q ss_pred             CCCCcccccCCCCCcchhHhc---CCCCCccccchhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCC----ccCC
Q 011698          302 ENTRSNSMCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIKDKIKLP----AFLS  373 (479)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~---~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~-~~~~~~i~~~~~~~p----~~~s  373 (479)
                      ........+||+.|+|||++.   +..++.++|||||||++|+|++|..||..... ..+...+..+...+.    ..++
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (322)
T 2ycf_A          169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS  248 (322)
T ss_dssp             CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSC
T ss_pred             cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcC
Confidence            554445678999999999984   46789999999999999999999999976543 345555666555443    4589


Q ss_pred             HHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhh
Q 011698          374 SEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK  415 (479)
Q Consensus       374 ~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~  415 (479)
                      .++.+||.+||+.||++||     +++++++||||+..+|..
T Consensus       249 ~~~~~li~~~l~~dP~~Rp-----s~~~~l~h~~~~~~~~~~  285 (322)
T 2ycf_A          249 EKALDLVKKLLVVDPKARF-----TTEEALRHPWLQDEDMKR  285 (322)
T ss_dssp             HHHHHHHHHHSCSSTTTSC-----CHHHHHTSGGGCCHHHHH
T ss_pred             HHHHHHHHHHcccCHhhCC-----CHHHHhhCcCcCCHHHHH
Confidence            9999999999999999999     999999999999987754

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.1e-48  Score=389.07  Aligned_cols=256  Identities=28%  Similarity=0.460  Sum_probs=216.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC--CCeeeEeEEEeeCCe
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--PFIVQLRYSFQTKYR  224 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~~~~~~~  224 (479)
                      +.-++|++++.||+|+||+||+|.+. +++.||||++..... .....+.+.+|+.+|++++|  |||+++++++.+...
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            44568999999999999999999884 688999999986543 34455678899999999986  999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      +|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus        84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            999999 56789999999999999999999999999999999999999999999999996 7899999999998764433


Q ss_pred             ---CcccccCCCCCcchhHhcC-----------CCCCccccchhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhc--cCC
Q 011698          305 ---RSNSMCGTLEYMSPEIVLG-----------KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKD--KIK  367 (479)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~-----------~~~~~~~DiwSLGvilyelltG~~Pf~~~~-~~~~~~~i~~~--~~~  367 (479)
                         .....+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.+.. .......+...  ...
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  241 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  241 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence               2346789999999999975           678999999999999999999999998743 33344444432  456


Q ss_pred             CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          368 LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       368 ~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +|...+.++.+||..||+.||.+||     ++.|+++||||+..
T Consensus       242 ~~~~~~~~l~~li~~~L~~dp~~Rp-----t~~e~l~hp~~~~~  280 (343)
T 3dbq_A          242 FPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQIQ  280 (343)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHSC
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCC-----CHHHHHhCcccccc
Confidence            7788899999999999999999999     99999999999753

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.1e-48  Score=377.25  Aligned_cols=256  Identities=29%  Similarity=0.512  Sum_probs=227.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe--eCCeEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ--TKYRLY  226 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~~~~  226 (479)
                      .++|++++.||+|+||+||+|+++.+++.||+|++..... .....+.+.+|+.++++++||||+++++++.  ....+|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            4789999999999999999999999999999999987543 3344667889999999999999999999874  467899


Q ss_pred             EEEEeccCCcHHHHHHHc----CCCcHHHHHHHHHHHHHHHHHHHhCC-----CccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          227 LVLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANG-----IMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~-----IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                      +||||++|++|.+++...    ..+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            999999999999998754    34899999999999999999999999     999999999999999999999999999


Q ss_pred             cccCCCCC-cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCccCCHH
Q 011698          298 KQFDENTR-SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSE  375 (479)
Q Consensus       298 ~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~  375 (479)
                      +....... ....+||+.|+|||++.+..++.++||||||+++|+|++|+.||...+...+...+..+.. .+|..++.+
T Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (279)
T 2w5a_A          164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE  243 (279)
T ss_dssp             HHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             eeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHH
Confidence            87654322 2346799999999999999999999999999999999999999999988888888887755 577889999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      +.++|.+||+.||.+||     +++|+++|+|+..
T Consensus       244 l~~li~~~l~~~p~~Rp-----s~~~ll~~~~~~~  273 (279)
T 2w5a_A          244 LNEIITRMLNLKDYHRP-----SVEEILENPLILE  273 (279)
T ss_dssp             HHHHHHHHTCSSGGGSC-----CHHHHHTSTTCCG
T ss_pred             HHHHHHHHcCCCcccCC-----CHHHHHhChhhhh
Confidence            99999999999999999     9999999999976

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-48  Score=392.66  Aligned_cols=260  Identities=27%  Similarity=0.417  Sum_probs=218.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhch--HHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME--KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.......  ....+.+.+|+.++++++||||+++++++.+...++
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            478999999999999999999999999999999997643221  112245778999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-C
Q 011698          227 LVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-T  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~  304 (479)
                      +||||+++ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+... .
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence            99999987 787777654 46899999999999999999999999999999999999999999999999999876433 3


Q ss_pred             CcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-----CC----------
Q 011698          305 RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-----KL----------  368 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-----~~----------  368 (479)
                      .....+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+...++.....     .+          
T Consensus       168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T 1ua2_A          168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  247 (346)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence            34567899999999999764 589999999999999999999999999888887777765311     00          


Q ss_pred             -------------CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          369 -------------PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       369 -------------p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                                   ...++.++.+||++||+.||++||     |++|+++||||++..|.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI-----TATQALKMKYFSNRPGP  301 (346)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC-----CHHHHHTSGGGTSSSCC
T ss_pred             cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCC-----CHHHHhcChhhhcCCCC
Confidence                         134678999999999999999999     99999999999987554

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.6e-47  Score=374.34  Aligned_cols=251  Identities=18%  Similarity=0.307  Sum_probs=215.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      .++|++++.||+|+||+||+|+++.+++.||+|++....... .....+.+|+..+..+ +||||+++++++.+.+.+++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            368999999999999999999999999999999998654322 2345577899999998 99999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHc----CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC----------------
Q 011698          228 VLDFVNGGHLFFQLYRQ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG----------------  287 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g----------------  287 (479)
                      ||||++|++|.+++...    +.+++..++.++.||+.||.|||++||+||||||+|||++.+|                
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            99999999999999765    6799999999999999999999999999999999999998544                


Q ss_pred             ---cEEEeecCCccccCCCCCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 011698          288 ---HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK  363 (479)
Q Consensus       288 ---~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~  363 (479)
                         .+||+|||++......   ....||+.|+|||++.+. .++.++|||||||++|+|++|.+++...+   ....+..
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~  242 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQ  242 (289)
T ss_dssp             -CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHT
T ss_pred             CceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHc
Confidence               7999999999876543   234699999999999876 56789999999999999999998875432   3344444


Q ss_pred             c-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          364 D-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       364 ~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      + ...+|..++.++.+||.+||+.||++||     +++++++||||.+.
T Consensus       243 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  286 (289)
T 1x8b_A          243 GRLPRIPQVLSQEFTELLKVMIHPDPERRP-----SAMALVKHSVLLSA  286 (289)
T ss_dssp             TCCCCCSSCCCHHHHHHHHHHTCSSGGGSC-----CHHHHHTCTTC---
T ss_pred             CCCCCCCcccCHHHHHHHHHHhCCCcccCC-----CHHHHhhChHhhhh
Confidence            4 3457788999999999999999999999     99999999999874

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.9e-47  Score=381.82  Aligned_cols=251  Identities=24%  Similarity=0.396  Sum_probs=215.3

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+..++|++.+.||+|+||+||+|++  +++.||+|++..... .....+.+.+|+.+|++++||||+++++++.+...+
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            45678999999999999999999987  578899999976543 334456788999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCC---CcHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCccEEeCCCCcEEEeecCCcccc
Q 011698          226 YLVLDFVNGGHLFFQLYRQGL---FREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~~--IiHrDLKpeNILl~~~g~vkL~DFGla~~~  300 (479)
                      ++||||+.||+|.+++.+.+.   +++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||+++..
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            999999999999999987654   899999999999999999999999  999999999999999999999999999865


Q ss_pred             CCC-CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCCCccCCHHHH
Q 011698          301 DEN-TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK--DKIKLPAFLSSEAH  377 (479)
Q Consensus       301 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~  377 (479)
                      ... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..  ....+|..+++++.
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  269 (309)
T 3p86_A          190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA  269 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred             cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence            433 234567899999999999999999999999999999999999999999888887777753  35677889999999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +||.+||+.||.+||     +++++++
T Consensus       270 ~li~~~l~~dP~~Rp-----s~~~ll~  291 (309)
T 3p86_A          270 AIIEGCWTNEPWKRP-----SFATIMD  291 (309)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHccCChhhCc-----CHHHHHH
Confidence            999999999999999     8999886

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.2e-47  Score=395.68  Aligned_cols=257  Identities=27%  Similarity=0.453  Sum_probs=220.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC--CCCeeeEeEEEeeCCe
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD--HPFIVQLRYSFQTKYR  224 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~~~  224 (479)
                      +..++|++++.||+|+||+||+|.+.. ++.||||++..... .....+.+.+|+.+|++++  ||||+++++++.....
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~  130 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  130 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence            444679999999999999999999875 88999999987543 3445677899999999996  5999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      +|+||| +.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            999999 56789999999988999999999999999999999999999999999999995 6899999999998765432


Q ss_pred             ---CcccccCCCCCcchhHhcC-----------CCCCccccchhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhc--cCC
Q 011698          305 ---RSNSMCGTLEYMSPEIVLG-----------KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKD--KIK  367 (479)
Q Consensus       305 ---~~~~~~gt~~y~APE~l~~-----------~~~~~~~DiwSLGvilyelltG~~Pf~~~~-~~~~~~~i~~~--~~~  367 (479)
                         .....+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.+.. .......+...  ...
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~  288 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  288 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence               2346789999999999976           368999999999999999999999998753 34455555544  445


Q ss_pred             CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          368 LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       368 ~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      +|...+.++.+||.+||+.||.+||     +++|+++||||+...
T Consensus       289 ~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~ell~hp~~~~~~  328 (390)
T 2zmd_A          289 FPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQIQT  328 (390)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHSCC
T ss_pred             CCccchHHHHHHHHHHcccChhhCC-----CHHHHhhCcCccccC
Confidence            6778899999999999999999999     999999999998643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-48  Score=387.34  Aligned_cols=254  Identities=27%  Similarity=0.430  Sum_probs=219.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC--e
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--R  224 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~  224 (479)
                      +..++|++.+.||+|+||+||+|++..+++.||||++.......  ..+.+.+|+.+|++++||||+++++++....  .
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence            34468999999999999999999999999999999998654322  2455678999999999999999999998765  7


Q ss_pred             EEEEEEeccCCcHHHHHHHcCC---CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe----CCCCcEEEeecCCc
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGL---FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL----DADGHVMLTDFGLA  297 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl----~~~g~vkL~DFGla  297 (479)
                      +|+||||++|++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            8999999999999999986543   8999999999999999999999999999999999999    88889999999999


Q ss_pred             cccCCCCCcccccCCCCCcchhHhc--------CCCCCccccchhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhcc
Q 011698          298 KQFDENTRSNSMCGTLEYMSPEIVL--------GKGHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKDK  365 (479)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~--------~~~~~~~~DiwSLGvilyelltG~~Pf~~~----~~~~~~~~i~~~~  365 (479)
                      +.+.........+||+.|+|||++.        +..++.++|||||||++|||++|+.||...    ...++..++..+.
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            9887776667788999999999997        577899999999999999999999999743    2345556665543


Q ss_pred             C-------------------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCcc
Q 011698          366 I-------------------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKW  407 (479)
Q Consensus       366 ~-------------------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~  407 (479)
                      +                         .++..++..+.+||++||+.||++|+     +++|+++||=
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~-----s~~ell~h~~  305 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW-----GFDQFFAETS  305 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC-----CHHHHHHHHH
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhc-----cHHHhhhccH
Confidence            3                         12234567899999999999999999     9999999863

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.2e-48  Score=377.47  Aligned_cols=256  Identities=30%  Similarity=0.486  Sum_probs=223.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            3689999999999999999999999999999999976542  23456788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC---CC
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TR  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~---~~  305 (479)
                      |||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+...   ..
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            999999999999887778999999999999999999999999999999999999999999999999999865332   22


Q ss_pred             cccccCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCC--CCccCCHHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKIK--LPAFLSSEAHSLLK  381 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~--~p~~~s~~~~~lI~  381 (479)
                      ....+||+.|+|||++.+..+ +.++||||||+++|||++|+.||...+.. .....+......  ....++.++.+||.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence            456789999999999988775 78999999999999999999999875543 233333333222  23468999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +||+.||++||     +++|+++||||+..
T Consensus       244 ~~l~~~p~~Rp-----s~~~il~~~~~~~~  268 (276)
T 2yex_A          244 KILVENPSARI-----TIPDIKKDRWYNKP  268 (276)
T ss_dssp             HHSCSSTTTSC-----CHHHHTTCTTTTCC
T ss_pred             HHCCCCchhCC-----CHHHHhcCccccCh
Confidence            99999999999     99999999999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=9.4e-48  Score=393.53  Aligned_cols=256  Identities=25%  Similarity=0.387  Sum_probs=204.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC------C
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK------Y  223 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~------~  223 (479)
                      ++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++...      .
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            68999999999999999999999999999999997643 2334556678999999999999999999999754      5


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      .+|+|||++ +++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~  185 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE  185 (367)
T ss_dssp             CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred             eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence            689999999 6799887765 67999999999999999999999999999999999999999999999999999875432


Q ss_pred             CCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------------
Q 011698          304 TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-----------------  365 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-----------------  365 (479)
                        ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......|....                 
T Consensus       186 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~  263 (367)
T 2fst_X          186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  263 (367)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred             --CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence              345689999999999987 678999999999999999999999999988777766665411                 


Q ss_pred             ------CCC--------CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhh
Q 011698          366 ------IKL--------PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK  415 (479)
Q Consensus       366 ------~~~--------p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~  415 (479)
                            ...        ...+++++.+||++||+.||++||     |++|+++||||+......
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~-----t~~e~L~hp~~~~~~~~~  322 (367)
T 2fst_X          264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-----TAAQALAHAYFAQYHDPD  322 (367)
T ss_dssp             HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTTCCGG
T ss_pred             HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc-----CHHHHhcChhhhhccCCC
Confidence                  001        124688999999999999999999     999999999999876543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.3e-47  Score=390.86  Aligned_cols=252  Identities=19%  Similarity=0.357  Sum_probs=224.1

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc-------CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRI-------GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~  217 (479)
                      .+..++|++.+.||+|+||+||+|++.       .++..||+|+++...  .....+.+.+|+.+|+++ +||||+++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            355689999999999999999999975       356689999997653  344566788999999999 8999999999


Q ss_pred             EEeeCCeEEEEEEeccCCcHHHHHHHcC----------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccE
Q 011698          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (479)
Q Consensus       218 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNI  281 (479)
                      ++.+...+|+||||+.||+|.+++....                .+++..++.++.||+.||.|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999998753                478899999999999999999999999999999999


Q ss_pred             EeCCCCcEEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHH
Q 011698          282 LLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI  357 (479)
Q Consensus       282 Ll~~~g~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~  357 (479)
                      |++.+|.+||+|||+++.+....   ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            99999999999999998764332   2344567889999999999999999999999999999999 9999999888888


Q ss_pred             HHHHHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          358 QQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       358 ~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ...+..+ ....|..++.++.+||.+||+.||.+||     ++.|+++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~  357 (370)
T 2psq_A          315 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP-----TFKQLVE  357 (370)
T ss_dssp             HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            8877766 4567888999999999999999999999     8999886

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.1e-48  Score=381.11  Aligned_cols=260  Identities=30%  Similarity=0.478  Sum_probs=224.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++++.||+|+||+||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.....+++|
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            468999999999999999999999999999999987643   22345678899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC-CCCc
Q 011698          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRS  306 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~-~~~~  306 (479)
                      |||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR  174 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence            999999999988876 46799999999999999999999999999999999999999999999999999764321 1223


Q ss_pred             ccccCCCCCcchhHhc-----CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---CCCccCCHHHHH
Q 011698          307 NSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---KLPAFLSSEAHS  378 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~-----~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~  378 (479)
                      ...+||+.|+|||++.     +..++.++|||||||++|+|++|..||...+.......+.....   ..+..++.++.+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  254 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD  254 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHH
Confidence            4567999999999984     67789999999999999999999999999888887777776543   245678999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                      ||..||+.||.+||     +++++++||||+.+.|...
T Consensus       255 li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~  287 (302)
T 2j7t_A          255 FLKIALDKNPETRP-----SAAQLLEHPFVSSITSNKA  287 (302)
T ss_dssp             HHHHHSCSCTTTSC-----CHHHHTTSTTTTTCCCCHH
T ss_pred             HHHHHcccChhhCC-----CHHHHhcChHHhhhccchh
Confidence            99999999999999     9999999999999988654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.3e-47  Score=383.35  Aligned_cols=258  Identities=24%  Similarity=0.386  Sum_probs=219.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC-----C
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----Y  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~  223 (479)
                      .++|++.+.||+|+||+||+|++..+|+.||||++....  .......+.+|+.++++++||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            478999999999999999999999999999999996532  334455678899999999999999999988654     6


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      .+|+||||+. |+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            7999999997 589888876 57899999999999999999999999999999999999999999999999999876432


Q ss_pred             C-----------CcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------
Q 011698          304 T-----------RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD-------  364 (479)
Q Consensus       304 ~-----------~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~-------  364 (479)
                      .           .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...       
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD  245 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence            1           1234578999999998865 67899999999999999999999999988766555544321       


Q ss_pred             -----------------cCC--------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhh
Q 011698          365 -----------------KIK--------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK  415 (479)
Q Consensus       365 -----------------~~~--------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~  415 (479)
                                       ...        .+..++.++.+||++||+.||++||     +++|+++||||+.+.+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI-----TAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTTCCTT
T ss_pred             ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCC-----CHHHHhcCccccccCCcc
Confidence                             000        1136889999999999999999999     999999999999987654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.6e-47  Score=382.68  Aligned_cols=260  Identities=27%  Similarity=0.419  Sum_probs=222.6

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEc-CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC---CCCCeeeEeEEEe----
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRI-GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQ----  220 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~----  220 (479)
                      .++|++++.||+|+||+||+|++. .+++.||+|+++...... .....+.+|+.+++.+   +||||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            368999999999999999999995 678999999997643211 1112345677766665   8999999999987    


Q ss_pred             -eCCeEEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          221 -TKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       221 -~~~~~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                       ....+++||||+. |+|..++....  .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence             5678999999998 59999988754  4899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc------------
Q 011698          298 KQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK------------  365 (479)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~------------  365 (479)
                      +...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....            
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (326)
T 1blx_A          168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  247 (326)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             ccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccc
Confidence            87665555566789999999999999999999999999999999999999999988877777776420            


Q ss_pred             ---------------CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhh
Q 011698          366 ---------------IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK  415 (479)
Q Consensus       366 ---------------~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~  415 (479)
                                     ..++..++..+.+||.+||+.||.+||     +++|+++||||+.+++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-----SAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC-----CHHHHHTSGGGTTCCCCC
T ss_pred             ccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCC-----CHHHHhcCccccccchhh
Confidence                           012346789999999999999999999     999999999999987653

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2e-47  Score=385.31  Aligned_cols=263  Identities=24%  Similarity=0.361  Sum_probs=220.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCC-eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCC------eeeEeEEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF------IVQLRYSF  219 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~------Iv~l~~~~  219 (479)
                      +..++|++++.||+|+||+||+|++..++ +.||+|+++...    ...+.+.+|+.++++++|++      ++.+++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            44579999999999999999999998776 799999997532    33456778999999887655      99999999


Q ss_pred             eeCCeEEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe--------------
Q 011698          220 QTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL--------------  283 (479)
Q Consensus       220 ~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl--------------  283 (479)
                      .....+|+||||+ +++|...+....  .+++..++.++.||+.||.|||++||+||||||+|||+              
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence            9999999999999 556666766553  69999999999999999999999999999999999999              


Q ss_pred             -----CCCCcEEEeecCCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHH
Q 011698          284 -----DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ  358 (479)
Q Consensus       284 -----~~~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~  358 (479)
                           +.++.+||+|||+++....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+..
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL  248 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence                 5678999999999987543  334568999999999999999999999999999999999999999988776655


Q ss_pred             HHHHhccCCCCc--------------------------------------------cCCHHHHHHHHhhhhhchhhhcCC
Q 011698          359 QKIIKDKIKLPA--------------------------------------------FLSSEAHSLLKGLLQKEASKRLGS  394 (479)
Q Consensus       359 ~~i~~~~~~~p~--------------------------------------------~~s~~~~~lI~~~L~~dP~~R~~~  394 (479)
                      ..+......+|.                                            ..+.++.+||++||+.||++||  
T Consensus       249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp--  326 (355)
T 2eu9_A          249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI--  326 (355)
T ss_dssp             HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC--
T ss_pred             HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc--
Confidence            554432222221                                            1245789999999999999999  


Q ss_pred             CCCCHHHHHhCccccCCChhhhhcccC
Q 011698          395 GPGGSQEIKSHKWFKMINWKKLEARET  421 (479)
Q Consensus       395 ~~~t~~eil~hp~f~~~~~~~l~~~~~  421 (479)
                         |++|+++||||++++|........
T Consensus       327 ---t~~e~l~hp~f~~~~~~~~~~~~~  350 (355)
T 2eu9_A          327 ---TLAEALLHPFFAGLTPEERSFHTS  350 (355)
T ss_dssp             ---CHHHHTTSGGGGGCCHHHHC----
T ss_pred             ---CHHHHhcChhhcCCChhhcccccc
Confidence               999999999999999976654443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.1e-48  Score=383.09  Aligned_cols=264  Identities=28%  Similarity=0.452  Sum_probs=201.8

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+..++|++.+.||+|+||.||+|++..+++.||+|++.....  ....+.+.+|+.++++++||||+++++++...+..
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            3566899999999999999999999999999999999876432  23345678899999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHH--------cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          226 YLVLDFVNGGHLFFQLYR--------QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~--------~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                      ++||||++|++|.+++..        .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999998874        456899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCC------CcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC----
Q 011698          298 KQFDENT------RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI----  366 (479)
Q Consensus       298 ~~~~~~~------~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~----  366 (479)
                      .......      .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.............    
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  248 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE  248 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence            7654321      2345679999999999976 5689999999999999999999999998776665555544322    


Q ss_pred             ------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          367 ------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       367 ------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                            .....++.++.+||.+||+.||.+||     +++++++||||+...+..+
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~  299 (303)
T 2vwi_A          249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP-----TAAELLRHKFFQKAKNKEF  299 (303)
T ss_dssp             C-----CCCCCCCHHHHHHHHHHCCSSGGGSC-----CHHHHHTSTTC--------
T ss_pred             cccccchhhhhhhHHHHHHHHHHccCChhhCc-----CHHHHhhChhhhcCCCCcc
Confidence                  12346789999999999999999999     9999999999999876554

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-49  Score=408.21  Aligned_cols=250  Identities=17%  Similarity=0.184  Sum_probs=208.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHH---HHHhCCCCCeeeEe-------EE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN---ILTKVDHPFIVQLR-------YS  218 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~---iL~~l~hp~Iv~l~-------~~  218 (479)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.   +|++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            468999999999999999999999999999999998755445556677889994   55556899999998       66


Q ss_pred             EeeCC-----------------eEEEEEEeccCCcHHHHHHHcCCCcH-------HHHHHHHHHHHHHHHHHHhCCCccC
Q 011698          219 FQTKY-----------------RLYLVLDFVNGGHLFFQLYRQGLFRE-------DLARIYTAEIVSAVSHLHANGIMHR  274 (479)
Q Consensus       219 ~~~~~-----------------~~~lV~E~~~ggsL~~~l~~~~~l~e-------~~~~~~~~qi~~aL~~LH~~~IiHr  274 (479)
                      +.+.+                 ..|+||||+ +|+|.+++...+.+++       ..++.++.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            66553                 289999999 6799999987665555       7778899999999999999999999


Q ss_pred             CCCCccEEeCCCCcEEEeecCCccccCCCCCcccccCCCCCcchhHhcCC-----------CCCccccchhhHHHHHHHH
Q 011698          275 DLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK-----------GHDKAADWWSVGILLFEML  343 (479)
Q Consensus       275 DLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~~~~~DiwSLGvilyell  343 (479)
                      ||||+|||++.+|.+||+|||+++...  ......+| +.|+|||++.+.           .++.++|||||||++|||+
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell  307 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW  307 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence            999999999999999999999998643  34456778 999999999988           8999999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          344 TGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       344 tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +|+.||.+.+.......+.    ..+..++.++.+||.+||+.||++||     ++.++++||||+.+
T Consensus       308 tg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~f~~~  366 (377)
T 3byv_A          308 CADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRL-----LPLQAMETPEYEQL  366 (377)
T ss_dssp             HSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCC-----CHHHHHTSHHHHHH
T ss_pred             HCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCC-----CHHHHhhChHHHHH
Confidence            9999998765443333332    23467899999999999999999999     99999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.4e-47  Score=383.18  Aligned_cols=267  Identities=20%  Similarity=0.315  Sum_probs=205.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCe---EEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      +..++|++.+.||+|+||+||+|++..++.   .||+|+++..... ....+.+.+|+.++++++||||+++++++....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            455789999999999999999999887765   8999999765432 334667889999999999999999999998776


Q ss_pred             eE------EEEEEeccCCcHHHHHHHcC------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEE
Q 011698          224 RL------YLVLDFVNGGHLFFQLYRQG------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVML  291 (479)
Q Consensus       224 ~~------~lV~E~~~ggsL~~~l~~~~------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL  291 (479)
                      ..      ++||||+.+|+|..++....      .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence            65      99999999999999986543      5899999999999999999999999999999999999999999999


Q ss_pred             eecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cC
Q 011698          292 TDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KI  366 (479)
Q Consensus       292 ~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~  366 (479)
                      +|||+++.......   .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+..+ ..
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~  258 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRL  258 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCC
Confidence            99999987644322   223456788999999999999999999999999999999 99999998888888887766 46


Q ss_pred             CCCccCCHHHHHHHHhhhhhchhhhcCCCCCC-------HHHHHhCccccCCChhhhhcc
Q 011698          367 KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGG-------SQEIKSHKWFKMINWKKLEAR  419 (479)
Q Consensus       367 ~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t-------~~eil~hp~f~~~~~~~l~~~  419 (479)
                      ..+..++.++.+||.+||+.||.+||     +       ++++++|+|+....+..+...
T Consensus       259 ~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~l~~~l~~~~~~~~~~~pl~~~  313 (323)
T 3qup_A          259 KQPPECMEEVYDLMYQCWSADPKQRP-----SFTCLRMELENILGHLSVLSTSQDPLYIN  313 (323)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSC-----CHHHHHHHHHHHHHC--------------
T ss_pred             CCCCccCHHHHHHHHHHccCChhhCc-----CHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Confidence            67888999999999999999999999     7       788999999998776655443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=378.62  Aligned_cols=260  Identities=26%  Similarity=0.448  Sum_probs=225.4

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++....     ..+.+.+|+.++++++||||+++++++.....+|+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            3468999999999999999999999999999999997643     13457889999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHH-HcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CC
Q 011698          228 VLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TR  305 (479)
Q Consensus       228 V~E~~~ggsL~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~  305 (479)
                      ||||+.+++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ..
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK  181 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence            999999999999987 4567999999999999999999999999999999999999999999999999999876443 23


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---CCCCccCCHHHHHHHHh
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSLLKG  382 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~lI~~  382 (479)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....   ...+..++.++.+||.+
T Consensus       182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  261 (314)
T 3com_A          182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ  261 (314)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred             cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHH
Confidence            455689999999999999999999999999999999999999999887766665555542   33456789999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhCccccCCChhhhh
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLE  417 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~  417 (479)
                      ||+.||.+||     +++++++||||+...+....
T Consensus       262 ~l~~dp~~Rp-----t~~~ll~~~~~~~~~~~~~~  291 (314)
T 3com_A          262 CLVKSPEQRA-----TATQLLQHPFVRSAKGVSIL  291 (314)
T ss_dssp             HTCSCTTTSC-----CHHHHTTSHHHHTCCCGGGG
T ss_pred             HccCChhhCc-----CHHHHHhCHHHhcCCcchHH
Confidence            9999999999     99999999999998765543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.4e-47  Score=377.01  Aligned_cols=253  Identities=28%  Similarity=0.495  Sum_probs=228.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +.|++++.||+|+||+||+|++..+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            579999999999999999999999999999999986542  223566889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Cccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~~  308 (479)
                      ||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... ....
T Consensus       100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred             EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence            99999999988864 578999999999999999999999999999999999999999999999999998764432 3456


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-CCCCccCCHHHHHHHHhhhhhc
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.... ..++..++..+.+||.+||+.|
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  258 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE  258 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSS
T ss_pred             cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCC
Confidence            789999999999999999999999999999999999999999888887777776653 4567789999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHhCccccC
Q 011698          388 ASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      |.+||     +++++++||||..
T Consensus       259 p~~Rp-----s~~~ll~~~~~~~  276 (303)
T 3a7i_A          259 PSFRP-----TAKELLKHKFILR  276 (303)
T ss_dssp             GGGSC-----CHHHHTTCHHHHH
T ss_pred             hhhCc-----CHHHHhhChhhhc
Confidence            99999     9999999999965

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-47  Score=379.02  Aligned_cols=261  Identities=28%  Similarity=0.459  Sum_probs=220.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEee----
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQT----  221 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~----  221 (479)
                      ...++|++++.||+|+||+||+|++..+++.||+|++.....    ..+.+.+|+.+++++ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            345789999999999999999999999999999999975432    234578899999998 79999999999987    


Q ss_pred             --CCeEEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          222 --KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       222 --~~~~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                        ...+|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence              56899999999999999999864  57899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC-CCcccccCCCCCcchhHhc-----CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CC
Q 011698          298 KQFDEN-TRSNSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--LP  369 (479)
Q Consensus       298 ~~~~~~-~~~~~~~gt~~y~APE~l~-----~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--~p  369 (479)
                      ...... ......+||+.|+|||++.     +..++.++|||||||++|+|++|..||.+.+.......+......  .+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 2x7f_A          177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS  256 (326)
T ss_dssp             C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred             eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCc
Confidence            876433 2334568999999999997     566899999999999999999999999988877777666665332  24


Q ss_pred             ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          370 AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       370 ~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                      ..++..+.+||.+||+.||.+||     +++++++||||+...+...
T Consensus       257 ~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~hp~~~~~~~~~~  298 (326)
T 2x7f_A          257 KKWSKKFQSFIESCLVKNHSQRP-----ATEQLMKHPFIRDQPNERQ  298 (326)
T ss_dssp             SCSCHHHHHHHHHHCCSSGGGSC-----CHHHHHTSHHHHCCTTHHH
T ss_pred             cccCHHHHHHHHHHhccChhhCC-----CHHHHhhChHHhhCccccc
Confidence            56899999999999999999999     9999999999999876543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.5e-47  Score=389.23  Aligned_cols=256  Identities=27%  Similarity=0.396  Sum_probs=218.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE----
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL----  225 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~----  225 (479)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.... ......+.+.+|+.+++.++||||+++++++......    
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            68999999999999999999999999999999997654 2344566788999999999999999999999887765    


Q ss_pred             --EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          226 --YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       226 --~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                        |+||||+. ++|...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... 
T Consensus       121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-  196 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-  196 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred             eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence              99999998 57877663  4589999999999999999999999999999999999999999999999999986543 


Q ss_pred             CCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC----------------
Q 011698          304 TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI----------------  366 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~----------------  366 (479)
                       .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....                
T Consensus       197 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  275 (371)
T 4exu_A          197 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK  275 (371)
T ss_dssp             ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred             -CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence             3345689999999999988 6789999999999999999999999999887777766654110                


Q ss_pred             ---------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          367 ---------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       367 ---------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                                     .++..+++++.+||++||+.||++||     +++|+++||||+.+.....
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~~~~~  335 (371)
T 4exu_A          276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL-----TAAQALTHPFFEPFRDPEE  335 (371)
T ss_dssp             HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSC-----CHHHHHTSGGGTTTCCGGG
T ss_pred             hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcC-----CHHHHhcCcccccCCCccc
Confidence                           01235789999999999999999999     9999999999998766543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.8e-48  Score=388.01  Aligned_cols=251  Identities=21%  Similarity=0.338  Sum_probs=215.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeE----EEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEI----YAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      +..++|++++.||+|+||+||+|++..+++.    ||+|++....  .......+.+|+.++++++||||+++++++. .
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A           10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            4567999999999999999999999988876    6666664332  1122234667999999999999999999886 4


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      ...++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+.
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            6689999999999999999764 578999999999999999999999999999999999999999999999999998864


Q ss_pred             CCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHH
Q 011698          302 ENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       302 ~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                      ...   ......||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+...+...+..+ ....|..++.++
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV  246 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTT
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHH
Confidence            432   2345668889999999999999999999999999999999 99999998888888877766 566778899999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      .+||.+||+.||.+||     ++++++++
T Consensus       247 ~~li~~~l~~dp~~Rp-----s~~el~~~  270 (325)
T 3kex_A          247 YMVMVKCWMIDENIRP-----TFKELANE  270 (325)
T ss_dssp             THHHHHHTCSCTTTSC-----CHHHHHHH
T ss_pred             HHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            9999999999999999     88888764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.5e-47  Score=397.15  Aligned_cols=252  Identities=26%  Similarity=0.415  Sum_probs=217.4

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC------CCCCeeeEeEEEee
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV------DHPFIVQLRYSFQT  221 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l------~hp~Iv~l~~~~~~  221 (479)
                      ...+|++++.||+|+||+||+|++..+++.||||+++...    .....+.+|+.+++.+      +|+||+++++++..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            3468999999999999999999999999999999997643    2334567788888776      57899999999999


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc--EEEeecCCc
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH--VMLTDFGLA  297 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~--vkL~DFGla  297 (479)
                      ...+|+||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++
T Consensus       171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999999996 58888887754  4899999999999999999999999999999999999999987  999999999


Q ss_pred             cccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC----------
Q 011698          298 KQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK----------  367 (479)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----------  367 (479)
                      +....  ...+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+....-.          
T Consensus       250 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~  327 (429)
T 3kvw_A          250 CYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK  327 (429)
T ss_dssp             EETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred             eecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence            76543  345678999999999999999999999999999999999999999998887776666532000          


Q ss_pred             -------------------------------------------------CCccCCHHHHHHHHhhhhhchhhhcCCCCCC
Q 011698          368 -------------------------------------------------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGG  398 (479)
Q Consensus       368 -------------------------------------------------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t  398 (479)
                                                                       ++...++++.+||++||+.||++||     |
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp-----t  402 (429)
T 3kvw_A          328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM-----T  402 (429)
T ss_dssp             THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC-----C
T ss_pred             hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC-----C
Confidence                                                             1112378899999999999999999     9


Q ss_pred             HHHHHhCccccCC
Q 011698          399 SQEIKSHKWFKMI  411 (479)
Q Consensus       399 ~~eil~hp~f~~~  411 (479)
                      ++|+++||||+..
T Consensus       403 a~e~L~Hpw~~~~  415 (429)
T 3kvw_A          403 PGQALRHPWLRRR  415 (429)
T ss_dssp             HHHHHTSTTTC--
T ss_pred             HHHHhCChhhccC
Confidence            9999999999874

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.5e-47  Score=376.68  Aligned_cols=257  Identities=26%  Similarity=0.391  Sum_probs=214.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe--------
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ--------  220 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--------  220 (479)
                      .++|++++.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.++++++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            46899999999999999999999999999999998754   2344567889999999999999999998873        


Q ss_pred             ------eCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeC-CCCcEEEee
Q 011698          221 ------TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-ADGHVMLTD  293 (479)
Q Consensus       221 ------~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~-~~g~vkL~D  293 (479)
                            ....+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence                  4578999999998 589888754 6789999999999999999999999999999999999997 567999999


Q ss_pred             cCCccccCCC----CCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-
Q 011698          294 FGLAKQFDEN----TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK-  367 (479)
Q Consensus       294 FGla~~~~~~----~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-  367 (479)
                      ||+++.....    .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+...... 
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999876432    22345678999999999876 67899999999999999999999999998877777666543211 


Q ss_pred             -----------------------------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhh
Q 011698          368 -----------------------------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK  415 (479)
Q Consensus       368 -----------------------------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~  415 (479)
                                                   ++..++.++.+||++||+.||.+||     +++|+++||||+...|..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL-----TAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSC-----CHHHHHTSHHHHTTCC--
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccC-----CHHHHhCCcccccccCcc
Confidence                                         1245899999999999999999999     999999999999988754

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.3e-47  Score=391.04  Aligned_cols=253  Identities=25%  Similarity=0.373  Sum_probs=212.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC--------CCCeeeEeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD--------HPFIVQLRY  217 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~--------hp~Iv~l~~  217 (479)
                      .+..++|++++.||+|+||+||+|++..+++.||||+++...    ...+.+.+|+.+|+.++        |+||+++++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~  108 (397)
T 1wak_A           33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD  108 (397)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred             hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence            344578999999999999999999999999999999997542    34556788999999885        788999999


Q ss_pred             EEe----eCCeEEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCCC---
Q 011698          218 SFQ----TKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADG---  287 (479)
Q Consensus       218 ~~~----~~~~~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g---  287 (479)
                      ++.    ....+|+||||+. ++|...+.+.  +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++   
T Consensus       109 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          109 DFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred             ceeecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence            997    5668999999995 5666666544  4699999999999999999999998 999999999999999876   


Q ss_pred             ----------------------------------------------cEEEeecCCccccCCCCCcccccCCCCCcchhHh
Q 011698          288 ----------------------------------------------HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV  321 (479)
Q Consensus       288 ----------------------------------------------~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l  321 (479)
                                                                    .+||+|||+++.....  ....+||+.|+|||++
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhh
Confidence                                                          7999999999876543  3456899999999999


Q ss_pred             cCCCCCccccchhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHh--------------------------------
Q 011698          322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGN------RQKIQQKIIK--------------------------------  363 (479)
Q Consensus       322 ~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~------~~~~~~~i~~--------------------------------  363 (479)
                      .+..++.++|||||||++|||++|+.||.+.+      .......+..                                
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            99999999999999999999999999997644      2222222221                                


Q ss_pred             ----------ccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          364 ----------DKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       364 ----------~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                                ....++...+.++.+||.+||+.||++||     |++|+++||||++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~~~~  397 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA-----TAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSC-----CHHHHHTSGGGGC
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcC-----CHHHHhhCccccC
Confidence                      11223344567889999999999999999     9999999999974

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.5e-47  Score=386.58  Aligned_cols=257  Identities=23%  Similarity=0.361  Sum_probs=210.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhh--------chHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI--------MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  220 (479)
                      .++|++.+.||+|+||.||+|.+.. |+.||||++.....        ......+.+.+|+.++++++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            4789999999999999999999865 88999999965321        22334577889999999999999999999984


Q ss_pred             e-----CCeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeec
Q 011698          221 T-----KYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDF  294 (479)
Q Consensus       221 ~-----~~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DF  294 (479)
                      .     ...+|+||||+.| +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       100 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             ECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             eccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence            3     3478999999985 777777654 46999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCCCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-------
Q 011698          295 GLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-------  366 (479)
Q Consensus       295 Gla~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-------  366 (479)
                      |+++...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....       
T Consensus       179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (362)
T 3pg1_A          179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV  258 (362)
T ss_dssp             TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHh
Confidence            99987666556667789999999999987 6789999999999999999999999999887777766654110       


Q ss_pred             -------------------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          367 -------------------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       367 -------------------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                                               ..+..+++.+.+||.+||+.||.+||     |++|+++||||+.+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~f~~~~  324 (362)
T 3pg1_A          259 VMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI-----STEQALRHPYFESLF  324 (362)
T ss_dssp             HHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGTTTC
T ss_pred             hhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCC-----CHHHHHcCchhhhcc
Confidence                                     11235688999999999999999999     999999999999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.5e-47  Score=388.47  Aligned_cols=258  Identities=28%  Similarity=0.400  Sum_probs=208.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe--
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR--  224 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~--  224 (479)
                      ..+++|++.+.||+|+||+||+|+++.+++.||||++.......    ....+|+..++.++||||++++++|.....  
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            45689999999999999999999999999999999987643222    234567778889999999999999966443  


Q ss_pred             -----EEEEEEeccCCcHH---HHHHHcCCCcHHHHHHHHHHHHHHHHHHH--hCCCccCCCCCccEEeCC-CCcEEEee
Q 011698          225 -----LYLVLDFVNGGHLF---FQLYRQGLFREDLARIYTAEIVSAVSHLH--ANGIMHRDLKPENILLDA-DGHVMLTD  293 (479)
Q Consensus       225 -----~~lV~E~~~ggsL~---~~l~~~~~l~e~~~~~~~~qi~~aL~~LH--~~~IiHrDLKpeNILl~~-~g~vkL~D  293 (479)
                           +++||||+.++.+.   ..+.....+++..++.++.||+.||.|||  ++||+||||||+|||++. ++.+||+|
T Consensus        96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred             ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence                 89999999985332   22234567899999999999999999999  999999999999999997 89999999


Q ss_pred             cCCccccCCCCCcccccCCCCCcchhHhcCCC-CCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------
Q 011698          294 FGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI------  366 (479)
Q Consensus       294 FGla~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~------  366 (479)
                      ||+++.+.........+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+.....      
T Consensus       176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3e3p_A          176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV  255 (360)
T ss_dssp             CTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             CCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence            99999877666666788999999999997654 89999999999999999999999999888877777664211      


Q ss_pred             --------------------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          367 --------------------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       367 --------------------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                                                ..+...+.++.+||.+||+.||.+||     ++.|+++||||+.+.+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM-----KPYEALCHPYFDELHD  323 (360)
T ss_dssp             HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSC-----CHHHHTTSGGGGGGGC
T ss_pred             HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccC-----CHHHHhcCccccccCC
Confidence                                      11122578999999999999999999     9999999999998754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.3e-47  Score=380.12  Aligned_cols=254  Identities=26%  Similarity=0.434  Sum_probs=218.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE-cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCC------CeeeEeEEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRR-IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP------FIVQLRYSF  219 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp------~Iv~l~~~~  219 (479)
                      +..++|++++.||+|+||+||+|.+ +.+++.||+|+++...    ...+.+.+|+.+++.++|+      +|+++++++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            4457999999999999999999998 5688999999997532    3455678899999988665      499999999


Q ss_pred             eeCCeEEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC------------
Q 011698          220 QTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA------------  285 (479)
Q Consensus       220 ~~~~~~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~------------  285 (479)
                      .+...+|+||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.            
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            9999999999999 889999998775  6899999999999999999999999999999999999987            


Q ss_pred             -------CCcEEEeecCCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHH
Q 011698          286 -------DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ  358 (479)
Q Consensus       286 -------~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~  358 (479)
                             ++.+||+|||+++....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+..
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             cccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                   67899999999987543  334568999999999999999999999999999999999999999988776655


Q ss_pred             HHHHhccCCCC--------------------------------------------ccCCHHHHHHHHhhhhhchhhhcCC
Q 011698          359 QKIIKDKIKLP--------------------------------------------AFLSSEAHSLLKGLLQKEASKRLGS  394 (479)
Q Consensus       359 ~~i~~~~~~~p--------------------------------------------~~~s~~~~~lI~~~L~~dP~~R~~~  394 (479)
                      ..+......+|                                            ...+.++.+||.+||+.||.+||  
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp--  321 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI--  321 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC--
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc--
Confidence            55443222211                                            22357789999999999999999  


Q ss_pred             CCCCHHHHHhCccccCCC
Q 011698          395 GPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       395 ~~~t~~eil~hp~f~~~~  412 (479)
                         +++|+++||||+.+.
T Consensus       322 ---t~~ell~hp~f~~~~  336 (339)
T 1z57_A          322 ---TLREALKHPFFDLLK  336 (339)
T ss_dssp             ---CHHHHTTSGGGGGGG
T ss_pred             ---CHHHHhcCHHHHHHh
Confidence               999999999998753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=390.09  Aligned_cols=261  Identities=20%  Similarity=0.276  Sum_probs=227.4

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE-----cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  220 (479)
                      .+..++|++++.||+|+||+||+|++     ..+++.||||+++...  .......+.+|+.++++++||||+++++++.
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  144 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL  144 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            35567899999999999999999994     4577899999997532  2334456788999999999999999999999


Q ss_pred             eCCeEEEEEEeccCCcHHHHHHHcC-------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC---cEE
Q 011698          221 TKYRLYLVLDFVNGGHLFFQLYRQG-------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG---HVM  290 (479)
Q Consensus       221 ~~~~~~lV~E~~~ggsL~~~l~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g---~vk  290 (479)
                      +....|+||||+.||+|.+++...+       .+++..++.++.||+.||.|||++||+||||||+|||++.+|   .+|
T Consensus       145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999999998753       489999999999999999999999999999999999999655   599


Q ss_pred             EeecCCccccC---CCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-c
Q 011698          291 LTDFGLAKQFD---ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-K  365 (479)
Q Consensus       291 L~DFGla~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~  365 (479)
                      |+|||+++.+.   .........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+..+ .
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999998642   2233445678999999999999999999999999999999998 99999999999888888876 4


Q ss_pred             CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          366 IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       366 ~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      ...+..++.++.+||.+||+.||.+||     ++++|+++.++-.-+.
T Consensus       305 ~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          305 MDPPKNCPGPVYRIMTQCWQHQPEDRP-----NFAIILERIEYCTQDP  347 (367)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHHHHHCH
T ss_pred             CCCCccCCHHHHHHHHHHcCCCHhHCc-----CHHHHHHHHHHHhhCh
Confidence            566788999999999999999999999     9999999887765444

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.2e-47  Score=380.52  Aligned_cols=252  Identities=21%  Similarity=0.333  Sum_probs=221.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCe---EEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      .+..++|++.+.||+|+||+||+|++..+++   .||||+++...  .....+.+.+|+.+|++++||||+++++++.+.
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            4566899999999999999999999986554   59999997643  334456788999999999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      ..+|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999999999755 579999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC----cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHH
Q 011698          302 ENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (479)
Q Consensus       302 ~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  375 (479)
                      ....    .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+..+ ....|..++.+
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA  282 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHH
Confidence            4321    223456788999999999999999999999999999999 99999999988888888776 56677889999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +.+||..||+.||.+||     ++++|++
T Consensus       283 l~~li~~~l~~dp~~Rp-----s~~eil~  306 (325)
T 3kul_A          283 LHQLMLDCWHKDRAQRP-----RFSQIVS  306 (325)
T ss_dssp             HHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHccCChhhCc-----CHHHHHH
Confidence            99999999999999999     8998875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.6e-47  Score=383.66  Aligned_cols=261  Identities=29%  Similarity=0.455  Sum_probs=227.8

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH---HHHHHHHHHHHHHHhCC--CCCeeeEeEEEe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVD--HPFIVQLRYSFQ  220 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~  220 (479)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++........   ...+.+.+|+.++++++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            3445789999999999999999999999999999999987543221   11234567999999996  599999999999


Q ss_pred             eCCeEEEEEEeccC-CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeC-CCCcEEEeecCCcc
Q 011698          221 TKYRLYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-ADGHVMLTDFGLAK  298 (479)
Q Consensus       221 ~~~~~~lV~E~~~g-gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~-~~g~vkL~DFGla~  298 (479)
                      ....+++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            99999999999986 89999999889999999999999999999999999999999999999999 78999999999998


Q ss_pred             ccCCCCCcccccCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHH
Q 011698          299 QFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAH  377 (479)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  377 (479)
                      ..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...      ..+......++..++.++.
T Consensus       199 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~------~~~~~~~~~~~~~~~~~~~  271 (320)
T 3a99_A          199 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQ  271 (320)
T ss_dssp             ECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHH
T ss_pred             ccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh------hhhhcccccccccCCHHHH
Confidence            76543 3445679999999999987766 68899999999999999999999753      2455667778889999999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhc
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEA  418 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~  418 (479)
                      +||.+||+.||++||     +++++++||||+.+.+.....
T Consensus       272 ~li~~~l~~dp~~Rp-----s~~~ll~hp~~~~~~~~~~~~  307 (320)
T 3a99_A          272 HLIRWCLALRPSDRP-----TFEEIQNHPWMQDVLLPQETA  307 (320)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHTSGGGSSCCCHHHHH
T ss_pred             HHHHHHccCChhhCc-----CHHHHhcCHhhcCccCccccc
Confidence            999999999999999     999999999999987655443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.1e-47  Score=378.13  Aligned_cols=267  Identities=20%  Similarity=0.286  Sum_probs=230.8

Q ss_pred             CcccCCCCeEEEEEeccCCceEEEEEEEc-----CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEE
Q 011698          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYS  218 (479)
Q Consensus       144 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~  218 (479)
                      ...+..++|++.+.||+|+||.||+|+++     .+++.||+|++....  .......+.+|+.++++++||||++++++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            34566689999999999999999999887     367889999997643  23345568899999999999999999999


Q ss_pred             EeeCCeEEEEEEeccCCcHHHHHHHc----------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc
Q 011698          219 FQTKYRLYLVLDFVNGGHLFFQLYRQ----------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH  288 (479)
Q Consensus       219 ~~~~~~~~lV~E~~~ggsL~~~l~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~  288 (479)
                      +.+....++||||+.||+|.+++...          ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence            99999999999999999999998753          35689999999999999999999999999999999999999999


Q ss_pred             EEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 011698          289 VMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD  364 (479)
Q Consensus       289 vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~  364 (479)
                      +||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...+...+..+
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  256 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  256 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence            9999999998654332   2234567889999999999999999999999999999999 99999999888888888776


Q ss_pred             c-CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC------ccccCCChhhhh
Q 011698          365 K-IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH------KWFKMINWKKLE  417 (479)
Q Consensus       365 ~-~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h------p~f~~~~~~~l~  417 (479)
                      . ...+..++.++.+||.+||+.||.+||     ++.++++|      ++|+.++|...+
T Consensus       257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~e~l~~L~~~~~~~~~~~~~~~~~  311 (322)
T 1p4o_A          257 GLLDKPDNCPDMLFELMRMCWQYNPKMRP-----SFLEIISSIKEEMEPGFREVSFYYSE  311 (322)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHGGGSCTTHHHHCSTTST
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCc-----CHHHHHHHHHHhhccCCccccccccc
Confidence            4 456788999999999999999999999     89999876      666665554443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9.2e-47  Score=379.22  Aligned_cols=254  Identities=23%  Similarity=0.306  Sum_probs=217.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      .++|++.+.||+|+||+||+|++..+++.||||++.....     .+.+.+|+.+++++ +||||+++++++......|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            4689999999999999999999999999999999976432     22477899999999 99999999999999999999


Q ss_pred             EEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc-----EEEeecCCccccC
Q 011698          228 VLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH-----VMLTDFGLAKQFD  301 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~-----vkL~DFGla~~~~  301 (479)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++.+.
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99999 8999999987 467999999999999999999999999999999999999999988     9999999998764


Q ss_pred             CCCC--------cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhccCCCCc
Q 011698          302 ENTR--------SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKDKIKLPA  370 (479)
Q Consensus       302 ~~~~--------~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~~p~  370 (479)
                      ....        ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.   +..+....+.......+.
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  241 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI  241 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence            3322        24678999999999999999999999999999999999999999874   445556666555444332


Q ss_pred             -----cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh----------CccccCCChh
Q 011698          371 -----FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS----------HKWFKMINWK  414 (479)
Q Consensus       371 -----~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~----------hp~f~~~~~~  414 (479)
                           .++ ++.+||..||+.||.+||     ++++|++          ..+...++|.
T Consensus       242 ~~~~~~~p-~~~~li~~~l~~~p~~RP-----~~~~l~~~l~~~~~~~~~~~~~~~dw~  294 (330)
T 2izr_A          242 EVLCENFP-EMATYLRYVRRLDFFEKP-----DYDYLRKLFTDLFDRKGYMFDYEYDWI  294 (330)
T ss_dssp             HHHTTTCH-HHHHHHHHHHHCCTTCCC-----CHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred             HHHhccCh-HHHHHHHHHHhCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence                 244 999999999999999999     7777654          3344456775

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-48  Score=399.65  Aligned_cols=259  Identities=16%  Similarity=0.228  Sum_probs=202.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC--CCCCeeeEe-------EEEe
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV--DHPFIVQLR-------YSFQ  220 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~-------~~~~  220 (479)
                      .+|++.+.||+|+||+||+|++..+++.||||++...........+.+++|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            4699999999999999999999999999999999987655556677788886555544  699988855       4443


Q ss_pred             eC-----------------CeEEEEEEeccCCcHHHHHHHcC-CCcHHHH------HHHHHHHHHHHHHHHhCCCccCCC
Q 011698          221 TK-----------------YRLYLVLDFVNGGHLFFQLYRQG-LFREDLA------RIYTAEIVSAVSHLHANGIMHRDL  276 (479)
Q Consensus       221 ~~-----------------~~~~lV~E~~~ggsL~~~l~~~~-~l~e~~~------~~~~~qi~~aL~~LH~~~IiHrDL  276 (479)
                      ..                 ..+|+||||++ |+|.+++...+ .+.+...      ..++.||+.||+|||++||+||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            32                 34899999999 79999998643 3444444      466699999999999999999999


Q ss_pred             CCccEEeCCCCcEEEeecCCccccCCCCCcccccCCCCCcchhHhcC--CCCCccccchhhHHHHHHHHhCCCCCCCCCH
Q 011698          277 KPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFTGGNR  354 (479)
Q Consensus       277 KpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~DiwSLGvilyelltG~~Pf~~~~~  354 (479)
                      ||+|||++.+|.+||+|||+++.....  .....||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+...
T Consensus       221 kp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~  298 (371)
T 3q60_A          221 TPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP  298 (371)
T ss_dssp             SGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred             CHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence            999999999999999999999876432  224567799999999988  7799999999999999999999999987633


Q ss_pred             HHH--HHH-----HHhccCCCC--ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          355 QKI--QQK-----IIKDKIKLP--AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       355 ~~~--~~~-----i~~~~~~~p--~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                      ...  ...     .......++  ..++.++.+||.+||+.||++||     +++++++||||+.+.|..-
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~e~l~hp~f~~~~~~~~  364 (371)
T 3q60_A          299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL-----LPLEAMETPEFLQLQNEIS  364 (371)
T ss_dssp             TCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCC-----CHHHHTTSHHHHHHHHHHH
T ss_pred             ccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCC-----CHHHHhcCHHHHHHHHHHh
Confidence            211  000     011122233  47899999999999999999999     9999999999999988643

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=382.12  Aligned_cols=256  Identities=26%  Similarity=0.399  Sum_probs=217.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe-----
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR-----  224 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~-----  224 (479)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.....     
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            68999999999999999999999999999999997643 234455678899999999999999999999987654     


Q ss_pred             -EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          225 -LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       225 -~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                       +|+||||+. ++|...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       103 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  179 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE  179 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred             eEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence             499999998 48876664  35899999999999999999999999999999999999999999999999999875432


Q ss_pred             CCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------------
Q 011698          304 TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK-----------------  365 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~-----------------  365 (479)
                        ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....                 
T Consensus       180 --~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  257 (353)
T 3coi_A          180 --MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK  257 (353)
T ss_dssp             ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred             --ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence              345689999999999987 678999999999999999999999999888776666554310                 


Q ss_pred             --------------CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          366 --------------IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       366 --------------~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                                    ...+..++.++.+||.+||+.||++||     +++++++||||+.+.....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp-----t~~e~l~hp~f~~~~~~~~  317 (353)
T 3coi_A          258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL-----TAAQALTHPFFEPFRDPEE  317 (353)
T ss_dssp             HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSC-----CHHHHHTSGGGTTTCCGGG
T ss_pred             HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCC-----CHHHHhcCcchhhccCccc
Confidence                          112346799999999999999999999     9999999999998765443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-46  Score=366.58  Aligned_cols=250  Identities=20%  Similarity=0.372  Sum_probs=222.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+..++|++++.||+|+||+||+|++. +++.||+|++......    .+.+.+|+.++++++||||+++++++.+...+
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A            6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence            356689999999999999999999987 4667999999865432    24578899999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      |+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            9999999999999999754 468999999999999999999999999999999999999999999999999998754322


Q ss_pred             --CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHH
Q 011698          305 --RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (479)
Q Consensus       305 --~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI  380 (479)
                        ......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..++...+..+ ....|..++.++.++|
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM  240 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHH
Confidence              2334567888999999999999999999999999999999 99999999999888888876 5566778999999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ..||+.||++||     +++++++|
T Consensus       241 ~~~l~~~p~~Rp-----s~~~ll~~  260 (269)
T 4hcu_A          241 NHCWRERPEDRP-----AFSRLLRQ  260 (269)
T ss_dssp             HHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHccCCcccCc-----CHHHHHHH
Confidence            999999999999     89999874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.6e-46  Score=368.27  Aligned_cols=253  Identities=19%  Similarity=0.350  Sum_probs=221.5

Q ss_pred             CCcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       143 ~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      ....+..++|++++.||+|+||+||+|++. ++..||+|++......    .+.+.+|+.++++++||||+++++++.+.
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   91 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ   91 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence            344567789999999999999999999887 5677999999865432    24478899999999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      ..+|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A           92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            999999999999999999976 5679999999999999999999999999999999999999999999999999998754


Q ss_pred             CCC--CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHH
Q 011698          302 ENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (479)
Q Consensus       302 ~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (479)
                      ...  ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||...+.......+... ....|..++..+.
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  251 (283)
T 3gen_A          172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY  251 (283)
T ss_dssp             CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHH
Confidence            322  2234456788999999999999999999999999999998 99999999988888888876 4556778899999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      +||..||+.||.+||     +++++++|
T Consensus       252 ~li~~~l~~~p~~Rp-----s~~~ll~~  274 (283)
T 3gen_A          252 TIMYSCWHEKADERP-----TFKILLSN  274 (283)
T ss_dssp             HHHHHTTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHccCChhHCc-----CHHHHHHH
Confidence            999999999999999     89999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-47  Score=379.81  Aligned_cols=251  Identities=20%  Similarity=0.343  Sum_probs=223.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  221 (479)
                      +..++|++++.||+|+||.||+|++..     +++.||+|+++...  .....+.+.+|+.++++++||||+++++++.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            456799999999999999999999973     55899999998653  33445678899999999999999999999999


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHc------------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQ------------------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLK  277 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~------------------------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLK  277 (479)
                      ...+|+||||+++|+|.+++...                        ..+++..++.++.||+.||.|||++||+|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            99999999999999999999874                        568999999999999999999999999999999


Q ss_pred             CccEEeCCCCcEEEeecCCccccCCC---CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 011698          278 PENILLDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGN  353 (479)
Q Consensus       278 peNILl~~~g~vkL~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~  353 (479)
                      |+|||++.++.+||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            99999999999999999999865432   22344578899999999999999999999999999999999 999999999


Q ss_pred             HHHHHHHHHhcc-CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          354 RQKIQQKIIKDK-IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       354 ~~~~~~~i~~~~-~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ..++...+..+. ..+|..++.++.+||++||+.||.+||     ++.++++
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~~~  328 (343)
T 1luf_A          282 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP-----SFCSIHR  328 (343)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             hHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCC-----CHHHHHH
Confidence            888888888764 457788999999999999999999999     8999875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.5e-46  Score=385.79  Aligned_cols=255  Identities=28%  Similarity=0.419  Sum_probs=216.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CC-----CeeeEeEEEe
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HP-----FIVQLRYSFQ  220 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp-----~Iv~l~~~~~  220 (479)
                      ...++|++.+.||+|+||+||+|+++.+++.||||+++...    .....+..|+.+++.++ |+     +|+++++++.
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            44689999999999999999999999999999999997542    23455677888888875 44     4999999999


Q ss_pred             eCCeEEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHH--hCCCccCCCCCccEEeC--CCCcEEEeec
Q 011698          221 TKYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLH--ANGIMHRDLKPENILLD--ADGHVMLTDF  294 (479)
Q Consensus       221 ~~~~~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH--~~~IiHrDLKpeNILl~--~~g~vkL~DF  294 (479)
                      ....+|+||||+.+ +|.+++...  +.+++..++.++.||+.||.|||  +.||+||||||+|||++  .++.+||+||
T Consensus       127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            99999999999975 999998875  45899999999999999999999  57999999999999994  5788999999


Q ss_pred             CCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc----
Q 011698          295 GLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----  370 (479)
Q Consensus       295 Gla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----  370 (479)
                      |+++....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.......|.    
T Consensus       206 G~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  283 (382)
T 2vx3_A          206 GSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD  283 (382)
T ss_dssp             TTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             cCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99987643  345678999999999999999999999999999999999999999998888777777653111110    


Q ss_pred             --------------c----------------------------------------------CCHHHHHHHHhhhhhchhh
Q 011698          371 --------------F----------------------------------------------LSSEAHSLLKGLLQKEASK  390 (479)
Q Consensus       371 --------------~----------------------------------------------~s~~~~~lI~~~L~~dP~~  390 (479)
                                    .                                              .+.++.+||.+||+.||++
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  363 (382)
T 2vx3_A          284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT  363 (382)
T ss_dssp             TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred             hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence                          0                                              0137899999999999999


Q ss_pred             hcCCCCCCHHHHHhCccccCCCh
Q 011698          391 RLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       391 R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      ||     |++|+++||||+...|
T Consensus       364 Rp-----ta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          364 RI-----QPYYALQHSFFKKTAD  381 (382)
T ss_dssp             SC-----CHHHHTTSGGGCC---
T ss_pred             CC-----CHHHHhcCcccccCCC
Confidence            99     9999999999998654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6e-47  Score=376.75  Aligned_cols=252  Identities=20%  Similarity=0.347  Sum_probs=216.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++.+.||+|+||+||+|++..+++.||+|++...   .....+.+.+|+.++++++||||+++++++.+...++
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            5568999999999999999999999999999999998543   3445667889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          227 LVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      +||||+.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999999987 56799999999999999999999999999999999999999999999999999987643322


Q ss_pred             c---------------ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcc
Q 011698          306 S---------------NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQK-----IQQKIIKDK  365 (479)
Q Consensus       306 ~---------------~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~-----~~~~i~~~~  365 (479)
                      .               ...+||+.|+|||++.+..++.++|||||||++|||++|..||.......     ......  .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--~  241 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--D  241 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--H
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--c
Confidence            1               25689999999999999999999999999999999999999997532211     011111  1


Q ss_pred             CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          366 IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       366 ~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      ...|..+++++.+||.+||+.||++||     +++++++  |++.
T Consensus       242 ~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~~l~~--~L~~  279 (310)
T 3s95_A          242 RYCPPNCPPSFFPITVRCCDLDPEKRP-----SFVKLEH--WLET  279 (310)
T ss_dssp             HTCCTTCCTTHHHHHHHHTCSSGGGSC-----CHHHHHH--HHHH
T ss_pred             ccCCCCCCHHHHHHHHHHccCChhhCc-----CHHHHHH--HHHH
Confidence            234677899999999999999999999     8999986  4443

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-46  Score=382.80  Aligned_cols=253  Identities=21%  Similarity=0.367  Sum_probs=226.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCC-------CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGT-------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~  217 (479)
                      .+..++|++.+.||+|+||+||+|++..+       +..||+|+++...  .......+.+|+.+++++ +||||+++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            45668999999999999999999997643       3679999997653  344556788999999999 9999999999


Q ss_pred             EEeeCCeEEEEEEeccCCcHHHHHHHcC----------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccE
Q 011698          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (479)
Q Consensus       218 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNI  281 (479)
                      ++.+...+|+||||+.||+|.+++....                .+++..++.++.||+.||.|||++||+||||||+||
T Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  222 (382)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence            9999999999999999999999998754                489999999999999999999999999999999999


Q ss_pred             EeCCCCcEEEeecCCccccCCC---CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHH
Q 011698          282 LLDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI  357 (479)
Q Consensus       282 Ll~~~g~vkL~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~  357 (479)
                      |++.++.+||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999999876443   23345567899999999999999999999999999999999 9999999998888


Q ss_pred             HHHHHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          358 QQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       358 ~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      .+.+..+ ....|..++.++.+||.+||+.||++||     +++|++++
T Consensus       303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~  346 (382)
T 3tt0_A          303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-----TFKQLVED  346 (382)
T ss_dssp             HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            8888776 5567788999999999999999999999     89999873

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.4e-46  Score=373.48  Aligned_cols=253  Identities=22%  Similarity=0.347  Sum_probs=224.4

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc-----CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  220 (479)
                      .+..++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+.++++++||||+++++++.
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            455689999999999999999999983     456899999997643  3445567889999999999999999999999


Q ss_pred             eCCeEEEEEEeccCCcHHHHHHHcCC------------------------CcHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 011698          221 TKYRLYLVLDFVNGGHLFFQLYRQGL------------------------FREDLARIYTAEIVSAVSHLHANGIMHRDL  276 (479)
Q Consensus       221 ~~~~~~lV~E~~~ggsL~~~l~~~~~------------------------l~e~~~~~~~~qi~~aL~~LH~~~IiHrDL  276 (479)
                      +...+|+||||+.||+|.+++.....                        +++..++.++.||+.||.|||++||+||||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di  176 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL  176 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence            99999999999999999999987543                        889999999999999999999999999999


Q ss_pred             CCccEEeCCCCcEEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCC
Q 011698          277 KPENILLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGG  352 (479)
Q Consensus       277 KpeNILl~~~g~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~  352 (479)
                      ||+|||++.++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999998764432   2234567889999999999999999999999999999999 99999998


Q ss_pred             CHHHHHHHHHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          353 NRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       353 ~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      +...+...+..+ ....+..++.++.+||.+||+.||.+||     ++++++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~l~~~  305 (314)
T 2ivs_A          257 PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP-----VFADISKD  305 (314)
T ss_dssp             CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             CHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCc-----CHHHHHHH
Confidence            888888777765 4567788999999999999999999999     89998864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.5e-46  Score=371.83  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=212.1

Q ss_pred             CcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       144 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      .....+++|++.+.||+|+||+||+|++..+++.||+|++...........+.+.+|+.++++++||||+++++++....
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            34456789999999999999999999999999999999998765555556678899999999999999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      .+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999876443


Q ss_pred             C--CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---CCCccCCHHHHH
Q 011698          304 T--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---KLPAFLSSEAHS  378 (479)
Q Consensus       304 ~--~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~  378 (479)
                      .  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+...+...+.....   ..+..++.++.+
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred             ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence            2  23456799999999999999999999999999999999999999998776655544443322   345678999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +|.+||+.||++||+    +++++++
T Consensus       268 li~~~l~~dP~~Rp~----s~~~l~~  289 (309)
T 2h34_A          268 VIARGMAKNPEDRYV----TCGDLSA  289 (309)
T ss_dssp             HHHHHTCSSGGGSCS----SHHHHHH
T ss_pred             HHHHhccCCHHHHHH----hHHHHHH
Confidence            999999999999983    6777764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.6e-47  Score=389.34  Aligned_cols=255  Identities=22%  Similarity=0.372  Sum_probs=224.6

Q ss_pred             CCcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       143 ~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      ....+..++|++.+.||+|+||+||+|+++.+++.||||+++...  .....+.+.+|+.+|++++||||+++++++...
T Consensus       107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            344567789999999999999999999999999999999997542  233445678899999999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      ..+|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            99999999999999999997654 58999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCc---ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHH
Q 011698          302 ENTRS---NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       302 ~~~~~---~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                      .....   ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+..+ .+..|..++.++
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  344 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV  344 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            32211   12235678999999999899999999999999999998 99999998888887777665 566788899999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+||..||+.||++||     +++++++
T Consensus       345 ~~li~~cl~~dP~~Rp-----s~~~i~~  367 (377)
T 3cbl_A          345 FRLMEQCWAYEPGQRP-----SFSTIYQ  367 (377)
T ss_dssp             HHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHcCCCchhCc-----CHHHHHH
Confidence            9999999999999999     8988875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.2e-46  Score=369.04  Aligned_cols=256  Identities=29%  Similarity=0.508  Sum_probs=213.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee--------
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--------  221 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--------  221 (479)
                      ++|++++.||+|+||.||+|++..+++.||+|++...    ....+.+.+|+.++++++||||+++++++.+        
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            5799999999999999999999999999999999653    2345678899999999999999999998865        


Q ss_pred             -----CCeEEEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecC
Q 011698          222 -----KYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFG  295 (479)
Q Consensus       222 -----~~~~~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFG  295 (479)
                           ...+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence                 467899999999999999998654 57889999999999999999999999999999999999999999999999


Q ss_pred             CccccCCC---------------CCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCC-CCHHHHH
Q 011698          296 LAKQFDEN---------------TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQ  358 (479)
Q Consensus       296 la~~~~~~---------------~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~-~~~~~~~  358 (479)
                      ++......               ......+||+.|+|||++.+. .++.++|||||||++|||++   ||.. .+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~  238 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL  238 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence            99875422               223456799999999999875 68999999999999999998   6643 3344555


Q ss_pred             HHHHhccCCCC----ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhh
Q 011698          359 QKIIKDKIKLP----AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLE  417 (479)
Q Consensus       359 ~~i~~~~~~~p----~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~  417 (479)
                      ..+......+|    ...+..+.+||++||+.||.+||     +++++++||||+...++...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~~~~~~~  296 (303)
T 1zy4_A          239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP-----GARTLLNSGWLPVKHQDEVI  296 (303)
T ss_dssp             HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSC-----CHHHHHHSSCSCCCCHHHHH
T ss_pred             HhccccccccCccccccchHHHHHHHHHHHhcCcccCc-----CHHHHhCCCCcCCCChHHHH
Confidence            56655555544    34567799999999999999999     99999999999998877654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.5e-47  Score=383.58  Aligned_cols=252  Identities=23%  Similarity=0.402  Sum_probs=216.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEE-----EcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEe
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVR-----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQ  220 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~  220 (479)
                      +..++|++.+.||+|+||.||+|+     ...+++.||||+++...  .....+.+.+|+.+++++ +||||+++++++.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~   96 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT   96 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence            556899999999999999999999     45567999999997643  233456788999999999 7899999999998


Q ss_pred             eCC-eEEEEEEeccCCcHHHHHHHcCC-----------------------------------------------------
Q 011698          221 TKY-RLYLVLDFVNGGHLFFQLYRQGL-----------------------------------------------------  246 (479)
Q Consensus       221 ~~~-~~~lV~E~~~ggsL~~~l~~~~~-----------------------------------------------------  246 (479)
                      +.. .+++||||+.||+|.+++.....                                                     
T Consensus        97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A           97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence            755 49999999999999999976543                                                     


Q ss_pred             -------------CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC---Cccccc
Q 011698          247 -------------FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---RSNSMC  310 (479)
Q Consensus       247 -------------l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~---~~~~~~  310 (479)
                                   +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....   ......
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  256 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR  256 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence                         8999999999999999999999999999999999999999999999999998764332   234567


Q ss_pred             CCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHH-HHHhc-cCCCCccCCHHHHHHHHhhhhhc
Q 011698          311 GTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQ-KIIKD-KIKLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       311 gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~-~i~~~-~~~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      ||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+...... .+..+ ....|..+++++.++|.+||+.|
T Consensus       257 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  336 (359)
T 3vhe_A          257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  336 (359)
T ss_dssp             ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence            8899999999999999999999999999999998 999998876544443 33333 55678889999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHhC
Q 011698          388 ASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~h  405 (479)
                      |.+||     +++|+++|
T Consensus       337 P~~Rp-----s~~ell~~  349 (359)
T 3vhe_A          337 PSQRP-----TFSELVEH  349 (359)
T ss_dssp             GGGSC-----CHHHHHHH
T ss_pred             hhhCC-----CHHHHHHH
Confidence            99999     89999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.3e-46  Score=381.16  Aligned_cols=253  Identities=26%  Similarity=0.426  Sum_probs=213.2

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-----------CCCeeeE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----------HPFIVQL  215 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-----------hp~Iv~l  215 (479)
                      +..++|++++.||+|+||+||+|++..+++.||||++....    ...+.+.+|+.++++++           ||||+++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            45679999999999999999999999999999999997543    23455778999998876           8999999


Q ss_pred             eEEEeeCC----eEEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeC----
Q 011698          216 RYSFQTKY----RLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLD----  284 (479)
Q Consensus       216 ~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~----  284 (479)
                      ++++....    .+++||||+ +++|.+++...  +.+++..++.++.||+.||.|||++ ||+||||||+|||++    
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99998654    899999999 88999999763  4599999999999999999999998 999999999999994    


Q ss_pred             --CCCcEEEeecCCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCH------HH
Q 011698          285 --ADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR------QK  356 (479)
Q Consensus       285 --~~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~------~~  356 (479)
                        ..+.+||+|||+++.....  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.      ..
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence              4458999999999876543  3456899999999999999999999999999999999999999986441      22


Q ss_pred             HHHHH------------------------------------------HhccCCCCccCCHHHHHHHHhhhhhchhhhcCC
Q 011698          357 IQQKI------------------------------------------IKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGS  394 (479)
Q Consensus       357 ~~~~i------------------------------------------~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~  394 (479)
                      ....+                                          ......++..++.++.+||.+||+.||++||  
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp--  326 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA--  326 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB--
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC--
Confidence            22222                                          2233445566788999999999999999999  


Q ss_pred             CCCCHHHHHhCccccCC
Q 011698          395 GPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       395 ~~~t~~eil~hp~f~~~  411 (479)
                         +++|+++||||++.
T Consensus       327 ---t~~ell~hp~f~~~  340 (373)
T 1q8y_A          327 ---DAGGLVNHPWLKDT  340 (373)
T ss_dssp             ---CHHHHHTCGGGTTC
T ss_pred             ---CHHHHhhChhhhcc
Confidence               99999999999985

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.6e-46  Score=362.93  Aligned_cols=250  Identities=21%  Similarity=0.344  Sum_probs=221.3

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+..++|++++.||+|+||.||+|+++ ++..||+|++......    .+.+.+|+.++++++||||+++++++.+...+
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            355689999999999999999999886 4667999999865432    24478899999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      ++||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999999997754 49999999999999999999999999999999999999999999999999998764433


Q ss_pred             C--cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-CCCCccCCHHHHHHH
Q 011698          305 R--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLL  380 (479)
Q Consensus       305 ~--~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~lI  380 (479)
                      .  .....||+.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+..+. ...|..+++++.++|
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  238 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIM  238 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHH
Confidence            2  233456778999999999899999999999999999999 999999988888888877764 455677899999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ..||+.||.+||     ++++++++
T Consensus       239 ~~~l~~~p~~Rp-----s~~~ll~~  258 (268)
T 3sxs_A          239 YSCWHELPEKRP-----TFQQLLSS  258 (268)
T ss_dssp             HHTTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHcCCChhhCc-----CHHHHHHH
Confidence            999999999999     89999874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.3e-46  Score=361.95  Aligned_cols=250  Identities=28%  Similarity=0.489  Sum_probs=207.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhch-HHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      +..++|++.+.||+|+||.||+|++.  ++.||+|+++...... ....+.+.+|+.+++.++||||+++++++.+...+
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            45689999999999999999999984  7889999997643222 22346688999999999999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCC---CccCCCCCccEEeCC--------CCcEEEeec
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG---IMHRDLKPENILLDA--------DGHVMLTDF  294 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~---IiHrDLKpeNILl~~--------~g~vkL~DF  294 (479)
                      |+||||++|++|.+++. .+.+++..++.++.||+.||.|||++|   |+||||||+|||++.        ++.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999988875 467899999999999999999999999   899999999999986        788999999


Q ss_pred             CCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CCCCccC
Q 011698          295 GLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--IKLPAFL  372 (479)
Q Consensus       295 Gla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~  372 (479)
                      |+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+....  ..++..+
T Consensus       161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (271)
T 3dtc_A          161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC  239 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred             Cccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence            9998765433 335679999999999999999999999999999999999999999988887777777664  4566789


Q ss_pred             CHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       373 s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      +.++.++|.+||+.||.+||     +++|++++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rp-----s~~e~l~~  267 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRP-----SFTNILDQ  267 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             CHHHHHHHHHHhcCCcccCc-----CHHHHHHH
Confidence            99999999999999999999     89999864

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.4e-46  Score=369.94  Aligned_cols=259  Identities=29%  Similarity=0.472  Sum_probs=204.2

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      ...+++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.++..+++.++||||+++++++.+...+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~   99 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV   99 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence            3557899999999999999999999999999999999987542 233344555666778889999999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          226 YLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      |+||||+ ++.+..+... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..+...
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999999 5555555543 56799999999999999999999996 9999999999999999999999999999877655


Q ss_pred             CCcccccCCCCCcchhHhc-----CCCCCccccchhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCC-CC--ccCCH
Q 011698          304 TRSNSMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKDKIK-LP--AFLSS  374 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~-----~~~~~~~~DiwSLGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~-~p--~~~s~  374 (479)
                      ......+||+.|+|||++.     +..++.++|||||||++|||++|+.||.. .+.......+..+... +|  ..++.
T Consensus       179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (318)
T 2dyl_A          179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG  258 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCH
T ss_pred             ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCH
Confidence            5556678999999999995     45688999999999999999999999987 4555666666665432 33  35899


Q ss_pred             HHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          375 EAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       375 ~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ++.+||..||+.||.+||     +++++++||||+..
T Consensus       259 ~l~~li~~~l~~dp~~Rp-----s~~~ll~h~~~~~~  290 (318)
T 2dyl_A          259 DFQSFVKDCLTKDHRKRP-----KYNKLLEHSFIKRY  290 (318)
T ss_dssp             HHHHHHHHHTCSCTTTSC-----CHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHccCChhHCc-----CHHHHhhCHHHHhc
Confidence            999999999999999999     99999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.8e-46  Score=365.84  Aligned_cols=251  Identities=22%  Similarity=0.373  Sum_probs=209.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCC---CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      .+..++|++.+.||+|+||+||+|++..+   +..||+|++....  .....+.+.+|+.++++++||||+++++++. .
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            35567999999999999999999998654   5679999987542  3445667889999999999999999999984 5


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      +..|+||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            67899999999999999998654 68999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC--cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHH
Q 011698          302 ENTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (479)
Q Consensus       302 ~~~~--~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (479)
                      ....  .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+..+ ...++..++.++.
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  247 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  247 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            4332  234457789999999999999999999999999999997 99999998888888877765 4567888999999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ++|.+||+.||++||     ++.++++
T Consensus       248 ~li~~~l~~~p~~Rp-----s~~~l~~  269 (281)
T 1mp8_A          248 SLMTKCWAYDPSRRP-----RFTELKA  269 (281)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHccCChhhCc-----CHHHHHH
Confidence            999999999999999     8999876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.8e-45  Score=362.86  Aligned_cols=247  Identities=20%  Similarity=0.299  Sum_probs=213.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~  225 (479)
                      +..++|++.+.||+|+||+||+|++..+++.||+|++.....     .+.+.+|+.+++.+ +|++|+++++++......
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            445789999999999999999999999999999999875432     23367899999999 799999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc-----EEEeecCCccc
Q 011698          226 YLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH-----VMLTDFGLAKQ  299 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~-----vkL~DFGla~~  299 (479)
                      ++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||+++.
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999 999999998754 5999999999999999999999999999999999999988776     99999999987


Q ss_pred             cCCCC--------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhccCC-
Q 011698          300 FDENT--------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG---NRQKIQQKIIKDKIK-  367 (479)
Q Consensus       300 ~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~-  367 (479)
                      .....        .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.   +.......+...... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            65432        235668999999999999999999999999999999999999999874   444555555443322 


Q ss_pred             ----CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          368 ----LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       368 ----~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                          +...++.++.+||..||+.||++||     ++++|++
T Consensus       241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP-----~~~~l~~  276 (298)
T 1csn_A          241 PLRELCAGFPEEFYKYMHYARNLAFDATP-----DYDYLQG  276 (298)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHCCTTCCC-----CHHHHHH
T ss_pred             cHHHHHhhCcHHHHHHHHHHhcCCcccCC-----CHHHHHH
Confidence                2346899999999999999999999     8888754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.4e-46  Score=375.44  Aligned_cols=252  Identities=22%  Similarity=0.367  Sum_probs=220.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEE--EEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY--AMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKY  223 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~v--AiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~  223 (479)
                      +..++|++.+.||+|+||.||+|+++.++..+  |+|.+....  .....+.+.+|+.+++++ +||||+++++++.+..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            56789999999999999999999999888865  999987532  333456688999999999 8999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHcC----------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG  287 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g  287 (479)
                      .+|+||||+++|+|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            9999999999999999998754                689999999999999999999999999999999999999999


Q ss_pred             cEEEeecCCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-c
Q 011698          288 HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-K  365 (479)
Q Consensus       288 ~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~  365 (479)
                      .+||+|||+++............+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+..+ .
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  259 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  259 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence            999999999986544444455667899999999999989999999999999999998 99999999988888887766 4


Q ss_pred             CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          366 IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       366 ~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ...|..++.++.+||.+||+.||.+||     ++++++++
T Consensus       260 ~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~  294 (327)
T 1fvr_A          260 LEKPLNCDDEVYDLMRQCWREKPYERP-----SFAQILVS  294 (327)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCc-----CHHHHHHH
Confidence            567778999999999999999999999     89999874

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=367.96  Aligned_cols=258  Identities=27%  Similarity=0.430  Sum_probs=216.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ...++|.....||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.....++
T Consensus        19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   95 (295)
T 2clq_A           19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK   95 (295)
T ss_dssp             ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence            33445555668999999999999999999999999997643   234566889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcC---CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC-CCcEEEeecCCccccCC
Q 011698          227 LVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~-~g~vkL~DFGla~~~~~  302 (479)
                      +||||+++++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            9999999999999998652   4678899999999999999999999999999999999987 89999999999987643


Q ss_pred             C-CCcccccCCCCCcchhHhcCCC--CCccccchhhHHHHHHHHhCCCCCCCCCHH-HHHHH--HHhccCCCCccCCHHH
Q 011698          303 N-TRSNSMCGTLEYMSPEIVLGKG--HDKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQK--IIKDKIKLPAFLSSEA  376 (479)
Q Consensus       303 ~-~~~~~~~gt~~y~APE~l~~~~--~~~~~DiwSLGvilyelltG~~Pf~~~~~~-~~~~~--i~~~~~~~p~~~s~~~  376 (479)
                      . .......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||...... .....  .......+|..++.++
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (295)
T 2clq_A          176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA  255 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred             CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHH
Confidence            2 2344568999999999997653  889999999999999999999999764322 22222  2233556788899999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      .+||.+||+.||++||     +++++++||||+...
T Consensus       256 ~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~  286 (295)
T 2clq_A          256 KAFILKCFEPDPDKRA-----CANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHHHTTCSSTTTSC-----CHHHHHTSGGGCC--
T ss_pred             HHHHHHHccCChhhCC-----CHHHHhcChhhhhcc
Confidence            9999999999999999     999999999998764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.6e-46  Score=367.50  Aligned_cols=247  Identities=22%  Similarity=0.314  Sum_probs=214.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCC-------eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTS-------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF  219 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  219 (479)
                      +..++|++.+.||+|+||+||+|+++.++       ..||+|++....   ....+.+.+|+.++++++||||+++++++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   81 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC   81 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            45689999999999999999999998877       479999997643   23346688999999999999999999999


Q ss_pred             eeCCeEEEEEEeccCCcHHHHHHHcCC-CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc--------EE
Q 011698          220 QTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH--------VM  290 (479)
Q Consensus       220 ~~~~~~~lV~E~~~ggsL~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~--------vk  290 (479)
                      .+....++||||+.||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.        +|
T Consensus        82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999999987654 999999999999999999999999999999999999998887        99


Q ss_pred             EeecCCccccCCCCCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCC-CCCCCCCHHHHHHHHHhccCCC
Q 011698          291 LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQ-PPFTGGNRQKIQQKIIKDKIKL  368 (479)
Q Consensus       291 L~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~-~Pf~~~~~~~~~~~i~~~~~~~  368 (479)
                      |+|||++.....   .....||+.|+|||++.+ ..++.++|||||||++|||++|. +||...+ ......+......+
T Consensus       162 l~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-~~~~~~~~~~~~~~  237 (289)
T 4fvq_A          162 LSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-SQRKLQFYEDRHQL  237 (289)
T ss_dssp             ECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHHHHTTCCC
T ss_pred             eccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-hHHHHHHhhccCCC
Confidence            999999976532   234568899999999988 77899999999999999999955 5554444 44444555667778


Q ss_pred             CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          369 PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       369 p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      |...+.++.+||.+||+.||.+||     +++++++|
T Consensus       238 ~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  269 (289)
T 4fvq_A          238 PAPKAAELANLINNCMDYEPDHRP-----SFRAIIRD  269 (289)
T ss_dssp             CCCSSCTTHHHHHHHSCSSGGGSC-----CHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence            888899999999999999999999     89999873

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.3e-47  Score=379.41  Aligned_cols=264  Identities=27%  Similarity=0.420  Sum_probs=197.1

Q ss_pred             CcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHH-HHHhCCCCCeeeEeEEEeeC
Q 011698          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERN-ILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       144 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      ...+..++|++++.||+|+||.||+|.++.+|+.||+|++..... .. ....+..|.. +++.++||||+++++++...
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~   93 (327)
T 3aln_A           16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EK-EQKQLLMDLDVVMRSSDCPYIVQFYGALFRE   93 (327)
T ss_dssp             EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HH-HHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred             hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-ch-HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence            345667899999999999999999999999999999999976532 22 2333444554 77788999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHH-----cCCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCCCcEEEeecCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYR-----QGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGL  296 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g~vkL~DFGl  296 (479)
                      +..++||||+.| +|..++..     ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A           94 GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence            999999999986 77666653     56799999999999999999999999 999999999999999999999999999


Q ss_pred             ccccCCCCCcccccCCCCCcchhHh----cCCCCCccccchhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcc-CCCC-
Q 011698          297 AKQFDENTRSNSMCGTLEYMSPEIV----LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIKDK-IKLP-  369 (479)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~APE~l----~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~-~~~~~~i~~~~-~~~p-  369 (479)
                      ++............||+.|+|||++    .+..++.++|||||||++|+|++|+.||.+.+. .+....+..+. ..++ 
T Consensus       173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  252 (327)
T 3aln_A          173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN  252 (327)
T ss_dssp             SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC
T ss_pred             ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC
Confidence            9887655555556899999999999    456789999999999999999999999986432 22222222222 2222 


Q ss_pred             ---ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhh
Q 011698          370 ---AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK  415 (479)
Q Consensus       370 ---~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~  415 (479)
                         ..++.++.+||..||+.||.+||     ++.++++||||....+..
T Consensus       253 ~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~hp~~~~~~~~~  296 (327)
T 3aln_A          253 SEEREFSPSFINFVNLCLTKDESKRP-----KYKELLKHPFILMYEERA  296 (327)
T ss_dssp             CSSCCCCHHHHHHHHHHTCSSGGGSC-----CHHHHTTSHHHHHHHHSC
T ss_pred             cccccCCHHHHHHHHHHhhCChhhCc-----CHHHHHhChHHHHhHhhH
Confidence               35899999999999999999999     999999999998765543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=387.85  Aligned_cols=254  Identities=27%  Similarity=0.441  Sum_probs=195.2

Q ss_pred             CeEE-EEEeccCCceEEEEEEEc--CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe--eCCeE
Q 011698          151 DFEV-LKVVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ--TKYRL  225 (479)
Q Consensus       151 ~y~~-~~~LG~G~fG~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~~~  225 (479)
                      .|++ .++||+|+||+||+|+++  .+++.||||++......     ..+.+|+.+|++++||||+++++++.  ....+
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            4666 347999999999999976  46889999999765422     24678999999999999999999995  47789


Q ss_pred             EEEEEeccCCcHHHHHHHc---------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe----CCCCcEEEe
Q 011698          226 YLVLDFVNGGHLFFQLYRQ---------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL----DADGHVMLT  292 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl----~~~g~vkL~  292 (479)
                      |+||||+.| +|...+...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999999975 777776532         248999999999999999999999999999999999999    778999999


Q ss_pred             ecCCccccCCC----CCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHH---------HHH
Q 011698          293 DFGLAKQFDEN----TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQ---------KIQ  358 (479)
Q Consensus       293 DFGla~~~~~~----~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~---------~~~  358 (479)
                      |||+++.+...    ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..         +..
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            99999876433    234567899999999999884 5899999999999999999999999765432         333


Q ss_pred             HHHHhcc--CC------------------------------------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHH
Q 011698          359 QKIIKDK--IK------------------------------------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQ  400 (479)
Q Consensus       359 ~~i~~~~--~~------------------------------------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~  400 (479)
                      ..|....  +.                                    .....+.++.+||++||+.||.+||     |++
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~-----ta~  329 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI-----TSE  329 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC-----CHH
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC-----CHH
Confidence            3333210  00                                    0011278899999999999999999     999


Q ss_pred             HHHhCccccCCChhh
Q 011698          401 EIKSHKWFKMINWKK  415 (479)
Q Consensus       401 eil~hp~f~~~~~~~  415 (479)
                      |+++||||....|..
T Consensus       330 e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          330 QAMQDPYFLEDPLPT  344 (405)
T ss_dssp             HHHTSGGGTSSSCCC
T ss_pred             HHhcChhhccCCCCc
Confidence            999999999876543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.5e-46  Score=377.80  Aligned_cols=251  Identities=29%  Similarity=0.522  Sum_probs=186.9

Q ss_pred             cCCCCeEEEE-EeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee----
Q 011698          147 VGLEDFEVLK-VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----  221 (479)
Q Consensus       147 ~~~~~y~~~~-~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----  221 (479)
                      ...++|++++ .||+|+||+||+|+++.+++.||+|++....       ....+....++.++||||+++++++..    
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~   97 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHG   97 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence            4457899976 5999999999999999999999999997532       112223344677899999999999976    


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC---CCcEEEeecCC
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGL  296 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~---~g~vkL~DFGl  296 (479)
                      ...+++||||++||+|.+++.+.+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A           98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            556899999999999999998764  6999999999999999999999999999999999999976   45599999999


Q ss_pred             ccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccCCCC---
Q 011698          297 AKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI----QQKIIKDKIKLP---  369 (479)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~----~~~i~~~~~~~p---  369 (479)
                      ++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....    ...+......++   
T Consensus       178 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (336)
T 3fhr_A          178 AKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE  256 (336)
T ss_dssp             CEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTT
T ss_pred             ceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence            9876533 34567889999999999988899999999999999999999999987654433    233333333333   


Q ss_pred             -ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          370 -AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       370 -~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                       ..++.++.+||.+||+.||.+||     +++|+++||||+.
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rp-----t~~ell~hp~~~~  293 (336)
T 3fhr_A          257 WSEVSEDAKQLIRLLLKTDPTERL-----TITQFMNHPWINQ  293 (336)
T ss_dssp             STTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHHSHHHHT
T ss_pred             hccCCHHHHHHHHHHCCCChhHCc-----CHHHHhcCccccc
Confidence             46899999999999999999999     9999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.3e-46  Score=374.30  Aligned_cols=251  Identities=23%  Similarity=0.373  Sum_probs=212.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEE----EEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY----AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      +..++|++++.||+|+||+||+|++..+++.+    |+|.++...  .....+.+.+|+.++++++||||+++++++.+.
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            45678999999999999999999998887755    667665432  223346688999999999999999999999876


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      . .++|+||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+.
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            5 78899999999999999874 579999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHH
Q 011698          302 ENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       302 ~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                      ....   .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+...+...+..+ ....|..++.++
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  248 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence            4332   233456889999999999999999999999999999999 99999998888877777665 456778899999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      .++|.+||+.||.+||     ++.+++++
T Consensus       249 ~~li~~~l~~~p~~Rp-----s~~ell~~  272 (327)
T 3poz_A          249 YMIMVKCWMIDADSRP-----KFRELIIE  272 (327)
T ss_dssp             HHHHHHHTCSCGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHcCCChhhCC-----CHHHHHHH
Confidence            9999999999999999     89999874

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.9e-46  Score=366.73  Aligned_cols=251  Identities=21%  Similarity=0.330  Sum_probs=209.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEE----EcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  221 (479)
                      .+..++|++++.||+|+||+||+|+    +..+++.||+|++...   .....+.+.+|+.++++++||||+++++++..
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3556899999999999999999999    5668999999999754   23445678899999999999999999999854


Q ss_pred             --CCeEEEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcc
Q 011698          222 --KYRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (479)
Q Consensus       222 --~~~~~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~  298 (479)
                        ...+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence              456899999999999999998754 49999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC----CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHH----------------HHH
Q 011698          299 QFDENT----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ----------------KIQ  358 (479)
Q Consensus       299 ~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~----------------~~~  358 (479)
                      ......    ......||+.|+|||++.+..++.++|||||||++|||+||..||......                .+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            764432    223445778899999999999999999999999999999999998643211                222


Q ss_pred             HHHHh-ccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          359 QKIIK-DKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       359 ~~i~~-~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ..+.. .....|..++.++.+||..||+.||++||     +++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~el~~  284 (295)
T 3ugc_A          243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP-----SFRDLAL  284 (295)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHH
T ss_pred             HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCC-----CHHHHHH
Confidence            22222 25567788999999999999999999999     8998875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.3e-45  Score=358.11  Aligned_cols=247  Identities=18%  Similarity=0.290  Sum_probs=218.5

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC--C
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK--Y  223 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--~  223 (479)
                      .+..++|++.+.||+|+||+||+|++.  ++.||+|++..... .....+.+.+|+.++++++||||+++++++.+.  .
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP   82 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence            466789999999999999999999984  78899999987543 333456688999999999999999999999887  7


Q ss_pred             eEEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~--IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      .+++||||++||+|.+++.+..  .+++..++.++.||+.||.|||++|  |+||||||+|||++.+|.++|+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            8999999999999999998765  4899999999999999999999999  99999999999999999999999988755


Q ss_pred             cCCCCCcccccCCCCCcchhHhcCCCCCc---cccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCCccCCH
Q 011698          300 FDENTRSNSMCGTLEYMSPEIVLGKGHDK---AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD--KIKLPAFLSS  374 (479)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~---~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~  374 (479)
                      ..    .....||+.|+|||++.+..++.   ++|||||||++|||++|+.||.+.+.......+...  ...+|..++.
T Consensus       163 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3kmu_A          163 FQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP  238 (271)
T ss_dssp             TS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred             ec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence            32    23457899999999999876544   799999999999999999999998888887777765  4567788999


Q ss_pred             HHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          375 EAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       375 ~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ++.++|.+||+.||++||     +++++++
T Consensus       239 ~~~~li~~~l~~~p~~Rp-----s~~~il~  263 (271)
T 3kmu_A          239 HVSKLMKICMNEDPAKRP-----KFDMIVP  263 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            999999999999999999     8999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=9.2e-46  Score=367.44  Aligned_cols=253  Identities=23%  Similarity=0.345  Sum_probs=220.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE-----cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSF  219 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~  219 (479)
                      .+..++|++.+.||+|+||+||+|++     ..+++.||+|+++...  .....+.+.+|+.+++++ +||||+++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            35567999999999999999999986     4578899999998653  233456788999999999 999999999999


Q ss_pred             eeCCeEEEEEEeccCCcHHHHHHHcC------------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccE
Q 011698          220 QTKYRLYLVLDFVNGGHLFFQLYRQG------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (479)
Q Consensus       220 ~~~~~~~lV~E~~~ggsL~~~l~~~~------------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNI  281 (479)
                      .+....++||||+++|+|.+++....                  .+++..++.++.||+.||.|||++||+||||||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            99999999999999999999998754                  489999999999999999999999999999999999


Q ss_pred             EeCCCCcEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHH
Q 011698          282 LLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI  357 (479)
Q Consensus       282 Ll~~~g~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~  357 (479)
                      |++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||+| |..||.+......
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            999999999999999987654432   234567889999999999999999999999999999999 9999988766555


Q ss_pred             HHHHHhc--cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          358 QQKIIKD--KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       358 ~~~i~~~--~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ...+...  ....+..++.++.+||.+||+.||.+||     ++++++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~  301 (313)
T 1t46_A          257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP-----TFKQIVQL  301 (313)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCc-----CHHHHHHH
Confidence            5544443  3345677999999999999999999999     89998863

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-45  Score=362.87  Aligned_cols=251  Identities=23%  Similarity=0.354  Sum_probs=224.8

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      ..+..++|++.+.||+|+||+||+|.++.++..||+|++....    ...+.+.+|+.++++++||||+++++++.+...
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   83 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   83 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3456689999999999999999999999999999999997643    235567899999999999999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      +|+||||+.|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            99999999999999999874  3489999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC--cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHH
Q 011698          303 NTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (479)
Q Consensus       303 ~~~--~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (479)
                      ...  .....||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+...+...+... ....|..++.++.+
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  243 (288)
T 3kfa_A          164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE  243 (288)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHH
Confidence            332  234557889999999999999999999999999999999 99999998888877777765 56677889999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ||+.||+.||.+||     +++++++
T Consensus       244 li~~~l~~dp~~Rp-----s~~~~~~  264 (288)
T 3kfa_A          244 LMRACWQWNPSDRP-----SFAEIHQ  264 (288)
T ss_dssp             HHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHhCCChhhCc-----CHHHHHH
Confidence            99999999999999     8998875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-46  Score=374.91  Aligned_cols=253  Identities=25%  Similarity=0.392  Sum_probs=217.5

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE-----cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSF  219 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~  219 (479)
                      .+..++|++.+.||+|+||+||+|++     ..++..||+|++....  .....+.+.+|+.+|+++ +||||+++++++
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            35568999999999999999999997     3467789999997543  233456788999999999 899999999999


Q ss_pred             eeCCeEEEEEEeccCCcHHHHHHHcC-----------------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 011698          220 QTKYRLYLVLDFVNGGHLFFQLYRQG-----------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDL  276 (479)
Q Consensus       220 ~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDL  276 (479)
                      ...+.+|+||||++||+|.+++....                       .+++..++.++.||+.||.|||++||+||||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99999999999999999999997653                       2789999999999999999999999999999


Q ss_pred             CCccEEeCCCCcEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCC
Q 011698          277 KPENILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGG  352 (479)
Q Consensus       277 KpeNILl~~~g~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~  352 (479)
                      ||+|||++.++.+||+|||++..+.....   .....||+.|+|||++.+..++.++|||||||++|||+| |..||.+.
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999987644322   234567889999999999999999999999999999998 99999887


Q ss_pred             CHHHHHHHHHhc--cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          353 NRQKIQQKIIKD--KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       353 ~~~~~~~~i~~~--~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      +.......+...  ....|..++.++.+||.+||+.||.+||     ++.++++|
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~  328 (344)
T 1rjb_A          279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP-----SFPNLTSF  328 (344)
T ss_dssp             CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCc-----CHHHHHHH
Confidence            765555555544  4456778999999999999999999999     89999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.9e-45  Score=370.32  Aligned_cols=253  Identities=20%  Similarity=0.358  Sum_probs=222.5

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc-------CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRI-------GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~  217 (479)
                      .+..++|++.+.||+|+||+||+|++.       .++..||+|+++...  .....+.+.+|+.+++++ +||||+++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            355689999999999999999999986       356789999997653  334456788999999999 8999999999


Q ss_pred             EEeeCCeEEEEEEeccCCcHHHHHHHcC----------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccE
Q 011698          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (479)
Q Consensus       218 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNI  281 (479)
                      ++.+...+|+||||+.+|+|.+++....                .+++..++.++.||+.||.|||++||+||||||+||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  188 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence            9999999999999999999999998654                388999999999999999999999999999999999


Q ss_pred             EeCCCCcEEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHH
Q 011698          282 LLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI  357 (479)
Q Consensus       282 Ll~~~g~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~  357 (479)
                      |++.++.+||+|||+++......   ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  268 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  268 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence            99999999999999998765432   2334567889999999999999999999999999999999 9999999988888


Q ss_pred             HHHHHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          358 QQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       358 ~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ...+..+ ....+..++.++.+||.+||+.||.+||     ++++++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~  312 (334)
T 2pvf_A          269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP-----TFKQLVED  312 (334)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCc-----CHHHHHHH
Confidence            8877776 4567788999999999999999999999     89998863

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=371.32  Aligned_cols=254  Identities=28%  Similarity=0.492  Sum_probs=214.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH---HHHHHHHHHHHHHHhC----CCCCeeeEeEEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKV----DHPFIVQLRYSF  219 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~iL~~l----~hp~Iv~l~~~~  219 (479)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++........   .....+.+|+.+++++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            345789999999999999999999999999999999976543221   1223355789999988    899999999999


Q ss_pred             eeCCeEEEEEEe-ccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeC-CCCcEEEeecCCc
Q 011698          220 QTKYRLYLVLDF-VNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD-ADGHVMLTDFGLA  297 (479)
Q Consensus       220 ~~~~~~~lV~E~-~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~-~~g~vkL~DFGla  297 (479)
                      ...+..++|||+ +.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~  187 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG  187 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence            999999999999 78999999999988999999999999999999999999999999999999999 8999999999999


Q ss_pred             cccCCCCCcccccCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHH
Q 011698          298 KQFDENTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEA  376 (479)
Q Consensus       298 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~  376 (479)
                      +..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...      ..+......++..++.++
T Consensus       188 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~~~~~  260 (312)
T 2iwi_A          188 ALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDC  260 (312)
T ss_dssp             EECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCCTTSCHHH
T ss_pred             hhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCcccCCHHH
Confidence            876543 3456679999999999987766 45899999999999999999999752      345566778889999999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      .+||.+||+.||++||     +++|+++||||+...
T Consensus       261 ~~li~~~l~~~p~~Rp-----s~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          261 CALIRRCLAPKPSSRP-----SLEEILLDPWMQTPA  291 (312)
T ss_dssp             HHHHHHHTCSSTTTSC-----CHHHHHHSTTTCC--
T ss_pred             HHHHHHHccCChhhCc-----CHHHHhcChhhcCch
Confidence            9999999999999999     999999999998753

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.3e-45  Score=356.34  Aligned_cols=248  Identities=21%  Similarity=0.369  Sum_probs=221.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++.+.||+|+||.||+|++. +++.||+|++......    .+.+.+|+.++++++||||+++++++.+...++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            45679999999999999999999997 5678999999875432    245788999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-
Q 011698          227 LVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-  304 (479)
                      +||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...... 
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            999999999999999775 568999999999999999999999999999999999999999999999999998754321 


Q ss_pred             -CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHH
Q 011698          305 -RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK  381 (479)
Q Consensus       305 -~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~  381 (479)
                       ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+.......+..+ ....|..++.++.++|.
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  239 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN  239 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence             2234567889999999999999999999999999999999 99999999888888888776 45567788999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHh
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +||+.||++||     +++++++
T Consensus       240 ~~l~~~p~~Rp-----s~~~ll~  257 (267)
T 3t9t_A          240 HCWRERPEDRP-----AFSRLLR  257 (267)
T ss_dssp             HHTCSSGGGSC-----CHHHHHH
T ss_pred             HHccCChhhCc-----CHHHHHH
Confidence            99999999999     8999876

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.7e-45  Score=363.07  Aligned_cols=253  Identities=19%  Similarity=0.316  Sum_probs=219.6

Q ss_pred             cccCCCCeEEEE-EeccCCceEEEEEEE--cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee
Q 011698          145 QCVGLEDFEVLK-VVGQGAFAKVYQVRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (479)
Q Consensus       145 ~~~~~~~y~~~~-~LG~G~fG~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  221 (479)
                      ..+..++|++.+ .||+|+||+||+|.+  +.+++.||+|+++.... .....+.+.+|+.+++.++||||+++++++ .
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            345567899998 999999999999954  56788999999986532 333456788999999999999999999999 5


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      ...+++||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            67789999999999999999998889999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC----cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHH
Q 011698          302 ENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (479)
Q Consensus       302 ~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  375 (479)
                      ....    .....||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+...+...+..+ ...+|..++.+
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE  248 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            4332    223456789999999999889999999999999999999 99999998888888877765 45677889999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +.++|..||+.||.+||     ++.++++
T Consensus       249 l~~li~~~l~~dp~~Rp-----s~~~l~~  272 (291)
T 1xbb_A          249 MYDLMNLCWTYDVENRP-----GFAAVEL  272 (291)
T ss_dssp             HHHHHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             HHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            99999999999999999     8888875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.1e-45  Score=386.01  Aligned_cols=246  Identities=23%  Similarity=0.412  Sum_probs=217.2

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-  223 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-  223 (479)
                      ..+..++|++++.||+|+||+||+|+++  ++.||||+++...     ..+.+.+|+.+|++++||||+++++++.... 
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  260 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG  260 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence            3467789999999999999999999985  6789999997653     2345788999999999999999999986655 


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCC--CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      .+|+||||+++|+|.+++...+.  +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            79999999999999999987654  7999999999999999999999999999999999999999999999999998654


Q ss_pred             CCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHH
Q 011698          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSL  379 (479)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l  379 (479)
                      ..  .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+ ++..|..+++++.+|
T Consensus       341 ~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  418 (450)
T 1k9a_A          341 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV  418 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence            32  233467899999999999999999999999999999998 99999988888888777766 567788999999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      |..||+.||.+||     ++.++++
T Consensus       419 i~~cl~~dp~~Rp-----t~~~l~~  438 (450)
T 1k9a_A          419 MKNCWHLDAATRP-----TFLQLRE  438 (450)
T ss_dssp             HHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHcCCChhHCc-----CHHHHHH
Confidence            9999999999999     8888865

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.1e-45  Score=366.11  Aligned_cols=258  Identities=28%  Similarity=0.453  Sum_probs=216.2

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC--CCCeeeEeEEEeeC
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD--HPFIVQLRYSFQTK  222 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~  222 (479)
                      ..+..++|++++.||+|+||.||+|++. +++.||+|++..... .....+.+.+|+.++++++  ||||+++++++...
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            3455578999999999999999999986 488899999976543 3345667889999999997  59999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      ..+|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+..
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred             CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence            99999999 56789999999988999999999999999999999999999999999999996 59999999999987644


Q ss_pred             CC---CcccccCCCCCcchhHhcC-----------CCCCccccchhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhc--c
Q 011698          303 NT---RSNSMCGTLEYMSPEIVLG-----------KGHDKAADWWSVGILLFEMLTGQPPFTGGN-RQKIQQKIIKD--K  365 (479)
Q Consensus       303 ~~---~~~~~~gt~~y~APE~l~~-----------~~~~~~~DiwSLGvilyelltG~~Pf~~~~-~~~~~~~i~~~--~  365 (479)
                      ..   .....+||+.|+|||++.+           ..++.++|||||||++|||++|..||.... .......+...  .
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  258 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  258 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence            32   2245679999999999976           468899999999999999999999998653 33334444433  3


Q ss_pred             CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          366 IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       366 ~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ..+|...+.++.+||.+||+.||.+||     +++|+++||||+..
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~h~~~~~~  299 (313)
T 3cek_A          259 IEFPDIPEKDLQDVLKCCLKRDPKQRI-----SIPELLAHPYVQIQ  299 (313)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHCC
T ss_pred             cCCcccchHHHHHHHHHHccCCcccCc-----CHHHHhcCccccCC
Confidence            456778899999999999999999999     99999999999864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.3e-45  Score=358.81  Aligned_cols=249  Identities=22%  Similarity=0.359  Sum_probs=212.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHH----HHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNH----AEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~----~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      +..++|++.+.||+|+||+||+|++..+++.||+|++..........    .+.+.+|+.++++++||||+++++++.+.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            55689999999999999999999999999999999997644322221    15688999999999999999999999776


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCccEEeCCCCc-----EEEeec
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGH-----VMLTDF  294 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~--IiHrDLKpeNILl~~~g~-----vkL~DF  294 (479)
                      .  ++||||+++|+|.+.+.+. ..+++..++.++.||+.||.|||++|  |+||||||+|||++.++.     +||+||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            5  6999999999998888655 46999999999999999999999999  999999999999988887     999999


Q ss_pred             CCccccCCCCCcccccCCCCCcchhHhc--CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHH--HHHHHhc--cCCC
Q 011698          295 GLAKQFDENTRSNSMCGTLEYMSPEIVL--GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKI--QQKIIKD--KIKL  368 (479)
Q Consensus       295 Gla~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~--~~~i~~~--~~~~  368 (479)
                      |+++....  .....+||+.|+|||++.  +..++.++|||||||++|||++|+.||...+....  ...+...  ...+
T Consensus       174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T 4f0f_A          174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI  251 (287)
T ss_dssp             TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCC
T ss_pred             Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCC
Confidence            99986433  345578999999999994  45578999999999999999999999987554333  4444433  4457


Q ss_pred             CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          369 PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       369 p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +..+++++.+||.+||+.||.+||     +++++++
T Consensus       252 ~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~  282 (287)
T 4f0f_A          252 PEDCPPRLRNVIELCWSGDPKKRP-----HFSYIVK  282 (287)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CcccCHHHHHHHHHHhcCChhhCc-----CHHHHHH
Confidence            788999999999999999999999     8999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-45  Score=379.01  Aligned_cols=252  Identities=23%  Similarity=0.350  Sum_probs=210.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEc---CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      .+..++|++.+.||+|+||+||+|+++   .++..||||+++...  .....+.+.+|+.+|++++||||+++++++.+.
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  118 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS  118 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            355678999999999999999999987   567789999997643  334456788999999999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      ..+|+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999999998754 69999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC----cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHH
Q 011698          302 ENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (479)
Q Consensus       302 ~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  375 (479)
                      ....    .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+ ....+..++.+
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  278 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA  278 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHH
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence            3321    122345778999999999999999999999999999998 99999998888888877765 45566788999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +.+||..||+.||.+||     +++++++
T Consensus       279 l~~li~~cl~~dp~~RP-----s~~~i~~  302 (373)
T 2qol_A          279 LYQLMLDCWQKDRNNRP-----KFEQIVS  302 (373)
T ss_dssp             HHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHhCcChhhCc-----CHHHHHH
Confidence            99999999999999999     8888875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.5e-45  Score=358.65  Aligned_cols=252  Identities=23%  Similarity=0.372  Sum_probs=217.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcC---CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      .+..++|++.+.||+|+||+||+|++..   ++..||+|++....  .....+.+.+|+.++++++||||+++++++.+.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   85 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE   85 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence            4566899999999999999999998754   34579999998653  234456788999999999999999999998754


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                       ..|+||||+.+++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence             568999999999999999765 459999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC--CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHH
Q 011698          302 ENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (479)
Q Consensus       302 ~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (479)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++ |+.||...+.......+..+ ....|..+++.+.
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  244 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLY  244 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHH
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            432  2234567889999999999999999999999999999998 99999887777777776665 5567788999999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ++|.+||+.||.+||     ++.+++++
T Consensus       245 ~li~~~l~~~p~~Rp-----s~~ell~~  267 (281)
T 3cc6_A          245 TLMTRCWDYDPSDRP-----RFTELVCS  267 (281)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHccCCchhCc-----CHHHHHHH
Confidence            999999999999999     89998864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.8e-45  Score=360.84  Aligned_cols=253  Identities=30%  Similarity=0.481  Sum_probs=208.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ..+++|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.++++++||||+++++++.....++
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            34678999999999999999999999999999999998755555566777889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          227 LVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      +||||+.+++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999988864    45689999999999999999999999999999999999999999999999999987643


Q ss_pred             CC-CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC--CHHHHHHHHHhccCC-C-CccCCHHHH
Q 011698          303 NT-RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG--NRQKIQQKIIKDKIK-L-PAFLSSEAH  377 (479)
Q Consensus       303 ~~-~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~--~~~~~~~~i~~~~~~-~-p~~~s~~~~  377 (479)
                      .. ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.  +...+...+...... . +..++.++.
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  268 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR  268 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHH
T ss_pred             CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHH
Confidence            32 234567999999999999999999999999999999999999999764  334555555554332 2 256899999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +||..||+.||.+||     +++++++
T Consensus       269 ~li~~~l~~dp~~Rp-----s~~~il~  290 (310)
T 2wqm_A          269 QLVNMCINPDPEKRP-----DVTYVYD  290 (310)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHcCCChhhCC-----CHHHHHH
Confidence            999999999999999     8999886

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-45  Score=366.16  Aligned_cols=253  Identities=21%  Similarity=0.316  Sum_probs=216.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCC----eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTS----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  221 (479)
                      .+..++|++.+.||+|+||+||+|+++.++    ..||+|+++...  .......+.+|+.++++++||||+++++++.+
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            355689999999999999999999987653    469999997643  23345568899999999999999999999999


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~  300 (479)
                      ...+++||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999999765 57999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCCC----cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCH
Q 011698          301 DENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSS  374 (479)
Q Consensus       301 ~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~  374 (479)
                      .....    .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+..+ ....+..++.
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS  277 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence            43321    223456789999999999999999999999999999999 99999998888888888766 5566778999


Q ss_pred             HHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          375 EAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       375 ~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ++.++|.+||+.||++||     ++.+++++
T Consensus       278 ~l~~li~~~l~~~p~~Rp-----s~~~l~~~  303 (333)
T 1mqb_A          278 AIYQLMMQCWQQERARRP-----KFADIVSI  303 (333)
T ss_dssp             HHHHHHHHHTCSSTTTSC-----CHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            999999999999999999     88888763

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-45  Score=359.38  Aligned_cols=251  Identities=22%  Similarity=0.325  Sum_probs=220.5

Q ss_pred             cCCCCeEEEE-EeccCCceEEEEEEEc--CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          147 VGLEDFEVLK-VVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       147 ~~~~~y~~~~-~LG~G~fG~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      +..++|.+++ .||+|+||.||+|.+.  .++..||+|+++...  .....+.+.+|+.++++++||||+++++++ ..+
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            4557899988 9999999999999864  468889999998643  344567788999999999999999999999 456


Q ss_pred             eEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      .+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            799999999999999988654 5699999999999999999999999999999999999999999999999999987643


Q ss_pred             CCC----cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHH
Q 011698          303 NTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                      ...    .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+ ...+|..++.++
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  242 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL  242 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHH
Confidence            322    234457899999999998889999999999999999998 99999998888888887776 466788899999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      .++|..||+.||++||     ++.+++++
T Consensus       243 ~~li~~~l~~~p~~Rp-----s~~~l~~~  266 (287)
T 1u59_A          243 YALMSDCWIYKWEDRP-----DFLTVEQR  266 (287)
T ss_dssp             HHHHHHTTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            9999999999999999     89999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2e-45  Score=368.78  Aligned_cols=258  Identities=19%  Similarity=0.282  Sum_probs=220.6

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEE-----EcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVR-----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  220 (479)
                      .+..++|++++.||+|+||.||+|+     ...+++.||+|++....  .......+.+|+.++++++||||+++++++.
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            3556899999999999999999999     55678899999997532  2334556788999999999999999999999


Q ss_pred             eCCeEEEEEEeccCCcHHHHHHHcC-------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC---CcEE
Q 011698          221 TKYRLYLVLDFVNGGHLFFQLYRQG-------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD---GHVM  290 (479)
Q Consensus       221 ~~~~~~lV~E~~~ggsL~~~l~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~---g~vk  290 (479)
                      ....+|+||||++||+|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999999998763       48899999999999999999999999999999999999844   4699


Q ss_pred             EeecCCccccCCC---CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-c
Q 011698          291 LTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-K  365 (479)
Q Consensus       291 L~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~  365 (479)
                      |+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|+| |..||.+.+...+...+..+ .
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  263 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  263 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence            9999999764322   22344678999999999999999999999999999999998 99999998888888877765 4


Q ss_pred             CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          366 IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       366 ~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      ...+..++..+.+||.+||+.||.+||     +++++++|.|+-.
T Consensus       264 ~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~l~~~~  303 (327)
T 2yfx_A          264 MDPPKNCPGPVYRIMTQCWQHQPEDRP-----NFAIILERIEYCT  303 (327)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCc-----CHHHHHHHHHHHh
Confidence            556778999999999999999999999     9999999988654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.2e-45  Score=365.22  Aligned_cols=252  Identities=23%  Similarity=0.401  Sum_probs=217.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE-----cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEe
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRR-----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQ  220 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~  220 (479)
                      +..++|++.+.||+|+||+||+|++     ..+++.||+|+++...  .....+.+.+|+.+++++ +||||+++++++.
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  101 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT  101 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence            4457999999999999999999986     3567899999997653  233456688999999999 7999999999987


Q ss_pred             eCC-eEEEEEEeccCCcHHHHHHHcCC----------------CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe
Q 011698          221 TKY-RLYLVLDFVNGGHLFFQLYRQGL----------------FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL  283 (479)
Q Consensus       221 ~~~-~~~lV~E~~~ggsL~~~l~~~~~----------------l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl  283 (479)
                      ..+ .+++||||++||+|.+++.....                +++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~  181 (316)
T 2xir_A          102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  181 (316)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence            754 59999999999999999987654                8999999999999999999999999999999999999


Q ss_pred             CCCCcEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHH-HHH
Q 011698          284 DADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQ-KIQ  358 (479)
Q Consensus       284 ~~~g~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~-~~~  358 (479)
                      +.++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+.. ...
T Consensus       182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~  261 (316)
T 2xir_A          182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  261 (316)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence            9999999999999987643322   234567899999999999999999999999999999998 99999876644 334


Q ss_pred             HHHHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          359 QKIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       359 ~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ..+..+ ....|..+++++.++|..||+.||.+||     +++++++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~ell~~  304 (316)
T 2xir_A          262 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-----TFSELVEH  304 (316)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            444443 4567788999999999999999999999     89999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.2e-45  Score=368.31  Aligned_cols=251  Identities=22%  Similarity=0.327  Sum_probs=205.5

Q ss_pred             CCCcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee
Q 011698          142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (479)
Q Consensus       142 ~~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  221 (479)
                      ..+..+..++|++++.||+|+||+||+|++.  ++.||||++....    ........|+.+|++++||||+++++++..
T Consensus        16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   89 (322)
T 3soc_A           16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKR   89 (322)
T ss_dssp             CCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             ccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence            3444567789999999999999999999885  7899999997643    223345568999999999999999999987


Q ss_pred             CC----eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC----------CCccCCCCCccEEeCCCC
Q 011698          222 KY----RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN----------GIMHRDLKPENILLDADG  287 (479)
Q Consensus       222 ~~----~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~----------~IiHrDLKpeNILl~~~g  287 (479)
                      ..    .+|+||||+++|+|.+++... .+++..++.++.||+.||.|||+.          ||+||||||+|||++.++
T Consensus        90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           90 GTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence            44    479999999999999999764 589999999999999999999999          999999999999999999


Q ss_pred             cEEEeecCCccccCCCC---CcccccCCCCCcchhHhcCC-----CCCccccchhhHHHHHHHHhCCCCCCCCC------
Q 011698          288 HVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGK-----GHDKAADWWSVGILLFEMLTGQPPFTGGN------  353 (479)
Q Consensus       288 ~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~-----~~~~~~DiwSLGvilyelltG~~Pf~~~~------  353 (479)
                      .+||+|||+++.+....   .....+||+.|+|||++.+.     .++.++|||||||++|||+||+.||.+..      
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            99999999998764332   23446899999999999873     45678999999999999999999997532      


Q ss_pred             ----------HHHHHHHHHhccC--CCCcc-----CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          354 ----------RQKIQQKIIKDKI--KLPAF-----LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       354 ----------~~~~~~~i~~~~~--~~p~~-----~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                                ...+...+.....  .++..     .+.++.+||.+||+.||++||     +++++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~  311 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL-----SAGCVGE  311 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCc-----CHHHHHH
Confidence                      2233333333222  22222     234599999999999999999     8998875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.6e-45  Score=375.62  Aligned_cols=270  Identities=17%  Similarity=0.171  Sum_probs=206.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCC-----CeEEEEEEeehhhhchHHHH--------HHHHHHHHHHHhCCCCCeee
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGT-----SEIYAMKVMRKDKIMEKNHA--------EYMKSERNILTKVDHPFIVQ  214 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~-----~~~vAiK~i~~~~~~~~~~~--------~~~~~E~~iL~~l~hp~Iv~  214 (479)
                      ..++|++.+.||+|+||+||+|.++.+     ++.||||++...........        .....|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            446899999999999999999999765     57899999876532111111        12334566777889999999


Q ss_pred             EeEEEeeC----CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeC--CCC
Q 011698          215 LRYSFQTK----YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD--ADG  287 (479)
Q Consensus       215 l~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~--~~g  287 (479)
                      +++++...    ..+|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++  .++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            99998765    5689999999 99999999876 6799999999999999999999999999999999999999  889


Q ss_pred             cEEEeecCCccccCCCC--------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHH
Q 011698          288 HVMLTDFGLAKQFDENT--------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ  359 (479)
Q Consensus       288 ~vkL~DFGla~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~  359 (479)
                      .+||+|||+++.+....        .....+||+.|+|||++.+..++.++|||||||++|||+||+.||.+........
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~  271 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV  271 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence            99999999998754321        1244569999999999999999999999999999999999999998633222111


Q ss_pred             HHHh----cc-------CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh----------CccccCCChhhhhc
Q 011698          360 KIIK----DK-------IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS----------HKWFKMINWKKLEA  418 (479)
Q Consensus       360 ~i~~----~~-------~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~----------hp~f~~~~~~~l~~  418 (479)
                      ....    ..       .-.+..++.++.+||..||+.||.+||     ++++|++          .++-..++|...+.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP-----~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~  346 (364)
T 3op5_A          272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKP-----LYENLRDILLQGLKAIGSKDDGKLDLSVVEN  346 (364)
T ss_dssp             HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCC-----CHHHHHHHHHHHHHHTTCCCCCCCCC-----
T ss_pred             HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCcCCccceEeccC
Confidence            1111    00       011256799999999999999999999     7777654          24445556665554


Q ss_pred             ccCCC
Q 011698          419 RETRP  423 (479)
Q Consensus       419 ~~~~p  423 (479)
                      ....+
T Consensus       347 ~~~~~  351 (364)
T 3op5_A          347 GGLKA  351 (364)
T ss_dssp             -----
T ss_pred             Cccch
Confidence            44433

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=8.5e-45  Score=381.67  Aligned_cols=250  Identities=22%  Similarity=0.368  Sum_probs=220.1

Q ss_pred             CcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       144 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      ...+..++|++.+.||+|+||+||+|+++. +..||||+++....    ..+.+.+|+.+|++++||||+++++++. ..
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            345677899999999999999999999864 67799999986542    2456889999999999999999999986 66


Q ss_pred             eEEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      .+|+||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            789999999999999999754  368899999999999999999999999999999999999999999999999998764


Q ss_pred             CCC--CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHH
Q 011698          302 ENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (479)
Q Consensus       302 ~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (479)
                      ...  ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+..+ ....|..++.++.
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  415 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY  415 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            321  1233456789999999999999999999999999999999 99999999988888888776 5567788999999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +||.+||+.||++||     ++++|++
T Consensus       416 ~li~~cl~~dp~~RP-----t~~~i~~  437 (454)
T 1qcf_A          416 NIMMRCWKNRPEERP-----TFEYIQS  437 (454)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHccCChhHCc-----CHHHHHH
Confidence            999999999999999     8888864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.4e-45  Score=390.14  Aligned_cols=251  Identities=23%  Similarity=0.356  Sum_probs=223.9

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      ..+..++|++.+.||+|+||+||+|+++.++..||||+++....    ..+.+.+|+.+|++++||||+++++++.....
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  290 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP  290 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            34566789999999999999999999999999999999976532    24567889999999999999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      +|+||||+.+|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            99999999999999999864  4589999999999999999999999999999999999999999999999999987644


Q ss_pred             CCC--cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHH
Q 011698          303 NTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (479)
Q Consensus       303 ~~~--~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (479)
                      ...  .....+++.|+|||++.+..++.++|||||||++|||+| |..||.+.+...+.+.+..+ ....|..++.++.+
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  450 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE  450 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            322  233456789999999999999999999999999999999 99999998888877777665 55678889999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ||.+||+.||.+||     ++++|++
T Consensus       451 li~~cl~~dP~~RP-----s~~el~~  471 (495)
T 1opk_A          451 LMRACWQWNPSDRP-----SFAEIHQ  471 (495)
T ss_dssp             HHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHcCcChhHCc-----CHHHHHH
Confidence            99999999999999     8998875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6e-45  Score=362.50  Aligned_cols=253  Identities=20%  Similarity=0.306  Sum_probs=210.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcC---CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      +..++|++.+.||+|+||.||+|++..   ++..||+|++..... .....+.+.+|+.++++++||||+++++++.+..
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            455789999999999999999998865   566899999976543 3344567889999999999999999999997755


Q ss_pred             -----eEEEEEEeccCCcHHHHHHH------cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEe
Q 011698          224 -----RLYLVLDFVNGGHLFFQLYR------QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLT  292 (479)
Q Consensus       224 -----~~~lV~E~~~ggsL~~~l~~------~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~  292 (479)
                           ..++||||+.+|+|..++..      ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~  189 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA  189 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence                 35999999999999999853      3569999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCC
Q 011698          293 DFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIK  367 (479)
Q Consensus       293 DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~  367 (479)
                      |||+++.+....   ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...+...+..+ ...
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  269 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK  269 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC
Confidence            999998764332   2234567889999999999999999999999999999999 99999998888888877766 556


Q ss_pred             CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          368 LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       368 ~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      .|..++.++.+||.+||+.||.+||     ++.+++++
T Consensus       270 ~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~~  302 (313)
T 3brb_A          270 QPEDCLDELYEIMYSCWRTDPLDRP-----TFSVLRLQ  302 (313)
T ss_dssp             CBTTCCHHHHHHHHHTTCSSGGGSC-----CHHHHHHH
T ss_pred             CCccccHHHHHHHHHHcCCChhhCc-----CHHHHHHH
Confidence            7788999999999999999999999     89998763

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.4e-45  Score=367.47  Aligned_cols=253  Identities=24%  Similarity=0.374  Sum_probs=219.8

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCe-----EEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEE
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE-----IYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~  218 (479)
                      ..+..++|++.+.||+|+||+||+|.+..+++     .||+|++....  .....+.+.+|+.+++++ +||||++++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            34667899999999999999999999987664     79999997643  233456788999999999 89999999999


Q ss_pred             EeeCCeEEEEEEeccCCcHHHHHHHc--------------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeC
Q 011698          219 FQTKYRLYLVLDFVNGGHLFFQLYRQ--------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD  284 (479)
Q Consensus       219 ~~~~~~~~lV~E~~~ggsL~~~l~~~--------------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~  284 (479)
                      +.+...+|+||||+++|+|.+++...              ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence            99999999999999999999998753              3579999999999999999999999999999999999999


Q ss_pred             CCCcEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 011698          285 ADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQK  360 (479)
Q Consensus       285 ~~g~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~  360 (479)
                      .++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||+| |..||.+.........
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            999999999999987543322   234567889999999999999999999999999999999 9999988766555555


Q ss_pred             HHhc--cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          361 IIKD--KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       361 i~~~--~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +...  ....|..++.++.+||..||+.||.+||     +++++++
T Consensus       279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~l~~  319 (333)
T 2i1m_A          279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRP-----TFQQICS  319 (333)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCc-----CHHHHHH
Confidence            5544  3445677899999999999999999999     8999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.9e-45  Score=360.71  Aligned_cols=252  Identities=22%  Similarity=0.332  Sum_probs=211.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEE----EcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  221 (479)
                      .+..++|++++.||+|+||.||+|+    +..+++.||+|++....  .....+.+.+|+.++++++||||+++++++..
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            3455679999999999999999999    46789999999997653  22334668899999999999999999999987


Q ss_pred             C--CeEEEEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcc
Q 011698          222 K--YRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (479)
Q Consensus       222 ~--~~~~lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~  298 (479)
                      .  ..+++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence            6  678999999999999999954 4679999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCC----CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC---------------CHHHHHH
Q 011698          299 QFDENT----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG---------------NRQKIQQ  359 (479)
Q Consensus       299 ~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~---------------~~~~~~~  359 (479)
                      ......    ......||..|+|||++.+..++.++|||||||++|+|++|..|+...               ....+..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            765443    234567888999999999999999999999999999999999986421               1122233


Q ss_pred             HHHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          360 KIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       360 ~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+..+ ....|..++.++.+||.+||+.||.+||     +++++++
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~  295 (302)
T 4e5w_A          255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRT-----SFQNLIE  295 (302)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC-----CHHHHHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCC-----CHHHHHH
Confidence            33332 4567788999999999999999999999     8998875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9e-45  Score=357.13  Aligned_cols=244  Identities=20%  Similarity=0.301  Sum_probs=204.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeE-EEeeCCeEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRY-SFQTKYRLYLV  228 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~~~~~~~~~lV  228 (479)
                      ++|++.+.||+|+||+||+|++..+++.||+|++......     ..+.+|+.+++.++|++++..+. ++......++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            6899999999999999999999999999999987654322     23678999999998877665554 45778889999


Q ss_pred             EEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe---CCCCcEEEeecCCccccCCCC
Q 011698          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl---~~~g~vkL~DFGla~~~~~~~  304 (479)
                      |||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++......
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            9999 8999999875 4579999999999999999999999999999999999999   789999999999998765432


Q ss_pred             --------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCC----
Q 011698          305 --------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR---QKIQQKIIKDKIKLP----  369 (479)
Q Consensus       305 --------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~p----  369 (479)
                              .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.   ......+.......|    
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  242 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence                    23456899999999999999999999999999999999999999986432   233444444433333    


Q ss_pred             -ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          370 -AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       370 -~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                       ..++.++.+||..||+.||++||     +++++++
T Consensus       243 ~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~l~~  273 (296)
T 4hgt_A          243 CKGYPSEFATYLNFCRSLRFDDKP-----DYSYLRQ  273 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCC-----CHHHHHH
T ss_pred             hccCCHHHHHHHHHHHhcCCCCCC-----CHHHHHH
Confidence             66899999999999999999999     8888765

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.4e-45  Score=367.33  Aligned_cols=250  Identities=23%  Similarity=0.380  Sum_probs=211.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEE----EEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIY----AMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      +..++|++++.||+|+||+||+|++..+++.|    |+|.+....  .....+.+.+|+.++++++||||+++++++...
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            45679999999999999999999999888766    555554322  223356688899999999999999999999876


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      . .++|+||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            5 78999999999999999774 569999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHH
Q 011698          302 ENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       302 ~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                      ....   .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+...+...+..+ ....|..++.++
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  248 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence            3322   233456789999999999999999999999999999999 99999998888887777765 456778899999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+||++||+.||.+||     +++|+++
T Consensus       249 ~~li~~~l~~dp~~Rp-----s~~ell~  271 (327)
T 3lzb_A          249 YMIMRKCWMIDADSRP-----KFRELII  271 (327)
T ss_dssp             HHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHcCCChhHCc-----CHHHHHH
Confidence            9999999999999999     8999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.7e-45  Score=357.71  Aligned_cols=246  Identities=25%  Similarity=0.394  Sum_probs=216.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee-------
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-------  221 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-------  221 (479)
                      .++|++++.||+|+||.||+|++..+++.||+|++....       +.+.+|+.++++++||||+++++++..       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            357999999999999999999999999999999997643       235689999999999999999998865       


Q ss_pred             ---------CCeEEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEE
Q 011698          222 ---------KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVM  290 (479)
Q Consensus       222 ---------~~~~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vk  290 (479)
                               ...+|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence                     45689999999999999999754  5799999999999999999999999999999999999999999999


Q ss_pred             EeecCCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc
Q 011698          291 LTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA  370 (479)
Q Consensus       291 L~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~  370 (479)
                      |+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||..  .......+..  ..++.
T Consensus       163 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~--~~~~~  238 (284)
T 2a19_B          163 IGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRD--GIISD  238 (284)
T ss_dssp             ECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHT--TCCCT
T ss_pred             ECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhc--ccccc
Confidence            9999999887666566677899999999999999999999999999999999999999853  2233333333  23567


Q ss_pred             cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       371 ~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      .++.++.+||.+||+.||.+||     ++.|+++|.+.-.
T Consensus       239 ~~~~~~~~li~~~l~~dp~~Rp-----s~~e~l~~l~~~~  273 (284)
T 2a19_B          239 IFDKKEKTLLQKLLSKKPEDRP-----NTSEILRTLTVWK  273 (284)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhhCc-----CHHHHHHHHHHHh
Confidence            7899999999999999999999     8999999877644

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7e-45  Score=355.99  Aligned_cols=245  Identities=24%  Similarity=0.421  Sum_probs=209.1

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee-CCe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-KYR  224 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~  224 (479)
                      .+..++|++++.||+|+||+||+|++  +|+.||+|+++...     ..+.+.+|+.++++++||||+++++++.. ...
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            46678999999999999999999988  47899999997543     34567889999999999999999998654 457


Q ss_pred             EEEEEEeccCCcHHHHHHHcCC--CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGL--FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      +|+||||+++++|.+++.+.+.  +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            9999999999999999976543  89999999999999999999999999999999999999999999999999986543


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHH
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI  380 (479)
                      .  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..++...+..+ ....+..+++++.++|
T Consensus       170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  247 (278)
T 1byg_A          170 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM  247 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred             c--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHH
Confidence            2  234467899999999999999999999999999999998 99999988888877777665 5567788999999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHh
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +.||+.||.+||     +++++++
T Consensus       248 ~~~l~~~p~~Rp-----s~~~l~~  266 (278)
T 1byg_A          248 KNCWHLDAAMRP-----SFLQLRE  266 (278)
T ss_dssp             HHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHhcCChhhCC-----CHHHHHH
Confidence            999999999999     8888875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.1e-46  Score=382.14  Aligned_cols=250  Identities=28%  Similarity=0.446  Sum_probs=213.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC--eE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY--RL  225 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~~  225 (479)
                      ..++|++.+.||+|+||+||+|+++.+++.||||++......  ...+.+.+|+.+|++++||||+++++++....  ..
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            346899999999999999999999999999999999865432  22455678999999999999999999998765  78


Q ss_pred             EEEEEeccCCcHHHHHHHcCC---CcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe----CCCCcEEEeecCCcc
Q 011698          226 YLVLDFVNGGHLFFQLYRQGL---FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL----DADGHVMLTDFGLAK  298 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl----~~~g~vkL~DFGla~  298 (479)
                      |+||||++||+|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999999876433   8999999999999999999999999999999999999    888899999999999


Q ss_pred             ccCCCCCcccccCCCCCcchhHhcC--------CCCCccccchhhHHHHHHHHhCCCCCCC----CCHHHHHHHHHhccC
Q 011698          299 QFDENTRSNSMCGTLEYMSPEIVLG--------KGHDKAADWWSVGILLFEMLTGQPPFTG----GNRQKIQQKIIKDKI  366 (479)
Q Consensus       299 ~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~~DiwSLGvilyelltG~~Pf~~----~~~~~~~~~i~~~~~  366 (479)
                      ...........+||+.|+|||++.+        ..++.++|||||||++|||++|+.||..    ....++..++..+.+
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            8766666667889999999999875        5678899999999999999999999964    334556666665432


Q ss_pred             C-------------------------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          367 K-------------------------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       367 ~-------------------------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .                         ++..++..+.++|++||+.||++|+     +++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~-----s~~e~l~  302 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW-----GFDQFFA  302 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC-----CHHHHHH
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhc-----cHHHHHH
Confidence            1                         1234567889999999999999999     8888754

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.8e-45  Score=358.52  Aligned_cols=253  Identities=23%  Similarity=0.373  Sum_probs=210.6

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcC-CC--eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIG-TS--EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~-~~--~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      .+..++|++++.||+|+||+||+|++.. ++  ..||+|+++..........+.+.+|+.++++++||||+++++++.+.
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            3556799999999999999999998753 33  36999999876544555677789999999999999999999999876


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      . .++||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            5 89999999999999998764 568999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCC----cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc--CCCCccCCH
Q 011698          302 ENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK--IKLPAFLSS  374 (479)
Q Consensus       302 ~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~  374 (479)
                      ....    .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+...+...+....  ...+..++.
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  252 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence            4332    234567889999999999889999999999999999999 999999999888888887763  445678999


Q ss_pred             HHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          375 EAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       375 ~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ++.++|.+||+.||.+||     ++.++++
T Consensus       253 ~l~~li~~~l~~~p~~Rp-----s~~~l~~  277 (291)
T 1u46_A          253 DIYNVMVQCWAHKPEDRP-----TFVALRD  277 (291)
T ss_dssp             HHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHHccCCcccCc-----CHHHHHH
Confidence            999999999999999999     8999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.7e-44  Score=351.74  Aligned_cols=249  Identities=21%  Similarity=0.351  Sum_probs=218.0

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      ..+..++|++++.||+|+||.||+|++. ++..||+|++.....    ..+.+.+|+.++++++||||+++++++.. +.
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   81 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP   81 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence            3456689999999999999999999986 567799999976532    23557889999999999999999998864 56


Q ss_pred             EEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      .++||||+.|++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            899999999999999986543  689999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC--cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHH
Q 011698          303 NTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (479)
Q Consensus       303 ~~~--~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (479)
                      ...  .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++.+.+..+ ....+..++.++.+
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  241 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ  241 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHH
Confidence            332  234557889999999998889999999999999999999 99999998888888887765 45567789999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ||..||+.||++||     +++++++
T Consensus       242 li~~~l~~~p~~Rp-----s~~~l~~  262 (279)
T 1qpc_A          242 LMRLCWKERPEDRP-----TFDYLRS  262 (279)
T ss_dssp             HHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHhccChhhCC-----CHHHHHH
Confidence            99999999999999     8888875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.6e-45  Score=368.89  Aligned_cols=251  Identities=19%  Similarity=0.200  Sum_probs=203.8

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcC---CCeEEEEEEeehhhhchHH--------HHHHHHHHHHHHHhCCCCCeeeEe
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIG---TSEIYAMKVMRKDKIMEKN--------HAEYMKSERNILTKVDHPFIVQLR  216 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~---~~~~vAiK~i~~~~~~~~~--------~~~~~~~E~~iL~~l~hp~Iv~l~  216 (479)
                      ..++|++.+.||+|+||+||+|++..   ++..||+|++.........        ....+.+|+.+++.++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            34689999999999999999999987   7889999999764311111        112355788899999999999999


Q ss_pred             EEEee----CCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC--cEE
Q 011698          217 YSFQT----KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG--HVM  290 (479)
Q Consensus       217 ~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g--~vk  290 (479)
                      +++..    ...+|+||||+ |++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+|
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence            99988    78899999999 999999998888899999999999999999999999999999999999998887  999


Q ss_pred             EeecCCccccCCCC--------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCC--CCHHHHHHH
Q 011698          291 LTDFGLAKQFDENT--------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG--GNRQKIQQK  360 (479)
Q Consensus       291 L~DFGla~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~--~~~~~~~~~  360 (479)
                      |+|||+++.+....        .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+  .+.......
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  273 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA  273 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence            99999998764321        12456899999999999999999999999999999999999999965  233333222


Q ss_pred             HHhccCCCCc---------cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          361 IIKDKIKLPA---------FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       361 i~~~~~~~p~---------~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .......+|.         .++.++.+||..||+.||++||     ++++|++
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~  321 (345)
T 2v62_A          274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKP-----NYQALKK  321 (345)
T ss_dssp             HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCC-----CHHHHHH
T ss_pred             HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCC-----CHHHHHH
Confidence            2222222332         6889999999999999999999     8999876

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.1e-44  Score=354.83  Aligned_cols=245  Identities=20%  Similarity=0.305  Sum_probs=208.5

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEe-EEEeeCCeEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLR-YSFQTKYRLYL  227 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~-~~~~~~~~~~l  227 (479)
                      .++|++.+.||+|+||+||+|++..+++.||+|++......     +.+.+|+.+++.++|++++..+ .++......++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            36899999999999999999999999999999998765422     2477899999999987765544 44577788999


Q ss_pred             EEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe---CCCCcEEEeecCCccccCCC
Q 011698          228 VLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl---~~~g~vkL~DFGla~~~~~~  303 (479)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++.....
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99999 8899999974 4579999999999999999999999999999999999999   48899999999999876543


Q ss_pred             CC--------cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCCC---
Q 011698          304 TR--------SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKIKLP---  369 (479)
Q Consensus       304 ~~--------~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~p---  369 (479)
                      ..        ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+   .......+.......|   
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence            22        346689999999999999999999999999999999999999998633   3344455554444333   


Q ss_pred             --ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          370 --AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       370 --~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                        ..++.++.+||..||+.||.+||     +++++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~  273 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKP-----DYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCC-----CHHHHHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCC-----CHHHHHH
Confidence              67899999999999999999999     8888865

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-44  Score=352.63  Aligned_cols=247  Identities=20%  Similarity=0.315  Sum_probs=214.3

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCe---EEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE-E
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL-Y  226 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~-~  226 (479)
                      .|++.+.||+|+||+||+|++..+++   .||+|++....  .....+.+.+|+.++++++||||+++++++.+.+.. +
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            57788999999999999999866544   79999987532  344567788999999999999999999999876665 9


Q ss_pred             EEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC--
Q 011698          227 LVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--  303 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~--  303 (479)
                      +||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+...  
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            99999999999999976 456899999999999999999999999999999999999999999999999999865332  


Q ss_pred             ---CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHH
Q 011698          304 ---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (479)
Q Consensus       304 ---~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (479)
                         .......||+.|+|||.+.+..++.++|||||||++|+|++ |.+||...+...+...+... ....+..++.++.+
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  259 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ  259 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHH
Confidence               23345678899999999999999999999999999999999 66667777777777777665 45667789999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ||..||+.||.+||     +++++++
T Consensus       260 li~~~l~~~p~~Rp-----s~~~ll~  280 (298)
T 3pls_A          260 VMQQCWEADPAVRP-----TFRVLVG  280 (298)
T ss_dssp             HHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHccCChhhCc-----CHHHHHH
Confidence            99999999999999     8998876

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.8e-44  Score=355.60  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=199.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+..++|++.+.||+|+||+||+|++..   .||+|+++.... .....+.+.+|+.+|++++||||++++++. ....+
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence            4556799999999999999999998754   499999976542 344567788999999999999999999854 56678


Q ss_pred             EEEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC--
Q 011698          226 YLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE--  302 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~--  302 (479)
                      ++||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            999999999999999854 35689999999999999999999999999999999999999999999999999986543  


Q ss_pred             -CCCcccccCCCCCcchhHhc---CCCCCccccchhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCC-----CCccC
Q 011698          303 -NTRSNSMCGTLEYMSPEIVL---GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKIK-----LPAFL  372 (479)
Q Consensus       303 -~~~~~~~~gt~~y~APE~l~---~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~-----~p~~~  372 (479)
                       ........||+.|+|||++.   +..++.++|||||||++|+|++|+.||.+.+.. .+...+..+...     ++..+
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC  254 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence             22334567999999999997   567889999999999999999999999875544 444444444322     23468


Q ss_pred             CHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       373 s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +.++.+||..||+.||.+||     +++++++
T Consensus       255 ~~~l~~li~~~l~~~p~~Rp-----s~~ell~  281 (289)
T 3og7_A          255 PKRMKRLMAECLKKKRDERP-----SFPRILA  281 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCC-----CHHHHHH
Confidence            89999999999999999999     8999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.1e-45  Score=363.97  Aligned_cols=250  Identities=22%  Similarity=0.354  Sum_probs=214.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEE----EcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe--
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVR----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ--  220 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--  220 (479)
                      +..++|++++.||+|+||.||+|+    +..+++.||+|++....   ....+.+.+|+.++++++||||+++++++.  
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            455799999999999999999999    46789999999997643   344566889999999999999999999886  


Q ss_pred             eCCeEEEEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          221 TKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       221 ~~~~~~lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      ....+|+||||++|++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            55679999999999999999976 45699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC----CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCH---------------HHHHHH
Q 011698          300 FDENT----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR---------------QKIQQK  360 (479)
Q Consensus       300 ~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~---------------~~~~~~  360 (479)
                      .....    ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....               ..+...
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            65433    22345688899999999999999999999999999999999999965332               122233


Q ss_pred             HHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          361 IIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       361 i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +..+ ....+..++.++.+||.+||+.||.+||     +++++++
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~  296 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP-----SFSALGP  296 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            3332 4556788999999999999999999999     8998864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=384.96  Aligned_cols=269  Identities=20%  Similarity=0.338  Sum_probs=209.9

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~  225 (479)
                      ++..+|++.+.||+|+||+|+. ....+++.||||++..+...      .+.+|+.+|+++ +|||||++++++.+...+
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~   93 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQ   93 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred             EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence            4445799999999999999764 44457889999999765422      246799999999 799999999999999999


Q ss_pred             EEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC---C--CcEEEeecCCccc
Q 011698          226 YLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---D--GHVMLTDFGLAKQ  299 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~---~--g~vkL~DFGla~~  299 (479)
                      |+||||+. |+|.+++.... .+.+..++.++.||+.||.|||++||+||||||+|||++.   +  ..+||+|||+++.
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            99999997 49999887654 3556667789999999999999999999999999999953   2  3588999999987


Q ss_pred             cCCC----CCcccccCCCCCcchhHhcC---CCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccC---CC
Q 011698          300 FDEN----TRSNSMCGTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKI---KL  368 (479)
Q Consensus       300 ~~~~----~~~~~~~gt~~y~APE~l~~---~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~---~~  368 (479)
                      +...    ......+||+.|+|||++.+   ..++.++|||||||++|||++ |..||...........+.....   ..
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~  252 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP  252 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCT
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCc
Confidence            6543    23455789999999999984   567889999999999999999 9999976554443322222111   11


Q ss_pred             CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh---------hhhcccCCCCCccc
Q 011698          369 PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK---------KLEARETRPSFLPE  428 (479)
Q Consensus       369 p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~---------~l~~~~~~p~~~p~  428 (479)
                      +...+..+.+||.+||+.||.+||     +++++++||||+.++|.         .++.....+++++.
T Consensus       253 ~~~~~~~~~~li~~~L~~dP~~Rp-----s~~evl~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (432)
T 3p23_A          253 EKHEDVIARELIEKMIAMDPQKRP-----SAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQ  316 (432)
T ss_dssp             TCHHHHHHHHHHHHHSCSSGGGSC-----CHHHHHTSTTTCCHHHHHHHHHHHHHHCSCSCSSCHHHHH
T ss_pred             cccccHHHHHHHHHHHhCCHhhCC-----CHHHHHhCccccChHHHHHHHHHHHHHhhcccccchHHHH
Confidence            233566789999999999999999     99999999999999883         34444555555543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.2e-44  Score=391.39  Aligned_cols=251  Identities=20%  Similarity=0.327  Sum_probs=216.0

Q ss_pred             cCCCCeEEE-EEeccCCceEEEEEEE--cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          147 VGLEDFEVL-KVVGQGAFAKVYQVRR--IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       147 ~~~~~y~~~-~~LG~G~fG~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      +....+.+. +.||+|+||+||+|.+  +.+++.||||+++.... .....+.+.+|+.+|++++|||||++++++.. .
T Consensus       365 ~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~  442 (635)
T 4fl3_A          365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-E  442 (635)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred             ccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            334455554 4899999999999955  45678999999987543 33345678899999999999999999999965 4


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      .+++|||||.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus       443 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          443 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            58899999999999999999889999999999999999999999999999999999999999999999999999876443


Q ss_pred             C----CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHH
Q 011698          304 T----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (479)
Q Consensus       304 ~----~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (479)
                      .    ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+ ....|..++.++.
T Consensus       523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  602 (635)
T 4fl3_A          523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY  602 (635)
T ss_dssp             ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            2    2233456789999999999999999999999999999998 99999999998888888876 5667889999999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +||..||+.||++||     ++++|++
T Consensus       603 ~li~~cl~~dP~~RP-----s~~~l~~  624 (635)
T 4fl3_A          603 DLMNLCWTYDVENRP-----GFAAVEL  624 (635)
T ss_dssp             HHHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             HHHHHHcCCCHhHCc-----CHHHHHH
Confidence            999999999999999     8888864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.1e-44  Score=377.28  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=215.7

Q ss_pred             CCcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       143 ~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      ....+..++|++.+.||+|+||+||+|.++.+ ..||||+++.....    .+.+.+|+.+|++++||||+++++++.+ 
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-  250 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-  250 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence            34456678999999999999999999999764 56999999865422    3457889999999999999999999876 


Q ss_pred             CeEEEEEEeccCCcHHHHHHH--cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc
Q 011698          223 YRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~  300 (479)
                      ..+|+||||+.+|+|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            678999999999999999964  356899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCC--CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHH
Q 011698          301 DENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       301 ~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                      ....  ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+ ....|..++..+
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  410 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL  410 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred             CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            4332  2234457789999999999999999999999999999999 99999999888888888766 566788899999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+||.+||+.||++||     +++++++
T Consensus       411 ~~li~~cl~~dP~~Rp-----t~~~l~~  433 (452)
T 1fmk_A          411 HDLMCQCWRKEPEERP-----TFEYLQA  433 (452)
T ss_dssp             HHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHccCChhhCc-----CHHHHHH
Confidence            9999999999999999     8998875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.9e-44  Score=380.46  Aligned_cols=268  Identities=22%  Similarity=0.334  Sum_probs=221.0

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC-CCeeeEeEEEeeCCeEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~~~l  227 (479)
                      .++|+++++||+|+||.||+|++..+++.||||++......     ..+..|+.+++.++| ++|..+..++......++
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l   80 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL   80 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence            47899999999999999999999999999999998765422     236789999999986 666677777788889999


Q ss_pred             EEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe---CCCCcEEEeecCCccccCCC
Q 011698          228 VLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL---DADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl---~~~g~vkL~DFGla~~~~~~  303 (479)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||+++.+...
T Consensus        81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99999 8899999975 5679999999999999999999999999999999999999   68899999999999876543


Q ss_pred             CC--------cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccC-----C
Q 011698          304 TR--------SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKI-----K  367 (479)
Q Consensus       304 ~~--------~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~-----~  367 (479)
                      ..        ....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+..   ....+.++.....     .
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA  239 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence            22        236789999999999999999999999999999999999999998743   3444444444322     2


Q ss_pred             CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHH----------hCccccCCChhhhhcccCCCCCcc
Q 011698          368 LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIK----------SHKWFKMINWKKLEARETRPSFLP  427 (479)
Q Consensus       368 ~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil----------~hp~f~~~~~~~l~~~~~~p~~~p  427 (479)
                      ++..++.++.+||..||+.||.+||     ++++|+          .++|+..++|..+...+..++..|
T Consensus       240 l~~~~p~~l~~li~~cl~~dP~~RP-----s~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~p  304 (483)
T 3sv0_A          240 LCRGYPTEFASYFHYCRSLRFDDKP-----DYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAP  304 (483)
T ss_dssp             HHTTSCHHHHHHHHHHHTCCTTCCC-----CHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC---------
T ss_pred             HhcCCcHHHHHHHHHHhcCChhhCc-----CHHHHHHHHHHHHHHcCCCccCCcCchhhccccccccCCC
Confidence            2356899999999999999999999     676654          489999999999887766555544

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.3e-44  Score=353.57  Aligned_cols=248  Identities=21%  Similarity=0.315  Sum_probs=212.1

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCC---CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEE-eeCCeE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF-QTKYRL  225 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-~~~~~~  225 (479)
                      .+|++.+.||+|+||+||+|++..+   ...||+|.+....  .....+.+.+|+.++++++||||+++++++ ..+...
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            4799999999999999999997543   3468999987532  344566788999999999999999999985 566788


Q ss_pred             EEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      ++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            9999999999999999764 458999999999999999999999999999999999999999999999999998754322


Q ss_pred             -----CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-CCCCccCCHHHH
Q 011698          305 -----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAH  377 (479)
Q Consensus       305 -----~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~  377 (479)
                           ......||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+..+. ...|..++.++.
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  262 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY  262 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHH
Confidence                 2334567889999999999999999999999999999999 778888877777777777664 445778899999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ++|.+||+.||.+||     +++++++
T Consensus       263 ~li~~~l~~~p~~Rp-----s~~ell~  284 (298)
T 3f66_A          263 EVMLKCWHPKAEMRP-----SFSELVS  284 (298)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHcCCChhhCc-----CHHHHHH
Confidence            999999999999999     8998876

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=359.46  Aligned_cols=249  Identities=27%  Similarity=0.422  Sum_probs=191.5

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEE-----
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSF-----  219 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~-----  219 (479)
                      .+.-.+|++.+.||+|+||.||+|++..+++.||+|++....   ....+.+.+|+.+++++. ||||+++++++     
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            344568999999999999999999999999999999986542   334556788999999995 99999999998     


Q ss_pred             ---eeCCeEEEEEEeccCCcHHHHHHH---cCCCcHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCccEEeCCCCcEEE
Q 011698          220 ---QTKYRLYLVLDFVNGGHLFFQLYR---QGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLDADGHVML  291 (479)
Q Consensus       220 ---~~~~~~~lV~E~~~ggsL~~~l~~---~~~l~e~~~~~~~~qi~~aL~~LH~~~--IiHrDLKpeNILl~~~g~vkL  291 (479)
                         .....+++||||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||
T Consensus       101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence               34456899999996 588887765   467999999999999999999999999  999999999999999999999


Q ss_pred             eecCCccccCCCCC-------------cccccCCCCCcchhHh---cCCCCCccccchhhHHHHHHHHhCCCCCCCCCHH
Q 011698          292 TDFGLAKQFDENTR-------------SNSMCGTLEYMSPEIV---LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ  355 (479)
Q Consensus       292 ~DFGla~~~~~~~~-------------~~~~~gt~~y~APE~l---~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~  355 (479)
                      +|||+++.......             ....+||+.|+|||++   .+..++.++|||||||++|+|++|+.||.+....
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            99999987654322             1255799999999999   5667899999999999999999999999865544


Q ss_pred             HHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          356 KIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       356 ~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      .+.....  ....+...+..+.+||++||+.||.+||     +++|+++|
T Consensus       260 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~e~l~~  302 (337)
T 3ll6_A          260 RIVNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERL-----SIAEVVHQ  302 (337)
T ss_dssp             ------C--CCCTTCCSSGGGHHHHHHHSCSSGGGSC-----CHHHHHHH
T ss_pred             HhhcCcc--cCCcccccchHHHHHHHHHccCChhhCc-----CHHHHHHH
Confidence            3322211  2334456788999999999999999999     89999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=359.22  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=207.3

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe----eC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ----TK  222 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~----~~  222 (479)
                      +..++|++++.||+|+||.||+|++..+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.    ..
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            4557899999999999999999999999999999998653   2344567889999999999999999999986    34


Q ss_pred             CeEEEEEEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcc
Q 011698          223 YRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAK  298 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~  298 (479)
                      ..+|+||||+.+|+|.+++.+    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            578999999999999998876    4679999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCCC----------cccccCCCCCcchhHhcCCC---CCccccchhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHh
Q 011698          299 QFDENTR----------SNSMCGTLEYMSPEIVLGKG---HDKAADWWSVGILLFEMLTGQPPFTGGN--RQKIQQKIIK  363 (479)
Q Consensus       299 ~~~~~~~----------~~~~~gt~~y~APE~l~~~~---~~~~~DiwSLGvilyelltG~~Pf~~~~--~~~~~~~i~~  363 (479)
                      .......          .....||+.|+|||++.+..   ++.++|||||||++|||++|+.||....  .......+..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  262 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN  262 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence            6532111          12346799999999998664   6889999999999999999999995411  1112222222


Q ss_pred             -ccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          364 -DKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       364 -~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                       .....+..++.++.+||.+||+.||.+||     ++++++++
T Consensus       263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  300 (317)
T 2buj_A          263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRP-----HIPLLLSQ  300 (317)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             cCCCCccccCCHHHHHHHHHHhhcChhhCC-----CHHHHHHH
Confidence             12334457899999999999999999999     89999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7e-44  Score=388.25  Aligned_cols=251  Identities=22%  Similarity=0.325  Sum_probs=215.0

Q ss_pred             ccCCCCeEEEE-EeccCCceEEEEEEEc--CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          146 CVGLEDFEVLK-VVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       146 ~~~~~~y~~~~-~LG~G~fG~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      .+..+++.+.+ .||+|+||+||+|.++  .++..||||+++...  .....+.+.+|+++|++++|||||++++++.. 
T Consensus       331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-  407 (613)
T 2ozo_A          331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-  407 (613)
T ss_dssp             BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred             eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence            34556788777 8999999999999876  456789999997642  22345668899999999999999999999976 


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      +.+|+||||+.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus       408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            5699999999999999998754 459999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC----cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHH
Q 011698          302 ENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (479)
Q Consensus       302 ~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  375 (479)
                      ....    .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+ .+..|..++.+
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~  567 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE  567 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            3322    123345689999999999999999999999999999998 99999998888888888876 46778889999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +.+||..||+.||.+||     ++++|++
T Consensus       568 l~~li~~cl~~dP~~RP-----s~~~l~~  591 (613)
T 2ozo_A          568 LYALMSDCWIYKWEDRP-----DFLTVEQ  591 (613)
T ss_dssp             HHHHHHHTTCSSTTTSC-----CHHHHHH
T ss_pred             HHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            99999999999999999     8888753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.5e-44  Score=354.08  Aligned_cols=244  Identities=26%  Similarity=0.408  Sum_probs=198.5

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHh--CCCCCeeeEeEEEee---
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK--VDHPFIVQLRYSFQT---  221 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~~~~---  221 (479)
                      +..++|++++.||+|+||+||+|++  +++.||||++....      ......|.+++..  ++||||+++++++..   
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~   76 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRH   76 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence            3457899999999999999999988  68899999987542      2334556666666  799999999998654   


Q ss_pred             -CCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHH--------hCCCccCCCCCccEEeCCCCcEEEe
Q 011698          222 -KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH--------ANGIMHRDLKPENILLDADGHVMLT  292 (479)
Q Consensus       222 -~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH--------~~~IiHrDLKpeNILl~~~g~vkL~  292 (479)
                       ...+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||        ++||+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence             3568999999999999999854 57899999999999999999999        9999999999999999999999999


Q ss_pred             ecCCccccCCCCC-----cccccCCCCCcchhHhcCC------CCCccccchhhHHHHHHHHhC----------CCCCCC
Q 011698          293 DFGLAKQFDENTR-----SNSMCGTLEYMSPEIVLGK------GHDKAADWWSVGILLFEMLTG----------QPPFTG  351 (479)
Q Consensus       293 DFGla~~~~~~~~-----~~~~~gt~~y~APE~l~~~------~~~~~~DiwSLGvilyelltG----------~~Pf~~  351 (479)
                      |||+++.......     ....+||+.|+|||++.+.      .++.++|||||||++|||++|          ..||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            9999986543322     2345899999999999887      445799999999999999999          889865


Q ss_pred             CC-----HHHHHHHHHhc--cCCCCc-----cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          352 GN-----RQKIQQKIIKD--KIKLPA-----FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       352 ~~-----~~~~~~~i~~~--~~~~p~-----~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ..     ...+...+...  ...+|.     ..+.++.+||.+||+.||++||     +++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~~i~~  295 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL-----TALRIKK  295 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSC-----CHHHHHH
T ss_pred             cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCC-----CHHHHHH
Confidence            32     22333222222  223332     2457899999999999999999     8999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.9e-44  Score=374.58  Aligned_cols=247  Identities=27%  Similarity=0.382  Sum_probs=197.3

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +.|.+.+.||+|+||+||.+. ..+|+.||||++..+.      .+.+.+|+.+|+++ +||||+++++++.+...+|+|
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            456667899999999998754 4578999999987643      23467899999876 899999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcH-------HHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC-------------Cc
Q 011698          229 LDFVNGGHLFFQLYRQGLFRE-------DLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD-------------GH  288 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e-------~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~-------------g~  288 (479)
                      |||+. |+|.+++...+...+       ..++.++.||+.||+|||++||+||||||+|||++.+             ++
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence            99996 599999987654332       2356799999999999999999999999999999754             48


Q ss_pred             EEEeecCCccccCCCC-----CcccccCCCCCcchhHhcC-------CCCCccccchhhHHHHHHHHh-CCCCCCCCCHH
Q 011698          289 VMLTDFGLAKQFDENT-----RSNSMCGTLEYMSPEIVLG-------KGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQ  355 (479)
Q Consensus       289 vkL~DFGla~~~~~~~-----~~~~~~gt~~y~APE~l~~-------~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~  355 (479)
                      +||+|||+++.+....     .....+||+.|+|||++.+       ..++.++|||||||++|||+| |..||.+....
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            9999999998865432     2235689999999999976       568999999999999999999 99999765443


Q ss_pred             HHHHHHHhccCCCC-------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          356 KIQQKIIKDKIKLP-------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       356 ~~~~~i~~~~~~~p-------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      .  ..+..+...++       ..++.++.+||.+||+.||.+||     ++.++++||||+..
T Consensus       247 ~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----s~~eil~hp~f~~~  302 (434)
T 2rio_A          247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP-----TAMKVLRHPLFWPK  302 (434)
T ss_dssp             H--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSC-----CHHHHHTSGGGSCH
T ss_pred             H--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCC-----CHHHHHhCCccCCc
Confidence            3  34555443332       23568899999999999999999     99999999999764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.7e-44  Score=354.05  Aligned_cols=242  Identities=28%  Similarity=0.444  Sum_probs=201.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++.+.||+|+||+||+|++.  ++.||+|++....     ..+.+.+|+.+|++++||||+++++++.+  ..|
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~   75 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC   75 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence            45679999999999999999999984  6789999986532     34567889999999999999999998874  489


Q ss_pred             EEEEeccCCcHHHHHHHcC---CCcHHHHHHHHHHHHHHHHHHHh---CCCccCCCCCccEEeCCCCc-EEEeecCCccc
Q 011698          227 LVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHA---NGIMHRDLKPENILLDADGH-VMLTDFGLAKQ  299 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~---~~IiHrDLKpeNILl~~~g~-vkL~DFGla~~  299 (479)
                      +||||++||+|.+++....   .+++..+..++.||+.||.|||+   +||+||||||+|||++.++. +||+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            9999999999999998765   37889999999999999999999   89999999999999998886 79999999976


Q ss_pred             cCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhc-cCCCCccCCHHH
Q 011698          300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN--RQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~--~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                      ....  .....||+.|+|||++.+..++.++|||||||++|||++|+.||....  ...+...+..+ ....+..++..+
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (307)
T 2eva_A          156 IQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI  233 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHH
T ss_pred             cccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHH
Confidence            5432  334579999999999999999999999999999999999999997543  23333333333 455667899999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+||.+||+.||++||     +++++++
T Consensus       234 ~~li~~~l~~dp~~Rp-----s~~ell~  256 (307)
T 2eva_A          234 ESLMTRCWSKDPSQRP-----SMEEIVK  256 (307)
T ss_dssp             HHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHhcCChhhCc-----CHHHHHH
Confidence            9999999999999999     8999886

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-44  Score=368.54  Aligned_cols=248  Identities=21%  Similarity=0.318  Sum_probs=204.9

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCC---CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEE-eeCCeE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF-QTKYRL  225 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-~~~~~~  225 (479)
                      ..|++.+.||+|+||+||+|++..+   +..||+|.++...  .....+.+.+|+.++++++||||+++++++ ..+...
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            3588999999999999999997643   3468999987532  334567788999999999999999999986 456688


Q ss_pred             EEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      |+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999999765 458999999999999999999999999999999999999999999999999998653322


Q ss_pred             -----CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHH
Q 011698          305 -----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (479)
Q Consensus       305 -----~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (479)
                           ......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++...+..+ ....|..++..+.
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~  326 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY  326 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence                 1234567889999999999999999999999999999999 78899887777677667665 4456778999999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ++|.+||+.||++||     +++++++
T Consensus       327 ~li~~cl~~dp~~RP-----s~~ell~  348 (373)
T 3c1x_A          327 EVMLKCWHPKAEMRP-----SFSELVS  348 (373)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHcCCChhhCc-----CHHHHHH
Confidence            999999999999999     8999876

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.6e-44  Score=382.11  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=220.2

Q ss_pred             CCcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          143 ENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       143 ~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      ....+..++|++.+.||+|+||+||+|+++.+ ..||||+++.....    .+.+.+|+.+|++++||||+++++++.+ 
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-  333 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-  333 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            33456678899999999999999999999764 56999999865422    3457889999999999999999999876 


Q ss_pred             CeEEEEEEeccCCcHHHHHHH--cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc
Q 011698          223 YRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~  300 (479)
                      ..+|+||||+.+|+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus       334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            678999999999999999964  356899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCC--CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHH
Q 011698          301 DENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       301 ~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                      ....  ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+.+..++...+..+ ++..|..++.++
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  493 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL  493 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            4321  1233456789999999999999999999999999999999 99999999888888888766 556778899999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+||.+||+.||++||     ++++|++
T Consensus       494 ~~li~~cl~~dP~~RP-----t~~~l~~  516 (535)
T 2h8h_A          494 HDLMCQCWRKEPEERP-----TFEYLQA  516 (535)
T ss_dssp             HHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHcCCChhHCc-----CHHHHHH
Confidence            9999999999999999     8998875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.9e-45  Score=366.68  Aligned_cols=250  Identities=22%  Similarity=0.309  Sum_probs=209.2

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ...++|++.+.||+|+||+||+|+++ +++.||+|++....   ....+.+.+|+.++++++||||+++++++...+.++
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            34578999999999999999999964 68899999987643   234566889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcC----CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          227 LVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      +||||++||+|.+++....    .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999998886543    489999999999999999999999999999999999999999999999999987533


Q ss_pred             C---CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhccC------
Q 011698          303 N---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ-------QKIIKDKI------  366 (479)
Q Consensus       303 ~---~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~-------~~i~~~~~------  366 (479)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..       .....+.+      
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP  271 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence            2   2234557899999999999999999999999999999999999999764322111       11111111      


Q ss_pred             ----CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          367 ----KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       367 ----~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                          .++...+..+.++|.+||+.||++||     +++|++++
T Consensus       272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~  309 (321)
T 2qkw_B          272 NLADKIRPESLRKFGDTAVKCLALSSEDRP-----SMGDVLWK  309 (321)
T ss_dssp             SCTTCSCHHHHHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             hhccccCHHHHHHHHHHHHHHcCCCcccCc-----CHHHHHHH
Confidence                12234567899999999999999999     89999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.9e-44  Score=357.74  Aligned_cols=248  Identities=27%  Similarity=0.364  Sum_probs=209.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEE----cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee--C
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRR----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--K  222 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~  222 (479)
                      -+.|++++.||+|+||+||++.+    ..+++.||+|++....  .....+.+.+|+.+|++++||||+++++++.+  .
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            34459999999999999988865    3478999999998653  34456678899999999999999999999987  4


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      ..+++||||+++|+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            6899999999999999988765 489999999999999999999999999999999999999999999999999988754


Q ss_pred             CCC----cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHH---------------HHHHHHHh
Q 011698          303 NTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ---------------KIQQKIIK  363 (479)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~---------------~~~~~i~~  363 (479)
                      ...    .....||+.|+|||++.+..++.++|||||||++|+|++|..||......               .+...+..
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER  266 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence            432    33456888999999999999999999999999999999999999753211               12222222


Q ss_pred             c-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          364 D-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       364 ~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      . ....+..++.++.+||+.||+.||.+||     +++++++
T Consensus       267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~  303 (318)
T 3lxp_A          267 GERLPRPDKCPAEVYHLMKNCWETEASFRP-----TFENLIP  303 (318)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             ccCCCCCccccHHHHHHHHHHcCCCcccCc-----CHHHHHH
Confidence            2 4556788999999999999999999999     8999874

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.5e-44  Score=362.99  Aligned_cols=242  Identities=19%  Similarity=0.261  Sum_probs=204.0

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCC--------CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeee------
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGT--------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQ------  214 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~------  214 (479)
                      .++|++.+.||+|+||+||+|++..+        ++.||+|++...        +.+.+|+.++++++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            47899999999999999999999874        889999999764        24678999999999999987      


Q ss_pred             ---------EeEEEee-CCeEEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEE
Q 011698          215 ---------LRYSFQT-KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENIL  282 (479)
Q Consensus       215 ---------l~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNIL  282 (479)
                               +++++.. ...+|+||||+ +++|.+++...  +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     5666665 78899999999 99999999886  78999999999999999999999999999999999999


Q ss_pred             eCCCC--cEEEeecCCccccCCCC--------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 011698          283 LDADG--HVMLTDFGLAKQFDENT--------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG  352 (479)
Q Consensus       283 l~~~g--~vkL~DFGla~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~  352 (479)
                      ++.++  .+||+|||+++.+....        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  99999999998754321        224458999999999999999999999999999999999999999875


Q ss_pred             C--HHHHHHHHH---hccCCCC------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          353 N--RQKIQQKII---KDKIKLP------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       353 ~--~~~~~~~i~---~~~~~~p------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .  ...+...+.   .....++      ..++.++.+||..||+.||++||     +++++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~l~~  329 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKP-----PYAMLRN  329 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCC-----CHHHHHH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCC-----CHHHHHH
Confidence            3  333333222   2222222      24689999999999999999999     8888865

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=366.32  Aligned_cols=243  Identities=16%  Similarity=0.260  Sum_probs=201.0

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEE-----EEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC---CCCeeeEeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQV-----RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQLRY  217 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a-----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~  217 (479)
                      .+..++|++.+.||+|+||+||+|     .+..+++.||+|++....      ...+..|+.+++.++   |+||+++++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            355678999999999999999999     467789999999997643      234667888888886   999999999


Q ss_pred             EEeeCCeEEEEEEeccCCcHHHHHHH-----cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC-------
Q 011698          218 SFQTKYRLYLVLDFVNGGHLFFQLYR-----QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-------  285 (479)
Q Consensus       218 ~~~~~~~~~lV~E~~~ggsL~~~l~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~-------  285 (479)
                      ++...+..|+||||++||+|.+++..     .+.+++..++.++.||+.||+|||++||+||||||+|||++.       
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence            99999999999999999999999974     456999999999999999999999999999999999999998       


Q ss_pred             ----CCcEEEeecCCccccC---CCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHH
Q 011698          286 ----DGHVMLTDFGLAKQFD---ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ  358 (479)
Q Consensus       286 ----~g~vkL~DFGla~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~  358 (479)
                          ++.+||+|||+|+.+.   ........+||+.|||||++.+..++.++|||||||++|||+||+.||........ 
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-  293 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-  293 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence                8999999999997543   33445667899999999999999999999999999999999999999965332110 


Q ss_pred             HHHHhccCCCC-ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHH
Q 011698          359 QKIIKDKIKLP-AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIK  403 (479)
Q Consensus       359 ~~i~~~~~~~p-~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil  403 (479)
                          .-...++ ...+..+.+++..||+.+|.+|+.    +++++.
T Consensus       294 ----~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~----~~~~l~  331 (365)
T 3e7e_A          294 ----KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLP----SLDLLR  331 (365)
T ss_dssp             ----EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCC----CHHHHH
T ss_pred             ----eechhccccCcHHHHHHHHHHHcCCCCCCcch----HHHHHH
Confidence                0001111 124678899999999999999972    555554

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=9.7e-45  Score=363.06  Aligned_cols=257  Identities=22%  Similarity=0.286  Sum_probs=209.4

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      ..+..++|++.+.||+|+||+||+|++. +++.||+|++.......  ....+.+|+.+++.++||||+++++++.+...
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  101 (326)
T 3uim_A           25 LQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTE  101 (326)
T ss_dssp             HHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred             HHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence            3455688999999999999999999854 68899999997654221  12247889999999999999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcC----CCcHHHHHHHHHHHHHHHHHHHhC---CCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          225 LYLVLDFVNGGHLFFQLYRQG----LFREDLARIYTAEIVSAVSHLHAN---GIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~---~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                      .++||||+.+|+|.+++....    .+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+||+|||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~  181 (326)
T 3uim_A          102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA  181 (326)
T ss_dssp             CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred             eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence            999999999999999998653    389999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCC--CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC----CHHHHHHHHHhc-----c-
Q 011698          298 KQFDEN--TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG----NRQKIQQKIIKD-----K-  365 (479)
Q Consensus       298 ~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~----~~~~~~~~i~~~-----~-  365 (479)
                      +.....  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...    ............     . 
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (326)
T 3uim_A          182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL  261 (326)
T ss_dssp             EECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred             cccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence            876433  2334567999999999999988999999999999999999999999521    111011111111     0 


Q ss_pred             ---------CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCcccc
Q 011698          366 ---------IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK  409 (479)
Q Consensus       366 ---------~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~  409 (479)
                               ..++...+..+.++|..||+.||.+||     +++++++|-.-.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~ell~~L~~~  309 (326)
T 3uim_A          262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP-----KMSEVVRMLEGD  309 (326)
T ss_dssp             TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSC-----CHHHHHHHHHTS
T ss_pred             hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCC-----CHHHHHHHhcCc
Confidence                     112233457899999999999999999     899999865433

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=354.43  Aligned_cols=247  Identities=21%  Similarity=0.370  Sum_probs=192.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe-----
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ-----  220 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----  220 (479)
                      .+.+++|++++.||+|+||+||+|++  +++.||||++......    ......|+..+..++||||+++++.+.     
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh----hHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            46778999999999999999999987  6789999999754311    111223444455689999999987553     


Q ss_pred             eCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC---------CCccCCCCCccEEeCCCCcEEE
Q 011698          221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN---------GIMHRDLKPENILLDADGHVML  291 (479)
Q Consensus       221 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---------~IiHrDLKpeNILl~~~g~vkL  291 (479)
                      ....+|+||||+++|+|.+++.... .++..++.++.||+.||.|||++         ||+||||||+|||++.++.+||
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             CCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence            2346899999999999999997654 48888999999999999999999         9999999999999999999999


Q ss_pred             eecCCccccCCC---------CCcccccCCCCCcchhHhcC-------CCCCccccchhhHHHHHHHHhCCCCCCCCC--
Q 011698          292 TDFGLAKQFDEN---------TRSNSMCGTLEYMSPEIVLG-------KGHDKAADWWSVGILLFEMLTGQPPFTGGN--  353 (479)
Q Consensus       292 ~DFGla~~~~~~---------~~~~~~~gt~~y~APE~l~~-------~~~~~~~DiwSLGvilyelltG~~Pf~~~~--  353 (479)
                      +|||+++.+...         ......+||+.|+|||++.+       ..++.++|||||||++|||++|..||....  
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            999999876432         22335679999999999987       355678999999999999999977764321  


Q ss_pred             ----------------HHHHHHHHHhc--cCCCCcc------CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          354 ----------------RQKIQQKIIKD--KIKLPAF------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       354 ----------------~~~~~~~i~~~--~~~~p~~------~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                                      ...+...+...  ...+|..      ++.++.+||.+||+.||++||     +++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~e~l~  311 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL-----TAQXAEE  311 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSC-----CHHHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCc-----chHHHHH
Confidence                            11112222221  3334443      344799999999999999999     8999854

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-43  Score=350.14  Aligned_cols=245  Identities=24%  Similarity=0.378  Sum_probs=198.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHh--CCCCCeeeEeEEEeeC--
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK--VDHPFIVQLRYSFQTK--  222 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~~~~~--  222 (479)
                      ...++|++++.||+|+||+||+|++.  ++.||+|++.....      .....|..++..  ++||||+++++++...  
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            33468999999999999999999985  88999999865431      223345555554  4899999999999887  


Q ss_pred             --CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCccEEeCCCCcEEEe
Q 011698          223 --YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN--------GIMHRDLKPENILLDADGHVMLT  292 (479)
Q Consensus       223 --~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------~IiHrDLKpeNILl~~~g~vkL~  292 (479)
                        ..+|+||||+++|+|.+++... .+++..++.++.||+.||.|||++        ||+||||||+|||++.++.+||+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence              7899999999999999999664 689999999999999999999999        99999999999999999999999


Q ss_pred             ecCCccccCCCCC-----cccccCCCCCcchhHhcCCCCCcc------ccchhhHHHHHHHHhC----------CCCCCC
Q 011698          293 DFGLAKQFDENTR-----SNSMCGTLEYMSPEIVLGKGHDKA------ADWWSVGILLFEMLTG----------QPPFTG  351 (479)
Q Consensus       293 DFGla~~~~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~------~DiwSLGvilyelltG----------~~Pf~~  351 (479)
                      |||+++.+.....     ....+||+.|+|||++.+..++..      +|||||||++|||+||          +.||..
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            9999987643322     235689999999999998777665      9999999999999999          777764


Q ss_pred             C-----CHHHHHHHHHhc--cCCCCc-----cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          352 G-----NRQKIQQKIIKD--KIKLPA-----FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       352 ~-----~~~~~~~~i~~~--~~~~p~-----~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      .     ........+...  ...+|.     .++.++.+||.+||+.||++||     +++++++|
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----s~~ell~~  325 (337)
T 3mdy_A          265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL-----TALRVKKT  325 (337)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC-----CHHHHHHH
T ss_pred             hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCC-----CHHHHHHH
Confidence            3     222333333222  233443     4566799999999999999999     89999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=352.97  Aligned_cols=250  Identities=21%  Similarity=0.328  Sum_probs=211.4

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEE----cCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRR----IGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      +..++|++++.||+|+||.||+|++    ..+++.||+|++...   .....+.+.+|+.++++++||||+++++++...
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            4567899999999999999999994    568999999999764   234456788999999999999999999988664


Q ss_pred             C--eEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          223 Y--RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       223 ~--~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      .  .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            4  789999999999999999876 4589999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCCC----cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCH------------H----HHHH
Q 011698          300 FDENTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNR------------Q----KIQQ  359 (479)
Q Consensus       300 ~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~------------~----~~~~  359 (479)
                      ......    .....++..|+|||++.+..++.++|||||||++|||+||..||.....            .    .+.+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            654432    2334677889999999998899999999999999999999999864211            0    1122


Q ss_pred             HHHh-ccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          360 KIIK-DKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       360 ~i~~-~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+.. .....|..++.++.+||++||+.||++||     +++++++
T Consensus       275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~el~~  315 (326)
T 2w1i_A          275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP-----SFRDLAL  315 (326)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHH
T ss_pred             HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCc-----CHHHHHH
Confidence            2222 24566788999999999999999999999     8988875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.5e-43  Score=349.32  Aligned_cols=231  Identities=31%  Similarity=0.552  Sum_probs=194.9

Q ss_pred             cCCCCeEEE-EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHH-HhCCCCCeeeEeEEEee---
Q 011698          147 VGLEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNIL-TKVDHPFIVQLRYSFQT---  221 (479)
Q Consensus       147 ~~~~~y~~~-~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~~~~---  221 (479)
                      ..+++|.++ +.||+|+||.||+|.++.+++.||+|++...        ....+|+.++ +.++||||+++++++..   
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            345789998 7899999999999999999999999999753        2356788777 56799999999999987   


Q ss_pred             -CCeEEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC---CCcEEEeecC
Q 011698          222 -KYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFG  295 (479)
Q Consensus       222 -~~~~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~---~g~vkL~DFG  295 (479)
                       ...+|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             778999999999999999998765  6999999999999999999999999999999999999998   7899999999


Q ss_pred             CccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHhccCCCC--
Q 011698          296 LAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ----KIIKDKIKLP--  369 (479)
Q Consensus       296 la~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~----~i~~~~~~~p--  369 (479)
                      ++....                     +..++.++|||||||++|||++|+.||.+.+......    .+......+|  
T Consensus       166 ~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (299)
T 3m2w_A          166 FAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  224 (299)
T ss_dssp             TCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred             cccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence            997543                     2346789999999999999999999998765443322    2222333444  


Q ss_pred             --ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          370 --AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       370 --~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                        ..++.++.+||.+||+.||.+||     +++|+++||||+..
T Consensus       225 ~~~~~~~~~~~li~~~l~~dP~~Rp-----s~~e~l~hp~~~~~  263 (299)
T 3m2w_A          225 EWSEVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWIMQS  263 (299)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHTG
T ss_pred             hcccCCHHHHHHHHHHcccChhhCC-----CHHHHhcChhhccc
Confidence              46899999999999999999999     99999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.6e-42  Score=380.30  Aligned_cols=251  Identities=22%  Similarity=0.374  Sum_probs=217.7

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCC---CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      .+..++|++.+.||+|+||+||+|.+..+   +..||+|+++...  .....+.+.+|+.++++++||||+++++++. .
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            34567899999999999999999998654   4679999987532  3344567889999999999999999999985 4


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      +.+|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            67899999999999999998654 68999999999999999999999999999999999999999999999999998764


Q ss_pred             CCCC--cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHH
Q 011698          302 ENTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (479)
Q Consensus       302 ~~~~--~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (479)
                      ....  .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+..+ ...+|..++..+.
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  622 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  622 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHH
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence            4332  234567789999999999999999999999999999997 99999999988888888776 4667889999999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +||.+||+.||.+||     ++.++++
T Consensus       623 ~li~~~l~~dP~~RP-----s~~el~~  644 (656)
T 2j0j_A          623 SLMTKCWAYDPSRRP-----RFTELKA  644 (656)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHcCCChhHCc-----CHHHHHH
Confidence            999999999999999     8998875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.1e-44  Score=355.12  Aligned_cols=251  Identities=22%  Similarity=0.323  Sum_probs=211.8

Q ss_pred             CcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          144 NQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       144 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      ...+..++|++.+.||+|+||.||+|++..   .||+|++...... ....+.+.+|+.++++++||||+++++++.+..
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            345677899999999999999999999865   3999999764321 222344678999999999999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      .+++||||+.|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            9999999999999999997754 689999999999999999999999999999999999998 78999999999876431


Q ss_pred             ------CCCcccccCCCCCcchhHhcC---------CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Q 011698          303 ------NTRSNSMCGTLEYMSPEIVLG---------KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK  367 (479)
Q Consensus       303 ------~~~~~~~~gt~~y~APE~l~~---------~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  367 (479)
                            ........||+.|+|||++.+         ..++.++|||||||++|||++|+.||.+.+...+...+..+...
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  261 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP  261 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence                  123344568999999999975         45789999999999999999999999998888888877766433


Q ss_pred             C--CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          368 L--PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       368 ~--p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .  +..++.++.++|..||+.||.+||     +++++++
T Consensus       262 ~~~~~~~~~~l~~li~~~l~~~p~~Rp-----t~~~l~~  295 (319)
T 2y4i_B          262 NLSQIGMGKEISDILLFCWAFEQEERP-----TFTKLMD  295 (319)
T ss_dssp             CCCCSSCCTTHHHHHHHHHCSSTTTSC-----CHHHHHH
T ss_pred             CCCcCCCCHHHHHHHHHHhcCChhhCc-----CHHHHHH
Confidence            2  235889999999999999999999     8999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3e-43  Score=349.05  Aligned_cols=244  Identities=23%  Similarity=0.339  Sum_probs=203.4

Q ss_pred             EEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhh-hchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEe
Q 011698          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDK-IMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDF  231 (479)
Q Consensus       153 ~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~  231 (479)
                      ...+.||+|+||+||+|.+  +++.||+|++.... .......+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  111 (307)
T 2nru_A           34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY  111 (307)
T ss_dssp             TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence            3457899999999999986  57789999997532 22334567788999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHHH---cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC---C
Q 011698          232 VNGGHLFFQLYR---QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT---R  305 (479)
Q Consensus       232 ~~ggsL~~~l~~---~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~---~  305 (479)
                      +++++|.+++..   ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   .
T Consensus       112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  191 (307)
T 2nru_A          112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM  191 (307)
T ss_dssp             CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred             cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence            999999999874   3468999999999999999999999999999999999999999999999999998754332   2


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccC-----------CCCc
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ----KIQQKIIKDKI-----------KLPA  370 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~----~~~~~i~~~~~-----------~~p~  370 (479)
                      ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..    .+...+.....           ..+.
T Consensus       192 ~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (307)
T 2nru_A          192 TSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS  270 (307)
T ss_dssp             CSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCH
T ss_pred             ccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccch
Confidence            3456799999999998764 789999999999999999999999865432    22222222111           1233


Q ss_pred             cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          371 FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       371 ~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ..+..+.++|..||+.||.+||     +++++++
T Consensus       271 ~~~~~l~~li~~cl~~~p~~Rp-----s~~~l~~  299 (307)
T 2nru_A          271 TSVEAMYSVASQCLHEKKNKRP-----DIKKVQQ  299 (307)
T ss_dssp             HHHHHHHHHHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCcccCc-----CHHHHHH
Confidence            4567899999999999999999     8999876

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.3e-42  Score=349.27  Aligned_cols=244  Identities=25%  Similarity=0.366  Sum_probs=204.5

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHh--CCCCCeeeEeEEEeeCC--
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK--VDHPFIVQLRYSFQTKY--  223 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~~~~~~--  223 (479)
                      ..++|++.+.||+|+||+||+|++  +++.||+|++....      ...+.+|.++++.  ++||||+++++++....  
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            346899999999999999999998  58899999997542      2345678888887  78999999999998876  


Q ss_pred             --eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHH--------hCCCccCCCCCccEEeCCCCcEEEee
Q 011698          224 --RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH--------ANGIMHRDLKPENILLDADGHVMLTD  293 (479)
Q Consensus       224 --~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH--------~~~IiHrDLKpeNILl~~~g~vkL~D  293 (479)
                        .+|+||||+++|+|.+++.+ ..+++..++.++.||+.||.|||        ++||+||||||+|||++.++.+||+|
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  190 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  190 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred             cceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence              89999999999999999976 46899999999999999999999        89999999999999999999999999


Q ss_pred             cCCccccCCCC-----CcccccCCCCCcchhHhcCCC------CCccccchhhHHHHHHHHhC----------CCCCCCC
Q 011698          294 FGLAKQFDENT-----RSNSMCGTLEYMSPEIVLGKG------HDKAADWWSVGILLFEMLTG----------QPPFTGG  352 (479)
Q Consensus       294 FGla~~~~~~~-----~~~~~~gt~~y~APE~l~~~~------~~~~~DiwSLGvilyelltG----------~~Pf~~~  352 (479)
                      ||++.......     .....+||+.|+|||++.+..      ++.++|||||||++|||+||          ..||...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            99998765443     235568999999999998763      33789999999999999999          8899764


Q ss_pred             -----CHHHHHHHHHhcc--CCCCc-----cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          353 -----NRQKIQQKIIKDK--IKLPA-----FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       353 -----~~~~~~~~i~~~~--~~~p~-----~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                           ....+...+....  ..+|.     ..+..+.+||.+||+.||++||     +++++++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~~i~~~  330 (342)
T 1b6c_B          271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL-----TALRIKKT  330 (342)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC-----CHHHHHHH
T ss_pred             CcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCC-----CHHHHHHH
Confidence                 2344455554432  33343     2345789999999999999999     89999874

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.6e-44  Score=392.88  Aligned_cols=270  Identities=27%  Similarity=0.388  Sum_probs=219.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee-----
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-----  221 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----  221 (479)
                      ..+++|++.+.||+|+||.||+|.+..+|+.||||+++...  .....+.+.+|+.++++++||||+++++++..     
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~   88 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA   88 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence            34578999999999999999999999999999999987642  34456678899999999999999999998765     


Q ss_pred             -CCeEEEEEEeccCCcHHHHHHHcC---CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCc---EEEeec
Q 011698          222 -KYRLYLVLDFVNGGHLFFQLYRQG---LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGH---VMLTDF  294 (479)
Q Consensus       222 -~~~~~lV~E~~~ggsL~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~---vkL~DF  294 (479)
                       ....|+||||++||+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+||
T Consensus        89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence             678899999999999999998754   5899999999999999999999999999999999999997775   999999


Q ss_pred             CCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHH---------HH-----
Q 011698          295 GLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ---------QK-----  360 (479)
Q Consensus       295 Gla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~---------~~-----  360 (479)
                      |++............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......         ..     
T Consensus       169 G~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~  248 (676)
T 3qa8_A          169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD  248 (676)
T ss_dssp             CCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred             ccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence            9999887766667789999999999999999999999999999999999999999764322111         00     


Q ss_pred             HHhccCC----------CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCC
Q 011698          361 IIKDKIK----------LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSF  425 (479)
Q Consensus       361 i~~~~~~----------~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~  425 (479)
                      ...+...          ++..++..+.+||..||+.||++||     +++++++||||+.+  ..+..+.+...|
T Consensus       249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRP-----Ta~elL~hp~F~~l--~~iL~~kil~~f  316 (676)
T 3qa8_A          249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG-----TDPQNPNVGCFQAL--DSILSLKLLSVM  316 (676)
T ss_dssp             CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC--------CCTTCCCCTTHHHH--HHHHCCCEEECC
T ss_pred             hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCc-----CHHHHhcCHHHHHH--HHHHhccccccc
Confidence            0011111          2234678999999999999999999     88999999999984  455555544444

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7e-45  Score=366.40  Aligned_cols=245  Identities=18%  Similarity=0.240  Sum_probs=196.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc-----hHHHHHHHHHHHHHHHhCC---------CCCe
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM-----EKNHAEYMKSERNILTKVD---------HPFI  212 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~iL~~l~---------hp~I  212 (479)
                      +..++|++++.||+|+||+||+|++  +|+.||||++......     .....+.+.+|+.+|+.++         ||||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            3457899999999999999999998  6799999999875421     2223456788999988886         6666


Q ss_pred             eeEeEEE-----------------ee-------------CCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHH
Q 011698          213 VQLRYSF-----------------QT-------------KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA  262 (479)
Q Consensus       213 v~l~~~~-----------------~~-------------~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~a  262 (479)
                      +++.+.+                 .+             ...+|+||||+.+|++...+.+ +.+++..++.++.||+.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence            6665553                 32             7889999999999977666644 678999999999999999


Q ss_pred             HHHHH-hCCCccCCCCCccEEeCCCC--------------------cEEEeecCCccccCCCCCcccccCCCCCcchhHh
Q 011698          263 VSHLH-ANGIMHRDLKPENILLDADG--------------------HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV  321 (479)
Q Consensus       263 L~~LH-~~~IiHrDLKpeNILl~~~g--------------------~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l  321 (479)
                      |.||| ++||+||||||+|||++.+|                    .+||+|||+|+....    ...+||+.|||||++
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLF  249 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGG
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhh
Confidence            99999 99999999999999999887                    999999999987653    245899999999999


Q ss_pred             cCCCCCccccchhhHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhc-cC--C----CCccCCHHHHHHHHhhhhhchhhhc
Q 011698          322 LGKGHDKAADWWSVGIL-LFEMLTGQPPFTGGNR-QKIQQKIIKD-KI--K----LPAFLSSEAHSLLKGLLQKEASKRL  392 (479)
Q Consensus       322 ~~~~~~~~~DiwSLGvi-lyelltG~~Pf~~~~~-~~~~~~i~~~-~~--~----~p~~~s~~~~~lI~~~L~~dP~~R~  392 (479)
                      .+.. +.++||||||++ .+++++|..||.+... ..+...+... ..  .    .+..+++++++||++||++|     
T Consensus       250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----  323 (336)
T 2vuw_A          250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----  323 (336)
T ss_dssp             CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----
T ss_pred             cCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----
Confidence            9876 899999998777 7889999999954221 2233333322 11  1    12357899999999999965     


Q ss_pred             CCCCCCHHHHH-hCcccc
Q 011698          393 GSGPGGSQEIK-SHKWFK  409 (479)
Q Consensus       393 ~~~~~t~~eil-~hp~f~  409 (479)
                           |++|++ +||||+
T Consensus       324 -----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 -----SATDLLCQHSLFK  336 (336)
T ss_dssp             -----SHHHHHHHCGGGC
T ss_pred             -----CHHHHHhcCCCcC
Confidence                 799999 999995

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-43  Score=368.66  Aligned_cols=251  Identities=18%  Similarity=0.163  Sum_probs=199.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC-CCe----------ee---
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFI----------VQ---  214 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h-p~I----------v~---  214 (479)
                      ..+|++.+.||+|+||+||+|++..+|+.||||+++..........+.+++|+.+++.++| .+.          +.   
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3568999999999999999999999999999999985433333345668899999999977 221          11   


Q ss_pred             --------EeEEEee-----CCeEEEEEEeccCCcHHHHHHH-------cCCCcHHHHHHHHHHHHHHHHHHHhCCCccC
Q 011698          215 --------LRYSFQT-----KYRLYLVLDFVNGGHLFFQLYR-------QGLFREDLARIYTAEIVSAVSHLHANGIMHR  274 (479)
Q Consensus       215 --------l~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~-------~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHr  274 (479)
                              +...+..     ...++++|+++ +++|.+++..       .+.+++..+..++.||+.||.|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                    1111111     22467777766 5688888742       2346778888899999999999999999999


Q ss_pred             CCCCccEEeCCCCcEEEeecCCccccCCCCCcccccCCCCCcchhHh----------cCCCCCccccchhhHHHHHHHHh
Q 011698          275 DLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV----------LGKGHDKAADWWSVGILLFEMLT  344 (479)
Q Consensus       275 DLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l----------~~~~~~~~~DiwSLGvilyellt  344 (479)
                      ||||+|||++.+|.+||+|||+++.....  ....+| +.|+|||++          .+..++.++|||||||++|||++
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            99999999999999999999999875443  456788 999999999          55568899999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          345 GQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       345 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      |+.||.+.+.......+...    ...++.++.+||.+||+.||++||     ++.++++||||+.+.
T Consensus       313 g~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dP~~Rp-----t~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRL-----LPLQAMETPEYEQLR  371 (413)
T ss_dssp             SSCCCCTTGGGSCSGGGGSS----CCCCCHHHHHHHHHHTCSSGGGSC-----CHHHHTTSHHHHHHH
T ss_pred             CCCCCCCcchhhhHHHHHhh----cccCCHHHHHHHHHHccCChhhCc-----CHHHHHhCHHHHHHH
Confidence            99999887655444444332    235789999999999999999999     899999999999874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=9.4e-41  Score=329.95  Aligned_cols=224  Identities=13%  Similarity=0.153  Sum_probs=188.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            34478999999999999999999999999999999998766555556677889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~  306 (479)
                      +||||++|++|.+++.+ +. ....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|           
T Consensus       108 lv~e~~~g~~L~~~l~~-~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT-SP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTT-CC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             EEEEecCCCCHHHHHhc-CC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            99999999999999854 33 555678899999999999999999999999999999999999998443           


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHH---HHHHhccCC----CCccCCHHHHHH
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ---QKIIKDKIK----LPAFLSSEAHSL  379 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~---~~i~~~~~~----~p~~~s~~~~~l  379 (479)
                              |++       .++.++|||||||++|||+||+.||.+.+.....   .++..+...    ++..++.++.+|
T Consensus       175 --------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  239 (286)
T 3uqc_A          175 --------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV  239 (286)
T ss_dssp             --------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHH
T ss_pred             --------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHH
Confidence                    333       3789999999999999999999999876543211   011122221    235689999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      |.+||++||.+|      ++.|+++
T Consensus       240 i~~~l~~dP~~R------s~~el~~  258 (286)
T 3uqc_A          240 AARSVQGDGGIR------SASTLLN  258 (286)
T ss_dssp             HHHHHCTTSSCC------CHHHHHH
T ss_pred             HHHHcccCCccC------CHHHHHH
Confidence            999999999999      4777765

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-41  Score=374.56  Aligned_cols=243  Identities=24%  Similarity=0.314  Sum_probs=201.7

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcC-CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe--
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIG-TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR--  224 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~--  224 (479)
                      ..++|++++.||+|+||+||+|.+.. +++.||||++....  .......+.+|+.+|++++||||+++++++.....  
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            34789999999999999999999976 78999999987542  33445667899999999999999999999987665  


Q ss_pred             ---EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          225 ---LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       225 ---~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                         .|+||||++|++|...+..  .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++...
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence               7999999999999887654  78999999999999999999999999999999999999875 99999999998765


Q ss_pred             CCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHH
Q 011698          302 ENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK  381 (479)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~  381 (479)
                      ..   ...+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.....+.      ........+..+.+||.
T Consensus       233 ~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~  302 (681)
T 2pzi_A          233 SF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------EDDPVLKTYDSYGRLLR  302 (681)
T ss_dssp             CC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------TTCHHHHHCHHHHHHHH
T ss_pred             cC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc------ccccccccCHHHHHHHh
Confidence            43   456899999999999876 489999999999999999999998752211000      00000124678999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      +||++||.+||     +..+.+.|+|+.-
T Consensus       303 ~~l~~dP~~R~-----~~~~~l~~~l~~~  326 (681)
T 2pzi_A          303 RAIDPDPRQRF-----TTAEEMSAQLTGV  326 (681)
T ss_dssp             HHTCSSGGGSC-----SSHHHHHHHHHHH
T ss_pred             hhccCChhhCC-----CHHHHHHHHHHHH
Confidence            99999999999     6778888888754

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.3e-35  Score=320.27  Aligned_cols=189  Identities=17%  Similarity=0.160  Sum_probs=141.0

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhh-------chHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeCCeEEE
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-------MEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++.|++|.+..++....|+.||+|++.++..       ..+...+.+.+|+++|+++ .|+||++++++++++..+||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            456788888888888888899999999986421       1234456789999999999 69999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCc
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRS  306 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~  306 (479)
                      ||||++|++|.+.+.+.+.+++.   .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+..... ...
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            99999999999999999998875   47899999999999999999999999999999999999999999876543 445


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCC
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPP  348 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~P  348 (479)
                      .+.+||+.|||||++.+. +..++|+||+|+++|+|.++..+
T Consensus       397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             cCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            678999999999999875 67789999999999888766444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.6e-29  Score=271.14  Aligned_cols=186  Identities=19%  Similarity=0.168  Sum_probs=148.3

Q ss_pred             EEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhh-----chHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-----MEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       153 ~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ...+.||+|+||+||+|++  .++.+|+|+......     ......+.+.+|+.+|++++||||+++..++......|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            3456899999999999954  567789998654322     222235568899999999999999966666667778899


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC--
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR--  305 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~--  305 (479)
                      ||||++|++|.+++.+        +..++.||+.||.|||++||+||||||+|||++.  ++||+|||+++.......  
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            9999999999988875        5678999999999999999999999999999998  999999999998754322  


Q ss_pred             ------cccccCCCCCcchhHhcC--CCCCccccchhhHHHHHHHHhCCCCCC
Q 011698          306 ------SNSMCGTLEYMSPEIVLG--KGHDKAADWWSVGILLFEMLTGQPPFT  350 (479)
Q Consensus       306 ------~~~~~gt~~y~APE~l~~--~~~~~~~DiwSLGvilyelltG~~Pf~  350 (479)
                            ..+.+||+.|||||++.+  ..|+..+|+||..+-..+.+.++.+|.
T Consensus       487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                  246789999999999987  678889999999999988888777763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2.5e-26  Score=226.42  Aligned_cols=159  Identities=17%  Similarity=0.169  Sum_probs=124.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH---------------HHHHHHHHHHHHHHhCCCCCeeeE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---------------NHAEYMKSERNILTKVDHPFIVQL  215 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~---------------~~~~~~~~E~~iL~~l~hp~Iv~l  215 (479)
                      .|++.+.||+|+||.||+|++ .+|+.||+|+++.......               .....+.+|+.+|++++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            355669999999999999999 8899999999975332111               23556889999999999  4 566


Q ss_pred             eEEEeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecC
Q 011698          216 RYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFG  295 (479)
Q Consensus       216 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFG  295 (479)
                      .+++.. +..|+||||++||+|.. +      .......++.||+.||.|||++||+||||||+|||++ +|.+||+|||
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence            665544 55699999999999976 3      1234557999999999999999999999999999999 9999999999


Q ss_pred             CccccCCCCCcccccCCCCCcchhHhcC----------CCCCccccchh
Q 011698          296 LAKQFDENTRSNSMCGTLEYMSPEIVLG----------KGHDKAADWWS  334 (479)
Q Consensus       296 la~~~~~~~~~~~~~gt~~y~APE~l~~----------~~~~~~~DiwS  334 (479)
                      +|+.            +..|+|||.+..          +.|+..+|+|.
T Consensus       238 ~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          238 QSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             TCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             CCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            9964            345899999864          33455556654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=1e-21  Score=190.72  Aligned_cols=140  Identities=19%  Similarity=0.186  Sum_probs=109.4

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeE--EEEEEeehhhhc---------------------hHHHHHHHHHHHHHHHhCC
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEI--YAMKVMRKDKIM---------------------EKNHAEYMKSERNILTKVD  208 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~--vAiK~i~~~~~~---------------------~~~~~~~~~~E~~iL~~l~  208 (479)
                      |++.+.||+|+||.||+|.+..+|+.  ||||+++.....                     .......+.+|+.+|+++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999999778888  999997653211                     0112245788999999998


Q ss_pred             CCCe--eeEeEEEeeCCeEEEEEEeccC-C----cHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCcc
Q 011698          209 HPFI--VQLRYSFQTKYRLYLVLDFVNG-G----HLFFQLYRQGLFREDLARIYTAEIVSAVSHLH-ANGIMHRDLKPEN  280 (479)
Q Consensus       209 hp~I--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH-~~~IiHrDLKpeN  280 (479)
                      |++|  +.++..    ...++||||+.+ |    +|.+....   .++..+..++.||+.||.||| +.||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            8754  334332    356899999942 3    66554332   235567889999999999999 9999999999999


Q ss_pred             EEeCCCCcEEEeecCCcccc
Q 011698          281 ILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       281 ILl~~~g~vkL~DFGla~~~  300 (479)
                      ||++.  .++|+|||+|...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99987  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=6.2e-18  Score=172.62  Aligned_cols=140  Identities=14%  Similarity=0.164  Sum_probs=101.6

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc---------------hHHH----HHHHHHHHHHHHhCCCCCe
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---------------EKNH----AEYMKSERNILTKVDHPFI  212 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~---------------~~~~----~~~~~~E~~iL~~l~hp~I  212 (479)
                      |++.+.||.|+||.||+|.+. +|+.||||+++.....               ..+.    .-...+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999985 6899999998643210               0011    1123457777777755444


Q ss_pred             eeEeEEEeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC-----
Q 011698          213 VQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-----  287 (479)
Q Consensus       213 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g-----  287 (479)
                      .... .+... ..+|||||++|+.|..+.      ..+.+..++.||+.+|.+||+.|||||||||.|||++.+|     
T Consensus       176 ~vp~-p~~~~-~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPE-PIAQS-RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCC-EEEEE-TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCe-eeecc-CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            2211 11111 237999999998885322      2234566889999999999999999999999999998877     


Q ss_pred             -----cEEEeecCCcccc
Q 011698          288 -----HVMLTDFGLAKQF  300 (479)
Q Consensus       288 -----~vkL~DFGla~~~  300 (479)
                           .+.|+||+-+...
T Consensus       248 ~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TSEEEEEEECCCTTCEET
T ss_pred             cccccceEEEEeCCcccC
Confidence                 4899999988654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.40  E-value=1.2e-12  Score=126.16  Aligned_cols=141  Identities=14%  Similarity=0.099  Sum_probs=111.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ++.|++...+|.|+.+.||++...  +..+++|+........   ...+.+|+.+|+.+. +..+.++++++...+..|+
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            457999999999999999999753  5789999987532111   224788999999884 6778889999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA---------------------------------------  268 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~---------------------------------------  268 (479)
                      ||||++|.+|...+.     +......++.+++.+|..||+                                       
T Consensus        88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999999865421     122334677889999999998                                       


Q ss_pred             --------------------CCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          269 --------------------NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       269 --------------------~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                                          ..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                3489999999999998766667999998853

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.28  E-value=7.1e-12  Score=119.67  Aligned_cols=136  Identities=15%  Similarity=0.116  Sum_probs=99.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCC--eeeEeEEEeeCCeEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF--IVQLRYSFQTKYRLY  226 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~~~~~~~~~  226 (479)
                      +.++.+....+.|..+.||++.. .+|..+++|+.....      ...+.+|+.+++.+.+.+  +.+++++....+..+
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence            34566655445667799999965 456779999976531      134678899998885434  566888888888899


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG------------------------------------  270 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~------------------------------------  270 (479)
                      +||||++|.+|.  .   ....   ...++.+++..|..||+..                                    
T Consensus        92 ~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           92 LLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             EEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999999998883  1   1111   1245667777777777643                                    


Q ss_pred             ----------------------CccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          271 ----------------------IMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       271 ----------------------IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                                            ++|+|++|.|||++.++.+.|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                  99999999999998776677999999854

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.14  E-value=1.1e-10  Score=117.74  Aligned_cols=140  Identities=15%  Similarity=0.287  Sum_probs=104.4

Q ss_pred             EEEEeccCCceEEEEEEEcCCCeEEEEEEee--hhhhchHHHHHHHHHHHHHHHhCC--CCCeeeEeEEEeeC---CeEE
Q 011698          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMR--KDKIMEKNHAEYMKSERNILTKVD--HPFIVQLRYSFQTK---YRLY  226 (479)
Q Consensus       154 ~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~--~~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~---~~~~  226 (479)
                      .++.|+.|.++.||++...  +..+++|+..  .....  .....+.+|..+++.+.  +..+++++.++.+.   +..|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            4678999999999998864  3568889876  33211  12345778999999986  44578888888776   4589


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA--------------------------------------  268 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~--------------------------------------  268 (479)
                      +||||++|..+.+.  ....+++.....++.+++.+|..||+                                      
T Consensus       118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99999999876321  11235677788889999999999997                                      


Q ss_pred             --------------------CCCccCCCCCccEEeCCCCc--EEEeecCCccc
Q 011698          269 --------------------NGIMHRDLKPENILLDADGH--VMLTDFGLAKQ  299 (479)
Q Consensus       269 --------------------~~IiHrDLKpeNILl~~~g~--vkL~DFGla~~  299 (479)
                                          ..++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                35899999999999997763  68999999864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.09  E-value=8.5e-11  Score=115.96  Aligned_cols=180  Identities=17%  Similarity=0.264  Sum_probs=120.3

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCC--eeeEeEEEeeCC---eEEEEE
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPF--IVQLRYSFQTKY---RLYLVL  229 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~--Iv~l~~~~~~~~---~~~lV~  229 (479)
                      +.++.|....||++.     ..+++|+....     .....+.+|..+|+.+ .+..  +.+++.......   ..|+||
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            458999999999864     34899986533     2345688899999887 3332  344555444333   358899


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA-----------------------------------------  268 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-----------------------------------------  268 (479)
                      ++++|..|.....  ..++.+....++.+++..|..||+                                         
T Consensus        96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9999988864332  235666677778888888888885                                         


Q ss_pred             -----------------CCCccCCCCCccEEeCC--CCcEEEeecCCccccCCCCCcccccCCCCC---cchhHhcC--C
Q 011698          269 -----------------NGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTRSNSMCGTLEY---MSPEIVLG--K  324 (479)
Q Consensus       269 -----------------~~IiHrDLKpeNILl~~--~g~vkL~DFGla~~~~~~~~~~~~~gt~~y---~APE~l~~--~  324 (479)
                                       ..++|+|+++.|||++.  ++.+.|+||+.+.......   .......+   ..|+....  .
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhccccCHHHHHHHHH
Confidence                             13699999999999988  4568899999987532211   00011111   23333221  0


Q ss_pred             CC------------CccccchhhHHHHHHHHhCCCCCC
Q 011698          325 GH------------DKAADWWSVGILLFEMLTGQPPFT  350 (479)
Q Consensus       325 ~~------------~~~~DiwSLGvilyelltG~~Pf~  350 (479)
                      .|            ....++|++|.++|.+.+|..+|.
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            11            123689999999999999988773

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.57  E-value=8.3e-07  Score=87.55  Aligned_cols=133  Identities=18%  Similarity=0.207  Sum_probs=89.7

Q ss_pred             EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCC---CeeeEeEEEe-eCCeEEEEEE
Q 011698          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP---FIVQLRYSFQ-TKYRLYLVLD  230 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp---~Iv~l~~~~~-~~~~~~lV~E  230 (479)
                      ++.++.|....||+.     +..+++|+-...     .....+.+|..+|+.+.+.   .+.+++.+.. ..+..|+|||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            456789999999988     355889985322     2345688999999998642   2556666653 4556789999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-----------------------------------------  269 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-----------------------------------------  269 (479)
                      |++|..+.....  ..++......++.++...|..||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988765321  1223333333444444444444432                                         


Q ss_pred             -------------------CCccCCCCCccEEeCC---CCc-EEEeecCCccc
Q 011698          270 -------------------GIMHRDLKPENILLDA---DGH-VMLTDFGLAKQ  299 (479)
Q Consensus       270 -------------------~IiHrDLKpeNILl~~---~g~-vkL~DFGla~~  299 (479)
                                         .++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                               4699999999999987   455 48999998865

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.55  E-value=1.3e-06  Score=83.81  Aligned_cols=133  Identities=15%  Similarity=0.134  Sum_probs=93.6

Q ss_pred             EeccCCce-EEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEEEEEEeccC
Q 011698          157 VVGQGAFA-KVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYLVLDFVNG  234 (479)
Q Consensus       157 ~LG~G~fG-~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~lV~E~~~g  234 (479)
                      .+..|..| .||+......+..+.+|+-...      ....+.+|..+|+.+. +--+.+++.++.+.+..|+|||+++|
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G  104 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG  104 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence            34445554 7999888777778999986543      2345778999998874 22367788888999999999999999


Q ss_pred             CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 011698          235 GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN---------------------------------------------  269 (479)
Q Consensus       235 gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---------------------------------------------  269 (479)
                      .++........    .....+..++...|.-||+.                                             
T Consensus       105 ~~~~~~~~~~~----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          105 KTAFQVLEEYP----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             EEHHHHHHHCG----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             ccccccccCCH----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            88766543321    11222344444444444421                                             


Q ss_pred             -------------CCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          270 -------------GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       270 -------------~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                                   .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                         268999999999998877778999999854

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.35  E-value=9.1e-07  Score=90.24  Aligned_cols=80  Identities=13%  Similarity=0.157  Sum_probs=50.0

Q ss_pred             EEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhh-chH---HHHHHHHHHHHHHHhCCC--CC-eeeEeEEEeeCCeEE
Q 011698          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKI-MEK---NHAEYMKSERNILTKVDH--PF-IVQLRYSFQTKYRLY  226 (479)
Q Consensus       154 ~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~-~~~---~~~~~~~~E~~iL~~l~h--p~-Iv~l~~~~~~~~~~~  226 (479)
                      .++.||.|..+.||++....+++.+++|....... ...   ...+.+..|..+|+.+..  +. +.+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            35789999999999997665677899998653211 000   112345678888887732  33 4455543  345568


Q ss_pred             EEEEeccCC
Q 011698          227 LVLDFVNGG  235 (479)
Q Consensus       227 lV~E~~~gg  235 (479)
                      +|||+++|.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999874

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.16  E-value=2.3e-05  Score=77.31  Aligned_cols=137  Identities=13%  Similarity=0.142  Sum_probs=78.2

Q ss_pred             EEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-----CCCCeeeEe-E--EEeeCCeE
Q 011698          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-----DHPFIVQLR-Y--SFQTKYRL  225 (479)
Q Consensus       154 ~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~-~--~~~~~~~~  225 (479)
                      -++.|+.|..+.||++... +| .+++|+.....       ..+..|..+++.+     ..|.++... +  +....+..
T Consensus        36 ~~~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~  106 (346)
T 2q83_A           36 KIDVIQGNQMALVWKVHTD-SG-AVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL  106 (346)
T ss_dssp             EEEECC----CEEEEEEET-TE-EEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred             EeeeccccccCcEEEEEeC-CC-CEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence            3456777889999999863 33 48999987521       1223344444443     234444310 0  12346778


Q ss_pred             EEEEEeccCCcHH--------------HHHHHc-CCC--c-----------HH--------H------------------
Q 011698          226 YLVLDFVNGGHLF--------------FQLYRQ-GLF--R-----------ED--------L------------------  251 (479)
Q Consensus       226 ~lV~E~~~ggsL~--------------~~l~~~-~~l--~-----------e~--------~------------------  251 (479)
                      +++|+|++|..+.              ..++.. ..+  +           ..        .                  
T Consensus       107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  186 (346)
T 2q83_A          107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ  186 (346)
T ss_dssp             EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred             EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence            9999999986431              112211 101  0           00        0                  


Q ss_pred             -----HHHHHHHHHHHHHHHH-------------hCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          252 -----ARIYTAEIVSAVSHLH-------------ANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       252 -----~~~~~~qi~~aL~~LH-------------~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                           +..+..++..++.+|+             ...++|+|+++.|||++.++.+.|+||+.+..
T Consensus       187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence                 1111222334566665             35799999999999998888999999998853

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.14  E-value=3.7e-06  Score=84.24  Aligned_cols=86  Identities=12%  Similarity=0.088  Sum_probs=55.6

Q ss_pred             eEEEEEe-ccCCceEEEEEEEc--C----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-C--CCeeeEeEEEee
Q 011698          152 FEVLKVV-GQGAFAKVYQVRRI--G----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-H--PFIVQLRYSFQT  221 (479)
Q Consensus       152 y~~~~~L-G~G~fG~V~~a~~~--~----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-h--p~Iv~l~~~~~~  221 (479)
                      ...++.| +.|....+|++...  .    ++..+++|+..............+.+|..+|+.+. +  -.+.+++.+..+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3456788 89999999998763  1    15678999865432000000123567888888774 2  346677777665


Q ss_pred             C---CeEEEEEEeccCCcH
Q 011698          222 K---YRLYLVLDFVNGGHL  237 (479)
Q Consensus       222 ~---~~~~lV~E~~~ggsL  237 (479)
                      .   +..|+||||++|..+
T Consensus       102 ~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             STTTSSCEEEEECCCCBCC
T ss_pred             CCccCCceEEEEecCCCCh
Confidence            5   356899999998654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.78  E-value=0.00023  Score=70.28  Aligned_cols=76  Identities=9%  Similarity=0.115  Sum_probs=59.6

Q ss_pred             EEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC---CCCeeeEeEEEeeCCeEEEEEE
Q 011698          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD---HPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       154 ~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      -++.|+.|....+|+...  ++..+++|+....      ....+..|...|+.+.   ...+++++.+....+..++|||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            467899999999999875  4567889987643      1455788988888773   3567888888888889999999


Q ss_pred             eccCCcH
Q 011698          231 FVNGGHL  237 (479)
Q Consensus       231 ~~~ggsL  237 (479)
                      |++|..+
T Consensus       112 ~l~G~~~  118 (312)
T 3jr1_A          112 ALNKSKN  118 (312)
T ss_dssp             CCCCCCC
T ss_pred             eccCCCC
Confidence            9998753

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.77  E-value=0.00011  Score=75.38  Aligned_cols=78  Identities=10%  Similarity=0.115  Sum_probs=47.1

Q ss_pred             HhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccccC--CCCCcchhHhcCCC---CCccccchhhHHHHHH
Q 011698          267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCG--TLEYMSPEIVLGKG---HDKAADWWSVGILLFE  341 (479)
Q Consensus       267 H~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~g--t~~y~APE~l~~~~---~~~~~DiwSLGvilye  341 (479)
                      +...++|+|+++.|||++.++ ++|+||+.+..-..........+  ...|++|+......   .....++.++...+|+
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            456799999999999998777 99999999865321100000110  12355655543211   1123444577777887


Q ss_pred             HHhC
Q 011698          342 MLTG  345 (479)
Q Consensus       342 lltG  345 (479)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.54  E-value=0.0002  Score=69.85  Aligned_cols=132  Identities=14%  Similarity=0.070  Sum_probs=73.3

Q ss_pred             EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCe-eeEeEEEeeCCeEEEEEEec-
Q 011698          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRLYLVLDFV-  232 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~~~~~~~~~lV~E~~-  232 (479)
                      ++.|+.|....+|++      ..+++|+.......    .....+|..+++.+....+ .++++..  ...-++|+||+ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence            678999999999998      34899987653110    1112457777776632222 4555543  33346899999 


Q ss_pred             cCCcHHH------------------HHHHcCC-Cc-----HHHHHHHHHH--------------HHHHHHH----HHh--
Q 011698          233 NGGHLFF------------------QLYRQGL-FR-----EDLARIYTAE--------------IVSAVSH----LHA--  268 (479)
Q Consensus       233 ~ggsL~~------------------~l~~~~~-l~-----e~~~~~~~~q--------------i~~aL~~----LH~--  268 (479)
                      +|..+..                  .++..+. +.     ...+..+...              +...+..    +..  
T Consensus        91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~  170 (301)
T 3dxq_A           91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP  170 (301)
T ss_dssp             TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence            6654421                  0111110 10     1111111111              1111111    111  


Q ss_pred             --CCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          269 --NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       269 --~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                        ..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence              24799999999999 5677889999998864

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.46  E-value=0.00052  Score=67.29  Aligned_cols=142  Identities=16%  Similarity=0.136  Sum_probs=79.5

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCC--eeeEeEE------EeeC
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF--IVQLRYS------FQTK  222 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~------~~~~  222 (479)
                      ...-++.|+.|....+|++...+ | .+++|+.....     ..+.+..|..+++.+....  +.+++..      ....
T Consensus        23 ~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~   95 (322)
T 2ppq_A           23 SLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS   95 (322)
T ss_dssp             CEEEEEEECC---EEEEEEEESS-C-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred             cceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence            44557788899999999998643 3 58899987521     1123455676666653111  2333321      1234


Q ss_pred             CeEEEEEEeccCCcHH--------------HHHHHc-CCC--------cHHHHHH---------------HHHHHHHHHH
Q 011698          223 YRLYLVLDFVNGGHLF--------------FQLYRQ-GLF--------REDLARI---------------YTAEIVSAVS  264 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~--------------~~l~~~-~~l--------~e~~~~~---------------~~~qi~~aL~  264 (479)
                      +..+++|+|++|..+.              ..++.. ..+        ....-..               +...+...+.
T Consensus        96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~  175 (322)
T 2ppq_A           96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID  175 (322)
T ss_dssp             TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred             CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence            6679999999986431              112211 000        1000000               0112334455


Q ss_pred             HHHh-------CCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          265 HLHA-------NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       265 ~LH~-------~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      .+..       .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus       176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            5542       3689999999999998776668999998853

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.26  E-value=0.0018  Score=60.18  Aligned_cols=121  Identities=16%  Similarity=0.076  Sum_probs=81.8

Q ss_pred             cHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcccccCCC
Q 011698          236 HLFFQLYR-QGLFREDLARIYTAEIVSAVSHL-HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTL  313 (479)
Q Consensus       236 sL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~L-H~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~gt~  313 (479)
                      +|.+.|.. ..+++|+++|.++.|.+.+|.-+ +.+.-..+=+.|..|++..+|.|-+.+ +.+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            78888864 56899999999999999998776 222222344567999999999998774 1111           1123


Q ss_pred             CCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhh
Q 011698          314 EYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       314 ~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~  386 (479)
                      .+.|||... ...+.+.=|||||+++|..+-=..|=                 .-+..+|+++.+||..|.+-
T Consensus       102 ~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          102 PPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             -----CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred             CCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence            456777653 34567888999999999988622221                 12456899999999999866

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.24  E-value=0.0017  Score=63.68  Aligned_cols=136  Identities=18%  Similarity=0.175  Sum_probs=76.8

Q ss_pred             EEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCC--CeeeEeEE-----EeeCCeEEEE
Q 011698          156 KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP--FIVQLRYS-----FQTKYRLYLV  228 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~-----~~~~~~~~lV  228 (479)
                      ..|+ |....||++... +|+.+++|+.+.....    ...+..|..+++.+...  .+++++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4566 888899987653 4557999998743211    23355677777766321  13444432     2234567889


Q ss_pred             EEeccCCcHH-----------HH---HHHc---C------CCcHHHH----HH------------------HHHHHHHHH
Q 011698          229 LDFVNGGHLF-----------FQ---LYRQ---G------LFREDLA----RI------------------YTAEIVSAV  263 (479)
Q Consensus       229 ~E~~~ggsL~-----------~~---l~~~---~------~l~e~~~----~~------------------~~~qi~~aL  263 (479)
                      |+|++|..+.           ..   ++..   .      .++....    +.                  .+.+++..+
T Consensus       106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l  185 (328)
T 1zyl_A          106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  185 (328)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence            9999985421           01   1110   0      1111100    00                  111122222


Q ss_pred             HHH----HhCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          264 SHL----HANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       264 ~~L----H~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      .-+    ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            211    234589999999999998 4 899999998854

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.21  E-value=0.001  Score=68.50  Aligned_cols=74  Identities=11%  Similarity=0.094  Sum_probs=49.4

Q ss_pred             EEEEeccCCceEEEEEEEcC-------CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeE
Q 011698          154 VLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       154 ~~~~LG~G~fG~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~  225 (479)
                      -++.|+.|....||++....       .+..+++|+.....  .   .+.+.+|..+++.+. +....++++.+.+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence            35778899999999998753       25679999884321  1   122346888888774 3333667766543    


Q ss_pred             EEEEEeccCCc
Q 011698          226 YLVLDFVNGGH  236 (479)
Q Consensus       226 ~lV~E~~~ggs  236 (479)
                      .+|+||++|..
T Consensus       148 g~v~e~l~G~~  158 (429)
T 1nw1_A          148 GRLEEYIPSRP  158 (429)
T ss_dssp             EEEECCCCEEE
T ss_pred             CEEEEEeCCcc
Confidence            28999998743

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.15  E-value=0.0011  Score=65.43  Aligned_cols=31  Identities=32%  Similarity=0.419  Sum_probs=27.4

Q ss_pred             CCCccCCCCCccEEeCCC----CcEEEeecCCccc
Q 011698          269 NGIMHRDLKPENILLDAD----GHVMLTDFGLAKQ  299 (479)
Q Consensus       269 ~~IiHrDLKpeNILl~~~----g~vkL~DFGla~~  299 (479)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            469999999999999875    7899999999865

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.10  E-value=0.00068  Score=68.81  Aligned_cols=136  Identities=15%  Similarity=0.132  Sum_probs=80.3

Q ss_pred             EEeccCCceEEEEEEEcC-------CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEEE
Q 011698          156 KVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~l  227 (479)
                      +.|..|-...+|++....       +++.|.+|+.....    .....+.+|..+++.+. +.-..++++.+.+    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            567778888899988642       34679999864321    11234557888888774 3334667776654    28


Q ss_pred             EEEeccCCcHH--------------HH---HHHcC-----CC--cHHHHHHHHHHHHH-------------------HHH
Q 011698          228 VLDFVNGGHLF--------------FQ---LYRQG-----LF--REDLARIYTAEIVS-------------------AVS  264 (479)
Q Consensus       228 V~E~~~ggsL~--------------~~---l~~~~-----~l--~e~~~~~~~~qi~~-------------------aL~  264 (479)
                      ||||++|..|.              ..   ++...     ..  -...+..|..++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            99999986431              11   11111     11  13445555544321                   223


Q ss_pred             HHH----hC----CCccCCCCCccEEeCCC----CcEEEeecCCccc
Q 011698          265 HLH----AN----GIMHRDLKPENILLDAD----GHVMLTDFGLAKQ  299 (479)
Q Consensus       265 ~LH----~~----~IiHrDLKpeNILl~~~----g~vkL~DFGla~~  299 (479)
                      .|.    ..    .++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            332    22    58999999999999876    7899999999853

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.01  E-value=0.0014  Score=65.76  Aligned_cols=75  Identities=13%  Similarity=0.066  Sum_probs=44.3

Q ss_pred             EEEEeccCCceEEEEEEEcC--------CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCC-eeeEeEEEeeCCe
Q 011698          154 VLKVVGQGAFAKVYQVRRIG--------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTKYR  224 (479)
Q Consensus       154 ~~~~LG~G~fG~V~~a~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~~~~~~~  224 (479)
                      -++.|+.|....+|++....        .+..+++|+.......    ......|..+++.+...+ +.++++.+  .  
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--  108 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--N--  108 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--C--
Confidence            35678889899999998753        1257899987643211    111356777777774223 44666554  2  


Q ss_pred             EEEEEEeccCCc
Q 011698          225 LYLVLDFVNGGH  236 (479)
Q Consensus       225 ~~lV~E~~~ggs  236 (479)
                      -++||||++|..
T Consensus       109 ~~~v~e~i~G~~  120 (369)
T 3c5i_A          109 GGRIEEWLYGDP  120 (369)
T ss_dssp             TEEEEECCCSEE
T ss_pred             CcEEEEEecCCc
Confidence            268999999853

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.00  E-value=0.011  Score=56.89  Aligned_cols=78  Identities=13%  Similarity=0.086  Sum_probs=54.1

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC---CCeeeEeEEEeeCCeEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH---PFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h---p~Iv~l~~~~~~~~~~~l  227 (479)
                      ...-++.+|.|..+.||+++.. +|+.|.+|+-......   ....+..|...|+.+.-   --+++++...    .-++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence            4667889999999999999874 6788999986543211   12346789998888742   1244454432    2378


Q ss_pred             EEEeccCCc
Q 011698          228 VLDFVNGGH  236 (479)
Q Consensus       228 V~E~~~ggs  236 (479)
                      ||||+.++.
T Consensus        88 v~e~l~~~~   96 (288)
T 3f7w_A           88 AMEWVDERP   96 (288)
T ss_dssp             EEECCCCCC
T ss_pred             EEEeecccC
Confidence            999998764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.00  E-value=0.0045  Score=61.48  Aligned_cols=31  Identities=16%  Similarity=0.354  Sum_probs=27.7

Q ss_pred             CCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       269 ~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      ..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3689999999999999888999999988764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.67  E-value=0.016  Score=60.15  Aligned_cols=76  Identities=14%  Similarity=0.211  Sum_probs=49.3

Q ss_pred             EEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCe-eeEeEEEeeCCeEEEEEEec
Q 011698          154 VLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-VQLRYSFQTKYRLYLVLDFV  232 (479)
Q Consensus       154 ~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~~~~~~~~~lV~E~~  232 (479)
                      -++.|+.|-...+|++.....+..|++|+...... .  .. ...+|..+++.+...++ .++++.+.  +  .+||||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~--~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-E--II-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-S--CS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-h--hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence            45688899999999998865457899998754210 0  00 12578888888864444 56777763  2  2599999


Q ss_pred             cCCcH
Q 011698          233 NGGHL  237 (479)
Q Consensus       233 ~ggsL  237 (479)
                      +|..|
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.87  E-value=0.022  Score=58.53  Aligned_cols=75  Identities=12%  Similarity=0.138  Sum_probs=48.3

Q ss_pred             EEEEeccCCceEEEEEEEcCC-------CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeE
Q 011698          154 VLKVVGQGAFAKVYQVRRIGT-------SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       154 ~~~~LG~G~fG~V~~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~  225 (479)
                      -++.|..|-...+|++.....       +..|++|+.....   . ..-...+|..+++.+. +.-..++++.+.    -
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---G-KFYDSKVELDVFRYLSNINIAPNIIADFP----E  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---c-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence            456777888899999987531       5679999865421   0 0111356888887774 333455665442    2


Q ss_pred             EEEEEeccCCc
Q 011698          226 YLVLDFVNGGH  236 (479)
Q Consensus       226 ~lV~E~~~ggs  236 (479)
                      ++||||++|..
T Consensus       146 ~~I~efI~G~~  156 (424)
T 3mes_A          146 GRIEEFIDGEP  156 (424)
T ss_dssp             EEEEECCCSEE
T ss_pred             CEEEEEeCCcc
Confidence            68999999865

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.60  E-value=0.26  Score=49.87  Aligned_cols=29  Identities=34%  Similarity=0.531  Sum_probs=25.1

Q ss_pred             CccCCCCCccEEe------CCCCcEEEeecCCccc
Q 011698          271 IMHRDLKPENILL------DADGHVMLTDFGLAKQ  299 (479)
Q Consensus       271 IiHrDLKpeNILl------~~~g~vkL~DFGla~~  299 (479)
                      ++|+|+.+.|||+      +.++.+.++||-.|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      4567899999998853

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.16  E-value=0.16  Score=52.58  Aligned_cols=57  Identities=4%  Similarity=-0.016  Sum_probs=13.8

Q ss_pred             ceEEEEEEEcCCCeEEEE------EEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe
Q 011698          163 FAKVYQVRRIGTSEIYAM------KVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ  220 (479)
Q Consensus       163 fG~V~~a~~~~~~~~vAi------K~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~  220 (479)
                      ||.||+|.+......||+      |..+.... ..+....+.+|..+++.++|||+++.+.+-.
T Consensus       152 fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          152 YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred             chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence            999999999776667888      66654332 2333445667888899999999999876653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	479
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-108
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-104
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-100
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-99
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-98
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-96
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-93
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-87
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-86
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-83
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-83
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-83
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-82
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-82
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-81
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-81
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-80
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-80
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-80
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-78
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-75
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-72
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-71
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-70
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-69
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-68
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-67
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-66
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-66
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-66
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-66
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-65
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-64
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-64
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-63
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-63
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-63
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-61
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-61
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-61
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-60
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-60
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-60
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-59
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-57
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-57
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-56
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-55
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-55
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-52
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-47
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-43
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-20

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  321 bits (824), Expect = e-108
 Identities = 123/333 (36%), Positives = 203/333 (60%), Gaps = 11/333 (3%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           V + DF+ LK++G+G F KV  VR   T   YAMK++RK+ I+ K+   +  +E  +L  
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
             HPF+  L+Y+FQT  RL  V+++ NGG LFF L R+ +F E+ AR Y AEIVSA+ +L
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKG 325
           H+  +++RD+K EN++LD DGH+ +TDFGL K+   +     + CGT EY++PE++    
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQ 385
           + +A DWW +G++++EM+ G+ PF   + +++ + I+ ++I+ P  LS EA SLL GLL+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241

Query: 386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNM 445
           K+  +RLG GP  ++E+  H++F  INW+ +  ++  P F P+V  +     F++ +T  
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQ 301

Query: 446 PLLDSPVASPKF----------NENPFKGFTYV 468
            +  +P                 +  F+ F Y+
Sbjct: 302 SITITPPDRYDSLGLLELDQREEQEMFEDFDYI 334

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  310 bits (796), Expect = e-104
 Identities = 116/324 (35%), Positives = 191/324 (58%), Gaps = 9/324 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           +EDF + K++G+G+F KV+      T++ +A+K ++KD ++  +  E    E+ +L+   
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           +HPF+  +  +FQTK  L+ V++++NGG L + +     F    A  Y AEI+  +  LH
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQF-DENTRSNSMCGTLEYMSPEIVLGKGH 326
           + GI++RDLK +NILLD DGH+ + DFG+ K+    + ++N+ CGT +Y++PEI+LG+ +
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQK 386
           + + DWWS G+LL+EML GQ PF G + +++   I  D    P +L  EA  LL  L  +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240

Query: 387 EASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMP 446
           E  KRLG       +I+ H  F+ INW++LE +E  P F P+V      +NF++ + N  
Sbjct: 241 EPEKRLGV----RGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEK 296

Query: 447 LLDSPVASPKFN---ENPFKGFTY 467
              S       N   +N F+ F++
Sbjct: 297 PRLSFADRALINSMDQNMFRNFSF 320

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  302 bits (773), Expect = e-100
 Identities = 111/318 (34%), Positives = 195/318 (61%), Gaps = 5/318 (1%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+DF++L+ +G G+F +V+ +R       YAMKV++K+ ++     E+   ER +L+ V 
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HPFI+++  +FQ   ++++++D++ GG LF  L +   F   +A+ Y AE+  A+ +LH+
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             I++RDLKPENILLD +GH+ +TDFG AK   + T   ++CGT +Y++PE+V  K ++K
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVVSTKPYNK 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA 388
           + DWWS GIL++EML G  PF   N  K  +KI+  +++ P F + +   LL  L+ ++ 
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL 240

Query: 389 SKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVA-GKHCVANFEECWTNMPL 447
           S+RLG+   G++++K+H WFK + W+KL +R     + P +  G+   + F++ +    +
Sbjct: 241 SQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDK-YPEEDI 299

Query: 448 LDSPVASPKFNENPFKGF 465
                    + +  F+ F
Sbjct: 300 NYGVQGEDPYAD-LFRDF 316

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  298 bits (763), Expect = 3e-99
 Identities = 112/282 (39%), Positives = 174/282 (61%), Gaps = 6/282 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           EDF+  K++G+G+F+ V   R + TS  YA+K++ K  I+++N   Y+  ER++++++DH
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           PF V+L ++FQ   +LY  L +   G L   + + G F E   R YTAEIVSA+ +LH  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQF---DENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPENILL+ D H+ +TDFG AK      +  R+NS  GT +Y+SPE++  K  
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQK 386
            K++D W++G ++++++ G PPF  GN   I QKIIK +   P     +A  L++ LL  
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247

Query: 387 EASKRLGSG-PGGSQEIKSHKWFKMINWKKLEARETRPSFLP 427
           +A+KRLG     G   +K+H +F+ + W+ L  +   P  L 
Sbjct: 248 DATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT--PPKLT 287

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  297 bits (762), Expect = 4e-98
 Identities = 112/332 (33%), Positives = 185/332 (55%), Gaps = 19/332 (5%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV- 207
           + DF V +++G+G F +VY  R+  T ++YAMK + K +I  K       +ER +L+ V 
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 208 --DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             D PFIV + Y+F T  +L  +LD +NGG L + L + G+F E   R Y AEI+  + H
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL-GK 324
           +H   +++RDLKP NILLD  GHV ++D GLA  F    + ++  GT  YM+PE++  G 
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKGV 181

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKIKLPAFLSSEAHSLLK 381
            +D +ADW+S+G +LF++L G  PF       + +I +  +   ++LP   S E  SLL+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241

Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHC-----VA 436
           GLLQ++ ++RLG    G+QE+K   +F+ ++W+ +  ++  P  +P     +      + 
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIG 301

Query: 437 NFEECWTNMPLLDSPVASPKFNENPFKGFTYV 468
           +F+E  T    L         ++  ++ F   
Sbjct: 302 SFDEEDTKGIKLLDS------DQELYRNFPLT 327

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  293 bits (751), Expect = 1e-96
 Identities = 120/325 (36%), Positives = 196/325 (60%), Gaps = 7/325 (2%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           PS+N    L+ F+ +K +G G+F +V  V+   +   YAMK++ K K+++    E+  +E
Sbjct: 33  PSQNT-AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
           + IL  V+ PF+V+L +SF+    LY+V+++V GG +F  L R G F E  AR Y A+IV
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
               +LH+  +++RDLKPEN+L+D  G++ +TDFG AK+     R+ ++CGT E ++PEI
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEI 209

Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLL 380
           +L KG++KA DWW++G+L++EM  G PPF      +I +KI+  K++ P+  SS+   LL
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269

Query: 381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEE 440
           + LLQ + +KR G+   G  +IK+HKWF   +W  +  R+    F+P+  G    +NF++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDD 329

Query: 441 CWTNMPLLDSPVASPKFNENPFKGF 465
            +    +  S     +     F  F
Sbjct: 330 -YEEEEIRVSI---NEKCGKEFTEF 350

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  281 bits (719), Expect = 4e-93
 Identities = 84/261 (32%), Positives = 147/261 (56%), Gaps = 6/261 (2%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           LEDFE+ + +G+G F  VY  R   +  I A+KV+ K ++ +      ++ E  I + + 
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           HP I++L   F    R+YL+L++   G ++ +L +   F E     Y  E+ +A+S+ H+
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
             ++HRD+KPEN+LL + G + + DFG +     ++R  ++CGTL+Y+ PE++ G+ HD+
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDE 183

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKEA 388
             D WS+G+L +E L G+PPF     Q+  ++I + +   P F++  A  L+  LL+   
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 243

Query: 389 SKRLGSGPGGSQEIKSHKWFK 409
           S+R        +E+  H W  
Sbjct: 244 SQRP-----MLREVLEHPWIT 259

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  268 bits (686), Expect = 2e-87
 Identities = 140/304 (46%), Positives = 205/304 (67%), Gaps = 13/304 (4%)

Query: 139 NLPSENQCVGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHA- 194
           NL    + VG+E+FE+LKV+G GA+ KV+ VR+I    T ++YAMKV++K  I++K    
Sbjct: 13  NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 72

Query: 195 EYMKSERNILTKVDH-PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLAR 253
           E+ ++ER +L  +   PF+V L Y+FQT+ +L+L+LD++NGG LF  L ++  F E   +
Sbjct: 73  EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ 132

Query: 254 IYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD--ENTRSNSMCG 311
           IY  EIV A+ HLH  GI++RD+K ENILLD++GHV+LTDFGL+K+F   E  R+   CG
Sbjct: 133 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 192

Query: 312 TLEYMSPEIVLGK--GHDKAADWWSVGILLFEMLTGQPPFTGGNRQ----KIQQKIIKDK 365
           T+EYM+P+IV G   GHDKA DWWS+G+L++E+LTG  PFT    +    +I ++I+K +
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252

Query: 366 IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSF 425
              P  +S+ A  L++ LL K+  KRLG GP  + EIK H +F+ INW  L A++    F
Sbjct: 253 PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPF 312

Query: 426 LPEV 429
            P +
Sbjct: 313 KPVI 316

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  265 bits (678), Expect = 9e-86
 Identities = 70/286 (24%), Positives = 129/286 (45%), Gaps = 15/286 (5%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ +++ + +G GAF  V++V    T   +A K +      +K   E ++ E   ++ + 
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQTMSVLR 81

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLH 267
           HP +V L  +F+    + ++ +F++GG LF ++  +     ED A  Y  ++   + H+H
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141

Query: 268 ANGIMHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
            N  +H DLKPENI+        + L DFGL    D         GT E+ +PE+  GK 
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 201

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK 381
                D WSVG+L + +L+G  PF G N  +  + +      +     + +S +    ++
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261

Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLP 427
            LL  + + R+        +   H W    N    +++     +  
Sbjct: 262 KLLLADPNTRM-----TIHQALEHPWLTPGNAPGRDSQIPSSRYTK 302

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  259 bits (662), Expect = 1e-83
 Identities = 65/313 (20%), Positives = 132/313 (42%), Gaps = 53/313 (16%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +DFE +  +G G    V++V    +  + A K++  +  ++      +  E  +L + + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH-A 268
           P+IV    +F +   + + ++ ++GG L   L + G   E +    +  ++  +++L   
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDK 328
           + IMHRD+KP NIL+++ G + L DFG++ Q   ++ +NS  GT  YMSPE + G  +  
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTHYSV 182

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAF----------------- 371
            +D WS+G+ L EM  G+ P    + ++++           A                  
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242

Query: 372 ---------------------------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS 404
                                       S E    +   L K  ++R        +++  
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA-----DLKQLMV 297

Query: 405 HKWFKMINWKKLE 417
           H + K  + ++++
Sbjct: 298 HAFIKRSDAEEVD 310

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  257 bits (658), Expect = 1e-83
 Identities = 82/277 (29%), Positives = 138/277 (49%), Gaps = 18/277 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +E++  +G GAF KVY+ +   TS + A KV+       +   E    E +IL   DH
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDH 68

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHA 268
           P IV+L  +F  +  L+++++F  GG +   +   +    E   ++   + + A+++LH 
Sbjct: 69  PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMSPEIVLG---- 323
           N I+HRDLK  NIL   DG + L DFG++ +      R +S  GT  +M+PE+V+     
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSL 379
            + +D  AD WS+GI L EM   +PP    N  ++  KI K +   +  P+  SS     
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248

Query: 380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL 416
           LK  L+K    R       + ++  H +  + + K +
Sbjct: 249 LKKCLEKNVDARW-----TTSQLLQHPFVTVDSNKPI 280

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  255 bits (652), Expect = 7e-83
 Identities = 79/268 (29%), Positives = 140/268 (52%), Gaps = 14/268 (5%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +ED+++++ +G+GA+ +V       T E  A+K++   + ++    E +K E  I   ++
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC--PENIKKEICINKMLN 61

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  +V+     +     YL L++ +GG LF ++       E  A+ +  ++++ V +LH 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS---NSMCGTLEYMSPEIVLGKG 325
            GI HRD+KPEN+LLD   ++ ++DFGLA  F  N R    N MCGTL Y++PE++  + 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 326 -HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSLLK 381
            H +  D WS GI+L  ML G+ P+   +    +    K+K   +     + S   +LL 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241

Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWFK 409
            +L +  S R+        +IK  +W+ 
Sbjct: 242 KILVENPSARI-----TIPDIKKDRWYN 264

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  257 bits (657), Expect = 1e-82
 Identities = 76/278 (27%), Positives = 139/278 (50%), Gaps = 16/278 (5%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
            + +++L+ +G GAF  V++     T  ++  K +     ++K     +K+E +I+ ++ 
Sbjct: 28  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLH 84

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLH 267
           HP ++ L  +F+ KY + L+L+F++GG LF ++  +     E     Y  +    + H+H
Sbjct: 85  HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144

Query: 268 ANGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
            + I+H D+KPENI+ +      V + DFGLA + + +        T E+ +PEIV  + 
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 204

Query: 326 HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK 381
                D W++G+L + +L+G  PF G +  +  Q + +   +      + +S EA   +K
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264

Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEAR 419
            LLQKE  KRL        +   H W K  +   L +R
Sbjct: 265 NLLQKEPRKRL-----TVHDALEHPWLKG-DHSNLTSR 296

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  254 bits (649), Expect = 4e-82
 Identities = 75/265 (28%), Positives = 132/265 (49%), Gaps = 13/265 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +   + +GQGA   VY    + T +  A++ M   +  +K   E + +E  ++ +  +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV    S+     L++V++++ GG L   +       E        E + A+  LH+N
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSN 135

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFD-ENTRSNSMCGTLEYMSPEIVLGKGHDK 328
            ++HRD+K +NILL  DG V LTDFG   Q   E ++ ++M GT  +M+PE+V  K +  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLLQ 385
             D WS+GI+  EM+ G+PP+   N  +    I  +   +++ P  LS+     L   L 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 386 KEASKRLGSGPGGSQEIKSHKWFKM 410
            +  KR       ++E+  H++ K+
Sbjct: 256 MDVEKRG-----SAKELLQHQFLKI 275

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  253 bits (647), Expect = 1e-81
 Identities = 68/265 (25%), Positives = 115/265 (43%), Gaps = 13/265 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + F  L+ +G G+F  VY  R +  SE+ A+K M           + +  E   L K+ H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P  +Q R  +  ++  +LV+++  G         +   +E      T   +  +++LH++
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 270 GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG---KGH 326
            ++HRD+K  NILL   G V L DFG A        +NS  GT  +M+PE++L      +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQY 191

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL--PAFLSSEAHSLLKGLL 384
           D   D WS+GI   E+   +PP    N       I +++         S    + +   L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251

Query: 385 QKEASKRLGSGPGGSQEIKSHKWFK 409
           QK    R       S+ +  H++  
Sbjct: 252 QKIPQDRP-----TSEVLLKHRFVL 271

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  251 bits (643), Expect = 2e-81
 Identities = 80/277 (28%), Positives = 133/277 (48%), Gaps = 22/277 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMK------SERNI 203
           E++E  +++G+G  + V +     T + YA+K++        +  E  +       E +I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 204 LTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           L KV  HP I+QL+ +++T    +LV D +  G LF  L  +    E   R     ++  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           +  LH   I+HRDLKPENILLD D ++ LTDFG + Q D   +   +CGT  Y++PEI+ 
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182

Query: 323 G------KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFL 372
                   G+ K  D WS G++++ +L G PPF    +  + + I+    +         
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242

Query: 373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           S     L+   L  +  KR       ++E  +H +F+
Sbjct: 243 SDTVKDLVSRFLVVQPQKRY-----TAEEALAHPFFQ 274

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  250 bits (639), Expect = 1e-80
 Identities = 81/288 (28%), Positives = 142/288 (49%), Gaps = 17/288 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA---EYMKSERNILTK 206
           + ++  + +G G FA V + R   T   YA K ++K +          E ++ E +IL +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           + HP ++ L   ++ K  + L+L+ V GG LF  L  +    E+ A  +  +I++ V +L
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129

Query: 267 HANGIMHRDLKPENILLDADG----HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           H+  I H DLKPENI+L         + + DFGLA + D      ++ GT E+++PEIV 
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHS 378
            +     AD WS+G++ + +L+G  PF G  +Q+    +     +      +  S+ A  
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 249

Query: 379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK-LEARETRPSF 425
            ++ LL K+  KR+       Q+   H W K  + ++ L +  + P F
Sbjct: 250 FIRRLLVKDPKKRM-----TIQDSLQHPWIKPKDTQQALSSAWSHPQF 292

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  249 bits (637), Expect = 4e-80
 Identities = 86/287 (29%), Positives = 152/287 (52%), Gaps = 17/287 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + ++   V+G GAF++V       T ++ A+K + K  +  K     M++E  +L K+ H
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKH 66

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN 269
           P IV L   +++   LYL++  V+GG LF ++  +G + E  A     +++ AV +LH  
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 270 GIMHRDLKPENILL---DADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           GI+HRDLKPEN+L    D D  +M++DFGL+K  D  +  ++ CGT  Y++PE++  K +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 186

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLKG 382
            KA D WS+G++ + +L G PPF   N  K+ ++I+K + +  +     +S  A   ++ 
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEV 429
           L++K+  KR        ++   H W           +    S   ++
Sbjct: 247 LMEKDPEKRF-----TCEQALQHPWIAGDTALD---KNIHQSVSEQI 285

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (632), Expect = 6e-80
 Identities = 74/271 (27%), Positives = 136/271 (50%), Gaps = 19/271 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           ED+EVL  +G G++ +  ++RR    +I   K +    + E    + + SE N+L ++ H
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKH 62

Query: 210 PFIVQLRYSF--QTKYRLYLVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAV 263
           P IV+       +T   LY+V+++  GG L   + +    +    E+       ++  A+
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 264 SHLH-----ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSMCGTLEYMS 317
              H      + ++HRDLKP N+ LD   +V L DFGLA+  + + + + +  GT  YMS
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSEA 376
           PE +    +++ +D WS+G LL+E+    PPFT  +++++  KI + K  ++P   S E 
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDEL 242

Query: 377 HSLLKGLLQKEASKRLGSGPGGSQEIKSHKW 407
           + ++  +L  +   R        +EI  +  
Sbjct: 243 NEIITRMLNLKDYHRP-----SVEEILENPL 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (622), Expect = 8e-78
 Identities = 67/287 (23%), Positives = 125/287 (43%), Gaps = 20/287 (6%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E + + + +G+G F  V++     + + Y  K ++     +      +K E +IL    H
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARH 60

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL-FREDLARIYTAEIVSAVSHLHA 268
             I+ L  SF++   L ++ +F++G  +F ++        E     Y  ++  A+  LH+
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 269 NGIMHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGH 326
           + I H D++PENI+        + + +FG A+Q         +    EY +PE+      
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLKG 382
             A D WS+G L++ +L+G  PF     Q+I + I+  +          +S EA   +  
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFK----MINWKKLEARETRPSF 425
           LL KE   R+      + E   H W K     ++ K +   + R  +
Sbjct: 241 LLVKERKSRM-----TASEALQHPWLKQKIERVSTKVIRTLKHRRYY 282

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (603), Expect = 1e-75
 Identities = 62/268 (23%), Positives = 126/268 (47%), Gaps = 18/268 (6%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
            +    +G+G+F  VY+     T+   A   ++  K + K+  +  K E  +L  + HP 
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPN 69

Query: 212 IVQLRYSFQT----KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           IV+   S+++    K  + LV + +  G L   L R  + +  + R +  +I+  +  LH
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 268 ANG--IMHRDLKPENILLDA-DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGK 324
                I+HRDLK +NI +    G V + D GLA      + + ++ GT E+M+PE+   K
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEEK 188

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK---LPAFLSSEAHSLLK 381
            +D++ D ++ G+ + EM T + P++         + +   +K          E   +++
Sbjct: 189 -YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 247

Query: 382 GLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           G +++   +R        +++ +H +F+
Sbjct: 248 GCIRQNKDERY-----SIKDLLNHAFFQ 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  228 bits (581), Expect = 3e-72
 Identities = 69/257 (26%), Positives = 135/257 (52%), Gaps = 12/257 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           + +E+ +++G G  ++V+  R +      A+KV+R D   + +     + E      ++H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 210 PFIVQLRYSFQTK----YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
           P IV +  + + +       Y+V+++V+G  L   ++ +G      A    A+   A++ 
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF----DENTRSNSMCGTLEYMSPEIV 321
            H NGI+HRD+KP NI++ A   V + DFG+A+      +  T++ ++ GT +Y+SPE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 322 LGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAF----LSSEAH 377
            G   D  +D +S+G +L+E+LTG+PPFTG +   +  + +++    P+     LS++  
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246

Query: 378 SLLKGLLQKEASKRLGS 394
           +++   L K    R  +
Sbjct: 247 AVVLKALAKNPENRYQT 263

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (574), Expect = 2e-71
 Identities = 77/277 (27%), Positives = 131/277 (47%), Gaps = 20/277 (7%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN---HAEYMKSERNILTKV 207
            ++V  ++G G F  VY   R+  +   A+K + KD+I +     +   +  E  +L KV
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 208 D--HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVS 264
                 +++L   F+      L+L+        F    + G  +E+LAR +  +++ AV 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 265 HLHANGIMHRDLKPENILLDAD-GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
           H H  G++HRD+K ENIL+D + G + L DFG       +T      GT  Y  PE +  
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRY 183

Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKG 382
            + H ++A  WS+GILL++M+ G  PF          +II+ ++     +SSE   L++ 
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRW 237

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEAR 419
            L    S R        +EI++H W + +   +  A 
Sbjct: 238 CLALRPSDRP-----TFEEIQNHPWMQDVLLPQETAE 269

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (564), Expect = 9e-70
 Identities = 59/255 (23%), Positives = 110/255 (43%), Gaps = 18/255 (7%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
               V + +G G+F  VY+ +  G     A+K++       +    +   E  +L K  H
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRH 63

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHA 268
             I+     + T  +L +V  +  G  L+  L+  +  F          +    + +LHA
Sbjct: 64  VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE---NTRSNSMCGTLEYMSPEIVLGKG 325
             I+HRDLK  NI L  D  V + DFGLA        + +   + G++ +M+PE++  + 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 326 ---HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAF------LSSEA 376
              +   +D ++ GI+L+E++TGQ P++  N +     ++      P             
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242

Query: 377 HSLLKGLLQKEASKR 391
             L+   L+K+  +R
Sbjct: 243 KRLMAECLKKKRDER 257

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 9e-69
 Identities = 75/280 (26%), Positives = 141/280 (50%), Gaps = 32/280 (11%)

Query: 149 LEDFEVL-KVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV 207
           ++D++V  +V+G G   KV Q+    T E +A+K+++      +        E  +  + 
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA 61

Query: 208 -DHPFIVQLRYSFQTKYR----LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIV 260
              P IV++   ++  Y     L +V++ ++GG LF ++  +G   F E  A      I 
Sbjct: 62  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121

Query: 261 SAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENTRSNSMCGTLEYMS 317
            A+ +LH+  I HRD+KPEN+L  +   +  + LTDFG AK+   +    + C T  Y++
Sbjct: 122 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 181

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN----RQKIQQKIIKDKIKLP---- 369
           PE++  + +DK+ D WS+G++++ +L G PPF   +       ++ +I   + + P    
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241

Query: 370 AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
           + +S E   L++ LL+ E ++R+        E  +H W  
Sbjct: 242 SEVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWIM 276

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 1e-68
 Identities = 76/304 (25%), Positives = 124/304 (40%), Gaps = 37/304 (12%)

Query: 153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHA--EYMKSERNILTKVDHP 210
           E L  +G+G FA VY+ R   T++I A+K ++     E           E  +L ++ HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I+ L  +F  K  + LV DF+             +      + Y    +  + +LH + 
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLG-KGHDK 328
           I+HRDLKP N+LLD +G + L DFGLAK F    R+ +    T  Y +PE++ G + +  
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180

Query: 329 AADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK-----------DKIKLPAF------ 371
             D W+VG +L E+L   P   G +      +I +           D   LP +      
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240

Query: 372 -----------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARE 420
                         +   L++GL       R+      + +    K+F          + 
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI-----TATQALKMKYFSNRPGPTPGCQL 295

Query: 421 TRPS 424
            RP+
Sbjct: 296 PRPN 299

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 6e-67
 Identities = 63/271 (23%), Positives = 127/271 (46%), Gaps = 24/271 (8%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           + +++ ++L+ +G+G F  V      G     A+K ++ D   +        +E +++T+
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQA-----FLAEASVMTQ 56

Query: 207 VDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAV 263
           + H  +VQL     + K  LY+V +++  G L   L  +G  +   D    ++ ++  A+
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            +L  N  +HRDL   N+L+  D    ++DFGL K+       ++    +++ +PE +  
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE 174

Query: 324 KGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK 381
           K     +D WS GILL+E+ + G+ P+     + +  ++ K  K+  P       + ++K
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234

Query: 382 GLLQKEASKRLGSGPGGSQ------EIKSHK 406
                +A+ R    P   Q       IK+H+
Sbjct: 235 NCWHLDAAMR----PSFLQLREQLEHIKTHE 261

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 3e-66
 Identities = 61/256 (23%), Positives = 111/256 (43%), Gaps = 12/256 (4%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNI 203
           +G +D  +L+ +G G+F  V +       G +   A+K ++ D + +    +    E N 
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSA 262
           +  +DH  +++L Y       + +V +    G L  +L   QG F       Y  ++   
Sbjct: 65  MHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSP 318
           + +L +   +HRDL   N+LL     V + DFGL +   +N               + +P
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 319 EIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDKIKL--PAFLSSE 375
           E +  +    A+D W  G+ L+EM T GQ P+ G N  +I  KI K+  +L  P     +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243

Query: 376 AHSLLKGLLQKEASKR 391
            ++++      +   R
Sbjct: 244 IYNVMVQCWAHKPEDR 259

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 4e-66
 Identities = 55/281 (19%), Positives = 121/281 (43%), Gaps = 20/281 (7%)

Query: 143 ENQCVGLEDFEVLKVVGQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           + + + LED    K +G G F  V +   +     +  A+K+++ +   +    + + +E
Sbjct: 4   DRKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAE 58

Query: 201 RNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIV 260
            N++ ++D+P+IV++           LV++    G L   L +    ++        ++ 
Sbjct: 59  ANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117

Query: 261 SAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYM 316
             + +L  +  +HRDL   N+LL    +  ++DFGL+K    +             +++ 
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK-IKLPAFLSS 374
           +PE +        +D WS G+L++E  + GQ P+ G    ++   + K + +  PA    
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 237

Query: 375 EAHSLLKGLLQKEASKRLGSGPGGSQ--EIKSHKWFKMINW 413
           E + L+      +   R    PG +       + ++ ++N 
Sbjct: 238 EMYDLMNLCWTYDVENR----PGFAAVELRLRNYYYDVVNE 274

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 5e-66
 Identities = 68/306 (22%), Positives = 123/306 (40%), Gaps = 41/306 (13%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-EIYAMKVMRKDKIMEKNHAEYMK--SERN 202
           C   + +E +  +G+GA+ KV++ R +       A+K +R     E      ++  +   
Sbjct: 3   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62

Query: 203 ILTKVDHPFIVQLRYSFQT-----KYRLYLVLDFVNGGHL-FFQLYRQGLFREDLARIYT 256
            L   +HP +V+L           + +L LV + V+     +     +     +  +   
Sbjct: 63  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122

Query: 257 AEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYM 316
            +++  +  LH++ ++HRDLKP+NIL+ + G + L DFGLA+ +       S+  TL Y 
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 182

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK------------- 363
           +PE++L   +    D WSVG +  EM   +P F G +      KI+              
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 364 --------------DKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                            K    +      LL   L    +KR+      +    SH +F+
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-----SAYSALSHPYFQ 297

Query: 410 MINWKK 415
            +   K
Sbjct: 298 DLERCK 303

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 5e-66
 Identities = 71/310 (22%), Positives = 117/310 (37%), Gaps = 52/310 (16%)

Query: 146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT 205
           C  +  +E L  +GQG F +V++ R   T +  A+K +  +   E      ++ E  IL 
Sbjct: 6   CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQ 64

Query: 206 KVDHPFIVQLRYSFQT--------KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTA 257
            + H  +V L    +T        K  +YLV DF               F     +    
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124

Query: 258 EIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS-----NSMCGT 312
            +++ + ++H N I+HRD+K  N+L+  DG + L DFGLA+ F     S      +   T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 313 LEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-- 369
           L Y  PE++LG + +    D W  G ++ EM T  P   G   Q     I +    +   
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 370 ------------------------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGS 399
                                               A  L+  LL  + ++R+      S
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI-----DS 299

Query: 400 QEIKSHKWFK 409
            +  +H +F 
Sbjct: 300 DDALNHDFFW 309

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 6e-65
 Identities = 78/296 (26%), Positives = 143/296 (48%), Gaps = 38/296 (12%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E+F+ ++ +G+G +  VY+ R   T E+ A+K +R D   E   +  ++ E ++L +++
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELN 59

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVN-GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+ +LYLV +F++     F            L + Y  +++  ++  H
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-SNSMCGTLEYMSPEIVLGKGH 326
           ++ ++HRDLKP+N+L++ +G + L DFGLA+ F    R       TL Y +PEI+LG  +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 327 -DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK---------------------- 363
              A D WS+G +  EM+T +  F G +      +I +                      
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 364 -------DKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN 412
                  D  K+   L  +  SLL  +L  + +KR+      ++   +H +F+ + 
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI-----SAKAALAHPFFQDVT 290

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 1e-64
 Identities = 91/347 (26%), Positives = 149/347 (42%), Gaps = 61/347 (17%)

Query: 151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP 210
            +   KV+G G+F  VYQ +   + E+ A+K + +DK  +         E  I+ K+DH 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73

Query: 211 FIVQLRYSFQT------KYRLYLVLDFVNGGHLFFQLY---RQGLFREDLARIYTAEIVS 261
            IV+LRY F +      +  L LVLD+V         +    +        ++Y  ++  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVM-LTDFGLAKQFDENTRSNSMCGTLEYMSPEI 320
           +++++H+ GI HRD+KP+N+LLD D  V+ L DFG AKQ      + S   +  Y +PE+
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193

Query: 321 VLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIK---------------- 363
           + G   +  + D WS G +L E+L GQP F G +      +IIK                
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 364 -DKIKLPAF------------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM 410
             + K P                 EA +L   LL+   + RL        E  +H +F  
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL-----TPLEACAHSFFDE 308

Query: 411 INWKKLEARETRPSFLPEVAGKHCVANF-EECWTNMPLLDSPVASPK 456
           +    ++        LP       + NF  +  ++ P L + +  P 
Sbjct: 309 LRDPNVK--------LPNGRDTPALFNFTTQELSSNPPLATILIPPH 347

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 7e-64
 Identities = 52/247 (21%), Positives = 115/247 (46%), Gaps = 10/247 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           +D   LK +G G F  V   +  G  +  A+K++++  + E         E  ++  + H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDE----FIEEAKVMMNLSH 58

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHA 268
             +VQL      +  ++++ +++  G L   L   +  F+         ++  A+ +L +
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGH 326
              +HRDL   N L++  G V ++DFGL++    DE T S      + +  PE+++    
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 327 DKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLL 384
              +D W+ G+L++E+ + G+ P+      +  + I +  ++  P   S + ++++    
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238

Query: 385 QKEASKR 391
            ++A +R
Sbjct: 239 HEKADER 245

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  206 bits (524), Expect = 1e-63
 Identities = 68/292 (23%), Positives = 132/292 (45%), Gaps = 38/292 (13%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           +E +  L+ +G+G +  VY+ +     E +A+K +R +K  E   +  ++ E +IL ++ 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR-EISILKELK 58

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     TK RL LV + ++          +G      A+ +  ++++ +++ H 
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRSNSMCGTLEYMSPEIVLGKG-H 326
             ++HRDLKP+N+L++ +G + + DFGLA+ F     +      TL Y +P++++G   +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 327 DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-------------------- 366
               D WSVG +  EM+ G P F G +      +I +                       
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 367 ---------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                         L      LL  +L+ + ++R+      +++   H +FK
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI-----TAKQALEHAYFK 285

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 1e-63
 Identities = 53/270 (19%), Positives = 114/270 (42%), Gaps = 19/270 (7%)

Query: 141 PSENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE 200
           P+    +   D +   V+G+G F +V + R           + R  +   K+       E
Sbjct: 1   PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE 60

Query: 201 RNILTKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ--------------- 244
             +L K+  HP I+ L  + + +  LYL +++   G+L   L +                
Sbjct: 61  LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120

Query: 245 -GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN 303
                      + A++   + +L     +HRDL   NIL+  +    + DFGL++  +  
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKII 362
            +       + +M+ E +    +   +D WS G+LL+E+++ G  P+ G    ++ +K+ 
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240

Query: 363 KD-KIKLPAFLSSEAHSLLKGLLQKEASKR 391
           +  +++ P     E + L++   +++  +R
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYER 270

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 2e-63
 Identities = 64/293 (21%), Positives = 129/293 (44%), Gaps = 38/293 (12%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           ++ +E L+ +G+G +  V++ +   T EI A+K +R D   ++        E  +L ++ 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELK 59

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           H  IV+L     +  +L LV +F +     +     G    ++ + +  +++  +   H+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSM-CGTLEYMSPEIVLGKG-H 326
             ++HRDLKP+N+L++ +G + L +FGLA+ F    R  S    TL Y  P+++ G   +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 327 DKAADWWSVGILLFEMLTG-QPPFTGGNRQKIQQKIIK---------------------- 363
             + D WS G +  E+    +P F G +     ++I +                      
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 364 -------DKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                    + +   L++    LL+ LL+    +R+      ++E   H +F 
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI-----SAEEALQHPYFS 287

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (520), Expect = 5e-63
 Identities = 60/252 (23%), Positives = 110/252 (43%), Gaps = 13/252 (5%)

Query: 150 EDFEVLKVV-GQGAFAKVYQV--RRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           ++  +  +  G G F  V Q   R        A+KV+++    EK   E M  E  I+ +
Sbjct: 8   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQ 65

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSH 265
           +D+P+IV+L    Q    L LV++   GG L   L  +              ++   + +
Sbjct: 66  LDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 124

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIV 321
           L     +HRDL   N+LL    +  ++DFGL+K    +    T  ++    L++ +PE +
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184

Query: 322 LGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSL 379
             +     +D WS G+ ++E L+ GQ P+      ++   I + K ++ P     E ++L
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 244

Query: 380 LKGLLQKEASKR 391
           +      +   R
Sbjct: 245 MSDCWIYKWEDR 256

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 6e-63
 Identities = 60/286 (20%), Positives = 115/286 (40%), Gaps = 11/286 (3%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRK--DKIMEKNHAEYMKSERNILTKV 207
            +F+ +KV+G GAF  VY+   I   E   + V  K   +       + +  E  ++  V
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 208 DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           D+P + +L     T     +      G  L +    +          +  +I   +++L 
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGK 324
              ++HRDL   N+L+    HV +TDFGLAK          +      +++M+ E +L +
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188

Query: 325 GHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLLKG 382
            +   +D WS G+ ++E++T G  P+ G    +I   + K + +  P   + + + ++  
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 248

Query: 383 LLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPE 428
               +A  R    P   + I           + L  +      LP 
Sbjct: 249 CWMIDADSR----PKFRELIIEFSKMARDPQRYLVIQGDERMHLPS 290

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (517), Expect = 1e-62
 Identities = 55/257 (21%), Positives = 114/257 (44%), Gaps = 14/257 (5%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNI 203
           + +   ++ +V+G G F +V         +     A+K ++      +       SE +I
Sbjct: 23  IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASI 80

Query: 204 LTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSA 262
           + + DHP ++ L         + ++ +F+  G L  F     G F           I + 
Sbjct: 81  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN------TRSNSMCGTLEYM 316
           + +L     +HRDL   NIL++++    ++DFGL++  +++      T +      + + 
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 317 SPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSS 374
           +PE +  +    A+D WS GI+++E+++ G+ P+     Q +   I +D ++  P    S
Sbjct: 201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS 260

Query: 375 EAHSLLKGLLQKEASKR 391
             H L+    QK+ + R
Sbjct: 261 ALHQLMLDCWQKDRNHR 277

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 3e-62
 Identities = 51/247 (20%), Positives = 116/247 (46%), Gaps = 10/247 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
            +   ++ +G G F  V+    +   +  A+K +R+  + E++       E  ++ K+ H
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEED----FIEEAEVMMKLSH 59

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHA 268
           P +VQL      +  + LV +F+  G L  +   ++GLF  +       ++   +++L  
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119

Query: 269 NGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVLGKGH 326
             ++HRDL   N L+  +  + ++DFG+ +    D+ T S      +++ SPE+     +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 327 DKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLL 384
              +D WS G+L++E+ + G+ P+   +  ++ + I    ++  P   S+  + ++    
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239

Query: 385 QKEASKR 391
           ++    R
Sbjct: 240 KERPEDR 246

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 3e-62
 Identities = 61/248 (24%), Positives = 117/248 (47%), Gaps = 12/248 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E   +   +GQG F +V+     GT+   A+K ++   +  +        E  ++ K+ H
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA----FLQEAQVMKKLRH 71

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLH 267
             +VQL Y+  ++  +Y+V ++++ G L   L  +     R        A+I S ++++ 
Sbjct: 72  EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+  +    + DFGLA+  ++N  T        +++ +PE  L   
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGL 383
               +D WS GILL E+ T G+ P+ G   +++  ++ +  ++  P       H L+   
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250

Query: 384 LQKEASKR 391
            +KE  +R
Sbjct: 251 WRKEPEER 258

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 1e-61
 Identities = 61/277 (22%), Positives = 118/277 (42%), Gaps = 37/277 (13%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEI-----YAMKVMRKDKIMEKNHAEYMKSERNIL 204
           E+ E  KV+G GAF KV      G S+       A+K++++    + +  E + SE  ++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMM 94

Query: 205 TKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQ------------------- 244
           T++  H  IV L  +      +YL+ ++   G L   L  +                   
Sbjct: 95  TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 245 ----GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
                +   +    +  ++   +  L     +HRDL   N+L+     V + DFGLA+  
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK 356
             +       +    +++M+PE +    +   +D WS GILL+E+ + G  P+ G     
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 357 IQQKIIKDKIKL--PAFLSSEAHSLLKGLLQKEASKR 391
              K+I++  K+  P + + E + +++     ++ KR
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  199 bits (507), Expect = 4e-61
 Identities = 56/251 (22%), Positives = 112/251 (44%), Gaps = 10/251 (3%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK 206
           +   D  +   +G G + +VY+      S   A+K +++D +  +        E  ++ +
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKE 69

Query: 207 VDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVS 264
           + HP +VQL      +   Y++ +F+  G+L   L           +      +I SA+ 
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF--DENTRSNSMCGTLEYMSPEIVL 322
           +L     +HRDL   N L+  +  V + DFGL++    D  T        +++ +PE + 
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189

Query: 323 GKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL 380
                  +D W+ G+LL+E+ T G  P+ G +  ++ + + KD +++ P     + + L+
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 249

Query: 381 KGLLQKEASKR 391
           +   Q   S R
Sbjct: 250 RACWQWNPSDR 260

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 5e-61
 Identities = 53/248 (21%), Positives = 118/248 (47%), Gaps = 12/248 (4%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E  ++++ +G G F +V+     G ++  A+K +++  +          +E N++ ++ H
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDA----FLAEANLMKQLQH 67

Query: 210 PFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARI--YTAEIVSAVSHLH 267
             +V+L Y+  T+  +Y++ +++  G L   L      +  + ++    A+I   ++ + 
Sbjct: 68  QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--RSNSMCGTLEYMSPEIVLGKG 325
               +HRDL+  NIL+       + DFGLA+  ++N           +++ +PE +    
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGL 383
               +D WS GILL E++T G+ P+ G    ++ Q + +  ++  P     E + L++  
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246

Query: 384 LQKEASKR 391
            ++    R
Sbjct: 247 WKERPEDR 254

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  199 bits (507), Expect = 1e-60
 Identities = 69/307 (22%), Positives = 129/307 (42%), Gaps = 57/307 (18%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-D 208
           +D+++++ +G+G +++V++   I  +E   +K+++  K       + +K E  IL  +  
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRG 88

Query: 209 HPFIVQLRYSFQ--TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
            P I+ L    +        LV + VN      QLY+     +   R Y  EI+ A+ + 
Sbjct: 89  GPNIITLADIVKDPVSRTPALVFEHVNNTDF-KQLYQT--LTDYDIRFYMYEILKALDYC 145

Query: 267 HANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG-K 324
           H+ GIMHRD+KP N+++D +   + L D+GLA+ +      N    +  +  PE+++  +
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205

Query: 325 GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP--------------- 369
            +D + D WS+G +L  M+  + PF  G+    Q   I   +                  
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 370 -----------------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHK 406
                                    +S EA   L  LL+ +   RL      ++E   H 
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL-----TAREAMEHP 320

Query: 407 WFKMINW 413
           +F  +  
Sbjct: 321 YFYTVVK 327

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 1e-60
 Identities = 54/248 (21%), Positives = 117/248 (47%), Gaps = 7/248 (2%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE-IYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           E  E+ + +G+G F  V+Q   +       A+ +         +  E    E   + + D
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 209 HPFIVQLRYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLH 267
           HP IV+L     T+  ++++++    G L  F   R+         +Y  ++ +A+++L 
Sbjct: 67  HPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 268 ANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--TRSNSMCGTLEYMSPEIVLGKG 325
           +   +HRD+   N+L+ ++  V L DFGL++  +++   +++     +++M+PE +  + 
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIK-DKIKLPAFLSSEAHSLLKGL 383
              A+D W  G+ ++E+L  G  PF G     +  +I   +++ +P       +SL+   
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKC 245

Query: 384 LQKEASKR 391
              + S+R
Sbjct: 246 WAYDPSRR 253

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 5e-60
 Identities = 73/306 (23%), Positives = 128/306 (41%), Gaps = 48/306 (15%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
             +  L+ VG GA+  V       T    A+K + +    E       + E  +L  + H
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRH 76

Query: 210 PFIVQLRYSFQTK------YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAV 263
             ++ L   F            YLV+ F+  G    +L +     ED  +    +++  +
Sbjct: 77  ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134

Query: 264 SHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLG 323
            ++HA GI+HRDLKP N+ ++ D  + + DFGLA+Q D          T  Y +PE++L 
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTRWYRAPEVILN 192

Query: 324 -KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAF----------- 371
              + +  D WSVG ++ EM+TG+  F G +     ++I+K     PA            
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

Query: 372 --------------------LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI 411
                                S  A +LL+ +L  +A +R+      + E  +H +F+ +
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV-----TAGEALAHPYFESL 307

Query: 412 NWKKLE 417
           +  + E
Sbjct: 308 HDTEDE 313

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 1e-59
 Identities = 65/299 (21%), Positives = 117/299 (39%), Gaps = 50/299 (16%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF 211
           +  L  +G+GA+  V            A+K +   +   + + +    E  IL +  H  
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHEN 67

Query: 212 IVQLRYSFQTKY-----RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHL 266
           I+ +    +         +YLV   +      ++L +      D    +  +I+  + ++
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADL--YKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 267 HANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEIVL 322
           H+  ++HRDLKP N+LL+    + + DFGLA+  D +            T  Y +PEI+L
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 323 -GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI--------------- 366
             KG+ K+ D WSVG +L EML+ +P F G +       I+                   
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245

Query: 367 ----------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFK 409
                           +L     S+A  LL  +L     KR+       ++  +H + +
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-----EVEQALAHPYLE 299

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  192 bits (488), Expect = 3e-58
 Identities = 54/295 (18%), Positives = 105/295 (35%), Gaps = 38/295 (12%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHP- 210
           + + + +G G+F  +Y    I   E  A+K+        +     +  E  I   +    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQGGV 63

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I  +R+         +V++ +         +    F      +   +++S + ++H+  
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 271 IMHRDLKPENIL---LDADGHVMLTDFGLAKQFDENT--------RSNSMCGTLEYMSPE 319
            +HRD+KP+N L         V + DFGLAK++ +           + ++ GT  Y S  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 320 IVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--------LPAF 371
             LG    +  D  S+G +L     G  P+ G      +QK  +   K        L   
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243

Query: 372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQ--EIKSHKWFKM-------INWKKLE 417
             SE  + L          +    P  S   ++  + + +         +W  L+
Sbjct: 244 YPSEFATYLNFCRSLRFDDK----PDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 294

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (482), Expect = 2e-57
 Identities = 49/276 (17%), Positives = 109/276 (39%), Gaps = 36/276 (13%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
            + E ++ +G+GAF +V+Q R  G        + A+K+++++     +     + E  ++
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 70

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL------------------ 246
            + D+P IV+L         + L+ +++  G L   L                       
Sbjct: 71  AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 247 ------FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF 300
                            ++ + +++L     +HRDL   N L+  +  V + DFGL++  
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 301 DEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQ-PPFTGGNRQK 356
                     +    + +M PE +    +   +D W+ G++L+E+ +    P+ G   ++
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 357 IQQKIIKDKI-KLPAFLSSEAHSLLKGLLQKEASKR 391
           +   +    I   P     E ++L++    K  + R
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 286

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 2e-57
 Identities = 69/328 (21%), Positives = 125/328 (38%), Gaps = 59/328 (17%)

Query: 149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD 208
           L+ ++ LK +G GA   V            A+K + +     + HA+    E  ++  V+
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 74

Query: 209 HPFIVQLRYSFQTK------YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSA 262
           H  I+ L   F  +        +YLV++ ++          Q     +       +++  
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCG 131

Query: 263 VSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVL 322
           + HLH+ GI+HRDLKP NI++ +D  + + DFGLA+    +        T  Y +PE++L
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 323 GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP------------- 369
           G G+ +  D WSVG ++ EM+  +  F G +      K+I+                   
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 370 -----------------------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQ 400
                                           +S+A  LL  +L  + +KR+        
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-----SVD 306

Query: 401 EIKSHKWFKMINWKKLEARETRPSFLPE 428
           +   H +  +  W      E  P  + +
Sbjct: 307 DALQHPYINV--WYDPAEVEAPPPQIYD 332

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  187 bits (475), Expect = 2e-56
 Identities = 46/262 (17%), Positives = 97/262 (37%), Gaps = 27/262 (10%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-P 210
           ++V + +G+G+F  +++   +  ++  A+K   +     ++ A  ++ E      +    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61

Query: 211 FIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
            I  + Y  Q      LV+D +              F      +   ++++ V  +H   
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 271 IMHRDLKPENILLDA-----DGHVMLTDFGLAKQFDE--------NTRSNSMCGTLEYMS 317
           +++RD+KP+N L+          + + DFG+ K + +             ++ GT  YMS
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 318 PEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--------LP 369
               LG+   +  D  ++G +    L G  P+ G      +QK  +   K        L 
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 370 AFLSSEAHSLLKGLLQKEASKR 391
           A    E +  +           
Sbjct: 242 AGFPEEFYKYMHYARNLAFDAT 263

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (474), Expect = 1e-55
 Identities = 67/299 (22%), Positives = 120/299 (40%), Gaps = 44/299 (14%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
           E ++ L  VG GA+  V       T    A+K + +       HA+    E  +L  + H
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKH 76

Query: 210 PFIVQLRYSFQTKYRL----YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             ++ L   F     L     + L     G     + +     +D  +    +I+  + +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 266 LHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKG 325
           +H+  I+HRDLKP N+ ++ D  + + DFGLA+  D+         T  Y +PEI+L   
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWM 194

Query: 326 H-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFL------------ 372
           H ++  D WSVG ++ E+LTG+  F G +     + I++      A L            
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254

Query: 373 -------------------SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN 412
                              +  A  LL+ +L  ++ KR+      + +  +H +F   +
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-----TAAQALAHAYFAQYH 308

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 4e-55
 Identities = 57/272 (20%), Positives = 109/272 (40%), Gaps = 32/272 (11%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
                 K +G GAF KV +    G      +   A+K+++    +     E + SE  +L
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80

Query: 205 TKV-DHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGL----------------- 246
           + + +H  IV L  +        ++ ++   G L   L R+                   
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 247 -FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-- 303
               +    ++ ++   ++ L +   +HRDL   NILL       + DFGLA+    +  
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 304 -TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKI 361
                +    +++M+PE +    +   +D WS GI L+E+ + G  P+ G        K+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 362 IKDKIKL--PAFLSSEAHSLLKGLLQKEASKR 391
           IK+  ++  P    +E + ++K     +  KR
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 9e-55
 Identities = 52/253 (20%), Positives = 105/253 (41%), Gaps = 13/253 (5%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILT 205
                 KV+G G F +VY+     +S       A+K ++      +        E  I+ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMG 64

Query: 206 KVDHPFIVQLRYSFQTKYRLYLVLDFVNGG-HLFFQLYRQGLFREDLARIYTAEIVSAVS 264
           +  H  I++L         + ++ +++  G    F   + G F           I + + 
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 265 HLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN----TRSNSMCGTLEYMSPEI 320
           +L     +HRDL   NIL++++    ++DFGL++  +++      ++     + + +PE 
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 321 VLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKL--PAFLSSEAHS 378
           +  +    A+D WS GI+++E++T               K I D  +L  P    S  + 
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244

Query: 379 LLKGLLQKEASKR 391
           L+    Q+E ++R
Sbjct: 245 LMMQCWQQERARR 257

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 2e-53
 Identities = 52/270 (19%), Positives = 119/270 (44%), Gaps = 29/270 (10%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSE-------IYAMKVMRKDKIMEKNHAEYMKSERN 202
           +   + K +G+GAF +V     IG  +         A+K+++ D   EK+ ++ +     
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEM 71

Query: 203 ILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------L 246
           +     H  I+ L  +      LY+++++ + G+L   L  +                  
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 247 FREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--- 303
                      ++   + +L +   +HRDL   N+L+  D  + + DFGLA+        
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 304 TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKII 362
            ++ +    +++M+PE +  + +   +D WS G+LL+E+ T G  P+ G   +++ + + 
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 363 KD-KIKLPAFLSSEAHSLLKGLLQKEASKR 391
           +  ++  P+  ++E + +++       S+R
Sbjct: 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 3e-53
 Identities = 54/248 (21%), Positives = 105/248 (42%), Gaps = 14/248 (5%)

Query: 156 KVVGQGAFAKVYQVRRI---GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI 212
           +V+G+G F  VY    +   G     A+K +  ++I +        +E  I+    HP +
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 90

Query: 213 VQL-RYSFQTKYRLYLVLDFVNGGHLF-FQLYRQGLFREDLARIYTAEIVSAVSHLHANG 270
           + L     +++    +VL ++  G L  F               +  ++   +  L +  
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150

Query: 271 IMHRDLKPENILLDADGHVMLTDFGLAK-----QFDENTRSNSMCGTLEYMSPEIVLGKG 325
            +HRDL   N +LD    V + DFGLA+     +FD           +++M+ E +  + 
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210

Query: 326 HDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK-IKLPAFLSSEAHSLLKGL 383
               +D WS G+LL+E++T G PP+   N   I   +++ + +  P +     + ++   
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 270

Query: 384 LQKEASKR 391
              +A  R
Sbjct: 271 WHPKAEMR 278

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-52
 Identities = 56/270 (20%), Positives = 114/270 (42%), Gaps = 29/270 (10%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNIL 204
           +  ++ K +G+GAF +V +    G     T    A+K++++       H   M   + ++
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILI 71

Query: 205 TKVDHPFIVQLR-YSFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LF 247
               H  +V L     +    L ++++F   G+L   L  +                   
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 248 REDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---T 304
             +    Y+ ++   +  L +   +HRDL   NILL     V + DFGLA+   ++    
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTG-QPPFTGGNRQKIQQKIIK 363
           R       L++M+PE +  + +   +D WS G+LL+E+ +    P+ G    +   + +K
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 364 D--KIKLPAFLSSEAHSLLKGLLQKEASKR 391
           +  +++ P + + E +  +      E S+R
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 281

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-50
 Identities = 50/265 (18%), Positives = 106/265 (40%), Gaps = 22/265 (8%)

Query: 147 VGLEDFEVLKVVGQGAFAKVYQVR-----RIGTSEIYAMKVMRKDKIMEKNHAEYMKSER 201
           V  E   + + +GQG+F  VY+       +       A+K + +   M +       +E 
Sbjct: 17  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEA 74

Query: 202 NILTKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDL---------- 251
           +++ + +   +V+L           ++++ +  G L   L        +           
Sbjct: 75  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 252 ARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TRSNS 308
                 EI   +++L+AN  +HRDL   N ++  D  V + DFG+ +   E     +   
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTG-QPPFTGGNRQKIQQKIIKDKI- 366
               + +MSPE +        +D WS G++L+E+ T  + P+ G + +++ + +++  + 
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254

Query: 367 KLPAFLSSEAHSLLKGLLQKEASKR 391
             P         L++   Q     R
Sbjct: 255 DKPDNCPDMLFELMRMCWQYNPKMR 279

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-47
 Identities = 56/288 (19%), Positives = 110/288 (38%), Gaps = 52/288 (18%)

Query: 150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH 209
               + + +G+G F +V++ +     E  A+K+    +        + ++E      + H
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS----WFREAEIYQTVMLRH 56

Query: 210 PFIVQLRYSFQ----TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSH 265
             I+    +      T  +L+LV D+   G LF  L R  +  E + ++      S ++H
Sbjct: 57  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA-LSTASGLAH 115

Query: 266 LHA--------NGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-----NTRSNSMCGT 312
           LH           I HRDLK +NIL+  +G   + D GLA + D      +   N   GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 313 LEYMSPEIVLGKGH------DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ-------- 358
             YM+PE++    +       K AD +++G++ +E+             ++         
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 359 ------QKIIKDKIKLPAF--------LSSEAHSLLKGLLQKEASKRL 392
                 +K++ ++   P                 +++       + RL
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  153 bits (386), Expect = 8e-43
 Identities = 57/323 (17%), Positives = 112/323 (34%), Gaps = 70/323 (21%)

Query: 152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNI-------L 204
           + +++ +G G F+ V+  + +  +   AMK++R DK+  +   + +K  + +        
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 205 TKVDHPFIVQLRYSFQTKYRLYLVLDFVNGGH-----LFFQLYRQGLFREDLARIYTAEI 259
             +    I++L   F  K    + +  V            + Y          +  + ++
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 260 VSAVSHLHAN-GIMHRDLKPENILLDADGHVM----LTDFGLAKQFDENTRSNSMCGTLE 314
           +  + ++H   GI+H D+KPEN+L++          +    L      +    +   T E
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 315 YMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ---------------- 358
           Y SPE++LG      AD WS   L+FE++TG   F                         
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 359 --------------------------------QKIIKDKIKLPAFLSSEAHSLLKGLLQK 386
                                           + ++ +K K     + E    L  +LQ 
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314

Query: 387 EASKRLGSGPGGSQEIKSHKWFK 409
           +  KR       +  + +H W K
Sbjct: 315 DPRKRA-----DAGGLVNHPWLK 332

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.0 bits (212), Expect = 4e-20
 Identities = 26/205 (12%), Positives = 66/205 (32%), Gaps = 32/205 (15%)

Query: 153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN-------HAEYMKSERNILT 205
            + K++G+G  + V+            +K  +      K           +         
Sbjct: 3   AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 206 KVDHPFIVQLRYSFQTK----YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVS 261
           + +   + +L+     K        ++++ ++   L+         R +        I+ 
Sbjct: 62  RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYR-------VRVENPDEVLDMILE 114

Query: 262 AVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIV 321
            V+  +  GI+H DL   N+L+  +  + + DF  + +  E        G  E +  ++ 
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEE-------GWREILERDVR 166

Query: 322 -----LGKGHDKAADWWSVGILLFE 341
                  + +    D  S    + +
Sbjct: 167 NIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	479
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.41
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.08
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.86
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.14
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.96
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.43

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-72  Score=565.29  Aligned_cols=324  Identities=38%  Similarity=0.749  Sum_probs=295.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|++++||||++++++|++...+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            57889999999999999999999999999999999999877666666778889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC-CCC
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTR  305 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~-~~~  305 (479)
                      +|||||+||+|..++.+.+.++++.++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+.... ...
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999997543 455


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhh
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      ..+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++.+.+..+.+.+|..+|+++++||++||+
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~  241 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK  241 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhcc
Confidence            67789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC----------
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP----------  455 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~----------  455 (479)
                      +||.+|+++...+++||++||||++++|..+..+++.||++|.+....+..+|+..++......+|....          
T Consensus       242 ~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (337)
T d1o6la_         242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQ  321 (337)
T ss_dssp             SSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSCHHHHTSCCC-----------------
T ss_pred             CCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCChhhhhhcCchhhhccCCCCCCccccccccccccc
Confidence            9999999887778999999999999999999999999999999998888999999887766554433211          


Q ss_pred             CCCCCCccCeeeecC
Q 011698          456 KFNENPFKGFTYVRP  470 (479)
Q Consensus       456 ~~~~~~f~~f~~~~~  470 (479)
                      ...+..|+||+|+..
T Consensus       322 ~~~~~~f~~f~~v~d  336 (337)
T d1o6la_         322 REEQEMFEDFDYIAD  336 (337)
T ss_dssp             ---CCTTTTCCEECC
T ss_pred             hhhhhccCCCEeeCC
Confidence            234688999999863

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-68  Score=531.34  Aligned_cols=314  Identities=37%  Similarity=0.716  Sum_probs=258.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHH-hCCCCCeeeEeEEEeeCCeEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILT-KVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      +++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+..|..++. .++|||||++++++++++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            479999999999999999999999999999999998866544444555666766655 6899999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC-CCCc
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE-NTRS  306 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~-~~~~  306 (479)
                      |||||+||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.... ....
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999987543 3344


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~  386 (479)
                      ...+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++..+|..+.+.+|..+|+++.+||++||++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~  240 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR  240 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhccc
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             chhhhcCCCCCCHH-HHHhCccccCCChhhhhcccCCCCCccccCCcccccCccccccCCCCCCCCCCCC---CCCCCCc
Q 011698          387 EASKRLGSGPGGSQ-EIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEECWTNMPLLDSPVASP---KFNENPF  462 (479)
Q Consensus       387 dP~~R~~~~~~t~~-eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~---~~~~~~f  462 (479)
                      ||++||     +++ ++++||||++++|+.+..+++.||++|.+....+..+|+..++......++....   ..+++.|
T Consensus       241 dP~~R~-----s~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f  315 (320)
T d1xjda_         241 EPEKRL-----GVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMF  315 (320)
T ss_dssp             SGGGSB-----TTBSCGGGSGGGTTCCHHHHHTTCSCC--------------------------------------CCTT
T ss_pred             CCCCCc-----CHHHHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccchhhcChHhhhCCccCCCCcccccCchhhccc
Confidence            999999     664 8999999999999999999999999999998888999998776544443333322   3568899


Q ss_pred             cCeee
Q 011698          463 KGFTY  467 (479)
Q Consensus       463 ~~f~~  467 (479)
                      .||+|
T Consensus       316 ~~f~~  320 (320)
T d1xjda_         316 RNFSF  320 (320)
T ss_dssp             TTCCC
T ss_pred             CcCcC
Confidence            99998

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-67  Score=527.94  Aligned_cols=292  Identities=37%  Similarity=0.758  Sum_probs=265.6

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|++++|||||++++++++.+.+|+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            46899999999999999999999999999999999998766555667788999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcc
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~  307 (479)
                      |||||.||+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....  ...
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--~~~  159 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTY  159 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBC
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc--ccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999988654  345


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhc
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      +.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++..+|..+...+|..++++++++|.+||++|
T Consensus       160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d  239 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD  239 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSC
T ss_pred             cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhC
Confidence            68999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCC-cccccCcccc
Q 011698          388 ASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAG-KHCVANFEEC  441 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~-~~~~~~f~~~  441 (479)
                      |.+|+++...++++|++||||++++|+++..+.+.|||+|.+.. ..+.++|++.
T Consensus       240 p~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~~~d~~~f~~~  294 (316)
T d1fota_         240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKY  294 (316)
T ss_dssp             TTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-------------
T ss_pred             HHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCCCcchhhhcCCC
Confidence            99999887779999999999999999999999999999997643 3466777653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-66  Score=526.09  Aligned_cols=292  Identities=39%  Similarity=0.777  Sum_probs=274.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+...+++
T Consensus        39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  118 (350)
T d1rdqe_          39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence            36899999999999999999999999999999999988766555566778899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCcc
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSN  307 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~  307 (479)
                      ||||+.||+|..++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+..  ...
T Consensus       119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--~~~  196 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--RTW  196 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--CBC
T ss_pred             ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--ccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998754  345


Q ss_pred             cccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhhc
Q 011698          308 SMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      +.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+...+..+|..+.+.+|..+++++.+||++||++|
T Consensus       197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d  276 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD  276 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSC
T ss_pred             cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhC
Confidence            67899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCcccc
Q 011698          388 ASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFEEC  441 (479)
Q Consensus       388 P~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~~~  441 (479)
                      |.+|+.....+++++++||||++++|..+..+++.|||+|.+....+.+||+..
T Consensus       277 P~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~s~~~~~  330 (350)
T d1rdqe_         277 LTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDY  330 (350)
T ss_dssp             TTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSCCC
T ss_pred             HHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchhhhcCCC
Confidence            999986666799999999999999999999999999999999888888898753

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-66  Score=507.99  Aligned_cols=278  Identities=40%  Similarity=0.743  Sum_probs=250.2

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++|||||+++++|++++.+|+
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            34789999999999999999999999999999999998766566667789999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC---C
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---T  304 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~---~  304 (479)
                      |||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+...   .
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999986432   2


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhh
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLL  384 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L  384 (479)
                      ...+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++.++|.+..+.+|..+++++++||++||
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L  245 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLL  245 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTS
T ss_pred             ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence            34567899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhchhhhcCCCC-CCHHHHHhCccccCCChhhhhcccCCCCCcc
Q 011698          385 QKEASKRLGSGP-GGSQEIKSHKWFKMINWKKLEARETRPSFLP  427 (479)
Q Consensus       385 ~~dP~~R~~~~~-~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p  427 (479)
                      ++||++|+++.. .....|++||||++++|+++..+  .||-+|
T Consensus       246 ~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~--~pP~l~  287 (288)
T d1uu3a_         246 VLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ--TPPKLT  287 (288)
T ss_dssp             CSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS--CCCCCC
T ss_pred             cCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcC--CCCCCC
Confidence            999999994321 12234799999999999999754  355444

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.7e-64  Score=514.84  Aligned_cols=316  Identities=34%  Similarity=0.651  Sum_probs=262.5

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHH---HHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSE---RNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E---~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|   +.+++.++|||||+++++|++.+.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            57899999999999999999999999999999999987665444333334444   666777789999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~  304 (479)
                      +|+|||||+||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+... 
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999977543 


Q ss_pred             CcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCCccCCHHHHHHH
Q 011698          305 RSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNR---QKIQQKIIKDKIKLPAFLSSEAHSLL  380 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~p~~~s~~~~~lI  380 (479)
                      .....+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.+.   ..+...+......+|..+|+++++||
T Consensus       161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  240 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL  240 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHH
T ss_pred             cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHH
Confidence            4456789999999999974 6789999999999999999999999987543   34455555667778889999999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCcccccCcc-----ccccCCCCCCCCCCCC
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHCVANFE-----ECWTNMPLLDSPVASP  455 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~~~~f~-----~~~~~~~~~~~~~~~~  455 (479)
                      .+||++||++||++...+++|+++||||++++|..+..++..||++|......+...|+     +..+..      ....
T Consensus       241 ~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~~~~~~~~~d~~~~~~~~~~~------~~~~  314 (364)
T d1omwa3         241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKG------IKLL  314 (364)
T ss_dssp             HHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC--------------------------CCCC
T ss_pred             HHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCCCCCcCCccccccCChhhccC------CCCC
Confidence            99999999999977666799999999999999999999999999999776655544443     222211      1111


Q ss_pred             CCCCCCccCeeeecC
Q 011698          456 KFNENPFKGFTYVRP  470 (479)
Q Consensus       456 ~~~~~~f~~f~~~~~  470 (479)
                      ..++..|.+|++..+
T Consensus       315 ~~~~~~~~~~~~~~~  329 (364)
T d1omwa3         315 DSDQELYRNFPLTIS  329 (364)
T ss_dssp             SSSSGGGTTCCEECH
T ss_pred             ChHHHHHhcCCccCc
Confidence            234677889988754

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-64  Score=488.41  Aligned_cols=258  Identities=33%  Similarity=0.641  Sum_probs=243.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ..+++|++++.||+|+||+||+|+++.+++.||+|++.+....+....+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus         3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            45789999999999999999999999999999999998876655556777899999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCc
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~  306 (479)
                      +|||||+||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ..
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~  161 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RR  161 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CC
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999876543 34


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHHhhhhh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLKGLLQK  386 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~~~L~~  386 (479)
                      ...+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++.+++.+..+.+|..+|+++++||.+||++
T Consensus       162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~  241 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH  241 (263)
T ss_dssp             EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCS
T ss_pred             cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccC
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             chhhhcCCCCCCHHHHHhCccccC
Q 011698          387 EASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       387 dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      ||++||     |++|+++||||..
T Consensus       242 dp~~R~-----t~~eil~hp~~~~  260 (263)
T d2j4za1         242 NPSQRP-----MLREVLEHPWITA  260 (263)
T ss_dssp             SGGGSC-----CHHHHHTCHHHHH
T ss_pred             CHhHCc-----CHHHHHcCcCcCC
Confidence            999999     9999999999964

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-61  Score=475.37  Aligned_cols=266  Identities=29%  Similarity=0.483  Sum_probs=238.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH---HHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK---NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+......   ...+.+.+|+.+|++++|||||+++++|++...+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            579999999999999999999999999999999987543222   23567889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC----cEEEeecCCccccCC
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG----HVMLTDFGLAKQFDE  302 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g----~vkL~DFGla~~~~~  302 (479)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|    .+||+|||+|+.+..
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            9999999999999999989999999999999999999999999999999999999998877    599999999998877


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHH
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHS  378 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~  378 (479)
                      .....+.+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..++...|......++    ..+|.++++
T Consensus       170 ~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  249 (293)
T d1jksa_         170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD  249 (293)
T ss_dssp             SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred             CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHH
Confidence            7777788999999999999999999999999999999999999999999999999999998877665    468999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhccc
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARE  420 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~  420 (479)
                      ||++||++||++||     |++|+++||||+..+|.......
T Consensus       250 li~~~L~~dP~~R~-----s~~eil~hp~~~~~~~~~~l~~~  286 (293)
T d1jksa_         250 FIRRLLVKDPKKRM-----TIQDSLQHPWIKPKDTQQALSSA  286 (293)
T ss_dssp             HHHTTSCSSGGGSC-----CHHHHHHSTTTCC----------
T ss_pred             HHHHHccCChhHCc-----CHHHHhcCcccCCCChhHhhccC
Confidence            99999999999999     99999999999999997754433

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.6e-61  Score=476.89  Aligned_cols=255  Identities=33%  Similarity=0.596  Sum_probs=216.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +.|++++.||+|+||+||+|+++.+|+.||||++.+.....  ....+.+|+.+|++++|||||++++++++++.+|+||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56999999999999999999999999999999998765332  2456789999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeC---CCCcEEEeecCCccccCCCCCc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD---ADGHVMLTDFGLAKQFDENTRS  306 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~---~~g~vkL~DFGla~~~~~~~~~  306 (479)
                      |||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+.   .+|.+||+|||+|+........
T Consensus        87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~  166 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL  166 (307)
T ss_dssp             CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence            9999999999999999999999999999999999999999999999999999994   5789999999999987777677


Q ss_pred             ccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHHHHHh
Q 011698          307 NSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLKG  382 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~lI~~  382 (479)
                      .+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...|......++    ..+|+++++||++
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  246 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH  246 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence            788999999999999999999999999999999999999999999999999999998866544    5789999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      ||++||++||     |++|+++||||++.
T Consensus       247 ~L~~dP~~R~-----s~~eil~hp~~~~~  270 (307)
T d1a06a_         247 LMEKDPEKRF-----TCEQALQHPWIAGD  270 (307)
T ss_dssp             HSCSSGGGSC-----CHHHHHHSTTTTSS
T ss_pred             HccCCHhHCc-----CHHHHhcCHhhCCC
Confidence            9999999999     99999999999863

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-61  Score=473.11  Aligned_cols=255  Identities=30%  Similarity=0.491  Sum_probs=222.0

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+...  .+..+.+.+|+.+|++++|||||++++++.+++.+|+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            5789999999999999999999999999999999987542  22345688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC---CC
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN---TR  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~---~~  305 (479)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+...   ..
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999999876433   23


Q ss_pred             cccccCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCC--CCccCCHHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQ-KIQQKIIKDKIK--LPAFLSSEAHSLLK  381 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~--~p~~~s~~~~~lI~  381 (479)
                      ..+.+||+.|||||++.+..+ +.++|||||||++|||+||+.||...+.. .....+......  ....+|+++.+||.
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  241 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence            456789999999999998876 67899999999999999999999775543 333333333222  23578999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      +||++||++||     |++|+++||||+.
T Consensus       242 ~~L~~dP~~R~-----t~~eil~hpwf~~  265 (271)
T d1nvra_         242 KILVENPSARI-----TIPDIKKDRWYNK  265 (271)
T ss_dssp             HHSCSSTTTSC-----CHHHHTTCTTTTC
T ss_pred             HHcCCChhHCc-----CHHHHhcCHhhCc
Confidence            99999999999     9999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-60  Score=471.90  Aligned_cols=253  Identities=29%  Similarity=0.493  Sum_probs=230.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      ++|++++.||+|+||+||+|+++.+|+.||||++......   ..+.+.+|+.+|++++|||||+++++|.+.+.+|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            4799999999999999999999999999999999875432   2456889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCccc
Q 011698          230 DFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNS  308 (479)
Q Consensus       230 E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~~  308 (479)
                      |||+||+|..++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+... .....
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            99999999987765 56999999999999999999999999999999999999999999999999999987543 44567


Q ss_pred             ccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---cCCCCccCCHHHHHHHHhhhh
Q 011698          309 MCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---KIKLPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       309 ~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~lI~~~L~  385 (479)
                      .+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+.......+...   .+..|..+++++++||.+||+
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  255 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence            78999999999999999999999999999999999999999998887777777655   345567899999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccCC
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +||++||     |++|+++||||+..
T Consensus       256 ~dP~~R~-----s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         256 MDVEKRG-----SAKELLQHQFLKIA  276 (293)
T ss_dssp             SSTTTSC-----CHHHHTTCGGGGGC
T ss_pred             CChhHCc-----CHHHHhcCHhhCCC
Confidence            9999999     99999999999753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.7e-60  Score=478.75  Aligned_cols=259  Identities=27%  Similarity=0.507  Sum_probs=239.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+...   ...+.+.+|+.+|++++|||||+++++|++++.+|+|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            5799999999999999999999999999999999976542   3456788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHH-HcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC--CCcEEEeecCCccccCCCCC
Q 011698          229 LDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA--DGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~--~g~vkL~DFGla~~~~~~~~  305 (479)
                      ||||+||+|.+++. ..+.+++..++.++.||+.||.|||++|||||||||+|||++.  +|.+||+|||+|+.+.....
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            99999999999985 4467999999999999999999999999999999999999954  68999999999998877777


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK  381 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~lI~  381 (479)
                      ..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..++...|......++    ..+|+++++||+
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  261 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR  261 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHH
T ss_pred             cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            7788999999999999999999999999999999999999999999999999999998876655    458999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccCCChhh
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKK  415 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~  415 (479)
                      +||++||++||     |++|+++||||+..+|..
T Consensus       262 ~~L~~dP~~R~-----t~~eil~hp~~~~~~~~~  290 (350)
T d1koaa2         262 KLLLADPNTRM-----TIHQALEHPWLTPGNAPG  290 (350)
T ss_dssp             HHCCSSGGGSC-----CHHHHHHSTTTSCTTCCS
T ss_pred             HHccCChhHCc-----CHHHHhcCcccCCCCCCC
Confidence            99999999999     999999999999987754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-60  Score=462.26  Aligned_cols=254  Identities=29%  Similarity=0.517  Sum_probs=219.9

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee--CCeEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT--KYRLY  226 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~~~  226 (479)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+.... +...+.+.+|+++|++++|||||++++++.+  ...+|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            47899999999999999999999999999999999876543 3446778899999999999999999999864  45689


Q ss_pred             EEEEeccCCcHHHHHHH----cCCCcHHHHHHHHHHHHHHHHHHHhCC-----CccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          227 LVLDFVNGGHLFFQLYR----QGLFREDLARIYTAEIVSAVSHLHANG-----IMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~-----IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                      +|||||+||+|.+++.+    .+.+++..++.++.||+.||.|||++|     |+||||||+|||++.+|.+||+|||+|
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            99999999999998864    467999999999999999999999976     999999999999999999999999999


Q ss_pred             cccCCCC-CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCCccCCHH
Q 011698          298 KQFDENT-RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI-KLPAFLSSE  375 (479)
Q Consensus       298 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~  375 (479)
                      +.+.... ...+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++..+|..+.. .+|..+|++
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  241 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE  241 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence            9875443 34568999999999999999999999999999999999999999999999999999988765 577889999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      +++||++||+.||++||     |++|+++|||+
T Consensus       242 l~~li~~~L~~dp~~Rp-----s~~ell~hp~i  269 (269)
T d2java1         242 LNEIITRMLNLKDYHRP-----SVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHTCSSGGGSC-----CHHHHHTSTTC
T ss_pred             HHHHHHHHcCCChhHCc-----CHHHHHhCCcC
Confidence            99999999999999999     99999999995

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-61  Score=479.33  Aligned_cols=262  Identities=26%  Similarity=0.459  Sum_probs=226.0

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEE
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLY  226 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~  226 (479)
                      +..++|++++.||+|+||+||+|+++.+|+.||+|++++..  .....+.+.+|+.+|++++|||||+++++|.++.++|
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            34578999999999999999999999999999999998653  2344567889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC
Q 011698          227 LVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHAN-GIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       227 lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~  305 (479)
                      +|||||+||+|..++.+.+.+++..++.++.||+.||.|||++ ||+||||||+|||++.+|++||+|||+|+.+.. ..
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-~~  159 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SM  159 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-HT
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC-Cc
Confidence            9999999999999999999999999999999999999999974 999999999999999999999999999987643 23


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHH---------------------------
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ---------------------------  358 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~---------------------------  358 (479)
                      ..+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.....                           
T Consensus       160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            45679999999999999999999999999999999999999999875433211                           


Q ss_pred             ---------------HHHHhc-cCCCC-ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhh
Q 011698          359 ---------------QKIIKD-KIKLP-AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKL  416 (479)
Q Consensus       359 ---------------~~i~~~-~~~~p-~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l  416 (479)
                                     ..+... ...+| ..+|.++.+||.+||+.||++||     |++|+++||||+..+|+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----ta~e~L~Hpf~~~~~~~~~  309 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA-----DLKQLMVHAFIKRSDAEEV  309 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSHHHHHHHHSCC
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCc-----CHHHHhhCHhhCcCCcccc
Confidence                           111111 11122 23689999999999999999999     9999999999998877544

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-60  Score=466.20  Aligned_cols=254  Identities=32%  Similarity=0.509  Sum_probs=228.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVL  229 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~  229 (479)
                      +.|++++.||+|+||+||+|+++.+++.||+|++.+...   ...+.+.+|+++|++++|||||++++++.+.+.+|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            469999999999999999999999999999999976432   23456788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcc
Q 011698          230 DFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (479)
Q Consensus       230 E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~  307 (479)
                      |||+||+|..++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... ....
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~  168 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  168 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence            99999999998765 467999999999999999999999999999999999999999999999999999865332 2345


Q ss_pred             cccCCCCCcchhHhc-----CCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---CCCCccCCHHHHHH
Q 011698          308 SMCGTLEYMSPEIVL-----GKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---IKLPAFLSSEAHSL  379 (479)
Q Consensus       308 ~~~gt~~y~APE~l~-----~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~l  379 (479)
                      +.+||+.|||||++.     +..|+.++|||||||++|||+||+.||.+.+..++..++..+.   +..|..+|+++++|
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l  248 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF  248 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence            678999999999994     4568999999999999999999999999999888888888874   34467899999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      |++||++||++||     |++|+++||||+.-
T Consensus       249 i~~~L~~dp~~R~-----t~~ell~hp~~~~~  275 (288)
T d2jfla1         249 LKKCLEKNVDARW-----TTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHSCSSTTTSC-----CHHHHTTSGGGCCC
T ss_pred             HHHHccCChhHCc-----CHHHHhcCcccCCC
Confidence            9999999999999     99999999999753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-59  Score=465.65  Aligned_cols=252  Identities=27%  Similarity=0.395  Sum_probs=231.3

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      .|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            49999999999999999999999999999999988766666667788999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCCccccc
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTRSNSMC  310 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~  310 (479)
                      ||.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....   ....+
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~~  172 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSFV  172 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCccc
Confidence            999999988888888999999999999999999999999999999999999999999999999999987543   34678


Q ss_pred             CCCCCcchhHhcC---CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--CCccCCHHHHHHHHhhhh
Q 011698          311 GTLEYMSPEIVLG---KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--LPAFLSSEAHSLLKGLLQ  385 (479)
Q Consensus       311 gt~~y~APE~l~~---~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~lI~~~L~  385 (479)
                      ||+.|||||++.+   ..|+.++|||||||++|||++|..||.+.+..+...++..+...  .+..+|+++++||.+||+
T Consensus       173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~  252 (309)
T d1u5ra_         173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ  252 (309)
T ss_dssp             SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTC
T ss_pred             cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCc
Confidence            9999999999975   45899999999999999999999999998888888888876543  345689999999999999


Q ss_pred             hchhhhcCCCCCCHHHHHhCccccC
Q 011698          386 KEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       386 ~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      +||++||     |++|+++||||..
T Consensus       253 ~dP~~Rp-----t~~ell~Hp~~~~  272 (309)
T d1u5ra_         253 KIPQDRP-----TSEVLLKHRFVLR  272 (309)
T ss_dssp             SSGGGSC-----CHHHHTTCHHHHS
T ss_pred             CChhHCc-----CHHHHHhCHHhcC
Confidence            9999999     9999999999975

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3e-59  Score=473.82  Aligned_cols=255  Identities=29%  Similarity=0.523  Sum_probs=236.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++++.||+|+||+||+|+++.+|+.||||++++...   ...+.+.+|+.+|++++|||||+++++|.+++.+|+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4789999999999999999999999999999999987542   2345678999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeC--CCCcEEEeecCCccccCCCCC
Q 011698          229 LDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLD--ADGHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~--~~g~vkL~DFGla~~~~~~~~  305 (479)
                      ||||+||+|.+.+...+ .+++..++.++.||+.||.|||++||+||||||+||||+  .+|.+||+|||+|+.+.....
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            99999999998876554 699999999999999999999999999999999999998  678999999999999887777


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAHSLLK  381 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~lI~  381 (479)
                      ..+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++...|......+|    ..+|+++++||+
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  264 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK  264 (352)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred             eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            7788999999999999999999999999999999999999999999999999999998877665    468999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                      +||++||.+||     |++|+++||||++.
T Consensus       265 ~~L~~dp~~R~-----s~~eil~Hp~~~~~  289 (352)
T d1koba_         265 NLLQKEPRKRL-----TVHDALEHPWLKGD  289 (352)
T ss_dssp             TTSCSSGGGSC-----CHHHHHTSTTTSSC
T ss_pred             HHccCChhHCc-----CHHHHhcCHhhCCC
Confidence            99999999999     99999999999874

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-59  Score=467.93  Aligned_cols=289  Identities=47%  Similarity=0.861  Sum_probs=253.5

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEE---cCCCeEEEEEEeehhhhch-HHHHHHHHHHHHHHHhCCC-CCeeeEeEEEe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRR---IGTSEIYAMKVMRKDKIME-KNHAEYMKSERNILTKVDH-PFIVQLRYSFQ  220 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~---~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~  220 (479)
                      .+++++|++++.||+|+||+||+|++   +.+|+.||||++++..... ....+.+.+|+.+|++++| |||+++++++.
T Consensus        20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~   99 (322)
T d1vzoa_          20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ   99 (322)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence            36789999999999999999999987   4578999999997654322 2234557789999999976 89999999999


Q ss_pred             eCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc
Q 011698          221 TKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       221 ~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~  300 (479)
                      +...++++|||+.||+|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+
T Consensus       100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999876


Q ss_pred             CCC--CCcccccCCCCCcchhHhcCC--CCCccccchhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhccCCCCccC
Q 011698          301 DEN--TRSNSMCGTLEYMSPEIVLGK--GHDKAADWWSVGILLFEMLTGQPPFTGGNR----QKIQQKIIKDKIKLPAFL  372 (479)
Q Consensus       301 ~~~--~~~~~~~gt~~y~APE~l~~~--~~~~~~DiwSLGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~p~~~  372 (479)
                      ...  ....+.+||+.|+|||.+.+.  .++.++|||||||+||||++|+.||.+.+.    ..+........+.+|..+
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  259 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence            432  334567899999999999865  468899999999999999999999987544    344455556677888999


Q ss_pred             CHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChhhhhcccCCCCCccccCCccc
Q 011698          373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWKKLEARETRPSFLPEVAGKHC  434 (479)
Q Consensus       373 s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~~l~~~~~~p~~~p~~~~~~~  434 (479)
                      ++++.+||++||++||++|+++...+++|+++||||+.++|..+..++++||++|.+.+..+
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~~~~~  321 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD  321 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-CC
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCCCCCC
Confidence            99999999999999999999887778999999999999999999999999999998876543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.8e-58  Score=453.11  Aligned_cols=257  Identities=31%  Similarity=0.531  Sum_probs=236.0

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhch------HHHHHHHHHHHHHHHhCC-CCCeeeEeEEEee
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME------KNHAEYMKSERNILTKVD-HPFIVQLRYSFQT  221 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~------~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~  221 (479)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.....      +...+.+.+|+.+|++++ ||||++++++|.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            479999999999999999999999999999999998754321      233456788999999997 9999999999999


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      ++++|+|||||+||+|.+++..++.++++.++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCCcccccCCCCCcchhHhcC------CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc----c
Q 011698          302 ENTRSNSMCGTLEYMSPEIVLG------KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----F  371 (479)
Q Consensus       302 ~~~~~~~~~gt~~y~APE~l~~------~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~  371 (479)
                      ........+||+.|+|||++.+      ..++.++||||+||++|||++|+.||.+.+.....+.|..+...++.    .
T Consensus       162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (277)
T d1phka_         162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD  241 (277)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred             CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            7766777899999999999964      35688999999999999999999999999999999999988765443    7


Q ss_pred             CCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          372 LSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       372 ~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      +|+++++||++||++||++||     +++||++||||+.
T Consensus       242 ~s~~~~~li~~~L~~~p~~R~-----s~~eil~h~~~~~  275 (277)
T d1phka_         242 YSDTVKDLVSRFLVVQPQKRY-----TAEEALAHPFFQQ  275 (277)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSC-----CHHHHTTSGGGCT
T ss_pred             CCHHHHHHHHHHccCChhHCc-----CHHHHHcCHHHHH
Confidence            899999999999999999999     8999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-58  Score=451.47  Aligned_cols=250  Identities=25%  Similarity=0.441  Sum_probs=221.3

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee----CCeEEE
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT----KYRLYL  227 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~~~l  227 (479)
                      |++.++||+|+||+||+|+++.+++.||+|++...... ....+.+.+|+++|++++|||||+++++|.+    ...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            47778999999999999999999999999999876543 3446678999999999999999999999875    456899


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCccEEeC-CCCcEEEeecCCccccCCCC
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANG--IMHRDLKPENILLD-ADGHVMLTDFGLAKQFDENT  304 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~--IiHrDLKpeNILl~-~~g~vkL~DFGla~~~~~~~  304 (479)
                      ||||++||+|.+++.+.+.+++..++.++.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+|+... ..
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~-~~  168 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-AS  168 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-TT
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-CC
Confidence            9999999999999999999999999999999999999999998  99999999999996 57999999999998643 34


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcc--CCCCccCCHHHHHHHH
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGG-NRQKIQQKIIKDK--IKLPAFLSSEAHSLLK  381 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~-~~~~~~~~i~~~~--~~~p~~~s~~~~~lI~  381 (479)
                      ...+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+. +...+.+.+..+.  ..++..+++++++||.
T Consensus       169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~  247 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE  247 (270)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred             ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHH
Confidence            4567899999999999876 5999999999999999999999999765 4556666666553  2345678999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCcccc
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFK  409 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~  409 (479)
                      +||++||++||     |++|+++||||+
T Consensus       248 ~~l~~dp~~R~-----s~~ell~Hp~fk  270 (270)
T d1t4ha_         248 GCIRQNKDERY-----SIKDLLNHAFFQ  270 (270)
T ss_dssp             HHSCSSGGGSC-----CHHHHHTSGGGC
T ss_pred             HHccCCHhHCc-----CHHHHhCCcccC
Confidence            99999999999     999999999996

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-58  Score=461.35  Aligned_cols=253  Identities=26%  Similarity=0.462  Sum_probs=235.4

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      .++|++++.||+|+||+||+|+++.+++.||||++++...    ....+.+|+.+|+.++|||||+++++|++.+++|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            5789999999999999999999999999999999987542    234578999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC--CcEEEeecCCccccCCCCC
Q 011698          229 LDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD--GHVMLTDFGLAKQFDENTR  305 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~--g~vkL~DFGla~~~~~~~~  305 (479)
                      ||||+||+|.+++.+.+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+  +.+||+|||+++.......
T Consensus        80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            99999999999998765 69999999999999999999999999999999999999854  4899999999998877666


Q ss_pred             cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc----cCCHHHHHHHH
Q 011698          306 SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----FLSSEAHSLLK  381 (479)
Q Consensus       306 ~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~lI~  381 (479)
                      ....+||+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+..++..+|..+.+.++.    .+|+++++||+
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  239 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD  239 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred             ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHH
Confidence            77789999999999999999999999999999999999999999999999999999999888774    68999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                      +||++||++||     |++|+++||||+.
T Consensus       240 ~~L~~dp~~R~-----s~~eil~hp~~~~  263 (321)
T d1tkia_         240 RLLVKERKSRM-----TASEALQHPWLKQ  263 (321)
T ss_dssp             TTSCSSGGGSC-----CHHHHHHSHHHHS
T ss_pred             HHccCChhHCc-----CHHHHhcCHhhcc
Confidence            99999999999     9999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-57  Score=447.04  Aligned_cols=254  Identities=28%  Similarity=0.420  Sum_probs=218.8

Q ss_pred             EEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchH--HHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEE
Q 011698          153 EVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEK--NHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLD  230 (479)
Q Consensus       153 ~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E  230 (479)
                      +.+++||+|+||+||+|+++.+|+.||||+++.......  ...+.+.+|+.+|++++|||||++++++.+++++|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            357899999999999999999999999999976543221  223567899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcccc
Q 011698          231 FVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSNSM  309 (479)
Q Consensus       231 ~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~~~  309 (479)
                      |+.|+++.......+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ....+.
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence            9999988777777778999999999999999999999999999999999999999999999999999876543 344567


Q ss_pred             cCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--------------------C
Q 011698          310 CGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK--------------------L  368 (479)
Q Consensus       310 ~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--------------------~  368 (479)
                      +||+.|||||++.+ ..|+.++|||||||++|||+||..||.+.+..+...+|.+....                    +
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ua2a_         161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF  240 (299)
T ss_dssp             CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred             ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence            89999999999975 46799999999999999999999999999988888877652100                    0


Q ss_pred             --------CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          369 --------PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       369 --------p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                              ...+++++.+||++||+.||++||     |++|+++||||++.
T Consensus       241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~-----sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI-----TATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC-----CHHHHHTSGGGTSS
T ss_pred             CCCChHHhcccCCHHHHHHHHHHccCChhhCc-----CHHHHhCCHhhCCC
Confidence                    124688999999999999999999     99999999999874

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-57  Score=440.48  Aligned_cols=252  Identities=30%  Similarity=0.489  Sum_probs=224.0

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHH---HHHHHHHHHHHHHhCC--CCCeeeEeEEEeeCCe
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKN---HAEYMKSERNILTKVD--HPFIVQLRYSFQTKYR  224 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~~E~~iL~~l~--hp~Iv~l~~~~~~~~~  224 (479)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++++.......   ....+.+|+.+|++++  |||||+++++|++.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999999999999999999876543221   1233568999999986  8999999999999999


Q ss_pred             EEEEEEeccC-CcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC-CCcEEEeecCCccccCC
Q 011698          225 LYLVLDFVNG-GHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-DGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       225 ~~lV~E~~~g-gsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~-~g~vkL~DFGla~~~~~  302 (479)
                      +|+||||+.+ +++..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~  163 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  163 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence            9999999986 588888888899999999999999999999999999999999999999985 47999999999987543


Q ss_pred             CCCcccccCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCccCCHHHHHHHH
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPAFLSSEAHSLLK  381 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~lI~  381 (479)
                       ....+.+||+.|||||++.+..+ +.++|||||||++|||+||+.||.+.      ..+......++..+|+++++||+
T Consensus       164 -~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~~~li~  236 (273)
T d1xwsa_         164 -TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIR  236 (273)
T ss_dssp             -SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHHHHHH
T ss_pred             -ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHHHHHHH
Confidence             34456889999999999987765 67899999999999999999999762      35677888899999999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                      +||++||++||     |++|+++||||+++..
T Consensus       237 ~~L~~dp~~R~-----s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         237 WCLALRPSDRP-----TFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             HHTCSSGGGSC-----CHHHHHTSGGGSSCCC
T ss_pred             HHccCCHhHCc-----CHHHHhcCHhhCCCCC
Confidence            99999999999     9999999999998753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-56  Score=439.10  Aligned_cols=258  Identities=29%  Similarity=0.502  Sum_probs=220.3

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+.+|+++|++++|||||+++++|++..++|+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            4799999999999999999999999999999999976542 223356688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCc
Q 011698          229 LDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRS  306 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~  306 (479)
                      |||+.++.+...... .+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..... ...
T Consensus        80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred             EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence            999987655444333 456999999999999999999999999999999999999999999999999999886443 345


Q ss_pred             ccccCCCCCcchhHhcCCCC-CccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC------------------
Q 011698          307 NSMCGTLEYMSPEIVLGKGH-DKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIK------------------  367 (479)
Q Consensus       307 ~~~~gt~~y~APE~l~~~~~-~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~------------------  367 (479)
                      ...+||+.|+|||++....+ +.++|+|||||++|+|++|+.||.+.+..+...++......                  
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS  239 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence            56789999999999887664 78999999999999999999999998887777766542110                  


Q ss_pred             CC-----------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCC
Q 011698          368 LP-----------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMIN  412 (479)
Q Consensus       368 ~p-----------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~  412 (479)
                      ++           ..+|.++.+||++||++||++||     |++|+++||||++++
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~-----t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI-----SAKAALAHPFFQDVT  290 (298)
T ss_dssp             SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSGGGTTCC
T ss_pred             cccccccchhhhccCCCHHHHHHHHHHccCChhHCc-----CHHHHhCCHhhccCC
Confidence            10           24678999999999999999999     999999999998873

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-57  Score=453.10  Aligned_cols=250  Identities=30%  Similarity=0.523  Sum_probs=218.7

Q ss_pred             CCCCeEEEE-EeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHh-CCCCCeeeEeEEEee----
Q 011698          148 GLEDFEVLK-VVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTK-VDHPFIVQLRYSFQT----  221 (479)
Q Consensus       148 ~~~~y~~~~-~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~~~~----  221 (479)
                      .+++|++++ .||+|+||+||+|+++.+++.||||++++.        ..+++|+.++.+ ++|||||+++++|++    
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~   80 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG   80 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence            367999986 599999999999999999999999999753        235678888655 589999999999976    


Q ss_pred             CCeEEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC---CCcEEEeecCC
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGL  296 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~---~g~vkL~DFGl  296 (479)
                      ...+|+|||||+||+|++++.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+
T Consensus        81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence            46799999999999999999875  36999999999999999999999999999999999999985   56799999999


Q ss_pred             ccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHhccCCCCc--
Q 011698          297 AKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQ----KIIKDKIKLPA--  370 (479)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~----~i~~~~~~~p~--  370 (479)
                      |+...........+||+.|||||++.+..|+.++|||||||++|+|+||+.||.+.+......    .+..+...+|.  
T Consensus       161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~  240 (335)
T d2ozaa1         161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE  240 (335)
T ss_dssp             CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred             eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence            998877777778899999999999999999999999999999999999999998766544433    34445555553  


Q ss_pred             --cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          371 --FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       371 --~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                        .+|+++++||++||++||++||     |++|+++||||..
T Consensus       241 ~~~~s~~~~~li~~~L~~dP~~R~-----s~~eil~hp~~~~  277 (335)
T d2ozaa1         241 WSEVSEEVKMLIRNLLKTEPTQRM-----TITEFMNHPWIMQ  277 (335)
T ss_dssp             HHHSCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSHHHHT
T ss_pred             cccCCHHHHHHHHHHccCChhHCc-----CHHHHHcCHHhhC
Confidence              5899999999999999999999     8999999999965

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-56  Score=440.26  Aligned_cols=258  Identities=26%  Similarity=0.417  Sum_probs=221.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCC-CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC---CCCCeeeEeEEEee----
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGT-SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV---DHPFIVQLRYSFQT----  221 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~~~~----  221 (479)
                      ++|++++.||+|+||+||+|++..+ ++.||||+++...... .....+.+|+.+|+.+   +||||++++++|..    
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            6899999999999999999999765 6789999997643222 1122345677776655   89999999999853    


Q ss_pred             -CCeEEEEEEeccCCcHHHHHH-HcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          222 -KYRLYLVLDFVNGGHLFFQLY-RQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       222 -~~~~~lV~E~~~ggsL~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                       ...+|++|||+.++.+..... ....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence             357899999999987754444 345689999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--------------
Q 011698          300 FDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK--------------  365 (479)
Q Consensus       300 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------------  365 (479)
                      ..........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+...+|....              
T Consensus       166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  245 (305)
T d1blxa_         166 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  245 (305)
T ss_dssp             CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred             hcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence            766666778899999999999999999999999999999999999999999999888887776420              


Q ss_pred             -------------CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          366 -------------IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       366 -------------~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                                   ..++..+++++.+||++||++||++||     |++|+++||||+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~-----sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI-----SAYSALSHPYFQDLER  301 (305)
T ss_dssp             CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC-----CHHHHHTSGGGTTCCC
T ss_pred             hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCc-----CHHHHhcChhhcCchh
Confidence                         012346789999999999999999999     9999999999999865

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.8e-55  Score=431.24  Aligned_cols=254  Identities=28%  Similarity=0.466  Sum_probs=220.7

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC----eE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----RL  225 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----~~  225 (479)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+.+|+.++|||||++++++....    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            67999999999999999999999999999999998876656666778999999999999999999999997654    48


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC--
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~--  303 (479)
                      |+||||++||+|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.++.....  
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~  166 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  166 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998765332  


Q ss_pred             --CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----ccCCHHHH
Q 011698          304 --TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP----AFLSSEAH  377 (479)
Q Consensus       304 --~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~  377 (479)
                        ....+.+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..++..++..+....|    ..+|+++.
T Consensus       167 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  246 (277)
T d1o6ya_         167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD  246 (277)
T ss_dssp             ------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHH
T ss_pred             cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHH
Confidence              234567899999999999999999999999999999999999999999999988888888765443    56899999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHhCccc
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKSHKWF  408 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f  408 (479)
                      +||.+||++||.+||.    ++++++ |+|.
T Consensus       247 ~li~~~L~~dp~~R~~----sa~~l~-~~l~  272 (277)
T d1o6ya_         247 AVVLKALAKNPENRYQ----TAAEMR-ADLV  272 (277)
T ss_dssp             HHHHHHTCSSGGGSCS----SHHHHH-HHHH
T ss_pred             HHHHHHccCCHhHCHh----HHHHHH-HHHH
Confidence            9999999999999993    566664 4443

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.3e-55  Score=431.21  Aligned_cols=251  Identities=23%  Similarity=0.342  Sum_probs=222.3

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCe
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYR  224 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  224 (479)
                      +.+..++|++.+.||+|+||+||+|+++.+++.||||+++++..    ..+.+.+|+.+|++++|||||++++++.+.+.
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            34667899999999999999999999999999999999976542    23457899999999999999999999999999


Q ss_pred             EEEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      +|+|||||++|+|..++.+.  ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            99999999999999999764  5689999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC--cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCC-CCCCCCHHHHHHHHHhc-cCCCCccCCHHHHH
Q 011698          303 NTR--SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQP-PFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (479)
Q Consensus       303 ~~~--~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~-Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (479)
                      ...  .....||+.|||||++.+..|+.++|||||||++|||++|.. ||.+.+...+.+.+..+ .+.+|..+++++.+
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  247 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE  247 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHH
Confidence            432  233458899999999999999999999999999999999655 55666777777666655 56788899999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ||.+||+.||++||     |++||++
T Consensus       248 li~~cl~~dP~~Rp-----s~~ei~~  268 (287)
T d1opja_         248 LMRACWQWNPSDRP-----SFAEIHQ  268 (287)
T ss_dssp             HHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHcCCCHhHCc-----CHHHHHH
Confidence            99999999999999     8999965

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-54  Score=429.96  Aligned_cols=252  Identities=22%  Similarity=0.361  Sum_probs=212.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCCe---EEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTSE---IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      +..++|++.++||+|+||+||+|+++.+++   .||||.+....  .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            445789999999999999999999987664   58899886543  3344567889999999999999999999999999


Q ss_pred             eEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      .+|+|||||+||+|..++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+.+..
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999999999988774 5699999999999999999999999999999999999999999999999999987654


Q ss_pred             CCC------cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCH
Q 011698          303 NTR------SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSS  374 (479)
Q Consensus       303 ~~~------~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~  374 (479)
                      ...      .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+..+ ++..|..++.
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  260 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS  260 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchH
Confidence            322      123457899999999999999999999999999999998 89999999999998888876 5677888999


Q ss_pred             HHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          375 EAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       375 ~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ++.+||.+||+.||++||     ++.||+++
T Consensus       261 ~l~~li~~cl~~~P~~RP-----s~~ei~~~  286 (299)
T d1jpaa_         261 ALHQLMLDCWQKDRNHRP-----KFGQIVNT  286 (299)
T ss_dssp             HHHHHHHHHTCSSTTTSC-----CHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCc-----CHHHHHHH
Confidence            999999999999999999     88888763

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.6e-55  Score=428.50  Aligned_cols=255  Identities=26%  Similarity=0.463  Sum_probs=220.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|+++++||+|+||+||+|+++ +|+.||||+++.... .....+.+.+|+.+|++++|||||+++++|.+.+..|++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            479999999999999999999986 789999999977543 333456788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-CCcc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-TRSN  307 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-~~~~  307 (479)
                      ||++.++.+.......+.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++...... ....
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            999999888877777888999999999999999999999999999999999999999999999999999886543 3345


Q ss_pred             cccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---------------------
Q 011698          308 SMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDK---------------------  365 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~---------------------  365 (479)
                      ...|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+...++....                     
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            56799999999999765 46899999999999999999999999988877777765411                     


Q ss_pred             --------CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          366 --------IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       366 --------~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                              ..++..+++++.+||++||++||++||     |++|+++||||+.
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~-----s~~ell~Hp~f~~  286 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI-----TAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC-----CHHHHHTSGGGGC
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCc-----CHHHHhcCcccCc
Confidence                    012345789999999999999999999     9999999999974

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=421.59  Aligned_cols=248  Identities=21%  Similarity=0.371  Sum_probs=212.5

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|++++.||+|+||+||+|+++ +++.||||++++....    .+.+.+|+.++++++|||||++++++.+++.+|+
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l   77 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   77 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence            4578999999999999999999987 4678999999865432    2457889999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC--
Q 011698          228 VLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT--  304 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~--  304 (479)
                      ||||+++|+|.+++... ..++++.+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++......  
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            99999999999988765 568899999999999999999999999999999999999999999999999998765433  


Q ss_pred             CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHh
Q 011698          305 RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKG  382 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~  382 (479)
                      ......||+.|||||++.+..|+.++|||||||++|||+| |.+||...+..++.+.+..+ +...|..+++++.+||..
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  237 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH  237 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence            2334678999999999999999999999999999999999 68888888888888888876 566788899999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhC
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ||+.||++||     +++||++|
T Consensus       238 cl~~~p~~Rp-----s~~~il~~  255 (263)
T d1sm2a_         238 CWKERPEDRP-----AFSRLLRQ  255 (263)
T ss_dssp             HTCSSGGGSC-----CHHHHHHH
T ss_pred             HccCCHhHCc-----CHHHHHHH
Confidence            9999999999     89999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-55  Score=428.75  Aligned_cols=251  Identities=20%  Similarity=0.352  Sum_probs=217.9

Q ss_pred             EEeccCCceEEEEEEEc--CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEEEEecc
Q 011698          156 KVVGQGAFAKVYQVRRI--GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLVLDFVN  233 (479)
Q Consensus       156 ~~LG~G~fG~V~~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~  233 (479)
                      ++||+|+||+||+|.++  .+++.||||+++.... +....+.+.+|+.+|++++|||||+++++++++ ..|+|||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            57999999999999875  4567899999976542 344556789999999999999999999999654 5789999999


Q ss_pred             CCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC----cccc
Q 011698          234 GGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR----SNSM  309 (479)
Q Consensus       234 ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~----~~~~  309 (479)
                      ||+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+.....    ....
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999987654322    2345


Q ss_pred             cCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHhhhhhc
Q 011698          310 CGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKGLLQKE  387 (479)
Q Consensus       310 ~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~d  387 (479)
                      .||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...+..+ ++.+|..++.++.+||.+||+.|
T Consensus       171 ~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~d  250 (277)
T d1xbba_         171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD  250 (277)
T ss_dssp             CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCC
Confidence            78999999999999999999999999999999998 99999999988888888875 57788999999999999999999


Q ss_pred             hhhhcCCCCCCHHHH---HhCccccCCCh
Q 011698          388 ASKRLGSGPGGSQEI---KSHKWFKMINW  413 (479)
Q Consensus       388 P~~R~~~~~~t~~ei---l~hp~f~~~~~  413 (479)
                      |++||     ++++|   |+|+|++.+|+
T Consensus       251 p~~RP-----s~~~i~~~L~~~~~~~~~e  274 (277)
T d1xbba_         251 VENRP-----GFAAVELRLRNYYYDVVNE  274 (277)
T ss_dssp             TTTSC-----CHHHHHHHHHHHHHHHHHH
T ss_pred             HhHCc-----CHHHHHHHhhCHHhhcCCC
Confidence            99999     78877   57777765543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-55  Score=436.50  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=219.1

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCe-----EEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSE-----IYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSF  219 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~  219 (479)
                      .+..++|++.++||+|+||+||+|++..+++     .||+|++....  .......+.+|+.+|+++ +|||||++++++
T Consensus        33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~  110 (325)
T d1rjba_          33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC  110 (325)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence            3556899999999999999999999976654     69999987543  233345678899999998 899999999999


Q ss_pred             eeCCeEEEEEEeccCCcHHHHHHHc-----------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 011698          220 QTKYRLYLVLDFVNGGHLFFQLYRQ-----------------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDL  276 (479)
Q Consensus       220 ~~~~~~~lV~E~~~ggsL~~~l~~~-----------------------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDL  276 (479)
                      .+.+.+|+|||||+||+|.+++...                       +.+++..++.++.||+.||.|||+++||||||
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl  190 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  190 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            9999999999999999999999754                       24889999999999999999999999999999


Q ss_pred             CCccEEeCCCCcEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCC
Q 011698          277 KPENILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGG  352 (479)
Q Consensus       277 KpeNILl~~~g~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~  352 (479)
                      ||+|||++.++++||+|||+|+.......   ..+.+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987644332   245678999999999999999999999999999999998 99999987


Q ss_pred             CHHHHHHHHHhc--cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          353 NRQKIQQKIIKD--KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       353 ~~~~~~~~i~~~--~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      +......++...  ++..|..+++++++||.+||+.||++||     |++||++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP-----t~~ei~~~  320 (325)
T d1rjba_         271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP-----SFPNLTSF  320 (325)
T ss_dssp             CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence            776666666655  4567788999999999999999999999     99999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=425.42  Aligned_cols=255  Identities=22%  Similarity=0.331  Sum_probs=222.7

Q ss_pred             cCCCCeEEEEE-eccCCceEEEEEEEcC--CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          147 VGLEDFEVLKV-VGQGAFAKVYQVRRIG--TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       147 ~~~~~y~~~~~-LG~G~fG~V~~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      +..++|.+.+. ||+|+||+||+|.++.  ++..||||++++..  .....+.+.+|+++|++++|||||++++++++ +
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~   81 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E   81 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence            34467899885 9999999999998764  45589999997643  34456778899999999999999999999875 4


Q ss_pred             eEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      .+|+|||||+||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            689999999999999987654 5799999999999999999999999999999999999999999999999999998654


Q ss_pred             CC----CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHH
Q 011698          303 NT----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEA  376 (479)
Q Consensus       303 ~~----~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~  376 (479)
                      ..    .....+||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...|..+ ++.+|..+++++
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l  241 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL  241 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence            32    2335678999999999999999999999999999999998 99999998888888888876 567889999999


Q ss_pred             HHHHHhhhhhchhhhcCCCCCCHHHH---HhCcccc
Q 011698          377 HSLLKGLLQKEASKRLGSGPGGSQEI---KSHKWFK  409 (479)
Q Consensus       377 ~~lI~~~L~~dP~~R~~~~~~t~~ei---l~hp~f~  409 (479)
                      .+||..||+.||++||     ++.+|   ++|+|+.
T Consensus       242 ~~li~~cl~~~p~~RP-----s~~~i~~~L~~~~~~  272 (285)
T d1u59a_         242 YALMSDCWIYKWEDRP-----DFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHTTCSSGGGSC-----CHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCc-----CHHHHHHHHHHHHHH
Confidence            9999999999999999     66666   6777764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=422.44  Aligned_cols=254  Identities=21%  Similarity=0.356  Sum_probs=222.5

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+..++|++++.||+|+||+||+|+++ +++.||||+++.....    .+.+.+|+.+|++++|||||++++++.+ +.+
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~   82 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI   82 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCe
Confidence            455689999999999999999999986 5678999999765432    3457899999999999999999998754 567


Q ss_pred             EEEEEeccCCcHHHHHHHc--CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQ--GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      |+||||+++|+|.+++...  ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence            9999999999998876443  35899999999999999999999999999999999999999999999999999987544


Q ss_pred             C--CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHH
Q 011698          304 T--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSL  379 (479)
Q Consensus       304 ~--~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l  379 (479)
                      .  ......||+.|||||++.+..++.++|||||||++|||+| |.+||...+..++.+.+..+ ++..|..++.++.+|
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  242 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL  242 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHH
Confidence            3  2345678999999999999999999999999999999999 56677778888888888776 566788999999999


Q ss_pred             HHhhhhhchhhhcCCCCCCHHHHHh--CccccC
Q 011698          380 LKGLLQKEASKRLGSGPGGSQEIKS--HKWFKM  410 (479)
Q Consensus       380 I~~~L~~dP~~R~~~~~~t~~eil~--hp~f~~  410 (479)
                      |.+||+.||++||     |+++|++  |+||..
T Consensus       243 i~~cl~~~P~~Rp-----t~~ei~~~L~~~fts  270 (272)
T d1qpca_         243 MRLCWKERPEDRP-----TFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHTCSSGGGSC-----CHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCc-----CHHHHHHHhhhhhhc
Confidence            9999999999999     8999988  778753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-54  Score=418.49  Aligned_cols=248  Identities=19%  Similarity=0.358  Sum_probs=224.5

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ..++|+++++||+|+||+||+|+++ +++.||||++++....    .+.+.+|+.++++++||||+++++++.+++.+++
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i   76 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence            3478999999999999999999985 6788999999876543    2457899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC-
Q 011698          228 VLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR-  305 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~-  305 (479)
                      ||||+++|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+..... 
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            9999999999888654 46789999999999999999999999999999999999999999999999999987654332 


Q ss_pred             -cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHHHh
Q 011698          306 -SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLLKG  382 (479)
Q Consensus       306 -~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~~  382 (479)
                       .....||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++..++..+ ++..|...++++.+||++
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  236 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS  236 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence             334678999999999999999999999999999999998 89999999999999999886 567788899999999999


Q ss_pred             hhhhchhhhcCCCCCCHHHHHhC
Q 011698          383 LLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       383 ~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ||+.||++||     |+++|++|
T Consensus       237 cl~~dP~~RP-----t~~eil~~  254 (258)
T d1k2pa_         237 CWHEKADERP-----TFKILLSN  254 (258)
T ss_dssp             TTCSSGGGSC-----CHHHHHHH
T ss_pred             HccCCHhHCc-----CHHHHHHH
Confidence            9999999999     89999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=424.12  Aligned_cols=250  Identities=24%  Similarity=0.328  Sum_probs=209.2

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRL  225 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~  225 (479)
                      .+..++|++.+.||+|+||+||+|++++   .||||+++.... .....+.+++|+.+|++++|||||++++++. .+.+
T Consensus         4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~   78 (276)
T d1uwha_           4 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL   78 (276)
T ss_dssp             BCCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             ccccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEE
Confidence            3556789999999999999999998643   499999976543 3345677899999999999999999998764 5678


Q ss_pred             EEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC-
Q 011698          226 YLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN-  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~-  303 (479)
                      ++|||||+||+|.+++... +.+++..+..++.||+.||+|||++|||||||||+|||++.++++||+|||+|+..... 
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999999999765 56999999999999999999999999999999999999999999999999999876432 


Q ss_pred             --CCcccccCCCCCcchhHhcCC---CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHH-HHHHhccC-----CCCccC
Q 011698          304 --TRSNSMCGTLEYMSPEIVLGK---GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQ-QKIIKDKI-----KLPAFL  372 (479)
Q Consensus       304 --~~~~~~~gt~~y~APE~l~~~---~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~-~~i~~~~~-----~~p~~~  372 (479)
                        ....+.+||+.|||||++.+.   .|+.++|||||||++|||+||+.||.+.+..... ..+..+..     .++..+
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  238 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC  238 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence              234567899999999999753   4899999999999999999999999886655444 44444322     245678


Q ss_pred             CHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          373 SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       373 s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ++++.+||.+||+.||++||     |++||+++
T Consensus       239 ~~~l~~li~~cl~~dp~~RP-----t~~~il~~  266 (276)
T d1uwha_         239 PKAMKRLMAECLKKKRDERP-----LFPQILAS  266 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCc-----CHHHHHHH
Confidence            99999999999999999999     89999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=426.47  Aligned_cols=256  Identities=27%  Similarity=0.388  Sum_probs=217.8

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee-------
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-------  221 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-------  221 (479)
                      +++|+++++||+|+||+||+|+++.+|+.||||++.++.. .......+.+|+.+|++++||||+++++++..       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            5799999999999999999999999999999999977543 23344567889999999999999999998855       


Q ss_pred             -CCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCcccc
Q 011698          222 -KYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQF  300 (479)
Q Consensus       222 -~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~  300 (479)
                       +.++|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence             4568999999998877766666778999999999999999999999999999999999999999999999999999875


Q ss_pred             CCC-----CCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCc----
Q 011698          301 DEN-----TRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLPA----  370 (479)
Q Consensus       301 ~~~-----~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----  370 (479)
                      ...     ....+.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+.......+......++.    
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            432     233456899999999999875 6899999999999999999999999998888777776653222211    


Q ss_pred             ----------------------------cCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccC
Q 011698          371 ----------------------------FLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKM  410 (479)
Q Consensus       371 ----------------------------~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~  410 (479)
                                                  ..++++.+||.+||+.||++|+     |++|+++||||+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~-----sa~elL~Hpff~~  310 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI-----DSDDALNHDFFWS  310 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGSS
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCc-----CHHHHHcChhhcc
Confidence                                        1377889999999999999999     9999999999975

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.3e-53  Score=427.72  Aligned_cols=252  Identities=27%  Similarity=0.438  Sum_probs=215.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEee--CCeE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQT--KYRL  225 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~--~~~~  225 (479)
                      .++|+++++||+|+||+||+|+++.+|+.||||++++..      .+.+.+|+.+|++++ ||||++++++|..  ...+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            468999999999999999999999999999999997643      345788999999995 9999999999974  4569


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC-cEEEeecCCccccCCCC
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQFDENT  304 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g-~vkL~DFGla~~~~~~~  304 (479)
                      ++|||||.+++|...   .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       108 ~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         108 ALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999999998654   35699999999999999999999999999999999999998655 69999999999887777


Q ss_pred             CcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHh-------------ccC---
Q 011698          305 RSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNR-QKIQQKIIK-------------DKI---  366 (479)
Q Consensus       305 ~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~-~~~~~~i~~-------------~~~---  366 (479)
                      .....+||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ......+..             ...   
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            77788999999999998875 479999999999999999999999976432 222222211             000   


Q ss_pred             ---------------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          367 ---------------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       367 ---------------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                                           .....+++++.+||++||++||++|+     |++|+|+||||+.+.|+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~-----ta~e~L~Hp~F~~v~~~  328 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL-----TAREAMEHPYFYTVVKD  328 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTSCCC
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCc-----CHHHHhcCcccCCCCCC
Confidence                                 01134789999999999999999999     99999999999999985

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=430.20  Aligned_cols=249  Identities=33%  Similarity=0.503  Sum_probs=215.7

Q ss_pred             CeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee------CCe
Q 011698          151 DFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------KYR  224 (479)
Q Consensus       151 ~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------~~~  224 (479)
                      +|+.+++||+|+||+||+|+++.+|+.||||++.++..       ...+|+.+|++++||||++++++|..      ..+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            69999999999999999999999999999999987542       13469999999999999999999853      346


Q ss_pred             EEEEEEeccCCcHHHHH---HHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCC-cEEEeecCCcccc
Q 011698          225 LYLVLDFVNGGHLFFQL---YRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADG-HVMLTDFGLAKQF  300 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l---~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g-~vkL~DFGla~~~  300 (479)
                      +|+|||||+++.+....   .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            89999999877443332   3456799999999999999999999999999999999999999876 8999999999988


Q ss_pred             CCCCCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------
Q 011698          301 DENTRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKD---------------  364 (479)
Q Consensus       301 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~---------------  364 (479)
                      .......+.+||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||.+.+..+...+|...               
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred             cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence            77777778899999999999876 46899999999999999999999999998887777666531               


Q ss_pred             --cCCC------------CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          365 --KIKL------------PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       365 --~~~~------------p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                        ...+            ...+++++.+||++||+.||++||     |++|+++||||+.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~-----ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL-----TPLEACAHSFFDEL  309 (350)
T ss_dssp             --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGGGG
T ss_pred             hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCc-----CHHHHhcCHhhccc
Confidence              1111            234789999999999999999999     99999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-53  Score=416.29  Aligned_cols=258  Identities=24%  Similarity=0.372  Sum_probs=219.3

Q ss_pred             CCCcccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee
Q 011698          142 SENQCVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT  221 (479)
Q Consensus       142 ~~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~  221 (479)
                      ...+.+..++|++.+.||+|+||+||+|+++.+ +.||||+++.....    .+.+.+|+.+|++++|||||++++++.+
T Consensus         9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~   83 (285)
T d1fmka3           9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE   83 (285)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence            344456778999999999999999999999766 56999999765432    3457899999999999999999999855


Q ss_pred             CCeEEEEEEeccCCcHHHHHHH--cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          222 KYRLYLVLDFVNGGHLFFQLYR--QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                       +.+++||||+++|+|...+..  .+.+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.
T Consensus        84 -~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~  162 (285)
T d1fmka3          84 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  162 (285)
T ss_dssp             -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             -CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhh
Confidence             568999999999999888754  35799999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCC--CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHH
Q 011698          300 FDENT--RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (479)
Q Consensus       300 ~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  375 (479)
                      +....  .....+||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++...+..+ ++..|..++++
T Consensus       163 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (285)
T d1fmka3         163 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES  242 (285)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred             ccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHH
Confidence            64332  3345679999999999999999999999999999999999 55666777777888887766 56788899999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHh--CccccC
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKS--HKWFKM  410 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~--hp~f~~  410 (479)
                      +++||.+||+.||++||     ++++|++  ++||..
T Consensus       243 l~~li~~cl~~dP~~Rp-----s~~~i~~~L~~~~~~  274 (285)
T d1fmka3         243 LHDLMCQCWRKEPEERP-----TFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHHHHHHHTCSSGGGSC-----CHHHHHHHHHTTTSC
T ss_pred             HHHHHHHHcccCHhHCc-----CHHHHHHHHhhhhcC
Confidence            99999999999999999     9999987  788866

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-53  Score=414.45  Aligned_cols=257  Identities=24%  Similarity=0.464  Sum_probs=226.0

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCCeEEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~~~lV  228 (479)
                      +++|+++++||+|+||+||+|+++.+++.||||+++.... .......+.+|+.+|+.++||||+++++++.+...+++|
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            4789999999999999999999999999999999987643 445567789999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCC-Ccc
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENT-RSN  307 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~-~~~  307 (479)
                      +|++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++...... ...
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            9999999999988888999999999999999999999999999999999999999999999999999999875443 334


Q ss_pred             cccCCCCCcchhHhcCCC-CCccccchhhHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcc--------------------
Q 011698          308 SMCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPF-TGGNRQKIQQKIIKDK--------------------  365 (479)
Q Consensus       308 ~~~gt~~y~APE~l~~~~-~~~~~DiwSLGvilyelltG~~Pf-~~~~~~~~~~~i~~~~--------------------  365 (479)
                      ...+++.|+|||++.+.. ++.++|||||||++|||++|+.|| .+.+..+...++....                    
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            556788999999998765 689999999999999999999885 5566666666654311                    


Q ss_pred             ---------CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          366 ---------IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       366 ---------~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                               ...+..+++++.+||++||+.||.+||     |++|+|+||||+.+
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~-----sa~e~L~Hp~f~~~  289 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI-----SAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHTTSGGGSSC
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCc-----CHHHHhcChhhcCC
Confidence                     112245789999999999999999999     99999999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-53  Score=427.76  Aligned_cols=256  Identities=27%  Similarity=0.406  Sum_probs=215.2

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC-----
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY-----  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~-----  223 (479)
                      .++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|++++|||||+++++|...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            4689999999999999999999999999999999986543 4455677889999999999999999999997665     


Q ss_pred             -eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 -RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 -~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                       .+|+||||+ |++|...+ +.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence             579999999 55676655 456799999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcccccCCCCCcchhHhcCC-CCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------------
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGK-GHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI---------------  366 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~-~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------------  366 (479)
                        .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+.....               
T Consensus       174 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (346)
T d1cm8a_         174 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  251 (346)
T ss_dssp             --SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             --ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence              34567899999999999874 568999999999999999999999998877666555443211               


Q ss_pred             ----------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCChh
Q 011698          367 ----------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINWK  414 (479)
Q Consensus       367 ----------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~~  414 (479)
                                      .....+++++.+||++||+.||++||     |++||++||||+.+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~-----ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV-----TAGEALAHPYFESLHDT  310 (346)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC-----CHHHHHHSGGGTTTC--
T ss_pred             hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCc-----CHHHHhcChhhCcCCCc
Confidence                            12245789999999999999999999     99999999999998754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-53  Score=413.92  Aligned_cols=251  Identities=22%  Similarity=0.375  Sum_probs=212.1

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCC---CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      +..++|++.+.||+|+||+||+|++..+   +..||||+++...  .....+.+.+|+.+|++++|||||++++++. ++
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~   80 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   80 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            4457999999999999999999998754   3568899886532  3445677889999999999999999999996 56


Q ss_pred             eEEEEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      .+|+||||+++|+|..++.. .+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            78999999999999988765 45699999999999999999999999999999999999999999999999999987643


Q ss_pred             C--CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHH
Q 011698          303 N--TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHS  378 (479)
Q Consensus       303 ~--~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~  378 (479)
                      .  ......+||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..++..++..+ .+.+|..+++++.+
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  240 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  240 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            3  23445678999999999999999999999999999999998 99999999999999888876 46788999999999


Q ss_pred             HHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          379 LLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       379 lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ||.+||+.||++||     |++||++|
T Consensus       241 li~~cl~~dp~~Rp-----s~~ei~~~  262 (273)
T d1mp8a_         241 LMTKCWAYDPSRRP-----RFTELKAQ  262 (273)
T ss_dssp             HHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHcCCCHhHCc-----CHHHHHHH
Confidence            99999999999999     89999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=411.64  Aligned_cols=251  Identities=22%  Similarity=0.325  Sum_probs=212.8

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCCC----eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGTS----EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      +..++|++.++||+|+||+||+|.++.++    ..||||+++...  .......+.+|+.+|++++|||||++++++.+.
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            45578999999999999999999988665    479999997543  233455688999999999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFD  301 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~  301 (479)
                      ..+++|||||.+|++...+... +.+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+.
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999999998887655 579999999999999999999999999999999999999999999999999998764


Q ss_pred             CCC----CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHH
Q 011698          302 ENT----RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSE  375 (479)
Q Consensus       302 ~~~----~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~  375 (479)
                      ...    ......||+.|||||++.+..++.++|||||||++|||++ |.+||.+.+..++.+.+..+ ++..|..++.+
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  241 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA  241 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHH
Confidence            332    2234578999999999999999999999999999999999 55666677778888777765 56778889999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +.+||..||+.||++||     ++.||++
T Consensus       242 l~~li~~cl~~~p~~RP-----t~~eil~  265 (283)
T d1mqba_         242 IYQLMMQCWQQERARRP-----KFADIVS  265 (283)
T ss_dssp             HHHHHHHHTCSSTTTSC-----CHHHHHH
T ss_pred             HHHHHHHHCcCCHhHCc-----CHHHHHH
Confidence            99999999999999999     8999876

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-53  Score=419.59  Aligned_cols=253  Identities=21%  Similarity=0.350  Sum_probs=222.5

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeE--EEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEeeC
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEI--YAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQTK  222 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~  222 (479)
                      .+..++|++.++||+|+||+||+|+++.+|..  ||||.++...  .....+.+.+|+++|+++ +|||||++++++.++
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            46778999999999999999999999988875  6677765432  333456688999999998 799999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHc----------------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDAD  286 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~  286 (479)
                      +.+|+||||++||+|.+++++.                ..+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence            9999999999999999999754                568999999999999999999999999999999999999999


Q ss_pred             CcEEEeecCCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhC-CCCCCCCCHHHHHHHHHhc-
Q 011698          287 GHVMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTG-QPPFTGGNRQKIQQKIIKD-  364 (479)
Q Consensus       287 g~vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG-~~Pf~~~~~~~~~~~i~~~-  364 (479)
                      +.+||+|||+++...........+||..|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..++.+.+..+ 
T Consensus       164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~  243 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  243 (309)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence            99999999999876655556677899999999999999999999999999999999995 5689999999999988875 


Q ss_pred             cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          365 KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       365 ~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ++.+|..+++++++||.+||+.||++||     +++||++|
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~eil~~  279 (309)
T d1fvra_         244 RLEKPLNCDDEVYDLMRQCWREKPYERP-----SFAQILVS  279 (309)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence            6778889999999999999999999999     99999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=423.98  Aligned_cols=256  Identities=26%  Similarity=0.395  Sum_probs=209.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee------C
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT------K  222 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~------~  222 (479)
                      +++|+++++||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|++++|||||+++++|..      .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            4789999999999999999999999999999999987653 44556678899999999999999999999964      4


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      .++|+|||||.|+.+ ..+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++....
T Consensus        95 ~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          95 QDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             CEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence            689999999987654 444  35689999999999999999999999999999999999999999999999999998877


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC----------------
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI----------------  366 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~----------------  366 (479)
                      .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+......++.....                
T Consensus       172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  251 (355)
T d2b1pa1         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred             ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence            7777788999999999999999999999999999999999999999998887766666543211                


Q ss_pred             ------CC--------------------CccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCCCh
Q 011698          367 ------KL--------------------PAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMINW  413 (479)
Q Consensus       367 ------~~--------------------p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~~~  413 (479)
                            ..                    +...++++.+||++||..||++||     ||+|+|+||||+..-+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~-----ta~elL~Hpw~~~~~~  319 (355)
T d2b1pa1         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI-----SVDDALQHPYINVWYD  319 (355)
T ss_dssp             HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC-----CHHHHHTSTTTGGGCC
T ss_pred             HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCc-----CHHHHhcCcccCCCCC
Confidence                  00                    012467899999999999999999     9999999999997433

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=416.85  Aligned_cols=250  Identities=23%  Similarity=0.374  Sum_probs=214.5

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCe----EEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSE----IYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      .-++|+++++||+|+||+||+|++..+|+    .||+|.++...  .....+.+.+|+.+|++++|||||++++++.++ 
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            34689999999999999999999988876    57778776432  233456688999999999999999999999865 


Q ss_pred             eEEEEEEeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      ..+++|||+.+|+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.+..
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            567888999999998887764 5799999999999999999999999999999999999999999999999999998654


Q ss_pred             CCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHH
Q 011698          303 NTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAH  377 (479)
Q Consensus       303 ~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~  377 (479)
                      ...   .....||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+..++...+..+ ++..|..++.++.
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~  243 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  243 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHH
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHH
Confidence            332   234568999999999999999999999999999999999 89999998888888888776 4678889999999


Q ss_pred             HHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          378 SLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       378 ~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      +||.+||+.||.+||     |+.||++|
T Consensus       244 ~li~~cl~~dP~~RP-----s~~eil~~  266 (317)
T d1xkka_         244 MIMVKCWMIDADSRP-----KFRELIIE  266 (317)
T ss_dssp             HHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHHHhCCCChhhCc-----CHHHHHHH
Confidence            999999999999999     89999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-52  Score=419.10  Aligned_cols=254  Identities=26%  Similarity=0.377  Sum_probs=212.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC----eE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----RL  225 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----~~  225 (479)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++..  .....+.+.+|+.+|++++||||+++++++....    ..
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            47999999999999999999999999999999997643  3344567889999999999999999999997653    23


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC--
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN--  303 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~--  303 (479)
                      +++++++.||+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++.....  
T Consensus        86 ~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            4555667799999998764 6899999999999999999999999999999999999999999999999999875332  


Q ss_pred             --CCcccccCCCCCcchhHhcC-CCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC--------------
Q 011698          304 --TRSNSMCGTLEYMSPEIVLG-KGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKI--------------  366 (479)
Q Consensus       304 --~~~~~~~gt~~y~APE~l~~-~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--------------  366 (479)
                        ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||.+.+..+....+.....              
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence              23456789999999999854 5678999999999999999999999998876655554432100              


Q ss_pred             -----------------CCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          367 -----------------KLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       367 -----------------~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                       .....+++++.+||.+||++||.+||     |++|+++||||+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----ta~e~L~hpf~~~~  301 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI-----EVEQALAHPYLEQY  301 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC-----CHHHHHTSGGGTTT
T ss_pred             hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc-----CHHHHhcCHhhccC
Confidence                             01235788999999999999999999     99999999999865

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-52  Score=411.15  Aligned_cols=250  Identities=20%  Similarity=0.335  Sum_probs=221.1

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK  222 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  222 (479)
                      ..++|++++.||+|+||+||+|++++     +++.||||+++...  .....+.+.+|+.+|++++||||+++++++.+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence            34689999999999999999999864     56889999997643  334566789999999999999999999999999


Q ss_pred             CeEEEEEEeccCCcHHHHHHHcC------------------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q 011698          223 YRLYLVLDFVNGGHLFFQLYRQG------------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKP  278 (479)
Q Consensus       223 ~~~~lV~E~~~ggsL~~~l~~~~------------------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKp  278 (479)
                      ..+++||||+.+|+|.+++....                        .+++..+..++.||+.||+|||+++||||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            99999999999999999987532                        378889999999999999999999999999999


Q ss_pred             ccEEeCCCCcEEEeecCCccccCCC---CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCC-CCCCCCCH
Q 011698          279 ENILLDADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQ-PPFTGGNR  354 (479)
Q Consensus       279 eNILl~~~g~vkL~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~-~Pf~~~~~  354 (479)
                      +|||++.++++||+|||+|+.+...   ....+.+||+.|||||++.+..|+.++|||||||++|||++|. +||.+.+.
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            9999999999999999999875433   2334578999999999999999999999999999999999984 78999999


Q ss_pred             HHHHHHHHhcc-CCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          355 QKIQQKIIKDK-IKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       355 ~~~~~~i~~~~-~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .++...+..+. +..|..+++++.+||..||+.||++||     |+.||++
T Consensus       249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RP-----t~~ev~~  294 (301)
T d1lufa_         249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP-----SFCSIHR  294 (301)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            99999888874 457888999999999999999999999     8999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-52  Score=419.83  Aligned_cols=254  Identities=25%  Similarity=0.358  Sum_probs=217.1

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeC-----C
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTK-----Y  223 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~  223 (479)
                      .++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|++++|||||++++++...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            3689999999999999999999999999999999987543 334456688999999999999999999999643     3


Q ss_pred             eEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDEN  303 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~  303 (479)
                      ..+++|+|+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++....  
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~--  172 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--  172 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred             ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC--
Confidence            44667788889999988854 579999999999999999999999999999999999999999999999999997653  


Q ss_pred             CCcccccCCCCCcchhHhcCCC-CCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-------------
Q 011698          304 TRSNSMCGTLEYMSPEIVLGKG-HDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKIIKDKIKLP-------------  369 (479)
Q Consensus       304 ~~~~~~~gt~~y~APE~l~~~~-~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p-------------  369 (479)
                      ....+.+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......|.......+             
T Consensus       173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  252 (348)
T d2gfsa1         173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  252 (348)
T ss_dssp             GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred             cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence            3345678999999999987764 58999999999999999999999999888877777765322111             


Q ss_pred             ------------------ccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhCccccCC
Q 011698          370 ------------------AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSHKWFKMI  411 (479)
Q Consensus       370 ------------------~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~hp~f~~~  411 (479)
                                        ..+++++.+||++||+.||++|+     |++|+++||||+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~-----ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI-----TAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC-----CHHHHHTSGGGTTT
T ss_pred             hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc-----CHHHHhcCHhhCCC
Confidence                              24789999999999999999999     99999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=408.54  Aligned_cols=252  Identities=23%  Similarity=0.377  Sum_probs=210.7

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcCC---CeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIGT---SEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY  223 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  223 (479)
                      +..++|++++.||+|+||+||+|++..+   ...||||++.+.........+.+.+|+.+|++++|||||++++++.+ .
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            4457899999999999999999987543   34789999988766566667788999999999999999999999976 4


Q ss_pred             eEEEEEEeccCCcHHHHHHH-cCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          224 RLYLVLDFVNGGHLFFQLYR-QGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       224 ~~~lV~E~~~ggsL~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      .+++||||+++|++.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            77899999999999887755 45799999999999999999999999999999999999999999999999999998754


Q ss_pred             CCC----cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc--CCCCccCCHH
Q 011698          303 NTR----SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKDK--IKLPAFLSSE  375 (479)
Q Consensus       303 ~~~----~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~  375 (479)
                      ...    ....+||..|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++..++.+..  +..|..++++
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD  243 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence            432    234567889999999999999999999999999999998 899999999999999998774  4566789999


Q ss_pred             HHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          376 AHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       376 ~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      +.+||.+||+.||++||     |+++|++
T Consensus       244 l~~li~~cl~~dp~~RP-----t~~ei~~  267 (273)
T d1u46a_         244 IYNVMVQCWAHKPEDRP-----TFVALRD  267 (273)
T ss_dssp             HHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            99999999999999999     8999863

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-52  Score=405.35  Aligned_cols=245  Identities=24%  Similarity=0.423  Sum_probs=211.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEe-eCCe
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQ-TKYR  224 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-~~~~  224 (479)
                      .+..++|++++.||+|+||.||+|+++  |+.||||+++++.     ..+.+.+|+.+|++++||||+++++++. +.+.
T Consensus         3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~   75 (262)
T d1byga_           3 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   75 (262)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             ccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCc
Confidence            467889999999999999999999984  6789999997643     2356789999999999999999999884 4567


Q ss_pred             EEEEEEeccCCcHHHHHHHcC--CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCC
Q 011698          225 LYLVLDFVNGGHLFFQLYRQG--LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       225 ~~lV~E~~~ggsL~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~  302 (479)
                      +|+||||+++|+|.+++...+  .+++..++.++.||+.||.|||+++|+||||||+|||++.+|++||+|||+++....
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence            899999999999999996543  489999999999999999999999999999999999999999999999999987643


Q ss_pred             CCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-cCCCCccCCHHHHHHH
Q 011698          303 NTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKIQQKIIKD-KIKLPAFLSSEAHSLL  380 (479)
Q Consensus       303 ~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI  380 (479)
                      .  .....+|+.|+|||++.+..++.++|||||||++|||+| |++||...+..++...|..+ ++.+|..+++++++||
T Consensus       156 ~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li  233 (262)
T d1byga_         156 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM  233 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHH
T ss_pred             C--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence            3  345678999999999999999999999999999999998 89999999988988888775 6778899999999999


Q ss_pred             HhhhhhchhhhcCCCCCCHHHHHh
Q 011698          381 KGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       381 ~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ++||+.||++||     |+.++++
T Consensus       234 ~~cl~~dP~~Rp-----s~~~l~~  252 (262)
T d1byga_         234 KNCWHLDAAMRP-----SFLQLRE  252 (262)
T ss_dssp             HHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHcccCHhHCc-----CHHHHHH
Confidence            999999999999     8999876

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-52  Score=409.77  Aligned_cols=252  Identities=23%  Similarity=0.405  Sum_probs=204.6

Q ss_pred             cCCCCeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEEEe
Q 011698          147 VGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYSFQ  220 (479)
Q Consensus       147 ~~~~~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~  220 (479)
                      +..++|+++++||+|+||+||+|++..     +++.||||+++...  .....+.+.+|..++.++ +|+||+.+++++.
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            445789999999999999999999865     45789999997643  223344566677777766 6899999999876


Q ss_pred             e-CCeEEEEEEeccCCcHHHHHHHc----------------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEe
Q 011698          221 T-KYRLYLVLDFVNGGHLFFQLYRQ----------------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILL  283 (479)
Q Consensus       221 ~-~~~~~lV~E~~~ggsL~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl  283 (479)
                      . ...+++|||||+||+|.+++...                ..+++..++.++.||+.||.|||++|||||||||+||||
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl  167 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  167 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence            5 45789999999999999999754                248899999999999999999999999999999999999


Q ss_pred             CCCCcEEEeecCCccccCCC---CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhC-CCCCCCCCHHHHH-
Q 011698          284 DADGHVMLTDFGLAKQFDEN---TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTG-QPPFTGGNRQKIQ-  358 (479)
Q Consensus       284 ~~~g~vkL~DFGla~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG-~~Pf~~~~~~~~~-  358 (479)
                      +.++++||+|||+|+.....   ......+||+.|||||++.+..++.++|||||||++|||+|| .+||.+.+..... 
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~  247 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  247 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999999875433   234567899999999999999999999999999999999986 6788876654444 


Q ss_pred             HHHHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHhC
Q 011698          359 QKIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       359 ~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      ..+..+ .+..|..+++++.+||.+||+.||++||     |++||++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~eil~~  290 (299)
T d1ywna1         248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP-----TFSELVEH  290 (299)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCc-----CHHHHHHH
Confidence            444443 5677888999999999999999999999     99999986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=406.45  Aligned_cols=252  Identities=21%  Similarity=0.370  Sum_probs=218.9

Q ss_pred             ccCCCCeEEEEEeccCCceEEEEEEEcCCC-------eEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeE
Q 011698          146 CVGLEDFEVLKVVGQGAFAKVYQVRRIGTS-------EIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRY  217 (479)
Q Consensus       146 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~  217 (479)
                      .+..++|++.+.||+|+||.||+|++..++       ..||||+++++.  .......+.+|...+.++ +|||||++++
T Consensus         9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~   86 (299)
T d1fgka_           9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG   86 (299)
T ss_dssp             BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence            456789999999999999999999987654       479999998754  233445677788888887 8999999999


Q ss_pred             EEeeCCeEEEEEEeccCCcHHHHHHHcC----------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccE
Q 011698          218 SFQTKYRLYLVLDFVNGGHLFFQLYRQG----------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENI  281 (479)
Q Consensus       218 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNI  281 (479)
                      ++.++..+++|||||++|+|.+++....                .+++..++.++.||+.||+|||+++||||||||+||
T Consensus        87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni  166 (299)
T d1fgka_          87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  166 (299)
T ss_dssp             EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence            9999999999999999999999997543                489999999999999999999999999999999999


Q ss_pred             EeCCCCcEEEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHHH
Q 011698          282 LLDADGHVMLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQKI  357 (479)
Q Consensus       282 Ll~~~g~vkL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~~  357 (479)
                      |++.+|.+||+|||+++......   .....+||+.|+|||.+.+..|+.++|||||||++|||++ |.+||.+.+...+
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            99999999999999998764432   3455789999999999999999999999999999999998 7999999999988


Q ss_pred             HHHHHhc-cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          358 QQKIIKD-KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       358 ~~~i~~~-~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+.+..+ .+..|..+++++.+||.+||++||++||     |+.||++
T Consensus       247 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rp-----s~~eil~  289 (299)
T d1fgka_         247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-----TFKQLVE  289 (299)
T ss_dssp             HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCc-----CHHHHHH
Confidence            8888765 6678889999999999999999999999     8999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=406.02  Aligned_cols=253  Identities=21%  Similarity=0.292  Sum_probs=224.2

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEcC-----CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEE
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRIG-----TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSF  219 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  219 (479)
                      +.+..++|++.+.||+|+||+||+|.++.     ++..||||++++..  .......+.+|+.++++++|||||++++++
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            45667899999999999999999999863     35789999997643  333456688999999999999999999999


Q ss_pred             eeCCeEEEEEEeccCCcHHHHHHHc----------CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcE
Q 011698          220 QTKYRLYLVLDFVNGGHLFFQLYRQ----------GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHV  289 (479)
Q Consensus       220 ~~~~~~~lV~E~~~ggsL~~~l~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~v  289 (479)
                      ..+..+++||||+.+|+|..++...          ..+++..+..++.||+.||.|||+++|+||||||+|||++.++++
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence            9999999999999999999988643          246888999999999999999999999999999999999999999


Q ss_pred             EEeecCCccccCCCC---CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhC-CCCCCCCCHHHHHHHHHhc-
Q 011698          290 MLTDFGLAKQFDENT---RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTG-QPPFTGGNRQKIQQKIIKD-  364 (479)
Q Consensus       290 kL~DFGla~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG-~~Pf~~~~~~~~~~~i~~~-  364 (479)
                      ||+|||+|+.+....   .....+||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..++...+..+ 
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~  252 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG  252 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence            999999998764332   23445789999999999999999999999999999999997 6899999999999988876 


Q ss_pred             cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          365 KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       365 ~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .+..|..+++.+.+||.+||+.||++||     |+++|++
T Consensus       253 ~~~~p~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  287 (308)
T d1p4oa_         253 LLDKPDNCPDMLFELMRMCWQYNPKMRP-----SFLEIIS  287 (308)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             CCCCcccchHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            4567888999999999999999999999     8999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-50  Score=399.14  Aligned_cols=253  Identities=23%  Similarity=0.345  Sum_probs=220.8

Q ss_pred             cccCCCCeEEEEEeccCCceEEEEEEEc-----CCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhC-CCCCeeeEeEE
Q 011698          145 QCVGLEDFEVLKVVGQGAFAKVYQVRRI-----GTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKV-DHPFIVQLRYS  218 (479)
Q Consensus       145 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~  218 (479)
                      +.+..++|++.++||+|+||.||+|++.     .+++.||||++++..  .......+.+|+.+++++ +|||||+++++
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3456689999999999999999999874     467899999998654  233455688999999998 69999999999


Q ss_pred             EeeCCeEEEEEEeccCCcHHHHHHHcC------------------CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCcc
Q 011698          219 FQTKYRLYLVLDFVNGGHLFFQLYRQG------------------LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPEN  280 (479)
Q Consensus       219 ~~~~~~~~lV~E~~~ggsL~~~l~~~~------------------~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeN  280 (479)
                      +.+...+|+|||||++|+|..++.+..                  .+++..++.++.||+.||+|||+++|+||||||+|
T Consensus        96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N  175 (311)
T d1t46a_          96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (311)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence            999999999999999999999997653                  58999999999999999999999999999999999


Q ss_pred             EEeCCCCcEEEeecCCccccCCCCC---cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHh-CCCCCCCCCHHH
Q 011698          281 ILLDADGHVMLTDFGLAKQFDENTR---SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLT-GQPPFTGGNRQK  356 (479)
Q Consensus       281 ILl~~~g~vkL~DFGla~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyellt-G~~Pf~~~~~~~  356 (479)
                      ||++.++.+||+|||+++.......   ....+||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987654322   245688999999999999999999999999999999999 777787777666


Q ss_pred             HHHHHHhc--cCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          357 IQQKIIKD--KIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       357 ~~~~i~~~--~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      ...++...  ++..|..++.++.+||.+||+.||++||     ++++|++
T Consensus       256 ~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----s~~~il~  300 (311)
T d1t46a_         256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP-----TFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC-----CHHHHHH
T ss_pred             HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCc-----CHHHHHH
Confidence            66555544  4556778999999999999999999999     8999885

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.1e-49  Score=387.72  Aligned_cols=250  Identities=20%  Similarity=0.300  Sum_probs=201.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCC-eeeEeEEEeeCCeEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPF-IVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~~~~~~~~~lV  228 (479)
                      ++|++++.||+|+||+||+|+++.+|+.||||++......     +.+..|+++++.++|++ |+.+.+++.+....++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            4799999999999999999999999999999998764321     23678999999998665 55666777888999999


Q ss_pred             EEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC---CCcEEEeecCCccccCCCC-
Q 011698          229 LDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA---DGHVMLTDFGLAKQFDENT-  304 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~---~g~vkL~DFGla~~~~~~~-  304 (479)
                      |||+.++.+.......+.+++..+..++.||+.||+|||++||+||||||+|||++.   +..+||+|||+|+.+.... 
T Consensus        82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            999966444444455668999999999999999999999999999999999999864   4579999999999864332 


Q ss_pred             -------CcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---hccC-----CCC
Q 011698          305 -------RSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQKIQQKII---KDKI-----KLP  369 (479)
Q Consensus       305 -------~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~~~~~~i~---~~~~-----~~p  369 (479)
                             ...+.+||+.|||||++.+..++.++|||||||++|||+||+.||.+.........+.   ....     ..+
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC  241 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc
Confidence                   2345689999999999999999999999999999999999999998765443333222   1111     134


Q ss_pred             ccCCHHHHHHHHhhhhhchhhhcCCCCCCHH---HHHhCcccc
Q 011698          370 AFLSSEAHSLLKGLLQKEASKRLGSGPGGSQ---EIKSHKWFK  409 (479)
Q Consensus       370 ~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~---eil~hp~f~  409 (479)
                      ..+++++.+||..||+.||++||     +++   ++++|+|.+
T Consensus       242 ~~~p~~~~~li~~cl~~~p~~RP-----~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         242 KGYPSEFATYLNFCRSLRFDDKP-----DYSYLRQLFRNLFHR  279 (299)
T ss_dssp             TTSCHHHHHHHHHHHHSCTTCCC-----CHHHHHHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCChhHCc-----CHHHHHHHHHHHHHH
Confidence            57899999999999999999999     554   567777653

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=387.42  Aligned_cols=245  Identities=20%  Similarity=0.281  Sum_probs=206.8

Q ss_pred             EEEEeccCCceEEEEEEEcCCC---eEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEee-CCeEEEEE
Q 011698          154 VLKVVGQGAFAKVYQVRRIGTS---EIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQT-KYRLYLVL  229 (479)
Q Consensus       154 ~~~~LG~G~fG~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~~~lV~  229 (479)
                      +.++||+|+||+||+|++..++   ..||||++++.  ......+.+.+|+++|++++||||+++++++.+ +..+++||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            3578999999999999986643   36999998753  244556779999999999999999999998765 56899999


Q ss_pred             EeccCCcHHHHHHHc-CCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCCccccCCCCC---
Q 011698          230 DFVNGGHLFFQLYRQ-GLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGLAKQFDENTR---  305 (479)
Q Consensus       230 E~~~ggsL~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGla~~~~~~~~---  305 (479)
                      |||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+++++.+||+|||+++.......   
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999988754 4577888899999999999999999999999999999999999999999999987643322   


Q ss_pred             --cccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhc-cCCCCccCCHHHHHHHH
Q 011698          306 --SNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTG-GNRQKIQQKIIKD-KIKLPAFLSSEAHSLLK  381 (479)
Q Consensus       306 --~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~-~~~~~~~~~i~~~-~~~~p~~~s~~~~~lI~  381 (479)
                        .....||+.|+|||.+.+..++.++|||||||++|||+||..||.. .+..++...+..+ ++..|..+++++.+||.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence              2335689999999999999999999999999999999997777654 4455566666665 56678889999999999


Q ss_pred             hhhhhchhhhcCCCCCCHHHHHhC
Q 011698          382 GLLQKEASKRLGSGPGGSQEIKSH  405 (479)
Q Consensus       382 ~~L~~dP~~R~~~~~~t~~eil~h  405 (479)
                      +||+.||++||     ++.||++|
T Consensus       269 ~cl~~dP~~RP-----s~~ei~~~  287 (311)
T d1r0pa_         269 KCWHPKAEMRP-----SFSELVSR  287 (311)
T ss_dssp             HHTCSSGGGSC-----CHHHHHHH
T ss_pred             HHcCCCHhHCc-----CHHHHHHH
Confidence            99999999999     89999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.2e-47  Score=375.65  Aligned_cols=243  Identities=20%  Similarity=0.308  Sum_probs=205.8

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC-CCeeeEeEEEeeCCeEEEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH-PFIVQLRYSFQTKYRLYLV  228 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~~~lV  228 (479)
                      ++|++++.||+|+||+||+|++..+|+.||||++.....     ...+++|+++++.++| +||+.+++++......|+|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            689999999999999999999999999999999866432     2236778999999975 8999999999999999999


Q ss_pred             EEeccCCcHHHHHHHcC-CCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCC-----CCcEEEeecCCccccCC
Q 011698          229 LDFVNGGHLFFQLYRQG-LFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDA-----DGHVMLTDFGLAKQFDE  302 (479)
Q Consensus       229 ~E~~~ggsL~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~-----~g~vkL~DFGla~~~~~  302 (479)
                      |||+ |++|...+...+ .+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+.+..
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9999 678888887654 6999999999999999999999999999999999999974     67899999999987643


Q ss_pred             C--------CCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCC----
Q 011698          303 N--------TRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGN---RQKIQQKIIKDKIK----  367 (479)
Q Consensus       303 ~--------~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~----  367 (479)
                      .        ....+.+||+.|||||++.+..++.++|||||||++|||+||+.||.+.+   ......++......    
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  238 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence            2        12345789999999999999999999999999999999999999997643   33344444433221    


Q ss_pred             -CCccCCHHHHHHHHhhhhhchhhhcCCCCCCHHHHH
Q 011698          368 -LPAFLSSEAHSLLKGLLQKEASKRLGSGPGGSQEIK  403 (479)
Q Consensus       368 -~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil  403 (479)
                       ++..+++++.+++..|+..+|++||     +.+.+.
T Consensus       239 ~l~~~~p~~l~~ii~~~~~~~~~~rP-----~y~~l~  270 (293)
T d1csna_         239 ELCAGFPEEFYKYMHYARNLAFDATP-----DYDYLQ  270 (293)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCC-----CHHHHH
T ss_pred             HhcCCCCHHHHHHHHHHhcCCcccCc-----CHHHHH
Confidence             2356889999999999999999999     555543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-47  Score=376.77  Aligned_cols=243  Identities=23%  Similarity=0.339  Sum_probs=195.5

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCeeeEeEEEeeCC----eE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFIVQLRYSFQTKY----RL  225 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----~~  225 (479)
                      ++|.+.+.||+|+||+||+|++  +|+.||||+++.+..    .....+.|+..+++++|||||++++++.+.+    .+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            5799999999999999999997  678999999975431    1222334666667889999999999997654    68


Q ss_pred             EEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHh--------CCCccCCCCCccEEeCCCCcEEEeecCCc
Q 011698          226 YLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHA--------NGIMHRDLKPENILLDADGHVMLTDFGLA  297 (479)
Q Consensus       226 ~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~--------~~IiHrDLKpeNILl~~~g~vkL~DFGla  297 (479)
                      |+|||||++|+|..++++. .++++....++.|++.||+|||+        +||+||||||+||||+.+|++||+|||++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            9999999999999999875 58889999999999999999996        59999999999999999999999999999


Q ss_pred             cccCCCC-----CcccccCCCCCcchhHhcCCC------CCccccchhhHHHHHHHHhCCCCCCC---------------
Q 011698          298 KQFDENT-----RSNSMCGTLEYMSPEIVLGKG------HDKAADWWSVGILLFEMLTGQPPFTG---------------  351 (479)
Q Consensus       298 ~~~~~~~-----~~~~~~gt~~y~APE~l~~~~------~~~~~DiwSLGvilyelltG~~Pf~~---------------  351 (479)
                      +......     .....+||+.|||||++.+..      ++.++|||||||+||||+||..||..               
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            8764432     234578999999999998753      56789999999999999999887742               


Q ss_pred             CCHHHHHHHHHhcc--CCCCccC-----CHHHHHHHHhhhhhchhhhcCCCCCCHHHHHh
Q 011698          352 GNRQKIQQKIIKDK--IKLPAFL-----SSEAHSLLKGLLQKEASKRLGSGPGGSQEIKS  404 (479)
Q Consensus       352 ~~~~~~~~~i~~~~--~~~p~~~-----s~~~~~lI~~~L~~dP~~R~~~~~~t~~eil~  404 (479)
                      .....+.+.+..+.  +.+|...     ...+.+||.+||+.||++||     |+.||++
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ei~~  290 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL-----TALRIKK  290 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC-----CHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCc-----CHHHHHH
Confidence            12334444444433  2333332     24589999999999999999     8999876

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-45  Score=373.29  Aligned_cols=252  Identities=27%  Similarity=0.428  Sum_probs=200.6

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-----------CCCeeeEeEE
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----------HPFIVQLRYS  218 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-----------hp~Iv~l~~~  218 (479)
                      .+|+++++||+|+||+||+|+++.+|+.||||+++++..    ..+...+|+++++.++           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            469999999999999999999999999999999987542    2345677888887775           5789999888


Q ss_pred             Eee--CCeEEEEEEeccCCcHHHHHH---HcCCCcHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCccEEeCCCCc----
Q 011698          219 FQT--KYRLYLVLDFVNGGHLFFQLY---RQGLFREDLARIYTAEIVSAVSHLHA-NGIMHRDLKPENILLDADGH----  288 (479)
Q Consensus       219 ~~~--~~~~~lV~E~~~ggsL~~~l~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~~IiHrDLKpeNILl~~~g~----  288 (479)
                      +..  ....+++|+++.++.......   ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.    
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            754  456777777776654333322   33578999999999999999999998 89999999999999987764    


Q ss_pred             --EEEeecCCccccCCCCCcccccCCCCCcchhHhcCCCCCccccchhhHHHHHHHHhCCCCCCCCCHH------HHHHH
Q 011698          289 --VMLTDFGLAKQFDENTRSNSMCGTLEYMSPEIVLGKGHDKAADWWSVGILLFEMLTGQPPFTGGNRQ------KIQQK  360 (479)
Q Consensus       289 --vkL~DFGla~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~DiwSLGvilyelltG~~Pf~~~~~~------~~~~~  360 (479)
                        ++|+|||.+.....  .....+||+.|+|||++.+..|+.++|+|||||++++|++|+.||...+..      .....
T Consensus       169 ~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             ceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence              99999999987543  345678999999999999999999999999999999999999999754321      11111


Q ss_pred             HH------------------------------------------hccCCCCccCCHHHHHHHHhhhhhchhhhcCCCCCC
Q 011698          361 II------------------------------------------KDKIKLPAFLSSEAHSLLKGLLQKEASKRLGSGPGG  398 (479)
Q Consensus       361 i~------------------------------------------~~~~~~p~~~s~~~~~lI~~~L~~dP~~R~~~~~~t  398 (479)
                      +.                                          .....++...++++.+||.+||..||.+||     |
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp-----t  321 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA-----D  321 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB-----C
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc-----C
Confidence            10                                          111222334578899999999999999999     9


Q ss_pred             HHHHHhCccccCCC
Q 011698          399 SQEIKSHKWFKMIN  412 (479)
Q Consensus       399 ~~eil~hp~f~~~~  412 (479)
                      ++|+|+||||++..
T Consensus       322 a~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         322 AGGLVNHPWLKDTL  335 (362)
T ss_dssp             HHHHHTCGGGTTCT
T ss_pred             HHHHhcCcccCCCC
Confidence            99999999999654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=4.6e-26  Score=209.14  Aligned_cols=167  Identities=15%  Similarity=0.160  Sum_probs=123.9

Q ss_pred             eEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhc---------------hHHHHHHHHHHHHHHHhCCCCCeeeEe
Q 011698          152 FEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIM---------------EKNHAEYMKSERNILTKVDHPFIVQLR  216 (479)
Q Consensus       152 y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~---------------~~~~~~~~~~E~~iL~~l~hp~Iv~l~  216 (479)
                      +.+.++||+|+||+||+|++. +|+.||||+++.....               ..........|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            457899999999999999985 6889999987642110               111223455788899999999999887


Q ss_pred             EEEeeCCeEEEEEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHHhCCCccCCCCCccEEeCCCCcEEEeecCC
Q 011698          217 YSFQTKYRLYLVLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLHANGIMHRDLKPENILLDADGHVMLTDFGL  296 (479)
Q Consensus       217 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~IiHrDLKpeNILl~~~g~vkL~DFGl  296 (479)
                      ++..    .+++|||+++..+.       .+++..+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||+
T Consensus        81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            6532    37999999987652       24556677899999999999999999999999999999865 589999999


Q ss_pred             ccccCCCCCcccccCCCCCcch------hHhcCCCCCccccchhhHHHH
Q 011698          297 AKQFDENTRSNSMCGTLEYMSP------EIVLGKGHDKAADWWSVGILL  339 (479)
Q Consensus       297 a~~~~~~~~~~~~~gt~~y~AP------E~l~~~~~~~~~DiwSLGvil  339 (479)
                      |.........       .|...      +.+ .+.|+.++|+||+.--+
T Consensus       149 a~~~~~~~~~-------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         149 SVEVGEEGWR-------EILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CEETTSTTHH-------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             cccCCCCCcH-------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            9775433211       12111      111 35678999999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.41  E-value=7.2e-07  Score=82.89  Aligned_cols=141  Identities=13%  Similarity=0.105  Sum_probs=91.7

Q ss_pred             CCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEeeCCeEEE
Q 011698          149 LEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       149 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~~~l  227 (479)
                      ++.|++++..+.++.+.||+...  .+..+.+|+........   ...+.+|..+++.+. +--+.+++++...++..++
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            35778877766666689998763  45567888876543211   223567888887764 3335677888888899999


Q ss_pred             EEEeccCCcHHHHHHHcCCCcHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 011698          228 VLDFVNGGHLFFQLYRQGLFREDLARIYTAEIVSAVSHLH----------------------------------------  267 (479)
Q Consensus       228 V~E~~~ggsL~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH----------------------------------------  267 (479)
                      ||++++|..+........     ....++.++...+..||                                        
T Consensus        88 v~~~l~G~~~~~~~~~~~-----~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDEQ-----SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHTTTCS-----CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred             EEEecccccccccccccc-----cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence            999999987744321110     01112222222222232                                        


Q ss_pred             -------------hC------CCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          268 -------------AN------GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       268 -------------~~------~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                                   +.      .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                         11      278999999999998776677999999854

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.08  E-value=6.7e-06  Score=81.59  Aligned_cols=81  Identities=12%  Similarity=0.153  Sum_probs=49.8

Q ss_pred             EEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhch----HHHHHHHHHHHHHHHhCC-C--CCeeeEeEEEeeCCeEEE
Q 011698          155 LKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIME----KNHAEYMKSERNILTKVD-H--PFIVQLRYSFQTKYRLYL  227 (479)
Q Consensus       155 ~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~~E~~iL~~l~-h--p~Iv~l~~~~~~~~~~~l  227 (479)
                      .+.||.|....||++....+++.|++|.-.......    ....++...|...|+.+. +  ..+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            567999999999999987778889999754321100    011233556888787662 2  345555543  4455678


Q ss_pred             EEEeccCCcH
Q 011698          228 VLDFVNGGHL  237 (479)
Q Consensus       228 V~E~~~ggsL  237 (479)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.86  E-value=2.6e-05  Score=71.50  Aligned_cols=136  Identities=16%  Similarity=0.121  Sum_probs=82.0

Q ss_pred             EeccCCc-eEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCC--CCeeeEeEEEeeCCeEEEEEEecc
Q 011698          157 VVGQGAF-AKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDH--PFIVQLRYSFQTKYRLYLVLDFVN  233 (479)
Q Consensus       157 ~LG~G~f-G~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~~~~~~~~~lV~E~~~  233 (479)
                      .+..|.. +.||+.... .+..+.+|.......      ..+..|...|+.+..  --+.+++.+..+.+..++||++++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            4455554 689988764 466688898655431      235677777776632  235677888888889999999998


Q ss_pred             CCcHHH--------------HHHHcC-------CCcH--H-HHHH----HH---------------HHHHHHHHHHHhC-
Q 011698          234 GGHLFF--------------QLYRQG-------LFRE--D-LARI----YT---------------AEIVSAVSHLHAN-  269 (479)
Q Consensus       234 ggsL~~--------------~l~~~~-------~l~e--~-~~~~----~~---------------~qi~~aL~~LH~~-  269 (479)
                      |.++..              .+.+-.       .+..  . ....    +.               ......+..+... 
T Consensus        90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  169 (255)
T d1nd4a_          90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM  169 (255)
T ss_dssp             SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred             ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence            865421              111100       0000  0 0000    00               0011123333332 


Q ss_pred             ------CCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          270 ------GIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       270 ------~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                            .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                  379999999999998776678999999854

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.14  E-value=0.00056  Score=65.30  Aligned_cols=69  Identities=16%  Similarity=0.239  Sum_probs=44.0

Q ss_pred             ceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCCCCCe-----eeE--eEEEeeCCeEEEEEEeccCC
Q 011698          163 FAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVDHPFI-----VQL--RYSFQTKYRLYLVLDFVNGG  235 (479)
Q Consensus       163 fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~hp~I-----v~l--~~~~~~~~~~~lV~E~~~gg  235 (479)
                      --.||+++.. +|+.|++|+.+.....    .+.+..|..++..|....|     +..  -..+......+.+++++.|.
T Consensus        35 EN~vy~v~~~-dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQDE-DRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECCT-TCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEcC-CCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            3689999874 6778999998765422    3446678877777642211     111  12234566788999999875


Q ss_pred             c
Q 011698          236 H  236 (479)
Q Consensus       236 s  236 (479)
                      .
T Consensus       110 ~  110 (325)
T d1zyla1         110 Q  110 (325)
T ss_dssp             E
T ss_pred             C
Confidence            3

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.96  E-value=0.0013  Score=64.29  Aligned_cols=78  Identities=13%  Similarity=0.142  Sum_probs=52.2

Q ss_pred             CCeEEEEEeccCCceEEEEEEEcC-------CCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-CCCeeeEeEEEee
Q 011698          150 EDFEVLKVVGQGAFAKVYQVRRIG-------TSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-HPFIVQLRYSFQT  221 (479)
Q Consensus       150 ~~y~~~~~LG~G~fG~V~~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~  221 (479)
                      ++++ ++.|+.|-.-.+|++....       .++.|.+++.....  .   .....+|..+++.+. +.-..++++++..
T Consensus        43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~  116 (395)
T d1nw1a_          43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG  116 (395)
T ss_dssp             GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred             cceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence            4454 4678889999999998754       34567788765321  1   122457888888774 4445677777753


Q ss_pred             CCeEEEEEEeccCCcH
Q 011698          222 KYRLYLVLDFVNGGHL  237 (479)
Q Consensus       222 ~~~~~lV~E~~~ggsL  237 (479)
                          .+|+||++|..|
T Consensus       117 ----g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ----GRLEEYIPSRPL  128 (395)
T ss_dssp             ----EEEECCCCEEEC
T ss_pred             ----ceEEEEeccccC
Confidence                589999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.43  E-value=0.012  Score=54.87  Aligned_cols=145  Identities=14%  Similarity=0.164  Sum_probs=76.9

Q ss_pred             CCCCeEEEEEeccCCceEEEEEEEcCCCeEEEEEEeehhhhchHHHHHHHHHHHHHHHhCC-----CCCeeeEe---EEE
Q 011698          148 GLEDFEVLKVVGQGAFAKVYQVRRIGTSEIYAMKVMRKDKIMEKNHAEYMKSERNILTKVD-----HPFIVQLR---YSF  219 (479)
Q Consensus       148 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~iL~~l~-----hp~Iv~l~---~~~  219 (479)
                      ++....-++.|..|---+.|+++..+ | .|++|+.....  .   .+.+..|..++..|.     .|..+...   ...
T Consensus        16 ~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~   88 (316)
T d2ppqa1          16 DVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG   88 (316)
T ss_dssp             CCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred             CCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--C---HHHHHHHHHHHHhhhhccccccccceecCCCcce
Confidence            34556667788888889999998653 4 49999986532  1   123444566666553     22222210   112


Q ss_pred             eeCCeEEEEEEeccCCcH--------------HHHHHHcC---------CCcHH------------------HHHHHHHH
Q 011698          220 QTKYRLYLVLDFVNGGHL--------------FFQLYRQG---------LFRED------------------LARIYTAE  258 (479)
Q Consensus       220 ~~~~~~~lV~E~~~ggsL--------------~~~l~~~~---------~l~e~------------------~~~~~~~q  258 (479)
                      .-......++.++.|...              ...++...         .....                  .....+..
T Consensus        89 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  168 (316)
T d2ppqa1          89 ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRP  168 (316)
T ss_dssp             EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHH
T ss_pred             eeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHH
Confidence            234456667777766432              00111000         00000                  11111222


Q ss_pred             HHHHHHHHHh----CCCccCCCCCccEEeCCCCcEEEeecCCccc
Q 011698          259 IVSAVSHLHA----NGIMHRDLKPENILLDADGHVMLTDFGLAKQ  299 (479)
Q Consensus       259 i~~aL~~LH~----~~IiHrDLKpeNILl~~~g~vkL~DFGla~~  299 (479)
                      +...+.-.+.    .|+||+|+.+.||+++.++..-|+||+.+..
T Consensus       169 ~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         169 EIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             HHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            2222222222    3799999999999999888778999999953